Citrus Sinensis ID: 005572
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 690 | 2.2.26 [Sep-21-2011] | |||||||
| C0LGK9 | 853 | Probable LRR receptor-lik | no | no | 0.811 | 0.656 | 0.345 | 2e-84 | |
| Q9LVN2 | 785 | Probably inactive leucine | no | no | 0.826 | 0.726 | 0.326 | 1e-69 | |
| Q9LYN8 | 1192 | Leucine-rich repeat recep | no | no | 0.786 | 0.455 | 0.317 | 4e-58 | |
| Q9ZWC8 | 1166 | Serine/threonine-protein | no | no | 0.827 | 0.489 | 0.273 | 8e-53 | |
| O22476 | 1196 | Protein BRASSINOSTEROID I | no | no | 0.871 | 0.502 | 0.274 | 3e-51 | |
| C0LGP9 | 784 | Probable leucine-rich rep | no | no | 0.795 | 0.700 | 0.283 | 5e-51 | |
| Q8L899 | 1207 | Systemin receptor SR160 O | N/A | no | 0.847 | 0.484 | 0.272 | 4e-50 | |
| Q8GUQ5 | 1207 | Brassinosteroid LRR recep | N/A | no | 0.847 | 0.484 | 0.272 | 1e-49 | |
| Q9ZVR7 | 1008 | Phytosulfokine receptor 1 | no | no | 0.773 | 0.529 | 0.269 | 9e-47 | |
| Q8LPB4 | 1021 | Phytosulfokine receptor 1 | N/A | no | 0.810 | 0.547 | 0.272 | 2e-46 |
| >sp|C0LGK9|Y2242_ARATH Probable LRR receptor-like serine/threonine-protein kinase At2g24230 OS=Arabidopsis thaliana GN=At2g24230 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 314 bits (804), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 231/668 (34%), Positives = 346/668 (51%), Gaps = 108/668 (16%)
Query: 81 NMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVL 140
+M + +++S N GSV G F ++L +LSKNRF G I + S + S+ L
Sbjct: 233 DMKSISFLNISGNQFDGSVTGVF--KETLEVADLSKNRFQGHISSQVDSN---WFSLVYL 287
Query: 141 NLSSNRFTNLV-------------------------KLSQFSKLMVLDVSNNDLR-ILPS 174
+LS N + ++ ++ S L L++SN +L +P
Sbjct: 288 DLSENELSGVIKNLTLLKKLKHLNLAWNRFNRGMFPRIEMLSGLEYLNLSNTNLSGHIPR 347
Query: 175 GFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFP-SDFPPLSGVKFLN 233
+ LS L LD+S ++G+I P+ + +L +DVS N++ G P S L ++ N
Sbjct: 348 EISKLSDLSTLDVSGNHLAGHI-PILSIKNLVAIDVSRNNLTGEIPMSILEKLPWMERFN 406
Query: 234 ISLNKFTGFVGHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVH 293
S N T G KF SA SF T P +N
Sbjct: 407 FSFNNLTFCSG-----KF--SAETLNRSFFGSTNSCPIAAN------------------- 440
Query: 294 KHNPAV-QKHRSKAKALVIGLSCA-SAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVN 351
PA+ ++ RS L + L+ S + G I RRK + K
Sbjct: 441 ---PALFKRKRSVTGGLKLALAVTLSTMCLLIGALIFVAFGCRRKTKSGEAK-------- 489
Query: 352 QQLPFKVEKS--GPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHF 409
L K E+S GPFSF+T+S T+W+AD+K+ + V++ KPL+N +TF DL++ATS+F
Sbjct: 490 -DLSVKEEQSISGPFSFQTDS-TTWVADVKQANAVPVVIFEKPLLN-ITFSDLLSATSNF 546
Query: 410 GKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLA 469
+++LLA+G+ GPVYR LPG +HVA+KVL + + +A + L R+KHPNL+PL
Sbjct: 547 DRDTLLADGKFGPVYRGFLPGGIHVAVKVLVHGSTLSDQEAARELEFLGRIKHPNLVPLT 606
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK-- 527
GYCIAG +++ + E+M NG+L LH+LP G +DW+TDTW+ G+ E
Sbjct: 607 GYCIAGDQRIAIYEYMENGNLQNLLHDLPFGVQTTDDWTTDTWEEETDNGTQNIGTEGPV 666
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGS---THGHLVTSSILLAESLEPKIAGFGLRNIGVKN 584
W RH+IA+G AR LA+LHH S H + SS+ L ++ EP+++ FGL +
Sbjct: 667 ATWRFRHKIALGTARALAFLHHGCSPPIIHRDVKASSVYLDQNWEPRLSDFGLAKVFGNG 726
Query: 585 VGE---------------RSENETCGPESDVYCFGVILMELLTGKRGTDD---------C 620
+ + + E+E P+SDVYCFGV+L EL+TGK+ +D
Sbjct: 727 LDDEIIHGSPGYLPPEFLQPEHELPTPKSDVYCFGVVLFELMTGKKPIEDDYLDEKDTNL 786
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680
V WVR LV++ A+D +++ S +M E+L++GYLCTAD P KRP+MQQV+GLL
Sbjct: 787 VSWVRSLVRKNQASKAIDPKIQ--ETGSEEQMEEALKIGYLCTADLPSKRPSMQQVVGLL 844
Query: 681 KDIRPSAD 688
KDI P ++
Sbjct: 845 KDIEPKSN 852
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LVN2|Y5815_ARATH Probably inactive leucine-rich repeat receptor-like protein kinase At5g58150 OS=Arabidopsis thaliana GN=At5g58150 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (677), Expect = 1e-69, Method: Compositional matrix adjust.
Identities = 212/649 (32%), Positives = 328/649 (50%), Gaps = 79/649 (12%)
Query: 63 LNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGT 122
++LSS L+ + F L S++LS N +GS+ G +++ V+LS+NRF G
Sbjct: 190 IDLSSNRLNESLPVGFGSAFPLLKSLNLSRNLFQGSLIGVLH--ENVETVDLSENRFDGH 247
Query: 123 IGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLRI--LPSGFAN 178
I + S+ L+LS N F + LS KL L+++ N R P
Sbjct: 248 ILQLIPGHKHNWSSLIHLDLSDNSFVGHIFNGLSSAHKLGHLNLACNRFRAQEFPE-IGK 306
Query: 179 LSKLRHLDISSCKISGNI-KPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
LS L +L++S ++ I + +S L LK LD+S+N++ G P + ++ L++SLN
Sbjct: 307 LSALHYLNLSRTNLTNIIPREISRLSHLKVLDLSSNNLTGHVP--MLSVKNIEVLDLSLN 364
Query: 238 KFTGFVGHDKYQKFGKSAFIQGGSFVFD--TTKTPRPSNNHIM-PHVDSSRTPPYKIVHK 294
K G + +K A +Q +F F+ T P S I ++ P+
Sbjct: 365 KLDGDIPRPLLEKL---AMMQRFNFSFNNLTFCNPNFSQETIQRSFINIRNNCPFAA--- 418
Query: 295 HNPAVQKHRS---KAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVN 351
P + K + K L IGL A + F+ ++ + R + +R WA +N
Sbjct: 419 -KPIITKGKKVNKKNTGLKIGLGLAISMAFLLIGLLLILVALRVRRKSR--TWATKLAIN 475
Query: 352 QQLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGK 411
E + P ++ + DIK+ T V+M KPL+ +T DL AAT +F +
Sbjct: 476 N-----TEPNSPDQHDSTT------DIKQATQIPVVMIDKPLMK-MTLADLKAATFNFDR 523
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
++L EG+ GP Y AVLPG A+KV+ + + + F+ L+R+ HPNL PL GY
Sbjct: 524 GTMLWEGKSGPTYGAVLPGGFRAALKVIPSGTTLTDTEVSIAFERLARINHPNLFPLCGY 583
Query: 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWV 531
CIA ++++ + E + +L LH N +D S+P W
Sbjct: 584 CIATEQRIAIYEDLDMVNLQSLLHN------NGDD----------------SAP----WR 617
Query: 532 TRHRIAIGVARGLAYLHH---VGSTHGHLVTSSILLAESLEPKIAGFGLRNI------GV 582
RH+IA+G AR LA+LHH HG + ++ILL S EP++A FGL + G
Sbjct: 618 LRHKIALGTARALAFLHHGCIPPMVHGEVKAATILLDSSQEPRLADFGLVKLLDEQFPGS 677
Query: 583 KNVG-----ERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDAL 637
+++ E+ N + ESDVY FGV+L+EL++GK+ D V WVR LV++G G A+
Sbjct: 678 ESLDGYTPPEQERNASPTLESDVYSFGVVLLELVSGKKPEGDLVNWVRGLVRQGQGLRAI 737
Query: 638 DFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686
D ++ + E+ E++++GYLCTAD P KRPTMQQV+GLLKDI P+
Sbjct: 738 DPTMQETVPED--EIAEAVKIGYLCTADLPWKRPTMQQVVGLLKDISPN 784
|
Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9LYN8|EXS_ARATH Leucine-rich repeat receptor protein kinase EXS OS=Arabidopsis thaliana GN=EXS PE=1 SV=1 | Back alignment and function description |
|---|
Score = 226 bits (577), Expect = 4e-58, Method: Compositional matrix adjust.
Identities = 211/664 (31%), Positives = 308/664 (46%), Gaps = 121/664 (18%)
Query: 62 ELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGG 121
E++LS+ +LSG I R ++ L +DLS N+L GS+P ++ L +NL+ N+ G
Sbjct: 608 EISLSNNHLSGEIPASLSR-LTNLTILDLSGNALTGSIPKEMGNSLKLQGLNLANNQLNG 666
Query: 122 TIGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLR-ILPSGFAN 178
I P S G S+ LNL+ N+ V L +L +D+S N+L L S +
Sbjct: 667 HI---PESF-GLLGSLVKLNLTKNKLDGPVPASLGNLKELTHMDLSFNNLSGELSSELST 722
Query: 179 LSKLRHLDISSCKISGNI-KPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
+ KL L I K +G I + L L+YLDVS N ++G P+ L ++FLN++ N
Sbjct: 723 MEKLVGLYIEQNKFTGEIPSELGNLTQLEYLDVSENLLSGEIPTKICGLPNLEFLNLAKN 782
Query: 238 KFTGFVGHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHKHNP 297
G V D + A + G N + V S KI
Sbjct: 783 NLRGEVPSDGVCQDPSKALLSG--------------NKELCGRVVGSDC---KI------ 819
Query: 298 AVQKHRSK--AKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVNQQL- 354
K RS L++G + FVFVF + +WA++K V Q+
Sbjct: 820 EGTKLRSAWGIAGLMLGFTII-VFVFVFSL----------------RRWAMTKRVKQRDD 862
Query: 355 PFKVEKSGPFSFETE-----SGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHF 409
P ++E+S F + SG+ +EP S + M +PL+ + D++ AT HF
Sbjct: 863 PERMEESRLKGFVDQNLYFLSGSRS----REPLSINIAMFEQPLLK-VRLGDIVEATDHF 917
Query: 410 GKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLA 469
K++++ +G G VY+A LPGE VA+K L AK + + +A + L ++KHPNL+ L
Sbjct: 918 SKKNIIGDGGFGTVYKACLPGEKTVAVKKLSEAKTQGNREFMAEMETLGKVKHPNLVSLL 977
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTN 529
GYC +EKL++ E+M NG L WL TG V DWS
Sbjct: 978 GYCSFSEEKLLVYEYMVNGSLDHWLRN-QTGMLEVLDWS--------------------- 1015
Query: 530 WVTRHRIAIGVARGLAYLHH---VGSTHGHLVTSSILLAESLEPKIAGFGLRNI------ 580
R +IA+G ARGLA+LHH H + S+ILL EPK+A FGL +
Sbjct: 1016 --KRLKIAVGAARGLAFLHHGFIPHIIHRDIKASNILLDGDFEPKVADFGLARLISACES 1073
Query: 581 GVKNV---------GERSENETCGPESDVYCFGVILMELLTGKRGT---------DDCVK 622
V V E ++ + DVY FGVIL+EL+TGK T + V
Sbjct: 1074 HVSTVIAGTFGYIPPEYGQSARATTKGDVYSFGVILLELVTGKEPTGPDFKESEGGNLVG 1133
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVA---EMVESLRVGYLCTADSPGKRPTMQQVLGL 679
W + + +G D +D L SVA + L++ LC A++P KRP M VL
Sbjct: 1134 WAIQKINQGKAVDVIDPLLV-----SVALKNSQLRLLQIAMLCLAETPAKRPNMLDVLKA 1188
Query: 680 LKDI 683
LK+I
Sbjct: 1189 LKEI 1192
|
Receptor with a serine/threonine-protein kinase activity required for the specification of the correct number of male archesporial initials and for the subsequent specification of tapetal and middle cell layer identities. In seeds, required for enhancing cell size and the rate of embryonic development. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZWC8|BRL1_ARATH Serine/threonine-protein kinase BRI1-like 1 OS=Arabidopsis thaliana GN=BRL1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 209 bits (531), Expect = 8e-53, Method: Compositional matrix adjust.
Identities = 198/723 (27%), Positives = 318/723 (43%), Gaps = 152/723 (21%)
Query: 51 LNGSNPSTPIRELN-----LSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWS 105
L GS P + R N LSS L+G I + N+S+L + L NNSL G+VP +
Sbjct: 487 LTGSIPESISRCTNMIWISLSSNRLTGKIP-SGIGNLSKLAILQLGNNSLSGNVPRQLGN 545
Query: 106 TQSLTQVNLSKNRFGGTIGFKPTSRNG------------------------------PFP 135
+SL ++L+ N G + + S+ G F
Sbjct: 546 CKSLIWLDLNSNNLTGDLPGELASQAGLVMPGSVSGKQFAFVRNEGGTDCRGAGGLVEFE 605
Query: 136 SVQVLNLS---------SNRFTNLVKLSQFS---KLMVLDVSNNDLR-ILPSGFANLSKL 182
++ L + R + + + FS ++ D+S N + +P G+ N+ L
Sbjct: 606 GIRAERLERLPMVHSCPATRIYSGMTMYTFSANGSMIYFDISYNAVSGFIPPGYGNMGYL 665
Query: 183 RHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
+ L++ +I+G I P SF L ++ LD+S+N++ G P LS + L++S N T
Sbjct: 666 QVLNLGHNRITGTI-PDSFGGLKAIGVLDLSHNNLQGYLPGSLGSLSFLSDLDVSNNNLT 724
Query: 241 GFVGHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNH------IMPHVDSSRTPPYKIVHK 294
G + FG T R +NN + P + R P +H
Sbjct: 725 GPI------PFGGQ---------LTTFPVSRYANNSGLCGVPLRPCGSAPRRPITSRIHA 769
Query: 295 HNPAVQKHRSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVNQQL 354
K ++ A A++ G+ AF F+ + ++ + R RK+ + K + + L
Sbjct: 770 ------KKQTVATAVIAGI----AFSFMCFVMLVMALYRVRKVQKKEQK---REKYIESL 816
Query: 355 PFKVEKSGPFSFETESGTSW-MADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKES 413
P T SW ++ + EP S V KPL LTF L+ AT+ F E+
Sbjct: 817 P------------TSGSCSWKLSSVPEPLSINVATFEKPL-RKLTFAHLLEATNGFSAET 863
Query: 414 LLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCI 473
++ G G VY+A L VAIK L G + +A + + ++KH NL+PL GYC
Sbjct: 864 MVGSGGFGEVYKAQLRDGSVVAIKKLIRITGQGDREFMAEMETIGKIKHRNLVPLLGYCK 923
Query: 474 AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTR 533
G+E+L++ E+M G L LHE + + + NW R
Sbjct: 924 VGEERLLVYEYMKWGSLETVLHEKSSKKGGI----------------------YLNWAAR 961
Query: 534 HRIAIGVARGLAYLHHVG---STHGHLVTSSILLAESLEPKIAGFGL--------RNIGV 582
+IAIG ARGLA+LHH H + +S++LL E E +++ FG+ ++ V
Sbjct: 962 KKIAIGAARGLAFLHHSCIPHIIHRDMKSSNVLLDEDFEARVSDFGMARLVSALDTHLSV 1021
Query: 583 KNVG--------ERSENETCGPESDVYCFGVILMELLTGKRGTD--------DCVKWVRK 626
+ E ++ C + DVY +GVIL+ELL+GK+ D + V W ++
Sbjct: 1022 STLAGTPGYVPPEYYQSFRCTAKGDVYSYGVILLELLSGKKPIDPGEFGEDNNLVGWAKQ 1081
Query: 627 LVKEGAGGDALDFRLKLG-SGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685
L +E G + LD L SGD E+ L++ C D P KRPTM Q++ + K+++
Sbjct: 1082 LYREKRGAEILDPELVTDKSGD--VELFHYLKIASQCLDDRPFKRPTMIQLMAMFKEMKA 1139
Query: 686 SAD 688
+
Sbjct: 1140 DTE 1142
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development. Binds brassinolide. May be involved in cell growth and vascular differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22476|BRI1_ARATH Protein BRASSINOSTEROID INSENSITIVE 1 OS=Arabidopsis thaliana GN=BRI1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (517), Expect = 3e-51, Method: Compositional matrix adjust.
Identities = 201/733 (27%), Positives = 315/733 (42%), Gaps = 132/733 (18%)
Query: 31 VSKAFSSVSTFNISWLKPTNLNGSNPS-----TPIRELNLSSRNLSGIISWKFLRNMSEL 85
+ + V T L +L G PS T + ++LS+ L+G I K++ + L
Sbjct: 480 IPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIP-KWIGRLENL 538
Query: 86 HSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFP---------- 135
+ LSNNS G++P +SL ++L+ N F GTI ++G
Sbjct: 539 AILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYV 598
Query: 136 ------------------------SVQVLNLSSNRFTNLVK----------LSQFSKLMV 161
S Q+ LS+ N+ +M
Sbjct: 599 YIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMF 658
Query: 162 LDVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNI-KPVSFLHSLKYLDVSNNSMNGTF 219
LD+S N L +P ++ L L++ ISG+I V L L LD+S+N ++G
Sbjct: 659 LDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRI 718
Query: 220 PSDFPPLSGVKFLNISLNKFTGFVGH-DKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIM 278
P L+ + +++S N +G + +++ F + F+ + +
Sbjct: 719 PQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLC-----------GYPL 767
Query: 279 PHVDSSRTPPYKIVHKHNPAVQKHRSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKIL 338
P D S Y H ++ S A ++ +GL +FV +FG+ IL
Sbjct: 768 PRCDPSNADGY--AHHQRSHGRRPASLAGSVAMGL--LFSFVCIFGL-----------IL 812
Query: 339 ARRNKWAISKPVNQQLPFKVEKSGPFSFETESGTSW-MADIKEPTSAAVIMCSKPLVNYL 397
R + +L E G T + T+W + +KE S + KPL L
Sbjct: 813 VGREMRKRRRKKEAELEMYAEGHGNSGDRTANNTNWKLTGVKEALSINLAAFEKPL-RKL 871
Query: 398 TFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDEL 457
TF DL+ AT+ F +SL+ G G VY+A+L VAIK L + G + +A + +
Sbjct: 872 TFADLLQATNGFHNDSLIGSGGFGDVYKAILKDGSAVAIKKLIHVSGQGDREFMAEMETI 931
Query: 458 SRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG 517
++KH NL+PL GYC G E+L++ EFM G L LH+
Sbjct: 932 GKIKHRNLVPLLGYCKVGDERLLVYEFMKYGSLEDVLHD------------------PKK 973
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS---THGHLVTSSILLAESLEPKIAG 574
AG K NW TR +IAIG ARGLA+LHH S H + +S++LL E+LE +++
Sbjct: 974 AGV------KLNWSTRRKIAIGSARGLAFLHHNCSPHIIHRDMKSSNVLLDENLEARVSD 1027
Query: 575 FGL--------RNIGVKNVG--------ERSENETCGPESDVYCFGVILMELLTGKRGTD 618
FG+ ++ V + E ++ C + DVY +GV+L+ELLTGKR TD
Sbjct: 1028 FGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYSYGVVLLELLTGKRPTD 1087
Query: 619 -------DCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP 671
+ V WV++ K D D L E+++ L+V C D +RP
Sbjct: 1088 SPDFGDNNLVGWVKQHAKLRI-SDVFDPELMKEDPALEIELLQHLKVAVACLDDRAWRRP 1146
Query: 672 TMQQVLGLLKDIR 684
TM QV+ + K+I+
Sbjct: 1147 TMVQVMAMFKEIQ 1159
|
Receptor with a dual specificity kinase activity acting on both serine/threonine- and tyrosine-containing substrates. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. Binds brassinolide, and less effectively castasterone, but not 2,3,22,23-O-tetramethylbrassinolide or ecdysone. May be involved in a feedback regulation of brassinosteroid biosynthesis. Phosphorylates BRI1-associated receptor kinase 1 (BAK1), Transthyretin-Like protein (TTL) and SERK1 on 'Ser-299' and 'Thr-462' in vitro. May have a guanylyl cyclase activity. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGP9|IMK3_ARATH Probable leucine-rich repeat receptor-like protein kinase IMK3 OS=Arabidopsis thaliana GN=IMK3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 5e-51, Method: Compositional matrix adjust.
Identities = 188/664 (28%), Positives = 286/664 (43%), Gaps = 115/664 (17%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
++ L+LS+ LS II L + S+L ++LS NSL G +P + SL + L N
Sbjct: 175 LQTLDLSNNLLSEIIPPN-LADSSKLLRLNLSFNSLSGQIPVSLSRSSSLQFLALDHNNL 233
Query: 120 GGTI--------------GFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVS 165
G I S +GPFP NL +L FS S
Sbjct: 234 SGPILDTWGSKSLNLRVLSLDHNSLSGPFPF---------SLCNLTQLQDFS------FS 278
Query: 166 NNDLR-ILPSGFANLSKLRHLDISSCKISGNI-KPVSFLHSLKYLDVSNNSMNGTFPSDF 223
+N +R LPS + L+KLR +DIS +SG+I + + + SL +LD+S N + G P
Sbjct: 279 HNRIRGTLPSELSKLTKLRKMDISGNSVSGHIPETLGNISSLIHLDLSQNKLTGEIPISI 338
Query: 224 PPLSGVKFLNISLNKFTGFVGHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMPHVDS 283
L + F N+S N +G V QKF S+F+ + TP P+ P +
Sbjct: 339 SDLESLNFFNVSYNNLSGPVPTLLSQKFNSSSFVGNSLLCGYSVSTPCPTLPS--PSPEK 396
Query: 284 SRTPPYKIVHKHNPAVQKHRSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNK 343
R P HR+ + +I ++ + + + + + C R+K + K
Sbjct: 397 ERKP-------------SHRNLSTKDIILIASGALLIVMLILVCVLCCLLRKKANETKAK 443
Query: 344 WAISKPVNQQLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLI 403
+ P + K EK G E E+G T ++ P+ T DL+
Sbjct: 444 GGEAGP--GAVAAKTEKGG----EAEAGGE--------TGGKLVHFDGPMA--FTADDLL 487
Query: 404 AATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHP 463
AT+ ++ + G VY+A L VA+K L + + L R++HP
Sbjct: 488 CATAE-----IMGKSTYGTVYKATLEDGSQVAVKRLREKITKSQKEFENEINVLGRIRHP 542
Query: 464 NLLPLAGYCIAGK-EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
NLL L Y + K EKLV+ ++M+ G L +LH G HI
Sbjct: 543 NLLALRAYYLGPKGEKLVVFDYMSRGSLATFLHA-------------------RGPDVHI 583
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLH-HVGSTHGHLVTSSILLAESLEPKIAGFGLRNIG 581
NW TR + G+ARGL YLH H HG+L +S++LL E++ KI+ +GL +
Sbjct: 584 ------NWPTRMSLIKGMARGLFYLHTHANIIHGNLTSSNVLLDENITAKISDYGLSRLM 637
Query: 582 VKNVG---------------ERSENETCGPESDVYCFGVILMELLTGKRGTD-----DCV 621
G E S+ + ++DVY GVI++ELLTGK ++ D
Sbjct: 638 TAAAGSSVIATAGALGYRAPELSKLKKANTKTDVYSLGVIILELLTGKSPSEALNGVDLP 697
Query: 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681
+WV VKE + D L E++ +L++ C +P RP QQV+ L
Sbjct: 698 QWVATAVKEEWTNEVFDLELLNDVNTMGDEILNTLKLALHCVDATPSTRPEAQQVMTQLG 757
Query: 682 DIRP 685
+IRP
Sbjct: 758 EIRP 761
|
Can phosphorylate AGL24. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8L899|BRI1_SOLPE Systemin receptor SR160 OS=Solanum peruvianum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 200 bits (508), Expect = 4e-50, Method: Compositional matrix adjust.
Identities = 189/694 (27%), Positives = 311/694 (44%), Gaps = 109/694 (15%)
Query: 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKN 117
T + ++LS+ LSG I R +S L + L NNS+ G++P + QSL ++L+ N
Sbjct: 523 TKLNWISLSNNQLSGEIPASLGR-LSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTN 581
Query: 118 RFGGTIGFKPTSRNGPFPSVQVLNLSSNRFT--------------NLVKLSQFSKLMVLD 163
G+I ++G ++ V L+ R+ NL++ + +
Sbjct: 582 FLNGSIPPPLFKQSG---NIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLDR 638
Query: 164 VSN----NDLR----ILPSGFANLSKLRHLDISSCKISGNI-KPVSFLHSLKYLDVSNNS 214
+S N R I F + + LD+S K+ G+I K + ++ L L++ +N
Sbjct: 639 ISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHND 698
Query: 215 MNGTFPSDFPPLSGVKFLNISLNKFTG----------FVGHDKYQKFGKSAFIQGGSFVF 264
++G P L V L++S N+F G +G S I S F
Sbjct: 699 LSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPE-SAPF 757
Query: 265 DTTKTPRPSNNHI--MPHVDSSRTPPYKIVHKHNPAVQKHRSKAKALVIGLSCASAFVFV 322
DT R +NN + P + P ++H + ++ S A ++ +GL + +
Sbjct: 758 DTFPDYRFANNSLCGYPLPLPCSSGPKSDANQHQKSHRRQASLAGSVAMGL--LFSLFCI 815
Query: 323 FGIAIIFCMCRRRKILARRNKWAISKPVNQQLPFKVEKSGPFSFETESGTSW-MADIKEP 381
FG+ I+ ++R+ R+ + A+ ++ S + ++W +E
Sbjct: 816 FGLIIVAIETKKRR---RKKEAALEAYMDGH-----------SHSATANSAWKFTSAREA 861
Query: 382 TSAAVIMCSKPLVNYLTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDN 441
S + KPL LTF DL+ AT+ F +SL+ G G VY+A L VAIK L +
Sbjct: 862 LSINLAAFEKPL-RKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH 920
Query: 442 AKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGE 501
G + A + + ++KH NL+PL GYC G+E+L++ E+M G L LH+
Sbjct: 921 VSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHD----- 975
Query: 502 PNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH---VGSTHGHLV 558
+ K NW R +IAIG ARGLA+LHH H +
Sbjct: 976 -------------------RKKTGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMK 1016
Query: 559 TSSILLAESLEPKIAGFGL--------RNIGVKNVG--------ERSENETCGPESDVYC 602
+S++LL E+LE +++ FG+ ++ V + E ++ C + DVY
Sbjct: 1017 SSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYS 1076
Query: 603 FGVILMELLTGKRGTD-------DCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVES 655
+GV+L+ELLTGK+ TD + V WV KL +G D D L E+++
Sbjct: 1077 YGVVLLELLTGKQPTDSADFGDNNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQH 1135
Query: 656 LRVGYLCTADSPGKRPTMQQVLGLLKDIRPSADL 689
L+V C D KRPTM QV+ + K+I+ + +
Sbjct: 1136 LKVACACLDDRHWKRPTMIQVMAMFKEIQAGSGM 1169
|
Receptor with a serine/threonine-protein kinase activity. Involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. May also regulate, in response to brassinosteroid binding, a signaling cascade involved in plant development. Solanum peruvianum (taxid: 4082) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8GUQ5|BRI1_SOLLC Brassinosteroid LRR receptor kinase OS=Solanum lycopersicum GN=CURL3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 198 bits (504), Expect = 1e-49, Method: Compositional matrix adjust.
Identities = 189/694 (27%), Positives = 310/694 (44%), Gaps = 109/694 (15%)
Query: 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKN 117
T + ++LS+ LSG I R +S L + L NNS+ G++P + QSL ++L+ N
Sbjct: 523 TKLNWISLSNNQLSGEIPASLGR-LSNLAILKLGNNSISGNIPAELGNCQSLIWLDLNTN 581
Query: 118 RFGGTIGFKPTSRNGPFPSVQVLNLSSNRFT--------------NLVKLSQFSKLMVLD 163
G+I ++G ++ V L+ R+ NL++ + +
Sbjct: 582 FLNGSIPPPLFKQSG---NIAVALLTGKRYVYIKNDGSKECHGAGNLLEFGGIRQEQLDR 638
Query: 164 VSN----NDLR----ILPSGFANLSKLRHLDISSCKISGNI-KPVSFLHSLKYLDVSNNS 214
+S N R I F + + LD+S K+ G+I K + ++ L L++ +N
Sbjct: 639 ISTRHPCNFTRVYRGITQPTFNHNGSMIFLDLSYNKLEGSIPKELGAMYYLSILNLGHND 698
Query: 215 MNGTFPSDFPPLSGVKFLNISLNKFTG----------FVGHDKYQKFGKSAFIQGGSFVF 264
++G P L V L++S N+F G +G S I S F
Sbjct: 699 LSGMIPQQLGGLKNVAILDLSYNRFNGTIPNSLTSLTLLGEIDLSNNNLSGMIPE-SAPF 757
Query: 265 DTTKTPRPSNNHI--MPHVDSSRTPPYKIVHKHNPAVQKHRSKAKALVIGLSCASAFVFV 322
DT R +NN + P + P ++H + ++ S A ++ +GL + +
Sbjct: 758 DTFPDYRFANNSLCGYPLPIPCSSGPKSDANQHQKSHRRQASLAGSVAMGL--LFSLFCI 815
Query: 323 FGIAIIFCMCRRRKILARRNKWAISKPVNQQLPFKVEKSGPFSFETESGTSW-MADIKEP 381
FG+ I+ ++R+ R+ + A+ ++ S + ++W +E
Sbjct: 816 FGLIIVAIETKKRR---RKKEAALEAYMDGH-----------SHSATANSAWKFTSAREA 861
Query: 382 TSAAVIMCSKPLVNYLTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDN 441
S + KPL LTF DL+ AT+ F +SL+ G G VY+A L VAIK L +
Sbjct: 862 LSINLAAFEKPL-RKLTFADLLEATNGFHNDSLVGSGGFGDVYKAQLKDGSVVAIKKLIH 920
Query: 442 AKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGE 501
G + A + + ++KH NL+PL GYC G+E+L++ E+M G L LH+
Sbjct: 921 VSGQGDREFTAEMETIGKIKHRNLVPLLGYCKVGEERLLVYEYMKYGSLEDVLHD----- 975
Query: 502 PNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH---VGSTHGHLV 558
K NW R +IAIG ARGLA+LHH H +
Sbjct: 976 -------------------RKKIGIKLNWPARRKIAIGAARGLAFLHHNCIPHIIHRDMK 1016
Query: 559 TSSILLAESLEPKIAGFGL--------RNIGVKNVG--------ERSENETCGPESDVYC 602
+S++LL E+LE +++ FG+ ++ V + E ++ C + DVY
Sbjct: 1017 SSNVLLDENLEARVSDFGMARLMSAMDTHLSVSTLAGTPGYVPPEYYQSFRCSTKGDVYS 1076
Query: 603 FGVILMELLTGKRGTD-------DCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVES 655
+GV+L+ELLTGK+ TD + V WV KL +G D D L E+++
Sbjct: 1077 YGVVLLELLTGKQPTDSADFGDNNLVGWV-KLHAKGKITDVFDRELLKEDASIEIELLQH 1135
Query: 656 LRVGYLCTADSPGKRPTMQQVLGLLKDIRPSADL 689
L+V C D KRPTM QV+ + K+I+ + +
Sbjct: 1136 LKVACACLDDRHWKRPTMIQVMAMFKEIQAGSGM 1169
|
Receptor with a serine/threonine-protein kinase activity. Regulates, in response to brassinosteroid binding, a signaling cascade involved in plant development, including expression of light- and stress-regulated genes, promotion of cell elongation, normal leaf and chloroplast senescence, and flowering. May be involved in a feedback regulation of brassinosteroid biosynthesis. May be also involved in the perception of systemin, a peptide hormone responsible for the systemic activation of defense genes in leaves of wounded plants. Solanum lycopersicum (taxid: 4081) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZVR7|PSKR1_ARATH Phytosulfokine receptor 1 OS=Arabidopsis thaliana GN=PSKR1 PE=2 SV=4 | Back alignment and function description |
|---|
Score = 189 bits (479), Expect = 9e-47, Method: Compositional matrix adjust.
Identities = 175/649 (26%), Positives = 283/649 (43%), Gaps = 115/649 (17%)
Query: 77 KFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPT-------- 128
++L + +EL +DLS N L G++P W ++L ++LS N F G I T
Sbjct: 433 RWLSSSNELQLLDLSWNRLTGAIPSWIGDFKALFYLDLSNNSFTGEIPKSLTKLESLTSR 492
Query: 129 --SRNGPFPSVQVLNLSSNRFTNLVKLSQ-FSKLMVLDVSNNDLR-ILPSGFANLSKLRH 184
S N P P + N ++ +Q F +++ +N+L + F NL KL
Sbjct: 493 NISVNEPSPDFPFF-MKRNESARALQYNQIFGFPPTIELGHNNLSGPIWEEFGNLKKLHV 551
Query: 185 LDISSCKISGNI-KPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFV 243
D+ +SG+I +S + SL+ LD+SNN ++G+ P LS + +++ N +G +
Sbjct: 552 FDLKWNALSGSIPSSLSGMTSLEALDLSNNRLSGSIPVSLQQLSFLSKFSVAYNNLSGVI 611
Query: 244 -GHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHKHNPAVQKH 302
++Q F S+F ++ H P + + + A+ K
Sbjct: 612 PSGGQFQTFPNSSF-----------ESNHLCGEHRFPCSEGTES-----------ALIKR 649
Query: 303 RSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVNQQLPFKVEKSG 362
+++ IG++ AF VF + ++ + R ARR +SG
Sbjct: 650 SRRSRGGDIGMAIGIAFGSVFLLTLLSLIVLR----ARR------------------RSG 687
Query: 363 PFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKESLLAEGRCGP 422
E E S + +++ + L++ DL+ +T+ F + +++ G G
Sbjct: 688 EVDPEIEESESMNRKELGEIGSKLVVLFQSNDKELSYDDLLDSTNSFDQANIIGCGGFGM 747
Query: 423 VYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482
VY+A LP VAIK L G + A + LSR +HPNL+ L G+C ++L++
Sbjct: 748 VYKATLPDGKKVAIKKLSGDCGQIEREFEAEVETLSRAQHPNLVLLRGFCFYKNDRLLIY 807
Query: 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVAR 542
+M NG L WLHE G P W TR RIA G A+
Sbjct: 808 SYMENGSLDYWLHERNDG------------------------PALLKWKTRLRIAQGAAK 843
Query: 543 GLAYLH-----HVGSTHGHLVTSSILLAESLEPKIAGFGL--------RNIGVKNVG--- 586
GL YLH H+ H + +S+ILL E+ +A FGL ++ VG
Sbjct: 844 GLLYLHEGCDPHI--LHRDIKSSNILLDENFNSHLADFGLARLMSPYETHVSTDLVGTLG 901
Query: 587 ----ERSENETCGPESDVYCFGVILMELLTGKRGTDDC--------VKWVRKLVKEGAGG 634
E + + DVY FGV+L+ELLT KR D C + WV K+ E
Sbjct: 902 YIPPEYGQASVATYKGDVYSFGVVLLELLTDKRPVDMCKPKGCRDLISWVVKMKHESRAS 961
Query: 635 DALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+ D + S ++ EM L + LC +++P +RPT QQ++ L D+
Sbjct: 962 EVFDPLIY--SKENDKEMFRVLEIACLCLSENPKQRPTTQQLVSWLDDV 1008
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis, somatic embryogenesis, cellular proliferation and plant growth. Not involved in PSY perception. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8LPB4|PSKR1_DAUCA Phytosulfokine receptor 1 OS=Daucus carota GN=PSKR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 188 bits (477), Expect = 2e-46, Method: Compositional matrix adjust.
Identities = 185/678 (27%), Positives = 294/678 (43%), Gaps = 119/678 (17%)
Query: 56 PSTP------IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSL 109
PS P ++ L ++S L G + ++L N L +DLS N L G++P W S SL
Sbjct: 417 PSVPSLQFKNLKVLIIASCQLRGTVP-QWLSNSPSLQLLDLSWNQLSGTIPPWLGSLNSL 475
Query: 110 TQVNLSKNRFGGTIGFKPTSRNG----------PFPSVQVLNLSSNRFTNLVKLSQFSKL 159
++LS N F G I TS P P + L S
Sbjct: 476 FYLDLSNNTFIGEIPHSLTSLQSLVSKENAVEEPSPDFPFFKKKNTNAGGLQYNQPSSFP 535
Query: 160 MVLDVSNNDLR--ILPSGFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNSMN 216
++D+S N L I P F +L +L L++ + +SGNI +S + SL+ LD+S+N+++
Sbjct: 536 PMIDLSYNSLNGSIWPE-FGDLRQLHVLNLKNNNLSGNIPANLSGMTSLEVLDLSHNNLS 594
Query: 217 GTFPSDFPPLSGVKFLNISLNKFTGFVGHD-KYQKFGKSAFIQGGSFVFDTTKTPRPSNN 275
G P LS + +++ NK +G + ++Q F S+F +G +
Sbjct: 595 GNIPPSLVKLSFLSTFSVAYNKLSGPIPTGVQFQTFPNSSF-EGNQGL---------CGE 644
Query: 276 HIMPHVDSSRTPPYKIVHKHNPAVQKHRSKAKALVIGLSCASAFVFVFGIAIIFCMCRRR 335
H P + ++P H AV+ ++ K + + + G+ +F +
Sbjct: 645 HASPCHITDQSP-------HGSAVKSKKNIRKIVAVAVGT--------GLGTVFLLTVTL 689
Query: 336 KILARRNKWAISKPVNQQLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVN 395
I+ R P EK +I+ + + V+ +K N
Sbjct: 690 LIILRTTSRGEVDP---------EKKAD-----------ADEIELGSRSVVLFHNKDSNN 729
Query: 396 YLTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFD 455
L+ D++ +TS F + +++ G G VY+A LP VAIK L G + A +
Sbjct: 730 ELSLDDILKSTSSFNQANIIGCGGFGLVYKATLPDGTKVAIKRLSGDTGQMDREFQAEVE 789
Query: 456 ELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHH 515
LSR +HPNL+ L GYC +KL++ +M NG L WLHE G P+++
Sbjct: 790 TLSRAQHPNLVHLLGYCNYKNDKLLIYSYMDNGSLDYWLHEKVDGPPSLD---------- 839
Query: 516 PGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS---THGHLVTSSILLAESLEPKI 572
W TR RIA G A GLAYLH H + +S+ILL+++ +
Sbjct: 840 --------------WKTRLRIARGAAEGLAYLHQSCEPHILHRDIKSSNILLSDTFVAHL 885
Query: 573 AGFGL--------RNIGVKNVG-------ERSENETCGPESDVYCFGVILMELLTGK--- 614
A FGL ++ VG E + + DVY FGV+L+ELLTG+
Sbjct: 886 ADFGLARLILPYDTHVTTDLVGTLGYIPPEYGQASVATYKGDVYSFGVVLLELLTGRRPM 945
Query: 615 -----RGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGK 669
RG+ D + WV ++ E + D + D EM+ L + C ++P
Sbjct: 946 DVCKPRGSRDLISWVLQMKTEKRESEIFDPFIY--DKDHAEEMLLVLEIACRCLGENPKT 1003
Query: 670 RPTMQQVLGLLKDIRPSA 687
RPT QQ++ L++I S+
Sbjct: 1004 RPTTQQLVSWLENIDVSS 1021
|
Phytosulfokine receptor with a serine/threonine-protein kinase activity. Regulates, in response to phytosulfokine binding, a signaling cascade involved in plant cell differentiation, organogenesis and somatic embryogenesis. Daucus carota (taxid: 4039) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 690 | ||||||
| 255562440 | 689 | receptor kinase, putative [Ricinus commu | 0.973 | 0.975 | 0.643 | 0.0 | |
| 224116856 | 682 | predicted protein [Populus trichocarpa] | 0.972 | 0.983 | 0.653 | 0.0 | |
| 224079077 | 677 | predicted protein [Populus trichocarpa] | 0.965 | 0.983 | 0.656 | 0.0 | |
| 359483763 | 683 | PREDICTED: probable LRR receptor-like se | 0.969 | 0.979 | 0.643 | 0.0 | |
| 449465010 | 679 | PREDICTED: probable LRR receptor-like se | 0.946 | 0.961 | 0.579 | 0.0 | |
| 449500851 | 679 | PREDICTED: probable LRR receptor-like se | 0.946 | 0.961 | 0.579 | 0.0 | |
| 356555431 | 682 | PREDICTED: probable LRR receptor-like se | 0.963 | 0.975 | 0.587 | 0.0 | |
| 147820561 | 684 | hypothetical protein VITISV_009178 [Viti | 0.923 | 0.931 | 0.630 | 0.0 | |
| 297740518 | 601 | unnamed protein product [Vitis vinifera] | 0.862 | 0.990 | 0.605 | 0.0 | |
| 358345477 | 696 | LRR receptor-like serine/threonine-prote | 0.942 | 0.933 | 0.577 | 0.0 |
| >gi|255562440|ref|XP_002522226.1| receptor kinase, putative [Ricinus communis] gi|223538479|gb|EEF40084.1| receptor kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2260), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 450/699 (64%), Positives = 557/699 (79%), Gaps = 27/699 (3%)
Query: 1 MKIFCRLPLLFSLSLVVL-AQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTP 59
M++FCR L+FSL ++V ++STCNS D++L+SKAF SVS FN+SW ++ N S+P P
Sbjct: 1 MEMFCRFLLVFSLLVLVAESESTCNSTDRKLLSKAFKSVSGFNLSWFHLSDFNCSHP--P 58
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
I+E+ L SRNLSGIISW++ +NMS+LH IDLS+NS++G VPGWFWST+SL +VNL+KN
Sbjct: 59 IKEIRLPSRNLSGIISWRYFKNMSKLHVIDLSSNSIQGQVPGWFWSTKSLKEVNLAKNML 118
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
GG+IGF+P NG F S+++LNLS+NRFTNL KLS F+ L LD+S+N L L F+NL
Sbjct: 119 GGSIGFEPNQGNGSFSSIKLLNLSTNRFTNLGKLSGFANLQSLDLSSNILGSLSFDFSNL 178
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKF 239
+KL L+ISSCKI G++K +S LH LKYLDVSNN+MNGTFPSDFPPL G+ FLN+SLN F
Sbjct: 179 TKLEFLNISSCKILGSVKAISGLHLLKYLDVSNNTMNGTFPSDFPPLDGLAFLNVSLNNF 238
Query: 240 TGFVGHDKYQKFGKSAFIQGGSFVFDTTKTP--RPSNNHIMPH-----VDSSRTPPYKIV 292
TG V DK+ KFG+SAF+ GGSF F + KTP PSNN + PH P +
Sbjct: 239 TGIVHSDKFNKFGRSAFLHGGSFNFTSLKTPSESPSNNTMKPHPKQIPTHKKNIPKQNEL 298
Query: 293 HKHNPA--VQKHRSKAKALVIGLSCASAFVFVFGIAI-IFCMCRRRKILARRNKWAISKP 349
H +P ++K +SK + L+I +S S+F F+ IAI FCM RRRK+ A RNKWAIS P
Sbjct: 299 HPSSPKNPIKKTKSKTETLIICVSSMSSF-FLVSIAICFFCMHRRRKV-AARNKWAISTP 356
Query: 350 VNQQLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHF 409
+ Q PFK++KSGPFSFETESGTSW+ADIKEPTSA VIM SKPL+N +TFKDLIAATSHF
Sbjct: 357 I--QFPFKMDKSGPFSFETESGTSWVADIKEPTSAPVIMSSKPLMN-MTFKDLIAATSHF 413
Query: 410 GKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLA 469
GK+SLL+EGRCGP+YRAVL G+LHVAIKVL+NA+ I+ ++AV +F+ LSRLKHPNLLPL
Sbjct: 414 GKDSLLSEGRCGPLYRAVLSGDLHVAIKVLENAREINDEEAVTIFEGLSRLKHPNLLPLC 473
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP-EKT 528
GYCIAGKEKL+L EFMANGDL RWLHELPT +PNVEDWSTDTW+H +GSH+SSP EKT
Sbjct: 474 GYCIAGKEKLILYEFMANGDLRRWLHELPTLKPNVEDWSTDTWEHQNISGSHVSSPEEKT 533
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIG--VKNVG 586
NW+TRH IA+GVARG+AYLHH GSTHGHLV+S+ILL+++LEP++A FGLRNIG KN+G
Sbjct: 534 NWLTRHYIAVGVARGVAYLHHAGSTHGHLVSSNILLSDTLEPRVADFGLRNIGPKSKNIG 593
Query: 587 ERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSG 646
CG E DVYCFG +L+E+LTGK G+++ V+WVR+LV+EG GGDALD RL++ G
Sbjct: 594 HE-----CGVEFDVYCFGCVLIEILTGKEGSEESVEWVRRLVREGHGGDALDSRLRV-VG 647
Query: 647 DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685
DS+ EMVE LR+GYLCTA+ P KRPTMQQVLGLLKDI P
Sbjct: 648 DSMNEMVECLRIGYLCTAELPSKRPTMQQVLGLLKDIHP 686
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116856|ref|XP_002317411.1| predicted protein [Populus trichocarpa] gi|222860476|gb|EEE98023.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 873 bits (2256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/693 (65%), Positives = 543/693 (78%), Gaps = 22/693 (3%)
Query: 1 MKIFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLK--PTNLNGSNPST 58
M++FCR L +SL V +STCNS DQELVSKAF SVS FN+SW + + N S+PS
Sbjct: 1 MEVFCRF--LLVVSLFVFVESTCNSTDQELVSKAFGSVSGFNLSWFQHAGSTSNCSHPS- 57
Query: 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNR 118
+ E+ L SRNLSG ISW +L+NMS+LH IDLS+NSL+G VP WFWS +SL+ VNLSKNR
Sbjct: 58 -VTEIRLPSRNLSGSISWHYLKNMSQLHIIDLSSNSLRGQVPAWFWSIKSLSDVNLSKNR 116
Query: 119 FGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFAN 178
GG+IGF S + ++VLNLS+NRFTNLVKLS F+ L VLD+S+ND+ LPSGF N
Sbjct: 117 LGGSIGFGINSSSSSM--IKVLNLSTNRFTNLVKLSGFANLEVLDISHNDIGSLPSGFPN 174
Query: 179 LSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNK 238
L+KL L+ISSCKI GNI+ +S L SLKYLDVSNN+M+G FPSDFPPL G+ FLN+SLN
Sbjct: 175 LTKLESLNISSCKILGNIRVISGLQSLKYLDVSNNNMSGKFPSDFPPLDGLMFLNVSLNN 234
Query: 239 FTGFVGHDKYQKFGKSAFIQGGSFVFDTTKTP-----RPSNNHIMPHVDSSRTPPYKIVH 293
F+G VG DKY+KFGKSAF GGS +F+T+K P +P N H + + P +H
Sbjct: 235 FSGLVGLDKYRKFGKSAFSHGGSLIFNTSKIPTNPIKKPRLNQTQLHKKTIKKYPPIYLH 294
Query: 294 KHNPAVQKHRSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVNQQ 353
K +SK K LVI +S S+ V V +FCM RRRKI A RNKWAISKPV
Sbjct: 295 A---KKTKPKSKTKTLVICVSATSSLVVVSIAICVFCMHRRRKI-ATRNKWAISKPV--H 348
Query: 354 LPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKES 413
L FK+EKSGPFSFETESG+SW+ADIKEPTSA VIM SKPL+N LTFKDLI +TSHFG +S
Sbjct: 349 LTFKMEKSGPFSFETESGSSWVADIKEPTSAPVIMPSKPLMN-LTFKDLIVSTSHFGTDS 407
Query: 414 LLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCI 473
LLAEGRCGP+YRAVLPG+LHVAIKVL+NA+ +DHDDAVA+F+++SRLKHPNLLPL GYCI
Sbjct: 408 LLAEGRCGPLYRAVLPGDLHVAIKVLENARDLDHDDAVALFEDISRLKHPNLLPLCGYCI 467
Query: 474 AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP-EKTNWVT 532
AGKEKLVL EFM NGDLHRWLHELPT + NVEDWSTDTW++ H++SP EKTNW+T
Sbjct: 468 AGKEKLVLYEFMFNGDLHRWLHELPTLKTNVEDWSTDTWENQNVHRFHVASPEEKTNWLT 527
Query: 533 RHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSENE 592
RH+IA+GVARG+AYLHH GSTHG LV S+ILL++SLEP++A FGLRN+G N E +
Sbjct: 528 RHQIAVGVARGVAYLHHAGSTHGQLVASNILLSDSLEPRVADFGLRNVGSSNKSVGLEKQ 587
Query: 593 TCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEM 652
CG E DVYCFGV+L+EL+TGK+G++ V+WVR+LV+EG GGDALD RL+LG GDSV+EM
Sbjct: 588 DCGFELDVYCFGVVLIELMTGKQGSEGNVEWVRRLVREGRGGDALDSRLRLG-GDSVSEM 646
Query: 653 VESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685
VE LRVGYLCTA+ P KRPTMQQVLGLLKDI P
Sbjct: 647 VECLRVGYLCTAELPEKRPTMQQVLGLLKDIHP 679
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224079077|ref|XP_002305740.1| predicted protein [Populus trichocarpa] gi|222848704|gb|EEE86251.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 873 bits (2256), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 456/695 (65%), Positives = 550/695 (79%), Gaps = 29/695 (4%)
Query: 1 MKIFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTN--LNGSNPST 58
M +FCR LF SL V +STCNS DQELVSKAFSSVS FN+SW + + N S+PS
Sbjct: 1 MDVFCRF--LFVFSLFVFVESTCNSTDQELVSKAFSSVSGFNLSWFQHSGPASNCSHPS- 57
Query: 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNR 118
I E+ L SRNLSG ISWK+L+NMS+LH IDLS+NSL+G VP WFWS +SL +VNLSKN
Sbjct: 58 -ITEIRLPSRNLSGSISWKYLKNMSQLHIIDLSSNSLQGRVPAWFWSIKSLREVNLSKNG 116
Query: 119 FGGTIGFKPTSRNGPFPSV-QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFA 177
GG++G + NG S+ +VLNLS+NRFTNL KLS F L VLD+S+NDL LPSGFA
Sbjct: 117 LGGSVG---SGINGSSISMLKVLNLSTNRFTNLDKLSGFGNLEVLDISHNDLGSLPSGFA 173
Query: 178 NLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
NL+KL L+ISSC ISGNI +S L SLKYLDVSNN+MNG FPSDFPPL G++FLN+SLN
Sbjct: 174 NLTKLESLNISSCNISGNITVISGLQSLKYLDVSNNTMNGKFPSDFPPLDGLEFLNVSLN 233
Query: 238 KFTGFVGHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHKHNP 297
F+G VG+DKY KFGKSAF GGS +F+T+KTP +N + P ++ P++ K P
Sbjct: 234 NFSGLVGYDKYNKFGKSAFSHGGSLIFNTSKTP--TNRTMKP-----QSQPHEGTIKKYP 286
Query: 298 AVQKH------RSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVN 351
V H +SKAK L+I +S SAF+ V +FCM RRRKI A+RNKWAISKPV
Sbjct: 287 PVYLHAKKARPKSKAKTLIISVSSTSAFLLVSIAVCVFCMHRRRKI-AKRNKWAISKPV- 344
Query: 352 QQLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGK 411
Q FK++KSGPFSFETESG+SW+ADIKEPTSA VIM SKPL+N+ TFKDLIAATS FGK
Sbjct: 345 -QFTFKMDKSGPFSFETESGSSWVADIKEPTSAPVIMSSKPLMNF-TFKDLIAATSQFGK 402
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
+SLLAEGRCGP+YRAVLPG+LHVAIKVL+NA+ +DH DAVA+F++ S+LKHPNLLPL GY
Sbjct: 403 DSLLAEGRCGPLYRAVLPGDLHVAIKVLENARDLDHGDAVAIFEDFSKLKHPNLLPLCGY 462
Query: 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP-EKTNW 530
CIAGKEKLVL EFM NGDLHRWLHELPT + N+EDWS DTW++ GSH++SP EKTNW
Sbjct: 463 CIAGKEKLVLHEFMFNGDLHRWLHELPTLKTNLEDWSADTWENQNIHGSHVASPEEKTNW 522
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSE 590
+TRHRIA+GVARG+AYLHH GS HGHLV S+ILL++S+EP++A FGLR++G KN +
Sbjct: 523 LTRHRIAVGVARGVAYLHHAGSIHGHLVASNILLSDSIEPRVADFGLRDVGQKNRSVGLD 582
Query: 591 NETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVA 650
N+ CG E DVYCFGV+L+EL+TG++G+ + V WVR+LV+EG GGDA+D RL+LG GDS +
Sbjct: 583 NKDCGFEYDVYCFGVVLIELMTGEQGSGENVGWVRRLVREGRGGDAIDSRLRLG-GDSTS 641
Query: 651 EMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685
EMVE LRVGYLCTA+ P KRPTMQQVLGLLKDI P
Sbjct: 642 EMVECLRVGYLCTAELPEKRPTMQQVLGLLKDIHP 676
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359483763|ref|XP_002265984.2| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 828 bits (2138), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/704 (64%), Positives = 547/704 (77%), Gaps = 35/704 (4%)
Query: 1 MKIFCRLPLLFSLSLVVLAQSTCNSK-DQELVSKAFSSVSTFNISWLKPTNLNGSNPSTP 59
M++F RL L+ SL +VV A+STCNS D +LV KAF V+ FN SW+K ++ +G+ S P
Sbjct: 1 MEMFWRLLLVLSLVMVVAAESTCNSTTDSKLVLKAFKGVTGFNSSWVK-SHDHGNCSSPP 59
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+REL SSRNLSG ISW+FLRNMS+L +IDLS+NSL+G VPGWFWS +SL +VNLS+NRF
Sbjct: 60 MRELKFSSRNLSGTISWEFLRNMSQLQAIDLSHNSLRGHVPGWFWSIRSLVKVNLSQNRF 119
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
GG++GF+ G S+QVLNLS NRFTNLV+LS F L VLD+SNNDLR+LPSGF NL
Sbjct: 120 GGSVGFEGL---GSTSSMQVLNLSDNRFTNLVRLSGFQALTVLDLSNNDLRVLPSGFENL 176
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKF 239
+KL HLDISSC ISGN+KP+S L L +LDVS+N+MNGTFPSDFPPL G++FLN+SLNKF
Sbjct: 177 TKLEHLDISSCNISGNLKPISSLRRLTHLDVSDNNMNGTFPSDFPPLIGLRFLNVSLNKF 236
Query: 240 TGFVGHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHI--MPHVD------SSRTPPYKI 291
TG +G + ++KFG SAFI G+F T TP P H +PH S TPP+K
Sbjct: 237 TGLIGSEFHKKFGNSAFIHAGNFNVSKTATP-PIGPHSTPLPHKPLLELRPHSSTPPHKP 295
Query: 292 VHKHNPAVQKHRSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVN 351
+ +H A +K +SK K LV+ LSCASAF+ + +CM RR+ L RRN+WAISKP+
Sbjct: 296 LPEH-LAKKKRKSKPKLLVLSLSCASAFLVLAMAICTYCM-YRRRKLKRRNRWAISKPM- 352
Query: 352 QQLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGK 411
Q FK+EKSGPFSFETESGTSW+ADIKEP+SA V+M KPL+N LTFKDLIAATSHFGK
Sbjct: 353 -QAEFKMEKSGPFSFETESGTSWVADIKEPSSAPVVMFEKPLMN-LTFKDLIAATSHFGK 410
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
ES LAEGRCGPVYRAVLPG++HVAIKVL+NA+ +DH+DAV MF+ L+RLKHPNLLPL+GY
Sbjct: 411 ESQLAEGRCGPVYRAVLPGDIHVAIKVLENARSVDHNDAVPMFESLARLKHPNLLPLSGY 470
Query: 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDH-HPGAG-SHISSPEKTN 529
CIAG+EKLVL EFMANGDLHRWLHELPTG PNVEDWSTDTW+H + G S SSPEK
Sbjct: 471 CIAGREKLVLYEFMANGDLHRWLHELPTGAPNVEDWSTDTWEHINDGESVSRASSPEKME 530
Query: 530 WVTRHRIAIGVARGLAYLHHVGST---HGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
W TRHRIA+GVARGLAYLHH GS HGHLV S++LLA+ EP+IA FGLR
Sbjct: 531 WRTRHRIAVGVARGLAYLHHAGSKPIFHGHLVASNVLLADDFEPRIADFGLRR------- 583
Query: 587 ERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSG 646
+ + E+DVYCFGV+L+ELLTGK G+++ + W RKLVK+ G +ALD RL +G G
Sbjct: 584 ---DRDIGNTEADVYCFGVVLIELLTGKPGSEETIAWARKLVKDRLGVNALDPRLGVG-G 639
Query: 647 DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSADLS 690
DSV+EMVE LRVGYLCTA+SPGKRPTMQQV+GLLKDI P +L+
Sbjct: 640 DSVSEMVECLRVGYLCTAESPGKRPTMQQVVGLLKDIHPGPELN 683
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465010|ref|XP_004150222.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 791 bits (2042), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/699 (57%), Positives = 521/699 (74%), Gaps = 46/699 (6%)
Query: 7 LPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLS 66
+ LL S S V S CN+ D + VS+AF SVS+FN+SW+ +++N +N S ++ + L
Sbjct: 1 MALLISSSFV---DSACNTSDTQFVSRAFHSVSSFNLSWIVHSSVNSTNCS--VQHIILP 55
Query: 67 SRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFK 126
S+NL+GI+SW+FLRN++ L SIDLS NSL+G VP W W +L ++LS NRFGGT+GFK
Sbjct: 56 SKNLTGIVSWRFLRNLTHLRSIDLSRNSLEGFVPNWLWGIPTLVHLDLSHNRFGGTVGFK 115
Query: 127 --PTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRH 184
+SR P S++VLNLS NRF+N V+LS FS+L +LD+S N+LR LP G NLS L H
Sbjct: 116 LSNSSRGFPSSSIRVLNLSDNRFSNTVRLSGFSRLEILDLSRNNLRNLPFGLENLSNLTH 175
Query: 185 LDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVG 244
LD+S C ISGN+KP+S LHSL+YLDVS+NSM G FPSDFP L+G+KFLN+SLNKF G +
Sbjct: 176 LDVSRCNISGNLKPISVLHSLEYLDVSDNSMTGNFPSDFPRLNGLKFLNVSLNKFKGVIN 235
Query: 245 HDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHKHNPAVQKH-- 302
+ Y+KFGKSAF+Q G + S N +P+ S P+ HN +Q H
Sbjct: 236 SESYKKFGKSAFVQTGITLLQIKTN---SGNRGIPNPPQSSKRPH-----HNNTIQSHMP 287
Query: 303 ----------RSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVNQ 352
+SK KAL+ LS A +F+ ++++ + RR++++ R+ KWAIS P+
Sbjct: 288 NKEPARKAKPKSKTKALIFALSFGVAGLFL--VSVVLAIWRRKRMMKRKTKWAISTPI-- 343
Query: 353 QLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKE 412
Q+ FK+EKSGPF+FETESG+SW+ADI+EP+SA+V+M KPL+N LTFKDLIAATSHFGKE
Sbjct: 344 QVQFKMEKSGPFAFETESGSSWIADIREPSSASVVMFEKPLIN-LTFKDLIAATSHFGKE 402
Query: 413 SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYC 472
SLLAEGRCGPVYRAVLPG++HVAIKVL++A+ + D+AVAMF++LS LKH NLLPL GYC
Sbjct: 403 SLLAEGRCGPVYRAVLPGDIHVAIKVLESARTVARDEAVAMFEDLSALKHSNLLPLFGYC 462
Query: 473 IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWD--HHPGAGSHISSPEKTNW 530
IAGKEKLVL EFM+NGDLHRWLHELPTG+PNVEDWSTDTW+ ++ G+H+S PEK W
Sbjct: 463 IAGKEKLVLYEFMSNGDLHRWLHELPTGQPNVEDWSTDTWEINNNYVNGTHLSLPEKLGW 522
Query: 531 VTRHRIAIGVARGLAYLHHVGS---THGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGE 587
TRHRIA+G+ARGLAYLHH GS HGHLVTS+ILLA+ E +I GFGLR++ G+
Sbjct: 523 ATRHRIAVGIARGLAYLHHAGSKPIVHGHLVTSNILLADDFEARIGGFGLRHVE----GK 578
Query: 588 RSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGD 647
+ E+ G E DVYCFGV+LMELLTG G+ + V VRK+V++G +A+D RL++G G+
Sbjct: 579 KGED---GVEKDVYCFGVVLMELLTGMPGSANTVVGVRKMVRDGKALEAIDPRLRVGGGE 635
Query: 648 SVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686
S EMVESLRV YLCTA++ KRPTMQQVLGLLKDI P+
Sbjct: 636 S--EMVESLRVAYLCTAETAVKRPTMQQVLGLLKDIHPT 672
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449500851|ref|XP_004161211.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2041), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 405/699 (57%), Positives = 521/699 (74%), Gaps = 46/699 (6%)
Query: 7 LPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLS 66
+ LL S S V S CN+ D + VS+AF SVS+FN+SW+ +++N +N S ++ + L
Sbjct: 1 MALLISSSFV---DSACNTSDTQFVSRAFHSVSSFNLSWIVHSSVNSTNCS--VQHIILP 55
Query: 67 SRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFK 126
S+NL+GI+SW+FLRN++ L SIDLS NSL+G VP W W +L ++LS NRFGGT+GFK
Sbjct: 56 SKNLTGIVSWRFLRNLTHLRSIDLSRNSLEGFVPNWLWGIPTLVHLDLSHNRFGGTVGFK 115
Query: 127 --PTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRH 184
+SR P S++VLNLS NRF+N V+LS FS+L +LD+S N+LR LP G NLS L H
Sbjct: 116 LSNSSRRFPSSSIRVLNLSDNRFSNTVRLSGFSRLEILDLSRNNLRNLPFGLENLSNLTH 175
Query: 185 LDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVG 244
LD+S C ISGN+KP+S LHSL+YLDVS+NSM G FPSDFP L+G+KFLN+SLNKF G +
Sbjct: 176 LDVSRCNISGNLKPISVLHSLEYLDVSDNSMTGNFPSDFPRLNGLKFLNVSLNKFKGVIN 235
Query: 245 HDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHKHNPAVQKH-- 302
+ Y+KFGKSAF+Q G + S N +P+ S P+ HN +Q H
Sbjct: 236 SESYKKFGKSAFVQTGITLLQIKTN---SGNRGIPNPPQSSKRPH-----HNNTIQSHMP 287
Query: 303 ----------RSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVNQ 352
+SK KAL+ LS A +F+ ++++ + RR++++ R+ KWAIS P+
Sbjct: 288 NKEPARKAKPKSKTKALIFALSFGVAGLFL--VSVVLAIWRRKRMMKRKTKWAISTPI-- 343
Query: 353 QLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKE 412
Q+ FK+EKSGPF+FETESG+SW+ADI+EP+SA+V+M KPL+N LTFKDLIAATSHFGKE
Sbjct: 344 QVQFKMEKSGPFAFETESGSSWIADIREPSSASVVMFEKPLIN-LTFKDLIAATSHFGKE 402
Query: 413 SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYC 472
SLLAEGRCGPVYRAVLPG++HVAIKVL++A+ + D+AVAMF++LS LKH NLLPL GYC
Sbjct: 403 SLLAEGRCGPVYRAVLPGDIHVAIKVLESARTVARDEAVAMFEDLSALKHSNLLPLFGYC 462
Query: 473 IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWD--HHPGAGSHISSPEKTNW 530
IAGKEKLVL EFM+NGDLHRWLHELPTG+PNVEDWSTDTW+ ++ G+H+S PEK W
Sbjct: 463 IAGKEKLVLYEFMSNGDLHRWLHELPTGQPNVEDWSTDTWEINNNYVNGTHLSLPEKLGW 522
Query: 531 VTRHRIAIGVARGLAYLHHVGS---THGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGE 587
TRHRIA+G+ARGLAYLHH GS HGHLVTS+ILLA+ E +I GFGLR++ G+
Sbjct: 523 ATRHRIAVGIARGLAYLHHAGSKPIVHGHLVTSNILLADDFEARIGGFGLRHVE----GK 578
Query: 588 RSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGD 647
+ E+ G E DVYCFGV+LMELLTG G+ + V VRK+V++G +A+D RL++G G+
Sbjct: 579 KGED---GVEKDVYCFGVVLMELLTGMPGSANTVVGVRKMVRDGKALEAIDPRLRVGGGE 635
Query: 648 SVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686
S EMVESLRV YLCTA++ KRPTMQQVLGLLKDI P+
Sbjct: 636 S--EMVESLRVAYLCTAETAVKRPTMQQVLGLLKDIHPT 672
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555431|ref|XP_003546035.1| PREDICTED: probable LRR receptor-like serine/threonine-protein kinase At2g24230-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 780 bits (2014), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 414/705 (58%), Positives = 514/705 (72%), Gaps = 40/705 (5%)
Query: 1 MKIFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTP- 59
MK FC + LV+L +S+C ++DQE+VSKAF SVS FN SW + GSN S
Sbjct: 1 MKPFCTF-FILLSLLVILVESSCKNEDQEMVSKAFQSVSGFNSSWFE----TGSNCSNAE 55
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
I+ +NLSS+NLSG ISWK+LRN+S+L +DLS N L+G VP WFW + +L VNLS NRF
Sbjct: 56 IKGINLSSKNLSGNISWKYLRNISKLKVLDLSGNFLQGQVPNWFWRSSTLLVVNLSSNRF 115
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
GG+I PTS+NG F S+Q LNLS NRFTN + LS FS L LD+S+N+L LPSGF NL
Sbjct: 116 GGSI--NPTSQNGSFSSLQNLNLSHNRFTNRLHLSGFSNLESLDLSHNNLGTLPSGFQNL 173
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKF 239
+ L HLD+S+C I GN+KP+S L +L +LD+SNN++NG+FPSDFPPL+ +KFLN+S N
Sbjct: 174 TNLHHLDLSNCNIKGNVKPISSLTTLSFLDLSNNTLNGSFPSDFPPLNNIKFLNVSHNNL 233
Query: 240 TGFVGHDKYQKFGKSAFIQGGSF--VFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHKHNP 297
D+++KFGKSAFI G ++ +KTP+ +DS+ TP ++ H +
Sbjct: 234 KASTTLDRFKKFGKSAFIHAGHNFNYYNESKTPK---------LDSNSTPQHQQPHHIHA 284
Query: 298 AVQKHRS------KAKALVIGLSCASAFVFV-FGIAIIFCMCRRRKILARRNKWAISKPV 350
++ + K + +++ SCASA V V + +++C CRRR+ LA+R+KWAISKP
Sbjct: 285 KKKRSKEKQKSKHKTRTMIVASSCASALVVVSLCMCLVWC-CRRRRQLAKRSKWAISKPA 343
Query: 351 NQQLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFG 410
+ +EKSGPF+FETESGTSW+AD+KEP+SA V++ KPL+N LTF DL+A TSHFG
Sbjct: 344 PLSIKM-MEKSGPFAFETESGTSWVADLKEPSSAPVVVFEKPLMN-LTFVDLLAGTSHFG 401
Query: 411 KESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAG 470
K+SLLAEGRCGPVYRAVLPG++HVAIKVL+NA+ + DDAVA+F +LS+LKHPNLLPL+G
Sbjct: 402 KDSLLAEGRCGPVYRAVLPGDIHVAIKVLENARDVHDDDAVALFVDLSQLKHPNLLPLSG 461
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWD-HHPGAGSHISSPEKTN 529
YCIAGKEKLVL EFM+NGDL RWL ELPTGE NVEDWS DTWD GA S S PEK
Sbjct: 462 YCIAGKEKLVLYEFMSNGDLGRWLQELPTGETNVEDWSGDTWDIIQNGAASRASPPEKMG 521
Query: 530 WVTRHRIAIGVARGLAYLHHVGS---THGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
W+ RHRIA+GVARGLA+LHH GS HGHLVTS++LL + EP+IA FG R G
Sbjct: 522 WLVRHRIAVGVARGLAFLHHAGSRPVVHGHLVTSNVLLGDDFEPRIADFGFRKF-----G 576
Query: 587 ERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKL--G 644
S C E+DVYCFGV+LMELLTG+ GT + V WVRK V+EG ALD RLKL G
Sbjct: 577 RESATANCSTETDVYCFGVVLMELLTGRAGTAETVVWVRKAVREGHAVRALDERLKLGGG 636
Query: 645 SGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSADL 689
SGDS +EMVESLRV YLCTA+SPGKRPTMQQVLGLLKDI PS L
Sbjct: 637 SGDSESEMVESLRVAYLCTAESPGKRPTMQQVLGLLKDIHPSHAL 681
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147820561|emb|CAN69833.1| hypothetical protein VITISV_009178 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 772 bits (1994), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 424/673 (63%), Positives = 511/673 (75%), Gaps = 36/673 (5%)
Query: 19 AQSTCNSK-DQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWK 77
A+STCNS D +LV KA V+ FN SW+K + +G+ S P+REL SSRNLSG ISW+
Sbjct: 21 AESTCNSTTDSKLVLKAXKGVTGFNSSWVKSHD-HGNCSSPPMRELKFSSRNLSGTISWE 79
Query: 78 FLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137
FLRNMS+L +IDLS+NSL+G VPGWFWS +SL +VNLS+NRFGG++GF+ G S+
Sbjct: 80 FLRNMSQLQAIDLSHNSLRGHVPGWFWSIRSLVKVNLSQNRFGGSVGFEGL---GSTSSM 136
Query: 138 QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIK 197
QVLNLS NRFTNLV+LS F L VLD+SNNDLR+LPSGF NL+KL HLDISSC ISGN+K
Sbjct: 137 QVLNLSDNRFTNLVRLSGFQALTVLDLSNNDLRVLPSGFENLTKLEHLDISSCNISGNLK 196
Query: 198 PVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHDKYQKFGKSAFI 257
P+S L L +LDVS+N+MNGTFPSDFPPL G++FLN+SLNKFTG +G + ++KFG SAFI
Sbjct: 197 PISSLRRLTHLDVSDNNMNGTFPSDFPPLIGLRFLNVSLNKFTGLIGSEFHKKFGNSAFI 256
Query: 258 QGGSFVFDTTKTPRPSNNHI--MPHVD------SSRTPPYKIVHKHNPAVQKHRSKAKAL 309
G+F T TP P H +PH S TPP+K + +H A +K +SK K L
Sbjct: 257 HAGNFNVSKTATP-PIGPHSTPLPHKPLLELRPHSSTPPHKPLPEH-LAKKKRKSKPKLL 314
Query: 310 VIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVNQQLPFKVEKSGPFSFETE 369
V+ LSCASAF+ + +CM RR+ L RRN+WAISKP+ Q FK+EKSGPFSFETE
Sbjct: 315 VLSLSCASAFLVLAMAICTYCM-YRRRKLKRRNRWAISKPM--QAEFKMEKSGPFSFETE 371
Query: 370 SGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKESLLAEGRCGPVYRAVLP 429
SGTSW+ADIKEP+SA V+M KPL+N LTFKDLIAATSHFGKES LAEGRCGPVYRAVLP
Sbjct: 372 SGTSWVADIKEPSSAPVVMFEKPLMN-LTFKDLIAATSHFGKESQLAEGRCGPVYRAVLP 430
Query: 430 GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGD 489
G++HVAIKVL+NA+ +DH+DAV MF+ L+RLKHPNLLPL+GYCIAG+EKLVL EFMANGD
Sbjct: 431 GDIHVAIKVLENARSVDHNDAVPMFESLARLKHPNLLPLSGYCIAGREKLVLYEFMANGD 490
Query: 490 LHRWLHELPTGEPNVEDWSTDTWDH-HPGAG-SHISSPEKTNWVTRHRIAIGVARGLAYL 547
LHRWLHELPTG PNVEDWSTDTW+H + G S SSPEK W TRHRIA+G ARGLAYL
Sbjct: 491 LHRWLHELPTGAPNVEDWSTDTWEHINDGESVSRASSPEKMEWRTRHRIAVGXARGLAYL 550
Query: 548 HHVGST---HGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSENETCGPESDVYCFG 604
HH GS HGHLV S++LLA+ EP+IA FGLR + + E+DVYCFG
Sbjct: 551 HHAGSKPIFHGHLVASNVLLADDFEPRIADFGLRR----------DRDIGNTEADVYCFG 600
Query: 605 VILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTA 664
V+L+ELLTGK G+++ + W RKLVK+ G +ALD RL +G GDSV+EMVE LRVGYL
Sbjct: 601 VVLIELLTGKPGSEETIAWARKLVKDRLGVNALDPRLGVG-GDSVSEMVECLRVGYLYVR 659
Query: 665 DSP-GKRPTMQQV 676
S GK P ++
Sbjct: 660 PSHLGKDPQCNRL 672
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297740518|emb|CBI30700.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 764 bits (1972), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 413/682 (60%), Positives = 496/682 (72%), Gaps = 87/682 (12%)
Query: 15 LVVLAQSTCNSK-DQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGI 73
+VV A+STCNS D +LV KAF V+ FN SW+K + +G+ S P+REL SSRNLSG
Sbjct: 1 MVVAAESTCNSTTDSKLVLKAFKGVTGFNSSWVKSHD-HGNCSSPPMRELKFSSRNLSGT 59
Query: 74 ISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGP 133
ISW+FLRNMS+L +IDLS+NSL+G VPGWFWS +SL +VNLS+NRFGG++GF+ G
Sbjct: 60 ISWEFLRNMSQLQAIDLSHNSLRGHVPGWFWSIRSLVKVNLSQNRFGGSVGFEGL---GS 116
Query: 134 FPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS 193
S+QVLNLS NRFTNLV+LS F L VLD+SNNDLR+LPSG
Sbjct: 117 TSSMQVLNLSDNRFTNLVRLSGFQALTVLDLSNNDLRVLPSG------------------ 158
Query: 194 GNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHDKYQKFGK 253
L L +LDVS+N+MNGTFPSDFPPL G++FLN+SLNKFTG +G + ++KFG
Sbjct: 159 --------LRRLTHLDVSDNNMNGTFPSDFPPLIGLRFLNVSLNKFTGLIGSEFHKKFGN 210
Query: 254 SAFIQGGSFVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHKHNPAVQKHRSKAKALVIGL 313
SAFI G+F +K +SK K LV+ L
Sbjct: 211 SAFIHAGNFN------------------------------------KKRKSKPKLLVLSL 234
Query: 314 SCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVNQQLPFKVEKSGPFSFETESGTS 373
SCASAF+ + +CM RR+ L RRN+WAISKP+ Q FK+EKSGPFSFETESGTS
Sbjct: 235 SCASAFLVLAMAICTYCM-YRRRKLKRRNRWAISKPM--QAEFKMEKSGPFSFETESGTS 291
Query: 374 WMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELH 433
W+ADIKEP+SA V+M KPL+N LTFKDLIAATSHFGKES LAEGRCGPVYRAVLPG++H
Sbjct: 292 WVADIKEPSSAPVVMFEKPLMN-LTFKDLIAATSHFGKESQLAEGRCGPVYRAVLPGDIH 350
Query: 434 VAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRW 493
VAIKVL+NA+ +DH+DAV MF+ L+RLKHPNLLPL+GYCIAG+EKLVL EFMANGDLHRW
Sbjct: 351 VAIKVLENARSVDHNDAVPMFESLARLKHPNLLPLSGYCIAGREKLVLYEFMANGDLHRW 410
Query: 494 LHELPTGEPNVEDWSTDTWDH-HPGAG-SHISSPEKTNWVTRHRIAIGVARGLAYLHHVG 551
LHELPTG PNVEDWSTDTW+H + G S SSPEK W TRHRIA+GVARGLAYLHH G
Sbjct: 411 LHELPTGAPNVEDWSTDTWEHINDGESVSRASSPEKMEWRTRHRIAVGVARGLAYLHHAG 470
Query: 552 ST---HGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSENETCGPESDVYCFGVILM 608
S HGHLV S++LLA+ EP+IA FGLR + + E+DVYCFGV+L+
Sbjct: 471 SKPIFHGHLVASNVLLADDFEPRIADFGLRR----------DRDIGNTEADVYCFGVVLI 520
Query: 609 ELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPG 668
ELLTGK G+++ + W RKLVK+ G +ALD RL +G GDSV+EMVE LRVGYLCTA+SPG
Sbjct: 521 ELLTGKPGSEETIAWARKLVKDRLGVNALDPRLGVG-GDSVSEMVECLRVGYLCTAESPG 579
Query: 669 KRPTMQQVLGLLKDIRPSADLS 690
KRPTMQQV+GLLKDI P +L+
Sbjct: 580 KRPTMQQVVGLLKDIHPGPELN 601
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|358345477|ref|XP_003636804.1| LRR receptor-like serine/threonine-protein kinase GSO1 [Medicago truncatula] gi|355502739|gb|AES83942.1| LRR receptor-like serine/threonine-protein kinase GSO1 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 758 bits (1958), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 403/698 (57%), Positives = 503/698 (72%), Gaps = 48/698 (6%)
Query: 19 AQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKF 78
+ S+CN++++ L+SKAF SVS FN + + + N S I EL S+NLSG ISW++
Sbjct: 19 SSSSCNNENKNLISKAFQSVSGFNTTLFQTKSFNCSKGQINIIEL--PSKNLSGNISWRY 76
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQS-LTQVNLSKNRFGGTIGFK--PTSRNGPFP 135
LRNM+ L +DLS N L+G VP WFWS+ S L+ VNLS NRFGGTI FK P S+NG
Sbjct: 77 LRNMTNLVFLDLSGNYLQGQVPNWFWSSSSNLSTVNLSNNRFGGTIAFKTKPISQNGS-- 134
Query: 136 SVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGN 195
++Q LNLS NRFTN + LS F L +LD+S+N+L LPSGF NL+KL +LD+S+C I GN
Sbjct: 135 TLQNLNLSHNRFTNQLHLSFFQNLKILDLSHNNLNTLPSGFQNLTKLNYLDLSNCNIIGN 194
Query: 196 IKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHDKY-QKFGKS 254
IKP+S+L SL +L++SNNS+NG+FPSDFP L+ +KFLNIS N F + + +KFGKS
Sbjct: 195 IKPISYLTSLSFLNLSNNSLNGSFPSDFPSLNNLKFLNISNNNFKSSTSLNNFIKKFGKS 254
Query: 255 AFIQGGSFV--FDTTKTPRPSNN---------HIMPHVDSSRTPPYKIVHKHNPAVQKHR 303
+FI + ++TTK P +N H + ++T P + KH K +
Sbjct: 255 SFIHNNFNLNHYNTTKKPNIHSNSNSISTLKHHHQQQLHVTKTKPIQTKPKH-----KQK 309
Query: 304 SKAKALVI-GLSCASAFVFVFGIAIIFCMC-----RRRKILARRNKWAIS--KPVNQ-QL 354
SK K ++I ++ AS +FV + C+C RR++ LA++NKWAIS KP+
Sbjct: 310 SKTKTMIIVAVTSASTLIFV-----VLCLCAFFGYRRKRKLAQKNKWAISISKPMTGLTT 364
Query: 355 PFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKESL 414
K+EKSGPF+FETESGTSW+AD+KEPTSA+V+M KPL+N ++F DL+ ATS+FGK+S
Sbjct: 365 TVKMEKSGPFAFETESGTSWVADLKEPTSASVVMFEKPLMN-ISFMDLMNATSYFGKDSQ 423
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA 474
LAEGRCGPVYRAVLPGELHVAIKVL+NA+ +DHDDAV F +LS+LKHPNLLPL+GYCIA
Sbjct: 424 LAEGRCGPVYRAVLPGELHVAIKVLENAREVDHDDAVDTFVDLSKLKHPNLLPLSGYCIA 483
Query: 475 GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRH 534
GKEKLVL EFM+NGDL RW+HELPTGE NVEDWS+DTW+ G GS SSPEK W TRH
Sbjct: 484 GKEKLVLYEFMSNGDLGRWMHELPTGETNVEDWSSDTWEIQNGTGSRASSPEKMGWPTRH 543
Query: 535 RIAIGVARGLAYLHHVGS---THGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSEN 591
RIA+GVARGLA+LHH GS HGHLVTS++LLA+ EP+IA FG R G +
Sbjct: 544 RIALGVARGLAFLHHAGSRPVVHGHLVTSNVLLADDFEPRIADFGFRKFG------QQCP 597
Query: 592 ETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAE 651
C E+DVYCFGV+LMELLTGK GT + V WVRKLV+E G ALD RLKLG GD ++
Sbjct: 598 PNCSTETDVYCFGVVLMELLTGKPGTAETVVWVRKLVRESHGVRALDDRLKLGGGDLESQ 657
Query: 652 MVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSADL 689
MVESLRV YLCTA+SPGKRPTMQQVLGLLKDI P L
Sbjct: 658 MVESLRVAYLCTAESPGKRPTMQQVLGLLKDIHPKNGL 695
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 690 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 3e-29 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-28 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 8e-24 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-23 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-19 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-18 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-17 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-16 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-14 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 7e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-13 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-12 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-12 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-12 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 8e-12 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-11 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-11 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-11 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-11 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 9e-10 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 2e-09 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-09 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 5e-09 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 5e-09 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 5e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 6e-09 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 6e-09 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 8e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 8e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 9e-09 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-08 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-08 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 3e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 6e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-07 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-07 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-07 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 5e-07 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 6e-07 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-06 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 3e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-06 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 4e-06 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 7e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-05 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-05 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-05 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 2e-05 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-05 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 9e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-04 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-04 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 3e-04 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 4e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-04 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-04 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 7e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-04 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 7e-04 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam12799 | 43 | pfam12799, LRR_4, Leucine Rich repeats (2 copies) | 0.001 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.001 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 0.001 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 0.001 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 0.002 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 0.002 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 0.002 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 0.002 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 0.002 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 0.002 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.003 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.003 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.003 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 0.003 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.004 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 0.004 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 0.004 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 0.004 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.004 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 3e-29
Identities = 152/647 (23%), Positives = 266/647 (41%), Gaps = 128/647 (19%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+R + L + SG + +F + + ++ +D+SNN+L+G + W SL ++L++N+F
Sbjct: 406 LRRVRLQDNSFSGELPSEFTK-LPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKF 464
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLR-ILPSGF 176
G + S+ ++ L+LS N+F+ V KL S+LM L +S N L +P
Sbjct: 465 FGGLPDSFGSKR-----LENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDEL 519
Query: 177 ANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNI 234
++ KL LD+S ++SG I P SF + L LD+S N ++G P + + + +NI
Sbjct: 520 SSCKKLVSLDLSHNQLSGQI-PASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNI 578
Query: 235 SLNKFTGFVGHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHK 294
S N G + G+F+ + N + +S PP K V K
Sbjct: 579 SHNHLHG-------------SLPSTGAFL-AINASAVAGNIDLCGGDTTSGLPPCKRVRK 624
Query: 295 HNPAVQKHRSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKPVNQQL 354
+ + I + AF+ + +A F R R L +
Sbjct: 625 ---------TPSWWFYITCTLG-AFLVLALVAFGFVFIRGRNNLELK------------- 661
Query: 355 PFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKESL 414
+VE E GT + S ++ T D++++ +E++
Sbjct: 662 --RVEN--------EDGTWELQFFDSKVSKSI-----------TINDILSSLK---EENV 697
Query: 415 LAEGRCGPVYRA-VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCI 473
++ G+ G Y+ + + +K +++ I + ++ +L+HPN++ L G C
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR 753
Query: 474 AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTR 533
+ K ++ E++ +L L L +W R
Sbjct: 754 SEKGAYLIHEYIEGKNLSEVLRNL-------------------------------SWERR 782
Query: 534 HRIAIGVARGLAYLHHVGSTH---GHLVTSSILLAESLEPK--IAGFGLRNIGVKNVG-- 586
+IAIG+A+ L +LH S G+L I++ EP ++ GL K
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISS 842
Query: 587 -----ERSENETCGPESDVYCFGVILMELLTGKRGTD-------DCVKWVRKLVKEGAGG 634
E E + +SD+Y FG+IL+ELLTGK D V+W R +
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLD 902
Query: 635 DALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681
+D ++ + E+VE + + CTA P RP VL L+
Sbjct: 903 MWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-28
Identities = 71/299 (23%), Positives = 115/299 (38%), Gaps = 71/299 (23%)
Query: 415 LAEGRCGPVYRAVL----PGELHVAIKVLDNAKGIDHDDAVAMFDEL---SRLKHPNLLP 467
L EG G VY+ L VA+K L ++ E +L HPN++
Sbjct: 3 LGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDA--SEEERKDFLKEARVMKKLGHPNVVR 60
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
L G C + ++LE+M GDL +L + P+ E S +S +
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEK-------------STLSLKDL 107
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVG 586
AI +A+G+ YL H L + L+ E L KI+ FGL R++ +
Sbjct: 108 L------SFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY 161
Query: 587 ERSEN----------ET-----CGPESDVYCFGVILMELLT-------GKRGTDDCVKWV 624
+ E+ +SDV+ FGV+L E+ T G + V
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE-----V 216
Query: 625 RKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681
+ +++G +RL D + E++ S C P RPT +++ L+
Sbjct: 217 LEYLRKG-------YRLPKPEYCPDELYELMLS------CWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 76/307 (24%), Positives = 120/307 (39%), Gaps = 84/307 (27%)
Query: 408 HFGKESLLAEGRCGPVYRAVL-----PGELHVAIKVLDNAKGIDHDDAVAMFDE---LSR 459
GK+ L EG G VY+ L E VA+K L G ++ +E + +
Sbjct: 2 ELGKK--LGEGAFGEVYKGTLKGDGEGTETKVAVKTLKE--GASEEEREEFLEEASIMKK 57
Query: 460 LKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
L HPN++ L G C G+ ++ E+M GDL +L +
Sbjct: 58 LSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK----------------------- 94
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-R 578
EK ++A+ +A+G+ YL H L + L+ E+L KI+ FGL R
Sbjct: 95 ----HGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSR 150
Query: 579 NIGVKNVGERSENET-----CGPE----------SDVYCFGVILMELLT-------GKRG 616
+I + + PE SDV+ FGV+L E+ T G
Sbjct: 151 DIYEDDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN 210
Query: 617 TDDCVKWVRKLVKEGAGGDALDFRLK--LGSGDSVAE-MVESLRVGYLCTADSPGKRPTM 673
+ V +L+++G +RL D + E M++ C A P RPT
Sbjct: 211 EE-----VLELLEDG-------YRLPRPENCPDELYELMLQ-------CWAYDPEDRPTF 251
Query: 674 QQVLGLL 680
+++ L
Sbjct: 252 SELVEDL 258
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 8e-24
Identities = 70/303 (23%), Positives = 119/303 (39%), Gaps = 81/303 (26%)
Query: 411 KESLLAEGRCGPVYRAVLPGELH-----VAIKVLDNAKGIDHDDAVAMF-DE---LSRLK 461
L EG G VY+ L G+ VA+K L K + + F E + +L
Sbjct: 3 LGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTL---KEDASEQQIEEFLREARIMRKLD 59
Query: 462 HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521
HPN++ L G C + +++E+M GDL +L + P
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLR-----------------KNRP----K 98
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNI 580
+S + ++ A+ +ARG+ YL H L + L+ E+L KI+ FGL R++
Sbjct: 99 LSLSDLLSF------ALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 152
Query: 581 G----VKNVGERS----------ENETCGPESDVYCFGVILMELLT-------GKRGTDD 619
+ G + + +SDV+ FGV+L E+ T G +
Sbjct: 153 YDDDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE- 211
Query: 620 CVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
V + +K G +RL + +++ C A+ P RPT +++
Sbjct: 212 ----VLEYLKNG-------YRLPQPPNCPPELYDLMLQ------CWAEDPEDRPTFSELV 254
Query: 678 GLL 680
+L
Sbjct: 255 EIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 3e-23
Identities = 69/303 (22%), Positives = 120/303 (39%), Gaps = 80/303 (26%)
Query: 411 KESLLAEGRCGPVYRAVLPGELH-----VAIKVLDNAKGIDHDDAVAMF-DE---LSRLK 461
L EG G VY+ L G+ VA+K L K + + F E + +L
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTL---KEDASEQQIEEFLREARIMRKLD 59
Query: 462 HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521
HPN++ L G C + ++++E+M GDL +L +
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRK------------------------- 94
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNI 580
+ P++ + A+ +ARG+ YL H L + L+ E+L KI+ FGL R++
Sbjct: 95 -NRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDL 153
Query: 581 GVKNV----GERS----------ENETCGPESDVYCFGVILMELLT-------GKRGTDD 619
+ G + + +SDV+ FGV+L E+ T G +
Sbjct: 154 YDDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAE- 212
Query: 620 CVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
V + +K+G +RL + +++ C A+ P RPT +++
Sbjct: 213 ----VLEYLKKG-------YRLPKPPNCPPELYKLMLQ------CWAEDPEDRPTFSELV 255
Query: 678 GLL 680
+L
Sbjct: 256 EIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 5e-19
Identities = 52/216 (24%), Positives = 77/216 (35%), Gaps = 49/216 (22%)
Query: 415 LAEGRCGPVYRAVLPGELH-VAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAG 470
L EG G VY A VAIK++ K + E L +L HPN++ L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIK--KEDSSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
+++E+ G L L E
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLS---------------------------E 91
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL-AESLEPKIAGFGL-RNIGVKNVGER 588
RI + + GL YLH G H L +ILL +++ + K+A FGL + + +
Sbjct: 92 DEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLK 151
Query: 589 SENET--------------CGPESDVYCFGVILMEL 610
+ T +SD++ GVIL EL
Sbjct: 152 TIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 70/290 (24%), Positives = 100/290 (34%), Gaps = 60/290 (20%)
Query: 411 KESLLAEGRCGPVYRAVLPGE-LHVAIKVLDNAKGIDHDDAVAMFDELS---RLKHPNLL 466
L G G VY+A G VA+K+L + E+ RL HPN++
Sbjct: 3 LLRKLGSGSFGTVYKAKHKGTGKIVAVKIL-KKRSEKSKKDQTARREIRILRRLSHPNIV 61
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L +++E+ GDL +L E
Sbjct: 62 RLIDAFEDKDHLYLVMEYCEGGDLFDYLSR------------------------GGPLSE 97
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
+ IA+ + RGL YLH G H L +ILL E+ KIA FGL +K+
Sbjct: 98 ---DEAKK-IALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSS 153
Query: 587 ERSEN----ETCGPE-----------SDVYCFGVILMELLTGK----RGTDDCVKWVRKL 627
+ PE DV+ GVIL ELLTGK + +
Sbjct: 154 SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRR 213
Query: 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+ S +E + L + D P KRPT +++L
Sbjct: 214 ILGP------PLEFDEPKWSSGSEEAKDL-IKKCLNKD-PSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 88.0 bits (218), Expect = 6e-18
Identities = 70/209 (33%), Positives = 104/209 (49%), Gaps = 14/209 (6%)
Query: 50 NLNGSNPS-----TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFW 104
NL G PS ++ L L LSG I + ++ +L S+DLS+NSL G +P
Sbjct: 247 NLTGPIPSSLGNLKNLQYLFLYQNKLSGPIP-PSIFSLQKLISLDLSDNSLSGEIPELVI 305
Query: 105 STQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVL 162
Q+L ++L N F G I TS P +QVL L SN+F+ + L + + L VL
Sbjct: 306 QLQNLEILHLFSNNFTGKIPVALTS----LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVL 361
Query: 163 DVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNSMNGTFP 220
D+S N+L +P G + L L + S + G I + SL+ + + +NS +G P
Sbjct: 362 DLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELP 421
Query: 221 SDFPPLSGVKFLNISLNKFTGFVGHDKYQ 249
S+F L V FL+IS N G + K+
Sbjct: 422 SEFTKLPLVYFLDISNNNLQGRINSRKWD 450
|
Length = 968 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 67/230 (29%), Positives = 102/230 (44%), Gaps = 47/230 (20%)
Query: 415 LAEGRCGPVYRA----VLPGE--LHVAIKVL------DNAKGIDHDDAV-AMFDELSRLK 461
+ +G G V++A +LP E VA+K+L D + A+ A FD
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD------ 66
Query: 462 HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWL-HELPTGEPNVEDWSTDTWDHHPGAGS 520
HPN++ L G C GK +L E+MA GDL+ +L H P + ++ H + +
Sbjct: 67 HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLS---------HSTSSA 117
Query: 521 HISSPEKTNWVTRHRIAIG--VARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL- 577
++ I VA G+AYL H L T + L+ E++ KIA FGL
Sbjct: 118 RKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
Query: 578 RNIGVKNVGERSENETC---------------GPESDVYCFGVILMELLT 612
RNI + + SEN+ ESDV+ +GV+L E+ +
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 3e-17
Identities = 65/235 (27%), Positives = 100/235 (42%), Gaps = 43/235 (18%)
Query: 402 LIAATSHFGKESLLAEGRCGPVYRA--VLPGELH----VAIKVL-DNAKGIDHDDAVAMF 454
+ + F +E L EG G VY+ P E VAIK L +NA+ +
Sbjct: 2 IPLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEA 59
Query: 455 DELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWL-HELPTGEPNVEDWSTDTWD 513
+ +S L+HPN++ L G C + +L E++A+GDLH +L P + E
Sbjct: 60 ELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV-- 117
Query: 514 HHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYL--HHVGSTHGHLVTSSILLAESLEPK 571
S + + + IAI +A G+ YL HH H L + L+ E L K
Sbjct: 118 -----KSSLDCSDFLH------IAIQIAAGMEYLSSHHF--VHRDLAARNCLVGEGLTVK 164
Query: 572 IAGFGLRNIGVKNVGERSENETCGP----------------ESDVYCFGVILMEL 610
I+ FGL R ++++ P ESD++ FGV+L E+
Sbjct: 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 59/222 (26%), Positives = 85/222 (38%), Gaps = 44/222 (19%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
F E L G G V+ + + VAIK+L + + D L RL+H +L+
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLI 65
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L C G+ ++ E M G L +L SPE
Sbjct: 66 SLFAVCSVGEPVYIITELMEKGSLLAFL----------------------------RSPE 97
Query: 527 KTNWVTRHRIAIG--VARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL------- 577
I + VA G+AYL S H L +IL+ E L K+A FGL
Sbjct: 98 GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157
Query: 578 ------RNIGVK-NVGERSENETCGPESDVYCFGVILMELLT 612
+ I K E + + T +SDV+ FG++L E+ T
Sbjct: 158 VYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFT 199
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-16
Identities = 80/266 (30%), Positives = 118/266 (44%), Gaps = 53/266 (19%)
Query: 22 TCNSKDQ----ELVSKAFS---SVSTFNISWLKPTNLNGSNPSTPI-----------REL 63
TCN+ + +L K S S + F + +++ NL+ + S PI R L
Sbjct: 64 TCNNSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYL 123
Query: 64 NLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTI 123
NLS+ N +G I + N L ++DLSNN L G +P S SL ++L N G I
Sbjct: 124 NLSNNNFTGSIPRGSIPN---LETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKI 180
Query: 124 GFKPTSRNGPFPSVQVLNLSSNRFT---------------------NL-----VKLSQFS 157
P S S++ L L+SN+ NL ++ +
Sbjct: 181 ---PNSL-TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLT 236
Query: 158 KLMVLD-VSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF-LHSLKYLDVSNNSM 215
L LD V NN +PS NL L++L + K+SG I P F L L LD+S+NS+
Sbjct: 237 SLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSL 296
Query: 216 NGTFPSDFPPLSGVKFLNISLNKFTG 241
+G P L ++ L++ N FTG
Sbjct: 297 SGEIPELVIQLQNLEILHLFSNNFTG 322
|
Length = 968 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-16
Identities = 59/210 (28%), Positives = 107/210 (50%), Gaps = 22/210 (10%)
Query: 24 NSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPS-----TPIRELNLSSRNLSGIIS--- 75
NS + E + K+ + + L+ + +G PS + L++S+ NL G I+
Sbjct: 390 NSLEGE-IPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRK 448
Query: 76 WKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFP 135
W +M L + L+ N G +P F S + L ++LS+N+F G + + G
Sbjct: 449 W----DMPSLQMLSLARNKFFGGLPDSFGSKR-LENLDLSRNQFSGAV----PRKLGSLS 499
Query: 136 SVQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLR-ILPSGFANLSKLRHLDISSCKI 192
+ L LS N+ + + +LS KL+ LD+S+N L +P+ F+ + L LD+S ++
Sbjct: 500 ELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQL 559
Query: 193 SGNIKP-VSFLHSLKYLDVSNNSMNGTFPS 221
SG I + + SL +++S+N ++G+ PS
Sbjct: 560 SGEIPKNLGNVESLVQVNISHNHLHGSLPS 589
|
Length = 968 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 4e-14
Identities = 54/213 (25%), Positives = 88/213 (41%), Gaps = 42/213 (19%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA 474
L G+ G V+ + VA+K L +D D +A + +L+HP L+ L C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTL 72
Query: 475 GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRH 534
+ ++ E M G L +L GAG + P+ +
Sbjct: 73 EEPIYIVTELMKYGSLLEYLQG--------------------GAGRALKLPQLID----- 107
Query: 535 RIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSEN--- 591
+A VA G+AYL H L ++L+ E+ K+A FGL + +++ E E
Sbjct: 108 -MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKF 166
Query: 592 --ETCGPE----------SDVYCFGVILMELLT 612
+ PE SDV+ FG++L E++T
Sbjct: 167 PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 71.8 bits (177), Expect = 7e-14
Identities = 70/284 (24%), Positives = 98/284 (34%), Gaps = 60/284 (21%)
Query: 414 LLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLA 469
L EG G VY A VAIKV+ K + + E L +LKHPN++ L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILR--EIKILKKLKHPNIVRLY 63
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTN 529
+ +++E+ GDL L + E
Sbjct: 64 DVFEDEDKLYLVMEYCEGGDLFDLLKK------------------------RGRLSED-- 97
Query: 530 WVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL----RNIGVKN- 584
R + L YLH G H L +ILL E K+A FGL
Sbjct: 98 -EARF-YLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTT 155
Query: 585 -VG-------ERSENETCGPESDVYCFGVILMELLTGK---RGTDDCVKWVRKLVKEGAG 633
VG E + G D++ GVIL ELLTGK G D ++ +K+ K
Sbjct: 156 FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGK---- 211
Query: 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+ +++ L D P KR T ++ L
Sbjct: 212 PKPPFPPPEWDISPEAKDLIRK-----LLVKD-PEKRLTAEEAL 249
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 62/232 (26%), Positives = 93/232 (40%), Gaps = 52/232 (22%)
Query: 415 LAEGRCGPVYRA----VLPGE--LHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPN 464
L EG G V+ + P VA+K L K +DA F+ L+ +H N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTL---KETASNDARKDFEREAELLTNFQHEN 69
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
++ G C G +++ E+M +GDL+++L H P A S
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRS-----------------HGPDAAFLKSP 112
Query: 525 PEKTNWVTR---HRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNI 580
+T +IA+ +A G+ YL H L T + L+ L KI FG+ R++
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV 172
Query: 581 GVKNVGERSENETCGP----------------ESDVYCFGVILMELLT-GKR 615
R T P ESDV+ FGV+L E+ T GK+
Sbjct: 173 -YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 4e-13
Identities = 52/192 (27%), Positives = 97/192 (50%), Gaps = 10/192 (5%)
Query: 50 NLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSL 109
N++ T + L+L + N++ I L S L +DLS+N ++ S+P + +L
Sbjct: 108 NISELLELTNLTSLDLDNNNITDIPPLIGL-LKSNLKELDLSDNKIE-SLPSPLRNLPNL 165
Query: 110 TQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNL-VKLSQFSKLMVLDVSNND 168
++LS N + P + ++ L+LS N+ ++L ++ S L LD+SNN
Sbjct: 166 KNLDLSFND----LSDLPKLLSNL-SNLNNLDLSGNKISDLPPEIELLSALEELDLSNNS 220
Query: 169 LRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG 228
+ L S +NL L L++S+ K+ + + L +L+ LD+SNN + S L+
Sbjct: 221 IIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNN--QISSISSLGSLTN 278
Query: 229 VKFLNISLNKFT 240
++ L++S N +
Sbjct: 279 LRELDLSGNSLS 290
|
Length = 394 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 33/224 (14%)
Query: 415 LAEGRCGPVYRAV------LPGELHVAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLLP 467
L EG G V +A G VA+K+L +NA + D ++ F+ L ++ HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEP---NVEDWSTDTWDHHPGAGSHISS 524
L G C L+++E+ G L +L E P + ++ +P
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE------ 121
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNI--- 580
A ++RG+ YL + H L ++L+AE + KI+ FGL R++
Sbjct: 122 -RALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEE 180
Query: 581 --GVKNVGERSENETCGPE----------SDVYCFGVILMELLT 612
VK R + E SDV+ FGV+L E++T
Sbjct: 181 DSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 76/298 (25%), Positives = 125/298 (41%), Gaps = 69/298 (23%)
Query: 411 KESL-----LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKH 462
+ESL L +G G V+ G VAIK L + A E + +L+H
Sbjct: 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRH 60
Query: 463 PNLLPLAGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521
L+PL Y + +E + ++ EFM G L +L E G G +
Sbjct: 61 DKLVPL--YAVVSEEPIYIVTEFMGKGSLLDFLKE--------------------GDGKY 98
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIG 581
+ P+ + +A +A G+AY+ + H L ++IL+ ++L KIA FGL +
Sbjct: 99 LKLPQLVD------MAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLI 152
Query: 582 VKN-----VGERSENETCGPE----------SDVYCFGVILMELLTGKRGTDDCVKWVRK 626
N G + + PE SDV+ FG++L EL+T R V +
Sbjct: 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR-----VPYPGM 207
Query: 627 LVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682
+ +E +R+ G +S+ E+++ LC P +RPT + + L+D
Sbjct: 208 VNREVLEQVERGYRMPCPQGCPESLHELMK------LCWKKDPDERPTFEYIQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 55/230 (23%), Positives = 91/230 (39%), Gaps = 57/230 (24%)
Query: 412 ESLLAEGRCGPVYRAVL--PG--ELHVAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLL 466
E ++ G G V R L PG E+ VAIK L + D + + + HPN++
Sbjct: 9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L G + +++ E+M NG L ++L + G
Sbjct: 69 RLEGVVTKSRPVMIITEYMENGSLDKFLR------------------ENDG--------- 101
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNV 585
K + G+A G+ YL + H L +IL+ +L K++ FGL R +
Sbjct: 102 KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE- 160
Query: 586 GERSENETCG---------PE----------SDVYCFGVILMELLT-GKR 615
+ T G PE SDV+ FG+++ E+++ G+R
Sbjct: 161 ---ATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 7e-12
Identities = 56/228 (24%), Positives = 86/228 (37%), Gaps = 52/228 (22%)
Query: 414 LLAEGRCGPVYRAVLPGE----LHVAIKVLDNAKGIDHDDAVAMFDELSRLK---HPNLL 466
+L EG G V L + L VA+K + + + E + +K HPN++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFDHPNVM 64
Query: 467 PLAGYCIAGKEK------LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
L G C +V+L FM +GDLH +L G
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG------------------- 105
Query: 521 HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RN 579
PEK T + + +A G+ YL + H L + +L E + +A FGL +
Sbjct: 106 ---LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKK 162
Query: 580 I--------------GVKNVG-ERSENETCGPESDVYCFGVILMELLT 612
I VK + E + +SDV+ FGV + E+ T
Sbjct: 163 IYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 210
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 8e-12
Identities = 69/295 (23%), Positives = 108/295 (36%), Gaps = 82/295 (27%)
Query: 411 KESLLAEGRCGPVYRAVLPGELHVAIKVL-DNAKGIDHDDAVAMFDELS---RLKHPNLL 466
+ + +G G V G+ VA+K L D++ A E S L+HPNL+
Sbjct: 10 LGATIGKGEFGDVMLGDYRGQ-KVAVKCLKDDSTAAQ-----AFLAEASVMTTLRHPNLV 63
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L G + G ++ E+MA G L +L G +
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSLVDYLRS---------------------RGRAV---- 98
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
+ A+ V G+ YL H L ++L++E L K++ FGL
Sbjct: 99 -ITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK------- 150
Query: 587 ERSENETCG--------PE----------SDVYCFGVILMELLTGKR------GTDDCVK 622
E S+ + G PE SDV+ FG++L E+ + R D V
Sbjct: 151 EASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
V K G +A + G V ++++ C P KRPT +Q+
Sbjct: 211 HVEK----GYRMEAPE-----GCPPEVYKVMKD------CWELDPAKRPTFKQLR 250
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 64/252 (25%), Positives = 103/252 (40%), Gaps = 70/252 (27%)
Query: 9 LLFSLSLVVLAQSTCNSKDQELVSKAFSSV-------STFNIS-----WLKPTNLNGSNP 56
L+F L + L S ++++ EL+ SS+ S +N S W T N S
Sbjct: 12 LIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCLWQGITCNNSSR- 70
Query: 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPG-WFWSTQSLTQVNLS 115
+ ++LS +N+SG IS R + + +I+LSNN L G +P F ++ SL +NLS
Sbjct: 71 ---VVSIDLSGKNISGKISSAIFR-LPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLS 126
Query: 116 KNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG 175
N F G+I P G
Sbjct: 127 NNNFTGSI-------------------------------------------------PRG 137
Query: 176 FANLSKLRHLDISSCKISGNI-KPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNI 234
+ L LD+S+ +SG I + SLK LD+ N + G P+ L+ ++FL +
Sbjct: 138 S--IPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTL 195
Query: 235 SLNKFTGFVGHD 246
+ N+ G + +
Sbjct: 196 ASNQLVGQIPRE 207
|
Length = 968 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 79/297 (26%), Positives = 130/297 (43%), Gaps = 48/297 (16%)
Query: 412 ESLLAEGRCGPVYRAVLPGE---LHVAIKVLDN-AKGIDHDDAVAMFDELSRL-KHPNLL 466
E ++ EG G V RA++ + ++ AIK+L A DH D + L +L HPN++
Sbjct: 7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTD-TWDHHPGAGSHISSP 525
L G C + +E+ G+L +L + E TD + G S ++S
Sbjct: 67 NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLE-------TDPAFAKEHGTASTLTSQ 119
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-------- 577
+ + A VA G+ YL H L ++L+ E+L KIA FGL
Sbjct: 120 QLL------QFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV 173
Query: 578 -RNIG---VKNVGERSENETC-GPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGA 632
+ +G V+ + S N + +SDV+ FGV+L E+++ GT C +L ++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS-LGGTPYCGMTCAELYEKLP 232
Query: 633 GGDALDFRLKL--GSGDSVAEMVESLRVGYLCTADSPGKRPTMQQV---LGLLKDIR 684
G +R++ D V E++ C D P +RP Q+ L + + R
Sbjct: 233 QG----YRMEKPRNCDDEVYELMRQ------CWRDRPYERPPFAQISVQLSRMLEAR 279
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 75/310 (24%), Positives = 114/310 (36%), Gaps = 88/310 (28%)
Query: 415 LAEGRCGPVYRAVLPG------ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKH---PNL 465
L +G G VY + G E VAIK ++ + + + +E S +K ++
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMR--ERIEFLNEASVMKEFNCHHV 71
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G G+ LV++E MA GDL +L P + +
Sbjct: 72 VRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPE---------AENNPGLGPPTLQ 119
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN 584
+ A +A G+AYL H L + ++AE L KI FG+ R+I
Sbjct: 120 KFIQM------AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDI---- 169
Query: 585 VGERSENET---------------CGPE----------SDVYCFGVILMELLT------- 612
ET PE SDV+ FGV+L E+ T
Sbjct: 170 ------YETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223
Query: 613 GKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT 672
G + V K V + G LD L D + E++ +C +P RPT
Sbjct: 224 GLSNEE-----VLKFVID---GGHLD--LPENCPDKLLELMR------MCWQYNPKMRPT 267
Query: 673 MQQVLGLLKD 682
+++ LKD
Sbjct: 268 FLEIVSSLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-11
Identities = 58/184 (31%), Positives = 89/184 (48%), Gaps = 12/184 (6%)
Query: 63 LNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGT 122
L L S SG I K L + L +DLS N+L G +P S+ +L ++ L N G
Sbjct: 337 LQLWSNKFSGEIP-KNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGE 395
Query: 123 IGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQ-FSKLMV---LDVSNNDLR-ILPSGFA 177
I P S G S++ + L N F+ +L F+KL + LD+SNN+L+ + S
Sbjct: 396 I---PKSL-GACRSLRRVRLQDNSFSG--ELPSEFTKLPLVYFLDISNNNLQGRINSRKW 449
Query: 178 NLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
++ L+ L ++ K G + L+ LD+S N +G P LS + L +S N
Sbjct: 450 DMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509
Query: 238 KFTG 241
K +G
Sbjct: 510 KLSG 513
|
Length = 968 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 7e-11
Identities = 56/225 (24%), Positives = 87/225 (38%), Gaps = 53/225 (23%)
Query: 411 KESL-----LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKH 462
+ESL L G+ G V+ G VA+K L A E + +L+H
Sbjct: 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRH 60
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
L+ L C + ++ E+M+ G L +L G G +
Sbjct: 61 DKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKS--------------------GEGKKL 100
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL----- 577
P+ + +A +A G+AYL H L +IL+ E+L KIA FGL
Sbjct: 101 RLPQLVD------MAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIE 154
Query: 578 RNIGVKNVGERSENETCGPE----------SDVYCFGVILMELLT 612
+ G + + PE SDV+ FG++L E++T
Sbjct: 155 DDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 44/228 (19%)
Query: 415 LAEGRCGPVYRA----VLPGE--LHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPL 468
L EG G V+ A +LP + + VA+K L A D + L+ L+H +++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA----GSHISS 524
G C G+ L++ E+M +GDL+R+L H P A G +
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRS-----------------HGPDAKILAGGEDVA 115
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVK 583
P + IA +A G+ YL + H L T + L+ + L KI FG+ R+I
Sbjct: 116 PGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 175
Query: 584 N---VGERS---------EN---ETCGPESDVYCFGVILMELLT-GKR 615
+ VG R+ E+ ESD++ FGV+L E+ T GK+
Sbjct: 176 DYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQ 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 71/283 (25%), Positives = 121/283 (42%), Gaps = 43/283 (15%)
Query: 414 LLAEGRCGPVYRAVLPGE---LHVAIKVL-DNAKGIDHDDAVAMFDELSRL-KHPNLLPL 468
++ EG G V +A + + + AIK + + A DH D + L +L HPN++ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
G C + +E+ +G+L +L + E + + S +SS +
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE------TDPAFAIANSTASTLSSQQLL 115
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL---------RN 579
A VARG+ YL H L +IL+ E+ KIA FGL +
Sbjct: 116 ------HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 169
Query: 580 IG---VKNVGERSENETC-GPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGD 635
+G V+ + S N + SDV+ +GV+L E+++ GT C +L ++ G
Sbjct: 170 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-LGGTPYCGMTCAELYEKLPQG- 227
Query: 636 ALDFRLKL--GSGDSVAEMVESLRVGYLCTADSPGKRPTMQQV 676
+RL+ D V +++ C + P +RP+ Q+
Sbjct: 228 ---YRLEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQI 261
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 2e-10
Identities = 60/200 (30%), Positives = 89/200 (44%), Gaps = 32/200 (16%)
Query: 432 LHVAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490
L VA+K+L +A +D + LSRLK PN++ L G C+ ++ E+M NGDL
Sbjct: 47 LLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 491 HRWL--HELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH 548
+++L H L E N D IS + +A+ +A G+ YL
Sbjct: 107 NQFLSSHHLDDKEENGND-----AVPPAHCLPAISYSSLLH------VALQIASGMKYLS 155
Query: 549 HVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENETCGP----------- 596
+ H L T + L+ E+L KIA FG+ RN+ + R + P
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY-YRIQGRAVLPIRWMAWECILM 214
Query: 597 -----ESDVYCFGVILMELL 611
SDV+ FGV L E+L
Sbjct: 215 GKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 9e-10
Identities = 74/267 (27%), Positives = 116/267 (43%), Gaps = 45/267 (16%)
Query: 432 LHVAIKVL-DNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMANGD 489
+ VA+K+L D+A D D V+ + + + KH N++ L G C VL+E+ + G+
Sbjct: 45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGN 104
Query: 490 LHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT-NWVTRHRIAIGVARGLAYLH 548
L +L P D+S DT PE+ + A VARG+ YL
Sbjct: 105 LREYLR---ARRPPGMDYSFDT----------CKLPEEQLTFKDLVSCAYQVARGMEYLA 151
Query: 549 HVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSEN-----ETCGPE----- 597
H L ++L+ E KIA FGL R++ + +++ N + PE
Sbjct: 152 SQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR 211
Query: 598 -----SDVYCFGVILMELLT--GKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVA 650
SDV+ FGV+L E+ T G V+ + KL+KEG D +
Sbjct: 212 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK--------PANCTH 263
Query: 651 EMVESLRVGYLCTADSPGKRPTMQQVL 677
E+ +R C P +RPT +Q++
Sbjct: 264 ELYMIMRE---CWHAVPSQRPTFKQLV 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA 474
L G+ G V+ G VAIK L + + +A + + +L+HP L+ L Y +
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRL--YAVV 70
Query: 475 GKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTR 533
+E + ++ E+M NG L + L T E G ++ + +
Sbjct: 71 TQEPIYIITEYMENGSL---VDFLKTPE-----------------GIKLTINKLID---- 106
Query: 534 HRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN-----VGER 588
+A +A G+A++ H L ++IL++E+L KIA FGL + N G +
Sbjct: 107 --MAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAK 164
Query: 589 SENETCGPE----------SDVYCFGVILMELLTGKR 615
+ PE SDV+ FG++L E++T R
Sbjct: 165 FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 78/307 (25%), Positives = 114/307 (37%), Gaps = 83/307 (27%)
Query: 414 LLAEGRCGPVYRAVL------PGELHVAIKVL-DNAKGIDHDDAVAMFDELSRL-KHPNL 465
L EG G V +A VA+K+L D+A D D V+ + + + KH N+
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G C V++E+ A+G+L +L P E S D
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLR---ARRPPGEYASPD--------DPRPPEE 127
Query: 526 EKTNWVTRHRI--AIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGV 582
T + + A VARG+ +L H L ++L+ E KIA FGL R+I
Sbjct: 128 TLTQ---KDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHH 184
Query: 583 -----KNVGERSENETCGPE----------SDVYCFGVILMELLTGKRGTDDCVKWVRKL 627
K R + PE SDV+ FGV+L E+ T
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT--------------- 229
Query: 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGY------LCTAD-----------SPGKR 670
GG G V E+ + L+ GY CT + P +R
Sbjct: 230 ----LGGSPY-------PGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQR 278
Query: 671 PTMQQVL 677
PT +Q++
Sbjct: 279 PTFKQLV 285
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 53/197 (26%), Positives = 86/197 (43%), Gaps = 36/197 (18%)
Query: 434 VAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHR 492
VA+K+L ++A +D + +SRLK PN++ L CI ++ E+M NGDL++
Sbjct: 49 VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108
Query: 493 WLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS 552
+L H P + + ++ T +A +A G+ YL +
Sbjct: 109 FLSR-----------------HEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNF 151
Query: 553 THGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENETCGP--------------- 596
H L T + L+ ++ KIA FG+ RN+ + R + P
Sbjct: 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMSWESILLGKFT 210
Query: 597 -ESDVYCFGVILMELLT 612
SDV+ FGV L E+LT
Sbjct: 211 TASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 76/287 (26%), Positives = 127/287 (44%), Gaps = 45/287 (15%)
Query: 412 ESLLAEGRCGPVYRAVLPGE---LHVAIKVL-DNAKGIDHDDAVAMFDELSRL-KHPNLL 466
+ ++ EG G V +A + + + AIK + + A DH D + L +L HPN++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG-AGSHISSP 525
L G C + +E+ +G+L +L + E TD P A ++ ++
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLE-------TD-----PAFAIANSTAS 119
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL---RNIGV 582
++ H A VARG+ YL H L +IL+ E+ KIA FGL + + V
Sbjct: 120 TLSSQQLLH-FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV 178
Query: 583 KNVGER---------SENETC-GPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGA 632
K R S N + SDV+ +GV+L E+++ GT C +L ++
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS-LGGTPYCGMTCAELYEKLP 237
Query: 633 GGDALDFRLK--LGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
G +RL+ L D V +++ C + P +RP+ Q+L
Sbjct: 238 QG----YRLEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQIL 274
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 3e-09
Identities = 80/298 (26%), Positives = 125/298 (41%), Gaps = 53/298 (17%)
Query: 415 LAEGRCGPVYRAVLPG--------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL--KHP 463
L EG G V RA G + VA+K+L DNA D D ++ EL +L KH
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEM-ELMKLIGKHK 78
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ L G C V++E+ A G+L +L P D++ D +S
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLR---ARRPPGPDYTFDITKVPEE---QLS 132
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGV 582
+ + A VARG+ YL H L ++L+ E KIA FGL R +
Sbjct: 133 FKDLVS------CAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHD 186
Query: 583 KNVGERSEN-----ETCGPE----------SDVYCFGVILMELLT--GKRGTDDCVKWVR 625
+ +++ N + PE SDV+ FG+++ E+ T G V+ +
Sbjct: 187 IDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELF 246
Query: 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
KL++EG D + E+ +R C P +RPT +Q++ L +
Sbjct: 247 KLLREGHRMDK--------PSNCTHELYMLMRE---CWHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 60/235 (25%), Positives = 98/235 (41%), Gaps = 56/235 (23%)
Query: 407 SHFGKESLLAEGRCGPVYRAVL--PG--ELHVAIKVLDNAKGIDHDDAVAMFDELS---R 459
SH K+ ++ G G V+R +L PG E+ VAIK L G E S +
Sbjct: 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLK--PGYTEKQRQDFLSEASIMGQ 62
Query: 460 LKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
H N++ L G K +++ E+M NG L ++L + H G
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRD------------------HDGEF 104
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRN 579
S G+A G+ YL + H L +IL+ +LE K++ FGL
Sbjct: 105 SSYQLVGMLR---------GIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSR 155
Query: 580 IGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLT-GKR 615
+ +++ E + + G PE SDV+ FG+++ E+++ G+R
Sbjct: 156 V-LEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGER 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 72/300 (24%), Positives = 122/300 (40%), Gaps = 73/300 (24%)
Query: 411 KESL-----LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKH 462
+ESL L G+ G V+ G VA+K L + +E + +L+H
Sbjct: 5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRH 60
Query: 463 PNLLPLAGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521
L+ L Y + +E + ++ E+M+ G L +L + G G
Sbjct: 61 DKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKD--------------------GEGRA 98
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIG 581
+ P + +A VA G+AY+ + H L +++IL+ + L KIA FGL +
Sbjct: 99 LKLPNLVD------MAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLI 152
Query: 582 VKN-----VGERSENETCGPE----------SDVYCFGVILMELLTGKR----GTDDCVK 622
N G + + PE SDV+ FG++L EL+T R G ++ +
Sbjct: 153 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN--R 210
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682
V + V+ G +R+ D + E + C P +RPT + + L+D
Sbjct: 211 EVLEQVERG-------YRMPC-PQDCPISLHELM---LQCWKKDPEERPTFEYLQSFLED 259
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 70/288 (24%), Positives = 113/288 (39%), Gaps = 56/288 (19%)
Query: 409 FGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPL 468
F KE L G+ G V+ G++ VAIK++ + DD + + +L HPNL+ L
Sbjct: 8 FLKE--LGSGQFGVVHLGKWRGKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQL 64
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
G C + ++ E+MANG L +L E G T
Sbjct: 65 YGVCTKQRPIFIVTEYMANGCLLNYLRE------------------RKGK-------LGT 99
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN---- 584
W+ + V + YL G H L + L+ E K++ FGL + +
Sbjct: 100 EWLL--DMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157
Query: 585 -VGERSENETCGPE----------SDVYCFGVILMELLTGKRGTDDCVKWVR-KLVKEGA 632
G + + PE SDV+ FGV++ E+ + G ++ ++V+ +
Sbjct: 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE--GKMPYERFSNSEVVESVS 215
Query: 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680
G L R KL + M Y C + P RP +++L L
Sbjct: 216 AGYRLY-RPKLAPTEVYTIM-------YSCWHEKPEDRPAFKKLLSQL 255
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 57/220 (25%), Positives = 92/220 (41%), Gaps = 33/220 (15%)
Query: 415 LAEGRCGPVYRA--VLPGELH---VAIKVLDNAKGIDH-DDAVAMFDELSRLKHPNLLPL 468
L E G +Y+ LPG H VAIK L + + ++ L HPN++ L
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCL 72
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
G + +L E++ GDLH +L P+ + + D G+ SS +
Sbjct: 73 LGVVTQEQPVCMLFEYLNQGDLHEFL---IMRSPHSDVGCSSDED-----GTVKSSLDHG 124
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGER 588
+++ IAI +A G+ YL H L +IL+ E L KI+ GL R
Sbjct: 125 DFL---HIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR 181
Query: 589 SENETCGP----------------ESDVYCFGVILMELLT 612
+ ++ P +SD++ FGV+L E+ +
Sbjct: 182 VQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 6e-09
Identities = 68/264 (25%), Positives = 112/264 (42%), Gaps = 43/264 (16%)
Query: 434 VAIKVL-DNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMANGDLH 491
VA+K+L D+A D D V+ + + + KH N++ L G C V++E+ + G+L
Sbjct: 50 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109
Query: 492 RWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG 551
+L P ++S D E+ + VARG+ YL
Sbjct: 110 EYLR---ARRPPGMEYSYDI---------ARVPDEQMTFKDLVSCTYQVARGMEYLASQK 157
Query: 552 STHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSEN-----ETCGPE-------- 597
H L ++L+ E+ KIA FGL R++ + +++ N + PE
Sbjct: 158 CIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217
Query: 598 --SDVYCFGVILMELLT--GKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMV 653
SDV+ FGV++ E+ T G V+ + KL+KEG D + E+
Sbjct: 218 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK--------PANCTNELY 269
Query: 654 ESLRVGYLCTADSPGKRPTMQQVL 677
+R C P RPT +Q++
Sbjct: 270 MMMRD---CWHAIPSHRPTFKQLV 290
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 52.2 bits (126), Expect = 6e-09
Identities = 25/60 (41%), Positives = 36/60 (60%), Gaps = 4/60 (6%)
Query: 158 KLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNS 214
L LD+SNN L ++P G F L L+ LD+S ++ I P +F L SL+ LD+S N+
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTS-ISPEAFSGLPSLRSLDLSGNN 59
|
Length = 60 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 8e-09
Identities = 59/228 (25%), Positives = 88/228 (38%), Gaps = 55/228 (24%)
Query: 414 LLAEGRCGPVYRAVLPGELH-----VAIK-VLDNAKGIDHDDAVAMFDE----LSRLKHP 463
LL EG G ++ +L E V +K V D+A I V + + L L H
Sbjct: 13 LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ----VTLLLQESCLLYGLSHQ 68
Query: 464 NLLPLAGYCIAGKEK-LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
N+LP+ CI E VL +M G+L +L +
Sbjct: 69 NILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQ----------------------CRLG 106
Query: 523 SSPEKTNWVTRHRI--AIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL--- 577
+ T+ + AI +A G++YLH G H + + ++ E L+ KI L
Sbjct: 107 EANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRD 166
Query: 578 ------------RNIGVKNVG-ERSENETCGPESDVYCFGVILMELLT 612
N VK + E N+ SDV+ FGV+L EL+T
Sbjct: 167 LFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 62/230 (26%), Positives = 97/230 (42%), Gaps = 50/230 (21%)
Query: 415 LAEGRCGPVYRA----VLPGE--LHVAIKVL----DNAKGIDHDDAVAMFDELSRLKHPN 464
L EG G V+ A + P + + VA+K L DNA+ H +A + L+ L+H +
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREA----ELLTNLQHEH 68
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA--GSHI 522
++ G C+ G +++ E+M +GDL+++L H P A +
Sbjct: 69 IVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRA-----------------HGPDAVLMAEG 111
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGV 582
+ P + IA +A G+ YL H L T + L+ E+L KI FG+
Sbjct: 112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY 171
Query: 583 KNVGERSENETCGP----------------ESDVYCFGVILMELLT-GKR 615
R T P ESDV+ GV+L E+ T GK+
Sbjct: 172 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 63/231 (27%), Positives = 96/231 (41%), Gaps = 61/231 (26%)
Query: 414 LLAEGRCGPVYRAVL----PGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLL 466
++ +G G VY L ++H A+K L+ + D ++ E + HPN+L
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLN--RITDLEEVEQFLKEGIIMKDFSHPNVL 59
Query: 467 PLAGYCIAGK-EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
L G C+ + LV+L +M +GDL ++ T P V+D
Sbjct: 60 SLLGICLPSEGSPLVVLPYMKHGDLRNFIRS-ETHNPTVKDL------------------ 100
Query: 526 EKTNWVTRHRIAIG--VARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNI-- 580
I G VA+G+ YL H L + +L ES K+A FGL R+I
Sbjct: 101 ----------IGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD 150
Query: 581 --------------GVKNVG-ERSENETCGPESDVYCFGVILMELLTGKRG 616
VK + E + + +SDV+ FGV+L EL+T RG
Sbjct: 151 KEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT--RG 199
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 9e-09
Identities = 55/197 (27%), Positives = 89/197 (45%), Gaps = 35/197 (17%)
Query: 434 VAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHR 492
VA+K+L + +D + +SRLK+PN++ L G C++ ++ E+M NGDL++
Sbjct: 47 VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQ 106
Query: 493 WLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS 552
+L + E ST T ++I S N + +A+ +A G+ YL +
Sbjct: 107 FLSQR-------EIESTFT------HANNIPSVSIANLL---YMAVQIASGMKYLASLNF 150
Query: 553 THGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENETCGP--------------- 596
H L T + L+ KIA FG+ RN+ + R + P
Sbjct: 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY-YRIQGRAVLPIRWMAWESILLGKFT 209
Query: 597 -ESDVYCFGVILMELLT 612
SDV+ FGV L E+ T
Sbjct: 210 TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 57.4 bits (137), Expect = 1e-08
Identities = 49/231 (21%), Positives = 73/231 (31%), Gaps = 55/231 (23%)
Query: 413 SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK----HPNLLPL 468
L EG G VY A VA+KVL + E+ L PN++ L
Sbjct: 6 RKLGEGSFGEVYLARDRKL--VALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
+ +++E++ G L L ++ E
Sbjct: 64 YDFFQDEGSLYLVMEYVDGGSLEDLLKKIG---------------------RKGPLSESE 102
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESL-EPKIAGFG----LRNIGVK 583
I + L YLH G H + +ILL K+ FG L + G
Sbjct: 103 AL----FILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158
Query: 584 NVGERSENETCG------PE-------------SDVYCFGVILMELLTGKR 615
+ + + G PE SD++ G+ L ELLTG
Sbjct: 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLP 209
|
Length = 384 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 1e-08
Identities = 77/302 (25%), Positives = 129/302 (42%), Gaps = 63/302 (20%)
Query: 415 LAEGRCGPVY----RAVLPGEL--HVAIKVLDNAKGIDHDDAVAMFDELSRLKHPN---L 465
L +G G VY R ++ GE VA+K ++ + + + + +E S +K +
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLR--ERIEFLNEASVMKGFTCHHV 71
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G G+ LV++E MA+GDL +L L P E+ +PG P
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSL---RPEAEN--------NPGR----PPP 116
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNI---- 580
+ ++A +A G+AYL+ H L + ++A KI FG+ R+I
Sbjct: 117 TLQEMI---QMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETD 173
Query: 581 ----------GVKNVGERS-ENETCGPESDVYCFGVILMELLT----GKRGTDDCVKWVR 625
V+ + S ++ SD++ FGV+L E+ + +G + + V
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN--EQVL 231
Query: 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK-DIR 684
K V +G L D+ E V L +C +P RPT +++ LLK D+
Sbjct: 232 KFVMDGG---------YLDQPDNCPERVTDLM--RMCWQFNPKMRPTFLEIVNLLKDDLH 280
Query: 685 PS 686
PS
Sbjct: 281 PS 282
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 19/197 (9%)
Query: 4 FCRLPLLFSLSLVVLA-QSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRE 62
F +LPL++ L + Q NS+ ++ S S++ L S S +
Sbjct: 424 FTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFF----GGLPDSFGSKRLEN 479
Query: 63 LNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGT 122
L+LS SG + K ++SEL + LS N L G +P S + L ++LS N+ G
Sbjct: 480 LDLSRNQFSGAVPRKL-GSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538
Query: 123 IGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLR-ILPSGFANL 179
I P S + P + L+LS N+ + + L L+ +++S+N L LPS A L
Sbjct: 539 I---PASFS-EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFL 594
Query: 180 SKLRHLDISSCKISGNI 196
+ I++ ++GNI
Sbjct: 595 A------INASAVAGNI 605
|
Length = 968 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (134), Expect = 2e-08
Identities = 52/206 (25%), Positives = 70/206 (33%), Gaps = 63/206 (30%)
Query: 435 AIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAGYCIAGKEKLVL-LEFMANGDL 490
A+KVL K I + E LSR+ HP ++ L Y +EKL L LE+ G+L
Sbjct: 22 AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH-YAFQTEEKLYLVLEYAPGGEL 80
Query: 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVAR-------- 542
SH+S R + AR
Sbjct: 81 F----------------------------SHLSK--------EGRFSEERARFYAAEIVL 104
Query: 543 GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN-------VGERS------ 589
L YLH +G + L +ILL K+ FGL G
Sbjct: 105 ALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEV 164
Query: 590 -ENETCGPESDVYCFGVILMELLTGK 614
+ G D + GV+L E+LTGK
Sbjct: 165 LLGKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 54/205 (26%), Positives = 83/205 (40%), Gaps = 44/205 (21%)
Query: 430 GELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485
+ VA+KVL D+A F + LSRL PN+ L G C +++E+M
Sbjct: 45 APVLVAVKVL--RPDAS-DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYM 101
Query: 486 ANGDLHRWL--HELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARG 543
NGDL+++L H T G + S + + +A +A G
Sbjct: 102 ENGDLNQFLQKHVAET----------------SGLACNSKSLSFSTLL---YMATQIASG 142
Query: 544 LAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSENETCGP------- 596
+ YL + H L T + L+ ++ KIA FG+ + R + P
Sbjct: 143 MRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE 202
Query: 597 ---------ESDVYCFGVILMELLT 612
+SDV+ FGV L E+LT
Sbjct: 203 SVLLGKFTTKSDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 4e-08
Identities = 58/247 (23%), Positives = 96/247 (38%), Gaps = 64/247 (25%)
Query: 415 LAEGRCGPVYRAVL--PGE---LHVAIKVLDNAKGIDH-----DDAVAMFDELSRLKHPN 464
L G G VY+ V GE + VAIKVL D+A M + + HP+
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVM----ASVDHPH 70
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
++ L G C++ + +L+ + M G L ++ H I S
Sbjct: 71 VVRLLGICLSSQVQLIT-QLMPLGCLLDYVRN------------------HKDN---IGS 108
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN 584
NW + +A+G++YL H L ++L+ KI FGL + +
Sbjct: 109 QYLLNW------CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL--LD 160
Query: 585 VGERSENETCG--------PE----------SDVYCFGVILMELLT-GKRGTDDC-VKWV 624
V E+ + G E SDV+ +GV + EL+T G + + +
Sbjct: 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
Query: 625 RKLVKEG 631
L+++G
Sbjct: 221 PDLLEKG 227
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 5e-08
Identities = 57/230 (24%), Positives = 82/230 (35%), Gaps = 54/230 (23%)
Query: 414 LLAEGRCGPVYRAVL-------PGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHP 463
L G G VY G + VA+K L KG + E +S HP
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL--RKGATDQEKKEFLKEAHLMSNFNHP 59
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ L G C+ + + +++E M GDL +L A
Sbjct: 60 NIVKLLGVCLLNEPQYIIMELMEGGDLLSYLR---------------------DARVERF 98
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP-----KIAGFGLR 578
P I + VA+G YL + H L + L++E KI FGL
Sbjct: 99 GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
Query: 579 NIGVKNVGERSENETCGP----------------ESDVYCFGVILMELLT 612
K+ R E E P +SDV+ FGV++ E+LT
Sbjct: 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 74/298 (24%), Positives = 126/298 (42%), Gaps = 64/298 (21%)
Query: 415 LAEGRCGPVYRAVLPG------ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPN---L 465
L +G G VY + G E VAIK ++ A + + + +E S +K N +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMR--ERIEFLNEASVMKEFNCHHV 71
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G G+ LV++E M GDL +L L P +E + + +P
Sbjct: 72 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSL---RPEME-------------NNPVQAP 115
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNI---- 580
+ + +A +A G+AYL+ H L + ++AE KI FG+ R+I
Sbjct: 116 PSLKKMIQ--MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173
Query: 581 ----GVKNV-------GERSENETCGPESDVYCFGVILMELLT----GKRGTDDCVKWVR 625
G K + E ++ SDV+ FGV+L E+ T +G + + V
Sbjct: 174 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN--EQVL 231
Query: 626 KLVKEGAGGDALDFRLKLGSGDSVAEMV-ESLRVGYLCTADSPGKRPTMQQVLGLLKD 682
+ V EG L D+ +M+ E +R +C +P RP+ +++ +K+
Sbjct: 232 RFVMEGG---------LLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 51/219 (23%), Positives = 79/219 (36%), Gaps = 47/219 (21%)
Query: 414 LLAEGRCGPVYRAV--LPGELHVAIK--VLDNAKGIDHDDAVAMFDELSRLKHPNLLPLA 469
L+ G G VY+ + G+ VAIK L+ K + D L LKHPN++
Sbjct: 7 LIGRGAFGVVYKGLNLETGDF-VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTN 529
G ++LE+ NG L + + G
Sbjct: 66 GSIETSDSLYIILEYAENGSLRQIIK--KFG--------------------PFPESLVAV 103
Query: 530 WVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERS 589
+V + V +GLAYLH G H + ++IL + K+A FG+ + +
Sbjct: 104 YVYQ------VLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDA 157
Query: 590 --------------ENETCGPESDVYCFGVILMELLTGK 614
E SD++ G ++ELLTG
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 69/288 (23%), Positives = 115/288 (39%), Gaps = 56/288 (19%)
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
E L +G G V+ G VAIK L + + + + +L+H L+ L Y
Sbjct: 11 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQL--Y 67
Query: 472 CIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
+ +E + ++ E+M+ G L +L GE G ++ P+ +
Sbjct: 68 AVVSEEPIYIVTEYMSKGSLLDFL----KGE----------------MGKYLRLPQLVDM 107
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN-----V 585
+ +A G+AY+ + H L ++IL+ E+L K+A FGL + N
Sbjct: 108 AAQ------IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 161
Query: 586 GERSENETCGPE----------SDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGD 635
G + + PE SDV+ FG++L EL T R V + + +E
Sbjct: 162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR-----VPYPGMVNREVLDQV 216
Query: 636 ALDFRLKLGSGDSVAEMVESLRVGYL-CTADSPGKRPTMQQVLGLLKD 682
+R+ E ESL C P +RPT + + L+D
Sbjct: 217 ERGYRMPCPP-----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLED 259
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-07
Identities = 59/229 (25%), Positives = 90/229 (39%), Gaps = 45/229 (19%)
Query: 415 LAEGRCGPVYRA----VLP--GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPL 468
L EG G V+ A + P ++ VA+K L + D + L+ L+H +++
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA-----GSHIS 523
G C G +++ E+M +GDL+++L H P A G
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRA-----------------HGPDAMILVDGQPRQ 115
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK 583
+ + IA +A G+ YL H L T + L+ +L KI FG+
Sbjct: 116 AKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 175
Query: 584 NVGERSENETCGP----------------ESDVYCFGVILMELLT-GKR 615
R T P ESDV+ FGVIL E+ T GK+
Sbjct: 176 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQ 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.9 bits (115), Expect = 2e-07
Identities = 20/60 (33%), Positives = 32/60 (53%), Gaps = 3/60 (5%)
Query: 136 SVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKI 192
+++ L+LS+NR T + L VLD+S N+L + F+ L LR LD+S +
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (128), Expect = 2e-07
Identities = 71/301 (23%), Positives = 112/301 (37%), Gaps = 82/301 (27%)
Query: 414 LLAEGRCGPVYRAVLP--GELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
LL G G VY A+ GEL +A+K ++ G ++ A+ E LS L+HPN++
Sbjct: 7 LLGRGSFGSVYLALDKDTGEL-MAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 469 AGYCIAGKEK--LVLLEFMANGDLHRWLHE---LPTGEPNVEDWSTDTWDHHPGAGSHIS 523
G ++ + LE+++ G L L + LP EP + ++
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLP--EPVIRKYTRQ------------- 109
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGV 582
+ GLAYLH G H + ++IL+ K+A FG + +G
Sbjct: 110 ----------------ILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLG- 152
Query: 583 KNVGERSENETCG------PE----------SDVYCFGVILMELLTGKRGTDDCVKWVRK 626
G PE +D++ G ++E+ TGK W
Sbjct: 153 DIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP------PWSEL 206
Query: 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYL-----CTADSPGKRPTMQQVLGLLK 681
G+ + K+GS E+ E L C P KRPT + LL+
Sbjct: 207 -------GNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE---LLQ 256
Query: 682 D 682
Sbjct: 257 H 257
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 68/264 (25%), Positives = 113/264 (42%), Gaps = 43/264 (16%)
Query: 434 VAIKVL-DNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMANGDLH 491
VA+K+L +A D D ++ + + + KH N++ L G C V++E+ + G+L
Sbjct: 53 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112
Query: 492 RWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG 551
+L P ++ + P +S + + A VARG+ YL
Sbjct: 113 EYLR---ARRPPGMEYCYNP-TQVPE--EQLSFKDLVS------CAYQVARGMEYLASKK 160
Query: 552 STHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSEN-----ETCGPE-------- 597
H L ++L+ E KIA FGL R+I + +++ N + PE
Sbjct: 161 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 220
Query: 598 --SDVYCFGVILMELLT--GKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMV 653
SDV+ FGV+L E+ T G V+ + KL+KEG D + E+
Sbjct: 221 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK--------PSNCTNELY 272
Query: 654 ESLRVGYLCTADSPGKRPTMQQVL 677
+R C P +RPT +Q++
Sbjct: 273 MMMRD---CWHAVPSQRPTFKQLV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-07
Identities = 35/94 (37%), Positives = 51/94 (54%), Gaps = 9/94 (9%)
Query: 60 IRELNLSSRNLSGII--SWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKN 117
I L L ++ L G I LR+ L SI+LS NS++G++P S SL ++LS N
Sbjct: 420 IDGLGLDNQGLRGFIPNDISKLRH---LQSINLSGNSIRGNIPPSLGSITSLEVLDLSYN 476
Query: 118 RFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV 151
F G+I P S G S+++LNL+ N + V
Sbjct: 477 SFNGSI---PESL-GQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 45/234 (19%)
Query: 415 LAEGRCGPVYRAVLPGELHV-AIKVLD--NAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
+ +G G V++ V + V A+K +D + ++A+ L++L ++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67
Query: 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWV 531
+ + +++E+ NGDLH+ L + G P PE W
Sbjct: 68 FLDKGKLNIVMEYAENGDLHKLLK-MQRGRP---------------------LPEDQVW- 104
Query: 532 TRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN------ 584
R I + GLA+LH H + + ++ L KI G+ + +
Sbjct: 105 ---RFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTI 161
Query: 585 VG-------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLVK 629
VG E E++ +SDV+ GV+L E TGK ++ + K+++
Sbjct: 162 VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 58/288 (20%), Positives = 99/288 (34%), Gaps = 74/288 (25%)
Query: 423 VYRAVLPGELHVAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481
VY E+ VA+K L + + +++L HP ++ L G C LV+
Sbjct: 15 VYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVM 74
Query: 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVA 541
E G L ++L + I + + VA
Sbjct: 75 -ELAPLGPLLKYLKKRR----------------------EIPVSDLKELAHQ------VA 105
Query: 542 RGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENETCG----- 595
G+AYL H L ++LL + KI+ FG+ R +G + R+ T G
Sbjct: 106 MGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA--TTAGRWPLK 163
Query: 596 ---PE----------SDVYCFGVILMELLT-------GKRGTDDCVKWVRKLVKEGAGGD 635
PE SDV+ +GV L E + +G + V +++ G
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE-----VIAMLESG---- 214
Query: 636 ALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+L + + + S+ + C P RPT ++ +
Sbjct: 215 -----ERLPRPEECPQEIYSIML--SCWKYRPEDRPTFSELESTFRRD 255
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 4e-07
Identities = 18/60 (30%), Positives = 29/60 (48%), Gaps = 1/60 (1%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
++ L+LS+ L+ I + + L +DLS N+L P F SL ++LS N
Sbjct: 2 LKSLDLSNNRLTVI-PDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-07
Identities = 55/236 (23%), Positives = 91/236 (38%), Gaps = 67/236 (28%)
Query: 407 SHFGKESLLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAV--AMFDELSRL-- 460
S + +L +G G VY+ G++ A+K + +D D+ + EL L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKI-YALKKIH----VDGDEEFRKQLLRELKTLRS 55
Query: 461 -KHPNLLPLAG-YCIAGKEKLVLLEFMANGDLHRWLHELPT-GEPNVEDWSTDTWDHHPG 517
+ P ++ G + G+ +VL E+M G L L ++ EP +
Sbjct: 56 CESPYVVKCYGAFYKEGEISIVL-EYMDGGSLADLLKKVGKIPEPVLA------------ 102
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV-----TSSILLAESLEPKI 572
IA + +GL YLH H++ S++L+ E KI
Sbjct: 103 -----------------YIARQILKGLDYLHTKR----HIIHRDIKPSNLLINSKGEVKI 141
Query: 573 AGFG----LRNIGVKN---VG-------ERSENETCGPESDVYCFGVILMELLTGK 614
A FG L N + VG ER + E+ +D++ G+ L+E GK
Sbjct: 142 ADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-07
Identities = 54/220 (24%), Positives = 84/220 (38%), Gaps = 55/220 (25%)
Query: 415 LAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDELSR------LKHPNLLP 467
L G+ G VY V L VA+K L +D + + + L +KHPNL+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL-------KEDTMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
L G C ++ EFM G+L +L E + ++
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRE--------------------------CNRQE 100
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLR-----NIGV 582
N V +A ++ + YL H L + L+ E+ K+A FGL +
Sbjct: 101 VNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160
Query: 583 KNVGERSENETCGPE----------SDVYCFGVILMELLT 612
+ G + + PE SDV+ FGV+L E+ T
Sbjct: 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 6e-07
Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 41/233 (17%)
Query: 405 ATSHFGKESLLAEGRCGPVYRAVL----PGE--LHVAIKVL-DNAKGIDHDDAVAMFDEL 457
+T F +E L E R G VY+ L PGE VAIK L D A+G ++
Sbjct: 5 STVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMR 62
Query: 458 SRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG 517
SRL+HPN++ L G + ++ + ++ DLH + L P+ + STD
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEF---LVMRSPHSDVGSTDD---DKT 116
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYL--HHVGSTHGHLVTSSILLAESLEPKIAGF 575
S + + + VT+ +A G+ +L HHV H L T ++L+ + L KI+
Sbjct: 117 VKSTLEPADFVHIVTQ------IAAGMEFLSSHHV--VHKDLATRNVLVFDKLNVKISDL 168
Query: 576 GL-RNIGVKNVGERSENE---------------TCGPESDVYCFGVILMELLT 612
GL R + + + N +SD++ +GV+L E+ +
Sbjct: 169 GLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 54/234 (23%)
Query: 403 IAATSHFGKESLLAEGRCGPVYRAVLPGE-----LHVAIKVLDNAKGIDHDDAVAMFDE- 456
I + + +L G G VY+ + E + VAIK+L+ G + V DE
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN--VEFMDEA 60
Query: 457 --LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDH 514
++ + HP+L+ L G C++ +LV + M +G L ++HE H
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLDYVHE-----------------H 102
Query: 515 HPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAG 574
GS + NW + +A+G+ YL H L ++L+ KI
Sbjct: 103 KDNIGSQLL----LNW------CVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITD 152
Query: 575 FGLRNIGVKNVGERSENETCGP----------------ESDVYCFGVILMELLT 612
FGL + + E + + P +SDV+ +GV + EL+T
Sbjct: 153 FGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 53/225 (23%), Positives = 87/225 (38%), Gaps = 48/225 (21%)
Query: 412 ESLLAEGRCGPVYRAVL--PG--ELHVAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLL 466
E +L GR G + R L P EL VAI L +A L + H N++
Sbjct: 10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIV 69
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L G G +++ E+M+NG L +L + H G + + +
Sbjct: 70 RLEGVITRGNTMMIVTEYMSNGALDSFLRK------------------HEG---QLVAGQ 108
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG---------- 576
+ G+A G+ YL +G H L +L+ L KI+GF
Sbjct: 109 LMGMLP------GLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI 162
Query: 577 LRNIGVKNVGERSENETC-----GPESDVYCFGVILMELLT-GKR 615
+ K+ + E SDV+ FG+++ E+++ G+R
Sbjct: 163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGER 207
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 59/228 (25%), Positives = 87/228 (38%), Gaps = 52/228 (22%)
Query: 414 LLAEGRCGPVYRAVLPGE----LHVAIKVLDNAKGIDHDDAVAMFDELSRLK---HPNLL 466
+L +G G V A L E VA+K+L A D E + +K HPN++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFDHPNVI 64
Query: 467 PLAGYCIAGKEK------LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
L G + + K +V+L FM +GDLH +L GE
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE------------------- 105
Query: 521 HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL--- 577
P T R I +A G+ YL H L + +L E++ +A FGL
Sbjct: 106 ---EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKK 162
Query: 578 ------------RNIGVKNVG-ERSENETCGPESDVYCFGVILMELLT 612
+ VK + E + SDV+ FGV + E++T
Sbjct: 163 IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT 210
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 54/219 (24%), Positives = 88/219 (40%), Gaps = 54/219 (24%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLLPLAG 470
L G+ G V+ VA+K L +V F E + L+H L+ L
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-----SVQAFLEEANLMKTLQHDKLVRL-- 66
Query: 471 YCIAGKEK--LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
Y + KE+ ++ E+MA G L +L G + P+
Sbjct: 67 YAVVTKEEPIYIITEYMAKGSLLDFLKS--------------------DEGGKVLLPKLI 106
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNV--- 585
++ + +A G+AY+ H L +++L++ESL KIA FGL + N
Sbjct: 107 DFSAQ------IAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTA 160
Query: 586 --GERSENETCGPE----------SDVYCFGVILMELLT 612
G + + PE SDV+ FG++L E++T
Sbjct: 161 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 3e-06
Identities = 52/229 (22%), Positives = 86/229 (37%), Gaps = 57/229 (24%)
Query: 415 LAEGRCGPVYRAVLPGE---LHVAIKVLDNA--KGIDHDDAVAMFDELSRLKHPNLLPLA 469
L EG G V L + L VA+K + A + +D ++ + HPN++ L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 470 GYCIAGKEK------LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
G C+ E +V+L FM +GDLH +L G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD---------------------- 104
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRN---- 579
P+ + +A G+ YL H L + +L E++ +A FGL
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYN 164
Query: 580 ----------------IGVKNVGERSENETCGPESDVYCFGVILMELLT 612
I ++++ +R +SDV+ FGV + E+ T
Sbjct: 165 GDYYRQGRIAKMPVKWIAIESLADRVYTT----KSDVWSFGVTMWEIAT 209
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 4e-06
Identities = 68/286 (23%), Positives = 110/286 (38%), Gaps = 56/286 (19%)
Query: 409 FGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPL 468
F KE L G+ G V G+ VAIK++ + D+ + + +L H L+ L
Sbjct: 8 FLKE--LGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQL 64
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
G C + ++ E+M+NG L +L E H + +
Sbjct: 65 YGVCTKQRPIYIVTEYMSNGCLLNYLRE------------------------HGKRFQPS 100
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNI-----GVK 583
+ + V G+AYL H L + L+ + K++ FGL
Sbjct: 101 QLL---EMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157
Query: 584 NVGERSENETCGPE----------SDVYCFGVILMELLT-GKRGTDDCVKWVRKLVKEGA 632
+VG + PE SDV+ FGV++ E+ + GK + + V++ +
Sbjct: 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN--SETVEKVS 215
Query: 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678
G L +R L S A M Y C + +RPT QQ+L
Sbjct: 216 QGLRL-YRPHLASEKVYAIM-------YSCWHEKAEERPTFQQLLS 253
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 4e-06
Identities = 52/217 (23%), Positives = 77/217 (35%), Gaps = 54/217 (24%)
Query: 427 VLPGELH-------VAIKVLDNAKGIDHDDAVAMFDELSR-LKHPNLLPLAGYCIAGKEK 478
VL GE H V +K L + D + R L HPN+L G CI
Sbjct: 11 VLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPY 70
Query: 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAI 538
L++LEF GDL +L + G + ++ + R+A
Sbjct: 71 LLVLEFCPLGDLKNYLRS------------------NRGMVAQMAQKD-----VLQRMAC 107
Query: 539 GVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL--------------------R 578
VA GL +LH H L + L L KI +GL R
Sbjct: 108 EVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLR 167
Query: 579 NIG---VKNVGERSENETCGPESDVYCFGVILMELLT 612
+ V+ G+ + +S+++ GV + EL T
Sbjct: 168 WLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 7e-06
Identities = 30/85 (35%), Positives = 48/85 (56%), Gaps = 4/85 (4%)
Query: 162 LDVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGT 218
L + N LR +P+ + L L+ +++S I GNI P S + SL+ LD+S NS NG+
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNI-PPSLGSITSLEVLDLSYNSFNGS 481
Query: 219 FPSDFPPLSGVKFLNISLNKFTGFV 243
P L+ ++ LN++ N +G V
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRV 506
|
Length = 623 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 71/285 (24%), Positives = 113/285 (39%), Gaps = 56/285 (19%)
Query: 409 FGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPL 468
F KE L G+ G V+ ++ VAIK + N + +D + + +L HP L+ L
Sbjct: 8 FMKE--LGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQL 64
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
G C K ++ EFM NG L +L + S D
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQ------RQGKLSKDML---------------- 102
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG-----LRNIGVK 583
+ V G+ YL H L + L++ + K++ FG L +
Sbjct: 103 -----LSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157
Query: 584 NVGERSENETCGPE----------SDVYCFGVILMELLT-GKRGTDDCVKWVRKLVKEGA 632
+ G + + PE SDV+ FGV++ E+ T GK + + ++V+ +
Sbjct: 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMIS 215
Query: 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
G L +R KL S +V E V Y C + P RPT ++L
Sbjct: 216 RGFRL-YRPKLAS-MTVYE------VMYSCWHEKPEGRPTFAELL 252
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 58/228 (25%), Positives = 96/228 (42%), Gaps = 52/228 (22%)
Query: 412 ESLLAEGRCGPVY--RAVLPG--ELHVAIKVLDNA-KGIDHDDAVAMFDELSRLKHPNLL 466
E ++ G G V R LPG E+ VAIK L D ++ + + HPN++
Sbjct: 9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L G K +++ E+M NG L +L + H G + I
Sbjct: 69 HLEGVVTKSKPVMIVTEYMENGSLDAFLRK------------------HDGQFTVI---- 106
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
V R G+A G+ YL +G H L +IL+ +L K++ FGL + +++
Sbjct: 107 --QLVGMLR---GIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV-LEDDP 160
Query: 587 ERSENETCG--------PE----------SDVYCFGVILMELLT-GKR 615
E + G PE SDV+ +G+++ E+++ G+R
Sbjct: 161 EAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 49/219 (22%), Positives = 84/219 (38%), Gaps = 51/219 (23%)
Query: 414 LLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK---HPNLLPLAG 470
LL +G G V++ L + VA+K + + + + E LK HPN++ L G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCK--EDLPQELKIKFLSEARILKQYDHPNIVKLIG 59
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
C + +++E + GD +L + +K
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRK-----------------------------KKDEL 90
Query: 531 VTRH--RIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGF------------- 575
T+ + A+ A G+AYL H L + L+ E+ KI+ F
Sbjct: 91 KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS 150
Query: 576 -GLRNIGVKNVGERSENE-TCGPESDVYCFGVILMELLT 612
GL+ I +K + N ESDV+ +G++L E +
Sbjct: 151 SGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 46/200 (23%), Positives = 76/200 (38%), Gaps = 27/200 (13%)
Query: 62 ELNLSSRNLSGIIS-WK----FLRNMSELHSIDLSNNSL-KGSVPGW--FWSTQSLTQVN 113
EL LS I + L L +DLS+N+L + SL ++
Sbjct: 55 ELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELK 114
Query: 114 LSKNRFGGTIG-FKPTSRNGPFPSVQVLNLSSNRFTN-----LVK-LSQFSKLMVLDVSN 166
L+ N G P+++ L L NR L K L L L+++N
Sbjct: 115 LNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLAN 174
Query: 167 NDL-----RILPSGFANLSKLRHLDISSCKIS--GNIK---PVSFLHSLKYLDVSNNSMN 216
N + R L G L LD+++ ++ G ++ L SL+ L++ +N++
Sbjct: 175 NGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLT 234
Query: 217 GTFPSDFPPLSGVKFLNISL 236
+ S + NISL
Sbjct: 235 DAGAAAL--ASALLSPNISL 252
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 54/225 (24%), Positives = 80/225 (35%), Gaps = 56/225 (24%)
Query: 415 LAEGRCGPVYRAVL------PGELHVAIKVLDNAKGIDH-DDAVAMFDELSRLKHPNLLP 467
L EG G V GE VA+K L+++ H D + L L H N++
Sbjct: 12 LGEGHFGKVELCRYDPLGDNTGEQ-VAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 468 LAGYCIA--GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
G C G+ +++E++ +G L +L
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR--------------------------- 103
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNI----- 580
++ N + + +G+ YL H L +IL+ KI+ FGL +
Sbjct: 104 DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK 163
Query: 581 ---GVKNVGERSENETCGPE----------SDVYCFGVILMELLT 612
VK GE S PE SDV+ FGV L EL T
Sbjct: 164 DYYYVKEPGE-SPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 57/231 (24%), Positives = 91/231 (39%), Gaps = 56/231 (24%)
Query: 412 ESLLAEGRCGPVYRAVL--PG--ELHVAIKVLDNAKGIDHDDAVAMFDELS---RLKHPN 464
E ++ G G V R L PG E+ VAIK L + G E S + HPN
Sbjct: 9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKS--GYTEKQRRDFLSEASIMGQFDHPN 66
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
++ L G + +++ EFM NG L +L G+ V
Sbjct: 67 IIHLEGVVTKSRPVMIITEFMENGALDSFL-RQNDGQFTV-------------------- 105
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN 584
V R G+A G+ YL + H L +IL+ +L K++ FGL +
Sbjct: 106 ---IQLVGMLR---GIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159
Query: 585 VGERSENETCG---------PE----------SDVYCFGVILMELLT-GKR 615
+ + + G PE SDV+ +G+++ E+++ G+R
Sbjct: 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGER 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 60/225 (26%), Positives = 75/225 (33%), Gaps = 57/225 (25%)
Query: 414 LLAEGRCGPVYRA--VLPG--ELHVAIKVL--DNAKGIDHD---DAVAMFDELSRLKHPN 464
L +G G V R G + VA+K L D I D +A M L H N
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIM----HSLDHEN 57
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
L+ L G + +V E G L L G IS
Sbjct: 58 LIRLYGVVLTHPLMMVT-ELAPLGSLLDRLR-----------------KDALGHFL-IS- 97
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVK 583
T A+ +A G+ YL H L +ILLA + KI FGL R +
Sbjct: 98 -------TLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN 150
Query: 584 NVGERSENET------CGPE----------SDVYCFGVILMELLT 612
E C PE SDV+ FGV L E+ T
Sbjct: 151 EDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFT 195
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-05
Identities = 64/287 (22%), Positives = 113/287 (39%), Gaps = 62/287 (21%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHD-DAVAMFDE---LSRLKH 462
++ EG G V + G+ VA+K I D A A +E +++L H
Sbjct: 6 QKLTLGEIIGEGEFGAVLQGEYTGQ-KVAVKN------IKCDVTAQAFLEETAVMTKLHH 58
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
NL+ L G I +++E M+ G+L +L G V
Sbjct: 59 KNLVRLLG-VILHNGLYIVMELMSKGNLVNFLRT--RGRALV------------------ 97
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGV 582
+ + + ++ VA G+ YL H L +IL++E K++ FGL +G
Sbjct: 98 ------SVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGS 151
Query: 583 KNVG-----------ERSENETCGPESDVYCFGVILMELLTGKRG--TDDCVKWVRKLVK 629
V E +++ +SDV+ +GV+L E+ + R +K V++ V+
Sbjct: 152 MGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVE 211
Query: 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQV 676
+G + + G V ++ S C P KRP+ ++
Sbjct: 212 KGYRMEPPE-----GCPADVYVLMTS------CWETEPKKRPSFHKL 247
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 53/223 (23%), Positives = 78/223 (34%), Gaps = 54/223 (24%)
Query: 417 EGRCGPVYRAV-LPGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIA 474
G VY A+ LP VAIK +D K D+ +S+ HPN++ +
Sbjct: 11 VGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV 70
Query: 475 GKEKLVLLEFMANGDLHRWL-HELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTR 533
G E +++ +++ G L + P G E
Sbjct: 71 GDELWLVMPYLSGGSLLDIMKSSYPRG----------------------GLDEAI----- 103
Query: 534 HRIAI---GVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSE 590
IA V +GL YLH G H + +ILL E KIA FG+ +
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRK 161
Query: 591 NET------C--GPE-----------SDVYCFGVILMELLTGK 614
C PE +D++ FG+ +EL TG
Sbjct: 162 VRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 8e-05
Identities = 65/258 (25%), Positives = 93/258 (36%), Gaps = 73/258 (28%)
Query: 415 LAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLLP 467
L G G VY + G EL VA+K L ++ D D + +S+ H N++
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
L G + +LLE MA GDL +L E P E P S ++ +
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRE---NRPRPE---------RP---SSLTMKDL 118
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP----KIAGFGL-RNIGV 582
A VA+G YL H + + LL P KIA FG+ R+I
Sbjct: 119 LF------CARDVAKGCKYLEENHFIHRDIAARNCLLT-CKGPGRVAKIADFGMARDI-- 169
Query: 583 KNVGERSENETCG-----------PE----------SDVYCFGVILMELL-------TGK 614
R+ G PE +DV+ FGV+L E+ G+
Sbjct: 170 ----YRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225
Query: 615 RGTDDCVKWVRKLVKEGA 632
+ V + V G
Sbjct: 226 TNQE-----VMEFVTGGG 238
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 9e-05
Identities = 59/229 (25%), Positives = 83/229 (36%), Gaps = 61/229 (26%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDH-DDAVAMFDELSRLKHPNLL 466
HFGK L R P GE VA+K L G +H D + L L H N++
Sbjct: 16 HFGKVELC---RYDP--EGDNTGEQ-VAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69
Query: 467 PLAGYCI--AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
G C G +++EF+ +G L +L P + I
Sbjct: 70 KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---------------------PRNKNKI-- 106
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN 584
N + + A+ + +G+ YL H L ++L+ + KI FGL K
Sbjct: 107 ----NLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGL----TKA 158
Query: 585 VGERSENETC-----------GPE----------SDVYCFGVILMELLT 612
+ E T PE SDV+ FGV L ELLT
Sbjct: 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 48/230 (20%), Positives = 81/230 (35%), Gaps = 70/230 (30%)
Query: 414 LLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLLPLA 469
+ +G G VY+ VL G VA+K + D F + L + HPN++ L
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVK---TCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLI 58
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLH----ELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
G C+ + +++E + G L +L L
Sbjct: 59 GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVK------------------------- 93
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG--------- 576
++++ A G+ YL H L + L+ E+ KI+ FG
Sbjct: 94 ------KLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGI 147
Query: 577 ------LRNIGVK-------NVGERSENETCGPESDVYCFGVILMELLTG 613
L+ I +K N G + ESDV+ +G++L E +
Sbjct: 148 YTVSDGLKQIPIKWTAPEALNYGRYTS------ESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 1e-04
Identities = 48/220 (21%), Positives = 84/220 (38%), Gaps = 55/220 (25%)
Query: 415 LAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLA 469
+ EG G VY+A G+ VAIK + + + + +E + KHPN++
Sbjct: 27 IGEGASGEVYKATDRATGKE-VAIKKMR----LRKQNKELIINEILIMKDCKHPNIVDYY 81
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG--AGSHISSPEK 527
+ G E V++E+M G L TD + I+
Sbjct: 82 DSYLVGDELWVVMEYMDGGSL------------------TDIITQNFVRMNEPQIA---- 119
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGE 587
+ V +GL YLH H + + +ILL++ K+A FG K +
Sbjct: 120 -------YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSK 172
Query: 588 RS--------------ENETCGPESDVYCFGVILMELLTG 613
R+ + + GP+ D++ G++ +E+ G
Sbjct: 173 RNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 52/225 (23%), Positives = 83/225 (36%), Gaps = 49/225 (21%)
Query: 408 HFGKESLLAEGRCGPVYRA-VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
F + +G G VY+A VAIKV+ + + L + KHPN++
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 467 PLAGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
G K++L +++EF + G L +D T S I+
Sbjct: 61 KYYG-SYLKKDELWIVMEFCSGGSL--------------KDLLKSTN--QTLTESQIAY- 102
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNV 585
+ + +GL YLH G H + ++ILL E K+ FGL
Sbjct: 103 ----------VCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSD-- 150
Query: 586 GERSENETCG------PE----------SDVYCFGVILMELLTGK 614
++ N G PE +D++ G+ +EL GK
Sbjct: 151 -TKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 2e-04
Identities = 61/314 (19%), Positives = 109/314 (34%), Gaps = 78/314 (24%)
Query: 408 HFGKESL-----LAEGRCGPVYRAVLPG------ELHVAIKVLDNAKGIDHDDAVAM--- 453
F + +L L G G V+ A G E V +K L K D+ +
Sbjct: 1 AFPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK----DENLQSEFR 56
Query: 454 --FDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDT 511
D +L H N++ L G C + ++LE+ GDL ++L + +
Sbjct: 57 RELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEK-------- 108
Query: 512 WDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPK 571
P + + + +A G+ +L + H L + L++ E K
Sbjct: 109 -----------LKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVK 157
Query: 572 IAGFGLRNIGVKNVGERSENETCGP----------------ESDVYCFGVILMELLTG-- 613
++ L V N P +SDV+ FGV++ E+ T
Sbjct: 158 VSLLSLSK-DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGE 216
Query: 614 ---KRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPG 668
+D+ V L + AG L + G + +++ C A +P
Sbjct: 217 LPFYGLSDEEV-----LNRLQAG----KLELPVPEGCPSRLYKLMTR------CWAVNPK 261
Query: 669 KRPTMQQVLGLLKD 682
RP+ +++ L +
Sbjct: 262 DRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 37/179 (20%), Positives = 71/179 (39%), Gaps = 46/179 (25%)
Query: 453 MFDELSRLK---HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWST 509
+F+E+ ++ HPN++ + + G E V++EF+ G L T
Sbjct: 63 LFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL------------------T 104
Query: 510 DTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLE 569
D H + ++ + + + V + L++LH G H + + SILL
Sbjct: 105 DIVTH-----TRMNEEQIAT------VCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR 153
Query: 570 PKIAGFGLRNIGVKNVGERSE--------------NETCGPESDVYCFGVILMELLTGK 614
K++ FG K V R G E D++ G++++E++ G+
Sbjct: 154 VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 28/97 (28%), Positives = 43/97 (44%), Gaps = 14/97 (14%)
Query: 532 TRHRIAIGVARGLAYLH-HVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGV----KNVG 586
T+ +AI +GL L+ + + +L + S L+ E+ + KI GL I KNV
Sbjct: 123 TKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVN 182
Query: 587 E---RSEN------ETCGPESDVYCFGVILMELLTGK 614
S + D+Y GV+L E+ TGK
Sbjct: 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGK 219
|
Length = 283 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 83/346 (23%), Positives = 124/346 (35%), Gaps = 90/346 (26%)
Query: 409 FGKESLLAEGRCGPVYRAVLPG------ELHVAIKVLDNAKGIDHDDAV-AMFDELSRL- 460
FGK L G G V A G L VA+K+L K H D A+ EL L
Sbjct: 42 FGK--TLGAGAFGKVVEATAFGLGKEDNVLRVAVKML---KASAHTDEREALMSELKILS 96
Query: 461 ---KHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHE-----------LPTGEPNVED 506
+H N++ L G C G LV+ E+ GDL +L + LP D
Sbjct: 97 HLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSD 156
Query: 507 W-------------------STDTW-DHHPGAGSHISSPEKTNWVTRH-----------R 535
+ +DT+ + P + S S + + R
Sbjct: 157 YKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLR 216
Query: 536 IAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-------RNIGVKNVGER 588
+ VA+G+ +L H + ++LL + KI FGL N VK R
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG-NAR 275
Query: 589 SENETCGPE----------SDVYCFGVILMELLT-GKRGTDDCVKWVR--KLVKEGAGGD 635
+ PE SDV+ +G++L E+ + GK + + K+VK G
Sbjct: 276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS 335
Query: 636 ALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681
DF E + +C P +RPT Q+ L++
Sbjct: 336 RPDFAPP-----------EIYSIMKMCWNLEPTERPTFSQISQLIQ 370
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 38.2 bits (90), Expect = 3e-04
Identities = 14/40 (35%), Positives = 23/40 (57%)
Query: 135 PSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPS 174
+++ L+LS+N+ T+L LS L LD+S N + L
Sbjct: 1 TNLETLDLSNNQITDLPPLSNLPNLETLDLSGNKITDLSP 40
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 13/93 (13%)
Query: 535 RIAIGVARGLAYLHHV-GSTHGHLVTSSILLAESLEPKIAGFG----LRN-IGVKNVG-- 586
+IA+ V +GL YLH H + S+IL+ + K+ FG L N + VG
Sbjct: 104 KIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTS 163
Query: 587 -----ERSENETCGPESDVYCFGVILMELLTGK 614
ER + +SD++ G+ L+EL TG+
Sbjct: 164 SYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 60/229 (26%), Positives = 79/229 (34%), Gaps = 63/229 (27%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDA-VAMFDELSRLKHPNLL 466
HFGK SL P GE+ VA+K L G + + L L H N++
Sbjct: 16 HFGKVSLY---CYDPANDGT--GEM-VAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 467 PLAGYCIAGKEKLVLL--EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
G C K + L E++ G L +L +
Sbjct: 70 KYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPK---------------------------- 101
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN 584
K N A + G+AYLH H L ++LL KI FGL K
Sbjct: 102 -HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGL----AKA 156
Query: 585 VGE-------RSENET--------CGPE------SDVYCFGVILMELLT 612
V E R + ++ C E SDV+ FGV L ELLT
Sbjct: 157 VPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 4e-04
Identities = 53/208 (25%), Positives = 77/208 (37%), Gaps = 59/208 (28%)
Query: 434 VAIKVL--DNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAGYCIAGKEKLVL-LEFMAN 487
AIKV+ + + D V E LS+ + P ++ L Y GK+ L L +E++
Sbjct: 21 YAIKVIKKADMIRKNQVDQV--LTERDILSQAQSPYVVKLY-YSFQGKKNLYLVMEYLPG 77
Query: 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYL 547
GDL L ++ S ++ V R IA V L YL
Sbjct: 78 GDLASLLE-------------------------NVGSLDED--VARIYIAEIVL-ALEYL 109
Query: 548 HHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGV------KNVGERSENETCG------ 595
H G H L +IL+ + K+ FGL +G+ N E+ + G
Sbjct: 110 HSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169
Query: 596 PE----------SDVYCFGVILMELLTG 613
PE D + G IL E L G
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 69/296 (23%), Positives = 116/296 (39%), Gaps = 72/296 (24%)
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
E L G+ G V+ A VA+K + A E + L+H L+ L
Sbjct: 11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKL 66
Query: 469 AGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
+ + KE + ++ EFMA G L L L + E GS P+
Sbjct: 67 --HAVVTKEPIYIITEFMAKGSL---LDFLKSDE-----------------GSKQPLPKL 104
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN--- 584
++ + +A G+A++ H L ++IL++ SL KIA FGL + N
Sbjct: 105 IDFSAQ------IAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158
Query: 585 --VGERSENETCGPE----------SDVYCFGVILMELLTGKR------GTDDCVKWVRK 626
G + + PE SDV+ FG++LME++T R + ++
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR---- 214
Query: 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682
AL+ ++ ++ E E + C + P +RPT + + +L D
Sbjct: 215 ---------ALERGYRMPRPENCPE--ELYNIMMRCWKNRPEERPTFEYIQSVLDD 259
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 35/138 (25%), Positives = 59/138 (42%), Gaps = 33/138 (23%)
Query: 431 ELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487
EL V +KVLD + D A+A F+ +S++ H +L + G C+ G E +++ EF+ +
Sbjct: 44 ELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEH 100
Query: 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYL 547
G L L + + W + +A +A L+YL
Sbjct: 101 GPLDVCLRK---------------------EKGRV----PVAW--KITVAQQLASALSYL 133
Query: 548 HHVGSTHGHLVTSSILLA 565
HG++ +ILLA
Sbjct: 134 EDKNLVHGNVCAKNILLA 151
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 7e-04
Identities = 17/48 (35%), Positives = 29/48 (60%), Gaps = 6/48 (12%)
Query: 181 KLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG 228
L LD+S+ +I+ ++ P+S L +L+ LD+S N + +D PLS
Sbjct: 2 NLETLDLSNNQIT-DLPPLSNLPNLETLDLSGNKI-----TDLSPLSN 43
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 46/169 (27%), Positives = 65/169 (38%), Gaps = 30/169 (17%)
Query: 409 FGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPL 468
FGK +L E G V+ EL V+ V + K ++ L+H NLL
Sbjct: 8 FGK-VILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEE------AQPYRSLQHSNLLQC 60
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
G C L+++EF GDL +L E + +P+ T
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAE--------------------LMTPDPT 100
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL 577
T R+A +A GL +LH H L + LL L KI +GL
Sbjct: 101 ---TLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGL 146
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 45/213 (21%), Positives = 80/213 (37%), Gaps = 43/213 (20%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA 474
+ G+ G V+ + VAIK + + +D + + +L HP L+ L G C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 475 GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRH 534
++ EFM +G L +L + K + T
Sbjct: 71 RSPICLVFEFMEHGCLSDYLR---------------------------AQRGKFSQETLL 103
Query: 535 RIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN-----VGERS 589
+ + V G+AYL H L + L+ E+ K++ FG+ + + G +
Sbjct: 104 GMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKF 163
Query: 590 ENETCGPE----------SDVYCFGVILMELLT 612
+ PE SDV+ FGV++ E+ +
Sbjct: 164 PVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFS 196
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.001
Identities = 41/196 (20%), Positives = 79/196 (40%), Gaps = 14/196 (7%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPG 101
++S L N SN + L+LS +S + + +S L +DLSNNS+ +
Sbjct: 174 DLSDLPKLLSNLSN----LNNLDLSGNKISDLP--PEIELLSALEELDLSNNSII-ELLS 226
Query: 102 WFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMV 161
+ ++L+ + LS N+ G +++ L+LS+N+ +++ L + L
Sbjct: 227 SLSNLKNLSGLELSNNKL-----EDLPESIGNLSNLETLDLSNNQISSISSLGSLTNLRE 281
Query: 162 LDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPS 221
LD+S N L L L + + ++ + L ++ +N + P
Sbjct: 282 LDLSGNSL-SNALPLIALLLLLLELLLNLLLTLKALELKLNSILLNNNILSN-GETSSPE 339
Query: 222 DFPPLSGVKFLNISLN 237
L + L N
Sbjct: 340 ALSILESLNNLWTLDN 355
|
Length = 394 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.001
Identities = 19/61 (31%), Positives = 34/61 (55%), Gaps = 3/61 (4%)
Query: 181 KLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNK 238
L+ LD+S+ +++ I +F L +LK LD+S N++ P F L ++ L++S N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 239 F 239
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies) | Back alignment and domain information |
|---|
Score = 37.1 bits (87), Expect = 0.001
Identities = 18/43 (41%), Positives = 26/43 (60%), Gaps = 2/43 (4%)
Query: 158 KLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVS 200
L LD+SNN + LP +NL L LD+S KI+ ++ P+S
Sbjct: 2 NLETLDLSNNQITDLP-PLSNLPNLETLDLSGNKIT-DLSPLS 42
|
Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 29/92 (31%), Positives = 43/92 (46%), Gaps = 12/92 (13%)
Query: 535 RIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG-----LRNIGVKNVG--- 586
RIA+ V +GL YL + H + S++L+ + K+ FG + +I VG
Sbjct: 99 RIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNA 158
Query: 587 ----ERSENETCGPESDVYCFGVILMELLTGK 614
ER E G SDV+ G+ MEL G+
Sbjct: 159 YMAPERISGEQYGIHSDVWSLGISFMELALGR 190
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 43/170 (25%), Positives = 64/170 (37%), Gaps = 41/170 (24%)
Query: 457 LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHP 516
L L+H N++ L+ I+ E + + + DLHR L
Sbjct: 63 LKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLT--------------------- 101
Query: 517 GAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
S P + ++ + RGL Y+H G H L S+IL+ E+ + KI FG
Sbjct: 102 ------SRPLEKQFI--QYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFG 153
Query: 577 LRNI-GVKNVGERSENETCGPE-----------SDVYCFGVILMELLTGK 614
L I + G S PE D++ G I E+L GK
Sbjct: 154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.001
Identities = 37/148 (25%), Positives = 61/148 (41%), Gaps = 36/148 (24%)
Query: 422 PVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAGYCIAGKE 477
V PG E+ V +KVL + DH D++A F+ +S+L H +L+ L G C+ +
Sbjct: 20 SDLDIVGPGQEVSVVLKVLGS----DHRDSLAFFETASLMSQLSHKHLVKLYGVCVRDEN 75
Query: 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIA 537
+V E++ G L +LH +W + +A
Sbjct: 76 IMVE-EYVKFGPLDVFLHREKNNVS-------------------------LHW--KLDVA 107
Query: 538 IGVARGLAYLHHVGSTHGHLVTSSILLA 565
+A L YL HG++ +IL+A
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVA 135
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 55/254 (21%), Positives = 88/254 (34%), Gaps = 70/254 (27%)
Query: 448 DDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDW 507
DA+ LS L+HPN++ + + L+ +E+ G L+ +
Sbjct: 44 RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVR----------- 92
Query: 508 STDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567
G E W + ++Y+H G H + T +I L ++
Sbjct: 93 ---------QKGQLFEE-EMVLWYL-----FQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137
Query: 568 LEPKIAGFGLRNIGVKNVG-ERSENETC-------GPE----------SDVYCFGVILME 609
K+ FG+ K +G E S ET PE SD++ G +L E
Sbjct: 138 GLIKLGDFGI----SKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYE 193
Query: 610 LLTGKRGTDD------CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCT 663
LLT KR D VK V+ + +E++ + +
Sbjct: 194 LLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYS-------------SELIS---LVHSLL 237
Query: 664 ADSPGKRPTMQQVL 677
P KRPT +VL
Sbjct: 238 QQDPEKRPTADEVL 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (96), Expect = 0.002
Identities = 59/234 (25%), Positives = 87/234 (37%), Gaps = 66/234 (28%)
Query: 409 FGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDD------AVAMFDELSRL 460
+ K L EG G VY+A GE+ VA+K + +D+++ A+ L L
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEI-VALKKIR----LDNEEEGIPSTALREISLLKEL 55
Query: 461 KHPNLLPLAGYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
KHPN++ L I + KL L E+ DL ++L + P
Sbjct: 56 KHPNIVKLLDV-IHTERKLYLVFEYCDM-DLKKYLDKRPGPLS----------------- 96
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-R 578
N + I + RGLAY H H L +IL+ K+A FGL R
Sbjct: 97 --------PNLI--KSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLAR 146
Query: 579 NIGV------KNV------------GERSENETCGPESDVYCFGVILMELLTGK 614
G+ V G + D++ G I E++TGK
Sbjct: 147 AFGIPLRTYTHEVVTLWYRAPEILLGSK----HYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 34/106 (32%), Positives = 49/106 (46%), Gaps = 17/106 (16%)
Query: 540 VARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENETCGPE- 597
+ RGL Y+H H L S++ + E E KI FGL R+ + G + PE
Sbjct: 129 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 188
Query: 598 ----------SDVYCFGVILMELLTGKR---GTD--DCVKWVRKLV 628
D++ G I+ ELLTG+ GTD D +K + +LV
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLV 234
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 45/165 (27%), Positives = 68/165 (41%), Gaps = 31/165 (18%)
Query: 415 LAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYC 472
+ G G VY+A V GEL AIKV+ G D + KH N++ G
Sbjct: 17 IGSGTYGDVYKARNVNTGEL-AAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 473 IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVT 532
+ + + +EF G L H TG P + S I+ +V+
Sbjct: 76 LRRDKLWICMEFCGGGSLQDIYH--VTG---------------PLSESQIA------YVS 112
Query: 533 RHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL 577
R + +GL YLH G H + ++ILL ++ K+A FG+
Sbjct: 113 RETL-----QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV 152
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.002
Identities = 73/303 (24%), Positives = 111/303 (36%), Gaps = 70/303 (23%)
Query: 409 FGKESLLAEGRCGPVYRAVLPG------ELHVAIKVLDNAKGIDHDDAVAMFDELSRL-- 460
FGK L G G V A G + VA+K+L + A+ EL +
Sbjct: 39 FGK--TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSH 94
Query: 461 --KHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA 518
H N++ L G C G LV+ E+ GDL +L E + T D
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRR------KRESFLT-LEDL---- 143
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL- 577
S VA+G+A+L H L ++LL KI FGL
Sbjct: 144 -LSFSYQ--------------VAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA 188
Query: 578 RNIG-----VKNVGERSENETCGPE----------SDVYCFGVILMELLT-GKRGTDDCV 621
R+I V R + PE SDV+ +G++L E+ + G
Sbjct: 189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMP 248
Query: 622 --KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679
KL+KEG + + + +++++ C P KRPT +Q++ L
Sbjct: 249 VDSKFYKLIKEGYRMAQPEH-----APAEIYDIMKT------CWDADPLKRPTFKQIVQL 297
Query: 680 LKD 682
+
Sbjct: 298 IGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.002
Identities = 59/291 (20%), Positives = 99/291 (34%), Gaps = 69/291 (23%)
Query: 413 SLLAEGRCGPVYRAV-LPGELHVAIKVLD--NAKGIDHDDAVAMFDELSRLKHPNLLPLA 469
L +G G VY+ L A+K +D + + +DAV L+ + HPN++
Sbjct: 6 KKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYK 65
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTN 529
+ G + +++E+ GDL + + + PE+
Sbjct: 66 EAFLDGNKLCIVMEYAPFGDLSKAISK--------------------RKKKRKLIPEQEI 105
Query: 530 WVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERS 589
W RI I + RGL LH H L +++ILL + KI G+ + KN+ +
Sbjct: 106 W----RIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ 161
Query: 590 ENETC--GPE----------SDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDAL 637
PE SD++ G +L E+ T +
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE--------------ARSMQ 207
Query: 638 DFRLKLGSG----------DSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678
D R K+ G + + S P RP ++L
Sbjct: 208 DLRYKVQRGKYPPIPPIYSQDLQNFIRS------MLQVKPKLRPNCDKILA 252
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.003
Identities = 36/158 (22%), Positives = 54/158 (34%), Gaps = 35/158 (22%)
Query: 423 VYRAVLPGELHVAIKV--LDNAKGIDHDDAVAMFDEL---SRLKHPNLLPLAGYCIAGKE 477
+ + L VA+K LD+ +D + E+ +L+HPN+LP I E
Sbjct: 18 LAKHKPTNTL-VAVKKINLDSC---SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE 73
Query: 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIA 537
V+ MA G D H PE + I
Sbjct: 74 LYVVSPLMAYGS------------------CEDLLKTH--------FPEGLPELAIAFIL 107
Query: 538 IGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGF 575
V L Y+H G H + S ILL+ + ++G
Sbjct: 108 KDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 50/219 (22%), Positives = 87/219 (39%), Gaps = 52/219 (23%)
Query: 415 LAEGRCGPVYRAVL--PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK---HPNLLPLA 469
+ EG G V A + G+L VA+K +D K + +F+E+ ++ H N++ +
Sbjct: 28 IGEGSTGIVCIATVKSSGKL-VAVKKMDLRKQQRRE---LLFNEVVIMRDYQHENVVEMY 83
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTN 529
+ G E V++EF+ G L TD H I++
Sbjct: 84 NSYLVGDELWVVMEFLEGGAL------------------TDIVTHTRMNEEQIAA----- 120
Query: 530 WVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERS 589
+ + V + L+ LH G H + + SILL K++ FG K V R
Sbjct: 121 ------VCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 174
Query: 590 --------------ENETCGPESDVYCFGVILMELLTGK 614
GPE D++ G++++E++ G+
Sbjct: 175 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 47/192 (24%), Positives = 73/192 (38%), Gaps = 39/192 (20%)
Query: 409 FGKESLLAEGRCGP-VYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLP 467
FGK LL+E V R V+ EL NA + ++ + D L+HPN+L
Sbjct: 8 FGK-VLLSEIYTDTGVARVVVK-ELKA------NASSKEQNEFLQQGDPYRILQHPNILQ 59
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
G C+ L++ E+ GDL +L + E W H +
Sbjct: 60 CLGQCVEAIPYLLVFEYCELGDLKSYLSQ--------EQW-------HRRNSQLL----- 99
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGE 587
R+A +A G+ ++H H L + L L K+ +G IG E
Sbjct: 100 ----LLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYG---IGPSRYKE 152
Query: 588 ---RSENETCGP 596
+E++ C P
Sbjct: 153 DYIETEDDKCVP 164
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 45/164 (27%), Positives = 66/164 (40%), Gaps = 30/164 (18%)
Query: 415 LAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYC 472
+ G G VY+A GEL VAIKV+ G D + L +HPN++ G
Sbjct: 11 IGSGTYGDVYKARDIATGEL-VAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSY 69
Query: 473 IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVT 532
+ + +++E+ G L T P E I+ +V
Sbjct: 70 LRRDKLWIVMEYCGGGSLQDIYQV--TRGPLSEL--------------QIA------YVC 107
Query: 533 RHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
R +GLAYLH G H + ++ILL E + K+A FG
Sbjct: 108 RE-----TLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFG 146
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 54/234 (23%), Positives = 91/234 (38%), Gaps = 54/234 (23%)
Query: 403 IAATSHFGKESLLAEGRCGPVYRAV-LP-GE---LHVAIKVLDNAKGIDHDDAVAMFDE- 456
I + F K +L G G VY+ + +P GE + VAIK L A + + DE
Sbjct: 3 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI--LDEA 60
Query: 457 --LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDH 514
++ + +P++ L G C+ +L+ + M G L ++ E
Sbjct: 61 YVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE------------------ 101
Query: 515 HPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAG 574
+I S NW + +A+G+ YL H L ++L+ KI
Sbjct: 102 ---HKDNIGSQYLLNW------CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITD 152
Query: 575 FGLR---------------NIGVKNVG-ERSENETCGPESDVYCFGVILMELLT 612
FGL + +K + E + +SDV+ +GV + EL+T
Sbjct: 153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.5 bits (93), Expect = 0.004
Identities = 29/96 (30%), Positives = 41/96 (42%), Gaps = 19/96 (19%)
Query: 543 GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSEN---------- 591
GL YLH G H + S+IL+ K+A FGL R +N + +
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171
Query: 592 -----ETCGPESDVYCFGVILMELLTGK---RGTDD 619
GPE D++ G IL EL GK +G+ +
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 79/314 (25%), Positives = 123/314 (39%), Gaps = 78/314 (24%)
Query: 434 VAIKVLDNAKGIDHDDAVAMFDELSRL----KHPNLLPLAGYCIA-GKEKLVLLEFMANG 488
VA+K+L +G H + A+ EL L H N++ L G C G +V++EF G
Sbjct: 40 VAVKMLK--EGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 97
Query: 489 DLHRWLH--------------ELPTGEPNVEDWSTDT---WDHHPGAGSHISS---PEKT 528
+L +L G+ D S D D + S SS EK+
Sbjct: 98 NLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKS 157
Query: 529 ----------------NWVTRHRI---AIGVARGLAYLHHVGSTHGHLVTSSILLAESLE 569
+T + + VA+G+ +L H L +ILL+E+
Sbjct: 158 LSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNV 217
Query: 570 PKIAGFGL-RNI-----GVKNVGERSENETCGPE----------SDVYCFGVILMELLTG 613
KI FGL R+I V+ R + PE SDV+ FGV+L E+ +
Sbjct: 218 VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 277
Query: 614 KRGTDDCVK----WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGK 669
VK + R+L KEG A D+ + EM +++ C P +
Sbjct: 278 GASPYPGVKIDEEFCRRL-KEGTRMRAPDY--------TTPEMYQTM---LDCWHGEPSQ 325
Query: 670 RPTMQQVLGLLKDI 683
RPT +++ L ++
Sbjct: 326 RPTFSELVEHLGNL 339
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 33/138 (23%)
Query: 431 ELHVAIKVLDNAKGIDHDDAVAMFDELSRLK---HPNLLPLAGYCIAGKEKLVLLEFMAN 487
E+ V +KVLD + D ++A F+ S ++ H +++ L G C+ E +++ EF+
Sbjct: 32 EIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEF 88
Query: 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYL 547
G L ++H S T W + ++A +A L+YL
Sbjct: 89 GPLDLFMHRK-------------------------SDVLTTPW--KFKVAKQLASALSYL 121
Query: 548 HHVGSTHGHLVTSSILLA 565
HG++ T +ILLA
Sbjct: 122 EDKDLVHGNVCTKNILLA 139
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.004
Identities = 49/232 (21%), Positives = 91/232 (39%), Gaps = 59/232 (25%)
Query: 407 SHFGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDD--------AVAMFDE 456
S + + L+ G G VYR V G + VA+K+++ +D D VA+ +
Sbjct: 1 SLYQRLELIGRGAYGAVYRGKHVPTGRV-VALKIIN----LDTPDDDVSDIQREVALLSQ 55
Query: 457 LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHP 516
L + + PN+ G + G +++E+ G + + P E
Sbjct: 56 LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEK-------------- 101
Query: 517 GAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
+IS + R V L Y+H VG H + ++IL+ + K+ FG
Sbjct: 102 ----YISV------IIRE-----VLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFG 146
Query: 577 LRNIGVKNVGERS---------------ENETCGPESDVYCFGVILMELLTG 613
+ + +N +RS E + ++D++ G+ + E+ TG
Sbjct: 147 VAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG 198
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 49/238 (20%), Positives = 85/238 (35%), Gaps = 62/238 (26%)
Query: 403 IAATSHFGKESLLAEGRCGPVYRAVLPGE-----LHVAIKVLDNAKG-------IDHDDA 450
I + K LL G G V++ + E + VAIK + + G DH A
Sbjct: 3 ILKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLA 62
Query: 451 VAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTD 510
+ D H ++ L G C +LV + G L + +
Sbjct: 63 MGSLD------HAYIVRLLGICPGASLQLVT-QLSPLGSLLDHVRQ-------------- 101
Query: 511 TWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570
H + + NW + +A+G+ YL H +L +ILL
Sbjct: 102 ----HRDS---LDPQRLLNW------CVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIV 148
Query: 571 KIAGFGLRNIGVKNVGERSENETCGP----------------ESDVYCFGVILMELLT 612
+IA FG+ ++ + + +E P +SDV+ +GV + E+++
Sbjct: 149 QIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 690 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.98 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.98 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.98 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.98 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.98 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.98 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.98 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.96 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.95 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.91 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.88 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.84 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.84 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.83 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.83 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.8 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.8 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.79 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.77 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.76 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.7 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.67 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.66 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 99.66 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.64 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.6 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.6 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.57 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.55 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.54 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.49 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.48 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 99.47 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.46 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.45 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.45 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.44 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.44 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.43 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.35 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.3 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.28 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.25 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.25 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.22 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.22 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.22 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.21 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.2 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.19 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.19 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.16 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.15 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.08 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.08 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.07 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.06 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.05 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.03 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.02 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.0 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.0 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.94 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 98.92 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.85 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.72 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 98.71 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.63 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.61 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.5 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.48 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.4 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.39 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.34 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.33 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.18 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.14 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.04 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.01 | |
| PF12799 | 44 | LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ | 97.99 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 97.99 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.94 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-63 Score=592.73 Aligned_cols=525 Identities=27% Similarity=0.448 Sum_probs=318.1
Q ss_pred CCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCC-
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS- 136 (690)
Q Consensus 58 ~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~- 136 (690)
++|+.|+|++|++++.+| ..+..+++|+.|+|++|++++.+|..|..+++|+.|+|++|++++.+ +..+..+++
T Consensus 380 ~~L~~L~l~~n~l~~~~p-~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~----~~~~~~l~~L 454 (968)
T PLN00113 380 GNLFKLILFSNSLEGEIP-KSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRI----NSRKWDMPSL 454 (968)
T ss_pred CCCCEEECcCCEecccCC-HHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCcc----ChhhccCCCC
Confidence 456666666666666655 33455666666666666666666666666666666666666655543 222333444
Q ss_pred ----------------------CcEEEccCCCCCCcc--ccCCCCCCcEEEccCCCCc-cCCccCCCCCCCcEEEcccCc
Q 005572 137 ----------------------VQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLR-ILPSGFANLSKLRHLDISSCK 191 (690)
Q Consensus 137 ----------------------L~~L~Ls~N~l~~~~--~~~~~~~L~~L~ls~N~l~-~~p~~~~~l~~L~~L~ls~N~ 191 (690)
|+.|++++|++++.. .+..+++|+.|++++|++. .+|..+.++++|+.|+|++|.
T Consensus 455 ~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 534 (968)
T PLN00113 455 QMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQ 534 (968)
T ss_pred cEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCc
Confidence 455555555554332 2444555555555555554 345555555555555555555
Q ss_pred CCcCCCC-cccccccceeecccccCCCCCCCCCCCCCCCCEEEeeCCCCccccCch-hhhcccccceeeCCceeecCCCC
Q 005572 192 ISGNIKP-VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHD-KYQKFGKSAFIQGGSFVFDTTKT 269 (690)
Q Consensus 192 l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 269 (690)
++|.+|. +..+++|+.|+|++|+++|.+|..+..+++|+.|++++|+++|.+|.. .+..+....+.+ +..+|+..
T Consensus 535 l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~--n~~lc~~~- 611 (968)
T PLN00113 535 LSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAG--NIDLCGGD- 611 (968)
T ss_pred ccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcC--CccccCCc-
Confidence 5554443 444555555555555555555555555555555555555555555532 122222222211 11122110
Q ss_pred CCCCCCCcCCCCCCCCCCCcccccCCCCccccccccceeeeehhhhhhHHHHHHHhhheeeeeeechhhhhcccccccCC
Q 005572 270 PRPSNNHIMPHVDSSRTPPYKIVHKHNPAVQKHRSKAKALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKWAISKP 349 (690)
Q Consensus 270 ~~~~~~~~~~~~~~s~~~p~~~~~~~~~~~~~~~s~~~~~ii~i~~~~~~~~~~~i~i~~~~~rrr~~~~~~~~~~~~~~ 349 (690)
.....++. ....++....+++++++++++++++ ++++++++|||+..+ ......
T Consensus 612 ------------~~~~~~~c---------~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~--- 665 (968)
T PLN00113 612 ------------TTSGLPPC---------KRVRKTPSWWFYITCTLGAFLVLAL-VAFGFVFIRGRNNLE-LKRVEN--- 665 (968)
T ss_pred ------------cccCCCCC---------ccccccceeeeehhHHHHHHHHHHH-HHHHHHHHHhhhccc-cccccc---
Confidence 00000000 0001111222333333332222222 222222222222111 000000
Q ss_pred cCCCccceecccCCcccccCCCCcccccccCCcccchhccCCCcccccCHHHHHHHhccCCCCceeccCCCccEEEEEc-
Q 005572 350 VNQQLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKESLLAEGRCGPVYRAVL- 428 (690)
Q Consensus 350 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~- 428 (690)
..+ .|.. ........+.++++++. ..|...+.||+|+||.||+|+.
T Consensus 666 ----------~~~----------~~~~----------~~~~~~~~~~~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~ 712 (968)
T PLN00113 666 ----------EDG----------TWEL----------QFFDSKVSKSITINDIL---SSLKEENVISRGKKGASYKGKSI 712 (968)
T ss_pred ----------ccc----------cccc----------cccccccchhhhHHHHH---hhCCcccEEccCCCeeEEEEEEC
Confidence 000 0000 00000111224555554 3577788999999999999995
Q ss_pred CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCC
Q 005572 429 PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWS 508 (690)
Q Consensus 429 ~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~ 508 (690)
.++..||||+++..... ...|++.+++++|||||+++|+|.+.+..++|||||++|+|.++++.
T Consensus 713 ~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------------ 776 (968)
T PLN00113 713 KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------------ 776 (968)
T ss_pred CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------------
Confidence 67889999998654322 23468889999999999999999999999999999999999999853
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh---hcCCCCCCCCCCcEEecCCCCceEcCCCcccccc---
Q 005572 509 TDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH---HVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGV--- 582 (690)
Q Consensus 509 ~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH---~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~--- 582 (690)
++|.++.+|+.|+|+||+||| +.+++||||||+||+++.++.+++. ||.+....
T Consensus 777 -------------------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~ 836 (968)
T PLN00113 777 -------------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDT 836 (968)
T ss_pred -------------------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCC
Confidence 789999999999999999999 5689999999999999999998876 66543321
Q ss_pred -------cccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc-------hHHHHHHHHHhcCCCCccccccccCCCCC
Q 005572 583 -------KNVGERSENETCGPESDVYCFGVILMELLTGKRGTDD-------CVKWVRKLVKEGAGGDALDFRLKLGSGDS 648 (690)
Q Consensus 583 -------~~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 648 (690)
..+||......+++++|||||||++|||+||+.||+. ..+|++............|+.+.......
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 1256666556889999999999999999999999853 34555443333223344455554444445
Q ss_pred HHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 649 VAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 649 ~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
..++.++.+++.+||+.||++||||+||++.|+++.+
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~ 953 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR 953 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence 6777888899999999999999999999999999855
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-52 Score=435.54 Aligned_cols=266 Identities=37% Similarity=0.641 Sum_probs=230.7
Q ss_pred cccCHHHHHHHhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEec
Q 005572 395 NYLTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA 474 (690)
Q Consensus 395 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 474 (690)
+.|+++++..||++|...+.||+|+||.||+|.++++..||||++.........+|..|++++++++|||+|+|+|||.+
T Consensus 63 ~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e 142 (361)
T KOG1187|consen 63 RSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLE 142 (361)
T ss_pred ceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEec
Confidence 44999999999999999999999999999999999989999998876543215669999999999999999999999999
Q ss_pred CC-eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC--
Q 005572 475 GK-EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG-- 551 (690)
Q Consensus 475 ~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-- 551 (690)
.+ +.+||||||++|+|.++|+... .. .++|.+|++||.++|+||+|||+..
T Consensus 143 ~~~~~~LVYEym~nGsL~d~L~~~~-------------------------~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~ 196 (361)
T KOG1187|consen 143 GGEHRLLVYEYMPNGSLEDHLHGKK-------------------------GE-PLDWETRLKIALGAARGLAYLHEGCPP 196 (361)
T ss_pred CCceEEEEEEccCCCCHHHHhCCCC-------------------------CC-CCCHHHHHHHHHHHHHHHHHHccCCCC
Confidence 88 5999999999999999998621 11 7899999999999999999999965
Q ss_pred -CCCCCCCCCcEEecCCCCceEcCCCccccccc-----------ccCcccCC----CCCCCCCcchhhHHHHHHHHhCCC
Q 005572 552 -STHGHLVTSSILLAESLEPKIAGFGLRNIGVK-----------NVGERSEN----ETCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 552 -~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~-----------~~~e~~~~----~~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
||||||||+|||||+++++||+|||+|+.... ..+|.+|+ ...++|+|||||||+|+|++||+.
T Consensus 197 ~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~ 276 (361)
T KOG1187|consen 197 PIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRK 276 (361)
T ss_pred CEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCc
Confidence 78999999999999999999999999977643 12344444 568899999999999999999998
Q ss_pred CCCc--------hHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCC
Q 005572 616 GTDD--------CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 616 p~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
|.+. +.+|+...+.++...+++|+++........+++.++..+|..|++.+|++||+|.||+++|+.+...
T Consensus 277 ~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 277 AVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred ccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 7652 6889888888888899999998742222236788899999999999999999999999999776544
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=403.28 Aligned_cols=243 Identities=26% Similarity=0.376 Sum_probs=207.0
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
+.+...+.||+|.||+||.|.+.+...||+|.++... ...++|.+|+++|++++|+|||+++|+|..++.+|||||||+
T Consensus 206 ~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 206 EELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 3344567899999999999999988899999997653 456789999999999999999999999999889999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+||+.. .+..+...+.+.|+.|||+||+||+++++|||||+++|||+++
T Consensus 285 ~GsLl~yLr~~--------------------------~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~ 338 (468)
T KOG0197|consen 285 KGSLLDYLRTR--------------------------EGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDE 338 (468)
T ss_pred cCcHHHHhhhc--------------------------CCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeecc
Confidence 99999999861 2456888899999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCch-HHHHHHHHH
Q 005572 567 SLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDC-VKWVRKLVK 629 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~-~~~~~~~~~ 629 (690)
+..+||+|||+|+...++ |||.+....++.|||||||||+||||+| |+.||..+ ...+.+.+.
T Consensus 339 ~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le 418 (468)
T KOG0197|consen 339 DLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE 418 (468)
T ss_pred CceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh
Confidence 999999999999964332 8888888999999999999999999999 89998763 444556666
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
.|.....++ .++ -.++++|..||..+|++|||++.+...|+++....
T Consensus 419 ~GyRlp~P~-----~CP------~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~ 465 (468)
T KOG0197|consen 419 RGYRLPRPE-----GCP------DEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST 465 (468)
T ss_pred ccCcCCCCC-----CCC------HHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence 654332211 121 25667888899999999999999999999886643
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-46 Score=386.65 Aligned_cols=238 Identities=30% Similarity=0.422 Sum_probs=194.6
Q ss_pred CCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCC--HHHHHHHHHHHHhcCCCCccceeeEEecCC-eeEEEEEecCC
Q 005572 411 KESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGID--HDDAVAMFDELSRLKHPNLLPLAGYCIAGK-EKLVLLEFMAN 487 (690)
Q Consensus 411 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~~ 487 (690)
..+.+|+|+||+||+|.|.+...||||++....... .++|.+|+.+|.+++|||||+++|+|.+.. ..+||||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 345599999999999999887679999997543222 458999999999999999999999999987 78999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC-CCCCCCCCCcEEecC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG-STHGHLVTSSILLAE 566 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~-~iHrDlk~~NiLl~~ 566 (690)
|+|.+++++. ....+++..+++||.|||+||.|||+++ |||||||++|||++.
T Consensus 125 GsL~~~l~~~--------------------------~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~ 178 (362)
T KOG0192|consen 125 GSLSVLLHKK--------------------------RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDL 178 (362)
T ss_pred CcHHHHHhhc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcC
Confidence 9999999862 2467999999999999999999999999 899999999999999
Q ss_pred CC-CceEcCCCccccccc--------------ccCcccC--CCCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHHHH
Q 005572 567 SL-EPKIAGFGLRNIGVK--------------NVGERSE--NETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRKL 627 (690)
Q Consensus 567 ~~-~~kl~DfGla~~~~~--------------~~~e~~~--~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~~~ 627 (690)
++ ++||+|||+++.... .|||... ...|+.|+|||||||++|||+||+.||.++.. .+...
T Consensus 179 ~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v 258 (362)
T KOG0192|consen 179 KGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV 258 (362)
T ss_pred CCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 98 999999999975442 1778777 45899999999999999999999999998554 22222
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
...+. .+.++..+.. .+..++.+||+.||+.||++.|++..|+.+..
T Consensus 259 ~~~~~-----Rp~~p~~~~~------~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 259 VVGGL-----RPPIPKECPP------HLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred HhcCC-----CCCCCccCCH------HHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 22221 1222222222 23345556999999999999999999997754
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=405.45 Aligned_cols=256 Identities=27% Similarity=0.371 Sum_probs=210.1
Q ss_pred hccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEecCCee
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 478 (690)
..+....+.||+|+||+||+|+.. +...||||.++..... .+.+|++|++.++.++|||||+|+|+|..++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~ 564 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL 564 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence 344455678999999999999843 3467999999876554 678999999999999999999999999999999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++|+|||..|||.+||+.......-. ..+. ..+..|+-.+.+.||.|||.||+||.++.+|||||+
T Consensus 565 ~MvFEYm~~GDL~eFLra~sP~a~~~------------~~g~--~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLA 630 (774)
T KOG1026|consen 565 CMVFEYMDHGDLHEFLRARSPKADKL------------ASGQ--DTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLA 630 (774)
T ss_pred EEEEEecccccHHHHHHhhCCccccc------------cCCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchh
Confidence 99999999999999999743211100 0000 125569999999999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCc-h
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDD-C 620 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~-~ 620 (690)
+|||||.++..+||+|||++|..... +||...+..|+++||||||||+|||++| |+.||.+ .
T Consensus 631 TRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 631 TRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred hhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 99999999999999999999865432 6788888899999999999999999999 9999887 4
Q ss_pred HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCC
Q 005572 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
.+.+.+.+..+......+ .+..+++.+|..||+..|++||+++||-..|+.....
T Consensus 711 n~EVIe~i~~g~lL~~Pe-----------~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~ 765 (774)
T KOG1026|consen 711 NQEVIECIRAGQLLSCPE-----------NCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA 765 (774)
T ss_pred hHHHHHHHHcCCcccCCC-----------CCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence 556667777665432222 2223677889999999999999999999999876544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=387.81 Aligned_cols=242 Identities=24% Similarity=0.407 Sum_probs=203.6
Q ss_pred CCCCceeccCCCccEEEEEcC--C--CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 409 FGKESLLAEGRCGPVYRAVLP--G--ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~--~--~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
..++++||.|.||+||+|+++ + ...||||.++.... +.+.+|..|..+|.+++||||++|-|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 355689999999999999853 2 46899999987643 456789999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
||+||+|+.||+++ .+.+++.+...|.++||.||.||.+++.|||||.++|||
T Consensus 711 yMENGsLDsFLR~~---------------------------DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNIL 763 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN---------------------------DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNIL 763 (996)
T ss_pred hhhCCcHHHHHhhc---------------------------CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhhee
Confidence 99999999999972 245899999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCc-hHHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDD-CVKWV 624 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~-~~~~~ 624 (690)
++.+...||+|||++|...++ +||.....+++.+||||||||||||.++ |++||=+ ..+.+
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV 843 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV 843 (996)
T ss_pred eccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH
Confidence 999999999999999876433 5666666789999999999999999877 9999755 44555
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCCC
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSAD 688 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~~ 688 (690)
.+.+.++ ++++... .+...+.++|+.||++|-.+||++.+|+..|+.+-..|+
T Consensus 844 IkaIe~g-------yRLPpPm----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~ 896 (996)
T KOG0196|consen 844 IKAIEQG-------YRLPPPM----DCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN 896 (996)
T ss_pred HHHHHhc-------cCCCCCC----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence 5566554 2333222 222367788999999999999999999999998765553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=356.06 Aligned_cols=233 Identities=25% Similarity=0.342 Sum_probs=189.5
Q ss_pred CCCceeccCCCccEEEEE-cCCCcEEEEEEeecc-CCCCHHHHHHHHHHHHhcCCCCccceeeEEecCC-eeEEEEEecC
Q 005572 410 GKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA-KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK-EKLVLLEFMA 486 (690)
Q Consensus 410 ~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-~~~lv~e~~~ 486 (690)
+..+.||+|..|+|||++ .++++.+|+|++... +...++++.+|++++++.+||+||+++|.|.... +.+|+||||+
T Consensus 82 e~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMD 161 (364)
T KOG0581|consen 82 ERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMD 161 (364)
T ss_pred hhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcC
Confidence 346789999999999999 567899999999543 3345678999999999999999999999999988 5999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcEEec
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSILLA 565 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~NiLl~ 565 (690)
+|||++++++ .+.+++...-+|+.+|.+||.|||+ ++||||||||+|||++
T Consensus 162 gGSLd~~~k~----------------------------~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvN 213 (364)
T KOG0581|consen 162 GGSLDDILKR----------------------------VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVN 213 (364)
T ss_pred CCCHHHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeec
Confidence 9999999975 3568899999999999999999995 9999999999999999
Q ss_pred CCCCceEcCCCcccccccc------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch----HHHHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC----VKWVRKLVK 629 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~----~~~~~~~~~ 629 (690)
..|++||||||.++..... +||+.....|+.++||||||+.++|+++|+.|+... ..|...+..
T Consensus 214 skGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~ 293 (364)
T KOG0581|consen 214 SKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCA 293 (364)
T ss_pred cCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHH
Confidence 9999999999998765433 778888889999999999999999999999998652 122211111
Q ss_pred hcCCCCccccccccC-CCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 630 EGAGGDALDFRLKLG-SGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.-....|+++.+ ++.+...++. .|+++||.+||++.|+++.
T Consensus 294 ---Iv~~ppP~lP~~~fS~ef~~FV~------~CL~Kdp~~R~s~~qLl~H 335 (364)
T KOG0581|consen 294 ---IVDEPPPRLPEGEFSPEFRSFVS------CCLRKDPSERPSAKQLLQH 335 (364)
T ss_pred ---HhcCCCCCCCcccCCHHHHHHHH------HHhcCCcccCCCHHHHhcC
Confidence 011122334333 4444444444 5999999999999999763
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=361.32 Aligned_cols=232 Identities=22% Similarity=0.353 Sum_probs=196.2
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeecc---CCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA---KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
..|...++||+|+|+.||+++ ...|..||+|++.+. +....+...+|+++.+.|+|||||++++++++.++.|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 468888999999999999999 488999999999763 3455678899999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
|+|++|+|.+++++ ...+++.++..+..||+.||.|||+++|+|||||..|+
T Consensus 98 ELC~~~sL~el~Kr----------------------------rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNl 149 (592)
T KOG0575|consen 98 ELCHRGSLMELLKR----------------------------RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNL 149 (592)
T ss_pred EecCCccHHHHHHh----------------------------cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhe
Confidence 99999999999985 34689999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch-HHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC-VKWVRKL 627 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~-~~~~~~~ 627 (690)
+|++++++||+|||||...... +||+.....++..+||||+||+||-|++|++||+.. .......
T Consensus 150 fL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~ 229 (592)
T KOG0575|consen 150 FLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNK 229 (592)
T ss_pred eecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHH
Confidence 9999999999999999876522 677777778999999999999999999999999862 3444333
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+... ++.++...+...++++ ...++.||.+|||+++|+.
T Consensus 230 Ik~~------~Y~~P~~ls~~A~dLI------~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 230 IKLN------EYSMPSHLSAEAKDLI------RKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred HHhc------CcccccccCHHHHHHH------HHHhcCCcccCCCHHHHhc
Confidence 3322 2223333333444444 4589999999999999985
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=344.42 Aligned_cols=185 Identities=24% Similarity=0.328 Sum_probs=165.5
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
.+|...+.||+|+||+||+|+ ..++..||||.+.+.+ .+..+.+..|+.+|+.++|||||+++++++.++..|+|||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 467777789999999999999 4557899999997653 2345667899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
||.+|||.+|++. .+.+++.....++.|+|.||++||+++||||||||.|||
T Consensus 90 yC~gGDLs~yi~~----------------------------~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiL 141 (429)
T KOG0595|consen 90 YCNGGDLSDYIRR----------------------------RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNIL 141 (429)
T ss_pred eCCCCCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEE
Confidence 9999999999987 346889999999999999999999999999999999999
Q ss_pred ecCC------CCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 564 LAES------LEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 564 l~~~------~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|+.. -.+||+|||+|+..... |||+....+|+.|+|+||.|+++|+|++|+.||+.
T Consensus 142 Ls~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 142 LSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred eccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 9865 45899999999987654 67777778999999999999999999999999985
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=388.84 Aligned_cols=248 Identities=27% Similarity=0.385 Sum_probs=201.8
Q ss_pred cCCCCceeccCCCccEEEEEcCC--C----cEEEEEEeecc-CCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLPG--E----LHVAIKVLDNA-KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~~--~----~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
.....+.||+|.||.||+|.+.+ + ..||||.++.. +.++..+|.+|..+|+.++|||||+++|+|.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 34445789999999999998533 2 35999999755 33556789999999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
++|||++|||..||++.+.... ....++..+.+.++.|||+|+.||+++++|||||.++
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~---------------------~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaR 831 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPF---------------------QPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAAR 831 (1025)
T ss_pred EehhcccCcHHHHHHhcccccC---------------------CCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhh
Confidence 9999999999999998442211 2456899999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW 623 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~ 623 (690)
||||+....+||+|||+|+..... +||...+..++.|+|||||||++||++| |..||.+...+
T Consensus 832 NCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~ 911 (1025)
T KOG1095|consen 832 NCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF 911 (1025)
T ss_pred heeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence 999999999999999999943321 6777777899999999999999999999 88999885544
Q ss_pred HH-HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 624 VR-KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 624 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
.. ....++. .+++ +..+++ .++++|..||+.+|++||++.++++++..|...+
T Consensus 912 ~v~~~~~~gg---RL~~--P~~CP~------~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~ 965 (1025)
T KOG1095|consen 912 EVLLDVLEGG---RLDP--PSYCPE------KLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA 965 (1025)
T ss_pred HHHHHHHhCC---ccCC--CCCCCh------HHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence 32 2233332 1221 111211 4567888899999999999999999998886554
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=352.77 Aligned_cols=246 Identities=26% Similarity=0.347 Sum_probs=194.0
Q ss_pred HhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCC-HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGID-HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+.+.....++||+|.||+|..|...++..||||+++...... ..+|.+|+++|.+++|||||+|+|+|...+.+++|+|
T Consensus 536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 344556668899999999999999989999999998765443 4889999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
||++|||.+|+.+.. ...+.-..-.+|+.|||.||+||.+.++||||+.++|||
T Consensus 616 YmEnGDLnqFl~ahe--------------------------apt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcL 669 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHE--------------------------LPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCL 669 (807)
T ss_pred HHhcCcHHHHHHhcc--------------------------CcccccchhHHHHHHHHHHHHHHHhhchhhcccccccee
Confidence 999999999998731 111233455779999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh--CCCCCCchHHH-H
Q 005572 564 LAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT--GKRGTDDCVKW-V 624 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t--g~~p~~~~~~~-~ 624 (690)
+|.++++||+|||+++-.... ++|..--.++++++|||+|||++||+++ ...||.++.+. +
T Consensus 670 v~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v 749 (807)
T KOG1094|consen 670 VDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV 749 (807)
T ss_pred ecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH
Confidence 999999999999999854333 3344444689999999999999999866 78899875432 1
Q ss_pred HHHHHh---cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 625 RKLVKE---GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 625 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.+-... ......+-. .+..+...++++++.||..|-++||+++++...|++.
T Consensus 750 ven~~~~~~~~~~~~~l~-------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 750 VENAGEFFRDQGRQVVLS-------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred HHhhhhhcCCCCcceecc-------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 111111 111111111 1122223566888999999999999999999988764
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=341.51 Aligned_cols=236 Identities=19% Similarity=0.244 Sum_probs=184.0
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCC-------CHHHHHHHHHHHHhcCCCCccceeeEEecCCee
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI-------DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 478 (690)
+.|...+.+|+|+||.|-+|. ..+++.||||++.+.+.. ......+|+++|++++|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 456667899999999999998 778999999999654321 223457999999999999999999999999999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
|+|||||+||+|.+++-.. ..+.+..-..++.|++.|+.|||++||+|||||
T Consensus 252 YmVlE~v~GGeLfd~vv~n----------------------------k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiK 303 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVAN----------------------------KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIK 303 (475)
T ss_pred EEEEEEecCccHHHHHHhc----------------------------cccccchhHHHHHHHHHHHHHHHHcCcccccCC
Confidence 9999999999999999763 334555567899999999999999999999999
Q ss_pred CCcEEecCC---CCceEcCCCcccccccc---------cCcccCC----C---CCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 559 TSSILLAES---LEPKIAGFGLRNIGVKN---------VGERSEN----E---TCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 559 ~~NiLl~~~---~~~kl~DfGla~~~~~~---------~~e~~~~----~---~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|+|||+..+ ..+||+|||+|+..... +.|.+|| . .+..++|+||+||+||-+++|.+||.+
T Consensus 304 PeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~ 383 (475)
T KOG0615|consen 304 PENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSE 383 (475)
T ss_pred cceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccc
Confidence 999999866 77999999999986533 3444444 2 233489999999999999999999986
Q ss_pred hH--HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 620 CV--KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 620 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
-. ....+.+..+.... -+.. ..+--.+.++++.+++..||++|||+.|+++
T Consensus 384 ~~~~~sl~eQI~~G~y~f--~p~~------w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 384 EYTDPSLKEQILKGRYAF--GPLQ------WDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred ccCCccHHHHHhcCcccc--cChh------hhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 21 11333443332211 1000 1111124567778899999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=359.18 Aligned_cols=252 Identities=25% Similarity=0.340 Sum_probs=200.1
Q ss_pred cCHHHHHHHhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCC--CHHHHHHHHHHHHhcCCCCccceeeEEec
Q 005572 397 LTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI--DHDDAVAMFDELSRLKHPNLLPLAGYCIA 474 (690)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 474 (690)
.+.++|.+..+.+.....||+|+||+||||+|.+. ||||+++..... ..+.|+.|+..+++-+|.||+-+.|||..
T Consensus 382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd--VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~ 459 (678)
T KOG0193|consen 382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHGD--VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN 459 (678)
T ss_pred ccccccccCHHHhhccceeccccccceeecccccc--eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence 34467777777778889999999999999999875 999999765432 34679999999999999999999999998
Q ss_pred CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC
Q 005572 475 GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTH 554 (690)
Q Consensus 475 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iH 554 (690)
++. .||+-+|++-+|+.+||.. ..+++..+.+.||.|||+||.|||.++|||
T Consensus 460 p~~-AIiTqwCeGsSLY~hlHv~---------------------------etkfdm~~~idIAqQiaqGM~YLHAK~IIH 511 (678)
T KOG0193|consen 460 PPL-AIITQWCEGSSLYTHLHVQ---------------------------ETKFDMNTTIDIAQQIAQGMDYLHAKNIIH 511 (678)
T ss_pred Cce-eeeehhccCchhhhhccch---------------------------hhhhhHHHHHHHHHHHHHhhhhhhhhhhhh
Confidence 777 8999999999999999972 357889999999999999999999999999
Q ss_pred CCCCCCcEEecCCCCceEcCCCcccccccc----------------cCcccCCC---CCCCCCcchhhHHHHHHHHhCCC
Q 005572 555 GHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENE---TCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 555 rDlk~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~---~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
||||+.||++.+++++||+|||++...... |||++..+ .|++.+||||||||+|||+||..
T Consensus 512 rDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~l 591 (678)
T KOG0193|consen 512 RDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGEL 591 (678)
T ss_pred hhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcC
Confidence 999999999999999999999997642211 66666543 78999999999999999999999
Q ss_pred CCCchHHHHHHHH-HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 616 GTDDCVKWVRKLV-KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 616 p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
||.. +...+++ ..+...-..| +........++ +.+++..||..++++||.+.+|+..|+.+.+
T Consensus 592 Pysi--~~~dqIifmVGrG~l~pd--~s~~~s~~pk~---mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 592 PYSI--QNRDQIIFMVGRGYLMPD--LSKIRSNCPKA---MKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred CcCC--CChhheEEEecccccCcc--chhhhccCHHH---HHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 9973 1111111 1122211112 22222223333 4445667999999999999999998887765
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=360.33 Aligned_cols=244 Identities=23% Similarity=0.350 Sum_probs=196.3
Q ss_pred hccCCCCceeccCCCccEEEEEcCC--C---cEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCe
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPG--E---LHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKE 477 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~---~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 477 (690)
-++....+.||+|+||.||+|++.. + ..||||..+... .....++.+|.++|++++|||||+++|++....+
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 3344445899999999999998532 2 238999987532 2345789999999999999999999999999999
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl 557 (690)
+++|||+|+||+|.+||++. +..++..++++++.|+|.||+|||++++|||||
T Consensus 236 l~ivmEl~~gGsL~~~L~k~---------------------------~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDI 288 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKN---------------------------KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDI 288 (474)
T ss_pred cEEEEEecCCCcHHHHHHhC---------------------------CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhH
Confidence 99999999999999999972 336899999999999999999999999999999
Q ss_pred CCCcEEecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK 622 (690)
Q Consensus 558 k~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~ 622 (690)
.+||||++.++.+||+|||+++..... |||......|++++|||||||++||+++ |..||.+...
T Consensus 289 AARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~ 368 (474)
T KOG0194|consen 289 AARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKN 368 (474)
T ss_pred hHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCH
Confidence 999999999999999999998865311 6888888899999999999999999999 8889987432
Q ss_pred -HHHHHH-HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 623 -WVRKLV-KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 623 -~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
.++..+ ..+......+ ....+ +..++..||..||++||+|.++.+.|+.+....
T Consensus 369 ~~v~~kI~~~~~r~~~~~--------~~p~~---~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~ 424 (474)
T KOG0194|consen 369 YEVKAKIVKNGYRMPIPS--------KTPKE---LAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKK 424 (474)
T ss_pred HHHHHHHHhcCccCCCCC--------CCHHH---HHHHHHHhccCChhhccCHHHHHHHHHHHHhcc
Confidence 233333 3332211111 12232 233455799999999999999999999876543
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=351.55 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=207.5
Q ss_pred HHHHHHhccCCCCceeccCCCccEEEEEcCC-CcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCee
Q 005572 400 KDLIAATSHFGKESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 400 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 478 (690)
++|+-...+..-..+||-|.||.||.|.|+. ...||||.++... ...++|..|..+|+.++|||+|+|+|+|......
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 3444334445556789999999999999865 6789999997654 4578999999999999999999999999999999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
|||+|||.+|+|.+||++. ....++-...+.||.||+.||+||..+++|||||.
T Consensus 339 YIiTEfM~yGNLLdYLRec--------------------------nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLA 392 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC--------------------------NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLA 392 (1157)
T ss_pred EEEEecccCccHHHHHHHh--------------------------chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhh
Confidence 9999999999999999983 23446666788999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCch-H
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDC-V 621 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~-~ 621 (690)
++|||+.++..+||+|||+++++..+ +||......++-|+|||+|||+|||+.| |..||..+ .
T Consensus 393 ARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl 472 (1157)
T KOG4278|consen 393 ARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 472 (1157)
T ss_pred hhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence 99999999999999999999976543 6666666788899999999999999988 88999874 3
Q ss_pred HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCCC
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSAD 688 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~~ 688 (690)
..+..++..+..++.. .+| . -.++++|..||++.|.+||+++|+-+.++.+.++..
T Consensus 473 SqVY~LLEkgyRM~~P-----eGC--P----pkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS 528 (1157)
T KOG4278|consen 473 SQVYGLLEKGYRMDGP-----EGC--P----PKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS 528 (1157)
T ss_pred HHHHHHHhccccccCC-----CCC--C----HHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence 4466666655433221 222 2 256777888999999999999999999998876543
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=344.55 Aligned_cols=229 Identities=28% Similarity=0.403 Sum_probs=188.5
Q ss_pred CCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 411 KESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 411 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
..+-||.|+-|.||+|++.+. .||||+++.-+ ..+++-|++++||||+.+.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl~ne-tVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNE-TVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeeccCc-eehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 456799999999999999865 79999885332 4567889999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
...|+. ...++......+..+||.||.|||.+.|||||||+-||||..+-.+
T Consensus 200 ~~VLka----------------------------~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~V 251 (904)
T KOG4721|consen 200 YEVLKA----------------------------GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVV 251 (904)
T ss_pred HHHHhc----------------------------cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceE
Confidence 999986 3567778888999999999999999999999999999999999999
Q ss_pred eEcCCCccccccc-------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcCCCCcc
Q 005572 571 KIAGFGLRNIGVK-------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDAL 637 (690)
Q Consensus 571 kl~DfGla~~~~~-------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 637 (690)
||+|||-++.... .+||++..+.+++|+||||||||||||+||..||.+.... ++..+.....+
T Consensus 252 KIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---AIIwGVGsNsL 328 (904)
T KOG4721|consen 252 KISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---AIIWGVGSNSL 328 (904)
T ss_pred EeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---eeEEeccCCcc
Confidence 9999998775432 2899999999999999999999999999999999874321 11222233333
Q ss_pred ccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 638 DFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 638 ~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
.-.++..+++.+.-++ ..||+..|.+||+|++++..|+-..
T Consensus 329 ~LpvPstcP~GfklL~------Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLL------KQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred cccCcccCchHHHHHH------HHHHhcCCCCCccHHHHHHHHhhcC
Confidence 3334444444444333 4599999999999999999987543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=316.16 Aligned_cols=243 Identities=19% Similarity=0.230 Sum_probs=183.4
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
.|+...++|+|+||.||||+ ..+|+.||||++..... .-.+-..+|++.|++++|||+|.|+.+|......++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 56777899999999999999 56699999999965432 2245678999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
|+. ++.+-|.. .+..++.....+++.|+++|+.|+|++++|||||||+||||
T Consensus 83 ~dh-TvL~eLe~---------------------------~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi 134 (396)
T KOG0593|consen 83 CDH-TVLHELER---------------------------YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI 134 (396)
T ss_pred cch-HHHHHHHh---------------------------ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE
Confidence 987 55555554 24457788899999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc-c---------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVK-N---------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~-~---------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~ 627 (690)
+.++.+|+||||+|+.... + ..|++|| .+|++.+||||.||++.||++|.+-|.+- .+....+
T Consensus 135 t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I 214 (396)
T KOG0593|consen 135 TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLI 214 (396)
T ss_pred ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHH
Confidence 9999999999999998652 2 2244443 58999999999999999999999887651 1111111
Q ss_pred HHh-cCC----------CCcc-ccccccCC-CCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKE-GAG----------GDAL-DFRLKLGS-GDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~-~~~----------~~~~-~~~~~~~~-~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... |.. ...+ -.+++... .++++ -.--+++++..|++.||++|++.+|++.
T Consensus 215 ~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 215 RKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred HHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 100 000 0000 00111100 00111 1124578999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=327.51 Aligned_cols=241 Identities=23% Similarity=0.315 Sum_probs=190.0
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCC-HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGID-HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
..+|+..+.||.|..+.||+|+ .+.+..||||+++.++... .+.+++|++.|+.++||||++++..|..+..+|+||.
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 4578888999999999999999 7778999999998765533 4889999999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
||.+||+.+.++.. -+..+++..+..|.+++++||.|||++|.||||||+.|||
T Consensus 105 fMa~GS~ldIik~~--------------------------~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTY--------------------------YPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred hhcCCcHHHHHHHH--------------------------ccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 99999999999872 2455889999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCccccccc--------------c----cCcccCC--CCCCCCCcchhhHHHHHHHHhCCCCCCchHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVK--------------N----VGERSEN--ETCGPESDVYCFGVILMELLTGKRGTDDCVKW 623 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~--------------~----~~e~~~~--~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~ 623 (690)
|+++|.+||+|||.+..... . +||+..+ ..|+.|+|||||||+..||.+|..||......
T Consensus 159 i~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 159 IDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred EcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 99999999999997532211 1 4555322 37999999999999999999999999875432
Q ss_pred HHHHHH-hcCCCC----ccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 624 VRKLVK-EGAGGD----ALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 624 ~~~~~~-~~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
-.-+.. .+.... ..+..-....+. .+.+++..|+++||.+|||++++++
T Consensus 239 kvLl~tLqn~pp~~~t~~~~~d~~k~~~k------sf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 239 KVLLLTLQNDPPTLLTSGLDKDEDKKFSK------SFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred HHHHHHhcCCCCCcccccCChHHhhhhcH------HHHHHHHHHhhcCcccCCCHHHHhc
Confidence 211111 111110 011111111111 3344455699999999999999975
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=321.09 Aligned_cols=239 Identities=20% Similarity=0.272 Sum_probs=184.8
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeecc--CCCCHHHHHHHHHHHHhcCCCCccceeeE-EecCCe-eEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA--KGIDHDDAVAMFDELSRLKHPNLLPLAGY-CIAGKE-KLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~-~~~~~~-~~lv~ 482 (690)
+|.+.++||+|.||+|||+. +.+|..+|.|.++-. ..+..++...|+.+|++++|||||+++++ +.+..+ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 45567899999999999998 788999999998632 22445778899999999999999999983 444444 88999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh--cC--CCCCCCC
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH--VG--STHGHLV 558 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~--~~--~iHrDlk 558 (690)
|||..|||...++..+. ..+.+++..+.+++.|++.||.++|+ .+ ++|||||
T Consensus 100 E~c~~GDLsqmIk~~K~------------------------qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIK 155 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKK------------------------QKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIK 155 (375)
T ss_pred HhhcccCHHHHHHHHHh------------------------ccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCc
Confidence 99999999999987432 24678999999999999999999999 44 6799999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HH
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KW 623 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~ 623 (690)
|.||+|+.+|.+|++|||+++..... .||+..+..|+.||||||+||++|||+.-.+||.... ..
T Consensus 156 PaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~ 235 (375)
T KOG0591|consen 156 PANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLS 235 (375)
T ss_pred chheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHH
Confidence 99999999999999999999876543 4666667899999999999999999999999997631 11
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
..+.+..+......+ .-++..+.+++. .|+..||+.||+...+++.+
T Consensus 236 L~~KI~qgd~~~~p~----~~YS~~l~~li~------~ci~vd~~~RP~t~~~v~di 282 (375)
T KOG0591|consen 236 LCKKIEQGDYPPLPD----EHYSTDLRELIN------MCIAVDPEQRPDTVPYVQDI 282 (375)
T ss_pred HHHHHHcCCCCCCcH----HHhhhHHHHHHH------HHccCCcccCCCcchHHHHH
Confidence 122222332111111 222334444444 49999999999854444443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=332.60 Aligned_cols=245 Identities=25% Similarity=0.282 Sum_probs=188.0
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKLV 480 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~l 480 (690)
...|+.++.||+|.||.||||+ ..+|..||+|+++... ......+.+|+.+|++++||||++|.|...+. ..+|+
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 3457777899999999999999 7889999999986543 45667889999999999999999999999876 68999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|+|||+. ||.-++.. ..-.++..++..++.|++.||+|+|++++.|||||.+
T Consensus 196 VFeYMdh-DL~GLl~~---------------------------p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~S 247 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLSS---------------------------PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGS 247 (560)
T ss_pred EEecccc-hhhhhhcC---------------------------CCcccChHHHHHHHHHHHHHHHHHhhcCeeecccccc
Confidence 9999987 99888764 2457899999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc---------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--H
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN---------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--K 622 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~ 622 (690)
|||||.+|.+||+|||||++.... +||...+ ..|+.++|+||.||||.||++|++.+..-. +
T Consensus 248 NiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve 327 (560)
T KOG0600|consen 248 NILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE 327 (560)
T ss_pred ceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH
Confidence 999999999999999999965433 3343332 489999999999999999999999987622 2
Q ss_pred HHHHHHHh-cCCC-------Cccc---cccccCCCCCHHHHH-----HHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 623 WVRKLVKE-GAGG-------DALD---FRLKLGSGDSVAEMV-----ESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 623 ~~~~~~~~-~~~~-------~~~~---~~~~~~~~~~~~~~~-----~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
....+.+. +... ++.. .+....+...+.|.. ..+++.-..|..||++|.|+.++++
T Consensus 328 Ql~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 328 QLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred HHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 22222221 1110 1110 011111111222221 2345566678889999999999875
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=329.78 Aligned_cols=239 Identities=26% Similarity=0.333 Sum_probs=185.5
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCC--eeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK--EKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~--~~~lv~e~ 484 (690)
++...+.||+|+||.||++.. ++|...|||.+........+.+.+|+++|++++|||||+++|...... .+++.|||
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy 97 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEY 97 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeec
Confidence 455568899999999999994 458899999987653223567899999999999999999999865554 58899999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++|+|.+++.+. +..+++..+.+++.||++||+|||+++++||||||+|||+
T Consensus 98 ~~~GsL~~~~~~~---------------------------g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl 150 (313)
T KOG0198|consen 98 APGGSLSDLIKRY---------------------------GGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL 150 (313)
T ss_pred cCCCcHHHHHHHc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE
Confidence 9999999999862 2268999999999999999999999999999999999999
Q ss_pred cC-CCCceEcCCCccccccc--c---------------cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCchHHHHH
Q 005572 565 AE-SLEPKIAGFGLRNIGVK--N---------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCVKWVR 625 (690)
Q Consensus 565 ~~-~~~~kl~DfGla~~~~~--~---------------~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~ 625 (690)
+. ++.+||+|||+++.... . +||..... ....++||||+||++.||+||++||.+....+.
T Consensus 151 ~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~ 230 (313)
T KOG0198|consen 151 DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE 230 (313)
T ss_pred eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH
Confidence 99 79999999998875441 0 55555532 223499999999999999999999987422222
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
.....+... .-|.++...+...++ +...|++.||++||||.|+++.--
T Consensus 231 ~~~~ig~~~--~~P~ip~~ls~~a~~------Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 231 ALLLIGRED--SLPEIPDSLSDEAKD------FLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred HHHHHhccC--CCCCCCcccCHHHHH------HHHHHhhcCcccCcCHHHHhhChh
Confidence 233322222 112333333333343 444599999999999999987643
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=333.61 Aligned_cols=244 Identities=23% Similarity=0.278 Sum_probs=192.5
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHH--HHHHHHHHHhcC-CCCccceeeEEecCC-eeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDD--AVAMFDELSRLK-HPNLLPLAGYCIAGK-EKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~--~~~e~~~l~~l~-H~niv~l~g~~~~~~-~~~lv 481 (690)
.+|...+.||.|.||.||+|+ ..++..||||++++.-. ..++ -.||++.|+++. |||||++.+++.+.+ .+|+|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 456677899999999999998 67788999999976543 2333 468999999998 999999999999988 99999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
||||+. +|+++++++ .+.+++.++..|+.||.+||+|+|.+|+.|||+||+|
T Consensus 89 fE~Md~-NLYqLmK~R---------------------------~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPEN 140 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDR---------------------------NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPEN 140 (538)
T ss_pred HHhhhh-hHHHHHhhc---------------------------CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhh
Confidence 999975 999999872 4679999999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccccC---------cccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKNVG---------ERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVR 625 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~~~---------e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~ 625 (690)
||+.....+||+|||+||.....+| |++|| ..|+.+.||||+||+++|+++-++-|.+. .+...
T Consensus 141 iLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~ 220 (538)
T KOG0661|consen 141 ILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY 220 (538)
T ss_pred eEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence 9999999999999999998766533 34444 47899999999999999999999887752 22222
Q ss_pred HHHHh-cC-----------CCCccccccccCCCCCHHHH-----HHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 626 KLVKE-GA-----------GGDALDFRLKLGSGDSVAEM-----VESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 626 ~~~~~-~~-----------~~~~~~~~~~~~~~~~~~~~-----~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
++..- |. ....+..+++...+..+..+ .+..+++..|+++||++|||+.|+++.
T Consensus 221 KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 221 KICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred HHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 22221 10 01112223333333333332 245677888999999999999999874
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=328.85 Aligned_cols=245 Identities=22% Similarity=0.311 Sum_probs=190.3
Q ss_pred cCHHHHHHHhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCC---HHHHHHHHHHHHhcCCCCccceeeEEe
Q 005572 397 LTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGID---HDDAVAMFDELSRLKHPNLLPLAGYCI 473 (690)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~ 473 (690)
++.+++ +......||+|++|.||+|.+ ++..||||+++...... .+.+.+|+++|++++||||++++|++.
T Consensus 15 i~~~~i-----~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~ 88 (283)
T PHA02988 15 IESDDI-----DKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFII 88 (283)
T ss_pred cCHHHc-----CCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEE
Confidence 455555 334446899999999999998 46789999997654333 356779999999999999999999987
Q ss_pred c----CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh
Q 005572 474 A----GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH 549 (690)
Q Consensus 474 ~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 549 (690)
+ ....++||||+++|+|.+++.. ...++|..+.+++.|++.||.|||+
T Consensus 89 ~~~~~~~~~~lv~Ey~~~g~L~~~l~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lH~ 140 (283)
T PHA02988 89 DIVDDLPRLSLILEYCTRGYLREVLDK----------------------------EKDLSFKTKLDMAIDCCKGLYNLYK 140 (283)
T ss_pred ecccCCCceEEEEEeCCCCcHHHHHhh----------------------------CCCCChhHHHHHHHHHHHHHHHHHh
Confidence 7 3468899999999999999975 2357889999999999999999998
Q ss_pred -cCCCCCCCCCCcEEecCCCCceEcCCCccccccc-----------ccCcccCC--CCCCCCCcchhhHHHHHHHHhCCC
Q 005572 550 -VGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK-----------NVGERSEN--ETCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 550 -~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~-----------~~~e~~~~--~~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
.+++||||||+|||+++++.+||+|||+++.... .+||...+ ..++.++|||||||++|||++|+.
T Consensus 141 ~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~ 220 (283)
T PHA02988 141 YTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKI 220 (283)
T ss_pred cCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCC
Confidence 4889999999999999999999999999874221 15555544 478899999999999999999999
Q ss_pred CCCchH-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 616 GTDDCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 616 p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
||.... ............ .+.++...+ . .+.+++.+||+.||++||||.|+++.|+.++.
T Consensus 221 Pf~~~~~~~~~~~i~~~~~----~~~~~~~~~---~---~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 221 PFENLTTKEIYDLIINKNN----SLKLPLDCP---L---EIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred CCCCCCHHHHHHHHHhcCC----CCCCCCcCc---H---HHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 998632 112222211111 111111121 1 34566778999999999999999999988753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-39 Score=339.94 Aligned_cols=270 Identities=23% Similarity=0.317 Sum_probs=192.5
Q ss_pred HhccCCCCceeccCCCccEEEEEc------CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL------PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGK 476 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 476 (690)
+.++|...+.||+|+||.||+|.. .++..||||+++.... ...+.+.+|++++..+ +||||++++|+|...+
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 445788889999999999999973 2346799999965432 2235688899999999 8999999999987644
Q ss_pred -eeEEEEEecCCCCHhhhhhcCCCCCCC-CCCCC---------------------------CCCC------CCCCCCCCC
Q 005572 477 -EKLVLLEFMANGDLHRWLHELPTGEPN-VEDWS---------------------------TDTW------DHHPGAGSH 521 (690)
Q Consensus 477 -~~~lv~e~~~~gsL~~~l~~~~~~~~~-~~~~~---------------------------~~~~------~~~~~~~~~ 521 (690)
..++||||+++|+|.+++...+..... .+... .... .........
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 578999999999999999863211000 00000 0000 000000000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCccccccc----------------cc
Q 005572 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK----------------NV 585 (690)
Q Consensus 522 ~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~ 585 (690)
......+++.++..++.||++||+|||+++++||||||+|||++.++.+||+|||+++.... .+
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 244 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMA 244 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccC
Confidence 01235689999999999999999999999999999999999999999999999999875321 13
Q ss_pred CcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH--HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhh
Q 005572 586 GERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV--KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLC 662 (690)
Q Consensus 586 ~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 662 (690)
||......++.++|||||||++|||++ |..||.... .........+.. ...+...+ ..+.+++..|
T Consensus 245 PE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-----~~~~~~~~------~~l~~li~~c 313 (338)
T cd05102 245 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTR-----MRAPENAT------PEIYRIMLAC 313 (338)
T ss_pred cHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCC-----CCCCCCCC------HHHHHHHHHH
Confidence 444444578999999999999999997 999987521 122222222211 11111111 1345677789
Q ss_pred cCCCCCCCCCHHHHHHHHhccCC
Q 005572 663 TADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 663 ~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
|+.||++|||+.|+++.|+++..
T Consensus 314 l~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 314 WQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred ccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=328.32 Aligned_cols=235 Identities=25% Similarity=0.330 Sum_probs=191.6
Q ss_pred HhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeecc---CCCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA---KGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 479 (690)
...+|...+.||+|+|++||+|+ ..++..+|||++.+. ++...+...+|-..|.+| .||.|++|+-.+.+...+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 34577888899999999999998 677899999999654 223345567788889999 7999999999999999999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+|+||+++|+|.++|++ .+.+++.....+|.+|..||+|||++|||||||||
T Consensus 151 FvLe~A~nGdll~~i~K----------------------------~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKP 202 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKK----------------------------YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKP 202 (604)
T ss_pred EEEEecCCCcHHHHHHH----------------------------hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCCh
Confidence 99999999999999987 35688888999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc---------------------------cCcccCCCCCCCCCcchhhHHHHHHHHh
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN---------------------------VGERSENETCGPESDVYCFGVILMELLT 612 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~---------------------------~~e~~~~~~~~~~~DVwSfGvvl~el~t 612 (690)
+|||||+|+++||+|||-|+..... .||.......++.+|+|+|||++|.|+.
T Consensus 203 ENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmla 282 (604)
T KOG0592|consen 203 ENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLA 282 (604)
T ss_pred hheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhc
Confidence 9999999999999999998865322 3444445678899999999999999999
Q ss_pred CCCCCCchHHHHH-HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 613 GKRGTDDCVKWVR-KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 613 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
|.+||....++.. +.+.. +++.++.+.+....+++ .+.+..||.+|+|..||.+.
T Consensus 283 G~PPFra~NeyliFqkI~~------l~y~fp~~fp~~a~dLv------~KLLv~dp~~Rlt~~qIk~H 338 (604)
T KOG0592|consen 283 GQPPFRAANEYLIFQKIQA------LDYEFPEGFPEDARDLI------KKLLVRDPSDRLTSQQIKAH 338 (604)
T ss_pred CCCCCccccHHHHHHHHHH------hcccCCCCCCHHHHHHH------HHHHccCccccccHHHHhhC
Confidence 9999987655531 11111 24455555544444444 45788999999999888653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=316.54 Aligned_cols=226 Identities=22% Similarity=0.236 Sum_probs=184.2
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
.++|+..++||+|+||.||.++ .++++.+|+|++++.+. .+.+...+|..+|.+++||.||+++..+.+.+.+|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 3578899999999999999998 56689999999976543 3456688899999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
+||+.||+|+..|++ ...+++..+.-++.+|+.||.|||+++||||||||+|
T Consensus 104 ld~~~GGeLf~hL~~----------------------------eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPEN 155 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQR----------------------------EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPEN 155 (357)
T ss_pred EeccCCccHHHHHHh----------------------------cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHH
Confidence 999999999999985 3568888889999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc--hHHHHH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD--CVKWVR 625 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~--~~~~~~ 625 (690)
||||.+|.++|+|||+++..... |||+..+..|+..+|.||+||++|||++|.+||.. ...+..
T Consensus 156 ILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~ 235 (357)
T KOG0598|consen 156 ILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD 235 (357)
T ss_pred eeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH
Confidence 99999999999999999853221 67777778999999999999999999999999875 333333
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP 671 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP 671 (690)
.+.... . ...+...+....+ +....+..||++|-
T Consensus 236 ~I~~~k-~-----~~~p~~ls~~ard------ll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 236 KILKGK-L-----PLPPGYLSEEARD------LLKKLLKRDPRQRL 269 (357)
T ss_pred HHhcCc-C-----CCCCccCCHHHHH------HHHHHhccCHHHhc
Confidence 333322 0 1111112223333 33457899999995
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=340.95 Aligned_cols=240 Identities=24% Similarity=0.380 Sum_probs=197.3
Q ss_pred CCCCceeccCCCccEEEEEc-CC----CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PG----ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
+...++||+|+||.||||.| +. ..+||+|++..... +...++.+|+-.|++++|||+++|+|+|.... ..||+
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 34467899999999999984 44 35799999865433 45678999999999999999999999998765 78999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
+||+.|+|.+|++.. .+.+.-...+.|..|||+||.|||+++.+||||.++||
T Consensus 777 q~mP~G~LlDyvr~h---------------------------r~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNV 829 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREH---------------------------RDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNV 829 (1177)
T ss_pred HhcccchHHHHHHHh---------------------------hccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhhe
Confidence 999999999999973 34577778899999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccccC----------------cccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCch-HHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKNVG----------------ERSENETCGPESDVYCFGVILMELLT-GKRGTDDC-VKWV 624 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~~~----------------e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~-~~~~ 624 (690)
|+.+-..+||.|||+++......- |......|+.++|||||||++||++| |..|++.+ .+.+
T Consensus 830 LVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI 909 (1177)
T KOG1025|consen 830 LVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI 909 (1177)
T ss_pred eecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh
Confidence 999999999999999997655411 22223478999999999999999999 99999874 4555
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
...++.+.. + +.+....+.++.++.+||..|++.||+++|+...+.++...+
T Consensus 910 ~dlle~geR-------L----sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp 961 (1177)
T KOG1025|consen 910 PDLLEKGER-------L----SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP 961 (1177)
T ss_pred hHHHhcccc-------C----CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence 666655432 1 112334457788889999999999999999999998876665
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=326.27 Aligned_cols=234 Identities=20% Similarity=0.319 Sum_probs=192.6
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
..|..-..||+|+.|.||.++ ..++..||||+++..+...++-+..|+.+|+..+|+|||.++..|...+++|+|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 345566789999999999998 6778899999999887777788899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+.+.+ ..+++.++..|++++++||+|||.++|+|||||..|||++
T Consensus 353 ~ggsLTDvVt~-----------------------------~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~ 403 (550)
T KOG0578|consen 353 EGGSLTDVVTK-----------------------------TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLT 403 (550)
T ss_pred CCCchhhhhhc-----------------------------ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEec
Confidence 99999998865 3488999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc--hHHHHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD--CVKWVRKLVK 629 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~--~~~~~~~~~~ 629 (690)
.+|.+||+|||++...... +||+..+..|++|+||||+|++++||+-|++||-. ..+..+.+..
T Consensus 404 ~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ 483 (550)
T KOG0578|consen 404 MDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT 483 (550)
T ss_pred cCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh
Confidence 9999999999997654332 66666677999999999999999999999999863 3333333333
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.+.. +.+.+...+..+++ +..+|++.||++||++.|+++.
T Consensus 484 ng~P----~lk~~~klS~~~kd------FL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 484 NGTP----KLKNPEKLSPELKD------FLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCCC----CcCCccccCHHHHH------HHHHHhhcchhcCCCHHHHhcC
Confidence 3321 11111112223333 3446999999999999999863
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=322.28 Aligned_cols=259 Identities=23% Similarity=0.324 Sum_probs=187.9
Q ss_pred ccCCCCceeccCCCccEEEEEcCC-----------------CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccce
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG-----------------ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPL 468 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l 468 (690)
++|...+.||+|+||.||+|.+.+ +..||+|.+..... ....++.+|++.+.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467778899999999999997432 34699999865432 224568899999999999999999
Q ss_pred eeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 005572 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH 548 (690)
Q Consensus 469 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 548 (690)
+|++...+..++||||+++|+|.+++......+.....- ...........++|.++.+++.|++.||.|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 155 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN---------DAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccc---------cccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999997632111100000 00000122356889999999999999999999
Q ss_pred hcCCCCCCCCCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh
Q 005572 549 HVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT 612 (690)
Q Consensus 549 ~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t 612 (690)
+.+++||||||+|||+++++.+||+|||+++.... .+||......++.++|||||||++|||++
T Consensus 156 ~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 235 (304)
T cd05096 156 SLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235 (304)
T ss_pred HCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHH
Confidence 99999999999999999999999999999874321 13444444578899999999999999987
Q ss_pred --CCCCCCchHH-----HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 613 --GKRGTDDCVK-----WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 613 --g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
+..||.+... .+........ .... ...+...+ ..+.+++.+||+.||++||||.||.+.|++
T Consensus 236 ~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~------~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 236 LCKEQPYGELTDEQVIENAGEFFRDQG-RQVY-LFRPPPCP------QGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred ccCCCCCCcCCHHHHHHHHHHHhhhcc-cccc-ccCCCCCC------HHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 5667765221 1111111110 0110 00011111 135567778999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=328.26 Aligned_cols=238 Identities=22% Similarity=0.369 Sum_probs=191.7
Q ss_pred CCCCceeccCCCccEEEEEcCC-----CcEEEEEEeecc-CCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 409 FGKESLLAEGRCGPVYRAVLPG-----ELHVAIKVLDNA-KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
....++||+|.||.||+|.+.+ ...||||.-+.. ...+.+.|.+|..+|++++|||||+|+|+|.+ ...||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm 469 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM 469 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence 3445789999999999998532 346899988764 33556789999999999999999999999986 6789999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
|.++-|.|.+||+. +...|+......++.||+.||+|||+.++|||||.++||
T Consensus 470 EL~~~GELr~yLq~---------------------------nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNi 522 (974)
T KOG4257|consen 470 ELAPLGELREYLQQ---------------------------NKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNI 522 (974)
T ss_pred ecccchhHHHHHHh---------------------------ccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhhe
Confidence 99999999999987 346788889999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH-HH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-VR 625 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-~~ 625 (690)
|+.+.--+|++|||+++..... +||...-..++.++|||-|||++||+++ |..||...... +-
T Consensus 523 LVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI 602 (974)
T KOG4257|consen 523 LVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVI 602 (974)
T ss_pred eecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceE
Confidence 9999999999999999976554 5565555688999999999999999987 99999753211 10
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
-.+..|. ....+..+ ...++.+|.+||++||.+||.+.|+...|.++.+
T Consensus 603 ~~iEnGe-----RlP~P~nC------Pp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENGE-----RLPCPPNC------PPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCCC-----CCCCCCCC------ChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1111111 11111222 2245677888999999999999999999988754
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=312.04 Aligned_cols=236 Identities=25% Similarity=0.393 Sum_probs=189.1
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
++|+..+.||+|+||.||++.+.++..+|+|.+.... ...+++..|++.+++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 3577778999999999999998887789999886432 345778999999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.++++.. ...++|..+..++.|++.||.|||+.+++||||||+||++++
T Consensus 83 ~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05114 83 NGCLLNYLRQR---------------------------QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS 135 (256)
T ss_pred CCcHHHHHHhC---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcC
Confidence 99999999751 235789999999999999999999999999999999999999
Q ss_pred CCCceEcCCCccccccc---------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH-HHHHHH
Q 005572 567 SLEPKIAGFGLRNIGVK---------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-VRKLVK 629 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~---------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-~~~~~~ 629 (690)
++.+||+|||+++.... .+||......++.++||||||+++|||++ |+.||...... ......
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~ 215 (256)
T cd05114 136 TGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS 215 (256)
T ss_pred CCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 99999999998864321 13444444567889999999999999999 89998753221 112222
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
.+.. ...+.. . ...+.+++.+||+.+|++||++.|+++.|.
T Consensus 216 ~~~~--~~~~~~------~---~~~~~~li~~c~~~~p~~Rps~~~l~~~l~ 256 (256)
T cd05114 216 RGFR--LYRPKL------A---SMTVYEVMYSCWHEKPEGRPTFAELLRAIT 256 (256)
T ss_pred CCCC--CCCCCC------C---CHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 2111 111110 1 124567888999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=291.79 Aligned_cols=244 Identities=24% Similarity=0.233 Sum_probs=189.0
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|...+.+|+|.||.||+|+ ..+++.||||+++.... .-.....+|++.|+.++|+||+.+++++-..+...||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 56777899999999999999 67899999999976533 2346789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
|+. ||...++. ....++..++..++.++.+|++|||++.|+||||||.|+|+
T Consensus 83 m~t-dLe~vIkd---------------------------~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi 134 (318)
T KOG0659|consen 83 MPT-DLEVVIKD---------------------------KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI 134 (318)
T ss_pred ccc-cHHHHhcc---------------------------cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE
Confidence 987 99999986 34578899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc----------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCc--hHHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN----------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDD--CVKWVRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~----------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~--~~~~~~~~ 627 (690)
+++|.+||+|||+|+..... ..|++|| ..|+..+||||.||++.||+-|.+-|.+ ..+....+
T Consensus 135 s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~I 214 (318)
T KOG0659|consen 135 SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKI 214 (318)
T ss_pred cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHH
Confidence 99999999999999976532 2344444 4799999999999999999999876654 22222222
Q ss_pred HHh-cC--------CCCccccccccCCC------CCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 628 VKE-GA--------GGDALDFRLKLGSG------DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 628 ~~~-~~--------~~~~~~~~~~~~~~------~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
+.. |. .....|+.--...+ -...+.-..++++..++..||.+|.|++|++++
T Consensus 215 f~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 215 FRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred HHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 221 10 01111111000000 011112244778888999999999999999864
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=332.58 Aligned_cols=268 Identities=24% Similarity=0.293 Sum_probs=192.0
Q ss_pred HhccCCCCceeccCCCccEEEEEc------CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL------PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGK 476 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 476 (690)
..++|...+.||+|+||.||+|++ .++..||||+++.... ...+.+.+|+++++.+ +||||++++|+|...+
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~ 112 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG 112 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence 345677889999999999999963 2356899999964432 2345688899999999 8999999999999999
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCC-------------------------CC-----------CCCCCCCCCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNV-------------------------ED-----------WSTDTWDHHPGAGS 520 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~-------------------------~~-----------~~~~~~~~~~~~~~ 520 (690)
..++|||||++|+|.++++..+...... .. .....-........
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 9999999999999999998633110000 00 00000000000000
Q ss_pred -----------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCccccccc------
Q 005572 521 -----------HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK------ 583 (690)
Q Consensus 521 -----------~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~------ 583 (690)
.......++|..+.+++.||++||+|||+.+++||||||+|||+++++.+||+|||+++....
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 272 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV 272 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence 001124689999999999999999999999999999999999999999999999999864321
Q ss_pred ----------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH--HHHHHHHHhcCCCCccccccccCCCCCHH
Q 005572 584 ----------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV--KWVRKLVKEGAGGDALDFRLKLGSGDSVA 650 (690)
Q Consensus 584 ----------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (690)
.+||......++.++|||||||++|||++ |..||.... ....+....+.... .+.. ...
T Consensus 273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-----~~~~---~~~ 344 (375)
T cd05104 273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML-----SPEC---APS 344 (375)
T ss_pred cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC-----CCCC---CCH
Confidence 14444444578899999999999999998 888886532 12222222221110 0001 111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 651 EMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 651 ~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
++.+++..||+.||++||+|.||++.|++.
T Consensus 345 ---~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 345 ---EMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred ---HHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 345677789999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=315.79 Aligned_cols=239 Identities=25% Similarity=0.364 Sum_probs=187.6
Q ss_pred ccCCCCceeccCCCccEEEEEcC----CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP----GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
.+|+..+.||+|+||.||+|.+. .+..||+|+++.... .....+.+|+..+++++||||++++|++...+..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 45777889999999999999742 356899999975432 2235688899999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|.+++... ...++|.+++.++.|++.||+|||+++++||||||+|
T Consensus 85 ~e~~~~~~L~~~l~~~---------------------------~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~n 137 (266)
T cd05064 85 TEYMSNGALDSFLRKH---------------------------EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHK 137 (266)
T ss_pred EEeCCCCcHHHHHHhC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhh
Confidence 9999999999999751 2358899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCccccccc---------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVK---------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WV 624 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~---------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~ 624 (690)
|+++.++.+|++|||.+..... .+||......++.++|||||||++||+++ |+.||.+... ..
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~ 217 (266)
T cd05064 138 VLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV 217 (266)
T ss_pred EEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 9999999999999998654211 13444444578899999999999999775 9999875322 12
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.+....+.. ...+...+ ..+.+++..||+.+|++||++.||.+.|+.+
T Consensus 218 ~~~~~~~~~-----~~~~~~~~------~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 218 IKAVEDGFR-----LPAPRNCP------NLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred HHHHHCCCC-----CCCCCCCC------HHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 222222211 11111111 1345567789999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=321.17 Aligned_cols=232 Identities=30% Similarity=0.470 Sum_probs=177.4
Q ss_pred CceeccCCCccEEEEEcC-----CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 412 ESLLAEGRCGPVYRAVLP-----GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.+.||.|.||.||+|.+. .+..|+||.++.... ...+++.+|++.+++++||||++++|+|...+..++|+|||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~ 83 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYC 83 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccccccccccc
Confidence 468999999999999965 257899999965332 22578899999999999999999999999888899999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.++|+.. ....+++.++.+|+.|||+||.|||+++++|+||+++||+++
T Consensus 84 ~~g~L~~~L~~~--------------------------~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 84 PGGSLDDYLKSK--------------------------NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp TTEBHHHHHHHT--------------------------CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred cccccccccccc--------------------------cccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999972 235689999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH-HHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-VRKL 627 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-~~~~ 627 (690)
+++.+||+|||+++..... +||......++.++||||||+++|||++ |+.||.+.... ....
T Consensus 138 ~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~ 217 (259)
T PF07714_consen 138 SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK 217 (259)
T ss_dssp TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999998765211 3444434567889999999999999999 78998764222 2222
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
+..+.... .+...+ . .+.+++..||+.||++||||.|+++.|
T Consensus 218 ~~~~~~~~-----~~~~~~---~---~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 218 LKQGQRLP-----IPDNCP---K---DIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp HHTTEETT-----SBTTSB---H---HHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ccccccce-----eccchh---H---HHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 23222111 111111 1 344667789999999999999999986
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=323.69 Aligned_cols=232 Identities=24% Similarity=0.334 Sum_probs=185.9
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeecc----CC-CCHHHHHHHHHHHHhcC-CCCccceeeEEecCCee
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA----KG-IDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~----~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~ 478 (690)
...|...+.||+|+||.|+.|. ..++..||+|+++.. .. ...+.+.+|+.++++++ ||||++++.++......
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 4578888999999999999997 566899999987654 11 23456678999999999 99999999999999999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
|+|||||.+|+|++++.. ..++.+.....++.|++.|++|+|+++|+|||||
T Consensus 96 ~ivmEy~~gGdL~~~i~~----------------------------~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK 147 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVN----------------------------KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLK 147 (370)
T ss_pred EEEEEecCCccHHHHHHH----------------------------cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence 999999999999999986 3467788999999999999999999999999999
Q ss_pred CCcEEecCC-CCceEcCCCcccccc-cc-------------cCcccCCCC-C-CCCCcchhhHHHHHHHHhCCCCCCchH
Q 005572 559 TSSILLAES-LEPKIAGFGLRNIGV-KN-------------VGERSENET-C-GPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 559 ~~NiLl~~~-~~~kl~DfGla~~~~-~~-------------~~e~~~~~~-~-~~~~DVwSfGvvl~el~tg~~p~~~~~ 621 (690)
|+|||+|.+ +.+||+|||++.... .. +||...... | +.++||||+||+||.|++|+.||++..
T Consensus 148 ~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 148 PENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred HHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 999999999 999999999998762 21 555555544 6 479999999999999999999998721
Q ss_pred -HHHHHHHHhcCCCCccccccccCC-CCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005572 622 -KWVRKLVKEGAGGDALDFRLKLGS-GDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677 (690)
Q Consensus 622 -~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~ 677 (690)
......+..+. ..++... +. .+..++.+|+..||.+|+|+.||+
T Consensus 228 ~~~l~~ki~~~~------~~~p~~~~S~------~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 228 VPNLYRKIRKGE------FKIPSYLLSP------EARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHHHHHhcCC------ccCCCCcCCH------HHHHHHHHHcCCCcccCCCHHHHh
Confidence 11112222221 1111111 22 334455569999999999999998
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=308.41 Aligned_cols=232 Identities=22% Similarity=0.302 Sum_probs=189.8
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHH---HHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHD---DAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~---~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
.+|+..+.||+|.||.|-+++ ...|+.||||.+++.+-.+.+ .+++|+++|+.++||||+.++.+|+..+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 356667889999999999998 577999999999876654444 4788999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||..+|.|++|+.+ .+.|++.+...+++||..|+.|+|.++++|||||.+||
T Consensus 133 EYaS~GeLYDYiSe----------------------------r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENI 184 (668)
T KOG0611|consen 133 EYASGGELYDYISE----------------------------RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENI 184 (668)
T ss_pred EecCCccHHHHHHH----------------------------hccccHHHHHHHHHHHHHHHHHHhhccceecccchhhe
Confidence 99999999999986 34689999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc-------------cCcccCCCCC-CCCCcchhhHHHHHHHHhCCCCCCch-HHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN-------------VGERSENETC-GPESDVYCFGVILMELLTGKRGTDDC-VKWVRKL 627 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~-~~~~DVwSfGvvl~el~tg~~p~~~~-~~~~~~~ 627 (690)
|+|.++.+||+|||++.++... .||+..+..| ++.+|-||+||+||.|+.|..||++. .....+.
T Consensus 185 LLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ 264 (668)
T KOG0611|consen 185 LLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ 264 (668)
T ss_pred eecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH
Confidence 9999999999999998765543 4555555544 68999999999999999999999972 2223333
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
+..+...+ +.-+ . ....++.+++..+|++|.|+.+|...
T Consensus 265 Is~GaYrE---P~~P----S------dA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 265 ISRGAYRE---PETP----S------DASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred hhcccccC---CCCC----c------hHHHHHHHHHhcCcccchhHHHHhhh
Confidence 33333222 1111 1 12344557889999999999999754
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-38 Score=291.82 Aligned_cols=247 Identities=20% Similarity=0.280 Sum_probs=197.9
Q ss_pred HHhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCC-----e
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK-----E 477 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~ 477 (690)
+...+|.+.+.+|+|+|+-||.++ ..++..+|+|++...+..+.+...+|++..++++||||+++++++..+. +
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 345678889999999999999999 7888899999998777677888999999999999999999999886543 5
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC--CCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG--STHG 555 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~iHr 555 (690)
.||+++|...|+|.+.+...+ ..+..+++.+.+.|+.+|++||++||+.. ..||
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k------------------------~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~ 153 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLK------------------------IKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHR 153 (302)
T ss_pred EEEEeehhccccHHHHHHHHh------------------------hcCCccCHHHHHHHHHHHHHHHHHHhccCCccccc
Confidence 999999999999999998743 12456899999999999999999999998 7899
Q ss_pred CCCCCcEEecCCCCceEcCCCccccccc-------------------ccCcccCCC-------CCCCCCcchhhHHHHHH
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVK-------------------NVGERSENE-------TCGPESDVYCFGVILME 609 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~-------------------~~~e~~~~~-------~~~~~~DVwSfGvvl~e 609 (690)
||||.|||+.+++.+++.|||.+..... ..||++||- ..++++|||||||+||+
T Consensus 154 DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa 233 (302)
T KOG2345|consen 154 DIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYA 233 (302)
T ss_pred CCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHH
Confidence 9999999999999999999998765321 167777762 57889999999999999
Q ss_pred HHhCCCCCCchHHHHHHHHHhcCC--CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 610 LLTGKRGTDDCVKWVRKLVKEGAG--GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 610 l~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
|+.|..||+... +.|.. ..+....+.........+ .+.+++.+|++.||.+||++.|++..++.+
T Consensus 234 ~mf~~sPfe~~~-------~~GgSlaLAv~n~q~s~P~~~~yse--~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 234 MMFGESPFERIY-------QQGGSLALAVQNAQISIPNSSRYSE--ALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred HHHcCCcchHHh-------hcCCeEEEeeeccccccCCCCCccH--HHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 999999997422 12211 011111221111111111 345667789999999999999999998875
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=321.46 Aligned_cols=229 Identities=24% Similarity=0.301 Sum_probs=187.4
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|.+.+.||+|+||.||||+ ..+.+.||+|.+++... ++.+.+.+|++++++++|||||.++++|+...+.++|+||
T Consensus 3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~ 82 (808)
T KOG0597|consen 3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEY 82 (808)
T ss_pred chhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehh
Confidence 56667789999999999998 45678999999976543 3346689999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
|.+ +|+.+|.. .+.+++.++..|+.|+..||.|||+.+|.|||+||.|||+
T Consensus 83 a~g-~L~~il~~----------------------------d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl 133 (808)
T KOG0597|consen 83 AVG-DLFTILEQ----------------------------DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL 133 (808)
T ss_pred hhh-hHHHHHHh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee
Confidence 976 99999986 3579999999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc--hHHHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD--CVKWVRKLV 628 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~--~~~~~~~~~ 628 (690)
+..+++|+||||+|+....+ +||...+..|+..+|.||+||++||+++|++||.. +...++.+.
T Consensus 134 ~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~ 213 (808)
T KOG0597|consen 134 EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSIL 213 (808)
T ss_pred cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHh
Confidence 99999999999999865432 67777778999999999999999999999999864 333333333
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.+ . ...+...+ .+ +..+...-+.+||.+|-|..+++.
T Consensus 214 ~d-----~--v~~p~~~S---~~---f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 214 KD-----P--VKPPSTAS---SS---FVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cC-----C--CCCccccc---HH---HHHHHHHHhhcChhhcccHHHHhc
Confidence 22 1 11111111 12 223334578999999999988864
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=321.52 Aligned_cols=242 Identities=20% Similarity=0.326 Sum_probs=189.1
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCc----EEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGEL----HVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
.+|+..+.||+|+||.||+|++ .++. .||+|+++.... ...+++.+|+.+++.++||||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 4688889999999999999985 3333 489999864432 3346788899999999999999999999864 5779
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|+||+++|+|.++++.. ...+++..++.++.||++||+|||+.+++||||||+
T Consensus 86 v~e~~~~g~l~~~l~~~---------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~ 138 (316)
T cd05108 86 ITQLMPFGCLLDYVREH---------------------------KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAAR 138 (316)
T ss_pred eeecCCCCCHHHHHHhc---------------------------cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence 99999999999999762 235788899999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK- 622 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~- 622 (690)
|||+++++.+||+|||+++..... +||......++.++|||||||++|||++ |+.||.+...
T Consensus 139 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 139 NVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred heEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999998754211 3444444578899999999999999998 9999876322
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
............ ..+..+ ...+.+++..||+.||++||++.|++..+..+...+
T Consensus 219 ~~~~~~~~~~~~-----~~~~~~------~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 219 EISSILEKGERL-----PQPPIC------TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred HHHHHHhCCCCC-----CCCCCC------CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 222222222110 001111 124556777899999999999999999998876544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=329.67 Aligned_cols=270 Identities=23% Similarity=0.299 Sum_probs=192.8
Q ss_pred HHhccCCCCceeccCCCccEEEEEc------CCCcEEEEEEeeccCCC-CHHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAVL------PGELHVAIKVLDNAKGI-DHDDAVAMFDELSRL-KHPNLLPLAGYCIAG 475 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 475 (690)
...++|+..+.||+|+||.||+|+. .++..||+|+++..... ..+.+.+|+++++.+ +||||++++|+|...
T Consensus 35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 3445788889999999999999873 22357999999754322 235678899999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCC-CCC-----------------------------------CCCCCCC---
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVED-WST-----------------------------------DTWDHHP--- 516 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~-~~~-----------------------------------~~~~~~~--- 516 (690)
+..++|||||++|+|.++++........... ... ...+...
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 9999999999999999999763211000000 000 0000000
Q ss_pred ---CCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCccccccc----------
Q 005572 517 ---GAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK---------- 583 (690)
Q Consensus 517 ---~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~---------- 583 (690)
...........+++.++.+++.||++||+|||+++++||||||+|||+++++.+||+|||+++....
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 0000011234689999999999999999999999999999999999999999999999999864321
Q ss_pred ------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH--HHHHHHHhcCCCCccccccccCCCCCHHHHHH
Q 005572 584 ------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK--WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVE 654 (690)
Q Consensus 584 ------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 654 (690)
.+||......++.++|||||||++|||++ |+.||..... ........+. .+..+...+ ..
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~------~~ 343 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-----QMSRPDFAP------PE 343 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-----CccCCCCCC------HH
Confidence 13444444578999999999999999997 9999875321 1112222111 111111111 13
Q ss_pred HHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 655 SLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 655 ~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
+.+++..||+.||++|||+.||+++|+++.
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 456677899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-37 Score=311.69 Aligned_cols=242 Identities=27% Similarity=0.412 Sum_probs=195.2
Q ss_pred HhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+..+|...+.||+|+||.||+|...++..+|+|.+........+++.+|++.++.++||||+++++++...+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34567788899999999999999877889999999766544567889999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++|+|.++++.. ....+++.++..++.|+++||+|||+.+++||||||+||++
T Consensus 84 ~~~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv 137 (261)
T cd05148 84 MEKGSLLAFLRSP--------------------------EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV 137 (261)
T ss_pred cccCCHHHHHhcC--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE
Confidence 9999999999752 13457899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KWVRKLV 628 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~~~~~~ 628 (690)
++++.+||+|||++...... +||......++.++||||||+++|||++ |+.||.... .......
T Consensus 138 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05148 138 GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217 (261)
T ss_pred cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 99999999999998653211 3444444577889999999999999998 899986532 1122222
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
..+.. ...+... ...+.+++.+||+.||++|||+.++++.|+.+
T Consensus 218 ~~~~~-----~~~~~~~------~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 218 TAGYR-----MPCPAKC------PQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred HhCCc-----CCCCCCC------CHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 22111 1111111 12355777889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=317.88 Aligned_cols=234 Identities=24% Similarity=0.333 Sum_probs=193.1
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCC-HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGID-HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.|...+.||+|.||.||||. ..+++.||+|+++.....+ .+++.+|+.+++.++++||.+++|.+..+..++++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 46666889999999999999 5678899999998765433 478999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
.+|++.+.|+.. ..+++....-|.+++..|+.|||+++.+|||||+.|||+.
T Consensus 94 ~gGsv~~lL~~~----------------------------~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s 145 (467)
T KOG0201|consen 94 GGGSVLDLLKSG----------------------------NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLS 145 (467)
T ss_pred cCcchhhhhccC----------------------------CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEe
Confidence 999999999752 2235555666889999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhc
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEG 631 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 631 (690)
.+|.+|++|||++...... |||+.....|+.|+||||+|++.+||.+|.+|+.++...... .
T Consensus 146 ~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----f 221 (467)
T KOG0201|consen 146 ESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----F 221 (467)
T ss_pred ccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----E
Confidence 9999999999997654322 788888779999999999999999999999999875431100 0
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
....-..|.+...++...+|+++. |+++||+.||++.++++.
T Consensus 222 lIpk~~PP~L~~~~S~~~kEFV~~------CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 222 LIPKSAPPRLDGDFSPPFKEFVEA------CLDKNPEFRPSAKELLKH 263 (467)
T ss_pred eccCCCCCccccccCHHHHHHHHH------HhhcCcccCcCHHHHhhh
Confidence 112223444555555567777776 999999999999999763
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=309.22 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=192.2
Q ss_pred hccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
..+|...+.||+|+||.||+|...++..||+|.++... ...+++.+|++.+++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 34677889999999999999998777889999986543 34577899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++... ....++|..+..++.|++.|+.|||+.+++||||||+||+++
T Consensus 84 ~~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 137 (261)
T cd05068 84 KYGSLLEYLQGG--------------------------AGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVG 137 (261)
T ss_pred cCCcHHHHHhcc--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEc
Confidence 999999999751 124588999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH-HHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-VRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-~~~~~ 628 (690)
+++.+||+|||+++..... +||......++.++||||||+++|||+| |+.||...... .....
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05068 138 ENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217 (261)
T ss_pred CCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999999988643211 3444434567889999999999999999 99998763322 22222
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
..... ....... ...+.+++.+||+.+|++||++.++++.|+++
T Consensus 218 ~~~~~-----~~~~~~~------~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 218 DQGYR-----MPCPPGC------PKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred HcCCC-----CCCCCcC------CHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 21110 0011111 12455677789999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=310.63 Aligned_cols=240 Identities=23% Similarity=0.311 Sum_probs=191.4
Q ss_pred hccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.++|+..+.||+|+||.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 35678889999999999999998778889999986433 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.++++.. ....+++.++..++.|+++||+|||+.+++||||||+||+++
T Consensus 84 ~~~~L~~~l~~~--------------------------~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~ 137 (261)
T cd05072 84 AKGSLLDFLKSD--------------------------EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVS 137 (261)
T ss_pred CCCcHHHHHHHh--------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEec
Confidence 999999999752 134578889999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KWVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~~~~~~ 628 (690)
+++.+||+|||+++..... +||......++.++|||||||++|||+| |+.||.... .......
T Consensus 138 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05072 138 ESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL 217 (261)
T ss_pred CCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH
Confidence 9999999999998754321 3343334567889999999999999999 999986522 2222222
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
..... ....... . ..+.+++.+||+.+|++||+++++.+.|+.+
T Consensus 218 ~~~~~-----~~~~~~~---~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 218 QRGYR-----MPRMENC---P---DELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred HcCCC-----CCCCCCC---C---HHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 22111 1111111 1 2355677789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=285.81 Aligned_cols=235 Identities=24% Similarity=0.277 Sum_probs=190.4
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||+|.||.||.|+ .+++..||+|++.+.. ..-..++.+|+++=+.++||||++++|++.+....|+++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 468888999999999999999 5667899999996542 244578899999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||.++|+++..|++.+ ...+++.....+..|+|.||.|+|.+++|||||||+|+
T Consensus 102 Eya~~gel~k~L~~~~--------------------------~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenl 155 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGR--------------------------MKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENL 155 (281)
T ss_pred EecCCchHHHHHHhcc--------------------------cccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHh
Confidence 9999999999998522 23466667778999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVK 629 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~ 629 (690)
|++..+..||+|||.+-....+ +||......++..+|+|++||+.||++.|.+||.... +...+.+.
T Consensus 156 Llg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~ 235 (281)
T KOG0580|consen 156 LLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIR 235 (281)
T ss_pred ccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHH
Confidence 9999999999999987554322 7888888899999999999999999999999998622 22222222
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.. |..++...+.... +++..|+..+|.+|.+..|++..
T Consensus 236 k~------~~~~p~~is~~a~------dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 236 KV------DLKFPSTISGGAA------DLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred Hc------cccCCcccChhHH------HHHHHHhccCccccccHHHHhhh
Confidence 11 2222222223333 44556999999999999998763
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=308.05 Aligned_cols=239 Identities=25% Similarity=0.394 Sum_probs=189.8
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.+|...+.||+|+||.||+|.. ..+..||+|.+.... ....++.+|++.+++++||||+++++++...+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 3466778999999999999985 457889999986432 34567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++... ....+++..+..++.|+++||+|||+.+++||||||+||+++
T Consensus 85 ~~~~L~~~~~~~--------------------------~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~ 138 (263)
T cd05052 85 TYGNLLDYLREC--------------------------NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVG 138 (263)
T ss_pred CCCcHHHHHHhC--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 999999999752 134588999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCch-HHHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDC-VKWVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~-~~~~~~~~ 628 (690)
+++.+||+|||+++..... +||......++.++|||||||++|||++ |..||... ........
T Consensus 139 ~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~ 218 (263)
T cd05052 139 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218 (263)
T ss_pred CCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999998754321 3444444577889999999999999998 89998652 12122222
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.... .+..+...+ ..+.+++.+||+.||++||++.|+++.|+.+
T Consensus 219 ~~~~-----~~~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 219 EKGY-----RMERPEGCP------PKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred HCCC-----CCCCCCCCC------HHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 2211 111111111 2355667789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=315.00 Aligned_cols=236 Identities=17% Similarity=0.140 Sum_probs=181.5
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
|+..+.||+|+||.||+|. ..++..||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 5667899999999999998 46788999999864321 2234577899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
|++|+|.+++... ....+++..+..++.|++.||+|||+.+++||||||+|||+
T Consensus 82 ~~~g~L~~~~~~~--------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill 135 (285)
T cd05631 82 MNGGDLKFHIYNM--------------------------GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL 135 (285)
T ss_pred cCCCcHHHHHHhh--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE
Confidence 9999999888641 12357899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc---------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-HHHHHHh
Q 005572 565 AESLEPKIAGFGLRNIGVK---------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLVKE 630 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~---------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-~~~~~~~ 630 (690)
++++.+||+|||++..... . +||......++.++|||||||++|||++|+.||...... .......
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~ 215 (285)
T cd05631 136 DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDR 215 (285)
T ss_pred CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHH
Confidence 9999999999999865321 1 455555567899999999999999999999999752111 0011111
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-----MQQVLG 678 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-----~~ev~~ 678 (690)
...... .......+ . .+.+++.+||+.||++||+ ++|+++
T Consensus 216 ~~~~~~--~~~~~~~s---~---~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 216 RVKEDQ--EEYSEKFS---E---DAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred Hhhccc--ccCCccCC---H---HHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 000000 01111111 1 3445667799999999997 788876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=325.10 Aligned_cols=231 Identities=25% Similarity=0.334 Sum_probs=186.5
Q ss_pred CceeccCCCccEEEEEcCC--C--cEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 412 ESLLAEGRCGPVYRAVLPG--E--LHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.++||+|.||.|++|.|.. | ..||||.++..... ..++|.+|+.+|.+|+|||+++|||+..+ ....+|+|.++
T Consensus 115 ~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELap 193 (1039)
T KOG0199|consen 115 YELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAP 193 (1039)
T ss_pred HHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcc
Confidence 4679999999999999743 3 56999999766543 57899999999999999999999999998 67789999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
.|||.+.|++.+ ...+-......++.|||.||.||.+++.|||||.++|+|+..
T Consensus 194 lGSLldrLrka~--------------------------~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllas 247 (1039)
T KOG0199|consen 194 LGSLLDRLRKAK--------------------------KAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLAS 247 (1039)
T ss_pred cchHHHHHhhcc--------------------------ccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecc
Confidence 999999998722 345667778889999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH-HHHH
Q 005572 567 SLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-VRKL 627 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-~~~~ 627 (690)
.-.+||+|||+.+-...+ +||......++.++|||+|||++|||+| |+.||.++... +.+.
T Consensus 248 prtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~ 327 (1039)
T KOG0199|consen 248 PRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKN 327 (1039)
T ss_pred cceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHh
Confidence 999999999998755432 5666666789999999999999999999 78899874322 2222
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
++++.. ++. ...+-..++++|+.||..+|++||||..|.+.+
T Consensus 328 iD~~er-------LpR----Pk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 328 IDAGER-------LPR----PKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred cccccc-------CCC----CCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 222211 111 111122567788899999999999999997443
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=307.09 Aligned_cols=236 Identities=23% Similarity=0.343 Sum_probs=187.6
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.+|...+.||+|+||.||+|...++..+|+|.+.... ...+++.+|++.+++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 3566778999999999999998777789999986433 345778999999999999999999999999889999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++... ...+++.++..++.||+.||+|||+.+++|+||||+||++++
T Consensus 83 ~~~l~~~i~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~ 135 (256)
T cd05113 83 NGCLLNYLREH---------------------------GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDD 135 (256)
T ss_pred CCcHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 99999999751 235789999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHHH
Q 005572 567 SLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVK 629 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~~ 629 (690)
++.+||+|||.++..... +||......++.++|||||||++|||++ |..||..... .......
T Consensus 136 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05113 136 QGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS 215 (256)
T ss_pred CCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh
Confidence 999999999987643211 3344333467889999999999999999 9999875332 1222222
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
.+... + ..... ...+.+++.+||+.+|++||++.++++.|+
T Consensus 216 ~~~~~----~-~~~~~------~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 216 QGLRL----Y-RPHLA------SEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred cCCCC----C-CCCCC------CHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 21111 0 01111 124556777899999999999999998774
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=309.60 Aligned_cols=242 Identities=20% Similarity=0.287 Sum_probs=185.5
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCc----EEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGEL----HVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
.+|+..+.||+|+||.||+|.+ .++. .+++|.+..... ....++..|+..+++++||||++++|++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEE
Confidence 3567788999999999999985 3343 477787753321 123566777788899999999999998864 55778
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
++||+++|+|.++++.. ...++|..+..++.||+.||.|||+.+++||||||+
T Consensus 86 i~e~~~~gsL~~~l~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 138 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH---------------------------RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR 138 (279)
T ss_pred EEEeCCCCcHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 99999999999999752 235889999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-H
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-K 622 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~ 622 (690)
|||+++++.+||+|||+++..... +||......++.++|||||||++||+++ |+.||.+.. .
T Consensus 139 nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 139 NILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred eEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999998643211 3444444578899999999999999998 999987632 2
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
........+... ..+. .+ ...+.+++.+||+.||++|||+.|+++.|..+...+
T Consensus 219 ~~~~~~~~~~~~--~~~~---~~------~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~ 272 (279)
T cd05111 219 EVPDLLEKGERL--AQPQ---IC------TIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP 272 (279)
T ss_pred HHHHHHHCCCcC--CCCC---CC------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence 223333322211 1111 11 123456677899999999999999999998876543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-37 Score=318.97 Aligned_cols=233 Identities=24% Similarity=0.304 Sum_probs=189.5
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
.|+..+.||+|+-|.|..|+ ..+|+.+|||++.+... .....+.+|+-+|+-+.||||+++++++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 45667889999999999998 67899999999976532 234568899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|.|+++|.+ .+++++.+..+++.||..|+.|+|..+|+|||+||+|+|
T Consensus 93 yv~gGELFdylv~----------------------------kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlL 144 (786)
T KOG0588|consen 93 YVPGGELFDYLVR----------------------------KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLL 144 (786)
T ss_pred ecCCchhHHHHHh----------------------------hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhh
Confidence 9999999999986 457889999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-------------cCcccCCCCC-CCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-------------VGERSENETC-GPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVK 629 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~-~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~ 629 (690)
||.++.+||+|||+|.....+ +||+..+..| +.++||||.|||||.|+||+.||++ +..+.++.
T Consensus 145 Ld~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD--dNir~LLl 222 (786)
T KOG0588|consen 145 LDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD--DNIRVLLL 222 (786)
T ss_pred hhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC--ccHHHHHH
Confidence 999999999999999765433 5666666655 5799999999999999999999986 22333332
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
....+ .+.++...+...++++ .+++..||+.|.|++||++.
T Consensus 223 KV~~G---~f~MPs~Is~eaQdLL------r~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 223 KVQRG---VFEMPSNISSEAQDLL------RRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HHHcC---cccCCCcCCHHHHHHH------HHHhccCccccccHHHHhhC
Confidence 21111 1122222222344444 45899999999999999874
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=309.11 Aligned_cols=254 Identities=25% Similarity=0.330 Sum_probs=190.7
Q ss_pred ccCCCCceeccCCCccEEEEEcCC------CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
.+|+..+.||+|+||.||+|...+ ...||+|.++.... .....+.+|++.+++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778899999999999998533 25799999864432 22456889999999999999999999999989999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
++|||+++|+|.+++.......... ...........+++.++..++.|++.||.|||+.+++||||||
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~------------~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp 152 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVG------------AESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAA 152 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccc------------cccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccc
Confidence 9999999999999998632111000 0000011235688999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV- 621 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~- 621 (690)
+||++++++.+||+|||+++.... .+||......++.++|||||||++|||++ |..||....
T Consensus 153 ~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 153 RNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred ceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999864311 13444444578899999999999999998 999987522
Q ss_pred HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
......+..+... ..+...+ .++.+++.+||+.||++||++.||++.|+.+
T Consensus 233 ~~~~~~i~~~~~~-----~~~~~~~------~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 233 QEVIEMIRSRQLL-----PCPEDCP------ARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred HHHHHHHHcCCcC-----CCcccCC------HHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 2222222222111 1111111 2455667789999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=323.82 Aligned_cols=270 Identities=21% Similarity=0.298 Sum_probs=193.3
Q ss_pred HhccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcC-CCCccceeeEEecCC
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGK 476 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~ 476 (690)
...+|...+.||+|+||.||+|+.. .+..||||+++.... ...+.+.+|++++++++ ||||++++|+|...+
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 3457778899999999999999842 134699999965432 23457889999999996 999999999999999
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCC----------------CCCCCCCCCC------------CCCC----------
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNV----------------EDWSTDTWDH------------HPGA---------- 518 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~----------------~~~~~~~~~~------------~~~~---------- 518 (690)
..|+|||||++|+|.++|++.+...... ..+....+.. ....
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999998643110000 0000000000 0000
Q ss_pred ----------C---C-----------------CCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCC
Q 005572 519 ----------G---S-----------------HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESL 568 (690)
Q Consensus 519 ----------~---~-----------------~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~ 568 (690)
+ . .......+++.++..++.|+++||+|||+.+++||||||+|||+++++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~ 274 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK 274 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC
Confidence 0 0 001124588999999999999999999999999999999999999999
Q ss_pred CceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH--HHHHHHHH
Q 005572 569 EPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV--KWVRKLVK 629 (690)
Q Consensus 569 ~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~--~~~~~~~~ 629 (690)
.+||+|||+++..... +||......++.++|||||||++|||++ |..||.... ........
T Consensus 275 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~ 354 (400)
T cd05105 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK 354 (400)
T ss_pred EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh
Confidence 9999999998643211 3444444578899999999999999997 899987532 11222222
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
.+.. ...+... ...+.+++..||+.||++||++.+|.++|+.+.+
T Consensus 355 ~~~~-----~~~~~~~------~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 355 SGYR-----MAKPDHA------TQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred cCCC-----CCCCccC------CHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 2110 1111111 1245567788999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=311.07 Aligned_cols=255 Identities=24% Similarity=0.332 Sum_probs=195.4
Q ss_pred ccCCCCceeccCCCccEEEEEc------CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL------PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
.+|...+.||+|+||.||++.. .++..+|+|.+........+.+.+|++.+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 4677888999999999999973 2345689999875543445678899999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
||||+++|+|.+++........... .......+++.++..++.|++.||+|||+++++||||||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~---------------~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~ 149 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMA---------------EGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATR 149 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCcccccc---------------ccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 9999999999999976321111000 0012345899999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-H
Q 005572 561 SILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-K 622 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~ 622 (690)
||++++++.+||+|||+++.... .+||......++.++|||||||++|||+| |..||.... .
T Consensus 150 Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred eEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999864311 13444444578889999999999999999 899987532 1
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
........+.... ..... . ..+.+++.+||+.||.+|||+.|+.+.|+.+....
T Consensus 230 ~~~~~i~~~~~~~-----~~~~~--~----~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~~ 283 (288)
T cd05093 230 EVIECITQGRVLQ-----RPRTC--P----KEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKAS 283 (288)
T ss_pred HHHHHHHcCCcCC-----CCCCC--C----HHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHhc
Confidence 1222222221111 11111 1 13566778899999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=305.07 Aligned_cols=235 Identities=26% Similarity=0.385 Sum_probs=187.1
Q ss_pred cCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 408 HFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+|...+.||+|+||.||+|...++..+|+|.+.... ...+++.+|++.+++++||||+++++++...+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 466778999999999999998777789999986432 3456788999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
++|.+++... ...++|..+..++.|++.||+|||+.+++||||||+||+++++
T Consensus 84 ~~L~~~l~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~ 136 (256)
T cd05059 84 GCLLNYLRER---------------------------KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGED 136 (256)
T ss_pred CCHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCC
Confidence 9999999752 2357899999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc---------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHHHh
Q 005572 568 LEPKIAGFGLRNIGVK---------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVKE 630 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~---------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~~~ 630 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++ |+.||..... ........
T Consensus 137 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~ 216 (256)
T cd05059 137 NVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA 216 (256)
T ss_pred CcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc
Confidence 9999999998864321 13444444578889999999999999999 8899865221 11112211
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
.. ....+... ...+.+++.+||+.+|++|||+.|+++.|.
T Consensus 217 ~~-----~~~~~~~~------~~~~~~li~~cl~~~p~~Rpt~~~~l~~l~ 256 (256)
T cd05059 217 GY-----RLYRPKLA------PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256 (256)
T ss_pred CC-----cCCCCCCC------CHHHHHHHHHHhcCChhhCcCHHHHHHHhC
Confidence 11 11111111 124567778899999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=305.21 Aligned_cols=239 Identities=26% Similarity=0.385 Sum_probs=189.6
Q ss_pred ccCCCCceeccCCCccEEEEEcC----CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP----GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
++|+..+.||+|+||.||+|++. +...||||.++.... ....++.+|+..+++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 46788899999999999999863 245799999865432 2345688899999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|.+++... ...+++.++.+++.|++.||+|||+.+++||||||+|
T Consensus 84 ~e~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~n 136 (266)
T cd05033 84 TEYMENGSLDKFLREN---------------------------DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARN 136 (266)
T ss_pred EEcCCCCCHHHHHHhc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence 9999999999999751 2368899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KW 623 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~ 623 (690)
|++++++.+||+|||+++.... .+||......++.++||||||+++|||++ |..||.+.. ..
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~ 216 (266)
T cd05033 137 ILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD 216 (266)
T ss_pred EEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH
Confidence 9999999999999999876431 13444444577889999999999999998 999986532 22
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
........... ..+...+ ..+.+++..||+.+|++||++.||++.|+++
T Consensus 217 ~~~~~~~~~~~-----~~~~~~~------~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 217 VIKAVEDGYRL-----PPPMDCP------SALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred HHHHHHcCCCC-----CCCCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 22222221111 0111111 1345677789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.59 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=186.5
Q ss_pred ccCCCCceeccCCCccEEEEEc-----CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-----PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKL 479 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~ 479 (690)
.+|+..+.||+|+||.||+|.. .++..||+|.+........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677788999999999999974 24778999998765434456788999999999999999999988643 4688
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+|+||+++|+|.+++.+. ...++|..+..++.|++.||+|||+.+++||||||
T Consensus 84 lv~e~~~~~~L~~~l~~~---------------------------~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp 136 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH---------------------------RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLAT 136 (284)
T ss_pred EEEEecCCCCHHHHHHhc---------------------------CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCH
Confidence 999999999999999751 23588999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK 622 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~ 622 (690)
+||++++++.+||+|||+++..... +||......++.++|||||||++|||++|..|+.....
T Consensus 137 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~ 216 (284)
T cd05081 137 RNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA 216 (284)
T ss_pred hhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch
Confidence 9999999999999999998753211 34444445678899999999999999998776543222
Q ss_pred HHHHHHHhcCCCCccc----------cccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 623 WVRKLVKEGAGGDALD----------FRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
+..+............ ..++... .. ...+.+++.+||+.+|++||||.||++.|+.++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 217 EFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPP-GC---PAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred hhhhhcccccccccchHHHHHHHhcCCcCCCCC-CC---CHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 1111111000000000 0000000 01 123556777899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=314.70 Aligned_cols=232 Identities=17% Similarity=0.133 Sum_probs=184.3
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|...+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 577889999999999999995 4688999999864321 234567889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+++++||||||+|||
T Consensus 82 ~~~~~~L~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIl 133 (291)
T cd05612 82 YVPGGELFSYLRN----------------------------SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENIL 133 (291)
T ss_pred CCCCCCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeE
Confidence 9999999999975 235788899999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHhc
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKEG 631 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~~ 631 (690)
+++++.+||+|||+++..... +||......++.++|||||||++|||++|+.||..... ........+
T Consensus 134 i~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 213 (291)
T cd05612 134 LDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG 213 (291)
T ss_pred ECCCCCEEEEecCcchhccCCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 999999999999998754321 55655556788999999999999999999999875321 112222221
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-----MQQVLGL 679 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-----~~ev~~~ 679 (690)
.. .++...+. .+.+++.+||+.||.+||+ +.|+++.
T Consensus 214 ~~------~~~~~~~~------~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 214 KL------EFPRHLDL------YAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred Cc------CCCccCCH------HHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 11 11111111 3445667799999999995 7777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=317.53 Aligned_cols=226 Identities=19% Similarity=0.213 Sum_probs=178.8
Q ss_pred ceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCC
Q 005572 413 SLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANG 488 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 488 (690)
+.||+|+||.||+++ ..++..||+|+++.... .....+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 369999999999998 45688999999975422 22345678999999999999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCC
Q 005572 489 DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESL 568 (690)
Q Consensus 489 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~ 568 (690)
+|.+++.. ...+++.++..++.||+.||+|||+.+++||||||+|||++.++
T Consensus 81 ~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~ 132 (323)
T cd05571 81 ELFFHLSR----------------------------ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG 132 (323)
T ss_pred cHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC
Confidence 99999875 23578999999999999999999999999999999999999999
Q ss_pred CceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhcCC
Q 005572 569 EPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEGAG 633 (690)
Q Consensus 569 ~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~~ 633 (690)
.+||+|||+++.... . +||......++.++|||||||++|||++|+.||.... ...........
T Consensus 133 ~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~- 211 (323)
T cd05571 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE- 211 (323)
T ss_pred CEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-
Confidence 999999999864211 1 4555555678999999999999999999999986522 11112221111
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
..++...+. .+.+++.+||+.||++|| ++.|+++
T Consensus 212 -----~~~p~~~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 212 -----IRFPRTLSP------EAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred -----CCCCCCCCH------HHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 111111211 234556679999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=318.44 Aligned_cols=232 Identities=19% Similarity=0.177 Sum_probs=184.1
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
.+|...+.||+|+||.||+|+. .++..||+|+++... ....+.+.+|++++++++||||+++++++...+..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 4677788999999999999995 458899999996432 123456889999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++++||||||+||
T Consensus 98 e~~~~~~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NI 149 (329)
T PTZ00263 98 EFVVGGELFTHLRK----------------------------AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL 149 (329)
T ss_pred cCCCCChHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHE
Confidence 99999999999975 23577888889999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHh
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKE 630 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~ 630 (690)
|++.++.+||+|||+++..... +||......++.++|||||||++|||++|+.||.+... ...+.+..
T Consensus 150 ll~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~ 229 (329)
T PTZ00263 150 LLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILA 229 (329)
T ss_pred EECCCCCEEEeeccCceEcCCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Confidence 9999999999999998754321 55555556788999999999999999999999875322 11222222
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-----MQQVLG 678 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-----~~ev~~ 678 (690)
+. ..++...+. .+.+++.+||+.||.+||+ +.|+++
T Consensus 230 ~~------~~~p~~~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 230 GR------LKFPNWFDG------RARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred CC------cCCCCCCCH------HHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 21 111111111 2345666799999999996 677663
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=316.43 Aligned_cols=185 Identities=24% Similarity=0.342 Sum_probs=159.9
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++|+..+.||+|+||.||+++. .++..+|+|.++.... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 5788889999999999999994 5688899999875422 2245688999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc-CCCCCCCCCCcEE
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV-GSTHGHLVTSSIL 563 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~iHrDlk~~NiL 563 (690)
+++|+|.+++.. ...+++..+..++.|++.||.|||+. +++||||||+|||
T Consensus 85 ~~~~~L~~~l~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil 136 (331)
T cd06649 85 MDGGSLDQVLKE----------------------------AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136 (331)
T ss_pred CCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEE
Confidence 999999999975 23478889999999999999999986 5999999999999
Q ss_pred ecCCCCceEcCCCcccccccc------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 564 LAESLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
++.++.+||+|||+++..... +||......++.++|||||||++|||+||+.||..
T Consensus 137 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~ 204 (331)
T cd06649 137 VNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPP 204 (331)
T ss_pred EcCCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence 999999999999998643211 45555556788999999999999999999999864
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=309.83 Aligned_cols=257 Identities=24% Similarity=0.313 Sum_probs=193.7
Q ss_pred ccCCCCceeccCCCccEEEEEc------CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL------PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
.+|...+.||+|+||.||+|+. .++..+++|.+........+.+.+|++.+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 3567778999999999999973 2345688999865543444678899999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
||||+++|+|.+++............ .........++|..++.++.|++.||+|||+++++||||||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 152 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVD------------GQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATR 152 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccc------------cccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcc
Confidence 99999999999999863221100000 000012345899999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-
Q 005572 561 SILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK- 622 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~- 622 (690)
||++++++.+||+|||+++.... .+||......++.++|||||||++|||+| |+.||.....
T Consensus 153 Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 232 (291)
T cd05094 153 NCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232 (291)
T ss_pred eEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999864321 14444444678889999999999999999 9999865222
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCC
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
...+....+.... ..... ...+.+++.+||+.||++|||+.+|+++|+++...
T Consensus 233 ~~~~~~~~~~~~~-----~~~~~------~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~ 285 (291)
T cd05094 233 EVIECITQGRVLE-----RPRVC------PKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA 285 (291)
T ss_pred HHHHHHhCCCCCC-----CCccC------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence 1222222221111 01111 12355677789999999999999999999998543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=301.42 Aligned_cols=232 Identities=22% Similarity=0.310 Sum_probs=182.4
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
+.||+|+||.||+|+. .++..+|+|.+..... .....+.+|++.+++++||||++++++|......++||||+++|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 3689999999999985 5688999998754322 2245688999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++... ...+++.++..++.|++.||+|||+.+++||||||+||+++.++.+
T Consensus 81 ~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~ 133 (252)
T cd05084 81 LTFLRTE---------------------------GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVL 133 (252)
T ss_pred HHHHHhC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcE
Confidence 9999651 2357899999999999999999999999999999999999999999
Q ss_pred eEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHHHhcC
Q 005572 571 KIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVKEGA 632 (690)
Q Consensus 571 kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~ 632 (690)
||+|||+++.... .+||......++.++|||||||++|||++ |..||..... ..........
T Consensus 134 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~ 213 (252)
T cd05084 134 KISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV 213 (252)
T ss_pred EECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC
Confidence 9999999764221 13444444567889999999999999998 8888865332 2222222211
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
.. ..+... ...+.+++.+||+.+|++|||+.|+.++|+.
T Consensus 214 ~~-----~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 214 RL-----PCPELC------PDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CC-----CCcccC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 10 111111 1145567778999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=317.49 Aligned_cols=240 Identities=16% Similarity=0.106 Sum_probs=185.6
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|+..+.||+|+||.||+|+. .++..||+|+++.... ...+.+..|++++..++||||+++++++...+..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 578889999999999999995 4588999999975421 234567889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.. ...+++.++..++.|++.||.|||+++++||||||+|||
T Consensus 82 ~~~g~~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 133 (333)
T cd05600 82 YVPGGDFRTLLNN----------------------------LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFL 133 (333)
T ss_pred CCCCCCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 9999999999975 235788899999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCccccccc-------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHhc
Q 005572 564 LAESLEPKIAGFGLRNIGVK-------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKEG 631 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~-------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~~ 631 (690)
++.++.+||+|||+++.... . +||......++.++|||||||++|||++|+.||..... .....+...
T Consensus 134 ~~~~~~~kL~Dfg~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 213 (333)
T cd05600 134 IDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW 213 (333)
T ss_pred ECCCCCEEEEeCcCCcccccccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc
Confidence 99999999999999875322 1 45555556789999999999999999999999975221 111111111
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.. ....+.......... ..+.+++.+||+.+|++||++.|+++.
T Consensus 214 ~~-~~~~~~~~~~~~~~s---~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 214 KE-TLQRPVYDDPRFNLS---DEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred cc-cccCCCCCccccccC---HHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 10 000011000000001 134456667999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=293.70 Aligned_cols=244 Identities=24% Similarity=0.263 Sum_probs=184.2
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv 481 (690)
++|+..+.|++|+||.||||+ ..++..||+|+++..+. .-.-...+|+.+|.+++|||||.+..+.... +..|+|
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 456777899999999999999 56788999999976543 3344578999999999999999999988754 479999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
||||+. ||...+.. .++++...++..++.|+++|++|||++.|+|||||++|
T Consensus 156 Me~~Eh-DLksl~d~---------------------------m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SN 207 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET---------------------------MKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSN 207 (419)
T ss_pred HHHHHh-hHHHHHHh---------------------------ccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhh
Confidence 999987 99999975 34678889999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc----------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN----------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDDC--VKWV 624 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~----------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~ 624 (690)
+|++..|.+||+|||+||.+... ..|++++ ..|+++.|+||+|||+.||+++++-|.+- .+..
T Consensus 208 LLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl 287 (419)
T KOG0663|consen 208 LLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQL 287 (419)
T ss_pred eeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHH
Confidence 99999999999999999976543 2244443 47999999999999999999999887652 2222
Q ss_pred HHHHHh-cCCCCccccc-----------cccCCCCC----HHHH---HHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 625 RKLVKE-GAGGDALDFR-----------LKLGSGDS----VAEM---VESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 625 ~~~~~~-~~~~~~~~~~-----------~~~~~~~~----~~~~---~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.+++.. +...+.+-+. ++...... .... -.-+++.-..+..||++|-|+.|.++
T Consensus 288 ~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 288 DKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred HHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 233322 1111111110 00000000 0000 12345555678889999999999875
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=304.59 Aligned_cols=247 Identities=19% Similarity=0.225 Sum_probs=190.2
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|...+.||+|+||.||+|+. .++..||||.+..... .....+.+|++.++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4678889999999999999984 5688999998864322 22346788999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.+++.... .....+++..+..++.|+++||.|||+++++||||||+||
T Consensus 82 e~~~~~~L~~~~~~~~------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni 137 (267)
T cd08228 82 ELADAGDLSQMIKYFK------------------------KQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANV 137 (267)
T ss_pred EecCCCcHHHHHHHhh------------------------hccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHE
Confidence 9999999999986421 1123578888999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLV 628 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~ 628 (690)
+++.++.+||+|||++...... +||...+..++.++||||||+++|||++|+.||...........
T Consensus 138 l~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08228 138 FITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLC 217 (267)
T ss_pred EEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHH
Confidence 9999999999999987653211 45555455778899999999999999999999854211111111
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
...... ..+... .......+.+++.+||+.+|++||++.||++.|++++
T Consensus 218 ~~~~~~--~~~~~~-----~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 218 QKIEQC--DYPPLP-----TEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred HHHhcC--CCCCCC-----hhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 110000 011110 0011123556777899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=309.23 Aligned_cols=237 Identities=17% Similarity=0.171 Sum_probs=186.1
Q ss_pred HhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
..++|+....||+|+||+||+|+ ..+|..+|+|++++... ...+..+.|-.+|...++|+||+|+..+.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999998 56799999999987654 334567789999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
||||.+|||+..+|.. .+.|++..+..++.+.+.|+.-+|+.|+|||||||+
T Consensus 219 iMEylPGGD~mTLL~~----------------------------~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPd 270 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMR----------------------------KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPD 270 (550)
T ss_pred EEEecCCccHHHHHHh----------------------------cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChh
Confidence 9999999999999986 456888888999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCccccccc-----------------------------c---------------------------
Q 005572 561 SILLAESLEPKIAGFGLRNIGVK-----------------------------N--------------------------- 584 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~-----------------------------~--------------------------- 584 (690)
|+|||..|.+||+||||+.-... .
T Consensus 271 NlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVG 350 (550)
T KOG0605|consen 271 NLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVG 350 (550)
T ss_pred heeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccC
Confidence 99999999999999999742110 0
Q ss_pred -----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc-hHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHH
Q 005572 585 -----VGERSENETCGPESDVYCFGVILMELLTGKRGTDD-CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRV 658 (690)
Q Consensus 585 -----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 658 (690)
|||+.....|+..+|.||+|||+|||+.|-+||.. ......+-+...... +..+-....+ .+..++
T Consensus 351 TPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--l~fP~~~~~s------~eA~DL 422 (550)
T KOG0605|consen 351 TPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET--LKFPEEVDLS------DEAKDL 422 (550)
T ss_pred CccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--ccCCCcCccc------HHHHHH
Confidence 45555556889999999999999999999999975 333333222221110 0000011111 345566
Q ss_pred HhhhcCCCCCCCC---CHHHHHH
Q 005572 659 GYLCTADSPGKRP---TMQQVLG 678 (690)
Q Consensus 659 ~~~C~~~dP~~RP---t~~ev~~ 678 (690)
+.+|+. ||++|- .+.||-+
T Consensus 423 I~rll~-d~~~RLG~~G~~EIK~ 444 (550)
T KOG0605|consen 423 ITRLLC-DPENRLGSKGAEEIKK 444 (550)
T ss_pred HHHHhc-CHHHhcCcccHHHHhc
Confidence 667777 999996 4666543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=305.77 Aligned_cols=240 Identities=21% Similarity=0.244 Sum_probs=185.3
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.+|+..+.||+|+||.||+|+ ..++..||+|++..........+.+|+..+++++||||+++++++...+..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 468888999999999999999 4668899999997554445567888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.++++. ...+++.++..++.|+++||.|||+.+++||||||+||+++
T Consensus 89 ~~~~L~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~ 140 (267)
T cd06646 89 GGGSLQDIYHV----------------------------TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLT 140 (267)
T ss_pred CCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEC
Confidence 99999999875 23578889999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccC---CCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSE---NETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~---~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~ 628 (690)
+++.+||+|||+++..... +||... ...++.++|||||||++|||++|+.||........ ..
T Consensus 141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~ 219 (267)
T cd06646 141 DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LF 219 (267)
T ss_pred CCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-he
Confidence 9999999999998643211 344332 23467799999999999999999999864321111 00
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
... ......+...... .....+.+++..||+.+|++|||++++++.|
T Consensus 220 ~~~-~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 220 LMS-KSNFQPPKLKDKT----KWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred eee-cCCCCCCCCcccc----ccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 000 0000111111000 0112455677789999999999999998754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=306.10 Aligned_cols=249 Identities=24% Similarity=0.331 Sum_probs=188.8
Q ss_pred HhccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCe
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKE 477 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 477 (690)
..++|+..+.||+|+||.||+|... .+..||+|++..... ....++.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999998743 246799999854322 234568889999999999999999999999999
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl 557 (690)
.++||||+++|+|.++++..+..... ......++|..+..++.|+++||+|||+.+++||||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dl 145 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMEN------------------NPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDL 145 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccc------------------cccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCc
Confidence 99999999999999999763211000 001235688899999999999999999999999999
Q ss_pred CCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCch
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDC 620 (690)
Q Consensus 558 k~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~ 620 (690)
||+||++++++.+||+|||+++.... .+||......++.++|||||||++|||++ |..||.+.
T Consensus 146 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 146 AARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred chheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999999999999999864211 13444444578899999999999999999 78888753
Q ss_pred HH-HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 621 VK-WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 621 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
.. ...+......... .+... . ..+.+++.+||+.||++|||+.|+++.|++
T Consensus 226 ~~~~~~~~~~~~~~~~-----~~~~~---~---~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 226 SNEQVLRFVMEGGLLD-----KPDNC---P---DMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CHHHHHHHHHcCCcCC-----CCCCC---C---HHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 22 2222222221111 11111 1 134567778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=288.59 Aligned_cols=185 Identities=22% Similarity=0.284 Sum_probs=165.2
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||.|+||.|.+++ ..++..+|+|+++..+- ...+....|..+|+.+.||.+++|++.|.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 467778999999999999999 56688999999976543 23345667889999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|.|+.+|++ .+++++..+..+|.||+.||+|||+.+|++|||||+||
T Consensus 124 eyv~GGElFS~Lrk----------------------------~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENi 175 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK----------------------------SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENL 175 (355)
T ss_pred eccCCccHHHHHHh----------------------------cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHe
Confidence 99999999999987 34688889999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|||.+|.+||+|||+|+..... +||......++.++|.|||||++|||+.|.+||..
T Consensus 176 LlD~~G~iKitDFGFAK~v~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~ 243 (355)
T KOG0616|consen 176 LLDQNGHIKITDFGFAKRVSGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYD 243 (355)
T ss_pred eeccCCcEEEEeccceEEecCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcC
Confidence 9999999999999999875433 67777778999999999999999999999999876
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=314.50 Aligned_cols=223 Identities=20% Similarity=0.250 Sum_probs=175.1
Q ss_pred eccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 415 LAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 415 lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
||+|+||.||+|+. .++..||+|+++... ......+.+|++++.+++||||+++++++...+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999984 567899999996532 22345677899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++.. ...+++..+..++.|+++||.|||+++++||||||+|||++.++.+
T Consensus 81 ~~~l~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~ 132 (312)
T cd05585 81 FHHLQR----------------------------EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHI 132 (312)
T ss_pred HHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcE
Confidence 999975 2357889999999999999999999999999999999999999999
Q ss_pred eEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHHHHhcCCC
Q 005572 571 KIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKLVKEGAGG 634 (690)
Q Consensus 571 kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~~~~~~~~ 634 (690)
||+|||+++.... . +||......++.++|||||||++|||++|+.||... ........ ...
T Consensus 133 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~-~~~-- 209 (312)
T cd05585 133 ALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKIL-QEP-- 209 (312)
T ss_pred EEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHH-cCC--
Confidence 9999999874211 1 455554567889999999999999999999998652 22122221 111
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 005572 635 DALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT---MQQVLG 678 (690)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt---~~ev~~ 678 (690)
..++...+. .+.+++.+||+.||++||+ +.|++.
T Consensus 210 ----~~~~~~~~~------~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 210 ----LRFPDGFDR------DAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred ----CCCCCcCCH------HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 111111211 2345566799999999985 555543
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-36 Score=307.51 Aligned_cols=244 Identities=18% Similarity=0.197 Sum_probs=181.5
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++|...+.||+|+||.||+|+. .++..||+|.++.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 4578889999999999999984 5688999999865432 2345678899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
++ |+|.+++... ...+++..+..++.|++.||+|||+++++||||||+|||+
T Consensus 85 ~~-~~l~~~l~~~---------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~ 136 (288)
T cd07871 85 LD-SDLKQYLDNC---------------------------GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI 136 (288)
T ss_pred CC-cCHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE
Confidence 97 4999998651 2347888999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc----------c----cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCc--hHHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVK----------N----VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDD--CVKWVRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~----------~----~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~--~~~~~~~~ 627 (690)
++++.+||+|||+++.... . +||...+ ..++.++||||+||++|||+||+.||.. ..+.....
T Consensus 137 ~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~ 216 (288)
T cd07871 137 NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216 (288)
T ss_pred CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999864321 1 3444332 3578899999999999999999999864 12222111
Q ss_pred HHhcC-CC-----Cc------cccccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEGA-GG-----DA------LDFRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~-~~-----~~------~~~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..... .. .. .....+......... -....+++.+|++.||.+|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred HHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 11100 00 00 000000000000000 013456778899999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=316.02 Aligned_cols=270 Identities=23% Similarity=0.282 Sum_probs=190.9
Q ss_pred hccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCCC-CHHHHHHHHHHHHhc-CCCCccceeeEEecC-C
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKGI-DHDDAVAMFDELSRL-KHPNLLPLAGYCIAG-K 476 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-~ 476 (690)
.++|+..+.||+|+||.||+|... ++..||+|+++..... ..+.+.+|++.+.++ +||||++++++|... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 356888899999999999999732 2468999998654321 234577899999999 799999999988754 5
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCC------------------CCCCCC---------------CCCCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWS------------------TDTWDH---------------HPGAGSHIS 523 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~------------------~~~~~~---------------~~~~~~~~~ 523 (690)
..+++|||+++|+|.+++.............. ....+. .........
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 67899999999999999975321100000000 000000 000000001
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCccccccc----------------ccCc
Q 005572 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK----------------NVGE 587 (690)
Q Consensus 524 ~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e 587 (690)
....++|..+..++.||+.||+|||+.+++||||||+|||+++++.+||+|||+++.... .+||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 124689999999999999999999999999999999999999999999999999875321 1444
Q ss_pred ccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH--HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcC
Q 005572 588 RSENETCGPESDVYCFGVILMELLT-GKRGTDDCV--KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTA 664 (690)
Q Consensus 588 ~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~ 664 (690)
......++.++|||||||++|||++ |..||.... +........+... ..+.. . ...+.+++.+||+
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~---~---~~~~~~l~~~cl~ 314 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM-----RAPEY---A---TPEIYSIMLDCWH 314 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC-----CCCcc---C---CHHHHHHHHHHcc
Confidence 4444678999999999999999998 999986521 1122222222111 01111 1 1245677888999
Q ss_pred CCCCCCCCHHHHHHHHhccCCC
Q 005572 665 DSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 665 ~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
.+|++||++.||++.|+++.+.
T Consensus 315 ~~p~~RPs~~ell~~l~~~~~~ 336 (337)
T cd05054 315 NNPEDRPTFSELVEILGDLLQE 336 (337)
T ss_pred CChhhCcCHHHHHHHHHHHHhc
Confidence 9999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=306.12 Aligned_cols=228 Identities=23% Similarity=0.320 Sum_probs=173.3
Q ss_pred eeccCCCccEEEEEcCC-------------------------CcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccce
Q 005572 414 LLAEGRCGPVYRAVLPG-------------------------ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPL 468 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~~~-------------------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l 468 (690)
.||+|+||.||+|.+.. ...||+|+++.........+.+|+..++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13588998865433334567888889999999999999
Q ss_pred eeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 005572 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH 548 (690)
Q Consensus 469 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 548 (690)
+|+|...+..++||||+++|+|..++.+. ...+++..+..++.|+++||+|||
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~lH 134 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---------------------------KGRVPVAWKITVAQQLASALSYLE 134 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999998651 235788999999999999999999
Q ss_pred hcCCCCCCCCCCcEEecCCC-------CceEcCCCccccccc------c----cCcccCC-CCCCCCCcchhhHHHHHHH
Q 005572 549 HVGSTHGHLVTSSILLAESL-------EPKIAGFGLRNIGVK------N----VGERSEN-ETCGPESDVYCFGVILMEL 610 (690)
Q Consensus 549 ~~~~iHrDlk~~NiLl~~~~-------~~kl~DfGla~~~~~------~----~~e~~~~-~~~~~~~DVwSfGvvl~el 610 (690)
+++++||||||+|||+++++ .+|++|||++..... . +||.... ..++.++|||||||++|||
T Consensus 135 ~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el 214 (274)
T cd05076 135 DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214 (274)
T ss_pred cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999998654 379999998753211 1 3443322 3578899999999999998
Q ss_pred -HhCCCCCCchHHHH-HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 611 -LTGKRGTDDCVKWV-RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 611 -~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
++|+.||....... ........ ..+... . ..+.+++.+||+.+|++||||.+|++.|.
T Consensus 215 ~~~g~~p~~~~~~~~~~~~~~~~~-------~~~~~~---~---~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 215 CFDGEVPLKERTPSEKERFYEKKH-------RLPEPS---C---KELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HhCCCCCccccChHHHHHHHHhcc-------CCCCCC---C---hHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 46899987532211 11111110 111111 1 13556777899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=302.82 Aligned_cols=242 Identities=26% Similarity=0.426 Sum_probs=185.6
Q ss_pred CCCCceeccCCCccEEEEEcC-C---CcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCe-----
Q 005572 409 FGKESLLAEGRCGPVYRAVLP-G---ELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKE----- 477 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~-~---~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----- 477 (690)
|...+.||+|+||.||+|... + +..||+|+++.... ...+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 456688999999999999853 2 36799999875432 223568889999999999999999999876554
Q ss_pred -eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 478 -KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 478 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
.++|+||+++|+|..++...+.. .....+++..+..++.|++.||+|||+.+++|||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~----------------------~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~d 138 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLG----------------------GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRD 138 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhcc----------------------CCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 78999999999999999753211 1134688999999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCc
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDD 619 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~ 619 (690)
|||+||++++++.+||+|||+++..... +||......++.++|||||||++|||++ |..||.+
T Consensus 139 lkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 139 LAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred cchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999999998753211 3444444567889999999999999999 8888875
Q ss_pred hHH-HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 620 CVK-WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 620 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
... ...+....+.. ...+... ...+.+++.+||+.||++|||+.|+++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~-----~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 219 VENHEIYDYLRHGNR-----LKQPEDC------LDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred CCHHHHHHHHHcCCC-----CCCCcCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 322 11122221111 1111111 12456677789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=306.03 Aligned_cols=251 Identities=24% Similarity=0.304 Sum_probs=190.9
Q ss_pred ccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
++|...+.||+|+||.||+|... ++..||||.++..... ..+.+.+|++++++++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45677789999999999999853 2478999998754332 3467899999999999999999999999999999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||+++|+|.++++.......... ........+++.++..++.|++.|++|||+.+++||||||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~--------------~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp 150 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLK--------------SPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLAT 150 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhc--------------ccccccccccHHHHHHHHHHHHHHHHHHhhCCeecccccc
Confidence 99999999999999986321100000 0011235688999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK 622 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~ 622 (690)
+||+++.++.+||+|||+++.... .+||......+++++|||||||++|||++ |+.||.....
T Consensus 151 ~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred ceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999864211 14554444678899999999999999999 9999865222
Q ss_pred -HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 623 -WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 623 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
........+.... .....+ ..+.+++.+||+.||++||++.||++.|++
T Consensus 231 ~~~~~~~~~~~~~~-----~~~~~~------~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 231 EEVIECITQGRLLQ-----RPRTCP------SEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred HHHHHHHHcCCcCC-----CCCCCC------HHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 1222222221111 111111 234567778999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.08 Aligned_cols=238 Identities=26% Similarity=0.387 Sum_probs=191.0
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.+|+..+.||+|+||.||+|... +..||+|.++.... ..+.+.+|+.++++++|+||+++++++...+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46777889999999999999875 56899999976543 45678899999999999999999999999899999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++... ....++|..+..++.|++.||.|||+.+++||||||+||++++
T Consensus 84 ~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~ 137 (256)
T cd05039 84 KGSLVDYLRSR--------------------------GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSE 137 (256)
T ss_pred CCcHHHHHHhc--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeC
Confidence 99999999762 1235889999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HHHHHHHHhcCC
Q 005572 567 SLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KWVRKLVKEGAG 633 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~~~~~~~~~~~ 633 (690)
++.+||+|||.++..... +||......++.++||||||+++||+++ |..||.... ............
T Consensus 138 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~ 217 (256)
T cd05039 138 DLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR 217 (256)
T ss_pred CCCEEEcccccccccccccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC
Confidence 999999999998754321 4555444577889999999999999998 999987532 222222222111
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
...+...+ ..+.+++.+||+.+|++|||+.|++++|+.+
T Consensus 218 -----~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -----MEAPEGCP------PEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -----CCCccCCC------HHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 11111111 2345677789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-36 Score=308.62 Aligned_cols=243 Identities=17% Similarity=0.155 Sum_probs=181.4
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|...+.||+|+||.||+|+. .++..+|+|++..... ...+.+.+|++++++++||||+++++++...+..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 578889999999999999995 4678999999865422 2345678899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
++++.+..+... ...+++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 82 ~~~~~l~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill 133 (287)
T cd07848 82 VEKNMLELLEEM----------------------------PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI 133 (287)
T ss_pred CCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 998776654332 2357888999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc---------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH--HHHH
Q 005572 565 AESLEPKIAGFGLRNIGVK---------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW--VRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~---------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~--~~~~ 627 (690)
+.++.+||+|||+++.... .+||......++.++|||||||++|||++|+.||...... ....
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~ 213 (287)
T cd07848 134 SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213 (287)
T ss_pred cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999865321 1445444457889999999999999999999999752111 1010
Q ss_pred HHh-cCC-----------CCccccccccC-CCCCHH------HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKE-GAG-----------GDALDFRLKLG-SGDSVA------EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~-~~~-----------~~~~~~~~~~~-~~~~~~------~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... +.. ........+.. ...... .-..+.+++.+|++.||++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred HHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000 000 00000000000 000000 0123567888899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=304.72 Aligned_cols=243 Identities=21% Similarity=0.329 Sum_probs=188.7
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCc----EEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGEL----HVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
..+|+..+.||+|+||.||+|++ .++. .||+|+++.... ...+++.+|+..++.++||||++++|+|.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 34677889999999999999984 3443 489999865432 234567889999999999999999999975 4577
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+++||+++|+|.++++.. ...+++..++.++.|++.||+|||+.+++||||||
T Consensus 85 l~~~~~~~g~l~~~l~~~---------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp 137 (279)
T cd05109 85 LVTQLMPYGCLLDYVREN---------------------------KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAA 137 (279)
T ss_pred EEEEcCCCCCHHHHHhhc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccccc
Confidence 999999999999999751 23588999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK 622 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~ 622 (690)
+|||+++++.+||+|||+++..... +||......++.++|||||||++|||++ |..||.....
T Consensus 138 ~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 217 (279)
T cd05109 138 RNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA 217 (279)
T ss_pred ceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 9999999999999999998753211 3444444567889999999999999998 8999875332
Q ss_pred H-HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 623 W-VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 623 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
. ....+..+.... ..... ...+.+++..||+.||++||++.|+++.|+.+...+
T Consensus 218 ~~~~~~~~~~~~~~-----~~~~~------~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05109 218 REIPDLLEKGERLP-----QPPIC------TIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP 272 (279)
T ss_pred HHHHHHHHCCCcCC-----CCccC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence 2 222232221110 11111 123456777899999999999999999999887665
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=313.64 Aligned_cols=226 Identities=19% Similarity=0.207 Sum_probs=177.7
Q ss_pred ceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCC
Q 005572 413 SLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANG 488 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 488 (690)
+.||+|+||.||+++ ..++..||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 369999999999998 45688999999975421 22345678999999999999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCC
Q 005572 489 DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESL 568 (690)
Q Consensus 489 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~ 568 (690)
+|.+++.. ...+++..+..++.|++.||+|||+++++||||||+|||++.++
T Consensus 81 ~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~ 132 (323)
T cd05595 81 ELFFHLSR----------------------------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG 132 (323)
T ss_pred cHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC
Confidence 99998865 23578999999999999999999999999999999999999999
Q ss_pred CceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhcCC
Q 005572 569 EPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEGAG 633 (690)
Q Consensus 569 ~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~~ 633 (690)
.+||+|||+++.... .+||......++.++|||||||++|||++|+.||.... ...........
T Consensus 133 ~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~- 211 (323)
T cd05595 133 HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE- 211 (323)
T ss_pred CEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-
Confidence 999999998764211 14555555678899999999999999999999986522 11111111111
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
..++...+. .+.+++..||+.||++|| ++.++++
T Consensus 212 -----~~~p~~~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 212 -----IRFPRTLSP------EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred -----CCCCCCCCH------HHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 111112211 234556679999999998 8888865
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=300.35 Aligned_cols=238 Identities=25% Similarity=0.339 Sum_probs=187.0
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.+|...+.||+|+||.||+|+..+...||+|+++... ...+.+.+|++.+++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4678889999999999999997776779999997533 34567899999999999999999999875 456889999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++... ....+++..+..++.|+++||+|||+.+++||||||+||++++
T Consensus 84 ~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~ 137 (262)
T cd05071 84 KGSLLDFLKGE--------------------------MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGE 137 (262)
T ss_pred CCcHHHHHhhc--------------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcC
Confidence 99999999751 1235789999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHHH
Q 005572 567 SLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVK 629 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~~ 629 (690)
++.+||+|||.++..... +||......++.++|||||||++|||+| |..||..... .......
T Consensus 138 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~ 217 (262)
T cd05071 138 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217 (262)
T ss_pred CCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh
Confidence 999999999998643211 2333333467889999999999999999 8888875322 1222221
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.... ..... .....+.+++.+||+.||++||++.++++.|++.
T Consensus 218 ~~~~-----~~~~~------~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 218 RGYR-----MPCPP------ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred cCCC-----CCCcc------ccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 1110 00111 1112456778889999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=306.57 Aligned_cols=256 Identities=25% Similarity=0.341 Sum_probs=189.6
Q ss_pred ccCCCCceeccCCCccEEEEEcCC-C--cEEEEEEeeccC-CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG-E--LHVAIKVLDNAK-GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv 481 (690)
++|+..+.||+|+||.||+|...+ + ..+++|.++... ....+.+.+|++.+.++ +||||+++++++...+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467788899999999999998543 3 347888886422 22345688899999999 799999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
+||+++|+|.++++......... ...........+++..+..++.|++.||+|||+.+++||||||+|
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~------------~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~N 149 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDP------------AFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARN 149 (297)
T ss_pred EEecCCCcHHHHHHhcccccccc------------ccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcce
Confidence 99999999999997633211100 000001123468999999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCccccccc-------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HHHHH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVK-------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KWVRK 626 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~-------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~~~~ 626 (690)
||+++++.+||+|||++..... .+||......++.++|||||||++|||++ |..||.... .....
T Consensus 150 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~ 229 (297)
T cd05089 150 VLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE 229 (297)
T ss_pred EEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999999753211 13444444567889999999999999998 999986522 11111
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
....+. .+..+...+ ..+.+++.+||+.+|.+||++.++++.|+.+..
T Consensus 230 ~~~~~~-----~~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 230 KLPQGY-----RMEKPRNCD------DEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred HHhcCC-----CCCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 121111 111111111 134567778999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=313.10 Aligned_cols=186 Identities=23% Similarity=0.338 Sum_probs=159.3
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
.++|+..+.||+|+||.||+++. .++..+|+|.+..... ...+.+.+|++++++++||||++++++|.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 35788889999999999999995 4678899998865422 223568899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc-CCCCCCCCCCcE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV-GSTHGHLVTSSI 562 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~iHrDlk~~Ni 562 (690)
|+++|+|.+++.. ...+++.....++.|++.||.|||+. +++||||||+||
T Consensus 84 ~~~~~~L~~~l~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Ni 135 (333)
T cd06650 84 HMDGGSLDQVLKK----------------------------AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 135 (333)
T ss_pred cCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhE
Confidence 9999999999975 23477888899999999999999985 799999999999
Q ss_pred EecCCCCceEcCCCccccccc--------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 563 LLAESLEPKIAGFGLRNIGVK--------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~--------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|+++++.+||+|||++..... . +||......++.++|||||||++|||++|+.||..
T Consensus 136 li~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~ 204 (333)
T cd06650 136 LVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPP 204 (333)
T ss_pred EEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999999864321 1 45555445788899999999999999999999874
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=305.54 Aligned_cols=264 Identities=24% Similarity=0.339 Sum_probs=191.6
Q ss_pred cCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
+|...+.||+|+||.||+|+.. +...+|+|.+..... ...+.+.+|++.++.++||||+++++.|...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 3667789999999999999842 235788998864432 223568889999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|+||+++|+|.+++...+............ .............+++.++..++.|++.||+|||+.+++||||||+
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ 156 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGN----RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAAR 156 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccc----cccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhh
Confidence 999999999999998643211110000000 0000000112356899999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-H
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-K 622 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~ 622 (690)
||++++++.+||+|||+++..... +||......++.++||||||+++|||+| |+.||.... .
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 236 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE 236 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999998643211 3333333467889999999999999999 999987532 2
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCC
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
........... ...+...+ ..+.+++..||+.+|++||++.|+++.|+++..+
T Consensus 237 ~~~~~~~~~~~-----~~~~~~~~------~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~~ 289 (290)
T cd05045 237 RLFNLLKTGYR-----MERPENCS------EEMYNLMLTCWKQEPDKRPTFADISKELEKMMVK 289 (290)
T ss_pred HHHHHHhCCCC-----CCCCCCCC------HHHHHHHHHHccCCcccCCCHHHHHHHHHHHHhc
Confidence 22222222111 11111111 1355677789999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=306.84 Aligned_cols=258 Identities=26% Similarity=0.331 Sum_probs=193.5
Q ss_pred HHhccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAG 475 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 475 (690)
...++|+..+.||+|+||.||++... ....+|+|.+..... ....++.+|++.+.++ +||||+++++++...
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34456788899999999999999853 236799999865422 2234678899999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
+..++||||+++|+|.++++.......... ..........+++..++.++.|++.||+|||+.+++||
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~------------~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~ 156 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYAS------------PDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHR 156 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccc------------cccccccccccCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999999999999999986432111000 00001234578999999999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCC
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTD 618 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~ 618 (690)
||||+||++++++.+||+|||+++.... .+||......++.++|||||||++|||++ |..||.
T Consensus 157 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~ 236 (293)
T cd05053 157 DLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 236 (293)
T ss_pred ccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence 9999999999999999999999875321 13444444578889999999999999998 889987
Q ss_pred chH-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 619 DCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 619 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
... ............ . ..+... ...+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~---~--~~~~~~------~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 237 GIPVEELFKLLKEGYR---M--EKPQNC------TQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred CCCHHHHHHHHHcCCc---C--CCCCCC------CHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 532 122222222211 0 111111 124556788899999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=298.93 Aligned_cols=237 Identities=24% Similarity=0.362 Sum_probs=187.0
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
++|+..+.||+|+||.||+|...++..+|+|.+.... ...+.+.+|+.++++++||||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4577788999999999999998888889999987543 34567899999999999999999999875 456889999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++++. ....+++.++..++.|++.||+|||+.+++||||||+||++++
T Consensus 84 ~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~ 137 (260)
T cd05070 84 KGSLLDFLKDG--------------------------EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGD 137 (260)
T ss_pred CCcHHHHHHhc--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeC
Confidence 99999999751 1245789999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HHHHHHHH
Q 005572 567 SLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KWVRKLVK 629 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~~~~~~~ 629 (690)
++.+||+|||++...... +||......++.++||||||+++|||++ |..||.+.. ........
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05070 138 GLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217 (260)
T ss_pred CceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999998643211 3333333567889999999999999999 888986522 11112221
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
... ....+... ...+.+++.+||+.+|++|||+.++.+.|++
T Consensus 218 ~~~-----~~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 218 RGY-----RMPCPQDC------PISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred cCC-----CCCCCCcC------CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 111 01111111 1245567788999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=302.11 Aligned_cols=241 Identities=24% Similarity=0.358 Sum_probs=181.8
Q ss_pred CCCceeccCCCccEEEEEcCC-C--cEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecC------Cee
Q 005572 410 GKESLLAEGRCGPVYRAVLPG-E--LHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG------KEK 478 (690)
Q Consensus 410 ~~~~~lg~G~~g~Vy~~~~~~-~--~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~ 478 (690)
...+.||+|+||.||+|+... + ..+|+|.++... ....+.+.+|++.++.++||||++++++|... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 345789999999999999644 3 268999886542 12345678899999999999999999988542 246
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++||||+++|+|.+++...+.. .....+++.....++.|++.||+|||+++++|||||
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk 139 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLG----------------------DCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLA 139 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhccc----------------------CCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 8999999999999998642110 123458999999999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV 621 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~ 621 (690)
|+|||+++++.+||+|||+++..... +||......++.++|||||||++|||++ |+.||....
T Consensus 140 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 140 ARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred hhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999999999999999998754211 2333344567889999999999999999 788986522
Q ss_pred -HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 622 -KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 622 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.........+... ...... .. .+.+++.+||+.||++|||+.|+++.|+.+
T Consensus 220 ~~~~~~~~~~~~~~-----~~~~~~---~~---~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 220 NSEIYDYLRQGNRL-----KQPPDC---LD---GLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred HHHHHHHHHcCCCC-----CCCCCC---CH---HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 2222222222111 111111 11 345677789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=312.70 Aligned_cols=227 Identities=19% Similarity=0.214 Sum_probs=178.6
Q ss_pred ceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCC
Q 005572 413 SLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANG 488 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 488 (690)
+.||+|+||.||+++ ..++..||+|++..... .....+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999998 45688999999975421 23356778999999999999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCC
Q 005572 489 DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESL 568 (690)
Q Consensus 489 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~ 568 (690)
+|.+++.. ...+++.++..++.|++.||+|||+++++||||||+|||++.++
T Consensus 81 ~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 132 (328)
T cd05593 81 ELFFHLSR----------------------------ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG 132 (328)
T ss_pred CHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC
Confidence 99998865 23588999999999999999999999999999999999999999
Q ss_pred CceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhcCC
Q 005572 569 EPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEGAG 633 (690)
Q Consensus 569 ~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~~ 633 (690)
.+||+|||+++.... . +||......++.++|||||||++|||++|+.||.... ..........
T Consensus 133 ~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~-- 210 (328)
T cd05593 133 HIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME-- 210 (328)
T ss_pred cEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC--
Confidence 999999999864211 1 4555444578899999999999999999999996521 1111111111
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLGL 679 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~~ 679 (690)
+..++...+. .+.+++.+||+.||++|| ++.|+++.
T Consensus 211 ----~~~~p~~~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 211 ----DIKFPRTLSA------DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred ----CccCCCCCCH------HHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 1111111211 234556679999999997 89988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=302.24 Aligned_cols=239 Identities=25% Similarity=0.424 Sum_probs=187.1
Q ss_pred ccCCCCceeccCCCccEEEEEcC-CC---cEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP-GE---LHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
++|+..+.||+|+||.||+|+.. ++ ..+|+|.++... ....+++..|++.+++++||||+++++++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46777889999999999999853 23 379999986542 22345688899999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|.++++.. ...+++.++..++.|++.|++|||+.+++||||||+|
T Consensus 85 ~e~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N 137 (268)
T cd05063 85 TEYMENGALDKYLRDH---------------------------DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARN 137 (268)
T ss_pred EEcCCCCCHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhh
Confidence 9999999999999751 2358899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK- 622 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~- 622 (690)
|++++++.+|++|||++...... +||......++.++|||||||++|||++ |+.||.....
T Consensus 138 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~ 217 (268)
T cd05063 138 ILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH 217 (268)
T ss_pred EEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 99999999999999998643211 2333333567889999999999999998 9999864221
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.....+..... . + ..... ...+.+++..||+.+|++||++.+|++.|+++
T Consensus 218 ~~~~~i~~~~~---~-~-~~~~~------~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 218 EVMKAINDGFR---L-P-APMDC------PSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred HHHHHHhcCCC---C-C-CCCCC------CHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 12222221110 0 0 00111 12456778889999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=304.29 Aligned_cols=254 Identities=23% Similarity=0.298 Sum_probs=188.5
Q ss_pred ccCCCCceeccCCCccEEEEEc-----CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-----PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
++|+..+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|++.+++++||||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3566778999999999999973 2457899999864332 223568889999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
||||+++|+|.+++......... .+... ........+++.+.+.++.|++.||.|||+++++||||||+
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~--~~~~~---------~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~ 153 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDV--GCSSD---------EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAAR 153 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCcc--ccccc---------cccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccc
Confidence 99999999999999753211000 00000 00011345889999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-H
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-K 622 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~ 622 (690)
|||+++++.+||+|||+++..... +||......++.++|||||||++|||++ |..||.... .
T Consensus 154 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~ 233 (283)
T cd05090 154 NILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233 (283)
T ss_pred eEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999998643211 3444434567899999999999999999 888986532 2
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
...+........ ..+...+ ..+.+++..||+.||++||++.+|.+.|..
T Consensus 234 ~~~~~~~~~~~~-----~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 234 EVIEMVRKRQLL-----PCSEDCP------PRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred HHHHHHHcCCcC-----CCCCCCC------HHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 222222222111 1111111 134556678999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=305.11 Aligned_cols=244 Identities=25% Similarity=0.328 Sum_probs=185.3
Q ss_pred CCCceeccCCCccEEEEEc-----CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeEEE
Q 005572 410 GKESLLAEGRCGPVYRAVL-----PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKLVL 481 (690)
Q Consensus 410 ~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv 481 (690)
+..+.||+|+||.||++.. .++..||+|.++.... .....+.+|++.+++++||||+++++++... ...++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999988652 3567899999875432 2346788999999999999999999998753 357899
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|.+++.. ..+++.++..++.|+++||.|||+++++||||||+|
T Consensus 87 ~e~~~~~~l~~~~~~-----------------------------~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~N 137 (283)
T cd05080 87 MEYVPLGSLRDYLPK-----------------------------HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARN 137 (283)
T ss_pred ecCCCCCCHHHHHHH-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChhe
Confidence 999999999999864 248899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV 624 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~ 624 (690)
|++++++.+||+|||+++..... +||...+..++.++|||||||++|||+||..|+.......
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~ 217 (283)
T cd05080 138 VLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF 217 (283)
T ss_pred EEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh
Confidence 99999999999999998753211 3444444577899999999999999999999986533222
Q ss_pred HHHHHhcCC-------CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 625 RKLVKEGAG-------GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 625 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
......... .+..+.......+. .....+.+++..||+.||++|||++++++.|+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 218 EEMIGPKQGQMTVVRLIELLERGMRLPCPK--NCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hhhhcccccccchhhhhhhhhcCCCCCCCC--CCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 111111000 00000000000000 01124566778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=299.75 Aligned_cols=238 Identities=26% Similarity=0.369 Sum_probs=188.1
Q ss_pred hccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.++|+..+.||+|+||.||+|...++..+|+|.+.... ...+++.+|+..+++++||||+++++++. .+..++||||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 45678889999999999999998888899999987543 34578899999999999999999999874 46789999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++... ....+++.++..++.|++.||+|||+.+++||||||+||+++
T Consensus 83 ~~~~L~~~~~~~--------------------------~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~ 136 (260)
T cd05067 83 ENGSLVDFLKTP--------------------------EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVS 136 (260)
T ss_pred CCCCHHHHHHhc--------------------------CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEc
Confidence 999999998752 124578999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~ 628 (690)
+++.++|+|||++...... +||......++.++|||||||++||+++ |+.||..... ......
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05067 137 ETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL 216 (260)
T ss_pred CCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH
Confidence 9999999999998643311 2333333467889999999999999999 9999975321 111222
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
..... ...+... . .++.+++.+||+.+|++||+++++++.|+.
T Consensus 217 ~~~~~-----~~~~~~~---~---~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 217 ERGYR-----MPRPDNC---P---EELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred HcCCC-----CCCCCCC---C---HHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 21111 0111111 1 135567778999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=326.60 Aligned_cols=242 Identities=19% Similarity=0.197 Sum_probs=191.3
Q ss_pred ccCCCCceeccCCCccEEEEEcCC-CcEEEEEEeeccCCCCHHHHHHHHHHHHhcC-CCCccceeeE-Eec---C---Ce
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPLAGY-CIA---G---KE 477 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~-~~~---~---~~ 477 (690)
.++.+++.|.+|||+.||.++... +..+|+|++-...+...+...+|+++|+.|+ |+|||.+++. ... . -+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 456667899999999999999554 4899999987666667788999999999998 9999999993 322 1 26
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC--CCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG--STHG 555 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~iHr 555 (690)
.+|.||||.+|+|-+++..+ -...|++.++++|+.|+|+|+++||... +|||
T Consensus 117 vllLmEyC~gg~Lvd~mn~R--------------------------lq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHR 170 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTR--------------------------LQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHR 170 (738)
T ss_pred EEeehhhccCCcHHHHHHHH--------------------------HhccCChHHHHHHHHHHHHHHHHHhcCCCccchh
Confidence 78999999999999999862 2345999999999999999999999987 8899
Q ss_pred CCCCCcEEecCCCCceEcCCCcccccccc-------------------cCcccCC-------CCCCCCCcchhhHHHHHH
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVKN-------------------VGERSEN-------ETCGPESDVYCFGVILME 609 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~-------------------~~e~~~~-------~~~~~~~DVwSfGvvl~e 609 (690)
|||.+||||+.++..||||||-|...... +-|++|| ..+++|+||||+||+||-
T Consensus 171 DLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYk 250 (738)
T KOG1989|consen 171 DLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYK 250 (738)
T ss_pred hhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHH
Confidence 99999999999999999999987642211 3455554 368999999999999999
Q ss_pred HHhCCCCCCchHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 610 LLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 610 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
|+....||++-. ...++...+.... .......+.+++..||+.||++||++.+|+..+.+++..+
T Consensus 251 LCy~t~PFe~sg-----------~laIlng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~ 315 (738)
T KOG1989|consen 251 LCYFTTPFEESG-----------KLAILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP 315 (738)
T ss_pred HHHhCCCcCcCc-----------ceeEEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence 999999998621 1222222222111 1122224445666799999999999999999998887654
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.36 Aligned_cols=231 Identities=21% Similarity=0.312 Sum_probs=179.8
Q ss_pred eeccCCCccEEEEEcC---CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCC
Q 005572 414 LLAEGRCGPVYRAVLP---GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGD 489 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 489 (690)
.||+|+||.||+|.+. ++..||+|++..... ...+.+.+|+.++++++||||++++++|. .+..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 3899999999999753 355799999865432 23456889999999999999999999885 457889999999999
Q ss_pred HhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCC
Q 005572 490 LHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLE 569 (690)
Q Consensus 490 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~ 569 (690)
|.+++... ...+++.++.+++.|++.||+|||+++++||||||+||+++.++.
T Consensus 81 L~~~l~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~ 133 (257)
T cd05115 81 LNKFLSGK---------------------------KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY 133 (257)
T ss_pred HHHHHHhC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc
Confidence 99998741 235889999999999999999999999999999999999999999
Q ss_pred ceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH-HHHHHHh
Q 005572 570 PKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-VRKLVKE 630 (690)
Q Consensus 570 ~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-~~~~~~~ 630 (690)
+||+|||+++..... +||......++.++|||||||++||+++ |..||.+.... .......
T Consensus 134 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~ 213 (257)
T cd05115 134 AKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQ 213 (257)
T ss_pred EEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHC
Confidence 999999998643211 2333333567889999999999999996 99999764322 2222222
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
+... ..+...+ .++.+++..||+.||++||++.+|.+.|+.+
T Consensus 214 ~~~~-----~~~~~~~------~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 214 GKRL-----DCPAECP------PEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred CCCC-----CCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 2111 1111111 2344567789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=314.72 Aligned_cols=233 Identities=19% Similarity=0.172 Sum_probs=183.6
Q ss_pred ccCCCCceeccCCCccEEEEEcCC--CcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG--ELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
.+|...+.||+|+||.||+|+... +..||+|++.... ....+.+.+|+++++.++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 357778999999999999998433 3689999986432 23345678899999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+|
T Consensus 110 ~Ey~~~g~L~~~i~~----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~N 161 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR----------------------------NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPEN 161 (340)
T ss_pred EeCCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHH
Confidence 999999999999975 2357888999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVK 629 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~ 629 (690)
||++.++.+||+|||+++..... +||......++.++|||||||++|||++|+.||..... .....+.
T Consensus 162 ILl~~~~~ikL~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 241 (340)
T PTZ00426 162 LLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL 241 (340)
T ss_pred EEECCCCCEEEecCCCCeecCCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh
Confidence 99999999999999998754321 45555455788999999999999999999999976322 1222222
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLGL 679 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~~ 679 (690)
.+.. .++...+. .+.+++.+|++.||++|+ +++|+++.
T Consensus 242 ~~~~------~~p~~~~~------~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 242 EGII------YFPKFLDN------NCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred cCCC------CCCCCCCH------HHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 2211 11111111 234566679999999995 88888653
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=299.91 Aligned_cols=229 Identities=23% Similarity=0.312 Sum_probs=175.1
Q ss_pred ceeccCCCccEEEEEcCC-------------CcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeE
Q 005572 413 SLLAEGRCGPVYRAVLPG-------------ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~-------------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
+.||+|+||.||+|++.+ ...||+|.++.........+.+|+..++.++||||++++|++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 358999999999998532 2358899886554444557788889999999999999999999999999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||+++|+|..+++.. ...+++..+.+++.||++||+|||+++++||||||
T Consensus 81 lv~e~~~~~~l~~~~~~~---------------------------~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 133 (262)
T cd05077 81 MVEEFVEFGPLDLFMHRK---------------------------SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCT 133 (262)
T ss_pred EEEecccCCCHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCc
Confidence 999999999999988641 23588899999999999999999999999999999
Q ss_pred CcEEecCCCC-------ceEcCCCcccccccc----------cCcccC-CCCCCCCCcchhhHHHHHHHH-hCCCCCCch
Q 005572 560 SSILLAESLE-------PKIAGFGLRNIGVKN----------VGERSE-NETCGPESDVYCFGVILMELL-TGKRGTDDC 620 (690)
Q Consensus 560 ~NiLl~~~~~-------~kl~DfGla~~~~~~----------~~e~~~-~~~~~~~~DVwSfGvvl~el~-tg~~p~~~~ 620 (690)
+|||++.++. +|++|||++...... +||... ...++.++|||||||++|||+ +|..|+...
T Consensus 134 ~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (262)
T cd05077 134 KNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213 (262)
T ss_pred ccEEEecCCccCCCCceeEeCCCCCCccccCcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence 9999987664 899999998653221 344433 235788999999999999997 588887652
Q ss_pred HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
............. . . ...... .+.+++.+||+.||++||++.||++.+
T Consensus 214 ~~~~~~~~~~~~~-~-----~---~~~~~~---~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 214 TLAEKERFYEGQC-M-----L---VTPSCK---ELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred chhHHHHHHhcCc-c-----C---CCCChH---HHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 2111111111110 0 0 001112 345677889999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=315.17 Aligned_cols=183 Identities=23% Similarity=0.363 Sum_probs=152.8
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCC-----eeE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK-----EKL 479 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~ 479 (690)
+|...+.||+|+||.||+|+ ..++..||||+++... ......+.+|++++++++||||+++++++...+ ..|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 36677899999999999998 5568899999986432 123456788999999999999999999986533 479
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+|||||. ++|.+++.. ...+++..+..++.|+++||.|||+++++||||||
T Consensus 81 lv~e~~~-~~L~~~l~~----------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 131 (338)
T cd07859 81 VVFELME-SDLHQVIKA----------------------------NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKP 131 (338)
T ss_pred EEEecCC-CCHHHHHHh----------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 9999995 699998865 23588999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCccccccc-------------c----cCcccCC--CCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVK-------------N----VGERSEN--ETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~-------------~----~~e~~~~--~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
+|||++.++.+||+|||+++.... . +||.... ..++.++|||||||++|||+||+.||..
T Consensus 132 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~ 210 (338)
T cd07859 132 KNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210 (338)
T ss_pred HHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999874311 1 3443322 4678899999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=297.49 Aligned_cols=237 Identities=22% Similarity=0.292 Sum_probs=186.4
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEe-cCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCI-AGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~lv~e~~ 485 (690)
.+|...+.||+|+||.||++... +..+|+|.++.. ...+.+.+|+..+++++|+||++++|++. ..+..++|+||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 36777899999999999999865 557999998643 23567889999999999999999999865 456789999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.++++... ...+++..+..++.|++.||+|||+++++||||||+||+++
T Consensus 83 ~~~~L~~~~~~~~--------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~ 136 (256)
T cd05082 83 AKGSLVDYLRSRG--------------------------RSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVS 136 (256)
T ss_pred CCCcHHHHHHhcC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEc
Confidence 9999999997621 23478999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCccccccc-----------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HHHHHHHHhcC
Q 005572 566 ESLEPKIAGFGLRNIGVK-----------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KWVRKLVKEGA 632 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~-----------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~~~~~~~~~~ 632 (690)
+++.+||+|||+++.... .+||......++.++|||||||++|||++ |+.||.... .........+.
T Consensus 137 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~ 216 (256)
T cd05082 137 EDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY 216 (256)
T ss_pred CCCcEEecCCccceeccccCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC
Confidence 999999999999875322 14555555678889999999999999998 999986421 11112222211
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.. ......+ ..+.+++.+||+.+|++|||+.++++.|+++
T Consensus 217 ~~-----~~~~~~~------~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 217 KM-----DAPDGCP------PVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred CC-----CCCCCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 11 1111111 2345667789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=298.54 Aligned_cols=237 Identities=27% Similarity=0.389 Sum_probs=185.1
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.+|.....||+|+||.||+|...++..+|+|.+.... ...+.+.+|++++++++|||++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 3577778999999999999998777789999886433 34567889999999999999999999875 466889999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.++++.. ....++|..+..++.|++.||.|||+.+++||||||+||++++
T Consensus 84 ~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~ 137 (260)
T cd05069 84 KGSLLDFLKEG--------------------------DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGD 137 (260)
T ss_pred CCCHHHHHhhC--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcC
Confidence 99999999752 1235789999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH-HHHHHH
Q 005572 567 SLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-VRKLVK 629 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-~~~~~~ 629 (690)
++.+||+|||+++..... +||......++.++|||||||++|||+| |+.||.+.... ......
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05069 138 NLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE 217 (260)
T ss_pred CCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999999998643211 2333333467889999999999999999 89998763321 112221
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
... .+...... ...+.+++.+||+.||++||++++|++.|++
T Consensus 218 ~~~-----~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 218 RGY-----RMPCPQGC------PESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred cCC-----CCCCCccc------CHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 111 01111111 1234566778999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=306.62 Aligned_cols=244 Identities=20% Similarity=0.249 Sum_probs=181.4
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++|...+.||+|+||.||+|+. .++..||+|+++.... .....+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEY 84 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEEC
Confidence 5788889999999999999995 4688999999865432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
++ |+|.+++... ...+++..+..++.|++.||+|||+++++||||||+|||+
T Consensus 85 ~~-~~l~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill 136 (303)
T cd07869 85 VH-TDLCQYMDKH---------------------------PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI 136 (303)
T ss_pred CC-cCHHHHHHhC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 95 6888888651 2357888899999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc----------c----cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHH---HHHH
Q 005572 565 AESLEPKIAGFGLRNIGVK----------N----VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVK---WVRK 626 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~----------~----~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~---~~~~ 626 (690)
++++.+||+|||+++.... . +||.... ..++.++||||+||++|||++|+.||....+ ....
T Consensus 137 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 216 (303)
T cd07869 137 SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLER 216 (303)
T ss_pred CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 9999999999999864221 1 3443322 3478899999999999999999999975321 1111
Q ss_pred HHHh-cCCCC----------cccc-ccccCCCCCHHH-------HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 627 LVKE-GAGGD----------ALDF-RLKLGSGDSVAE-------MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 627 ~~~~-~~~~~----------~~~~-~~~~~~~~~~~~-------~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... +.... ..++ ......+..... .-.+.+++.+|++.||++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 217 IFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred HHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 1111 00000 0000 000000111111 013446777899999999999999986
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=304.72 Aligned_cols=244 Identities=21% Similarity=0.259 Sum_probs=177.9
Q ss_pred cCCCCceeccCCCccEEEEEc--CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhc---CCCCccceeeEEec-----C
Q 005572 408 HFGKESLLAEGRCGPVYRAVL--PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRL---KHPNLLPLAGYCIA-----G 475 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~-----~ 475 (690)
+|...+.||+|+||.||+|+. .++..||+|.++.... .....+.+|+.+++.+ +||||++++++|.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 577889999999999999984 3467899999865432 2234566777777665 69999999999863 3
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
...++||||++ |+|.+++... ....+++.++..++.|++.||.|||+++++||
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~--------------------------~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~ 134 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKV--------------------------PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHR 134 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhC--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeC
Confidence 46889999996 6999998752 12357899999999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV- 621 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~- 621 (690)
||||+|||++.++.+||+|||+++..... +||......++.++|||||||++|||++|++||....
T Consensus 135 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 135 DLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred CCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 99999999999999999999998653211 4555445678899999999999999999999987522
Q ss_pred -HHHHHHHHhcCCCC---------ccccccccCCCCCHHHH-----HHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 622 -KWVRKLVKEGAGGD---------ALDFRLKLGSGDSVAEM-----VESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 622 -~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~-----~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+............. .....+..........+ ..+.+++.+|++.||++|||+.|+++
T Consensus 215 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 215 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred HHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 22222221110000 00000000000111111 12346788899999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=298.31 Aligned_cols=230 Identities=22% Similarity=0.353 Sum_probs=179.1
Q ss_pred eeccCCCccEEEEEc---CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCC
Q 005572 414 LLAEGRCGPVYRAVL---PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANG 488 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~---~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 488 (690)
.||+|+||.||+|.+ .++..+|+|+++.... ...+++..|+.+++.++||||++++|++. .+..++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 589999999999964 3577899999864432 22457888999999999999999999885 45678999999999
Q ss_pred CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCC
Q 005572 489 DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESL 568 (690)
Q Consensus 489 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~ 568 (690)
+|.+++.. ...+++..+..++.|++.||+|||+++++||||||+||++++++
T Consensus 81 ~L~~~l~~----------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~ 132 (257)
T cd05116 81 PLNKFLQK----------------------------NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH 132 (257)
T ss_pred cHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC
Confidence 99999965 23578889999999999999999999999999999999999999
Q ss_pred CceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HHHHHHHH
Q 005572 569 EPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KWVRKLVK 629 (690)
Q Consensus 569 ~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~~~~~~~ 629 (690)
.+||+|||+++..... +||......++.++|||||||++|||++ |+.||.... ........
T Consensus 133 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~ 212 (257)
T cd05116 133 YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE 212 (257)
T ss_pred eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 9999999998643211 2333333467789999999999999998 999997532 22222232
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.+.. +..+...+. .+.+++..||+.||++||++.+|++.|++.
T Consensus 213 ~~~~-----~~~~~~~~~------~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 213 SGER-----MECPQRCPP------EMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred CCCC-----CCCCCCCCH------HHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 2211 111122211 344566779999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=296.54 Aligned_cols=230 Identities=23% Similarity=0.347 Sum_probs=182.4
Q ss_pred eeccCCCccEEEEEcCCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHhh
Q 005572 414 LLAEGRCGPVYRAVLPGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHR 492 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 492 (690)
.||+|+||.||+|...++..+|+|.++.... .....+.+|++.+++++||||++++++|...+..++||||+++|+|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6899999999999987888999999865432 223467889999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceE
Q 005572 493 WLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKI 572 (690)
Q Consensus 493 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl 572 (690)
++... ...+++..+..++.|++.||.|+|+.+++||||||+||++++++.+||
T Consensus 82 ~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l 134 (250)
T cd05085 82 FLRKK---------------------------KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKI 134 (250)
T ss_pred HHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEE
Confidence 98651 234789999999999999999999999999999999999999999999
Q ss_pred cCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHHHhcCCCC
Q 005572 573 AGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVKEGAGGD 635 (690)
Q Consensus 573 ~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~~~ 635 (690)
+|||++...... +||......++.++|||||||++||+++ |..||..... ...........
T Consensus 135 ~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~-- 212 (250)
T cd05085 135 SDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR-- 212 (250)
T ss_pred CCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC--
Confidence 999998643211 3443333567889999999999999998 9999875322 22222222111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 636 ALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
...+... ...+.+++.+||+.+|++||++.|+++.|.
T Consensus 213 ---~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 213 ---MSCPQKC------PDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred ---CCCCCCC------CHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 0111111 124566778899999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=297.01 Aligned_cols=235 Identities=22% Similarity=0.258 Sum_probs=185.9
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|...+.||+|+||.||+|.. .++..|++|.+.... ....+.+.+|++.+++++||||+++++++...+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 366678999999999999985 568899999986432 23456788899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.++++.. ....+++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 81 ~~~~~L~~~l~~~--------------------------~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili 134 (256)
T cd08529 81 AENGDLHKLLKMQ--------------------------RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL 134 (256)
T ss_pred CCCCcHHHHHHHh--------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE
Confidence 9999999999762 12458889999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVK 629 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~ 629 (690)
++++.+||+|||+++..... +||......++.++|||||||++|||++|+.||..... .......
T Consensus 135 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 214 (256)
T cd08529 135 DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII 214 (256)
T ss_pred eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999987653221 45554455778899999999999999999999875322 1111111
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.+... .+.... ...+.+++.+||+.+|++||++.|+++.
T Consensus 215 ~~~~~-----~~~~~~------~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 215 RGVFP-----PVSQMY------SQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred cCCCC-----CCcccc------CHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 11111 111111 1235567778999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=305.52 Aligned_cols=255 Identities=25% Similarity=0.336 Sum_probs=188.1
Q ss_pred ccCCCCceeccCCCccEEEEEcC-CCc--EEEEEEeeccC-CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP-GEL--HVAIKVLDNAK-GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv 481 (690)
++|+..+.||+|+||.||+|... ++. .+|+|.++... ......+.+|++.+.++ +||||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46777889999999999999853 343 46777765432 12345688899999999 899999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|.+++++......... ..........+++.+++.++.|+++||+|||+++++||||||+|
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~------------~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~N 154 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPA------------FAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 154 (303)
T ss_pred EEeCCCCcHHHHHHhccccccccc------------ccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence 999999999999986432111100 00000123468999999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCccccccc-------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVK-------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRK 626 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~-------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~ 626 (690)
||+++++.+||+|||+++.... .+||......++.++|||||||++|||+| |..||..... ....
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 155 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred EEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 9999999999999999863211 13444444567889999999999999998 9999864221 1111
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
..... .....+... . ..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 235 ~~~~~-----~~~~~~~~~---~---~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~ 281 (303)
T cd05088 235 KLPQG-----YRLEKPLNC---D---DEVYDLMRQCWREKPYERPSFAQILVSLNRML 281 (303)
T ss_pred HHhcC-----CcCCCCCCC---C---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence 11111 001111111 1 13456778899999999999999999988763
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=304.04 Aligned_cols=251 Identities=23% Similarity=0.319 Sum_probs=186.8
Q ss_pred ccCCCCceeccCCCccEEEEEcC-----------------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccce
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP-----------------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPL 468 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~-----------------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l 468 (690)
++|+..+.||+|+||.||++... +...+|+|++..... ...+++.+|++.+++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46788899999999999998532 234689999865422 234678899999999999999999
Q ss_pred eeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 005572 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH 548 (690)
Q Consensus 469 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 548 (690)
++++...+..++||||+++|+|.+++......... .......+++.++..++.|++.||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~i~~al~~lH 147 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAA-----------------EKADVVTISYSTLIFMATQIASGMKYLS 147 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCccccc-----------------ccccccccCHHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999863321110 0112346889999999999999999999
Q ss_pred hcCCCCCCCCCCcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh
Q 005572 549 HVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT 612 (690)
Q Consensus 549 ~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t 612 (690)
+.+++||||||+||++++++.+||+|||+++..... +||......++.++|||||||++|||++
T Consensus 148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~ 227 (296)
T cd05095 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227 (296)
T ss_pred HCCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHH
Confidence 999999999999999999999999999998743211 2222223467889999999999999998
Q ss_pred --CCCCCCchH--HHHHH---HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 613 --GKRGTDDCV--KWVRK---LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 613 --g~~p~~~~~--~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
|..||.... +.... ...... .....+ .+... . ..+.+++.+||+.||++||++.||++.|++
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~--~----~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 228 LCKEQPYSQLSDEQVIENTGEFFRDQG-RQVYLP-KPALC--P----DSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred hCCCCCccccChHHHHHHHHHHHhhcc-ccccCC-CCCCC--C----HHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 678876421 11111 111110 000000 01111 1 245567888999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.92 Aligned_cols=252 Identities=24% Similarity=0.333 Sum_probs=189.3
Q ss_pred ccCCCCceeccCCCccEEEEEc------CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL------PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
.+|.....||+|+||.||++.. .++..+|+|.+........+.+.+|++.+++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 3566678999999999999963 2356799998876554455678999999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
||||+++|+|.++++.......... .........+++.++..++.|++.|++|||+.+++||||||+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~-------------~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~ 151 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILA-------------GGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATR 151 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhc-------------ccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHh
Confidence 9999999999999986321110000 001112346899999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH
Q 005572 561 SILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW 623 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~ 623 (690)
|||+++++.+||+|||+++.... .+||......++.++|||||||++|||++ |+.||......
T Consensus 152 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 231 (280)
T cd05092 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT 231 (280)
T ss_pred hEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence 99999999999999999864311 13444334578899999999999999998 89998653322
Q ss_pred H-HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 624 V-RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 624 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
. ......+.. ...+...+ ..+.+++..||+.||.+||++.||.+.|+.
T Consensus 232 ~~~~~~~~~~~-----~~~~~~~~------~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 232 EAIECITQGRE-----LERPRTCP------PEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHHHHHcCcc-----CCCCCCCC------HHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 1 111111111 01111111 134466677999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.53 Aligned_cols=245 Identities=25% Similarity=0.321 Sum_probs=188.0
Q ss_pred hccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCee
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 478 (690)
.++|...+.||+|+||.||+|... .+..||+|.+..... .....+.+|+..+++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 456888899999999999999854 356789998864332 2235688899999999999999999999998999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++||||+++|+|.+++...+... .....++|.++.+++.||+.||+|||+.+++|||||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~---------------------~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlk 143 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRP---------------------ERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIA 143 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCC---------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccc
Confidence 99999999999999998633111 112358999999999999999999999999999999
Q ss_pred CCcEEecCCC---CceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCC
Q 005572 559 TSSILLAESL---EPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTD 618 (690)
Q Consensus 559 ~~NiLl~~~~---~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~ 618 (690)
|+||+++.++ .+||+|||+++.... .+||......++.++|||||||++|||++ |..||.
T Consensus 144 p~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~ 223 (277)
T cd05036 144 ARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYP 223 (277)
T ss_pred hheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCC
Confidence 9999998764 599999999875321 13444444578999999999999999997 999987
Q ss_pred chH-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 619 DCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 619 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
... ............. ..+...+ ..+.+++.+||+.+|++||++.||++.|+.
T Consensus 224 ~~~~~~~~~~~~~~~~~-----~~~~~~~------~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~ 277 (277)
T cd05036 224 GRTNQEVMEFVTGGGRL-----DPPKGCP------GPVYRIMTDCWQHTPEDRPNFATILERIQY 277 (277)
T ss_pred CCCHHHHHHHHHcCCcC-----CCCCCCC------HHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence 532 2122222211110 1111111 245567778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.16 Aligned_cols=247 Identities=20% Similarity=0.252 Sum_probs=191.0
Q ss_pred ccCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||+|+||.||+|... ++..||+|.++... ....+.+.+|++.+++++|+||+++++++...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 46788899999999999999954 78899999886422 223467889999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.+++.... .....+++.++..++.|+++||.|||+.+++||||||+||
T Consensus 82 e~~~~~~L~~~l~~~~------------------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni 137 (267)
T cd08224 82 ELADAGDLSRMIKHFK------------------------KQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANV 137 (267)
T ss_pred ecCCCCCHHHHHHHhc------------------------ccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhE
Confidence 9999999999987521 1234578999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLV 628 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~ 628 (690)
+++.++.+||+|||++...... +||......++.++|||||||++|||++|+.||........+..
T Consensus 138 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08224 138 FITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 217 (267)
T ss_pred EECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHH
Confidence 9999999999999987643211 45544445678899999999999999999999854211111111
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
..... ....+ .+. ......+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 218 ~~~~~-~~~~~-~~~-----~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 218 KKIEK-CDYPP-LPA-----DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred hhhhc-CCCCC-CCh-----hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 11000 00000 100 011123456777899999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=300.51 Aligned_cols=247 Identities=21% Similarity=0.271 Sum_probs=189.3
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCC---CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI---DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|...+.||+|+||.||+|+ ..++..+|||.+...... ...++.+|++.++.++||||+++++++...+..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 356777899999999999999 467889999988643322 2356788999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++++|.+++.... .....+++..+..++.|+++||.|||+.+++|+||||+||
T Consensus 82 e~~~~~~L~~~~~~~~------------------------~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni 137 (267)
T cd08229 82 ELADAGDLSRMIKHFK------------------------KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANV 137 (267)
T ss_pred EecCCCCHHHHHHHhh------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 9999999999987421 1134688999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLV 628 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~ 628 (690)
+++.++.+||+|||++...... +||......++.++||||||+++|||++|..||...........
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 217 (267)
T cd08229 138 FITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC 217 (267)
T ss_pred EEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHh
Confidence 9999999999999987643211 45544445778899999999999999999999864221111111
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
.... ....+..... .. ...+.+++.+||+.||++||||.+|++.++++.
T Consensus 218 ~~~~--~~~~~~~~~~--~~---~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 218 KKIE--QCDYPPLPSD--HY---SEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred hhhh--cCCCCCCCcc--cc---cHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 1100 0001111100 01 113445667899999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=304.07 Aligned_cols=236 Identities=18% Similarity=0.257 Sum_probs=185.2
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.+|...+.||+|+||.||+|+ ..++..+|+|.+........+.+.+|+.+++.++||||+++++++......++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 367778899999999999998 4568899999997655455677889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++.. ..+++.++..++.|++.||+|||+.+++||||||+||+++
T Consensus 100 ~~~~L~~~~~~-----------------------------~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~ 150 (296)
T cd06654 100 AGGSLTDVVTE-----------------------------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (296)
T ss_pred CCCCHHHHHHh-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEc
Confidence 99999999864 2467889999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhc
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEG 631 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 631 (690)
.++.+||+|||++...... +||......++.++|||||||++|||++|+.||..............
T Consensus 151 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~ 230 (296)
T cd06654 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (296)
T ss_pred CCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhc
Confidence 9999999999987642211 34444445678899999999999999999999865322111111110
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
... +.+... ... ...+.+++.+||+.||++|||+.|+++.
T Consensus 231 ~~~----~~~~~~--~~~--~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 231 NGT----PELQNP--EKL--SAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred CCC----CCCCCc--ccc--CHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 000 001000 001 1134566778999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=305.15 Aligned_cols=252 Identities=23% Similarity=0.332 Sum_probs=185.0
Q ss_pred ccCCCCceeccCCCccEEEEEcCC---------------CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceee
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG---------------ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAG 470 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~---------------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g 470 (690)
.+|...+.||+|+||.||+++..+ ...||+|.++.... ...+.+.+|++.+++++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467888999999999999987532 23589999865322 22356889999999999999999999
Q ss_pred EEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc
Q 005572 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV 550 (690)
Q Consensus 471 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~ 550 (690)
++...+..++||||+++++|.+++......... ........++|..+..++.|++.||+|||+.
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~----------------~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 148 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTF----------------THANNIPSVSIANLLYMAVQIASGMKYLASL 148 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccc----------------cccccCCcccHHHHHHHHHHHHHHHHHHHhc
Confidence 999999999999999999999999752110000 0001123478999999999999999999999
Q ss_pred CCCCCCCCCCcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh--
Q 005572 551 GSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-- 612 (690)
Q Consensus 551 ~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-- 612 (690)
+++||||||+||++++++.+||+|||+++..... +||......++.++|||||||++|||++
T Consensus 149 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~ 228 (295)
T cd05097 149 NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLC 228 (295)
T ss_pred CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcC
Confidence 9999999999999999999999999998643211 3333334567899999999999999998
Q ss_pred CCCCCCchH--HHHHHH---HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 613 GKRGTDDCV--KWVRKL---VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 613 g~~p~~~~~--~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
|..||.... +..... ...... .... ...... ...+.+++.+||+.||++||+|.+|++.|++
T Consensus 229 ~~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~------~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 229 KEQPYSLLSDEQVIENTGEFFRNQGR-QIYL-SQTPLC------PSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred CCCCCcccChHHHHHHHHHhhhhccc-cccC-CCCCCC------CHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 567776421 111111 111000 0000 000001 1246677888999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=308.87 Aligned_cols=226 Identities=21% Similarity=0.225 Sum_probs=176.5
Q ss_pred ceeccCCCccEEEEEc----CCCcEEEEEEeeccC----CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 413 SLLAEGRCGPVYRAVL----PGELHVAIKVLDNAK----GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+.||+|+||.||+++. ..+..||+|+++... ......+..|+++++.++||||+++++++...+..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999984 347889999997532 12334567899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++|+|.+++.. ...+.+..+..++.|++.||+|||+++++||||||+|||+
T Consensus 82 ~~~~~L~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 133 (323)
T cd05584 82 LSGGELFMHLER----------------------------EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133 (323)
T ss_pred CCCchHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 999999999975 2346778888899999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-HHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLVK 629 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-~~~~~~ 629 (690)
+.++.+||+|||+++.... .+||......++.++|||||||++|||++|+.||...... ......
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~ 213 (323)
T cd05584 134 DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213 (323)
T ss_pred CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999999763211 1455554456788999999999999999999999763221 111111
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
.+. ..++...+. .+.+++.+||+.||++|| ++.++++
T Consensus 214 ~~~------~~~~~~~~~------~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 214 KGK------LNLPPYLTP------EARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred cCC------CCCCCCCCH------HHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 111 111111111 344566779999999999 7888765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=298.55 Aligned_cols=235 Identities=21% Similarity=0.249 Sum_probs=178.5
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--------------CCHHHHHHHHHHHHhcCCCCccceee
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--------------IDHDDAVAMFDELSRLKHPNLLPLAG 470 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--------------~~~~~~~~e~~~l~~l~H~niv~l~g 470 (690)
.+.|.....||+|.||.|-+|+ ..++..||||++.+... ...+...+|+.+|++++|||||+|+.
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 4578888999999999999999 56789999999964321 12257889999999999999999999
Q ss_pred EEecC--CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCHHHHHHHHHHHHHHHHhh
Q 005572 471 YCIAG--KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK-TNWVTRHRIAIGVARGLAYL 547 (690)
Q Consensus 471 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l~~~~~~~i~~~ia~gl~yL 547 (690)
+..+. +..|||+|||..|.+...=- ... ++..++.+|.+++..||+||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~-----------------------------d~~els~~~Ar~ylrDvv~GLEYL 226 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPP-----------------------------DKPELSEQQARKYLRDVVLGLEYL 226 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCC-----------------------------CcccccHHHHHHHHHHHHHHHHHH
Confidence 88764 57999999999987643211 123 88999999999999999999
Q ss_pred hhcCCCCCCCCCCcEEecCCCCceEcCCCcccccccc-------------------cCcccCCC----CCCCCCcchhhH
Q 005572 548 HHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN-------------------VGERSENE----TCGPESDVYCFG 604 (690)
Q Consensus 548 H~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~-------------------~~e~~~~~----~~~~~~DVwSfG 604 (690)
|.++||||||||+|+||+++|++||+|||.+...... |||...++ ..+.+.||||+|
T Consensus 227 H~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalG 306 (576)
T KOG0585|consen 227 HYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALG 306 (576)
T ss_pred HhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhh
Confidence 9999999999999999999999999999997644111 55554432 356789999999
Q ss_pred HHHHHHHhCCCCCCch--HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 605 VILMELLTGKRGTDDC--VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 605 vvl~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
|+||.|+.|+.||-+- .+...++... .+.. .....+. -.+-+++++++++||+.|.+..+|....
T Consensus 307 VTLYCllfG~~PF~~~~~~~l~~KIvn~-----pL~f----P~~pe~~--e~~kDli~~lL~KdP~~Ri~l~~ik~Hp 373 (576)
T KOG0585|consen 307 VTLYCLLFGQLPFFDDFELELFDKIVND-----PLEF----PENPEIN--EDLKDLIKRLLEKDPEQRITLPDIKLHP 373 (576)
T ss_pred hhHHHhhhccCCcccchHHHHHHHHhcC-----cccC----CCccccc--HHHHHHHHHHhhcChhheeehhhheecc
Confidence 9999999999998651 1112222211 1111 1111111 1334566779999999999999987544
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=302.42 Aligned_cols=250 Identities=23% Similarity=0.318 Sum_probs=188.5
Q ss_pred HhccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCe
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKE 477 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~ 477 (690)
...+|.+.+.||+|+||.||+|... .+..||+|.++.... .....+.+|+..+++++||||+++++++...+.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999999742 245799998864432 123457789999999999999999999999999
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl 557 (690)
.++||||+++|+|.++++........ .......++..+..++.|++.||.|||+++++||||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~di 145 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAEN------------------NPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDL 145 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhcccccc------------------CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCC
Confidence 99999999999999999863211100 011234677888999999999999999999999999
Q ss_pred CCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCch
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDC 620 (690)
Q Consensus 558 k~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~ 620 (690)
||+||++++++.+|++|||+++.... .+||......++.++|||||||++|||++ |..||...
T Consensus 146 kp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~ 225 (288)
T cd05061 146 AARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL 225 (288)
T ss_pred ChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999864311 13444444567889999999999999999 78888652
Q ss_pred H-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 621 V-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 621 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
. +........+... ..+... ...+.+++.+||+.||++|||+.|+++.|+..
T Consensus 226 ~~~~~~~~~~~~~~~-----~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 226 SNEQVLKFVMDGGYL-----DQPDNC------PERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred CHHHHHHHHHcCCCC-----CCCCCC------CHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 2 1122222111111 111111 12456677789999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=297.64 Aligned_cols=239 Identities=25% Similarity=0.379 Sum_probs=191.4
Q ss_pred hccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.++|...+.||+|+||.||+|...++..+|||.+.... ...+++.+|+..+++++||||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 45678889999999999999998777889999987543 34578999999999999999999999999888999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++++|.+++... ....+++.++..++.|++.|+.|||+++++||||||+||+++
T Consensus 84 ~~~~L~~~i~~~--------------------------~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~ 137 (261)
T cd05034 84 SKGSLLDFLKSG--------------------------EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVG 137 (261)
T ss_pred CCCCHHHHHhcc--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEc
Confidence 999999999752 124688999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~ 628 (690)
+++.+|++|||+++..... +||......++.++|||||||++||+++ |+.||..... ......
T Consensus 138 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~ 217 (261)
T cd05034 138 ENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQV 217 (261)
T ss_pred CCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 9999999999997654211 3444434567889999999999999999 9999865321 111111
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
.... ....+... ...+.+++.+||+.+|++||++.|+.+.|+.
T Consensus 218 ~~~~-----~~~~~~~~------~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 218 ERGY-----RMPRPPNC------PEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred HcCC-----CCCCCCCC------CHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 1111 00111111 1245667788999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=316.02 Aligned_cols=271 Identities=22% Similarity=0.314 Sum_probs=192.7
Q ss_pred HHHHhccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcC-CCCccceeeEEe
Q 005572 402 LIAATSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLK-HPNLLPLAGYCI 473 (690)
Q Consensus 402 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~ 473 (690)
+....++|...+.||+|+||.||+|++. .+..||+|+++.... ...+.+.+|++++.++. ||||++++|+|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344456777889999999999999853 246799999975432 22346888999999997 999999999999
Q ss_pred cCCeeEEEEEecCCCCHhhhhhcCCCCCCCC------CC---CCCC----------------------CCCCCCC-----
Q 005572 474 AGKEKLVLLEFMANGDLHRWLHELPTGEPNV------ED---WSTD----------------------TWDHHPG----- 517 (690)
Q Consensus 474 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~------~~---~~~~----------------------~~~~~~~----- 517 (690)
..+..++|||||++|+|.+++++.+....+. .. .... .+...+.
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 9999999999999999999998643210000 00 0000 0000000
Q ss_pred ----------------------------------CCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 518 ----------------------------------AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 518 ----------------------------------~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
..........++|.+..+++.|++.||+|||+.+++||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 0000122346889999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH--HHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV--KWV 624 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~--~~~ 624 (690)
+++++.+||+|||+++..... +||......++.++|||||||++|||++ |..||.... +..
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~ 351 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQF 351 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHH
Confidence 999999999999998743210 3333334567889999999999999998 888986532 111
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
......+.. +..+...+ ..+.+++..||+.+|.+||+++||++.|+.+
T Consensus 352 ~~~~~~~~~-----~~~p~~~~------~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 352 YNAIKRGYR-----MAKPAHAS------DEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred HHHHHcCCC-----CCCCCCCC------HHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 222222211 11111111 2355667789999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.36 Aligned_cols=231 Identities=23% Similarity=0.290 Sum_probs=173.8
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|+..+.||+|+||.||+|+. .++..||||++..... ...+.+.+|+++++.++|+||+++++++...+..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 344567899999999999984 5688999999864432 22456889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+.. ..++..+..++.||+.||+|||+++++||||||+|||++
T Consensus 155 ~~~~L~~~~--------------------------------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 202 (353)
T PLN00034 155 DGGSLEGTH--------------------------------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN 202 (353)
T ss_pred CCCcccccc--------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 999985432 234567788999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCc--hHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDD--CVKWV 624 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~--~~~~~ 624 (690)
+++.+||+|||+++..... +||.... ...+.++|||||||++|||++|+.||.. ..+|.
T Consensus 203 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 282 (353)
T PLN00034 203 SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA 282 (353)
T ss_pred CCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH
Confidence 9999999999998753211 3443311 1234689999999999999999999863 12222
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
........ .. .+......+ ..+.+++..||+.||++|||+.|+++.
T Consensus 283 ~~~~~~~~-~~--~~~~~~~~~------~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 283 SLMCAICM-SQ--PPEAPATAS------REFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred HHHHHHhc-cC--CCCCCCccC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11111100 00 011111111 134556677999999999999999875
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=316.68 Aligned_cols=178 Identities=21% Similarity=0.286 Sum_probs=154.8
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
..+|...+.||+|+||.||++. ..++..||+|... .+.+.+|++++++++||||+++++++......++|+||
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3579999999999999999998 5668899999753 24568899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+. ++|.+++.. ...+++.+++.++.|++.||+|||+++|+||||||+|||+
T Consensus 165 ~~-~~L~~~l~~----------------------------~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll 215 (391)
T PHA03212 165 YK-TDLYCYLAA----------------------------KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI 215 (391)
T ss_pred CC-CCHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE
Confidence 95 699988865 2357899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc---------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 565 AESLEPKIAGFGLRNIGVK---------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~---------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
+.++.+||+|||+++.... .+||......+++++|||||||++|||+||+.|+.
T Consensus 216 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 216 NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 9999999999999864211 14565555678999999999999999999998753
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=302.97 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=191.5
Q ss_pred hccCCCCceeccCCCccEEEEEcCC-----CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEec-CCee
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPG-----ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIA-GKEK 478 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~ 478 (690)
.++|...+.||+|+||.||+|.... +..|++|++..... ...+.+.+|+..+++++||||+++++++.. ....
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4567788999999999999999654 67899999864322 234567889999999999999999999876 4678
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++++||+++|+|.+++...+.... .....+++.++..++.|++.||+|||+.+++|||||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~--------------------~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~ 144 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEA--------------------NNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIA 144 (280)
T ss_pred EEEEEcCCCCcHHHHHHhcccccc--------------------ccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccC
Confidence 899999999999999976321100 123568999999999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV 621 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~ 621 (690)
|+||++++++.+||+|||+++.... .+||......++.++|||||||++||+++ |+.||.+..
T Consensus 145 p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 145 ARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred HhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 9999999999999999999874321 13444444567889999999999999999 999997632
Q ss_pred HH-HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 622 KW-VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 622 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
.. .......+. ........+ ..+.+++.+||+.||++|||+.|+++.|+++..
T Consensus 225 ~~~~~~~~~~~~-----~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 225 PFEMAAYLKDGY-----RLAQPINCP------DELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred HHHHHHHHHcCC-----CCCCCCcCC------HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 21 112222111 001111111 134567788999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=298.36 Aligned_cols=242 Identities=23% Similarity=0.276 Sum_probs=178.1
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCC-----eeEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK-----EKLVL 481 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lv 481 (690)
.|...+++|.|+||.||+|.+ .++..||||+.-..+ +.--+|+++|++++|||||+|.-++.... ...+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 455568999999999999994 557899999885433 23457899999999999999998886532 23499
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
||||+. +|.++++... .....++...+.-+..|+.+||.|||+.+|+||||||.|
T Consensus 101 leymP~-tL~~~~r~~~------------------------~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqN 155 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYT------------------------RANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQN 155 (364)
T ss_pred HHhchH-HHHHHHHHHh------------------------hcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChhe
Confidence 999987 9999998521 123457777888899999999999999999999999999
Q ss_pred EEecCC-CCceEcCCCcccccccc---------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCc--hHHHH
Q 005572 562 ILLAES-LEPKIAGFGLRNIGVKN---------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDD--CVKWV 624 (690)
Q Consensus 562 iLl~~~-~~~kl~DfGla~~~~~~---------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~--~~~~~ 624 (690)
+|+|.+ |.+||||||-|+....+ --|++|| ..|+.+.||||.|||+.||+-|++-|.+ ..+..
T Consensus 156 lLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL 235 (364)
T KOG0658|consen 156 LLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQL 235 (364)
T ss_pred EEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHH
Confidence 999965 99999999999987654 2244444 4899999999999999999999998765 22222
Q ss_pred HHHHHh-cC------------CCCccccccccCCCC---CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 625 RKLVKE-GA------------GGDALDFRLKLGSGD---SVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 625 ~~~~~~-~~------------~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..+++. |. ..+.-.+.+...... .-..-.+.++++.++++++|.+|.++.|++.
T Consensus 236 ~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 236 VEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred HHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 222221 00 001111222111100 0111124567778899999999999999875
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=301.61 Aligned_cols=251 Identities=21% Similarity=0.254 Sum_probs=185.8
Q ss_pred CCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 409 FGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
|...+.||+|+||.||+|... .+..||+|+++..... ..+.+.+|+.+++.++||||+++++++...+..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 455678999999999999853 2468999999754321 235678899999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
+||+++++|.+++........ ... ..........+++..+..++.|++.||+|||+++++||||||+|
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~-~~~-----------~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~N 154 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSD-VGS-----------TDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRN 154 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCcc-ccc-----------cccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhh
Confidence 999999999999975221100 000 00001123468899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KW 623 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~ 623 (690)
|++++++.+||+|||+++..... +||......++.++|||||||++|||++ |..||.... ..
T Consensus 155 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~ 234 (283)
T cd05091 155 VLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD 234 (283)
T ss_pred eEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 99999999999999987643211 3444334577889999999999999998 888876522 12
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
..+........ ..+... .. .+.+++..||+.+|++||++.||++.|+.
T Consensus 235 ~~~~i~~~~~~-----~~~~~~---~~---~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 235 VIEMIRNRQVL-----PCPDDC---PA---WVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHHHHHcCCcC-----CCCCCC---CH---HHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 22222222111 111111 11 24567778999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=311.36 Aligned_cols=269 Identities=23% Similarity=0.274 Sum_probs=190.1
Q ss_pred hccCCCCceeccCCCccEEEEEc------CCCcEEEEEEeeccCCC-CHHHHHHHHHHHHhc-CCCCccceeeEEecC-C
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL------PGELHVAIKVLDNAKGI-DHDDAVAMFDELSRL-KHPNLLPLAGYCIAG-K 476 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~-~ 476 (690)
.++|+..+.||+|+||.||+|.. .++..||||+++..... ..+.+.+|+.++.++ +||||++++++|... .
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 35688889999999999999973 34678999999754322 235678899999999 689999999988754 4
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCC--------------C------------CCCCCCCC-------------CC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVED--------------W------------STDTWDHH-------------PG 517 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~--------------~------------~~~~~~~~-------------~~ 517 (690)
..++|||||++|+|.++++........... + ....|... ..
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 678999999999999999763211000000 0 00000000 00
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCcccccccc-------------
Q 005572 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN------------- 584 (690)
Q Consensus 518 ~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~------------- 584 (690)
..........++|.++..++.|+++||+|||+++++||||||+||++++++++||+|||+++.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 0000001235889999999999999999999999999999999999999999999999998753211
Q ss_pred ---cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH--HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHH
Q 005572 585 ---VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV--KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRV 658 (690)
Q Consensus 585 ---~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 658 (690)
+||......++.++|||||||++|||++ |..||.... .........+... ..+... . ..+.++
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~--~----~~~~~~ 314 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-----RAPDYT--T----PEMYQT 314 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-----CCCCCC--C----HHHHHH
Confidence 3444444567889999999999999997 899986521 1122222222111 111111 1 135677
Q ss_pred HhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 659 GYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 659 ~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
+..||+.||++|||+.||++.|+.+.+
T Consensus 315 ~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 315 MLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 888999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=299.24 Aligned_cols=237 Identities=26% Similarity=0.323 Sum_probs=173.9
Q ss_pred eeccCCCccEEEEEcCC---CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCC
Q 005572 414 LLAEGRCGPVYRAVLPG---ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGD 489 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 489 (690)
.||+|+||.||+|...+ ...+|+|.+..... .....+.+|++.++.++||||++++|+|......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 58999999999997432 34688887754322 223567889999999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCC
Q 005572 490 LHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLE 569 (690)
Q Consensus 490 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~ 569 (690)
|.+++...+.. .....++.....++.|++.||+|||+.+++||||||+|||++++++
T Consensus 82 L~~~l~~~~~~-----------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~ 138 (269)
T cd05042 82 LKNYLRSNRGM-----------------------VAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS 138 (269)
T ss_pred HHHHHHhcccc-----------------------ccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc
Confidence 99999763210 1123567788999999999999999999999999999999999999
Q ss_pred ceEcCCCccccccc----------------ccCcccC-------CCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH--
Q 005572 570 PKIAGFGLRNIGVK----------------NVGERSE-------NETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-- 623 (690)
Q Consensus 570 ~kl~DfGla~~~~~----------------~~~e~~~-------~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-- 623 (690)
+||+|||+++.... .+||... ...++.++|||||||++|||++ |..||......
T Consensus 139 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 218 (269)
T cd05042 139 VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV 218 (269)
T ss_pred EEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHH
Confidence 99999999864211 0233221 1256789999999999999999 78888753221
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
....... ......++......+. ...+++..|| .||++|||+.||++.|.
T Consensus 219 ~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 219 LKQVVRE-QDIKLPKPQLDLKYSD------RWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred HHHHhhc-cCccCCCCcccccCCH------HHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 1222221 1112222222222211 2233455688 59999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=298.89 Aligned_cols=239 Identities=24% Similarity=0.407 Sum_probs=186.5
Q ss_pred ccCCCCceeccCCCccEEEEEcC----CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP----GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
.+|+..+.||+|+||.||+|+.. .+..+|+|.++.... ...+.+..|+..+++++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777889999999999999842 234799999864322 2245788899999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|.+++... ...+++.++..++.|++.||.|||+.+++||||||+|
T Consensus 84 ~e~~~~~~L~~~~~~~---------------------------~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~n 136 (267)
T cd05066 84 TEYMENGSLDAFLRKH---------------------------DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN 136 (267)
T ss_pred EEcCCCCCHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhc
Confidence 9999999999999751 2357899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK- 622 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~- 622 (690)
|+++.++.+|++|||+++..... +||......++.++|||||||++||+++ |..||.+...
T Consensus 137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~ 216 (267)
T cd05066 137 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ 216 (267)
T ss_pred EEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH
Confidence 99999999999999998653211 3343333567889999999999999886 9999875321
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
........+. ........ . ..+.+++.+||+.+|++||+|.++++.|+++
T Consensus 217 ~~~~~~~~~~-----~~~~~~~~---~---~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 217 DVIKAIEEGY-----RLPAPMDC---P---AALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred HHHHHHhCCC-----cCCCCCCC---C---HHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 1122222211 11111111 1 1345667789999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=295.44 Aligned_cols=232 Identities=23% Similarity=0.336 Sum_probs=181.8
Q ss_pred ceeccCCCccEEEEEcCC----CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVLPG----ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|++.. +..+|+|.+..... ...+++.+|++.+++++||||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 369999999999997422 26899999875543 23457889999999999999999999876 4568999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++..+..++.|++.||+|||+.+++||||||+||+++++
T Consensus 80 ~~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~ 131 (257)
T cd05060 80 GPLLKYLKK----------------------------RREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNR 131 (257)
T ss_pred CcHHHHHHh----------------------------CCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCC
Confidence 999999975 1257899999999999999999999999999999999999999
Q ss_pred CCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHH
Q 005572 568 LEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLV 628 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~ 628 (690)
+.+||+|||+++..... +||......++.++|||||||++|||++ |..||..... ......
T Consensus 132 ~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 132 HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred CcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 99999999998643211 3444444567889999999999999998 9999876322 122222
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
...... ..+...+ ..+.+++.+||+.+|++||++.++++.|+++.
T Consensus 212 ~~~~~~-----~~~~~~~------~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 212 ESGERL-----PRPEECP------QEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred HcCCcC-----CCCCCCC------HHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 222111 0111111 24556778899999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=297.34 Aligned_cols=238 Identities=25% Similarity=0.291 Sum_probs=175.4
Q ss_pred eeccCCCccEEEEEcCC---CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCC
Q 005572 414 LLAEGRCGPVYRAVLPG---ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGD 489 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~~~---~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 489 (690)
.||+|+||.||+|.+.+ +..+|+|.++.... .....+.+|+..+++++||||++++|++.+....++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 58999999999998543 45789998865432 233468889999999999999999999999899999999999999
Q ss_pred HhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCC
Q 005572 490 LHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLE 569 (690)
Q Consensus 490 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~ 569 (690)
|.++++..+.. .....++..+..++.|++.||+|||+.+++||||||+||+++.+++
T Consensus 82 L~~~l~~~~~~-----------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~ 138 (269)
T cd05087 82 LKGYLRSCRKA-----------------------ELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT 138 (269)
T ss_pred HHHHHHHhhhc-----------------------ccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc
Confidence 99999763210 1224567788899999999999999999999999999999999999
Q ss_pred ceEcCCCcccccccc------------cCcccCCC-----------CCCCCCcchhhHHHHHHHHh-CCCCCCchHHHH-
Q 005572 570 PKIAGFGLRNIGVKN------------VGERSENE-----------TCGPESDVYCFGVILMELLT-GKRGTDDCVKWV- 624 (690)
Q Consensus 570 ~kl~DfGla~~~~~~------------~~e~~~~~-----------~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~~- 624 (690)
+|++|||+++..... ..+.+||. .++.++|||||||++|||++ |+.||.......
T Consensus 139 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~ 218 (269)
T cd05087 139 VKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218 (269)
T ss_pred EEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH
Confidence 999999998642211 12333331 24789999999999999996 999987532211
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
.............++.+....+. .+.+++..|| .+|++|||+.||++.|+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~------~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 219 LTYTVREQQLKLPKPRLKLPLSD------RWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred HHHHhhcccCCCCCCccCCCCCh------HHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11111111111222222211111 2334556799 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=296.57 Aligned_cols=242 Identities=22% Similarity=0.284 Sum_probs=185.7
Q ss_pred cCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHH--hcCCCCccceeeEEecCC----eeEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELS--RLKHPNLLPLAGYCIAGK----EKLVL 481 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~g~~~~~~----~~~lv 481 (690)
.....+.||+|+||+||+|.|+++ .||||++... +.+.+.+|.++++ .++|+||+.+++.-..+. ++|||
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wrGe-~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLv 287 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWRGE-DVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLV 287 (513)
T ss_pred eeEEEEEecCccccceeeccccCC-ceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEe
Confidence 344567899999999999999865 7999999653 4567888888876 459999999998865433 68999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc--------CCC
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV--------GST 553 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~--------~~i 553 (690)
.||-+.|||+|||.+ ..++....+++++.+|.||+|||-. .|.
T Consensus 288 TdYHe~GSL~DyL~r-----------------------------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIA 338 (513)
T KOG2052|consen 288 TDYHEHGSLYDYLNR-----------------------------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIA 338 (513)
T ss_pred eecccCCcHHHHHhh-----------------------------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhh
Confidence 999999999999985 3578889999999999999999962 456
Q ss_pred CCCCCCCcEEecCCCCceEcCCCcccccccc------------------cCcccCCC------CCCCCCcchhhHHHHHH
Q 005572 554 HGHLVTSSILLAESLEPKIAGFGLRNIGVKN------------------VGERSENE------TCGPESDVYCFGVILME 609 (690)
Q Consensus 554 HrDlk~~NiLl~~~~~~kl~DfGla~~~~~~------------------~~e~~~~~------~~~~~~DVwSfGvvl~e 609 (690)
|||||+.|||+.+++...|+|+|||-..... |||+..+. ..-..+||||||.|+||
T Consensus 339 HRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWE 418 (513)
T KOG2052|consen 339 HRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWE 418 (513)
T ss_pred ccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHH
Confidence 9999999999999999999999998543221 45554442 11236999999999999
Q ss_pred HHhC----------CCCCCchH------HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 610 LLTG----------KRGTDDCV------KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 610 l~tg----------~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
+..+ +.||.+.+ +.+++.+- .+.+.|.++... ...+.+..+.++|..||..+|..|-|+
T Consensus 419 iarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVC----v~~~RP~ipnrW-~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 419 IARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVC----VQKLRPNIPNRW-KSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHHHhhcCCEehhhcCCcccCCCCCCCHHHHhccee----ecccCCCCCccc-ccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 8762 35776532 22332222 223333333322 244667778899999999999999999
Q ss_pred HHHHHHHhccCCCC
Q 005572 674 QQVLGLLKDIRPSA 687 (690)
Q Consensus 674 ~ev~~~L~~i~~~~ 687 (690)
--|-+.|.++.+.+
T Consensus 494 LriKKtl~~l~~~~ 507 (513)
T KOG2052|consen 494 LRIKKTLAKLSNSD 507 (513)
T ss_pred HHHHHHHHHHhcCh
Confidence 99999998887554
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=303.84 Aligned_cols=241 Identities=26% Similarity=0.349 Sum_probs=188.2
Q ss_pred hccCCCCceeccCCCccEEEEEc------CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhc-CCCCccceeeEEecCCe
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL------PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKE 477 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~ 477 (690)
.++|...+.||+|+||.||++.. ..+..+|+|+++.... ...+.+.+|++.++++ +||||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 34688889999999999999973 1245799999865432 2235688899999999 79999999999999999
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl 557 (690)
.++||||+++|+|.++++... ...+++.++..++.|++.||+|||+++++|+||
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~--------------------------~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 167 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKR--------------------------ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 999999999999999997521 233889999999999999999999999999999
Q ss_pred CCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCch
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDC 620 (690)
Q Consensus 558 k~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~ 620 (690)
||+|||++.++.+|++|||+++.... .+||......++.++|||||||++|||++ |..||...
T Consensus 168 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 168 AARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 99999999999999999999874321 13444444567889999999999999998 99998653
Q ss_pred HH--HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 621 VK--WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 621 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.. ...+....+... ..+... . ..+.+++.+||+.+|++|||+.|+++.|++.
T Consensus 248 ~~~~~~~~~~~~~~~~-----~~~~~~---~---~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 248 PVDSKFYKLIKEGYRM-----AQPEHA---P---AEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred CchHHHHHHHHcCCcC-----CCCCCC---C---HHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 21 122222222110 011111 1 1455677789999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=303.23 Aligned_cols=255 Identities=24% Similarity=0.329 Sum_probs=188.2
Q ss_pred ccCCCCceeccCCCccEEEEEcCC-----------------CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccce
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG-----------------ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPL 468 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~-----------------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l 468 (690)
.+|...+.||+|+||.||+|+... +..||+|.+..... ...+++.+|++++++++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 467888999999999999987432 24689999865432 234578889999999999999999
Q ss_pred eeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 005572 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH 548 (690)
Q Consensus 469 ~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 548 (690)
++++...+..++|+||+++++|.+++.+........ ......+++..+..++.|++.||+|||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~i~~al~~LH 147 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGL-----------------ACNSKSLSFSTLLYMATQIASGMRYLE 147 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc-----------------cccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999999999999997632111000 112346899999999999999999999
Q ss_pred hcCCCCCCCCCCcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh
Q 005572 549 HVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT 612 (690)
Q Consensus 549 ~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t 612 (690)
+.+++||||||+||++++++.+||+|||+++..... +||......++.++|||||||++|||++
T Consensus 148 ~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~ 227 (296)
T cd05051 148 SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227 (296)
T ss_pred HcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHh
Confidence 999999999999999999999999999998743211 3443333578899999999999999998
Q ss_pred --CCCCCCchH-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 613 --GKRGTDDCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 613 --g~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
|..||.... ........................ ... .++.+++.+||+.||++|||+.||++.|++
T Consensus 228 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 228 LCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPP-NCP---KDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred cCCCCCCCCcChHHHHHHHHhccccccccccCCCcc-CCC---HHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 677876522 111111111100000000000000 011 245677888999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=303.22 Aligned_cols=236 Identities=19% Similarity=0.164 Sum_probs=181.6
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
|+..+.||+|+||.||++.. .++..||+|.+..... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 66778999999999999984 5688999999865321 1234567899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++|+|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 82 ~~~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~ 135 (285)
T cd05605 82 MNGGDLKFHIYNM--------------------------GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL 135 (285)
T ss_pred cCCCcHHHHHHhc--------------------------CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE
Confidence 9999999988641 12358899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH-HHHHHh
Q 005572 565 AESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV-RKLVKE 630 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~-~~~~~~ 630 (690)
++++.+||+|||++...... +||......++.++|||||||++|||++|+.||....... .+....
T Consensus 136 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~ 215 (285)
T cd05605 136 DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER 215 (285)
T ss_pred CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH
Confidence 99999999999998753211 4555555678889999999999999999999997522111 011111
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
..... ........+ ..+.+++..||+.||++|| ++.++++
T Consensus 216 ~~~~~--~~~~~~~~~------~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 216 RVKED--QEEYSEKFS------EAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred Hhhhc--ccccCcccC------HHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00000 001111111 1345667789999999999 7888855
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=325.40 Aligned_cols=236 Identities=18% Similarity=0.152 Sum_probs=182.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCC-CcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPG-ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.|...+.||+|+||.||+|. ..+ +..||+|.+..........+.+|++.++.++|||||++++++...+..|+||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 37778899999999999997 334 6778888775443333456778999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.++++... .....+++..+..++.||+.||.|||+++++||||||+|||++
T Consensus 148 ~gg~L~~~l~~~~------------------------~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~ 203 (478)
T PTZ00267 148 SGGDLNKQIKQRL------------------------KEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLM 203 (478)
T ss_pred CCCCHHHHHHHHH------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEEC
Confidence 9999999987521 1134578889999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~ 628 (690)
.++.+||+|||+++..... +||......++.++|||||||++|||++|+.||..... ......
T Consensus 204 ~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~ 283 (478)
T PTZ00267 204 PTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283 (478)
T ss_pred CCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999998753211 34444456788999999999999999999999875321 111111
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..+... ..+...+ ..+.+++..||+.||++||++.+++.
T Consensus 284 ~~~~~~-----~~~~~~s------~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 284 LYGKYD-----PFPCPVS------SGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred HhCCCC-----CCCccCC------HHHHHHHHHHhccChhhCcCHHHHHh
Confidence 111111 0111111 13455667799999999999999864
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=299.67 Aligned_cols=238 Identities=22% Similarity=0.372 Sum_probs=185.7
Q ss_pred cCCCCceeccCCCccEEEEEcC-CC---cEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GE---LHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
+|+..+.||+|+||.||+|... ++ ..||+|.++... ....+++..|++.++.++||||+++++++......++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4667789999999999999853 23 369999986542 223467889999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.+++... ...+++.++..++.|++.||.|||+.+++||||||+||
T Consensus 85 e~~~~~~L~~~l~~~---------------------------~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 85 EFMENGALDSFLRQN---------------------------DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred ecCCCCcHHHHHhhC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 999999999999751 23578999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc-------------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN-------------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK 622 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~-------------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~ 622 (690)
+++.++.+|++|||+++..... +||......++.++|||||||++||+++ |..||.....
T Consensus 138 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 138 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred EEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 9999999999999987643211 3444434567889999999999999887 9999865322
Q ss_pred -HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 623 -WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 623 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.......... ........+ ..+.+++..||+.+|++||++.+|++.|+.+
T Consensus 218 ~~~~~~i~~~~-----~~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 218 QDVINAIEQDY-----RLPPPMDCP------TALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred HHHHHHHHcCC-----cCCCcccCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 1222222111 111111111 1345667789999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=300.03 Aligned_cols=229 Identities=20% Similarity=0.314 Sum_probs=174.6
Q ss_pred eeccCCCccEEEEEcCC--------CcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 414 LLAEGRCGPVYRAVLPG--------ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.||+|+||.||+|.... ...+|+|.+........+.+.+|+..++.++||||+++++++...+..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 68999999999998532 2348888876544344567888999999999999999999999989999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.++++.. ...+++..+..++.||+.||+|||+++++||||||+||+++
T Consensus 82 ~~g~L~~~l~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~ 134 (258)
T cd05078 82 KFGSLDTYLKKN---------------------------KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLI 134 (258)
T ss_pred CCCcHHHHHhcC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEe
Confidence 999999999752 23578999999999999999999999999999999999998
Q ss_pred CCCC--------ceEcCCCccccccc------ccCcccCC-----CCCCCCCcchhhHHHHHHHHhCC-CCCCchHHHHH
Q 005572 566 ESLE--------PKIAGFGLRNIGVK------NVGERSEN-----ETCGPESDVYCFGVILMELLTGK-RGTDDCVKWVR 625 (690)
Q Consensus 566 ~~~~--------~kl~DfGla~~~~~------~~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~-~p~~~~~~~~~ 625 (690)
.++. +|++|||++..... ..+|.+|| ..++.++|||||||++|||++|. .|+........
T Consensus 135 ~~~~~~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 135 REEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred cccccccCCCceEEecccccccccCCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 8765 59999998764332 12333443 34688999999999999999995 55544222111
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
...... . ..++... . ..+.+++..||+.||++|||++|+++.|.
T Consensus 215 ~~~~~~-~-----~~~~~~~--~----~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 215 LQFYED-R-----HQLPAPK--W----TELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred HHHHHc-c-----ccCCCCC--c----HHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 111111 0 1111111 1 23556777899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=300.19 Aligned_cols=243 Identities=22% Similarity=0.234 Sum_probs=183.1
Q ss_pred HHHhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 403 IAATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 403 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
..++..+.....||+|+||.||+|+ ..++..||+|.+........+.+.+|++++++++|+||++++|++...+..++|
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEE
Confidence 3455666667899999999999998 456788999998755444456788999999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
+||+++++|.++++... .....++..+..++.|++.||+|||+.+++||||||+|
T Consensus 84 ~e~~~~~~L~~~l~~~~-------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~n 138 (268)
T cd06624 84 MEQVPGGSLSALLRSKW-------------------------GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138 (268)
T ss_pred EecCCCCCHHHHHHHhc-------------------------ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 99999999999997521 01112677888999999999999999999999999999
Q ss_pred EEecC-CCCceEcCCCccccccc----------c----cCcccCC--CCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH
Q 005572 562 ILLAE-SLEPKIAGFGLRNIGVK----------N----VGERSEN--ETCGPESDVYCFGVILMELLTGKRGTDDCVKWV 624 (690)
Q Consensus 562 iLl~~-~~~~kl~DfGla~~~~~----------~----~~e~~~~--~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~ 624 (690)
|+++. ++.+||+|||++..... . +||.... ..++.++|||||||++|||++|+.||.+.....
T Consensus 139 il~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~ 218 (268)
T cd06624 139 VLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ 218 (268)
T ss_pred EEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh
Confidence 99986 67999999998764321 1 3443322 237789999999999999999999987532111
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.......... ..+.++... . ..+.+++.+||+.+|++|||+.|+++
T Consensus 219 ~~~~~~~~~~--~~~~~~~~~---~---~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 219 AAMFKVGMFK--IHPEIPESL---S---AEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred hhHhhhhhhc--cCCCCCccc---C---HHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 1111110000 011111111 1 13445677899999999999999976
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=297.13 Aligned_cols=249 Identities=26% Similarity=0.349 Sum_probs=183.9
Q ss_pred ceeccCCCccEEEEEcCC-Cc--EEEEEEeeccC-CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVLPG-EL--HVAIKVLDNAK-GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~-~~--~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+..+ +. .+|+|.++... ....+.+.+|++.+.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999643 43 57888886432 22345788899999999 799999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.++++..+...... ...........+++.++..++.|++.||+|||+.+++||||||+||+++++
T Consensus 81 ~~L~~~i~~~~~~~~~~------------~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~ 148 (270)
T cd05047 81 GNLLDFLRKSRVLETDP------------AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN 148 (270)
T ss_pred CcHHHHHHhcccccccc------------ccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCC
Confidence 99999998643211100 000011123468899999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc-------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HHHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK-------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KWVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~-------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~~~~~~~~~~ 632 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++ |..||.... ...........
T Consensus 149 ~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~ 228 (270)
T cd05047 149 YVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 228 (270)
T ss_pred CeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC
Confidence 9999999999752211 13443334567889999999999999997 999986521 11111111111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
. .+ ..... ...+.+++.+||+.||.+|||+.|+++.|+++-
T Consensus 229 ~---~~--~~~~~------~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 229 R---LE--KPLNC------DDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred C---CC--CCCcC------CHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0 01 11111 113557788899999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=298.77 Aligned_cols=238 Identities=19% Similarity=0.237 Sum_probs=182.4
Q ss_pred HhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeEEecC------C
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAG------K 476 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~------~ 476 (690)
+++.|...+.||+|+||.||+|.. .++..+|+|.+.... .....+.+|+.++.++ +||||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 456677788999999999999984 568899999986543 3456788999999998 699999999998753 4
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..++||||+++|+|.+++... ....++|..+..++.|++.||+|||+++++|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--------------------------~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~d 136 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT--------------------------KGNTLKEEWIAYICREILRGLSHLHQHKVIHRD 136 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc--------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCC
Confidence 588999999999999999752 124588999999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc--------------cCcccC-----CCCCCCCCcchhhHHHHHHHHhCCCCC
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSE-----NETCGPESDVYCFGVILMELLTGKRGT 617 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~-----~~~~~~~~DVwSfGvvl~el~tg~~p~ 617 (690)
|||+||++++++.+||+|||++...... +||... ...++.++|||||||++|||++|+.||
T Consensus 137 l~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~ 216 (272)
T cd06637 137 IKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216 (272)
T ss_pred CCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCc
Confidence 9999999999999999999998643211 344332 235778999999999999999999998
Q ss_pred CchHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 618 DDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 618 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.+............... ........ . ..+.+++.+||+.||.+|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~---~~~~~~~~---~---~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 217 CDMHPMRALFLIPRNPA---PRLKSKKW---S---KKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred cccCHHHHHHHHhcCCC---CCCCCCCc---C---HHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 75322211111111000 00000111 1 13456777899999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=300.52 Aligned_cols=260 Identities=26% Similarity=0.330 Sum_probs=191.5
Q ss_pred hccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCee
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 478 (690)
..+|+..+.||+|+||.||+|... ++..+|+|.+..... ...+++.+|++.+++++||||++++++|...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 356888899999999999999853 467899999864422 2245688899999999999999999999999999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++||||+++|+|.+++............ ....+..........+++.+++.++.|++.||+|||+.+++|||||
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~------~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~ 157 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLS------HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLA 157 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCcccccccc------ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccccc
Confidence 9999999999999999863221100000 0000011111233468899999999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV 621 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~ 621 (690)
|+||++++++.+||+|||+++..... +||......++.++|||||||++|||++ |..||....
T Consensus 158 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 158 TRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred HhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999997642110 2333333577889999999999999998 888886532
Q ss_pred -HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 622 -KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 622 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
.........+.... .+.. ...++.+++.+||+.||++|||+.|+++.|++
T Consensus 238 ~~~~~~~~~~~~~~~-----~~~~------~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 HEEVIYYVRDGNVLS-----CPDN------CPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHHHhcCCCCC-----CCCC------CCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 22222222221110 0111 11246677889999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=294.56 Aligned_cols=236 Identities=24% Similarity=0.375 Sum_probs=187.9
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.+|...+.||+|+||.||+|.+..+..+|+|.+.... ....++.+|++.+++++||||+++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 3566778999999999999997767789999886433 345678999999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++... ...+++..+..++.|++.|++|||+.+++||||||+||+++.
T Consensus 83 ~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~ 135 (256)
T cd05112 83 HGCLSDYLRAQ---------------------------RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGE 135 (256)
T ss_pred CCcHHHHHHhC---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcC
Confidence 99999998751 235788999999999999999999999999999999999999
Q ss_pred CCCceEcCCCccccccc---------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-HHHHHHHH
Q 005572 567 SLEPKIAGFGLRNIGVK---------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-KWVRKLVK 629 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~---------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~~~~~~~~ 629 (690)
++.+||+|||+++.... .+||......++.++|||||||++|||++ |+.||.... ........
T Consensus 136 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05112 136 NQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETIN 215 (256)
T ss_pred CCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHh
Confidence 99999999998764321 13444444577889999999999999998 899986421 11222222
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
.+. ....+.. . ...+.+++.+||+.+|++|||+.|+++.|.
T Consensus 216 ~~~--~~~~~~~---~------~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~ 256 (256)
T cd05112 216 AGF--RLYKPRL---A------SQSVYELMQHCWKERPEDRPSFSLLLHQLA 256 (256)
T ss_pred CCC--CCCCCCC---C------CHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence 111 1111111 1 124667788999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=304.38 Aligned_cols=258 Identities=26% Similarity=0.310 Sum_probs=192.4
Q ss_pred hccCCCCceeccCCCccEEEEEcC--------CCcEEEEEEeeccC-CCCHHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLP--------GELHVAIKVLDNAK-GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAG 475 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 475 (690)
.++|...+.||+|+||.||+++.. ....+|+|.++... .....++.+|++.+..+ +||||++++++|...
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 356888899999999999999742 13469999987542 22345678899999999 799999999999999
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
+..++||||+++|+|.+++...+.... +.+.. ........++|.++++++.|++.||+|||+++++||
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~--~~~~~----------~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 164 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGM--EYCYN----------PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHR 164 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCccc--ccccc----------cccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 999999999999999999986432110 00000 000123468999999999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCC
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTD 618 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~ 618 (690)
||||+||+++.++.+||+|||+++.... .+||......++.++|||||||++|||++ |..||.
T Consensus 165 dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 165 DLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred cccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999999999864321 13444434567889999999999999998 888886
Q ss_pred chH-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCC
Q 005572 619 DCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 619 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
... +............ ..+... ...+.+++..||+.+|++||||.||++.|+++...
T Consensus 245 ~~~~~~~~~~~~~~~~~-----~~~~~~------~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 245 GVPVEELFKLLKEGHRM-----DKPSNC------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred cCCHHHHHHHHHcCCCC-----CCCCcC------CHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 522 2222222222111 111111 12445667789999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=307.31 Aligned_cols=229 Identities=22% Similarity=0.210 Sum_probs=176.2
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHH---HhcCCCCccceeeEEecCCeeEEE
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDEL---SRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l---~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
|...+.||+|+||.||+|.. .++..||||+++... ....+.+.+|.+++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 45678999999999999984 568899999997532 12234566676654 567899999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|..++++ ..+++..+..++.|++.||+|||+.+++||||||+|
T Consensus 81 ~E~~~~~~L~~~~~~-----------------------------~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~N 131 (324)
T cd05589 81 MEYAAGGDLMMHIHT-----------------------------DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDN 131 (324)
T ss_pred EcCCCCCcHHHHhhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHH
Confidence 999999999988754 358899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRK 626 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~ 626 (690)
|++++++.+||+|||+++.... . +||......++.++|||||||++|||++|+.||.... .....
T Consensus 132 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~ 211 (324)
T cd05589 132 LLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD 211 (324)
T ss_pred eEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999998764211 1 4555555678899999999999999999999987522 11111
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
....... ..+...+ . .+.+++.+||+.||++|| ++.++++
T Consensus 212 ~i~~~~~------~~p~~~~---~---~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 212 SIVNDEV------RYPRFLS---R---EAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred HHHhCCC------CCCCCCC---H---HHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 1211111 1111111 1 234566789999999999 5666654
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=314.25 Aligned_cols=185 Identities=18% Similarity=0.172 Sum_probs=159.6
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||+|+||.||+|+ ..++..||+|+++.... .....+.+|+.++.+++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 367888999999999999998 45688999999965321 22356778999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
|||++|+|.+++.+ ...+++.++..++.|++.||+|||+++++||||||+||
T Consensus 81 E~~~gg~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI 132 (363)
T cd05628 81 EFLPGGDMMTLLMK----------------------------KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL 132 (363)
T ss_pred cCCCCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence 99999999999975 23588999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccccc-------------------------------------------------ccCcccCCCC
Q 005572 563 LLAESLEPKIAGFGLRNIGVK-------------------------------------------------NVGERSENET 593 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~-------------------------------------------------~~~e~~~~~~ 593 (690)
|++.++.+||+|||+++.... .+||......
T Consensus 133 Li~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~ 212 (363)
T cd05628 133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG 212 (363)
T ss_pred EECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC
Confidence 999999999999999763210 1444444457
Q ss_pred CCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 594 CGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 594 ~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
++.++|||||||++|||++|+.||..
T Consensus 213 ~~~~~DvwSlGvil~ell~G~~Pf~~ 238 (363)
T cd05628 213 YNKLCDWWSLGVIMYEMLIGYPPFCS 238 (363)
T ss_pred CCCchhhhhhHHHHHHHHhCCCCCCC
Confidence 88999999999999999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=316.06 Aligned_cols=237 Identities=18% Similarity=0.155 Sum_probs=179.0
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
.|...+.||+|+||.||+|+ ..++..+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57778899999999999998 56688999999965432 223567889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+|+||||||+|||
T Consensus 82 ~~~gg~L~~~l~~----------------------------~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nil 133 (381)
T cd05626 82 YIPGGDMMSLLIR----------------------------MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL 133 (381)
T ss_pred cCCCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEE
Confidence 9999999999975 235788888999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccc---------------------------------------------------------cc--
Q 005572 564 LAESLEPKIAGFGLRNIGV---------------------------------------------------------KN-- 584 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~---------------------------------------------------------~~-- 584 (690)
++.++++||+|||+++... ..
T Consensus 134 i~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (381)
T cd05626 134 IDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPN 213 (381)
T ss_pred ECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCcc
Confidence 9999999999999864210 01
Q ss_pred --cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHh
Q 005572 585 --VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGY 660 (690)
Q Consensus 585 --~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 660 (690)
+||......++.++|||||||++|||+||+.||..... ........... .........+....+++.. +
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~s~~~~dli~~----l 286 (381)
T cd05626 214 YIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENT---LHIPPQVKLSPEAVDLITK----L 286 (381)
T ss_pred ccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccc---cCCCCCCCCCHHHHHHHHH----H
Confidence 34444445788999999999999999999999975221 11111111100 0000000111122222221 1
Q ss_pred hhcCCCCCCCCCHHHHHHH
Q 005572 661 LCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 661 ~C~~~dP~~RPt~~ev~~~ 679 (690)
.|+..+|..||++.|+++.
T Consensus 287 l~~~~~~~~R~~~~~~l~h 305 (381)
T cd05626 287 CCSAEERLGRNGADDIKAH 305 (381)
T ss_pred ccCcccccCCCCHHHHhcC
Confidence 3777788889999999763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=308.07 Aligned_cols=226 Identities=19% Similarity=0.253 Sum_probs=177.2
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..||+|+++.... ...+.+.+|..++..+ +||||+++++++...+..++|||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999984 5688999999975422 2234577888899888 699999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++..+..++.|++.||.|||+++++||||||+|||++.+
T Consensus 81 g~L~~~~~~----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~ 132 (329)
T cd05588 81 GDLMFHMQR----------------------------QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAE 132 (329)
T ss_pred CCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 999998865 2458899999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc----------hHHH
Q 005572 568 LEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDD----------CVKW 623 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~----------~~~~ 623 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++|+.||+. ..++
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05588 133 GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDY 212 (329)
T ss_pred CCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHH
Confidence 9999999999864211 145555556788999999999999999999999963 1122
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC------HHHHHH
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT------MQQVLG 678 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt------~~ev~~ 678 (690)
..+...... ..++...+ ..+.+++.+|++.||.+||+ +.|+++
T Consensus 213 ~~~~~~~~~------~~~p~~~~------~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 213 LFQVILEKQ------IRIPRSLS------VKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred HHHHHHcCC------CCCCCCCC------HHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 222222211 11111111 13455667799999999997 567653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=296.09 Aligned_cols=227 Identities=23% Similarity=0.331 Sum_probs=175.8
Q ss_pred ceeccCCCccEEEEEcCC-C----------cEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 413 SLLAEGRCGPVYRAVLPG-E----------LHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~-~----------~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
+.||+|+||.||+|...+ + ..+++|.+...... ...+.+|+.++++++||||++++|++.. +..++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 368999999999999643 3 25778877544322 6778899999999999999999999988 778999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+++++||||||+|
T Consensus 79 ~e~~~~~~L~~~l~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~N 131 (259)
T cd05037 79 EEYVKFGPLDVFLHRE---------------------------KNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKN 131 (259)
T ss_pred EEcCCCCcHHHHHHhh---------------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccce
Confidence 9999999999999752 2257899999999999999999999999999999999
Q ss_pred EEecCCC-------CceEcCCCccccccc------c----cCcccCCC--CCCCCCcchhhHHHHHHHHh-CCCCCCchH
Q 005572 562 ILLAESL-------EPKIAGFGLRNIGVK------N----VGERSENE--TCGPESDVYCFGVILMELLT-GKRGTDDCV 621 (690)
Q Consensus 562 iLl~~~~-------~~kl~DfGla~~~~~------~----~~e~~~~~--~~~~~~DVwSfGvvl~el~t-g~~p~~~~~ 621 (690)
|+++.++ .+||+|||++..... . +||..... .++.++|||||||++|||++ |..|+....
T Consensus 132 ill~~~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 132 ILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLS 211 (259)
T ss_pred EEEecCccccCCceeEEeCCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCC
Confidence 9999888 799999999876322 1 34443333 67889999999999999999 577776532
Q ss_pred H-HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 622 K-WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 622 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
. .......... ..+... . ..+.+++..||..+|.+|||+.||++.|+
T Consensus 212 ~~~~~~~~~~~~-------~~~~~~--~----~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 212 SSEKERFYQDQH-------RLPMPD--C----AELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred chhHHHHHhcCC-------CCCCCC--c----hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 1 1111111110 011101 1 35567778899999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=295.60 Aligned_cols=238 Identities=25% Similarity=0.351 Sum_probs=187.7
Q ss_pred hccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
..+|...+.||+|+||.||++...++..+|+|.+.... ...+.+.+|++++++++|+||+++++++.. ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 35677889999999999999997777789999886433 234678899999999999999999999887 7789999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++.+. ....+++..+..++.|++.||+|||+.+++||||||+||+++
T Consensus 83 ~~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~ 136 (260)
T cd05073 83 AKGSLLDFLKSD--------------------------EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVS 136 (260)
T ss_pred CCCcHHHHHHhC--------------------------CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEc
Confidence 999999999752 124578889999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH-HHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-VRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-~~~~~ 628 (690)
.++.+||+|||.+...... +||......++.++|||||||++||++| |+.||...... .....
T Consensus 137 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05073 137 ASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL 216 (260)
T ss_pred CCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999999987643211 3444434567889999999999999999 89998753221 22222
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
..+... ..... . ...+.+++.+||+.+|++||++.++.+.|+.
T Consensus 217 ~~~~~~-----~~~~~---~---~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 217 ERGYRM-----PRPEN---C---PEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred hCCCCC-----CCccc---C---CHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 221110 01111 1 1235567778999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=296.39 Aligned_cols=234 Identities=25% Similarity=0.361 Sum_probs=177.2
Q ss_pred ceeccCCCccEEEEEcC----CCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEec-CCeeEEEEEecC
Q 005572 413 SLLAEGRCGPVYRAVLP----GELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIA-GKEKLVLLEFMA 486 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e~~~ 486 (690)
+.||+|+||.||+|... ....+|+|.+.... ....+.+.+|+..++.++||||++++++|.. .+..++|+||+.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 36899999999999842 24579999885432 2234577889999999999999999998864 456789999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++.+. ...+++..+..++.|+++||.|||+.+++||||||+|||+++
T Consensus 81 ~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~ 133 (262)
T cd05058 81 HGDLRNFIRSE---------------------------THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDE 133 (262)
T ss_pred CCCHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcC
Confidence 99999999752 224577888999999999999999999999999999999999
Q ss_pred CCCceEcCCCccccccc------------------ccCcccCCCCCCCCCcchhhHHHHHHHHhC-CCCCCchH--HHHH
Q 005572 567 SLEPKIAGFGLRNIGVK------------------NVGERSENETCGPESDVYCFGVILMELLTG-KRGTDDCV--KWVR 625 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~------------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg-~~p~~~~~--~~~~ 625 (690)
++.+||+|||+++.... .+||......++.++|||||||++|||++| .+||.... +...
T Consensus 134 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~ 213 (262)
T cd05058 134 SFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITV 213 (262)
T ss_pred CCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 99999999999864311 134444445778899999999999999995 55665421 1111
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
....+.. +..+... . ..+.+++..||+.+|++||++.||++.|+++..
T Consensus 214 -~~~~~~~-----~~~~~~~---~---~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 214 -YLLQGRR-----LLQPEYC---P---DPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred -HHhcCCC-----CCCCCcC---C---HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 1111110 0001111 1 135567788999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=301.77 Aligned_cols=232 Identities=17% Similarity=0.185 Sum_probs=175.9
Q ss_pred eccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 415 LAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 415 lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
||+|+||.||+++. .++..+|+|.+..... .....+..|++++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999984 5688999999864321 2234456799999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++... ....+++..+..++.|++.||+|||+.+++||||||+||++++++.+
T Consensus 81 ~~~~~~~--------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~ 134 (277)
T cd05607 81 KYHIYNV--------------------------GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNC 134 (277)
T ss_pred HHHHHhc--------------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCE
Confidence 9988652 12357889999999999999999999999999999999999999999
Q ss_pred eEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-HHHHHHhcCCCCc
Q 005572 571 KIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLVKEGAGGDA 636 (690)
Q Consensus 571 kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~~ 636 (690)
||+|||++...... +||......++.++|||||||++|||++|+.||...... .............
T Consensus 135 ~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 214 (277)
T cd05607 135 RLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE 214 (277)
T ss_pred EEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc
Confidence 99999997643211 455554557889999999999999999999998652211 1111111111111
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 637 LDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
..... ...+ . ++.+++.+||+.||++||+++|+++.
T Consensus 215 ~~~~~-~~~~---~---~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 215 VKFEH-QNFT---E---ESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred ccccc-ccCC---H---HHHHHHHHHhccCHhhCCCCccchhh
Confidence 11000 0111 1 34566777999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-35 Score=303.16 Aligned_cols=257 Identities=26% Similarity=0.341 Sum_probs=190.8
Q ss_pred hccCCCCceeccCCCccEEEEEc--------CCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL--------PGELHVAIKVLDNAK-GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAG 475 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~--------~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 475 (690)
..+|...+.||+|+||.||+|+. .++..||+|.++... ....+++.+|+..++.+ +||||+++++++...
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 45677789999999999999973 124579999886432 23346788999999999 899999999999999
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
...++||||+++|+|.+++...+..... +... + .......++|.++..++.|+++||+|||+++++||
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~---~~~~-~--------~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGME---YSYD-I--------ARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccc---cccc-c--------ccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 9999999999999999999874321100 0000 0 00123468999999999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCC
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTD 618 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~ 618 (690)
||||+||++++++.+||+|||+++.... .+||......++.++|||||||++|||++ |..||.
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999874321 03443333567889999999999999998 788876
Q ss_pred chH-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 619 DCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 619 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
... .............. .+... . ..+.+++.+||+.+|++||||.|+++.|+++..
T Consensus 242 ~~~~~~~~~~~~~~~~~~-----~~~~~---~---~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~ 298 (304)
T cd05101 242 GIPVEELFKLLKEGHRMD-----KPANC---T---NELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT 298 (304)
T ss_pred cCCHHHHHHHHHcCCcCC-----CCCCC---C---HHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence 522 22222222221110 11111 1 134556778999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=299.31 Aligned_cols=247 Identities=26% Similarity=0.362 Sum_probs=189.2
Q ss_pred ccCCCCceeccCCCccEEEEEcCC------CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
++|...+.||+|+||.||+|...+ +..||+|.+..... .....+.+|++.++.++||||++++|++......+
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~ 85 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTL 85 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcE
Confidence 467778999999999999998532 36899999864422 23456788999999999999999999999999999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||+++|+|.+++......... ......++|..+..++.|++.||.|||+.+++||||||
T Consensus 86 ~v~e~~~~~~L~~~l~~~~~~~~~------------------~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p 147 (277)
T cd05032 86 VVMELMAKGDLKSYLRSRRPEAEN------------------NPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAA 147 (277)
T ss_pred EEEecCCCCCHHHHHHhcccchhh------------------ccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCh
Confidence 999999999999999763211100 01134578999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV- 621 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~- 621 (690)
+||++++++.+||+|||+++..... +||......++.++|||||||++||++| |+.||....
T Consensus 148 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 227 (277)
T cd05032 148 RNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN 227 (277)
T ss_pred heEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH
Confidence 9999999999999999997643211 3444444578899999999999999998 899986522
Q ss_pred HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
....+....+.. +..+... ...+.+++..||+.+|++|||+.|+++.|++
T Consensus 228 ~~~~~~~~~~~~-----~~~~~~~------~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 228 EEVLKFVIDGGH-----LDLPENC------PDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred HHHHHHHhcCCC-----CCCCCCC------CHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 222222222111 1111111 1245567788999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=308.00 Aligned_cols=221 Identities=20% Similarity=0.257 Sum_probs=172.8
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..+|+|+++.... ...+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 3699999999999994 5678999999975422 2234567788888776 799999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|..++.. ...+++..+..++.|++.||+|||+++++||||||+||+++.+
T Consensus 81 ~~L~~~~~~----------------------------~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~ 132 (329)
T cd05618 81 GDLMFHMQR----------------------------QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSE 132 (329)
T ss_pred CCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCC
Confidence 999998865 2358899999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc----------hHHH
Q 005572 568 LEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDD----------CVKW 623 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~----------~~~~ 623 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++|+.||.. ...+
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~ 212 (329)
T cd05618 133 GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDY 212 (329)
T ss_pred CCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHH
Confidence 9999999999864211 145555556788999999999999999999999852 1122
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
..+...... ..++...+ ..+.+++.+||+.||++||++
T Consensus 213 ~~~~i~~~~------~~~p~~~~------~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 213 LFQVILEKQ------IRIPRSLS------VKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred HHHHHhcCC------CCCCCCCC------HHHHHHHHHHhcCCHHHcCCC
Confidence 222222211 11111111 134466778999999999983
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.91 Aligned_cols=237 Identities=17% Similarity=0.145 Sum_probs=181.6
Q ss_pred HhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
...+|...+.||+|+||.||+++. .++..+|+|.++... ......+.+|+.+++.++||||+++++++.+.+..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 456788899999999999999984 568899999996432 1233457789999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|||||++|+|.++++. ..++...+..++.|++.||+|||+++++||||||+
T Consensus 121 v~Ey~~gg~L~~~l~~-----------------------------~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~ 171 (370)
T cd05596 121 VMEYMPGGDLVNLMSN-----------------------------YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPD 171 (370)
T ss_pred EEcCCCCCcHHHHHHh-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 9999999999999864 23667778889999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCccccccc-----------c----cCcccCC----CCCCCCCcchhhHHHHHHHHhCCCCCCchH
Q 005572 561 SILLAESLEPKIAGFGLRNIGVK-----------N----VGERSEN----ETCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~-----------~----~~e~~~~----~~~~~~~DVwSfGvvl~el~tg~~p~~~~~ 621 (690)
|||++.++.+||+|||+++.... . +||.... ..++.++|||||||++|||++|+.||....
T Consensus 172 NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 172 NMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred HEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 99999999999999999864321 1 3443322 247889999999999999999999987522
Q ss_pred --HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 005572 622 --KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGK--RPTMQQVLGL 679 (690)
Q Consensus 622 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~--RPt~~ev~~~ 679 (690)
.....+..... . ..++.... .. ..+.+++..|++.+|++ ||++.|+++.
T Consensus 252 ~~~~~~~i~~~~~---~--~~~~~~~~-~s---~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 252 LVGTYSKIMDHKN---S--LTFPDDIE-IS---KQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHHHHHHHHcCCC---c--CCCCCcCC-CC---HHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 11222221110 0 11111000 01 13345666799999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=299.30 Aligned_cols=239 Identities=25% Similarity=0.363 Sum_probs=187.9
Q ss_pred cCCCCceeccCCCccEEEEEcC-----CCcEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEec--CCeeE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-----GELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIA--GKEKL 479 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-----~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~ 479 (690)
+|...+.||+|+||.||+|++. ++..+|||.+...... ..+++.+|++.++.++||||+++++++.. ....+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666788999999999999853 3678999999755432 35678999999999999999999999987 55789
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||+++|+|.+++... ...+++..+..++.|++.||+|||+.+++||||||
T Consensus 85 lv~e~~~~~~l~~~l~~~---------------------------~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p 137 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH---------------------------RDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAA 137 (284)
T ss_pred EEEecCCCCCHHHHHHhC---------------------------ccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 999999999999999752 23588999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK 622 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~ 622 (690)
+||+++.++.+||+|||++...... +||......++.++||||||+++|||+||+.|+.....
T Consensus 138 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~ 217 (284)
T cd05038 138 RNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPA 217 (284)
T ss_pred HhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccc
Confidence 9999999999999999998764411 24433345678899999999999999999998764211
Q ss_pred H----------------HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 623 W----------------VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 623 ~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
. ......... ...... ....++.+++.+||+.+|++||||.||+++|+.|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~----~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 218 EFLRMIGIAQGQMIVTRLLELLKEGE-------RLPRPP----SCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred hhccccccccccccHHHHHHHHHcCC-------cCCCCc----cCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 1 111111110 000000 11134667788999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=306.81 Aligned_cols=226 Identities=23% Similarity=0.252 Sum_probs=175.7
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..||+|+++... ....+.+..|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3689999999999985 557899999997532 22334567788888766 799999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++..+..++.|+++||.|||+++++||||||+|||++.+
T Consensus 81 ~~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~ 132 (321)
T cd05591 81 GDLMFQIQR----------------------------SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE 132 (321)
T ss_pred CcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCC
Confidence 999999875 2357888999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~ 632 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++|+.||..... ..........
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05591 133 GHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD 212 (321)
T ss_pred CCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999999764211 145555556789999999999999999999999975321 1112221111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-------CHHHHHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-------TMQQVLG 678 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-------t~~ev~~ 678 (690)
. ..+...+ . .+.+++..|++.||++|| ++.++++
T Consensus 213 ---~---~~p~~~~---~---~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 213 ---V---LYPVWLS---K---EAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred ---C---CCCCCCC---H---HHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0 1111111 1 344566779999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=309.75 Aligned_cols=227 Identities=19% Similarity=0.208 Sum_probs=177.5
Q ss_pred ceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCC
Q 005572 413 SLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANG 488 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 488 (690)
+.||+|+||.||+++ ..++..||+|+++.... .....+..|++++..++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 368999999999998 45688999999975421 22345677889999999999999999999999999999999999
Q ss_pred CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcEEecCC
Q 005572 489 DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSILLAES 567 (690)
Q Consensus 489 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~NiLl~~~ 567 (690)
+|.+++.. ...+++..+..++.|++.||+|||+ .+++||||||+|||++++
T Consensus 81 ~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~ 132 (325)
T cd05594 81 ELFFHLSR----------------------------ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKD 132 (325)
T ss_pred cHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCC
Confidence 99998865 2358899999999999999999997 799999999999999999
Q ss_pred CCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~ 632 (690)
+.+||+|||+++.... . +||......++.++|||||||++|||+||+.||..... ..........
T Consensus 133 ~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~ 212 (325)
T cd05594 133 GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE 212 (325)
T ss_pred CCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999999764211 1 45555456789999999999999999999999965221 1111211111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLGL 679 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~~ 679 (690)
..++...+. .+.+++.+||+.||++|+ ++.|+++.
T Consensus 213 ------~~~p~~~~~------~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 252 (325)
T cd05594 213 ------IRFPRTLSP------EAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH 252 (325)
T ss_pred ------CCCCCCCCH------HHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence 111111211 234556679999999996 89998753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=302.78 Aligned_cols=257 Identities=25% Similarity=0.341 Sum_probs=191.5
Q ss_pred hccCCCCceeccCCCccEEEEEcC--------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhc-CCCCccceeeEEecC
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLP--------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAG 475 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~ 475 (690)
..+|...+.||+|+||.||+|+.. ....+|+|.++.... ....++.+|+++++++ +||||++++++|...
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 456778899999999999999731 245789999864322 2235678899999999 699999999999998
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
+..++||||+++|+|.+++........... . .........++|.++.+++.|++.||.|||+++++||
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~---~---------~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~ 158 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYT---F---------DITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHR 158 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCccccc---c---------cccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999999999999999986432111000 0 0000123468999999999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCC
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTD 618 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~ 618 (690)
||||+||++++++.+||+|||+++.... .+||......++.++|||||||++|||++ |..||.
T Consensus 159 dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~ 238 (314)
T cd05099 159 DLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYP 238 (314)
T ss_pred cccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999874321 13444334568889999999999999999 888886
Q ss_pred chH-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 619 DCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 619 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
... ............. ..+... .. ++.+++.+||+.+|++|||+.|+++.|+++..
T Consensus 239 ~~~~~~~~~~~~~~~~~-----~~~~~~---~~---~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 239 GIPVEELFKLLREGHRM-----DKPSNC---TH---ELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred CCCHHHHHHHHHcCCCC-----CCCCCC---CH---HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 532 2222222222111 111111 11 34466778999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=293.20 Aligned_cols=232 Identities=28% Similarity=0.337 Sum_probs=181.6
Q ss_pred ceeccCCCccEEEEEcCC--C--cEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVLPG--E--LHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~--~--~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|++|.||+|.+.. + ..||+|.+..... ...+.+.+|++.+++++||||+++++++.. ...++|+||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998533 2 3699999976544 345678899999999999999999999988 889999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.... ...++|.....++.|+++||+|||+.+++||||||+||+++.+
T Consensus 80 ~~L~~~l~~~~--------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~ 133 (257)
T cd05040 80 GSLLDRLRKDA--------------------------LGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASD 133 (257)
T ss_pred CcHHHHHHhcc--------------------------cccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecC
Confidence 99999997621 1458899999999999999999999999999999999999999
Q ss_pred CCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH--HHHHHH
Q 005572 568 LEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV--KWVRKL 627 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~--~~~~~~ 627 (690)
+.+||+|||+++..... +||......++.++|||||||++|||++ |+.||.... +.....
T Consensus 134 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 213 (257)
T cd05040 134 DKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI 213 (257)
T ss_pred CEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 99999999998654221 3343334577889999999999999999 999986522 222222
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
...... ...+... ...+.+++..||+.+|++||++.|+++.|.+
T Consensus 214 ~~~~~~-----~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 257 (257)
T cd05040 214 DKEGER-----LERPEAC------PQDIYNVMLQCWAHNPADRPTFAALREFLPE 257 (257)
T ss_pred HhcCCc-----CCCCccC------CHHHHHHHHHHCCCCcccCCCHHHHHHHhcC
Confidence 111110 0011111 1245567778999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-35 Score=313.84 Aligned_cols=234 Identities=17% Similarity=0.159 Sum_probs=179.7
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||+|+||.||+|+. .++..||||+++... ......+.+|++++..++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 3688889999999999999994 568899999997532 123345778999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
|||++|+|.+++.. ...+++..+..++.|++.||+|||+++++||||||+||
T Consensus 81 E~~~~g~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NI 132 (364)
T cd05599 81 EYLPGGDMMTLLMK----------------------------KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132 (364)
T ss_pred CCCCCcHHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence 99999999999975 23588899999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccccc----------------------------------------------------ccCcccC
Q 005572 563 LLAESLEPKIAGFGLRNIGVK----------------------------------------------------NVGERSE 590 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~----------------------------------------------------~~~e~~~ 590 (690)
|++.++.+||+|||+++.... .+||...
T Consensus 133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 212 (364)
T cd05599 133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL 212 (364)
T ss_pred EECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc
Confidence 999999999999998753210 1344444
Q ss_pred CCCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCC
Q 005572 591 NETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPG 668 (690)
Q Consensus 591 ~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~ 668 (690)
...++.++|||||||++|||++|..||..... ...... ... ..+ ..+.... ... .+.+++.+|+. +|.
T Consensus 213 ~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~-~~~--~~~--~~~~~~~-~s~---~~~~li~~ll~-~p~ 282 (364)
T cd05599 213 QTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKII-NWK--ETL--QFPDEVP-LSP---EAKDLIKRLCC-EAE 282 (364)
T ss_pred CCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHH-cCC--Ccc--CCCCCCC-CCH---HHHHHHHHHcc-CHh
Confidence 45788999999999999999999999975321 111121 111 000 1111100 011 22334445775 899
Q ss_pred CCCC---HHHHHH
Q 005572 669 KRPT---MQQVLG 678 (690)
Q Consensus 669 ~RPt---~~ev~~ 678 (690)
+|++ +.|+++
T Consensus 283 ~R~~~~~~~~ll~ 295 (364)
T cd05599 283 RRLGNNGVNEIKS 295 (364)
T ss_pred hcCCCCCHHHHhc
Confidence 9997 888876
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=304.79 Aligned_cols=235 Identities=18% Similarity=0.217 Sum_probs=190.8
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCe-eEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKE-KLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~-~~lv~ 482 (690)
++|...+.+|+|+||.++.++. .++..+|+|.+..... ..++...+|+.++++++|||||.+.+.+...+. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 3567778999999999999984 4567899999976543 334578899999999999999999999998887 89999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
+||+||++.+.+.+.+ +..+++.+...++.|++.|+.|||+++|.|||||+.||
T Consensus 84 ~Y~eGg~l~~~i~~~k--------------------------~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Ni 137 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK--------------------------GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANI 137 (426)
T ss_pred eecCCCCHHHHHHHHh--------------------------hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhh
Confidence 9999999999998732 34688889999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc--hHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD--CVKWVRK 626 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~--~~~~~~~ 626 (690)
+++.+..+||+|||+|+..... .||......|+.|+||||+||++|||++-+++|.. ....+.+
T Consensus 138 fltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k 217 (426)
T KOG0589|consen 138 FLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILK 217 (426)
T ss_pred hccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHH
Confidence 9999999999999999876543 34555567899999999999999999999999975 3333333
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
+.... -..++..++...+ .++..|++.+|+.||++.+++.+
T Consensus 218 i~~~~------~~Plp~~ys~el~------~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 218 INRGL------YSPLPSMYSSELR------SLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred Hhhcc------CCCCCccccHHHH------HHHHHHhhcCCccCCCHHHHhhC
Confidence 33221 1122233333333 34456999999999999999876
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=295.36 Aligned_cols=236 Identities=22% Similarity=0.332 Sum_probs=172.8
Q ss_pred eeccCCCccEEEEEcCCC---cEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCC
Q 005572 414 LLAEGRCGPVYRAVLPGE---LHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGD 489 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~~~~---~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 489 (690)
.||+|+||.||+|...++ ..+++|.+.... ....+.+.+|+..++.++||||++++++|......++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 589999999999974333 345666665432 2334678899999999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCC
Q 005572 490 LHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLE 569 (690)
Q Consensus 490 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~ 569 (690)
|.+++++... .....++.....++.||++||+|||+.+++||||||+|||++.++.
T Consensus 82 L~~~l~~~~~------------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~ 137 (268)
T cd05086 82 LKSYLSQEQW------------------------HRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT 137 (268)
T ss_pred HHHHHHhhhc------------------------ccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCcc
Confidence 9999986211 1124566778899999999999999999999999999999999999
Q ss_pred ceEcCCCccccccc----------------ccCcccCC-------CCCCCCCcchhhHHHHHHHHh-CCCCCCchH--HH
Q 005572 570 PKIAGFGLRNIGVK----------------NVGERSEN-------ETCGPESDVYCFGVILMELLT-GKRGTDDCV--KW 623 (690)
Q Consensus 570 ~kl~DfGla~~~~~----------------~~~e~~~~-------~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~--~~ 623 (690)
+||+|||++..... .+||.... ..++.++|||||||++|||++ |..||.... +.
T Consensus 138 ~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~ 217 (268)
T cd05086 138 VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREV 217 (268)
T ss_pred EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 99999998753210 13333211 234679999999999999997 566876422 22
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
....... ......++.+....... +.+++..|| .+|++||+++||++.|.
T Consensus 218 ~~~~~~~-~~~~~~~~~~~~~~~~~------~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 218 LNHVIKD-QQVKLFKPQLELPYSER------WYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred HHHHHhh-cccccCCCccCCCCcHH------HHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 2222222 22223333333222222 333455699 57999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.79 Aligned_cols=234 Identities=21% Similarity=0.245 Sum_probs=180.7
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
|+..+.||+|+||.||+|.. .++..+|+|.+........+.+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 45567899999999999995 45778899998654433456788899999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++... ...+++..+..++.|+++||.|||+.+++||||||+||+++.+
T Consensus 87 ~~l~~~~~~~---------------------------~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~ 139 (282)
T cd06643 87 GAVDAVMLEL---------------------------ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLD 139 (282)
T ss_pred CcHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccC
Confidence 9999988641 2358899999999999999999999999999999999999999
Q ss_pred CCceEcCCCcccccccc--------------cCcccC-----CCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH--HHH
Q 005572 568 LEPKIAGFGLRNIGVKN--------------VGERSE-----NETCGPESDVYCFGVILMELLTGKRGTDDCVKW--VRK 626 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~~--------------~~e~~~-----~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~--~~~ 626 (690)
+.+||+|||++...... +||... ...++.++|||||||++|||++|+.||...... ...
T Consensus 140 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 219 (282)
T cd06643 140 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219 (282)
T ss_pred CCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHH
Confidence 99999999998643211 344331 234677999999999999999999998753221 111
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
... ....... .+...+ ..+.+++..||+.||.+||++.++++.
T Consensus 220 ~~~-~~~~~~~---~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~il~~ 262 (282)
T cd06643 220 IAK-SEPPTLA---QPSRWS------SEFKDFLKKCLEKNVDARWTTTQLLQH 262 (282)
T ss_pred Hhh-cCCCCCC---CccccC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 111 1110100 011111 134566678999999999999998754
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=286.21 Aligned_cols=251 Identities=21% Similarity=0.286 Sum_probs=187.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCC-ccceeeEEecCC------e
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPN-LLPLAGYCIAGK------E 477 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~n-iv~l~g~~~~~~------~ 477 (690)
.|...++||+|+||.||+|+ ..+|..||+|+++.... .-.....+|+.++++++|+| ||+|++++.+.+ .
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~ 91 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGK 91 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccce
Confidence 34555779999999999999 67788999999976533 34567899999999999999 999999999877 7
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl 557 (690)
.++|+||++. ||..|+...+.. ...++...+..++.|+++||+|||+++|+||||
T Consensus 92 l~lvfe~~d~-DL~~ymd~~~~~------------------------~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDL 146 (323)
T KOG0594|consen 92 LYLVFEFLDR-DLKKYMDSLPKK------------------------PQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDL 146 (323)
T ss_pred EEEEEEeecc-cHHHHHHhcccc------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecccC
Confidence 8899999976 999999863210 134556788999999999999999999999999
Q ss_pred CCCcEEecCCCCceEcCCCcccccccc--------------cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCchHH
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCVK 622 (690)
Q Consensus 558 k~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~~~~ 622 (690)
||.||||+++|.+||+|||+|+...-. +||+.-.. .|++..||||+||++.||++++.-|.+..+
T Consensus 147 KPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se 226 (323)
T KOG0594|consen 147 KPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE 226 (323)
T ss_pred CcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence 999999999999999999999854311 45554443 799999999999999999999888875322
Q ss_pred --HHHHHHHh-cC--------CCCccccccc--cCC-CCCHHHH-----HHHHHHHhhhcCCCCCCCCCHHHHHHH--Hh
Q 005572 623 --WVRKLVKE-GA--------GGDALDFRLK--LGS-GDSVAEM-----VESLRVGYLCTADSPGKRPTMQQVLGL--LK 681 (690)
Q Consensus 623 --~~~~~~~~-~~--------~~~~~~~~~~--~~~-~~~~~~~-----~~~~~l~~~C~~~dP~~RPt~~ev~~~--L~ 681 (690)
....+..- +. .....++... ... ....... ....++...|++++|++|.|+..+++. +.
T Consensus 227 ~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~ 306 (323)
T KOG0594|consen 227 IDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFS 306 (323)
T ss_pred HHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhc
Confidence 12222221 10 0111122111 110 0111110 134567778999999999999999885 54
Q ss_pred cc
Q 005572 682 DI 683 (690)
Q Consensus 682 ~i 683 (690)
.+
T Consensus 307 ~~ 308 (323)
T KOG0594|consen 307 EL 308 (323)
T ss_pred cc
Confidence 44
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=305.78 Aligned_cols=221 Identities=21% Similarity=0.242 Sum_probs=173.2
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..||+|+++... ....+.+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999994 568899999986432 22345567788888776 699999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.+ ...+++..+..++.|++.||+|||+++++||||||+|||++.+
T Consensus 81 g~L~~~i~~----------------------------~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~ 132 (320)
T cd05590 81 GDLMFHIQK----------------------------SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE 132 (320)
T ss_pred chHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence 999999875 2357888999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~ 632 (690)
+.+||+|||+++.... . +||......++.++|||||||++|||++|+.||..... .....+....
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~ 212 (320)
T cd05590 133 GHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE 212 (320)
T ss_pred CcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999999764211 1 45555556788999999999999999999999975321 1222222211
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
. ..+...+ . .+.+++..|++.||++||++
T Consensus 213 ~------~~~~~~~---~---~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 213 V------VYPTWLS---Q---DAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred C------CCCCCCC---H---HHHHHHHHHcccCHHHCCCC
Confidence 1 1111111 1 33456667999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=309.30 Aligned_cols=223 Identities=21% Similarity=0.221 Sum_probs=174.6
Q ss_pred ceeccCCCccEEEEEc----CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 413 SLLAEGRCGPVYRAVL----PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
+.||+|+||.||+++. .++..+|+|+++.... .....+..|++++++++||||+++++++...+..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999873 3578999999975422 233456789999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++.+ ...+++..+..++.|+++||+|||+++++||||||+||++++
T Consensus 82 ~~~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 133 (318)
T cd05582 82 GGDLFTRLSK----------------------------EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDE 133 (318)
T ss_pred CCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECC
Confidence 9999999865 235889999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHhc
Q 005572 567 SLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKEG 631 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~~ 631 (690)
++.+||+|||+++..... +||......++.++|||||||++|||++|+.||..... .........
T Consensus 134 ~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~ 213 (318)
T cd05582 134 EGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213 (318)
T ss_pred CCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcC
Confidence 999999999998653211 34544445778899999999999999999999975321 111111111
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQ 675 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~e 675 (690)
.. .++...+. .+.+++..||+.||++||++.+
T Consensus 214 ~~------~~p~~~~~------~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 214 KL------GMPQFLSP------EAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred CC------CCCCCCCH------HHHHHHHHHhhcCHhHcCCCCC
Confidence 11 11111111 2345566799999999999544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=303.94 Aligned_cols=225 Identities=21% Similarity=0.227 Sum_probs=171.9
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..||+|+++... ....+....|..++... +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 557889999997532 12334455666666644 799999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++.++..++.|++.||.|||+++++||||||+|||++.+
T Consensus 81 g~L~~~~~~----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~ 132 (316)
T cd05592 81 GDLMFHIQS----------------------------SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD 132 (316)
T ss_pred CcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCC
Confidence 999999875 2357888899999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~ 632 (690)
+.+||+|||+++.... . +||......++.++|||||||++|||++|+.||..... .....+...
T Consensus 133 ~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~- 211 (316)
T cd05592 133 GHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND- 211 (316)
T ss_pred CCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-
Confidence 9999999999864211 1 45554455788999999999999999999999975321 111111111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQ-QVL 677 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~-ev~ 677 (690)
.+.++...+ . .+.+++..||+.||++||++. ++.
T Consensus 212 -----~~~~~~~~~---~---~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 212 -----RPHFPRWIS---K---EAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred -----CCCCCCCCC---H---HHHHHHHHHccCCHHHcCCChHHHH
Confidence 011111111 1 234556679999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-35 Score=327.25 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=198.5
Q ss_pred HHhccCCCCceeccCCCccEEEEEcC--------CCcEEEEEEeeccC-CCCHHHHHHHHHHHHhc-CCCCccceeeEEe
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAVLP--------GELHVAIKVLDNAK-GIDHDDAVAMFDELSRL-KHPNLLPLAGYCI 473 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 473 (690)
....++...+.+|+|.||.|++|... ....||||+++... ..+.+.+.+|++.|..+ +||||+.++|+|.
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 33344445568999999999999732 14579999997543 24567899999999988 5999999999999
Q ss_pred cCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCC
Q 005572 474 AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGST 553 (690)
Q Consensus 474 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~i 553 (690)
..+..++|+||+..|+|.+||+..+.. ... ...+........++..+.+.++.|||.||+||++..++
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~-~~~-----------~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~v 440 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVT-ESI-----------DGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCV 440 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhcccc-ccc-----------cccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCcc
Confidence 999999999999999999999986510 000 00000001113589999999999999999999999999
Q ss_pred CCCCCCCcEEecCCCCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCC
Q 005572 554 HGHLVTSSILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKR 615 (690)
Q Consensus 554 HrDlk~~NiLl~~~~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~ 615 (690)
||||.+||||++++..+||+|||+|+..... |||...+..|+.|+|||||||+|||++| |..
T Consensus 441 HRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~ 520 (609)
T KOG0200|consen 441 HRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGT 520 (609)
T ss_pred chhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCC
Confidence 9999999999999999999999999853221 4566666789999999999999999999 889
Q ss_pred CCCch--HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 616 GTDDC--VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 616 p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
||.+. ...+.+.+..|...+... .+..+++++|..||+.+|++||++.|+++.++..
T Consensus 521 PYp~~~~~~~l~~~l~~G~r~~~P~-----------~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 521 PYPGIPPTEELLEFLKEGNRMEQPE-----------HCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred CCCCCCcHHHHHHHHhcCCCCCCCC-----------CCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 99872 233344455554322211 1123567888899999999999999999999874
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=310.40 Aligned_cols=234 Identities=18% Similarity=0.168 Sum_probs=180.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|...+.||+|+||.||+++ ..++..||+|+++.... ...+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 57788999999999999998 45688999999975432 234567889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.+. ...+++..+..++.|++.||.|||+.+++||||||+|||
T Consensus 82 ~~~~~~L~~~l~~~---------------------------~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIl 134 (330)
T cd05601 82 YQPGGDLLSLLNRY---------------------------EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134 (330)
T ss_pred CCCCCCHHHHHHHh---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheE
Confidence 99999999999762 245888999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc---------------cCcccC------CCCCCCCCcchhhHHHHHHHHhCCCCCCchH-
Q 005572 564 LAESLEPKIAGFGLRNIGVKN---------------VGERSE------NETCGPESDVYCFGVILMELLTGKRGTDDCV- 621 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~---------------~~e~~~------~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~- 621 (690)
++.++.+||+|||++...... +||... ...++.++|||||||++|||++|+.||....
T Consensus 135 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 214 (330)
T cd05601 135 IDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS 214 (330)
T ss_pred ECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH
Confidence 999999999999998643211 344332 2356789999999999999999999997522
Q ss_pred -HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 622 -KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 622 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
........... ..........+ . .+.+++..|++ +|++|||+.++++
T Consensus 215 ~~~~~~i~~~~~---~~~~~~~~~~~---~---~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 215 AKTYNNIMNFQR---FLKFPEDPKVS---S---DFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred HHHHHHHHcCCC---ccCCCCCCCCC---H---HHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 22222221111 11110001111 1 23344556887 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-35 Score=305.53 Aligned_cols=226 Identities=22% Similarity=0.224 Sum_probs=175.7
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCC-CCccceeeEEecCCeeEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKH-PNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lv~ 482 (690)
+|...+.||+|+||.||+|+. .++..||+|++.... ....+.+..|.+++..++| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 467788999999999999985 457889999997532 2334567788888998876 56888999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++++||||||+||
T Consensus 81 E~~~~g~L~~~~~~----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni 132 (324)
T cd05587 81 EYVNGGDLMYHIQQ----------------------------VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132 (324)
T ss_pred cCCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence 99999999999875 23578889999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKL 627 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~ 627 (690)
|+++++.+||+|||+++.... . +||......++.++|||||||++|||+||+.||..... .....
T Consensus 133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (324)
T cd05587 133 MLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQS 212 (324)
T ss_pred EEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999998764210 1 45555556788999999999999999999999975321 11112
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
..... ..++...+ . .+.+++.+||+.||++||+.
T Consensus 213 i~~~~------~~~~~~~~---~---~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 213 IMEHN------VSYPKSLS---K---EAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred HHcCC------CCCCCCCC---H---HHHHHHHHHhhcCHHHcCCC
Confidence 21111 11111111 1 34456677999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.38 Aligned_cols=235 Identities=20% Similarity=0.205 Sum_probs=184.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|+..+.||+|+||.||+++ ..++..+|+|.++... ....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 46677899999999999998 4568899999986432 234467788999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++... ....+++.....++.|++.||.|||+.+++|+||||+||+++
T Consensus 81 ~~~~l~~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~ 134 (255)
T cd08219 81 DGGDLMQKIKLQ--------------------------RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLT 134 (255)
T ss_pred CCCcHHHHHHhc--------------------------cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEC
Confidence 999999998652 123477888999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHh
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKE 630 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~ 630 (690)
+++.++++|||.++..... +||......++.++||||||+++|||++|+.||..... ........
T Consensus 135 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 214 (255)
T cd08219 135 QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ 214 (255)
T ss_pred CCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhc
Confidence 9999999999998644221 45555555788899999999999999999999975221 11111111
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
+.... ++...+ ..+.+++.+||+.||++||++.|++..
T Consensus 215 ~~~~~-----~~~~~~------~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 215 GSYKP-----LPSHYS------YELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CCCCC-----CCcccC------HHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 11110 111111 134466778999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-35 Score=303.84 Aligned_cols=225 Identities=22% Similarity=0.227 Sum_probs=174.4
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHh-cCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSR-LKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..||+|+++... ....+....|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 3689999999999995 457899999997542 1233456667777775 4899999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++.++..++.|++.||.|||+++++||||||+|||++.+
T Consensus 81 g~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~ 132 (316)
T cd05619 81 GDLMFHIQS----------------------------CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132 (316)
T ss_pred CcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCC
Confidence 999999875 2357888999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~ 632 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++|+.||.... ....+......
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~ 212 (316)
T cd05619 133 GHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN 212 (316)
T ss_pred CCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999999764211 14555555678999999999999999999999987522 11112221111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQ-QVL 677 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~-ev~ 677 (690)
+..+...+ . .+.+++.+||+.||++||++. ++.
T Consensus 213 ------~~~~~~~~---~---~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 213 ------PCYPRWLT---R---EAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred ------CCCCccCC---H---HHHHHHHHHhccCHhhcCCChHHHH
Confidence 11111111 1 234566679999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=299.45 Aligned_cols=231 Identities=17% Similarity=0.115 Sum_probs=175.5
Q ss_pred eccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 415 LAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 415 lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
||+|+||.||++. ..++..+|+|.+..... ...+.+..|+++++.++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 6999999999998 45688999999864322 1224567899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++.... .....+++..+..++.|++.||.|||+.+++||||||+||++++++.+
T Consensus 81 ~~~~~~~~------------------------~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~ 136 (280)
T cd05608 81 RYHIYNVD------------------------EENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNV 136 (280)
T ss_pred HHHHHhcc------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCE
Confidence 98885421 113458899999999999999999999999999999999999999999
Q ss_pred eEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH--HHHHHHhcCCC
Q 005572 571 KIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW--VRKLVKEGAGG 634 (690)
Q Consensus 571 kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~ 634 (690)
||+|||++..... .+||......++.++|||||||++|||++|+.||...... ........ ..
T Consensus 137 ~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~-~~ 215 (280)
T cd05608 137 RISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI-LN 215 (280)
T ss_pred EEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh-cc
Confidence 9999999864321 1455555567889999999999999999999998642111 11111111 01
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 635 DALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
.. ...+...+ ..+.+++..||+.||++|| +++|+++
T Consensus 216 ~~--~~~~~~~~------~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 216 DS--VTYPDKFS------PASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cC--CCCcccCC------HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 00 01111111 1344566679999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.92 Aligned_cols=241 Identities=22% Similarity=0.360 Sum_probs=185.8
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCc----EEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGEL----HVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~----~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
.+|+..+.||+|+||.||+|.. .++. .+|+|.+..... ....++.+|+..++.++||||++++|+|... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 4677788999999999999984 3443 478888865432 2234678899999999999999999999764 4679
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+++++||||||+
T Consensus 86 v~e~~~~g~l~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~ 138 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH---------------------------KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAAR 138 (303)
T ss_pred eehhcCCCCHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccc
Confidence 99999999999998751 235788899999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCch-HH
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDC-VK 622 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~-~~ 622 (690)
||++++++.+||+|||+++..... +||......++.++|||||||++|||++ |+.||... ..
T Consensus 139 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~ 218 (303)
T cd05110 139 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218 (303)
T ss_pred eeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999999999999999998753211 2333333567889999999999999998 89998753 22
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCC
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
........+... . ..... ...+.+++..||..+|++||++.|+++.|+.+...
T Consensus 219 ~~~~~~~~~~~~---~--~~~~~------~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~ 271 (303)
T cd05110 219 EIPDLLEKGERL---P--QPPIC------TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD 271 (303)
T ss_pred HHHHHHHCCCCC---C--CCCCC------CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 233333322111 0 01111 12455677889999999999999999999987544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=303.37 Aligned_cols=184 Identities=23% Similarity=0.330 Sum_probs=157.7
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|+..+.||+|+||.||+++ ..++..+|+|.+..... ...+++.+|++++.+++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~ 81 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHM 81 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeecc
Confidence 57888999999999999998 45678899998864322 22356888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcEEe
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSILL 564 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~NiLl 564 (690)
++|+|.++++. ...+++..+..++.|+++||.|||+ .+++||||||+|||+
T Consensus 82 ~~~~L~~~l~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~ 133 (308)
T cd06615 82 DGGSLDQVLKK----------------------------AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV 133 (308)
T ss_pred CCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE
Confidence 99999999975 2357888899999999999999998 589999999999999
Q ss_pred cCCCCceEcCCCcccccccc------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 565 AESLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
++++.+||+|||++...... +||......++.++|||||||++|||++|+.||..
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~ 200 (308)
T cd06615 134 NSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPP 200 (308)
T ss_pred ecCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999987653221 34544445678899999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=322.12 Aligned_cols=239 Identities=20% Similarity=0.221 Sum_probs=184.2
Q ss_pred HhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCC-----
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK----- 476 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----- 476 (690)
...+|...+.||+|+||.||+|+ ..++..||||+++.... .....+.+|+..+..++|+||+++++.+...+
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 34588889999999999999998 56788999999965432 22345778899999999999999988765432
Q ss_pred ---eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCC
Q 005572 477 ---EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGST 553 (690)
Q Consensus 477 ---~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~i 553 (690)
..++||||+++|+|.++++... .....+++..+..++.|++.||+|||+.+++
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~------------------------~~~~~l~e~~~~~i~~qll~aL~~lH~~~Ii 165 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRA------------------------KTNRTFREHEAGLLFIQVLLAVHHVHSKHMI 165 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhh------------------------ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 3679999999999999997522 1234688899999999999999999999999
Q ss_pred CCCCCCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCC
Q 005572 554 HGHLVTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLTGKRGT 617 (690)
Q Consensus 554 HrDlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~ 617 (690)
||||||+|||++.++.+||+|||+++.... .+||......++.++|||||||++|||++|+.||
T Consensus 166 HrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf 245 (496)
T PTZ00283 166 HRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF 245 (496)
T ss_pred cCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999865321 1455555567899999999999999999999999
Q ss_pred Cch--HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 618 DDC--VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 618 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
... .+...... .+.. ++ ++...+ . .+.+++..||+.||++||++.++++.
T Consensus 246 ~~~~~~~~~~~~~-~~~~----~~-~~~~~~---~---~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 246 DGENMEEVMHKTL-AGRY----DP-LPPSIS---P---EMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred CCCCHHHHHHHHh-cCCC----CC-CCCCCC---H---HHHHHHHHHcccChhhCcCHHHHHhC
Confidence 752 22222221 1111 11 111111 1 34456677999999999999999763
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=307.03 Aligned_cols=231 Identities=19% Similarity=0.200 Sum_probs=178.0
Q ss_pred cCCCCceeccCCCccEEEEEc----CCCcEEEEEEeeccC----CCCHHHHHHHHHHHHhcC-CCCccceeeEEecCCee
Q 005572 408 HFGKESLLAEGRCGPVYRAVL----PGELHVAIKVLDNAK----GIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~ 478 (690)
+|+..+.||+|+||.||+++. .++..||+|++.... ....+.+..|++++..++ ||||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 467788999999999999874 357899999986432 123356778999999994 99999999999999999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++||||+++|+|.+++.. ...+++.++..++.||+.||+|||+++++|||||
T Consensus 81 ~lv~e~~~~g~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlk 132 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ----------------------------RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIK 132 (332)
T ss_pred EEEEeCCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCC
Confidence 999999999999999975 2357888999999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCccccccc-----------c----cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCc---
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVK-----------N----VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDD--- 619 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~-----------~----~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~--- 619 (690)
|+|||++.++.+||+|||+++.... . +||..... .++.++|||||||++|||+||+.||..
T Consensus 133 p~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 212 (332)
T cd05614 133 LENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGE 212 (332)
T ss_pred HHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCC
Confidence 9999999999999999999864311 1 34443332 478899999999999999999999863
Q ss_pred --hHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 620 --CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 620 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
............ ++.++...+. .+.+++.+||+.||++|| +++|+++
T Consensus 213 ~~~~~~~~~~~~~~------~~~~~~~~~~------~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 213 RNTQSEVSRRILKC------DPPFPSFIGP------EAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred CCCHHHHHHHHhcC------CCCCCCCCCH------HHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 111121111111 1112111111 234556679999999999 6777765
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=298.66 Aligned_cols=232 Identities=18% Similarity=0.280 Sum_probs=184.4
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
+|...+.||.|+||.||+|. ..++..||+|.+........+.+.+|+..++.++||||+++++++...+..++|+||++
T Consensus 20 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 99 (296)
T cd06655 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLA 99 (296)
T ss_pred eEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecC
Confidence 57778899999999999998 56788999999976554556778899999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++.. ..+++.++..++.|++.||+|||+.+++||||||+||+++.
T Consensus 100 ~~~L~~~~~~-----------------------------~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~ 150 (296)
T cd06655 100 GGSLTDVVTE-----------------------------TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGM 150 (296)
T ss_pred CCcHHHHHHh-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECC
Confidence 9999998864 24789999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH--HHHHHHh
Q 005572 567 SLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW--VRKLVKE 630 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~--~~~~~~~ 630 (690)
++.+||+|||++...... +||......++.++|||||||++|||++|+.||...... ......
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~- 229 (296)
T cd06655 151 DGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT- 229 (296)
T ss_pred CCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Confidence 999999999987643211 344444456788999999999999999999998753221 111111
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..... ...+...+ . .+.+++.+||+.||++||++.++++
T Consensus 230 ~~~~~---~~~~~~~~---~---~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 230 NGTPE---LQNPEKLS---P---IFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred cCCcc---cCCcccCC---H---HHHHHHHHHhhcChhhCCCHHHHhh
Confidence 11000 00111111 1 3445667899999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=296.53 Aligned_cols=236 Identities=22% Similarity=0.241 Sum_probs=181.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
+|...+.||+|+||.||+|+ ..++..+|+|.++.........+.+|+..++.++||||+++++++...+..++|+||++
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~ 89 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCG 89 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccC
Confidence 45556789999999999998 45688999999876544445567889999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++.. ...+++.++..++.|++.||.|||+.+++||||||+||+++.
T Consensus 90 ~~~L~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~ 141 (267)
T cd06645 90 GGSLQDIYHV----------------------------TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred CCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 9999999865 235788999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc--------------cCcccC---CCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHH-HHH
Q 005572 567 SLEPKIAGFGLRNIGVKN--------------VGERSE---NETCGPESDVYCFGVILMELLTGKRGTDDCVKWVR-KLV 628 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~--------------~~e~~~---~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~-~~~ 628 (690)
++.+||+|||++...... +||... ...++.++|||||||++|||++|+.||........ ...
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~ 221 (267)
T cd06645 142 NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred CCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh
Confidence 999999999997543211 344432 23477899999999999999999999864321111 111
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..... ..+......... . .+.+++.+||+.+|++||++.++++
T Consensus 222 ~~~~~---~~~~~~~~~~~~-~---~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 222 TKSNF---QPPKLKDKMKWS-N---SFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred hccCC---CCCcccccCCCC-H---HHHHHHHHHccCCchhCcCHHHHhc
Confidence 11110 011111000001 1 2445677899999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=301.58 Aligned_cols=240 Identities=18% Similarity=0.268 Sum_probs=186.9
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.+|...+.||+|+||.||+|+ ..++..||+|.+........+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 578888999999999999999 4678899999997655455567888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++.+ ..+++.++..++.|++.||.|||+.+++||||||+||+++
T Consensus 99 ~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~ 149 (297)
T cd06656 99 AGGSLTDVVTE-----------------------------TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLG 149 (297)
T ss_pred CCCCHHHHHHh-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEC
Confidence 99999999864 2467889999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhc
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEG 631 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 631 (690)
.++.+||+|||++...... +||......++.++|||||||++|||++|+.||....... ......
T Consensus 150 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~-~~~~~~ 228 (297)
T cd06656 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIA 228 (297)
T ss_pred CCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcch-heeeec
Confidence 9999999999987643211 3444444567889999999999999999999986422111 000000
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhcc
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG--LLKDI 683 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~--~L~~i 683 (690)
. .. .+... ..... ...+.+++.+||+.+|++||++.|+++ .++..
T Consensus 229 ~-~~--~~~~~--~~~~~--~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 275 (297)
T cd06656 229 T-NG--TPELQ--NPERL--SAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLA 275 (297)
T ss_pred c-CC--CCCCC--Ccccc--CHHHHHHHHHHccCChhhCcCHHHHhcCchhccc
Confidence 0 00 00000 00011 112345677899999999999999987 44433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=293.29 Aligned_cols=235 Identities=20% Similarity=0.265 Sum_probs=185.3
Q ss_pred ccCCCCceeccCCCccEEEEEcCC-CcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
++|+..+.||+|+||.||+|.... +..+|+|.+..... .+++.+|++.+++++||||++++|++......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 467888899999999999999654 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++++|.+++.. ....+++..+..++.|+++||.|||+.+++||||+|+||+++
T Consensus 81 ~~~~L~~~l~~---------------------------~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~ 133 (256)
T cd06612 81 GAGSVSDIMKI---------------------------TNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLN 133 (256)
T ss_pred CCCcHHHHHHh---------------------------CccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEC
Confidence 99999999864 124688999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhc
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEG 631 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 631 (690)
+++.+||+|||++...... +||......++.++|||||||++|||++|+.||........ .....
T Consensus 134 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~-~~~~~ 212 (256)
T cd06612 134 EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRA-IFMIP 212 (256)
T ss_pred CCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhh-hhhhc
Confidence 9999999999997653321 34444445778899999999999999999999875322111 11100
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.. ....... ....-..+.+++.+||+.||++|||+.||++
T Consensus 213 ~~---~~~~~~~----~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 213 NK---PPPTLSD----PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred cC---CCCCCCc----hhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 00 0000100 0000113456677899999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=298.99 Aligned_cols=238 Identities=24% Similarity=0.328 Sum_probs=183.4
Q ss_pred cCCCCceeccCCCccEEEEEc-----CCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-----PGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKL 479 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~ 479 (690)
.|++.+.||+|+||.||++++ .++..||+|.++... ....+.+.+|++.+++++||||+++++++... ...+
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK 84 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence 356778999999999999973 347789999986543 22346788999999999999999999999875 5688
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||+++|+|.+++.+. ...++|.++..++.|++.||+|||+++++||||||
T Consensus 85 lv~e~~~g~~L~~~l~~~---------------------------~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp 137 (284)
T cd05079 85 LIMEFLPSGSLKEYLPRN---------------------------KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAA 137 (284)
T ss_pred EEEEccCCCCHHHHHHhc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccch
Confidence 999999999999999651 23578999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK 622 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~ 622 (690)
+||+++.++.+||+|||+++..... +||......++.++|||||||++|||+|++.|......
T Consensus 138 ~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~ 217 (284)
T cd05079 138 RNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMT 217 (284)
T ss_pred heEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccc
Confidence 9999999999999999998643211 34433345678899999999999999998766432100
Q ss_pred ----------------HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 623 ----------------WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 623 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
........+.. ...... ....+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 218 LFLKMIGPTHGQMTVTRLVRVLEEGKR-----LPRPPN------CPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred hhhhhcccccccccHHHHHHHHHcCcc-----CCCCCC------CCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00111111100 000111 112456677889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.41 Aligned_cols=225 Identities=20% Similarity=0.201 Sum_probs=173.8
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..||+|.++... ....+....|..++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 3699999999999995 468899999997532 12344566777777654 899999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++.++..++.|+++||+|||+++++||||||+|||++.+
T Consensus 81 g~L~~~i~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~ 132 (316)
T cd05620 81 GDLMFHIQD----------------------------KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD 132 (316)
T ss_pred CcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 999999875 2357888999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~ 632 (690)
+.+||+|||+++.... . +||......++.++|||||||++|||++|+.||.... ....+.....
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~- 211 (316)
T cd05620 133 GHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD- 211 (316)
T ss_pred CCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Confidence 9999999999764210 1 4555555678999999999999999999999987522 1112222111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHH-HHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQ-QVL 677 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~-ev~ 677 (690)
.+.++...+. .+.+++..||+.||++||++. ++.
T Consensus 212 -----~~~~~~~~~~------~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 212 -----TPHYPRWITK------ESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -----CCCCCCCCCH------HHHHHHHHHccCCHHHcCCChHHHH
Confidence 1111111111 234556679999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=310.91 Aligned_cols=234 Identities=21% Similarity=0.208 Sum_probs=182.8
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|...+.||+|+||.||+|+. .++..||+|+++... ......+.+|++++..++||||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 677889999999999999994 468899999997532 1334568889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+++||||||+|||
T Consensus 82 ~~~~~~L~~~l~~----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIl 133 (350)
T cd05573 82 YMPGGDLMNLLIR----------------------------KDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNIL 133 (350)
T ss_pred CCCCCCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence 9999999999975 245788899999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-------------------------------------------cCcccCCCCCCCCCcc
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-------------------------------------------VGERSENETCGPESDV 600 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-------------------------------------------~~e~~~~~~~~~~~DV 600 (690)
++.++.+||+|||+++..... +||......++.++||
T Consensus 134 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di 213 (350)
T cd05573 134 IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW 213 (350)
T ss_pred ECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceee
Confidence 999999999999998643211 3444444578899999
Q ss_pred hhhHHHHHHHHhCCCCCCchHH--HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-HHHHH
Q 005572 601 YCFGVILMELLTGKRGTDDCVK--WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-MQQVL 677 (690)
Q Consensus 601 wSfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-~~ev~ 677 (690)
|||||++|||++|+.||..... .......... . .........+ . .+.+++..|++ ||++||+ +.|++
T Consensus 214 wSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~--~-~~~p~~~~~~---~---~~~~li~~ll~-dp~~R~~s~~~ll 283 (350)
T cd05573 214 WSLGVILYEMLYGFPPFYSDTLQETYNKIINWKE--S-LRFPPDPPVS---P---EAIDLICRLLC-DPEDRLGSFEEIK 283 (350)
T ss_pred EecchhhhhhccCCCCCCCCCHHHHHHHHhccCC--c-ccCCCCCCCC---H---HHHHHHHHHcc-ChhhcCCCHHHHh
Confidence 9999999999999999976321 1112221100 0 0000000011 1 23345556897 9999999 99998
Q ss_pred HH
Q 005572 678 GL 679 (690)
Q Consensus 678 ~~ 679 (690)
+.
T Consensus 284 ~h 285 (350)
T cd05573 284 SH 285 (350)
T ss_pred cC
Confidence 74
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=303.75 Aligned_cols=226 Identities=24% Similarity=0.285 Sum_probs=177.3
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..||+|+++... ....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999985 457899999997542 22345567788888877 699999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++.++..++.|++.||.|||+.+++||||||+||+++++
T Consensus 81 ~~L~~~~~~----------------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~ 132 (318)
T cd05570 81 GDLMFHIQR----------------------------SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSE 132 (318)
T ss_pred CCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCC
Confidence 999998875 2358899999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~ 632 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++|+.||..... ..........
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~ 212 (318)
T cd05570 133 GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDE 212 (318)
T ss_pred CcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999998764211 145555556788999999999999999999999975221 1111121111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH-----HHHHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM-----QQVLG 678 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~-----~ev~~ 678 (690)
...+...+. .+.+++.+||+.||++||++ .++++
T Consensus 213 ------~~~~~~~~~------~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 213 ------VRYPRWLSK------EAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred ------CCCCCcCCH------HHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 111111111 34566778999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=295.50 Aligned_cols=242 Identities=21% Similarity=0.348 Sum_probs=188.7
Q ss_pred ccCCCCceeccCCCccEEEEEcC-CC----cEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP-GE----LHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~-~~----~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
.+|...+.||+|+||.||+|... ++ ..+|+|.+..... ....++.+|+..+++++||||++++++|.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677789999999999999853 23 3589998865532 233568889999999999999999999987 78899
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|+||+++|+|.+++... ...+++..+..++.|++.||+|||+.+++||||||+
T Consensus 86 v~e~~~~g~L~~~l~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~ 138 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH---------------------------KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAAR 138 (279)
T ss_pred EEecCCCCcHHHHHHhc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcc
Confidence 99999999999999751 234889999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchH-H
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-K 622 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~-~ 622 (690)
||++++++.+||+|||+++..... +||......++.++|||||||++||+++ |+.||.... .
T Consensus 139 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 218 (279)
T cd05057 139 NVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218 (279)
T ss_pred eEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 999999999999999998753211 2333333567889999999999999999 999987632 2
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCCC
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~~ 687 (690)
........+.. . ..+... . ..+.+++.+||..||++||++.++++.|+++...+
T Consensus 219 ~~~~~~~~~~~---~--~~~~~~--~----~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (279)
T cd05057 219 EIPDLLEKGER---L--PQPPIC--T----IDVYMVLVKCWMIDAESRPTFKELINEFSKMARDP 272 (279)
T ss_pred HHHHHHhCCCC---C--CCCCCC--C----HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCC
Confidence 22222222211 0 011111 1 23556677899999999999999999999876554
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=304.12 Aligned_cols=226 Identities=22% Similarity=0.220 Sum_probs=176.2
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~ 482 (690)
+|...+.||+|+||.||+|+. .++..||+|+++.... ...+....|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 467788999999999999984 4578999999975422 2234456677777776 5899999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+++++||||||+||
T Consensus 81 E~~~~g~L~~~~~~----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Ni 132 (323)
T cd05616 81 EYVNGGDLMYQIQQ----------------------------VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNV 132 (323)
T ss_pred cCCCCCCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHe
Confidence 99999999999875 23578889999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKL 627 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~ 627 (690)
|+++++.+||+|||+++.... .+||......++.++|||||||++|||+||+.||..... .....
T Consensus 133 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~ 212 (323)
T cd05616 133 MLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS 212 (323)
T ss_pred EECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999864211 145555556789999999999999999999999976321 12222
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
+.... ..++...+ . .+.+++.+|++.||++|++.
T Consensus 213 i~~~~------~~~p~~~s---~---~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 213 IMEHN------VAYPKSMS---K---EAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred HHhCC------CCCCCcCC---H---HHHHHHHHHcccCHHhcCCC
Confidence 22211 11111111 1 34456678999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=297.58 Aligned_cols=237 Identities=22% Similarity=0.268 Sum_probs=183.2
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
++|.+.+.||+|+||.||+|.. .++..+|+|.++.......+.+.+|++.+++++||||+++++++......++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 4577778899999999999995 467899999987554344567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++.+. ...+++..+..++.|++.||.|||+.+++||||||+||+++
T Consensus 85 ~~~~L~~~~~~~---------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~ 137 (280)
T cd06611 85 DGGALDSIMLEL---------------------------ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLT 137 (280)
T ss_pred CCCcHHHHHHHh---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEC
Confidence 999999998751 23588999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccC-----CCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH-H
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSE-----NETCGPESDVYCFGVILMELLTGKRGTDDCVKWV-R 625 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~-----~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~-~ 625 (690)
.++.+||+|||++...... +||... ...++.++|||||||++|||++|+.||....... .
T Consensus 138 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~ 217 (280)
T cd06611 138 LDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL 217 (280)
T ss_pred CCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH
Confidence 9999999999987543211 333321 1246779999999999999999999987532111 1
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
........ ..++ .+...+. .+.+++..||+.+|++||++.++++.
T Consensus 218 ~~~~~~~~-~~~~--~~~~~~~------~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 218 LKILKSEP-PTLD--QPSKWSS------SFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred HHHhcCCC-CCcC--CcccCCH------HHHHHHHHHhccChhhCcCHHHHhcC
Confidence 11111110 0000 0111111 34456677999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=290.95 Aligned_cols=235 Identities=22% Similarity=0.388 Sum_probs=184.4
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.+|...+.||+|+||.||+|.. .+..+|+|.++.. ...+.+.+|+..+++++||||+++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4577788999999999999985 4567999998643 234678899999999999999999999865 45789999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||+++.
T Consensus 82 ~~~L~~~l~~~--------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~ 135 (254)
T cd05083 82 KGNLVNFLRTR--------------------------GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSE 135 (254)
T ss_pred CCCHHHHHHhc--------------------------CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcC
Confidence 99999999752 1235788999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHHHhcCC
Q 005572 567 SLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVKEGAG 633 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~ 633 (690)
++.+||+|||+++..... +||......++.++|||||||++|||++ |+.||..... ........+..
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 215 (254)
T cd05083 136 DGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYR 215 (254)
T ss_pred CCcEEECCCccceeccccCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCC
Confidence 999999999998643221 4454444678889999999999999998 9999875321 22222222211
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
.+ .....+ ..+.+++.+||+.+|++||++.++++.|+.
T Consensus 216 ---~~--~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 216 ---ME--PPEGCP------ADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred ---CC--CCCcCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 11 111111 234567778999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=297.39 Aligned_cols=237 Identities=21% Similarity=0.256 Sum_probs=182.6
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+.|+..+.||+|+||.||+|+. .++..+|+|.+........+.+.+|++.++.++||||+++++++......++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 4577788999999999999995 458899999987654344567888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|..++.+. ...+++..+..++.|++.||+|||+.+++||||||+||+++
T Consensus 92 ~~~~l~~~~~~~---------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~ 144 (292)
T cd06644 92 PGGAVDAIMLEL---------------------------DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLT 144 (292)
T ss_pred CCCcHHHHHHhh---------------------------cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEc
Confidence 999999887641 23588999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccC-----CCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSE-----NETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRK 626 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~-----~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~ 626 (690)
.++.+||+|||++...... +||... ...++.++|||||||++|||++|+.||....... .
T Consensus 145 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~ 223 (292)
T cd06644 145 LDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-V 223 (292)
T ss_pred CCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-H
Confidence 9999999999987642211 344331 2346779999999999999999999986532111 1
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
........ .+...... .....+.+++.+||+.||++||++.|+++
T Consensus 224 ~~~~~~~~---~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 224 LLKIAKSE---PPTLSQPS----KWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred HHHHhcCC---CccCCCCc----ccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 11111000 01110000 01123456677899999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=305.53 Aligned_cols=222 Identities=21% Similarity=0.214 Sum_probs=171.0
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHH-HHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFD-ELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..||+|++..... ....++..|.. .++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 3699999999999994 5688999999964321 22234444544 46789999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++..+..++.||++||.|||+++++||||||+|||++.+
T Consensus 81 g~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~ 132 (323)
T cd05575 81 GELFFHLQR----------------------------ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQ 132 (323)
T ss_pred CCHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCC
Confidence 999999875 2357888899999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~ 632 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++|+.||.... ....+......
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~ 212 (323)
T cd05575 133 GHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP 212 (323)
T ss_pred CcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999999864211 14555555678899999999999999999999987521 11111111111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQ 674 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ 674 (690)
. .+....+. .+.+++.+|++.||++||++.
T Consensus 213 ~------~~~~~~~~------~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 213 L------RLKPNISV------SARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred C------CCCCCCCH------HHHHHHHHHhhcCHHhCCCCC
Confidence 0 11111111 344566679999999999885
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=295.06 Aligned_cols=241 Identities=20% Similarity=0.294 Sum_probs=185.7
Q ss_pred ccCCCCceeccCCCccEEEEEcCC----CcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG----ELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
.+|...+.||+|+||.||+|...+ ...||+|...... ....+.+.+|++.+++++||||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 346677899999999999998532 3468999886543 2334578889999999999999999999875 567899
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+++|+|.+++... ...+++..+..++.|++.||+|||+.+++||||||+|
T Consensus 85 ~e~~~~~~L~~~l~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~n 137 (270)
T cd05056 85 MELAPLGELRSYLQVN---------------------------KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARN 137 (270)
T ss_pred EEcCCCCcHHHHHHhC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChhe
Confidence 9999999999999751 2357899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH-H
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW-V 624 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~-~ 624 (690)
|+++.++.+||+|||+++..... +||......++.++|||||||++||+++ |..||...... .
T Consensus 138 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~ 217 (270)
T cd05056 138 VLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV 217 (270)
T ss_pred EEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 99999999999999998643211 3444434567889999999999999986 99998763221 1
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCC
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
......+.. ...+...+ ..+.+++.+||..+|++|||+.|+++.|+++...
T Consensus 218 ~~~~~~~~~-----~~~~~~~~------~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 218 IGRIENGER-----LPMPPNCP------PTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred HHHHHcCCc-----CCCCCCCC------HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 111111111 11111111 1345567789999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=291.44 Aligned_cols=236 Identities=18% Similarity=0.237 Sum_probs=183.2
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC-----CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG-----IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
++|+..+.||+|++|.||+|. ..++..+|+|.+..... ...+.+.+|++.+++++||||+++++++...+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 467888999999999999998 45688999999864321 122467889999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+
T Consensus 82 v~e~~~~~~l~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ 133 (263)
T cd06625 82 FMEYMPGGSVKDQLKA----------------------------YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGA 133 (263)
T ss_pred EEEECCCCcHHHHHHH----------------------------hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9999999999999875 234778888999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCccccccc-----------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH
Q 005572 561 SILLAESLEPKIAGFGLRNIGVK-----------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW 623 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~-----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~ 623 (690)
||++++++.+||+|||+++.... .+||......++.++|||||||++|||++|+.||......
T Consensus 134 nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 213 (263)
T cd06625 134 NILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAM 213 (263)
T ss_pred HEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchH
Confidence 99999999999999999864211 1344444456788999999999999999999998753221
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.. ........ ..+.++...+. .+.+++..||+.+|++|||+.|+++.
T Consensus 214 ~~-~~~~~~~~--~~~~~~~~~~~------~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 214 AA-IFKIATQP--TNPQLPSHVSP------DARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred HH-HHHHhccC--CCCCCCccCCH------HHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 11 11110000 11112111211 23456667999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=290.14 Aligned_cols=232 Identities=22% Similarity=0.364 Sum_probs=183.7
Q ss_pred ceeccCCCccEEEEEcCCCcEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHh
Q 005572 413 SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLH 491 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 491 (690)
+.||+|+||.||++...++..||+|.+...... ....+.+|++.+++++||||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 368999999999999766889999998654332 3467889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCce
Q 005572 492 RWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPK 571 (690)
Q Consensus 492 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~k 571 (690)
+++... ...+++..+..++.|++.|++|||+++++||||||+||+++.++.+|
T Consensus 81 ~~l~~~---------------------------~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~ 133 (251)
T cd05041 81 TFLRKK---------------------------KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLK 133 (251)
T ss_pred HHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEE
Confidence 999751 23578889999999999999999999999999999999999999999
Q ss_pred EcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHHHhcCC
Q 005572 572 IAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVKEGAG 633 (690)
Q Consensus 572 l~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~~~~~~ 633 (690)
|+|||+++.... .+||......++.++|||||||++|||+| |..||..... ..........
T Consensus 134 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~- 212 (251)
T cd05041 134 ISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY- 212 (251)
T ss_pred EeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-
Confidence 999999864321 13444434567889999999999999999 8888865322 1112221111
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
. ...+.. ....+.+++.+||+.+|++|||+.|+++.|+.
T Consensus 213 -~---~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~ 251 (251)
T cd05041 213 -R---MPAPQL------CPEEIYRLMLQCWAYDPENRPSFSEIYNELQI 251 (251)
T ss_pred -C---CCCCcc------CCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence 0 001001 11245667788999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=293.22 Aligned_cols=238 Identities=23% Similarity=0.277 Sum_probs=187.1
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
++|...+.||+|+||.||+|.. .++..+|+|.+........+.+.+|++.+++++||||++++|++...+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 4677889999999999999985 557789999997655455678899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++++|.+++... ...+++.++..++.|++.||+|||+.+++||||||+||+++
T Consensus 83 ~~~~l~~~~~~~---------------------------~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 135 (262)
T cd06613 83 GGGSLQDIYQVT---------------------------RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLT 135 (262)
T ss_pred CCCcHHHHHHhh---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEEC
Confidence 999999998751 13578889999999999999999999999999999999999
Q ss_pred CCCCceEcCCCccccccc--------------ccCcccCCC---CCCCCCcchhhHHHHHHHHhCCCCCCchHHHHH-HH
Q 005572 566 ESLEPKIAGFGLRNIGVK--------------NVGERSENE---TCGPESDVYCFGVILMELLTGKRGTDDCVKWVR-KL 627 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~--------------~~~e~~~~~---~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~-~~ 627 (690)
+++.+||+|||++..... .+||..... .++.++|||||||++|||+||+.||.+....-. ..
T Consensus 136 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~ 215 (262)
T cd06613 136 EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL 215 (262)
T ss_pred CCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999998764321 134444334 677899999999999999999999876332111 11
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
...... ....+. ........+.+++.+||+.+|.+|||+.||+.
T Consensus 216 ~~~~~~---~~~~~~----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 216 ISKSNF---PPPKLK----DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred HHhccC---CCcccc----chhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 111100 001110 01111224566778899999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=309.66 Aligned_cols=238 Identities=18% Similarity=0.171 Sum_probs=179.3
Q ss_pred HHhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeE
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
....+|+..+.||+|+||.||+++. .++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 3456888999999999999999994 567899999986432 223455778999999999999999999999999999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+|||||++|+|.+++.. ..+++..+..++.|++.||+|||+++++||||||
T Consensus 120 lv~Ey~~gg~L~~~l~~-----------------------------~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp 170 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN-----------------------------YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKP 170 (370)
T ss_pred EEEcCCCCCcHHHHHHh-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCH
Confidence 99999999999999864 2367788899999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCccccccc-----------ccCcccCC----C----CCCCCCcchhhHHHHHHHHhCCCCCCch
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVK-----------NVGERSEN----E----TCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~-----------~~~e~~~~----~----~~~~~~DVwSfGvvl~el~tg~~p~~~~ 620 (690)
+|||+++++.+||+|||+++.... ...|.+|| . .++.++||||+||++|||++|+.||...
T Consensus 171 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~ 250 (370)
T cd05621 171 DNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD 250 (370)
T ss_pred HHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence 999999999999999999875321 12233333 1 3778999999999999999999999752
Q ss_pred H--HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 005572 621 V--KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGK--RPTMQQVLGL 679 (690)
Q Consensus 621 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~--RPt~~ev~~~ 679 (690)
. ............ +........+.. +.+++..|++.+|.+ ||++.|+++.
T Consensus 251 ~~~~~~~~i~~~~~~---~~~p~~~~~s~~------~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 251 SLVGTYSKIMDHKNS---LNFPEDVEISKH------AKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred CHHHHHHHHHhCCcc---cCCCCcccCCHH------HHHHHHHHccCchhccCCCCHHHHhcC
Confidence 2 222222221110 110000011112 233445577755543 8899998875
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=292.05 Aligned_cols=235 Identities=21% Similarity=0.289 Sum_probs=182.4
Q ss_pred cCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCC------CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI------DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
+|...+.||+|+||.||+|...++..+|+|.++..... ....+.+|++.+++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 36677899999999999999878889999998643211 124577899999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
+||+++|+|.+++.+ ...+++..+..++.|++.||+|||+.+++|+||||+|
T Consensus 81 ~e~~~~~~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~n 132 (265)
T cd06631 81 MEFVPGGSISSILNR----------------------------FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNN 132 (265)
T ss_pred EecCCCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHh
Confidence 999999999999975 2347788899999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCccccccc--------------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVK--------------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~--------------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~ 621 (690)
|++++++.+||+|||++..... .+||......++.++|||||||++|||++|+.||....
T Consensus 133 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 212 (265)
T cd06631 133 VMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMD 212 (265)
T ss_pred EEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence 9999999999999998764310 13454444567889999999999999999999997532
Q ss_pred HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
........ ... ....+.++...+ ..+.+++.+||+.+|++||++.|+++
T Consensus 213 ~~~~~~~~-~~~-~~~~~~~~~~~~------~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 213 RLAAMFYI-GAH-RGLMPRLPDSFS------AAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred hHHHHHHh-hhc-cCCCCCCCCCCC------HHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22111111 100 001111211111 13455667899999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=313.23 Aligned_cols=185 Identities=19% Similarity=0.158 Sum_probs=158.3
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||+|+||.||+++ ..++..||+|++.... ......+.+|++++++++||||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 368888999999999999998 4568899999986432 123456788999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
|||++|+|.+++.+ ...+++.....++.||+.||+|||+++|+||||||+||
T Consensus 81 E~~~~g~L~~~i~~----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni 132 (376)
T cd05598 81 DYIPGGDMMSLLIR----------------------------LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132 (376)
T ss_pred eCCCCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHE
Confidence 99999999999975 23467788888999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccc-----------------------------------------------------cc----c
Q 005572 563 LLAESLEPKIAGFGLRNIGV-----------------------------------------------------KN----V 585 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~-----------------------------------------------------~~----~ 585 (690)
|++.++.+||+|||++.... .. +
T Consensus 133 ll~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 212 (376)
T cd05598 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA 212 (376)
T ss_pred EECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccC
Confidence 99999999999999864110 01 3
Q ss_pred CcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 586 GERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 586 ~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
||......++.++|||||||++|||++|+.||..
T Consensus 213 PE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~ 246 (376)
T cd05598 213 PEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 246 (376)
T ss_pred HHHHcCCCCCcceeeeeccceeeehhhCCCCCCC
Confidence 4444445788899999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=299.72 Aligned_cols=233 Identities=23% Similarity=0.310 Sum_probs=178.8
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|+..+.||+|+||.||+|+ ..++..+|+|.+..... ...+.+.+|++++++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 56677899999999999998 46688999999865422 22356888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|..+. .+++..+..++.|++.||.|||+.+++|+||||+||+++
T Consensus 82 ~~~~l~~~~--------------------------------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~ 129 (279)
T cd06619 82 DGGSLDVYR--------------------------------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVN 129 (279)
T ss_pred CCCChHHhh--------------------------------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEEC
Confidence 999986542 256778889999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH-----HHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV-----RKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~-----~~~~ 628 (690)
.++.+||+|||++...... +||......++.++|||||||++|||++|+.||....... ....
T Consensus 130 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 209 (279)
T cd06619 130 TRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL 209 (279)
T ss_pred CCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH
Confidence 9999999999998643211 4555555678899999999999999999999986421100 0000
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.. ... ...+..... ... ..+.+++.+||+.+|++||+++|+++.
T Consensus 210 ~~-~~~-~~~~~~~~~--~~~---~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 210 QC-IVD-EDPPVLPVG--QFS---EKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred HH-Hhc-cCCCCCCCC--cCC---HHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 00 000 001111100 011 134567778999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=308.88 Aligned_cols=227 Identities=23% Similarity=0.251 Sum_probs=183.8
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 480 (690)
..+|...++||+|.||.|+++.. .++..+|||++++..- .+.+....|-+++... +||-++.|+.++.+.++.|.
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 45788889999999999999995 5578999999987642 3445677788877666 59999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
||||+.|||+..+.+. +.+++..+.-+|..|+.||+|||+++||+||||.+
T Consensus 447 vmey~~Ggdm~~~~~~-----------------------------~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLd 497 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT-----------------------------DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLD 497 (694)
T ss_pred EEEecCCCcEEEEEec-----------------------------ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchh
Confidence 9999999996655542 56899999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc-hHHHHH
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD-CVKWVR 625 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~-~~~~~~ 625 (690)
|||||.+|.+||+|||+++..... +||+..+..|+..+|.|||||+||||+.|..||.. ..+.+.
T Consensus 498 NiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~F 577 (694)
T KOG0694|consen 498 NLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVF 577 (694)
T ss_pred heEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 999999999999999999864311 78888889999999999999999999999999984 333343
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
..+... ++..+... ..+...++.+.+..+|++|--+
T Consensus 578 dsI~~d------~~~yP~~l------s~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 578 DSIVND------EVRYPRFL------SKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HHHhcC------CCCCCCcc------cHHHHHHHHHHhccCcccccCC
Confidence 333321 12222222 1234455667899999999765
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=290.47 Aligned_cols=232 Identities=22% Similarity=0.319 Sum_probs=180.3
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCC---------HHHHHHHHHHHHhcCCCCccceeeEEecCCee
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGID---------HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---------~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 478 (690)
|.....||+|+||.||+|.. .++..+|+|.+....... .+.+.+|++++++++||||+++++++...+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 55668899999999999984 557899999886443221 14577899999999999999999999999999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++|+||+++++|.+++.. ...+++..+..++.|++.||+|||+.+++|||||
T Consensus 82 ~lv~e~~~~~~L~~~l~~----------------------------~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~ 133 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN----------------------------YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIK 133 (267)
T ss_pred EEEEEecCCCCHHHHHHh----------------------------ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCC
Confidence 999999999999999975 2357888899999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc--------------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN--------------------VGERSENETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~--------------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
|+||++++++.+||+|||+++..... +||......++.++|||||||++|||++|+.||.
T Consensus 134 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 213 (267)
T cd06628 134 GANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213 (267)
T ss_pred HHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCC
Confidence 99999999999999999987654310 2333333467789999999999999999999998
Q ss_pred chHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 619 DCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 619 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+..... ....... ...+.++...+ ..+.+++.+||+.||.+||++.||++
T Consensus 214 ~~~~~~-~~~~~~~---~~~~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 214 DCTQLQ-AIFKIGE---NASPEIPSNIS------SEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred CccHHH-HHHHHhc---cCCCcCCcccC------HHHHHHHHHHccCCchhCcCHHHHhh
Confidence 643221 1111111 11111111111 13445666799999999999999976
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=305.15 Aligned_cols=226 Identities=20% Similarity=0.210 Sum_probs=172.9
Q ss_pred ceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHH-HHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDE-LSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+ ..++..+|+|++..... .....+..|... ++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 368999999999998 45688999999965321 223345555544 6778999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|..++.. ...+++.++..++.||+.||+|||+.+++||||||+|||++++
T Consensus 81 ~~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~ 132 (325)
T cd05604 81 GELFFHLQR----------------------------ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQ 132 (325)
T ss_pred CCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC
Confidence 999998865 2357889999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~ 632 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++|+.||.... ....+......
T Consensus 133 ~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~ 212 (325)
T cd05604 133 GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212 (325)
T ss_pred CCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999999864211 14555555678899999999999999999999986521 11111111111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
. .+....+ ..+.+++..|++.+|.+||++++.++
T Consensus 213 ~------~~~~~~~------~~~~~ll~~ll~~~p~~R~~~~~~~~ 246 (325)
T cd05604 213 L------VLRPGAS------LTAWSILEELLEKDRQRRLGAKEDFL 246 (325)
T ss_pred c------cCCCCCC------HHHHHHHHHHhccCHHhcCCCCCCHH
Confidence 0 1111111 13445667799999999998864333
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=300.52 Aligned_cols=244 Identities=18% Similarity=0.214 Sum_probs=180.4
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
.+|...+.||+|+||.||+|+. .++..||+|.++.... .....+.+|++++++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 3577788999999999999984 4578899999875432 2334677899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++ +|.+++... ...+++..+..++.|++.||+|||+++++||||||+||++
T Consensus 86 ~~~-~l~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill 137 (309)
T cd07872 86 LDK-DLKQYMDDC---------------------------GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI 137 (309)
T ss_pred CCC-CHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 975 898888651 2357888999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc----------c----cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVK----------N----VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~----------~----~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~ 627 (690)
+.++.+||+|||+++.... . +||.... ..++.++|||||||++|||+||+.||... .+.....
T Consensus 138 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~ 217 (309)
T cd07872 138 NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLI 217 (309)
T ss_pred CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999999999864321 1 3443322 35788999999999999999999998652 1111111
Q ss_pred HHhcCC-C-----------CccccccccCCCCCH-----HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEGAG-G-----------DALDFRLKLGSGDSV-----AEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~~-~-----------~~~~~~~~~~~~~~~-----~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
...... . ...+...+....... .--....+++.+|++.||.+|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 218 FRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred HHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 110000 0 000000000000000 00113456778899999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=310.85 Aligned_cols=184 Identities=20% Similarity=0.193 Sum_probs=157.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|...+.||+|+||.||+++ ..++..||||++.... ....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 67788999999999999998 5668899999986432 1223567789999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.. ...+++..+..++.|++.||+|||+.+++||||||+|||
T Consensus 82 ~~~gg~L~~~l~~----------------------------~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIl 133 (377)
T cd05629 82 FLPGGDLMTMLIK----------------------------YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNIL 133 (377)
T ss_pred CCCCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence 9999999999975 235778888899999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccc---------------------------------------------------------cc--
Q 005572 564 LAESLEPKIAGFGLRNIGV---------------------------------------------------------KN-- 584 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~---------------------------------------------------------~~-- 584 (690)
++.++.+||+|||+++... ..
T Consensus 134 l~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (377)
T cd05629 134 IDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPD 213 (377)
T ss_pred ECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCcc
Confidence 9999999999999985210 01
Q ss_pred --cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 585 --VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 585 --~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
+||......++.++|||||||++|||++|+.||..
T Consensus 214 y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (377)
T cd05629 214 YIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCS 250 (377)
T ss_pred ccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCC
Confidence 34444445788999999999999999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-35 Score=274.59 Aligned_cols=238 Identities=19% Similarity=0.239 Sum_probs=188.1
Q ss_pred HhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC----CC----HHHHHHHHHHHHhc-CCCCccceeeEEec
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG----ID----HDDAVAMFDELSRL-KHPNLLPLAGYCIA 474 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~----~~----~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 474 (690)
..+.|...+.+|.|..+.|.++. ..++..+|+|+++.... .. .+.-.+|+.+|+++ .||+|+.+.+++++
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 34567778899999999999997 56788999999864321 11 23456789999988 59999999999999
Q ss_pred CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC
Q 005572 475 GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTH 554 (690)
Q Consensus 475 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iH 554 (690)
+...++|+|.|+.|.|+|||.. .-.+++....+|+.|+.+|++|||..+|+|
T Consensus 95 ~sF~FlVFdl~prGELFDyLts----------------------------~VtlSEK~tR~iMrqlfegVeylHa~~IVH 146 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTS----------------------------KVTLSEKETRRIMRQLFEGVEYLHARNIVH 146 (411)
T ss_pred cchhhhhhhhcccchHHHHhhh----------------------------heeecHHHHHHHHHHHHHHHHHHHHhhhhh
Confidence 9999999999999999999975 346889999999999999999999999999
Q ss_pred CCCCCCcEEecCCCCceEcCCCcccccccc---------cCcccCC----------CCCCCCCcchhhHHHHHHHHhCCC
Q 005572 555 GHLVTSSILLAESLEPKIAGFGLRNIGVKN---------VGERSEN----------ETCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 555 rDlk~~NiLl~~~~~~kl~DfGla~~~~~~---------~~e~~~~----------~~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
|||||+|||+|++..+||+|||++...... ++|.+|+ ..|+..+|+||.||+||.|+.|.+
T Consensus 147 RDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcp 226 (411)
T KOG0599|consen 147 RDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCP 226 (411)
T ss_pred cccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999876543 5566555 268889999999999999999999
Q ss_pred CCCch-HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 616 GTDDC-VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 616 p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
||-.- ...+.+.+.++.... -.+.. .+.+.. ..+++.+|++.||.+|.|+.|+++
T Consensus 227 PFwHRkQmlMLR~ImeGkyqF-~speW-adis~~------~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 227 PFWHRKQMLMLRMIMEGKYQF-RSPEW-ADISAT------VKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred chhHHHHHHHHHHHHhccccc-CCcch-hhcccc------HHHHHHHHHeeCchhcccHHHHhc
Confidence 98642 223345555553210 01111 111222 345556799999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-34 Score=292.60 Aligned_cols=246 Identities=22% Similarity=0.326 Sum_probs=187.8
Q ss_pred ccCCCCceeccCCCccEEEEEcC------CCcEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
++|+....||+|+||.||+|+.. +...+|+|.+...... ..+++.+|++++++++||||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778899999999999999853 2467999988654432 3467899999999999999999999999989999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||+++|+|.+++........ ......+++..+..++.|++.||+|||+.+++||||||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~-------------------~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp 145 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDE-------------------KLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAA 145 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccc-------------------cccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCcc
Confidence 99999999999999976321100 01223689999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCccccccc---------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHHH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVK---------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVKW 623 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~---------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~~ 623 (690)
+||+++.++.+|++|||+++.... .+||.......+.++|||||||++|||++ |..||......
T Consensus 146 ~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~ 225 (275)
T cd05046 146 RNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE 225 (275)
T ss_pred ceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH
Confidence 999999999999999999764221 13444444567789999999999999999 78888653221
Q ss_pred -HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 624 -VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 624 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
.......+... .......+ ..+.+++.+||+.+|++||++.|+++.|.
T Consensus 226 ~~~~~~~~~~~~----~~~~~~~~------~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 226 EVLNRLQAGKLE----LPVPEGCP------SRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred HHHHHHHcCCcC----CCCCCCCC------HHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 11111111111 11111111 13556777899999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=297.36 Aligned_cols=231 Identities=21% Similarity=0.288 Sum_probs=181.0
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
|+..+.||+|+||.||+|.. .++..||+|.++.... ...+.+.+|++.+++++||||+++++++...+..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 44456799999999999984 5578899999864432 234568889999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++.. ..+++..+..++.|+++|+.|||+++++|+||+|+||++++
T Consensus 86 ~~~L~~~~~~-----------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~ 136 (277)
T cd06642 86 GGSALDLLKP-----------------------------GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSE 136 (277)
T ss_pred CCcHHHHhhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeC
Confidence 9999998853 34788899999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcC
Q 005572 567 SLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGA 632 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~ 632 (690)
++.+|++|||++...... +||......++.++|||||||++|||++|+.|+.+.............
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~ 216 (277)
T cd06642 137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN 216 (277)
T ss_pred CCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC
Confidence 999999999998653221 344444456788999999999999999999998753222111111000
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..+.+... ....+.+++.+||+.+|++||+|.|+++
T Consensus 217 ----~~~~~~~~------~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06642 217 ----SPPTLEGQ------YSKPFKEFVEACLNKDPRFRPTAKELLK 252 (277)
T ss_pred ----CCCCCCcc------cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 01111111 1123456677899999999999999987
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=285.58 Aligned_cols=254 Identities=24% Similarity=0.308 Sum_probs=198.4
Q ss_pred HHHHHHHhccCCCCceeccCCCccEEEEEcCC------CcEEEEEEeecc-CCCCHHHHHHHHHHHHhcCCCCccceeeE
Q 005572 399 FKDLIAATSHFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVLDNA-KGIDHDDAVAMFDELSRLKHPNLLPLAGY 471 (690)
Q Consensus 399 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~~vavK~l~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~ 471 (690)
.+++.....++....++.+|.||.||+|.|.+ .+.|-||.++.. +......+.+|--.+..+.|||+..+.|+
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 45666666778888899999999999997643 345667777543 22334567778888889999999999999
Q ss_pred Eec-CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc
Q 005572 472 CIA-GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV 550 (690)
Q Consensus 472 ~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~ 550 (690)
+.+ .+..+++|.++.-|+|..||...+..++ ...+.++-.+...++.|++.||+|||.+
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~--------------------~~aqtvtt~qlV~masQla~am~hlh~~ 415 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDP--------------------SYAQTVTTIQLVLMASQLAMAMEHLHNH 415 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCC--------------------ccccchhHHHHHHHHHHHHHHHHHHHhc
Confidence 875 5678899999999999999996543222 2345677888999999999999999999
Q ss_pred CCCCCCCCCCcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-C
Q 005572 551 GSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-G 613 (690)
Q Consensus 551 ~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g 613 (690)
++||.||.++|++||+..++||+|-.++|..-+. ++|......|+.++|||||||+||||+| |
T Consensus 416 ~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg 495 (563)
T KOG1024|consen 416 GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLG 495 (563)
T ss_pred CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999865432 3344455689999999999999999998 9
Q ss_pred CCCCCchH-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 614 KRGTDDCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 614 ~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
+.||.++. .++...+++|.... . +..+++ +++.+|.-||..+|++||+++|++..|.+.
T Consensus 496 ~~PyaeIDPfEm~~ylkdGyRla---Q--P~NCPD------eLf~vMacCWallpeeRPsf~Qlv~cLseF 555 (563)
T KOG1024|consen 496 KLPYAEIDPFEMEHYLKDGYRLA---Q--PFNCPD------ELFTVMACCWALLPEERPSFSQLVICLSEF 555 (563)
T ss_pred CCCccccCHHHHHHHHhccceec---C--CCCCcH------HHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 99998854 34455555543211 1 112222 466677789999999999999999999875
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.78 Aligned_cols=184 Identities=19% Similarity=0.139 Sum_probs=157.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
.|...+.||+|+||.||+|+ ..++..+|+|++..... ...+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57788999999999999998 45688999999965321 223567889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
||++|+|.+++.+ ...+++.....++.|++.||+|||+++|+||||||+|||
T Consensus 82 ~~~gg~L~~~l~~----------------------------~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NIL 133 (382)
T cd05625 82 YIPGGDMMSLLIR----------------------------MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL 133 (382)
T ss_pred CCCCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9999999999975 234678888899999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccc---------------------------------------------------------c---
Q 005572 564 LAESLEPKIAGFGLRNIGV---------------------------------------------------------K--- 583 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~---------------------------------------------------------~--- 583 (690)
++.++.+||+|||+++... .
T Consensus 134 l~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 213 (382)
T cd05625 134 IDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPN 213 (382)
T ss_pred ECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcc
Confidence 9999999999999864210 0
Q ss_pred -ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 584 -NVGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 584 -~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
.+||......++.++|||||||++|||++|+.||..
T Consensus 214 Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~ 250 (382)
T cd05625 214 YIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLA 250 (382)
T ss_pred cCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCC
Confidence 144444445788999999999999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=297.36 Aligned_cols=248 Identities=20% Similarity=0.230 Sum_probs=188.0
Q ss_pred cCHHHHHHHhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeEEec
Q 005572 397 LTFKDLIAATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIA 474 (690)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 474 (690)
++++++..++++|...+.||+|+||.||++.. .++..+|+|.+.... .....+.+|+.++.++ +||||+++++++..
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 44556666788999999999999999999984 568899999986432 2345678899999998 79999999999875
Q ss_pred C-----CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh
Q 005572 475 G-----KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH 549 (690)
Q Consensus 475 ~-----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~ 549 (690)
. +..++|+||+++|+|.++++... .....+++..+..++.|++.||+|||+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~------------------------~~~~~~~~~~~~~~~~qi~~al~~lH~ 146 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLL------------------------ICGQRLDEAMISYILYGALLGLQHLHN 146 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhh------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4 35899999999999999987421 123458899999999999999999999
Q ss_pred cCCCCCCCCCCcEEecCCCCceEcCCCccccccc----------c----cCcccCCC-----CCCCCCcchhhHHHHHHH
Q 005572 550 VGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK----------N----VGERSENE-----TCGPESDVYCFGVILMEL 610 (690)
Q Consensus 550 ~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~----------~----~~e~~~~~-----~~~~~~DVwSfGvvl~el 610 (690)
.+++||||||+||++++++.+||+|||++..... . +||..... .++.++|||||||++|||
T Consensus 147 ~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el 226 (291)
T cd06639 147 NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226 (291)
T ss_pred CCeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHH
Confidence 9999999999999999999999999998764321 1 33332111 257899999999999999
Q ss_pred HhCCCCCCchHHHHHH-HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 611 LTGKRGTDDCVKWVRK-LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 611 ~tg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
++|+.||......... ........ .+.. .......+.+++.+||+.+|++||++.|+++
T Consensus 227 ~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~----~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 227 GDGDPPLFDMHPVKTLFKIPRNPPP-----TLLH----PEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred hhCCCCCCCCcHHHHHHHHhcCCCC-----CCCc----ccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 9999998763221110 11111110 1100 0111124566778899999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=310.57 Aligned_cols=243 Identities=20% Similarity=0.213 Sum_probs=178.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCC-----eeE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK-----EKL 479 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~ 479 (690)
+|+..+.||+|+||.||++. ..++..||+|++..... ...+.+.+|+++++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 47778999999999999998 45788999999864321 23456788999999999999999999998776 789
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+|+||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+++||||||
T Consensus 81 lv~e~~~-~~l~~~~~~----------------------------~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp 131 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS----------------------------PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKP 131 (372)
T ss_pred EEeeccc-cCHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 9999996 588888754 34588999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc---------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHHH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN---------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVKW 623 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~ 623 (690)
+|||++.++.+||+|||+++..... +||.... ..++.++|||||||++|||++|+.||......
T Consensus 132 ~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 132 GNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred HHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 9999999999999999998743211 2333222 24688999999999999999999999652111
Q ss_pred --HHHHHHhcCC------------------CCccc-cccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 624 --VRKLVKEGAG------------------GDALD-FRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 624 --~~~~~~~~~~------------------~~~~~-~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
...+...... ..... +...............+.+++.+|++.||++|||+.|+++.
T Consensus 212 ~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 212 QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred HHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 1111100000 00000 00000000000001234567788999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=289.32 Aligned_cols=239 Identities=26% Similarity=0.381 Sum_probs=186.0
Q ss_pred ceeccCCCccEEEEEcCC----CcEEEEEEeeccCCCC-HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVLPG----ELHVAIKVLDNAKGID-HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|.... +..+|+|.+....... .+.+.+|++.++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 368999999999999543 7789999997654332 57788999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++....... .......+++.++..++.|+++||+|||+++++||||||+||+++++
T Consensus 81 ~~L~~~l~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~ 141 (262)
T cd00192 81 GDLLDYLRKSRPVF-------------------PSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGED 141 (262)
T ss_pred CcHHHHHhhccccc-------------------cccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCC
Confidence 99999998632100 00113568999999999999999999999999999999999999999
Q ss_pred CCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH-HHHHHHH
Q 005572 568 LEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVK 629 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~-~~~~~~~ 629 (690)
+.+||+|||.+...... +||......++.++||||+||++|||++ |..||..... .......
T Consensus 142 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 221 (262)
T cd00192 142 LVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221 (262)
T ss_pred CcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999998754321 4454444578889999999999999999 6999876321 1222222
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
.+.. ...+... ..++.+++.+||+.+|++|||+.|+++.|+
T Consensus 222 ~~~~-----~~~~~~~------~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 222 KGYR-----LPKPEYC------PDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred cCCC-----CCCCccC------ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 1111 1111111 124556677899999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=302.16 Aligned_cols=255 Identities=27% Similarity=0.342 Sum_probs=190.0
Q ss_pred ccCCCCceeccCCCccEEEEEcC--------CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP--------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGK 476 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~--------~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 476 (690)
.+|...+.||+|+||.||+++.. ....||+|.++.... ...+++.+|++.++++ +||||++++++|...+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 45778899999999999999731 123689998864322 2346788999999999 7999999999999999
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..++|+||+++|+|.+++.......... .. .........++|.+++.++.|+++||+|||+++++|||
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~---~~---------~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~d 159 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDY---SF---------DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRD 159 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCccccc---cc---------ccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 9999999999999999998632110000 00 00001234689999999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCc
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDD 619 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~ 619 (690)
|||+|||+++++.+||+|||+++.... .+||......++.++|||||||++|||++ |..||..
T Consensus 160 lkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 160 LAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred cccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 999999999999999999999864321 13444444567889999999999999998 8888865
Q ss_pred hH-HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 620 CV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 620 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
.. .............+ .+... . ..+.+++.+||+.+|++||++.|+++.|+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~-----~~~~~---~---~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 240 IPVEELFKLLKEGHRMD-----KPANC---T---HELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred CCHHHHHHHHHcCCCCC-----CCCCC---C---HHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 32 22222222211111 11111 1 13556778899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=296.35 Aligned_cols=248 Identities=20% Similarity=0.229 Sum_probs=185.9
Q ss_pred HHHHHHHhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeEEe---
Q 005572 399 FKDLIAATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCI--- 473 (690)
Q Consensus 399 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~--- 473 (690)
++++..+..+|+..+.||+|+||.||+|+. .++..+|+|.++... ....++..|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 345556778899999999999999999984 557899999886432 2345678899999999 6999999999885
Q ss_pred --cCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC
Q 005572 474 --AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG 551 (690)
Q Consensus 474 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~ 551 (690)
..+..++||||+++|+|.+++.... .....+++..+..++.|+++||.|||+.+
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 144 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFL------------------------KRGERMEEPIIAYILHEALMGLQHLHVNK 144 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhh------------------------ccCccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 3456899999999999999886421 11245788899999999999999999999
Q ss_pred CCCCCCCCCcEEecCCCCceEcCCCcccccccc----------cCcccCC---------CCCCCCCcchhhHHHHHHHHh
Q 005572 552 STHGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------VGERSEN---------ETCGPESDVYCFGVILMELLT 612 (690)
Q Consensus 552 ~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~----------~~e~~~~---------~~~~~~~DVwSfGvvl~el~t 612 (690)
++||||||+||++++++.+||+|||+++..... ..|.+|+ ..++.++|||||||++|||++
T Consensus 145 i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~ 224 (286)
T cd06638 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGD 224 (286)
T ss_pred ccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhc
Confidence 999999999999999999999999998643211 2233333 246889999999999999999
Q ss_pred CCCCCCchHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 613 GKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 613 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
|+.||.+..... ........ ..+...... ... ..+.+++.+||+.||++|||+.|+++.
T Consensus 225 g~~p~~~~~~~~-~~~~~~~~---~~~~~~~~~-~~~---~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 225 GDPPLADLHPMR-ALFKIPRN---PPPTLHQPE-LWS---NEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred CCCCCCCCchhH-HHhhcccc---CCCcccCCC-CcC---HHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 999987642211 11111100 001110000 001 135567778999999999999999874
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.24 Aligned_cols=236 Identities=18% Similarity=0.150 Sum_probs=180.6
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
|...+.||+|+||+||+|.. .++..+|+|.+..... .....+.+|++++++++|+||+.+.+++...+..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 55567899999999999984 5688999999865422 2234567899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++|+|.+++... ....+++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 82 ~~~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili 135 (285)
T cd05632 82 MNGGDLKFHIYNM--------------------------GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL 135 (285)
T ss_pred ccCccHHHHHHHh--------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE
Confidence 9999999988651 12358999999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc-------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH-HHHHHh
Q 005572 565 AESLEPKIAGFGLRNIGVK-------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV-RKLVKE 630 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~-------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~-~~~~~~ 630 (690)
++++.+||+|||++..... .+||......++.++|||||||++|||++|..||....... ......
T Consensus 136 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~ 215 (285)
T cd05632 136 DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215 (285)
T ss_pred CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999998854321 14555555678899999999999999999999997532211 111111
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-----MQQVLG 678 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-----~~ev~~ 678 (690)
. .... ........+ ..+.+++..||+.||++||+ +.|++.
T Consensus 216 ~-~~~~-~~~~~~~~~------~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 216 R-VLET-EEVYSAKFS------EEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred h-hhcc-ccccCccCC------HHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0 0000 011111111 12345667799999999999 666655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=284.07 Aligned_cols=184 Identities=26% Similarity=0.318 Sum_probs=156.4
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeecc--CCCCHHHHHHHHHHHHhcCCCCccceeeEEec-----CCee
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA--KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA-----GKEK 478 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-----~~~~ 478 (690)
..|...+.||+|+||.|+.+. ..++..||||++.+. .....+...+|++.|+.++|+||+.+++.+.. -...
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 345556889999999999998 567899999998632 33456778899999999999999999999876 2468
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
|+|+|+|+ .||...++. ...|+......+..|+.+||.|+|+.+++|||||
T Consensus 102 YiV~elMe-tDL~~iik~----------------------------~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLK 152 (359)
T KOG0660|consen 102 YLVFELME-TDLHQIIKS----------------------------QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLK 152 (359)
T ss_pred EEehhHHh-hHHHHHHHc----------------------------CccccHHHHHHHHHHHHHhcchhhcccccccccc
Confidence 99999995 499999975 3348888899999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCccccccc----c--------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVK----N--------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~----~--------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|+|+|++.+...||+|||+|+.... . -.|++|| ..|+.+.||||.||++.||++|++-|.+
T Consensus 153 PsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG 230 (359)
T KOG0660|consen 153 PSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPG 230 (359)
T ss_pred hhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCC
Confidence 9999999999999999999998742 1 2344443 3799999999999999999999988764
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=304.88 Aligned_cols=183 Identities=21% Similarity=0.259 Sum_probs=153.3
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK------ 476 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 476 (690)
..+|...+.||+|+||.||+++ ..++..||+|++.... ......+.+|+.+++.++||||+++++++...+
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4678889999999999999998 4568899999986432 223456788999999999999999999986543
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..|+||||+++ +|.+.++. .+++..+..++.|+++||+|||+++++|||
T Consensus 100 ~~~lv~e~~~~-~l~~~~~~------------------------------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrD 148 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIHM------------------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 148 (359)
T ss_pred eeEEEEeCCCc-CHHHHHhc------------------------------cCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 47899999975 67666643 367788889999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCccccccc-------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVK-------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~-------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|||+|||++.++.+||+|||+++.... .+||......++.++|||||||++|||++|+.||..
T Consensus 149 lkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~ 224 (359)
T cd07876 149 LKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224 (359)
T ss_pred CCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 999999999999999999999865321 145555556788999999999999999999999964
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=297.99 Aligned_cols=230 Identities=23% Similarity=0.302 Sum_probs=179.2
Q ss_pred CceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 412 ESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
...||+|+||.||++.. .++..||+|.+........+.+.+|+..++.++||||+++++.+...+..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 35699999999999984 56789999998755444456788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++.. ..+++.++..++.|++.||.|||+++++||||||+||++++++.+
T Consensus 107 ~~~~~~-----------------------------~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~ 157 (292)
T cd06658 107 TDIVTH-----------------------------TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRI 157 (292)
T ss_pred HHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCE
Confidence 998853 247888999999999999999999999999999999999999999
Q ss_pred eEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-HHHHHHhcCCCC
Q 005572 571 KIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLVKEGAGGD 635 (690)
Q Consensus 571 kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~~~~ 635 (690)
||+|||++...... +||......++.++|||||||++|||++|+.||...... ........
T Consensus 158 kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~---- 233 (292)
T cd06658 158 KLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDN---- 233 (292)
T ss_pred EEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc----
Confidence 99999987643211 344444457788999999999999999999998653221 11111111
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 636 ALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
..+.+.... ... ..+.+++..||+.||++|||+.|+++.
T Consensus 234 -~~~~~~~~~--~~~--~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 234 -LPPRVKDSH--KVS--SVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred -CCCcccccc--ccC--HHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 111111111 011 123345667999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=312.29 Aligned_cols=245 Identities=17% Similarity=0.210 Sum_probs=176.1
Q ss_pred HhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecC--------
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG-------- 475 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-------- 475 (690)
...+|...+.||+|+||.||+|.. .++..||||++... .....+|+.+++.++||||+++++++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~----~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD----PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC----cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 345788899999999999999984 56889999988543 23345799999999999999999887532
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
...++||||+++ +|.+++.... .....+++..+..++.|+++||+|||+++++||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~------------------------~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHr 194 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYA------------------------RNNHALPLFLVKLYSYQLCRALAYIHSKFICHR 194 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHh------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecC
Confidence 246799999975 7877776411 123468899999999999999999999999999
Q ss_pred CCCCCcEEecCCC-CceEcCCCcccccccc-------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCch
Q 005572 556 HLVTSSILLAESL-EPKIAGFGLRNIGVKN-------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 556 Dlk~~NiLl~~~~-~~kl~DfGla~~~~~~-------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~ 620 (690)
||||+|||++.++ .+||+|||+++..... +||.... ..++.++|||||||++|||++|.+||...
T Consensus 195 DLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 195 DLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred CcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999664 7999999998753211 4444332 36889999999999999999999999752
Q ss_pred --HHHHHHHHHhcCCC----------CccccccccCCCCCHHH------HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 621 --VKWVRKLVKEGAGG----------DALDFRLKLGSGDSVAE------MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 621 --~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~------~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.+...+........ ...+..++......... ..++.+++.+||+.||.+|||+.|+++
T Consensus 275 ~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 275 SSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred ChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 12222222110000 00000000000000100 124556778899999999999999974
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=300.77 Aligned_cols=183 Identities=22% Similarity=0.257 Sum_probs=151.9
Q ss_pred CceeccC--CCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 412 ESLLAEG--RCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 412 ~~~lg~G--~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.++||+| +||+||+++ ..++..||+|+++.... ...+.+.+|+++++.++||||+++++++...+..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 4679999 788999998 46789999999975432 123456779999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++... ....+++..+..++.|++.||+|||+++++||||||+|||++.
T Consensus 83 ~~~l~~~~~~~--------------------------~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~ 136 (327)
T cd08227 83 YGSAKDLICTH--------------------------FMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV 136 (327)
T ss_pred CCcHHHHHHhh--------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEec
Confidence 99999999652 1235889999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccc-----------------c----ccCcccCC--CCCCCCCcchhhHHHHHHHHhCCCCCCch
Q 005572 567 SLEPKIAGFGLRNIGV-----------------K----NVGERSEN--ETCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~-----------------~----~~~e~~~~--~~~~~~~DVwSfGvvl~el~tg~~p~~~~ 620 (690)
++.+|++|||...... . .+||.... ..++.++|||||||++|||++|+.||.+.
T Consensus 137 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 137 DGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred CCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999998532210 0 13343322 35788999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=292.68 Aligned_cols=238 Identities=25% Similarity=0.411 Sum_probs=181.8
Q ss_pred ceeccCCCccEEEEEcCC-------CcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 413 SLLAEGRCGPVYRAVLPG-------ELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+.||+|+||.||+|+..+ +..+|+|.+.... ......+.+|++.++.++||||++++++|...+..++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 368999999999998532 2579999885432 23456788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++|+|.+++....... .....++|.+++.++.|++.||+|||+.+++|+||||+||++
T Consensus 81 ~~~~~L~~~l~~~~~~~---------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (269)
T cd05044 81 MEGGDLLSYLRDARVER---------------------FGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLV 139 (269)
T ss_pred cCCCcHHHHHHHhhhcc---------------------cCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEE
Confidence 99999999997632110 012347899999999999999999999999999999999999
Q ss_pred cCCC-----CceEcCCCccccccc----------------ccCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCchHH
Q 005572 565 AESL-----EPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK 622 (690)
Q Consensus 565 ~~~~-----~~kl~DfGla~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~~~ 622 (690)
+.+. .+|++|||+++.... .+||......++.++|||||||++|||+| |+.||.....
T Consensus 140 ~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~ 219 (269)
T cd05044 140 SEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN 219 (269)
T ss_pred ecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH
Confidence 9887 899999999864321 13444444678899999999999999998 9999875322
Q ss_pred HH-HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 623 WV-RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 623 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
.. ......+. .. ..... ... .+.+++.+||+.+|++||++.+|.+.|++
T Consensus 220 ~~~~~~~~~~~---~~--~~~~~---~~~---~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 220 QEVLQHVTAGG---RL--QKPEN---CPD---KIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred HHHHHHHhcCC---cc--CCccc---chH---HHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11 11111111 00 11111 111 34567778999999999999999999864
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=288.89 Aligned_cols=238 Identities=25% Similarity=0.285 Sum_probs=180.2
Q ss_pred CceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHH--hcCCCCccceeeEEecCC----eeEEEEEec
Q 005572 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELS--RLKHPNLLPLAGYCIAGK----EKLVLLEFM 485 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~--~l~H~niv~l~g~~~~~~----~~~lv~e~~ 485 (690)
...||+|+||.||||++.+ +.||||++.. .+.+.+..|-++++ .|+|+||++++++-.... +++||+||.
T Consensus 215 ~eli~~Grfg~V~KaqL~~-~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLDN-RLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred HHHhhcCccceeehhhccC-ceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 3579999999999999876 6899999975 34567777777754 678999999999877655 899999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc---------CCCCCC
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV---------GSTHGH 556 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~---------~~iHrD 556 (690)
++|+|.+||+. ..++|....+|+..+++||+|||+. .|+|||
T Consensus 291 ~kGsL~dyL~~-----------------------------ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRD 341 (534)
T KOG3653|consen 291 PKGSLCDYLKA-----------------------------NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRD 341 (534)
T ss_pred cCCcHHHHHHh-----------------------------ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCcccccc
Confidence 99999999986 4689999999999999999999973 578999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc----------------cCcccCCC-CCC-----CCCcchhhHHHHHHHHhCC
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENE-TCG-----PESDVYCFGVILMELLTGK 614 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~-~~~-----~~~DVwSfGvvl~el~tg~ 614 (690)
||++|||+.+|+++.|+|||+|...... +||+..+. .+. .+.||||+|.|||||+++-
T Consensus 342 lkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC 421 (534)
T KOG3653|consen 342 LKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRC 421 (534)
T ss_pred ccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhc
Confidence 9999999999999999999999865433 34443321 111 3689999999999999953
Q ss_pred C------------CCCc------hHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 005572 615 R------------GTDD------CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQV 676 (690)
Q Consensus 615 ~------------p~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev 676 (690)
. ||+. ..+.++..+-... .+|.++...... ..+..+.+.+-.||+.||+.|-|+.-|
T Consensus 422 ~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK----~RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 422 TDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKK----QRPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred ccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhc----cCCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 2 2221 2233433333222 223333222222 334455667778999999999999999
Q ss_pred HHHHhccCCCC
Q 005572 677 LGLLKDIRPSA 687 (690)
Q Consensus 677 ~~~L~~i~~~~ 687 (690)
.+++.++....
T Consensus 497 ~eR~~~l~~~~ 507 (534)
T KOG3653|consen 497 EERMAELMMLW 507 (534)
T ss_pred HHHHHHHhccC
Confidence 99888775543
|
|
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=286.32 Aligned_cols=235 Identities=23% Similarity=0.264 Sum_probs=184.9
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|+||.||.++ ..++..+++|.+.... ....+++.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 46778899999999999998 5668889999986542 23446788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++|+|.+++...+ ...+++.++..++.|+++||+|||+.+++||||||+||++
T Consensus 81 ~~~~~L~~~~~~~~--------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~ 134 (256)
T cd08221 81 ANGGTLYDKIVRQK--------------------------GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL 134 (256)
T ss_pred cCCCcHHHHHHhcc--------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE
Confidence 99999999997521 2357889999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKLV 628 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~~ 628 (690)
++++.+||+|||++...... +||......++.++||||||+++|||++|+.||... .+......
T Consensus 135 ~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~ 214 (256)
T cd08221 135 TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV 214 (256)
T ss_pred eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 99999999999987653221 344443446778999999999999999999998752 12222221
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
.+..... .... . ..+.+++..||+.+|++||++.|+++.+
T Consensus 215 -~~~~~~~-----~~~~---~---~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 215 -QGNYTPV-----VSVY---S---SELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred -cCCCCCC-----cccc---C---HHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 1111110 0111 1 1344566789999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=324.25 Aligned_cols=252 Identities=19% Similarity=0.176 Sum_probs=187.4
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCC---CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGI---DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|...+.||+|+||.||+|+. .++..||+|+++..... ..+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4688889999999999999984 56889999999653222 2356888999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.+++.......... ......+++..+++++.||++||+|||+.+++||||||+||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~-----------------e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNI 144 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLS-----------------KELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNI 144 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccc-----------------hhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheE
Confidence 9999999999997521110000 01134577888999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccc----------------------------cc----cCcccCCCCCCCCCcchhhHHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGV----------------------------KN----VGERSENETCGPESDVYCFGVILMEL 610 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~----------------------------~~----~~e~~~~~~~~~~~DVwSfGvvl~el 610 (690)
|++.++.+||+|||+++... .. +||......++.++|||||||++|||
T Consensus 145 LLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyEL 224 (932)
T PRK13184 145 LLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQM 224 (932)
T ss_pred EEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHH
Confidence 99999999999999987541 01 34444445778899999999999999
Q ss_pred HhCCCCCCchHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-CHHHHHHHHhcc
Q 005572 611 LTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-TMQQVLGLLKDI 683 (690)
Q Consensus 611 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-t~~ev~~~L~~i 683 (690)
+||+.||...... ............+...... .. ..+.+++.+|++.||++|| +++++.+.|+..
T Consensus 225 LTG~~PF~~~~~~--ki~~~~~i~~P~~~~p~~~---iP---~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~ 290 (932)
T PRK13184 225 LTLSFPYRRKKGR--KISYRDVILSPIEVAPYRE---IP---PFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290 (932)
T ss_pred HHCCCCCCCcchh--hhhhhhhccChhhcccccc---CC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999752111 1111111110000000001 11 1244667789999999996 677788877664
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-34 Score=299.53 Aligned_cols=226 Identities=21% Similarity=0.214 Sum_probs=175.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 482 (690)
+|+..+.||+|+||.||+|+ ..++..||+|++.... ....+.+..|.+++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 36667899999999999998 4568899999997532 123345677888888875 578888999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+++++||||||+||
T Consensus 81 Ey~~~g~L~~~i~~----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Ni 132 (323)
T cd05615 81 EYVNGGDLMYHIQQ----------------------------VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNV 132 (323)
T ss_pred cCCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence 99999999999875 24588999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKL 627 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~ 627 (690)
|+++++.+||+|||+++.... . +||......++.++|||||||++|||++|+.||..... ...+.
T Consensus 133 ll~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~ 212 (323)
T cd05615 133 MLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS 212 (323)
T ss_pred EECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999764211 1 45554456788999999999999999999999976321 11222
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
+..... ..+...+ ..+.+++.+||+.+|++|++.
T Consensus 213 i~~~~~------~~p~~~~------~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 213 IMEHNV------SYPKSLS------KEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred HHhCCC------CCCccCC------HHHHHHHHHHcccCHhhCCCC
Confidence 222111 1111111 134456678999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=300.99 Aligned_cols=221 Identities=19% Similarity=0.228 Sum_probs=173.0
Q ss_pred ceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+ ..++..+|+|+++.... ...+.+.+|..++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999998 45678999999975432 2234577888888888 699999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++..+..++.|++.||+|||+++++||||||+|||++.+
T Consensus 81 ~~L~~~~~~----------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~ 132 (327)
T cd05617 81 GDLMFHMQR----------------------------QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDAD 132 (327)
T ss_pred CcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCC
Confidence 999998865 2358899999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc--------hHHHHH
Q 005572 568 LEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDD--------CVKWVR 625 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~--------~~~~~~ 625 (690)
+.+||+|||+++.... . +||......++.++|||||||++|||++|+.||.. ..+...
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~ 212 (327)
T cd05617 133 GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF 212 (327)
T ss_pred CCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH
Confidence 9999999999864211 1 45555556788999999999999999999999953 112222
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
....... .+++...+ ..+.+++.+||+.||++||++
T Consensus 213 ~~~~~~~------~~~p~~~~------~~~~~li~~~L~~dP~~R~~~ 248 (327)
T cd05617 213 QVILEKP------IRIPRFLS------VKASHVLKGFLNKDPKERLGC 248 (327)
T ss_pred HHHHhCC------CCCCCCCC------HHHHHHHHHHhccCHHHcCCC
Confidence 2222111 11111111 123456677999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=301.34 Aligned_cols=222 Identities=22% Similarity=0.240 Sum_probs=169.8
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHH-HHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFD-ELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..||+|++..... .....+..|.. .++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999995 5688999999964321 22334555554 57889999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|..++.. ...+++.++..++.||++||+|||+.+++||||||+||+++.+
T Consensus 81 ~~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~ 132 (321)
T cd05603 81 GELFFHLQR----------------------------ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQ 132 (321)
T ss_pred CCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 999988865 2347788888999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~ 632 (690)
+.+||+|||+++.... . +||......++.++|||||||++|||++|+.||.... ...........
T Consensus 133 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 212 (321)
T cd05603 133 GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP 212 (321)
T ss_pred CCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC
Confidence 9999999999864211 1 4454444578899999999999999999999986522 11111111111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQ 674 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ 674 (690)
..++...+ ..+.+++.+|++.||++||++.
T Consensus 213 ------~~~~~~~~------~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 213 ------LQLPGGKT------VAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred ------CCCCCCCC------HHHHHHHHHHccCCHhhcCCCC
Confidence 11111111 1345667789999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=285.99 Aligned_cols=234 Identities=18% Similarity=0.230 Sum_probs=192.1
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
|++..+||+|+||.||++. ...|..+|+|.+... .+.+++..|+.+|++++.|+||+++|.|.....+|||||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 5667889999999999998 566999999998654 4678999999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|++.+.++.+ ...|++.++..+....++||+|||...-||||||+.|||++.+
T Consensus 113 GSiSDI~R~R---------------------------~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~ 165 (502)
T KOG0574|consen 113 GSISDIMRAR---------------------------RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD 165 (502)
T ss_pred CcHHHHHHHh---------------------------cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc
Confidence 9999999863 3578899999999999999999999999999999999999999
Q ss_pred CCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcCC
Q 005572 568 LEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAG 633 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 633 (690)
|.+|++|||.|...... +||+..+-.|++++||||+|++..||..|++||.++... +.++
T Consensus 166 G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPM-RAIF----- 239 (502)
T KOG0574|consen 166 GIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPM-RAIF----- 239 (502)
T ss_pred chhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccc-ceeE-----
Confidence 99999999998764322 788888889999999999999999999999999875432 1111
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
++....+.....+..=.-++-+++..|+-..|++|-|+.++++.
T Consensus 240 --MIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 240 --MIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred --eccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 11111111111111111234566677999999999999888764
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=290.36 Aligned_cols=242 Identities=25% Similarity=0.375 Sum_probs=182.0
Q ss_pred CCCCceeccCCCccEEEEEcC----CCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 005572 409 FGKESLLAEGRCGPVYRAVLP----GELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK------ 476 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 476 (690)
|...+.||+|+||.||+|.+. ++..||||++..... ...+++.+|++.+++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999842 367899999865422 23456788999999999999999999986542
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..++++||+++|+|.+++...+.. .....+++.....++.|++.||+|||+.+++|||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~----------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~d 138 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIG----------------------EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRD 138 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhccc----------------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecc
Confidence 247889999999999988642110 0123578889999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCc
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDD 619 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~ 619 (690)
|||+||++++++.+|++|||+++..... +||......++.++|||||||++|||++ |+.||..
T Consensus 139 ikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 139 LAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred cchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 9999999999999999999998754211 2233333456789999999999999999 8888865
Q ss_pred hHHH-HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 620 CVKW-VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 620 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.... .......... ...... ....+.+++..||+.+|++||++.|+++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~-----~~~~~~------~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 219 VENSEIYNYLIKGNR-----LKQPPD------CLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CCHHHHHHHHHcCCc-----CCCCCC------CCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 3221 1122221110 001111 112566778889999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-34 Score=293.72 Aligned_cols=243 Identities=20% Similarity=0.265 Sum_probs=181.4
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+....||+|+||.||+|+.. ++..||+|++..... ...+.+.+|++++++++||||+++++++......++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5777889999999999999954 588999999864422 2345678899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
++++.|..++.. ...+++..+..++.|++.||+|||+.+++||||||+||++
T Consensus 82 ~~~~~l~~~~~~----------------------------~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~ 133 (286)
T cd07847 82 CDHTVLNELEKN----------------------------PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI 133 (286)
T ss_pred cCccHHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE
Confidence 999888877653 2358899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHHH--HHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVKW--VRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~--~~~~ 627 (690)
+.++++||+|||++...... +||.... ..++.++|||||||++|||++|+.||.+.... ....
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~ 213 (286)
T cd07847 134 TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI 213 (286)
T ss_pred cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 99999999999998753221 3343322 35678999999999999999999998752211 1111
Q ss_pred HHh-cCC----------CCccc-ccccc-CCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKE-GAG----------GDALD-FRLKL-GSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~-~~~----------~~~~~-~~~~~-~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... +.. ..... ...+. ........ -..+.+++.+||+.||++||++.|++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 214 RKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred HHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 100 000 00000 00000 00001111 123567788899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=301.65 Aligned_cols=224 Identities=20% Similarity=0.220 Sum_probs=170.2
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHH-HHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFD-ELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~-~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|+. .++..+|+|++.... ......+..|.. .++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999984 557889999996432 122234444444 46788999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++.....++.|+++||+|||+++++||||||+|||++.+
T Consensus 81 ~~L~~~~~~----------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~ 132 (325)
T cd05602 81 GELFYHLQR----------------------------ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQ 132 (325)
T ss_pred CcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCC
Confidence 999999975 2346677888899999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHHHHhc
Q 005572 568 LEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKLVKEG 631 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~~~~~ 631 (690)
+.+||+|||+++.... .+||......++.++|||||||++|||++|+.||.... +....... .
T Consensus 133 ~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~ 211 (325)
T cd05602 133 GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILN-K 211 (325)
T ss_pred CCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHh-C
Confidence 9999999999864211 14555555678899999999999999999999987522 22222221 1
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~ 677 (690)
.. ......+. .+.+++.+|++.||.+||++.+.+
T Consensus 212 ~~------~~~~~~~~------~~~~li~~~l~~~p~~R~~~~~~~ 245 (325)
T cd05602 212 PL------QLKPNITN------SARHLLEGLLQKDRTKRLGAKDDF 245 (325)
T ss_pred Cc------CCCCCCCH------HHHHHHHHHcccCHHHCCCCCCCH
Confidence 10 11111111 233455579999999999877544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.18 Aligned_cols=232 Identities=20% Similarity=0.179 Sum_probs=181.1
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCC---CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI---DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
|+..+.||+|+||.||++. ..++..+|+|.+...... ....+.+|+.++++++|+||+.+++.+...+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 5667889999999999998 456889999998654222 123467899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++|+|.+++... ....+++.++..++.|++.||.|||+.+++||||||+||++
T Consensus 82 ~~g~~L~~~l~~~--------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~ 135 (285)
T cd05630 82 MNGGDLKFHIYHM--------------------------GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL 135 (285)
T ss_pred cCCCcHHHHHHHh--------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE
Confidence 9999999998652 12358889999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc-------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-----HHHH
Q 005572 565 AESLEPKIAGFGLRNIGVK-------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-----WVRK 626 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~-------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-----~~~~ 626 (690)
++++.+||+|||++..... .+||......++.++|||||||++|||++|+.||..... ....
T Consensus 136 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~ 215 (285)
T cd05630 136 DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVER 215 (285)
T ss_pred CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHh
Confidence 9999999999999864321 145555556788999999999999999999999975211 1111
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-----MQQVLG 678 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-----~~ev~~ 678 (690)
..... ........+ . .+.+++..||+.||++||| +.|+++
T Consensus 216 ~~~~~------~~~~~~~~~---~---~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 216 LVKEV------QEEYSEKFS---P---DARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred hhhhh------hhhcCccCC---H---HHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 11110 001111111 1 2345666799999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-34 Score=295.52 Aligned_cols=230 Identities=21% Similarity=0.261 Sum_probs=180.0
Q ss_pred CceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 412 ESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
...||+|+||.||++.. .++..||+|.++.......+.+.+|+..++.++||||+++++++...+..++|+||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 35799999999999984 56889999999765545566788999999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++.. ..+++.++..++.|++.||+|||+.+++||||||+||+++.++.+
T Consensus 106 ~~~~~~-----------------------------~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~ 156 (297)
T cd06659 106 TDIVSQ-----------------------------TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRV 156 (297)
T ss_pred HHHHhh-----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcE
Confidence 988753 347889999999999999999999999999999999999999999
Q ss_pred eEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH-HHHHHhcCCCC
Q 005572 571 KIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV-RKLVKEGAGGD 635 (690)
Q Consensus 571 kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~ 635 (690)
||+|||++...... +||......++.++|||||||++|||++|+.||....... ........ ..
T Consensus 157 kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~ 235 (297)
T cd06659 157 KLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSP-PP 235 (297)
T ss_pred EEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccC-CC
Confidence 99999987543211 3444444577889999999999999999999986422111 11111110 00
Q ss_pred ccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 636 ALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 636 ~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
........+ . .+.+++..||+.+|++||++.|+++.
T Consensus 236 --~~~~~~~~~---~---~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 236 --KLKNAHKIS---P---VLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred --CccccCCCC---H---HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 000001111 1 23456667999999999999999883
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=287.18 Aligned_cols=233 Identities=18% Similarity=0.232 Sum_probs=184.5
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|+||.||+++ ..++..+|+|.+.... ....+++.+|++.+++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 46778899999999999998 4568899999986432 23345788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.+++... ....+++.++..++.|++.||.|||+++++|+||+|+||++
T Consensus 81 ~~~~~l~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~ 134 (256)
T cd08218 81 CEGGDLYKKINAQ--------------------------RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL 134 (256)
T ss_pred CCCCcHHHHHHhc--------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE
Confidence 9999999998752 12357888999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKLV 628 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~~ 628 (690)
+.++.+||+|||++...... +||......++.++|||||||++|||++|+.||... .+.+....
T Consensus 135 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~ 214 (256)
T cd08218 135 TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII 214 (256)
T ss_pred cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh
Confidence 99999999999998643221 345444456788999999999999999999998642 22222222
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.+... ..+... ...+.+++.+||+.+|++||+|.||++
T Consensus 215 -~~~~~-----~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 215 -RGSYP-----PVSSHY------SYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred -cCCCC-----CCcccC------CHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11111 111111 113456677899999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=291.55 Aligned_cols=232 Identities=21% Similarity=0.307 Sum_probs=182.6
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.|+..+.||+|+||.||+|.. .++..||+|.++.... .....+.+|++.+++++||||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 456678899999999999985 4578999999875432 23456888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++.. ..+++.+...++.|++.||+|||+.+++|+||+|+||+++
T Consensus 85 ~~~~L~~~i~~-----------------------------~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~ 135 (277)
T cd06640 85 GGGSALDLLRA-----------------------------GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLS 135 (277)
T ss_pred CCCcHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEc
Confidence 99999999864 2467888999999999999999999999999999999999
Q ss_pred CCCCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-HHHHHHh
Q 005572 566 ESLEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLVKE 630 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-~~~~~~~ 630 (690)
+++.++|+|||++..... .+||......++.++|||||||++|||+||..||.+.... .......
T Consensus 136 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~ 215 (277)
T cd06640 136 EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPK 215 (277)
T ss_pred CCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhc
Confidence 999999999999854322 1344444456788999999999999999999998753211 1111111
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.. .+.+ .......+.+++.+||+.+|++||++.|+++.
T Consensus 216 ~~-----~~~~------~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 216 NN-----PPTL------TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred CC-----CCCC------chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 10 0111 11122345567788999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=303.98 Aligned_cols=184 Identities=19% Similarity=0.215 Sum_probs=153.6
Q ss_pred HhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecC------
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAG------ 475 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------ 475 (690)
..++|...+.||+|+||.||++.. ..+..||||++..... .....+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 346888899999999999999984 5678999999865422 2235677899999999999999999988643
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
...++||||+++ ++.+++.. .+++..+..++.|+++||+|||+++++||
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~~------------------------------~l~~~~~~~~~~qi~~aL~~LH~~givHr 143 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQM------------------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHR 143 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHhh------------------------------cCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 357899999965 67776643 36788889999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
||||+|||++.++.+||+|||+++..... +||......++.++|||||||++|||++|+.||..
T Consensus 144 Dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 220 (355)
T cd07874 144 DLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220 (355)
T ss_pred CCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998754321 44554445788999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=292.32 Aligned_cols=244 Identities=21% Similarity=0.222 Sum_probs=176.3
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhc---CCCCccceeeEEecC-----C
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRL---KHPNLLPLAGYCIAG-----K 476 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~-----~ 476 (690)
+|...+.||+|+||.||+|+ ..++..||+|.++.... .....+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 46778899999999999998 45688999999865322 2234566777776655 799999999998652 3
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..++||||++ ++|.+++... ....+++..+..++.|++.||.|||+.+++|||
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~--------------------------~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~d 133 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV--------------------------PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRD 133 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 5789999997 4899988752 123488999999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch--H
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--V 621 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~ 621 (690)
|||+||++++++.+||+|||+++..... +||......++.++|||||||++|||++|++||... .
T Consensus 134 ikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~ 213 (288)
T cd07863 134 LKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 213 (288)
T ss_pred CCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH
Confidence 9999999999999999999998754211 455544467889999999999999999999998642 1
Q ss_pred HHHHHHHHhcCCC--C-------ccccccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 622 KWVRKLVKEGAGG--D-------ALDFRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 622 ~~~~~~~~~~~~~--~-------~~~~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+...+........ . ...............+ -..+.+++.+|++.||++|||+.|++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 214 DQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred HHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 1111111110000 0 0000000000001111 113456778899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=289.09 Aligned_cols=233 Identities=19% Similarity=0.246 Sum_probs=176.8
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-----CCHHHHHHHHHHHHhcCCCCccceeeEEec--CCeeE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-----IDHDDAVAMFDELSRLKHPNLLPLAGYCIA--GKEKL 479 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~ 479 (690)
+|...+.||+|+||.||+|.. .++..+|+|.+..... ...+.+.+|++++++++||||+++++++.. ....+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 577889999999999999984 5688999998864321 112457789999999999999999998875 35678
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+++||||||
T Consensus 83 l~~e~~~~~~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p 134 (266)
T cd06651 83 IFMEYMPGGSVKDQLKA----------------------------YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKG 134 (266)
T ss_pred EEEeCCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCH
Confidence 99999999999999975 23478888999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCccccccc-------------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVK-------------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK 622 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~-------------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~ 622 (690)
+||++++++.+||+|||+++.... . +||......++.++|||||||++|||++|+.||.....
T Consensus 135 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~ 214 (266)
T cd06651 135 ANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA 214 (266)
T ss_pred HHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch
Confidence 999999999999999999864321 0 34444445678899999999999999999999976422
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... ...... ....+.++.... ..++.+..||..+|++||+|+||++
T Consensus 215 ~~~-~~~~~~--~~~~~~~~~~~~-------~~~~~li~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 215 MAA-IFKIAT--QPTNPQLPSHIS-------EHARDFLGCIFVEARHRPSAEELLR 260 (266)
T ss_pred HHH-HHHHhc--CCCCCCCchhcC-------HHHHHHHHHhcCChhhCcCHHHHhc
Confidence 211 111111 111122211111 1112223588999999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=289.72 Aligned_cols=231 Identities=24% Similarity=0.326 Sum_probs=182.9
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|...+.||.|+||.||+|+. .++..+|+|.+.... ......+.+|++.++.++||||+++++++.+....++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 567778899999999999994 468899999986543 233456888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++++|.+++.. ..+++..+..++.|++.||.|||+.+++||||+|+||+++
T Consensus 82 ~~~~L~~~~~~-----------------------------~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~ 132 (274)
T cd06609 82 GGGSCLDLLKP-----------------------------GKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLS 132 (274)
T ss_pred CCCcHHHHHhh-----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 99999999864 2578999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHh
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKE 630 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~ 630 (690)
+++.++|+|||+++..... +||......++.++|||||||++|||+||+.||..... ........
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 212 (274)
T cd06609 133 EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK 212 (274)
T ss_pred CCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhh
Confidence 9999999999998654321 34444445688999999999999999999999865221 11111111
Q ss_pred cCCCCccccccccC-CCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 631 GAGGDALDFRLKLG-SGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 631 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.. .+.+... .+. .+.+++..||..||++|||++++++
T Consensus 213 ~~-----~~~~~~~~~~~------~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 213 NN-----PPSLEGNKFSK------PFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred cC-----CCCCcccccCH------HHHHHHHHHhhCChhhCcCHHHHhh
Confidence 11 1111111 111 3445666799999999999999976
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=291.99 Aligned_cols=245 Identities=20% Similarity=0.242 Sum_probs=180.5
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|...+.||+|+||.||+|+. .++..||+|.++... ....+.+.+|+..+++++||||+++++++..++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 466778999999999999985 568899999986432 22346788899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
++ |+|.+++...+ ....+++.++..++.|+++||+|||+.+++||||||+||++
T Consensus 81 ~~-~~l~~~~~~~~-------------------------~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~ 134 (285)
T cd07861 81 LS-MDLKKYLDSLP-------------------------KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI 134 (285)
T ss_pred CC-CCHHHHHhcCC-------------------------CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE
Confidence 97 68998886521 12458899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc--------------ccCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVK--------------NVGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~--------------~~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~~~ 627 (690)
++++.+||+|||++..... .+||...+ ..++.++|||||||++|||+||+.||..... .....
T Consensus 135 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~ 214 (285)
T cd07861 135 DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214 (285)
T ss_pred cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 9999999999998764321 13444332 2467899999999999999999999864211 11111
Q ss_pred HHh-cCCC--------Cccccc--cccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKE-GAGG--------DALDFR--LKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~-~~~~--------~~~~~~--~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... +... ...+.. ........... -.++.+++.+||+.||++|||+.||++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 215 FRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 110 0000 000000 00000000000 013456777899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=304.81 Aligned_cols=243 Identities=19% Similarity=0.176 Sum_probs=181.3
Q ss_pred HHHHHHHhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEec
Q 005572 399 FKDLIAATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIA 474 (690)
Q Consensus 399 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~ 474 (690)
+.++.....+|...+.||+|+||.||+++. .++..+|+|++.... ....+.+.+|+.+++.++||||+++++++..
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 344555667899999999999999999994 568899999986422 1233457789999999999999999999999
Q ss_pred CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC
Q 005572 475 GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTH 554 (690)
Q Consensus 475 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iH 554 (690)
.+..++|||||++|+|.++++. ..++...+..++.|++.||+|||+++++|
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~-----------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 165 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN-----------------------------YDVPEKWARFYTAEVVLALDAIHSMGFIH 165 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh-----------------------------cCCCHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence 9999999999999999999865 23677788889999999999999999999
Q ss_pred CCCCCCcEEecCCCCceEcCCCccccccc-----------c----cCcccCCC----CCCCCCcchhhHHHHHHHHhCCC
Q 005572 555 GHLVTSSILLAESLEPKIAGFGLRNIGVK-----------N----VGERSENE----TCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 555 rDlk~~NiLl~~~~~~kl~DfGla~~~~~-----------~----~~e~~~~~----~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
|||||+|||++.++.+||+|||+++.... . +||..... .++.++|||||||++|||++|+.
T Consensus 166 rDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~ 245 (371)
T cd05622 166 RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDT 245 (371)
T ss_pred CCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCC
Confidence 99999999999999999999999864321 1 33433221 37889999999999999999999
Q ss_pred CCCchH--HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCC--CCCHHHHHHH
Q 005572 616 GTDDCV--KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGK--RPTMQQVLGL 679 (690)
Q Consensus 616 p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~--RPt~~ev~~~ 679 (690)
||.... .....+...... .........+. .+.+++..|+..++.+ ||++.|+++.
T Consensus 246 Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~s~------~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 246 PFYADSLVGTYSKIMNHKNS---LTFPDDNDISK------EAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred CCCCCCHHHHHHHHHcCCCc---ccCCCcCCCCH------HHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 997522 122222211111 11100011111 2334455688744433 7899998874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=299.49 Aligned_cols=185 Identities=17% Similarity=0.197 Sum_probs=157.1
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|+..+.||+|+||.||+++ ..++..||+|++.... ....+.+.+|..++..++|+||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 67888999999999999999 4568899999996422 2234557889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.+. ...+++..+..++.||+.||+|||+++++||||||+|||
T Consensus 82 ~~~g~~L~~~l~~~---------------------------~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 134 (331)
T cd05597 82 YYVGGDLLTLLSKF---------------------------EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVL 134 (331)
T ss_pred cCCCCcHHHHHHHh---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEE
Confidence 99999999999751 235788899999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCccccccc-----------c----cCcccC-----CCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 564 LAESLEPKIAGFGLRNIGVK-----------N----VGERSE-----NETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~-----------~----~~e~~~-----~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
++.++.+||+|||++..... . +||... ...++.++|||||||++|||++|+.||..
T Consensus 135 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 210 (331)
T cd05597 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred ECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC
Confidence 99999999999999754221 1 333332 13467899999999999999999999965
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=285.59 Aligned_cols=235 Identities=22% Similarity=0.295 Sum_probs=182.2
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCC--CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGI--DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|+||.||+|.. .++..+|+|.++..... ..+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 366778999999999999984 56889999999765432 456788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.+++.. ...+++..+..++.|+++||.|||+.+++|+||+|+||++
T Consensus 81 ~~~~~L~~~~~~----------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~ 132 (264)
T cd06626 81 CSGGTLEELLEH----------------------------GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL 132 (264)
T ss_pred CCCCcHHHHHhh----------------------------cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE
Confidence 999999999875 2346788899999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc------------------cCcccCCCC---CCCCCcchhhHHHHHHHHhCCCCCCchH-H
Q 005572 565 AESLEPKIAGFGLRNIGVKN------------------VGERSENET---CGPESDVYCFGVILMELLTGKRGTDDCV-K 622 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~------------------~~e~~~~~~---~~~~~DVwSfGvvl~el~tg~~p~~~~~-~ 622 (690)
++++.+||+|||++...... +||...... .+.++||||||+++||+++|+.||.... .
T Consensus 133 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~ 212 (264)
T cd06626 133 DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212 (264)
T ss_pred CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcch
Confidence 99999999999987653211 233332233 7789999999999999999999997542 2
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+......... ..+.++... .. ...+.+++..||+.+|++||++.|++.
T Consensus 213 ~~~~~~~~~~----~~~~~~~~~-~~---~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 213 FQIMFHVGAG----HKPPIPDSL-QL---SPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred HHHHHHHhcC----CCCCCCccc-cc---CHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 2111111111 111111111 00 112345667899999999999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=303.70 Aligned_cols=232 Identities=21% Similarity=0.239 Sum_probs=186.7
Q ss_pred ceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHh
Q 005572 413 SLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLH 491 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 491 (690)
-++|+|.||+||-|+ .++...+|||.+........+.+.+|+..-+.++|.|||+++|.|..++..-|.||-++||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999 6667889999997666566677889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC--CHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec-CCC
Q 005572 492 RWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT--NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA-ESL 568 (690)
Q Consensus 492 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~-~~~ 568 (690)
++|+.+ .+++ ++.+.-.+..||.+||.|||++.|||||||-.|||++ -.|
T Consensus 661 sLLrsk---------------------------WGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySG 713 (1226)
T KOG4279|consen 661 SLLRSK---------------------------WGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSG 713 (1226)
T ss_pred HHHHhc---------------------------cCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccc
Confidence 999852 1233 6677778999999999999999999999999999997 679
Q ss_pred CceEcCCCcccccccc--------------cCcccCCC--CCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcC
Q 005572 569 EPKIAGFGLRNIGVKN--------------VGERSENE--TCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGA 632 (690)
Q Consensus 569 ~~kl~DfGla~~~~~~--------------~~e~~~~~--~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~ 632 (690)
.+||+|||-++....- +||+...+ .|++++|||||||++.||.||++||.++...-..+++-|
T Consensus 714 vlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG- 792 (1226)
T KOG4279|consen 714 VLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG- 792 (1226)
T ss_pred eEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-
Confidence 9999999987654221 56665543 799999999999999999999999998655443344332
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.....|.++. +-..+...++++|+.+||.+||++.++++.
T Consensus 793 -myKvHP~iPe------elsaeak~FilrcFepd~~~R~sA~~LL~D 832 (1226)
T KOG4279|consen 793 -MYKVHPPIPE------ELSAEAKNFILRCFEPDPCDRPSAKDLLQD 832 (1226)
T ss_pred -ceecCCCCcH------HHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence 1122222221 111234567889999999999999998763
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=302.17 Aligned_cols=180 Identities=19% Similarity=0.272 Sum_probs=153.0
Q ss_pred HHhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
....+|...+.||+|+||.||+|+. .++..||+|+.... ....|+.++++++||||+++++++...+..++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 3446799999999999999999995 45678999975332 2356899999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+. |+|.+++.. ....++|..+..++.||+.||.|||+++++||||||+||
T Consensus 137 e~~~-~~l~~~l~~---------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Ni 188 (357)
T PHA03209 137 PHYS-SDLYTYLTK---------------------------RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENI 188 (357)
T ss_pred EccC-CcHHHHHHh---------------------------ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence 9995 699999865 134688999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccccc-------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCC
Q 005572 563 LLAESLEPKIAGFGLRNIGVK-------------NVGERSENETCGPESDVYCFGVILMELLTGKRGT 617 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~-------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~ 617 (690)
|++.++.+||+|||+++.... .+||......++.++|||||||++|||+++..|+
T Consensus 189 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 189 FINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred EECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 999999999999999874221 1566655567899999999999999999965553
|
|
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=292.16 Aligned_cols=240 Identities=21% Similarity=0.252 Sum_probs=185.4
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++|+..+.||+|+||.||++. ..++..+|+|++.... ....+.+.+|+++++.++||||+++++++...+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 456667899999999999998 4568899999886442 23456788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcEE
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSIL 563 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~NiL 563 (690)
+++|+|.+++.+ ...+++.....++.|++.||.|||+ .+++||||||+||+
T Consensus 85 ~~~~~L~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil 136 (284)
T cd06620 85 MDCGSLDRIYKK----------------------------GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNIL 136 (284)
T ss_pred CCCCCHHHHHHh----------------------------ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEE
Confidence 999999999875 2357899999999999999999997 68999999999999
Q ss_pred ecCCCCceEcCCCccccccc--------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH--------
Q 005572 564 LAESLEPKIAGFGLRNIGVK--------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-------- 623 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~--------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-------- 623 (690)
+++++.++|+|||++..... . +||......++.++|||||||++||++||+.||......
T Consensus 137 ~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 216 (284)
T cd06620 137 VNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM 216 (284)
T ss_pred ECCCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh
Confidence 99999999999998764311 1 455544457788999999999999999999998742210
Q ss_pred -HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 624 -VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 624 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
............ .+.+... .....+.+++.+||+.||++|||+.|+++...
T Consensus 217 ~~~~~~~~~~~~~--~~~~~~~-----~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~ 268 (284)
T cd06620 217 GILDLLQQIVQEP--PPRLPSS-----DFPEDLRDFVDACLLKDPTERPTPQQLCAMPP 268 (284)
T ss_pred HHHHHHHHHhhcc--CCCCCch-----hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 111111100000 0111100 01123556777899999999999999998643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=274.51 Aligned_cols=235 Identities=22% Similarity=0.220 Sum_probs=186.1
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
.|+..+.||+|.|+.||++. .++|+.+|+|+++..+ ..+.+++.+|+++.+.++||||++|...+.+....|+|+|+
T Consensus 12 ~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~ 91 (355)
T KOG0033|consen 12 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDL 91 (355)
T ss_pred hhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEec
Confidence 45556789999999999997 6789999999986443 34678899999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
|.||+|..-+-+ ....++..+-..+.||.+||.|+|.++|||||+||+|+|+
T Consensus 92 m~G~dl~~eIV~----------------------------R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllL 143 (355)
T KOG0033|consen 92 VTGGELFEDIVA----------------------------REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLL 143 (355)
T ss_pred ccchHHHHHHHH----------------------------HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheee
Confidence 999999876654 1346777888899999999999999999999999999999
Q ss_pred cCC---CCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc-hHHHHHHH
Q 005572 565 AES---LEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD-CVKWVRKL 627 (690)
Q Consensus 565 ~~~---~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~-~~~~~~~~ 627 (690)
.+. --+|++|||+|...... +||+.....|+..+|||+.||+||-|+.|.+||.+ ......+.
T Consensus 144 ASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~ 223 (355)
T KOG0033|consen 144 ASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQ 223 (355)
T ss_pred eeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHH
Confidence 643 34899999999765532 56666667999999999999999999999999876 44444455
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+..+... ++++-....+...+ +++.+++..||++|.|+.|.+.
T Consensus 224 I~~g~yd--~~~~~w~~is~~Ak------~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 224 IKAGAYD--YPSPEWDTVTPEAK------SLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HhccccC--CCCcccCcCCHHHH------HHHHHHhccChhhhccHHHHhC
Confidence 5444321 11111111222333 3445689999999999999874
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=291.72 Aligned_cols=245 Identities=20% Similarity=0.244 Sum_probs=185.3
Q ss_pred cCHHHHHHHhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeEEec
Q 005572 397 LTFKDLIAATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIA 474 (690)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~ 474 (690)
.++.++..+.+.|+..+.||+|+||.||+|+. .++..+|+|.+.... ....++..|+.++.++ +||||+++++++..
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 34556666778899999999999999999994 568899999986543 2345678889999988 69999999999853
Q ss_pred ------CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh
Q 005572 475 ------GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH 548 (690)
Q Consensus 475 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH 548 (690)
.+..+++|||+++|+|.+++...+ ...+++..+..++.|++.||.|||
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--------------------------~~~~~~~~~~~~~~qi~~al~~LH 138 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTK--------------------------GNALKEDWIAYICREILRGLAHLH 138 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHcc--------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Confidence 457899999999999999987521 234778888999999999999999
Q ss_pred hcCCCCCCCCCCcEEecCCCCceEcCCCccccccc----------c----cCcccC-----CCCCCCCCcchhhHHHHHH
Q 005572 549 HVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK----------N----VGERSE-----NETCGPESDVYCFGVILME 609 (690)
Q Consensus 549 ~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~----------~----~~e~~~-----~~~~~~~~DVwSfGvvl~e 609 (690)
+.+++||||||+||++++++.+||+|||++..... . +||... ...++.++|||||||++||
T Consensus 139 ~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~e 218 (282)
T cd06636 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIE 218 (282)
T ss_pred HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHH
Confidence 99999999999999999999999999999764321 1 344321 2356779999999999999
Q ss_pred HHhCCCCCCchHHHHHHHHHhcCCCCccccccc-cCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 610 LLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLK-LGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 610 l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
|++|+.||.+...... ...... ....... ...+ ..+.+++..||+.||.+|||+.|+++
T Consensus 219 l~~g~~p~~~~~~~~~-~~~~~~---~~~~~~~~~~~~------~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 219 MAEGAPPLCDMHPMRA-LFLIPR---NPPPKLKSKKWS------KKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred HHhCCCCccccCHHhh-hhhHhh---CCCCCCcccccC------HHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 9999999975322111 111000 0011110 0111 13556677899999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=288.10 Aligned_cols=241 Identities=20% Similarity=0.260 Sum_probs=181.9
Q ss_pred cCCCCceeccCCCccEEEEEcCC--CcEEEEEEeeccCC----------CCHHHHHHHHHHHHh-cCCCCccceeeEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAVLPG--ELHVAIKVLDNAKG----------IDHDDAVAMFDELSR-LKHPNLLPLAGYCIA 474 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~----------~~~~~~~~e~~~l~~-l~H~niv~l~g~~~~ 474 (690)
+|+..+.||+|+||.||+|.... +..+|+|.+..... ....++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 36677889999999999999644 67899998853211 122346667777764 789999999999999
Q ss_pred CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCC
Q 005572 475 GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGST 553 (690)
Q Consensus 475 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~i 553 (690)
.+..++||||+++++|.+++...+ .....+++..+..++.|++.||.|||+ .+++
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~------------------------~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~ 136 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLK------------------------EKKQRFTEERIWNIFVQMVLALRYLHKEKRIV 136 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHH------------------------hccCCCCHHHHHHHHHHHHHHHHHhccCCcee
Confidence 999999999999999999885411 113458888999999999999999996 6799
Q ss_pred CCCCCCCcEEecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch
Q 005572 554 HGHLVTSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 554 HrDlk~~NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~ 620 (690)
||||||+||++++++.+||+|||++...... +||......++.++||||||+++|||++|+.||...
T Consensus 137 H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 137 HRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred ecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 9999999999999999999999998653321 455554556788999999999999999999998652
Q ss_pred HH-HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 621 VK-WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 621 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
.. ............ +......+ ..+.+++.+||+.||++||++.|+..++++
T Consensus 217 ~~~~~~~~~~~~~~~----~~~~~~~~------~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 217 NMLSLATKIVEAVYE----PLPEGMYS------EDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred CHHHHHHHHhhccCC----cCCcccCC------HHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 21 111111111111 10000111 234566778999999999999999998863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=305.10 Aligned_cols=184 Identities=18% Similarity=0.181 Sum_probs=158.9
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|+..+.||+|+||.||+++. .++..||+|+++... ......+.+|++++..++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 577889999999999999984 568899999996432 2234567789999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
||++|+|.+++.+ ...+++..+..++.|++.||+|||+++++||||||+|||
T Consensus 82 ~~~gg~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIl 133 (360)
T cd05627 82 FLPGGDMMTLLMK----------------------------KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL 133 (360)
T ss_pred CCCCccHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEE
Confidence 9999999999975 235788899999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccc---------------------------------------------c----ccCcccCCCCC
Q 005572 564 LAESLEPKIAGFGLRNIGV---------------------------------------------K----NVGERSENETC 594 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~---------------------------------------------~----~~~e~~~~~~~ 594 (690)
++.++.+||+|||+++... . .+||......+
T Consensus 134 i~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~ 213 (360)
T cd05627 134 LDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY 213 (360)
T ss_pred ECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC
Confidence 9999999999999875321 0 14454445678
Q ss_pred CCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 595 GPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 595 ~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
+.++|||||||++|||++|+.||..
T Consensus 214 ~~~~DiwSlGvilyel~tG~~Pf~~ 238 (360)
T cd05627 214 NKLCDWWSLGVIMYEMLIGYPPFCS 238 (360)
T ss_pred CCcceeccccceeeecccCCCCCCC
Confidence 8999999999999999999999975
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=294.33 Aligned_cols=244 Identities=19% Similarity=0.203 Sum_probs=180.4
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++|...+.||+|+||.||+|+. .++..||+|.++.... .....+.+|++.+++++||||+++++++...+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 4577788999999999999985 4578999999864432 3345677899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
++ ++|.+++... ...+++..+..++.|+++||+|||+.+++||||||+||++
T Consensus 86 ~~-~~l~~~l~~~---------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~ 137 (301)
T cd07873 86 LD-KDLKQYLDDC---------------------------GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI 137 (301)
T ss_pred cc-cCHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE
Confidence 97 5999988751 2357888999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~ 627 (690)
++++.+||+|||++...... +||.... ..++.++|||||||++|||+||+.||... .+.....
T Consensus 138 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~ 217 (301)
T cd07873 138 NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFI 217 (301)
T ss_pred CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99999999999998643211 3333222 24678999999999999999999998752 1111111
Q ss_pred HHhc-CC-C----C------ccccccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEG-AG-G----D------ALDFRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~-~~-~----~------~~~~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... .. . . ......+......... -..+.+++.+|++.||.+|||+.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 218 FRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred HHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 1100 00 0 0 0000000000000000 012456778899999999999999987
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=285.20 Aligned_cols=233 Identities=22% Similarity=0.286 Sum_probs=180.3
Q ss_pred CCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC-----CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 409 FGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG-----IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-----~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
|...+.||+|+||.||+|... ++..|++|.+..... ...+.+.+|++.+++++||||+++++++...+..++|+
T Consensus 2 ~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 81 (258)
T cd06632 2 WRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81 (258)
T ss_pred ccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEE
Confidence 566788999999999999954 788999999865331 12356888999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++++|.+++.. ...+++..+..++.|+++||+|||+.+++|+||+|+||
T Consensus 82 e~~~~~~L~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni 133 (258)
T cd06632 82 ELVPGGSLAKLLKK----------------------------YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANI 133 (258)
T ss_pred EecCCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 99999999999975 23478889999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc-------------cCcccCCCC-CCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN-------------VGERSENET-CGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLV 628 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~-~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~ 628 (690)
+++.++.+||+|||++...... +||...... ++.++|||||||++|||++|+.||.+..... ...
T Consensus 134 ~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~-~~~ 212 (258)
T cd06632 134 LVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA-AVF 212 (258)
T ss_pred EECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH-HHH
Confidence 9999999999999987643211 233333333 7889999999999999999999997643211 111
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
........ +.++...+ ..+.+++.+||+.+|++||++.|+++
T Consensus 213 ~~~~~~~~--~~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 213 KIGRSKEL--PPIPDHLS------DEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred HHHhcccC--CCcCCCcC------HHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 11110000 11111111 12345666799999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=284.42 Aligned_cols=233 Identities=21% Similarity=0.270 Sum_probs=181.9
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|...+.||+|+||.||++.. .++..+|+|.+..... ...+.+.+|++.+++++||||+++++.+...+..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 467778999999999999984 5688999999875432 2346788899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.+++... ....+++..+..++.|+++||+|||+++++||||||+||++
T Consensus 81 ~~~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~ 134 (256)
T cd08220 81 APGGTLAEYIQKR--------------------------CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILL 134 (256)
T ss_pred CCCCCHHHHHHHh--------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 9999999999762 12357889999999999999999999999999999999999
Q ss_pred cCC-CCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHHH
Q 005572 565 AES-LEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKLV 628 (690)
Q Consensus 565 ~~~-~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~~ 628 (690)
+++ +.+|++|||++...... +||......++.++||||||+++|||++|+.||.... .......
T Consensus 135 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 214 (256)
T cd08220 135 DKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM 214 (256)
T ss_pred cCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH
Confidence 855 46899999998643321 3454444567889999999999999999999987522 1111111
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
. ..... +....+. .+.+++..||+.+|++|||+.|+++
T Consensus 215 ~-~~~~~-----~~~~~~~------~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 215 S-GTFAP-----ISDRYSP------DLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred h-cCCCC-----CCCCcCH------HHHHHHHHHccCChhhCCCHHHHhh
Confidence 1 11111 1111111 3445666799999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-34 Score=300.36 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=179.2
Q ss_pred HhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecC------
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAG------ 475 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------ 475 (690)
..++|...+.||+|+||.||+|. ..++..||||.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 34678889999999999999998 46678999999864321 2335577899999999999999999987543
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
...|+++|++ +++|.+++.. ..+++..+..++.|+++||+|||+++++||
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~~-----------------------------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 142 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVKC-----------------------------QKLSDEHVQFLIYQLLRGLKYIHSAGIIHR 142 (343)
T ss_pred CcEEEEeecC-CCCHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 3578999998 7799888753 348889999999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCcccccccc-----------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCch--H
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVKN-----------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDC--V 621 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~-----------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~ 621 (690)
||||+|||+++++.+||+|||+++..... +||.... ..++.++|||||||++|||++|+.||... .
T Consensus 143 dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 222 (343)
T cd07878 143 DLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI 222 (343)
T ss_pred cCChhhEEECCCCCEEEcCCccceecCCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH
Confidence 99999999999999999999998754321 3444333 35788999999999999999999998641 1
Q ss_pred HHHHHHHHh-cCCCC-cc-----------ccccccCCCCCHHHH-----HHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 622 KWVRKLVKE-GAGGD-AL-----------DFRLKLGSGDSVAEM-----VESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 622 ~~~~~~~~~-~~~~~-~~-----------~~~~~~~~~~~~~~~-----~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
+........ +.... .. ...++.......... ..+.+++.+|++.||++|||+.|+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 223 DQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 111111110 00000 00 000000000000000 124567788999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=284.76 Aligned_cols=233 Identities=21% Similarity=0.222 Sum_probs=181.6
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEec-CCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIA-GKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~~lv~e 483 (690)
+|+..+.||+|+||.||+++ ..++..+|+|.+..... ...+.+.+|++.+++++|||++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 36778899999999999998 45578899999865332 234567889999999999999999998764 446789999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++++|.+++... ....+++.++..++.|++.|++|||+.+++||||||+||+
T Consensus 81 ~~~~~~l~~~l~~~--------------------------~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil 134 (257)
T cd08223 81 FCEGGDLYHKLKEQ--------------------------KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVF 134 (257)
T ss_pred ccCCCcHHHHHHHh--------------------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEE
Confidence 99999999999752 1245889999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCccccccc----------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVK----------N----VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKL 627 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~----------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~ 627 (690)
++.++.+||+|||++..... . +||......++.++|||||||++|||++|+.||+.. .......
T Consensus 135 ~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 214 (257)
T cd08223 135 LTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRI 214 (257)
T ss_pred EecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999999864321 1 455444456788999999999999999999998752 2222222
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..+... ..+...+ ..+.+++.+||+.||++|||+.|+++
T Consensus 215 -~~~~~~-----~~~~~~~------~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 215 -IEGKLP-----PMPKDYS------PELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred -HhcCCC-----CCccccC------HHHHHHHHHHhccCcccCCCHHHHhc
Confidence 121110 1111111 23556777899999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=301.84 Aligned_cols=183 Identities=20% Similarity=0.230 Sum_probs=153.8
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecC------C
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG------K 476 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~ 476 (690)
..+|...+.||+|+||.||++. ...+..||||++.... ......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4578889999999999999998 4567889999986532 22345678899999999999999999987643 3
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..|+||||+++ +|.+++.. .+++..+..++.|+++||+|||+++++|||
T Consensus 103 ~~~lv~e~~~~-~l~~~~~~------------------------------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~D 151 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQM------------------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRD 151 (364)
T ss_pred eEEEEEeCCCC-CHHHHHHh------------------------------cCCHHHHHHHHHHHHHHHHHHhhCCeecCC
Confidence 57999999965 77777643 367888899999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|||+|||++.++.+||+|||+++..... +||......++.++|||||||++|||++|+.||..
T Consensus 152 lkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 227 (364)
T cd07875 152 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 227 (364)
T ss_pred CCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999998754321 45555556788999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=301.26 Aligned_cols=184 Identities=23% Similarity=0.285 Sum_probs=160.2
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC-C-----CCccceeeEEecCCeeEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-H-----PNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 480 (690)
+|.+.+.||+|+||.|.||. ..+++.||||++++.+ .-.++...|+.+|..++ | -|+|++++|+...++.||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 78889999999999999998 6779999999998754 23455677888888886 3 399999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|+|.++. +|+++|+..+ -..++......|+.||+.||.+||+.+|||+||||+
T Consensus 266 VfELL~~-NLYellK~n~--------------------------f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPE 318 (586)
T KOG0667|consen 266 VFELLST-NLYELLKNNK--------------------------FRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPE 318 (586)
T ss_pred eehhhhh-hHHHHHHhcC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChh
Confidence 9999966 9999999733 345888999999999999999999999999999999
Q ss_pred cEEecCC--CCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 561 SILLAES--LEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 561 NiLl~~~--~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
||||.+- ..+||+|||.+...... +||+.-+..|+.+.||||||||+.||++|.+-|.+
T Consensus 319 NILL~~~~r~~vKVIDFGSSc~~~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG 390 (586)
T KOG0667|consen 319 NILLKDPKRSRIKVIDFGSSCFESQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPG 390 (586)
T ss_pred heeeccCCcCceeEEecccccccCCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCC
Confidence 9999754 46999999999876543 77777778999999999999999999999876654
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=287.63 Aligned_cols=236 Identities=21% Similarity=0.296 Sum_probs=179.2
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---C-------CHHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---I-------DHDDAVAMFDELSRLKHPNLLPLAGYCIAGK 476 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~-------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 476 (690)
+|...+.||+|+||.||+|. ..++..+|+|.++.... . ..+.+.+|++.++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 35667899999999999998 45688999998853211 1 1135678999999999999999999999999
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..++||||+++|+|.+++++ ...+++..+..++.|++.||.|||+.+++|||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d 133 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRT----------------------------YGRFEEQLVRFFTEQVLEGLAYLHSKGILHRD 133 (272)
T ss_pred ceEEEEecCCCCcHHHHHhh----------------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCeeecC
Confidence 99999999999999999975 23578889999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc----------------cCcccCCC--CCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENE--TCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~--~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
|+|+||++++++.+|++|||+++..... +||..... .++.++||||||+++||+++|..||.
T Consensus 134 l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 213 (272)
T cd06629 134 LKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS 213 (272)
T ss_pred CChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc
Confidence 9999999999999999999998643211 23333222 37889999999999999999999986
Q ss_pred chHHH--HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 619 DCVKW--VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 619 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..... ..+... ......++.......+ ..+.+++..||+.||++||++.||++
T Consensus 214 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 214 DEEAIAAMFKLGN-KRSAPPIPPDVSMNLS------PVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred CcchHHHHHHhhc-cccCCcCCccccccCC------HHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 52221 111111 1111111111111111 23445667899999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=291.35 Aligned_cols=235 Identities=22% Similarity=0.240 Sum_probs=181.0
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCC---HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGID---HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
..|+..+.||+|+||.||+|+. .++..||+|.+....... .+++.+|++.++.++||||++++++|...+..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 3477788999999999999984 468899999986443222 246788999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||++ |++.+++... ...+++..+..++.|++.||.|||+.+++||||+|+||
T Consensus 95 e~~~-g~l~~~~~~~---------------------------~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nI 146 (307)
T cd06607 95 EYCL-GSASDILEVH---------------------------KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNI 146 (307)
T ss_pred HhhC-CCHHHHHHHc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence 9997 5787777541 23588999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc----------cCcccC---CCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHH-HH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN----------VGERSE---NETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRK-LV 628 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~----------~~e~~~---~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~-~~ 628 (690)
++++++.+||+|||++...... +||... +..++.++|||||||++|||+||+.||......... ..
T Consensus 147 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~ 226 (307)
T cd06607 147 LLTEPGTVKLADFGSASLVSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (307)
T ss_pred EECCCCCEEEeecCcceecCCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH
Confidence 9999999999999998654321 444431 245788999999999999999999998653221111 11
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.... .+.... ......+.+++.+||+.||++||++.+|+..
T Consensus 227 ~~~~-----~~~~~~-----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 227 AQND-----SPTLSS-----NDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred hcCC-----CCCCCc-----hhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 1110 011100 0011235566778999999999999999874
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=306.32 Aligned_cols=178 Identities=19% Similarity=0.242 Sum_probs=151.7
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
...|.+.+.||+|+||.||+|+. ..+..||||... ...+.+|++++++++|||||++++++...+..++||||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 34688889999999999999995 457889999642 23467899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+. |+|.+++... ...++|.++..++.|+++||+|||+++|+||||||+|||+
T Consensus 242 ~~-~~L~~~l~~~---------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl 293 (461)
T PHA03211 242 YR-SDLYTYLGAR---------------------------LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV 293 (461)
T ss_pred cC-CCHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE
Confidence 95 7999988651 2368999999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc------------c----cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCC
Q 005572 565 AESLEPKIAGFGLRNIGVK------------N----VGERSENETCGPESDVYCFGVILMELLTGKRGT 617 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~------------~----~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~ 617 (690)
+.++.+||+|||+++.... . +||......++.++|||||||++|||++|..|+
T Consensus 294 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 294 NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 9999999999999864321 1 344444457889999999999999999987653
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=287.01 Aligned_cols=231 Identities=20% Similarity=0.297 Sum_probs=181.9
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
|+..+.||+|+||.||+|.. .++..+|+|.+..... .....+.+|+..+++++||||+++++++...+..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 56678899999999999984 5678999999864432 233568889999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++.. ..+++..+..++.|++.|+.|||+.+++|+||||+||+++.
T Consensus 86 ~~~l~~~i~~-----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~ 136 (277)
T cd06641 86 GGSALDLLEP-----------------------------GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSE 136 (277)
T ss_pred CCcHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECC
Confidence 9999999864 24788999999999999999999999999999999999999
Q ss_pred CCCceEcCCCccccccc--------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH-HHHHHhc
Q 005572 567 SLEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV-RKLVKEG 631 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~-~~~~~~~ 631 (690)
++.++|+|||++..... .+||.......+.++|||||||++|||++|..||....... .......
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (277)
T cd06641 137 HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN 216 (277)
T ss_pred CCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC
Confidence 99999999998764322 13444444567889999999999999999999987532211 1111111
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
. .+.+....+ ..+.+++.+||+.+|++||++.++++.
T Consensus 217 ~-----~~~~~~~~~------~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 217 N-----PPTLEGNYS------KPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred C-----CCCCCcccC------HHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 1 111111111 134456677999999999999999883
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.81 Aligned_cols=185 Identities=22% Similarity=0.292 Sum_probs=147.1
Q ss_pred CceeccCCCccEEEEEcC---CCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEec--CCeeEEEEEecC
Q 005572 412 ESLLAEGRCGPVYRAVLP---GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA--GKEKLVLLEFMA 486 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~ 486 (690)
.++||+|+||.||+|+.. ++..+|+|.++... ....+.+|++++++++||||+++++++.. ....++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 357999999999999853 46789999986432 33567889999999999999999998864 456889999996
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe--
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL-- 564 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl-- 564 (690)
++|.+++........ ......+++..+..++.|++.||.|||+++++||||||+|||+
T Consensus 84 -~~l~~~~~~~~~~~~-------------------~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~ 143 (317)
T cd07868 84 -HDLWHIIKFHRASKA-------------------NKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMG 143 (317)
T ss_pred -CCHHHHHHhcccccc-------------------cCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEec
Confidence 589888864221100 0123458899999999999999999999999999999999999
Q ss_pred --cCCCCceEcCCCcccccccc-------------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 565 --AESLEPKIAGFGLRNIGVKN-------------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 565 --~~~~~~kl~DfGla~~~~~~-------------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
+.++.+||+|||+++..... ..|.+|| ..++.++||||+||++|||++|++||.
T Consensus 144 ~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 144 EGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred CCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 46689999999998653211 1234443 357889999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=313.47 Aligned_cols=189 Identities=22% Similarity=0.232 Sum_probs=152.4
Q ss_pred HHHHHhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCC------CCccceeeEEe
Q 005572 401 DLIAATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKH------PNLLPLAGYCI 473 (690)
Q Consensus 401 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H------~niv~l~g~~~ 473 (690)
++.....+|...+.||+|+||.||+|+ ..++..||||+++... ...++...|++++..++| .+++++++++.
T Consensus 123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 344456789999999999999999998 4567899999996432 223456667777776654 45888999887
Q ss_pred cC-CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cC
Q 005572 474 AG-KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VG 551 (690)
Q Consensus 474 ~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~ 551 (690)
.. ...++|||++ +++|.+++.+ ...+++..+..|+.||+.||+|||+ .+
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~----------------------------~~~l~~~~~~~i~~qi~~aL~yLH~~~g 252 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK----------------------------HGPFSHRHLAQIIFQTGVALDYFHTELH 252 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 64 4688999998 6789998875 2358899999999999999999998 59
Q ss_pred CCCCCCCCCcEEecCCC----------------CceEcCCCccccccc-----------ccCcccCCCCCCCCCcchhhH
Q 005572 552 STHGHLVTSSILLAESL----------------EPKIAGFGLRNIGVK-----------NVGERSENETCGPESDVYCFG 604 (690)
Q Consensus 552 ~iHrDlk~~NiLl~~~~----------------~~kl~DfGla~~~~~-----------~~~e~~~~~~~~~~~DVwSfG 604 (690)
|+||||||+|||++.++ .+||+|||.+..... .+||......++.++||||||
T Consensus 253 IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlG 332 (467)
T PTZ00284 253 LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMG 332 (467)
T ss_pred eecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHH
Confidence 99999999999998765 499999998754221 145555556789999999999
Q ss_pred HHHHHHHhCCCCCCc
Q 005572 605 VILMELLTGKRGTDD 619 (690)
Q Consensus 605 vvl~el~tg~~p~~~ 619 (690)
|++|||++|+.||+.
T Consensus 333 vil~elltG~~pf~~ 347 (467)
T PTZ00284 333 CIIYELYTGKLLYDT 347 (467)
T ss_pred HHHHHHHhCCCCCCC
Confidence 999999999999975
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=292.45 Aligned_cols=238 Identities=18% Similarity=0.158 Sum_probs=182.9
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|+..+.||+|+||.||++.. ..+..||+|.+..... ...+.+.+|++.++.++||||+++++.+...+..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 577889999999999999984 5578999999865432 223467789999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.. ...+++..+..++.|+++||.|||+.+++||||||+||+
T Consensus 82 ~~~g~~L~~~l~~----------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIl 133 (305)
T cd05609 82 YVEGGDCATLLKN----------------------------IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLL 133 (305)
T ss_pred cCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEE
Confidence 9999999999965 235788899999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccc-----------------------------cccCcccCCCCCCCCCcchhhHHHHHHHHhCC
Q 005572 564 LAESLEPKIAGFGLRNIGV-----------------------------KNVGERSENETCGPESDVYCFGVILMELLTGK 614 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~-----------------------------~~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~ 614 (690)
++.++.+|++|||+++... -.+||......++.++|||||||++|||++|+
T Consensus 134 l~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~ 213 (305)
T cd05609 134 ITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGC 213 (305)
T ss_pred ECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999876310 01344444457788999999999999999999
Q ss_pred CCCCch-HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 615 RGTDDC-VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 615 ~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
.||... ............. ..+...... .. .+.+++.+||+.||++||++.++.+.|+.
T Consensus 214 ~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~---~~---~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 214 VPFFGDTPEELFGQVISDDI---EWPEGDEAL---PA---DAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCCCCCHHHHHHHHHhccc---CCCCccccC---CH---HHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 998642 1111111111111 111110011 11 34566778999999999997666666554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=322.28 Aligned_cols=244 Identities=22% Similarity=0.266 Sum_probs=182.7
Q ss_pred HhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEec--CCeeE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIA--GKEKL 479 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~ 479 (690)
...+|.+.+.||+|+||.||+|+ ..++..+|+|.+..... .....+.+|+.+++.++|||||++++++.. ....|
T Consensus 11 ~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ly 90 (1021)
T PTZ00266 11 RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLY 90 (1021)
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEE
Confidence 34578889999999999999999 45577899999864422 234568899999999999999999998864 35689
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc-------CC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV-------GS 552 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-------~~ 552 (690)
|||||+++|+|.++|.... .....+++..++.|+.||+.||+|||+. +|
T Consensus 91 IVMEY~~gGSL~~lL~k~~------------------------~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~I 146 (1021)
T PTZ00266 91 ILMEFCDAGDLSRNIQKCY------------------------KMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERV 146 (1021)
T ss_pred EEEeCCCCCcHHHHHHHHh------------------------hccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCc
Confidence 9999999999999997521 1124689999999999999999999984 49
Q ss_pred CCCCCCCCcEEecC-----------------CCCceEcCCCccccccc---------c----cCcccCC--CCCCCCCcc
Q 005572 553 THGHLVTSSILLAE-----------------SLEPKIAGFGLRNIGVK---------N----VGERSEN--ETCGPESDV 600 (690)
Q Consensus 553 iHrDlk~~NiLl~~-----------------~~~~kl~DfGla~~~~~---------~----~~e~~~~--~~~~~~~DV 600 (690)
|||||||+||||+. .+.+||+|||+++.... . +||.... ..+++++||
T Consensus 147 VHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDV 226 (1021)
T PTZ00266 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDM 226 (1021)
T ss_pred eeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHH
Confidence 99999999999964 34589999999875421 1 3443321 347889999
Q ss_pred hhhHHHHHHHHhCCCCCCchHHH--HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH-
Q 005572 601 YCFGVILMELLTGKRGTDDCVKW--VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL- 677 (690)
Q Consensus 601 wSfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~- 677 (690)
|||||++|||+||+.||...... ....+... .+..+. .. . ..+.+++..||+.+|++||++.|++
T Consensus 227 WSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~-----p~lpi~-~~---S---~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 227 WALGCIIYELCSGKTPFHKANNFSQLISELKRG-----PDLPIK-GK---S---KELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred HHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC-----CCCCcC-CC---C---HHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 99999999999999999752221 11122111 011110 11 1 1345567789999999999999998
Q ss_pred -HHHhccC
Q 005572 678 -GLLKDIR 684 (690)
Q Consensus 678 -~~L~~i~ 684 (690)
..+..+.
T Consensus 295 h~~ik~i~ 302 (1021)
T PTZ00266 295 YQIIKNVG 302 (1021)
T ss_pred cHHHhhcC
Confidence 4555443
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=282.10 Aligned_cols=234 Identities=28% Similarity=0.451 Sum_probs=183.1
Q ss_pred CCCceeccCCCccEEEEEcCC-----CcEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 410 GKESLLAEGRCGPVYRAVLPG-----ELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 410 ~~~~~lg~G~~g~Vy~~~~~~-----~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
...+.||+|+||.||+++... +..||+|+++..... ..+.+.+|++.+..++|+||+++++++...+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999543 378999999655432 45678899999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++++|.+++.... ...+++.++..++.|++.||+|||+.+++||||||+||+
T Consensus 82 ~~~~~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil 135 (258)
T smart00219 82 YMEGGDLLDYLRKNR--------------------------PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCL 135 (258)
T ss_pred ccCCCCHHHHHHhhh--------------------------hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEE
Confidence 999999999997521 112889999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCCCCCch-HHHHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDC-VKWVRK 626 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~p~~~~-~~~~~~ 626 (690)
+++++.+||+|||+++..... +||......++.++||||+|+++|||++ |..||... .....+
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~ 215 (258)
T smart00219 136 VGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLE 215 (258)
T ss_pred EccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998644321 3343334567889999999999999998 78888642 111222
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
........ ...... ...+.+++.+||..||++|||+.|+++.|
T Consensus 216 ~~~~~~~~-----~~~~~~------~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 216 YLKKGYRL-----PKPENC------PPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred HHhcCCCC-----CCCCcC------CHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 22221111 011111 11355677789999999999999999865
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.43 Aligned_cols=185 Identities=17% Similarity=0.205 Sum_probs=156.3
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|...+.||+|+||.||+++. .++..+|+|++.... ......+.+|+.++..++|+||+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 677889999999999999995 457889999986421 1233457788899999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++++. ...+++..+..++.|++.||+|||+.+++||||||+|||
T Consensus 82 y~~~g~L~~~l~~~---------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nil 134 (332)
T cd05623 82 YYVGGDLLTLLSKF---------------------------EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134 (332)
T ss_pred ccCCCcHHHHHHHh---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEE
Confidence 99999999999751 235788889999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCccccccc-----------c----cCcccC-----CCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 564 LAESLEPKIAGFGLRNIGVK-----------N----VGERSE-----NETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~-----------~----~~e~~~-----~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
++.++.+||+|||++..... . +||... ...++.++|||||||++|||++|+.||..
T Consensus 135 i~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~ 210 (332)
T cd05623 135 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (332)
T ss_pred ECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC
Confidence 99999999999998754211 1 344332 23578899999999999999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=291.58 Aligned_cols=236 Identities=19% Similarity=0.257 Sum_probs=183.9
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.+|...+.||+|+||.||+|. ..++..+|+|.+........+.+.+|+..+++++||||+++++++...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 577888999999999999998 4567889999986554445567889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|+|.+++.+ ..+++.++..++.|++.||.|||+.+++||||||+||+++
T Consensus 99 ~~~~L~~~~~~-----------------------------~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~ 149 (293)
T cd06647 99 AGGSLTDVVTE-----------------------------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 149 (293)
T ss_pred CCCcHHHHHhh-----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEc
Confidence 99999999864 2467889999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhc
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEG 631 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 631 (690)
.++.+||+|||++...... +||......++.++|||||||++||+++|+.||....... ......
T Consensus 150 ~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~-~~~~~~ 228 (293)
T cd06647 150 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR-ALYLIA 228 (293)
T ss_pred CCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhh-heeehh
Confidence 9999999999987543211 3444444567889999999999999999999997521110 000000
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.. . .+... . .......+.+++..||+.+|++||++.|++..
T Consensus 229 ~~-~--~~~~~--~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 229 TN-G--TPELQ--N--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred cC-C--CCCCC--C--ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0 00000 0 00011134456778999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=290.77 Aligned_cols=244 Identities=19% Similarity=0.252 Sum_probs=180.4
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++|...+.||+|+||.||+|+. .++..||+|.+..... .....+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 4677788999999999999995 4678999999865432 2234567899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++ +|.+++... ...+++.....++.|+++||.|||+.+++||||||+||++
T Consensus 85 ~~~-~L~~~~~~~---------------------------~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~ 136 (291)
T cd07844 85 LDT-DLKQYMDDC---------------------------GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI 136 (291)
T ss_pred CCC-CHHHHHHhC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE
Confidence 974 999998752 2357888999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccccc--------------ccCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHHH---HHH
Q 005572 565 AESLEPKIAGFGLRNIGVK--------------NVGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVKW---VRK 626 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~--------------~~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~---~~~ 626 (690)
++++.+||+|||+++.... .+||...+ ..++.++|||||||++|||++|+.||...... ...
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~ 216 (291)
T cd07844 137 SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHK 216 (291)
T ss_pred cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 9999999999998764211 13443322 34678999999999999999999998653211 111
Q ss_pred HHHh-cCCCCcc-----------ccccccCCCC-------CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 627 LVKE-GAGGDAL-----------DFRLKLGSGD-------SVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 627 ~~~~-~~~~~~~-----------~~~~~~~~~~-------~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... +...... .......... .........+++.+|++.+|++|||+.|+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 217 IFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred HHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 1110 0000000 0000000000 0010134456778899999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=289.28 Aligned_cols=235 Identities=19% Similarity=0.274 Sum_probs=177.1
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHH-HHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDE-LSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|+||.||+|+. .++..||+|+++.... ....++..|+.. ++..+||||+++++++...+..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~ 81 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEV 81 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhh
Confidence 677888999999999999995 5688999999875432 233455566665 5667899999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc-CCCCCCCCCCcEE
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV-GSTHGHLVTSSIL 563 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~iHrDlk~~NiL 563 (690)
++ |+|.+++.... .....+++..+..++.|++.||+|||++ +++||||||+||+
T Consensus 82 ~~-~~l~~~l~~~~------------------------~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil 136 (283)
T cd06617 82 MD-TSLDKFYKKVY------------------------DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL 136 (283)
T ss_pred hc-ccHHHHHHHhc------------------------cCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEE
Confidence 96 68988886521 1124689999999999999999999997 9999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-------------cCcccCC----CCCCCCCcchhhHHHHHHHHhCCCCCCchH---HH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-------------VGERSEN----ETCGPESDVYCFGVILMELLTGKRGTDDCV---KW 623 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-------------~~e~~~~----~~~~~~~DVwSfGvvl~el~tg~~p~~~~~---~~ 623 (690)
++.++.+||+|||+++..... +||.... ..++.++|||||||++|||++|+.||.... +.
T Consensus 137 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~ 216 (283)
T cd06617 137 INRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ 216 (283)
T ss_pred ECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH
Confidence 999999999999998753211 3333221 346789999999999999999999986422 11
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
...... .. .+.++... ... .+.+++..||+.+|++||++.++++
T Consensus 217 ~~~~~~-~~-----~~~~~~~~--~~~---~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 217 LKQVVE-EP-----SPQLPAEK--FSP---EFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred HHHHHh-cC-----CCCCCccc--cCH---HHHHHHHHHccCChhhCcCHHHHhc
Confidence 111111 11 11111000 011 3445677899999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=287.24 Aligned_cols=231 Identities=21% Similarity=0.289 Sum_probs=181.7
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
|+..+.||+|++|.||++. ..++..+|+|+++.......+.+.+|+..++.++||||+++++++...+..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 4445789999999999998 456889999998755444456688999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
++|.+++.. ..+++..+..++.|++.||+|||+.+++||||+|+||+++.+
T Consensus 101 ~~L~~~~~~-----------------------------~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~ 151 (285)
T cd06648 101 GALTDIVTH-----------------------------TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSD 151 (285)
T ss_pred CCHHHHHHh-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCC
Confidence 999999864 247888999999999999999999999999999999999999
Q ss_pred CCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHHHHhc
Q 005572 568 LEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKLVKEG 631 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~~~~~ 631 (690)
+.+||+|||.+...... +||......++.++|||||||++|||++|+.||.... ....... ..
T Consensus 152 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~-~~ 230 (285)
T cd06648 152 GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIR-DN 230 (285)
T ss_pred CcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH-hc
Confidence 99999999987543211 3444444567889999999999999999999986521 2222211 11
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
. .+...... . .-..+.+++.+||+.+|++||++.|+++
T Consensus 231 ~-----~~~~~~~~--~--~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 231 L-----PPKLKNLH--K--VSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred C-----CCCCcccc--c--CCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 1 01111000 0 0124556777899999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=289.87 Aligned_cols=246 Identities=20% Similarity=0.210 Sum_probs=179.9
Q ss_pred HhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++.+|...+.||+|+||.||+|.. .++..+|+|++..... .....+.+|++.++.++|+||+++++++...+..++|+
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 346788889999999999999984 5678999999865432 22346778999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+. +++.+++... ...+++..+..++.|++.||.|||+.+++||||||+||
T Consensus 83 e~~~-~~l~~~~~~~---------------------------~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni 134 (291)
T cd07870 83 EYMH-TDLAQYMIQH---------------------------PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL 134 (291)
T ss_pred eccc-CCHHHHHHhC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence 9996 6888777541 23467888889999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccccc----------c----cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVK----------N----VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKL 627 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~----------~----~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~ 627 (690)
+++.++++||+|||+++.... . +||...+ ..++.++|||||||++|||++|+.||+.........
T Consensus 135 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~ 214 (291)
T cd07870 135 LISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214 (291)
T ss_pred EEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH
Confidence 999999999999998864321 1 3444332 246778999999999999999999997532211111
Q ss_pred HHh----cCCC-----------CccccccccCCCCC-------HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKE----GAGG-----------DALDFRLKLGSGDS-------VAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~----~~~~-----------~~~~~~~~~~~~~~-------~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... +... .............. ......+.+++.+|++.||++|||+.|++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 215 EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred HHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 100 0000 00000000000000 001123456677899999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=297.17 Aligned_cols=186 Identities=17% Similarity=0.175 Sum_probs=156.9
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|...+.||+|+||.||+++. .++..||+|++.... ......+.+|..++..++|+||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 3678889999999999999994 567889999986432 122345778888999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.+++.+. ...+++..+..++.|++.||+|||+++++||||||+||
T Consensus 81 Ey~~gg~L~~~l~~~---------------------------~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Ni 133 (331)
T cd05624 81 DYYVGGDLLTLLSKF---------------------------EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNV 133 (331)
T ss_pred eCCCCCcHHHHHHHh---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHE
Confidence 999999999999751 23578888999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccccc-----------ccCcccCC---------CCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 563 LLAESLEPKIAGFGLRNIGVK-----------NVGERSEN---------ETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~-----------~~~e~~~~---------~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|++.++.+||+|||+++.... ...|.+|| ..++.++|||||||++|||++|+.||..
T Consensus 134 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~ 210 (331)
T cd05624 134 LLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210 (331)
T ss_pred EEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC
Confidence 999999999999999764321 12233333 3578899999999999999999999975
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=293.00 Aligned_cols=236 Identities=24% Similarity=0.251 Sum_probs=187.7
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCC---CHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGI---DHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv 481 (690)
..|+..+.||+|.||.||+++. .+|..+|+|.+.+.... +.+...+|+++|+++. |||||.+.+.+++....++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 3466668999999999999994 55999999999766543 3468999999999998 99999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
||+|.+|.|++.+.+ . .+++.++..++.||+.|+.|||+.+++|||+||+|
T Consensus 115 mEL~~GGeLfd~i~~----------------------------~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN 165 (382)
T KOG0032|consen 115 MELCEGGELFDRIVK----------------------------K-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPEN 165 (382)
T ss_pred EEecCCchHHHHHHH----------------------------c-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHH
Confidence 999999999999976 1 28889999999999999999999999999999999
Q ss_pred EEecCC----CCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-
Q 005572 562 ILLAES----LEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW- 623 (690)
Q Consensus 562 iLl~~~----~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~- 623 (690)
+|+... +.+|++|||++...... +||+.....|+.++||||.||++|.|++|.+||....+.
T Consensus 166 ~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~ 245 (382)
T KOG0032|consen 166 LLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE 245 (382)
T ss_pred eeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence 999643 57999999999876542 555555578999999999999999999999999763321
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
....+..+.. + ++...-...+.. +-+++..|+..||.+|+|+.++++.
T Consensus 246 ~~~~i~~~~~-~-f~~~~w~~is~~------akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 246 IFLAILRGDF-D-FTSEPWDDISES------AKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHHHcCCC-C-CCCCCccccCHH------HHHHHHHhcccCcccCCCHHHHhcC
Confidence 2222222222 1 111111111222 3344556999999999999999983
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=296.19 Aligned_cols=241 Identities=22% Similarity=0.258 Sum_probs=186.5
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
|...+.||.|+||.||-++ ..+...||||++.-... ...+++..|++.|.+++|||+|.+.|+|......|+||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 4445789999999999999 67788999999964433 2346788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
|- ||-.|.+... ..++.+..+..|+.++++||+|||+.+.||||||+.|||+
T Consensus 108 Cl-GSAsDlleVh---------------------------kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL 159 (948)
T KOG0577|consen 108 CL-GSASDLLEVH---------------------------KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL 159 (948)
T ss_pred Hh-ccHHHHHHHH---------------------------hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe
Confidence 95 5888877652 3468888999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc----------cCccc---CCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhc
Q 005572 565 AESLEPKIAGFGLRNIGVKN----------VGERS---ENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEG 631 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~----------~~e~~---~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 631 (690)
++.|.+|++|||.|.+..+. +||+. .++.|+-|+||||+||+..||.-.++|...+.....-.....
T Consensus 160 se~g~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ 239 (948)
T KOG0577|consen 160 SEPGLVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 239 (948)
T ss_pred cCCCeeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh
Confidence 99999999999998775543 45543 357899999999999999999999999766543322111111
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCC
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
.. .|.+.. .+--.. +..++-.|++.-|.+|||..+++..---.++.
T Consensus 240 Ne----sPtLqs--~eWS~~---F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R 285 (948)
T KOG0577|consen 240 NE----SPTLQS--NEWSDY---FRNFVDSCLQKIPQERPTSEELLKHRFVLRER 285 (948)
T ss_pred cC----CCCCCC--chhHHH---HHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence 11 122211 111122 23344469999999999999998754444433
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=291.48 Aligned_cols=243 Identities=21% Similarity=0.254 Sum_probs=180.2
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|+||.||+|... ++..+|+|++..... ...+.+.+|++.++.++||||+++++++...+..++|+||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5777889999999999999964 588999998854322 2345678899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.++... ...++|.++..++.|+++||.|||+.+++||||+|+||++
T Consensus 82 ~~~~~l~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~ 133 (286)
T cd07846 82 VDHTVLDDLEKY----------------------------PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV 133 (286)
T ss_pred CCccHHHHHHhc----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE
Confidence 999999887653 2348899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~ 627 (690)
++++.+||+|||++...... +||.... ..++.++|||||||++|||++|++||.... +.....
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~ 213 (286)
T cd07846 134 SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHI 213 (286)
T ss_pred CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 99999999999997643211 3443322 346788999999999999999999886411 111111
Q ss_pred HHh-cCC----------CCcccc-cccc-CCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKE-GAG----------GDALDF-RLKL-GSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~-~~~----------~~~~~~-~~~~-~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... +.. ....+. ..+. ....... ....+.+++.+||+.+|++||++.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 214 IKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 110 000 000000 0000 0000000 0123566788899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=283.58 Aligned_cols=234 Identities=17% Similarity=0.184 Sum_probs=176.3
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--C---CHHHHHHHHHHHHhcCCCCccceeeEEecC--Cee
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--I---DHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEK 478 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~ 478 (690)
.+|...+.||+|+||.||+|.. .++..||+|.+..... . ..+.+.+|++.+++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 3677789999999999999984 5588999998853321 1 124677899999999999999999988763 467
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++||||+++|+|.+++.. ...+++....+++.|++.||+|||+.+++|+|||
T Consensus 82 ~~v~e~~~~~~L~~~l~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~ 133 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS----------------------------YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIK 133 (265)
T ss_pred EEEEEecCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 899999999999999875 2346788889999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCccccccc-----------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVK-----------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~-----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~ 621 (690)
|+||+++.++.+||+|||+++.... .+||......++.++|||||||++|||++|+.||....
T Consensus 134 p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 213 (265)
T cd06652 134 GANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE 213 (265)
T ss_pred HHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc
Confidence 9999999999999999998864221 03444444567889999999999999999999997632
Q ss_pred HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... ...... ....+..+. .....+.+++.+||. +|++||+++||++
T Consensus 214 ~~~~-~~~~~~--~~~~~~~~~------~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 214 AMAA-IFKIAT--QPTNPVLPP------HVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred hHHH-HHHHhc--CCCCCCCch------hhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 2111 111110 001111111 111123445556774 8999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=282.35 Aligned_cols=234 Identities=19% Similarity=0.251 Sum_probs=182.2
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|...+.||+|+||.||+|.. .++..+|+|.+.... ....+.+.+|++.++.++|+||+++++.+...+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 366778999999999999995 457889999986532 13445678999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.+++.+. ....+++..+..++.|+++||.|||+.+++|+||||+||++
T Consensus 81 ~~~~~L~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~ 134 (257)
T cd08225 81 CDGGDLMKRINRQ--------------------------RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL 134 (257)
T ss_pred CCCCcHHHHHHhc--------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE
Confidence 9999999999752 12357899999999999999999999999999999999999
Q ss_pred cCCC-CceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHH
Q 005572 565 AESL-EPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKL 627 (690)
Q Consensus 565 ~~~~-~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~ 627 (690)
++++ .+||+|||.+...... +||......++.++|||||||++|||++|..||... .+.....
T Consensus 135 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 214 (257)
T cd08225 135 SKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKI 214 (257)
T ss_pred cCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 9885 4699999987653221 344444456788999999999999999999998742 2222222
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.. ... .+ .....+ ..+.+++.+||+.+|++|||+.|+++.
T Consensus 215 ~~-~~~----~~-~~~~~~------~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 215 CQ-GYF----AP-ISPNFS------RDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred hc-ccC----CC-CCCCCC------HHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 21 111 10 111111 134556677999999999999999763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=302.83 Aligned_cols=179 Identities=18% Similarity=0.201 Sum_probs=153.6
Q ss_pred ccCCCCceeccCCCccEEEEEcC---CCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP---GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
.+|...+.||+|+||.||++... .+..||+|.+... ....+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 46888999999999999999743 3578999988543 345689999999999999999999999899999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+. ++|.+++.. ...+++.+++.++.|++.||.|||+++++||||||+|||
T Consensus 167 ~~~-~~l~~~l~~----------------------------~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil 217 (392)
T PHA03207 167 KYK-CDLFTYVDR----------------------------SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217 (392)
T ss_pred hcC-CCHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence 995 689998853 246889999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 564 LAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
++.++.+||+|||+++..... +||......++.++|||||||++|||++|+.||..
T Consensus 218 l~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 218 LDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred EcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 999999999999998643211 45555446788999999999999999999999854
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=288.87 Aligned_cols=239 Identities=20% Similarity=0.267 Sum_probs=181.1
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|+..+.||+|+||.||++... ++..+|+|.+.... ......+.+|++.+++++||||+++++++...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677789999999999999954 68899999886432 122457888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcEEe
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSILL 564 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~NiLl 564 (690)
++++|.+++.... ....+++..+..++.|+++||.|||+ .+++||||||+||++
T Consensus 82 ~~~~l~~~~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 136 (286)
T cd06622 82 DAGSLDKLYAGGV-------------------------ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV 136 (286)
T ss_pred CCCCHHHHHHhcc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE
Confidence 9999999987510 12368899999999999999999997 599999999999999
Q ss_pred cCCCCceEcCCCcccccccc------------cCcccCC------CCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN------------VGERSEN------ETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVR 625 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~------------~~e~~~~------~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~ 625 (690)
+.++.+||+|||++...... +||.... ..++.++|||||||++|||++|+.||.... ....
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 216 (286)
T cd06622 137 NGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF 216 (286)
T ss_pred CCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH
Confidence 99999999999988643211 3333211 134789999999999999999999986421 1111
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
......... ..+.++... ...+.+++.+||+.+|++||++.|+++.
T Consensus 217 ~~~~~~~~~--~~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 217 AQLSAIVDG--DPPTLPSGY------SDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HHHHHHhhc--CCCCCCccc------CHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 111110000 011111111 1234456778999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=290.31 Aligned_cols=244 Identities=23% Similarity=0.202 Sum_probs=180.6
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCC-----CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGI-----DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
+|+..+.||+|+||.||+|.. .++..||+|.++..... ....+..|++.+++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 366778899999999999995 46889999999754322 234567899999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||+ +|+|.+++... ...+++..+..++.||++||.|||+++++||||||+|
T Consensus 81 ~e~~-~~~L~~~i~~~---------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~n 132 (298)
T cd07841 81 FEFM-ETDLEKVIKDK---------------------------SIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNN 132 (298)
T ss_pred Eccc-CCCHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhh
Confidence 9999 89999999751 1258899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc----------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN----------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDDCVK--WV 624 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~----------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~ 624 (690)
|+++.++.+||+|||+++..... ..+.+++ ..++.++|||||||++|||++|.+||..... ..
T Consensus 133 ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~ 212 (298)
T cd07841 133 LLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQL 212 (298)
T ss_pred EEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHH
Confidence 99999999999999998754321 1123332 3467899999999999999999877754211 11
Q ss_pred HHHHHhcCCC---------Ccccccc-ccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 625 RKLVKEGAGG---------DALDFRL-KLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 625 ~~~~~~~~~~---------~~~~~~~-~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.......... ...+... ......... ....+.+++.+||+.||++|||+.|+++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 213 GKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred HHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 1111110000 0000000 000000101 11245677888999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=291.90 Aligned_cols=237 Identities=24% Similarity=0.340 Sum_probs=181.5
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCH--HHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDH--DDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~--~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
|+..+.||+|+||.||+++. .++..+|+|.+........ ....+|+..+++++||||+++++++......++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 34567899999999999994 5567899999976542221 22345899999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++++|.+++.. ...+++..+..++.|+++||.|||+.+++||||||+||+++
T Consensus 81 ~~~~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~ 132 (260)
T PF00069_consen 81 PGGSLQDYLQK----------------------------NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLD 132 (260)
T ss_dssp TTEBHHHHHHH----------------------------HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEES
T ss_pred ccccccccccc----------------------------ccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999973 23578999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCccccccc--------------ccCcccC-CCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVK--------------NVGERSE-NETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVK 629 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~--------------~~~e~~~-~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~ 629 (690)
+++.++|+|||.+..... .+||... ....+.++||||+|+++|||++|+.||.+.. ........
T Consensus 133 ~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~ 212 (260)
T PF00069_consen 133 ENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE 212 (260)
T ss_dssp TTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 999999999999863110 1566665 5678899999999999999999999988641 11111111
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
...... ....... ..... ..+.+++..||+.||++||++.|+++
T Consensus 213 ~~~~~~-~~~~~~~-~~~~~---~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 213 KILKRP-LPSSSQQ-SREKS---EELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHHHTH-HHHHTTS-HTTSH---HHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred hccccc-ccccccc-cchhH---HHHHHHHHHHccCChhHCcCHHHHhc
Confidence 100000 0000000 00011 34556677899999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-33 Score=285.21 Aligned_cols=242 Identities=24% Similarity=0.289 Sum_probs=183.3
Q ss_pred HHhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeEEecCC-----
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGK----- 476 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~----- 476 (690)
.++++|+..+.||+|+||.||+|.. .++..+++|++.... ...+.+.+|++.++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 3567899999999999999999995 457789999986543 2446788999999999 6999999999997644
Q ss_pred -eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 477 -EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 477 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
..++||||+++++|.+++.... .....+++..+..++.|+++||.|||+.+++||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~------------------------~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~ 137 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLR------------------------KKGKRLKEEWIAYILRETLRGLAYLHENKVIHR 137 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHh------------------------hcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccC
Confidence 4899999999999999987521 013468899999999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCcccccccc--------------cCcccC-----CCCCCCCCcchhhHHHHHHHHhCCCC
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSE-----NETCGPESDVYCFGVILMELLTGKRG 616 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~-----~~~~~~~~DVwSfGvvl~el~tg~~p 616 (690)
||+|+||++++++.+||+|||++...... +||... ...++.++|||||||++|||++|+.|
T Consensus 138 ~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p 217 (275)
T cd06608 138 DIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPP 217 (275)
T ss_pred CCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCC
Confidence 99999999999999999999987643211 333321 12467899999999999999999999
Q ss_pred CCchHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 617 TDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 617 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
|....... ....... . ..+.... .......+.+++.+||..||++|||+.|+++
T Consensus 218 ~~~~~~~~-~~~~~~~-~--~~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 218 LCDMHPMR-ALFKIPR-N--PPPTLKS----PENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred ccccchHH-HHHHhhc-c--CCCCCCc----hhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 97532111 1111100 0 0111110 1101113446677899999999999999986
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=287.85 Aligned_cols=244 Identities=18% Similarity=0.202 Sum_probs=180.1
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|+||.||+|+. .++..||||.++.... .....+.+|++.+++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 367788999999999999985 5688999999864322 2335688999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+. ++|.+++... ....+++..+..++.|++.||+|||+.+++||||+|+||++
T Consensus 81 ~~-~~l~~~~~~~--------------------------~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill 133 (284)
T cd07860 81 LH-QDLKKFMDAS--------------------------PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI 133 (284)
T ss_pred cc-cCHHHHHHhC--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 96 6899988752 13458899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~ 627 (690)
++++.+||+|||+++..... +||...+ ..++.++|||||||++|||+||+.||.... +...+.
T Consensus 134 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~ 213 (284)
T cd07860 134 NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI 213 (284)
T ss_pred CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 99999999999987643211 3333222 235788999999999999999999986421 111121
Q ss_pred HHhcC-CCCccc----------cccccCCCCCHHHH-----HHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEGA-GGDALD----------FRLKLGSGDSVAEM-----VESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~-~~~~~~----------~~~~~~~~~~~~~~-----~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..... ...... .............. ..+.+++.+||+.||++|||+.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 214 FRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 11110 000000 00000000011110 13456788899999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=298.02 Aligned_cols=224 Identities=17% Similarity=0.188 Sum_probs=167.8
Q ss_pred eccCCCccEEEEE-cCCCcEEEEEEeeccCCC---CHHHHHHHHHHHHhc---CCCCccceeeEEecCCeeEEEEEecCC
Q 005572 415 LAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI---DHDDAVAMFDELSRL---KHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 415 lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
||+|+||.||+|+ ..++..||||++...... .......|..++... +||||+++++++...+..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 6999999999998 456889999998643211 122344455666554 699999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.. ...+++..+..++.||++||+|||+++++||||||+|||++.+
T Consensus 81 g~L~~~l~~----------------------------~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~ 132 (330)
T cd05586 81 GELFWHLQK----------------------------EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDAT 132 (330)
T ss_pred ChHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCC
Confidence 999999875 2357888999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc----------c----cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhc
Q 005572 568 LEPKIAGFGLRNIGVK----------N----VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEG 631 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~----------~----~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~ 631 (690)
+.+||+|||+++.... . +||...+. .++.++|||||||++|||++|+.||.... .........+
T Consensus 133 ~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~ 212 (330)
T cd05586 133 GHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG 212 (330)
T ss_pred CCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC
Confidence 9999999999864211 1 34443322 47889999999999999999999986521 2222222221
Q ss_pred CCCCcccccccc-CCCCCHHHHHHHHHHHhhhcCCCCCCCC----CHHHHHH
Q 005572 632 AGGDALDFRLKL-GSGDSVAEMVESLRVGYLCTADSPGKRP----TMQQVLG 678 (690)
Q Consensus 632 ~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~C~~~dP~~RP----t~~ev~~ 678 (690)
.. .++. ..+. ...+++.+||+.||++|| ++.|+++
T Consensus 213 ~~------~~~~~~~~~------~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 213 KV------RFPKNVLSD------EGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CC------CCCCccCCH------HHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 11 1111 1111 234556679999999998 4566554
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=285.62 Aligned_cols=235 Identities=19% Similarity=0.252 Sum_probs=180.3
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCC------CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI------DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
+|+..+.||+|+||.||+|. ..++..+|+|.+...... ..+.+.+|++.+++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 46777899999999999998 466889999998643311 13567889999999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|+||+++++|.+++.+ ...+++..+..++.|++.||.|||+++++||||||+
T Consensus 81 v~e~~~~~~L~~~l~~----------------------------~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~ 132 (268)
T cd06630 81 FVEWMAGGSVSHLLSK----------------------------YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGA 132 (268)
T ss_pred EEeccCCCcHHHHHHH----------------------------hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 9999999999999975 235788899999999999999999999999999999
Q ss_pred cEEecCCC-CceEcCCCcccccccc------------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch-
Q 005572 561 SILLAESL-EPKIAGFGLRNIGVKN------------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC- 620 (690)
Q Consensus 561 NiLl~~~~-~~kl~DfGla~~~~~~------------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~- 620 (690)
||+++.++ .+||+|||++...... +||......++.++||||+|+++|||++|+.||...
T Consensus 133 nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 133 NLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred HEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 99998776 5999999997543211 344433456788999999999999999999998631
Q ss_pred -HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 621 -VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 621 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.............. ..+..+.. .-..+.+++..||+.+|++||++.|+++
T Consensus 213 ~~~~~~~~~~~~~~~--~~~~~~~~------~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 213 HSNHLALIFKIASAT--TAPSIPEH------LSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred CcchHHHHHHHhccC--CCCCCchh------hCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 11111111111000 00111111 1123455677899999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=284.19 Aligned_cols=233 Identities=21% Similarity=0.307 Sum_probs=180.8
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcC---CCCccceeeEEecCCeeEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLK---HPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~~~lv~ 482 (690)
.|+..+.||+|+||.||+|.. .++..+|+|.++... .....++.+|++++++++ ||||+++++++......++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 366678899999999999994 668899999986542 234466888999999886 999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++++|.++++. ..+++.....++.|++.||.|||+.+++||||+|+||
T Consensus 82 e~~~~~~L~~~~~~-----------------------------~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni 132 (277)
T cd06917 82 EYAEGGSVRTLMKA-----------------------------GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANI 132 (277)
T ss_pred ecCCCCcHHHHHHc-----------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHE
Confidence 99999999999864 2578999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc--------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKL 627 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~ 627 (690)
++++++.+||+|||++...... +||.... ..++.++|||||||++|||++|+.||........ .
T Consensus 133 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~-~ 211 (277)
T cd06917 133 LVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA-M 211 (277)
T ss_pred EEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh-h
Confidence 9999999999999987654221 2333222 2467899999999999999999999975321110 0
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.. ......+.+.... ....+.+++.+||+.||++||++.|+++
T Consensus 212 -~~--~~~~~~~~~~~~~-----~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 212 -ML--IPKSKPPRLEDNG-----YSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred -hc--cccCCCCCCCccc-----CCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 00 0001111111110 1124556777899999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-33 Score=286.84 Aligned_cols=242 Identities=21% Similarity=0.243 Sum_probs=183.0
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 483 (690)
+|...+.||.|++|.||+|.. .++..+|+|.+..... .....+.+|++.+++++||||++++++|... +..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e 81 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEE
Confidence 577788999999999999995 5688999999875432 2346688999999999999999999998653 46899999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.... .....+++.....++.|+++||.|||+.+++|+||+|+||+
T Consensus 82 ~~~~~~L~~~l~~~~------------------------~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil 137 (287)
T cd06621 82 YCEGGSLDSIYKKVK------------------------KRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL 137 (287)
T ss_pred ecCCCCHHHHHHHHH------------------------hcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence 999999999886421 11345788889999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH----H--HHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV----K--WVR 625 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~----~--~~~ 625 (690)
+++++.+||+|||++...... +||......++.++|||||||++|||++|+.||.... . ...
T Consensus 138 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (287)
T cd06621 138 LTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL 217 (287)
T ss_pred EecCCeEEEeeccccccccccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH
Confidence 999999999999997643211 3444444578889999999999999999999987531 0 111
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
........ +.+.........-.-.+.+++.+||+.+|++|||+.|+++
T Consensus 218 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 218 SYIVNMPN-----PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred HHHhcCCc-----hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 11111110 1111111000011124567788999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=282.10 Aligned_cols=237 Identities=20% Similarity=0.236 Sum_probs=182.9
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEec--CCeeEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIA--GKEKLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lv~ 482 (690)
+|+..+.||+|+||.||++. ..++..+|+|.+..... ...+.+..|++.+++++||||+++++++.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 46777899999999999998 45678899999864332 223567789999999999999999998864 34678999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh-----hcCCCCCCC
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH-----HVGSTHGHL 557 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-----~~~~iHrDl 557 (690)
||+++++|.+++.... .....+++..+..++.|+++||.||| +.+++||||
T Consensus 81 e~~~~~~L~~~l~~~~------------------------~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl 136 (265)
T cd08217 81 EYCEGGDLAQLIQKCK------------------------KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDL 136 (265)
T ss_pred hhccCCCHHHHHHHHh------------------------hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCC
Confidence 9999999999997521 12346889999999999999999999 889999999
Q ss_pred CCCcEEecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-H
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-K 622 (690)
Q Consensus 558 k~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~ 622 (690)
||+||++++++.+||+|||++...... +||......++.++||||||+++|||++|+.||.... .
T Consensus 137 ~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 216 (265)
T cd08217 137 KPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQL 216 (265)
T ss_pred CHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHH
Confidence 999999999999999999998754221 3444444567889999999999999999999987532 1
Q ss_pred HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
...+....+.. +.++... ...+.+++..||+.+|++||++.||++.
T Consensus 217 ~~~~~~~~~~~-----~~~~~~~------~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 217 QLASKIKEGKF-----RRIPYRY------SSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred HHHHHHhcCCC-----CCCcccc------CHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 11222222111 1111111 1244566778999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=286.79 Aligned_cols=238 Identities=24% Similarity=0.294 Sum_probs=182.6
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCC---CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGI---DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
|+..+.||+|+||.||+|+. .++..+|+|.+...... ....+..|++.+++++|||++++++++...+..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 56678899999999999994 56889999998654322 234678899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
++ |+|.+++.. ....++|.++..++.|++.||.|||+.+++||||+|+||++
T Consensus 107 ~~-g~l~~~~~~---------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~ 158 (317)
T cd06635 107 CL-GSASDLLEV---------------------------HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 158 (317)
T ss_pred CC-CCHHHHHHH---------------------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE
Confidence 96 588887754 12458899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc----------cCccc---CCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN----------VGERS---ENETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRKLVK 629 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~----------~~e~~---~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~~~~~ 629 (690)
+.++.+||+|||++...... +||.. ....++.++|||||||++|||++|+.||..... .......
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 238 (317)
T cd06635 159 TEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238 (317)
T ss_pred CCCCCEEEecCCCccccCCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 99999999999987654321 34443 124578899999999999999999999865321 1111111
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
... +... ..... ..+.+++.+||+.+|.+||++.|+++.+-....
T Consensus 239 ~~~------~~~~--~~~~~---~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 239 NES------PTLQ--SNEWS---DYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred ccC------CCCC--Ccccc---HHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 110 0000 00011 134566778999999999999999986654443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=280.71 Aligned_cols=235 Identities=22% Similarity=0.266 Sum_probs=186.3
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|+..+.||+|++|.||+|+.. ++..+|+|++..... ...+.+..|++.+.+++|+||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEec
Confidence 5777899999999999999954 588999999875543 34567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcEEe
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSILL 564 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~NiLl 564 (690)
++++|.+++.. ...+++..+..++.|+++|++|||+ .+++||||+|+||++
T Consensus 82 ~~~~L~~~l~~----------------------------~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~ 133 (264)
T cd06623 82 DGGSLADLLKK----------------------------VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI 133 (264)
T ss_pred CCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE
Confidence 99999999975 2457889999999999999999999 999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKLV 628 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~~ 628 (690)
+.++.+||+|||++...... +||......++.++||||||+++|||+||+.||.... .+... .
T Consensus 134 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~-~ 212 (264)
T cd06623 134 NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL-M 212 (264)
T ss_pred CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH-H
Confidence 99999999999987753221 4555555677889999999999999999999987643 22111 1
Q ss_pred HhcCCCCccccccccC-CCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 629 KEGAGGDALDFRLKLG-SGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
...... ..+..... .+ ..+.+++..||+.+|++||++.|+++.
T Consensus 213 ~~~~~~--~~~~~~~~~~~------~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 213 QAICDG--PPPSLPAEEFS------PEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred HHHhcC--CCCCCCcccCC------HHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 110000 01111111 11 134455667999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=288.89 Aligned_cols=184 Identities=22% Similarity=0.305 Sum_probs=146.5
Q ss_pred ceeccCCCccEEEEEcC---CCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEec--CCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVLP---GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA--GKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lv~e~~~~ 487 (690)
..||+|+||.||+|+.. ++..+|+|.+.... ....+.+|++++++++||||+++++++.. ....++|+||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 57999999999999854 35789999986532 33567889999999999999999999864 4578899999964
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe---
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL--- 564 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl--- 564 (690)
+|.+++........ ......+++..+..++.|++.||.|||+.+++||||||+|||+
T Consensus 85 -~l~~~~~~~~~~~~-------------------~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~ 144 (317)
T cd07867 85 -DLWHIIKFHRASKA-------------------NKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 144 (317)
T ss_pred -cHHHHHHhhhcccc-------------------CCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccC
Confidence 88888764221100 0123458899999999999999999999999999999999999
Q ss_pred -cCCCCceEcCCCcccccccc-------------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 565 -AESLEPKIAGFGLRNIGVKN-------------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 565 -~~~~~~kl~DfGla~~~~~~-------------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
++++.+||+|||+++..... ..|.+|| ..++.++|||||||++|||+||++||.
T Consensus 145 ~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~ 217 (317)
T cd07867 145 GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred CCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcc
Confidence 56789999999998753211 1233443 347889999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=281.99 Aligned_cols=239 Identities=23% Similarity=0.334 Sum_probs=183.9
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|+..+.||+|+||.||+|.. .++..+|+|++..... ...+.+.+|++.++.++|+||+++++.+...+..++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 81 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYL 81 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEecc
Confidence 677889999999999999994 5678899999864432 34567899999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++++|.++++... ....+++.....++.|++.||+|||+.+++||||||+||+++
T Consensus 82 ~~~~l~~~~~~~~-------------------------~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~ 136 (267)
T cd06610 82 SGGSLLDIMKSSY-------------------------PRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG 136 (267)
T ss_pred CCCcHHHHHHHhc-------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc
Confidence 9999999997521 124588999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc------------------cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCchHHH--H
Q 005572 566 ESLEPKIAGFGLRNIGVKN------------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCVKW--V 624 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~------------------~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~--~ 624 (690)
+++.+||+|||++...... +||..... .++.++|||||||++|||++|+.||...... .
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~ 216 (267)
T cd06610 137 EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL 216 (267)
T ss_pred CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH
Confidence 9999999999987533211 23333333 6788999999999999999999999753221 1
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.+..... .+....... ...-...+.+++..||+.||++||++.|+++
T Consensus 217 ~~~~~~~------~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 217 MLTLQND------PPSLETGAD-YKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred HHHhcCC------CCCcCCccc-cccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111110 111111000 0000123456677899999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=284.17 Aligned_cols=235 Identities=22% Similarity=0.298 Sum_probs=185.1
Q ss_pred hccCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+..|+..+.||+|+||.||+|... ++..+|+|+++.... ..+.+.+|++.+++++|+||+++++++...+..++|+||
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 96 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEY 96 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEec
Confidence 445666788999999999999965 578899999975443 456788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.+++... ...+++..+..++.|++.||+|||+.+++|+||+|+||++
T Consensus 97 ~~~~~L~~~l~~~---------------------------~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i 149 (286)
T cd06614 97 MDGGSLTDIITQN---------------------------FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL 149 (286)
T ss_pred cCCCcHHHHHHHh---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE
Confidence 9999999999862 1368899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH--HHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW--VRKLV 628 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~--~~~~~ 628 (690)
+.++.+||+|||++...... +||......++.++|||||||++|||++|+.||...... .....
T Consensus 150 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~ 229 (286)
T cd06614 150 SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT 229 (286)
T ss_pred cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999986543211 344444456788999999999999999999998753221 11111
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
......... ....+ ..+.+++.+||+.+|.+||++.++++
T Consensus 230 -~~~~~~~~~---~~~~~------~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 230 -TKGIPPLKN---PEKWS------PEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred -hcCCCCCcc---hhhCC------HHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111111000 00011 13445677899999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-33 Score=282.84 Aligned_cols=237 Identities=22% Similarity=0.294 Sum_probs=183.4
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|+..+.||+|+||.||++... ++..+|+|.+..... ...+++.+|++.+++++||||+++++++...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 4666788999999999999954 688999999875532 33456888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcEEe
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSILL 564 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~NiLl 564 (690)
++++|.+++... ...+++.....++.|+++||+|||+ .+++||||||+||++
T Consensus 82 ~~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~ 134 (265)
T cd06605 82 DGGSLDKILKEV---------------------------QGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV 134 (265)
T ss_pred CCCcHHHHHHHc---------------------------cCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE
Confidence 999999999751 1457888899999999999999999 999999999999999
Q ss_pred cCCCCceEcCCCccccccc------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH---HHHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVK------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV---KWVRKLVK 629 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~---~~~~~~~~ 629 (690)
++++.+||+|||.+..... .+||......++.++||||||+++|||++|+.||.... ........
T Consensus 135 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 214 (265)
T cd06605 135 NSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214 (265)
T ss_pred CCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH
Confidence 9999999999998764321 14555545678899999999999999999999986431 11111111
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..... ..+..+... .-..+.+++..||..||++|||+.|++.
T Consensus 215 ~~~~~--~~~~~~~~~-----~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 215 YIVNE--PPPRLPSGK-----FSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred HHhcC--CCCCCChhh-----cCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 10000 001111100 1113456677899999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=287.05 Aligned_cols=243 Identities=19% Similarity=0.197 Sum_probs=181.3
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|+||.||+|.. .++..||+|.++... ....+.+.+|++.+++++|+||+++++++...+..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 577788999999999999985 457899999986432 23346788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
++++.+..+... ...+++.++..++.||+.||+|||+.+++||||+|+||++
T Consensus 82 ~~~~~l~~~~~~----------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~ 133 (288)
T cd07833 82 VERTLLELLEAS----------------------------PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV 133 (288)
T ss_pred CCCCHHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 998777665543 2347889999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc---------------cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN---------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRK 626 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~---------------~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~ 626 (690)
++++.+||+|||++...... +||..... .++.++||||||+++|||++|+.||.... +....
T Consensus 134 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~ 213 (288)
T cd07833 134 SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYL 213 (288)
T ss_pred CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999997653221 34444444 67889999999999999999999986421 11111
Q ss_pred HHHh-cCCCC------cccc-----cccc-CCCCCH------HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 627 LVKE-GAGGD------ALDF-----RLKL-GSGDSV------AEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 627 ~~~~-~~~~~------~~~~-----~~~~-~~~~~~------~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... +.... ..+. .... ...... ..-..+.+++..||+.+|++||+++++++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 214 IQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred HHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 1110 00000 0000 0000 000000 00234567788899999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=295.59 Aligned_cols=233 Identities=21% Similarity=0.283 Sum_probs=185.0
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.++..||.|+||.||+++ ...+...|.|++........+++.-|+++|+.++||+||+|++.|+..+.++|+.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 4456789999999999998 455667788999877667778899999999999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|-.+..+-+ -...|+..++.-+++|++.||.|||+++|||||||+.|||++-+
T Consensus 114 GAVDaimlE---------------------------L~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~Tld 166 (1187)
T KOG0579|consen 114 GAVDAIMLE---------------------------LGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLD 166 (1187)
T ss_pred chHhHHHHH---------------------------hccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEec
Confidence 999988875 24679999999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc---------c-----cCccc-----CCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHH
Q 005572 568 LEPKIAGFGLRNIGVK---------N-----VGERS-----ENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLV 628 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~---------~-----~~e~~-----~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~ 628 (690)
|.++++|||.+..... + +||+. ....|+.++||||||++|.||.-+.+|..++.. ++.++
T Consensus 167 GdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp-MRVll 245 (1187)
T KOG0579|consen 167 GDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP-MRVLL 245 (1187)
T ss_pred CcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch-HHHHH
Confidence 9999999998643211 1 34332 235899999999999999999999999877432 22222
Q ss_pred HhcCCCCccccccc--cCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAGGDALDFRLK--LGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.-... + .|.+. ..++.. +-++...|+..||..||++.++++
T Consensus 246 KiaKS-e--PPTLlqPS~Ws~~------F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 246 KIAKS-E--PPTLLQPSHWSRS------FSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred HHhhc-C--CCcccCcchhhhH------HHHHHHHHHhcCCccCCCHHHHhh
Confidence 21111 1 11221 112222 334445699999999999999876
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=285.65 Aligned_cols=230 Identities=20% Similarity=0.202 Sum_probs=181.6
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|...+.||+|+||.||++.. .++..+|+|++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 577788999999999999984 4688999999865321 234567889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++|+|.+++.. ...+++..+..++.|+++||.|||+.+++||||+|+||+
T Consensus 82 ~~~~~~L~~~~~~----------------------------~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nil 133 (290)
T cd05580 82 YVPGGELFSHLRK----------------------------SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLL 133 (290)
T ss_pred cCCCCCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence 9999999999975 245788899999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-HHHHHHhc
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLVKEG 631 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-~~~~~~~~ 631 (690)
+++++.+||+|||+++..... +||.......+.++||||||+++|||++|+.||...... ..+....+
T Consensus 134 i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 213 (290)
T cd05580 134 LDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213 (290)
T ss_pred ECCCCCEEEeeCCCccccCCCCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 999999999999998754321 445444456778999999999999999999998753211 11111111
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVL 677 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~ 677 (690)
. ..++...+. .+.+++.+||+.||.+|| +++|++
T Consensus 214 ~------~~~~~~~~~------~l~~li~~~l~~~p~~R~~~~~~~~~~l~ 252 (290)
T cd05580 214 K------VRFPSFFSP------DAKDLIRNLLQVDLTKRLGNLKNGVNDIK 252 (290)
T ss_pred C------ccCCccCCH------HHHHHHHHHccCCHHHccCcccCCHHHHH
Confidence 1 111111111 334556679999999999 666665
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=282.62 Aligned_cols=230 Identities=20% Similarity=0.201 Sum_probs=182.6
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|...+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|++.+++++||||+++++++...+..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 3677789999999999999954 588999999975432 234678889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++++|.+++.. ...+++..+..++.|+++||.|||+.+++|+||+|+||+
T Consensus 81 ~~~~~~L~~~l~~----------------------------~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil 132 (258)
T cd05578 81 LLLGGDLRYHLSQ----------------------------KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNIL 132 (258)
T ss_pred CCCCCCHHHHHHh----------------------------cCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence 9999999999975 235788899999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH----HHHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV----KWVRK 626 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~----~~~~~ 626 (690)
+++++.+||+|||++...... +||......++.++||||||+++|+|++|+.||.... .+...
T Consensus 133 ~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (258)
T cd05578 133 LDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA 212 (258)
T ss_pred EcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH
Confidence 999999999999987653221 4555444567889999999999999999999987532 22211
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH--HHHH
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM--QQVL 677 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~--~ev~ 677 (690)
.... . ....+...+ ..+.+++.+||+.||.+||++ +|++
T Consensus 213 ~~~~--~----~~~~~~~~~------~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 213 KQET--A----DVLYPATWS------TEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred Hhcc--c----cccCcccCc------HHHHHHHHHHccCChhHcCCccHHHHh
Confidence 1111 0 111111111 244566778999999999999 5554
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=285.71 Aligned_cols=243 Identities=18% Similarity=0.174 Sum_probs=178.0
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|+||.||+|+. .+|..+|+|.++.... .....+.+|++.+++++||||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 366778999999999999995 5688999999864321 2235677899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
++ ++|.+++.. ....+++..+..++.||++||.|||+++++||||||+||++
T Consensus 81 ~~-~~l~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~ 132 (284)
T cd07839 81 CD-QDLKKYFDS---------------------------CNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI 132 (284)
T ss_pred CC-CCHHHHHHh---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE
Confidence 97 588888764 12458899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCc---hHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDD---CVKWVRK 626 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~---~~~~~~~ 626 (690)
+.++.+||+|||+++..... +||...+ ..++.++|||||||++|||+||+.|+.. ..+....
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~ 212 (284)
T cd07839 133 NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 212 (284)
T ss_pred cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHH
Confidence 99999999999988743211 3443322 2468899999999999999999988532 1111111
Q ss_pred HHHhcCC---------CCccccccccCCCC--C-----HHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 627 LVKEGAG---------GDALDFRLKLGSGD--S-----VAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 627 ~~~~~~~---------~~~~~~~~~~~~~~--~-----~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
....... ....+......... . ......+.+++.+||+.||.+|||+.|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 213 IFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred HHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 1110000 00000000000000 0 000123456777899999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=275.52 Aligned_cols=235 Identities=23% Similarity=0.314 Sum_probs=185.3
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
+|...+.||+|++|.||++... ++..+++|++........+.+.+|++.+++++||||+++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999964 688999999976544456788999999999999999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+++|.+++... ...+++..+..++.|++.||.|||+.+++||||+|+||++++
T Consensus 81 ~~~L~~~~~~~---------------------------~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~ 133 (253)
T cd05122 81 GGSLKDLLKST---------------------------NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTS 133 (253)
T ss_pred CCcHHHHHhhc---------------------------CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEcc
Confidence 99999998751 146889999999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-HHHHHHhcC
Q 005572 567 SLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLVKEGA 632 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-~~~~~~~~~ 632 (690)
++.+||+|||.+...... +||......++.++||||||+++|||++|+.||...... .........
T Consensus 134 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 213 (253)
T cd05122 134 DGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNG 213 (253)
T ss_pred CCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcC
Confidence 999999999987654321 344444456788999999999999999999998764211 111111111
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... ..... . -...+.+++..||+.||++|||+.|+++
T Consensus 214 ~~~-----~~~~~--~--~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 214 PPG-----LRNPE--K--WSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred CCC-----cCccc--c--cCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 111 11000 0 0113455667899999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=282.92 Aligned_cols=230 Identities=20% Similarity=0.140 Sum_probs=169.6
Q ss_pred eeccCCCccEEEEEc-CCCcEEEEEEeeccCCC---CHHHHHHHHHHH---HhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 414 LLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGI---DHDDAVAMFDEL---SRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~~l---~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.||+|+||.||++.. .++..+|+|.+...... ....+.+|...+ ...+||||+.+++++...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999984 56889999998654321 122234444333 33479999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+|||+++
T Consensus 81 ~~~L~~~i~~----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~ 132 (279)
T cd05633 81 GGDLHYHLSQ----------------------------HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDE 132 (279)
T ss_pred CCCHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECC
Confidence 9999999875 235899999999999999999999999999999999999999
Q ss_pred CCCceEcCCCccccccc--------c----cCcccC-CCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcCC
Q 005572 567 SLEPKIAGFGLRNIGVK--------N----VGERSE-NETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAG 633 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~--------~----~~e~~~-~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 633 (690)
++.+||+|||++..... . +||... ...++.++|||||||++|||++|..||................
T Consensus 133 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 212 (279)
T cd05633 133 HGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 212 (279)
T ss_pred CCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh
Confidence 99999999999864321 1 344432 2357889999999999999999999986421111111111100
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHHH
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLGL 679 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~~ 679 (690)
..+..++...+ ..+.+++..||+.||++|| +++|+++.
T Consensus 213 --~~~~~~~~~~~------~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 213 --TVNVELPDSFS------PELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred --cCCcCCccccC------HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 01111211111 1344556679999999999 59998774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=279.91 Aligned_cols=241 Identities=19% Similarity=0.232 Sum_probs=176.5
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcC-CCCccceeeEEecC--CeeEEEEE
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAG--KEKLVLLE 483 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~e 483 (690)
|...+.||+|+||.||+|+ ..++..+|+|.++... ........+|+..+.++. ||||+++++++.+. +..++|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 4556789999999999998 4568899999986542 222334557888888885 99999999999987 88999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|++ |+|.+++... ...++|.++..++.|++.||+|||+.+++||||||+||+
T Consensus 81 ~~~-~~l~~~l~~~---------------------------~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~ 132 (282)
T cd07831 81 LMD-MNLYELIKGR---------------------------KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENIL 132 (282)
T ss_pred cCC-ccHHHHHHhc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEE
Confidence 996 5888888651 235889999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-------------cCcccC-CCCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-------------VGERSE-NETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKL 627 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-------------~~e~~~-~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~ 627 (690)
++. +.+||+|||+++..... +||... ...++.++|||||||++|||++|..||... .+.+...
T Consensus 133 l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~ 211 (282)
T cd07831 133 IKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI 211 (282)
T ss_pred EcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence 999 99999999998754221 344221 234678999999999999999999998642 1111111
Q ss_pred HHh-cC----------CCCccccccccCCCCCH-----HHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKE-GA----------GGDALDFRLKLGSGDSV-----AEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~-~~----------~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... +. .....+...+....... .....+.+++.+||+.+|++||++.|+++
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 212 HDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred HHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 110 00 00001111111000001 11234667788999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=286.21 Aligned_cols=238 Identities=19% Similarity=0.227 Sum_probs=182.4
Q ss_pred HhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeecc--CCCCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNA--KGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv 481 (690)
....|++.+.||+|+.+.||++.-.+...+|+|++... +....+.+..|+..|.+++ |.+||+|++|-...+.+|+|
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 34567888999999999999999887778888876432 2344567999999999996 99999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||-+ .||..+|+++. .....| .+..++.|++.|+.++|++||||.||||.|
T Consensus 439 mE~Gd-~DL~kiL~k~~--------------------------~~~~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPAN 490 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKK--------------------------SIDPDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPAN 490 (677)
T ss_pred eeccc-ccHHHHHHhcc--------------------------CCCchH-HHHHHHHHHHHHHHHHHHhceeecCCCccc
Confidence 99985 49999998732 122334 678899999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc------------cCcccCC---------------CCCCCCCcchhhHHHHHHHHhCC
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN------------VGERSEN---------------ETCGPESDVYCFGVILMELLTGK 614 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~------------~~e~~~~---------------~~~~~~~DVwSfGvvl~el~tg~ 614 (690)
+|+- +|.+||+|||+|.....+ ..|+.|| ..++.++||||+||+||+|+.|+
T Consensus 491 FLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgk 569 (677)
T KOG0596|consen 491 FLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGK 569 (677)
T ss_pred EEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcC
Confidence 9985 688999999999865433 2233332 14678999999999999999999
Q ss_pred CCCCchHHHHHHHHHhcCC-CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 615 RGTDDCVKWVRKLVKEGAG-GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 615 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.||.+......++..-... .++.-+.++ ...+ +.++|..|++.||++|||+.|+++.
T Consensus 570 tPf~~~~n~~aKl~aI~~P~~~Iefp~~~-----~~~~---li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 570 TPFGQIINQIAKLHAITDPNHEIEFPDIP-----ENDE---LIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CchHHHHHHHHHHHhhcCCCccccccCCC-----CchH---HHHHHHHHHhcCcccCCCcHHHhcC
Confidence 9998765333222221111 111111111 1122 6677889999999999999999863
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=281.33 Aligned_cols=243 Identities=19% Similarity=0.220 Sum_probs=180.1
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
|+..+.||+|++|.||+|.. .++..||+|++..... ...+.+.+|++.++.++||||+++++++.+.+..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 45678899999999999984 5688999999865432 23356788999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
+ ++|.+++...+ ...+++..+..++.|+++||+|||+.+++||||+|+||+++
T Consensus 81 ~-~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~ 133 (283)
T cd07835 81 D-LDLKKYMDSSP--------------------------LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLID 133 (283)
T ss_pred C-cCHHHHHhhCC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEc
Confidence 5 69999987521 23588999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCccccccc--------------ccCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVK--------------NVGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~--------------~~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~~ 628 (690)
+++.+||+|||+++.... .+||.... ..++.++|||||||++|||++|+.||.... .......
T Consensus 134 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 213 (283)
T cd07835 134 REGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF 213 (283)
T ss_pred CCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999999864321 13443322 246789999999999999999999986421 1111111
Q ss_pred HhcC-CC--------Ccccc--ccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGA-GG--------DALDF--RLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~-~~--------~~~~~--~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... .. ...+. ............ ...+.+++.+||+.||++|||+.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred HHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 1100 00 00000 000000000000 024556788899999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=281.73 Aligned_cols=243 Identities=21% Similarity=0.238 Sum_probs=181.8
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|...+.||+|+||.||+|+. .++..||+|++.... ....+.+.+|+..+++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 366778999999999999995 568899999987543 23346788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+ +++|.+++... ...+++.++..++.||++||+|||+.+++|+||||+||++
T Consensus 81 ~-~~~L~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~ 132 (286)
T cd07832 81 M-PSDLSEVLRDE---------------------------ERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI 132 (286)
T ss_pred c-CCCHHHHHHhc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE
Confidence 9 99999998751 2458899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc---------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN---------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRK 626 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~---------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~~ 626 (690)
++++.+||+|||++...... +||.... ..++.++||||+||++|||+||.+||..... ....
T Consensus 133 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~ 212 (286)
T cd07832 133 SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAI 212 (286)
T ss_pred cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHH
Confidence 99999999999987654221 3333322 2457899999999999999999887754211 1111
Q ss_pred HHHhcCCC---------Ccccc---ccccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 627 LVKEGAGG---------DALDF---RLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 627 ~~~~~~~~---------~~~~~---~~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
........ +..+. ........... .-..+.+++.+|++.||++|||++++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 213 VFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred HHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 11110000 00000 00000000000 0134567778899999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-32 Score=283.22 Aligned_cols=228 Identities=21% Similarity=0.286 Sum_probs=177.7
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHh
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLH 491 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~ 491 (690)
..||+|+||.||++.. .++..||+|.+..........+.+|+..++.++|+||+++++++...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 5799999999999985 568899999986544444567888999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCce
Q 005572 492 RWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPK 571 (690)
Q Consensus 492 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~k 571 (690)
+++.. ..+++.....++.|++.||+|||+.+++||||||+||++++++.+|
T Consensus 106 ~~~~~-----------------------------~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~ 156 (292)
T cd06657 106 DIVTH-----------------------------TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVK 156 (292)
T ss_pred HHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEE
Confidence 98753 2478889999999999999999999999999999999999999999
Q ss_pred EcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH-HHHHHHHhcCCCCc
Q 005572 572 IAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKEGAGGDA 636 (690)
Q Consensus 572 l~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~ 636 (690)
|+|||++...... +||......++.++|||||||++|||++|..||..... ..........
T Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~---- 232 (292)
T cd06657 157 LSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL---- 232 (292)
T ss_pred EcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhC----
Confidence 9999986543211 34444345678899999999999999999999864221 1112221111
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 637 LDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
...+.... .... .+.+++.+||+.||.+||++.|+++
T Consensus 233 -~~~~~~~~-~~~~---~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 233 -PPKLKNLH-KVSP---SLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred -CcccCCcc-cCCH---HHHHHHHHHHhCCcccCcCHHHHhc
Confidence 01110000 0111 2345566799999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=284.57 Aligned_cols=185 Identities=24% Similarity=0.268 Sum_probs=154.2
Q ss_pred ccCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv 481 (690)
++|+..+.||+|+||.||+|... ++..+|+|.++.... .....+.+|++++++++||||+++++++... +..++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35777889999999999999954 578999999975432 2234567899999999999999999999877 789999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|||++ ++|.+++... ...+++..+..++.|+++||+|||+.+++||||||+|
T Consensus 85 ~e~~~-~~L~~~~~~~---------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~n 136 (293)
T cd07843 85 MEYVE-HDLKSLMETM---------------------------KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSN 136 (293)
T ss_pred ehhcC-cCHHHHHHhc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHH
Confidence 99997 5999988752 2358899999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc--------------cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN--------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|++++++.+||+|||+++..... +||..... .++.++|||||||++|||++|+.||..
T Consensus 137 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~ 209 (293)
T cd07843 137 LLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPG 209 (293)
T ss_pred EEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999987753221 23333222 357899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-33 Score=280.45 Aligned_cols=237 Identities=19% Similarity=0.248 Sum_probs=188.1
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
|+.++.||+|.|..|-+++ .-+|..||||++++.+. .....+.+|++-|+-++|||||+||.+......+|+|+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 5667889999999999998 56788999999987654 33467889999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++|||++|+-+. ...+.+.-..+++.||..|+.|+|+..+|||||||+||.+-
T Consensus 100 D~GDl~DyImKH---------------------------e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF 152 (864)
T KOG4717|consen 100 DGGDLFDYIMKH---------------------------EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF 152 (864)
T ss_pred CCchHHHHHHhh---------------------------hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe
Confidence 999999999873 24578888999999999999999999999999999998875
Q ss_pred -CCCCceEcCCCcccccccc-------------cCcccCCCCCC-CCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHh
Q 005572 566 -ESLEPKIAGFGLRNIGVKN-------------VGERSENETCG-PESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKE 630 (690)
Q Consensus 566 -~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~-~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~ 630 (690)
.-|-+|+.|||++....+. +||+..+..|+ +++||||+||+||-|++|+.||.+..+...
T Consensus 153 EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET----- 227 (864)
T KOG4717|consen 153 EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET----- 227 (864)
T ss_pred eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-----
Confidence 5688999999998654332 67776666554 689999999999999999999986332110
Q ss_pred cCCCCccc--cccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH--HHhccCC
Q 005572 631 GAGGDALD--FRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG--LLKDIRP 685 (690)
Q Consensus 631 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~--~L~~i~~ 685 (690)
...++| +.++.-.+. ++.+++.+++..||++|.+.+||+. +|+.+.+
T Consensus 228 --LTmImDCKYtvPshvS~------eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 228 --LTMIMDCKYTVPSHVSK------ECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred --hhhhhcccccCchhhhH------HHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 011112 112111111 3445666799999999999999975 4555544
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=279.90 Aligned_cols=230 Identities=18% Similarity=0.139 Sum_probs=175.0
Q ss_pred eccCCCccEEEEE-cCCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 415 LAEGRCGPVYRAV-LPGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 415 lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
||+|+||.||++. ..++..+|+|.+..... .....+..|+++++.++||||+++++++...+..|+||||+++|+|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 6899999999998 45688999999864321 2234567899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++.... ...+++.++..++.|++.||.|||+.+++||||+|+||++++++.+
T Consensus 81 ~~~l~~~~--------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~ 134 (277)
T cd05577 81 KYHIYNVG--------------------------EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNV 134 (277)
T ss_pred HHHHHHcC--------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCE
Confidence 99997521 2357899999999999999999999999999999999999999999
Q ss_pred eEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH-HHHHHhcCCCCc
Q 005572 571 KIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV-RKLVKEGAGGDA 636 (690)
Q Consensus 571 kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~-~~~~~~~~~~~~ 636 (690)
||+|||++...... +||......++.++|||||||++|||++|+.||.....+. ...+.......
T Consensus 135 ~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~- 213 (277)
T cd05577 135 RISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM- 213 (277)
T ss_pred EEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc-
Confidence 99999987643211 4454444567889999999999999999999986532211 11111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 637 LDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
....+...+. .+.+++.+||+.||++|| ++.++++
T Consensus 214 -~~~~~~~~~~------~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 214 -AVEYPDKFSP------EAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred -cccCCccCCH------HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 1111111111 334556679999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-32 Score=284.65 Aligned_cols=237 Identities=22% Similarity=0.199 Sum_probs=171.9
Q ss_pred eccCCCccEEEEEcCCCcEEEEEEeecc--CCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHhh
Q 005572 415 LAEGRCGPVYRAVLPGELHVAIKVLDNA--KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHR 492 (690)
Q Consensus 415 lg~G~~g~Vy~~~~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 492 (690)
+|.|+++.||++.. ++..||||++... .....+.+.+|++.++.++||||+++++++...+..+++|||+++|+|.+
T Consensus 10 ~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 10 FEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCED 88 (314)
T ss_pred hcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHH
Confidence 44445555555544 6789999998654 22345678899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceE
Q 005572 493 WLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKI 572 (690)
Q Consensus 493 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl 572 (690)
++... ....+++.....++.|+++||+|||+++++||||||+||+++.++.+||
T Consensus 89 ~l~~~--------------------------~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl 142 (314)
T cd08216 89 LLKTH--------------------------FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVL 142 (314)
T ss_pred HHHHh--------------------------cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEE
Confidence 99752 1235778889999999999999999999999999999999999999999
Q ss_pred cCCCccccccc---------------------ccCcccCC--CCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHH--HH
Q 005572 573 AGFGLRNIGVK---------------------NVGERSEN--ETCGPESDVYCFGVILMELLTGKRGTDDCVKWVR--KL 627 (690)
Q Consensus 573 ~DfGla~~~~~---------------------~~~e~~~~--~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~--~~ 627 (690)
+|||.+..... .+||.... ..++.++|||||||++|||++|+.||........ +.
T Consensus 143 ~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~ 222 (314)
T cd08216 143 SGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEK 222 (314)
T ss_pred ecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99998753211 03333322 2478899999999999999999999975322111 11
Q ss_pred HHhcCCCCcc--------------------ccccccCCCC--CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 628 VKEGAGGDAL--------------------DFRLKLGSGD--SVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 628 ~~~~~~~~~~--------------------~~~~~~~~~~--~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.. +...... ++........ .......+.+++..||+.||++|||+.|+++.
T Consensus 223 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 295 (314)
T cd08216 223 VR-GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH 295 (314)
T ss_pred Hh-ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence 10 0000000 0000000000 01111245678889999999999999999863
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=273.44 Aligned_cols=233 Identities=26% Similarity=0.307 Sum_probs=183.1
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|++|.||+++. .++..+|+|.+..... ...+.+.+|++.+++++|||++++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 366778999999999999984 4578899999976543 2446788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+++||||||+||++
T Consensus 81 ~~~~~L~~~~~~----------------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i 132 (254)
T cd06627 81 AENGSLRQIIKK----------------------------FGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT 132 (254)
T ss_pred CCCCcHHHHHHh----------------------------ccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE
Confidence 999999999875 2458899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHh
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKE 630 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~ 630 (690)
+.++.+||+|||++...... +||......++.++||||+|+++|||++|+.|+....... .....
T Consensus 133 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-~~~~~ 211 (254)
T cd06627 133 TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-ALFRI 211 (254)
T ss_pred CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-HHHHH
Confidence 99999999999988754321 3444333457789999999999999999999987532211 11111
Q ss_pred cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... ..+.++...+ ..+.+++.+||+.+|++|||+.|++.
T Consensus 212 ~~~---~~~~~~~~~~------~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 212 VQD---DHPPLPEGIS------PELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred hcc---CCCCCCCCCC------HHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 100 0111111111 13345667899999999999999874
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-32 Score=274.00 Aligned_cols=235 Identities=24% Similarity=0.311 Sum_probs=184.6
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv~ 482 (690)
+|...+.||+|++|.||+|... ++..+++|++..... ...+.+.+|++.+++++||||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999954 688999999865542 3356788999999999999999999999988 8899999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++++|.+++.. ...+++.++..++.|+++||+|||+.+++|+||+|+||
T Consensus 81 e~~~~~~L~~~~~~----------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni 132 (260)
T cd06606 81 EYVSGGSLSSLLKK----------------------------FGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANI 132 (260)
T ss_pred EecCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence 99999999999975 12688999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRK 626 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~ 626 (690)
+++.++.+||+|||.+...... +||.......+.++||||||+++|||++|..||.........
T Consensus 133 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~ 212 (260)
T cd06606 133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAA 212 (260)
T ss_pred EEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHH
Confidence 9999999999999987644321 344444445788999999999999999999998764322211
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
......... .+.++... ...+.+++.+|++.||++||++.|+++
T Consensus 213 ~~~~~~~~~--~~~~~~~~------~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 213 LYKIGSSGE--PPEIPEHL------SEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred HHhccccCC--CcCCCccc------CHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 111111000 11111111 123455667899999999999999985
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=290.08 Aligned_cols=233 Identities=20% Similarity=0.295 Sum_probs=183.8
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
...|....+||+|.|+.|..++ ..++..||+|.+++... ...+.+.+|+++|..++|||||+++.+.+....+|+||
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~ 134 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM 134 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence 4567888999999999999998 55688999999976543 22355889999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+.+|.+++|+.+. ..+....+..++.|+.+|++|||+++|+|||||++||
T Consensus 135 eya~~ge~~~yl~~~----------------------------gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNi 186 (596)
T KOG0586|consen 135 EYASGGELFDYLVKH----------------------------GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENI 186 (596)
T ss_pred EeccCchhHHHHHhc----------------------------ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhc
Confidence 999999999999872 3344577888999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc---------cCcccCC----C-CCCCCCcchhhHHHHHHHHhCCCCCCc--hHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN---------VGERSEN----E-TCGPESDVYCFGVILMELLTGKRGTDD--CVKWVRK 626 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~---------~~e~~~~----~-~~~~~~DVwSfGvvl~el~tg~~p~~~--~~~~~~~ 626 (690)
||+.+..+||+|||++...... .||.+|| . ..++++|+||+||++|-|+.|..||++ +.....+
T Consensus 187 lL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r 266 (596)
T KOG0586|consen 187 LLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR 266 (596)
T ss_pred ccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch
Confidence 9999999999999998765432 4454444 2 447899999999999999999999985 1111111
Q ss_pred HHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.+ .+ ..+++...+.+.+.++. +.+-.+|.+|++++++.+.
T Consensus 267 vl-~g------k~rIp~~ms~dce~lLr------k~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 267 VL-RG------KYRIPFYMSCDCEDLLR------KFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred he-ee------eecccceeechhHHHHH------HhhccCccccCCHHHhhhh
Confidence 11 11 12222223334444443 4677899999999998764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=273.51 Aligned_cols=235 Identities=23% Similarity=0.258 Sum_probs=182.3
Q ss_pred ccCCCCceeccCCCccEEEEEcCC-CcEEEEEEeeccCCC---CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGI---DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||.|..|.||++++.+ +..+|+|++++.... .......|-++|+.++||-+..|++.+++....|+||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345567889999999999999655 689999999865433 2345667889999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
|||+||+|+..+++. ....+++..+..+|.+|.-||+|||-.|||.|||||+||
T Consensus 157 eyCpGGdL~~LrqkQ--------------------------p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENI 210 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQ--------------------------PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENI 210 (459)
T ss_pred ecCCCccHHHHHhhC--------------------------CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCccee
Confidence 999999999999873 245788999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccccc------------------------c----------------------------------
Q 005572 563 LLAESLEPKIAGFGLRNIGVK------------------------N---------------------------------- 584 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~------------------------~---------------------------------- 584 (690)
||-++|.+-|+||-|+..... .
T Consensus 211 LvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~ 290 (459)
T KOG0610|consen 211 LVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGA 290 (459)
T ss_pred EEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCc
Confidence 999999999999987532100 0
Q ss_pred ------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHHHHHHhcCCCCccccccccCCCCCHH
Q 005572 585 ------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRKLVKEGAGGDALDFRLKLGSGDSVA 650 (690)
Q Consensus 585 ------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 650 (690)
|||+..+...+.++|.|+|||++|||+.|..||.+... -...++.+ +..++. ...
T Consensus 291 RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~-------~l~Fp~----~~~ 359 (459)
T KOG0610|consen 291 RSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ-------PLKFPE----EPE 359 (459)
T ss_pred cccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC-------CCcCCC----CCc
Confidence 45555556677899999999999999999999976322 11222211 111111 111
Q ss_pred HHHHHHHHHhhhcCCCCCCCCC----HHHHHH
Q 005572 651 EMVESLRVGYLCTADSPGKRPT----MQQVLG 678 (690)
Q Consensus 651 ~~~~~~~l~~~C~~~dP~~RPt----~~ev~~ 678 (690)
....+.+++.+-+.+||.+|-. +.||-+
T Consensus 360 vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~ 391 (459)
T KOG0610|consen 360 VSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR 391 (459)
T ss_pred chhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence 1223445566689999999987 777654
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=285.13 Aligned_cols=234 Identities=22% Similarity=0.252 Sum_probs=181.3
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCCC---CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKGI---DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+|+..+.||+|+||.||+|... ++..+|+|.+...... ..+.+..|++.++.++||||+++++++......++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5777889999999999999954 5889999999754322 33567889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+.+++|.+++... ....+++..+..++.|+++||+|||+.+++||||||+||+
T Consensus 82 ~~~~~~L~~~~~~~--------------------------~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 135 (316)
T cd05574 82 YCPGGELFRLLQRQ--------------------------PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENIL 135 (316)
T ss_pred ecCCCCHHHHHHhC--------------------------CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeE
Confidence 99999999998752 1246889999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCccccccc-------------------------------------------ccCcccCCCCCCCCCcc
Q 005572 564 LAESLEPKIAGFGLRNIGVK-------------------------------------------NVGERSENETCGPESDV 600 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~-------------------------------------------~~~e~~~~~~~~~~~DV 600 (690)
++.++.+||+|||++..... .+||......++.++||
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di 215 (316)
T cd05574 136 LHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDW 215 (316)
T ss_pred EcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHH
Confidence 99999999999998754211 02333333457789999
Q ss_pred hhhHHHHHHHHhCCCCCCchHHH--HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC----HH
Q 005572 601 YCFGVILMELLTGKRGTDDCVKW--VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT----MQ 674 (690)
Q Consensus 601 wSfGvvl~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt----~~ 674 (690)
|||||++|||++|+.||...... ...... .. ....... . ....+.+++.+||+.||++||| +.
T Consensus 216 ~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~-~~------~~~~~~~--~--~~~~~~~li~~~l~~~p~~R~s~~~~~~ 284 (316)
T cd05574 216 WTLGILLYEMLYGTTPFKGSNRDETFSNILK-KE------VTFPGSP--P--VSSSARDLIRKLLVKDPSKRLGSKRGAA 284 (316)
T ss_pred HHHHHHHHHHhhCCCCCCCCchHHHHHHHhc-CC------ccCCCcc--c--cCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence 99999999999999998753211 111111 10 0111110 0 1123456667899999999999 66
Q ss_pred HHHH
Q 005572 675 QVLG 678 (690)
Q Consensus 675 ev~~ 678 (690)
|+++
T Consensus 285 ~ll~ 288 (316)
T cd05574 285 EIKQ 288 (316)
T ss_pred HHHc
Confidence 6665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=285.35 Aligned_cols=182 Identities=24% Similarity=0.273 Sum_probs=149.1
Q ss_pred ceeccC--CCccEEEEEc-CCCcEEEEEEeeccCCC--CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEG--RCGPVYRAVL-PGELHVAIKVLDNAKGI--DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G--~~g~Vy~~~~-~~~~~vavK~l~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
..||+| +||+||+++. .++..||+|++...... ..+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 356666 8999999984 57899999998654322 235678888889999999999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.+++.... ...+++..+..++.|++.||+|||+.+++||||||+||+++.+
T Consensus 84 ~~l~~~l~~~~--------------------------~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~ 137 (328)
T cd08226 84 GSANSLLKTYF--------------------------PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGD 137 (328)
T ss_pred CCHHHHHHhhc--------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCC
Confidence 99999987621 2357888999999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc-----------------ccCcccCC------CCCCCCCcchhhHHHHHHHHhCCCCCCch
Q 005572 568 LEPKIAGFGLRNIGVK-----------------NVGERSEN------ETCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~-----------------~~~e~~~~------~~~~~~~DVwSfGvvl~el~tg~~p~~~~ 620 (690)
+.+|++|||....... ..++.+|+ ..++.++|||||||++|||++|+.||...
T Consensus 138 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 138 GLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred CcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999974321100 01233333 24678999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-32 Score=275.88 Aligned_cols=232 Identities=18% Similarity=0.147 Sum_probs=171.6
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCH---HHHHHHHHHH-HhcCCCCccceeeEEecCCeeEEEEEecCC
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDH---DDAVAMFDEL-SRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~---~~~~~e~~~l-~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|.. .++..||+|+++....... ..+..|...+ ...+||||+++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 4689999999999985 5578999999865332111 2234444443 445899999999999999999999999999
Q ss_pred CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~ 567 (690)
|+|.++++. ...+++..+..++.|+++||.|||+.+++||||+|+||+++++
T Consensus 82 ~~L~~~l~~----------------------------~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~ 133 (260)
T cd05611 82 GDCASLIKT----------------------------LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQT 133 (260)
T ss_pred CCHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCC
Confidence 999999975 2357888899999999999999999999999999999999999
Q ss_pred CCceEcCCCccccccc----------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHHhcCCCCc
Q 005572 568 LEPKIAGFGLRNIGVK----------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVKEGAGGDA 636 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~----------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~~~~~~~~ 636 (690)
+.+||+|||+++.... .+||......++.++||||||+++|||++|..||.... .............
T Consensus 134 ~~~~l~dfg~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-- 211 (260)
T cd05611 134 GHLKLTDFGLSRNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRIN-- 211 (260)
T ss_pred CcEEEeecccceeccccccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccC--
Confidence 9999999998765321 14555444567889999999999999999999986521 1111111111110
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 637 LDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
.........+ ..+.+++.+||+.+|++||++.++.+.|
T Consensus 212 ~~~~~~~~~~------~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 212 WPEEVKEFCS------PEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred CCCcccccCC------HHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 0111111111 2345667789999999999776555543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=280.84 Aligned_cols=242 Identities=24% Similarity=0.273 Sum_probs=180.5
Q ss_pred CCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeEEEEE
Q 005572 409 FGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKLVLLE 483 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~lv~e 483 (690)
|+..+.||+|+||.||+|+.. ++..+|+|++.... ....+.+.+|++++++++|||++++++++... +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456688999999999999954 58899999997653 23446788999999999999999999999987 78999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+++ +|.+++... ...+++.++..++.|+++||+|||+.+++|+||||+||+
T Consensus 81 ~~~~-~l~~~~~~~---------------------------~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil 132 (287)
T cd07840 81 YMDH-DLTGLLDSP---------------------------EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNIL 132 (287)
T ss_pred cccc-cHHHHHhcc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeE
Confidence 9975 898888641 235889999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-----------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-----------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVR 625 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-----------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~ 625 (690)
+++++.+||+|||++...... ..+.+|| ..++.++||||||+++|||+||+.||..... ...
T Consensus 133 ~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~ 212 (287)
T cd07840 133 INNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE 212 (287)
T ss_pred EcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 999999999999987644221 1233333 3568899999999999999999999875221 111
Q ss_pred HHHHhcCCCC------ccc------cccccCCCCCHH----H--HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 626 KLVKEGAGGD------ALD------FRLKLGSGDSVA----E--MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 626 ~~~~~~~~~~------~~~------~~~~~~~~~~~~----~--~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.......... ..+ ............ . ...+.+++..||+.+|++||++.++++
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 213 KIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred HHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 1111100000 000 000000000000 0 234567888999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=283.24 Aligned_cols=243 Identities=19% Similarity=0.230 Sum_probs=176.7
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|...+.||+|+||.||++. ..++..+|+|.+..... .....+.+|+..+.++. ||||++++|++...+..+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 34456789999999999998 45688999999865432 23456788999999996 99999999999998899999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc-CCCCCCCCCCcEE
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV-GSTHGHLVTSSIL 563 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~iHrDlk~~NiL 563 (690)
+.. ++.++..... ......+++.....++.|+++||+|||+. +++||||||+||+
T Consensus 85 ~~~-~l~~l~~~~~-----------------------~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 140 (288)
T cd06616 85 MDI-SLDKFYKYVY-----------------------EVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL 140 (288)
T ss_pred ccC-CHHHHHHHHH-----------------------HhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEE
Confidence 864 6655432100 00124688999999999999999999975 9999999999999
Q ss_pred ecCCCCceEcCCCcccccccc-------------cCcccCCC---CCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN-------------VGERSENE---TCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKL 627 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~---~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~ 627 (690)
++.++.+||+|||+++..... +||..... .++.++|||||||++|||++|+.||..........
T Consensus 141 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 220 (288)
T cd06616 141 LDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220 (288)
T ss_pred EccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH
Confidence 999999999999998643211 34433322 57889999999999999999999987533211111
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.... .. ..+.+.... .......+.+++.+||+.||++|||+.||++.
T Consensus 221 ~~~~-~~--~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 221 TQVV-KG--DPPILSNSE--EREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred hhhc-CC--CCCcCCCcC--CCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 1111 00 011111111 00111245567778999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=282.25 Aligned_cols=238 Identities=21% Similarity=0.225 Sum_probs=179.9
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
.|+..+.||+|+||.||+|+. .++..+|+|.+..... ...+++.+|++.++.++|+|++++++++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 355667899999999999994 5678899999864322 223467789999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|+. |++.+++... ...+++.++..++.|++.||.|||+.+++||||||+||+
T Consensus 96 ~~~-~~l~~~~~~~---------------------------~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil 147 (308)
T cd06634 96 YCL-GSASDLLEVH---------------------------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL 147 (308)
T ss_pred ccC-CCHHHHHHHc---------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEE
Confidence 996 6888877541 235788999999999999999999999999999999999
Q ss_pred ecCCCCceEcCCCcccccccc----------cCcccC---CCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH-HHHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVKN----------VGERSE---NETCGPESDVYCFGVILMELLTGKRGTDDCVKWV-RKLVK 629 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~----------~~e~~~---~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~-~~~~~ 629 (690)
++.++.+||+|||++...... +||... ...++.++|||||||++|||++|..||....... .....
T Consensus 148 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 227 (308)
T cd06634 148 LSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (308)
T ss_pred ECCCCcEEECCcccceeecCcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh
Confidence 999999999999998753321 344321 2357889999999999999999999986532211 11111
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
..... .. .....+ ..+.+++.+||+.+|++||++.++++.-...
T Consensus 228 ~~~~~---~~-~~~~~~------~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~ 271 (308)
T cd06634 228 QNESP---AL-QSGHWS------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271 (308)
T ss_pred hcCCC---Cc-Cccccc------HHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence 11110 00 000111 1244567789999999999999998765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-32 Score=282.38 Aligned_cols=244 Identities=22% Similarity=0.224 Sum_probs=176.4
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCC-------
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK------- 476 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------- 476 (690)
++|+..+.||+|+||.||+|+. .++..||||.+..... .....+.+|++.+++++||||++++++|...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 4688889999999999999994 5688999999864322 22345678999999999999999999987654
Q ss_pred -eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 477 -EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 477 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
..++||||+. ++|.+++... ...+++.++..++.|+++||+|||+++++||
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~~---------------------------~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~ 143 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSNK---------------------------NVKFTLSEIKKVMKMLLNGLYYIHRNKILHR 143 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence 3599999996 4888888641 2358899999999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCcccccccc--------------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCC
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRG 616 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p 616 (690)
||||+||+++.++.+||+|||++...... ..|.+|| ..++.++||||||+++|||+||+.|
T Consensus 144 dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~ 223 (310)
T cd07865 144 DMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPI 223 (310)
T ss_pred CCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCC
Confidence 99999999999999999999988643210 1233333 2367899999999999999999999
Q ss_pred CCchHHH-HHHHHHh--cCCCCcccc-----------ccccCCCCCHH-------HHHHHHHHHhhhcCCCCCCCCCHHH
Q 005572 617 TDDCVKW-VRKLVKE--GAGGDALDF-----------RLKLGSGDSVA-------EMVESLRVGYLCTADSPGKRPTMQQ 675 (690)
Q Consensus 617 ~~~~~~~-~~~~~~~--~~~~~~~~~-----------~~~~~~~~~~~-------~~~~~~~l~~~C~~~dP~~RPt~~e 675 (690)
|...... ....+.. +.......+ ..+........ +...+.+++..||+.||++|||+.|
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e 303 (310)
T cd07865 224 MQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADT 303 (310)
T ss_pred CCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHH
Confidence 8642111 1111111 000000000 00000000000 0123457888999999999999999
Q ss_pred HHH
Q 005572 676 VLG 678 (690)
Q Consensus 676 v~~ 678 (690)
+++
T Consensus 304 ~l~ 306 (310)
T cd07865 304 ALN 306 (310)
T ss_pred Hhc
Confidence 975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=280.43 Aligned_cols=246 Identities=24% Similarity=0.266 Sum_probs=180.4
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKLV 480 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~l 480 (690)
.++|+..+.||+|+||.||+|.. .++..||+|.++.... .....+.+|++++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 35788889999999999999994 5688999999864432 2233567899999999999999999998765 46899
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
||||+. ++|.+++... ...+++.++..++.|+++||+|||+.+++||||||+
T Consensus 86 v~e~~~-~~l~~~l~~~---------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 137 (309)
T cd07845 86 VMEYCE-QDLASLLDNM---------------------------PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVS 137 (309)
T ss_pred EEecCC-CCHHHHHHhc---------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 999996 4898888651 245889999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc--------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--HH
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--KW 623 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~ 623 (690)
||++++++.+||+|||++...... +||.... ..++.++|||||||++|||++|+.||.... +.
T Consensus 138 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~ 217 (309)
T cd07845 138 NLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217 (309)
T ss_pred HEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998754321 3343322 346889999999999999999999987521 11
Q ss_pred HHHHHHhcCCC-Ccc-----------ccccccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 624 VRKLVKEGAGG-DAL-----------DFRLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 624 ~~~~~~~~~~~-~~~-----------~~~~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
........... ... ............. ......+++.+|++.||++|||+.|+++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h 290 (309)
T cd07845 218 LDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES 290 (309)
T ss_pred HHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 22222110000 000 0000000000000 01234567788999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=287.64 Aligned_cols=244 Identities=20% Similarity=0.256 Sum_probs=178.0
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecCC-----ee
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK-----EK 478 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~ 478 (690)
.++|...+.||+|+||.||+|+ ..++..||+|.+.... ......+.+|+.++++++||||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 3578888999999999999998 5668899999986432 233456788999999999999999999876543 57
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++|+||+++ +|.+++.. ..+++..+..++.|+++||+|||+.+++|||||
T Consensus 84 ~lv~e~~~~-~l~~~~~~-----------------------------~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlk 133 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-----------------------------QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLK 133 (336)
T ss_pred EEEehhccc-CHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 999999974 88887753 358889999999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc-------------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCch
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~~ 620 (690)
|+||+++.++.+||+|||+++..... ..+.+|+ ..++.++|||||||++|||++|+.||...
T Consensus 134 p~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 134 PSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred HHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999998653211 1123333 35788999999999999999999998642
Q ss_pred H--HHHHHHHHhcCC--CCc----ccc-------ccccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 621 V--KWVRKLVKEGAG--GDA----LDF-------RLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 621 ~--~~~~~~~~~~~~--~~~----~~~-------~~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
. ............ .+. .+. ........... ....+.+++.+||+.||++|||+.|+++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred CHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 1 111111100000 000 000 00000000000 01235677888999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-32 Score=274.78 Aligned_cols=225 Identities=19% Similarity=0.199 Sum_probs=176.9
Q ss_pred eccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 415 LAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 415 lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
||+|+||.||+|+. .++..+|+|++..... ...+.+.+|++.+++++||||+++++++.+....++|+||+++|+|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999995 4578999999865432 2345688899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++.+ ...+++..+..++.|+++||+|||+.+++|+||+|+||+++.++.+
T Consensus 81 ~~~l~~----------------------------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~ 132 (262)
T cd05572 81 WTILRD----------------------------RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYV 132 (262)
T ss_pred HHHHhh----------------------------cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCE
Confidence 999975 2347888999999999999999999999999999999999999999
Q ss_pred eEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH----HHHHHHHHhcCC
Q 005572 571 KIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV----KWVRKLVKEGAG 633 (690)
Q Consensus 571 kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~----~~~~~~~~~~~~ 633 (690)
||+|||+++..... +||......++.++||||||+++|||++|..||.... +...... .+..
T Consensus 133 ~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~ 211 (262)
T cd05572 133 KLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL-KGNG 211 (262)
T ss_pred EEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh-ccCC
Confidence 99999998754321 3444444567889999999999999999999986532 1111111 1010
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-----HHHHHH
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-----MQQVLG 678 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-----~~ev~~ 678 (690)
....+... ...+.+++.+||+.+|++||+ +.|+++
T Consensus 212 ----~~~~~~~~------~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 212 ----KLEFPNYI------DKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ----CCCCCccc------CHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11111111 124556677899999999999 677765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-32 Score=280.46 Aligned_cols=243 Identities=23% Similarity=0.219 Sum_probs=180.2
Q ss_pred HhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCC-----
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK----- 476 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----- 476 (690)
..++|+..+.||+|+||.||+|.. .++..||+|+++... ......+.+|++.+++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~ 84 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDF 84 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhc
Confidence 456788889999999999999995 457899999996542 233456788999999999999999999997755
Q ss_pred -----eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC
Q 005572 477 -----EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG 551 (690)
Q Consensus 477 -----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~ 551 (690)
..++|+||+++ ++.+++.. ....+++..+..++.|++.||+|||+.+
T Consensus 85 ~~~~~~~~lv~e~~~~-~l~~~l~~---------------------------~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 136 (302)
T cd07864 85 KKDKGAFYLVFEYMDH-DLMGLLES---------------------------GLVHFSEDHIKSFMKQLLEGLNYCHKKN 136 (302)
T ss_pred cccCCcEEEEEcccCc-cHHHHHhc---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 78999999976 77777754 1235889999999999999999999999
Q ss_pred CCCCCCCCCcEEecCCCCceEcCCCcccccccc---------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCC
Q 005572 552 STHGHLVTSSILLAESLEPKIAGFGLRNIGVKN---------------VGERSEN-ETCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 552 ~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
++||||||+||++++++.+||+|||++...... +||.... ..++.++|||||||++|||++|+.
T Consensus 137 i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~ 216 (302)
T cd07864 137 FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKP 216 (302)
T ss_pred eecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999998753211 2333221 246789999999999999999999
Q ss_pred CCCch--HHHHHHHHHhcCCC--C----c--------ccc------ccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 616 GTDDC--VKWVRKLVKEGAGG--D----A--------LDF------RLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 616 p~~~~--~~~~~~~~~~~~~~--~----~--------~~~------~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
||... .+............ . . .+. ......... ...+.+++..||+.||++||++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~li~~~l~~~P~~Rp~~ 293 (302)
T cd07864 217 IFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFI---PTPALDLLDHMLTLDPSKRCTA 293 (302)
T ss_pred CCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCC---CHHHHHHHHHHccCChhhCCCH
Confidence 98742 11111111110000 0 0 000 000000001 1245567778999999999999
Q ss_pred HHHHH
Q 005572 674 QQVLG 678 (690)
Q Consensus 674 ~ev~~ 678 (690)
.++++
T Consensus 294 ~~il~ 298 (302)
T cd07864 294 EEALN 298 (302)
T ss_pred HHHhc
Confidence 99875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=275.81 Aligned_cols=236 Identities=16% Similarity=0.155 Sum_probs=174.1
Q ss_pred HHHHHhccCCCCcee--ccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeEEecCC
Q 005572 401 DLIAATSHFGKESLL--AEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGK 476 (690)
Q Consensus 401 ~~~~~~~~~~~~~~l--g~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~ 476 (690)
+.....++|+..+.+ |+|+||.||+++ ..++..+|+|.+...... .. |+.....+ +||||+++++++...+
T Consensus 8 ~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~---~~--e~~~~~~~~~h~~iv~~~~~~~~~~ 82 (267)
T PHA03390 8 ELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN---AI--EPMVHQLMKDNPNFIKLYYSVTTLK 82 (267)
T ss_pred HHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcc---hh--hHHHHHHhhcCCCEEEEEEEEecCC
Confidence 444445566666666 999999999998 456788999998643211 11 22222222 6999999999999999
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..++||||+++|+|.++++. ...++|.++..++.|+++||.|||+.+++|||
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~d 134 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKK----------------------------EGKLSEAEVKKIIRQLVEALNDLHKHNIIHND 134 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 99999999999999999975 23688999999999999999999999999999
Q ss_pred CCCCcEEecCCC-CceEcCCCcccccccc----------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH-
Q 005572 557 LVTSSILLAESL-EPKIAGFGLRNIGVKN----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV- 624 (690)
Q Consensus 557 lk~~NiLl~~~~-~~kl~DfGla~~~~~~----------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~- 624 (690)
|||+||+++.++ .+||+|||+++..... +||......++.++|||||||++|||++|+.||.......
T Consensus 135 l~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~ 214 (267)
T PHA03390 135 IKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEEL 214 (267)
T ss_pred CCHHHEEEeCCCCeEEEecCccceecCCCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchh
Confidence 999999999998 9999999987653321 4665555678899999999999999999999986421110
Q ss_pred -HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC-HHHHHH
Q 005572 625 -RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-MQQVLG 678 (690)
Q Consensus 625 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt-~~ev~~ 678 (690)
........ ... .......+ ..+.+++..||+.+|.+||+ ++|+++
T Consensus 215 ~~~~~~~~~-~~~--~~~~~~~~------~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 215 DLESLLKRQ-QKK--LPFIKNVS------KNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred hHHHHHHhh-ccc--CCcccccC------HHHHHHHHHHhccChhhCCchHHHHhc
Confidence 01111110 000 01111111 13445566799999999996 688874
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=274.45 Aligned_cols=236 Identities=23% Similarity=0.283 Sum_probs=185.3
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..+.||+|+||.||+++ ..++..+|+|.+..... ....++.+|++.+++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 46777899999999999998 45678999999865432 2345677899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.+++.+.. .....+++..+..++.|++.||+|||+.+++||||+|+||++
T Consensus 81 ~~~~~L~~~~~~~~------------------------~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~ 136 (256)
T cd08530 81 APFGDLSKAISKRK------------------------KKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL 136 (256)
T ss_pred cCCCCHHHHHHHHH------------------------hhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE
Confidence 99999999987621 112457899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-HHHHHHhc
Q 005572 565 AESLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLVKEG 631 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-~~~~~~~~ 631 (690)
++++.+|++|||++...... +||......++.++|+||||+++|||++|+.||...... ........
T Consensus 137 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~ 216 (256)
T cd08530 137 VANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG 216 (256)
T ss_pred ecCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC
Confidence 99999999999988654321 344444456788999999999999999999998753221 11112111
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... ... .....+.+++..||+.+|++||++.|+++
T Consensus 217 ~~~~-----~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 217 KYPP-----IPP------IYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred CCCC-----Cch------hhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1110 111 11123566777899999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=286.36 Aligned_cols=243 Identities=21% Similarity=0.252 Sum_probs=178.3
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEec----CCeeE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIA----GKEKL 479 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~ 479 (690)
.+|+..+.||+|+||.||+|. ..++..||+|++.... ....+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 578888999999999999998 4568899999986532 1334567789999999999999999998764 34689
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||+. |+|.+++.. ...+++..+..++.|+++||+|||+.+++||||||
T Consensus 85 lv~e~~~-~~l~~~~~~----------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp 135 (334)
T cd07855 85 VVMDLME-SDLHHIIHS----------------------------DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKP 135 (334)
T ss_pred EEEehhh-hhHHHHhcc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 9999995 699998864 23488999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc------------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCch
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN------------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~------------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~ 620 (690)
+||++++++.+||+|||+++..... +||.... ..++.++|||||||++|||++|+.||...
T Consensus 136 ~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~ 215 (334)
T cd07855 136 SNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGK 215 (334)
T ss_pred HHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCC
Confidence 9999999999999999998643211 2333222 35788999999999999999999998642
Q ss_pred H--HHHHHHHHh-cCCC-Cccc-----------cccccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 621 V--KWVRKLVKE-GAGG-DALD-----------FRLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 621 ~--~~~~~~~~~-~~~~-~~~~-----------~~~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
. ......... +... ...+ ............ ....+.+++..||+.||++||++.|++.
T Consensus 216 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 216 NYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred ChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 1 111111100 0000 0000 000000000000 1124566778899999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-31 Score=275.28 Aligned_cols=243 Identities=23% Similarity=0.255 Sum_probs=179.6
Q ss_pred CCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEEEec
Q 005572 409 FGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
|...+.||+|+||.||+|+.. ++..||+|.+..... .......+|+..+++++ ||||+++++++...+..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456688999999999999964 578899999865432 22334567889999999 999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
+|+|.+++... ....+++.++..++.|++.||.|||+++++|+||+|+||+++
T Consensus 81 -~~~l~~~~~~~--------------------------~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~ 133 (283)
T cd07830 81 -EGNLYQLMKDR--------------------------KGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVS 133 (283)
T ss_pred -CCCHHHHHHhc--------------------------ccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEc
Confidence 88999998752 124688999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc-------------cCcccC-CCCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN-------------VGERSE-NETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKLVK 629 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~-------------~~e~~~-~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~~~ 629 (690)
+++.+||+|||++...... +||... ...++.++||||||+++|||++|+.||... .+.......
T Consensus 134 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~ 213 (283)
T cd07830 134 GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICS 213 (283)
T ss_pred CCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHH
Confidence 9999999999998654321 344321 234678999999999999999999988542 111111111
Q ss_pred hcC------------CCCccccccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 630 EGA------------GGDALDFRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 630 ~~~------------~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... .....+............+ ...+.+++..||+.||++|||+.|++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 214 VLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred hcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 000 0000111111111111111 134667888999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5e-32 Score=275.81 Aligned_cols=229 Identities=21% Similarity=0.249 Sum_probs=176.9
Q ss_pred eccCCCccEEEEEcC-CCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 415 LAEGRCGPVYRAVLP-GELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 415 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
||+|+||.||+++.. ++..+|+|.+..... ...+.+.+|++.+++++||||+++++.+......++|+||+++|+|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 488999999865432 2345688899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++.. ...+++..+..++.|+++||+|||+.+++||||+|+||++++++.+
T Consensus 81 ~~~l~~----------------------------~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~ 132 (265)
T cd05579 81 ASLLEN----------------------------VGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHL 132 (265)
T ss_pred HHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCE
Confidence 999975 2357899999999999999999999999999999999999999999
Q ss_pred eEcCCCcccccccc----------------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHH
Q 005572 571 KIAGFGLRNIGVKN----------------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKL 627 (690)
Q Consensus 571 kl~DfGla~~~~~~----------------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~ 627 (690)
||+|||++...... +||.......+.++||||||+++||+++|+.||.... ......
T Consensus 133 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 212 (265)
T cd05579 133 KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQN 212 (265)
T ss_pred EEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999987643211 3343334457789999999999999999999987522 111111
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
...+. .. .+.... ....+.+++..||+.+|++|||+.++.+.|+
T Consensus 213 ~~~~~----~~--~~~~~~----~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 213 ILNGK----IE--WPEDVE----VSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred HhcCC----cC--CCcccc----CCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 11111 11 111110 0123456677899999999999966655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-31 Score=276.21 Aligned_cols=243 Identities=21% Similarity=0.214 Sum_probs=177.8
Q ss_pred CCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC--CCHHHHHHHHHHHHhc---CCCCccceeeEEecCCe-----
Q 005572 409 FGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG--IDHDDAVAMFDELSRL---KHPNLLPLAGYCIAGKE----- 477 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~~~~----- 477 (690)
|+..+.||+|+||.||+|+.. ++..+|+|+++.... .....+.+|+.++.++ +||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 456788999999999999965 488999999964322 1234566777776555 69999999999998776
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl 557 (690)
.+++|||+. ++|.+++.... ...+++.++..++.|+++||.|||+.+++|+||
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~~--------------------------~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l 133 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKCP--------------------------KPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDL 133 (287)
T ss_pred eEEEehhcc-cCHHHHHHHcc--------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccC
Confidence 899999997 48999887521 235889999999999999999999999999999
Q ss_pred CCCcEEecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch--HH
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--VK 622 (690)
Q Consensus 558 k~~NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~ 622 (690)
+|+||++++++.+||+|||++...... +||......++.++|||||||++|||++|+.||... .+
T Consensus 134 ~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~ 213 (287)
T cd07838 134 KPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD 213 (287)
T ss_pred ChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH
Confidence 999999999999999999998654221 344444456788999999999999999999998652 22
Q ss_pred HHHHHHHhcCCCCcc---------ccccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 623 WVRKLVKEGAGGDAL---------DFRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
...+........... .............+ .....+++..||+.||++||++.|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 214 QLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred HHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 222222211100000 00000000011111 123457788999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.8e-32 Score=279.42 Aligned_cols=247 Identities=17% Similarity=0.133 Sum_probs=179.1
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcC-CCCccceeeEEecCCe-----e
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKE-----K 478 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~-----~ 478 (690)
+|+..+.||+|+||.||+|.. .++..||+|.++.... .....+.+|+.++++++ ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 577889999999999999994 5688999998864322 23456888999999995 6999999999887655 8
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
|+||||+++ +|.+++..... .....+++..+..++.||++||.|||+.+++|||||
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~ 137 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGR-----------------------GPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLK 137 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcc-----------------------cCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 999999985 89998875221 012458899999999999999999999999999999
Q ss_pred CCcEEecC-CCCceEcCCCccccccc--------------ccCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCch--
Q 005572 559 TSSILLAE-SLEPKIAGFGLRNIGVK--------------NVGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDC-- 620 (690)
Q Consensus 559 ~~NiLl~~-~~~~kl~DfGla~~~~~--------------~~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~-- 620 (690)
|+||+++. ++.+||+|||+++.... .+||.... ..++.++|||||||++|||++|..||...
T Consensus 138 ~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 217 (295)
T cd07837 138 PQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217 (295)
T ss_pred hHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999998 89999999998864321 13443322 35688999999999999999999998642
Q ss_pred HHHHHHHHHhcCC-CCcccc---------ccccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 621 VKWVRKLVKEGAG-GDALDF---------RLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 621 ~~~~~~~~~~~~~-~~~~~~---------~~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
............. ....-+ ..+........ .-..+.+++..||+.||++||++.|++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 218 LQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred HHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 2222222211000 000000 00000000000 0123456778899999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-32 Score=284.74 Aligned_cols=188 Identities=22% Similarity=0.250 Sum_probs=153.7
Q ss_pred cCCCCceeccCCCccEEEEEc-C--CCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecC--CeeE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-P--GELHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEKL 479 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~--~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~~ 479 (690)
+|...+.||+|+||.||+|+. . ++..+|+|.+.... ....+.+.+|++++++++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 366778899999999999995 3 57899999997633 23346678899999999999999999999988 7899
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||+++ +|.+++..... .....+++..+..++.|++.||+|||+.+++||||||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~-----------------------~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp 136 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQ-----------------------AKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKP 136 (316)
T ss_pred EEEeCCCc-CHHHHHHhhcc-----------------------CCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCH
Confidence 99999975 77777754211 0123578889999999999999999999999999999
Q ss_pred CcEEecC----CCCceEcCCCcccccccc-------------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCC
Q 005572 560 SSILLAE----SLEPKIAGFGLRNIGVKN-------------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGT 617 (690)
Q Consensus 560 ~NiLl~~----~~~~kl~DfGla~~~~~~-------------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~ 617 (690)
+||+++. ++.+||+|||+++..... ..+.+|| ..++.++|||||||++|||++|+.||
T Consensus 137 ~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~ 216 (316)
T cd07842 137 ANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216 (316)
T ss_pred HHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCC
Confidence 9999999 999999999997753211 1233333 35688999999999999999999998
Q ss_pred Cc
Q 005572 618 DD 619 (690)
Q Consensus 618 ~~ 619 (690)
..
T Consensus 217 ~~ 218 (316)
T cd07842 217 KG 218 (316)
T ss_pred cC
Confidence 63
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.2e-31 Score=269.77 Aligned_cols=236 Identities=19% Similarity=0.232 Sum_probs=185.3
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|...+.||+|+||.||++.. .++..+|+|++..... ...+.+.+|++.++.++|||++++++.+...+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 466778999999999999995 4678999999975432 3456788999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.+++..... ....+++.++..++.|+++||.|||+.+++|+||+|+||++
T Consensus 81 ~~~~~L~~~l~~~~~------------------------~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~ 136 (258)
T cd08215 81 ADGGDLSQKIKKQKK------------------------EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL 136 (258)
T ss_pred cCCCcHHHHHHHhhc------------------------cCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE
Confidence 999999999986210 12568999999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-HHHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVK 629 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~~~~~~~~ 629 (690)
++++.+||+|||.+...... +||......++.++||||+|+++|||++|+.||.... ........
T Consensus 137 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 216 (258)
T cd08215 137 TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL 216 (258)
T ss_pred cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHh
Confidence 99999999999987653221 3444444567889999999999999999999986532 11111111
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... ..++...+ . .+.+++..||..+|++|||+.|+++
T Consensus 217 ~~~~-----~~~~~~~~---~---~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 217 KGQY-----PPIPSQYS---S---ELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred cCCC-----CCCCCCCC---H---HHHHHHHHHcCCChhhCcCHHHHhc
Confidence 1111 11111111 1 3445667799999999999999975
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=275.50 Aligned_cols=229 Identities=19% Similarity=0.137 Sum_probs=169.7
Q ss_pred eeccCCCccEEEEEc-CCCcEEEEEEeeccCCC---CHHHHHHHHH---HHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 414 LLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGI---DHDDAVAMFD---ELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~~e~~---~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.||+|+||.||++.. .+++.||+|.+...... ....+..|.. .++...||||+++++++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999984 56889999998653211 1122334433 3444579999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|.+++.. ...+++..+..++.|+++||.|||+.+++||||||+||++++
T Consensus 81 g~~L~~~l~~----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~ 132 (278)
T cd05606 81 GGDLHYHLSQ----------------------------HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDE 132 (278)
T ss_pred CCcHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECC
Confidence 9999998864 235899999999999999999999999999999999999999
Q ss_pred CCCceEcCCCccccccc--------c----cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcCC
Q 005572 567 SLEPKIAGFGLRNIGVK--------N----VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAG 633 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~--------~----~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~ 633 (690)
++.+||+|||++..... . +||.... ..++.++|||||||++|||++|+.||...............
T Consensus 133 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~- 211 (278)
T cd05606 133 HGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT- 211 (278)
T ss_pred CCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-
Confidence 99999999999764321 1 3444332 25788999999999999999999999753110000011000
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
...++.++...+ ..+.+++.+|++.+|++|| ++.|+++
T Consensus 212 -~~~~~~~~~~~s------~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 212 -LTMAVELPDSFS------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred -hccCCCCCCcCC------HHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 001111221111 2344556679999999999 9999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.6e-31 Score=277.76 Aligned_cols=232 Identities=22% Similarity=0.255 Sum_probs=177.8
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCC---HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGID---HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
|...+.||+|+||.||+|+. .++..+|+|.+....... .+.+.+|++.++.++|||++++++++.+.+..|+||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 45567799999999999984 568899999986543222 24577899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+. |++.+++.. ....+++.++..++.|++.||.|||+.+++||||||+||++
T Consensus 103 ~~-~~l~~~l~~---------------------------~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili 154 (313)
T cd06633 103 CL-GSASDLLEV---------------------------HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 154 (313)
T ss_pred CC-CCHHHHHHh---------------------------cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE
Confidence 95 588888764 12458899999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc----------cCcccC---CCCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN----------VGERSE---NETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKLVK 629 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~----------~~e~~~---~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~~~ 629 (690)
++++.+||+|||++...... +||... ...++.++|||||||++|||++|..||.... ........
T Consensus 155 ~~~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 234 (313)
T cd06633 155 TEPGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234 (313)
T ss_pred CCCCCEEEeecCCCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 99999999999987643211 344431 2457889999999999999999999986522 22222211
Q ss_pred hcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.. .... .....+ ..+.+++.+||+.+|.+||++.++++.
T Consensus 235 ~~-~~~~----~~~~~~------~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 235 ND-SPTL----QSNEWT------DSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred cC-CCCC----CccccC------HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 11 1000 000111 124456667999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-33 Score=259.88 Aligned_cols=230 Identities=20% Similarity=0.310 Sum_probs=172.1
Q ss_pred CceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEEEecCCC
Q 005572 412 ESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLLEFMANG 488 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~~g 488 (690)
...||.|..|.|++++. .++...|||.+.+... ...+.+...++++..-+ .|.||+.+||+......++.||.|..
T Consensus 97 l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~- 175 (391)
T KOG0983|consen 97 LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST- 175 (391)
T ss_pred HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-
Confidence 45799999999999994 5688999999976542 23345556666655544 89999999999999999999999954
Q ss_pred CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcEEecCC
Q 005572 489 DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSILLAES 567 (690)
Q Consensus 489 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~NiLl~~~ 567 (690)
.+..+|+. ...++++...-++...+.+||.||-+ +++||||+||+|||+|+.
T Consensus 176 C~ekLlkr---------------------------ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~ 228 (391)
T KOG0983|consen 176 CAEKLLKR---------------------------IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER 228 (391)
T ss_pred HHHHHHHH---------------------------hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccC
Confidence 56666664 24567777788899999999999976 678899999999999999
Q ss_pred CCceEcCCCcccccccc---------cCcccCCC-------CCCCCCcchhhHHHHHHHHhCCCCCCchHHH---HHHHH
Q 005572 568 LEPKIAGFGLRNIGVKN---------VGERSENE-------TCGPESDVYCFGVILMELLTGKRGTDDCVKW---VRKLV 628 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~~---------~~e~~~~~-------~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~---~~~~~ 628 (690)
|.+|+||||++.....+ ++|.+||. .|+-++|||||||.++||.||..||..+... ....+
T Consensus 229 GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvl 308 (391)
T KOG0983|consen 229 GNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVL 308 (391)
T ss_pred CCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHH
Confidence 99999999998765432 45555542 6788999999999999999999999874322 22222
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.+ . .+.++.... .-. .+.++...|+..|+.+||...++++.
T Consensus 309 n~--e----PP~L~~~~g-FSp---~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 309 NE--E----PPLLPGHMG-FSP---DFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred hc--C----CCCCCcccC-cCH---HHHHHHHHHhhcCcccCcchHHHhcC
Confidence 21 1 133332221 111 22334446999999999999988753
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=277.92 Aligned_cols=235 Identities=21% Similarity=0.340 Sum_probs=176.2
Q ss_pred ccCCCCceeccCCCccEEEEEcCC-CcEEEEEEeeccCC-CCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 483 (690)
++|...+.||+|+||.||+|...+ +..||||.++.... ....++.+|+..+.+.. ||||++++|+|.+....++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 456778899999999999999654 88999999975432 22345666777776665 9999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSI 562 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~Ni 562 (690)
|+. +++.+++.. ....+++..+..++.|+++||+|||+ .+++||||+|+||
T Consensus 95 ~~~-~~l~~l~~~---------------------------~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ni 146 (296)
T cd06618 95 LMS-TCLDKLLKR---------------------------IQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNI 146 (296)
T ss_pred ccC-cCHHHHHHH---------------------------hcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHE
Confidence 985 477777654 12368899999999999999999997 5999999999999
Q ss_pred EecCCCCceEcCCCcccccccc-------------cCcccCCC----CCCCCCcchhhHHHHHHHHhCCCCCCchHHH--
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN-------------VGERSENE----TCGPESDVYCFGVILMELLTGKRGTDDCVKW-- 623 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~----~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-- 623 (690)
++++++.+||+|||++...... +||..... .++.++||||||+++|||++|+.||......
T Consensus 147 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~ 226 (296)
T cd06618 147 LLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE 226 (296)
T ss_pred EEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH
Confidence 9999999999999998643211 33333222 3678999999999999999999999752221
Q ss_pred -HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 624 -VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 624 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
....... .. +...... ... .++.+++.+||+.||++||++.++++.
T Consensus 227 ~~~~~~~~-~~-----~~~~~~~-~~~---~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 227 VLTKILQE-EP-----PSLPPNE-GFS---PDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred HHHHHhcC-CC-----CCCCCCC-CCC---HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111111 10 0111000 011 134566778999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-31 Score=271.58 Aligned_cols=234 Identities=19% Similarity=0.221 Sum_probs=177.3
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC-----CCCHHHHHHHHHHHHhcCCCCccceeeEEecC--Cee
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK-----GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--KEK 478 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--~~~ 478 (690)
.+|...+.||+|+||.||+|+ ..++..+|+|.+.... ......+.+|++.+++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 367788999999999999998 4568899999875321 12234678899999999999999999998764 457
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+++|||||
T Consensus 82 ~~v~e~~~~~~L~~~~~~----------------------------~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~ 133 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA----------------------------YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIK 133 (264)
T ss_pred EEEEEeCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 899999999999999864 2347788899999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCccccccc-----------------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVK-----------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~-----------------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~ 621 (690)
|+||+++.++.+||+|||+++.... .+||.......+.++|||||||++|||++|+.||.+..
T Consensus 134 p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 213 (264)
T cd06653 134 GANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE 213 (264)
T ss_pred HHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccC
Confidence 9999999999999999999864321 13444444567889999999999999999999997643
Q ss_pred HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... ...... ....+.++..... .+.+++..||+ +|.+||++.+++.
T Consensus 214 ~~~~-~~~~~~--~~~~~~~p~~~~~------~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 214 AMAA-IFKIAT--QPTKPMLPDGVSD------ACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred HHHH-HHHHHc--CCCCCCCCcccCH------HHHHHHHHHhc-CcccCccHHHHhc
Confidence 2221 111110 0011111111111 23345556998 5799999998865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=279.17 Aligned_cols=240 Identities=13% Similarity=0.150 Sum_probs=164.1
Q ss_pred ccCCCCceeccCCCccEEEEEcCC----CcEEEEEEeeccCCCCH-----------HHHHHHHHHHHhcCCCCccceeeE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG----ELHVAIKVLDNAKGIDH-----------DDAVAMFDELSRLKHPNLLPLAGY 471 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~l~~~~~~~~-----------~~~~~e~~~l~~l~H~niv~l~g~ 471 (690)
.+|...+.||+|+||.||+|...+ +..+|+|+......... .....+...+..++|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 568888999999999999999543 34566665433221111 111223344566789999999997
Q ss_pred EecCC----eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 005572 472 CIAGK----EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYL 547 (690)
Q Consensus 472 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yL 547 (690)
+.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~l~~l 142 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKR----------------------------IKCKNKKLIKNIMKDMLTTLEYI 142 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHh----------------------------hccCCHHHHHHHHHHHHHHHHHH
Confidence 76543 34678888744 66666653 12346777889999999999999
Q ss_pred hhcCCCCCCCCCCcEEecCCCCceEcCCCccccccc---------------------ccCcccCCCCCCCCCcchhhHHH
Q 005572 548 HHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK---------------------NVGERSENETCGPESDVYCFGVI 606 (690)
Q Consensus 548 H~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~---------------------~~~e~~~~~~~~~~~DVwSfGvv 606 (690)
|+.+++||||||+|||++.++.+||+|||+++.... .+||......++.++|||||||+
T Consensus 143 H~~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~ 222 (294)
T PHA02882 143 HEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYC 222 (294)
T ss_pred HhCCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHH
Confidence 999999999999999999999999999999864311 03343444568899999999999
Q ss_pred HHHHHhCCCCCCchHH---HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHh
Q 005572 607 LMELLTGKRGTDDCVK---WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 607 l~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~ 681 (690)
+|||++|+.||..... .......+ ....+....... ....+ .+.+++..||+.+|++||++.++.+.++
T Consensus 223 l~el~~g~~P~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~---~~~~~~~~~~~~~~~~rp~~~~l~~~~~ 294 (294)
T PHA02882 223 MLKWAGIKLPWKGFGHNGNLIHAAKCD-FIKRLHEGKIKI--KNANK---FIYDFIECVTKLSYEEKPDYDALIKIFD 294 (294)
T ss_pred HHHHHhCCCCCCccccchHHHHHhHHH-HHHHhhhhhhcc--CCCCH---HHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence 9999999999975311 11100000 000000011100 01112 2445566799999999999999998763
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.7e-32 Score=284.08 Aligned_cols=247 Identities=21% Similarity=0.228 Sum_probs=181.7
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecC-----Cee
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG-----KEK 478 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~~ 478 (690)
.+|...+.||+|+||.||+|+ ..++..||||.++... ......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 468888999999999999998 5668899999986432 22345677899999999999999999988654 247
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++|+||+. ++|.+++.. ...+++..+..++.|++.||.|||+++++|||||
T Consensus 85 ~lv~e~~~-~~L~~~~~~----------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlk 135 (337)
T cd07858 85 YIVYELMD-TDLHQIIRS----------------------------SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLK 135 (337)
T ss_pred EEEEeCCC-CCHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 99999996 689988864 2358899999999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc--------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV-- 621 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-- 621 (690)
|+||+++.++.+||+|||+++..... +||.... ..++.++|||||||++|||++|+.||....
T Consensus 136 p~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 215 (337)
T cd07858 136 PSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV 215 (337)
T ss_pred HHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH
Confidence 99999999999999999998753221 3333322 357889999999999999999999986411
Q ss_pred HHHHHHHHh-cC--------------------CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH-
Q 005572 622 KWVRKLVKE-GA--------------------GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL- 679 (690)
Q Consensus 622 ~~~~~~~~~-~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~- 679 (690)
......... +. .....+........ .....+.+++.+||+.||++|||+.|+++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~P~~Rps~~ell~h~ 292 (337)
T cd07858 216 HQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFP---HANPLAIDLLEKMLVFDPSKRITVEEALAHP 292 (337)
T ss_pred HHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcc---cCCHHHHHHHHHHhcCChhhccCHHHHHcCc
Confidence 100000000 00 00000000000000 011235677888999999999999999876
Q ss_pred -HhccCC
Q 005572 680 -LKDIRP 685 (690)
Q Consensus 680 -L~~i~~ 685 (690)
++.+..
T Consensus 293 ~~~~~~~ 299 (337)
T cd07858 293 YLASLHD 299 (337)
T ss_pred chhhhcC
Confidence 555443
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=275.10 Aligned_cols=245 Identities=18% Similarity=0.197 Sum_probs=180.6
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+|+..+.||+|++|.||+|+. .++..||+|.++.... .....+.+|++.+++++||||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 477788999999999999995 4688999999875432 33456778999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++ +|.+++.... ....+++.++..++.|++.||.|||+.+++||||||+||+++
T Consensus 81 ~~-~l~~~~~~~~-------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~ 134 (284)
T cd07836 81 DK-DLKKYMDTHG-------------------------VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLIN 134 (284)
T ss_pred Cc-cHHHHHHhcC-------------------------CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEC
Confidence 85 8999886521 123588999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCccccccc--------------ccCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVK--------------NVGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~--------------~~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~~ 628 (690)
+++.+|++|||+++.... .+||...+ ..++.++|||||||++|||++|+.||.... +......
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 135 KRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214 (284)
T ss_pred CCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 999999999999864321 12333322 246789999999999999999999986421 1111111
Q ss_pred HhcC-----------CCCccccccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGA-----------GGDALDFRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~-----------~~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.... .........+......... ...+.+++..|++.||.+||++.|+++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 215 RIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred HHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1100 0000000000000000000 123456777899999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-32 Score=286.78 Aligned_cols=183 Identities=19% Similarity=0.225 Sum_probs=153.7
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecC------C
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG------K 476 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~ 476 (690)
..+|+..+.||+|+||.||+|+ ..++..||+|.+.... ......+.+|++++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 4678889999999999999998 5578899999986432 22335677899999999999999999988643 3
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..++||||+. |+|.+++.. .+++.++..++.|++.||+|||+.+++|||
T Consensus 95 ~~~lv~e~~~-~~l~~~~~~------------------------------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~d 143 (353)
T cd07850 95 DVYLVMELMD-ANLCQVIQM------------------------------DLDHERMSYLLYQMLCGIKHLHSAGIIHRD 143 (353)
T ss_pred cEEEEEeccC-CCHHHHHhh------------------------------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCC
Confidence 4799999996 588888753 267888899999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|||+||+++.++.+||+|||+++..... +||......++.++|||||||++|||++|+.||..
T Consensus 144 lkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 219 (353)
T cd07850 144 LKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPG 219 (353)
T ss_pred CCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCC
Confidence 9999999999999999999998753221 34444445788999999999999999999999864
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.9e-31 Score=282.45 Aligned_cols=248 Identities=20% Similarity=0.229 Sum_probs=180.1
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCC------e
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK------E 477 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~ 477 (690)
.+|...+.||+|+||.||+|+ ..++..||+|++.... ......+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 678888999999999999998 4568899999986432 122356788999999999999999999987543 4
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl 557 (690)
.++|+||+.. +|.+++. ..+++..+..++.|++.||+|||+.+++||||
T Consensus 95 ~~lv~e~~~~-~l~~~~~------------------------------~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl 143 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG------------------------------HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDL 143 (342)
T ss_pred EEEEeccccc-CHHHHHc------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCC
Confidence 6899999964 7766542 24788899999999999999999999999999
Q ss_pred CCCcEEecCCCCceEcCCCcccccccc-----------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--HH
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVKN-----------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--KW 623 (690)
Q Consensus 558 k~~NiLl~~~~~~kl~DfGla~~~~~~-----------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~ 623 (690)
||+||+++.++.+||+|||+++..... +||.... ..++.++|||||||++|||++|+.||.... ..
T Consensus 144 kp~NIll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~ 223 (342)
T cd07879 144 KPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 223 (342)
T ss_pred CHHHEEECCCCCEEEeeCCCCcCCCCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999999998753221 3444333 357889999999999999999999987521 11
Q ss_pred HHHHHHhcCCC--------------CccccccccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHHH--Hhc
Q 005572 624 VRKLVKEGAGG--------------DALDFRLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLGL--LKD 682 (690)
Q Consensus 624 ~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~~--L~~ 682 (690)
........... .... ..+........ .-..+.+++..||+.||++||++.|++.. ++.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~ 302 (342)
T cd07879 224 LTQILKVTGVPGPEFVQKLEDKAAKSYIK-SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDS 302 (342)
T ss_pred HHHHHHhcCCCCHHHHHHhcccchHHHHh-hcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhh
Confidence 11111110000 0000 00000000000 01134567778999999999999999843 666
Q ss_pred cCCC
Q 005572 683 IRPS 686 (690)
Q Consensus 683 i~~~ 686 (690)
++..
T Consensus 303 ~~~~ 306 (342)
T cd07879 303 FRDA 306 (342)
T ss_pred cccc
Confidence 6543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=276.66 Aligned_cols=242 Identities=22% Similarity=0.229 Sum_probs=181.3
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
|+..+.||+|++|.||+|.. .++..+|+|.++.... .....+.+|++.+++++||||+++++++..++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 45667899999999999985 4688999999865432 23467888999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++ +|.+++... ...+++.++..++.|+++||.|||+.+++|+||||+||+++
T Consensus 81 ~~-~l~~~l~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~ 132 (283)
T cd05118 81 DT-DLYKLIKDR---------------------------QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLIN 132 (283)
T ss_pred CC-CHHHHHHhh---------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEEC
Confidence 75 898888751 24688999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~~ 628 (690)
+++.+||+|||.+...... +||..... ..+.++||||||+++|||+||+.||... .+......
T Consensus 133 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 212 (283)
T cd05118 133 TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIF 212 (283)
T ss_pred CCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999987543221 33433333 6788999999999999999999998641 11111111
Q ss_pred HhcCCC------Ccc------ccccccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAGG------DAL------DFRLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~~------~~~------~~~~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
...... ... ............. ....+.+++..||+.||.+||++.|++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 213 RTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred HHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 110000 000 0000000001111 1134667888999999999999999975
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=284.02 Aligned_cols=243 Identities=24% Similarity=0.279 Sum_probs=177.2
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeecc--CCCCHHHHHHHHHHHHhc-CCCCccceeeEEecC--CeeE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNA--KGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAG--KEKL 479 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~--~~~~ 479 (690)
.++|...+.||+|+||.||+|.. .++..+|+|++... .......+.+|+..++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 34677778999999999999995 46789999988542 122345677899999999 999999999998653 3689
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||++ ++|..++.. ..++|..+..++.|++.||+|||+.+++||||||
T Consensus 86 lv~e~~~-~~L~~~~~~-----------------------------~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p 135 (337)
T cd07852 86 LVFEYME-TDLHAVIRA-----------------------------NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKP 135 (337)
T ss_pred EEecccc-cCHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCH
Confidence 9999997 599988864 1577888999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc---------------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN---------------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
+||+++.++.+||+|||++...... .++.+|+ ..++.++|||||||++|||+||+.||..
T Consensus 136 ~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~ 215 (337)
T cd07852 136 SNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215 (337)
T ss_pred HHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999998643211 1233333 3467899999999999999999999864
Q ss_pred hHH--HHHHHHHhcCC--------------CCccccccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 620 CVK--WVRKLVKEGAG--------------GDALDFRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 620 ~~~--~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... ...+....... ....+ ...........+ -..+.+++.+||+.||++|||+.++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~ 294 (337)
T cd07852 216 TSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLD-SLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALE 294 (337)
T ss_pred CChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhh-hcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhh
Confidence 211 11111111000 00000 000000000000 124567788899999999999999986
Q ss_pred H
Q 005572 679 L 679 (690)
Q Consensus 679 ~ 679 (690)
.
T Consensus 295 ~ 295 (337)
T cd07852 295 H 295 (337)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=281.75 Aligned_cols=250 Identities=23% Similarity=0.258 Sum_probs=185.6
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCC-----eeE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK-----EKL 479 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~ 479 (690)
+|...+.||+|+||.||+|+. .++..+|+|++.... ....+.+.+|++.++.++||||+++++++...+ ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 467788999999999999995 458899999986543 234567889999999999999999999998775 789
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||++ ++|.+++.. ...+++..+..++.|+++||+|||+.+++||||||
T Consensus 81 lv~e~~~-~~l~~~l~~----------------------------~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp 131 (330)
T cd07834 81 IVTELME-TDLHKVIKS----------------------------PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKP 131 (330)
T ss_pred EEecchh-hhHHHHHhC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence 9999997 589988864 23688999999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc-----------------cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCchH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~-----------------~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~~~ 621 (690)
+||+++.++.+||+|||++...... +||..... .++.++||||||+++|||++|+.||....
T Consensus 132 ~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 132 SNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred HHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 9999999999999999997653221 34443334 67889999999999999999999986521
Q ss_pred --HHHHHHHHhcCCCC--cc---------cc--ccccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHHH--
Q 005572 622 --KWVRKLVKEGAGGD--AL---------DF--RLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLGL-- 679 (690)
Q Consensus 622 --~~~~~~~~~~~~~~--~~---------~~--~~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~~-- 679 (690)
+............. .. +. ........... .-..+.+++..||+.+|++|||+.++++.
T Consensus 212 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~ 291 (330)
T cd07834 212 YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291 (330)
T ss_pred HHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCcc
Confidence 11112111110000 00 00 00000000000 01234567788999999999999999984
Q ss_pred HhccCCC
Q 005572 680 LKDIRPS 686 (690)
Q Consensus 680 L~~i~~~ 686 (690)
+++++..
T Consensus 292 ~~~~~~~ 298 (330)
T cd07834 292 LAQLHDP 298 (330)
T ss_pred HHhhccc
Confidence 6665544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.9e-32 Score=277.99 Aligned_cols=238 Identities=18% Similarity=0.154 Sum_probs=179.2
Q ss_pred CCCCceeccCCCccEEEEEc----CCCcEEEEEEeeccC----CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeE
Q 005572 409 FGKESLLAEGRCGPVYRAVL----PGELHVAIKVLDNAK----GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~----~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 479 (690)
|...+.||+|+||.||+++. .++..+|||+++... ....+.+..|++++.++ +||||+++++.+......+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 56678999999999999973 346789999986432 12335678899999999 5999999999999999999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
+||||+++|+|.+++.. ...+++.....++.|+++||.|||+.+++||||||
T Consensus 82 lv~e~~~~~~L~~~~~~----------------------------~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p 133 (288)
T cd05583 82 LILDYVNGGELFTHLYQ----------------------------REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKL 133 (288)
T ss_pred EEEecCCCCcHHHHHhh----------------------------cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence 99999999999999864 23578889999999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc---------------cCcccCCC--CCCCCCcchhhHHHHHHHHhCCCCCCchHH
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN---------------VGERSENE--TCGPESDVYCFGVILMELLTGKRGTDDCVK 622 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~~--~~~~~~DVwSfGvvl~el~tg~~p~~~~~~ 622 (690)
+||+++.++.+||+|||+++..... +||..... ..+.++||||||+++|||++|..||.....
T Consensus 134 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 213 (288)
T cd05583 134 ENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213 (288)
T ss_pred HHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc
Confidence 9999999999999999987653211 23332222 267899999999999999999999853110
Q ss_pred --HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 623 --WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 623 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
.......... .. .+..+...+ ..+.+++.+||+.||++|||+.++.+.|+..
T Consensus 214 ~~~~~~~~~~~~-~~--~~~~~~~~~------~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 214 QNSQSEISRRIL-KS--KPPFPKTMS------AEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred cchHHHHHHHHH-cc--CCCCCcccC------HHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 0111111100 00 011111111 1344566789999999999999888777653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.4e-31 Score=275.69 Aligned_cols=245 Identities=20% Similarity=0.218 Sum_probs=177.1
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
++|+..+.||+|.+|.||+|+. .++..||+|.+..... ...+.+.+|++.+++++||||+++++++...+..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 3677888999999999999995 4688999999864432 233568889999999999999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|++ ++|.+++.... ...+++.....++.||+.||+|||+++++||||||+||+
T Consensus 82 ~~~-~~l~~~~~~~~--------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nil 134 (294)
T PLN00009 82 YLD-LDLKKHMDSSP--------------------------DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLL 134 (294)
T ss_pred ccc-ccHHHHHHhCC--------------------------CCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEE
Confidence 996 58888876411 223577788899999999999999999999999999999
Q ss_pred ecC-CCCceEcCCCcccccccc--------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHH
Q 005572 564 LAE-SLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVR 625 (690)
Q Consensus 564 l~~-~~~~kl~DfGla~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~ 625 (690)
++. ++.+||+|||++...... +||.... ..++.++|||||||++|||+||+.||.... +...
T Consensus 135 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~ 214 (294)
T PLN00009 135 IDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF 214 (294)
T ss_pred EECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 985 567999999998643211 2333322 356789999999999999999999986421 1111
Q ss_pred HHHHh-cCC-C-------Cccccc--cccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 626 KLVKE-GAG-G-------DALDFR--LKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 626 ~~~~~-~~~-~-------~~~~~~--~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+.... +.. . ...+.. .+........ ....+.+++.+|++.+|++||++.++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 215 KIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred HHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 11111 000 0 000000 0000000000 0113456777899999999999999986
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=283.92 Aligned_cols=253 Identities=22% Similarity=0.232 Sum_probs=184.0
Q ss_pred cCHHHHHHHhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEe
Q 005572 397 LTFKDLIAATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCI 473 (690)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 473 (690)
...+++....++|...+.||+|+||.||+|. ..++..||+|+++.... ...+.+.+|++.+++++||||+++++++.
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~ 86 (345)
T cd07877 7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFT 86 (345)
T ss_pred hHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeee
Confidence 4456677788899999999999999999998 56788999999864321 22456778999999999999999999886
Q ss_pred cC------CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 005572 474 AG------KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYL 547 (690)
Q Consensus 474 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yL 547 (690)
.. ...++++|++ +++|.+++.. ..+++..+..++.|+++||+||
T Consensus 87 ~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----------------------------~~l~~~~~~~i~~qi~~aL~~L 136 (345)
T cd07877 87 PARSLEEFNDVYLVTHLM-GADLNNIVKC-----------------------------QKLTDDHVQFLIYQILRGLKYI 136 (345)
T ss_pred ecccccccccEEEEehhc-ccCHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHH
Confidence 43 3467888887 7899888753 2478999999999999999999
Q ss_pred hhcCCCCCCCCCCcEEecCCCCceEcCCCcccccccc-----------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCC
Q 005572 548 HHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN-----------VGERSEN-ETCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 548 H~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~-----------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
|+.+++||||||+||++++++.+||+|||+++..... +||.... ..++.++|||||||++|||++|+.
T Consensus 137 H~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~ 216 (345)
T cd07877 137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216 (345)
T ss_pred HHCCeeecCCChHHEEEcCCCCEEEecccccccccccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999999999999999999998754322 3343322 357889999999999999999999
Q ss_pred CCCch--HHHHHHHHHhcC-CCCcc-----cc-------ccccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHH
Q 005572 616 GTDDC--VKWVRKLVKEGA-GGDAL-----DF-------RLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQ 675 (690)
Q Consensus 616 p~~~~--~~~~~~~~~~~~-~~~~~-----~~-------~~~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~e 675 (690)
||... ............ ..... +. .+......... .-..+.+++..|++.||.+||++.|
T Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e 296 (345)
T cd07877 217 LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296 (345)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHH
Confidence 98641 111111111000 00000 00 00000000000 0113456778899999999999999
Q ss_pred HHHH
Q 005572 676 VLGL 679 (690)
Q Consensus 676 v~~~ 679 (690)
+++.
T Consensus 297 ~l~h 300 (345)
T cd07877 297 ALAH 300 (345)
T ss_pred HhcC
Confidence 8753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=271.77 Aligned_cols=234 Identities=21% Similarity=0.239 Sum_probs=176.0
Q ss_pred cCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccC-----CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAK-----GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
+|...+.||+|+||.||+++.. .+..+++|.++... .....++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4667789999999999999843 34456666654321 12334567789999999999999999999999999999
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
+||+++++|.+++.... .....+++.++..++.|+++||.|||+.+++|+||||+|
T Consensus 81 ~e~~~~~~l~~~~~~~~------------------------~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~n 136 (260)
T cd08222 81 TEYCEGRDLDCKLEELK------------------------HTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKN 136 (260)
T ss_pred EEeCCCCCHHHHHHHHh------------------------hcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhh
Confidence 99999999999987521 123468999999999999999999999999999999999
Q ss_pred EEecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHH
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVR 625 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~ 625 (690)
|++++ +.+||+|||+++..... +||......++.++||||||+++|||++|..||..... ...
T Consensus 137 ili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~ 215 (260)
T cd08222 137 IFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVL 215 (260)
T ss_pred eEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence 99975 56999999987653221 33433334667899999999999999999999865221 111
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... .+. .+..+... -..+.+++.+||+.+|++||++.|+++
T Consensus 216 ~~~-~~~-----~~~~~~~~------~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 216 RIV-EGP-----TPSLPETY------SRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred HHH-cCC-----CCCCcchh------cHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 111 111 11111111 124456777899999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=283.13 Aligned_cols=242 Identities=20% Similarity=0.208 Sum_probs=176.8
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecC----------
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG---------- 475 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~---------- 475 (690)
.+|...+.||+|+||.||+|. ..++..||+|.+........+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 578888999999999999998 456889999999766555567788999999999999999999876653
Q ss_pred ----CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC
Q 005572 476 ----KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG 551 (690)
Q Consensus 476 ----~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~ 551 (690)
...++|+||++ ++|.+++.. ..+++..+..++.|+++||.|||+.+
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~~-----------------------------~~l~~~~~~~~~~qi~~aL~~LH~~g 134 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLEQ-----------------------------GPLSEEHARLFMYQLLRGLKYIHSAN 134 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHHc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35789999997 599888753 24788899999999999999999999
Q ss_pred CCCCCCCCCcEEec-CCCCceEcCCCccccccc-------------c----cCcccC-CCCCCCCCcchhhHHHHHHHHh
Q 005572 552 STHGHLVTSSILLA-ESLEPKIAGFGLRNIGVK-------------N----VGERSE-NETCGPESDVYCFGVILMELLT 612 (690)
Q Consensus 552 ~iHrDlk~~NiLl~-~~~~~kl~DfGla~~~~~-------------~----~~e~~~-~~~~~~~~DVwSfGvvl~el~t 612 (690)
++||||||+||+++ +++.+|++|||+++.... . +||... ...++.++|||||||++|||++
T Consensus 135 ivH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~ 214 (342)
T cd07854 135 VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 214 (342)
T ss_pred cccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHh
Confidence 99999999999998 456789999999864311 1 334322 1357789999999999999999
Q ss_pred CCCCCCchHH--HHHHHHHhcCCCC---------ccccccc---cCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCH
Q 005572 613 GKRGTDDCVK--WVRKLVKEGAGGD---------ALDFRLK---LGSGDSVAE-----MVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 613 g~~p~~~~~~--~~~~~~~~~~~~~---------~~~~~~~---~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
|+.||..... ............. ....... ........+ ..++.+++.+||+.||++|||+
T Consensus 215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 294 (342)
T cd07854 215 GKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTA 294 (342)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCH
Confidence 9999964211 1111111000000 0000000 000001111 1234567788999999999999
Q ss_pred HHHHH
Q 005572 674 QQVLG 678 (690)
Q Consensus 674 ~ev~~ 678 (690)
.|+++
T Consensus 295 ~ell~ 299 (342)
T cd07854 295 EEALM 299 (342)
T ss_pred HHHhC
Confidence 99984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=280.38 Aligned_cols=247 Identities=23% Similarity=0.253 Sum_probs=180.4
Q ss_pred HHHhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEec-CCee
Q 005572 403 IAATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIA-GKEK 478 (690)
Q Consensus 403 ~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~ 478 (690)
...+++|...+.||+|+||.||++. ..++..||+|++.... ....+.+.+|+++++.++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 3456789999999999999999998 5578899999885432 2234677889999999999999999999876 5578
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++|+||+ +++|.++++. ..+++.....++.|+++||.|||+.+++|||||
T Consensus 86 ~lv~e~~-~~~L~~~~~~-----------------------------~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~ 135 (328)
T cd07856 86 YFVTELL-GTDLHRLLTS-----------------------------RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK 135 (328)
T ss_pred EEEeehh-ccCHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 8999999 5689888864 246777888899999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc-----------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HH
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN-----------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVK--WV 624 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~-----------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~ 624 (690)
|+||++++++.+||+|||++...... +||.... ..++.++|||||||++|||+||+.||..... ..
T Consensus 136 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~ 215 (328)
T cd07856 136 PSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQF 215 (328)
T ss_pred HHHEeECCCCCEEeCccccccccCCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999988643221 3444322 3578899999999999999999999864111 00
Q ss_pred HHHHHh-cC----------CCCccc--cccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 625 RKLVKE-GA----------GGDALD--FRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 625 ~~~~~~-~~----------~~~~~~--~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
...... +. .....+ ............+ ...+.+++.+||+.+|++|||+.|++..
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 216 SIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred HHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 00 000000 0000000001111 1245567778999999999999999765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=271.83 Aligned_cols=242 Identities=22% Similarity=0.222 Sum_probs=181.0
Q ss_pred CCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
|+..+.||+|.||.||+|+. .++..+|+|.+.... ....+.+..|++.+++++|+||+++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 44567899999999999995 458899999997543 233467788999999999999999999999999999999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
+ ++|.+++... ...+++..+..++.|+++||+|||+.+++||||+|+||+++
T Consensus 81 ~-~~l~~~i~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~ 132 (282)
T cd07829 81 D-MDLKKYLDKR---------------------------PGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILIN 132 (282)
T ss_pred C-cCHHHHHHhh---------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEc
Confidence 7 5999999761 13588999999999999999999999999999999999999
Q ss_pred CCCCceEcCCCcccccccc--------------cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCchH--HHHHHHH
Q 005572 566 ESLEPKIAGFGLRNIGVKN--------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKLV 628 (690)
Q Consensus 566 ~~~~~kl~DfGla~~~~~~--------------~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~~~~~~~ 628 (690)
+++.+||+|||+++..... +||..... .++.++|||||||++|||++|+.||.... .......
T Consensus 133 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 212 (282)
T cd07829 133 RDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212 (282)
T ss_pred CCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 9999999999997643221 34433333 67889999999999999999999986411 1111111
Q ss_pred HhcCC---------CCc--cccccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 629 KEGAG---------GDA--LDFRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 629 ~~~~~---------~~~--~~~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..... ... .+...+........+ -..+.+++..||+.||++||++.|++.
T Consensus 213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 213 QILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred HHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 10000 000 000010000000100 124667788899999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-32 Score=298.77 Aligned_cols=187 Identities=17% Similarity=0.184 Sum_probs=144.7
Q ss_pred hccCCCCceeccCCCccEEEEEcCC--CcEEEEEEee---------------c--cCCCCHHHHHHHHHHHHhcCCCCcc
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPG--ELHVAIKVLD---------------N--AKGIDHDDAVAMFDELSRLKHPNLL 466 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~---------------~--~~~~~~~~~~~e~~~l~~l~H~niv 466 (690)
..+|.+.+.||+|+||.||+|.... +...++|.+. . ........+.+|++++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987432 2222222110 0 0111234578899999999999999
Q ss_pred ceeeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 005572 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAY 546 (690)
Q Consensus 467 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~y 546 (690)
++++++...+..|+|+|++. ++|.+++..... .........+...++.|++.||+|
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~-----------------------~~~~~~~~~~~~~i~~ql~~aL~y 282 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYD-FDLYSFMYDEAF-----------------------DWKDRPLLKQTRAIMKQLLCAVEY 282 (501)
T ss_pred cEeEEEEECCeeEEEEeccc-cCHHHHHhhccc-----------------------cccccccHHHHHHHHHHHHHHHHH
Confidence 99999999999999999995 588888764210 001123355677899999999999
Q ss_pred hhhcCCCCCCCCCCcEEecCCCCceEcCCCcccccccc---------------cCcccCCCCCCCCCcchhhHHHHHHHH
Q 005572 547 LHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELL 611 (690)
Q Consensus 547 LH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvvl~el~ 611 (690)
||+++|+||||||+|||++.++.+||+|||+++..... +||......++.++|||||||++|||+
T Consensus 283 LH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 362 (501)
T PHA03210 283 IHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362 (501)
T ss_pred HHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999998643211 455555567889999999999999999
Q ss_pred hCCCC
Q 005572 612 TGKRG 616 (690)
Q Consensus 612 tg~~p 616 (690)
+|..+
T Consensus 363 ~~~~~ 367 (501)
T PHA03210 363 SHDFC 367 (501)
T ss_pred HCCCC
Confidence 98754
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-31 Score=280.55 Aligned_cols=238 Identities=21% Similarity=0.210 Sum_probs=175.1
Q ss_pred CceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCC--------------HHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 005572 412 ESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGID--------------HDDAVAMFDELSRLKHPNLLPLAGYCIAGK 476 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~--------------~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 476 (690)
.+.||+|+||.||+|. ..++..||+|.+....... ...+.+|++.++.++||||+++++++...+
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 4679999999999998 4568899999986432211 124678999999999999999999999999
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..++||||++ |+|.+++.. ...+++.....++.|++.||+|||+.+++|||
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~----------------------------~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDR----------------------------KIRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred cEEEEEeccc-cCHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 9999999997 699999864 23578889999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccc--------------c--------------ccCcccCC-CCCCCCCcchhhHHHH
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGV--------------K--------------NVGERSEN-ETCGPESDVYCFGVIL 607 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~--------------~--------------~~~e~~~~-~~~~~~~DVwSfGvvl 607 (690)
|||+||+++.++.+||+|||+++... . .+||...+ ..++.++|||||||++
T Consensus 145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF 224 (335)
T ss_pred ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence 99999999999999999999886543 0 02333322 2467899999999999
Q ss_pred HHHHhCCCCCCchHH--HHHHHHHhcC-CCC-----ccc---c-ccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCC
Q 005572 608 MELLTGKRGTDDCVK--WVRKLVKEGA-GGD-----ALD---F-RLKLGSGDSVAE-----MVESLRVGYLCTADSPGKR 670 (690)
Q Consensus 608 ~el~tg~~p~~~~~~--~~~~~~~~~~-~~~-----~~~---~-~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~R 670 (690)
|||++|+.||..... .......... ... ..+ . ......+....+ ...+.+++..||+.+|++|
T Consensus 225 ~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 225 AELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence 999999999865221 1111111100 000 000 0 000000000000 1235577888999999999
Q ss_pred CCHHHHHH
Q 005572 671 PTMQQVLG 678 (690)
Q Consensus 671 Pt~~ev~~ 678 (690)
|++.|++.
T Consensus 305 ~s~~~~l~ 312 (335)
T PTZ00024 305 ISAKEALK 312 (335)
T ss_pred cCHHHHhc
Confidence 99999986
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=277.77 Aligned_cols=245 Identities=21% Similarity=0.198 Sum_probs=177.7
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK------ 476 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 476 (690)
.++|...+.||+|+||.||+|+. .++..+|+|++..... .....+.+|++.+++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 35788889999999999999994 5678999999864432 22346788999999999999999999876533
Q ss_pred --eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCC
Q 005572 477 --EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTH 554 (690)
Q Consensus 477 --~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iH 554 (690)
..++|+||+.. ++...+.. ....+++.++..++.|+++||.|||+.+++|
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~---------------------------~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H 138 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN---------------------------PSVKLTESQIKCYMLQLLEGINYLHENHILH 138 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc---------------------------cccCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 46899999965 77777754 1235889999999999999999999999999
Q ss_pred CCCCCCcEEecCCCCceEcCCCcccccccc---------------------cCcccCC-----CCCCCCCcchhhHHHHH
Q 005572 555 GHLVTSSILLAESLEPKIAGFGLRNIGVKN---------------------VGERSEN-----ETCGPESDVYCFGVILM 608 (690)
Q Consensus 555 rDlk~~NiLl~~~~~~kl~DfGla~~~~~~---------------------~~e~~~~-----~~~~~~~DVwSfGvvl~ 608 (690)
|||||+||++++++.+||+|||+++..... ..|.+|| ..++.++|||||||++|
T Consensus 139 ~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~ 218 (311)
T cd07866 139 RDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFA 218 (311)
T ss_pred CCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHH
Confidence 999999999999999999999998643211 1133333 24788999999999999
Q ss_pred HHHhCCCCCCchHH--HHHHHHHhcCC------------CCccccccccCCCCCHHH-----HHHHHHHHhhhcCCCCCC
Q 005572 609 ELLTGKRGTDDCVK--WVRKLVKEGAG------------GDALDFRLKLGSGDSVAE-----MVESLRVGYLCTADSPGK 669 (690)
Q Consensus 609 el~tg~~p~~~~~~--~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~ 669 (690)
||++|++||..... ........... ....+............+ ...+.+++.+|++.||++
T Consensus 219 el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~ 298 (311)
T cd07866 219 EMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYK 298 (311)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCccc
Confidence 99999999865211 11111111000 000000000001111111 124567788899999999
Q ss_pred CCCHHHHHH
Q 005572 670 RPTMQQVLG 678 (690)
Q Consensus 670 RPt~~ev~~ 678 (690)
|||+.|++.
T Consensus 299 R~t~~ell~ 307 (311)
T cd07866 299 RLTASDALE 307 (311)
T ss_pred CcCHHHHhc
Confidence 999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=258.47 Aligned_cols=188 Identities=24% Similarity=0.286 Sum_probs=156.2
Q ss_pred ccCCCCceeccCCCccEEEEEc-C--C--CcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEec-CCee
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-P--G--ELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIA-GKEK 478 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~--~--~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~-~~~~ 478 (690)
..|+....||+|.||.||++.- + + ...+|+|+++..+. .-.....+|+..++.++||||+.|..++.+ ....
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 4678889999999999999962 2 2 23799999976643 224568899999999999999999999988 6688
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++++||.+. ||.+.++-.+.. ....++.....+|..||..|+.|||++-++|||||
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~-----------------------~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLK 159 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRAS-----------------------KAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLK 159 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccc-----------------------hhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCC
Confidence 999999987 999999864321 12468888999999999999999999999999999
Q ss_pred CCcEEecCC----CCceEcCCCcccccccc-------------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCC
Q 005572 559 TSSILLAES----LEPKIAGFGLRNIGVKN-------------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRG 616 (690)
Q Consensus 559 ~~NiLl~~~----~~~kl~DfGla~~~~~~-------------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p 616 (690)
|.|||+..+ |.+||+|||+++..... ..|++|| ..|+++.||||.||++.||+|-++-
T Consensus 160 PaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~Pl 239 (438)
T KOG0666|consen 160 PANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPL 239 (438)
T ss_pred cceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcc
Confidence 999999877 99999999999976543 1244443 3799999999999999999998776
Q ss_pred CC
Q 005572 617 TD 618 (690)
Q Consensus 617 ~~ 618 (690)
|.
T Consensus 240 F~ 241 (438)
T KOG0666|consen 240 FK 241 (438)
T ss_pred cc
Confidence 54
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-31 Score=271.80 Aligned_cols=231 Identities=17% Similarity=0.182 Sum_probs=175.3
Q ss_pred cCCCCceeccCCCccEEEEEc----CCCcEEEEEEeeccCC----CCHHHHHHHHHHHHhc-CCCCccceeeEEecCCee
Q 005572 408 HFGKESLLAEGRCGPVYRAVL----PGELHVAIKVLDNAKG----IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~l~~~~~----~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 478 (690)
+|+..+.||+|+||.||+++. .++..||+|+++.... ...+.+..|++++.++ +|+||+++++++......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 366778999999999999984 3678999999865321 2335678899999999 599999999999998899
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
++|+||+++|+|.+++.. ...+++.....++.|+++||.|||+.+++|||||
T Consensus 81 ~lv~e~~~~~~L~~~l~~----------------------------~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~ 132 (290)
T cd05613 81 HLILDYINGGELFTHLSQ----------------------------RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIK 132 (290)
T ss_pred EEEEecCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence 999999999999999975 2347788889999999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc---------------cCcccCC--CCCCCCCcchhhHHHHHHHHhCCCCCCch-
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN---------------VGERSEN--ETCGPESDVYCFGVILMELLTGKRGTDDC- 620 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~--~~~~~~~DVwSfGvvl~el~tg~~p~~~~- 620 (690)
|+|||++.++.+||+|||+++..... +||.... ..++.++||||||+++|||++|+.||...
T Consensus 133 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 212 (290)
T cd05613 133 LENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212 (290)
T ss_pred HHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCC
Confidence 99999999999999999998653221 2333321 24577899999999999999999998531
Q ss_pred ----HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC-----CHHHHHH
Q 005572 621 ----VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 621 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP-----t~~ev~~ 678 (690)
........... .+..+...+ ..+.+++.+||+.||++|| ++.+++.
T Consensus 213 ~~~~~~~~~~~~~~~------~~~~~~~~~------~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 213 EKNSQAEISRRILKS------EPPYPQEMS------ALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ccccHHHHHHHhhcc------CCCCCccCC------HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 11111111111 011111111 1344566779999999997 6666654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-33 Score=261.39 Aligned_cols=239 Identities=18% Similarity=0.232 Sum_probs=174.1
Q ss_pred CceeccCCCccEEEEE-cCCCcEEEEEEeeccCC-CCHHHHHHHHHH-HHhcCCCCccceeeEEecCCeeEEEEEecCCC
Q 005572 412 ESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG-IDHDDAVAMFDE-LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANG 488 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~e~~~-l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 488 (690)
...||.|+||.|+|-. .+.|+..|||+++.... .+++++..|.+. ++.-+.||||+++|.+...+..||.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~- 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI- 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh-
Confidence 4679999999999998 56799999999975543 455667778776 4555799999999999999999999999964
Q ss_pred CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCCCCCCCCCCcEEecCC
Q 005572 489 DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSSILLAES 567 (690)
Q Consensus 489 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~iHrDlk~~NiLl~~~ 567 (690)
||+.+-+.- +......+++.-.-.|+..+.+||.||-+ ..|||||+||+|||+|..
T Consensus 148 SlDklYk~v-----------------------y~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~ 204 (361)
T KOG1006|consen 148 SLDKLYKRV-----------------------YSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRH 204 (361)
T ss_pred hHHHHHHHH-----------------------HHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecC
Confidence 776554320 00113456777777788888999999976 588999999999999999
Q ss_pred CCceEcCCCcccccccc---------cCcccCCC------CCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcC
Q 005572 568 LEPKIAGFGLRNIGVKN---------VGERSENE------TCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGA 632 (690)
Q Consensus 568 ~~~kl~DfGla~~~~~~---------~~e~~~~~------~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~ 632 (690)
|.+|+||||++.....+ .||.+||. .|+-+|||||+|++|||+.||+.||........++.+-..
T Consensus 205 G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~ 284 (361)
T KOG1006|consen 205 GDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI 284 (361)
T ss_pred CCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc
Confidence 99999999997665433 34444442 4888999999999999999999999864433333222211
Q ss_pred CCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 633 GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 633 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
. |+...........--..+.+++-.|+-+|-..||...++.+
T Consensus 285 g----dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 285 G----DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred C----CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 1 11111111111112223445556699999999999998865
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-32 Score=285.17 Aligned_cols=183 Identities=22% Similarity=0.268 Sum_probs=157.1
Q ss_pred CceeccCCCccEEEEE-cCCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecC------CeeEEEEE
Q 005572 412 ESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG------KEKLVLLE 483 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~lv~e 483 (690)
.+.||+|+||.||+|+ ..+|..||||.++... ....+...+|+++|++++|||||+++++-++. ....+|||
T Consensus 18 ~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmE 97 (732)
T KOG4250|consen 18 DERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVME 97 (732)
T ss_pred hhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEe
Confidence 4679999999999999 7789999999997643 34567788999999999999999999986653 36789999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
||.+|||+..|.+. .+...|++.+.+.+..+++.||.|||+++|+||||||.||+
T Consensus 98 yC~gGsL~~~L~~P-------------------------EN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIv 152 (732)
T KOG4250|consen 98 YCSGGSLRKVLNSP-------------------------ENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIV 152 (732)
T ss_pred ecCCCcHHHHhcCc-------------------------ccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEE
Confidence 99999999999862 13456999999999999999999999999999999999999
Q ss_pred ec--CCCC--ceEcCCCcccccccc-------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 564 LA--ESLE--PKIAGFGLRNIGVKN-------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 564 l~--~~~~--~kl~DfGla~~~~~~-------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
+- .+|+ -||+|||.|+...++ +|+...+ ..|+.-+|.|||||++||++||..||..
T Consensus 153 l~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p 226 (732)
T KOG4250|consen 153 LQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP 226 (732)
T ss_pred EeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence 83 4444 699999999977654 5666664 6788999999999999999999999864
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=271.81 Aligned_cols=231 Identities=21% Similarity=0.284 Sum_probs=181.3
Q ss_pred cCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK---GIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 482 (690)
+|...+.||+|+||.||+|+. .++..+|+|++.... ....+.+.+|.+++++++ ||||+++++++...+..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 577788999999999999995 468899999986532 123456788999999998 999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+++|+||+|+||
T Consensus 82 e~~~~~~L~~~l~~----------------------------~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni 133 (280)
T cd05581 82 EYAPNGELLQYIRK----------------------------YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENI 133 (280)
T ss_pred cCCCCCcHHHHHHH----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence 99999999999975 23589999999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc----------------------------------cCcccCCCCCCCCCcchhhHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN----------------------------------VGERSENETCGPESDVYCFGVILM 608 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~----------------------------------~~e~~~~~~~~~~~DVwSfGvvl~ 608 (690)
+++.++.++++|||++...... +||......++.++||||||+++|
T Consensus 134 ~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~ 213 (280)
T cd05581 134 LLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIY 213 (280)
T ss_pred EECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHH
Confidence 9999999999999987643221 233333345677999999999999
Q ss_pred HHHhCCCCCCchHHHHH-HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH----HHHHH
Q 005572 609 ELLTGKRGTDDCVKWVR-KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM----QQVLG 678 (690)
Q Consensus 609 el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~----~ev~~ 678 (690)
|+++|+.||.....+.. ...... ...++... -..+.+++.+||+.+|++||++ +|+++
T Consensus 214 ~l~~g~~p~~~~~~~~~~~~~~~~------~~~~~~~~------~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 214 QMLTGKPPFRGSNEYLTFQKILKL------EYSFPPNF------PPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred HHHhCCCCCCCccHHHHHHHHHhc------CCCCCCcc------CHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 99999999976432221 111111 01111111 1134566778999999999999 77654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-31 Score=278.55 Aligned_cols=242 Identities=21% Similarity=0.220 Sum_probs=177.9
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCC------
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK------ 476 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------ 476 (690)
.++|+..+.||+|+||.||+|. ..++..||||++..... ...+.+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH 93 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence 4578888999999999999998 56788999999854321 22356788999999999999999999987643
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+++|||
T Consensus 94 ~~~lv~e~~-~~~l~~~~~~-----------------------------~~l~~~~~~~i~~qi~~al~~LH~~gi~H~d 143 (343)
T cd07880 94 DFYLVMPFM-GTDLGKLMKH-----------------------------EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRD 143 (343)
T ss_pred eEEEEEecC-CCCHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 358999999 6799888753 3578899999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc-----------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCchH--H
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN-----------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--K 622 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~-----------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~~--~ 622 (690)
|||+||++++++.+|++|||++...... +||.... ..++.++|||||||++||+++|+.||.... .
T Consensus 144 lkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 223 (343)
T cd07880 144 LKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD 223 (343)
T ss_pred CCHHHEEEcCCCCEEEeecccccccccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999999999999999999998754322 2333322 347789999999999999999999987521 1
Q ss_pred HHHHHHHhcCC-CCccc------------cccccCCCCCHHH-----HHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005572 623 WVRKLVKEGAG-GDALD------------FRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVL 677 (690)
Q Consensus 623 ~~~~~~~~~~~-~~~~~------------~~~~~~~~~~~~~-----~~~~~~l~~~C~~~dP~~RPt~~ev~ 677 (690)
........... ...+. ..++......... ...+.+++.+|++.||++|||+.+++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 224 QLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred HHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 11111111000 00000 0000000000000 11355777889999999999999998
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=282.08 Aligned_cols=227 Identities=22% Similarity=0.290 Sum_probs=175.5
Q ss_pred ceeccCCCccEEEEEc-CCCcEEEEEEeecc----CCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCe--eEEEEEec
Q 005572 413 SLLAEGRCGPVYRAVL-PGELHVAIKVLDNA----KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKE--KLVLLEFM 485 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~--~~lv~e~~ 485 (690)
.+||+|+|-+||||.. .+|..||.-.++.. .....+.+..|++.|+.|+|||||+++.++.+... .-+|+|.|
T Consensus 46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~ 125 (632)
T KOG0584|consen 46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF 125 (632)
T ss_pred hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence 4699999999999985 45778885443221 12334779999999999999999999999987654 66899999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC--CCCCCCCCCcEE
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG--STHGHLVTSSIL 563 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~--~iHrDlk~~NiL 563 (690)
..|+|+.|+++. +.++.....+|++||.+||.|||++. |||||||..||+
T Consensus 126 TSGtLr~Y~kk~----------------------------~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIF 177 (632)
T KOG0584|consen 126 TSGTLREYRKKH----------------------------RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIF 177 (632)
T ss_pred cCCcHHHHHHHh----------------------------ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEE
Confidence 999999999873 45778899999999999999999985 569999999999
Q ss_pred ecC-CCCceEcCCCcccccccc------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH--HHHH
Q 005572 564 LAE-SLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV--RKLV 628 (690)
Q Consensus 564 l~~-~~~~kl~DfGla~~~~~~------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~--~~~~ 628 (690)
|+. -|.+||+|.|||...... |||.. ++.|.+.+||||||++++||+|+..||.+|...+ .+.+
T Consensus 178 inG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmY-EE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV 256 (632)
T KOG0584|consen 178 VNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMY-EENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV 256 (632)
T ss_pred EcCCcCceeecchhHHHHhhccccceeccCccccChHHH-hhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH
Confidence 985 589999999998765433 45543 3689999999999999999999999999865432 2333
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
..|... ..+..-... ++.+++.+|+.. .++|||+.|++..
T Consensus 257 ~SGiKP----~sl~kV~dP------evr~fIekCl~~-~~~R~sa~eLL~d 296 (632)
T KOG0584|consen 257 TSGIKP----AALSKVKDP------EVREFIEKCLAT-KSERLSAKELLKD 296 (632)
T ss_pred HcCCCH----HHhhccCCH------HHHHHHHHHhcC-chhccCHHHHhhC
Confidence 222211 111111111 344555679999 8999999999863
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=297.37 Aligned_cols=239 Identities=21% Similarity=0.237 Sum_probs=169.3
Q ss_pred HHhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC-CCCHHHHHHHHHHHHhcCCCCccceeeEEecC------
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK-GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG------ 475 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------ 475 (690)
+-..+|++...||+|+||.||+++ .-||..+|||+|.... ......+.+|+..+++++|||||+++..+.+.
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 344578888999999999999999 5678899999996542 23345688999999999999999998622110
Q ss_pred --------------------------------------------------------------------------------
Q 005572 476 -------------------------------------------------------------------------------- 475 (690)
Q Consensus 476 -------------------------------------------------------------------------------- 475 (690)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ---------------------------------CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 005572 476 ---------------------------------KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522 (690)
Q Consensus 476 ---------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 522 (690)
..+||-||||+.-.+++++++...
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~----------------------- 692 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHF----------------------- 692 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhccc-----------------------
Confidence 124667777777666666654210
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCccccccc---c---------------
Q 005572 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK---N--------------- 584 (690)
Q Consensus 523 ~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~---~--------------- 584 (690)
.+ .-....+++++|++||.|+|++++|||||||.||++|++..+||+|||+|..... .
T Consensus 693 ~~----~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~ 768 (1351)
T KOG1035|consen 693 NS----QRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSN 768 (1351)
T ss_pred ch----hhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCC
Confidence 00 2335567999999999999999999999999999999999999999999976210 0
Q ss_pred --------------cCcccCCC---CCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcCCCCccccccccCCCC
Q 005572 585 --------------VGERSENE---TCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGD 647 (690)
Q Consensus 585 --------------~~e~~~~~---~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 647 (690)
+||..... .|+.|+|+||+|||++||+. ||..--+ ....+..-. +..++....-
T Consensus 769 ~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-Ra~iL~~LR-----~g~iP~~~~f 839 (1351)
T KOG1035|consen 769 DGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-RASILTNLR-----KGSIPEPADF 839 (1351)
T ss_pred CcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHH-HHHHHHhcc-----cCCCCCCccc
Confidence 44443332 58999999999999999987 5543111 111222111 1122221111
Q ss_pred CHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 648 SVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 648 ~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
...++..-.+++.++++.||.+|||+.|++.
T Consensus 840 ~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 840 FDPEHPEEASLIRWLLSHDPSKRPTATELLN 870 (1351)
T ss_pred ccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence 2233334456777899999999999999985
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=274.82 Aligned_cols=183 Identities=26% Similarity=0.264 Sum_probs=148.5
Q ss_pred cCCCCceeccCCCccEEEEEc-CC--CcEEEEEEeeccC--CCCHHHHHHHHHHHHhc-CCCCccceeeEEecC----Ce
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PG--ELHVAIKVLDNAK--GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAG----KE 477 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~-~~--~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~----~~ 477 (690)
+|...+.||+|+||.||+++. .. +..+|+|.+.... ....+.+.+|+++++++ +||||+++++++... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 366678899999999999994 34 6789999986432 12245678899999999 599999999976532 35
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl 557 (690)
.++++||+. ++|.+++.. ...+++..+..++.|++.||+|||+.+++||||
T Consensus 81 ~~~~~e~~~-~~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dl 131 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS----------------------------GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDL 131 (332)
T ss_pred EEEEEeccc-CCHHHHHhc----------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 788899986 689998864 245889999999999999999999999999999
Q ss_pred CCCcEEecCCCCceEcCCCccccccc--------------ccCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVK--------------NVGERSEN-----ETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 558 k~~NiLl~~~~~~kl~DfGla~~~~~--------------~~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
||+||++++++.+||+|||+++.... ...|.+|+ ..++.++|||||||++|||++|+.||.
T Consensus 132 kp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~ 211 (332)
T cd07857 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFK 211 (332)
T ss_pred CHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCC
Confidence 99999999999999999999864321 11233343 357889999999999999999999986
Q ss_pred c
Q 005572 619 D 619 (690)
Q Consensus 619 ~ 619 (690)
.
T Consensus 212 ~ 212 (332)
T cd07857 212 G 212 (332)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-32 Score=305.73 Aligned_cols=236 Identities=22% Similarity=0.288 Sum_probs=182.0
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
+-+++...+||.|.||.||.|. ..+|...|+|-++... ......+.+|+.++..++|||+|+++|+-...+..+|-|
T Consensus 1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHH
Confidence 3456777899999999999998 7889999999885332 233456889999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
|||++|+|.+.+.. ++..++.....+..|++.|+.|||++|||||||||.||
T Consensus 1314 EyC~~GsLa~ll~~----------------------------gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI 1365 (1509)
T KOG4645|consen 1314 EYCEGGSLASLLEH----------------------------GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANI 1365 (1509)
T ss_pred HHhccCcHHHHHHh----------------------------cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccce
Confidence 99999999999975 23455666667889999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc--------------cCcccCCC-------CCCCCCcchhhHHHHHHHHhCCCCCCchH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN--------------VGERSENE-------TCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~-------~~~~~~DVwSfGvvl~el~tg~~p~~~~~ 621 (690)
+|+.+|.+|.+|||.|...... +-|.+||. ...-+.||||+|||+.||+||++||.++.
T Consensus 1366 ~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1366 LLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred eeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 9999999999999998765443 22444432 34558999999999999999999998744
Q ss_pred -HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 622 -KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 622 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
+|.- +..-+. + -.|.++...+..- .+++-.|++.||++|-++.|+++.
T Consensus 1446 ne~aI-My~V~~-g--h~Pq~P~~ls~~g------~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1446 NEWAI-MYHVAA-G--HKPQIPERLSSEG------RDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred chhHH-HhHHhc-c--CCCCCchhhhHhH------HHHHHHHHhcCchhhhHHHHHHHh
Confidence 3321 111111 1 1222222222222 334446999999999888777654
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=279.23 Aligned_cols=243 Identities=22% Similarity=0.252 Sum_probs=179.0
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCe-----
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKE----- 477 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~----- 477 (690)
.++|...+.||+|+||.||+|+. .++..||+|++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ 93 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence 45788889999999999999995 467899999986432 1233557789999999999999999998876554
Q ss_pred -eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 478 -KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 478 -~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
.++|+||+ +++|.+++.. ..+++.++..++.|+++||+|||+.+++|||
T Consensus 94 ~~~lv~e~~-~~~L~~~~~~-----------------------------~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~d 143 (343)
T cd07851 94 DVYLVTHLM-GADLNNIVKC-----------------------------QKLSDDHIQFLVYQILRGLKYIHSAGIIHRD 143 (343)
T ss_pred cEEEEEecC-CCCHHHHHhc-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCeecCC
Confidence 89999999 5699998863 3588999999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc-----------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCCch--HH
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN-----------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDC--VK 622 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~-----------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~ 622 (690)
|||+||++++++.+||+|||++...... +||.... ..++.++|||||||++|||++|+.||... ..
T Consensus 144 lkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~ 223 (343)
T cd07851 144 LKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223 (343)
T ss_pred CCHHHeEECCCCCEEEccccccccccccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 9999999999999999999998754321 2333222 25678999999999999999999998642 11
Q ss_pred HHHHHHHhcCC-CCcccccc------------ccCCCCCHH-----HHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 623 WVRKLVKEGAG-GDALDFRL------------KLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 623 ~~~~~~~~~~~-~~~~~~~~------------~~~~~~~~~-----~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
........... .+.....+ ......... ....+.+++.+||+.||++|||+.||++
T Consensus 224 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 224 QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 12221111000 00000000 000000000 0124567788899999999999999976
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=253.60 Aligned_cols=184 Identities=23% Similarity=0.327 Sum_probs=155.0
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEe--eccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecC--------C
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVL--DNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG--------K 476 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l--~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~--------~ 476 (690)
.|....+||+|.||+||+++ ..+++.||+|++ ...++.-.....+|+++|..++|+|++.++..|... .
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 45556789999999999999 556778898865 455666677889999999999999999999998642 3
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..|+||++|+. ||.-.|.. ....++..++.+++.++..||.|+|+..|+|||
T Consensus 98 t~ylVf~~ceh-DLaGlLsn---------------------------~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRD 149 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSN---------------------------RKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRD 149 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcC---------------------------ccccccHHHHHHHHHHHHHHHHHHHHhhHHhhc
Confidence 58999999987 99988864 235688999999999999999999999999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc--------------cCcccCC-----CCCCCCCcchhhHHHHHHHHhCCCCC
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSEN-----ETCGPESDVYCFGVILMELLTGKRGT 617 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~-----~~~~~~~DVwSfGvvl~el~tg~~p~ 617 (690)
+||.|+||+.++.+||+|||+++..... .+|+.+| ..|+++.|||.-||++.||+||.+-+
T Consensus 150 mKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspim 229 (376)
T KOG0669|consen 150 MKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIM 229 (376)
T ss_pred ccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccc
Confidence 9999999999999999999999754322 2344433 47899999999999999999999877
Q ss_pred Cc
Q 005572 618 DD 619 (690)
Q Consensus 618 ~~ 619 (690)
..
T Consensus 230 qg 231 (376)
T KOG0669|consen 230 QG 231 (376)
T ss_pred cC
Confidence 64
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=253.70 Aligned_cols=227 Identities=20% Similarity=0.252 Sum_probs=174.9
Q ss_pred ceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeEEec----CCeeEEEEEecC
Q 005572 413 SLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIA----GKEKLVLLEFMA 486 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~----~~~~~lv~e~~~ 486 (690)
.+||-|-.|.|..+. ..+++.+|+|++. +....++|++.--.. .|||||+++++|+. ...+++|||.|+
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~me 142 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECME 142 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeeccc
Confidence 579999999999998 5678899999985 345678888874444 69999999999875 346789999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
||.|++-++++ ....+++.++-.|+.||+.|+.|||+.+|.||||||+|+|...
T Consensus 143 GGeLfsriq~~--------------------------g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~ 196 (400)
T KOG0604|consen 143 GGELFSRIQDR--------------------------GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTT 196 (400)
T ss_pred chHHHHHHHHc--------------------------ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeec
Confidence 99999999873 3456899999999999999999999999999999999999974
Q ss_pred ---CCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc-----hHHHHH
Q 005572 567 ---SLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD-----CVKWVR 625 (690)
Q Consensus 567 ---~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~-----~~~~~~ 625 (690)
|-..|++|||+|+..... +||+...+.|+..+|+||+||++|-|++|.+||.. +..-++
T Consensus 197 t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk 276 (400)
T KOG0604|consen 197 TSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK 276 (400)
T ss_pred CCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHH
Confidence 557999999999876522 45555556899999999999999999999999875 222233
Q ss_pred HHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..+..+.. .++........+ ...+++...+..+|.+|.|+.|++.
T Consensus 277 ~rI~~gqy------~FP~pEWs~VSe--~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 277 RRIRTGQY------EFPEPEWSCVSE--AAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHhhccCc------cCCChhHhHHHH--HHHHHHHHHhcCCchhheeHHHhhc
Confidence 33333221 111111111111 2334566678999999999999875
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=260.01 Aligned_cols=220 Identities=24% Similarity=0.255 Sum_probs=173.5
Q ss_pred eccCCCccEEEEEcC-CCcEEEEEEeeccCCC---CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCH
Q 005572 415 LAEGRCGPVYRAVLP-GELHVAIKVLDNAKGI---DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 415 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
||+|+||.||++... ++..+|+|.++..... ..+.+..|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999954 5889999998754322 345788899999999999999999999999999999999999999
Q ss_pred hhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCc
Q 005572 491 HRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570 (690)
Q Consensus 491 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~ 570 (690)
.+++.. ...+++.....++.|+++|+.|||+.+++|+||+|+||+++.++.+
T Consensus 81 ~~~l~~----------------------------~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~ 132 (250)
T cd05123 81 FSHLSK----------------------------EGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHI 132 (250)
T ss_pred HHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcE
Confidence 999975 2257899999999999999999999999999999999999999999
Q ss_pred eEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHH--HHHHHHHhcCCC
Q 005572 571 KIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRKLVKEGAGG 634 (690)
Q Consensus 571 kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~--~~~~~~~~~~~~ 634 (690)
+|+|||++...... +||.......+.++|+||||+++||+++|+.||..... ....... .
T Consensus 133 ~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~--- 208 (250)
T cd05123 133 KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-D--- 208 (250)
T ss_pred EEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-C---
Confidence 99999987653221 34444445677899999999999999999999865321 1111111 1
Q ss_pred CccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHH
Q 005572 635 DALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQ 675 (690)
Q Consensus 635 ~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~e 675 (690)
...++...+ ..+.+++.+||..||++||++.+
T Consensus 209 ---~~~~~~~~~------~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 209 ---PLRFPEFLS------PEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred ---CCCCCCCCC------HHHHHHHHHHhcCCHhhCCCccc
Confidence 111111111 13345667799999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.3e-31 Score=251.90 Aligned_cols=240 Identities=23% Similarity=0.275 Sum_probs=183.9
Q ss_pred CHHHHHHHhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC-CCCccceeeEEecC
Q 005572 398 TFKDLIAATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAG 475 (690)
Q Consensus 398 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~ 475 (690)
+++|+-.-++ +.||+|+|+.|-.++ +.++..+|||++++.....+....+|++++...+ |+||+.|++++++.
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3455554443 579999999999998 8889999999998876677788999999999986 99999999999999
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
...|+|||-|.||.|...+++ ...+++.++.++..+||.||.|||.+||.||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~----------------------------~~~F~E~EAs~vvkdia~aLdFlH~kgIAHR 200 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQK----------------------------RKHFNEREASRVVKDIASALDFLHTKGIAHR 200 (463)
T ss_pred ceEEEEEecccCchHHHHHHH----------------------------hhhccHHHHHHHHHHHHHHHHHHhhcCcccc
Confidence 999999999999999999987 3468889999999999999999999999999
Q ss_pred CCCCCcEEecCCCC---ceEcCCCcccccccc-----------------cCcccCC---------CCCCCCCcchhhHHH
Q 005572 556 HLVTSSILLAESLE---PKIAGFGLRNIGVKN-----------------VGERSEN---------ETCGPESDVYCFGVI 606 (690)
Q Consensus 556 Dlk~~NiLl~~~~~---~kl~DfGla~~~~~~-----------------~~e~~~~---------~~~~~~~DVwSfGvv 606 (690)
|+||+|||-.+-.. +|||||-++...... +-+++|+ ..|+.++|.||+|||
T Consensus 201 DlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvI 280 (463)
T KOG0607|consen 201 DLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVI 280 (463)
T ss_pred cCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHH
Confidence 99999999865443 899999886432211 2223333 268899999999999
Q ss_pred HHHHHhCCCCCCc----------------hHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCC
Q 005572 607 LMELLTGKRGTDD----------------CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKR 670 (690)
Q Consensus 607 l~el~tg~~p~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~R 670 (690)
+|-|++|.+||.+ +.+...+.++++... ..|.... ..+. +..+++..-+..||.+|
T Consensus 281 lYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYe-FPdkdWa-hIS~------eakdlisnLlvrda~~r 352 (463)
T KOG0607|consen 281 LYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYE-FPDKDWA-HISS------EAKDLISNLLVRDAKQR 352 (463)
T ss_pred HHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCc-CChhhhH-HhhH------HHHHHHHHHHhccHHhh
Confidence 9999999999864 222233333443211 1111110 0011 22344445677899999
Q ss_pred CCHHHHHH
Q 005572 671 PTMQQVLG 678 (690)
Q Consensus 671 Pt~~ev~~ 678 (690)
-++.++++
T Consensus 353 lsa~~vln 360 (463)
T KOG0607|consen 353 LSAAQVLN 360 (463)
T ss_pred hhhhhccC
Confidence 99988876
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=254.21 Aligned_cols=225 Identities=20% Similarity=0.232 Sum_probs=177.6
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHH---HHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDD---AVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~---~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..++||+|.||.|.+++ ..+++.+|+|++++.--..+++ -..|-++|...+||-+..|...+...+.++.||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 456667899999999999998 6678999999998654444444 345677899999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+.||.|+-+|.+ .+.+++.....+...|..||.|||+++||.||+|.+|.
T Consensus 248 eyanGGeLf~HLsr----------------------------er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENL 299 (516)
T KOG0690|consen 248 EYANGGELFFHLSR----------------------------ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENL 299 (516)
T ss_pred EEccCceEeeehhh----------------------------hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhh
Confidence 99999999988865 34577777788899999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc-hHHHHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD-CVKWVRKL 627 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~-~~~~~~~~ 627 (690)
|+|.+|.+||+|||+++..... +||+.....|+.++|.|..|||+|||++|+.||.. ..+...++
T Consensus 300 lLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL 379 (516)
T KOG0690|consen 300 LLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL 379 (516)
T ss_pred eeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH
Confidence 9999999999999998753321 67777778999999999999999999999999975 22222233
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCC
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP 671 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RP 671 (690)
+... +.+++...+.....++. ..+..||.+|-
T Consensus 380 Il~e------d~kFPr~ls~eAktLLs------GLL~kdP~kRL 411 (516)
T KOG0690|consen 380 ILME------DLKFPRTLSPEAKTLLS------GLLKKDPKKRL 411 (516)
T ss_pred HHhh------hccCCccCCHHHHHHHH------HHhhcChHhhc
Confidence 3222 22222223233333333 35788999994
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=258.82 Aligned_cols=209 Identities=17% Similarity=0.118 Sum_probs=161.2
Q ss_pred CCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHhhhhhc
Q 005572 418 GRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHE 496 (690)
Q Consensus 418 G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 496 (690)
|.||.||+++ ..++..+|+|++.... ...+|...+....||||+++++++...+..++||||+++|+|.+++.+
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 8899999999 5668899999996542 233455555666799999999999999999999999999999999875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCC
Q 005572 497 LPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576 (690)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfG 576 (690)
...+++..+..++.|+++||+|||+.+++||||||+||+++.++.+|++|||
T Consensus 79 ----------------------------~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~ 130 (237)
T cd05576 79 ----------------------------FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS 130 (237)
T ss_pred ----------------------------hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeccc
Confidence 2348899999999999999999999999999999999999999999999999
Q ss_pred ccccccc-----------ccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcCCCCccccccccCC
Q 005572 577 LRNIGVK-----------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGS 645 (690)
Q Consensus 577 la~~~~~-----------~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 645 (690)
.+..... .+||......++.++||||+||++|||++|+.|+....... .......++...
T Consensus 131 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~---------~~~~~~~~~~~~ 201 (237)
T cd05576 131 RWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGI---------NTHTTLNIPEWV 201 (237)
T ss_pred chhccccccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc---------ccccccCCcccC
Confidence 8654322 14444444567889999999999999999998865321100 000011111111
Q ss_pred CCCHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005572 646 GDSVAEMVESLRVGYLCTADSPGKRPTMQ 674 (690)
Q Consensus 646 ~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ 674 (690)
+ ..+.+++.+|++.||++||++.
T Consensus 202 ~------~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 202 S------EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred C------HHHHHHHHHHccCCHHHhcCCC
Confidence 1 1344566779999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=277.31 Aligned_cols=228 Identities=20% Similarity=0.261 Sum_probs=177.2
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEEEEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv~e 483 (690)
+.+|.....+|.|+|+.|-++. ..++...+||++.... .+..+|+.++... +||||+++.+.+.+..+.|+|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 5567777779999999999998 5678889999997652 2334566565555 69999999999999999999999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
++.+|-+.+-+...+ ... ..+..|+.+++.|+.|||++|++||||||+|||
T Consensus 397 ~l~g~ell~ri~~~~----------------------------~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL 447 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKP----------------------------EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNIL 447 (612)
T ss_pred hccccHHHHHHHhcc----------------------------hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhhee
Confidence 999998887776421 122 567789999999999999999999999999999
Q ss_pred e-cCCCCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhc
Q 005572 564 L-AESLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEG 631 (690)
Q Consensus 564 l-~~~~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~ 631 (690)
+ ++.+.++|+|||.++..... |||......|++++|+|||||+||||++|+.||.....- .++...
T Consensus 448 ~~~~~g~lrltyFG~a~~~~~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei~~~- 525 (612)
T KOG0603|consen 448 LDGSAGHLRLTYFGFWSELERSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEIHTR- 525 (612)
T ss_pred ecCCCCcEEEEEechhhhCchhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHHHHh-
Confidence 9 58999999999998765432 677777789999999999999999999999998753221 111111
Q ss_pred CCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+-.+......++..++++. .|++.||.+||+|.++..
T Consensus 526 ----i~~~~~s~~vS~~AKdLl~------~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 526 ----IQMPKFSECVSDEAKDLLQ------QLLQVDPALRLGADEIGA 562 (612)
T ss_pred ----hcCCccccccCHHHHHHHH------HhccCChhhCcChhhhcc
Confidence 1111122333445555555 499999999999999864
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=288.74 Aligned_cols=145 Identities=24% Similarity=0.296 Sum_probs=128.7
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCC---HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGID---HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
.+|.+.+.||+|+||.||+|+. .++..||+|+++...... ...+.+|+.++..++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 4677889999999999999995 468899999997543222 356788999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||+++|+|.++++. ...+++..++.|+.||+.||.|||+++|+||||||+||
T Consensus 84 Ey~~g~~L~~li~~----------------------------~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NI 135 (669)
T cd05610 84 EYLIGGDVKSLLHI----------------------------YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM 135 (669)
T ss_pred eCCCCCCHHHHHHh----------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHE
Confidence 99999999999975 23477888999999999999999999999999999999
Q ss_pred EecCCCCceEcCCCccc
Q 005572 563 LLAESLEPKIAGFGLRN 579 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~ 579 (690)
|++.++.+||+|||+++
T Consensus 136 Ll~~~g~vkL~DFGls~ 152 (669)
T cd05610 136 LISNEGHIKLTDFGLSK 152 (669)
T ss_pred EEcCCCCEEEEeCCCCc
Confidence 99999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=223.25 Aligned_cols=243 Identities=20% Similarity=0.232 Sum_probs=178.7
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeecc--CCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA--KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+|+..++||+|.||+||+|+ +.+++.||+|+++.. .+.-.....+|+-+++.++|.|||+++++..+.....+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45666889999999999999 777899999998644 334457789999999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
|+. +|..|... ..+.++.....+++.|+.+||.|+|++++.|||+||.|.||
T Consensus 83 cdq-dlkkyfds---------------------------lng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli 134 (292)
T KOG0662|consen 83 CDQ-DLKKYFDS---------------------------LNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI 134 (292)
T ss_pred hhH-HHHHHHHh---------------------------cCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe
Confidence 965 88888764 23468888899999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc----------cCcccCC-----CCCCCCCcchhhHHHHHHHHh-CCCCCCc--hHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN----------VGERSEN-----ETCGPESDVYCFGVILMELLT-GKRGTDD--CVKWVRK 626 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~----------~~e~~~~-----~~~~~~~DVwSfGvvl~el~t-g~~p~~~--~~~~~~~ 626 (690)
+.+|+.|++|||+++-.... ..|+.|. .-|++..|+||-||++.|+.. |++-|.+ ..+...+
T Consensus 135 n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkr 214 (292)
T KOG0662|consen 135 NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_pred ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHH
Confidence 99999999999999854322 1233333 357889999999999999987 5554653 3333333
Q ss_pred HHHh-cC--------CCCccccccccCCCC--CHHHHHH-----HHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 627 LVKE-GA--------GGDALDFRLKLGSGD--SVAEMVE-----SLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 627 ~~~~-~~--------~~~~~~~~~~~~~~~--~~~~~~~-----~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+... +. .....|+.....++. ...+++- -.++....+.-+|.+|.++++.++
T Consensus 215 if~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 215 IFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred HHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 3322 11 122333333222211 1111110 112333345558999999998875
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-30 Score=258.94 Aligned_cols=189 Identities=21% Similarity=0.212 Sum_probs=163.7
Q ss_pred HhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeecc---CCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA---KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
..+.|..-++||+|+||.||-++ ..+|+.+|.|.+++. +.....-...|-++|.+++.+-||.|-..+++.+.+++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 34567888999999999999998 456889999988543 12334456788899999999999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|+..|.||||.-+|... ....+++...+.+|.+|+.||++||..+||.||+||+
T Consensus 263 VLtlMNGGDLkfHiyn~--------------------------g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPe 316 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNH--------------------------GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPE 316 (591)
T ss_pred EEEeecCCceeEEeecc--------------------------CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChh
Confidence 99999999999888752 2346889999999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|||+|+.|.++|+|.|+|...... |||+..++.|+...|.||+||++|||+.|+.||..
T Consensus 317 NILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~ 388 (591)
T KOG0986|consen 317 NILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQ 388 (591)
T ss_pred heeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhh
Confidence 999999999999999998754432 66666667899999999999999999999999975
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-30 Score=283.67 Aligned_cols=241 Identities=19% Similarity=0.202 Sum_probs=186.6
Q ss_pred HHHHHHhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeec---cCCCCHHHHHHHHHHHHhcCCCCccceeeEEecC
Q 005572 400 KDLIAATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDN---AKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG 475 (690)
Q Consensus 400 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~---~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~ 475 (690)
.++.-..++|.+.++||+|+||.|..++. .++..+|+|++.+ .+..+..-|+.|-.+|.--+.+.|+.++..+.+.
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 45555678899999999999999999995 5688999999976 3334556788899999999999999999999999
Q ss_pred CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
.++|+|||||+||||..+|.+ -+++++..+..++..|.-||.-+|+.|+|||
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk----------------------------~~~~pE~~ArFY~aEiVlAldslH~mgyVHR 199 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSK----------------------------FDRLPEDWARFYTAEIVLALDSLHSMGYVHR 199 (1317)
T ss_pred cceEEEEecccCchHHHHHhh----------------------------cCCChHHHHHHHHHHHHHHHHHHHhccceec
Confidence 999999999999999999976 2357888888999999999999999999999
Q ss_pred CCCCCcEEecCCCCceEcCCCcccccccc-----------cCcccCC---------CCCCCCCcchhhHHHHHHHHhCCC
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVKN-----------VGERSEN---------ETCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 556 Dlk~~NiLl~~~~~~kl~DfGla~~~~~~-----------~~e~~~~---------~~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
||||.|||||.+|.+|++|||-+-....+ +.|+.|+ +.|++.+|.||+||++|||+.|..
T Consensus 200 DiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~T 279 (1317)
T KOG0612|consen 200 DIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGET 279 (1317)
T ss_pred cCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCC
Confidence 99999999999999999999976433211 4455443 478999999999999999999999
Q ss_pred CCCc--hHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC---HHHHHH
Q 005572 616 GTDD--CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT---MQQVLG 678 (690)
Q Consensus 616 p~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt---~~ev~~ 678 (690)
||+. ++.-..++...... +.++-....+...++++..+ --+|+.|-. +.++-.
T Consensus 280 PFYadslveTY~KIm~hk~~---l~FP~~~~VSeeakdLI~~l-------l~~~e~RLgrngiedik~ 337 (1317)
T KOG0612|consen 280 PFYADSLVETYGKIMNHKES---LSFPDETDVSEEAKDLIEAL-------LCDREVRLGRNGIEDIKN 337 (1317)
T ss_pred cchHHHHHHHHHHHhchhhh---cCCCcccccCHHHHHHHHHH-------hcChhhhcccccHHHHHh
Confidence 9974 34433444433221 11111111333555555532 126777776 777643
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=247.83 Aligned_cols=223 Identities=27% Similarity=0.273 Sum_probs=176.2
Q ss_pred CCccEEEEEcC-CCcEEEEEEeeccCCCC-HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHhhhhhc
Q 005572 419 RCGPVYRAVLP-GELHVAIKVLDNAKGID-HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHE 496 (690)
Q Consensus 419 ~~g~Vy~~~~~-~~~~vavK~l~~~~~~~-~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~ 496 (690)
+||.||+|+.. ++..+|+|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999965 48899999997654444 67899999999999999999999999999999999999999999999875
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCC
Q 005572 497 LPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576 (690)
Q Consensus 497 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfG 576 (690)
. ..+++..+..++.++++++.|||+.+++|+||+|+||++++++.++++|||
T Consensus 81 ~----------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~ 132 (244)
T smart00220 81 R----------------------------GRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFG 132 (244)
T ss_pred c----------------------------cCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEcccc
Confidence 1 127889999999999999999999999999999999999999999999999
Q ss_pred cccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCch--HHHHHHHHHhcCCCCcccccc
Q 005572 577 LRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKLVKEGAGGDALDFRL 641 (690)
Q Consensus 577 la~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~ 641 (690)
.+...... +||......++.++||||||+++||+++|..||... .....+........ ...
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~ 208 (244)
T smart00220 133 LARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP----FPP 208 (244)
T ss_pred ceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCC----Ccc
Confidence 98754331 344444457788999999999999999999998651 11122222211110 000
Q ss_pred ccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 642 KLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
... . ....+.+++.+||..+|++||++.++++
T Consensus 209 ~~~--~---~~~~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 209 PEW--K---ISPEAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred ccc--c---CCHHHHHHHHHHccCCchhccCHHHHhh
Confidence 000 0 1124556778899999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=279.92 Aligned_cols=262 Identities=15% Similarity=0.102 Sum_probs=158.5
Q ss_pred HhccCCCCceeccCCCccEEEEEc-CC----CcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeE------Ee
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL-PG----ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY------CI 473 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~----~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~------~~ 473 (690)
..++|...+.||+|+||.||+|+. .+ +..||+|++.... ..+....+ .+....+.+++.++.. +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 456788899999999999999995 44 6889999875422 11111111 1222223333332221 23
Q ss_pred cCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCC
Q 005572 474 AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGST 553 (690)
Q Consensus 474 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~i 553 (690)
.....++||||+++|+|.++++...... ....+.. +...............+..++.|++.||+|||+++|+
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~-~v~~~l~-------~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPY-NVEPYLL-------GKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCch-hHHHHhc-------cchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 4567999999999999999997532100 0000000 0000000111223345667999999999999999999
Q ss_pred CCCCCCCcEEecC-CCCceEcCCCcccccccc-----------cCcccCCC--------------------------CCC
Q 005572 554 HGHLVTSSILLAE-SLEPKIAGFGLRNIGVKN-----------VGERSENE--------------------------TCG 595 (690)
Q Consensus 554 HrDlk~~NiLl~~-~~~~kl~DfGla~~~~~~-----------~~e~~~~~--------------------------~~~ 595 (690)
||||||+|||+++ ++.+||+|||+++..... ..|.+||. .++
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 9999999999995 689999999999743211 22333331 234
Q ss_pred CCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcCCCCcccc--ccccCCCCCHHH--------HHHHHHHHhhhcCC
Q 005572 596 PESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDF--RLKLGSGDSVAE--------MVESLRVGYLCTAD 665 (690)
Q Consensus 596 ~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--------~~~~~~l~~~C~~~ 665 (690)
.++|||||||++|||+++..|++.........+..... +.... ...........+ -....+++.+|++.
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDY-DLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCC-cHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 56799999999999999888776532222222221110 00000 000000000000 01233677789999
Q ss_pred CCCCCCCHHHHHHH
Q 005572 666 SPGKRPTMQQVLGL 679 (690)
Q Consensus 666 dP~~RPt~~ev~~~ 679 (690)
||++|||+.|+++.
T Consensus 437 dP~kR~ta~e~L~H 450 (566)
T PLN03225 437 KGRQRISAKAALAH 450 (566)
T ss_pred CcccCCCHHHHhCC
Confidence 99999999999873
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=250.70 Aligned_cols=245 Identities=20% Similarity=0.253 Sum_probs=185.4
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC-C-C----CccceeeEEecCCee
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-H-P----NLLPLAGYCIAGKEK 478 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H-~----niv~l~g~~~~~~~~ 478 (690)
+.+|.+..++|+|.||.|..+.. ..+..||+|+++... .-.+...-|++++.++. + | -+|.+.+|+.-.++.
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 56788889999999999999984 447899999997654 34466778999999993 2 2 477788888889999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
+||+|.+ |-|+++||+. .+..+++...+..|+.|++++++|||+.+++|-|||
T Consensus 167 Civfell-G~S~~dFlk~--------------------------N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLK 219 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKE--------------------------NNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLK 219 (415)
T ss_pred EEEEecc-ChhHHHHhcc--------------------------CCccccchHHHHHHHHHHHHHHHHHHhcceeecCCC
Confidence 9999999 5599999986 234568888999999999999999999999999999
Q ss_pred CCcEEecC--------------------CCCceEcCCCcccccccc-----------cCcccCCCCCCCCCcchhhHHHH
Q 005572 559 TSSILLAE--------------------SLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVIL 607 (690)
Q Consensus 559 ~~NiLl~~--------------------~~~~kl~DfGla~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvvl 607 (690)
|+|||+.+ +..+||.|||-|....+. |||+..+-.++.++||||+||||
T Consensus 220 PENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL 299 (415)
T KOG0671|consen 220 PENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCIL 299 (415)
T ss_pred hheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEE
Confidence 99999942 245799999999865433 77777777999999999999999
Q ss_pred HHHHhCCCCCCchH-----HHHHHHH--------Hhc-----CCCCcccccc-----------------ccCCCCCHHHH
Q 005572 608 MELLTGKRGTDDCV-----KWVRKLV--------KEG-----AGGDALDFRL-----------------KLGSGDSVAEM 652 (690)
Q Consensus 608 ~el~tg~~p~~~~~-----~~~~~~~--------~~~-----~~~~~~~~~~-----------------~~~~~~~~~~~ 652 (690)
.|++||..-|.... ..+.+++ ... -....+|+.- .......-.+.
T Consensus 300 ~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~ 379 (415)
T KOG0671|consen 300 VELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEH 379 (415)
T ss_pred EEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHH
Confidence 99999998876311 1111111 000 0000111100 00011123455
Q ss_pred HHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 653 VESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 653 ~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
..+++++..++..||.+|+|+.|+++
T Consensus 380 ~~LfDLl~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 380 VQLFDLLRRMLEFDPARRITLREALS 405 (415)
T ss_pred hHHHHHHHHHHccCccccccHHHHhc
Confidence 67889999999999999999999975
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=229.13 Aligned_cols=189 Identities=17% Similarity=0.251 Sum_probs=153.2
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC-CCHHHHHHHHHHH-HhcCCCCccceeeEEecCCeeEEEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG-IDHDDAVAMFDEL-SRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l-~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
.+++.....||+|++|.|-+-+ .++|...|||.++..-. +.+.....|+.+. +....|.+|.++|........+|.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 3444556789999999998887 67899999999965422 3345566777764 4457999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc-CCCCCCCCCCc
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV-GSTHGHLVTSS 561 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~-~~iHrDlk~~N 561 (690)
|.|.. ||+.|-++. +..+..+++...-+||..|.+||.|||++ .+||||+||+|
T Consensus 125 E~M~t-Sldkfy~~v------------------------~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsN 179 (282)
T KOG0984|consen 125 ELMDT-SLDKFYRKV------------------------LKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSN 179 (282)
T ss_pred HHhhh-hHHHHHHHH------------------------HhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcce
Confidence 99965 888776541 12245678888889999999999999986 78899999999
Q ss_pred EEecCCCCceEcCCCcccccccc---------cCcccCC--------CCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN---------VGERSEN--------ETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 562 iLl~~~~~~kl~DfGla~~~~~~---------~~e~~~~--------~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
||++.+|++|+||||++.+..++ .||.+|| ..|+-|+||||+|+.+.||.+++.||+.
T Consensus 180 iLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~ 254 (282)
T KOG0984|consen 180 ILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES 254 (282)
T ss_pred EEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence 99999999999999998765543 3444443 2788899999999999999999999985
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-28 Score=264.62 Aligned_cols=263 Identities=16% Similarity=0.185 Sum_probs=168.1
Q ss_pred HhccCCCCceeccCCCccEEEEEc-----------------CCCcEEEEEEeeccCCCCHHH--------------HHHH
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL-----------------PGELHVAIKVLDNAKGIDHDD--------------AVAM 453 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~~~~vavK~l~~~~~~~~~~--------------~~~e 453 (690)
..++|++.++||+|+||.||+|.. ..+..||||++........++ ...|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999963 234679999986543222222 3345
Q ss_pred HHHHHhcCCCCc-----cceeeEEec--------CCeeEEEEEecCCCCHhhhhhcCCCCCC-CCCCCCCCCCCCCCCCC
Q 005572 454 FDELSRLKHPNL-----LPLAGYCIA--------GKEKLVLLEFMANGDLHRWLHELPTGEP-NVEDWSTDTWDHHPGAG 519 (690)
Q Consensus 454 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~ 519 (690)
+..+.+++|.++ ++++|+|.. .+..++||||+++|+|.++++....... ..+.... .....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~-----~g~~l 297 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMM-----AGKKI 297 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHh-----cCCch
Confidence 666777766554 778888764 3568999999999999999986321100 0000000 00000
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCccccccc-----------ccCcc
Q 005572 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK-----------NVGER 588 (690)
Q Consensus 520 ~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~-----------~~~e~ 588 (690)
........++|..+..++.|+++||.|||+.+++||||||+|||++.++.+||+|||+++.... .+.|.
T Consensus 298 ~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~ 377 (507)
T PLN03224 298 PDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYS 377 (507)
T ss_pred hhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCccee
Confidence 0011234578899999999999999999999999999999999999999999999999864321 12233
Q ss_pred cCCCC------------------------C--CCCCcchhhHHHHHHHHhCCC-CCCchHHHHHHHHHhc--------CC
Q 005572 589 SENET------------------------C--GPESDVYCFGVILMELLTGKR-GTDDCVKWVRKLVKEG--------AG 633 (690)
Q Consensus 589 ~~~~~------------------------~--~~~~DVwSfGvvl~el~tg~~-p~~~~~~~~~~~~~~~--------~~ 633 (690)
+||.. + ..+.||||+||++|||++|.. |+.+......+..... ..
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 33321 1 124799999999999999875 6654211111110000 00
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCC---CCCCCHHHHHH
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSP---GKRPTMQQVLG 678 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP---~~RPt~~ev~~ 678 (690)
....+.......+. ...+++.+++..+| .+|+|+.|+++
T Consensus 458 ~~~~~~~~~d~~s~------~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKYDFSLLDRNKE------AGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCCCcccccccCh------HHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 11112111111111 23455556777655 78999999985
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=265.26 Aligned_cols=246 Identities=21% Similarity=0.284 Sum_probs=191.9
Q ss_pred CHHHHHHHhccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeEEec-
Q 005572 398 TFKDLIAATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIA- 474 (690)
Q Consensus 398 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~- 474 (690)
.++.+.-.+.-|+++++||+|.+|.||+++ .++++.+|+|+++.... ..++++.|.++++.. +|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 344444556678888999999999999999 77888999999976543 346778888888877 59999999999864
Q ss_pred ----CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc
Q 005572 475 ----GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV 550 (690)
Q Consensus 475 ----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~ 550 (690)
++++|+|||||.+||..|+++... +..+.|..+..|++.++.|+.+||..
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~--------------------------g~rl~E~~IaYI~re~lrgl~HLH~n 142 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK--------------------------GNRLKEEWIAYILREILRGLAHLHNN 142 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc--------------------------ccchhhHHHHHHHHHHHHHHHHHhhc
Confidence 568999999999999999998732 45789999999999999999999999
Q ss_pred CCCCCCCCCCcEEecCCCCceEcCCCcccccccc--------------cCccc-----CCCCCCCCCcchhhHHHHHHHH
Q 005572 551 GSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN--------------VGERS-----ENETCGPESDVYCFGVILMELL 611 (690)
Q Consensus 551 ~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~-----~~~~~~~~~DVwSfGvvl~el~ 611 (690)
.++|||||-.|||++.++.+|+.|||++...... +||+. ++..|+.++|+||+|++..||.
T Consensus 143 kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEla 222 (953)
T KOG0587|consen 143 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMA 222 (953)
T ss_pred ceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhc
Confidence 9999999999999999999999999998754322 55543 2346888999999999999999
Q ss_pred hCCCCCCchHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 612 TGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 612 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
-|.+|+.++... +.++. ...-..+.+.. ...=..++-+++..|+..|-++||++.++++
T Consensus 223 dG~PPl~DmHPm-raLF~---IpRNPPPkLkr----p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 223 EGAPPLCDMHPM-RALFL---IPRNPPPKLKR----PKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred CCCCCccCcchh-hhhcc---CCCCCCccccc----hhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 999998775432 11211 11111122211 1122224455666799999999999998875
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7e-29 Score=245.43 Aligned_cols=187 Identities=25% Similarity=0.281 Sum_probs=155.1
Q ss_pred HhccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~ 479 (690)
...+|....+||+|+||.|.++.. .+.+.+|||++++.-- .+.+--..|-++|+-- +-|-+++++.++.+.+.+|
T Consensus 347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy 426 (683)
T KOG0696|consen 347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY 426 (683)
T ss_pred eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence 345788889999999999999984 4577899999975422 2222233455555544 4688999999999999999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~ 559 (690)
.||||+.+|+|...+++ .+++.+..+..+|.+||-||-+||+++||.||||.
T Consensus 427 FVMEyvnGGDLMyhiQQ----------------------------~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKL 478 (683)
T KOG0696|consen 427 FVMEYVNGGDLMYHIQQ----------------------------VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKL 478 (683)
T ss_pred eEEEEecCchhhhHHHH----------------------------hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccc
Confidence 99999999999999986 23466667888999999999999999999999999
Q ss_pred CcEEecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 560 ~NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
.||++|.+|.+||+|||+++..... +||+.....|+..+|.|||||+||||+.|++||+.
T Consensus 479 DNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdG 552 (683)
T KOG0696|consen 479 DNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDG 552 (683)
T ss_pred cceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCC
Confidence 9999999999999999998753211 56666667999999999999999999999999986
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=254.08 Aligned_cols=185 Identities=19% Similarity=0.165 Sum_probs=156.9
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCC---HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGID---HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
+-|..++.||-|+||+|.++. .++...+|.|.+++.+-.. ......|-.+|+..+.+.||+|+..|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 457778899999999999997 6667789999997654222 234677889999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
||++|||+..+|.+ .+.+.+.-+..++.++..|+++.|..|+|||||||.||
T Consensus 709 dYIPGGDmMSLLIr----------------------------mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNI 760 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLIR----------------------------MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 760 (1034)
T ss_pred eccCCccHHHHHHH----------------------------hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccce
Confidence 99999999999976 34577777788888999999999999999999999999
Q ss_pred EecCCCCceEcCCCccccc---------ccc-----------------------------------------------cC
Q 005572 563 LLAESLEPKIAGFGLRNIG---------VKN-----------------------------------------------VG 586 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~---------~~~-----------------------------------------------~~ 586 (690)
|||.+|.+||.||||+.-. ..+ +|
T Consensus 761 LIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiap 840 (1034)
T KOG0608|consen 761 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAP 840 (1034)
T ss_pred EEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccCh
Confidence 9999999999999996421 100 44
Q ss_pred cccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 587 ERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 587 e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|+.....|+.-+|.||.|||||||+.|+.||-.
T Consensus 841 evl~r~g~~q~cdwws~gvil~em~~g~~pf~~ 873 (1034)
T KOG0608|consen 841 EVLARTGYTQLCDWWSVGVILYEMLVGQPPFLA 873 (1034)
T ss_pred HHhcccCccccchhhHhhHHHHHHhhCCCCccC
Confidence 555556788899999999999999999999864
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=245.38 Aligned_cols=234 Identities=24% Similarity=0.285 Sum_probs=172.5
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC-------CCHHHHHHHHHHHHhcCCCCccceeeEEe-cCCeeE
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG-------IDHDDAVAMFDELSRLKHPNLLPLAGYCI-AGKEKL 479 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~g~~~-~~~~~~ 479 (690)
|-...+||+|+|++||++. +...+.||||+-...+. .-.+...+|.++-+.++||.||++++|+. +.+..+
T Consensus 465 YLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFC 544 (775)
T KOG1151|consen 465 YLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFC 544 (775)
T ss_pred HHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccce
Confidence 4445689999999999998 66778999998743321 11245678899999999999999999985 567889
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc--CCCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV--GSTHGHL 557 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~--~~iHrDl 557 (690)
-|+|||+|.||+-||+. ...+++.++.+|+.||+.||.||.+. .|||-||
T Consensus 545 TVLEYceGNDLDFYLKQ----------------------------hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDL 596 (775)
T KOG1151|consen 545 TVLEYCEGNDLDFYLKQ----------------------------HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDL 596 (775)
T ss_pred eeeeecCCCchhHHHHh----------------------------hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeecc
Confidence 99999999999999987 34688999999999999999999985 5679999
Q ss_pred CCCcEEec---CCCCceEcCCCcccccccc-----------------cCcccCC--------CCCCCCCcchhhHHHHHH
Q 005572 558 VTSSILLA---ESLEPKIAGFGLRNIGVKN-----------------VGERSEN--------ETCGPESDVYCFGVILME 609 (690)
Q Consensus 558 k~~NiLl~---~~~~~kl~DfGla~~~~~~-----------------~~e~~~~--------~~~~~~~DVwSfGvvl~e 609 (690)
||.|||+- ..|.+||.|||++++.... ..|..|+ -..+.|+||||.||++|.
T Consensus 597 KPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQ 676 (775)
T KOG1151|consen 597 KPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQ 676 (775)
T ss_pred CCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhh
Confidence 99999995 4688999999999986543 1223333 156789999999999999
Q ss_pred HHhCCCCCCchHHHHHHHHHhcCCCCc--cccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005572 610 LLTGKRGTDDCVKWVRKLVKEGAGGDA--LDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677 (690)
Q Consensus 610 l~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~ 677 (690)
++.|+.||..-.. -..++++...... +.+......+...+ .++.+|+++.-++|....++.
T Consensus 677 ClYGrKPFGhnqs-QQdILqeNTIlkAtEVqFP~KPvVsseAk------aFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 677 CLYGRKPFGHNQS-QQDILQENTILKATEVQFPPKPVVSSEAK------AFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred hhccCCCCCCchh-HHHHHhhhchhcceeccCCCCCccCHHHH------HHHHHHHHhhhhhhhhHHHHc
Confidence 9999999975211 1223332222111 11111122222233 344569988888887766654
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=250.28 Aligned_cols=183 Identities=22% Similarity=0.309 Sum_probs=159.0
Q ss_pred CceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCC
Q 005572 412 ESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANG 488 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~g 488 (690)
.++||.|.||+||-|+ .++|+.||||++++..- +....++.|+.+|.+++||.||.+--.|++.+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 3689999999999998 57799999999976532 34567899999999999999999999999999999999999 56
Q ss_pred CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCC-
Q 005572 489 DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES- 567 (690)
Q Consensus 489 sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~- 567 (690)
|..+.+-. .....|++.....+..||+.||.|||.++|+|+||||+|||+.+.
T Consensus 648 DMLEMILS--------------------------sEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~ 701 (888)
T KOG4236|consen 648 DMLEMILS--------------------------SEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASAS 701 (888)
T ss_pred hHHHHHHH--------------------------hhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCC
Confidence 88887764 235678888888899999999999999999999999999999743
Q ss_pred --CCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH
Q 005572 568 --LEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 568 --~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~ 621 (690)
-.+||||||+|++.... +||+.....|...-|+||.||++|--++|..||.+..
T Consensus 702 ~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE 770 (888)
T KOG4236|consen 702 PFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE 770 (888)
T ss_pred CCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc
Confidence 46999999999987654 5666667789999999999999999999999998643
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-28 Score=224.45 Aligned_cols=179 Identities=14% Similarity=0.253 Sum_probs=151.2
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC-CCCccceeeEEecCC--eeEEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGK--EKLVL 481 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~--~~~lv 481 (690)
.++|++.+++|+|.|++||.|. ..+...++||+++.. ..+.+.+|+.+|..++ ||||++|++...++. ...+|
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 3467777899999999999998 677888999999764 3567899999999998 999999999998754 57799
Q ss_pred EEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
+||+.+.|....-. .++..++..++.++++||.|+|++||+|||+||.|
T Consensus 114 FE~v~n~Dfk~ly~-------------------------------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhN 162 (338)
T KOG0668|consen 114 FEYVNNTDFKQLYP-------------------------------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHN 162 (338)
T ss_pred hhhhccccHHHHhh-------------------------------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcce
Confidence 99999988766543 36677888999999999999999999999999999
Q ss_pred EEecCC-CCceEcCCCcccccccc-------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 562 ILLAES-LEPKIAGFGLRNIGVKN-------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 562 iLl~~~-~~~kl~DfGla~~~~~~-------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
++||.. -+.++.|+|+|.+..+. -||..-. ..|+..-|+|||||++.+|+-.+.||-
T Consensus 163 vmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFF 234 (338)
T KOG0668|consen 163 VMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFF 234 (338)
T ss_pred eeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCccc
Confidence 999954 56999999999887654 2232222 357778999999999999999999974
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=249.61 Aligned_cols=228 Identities=18% Similarity=0.208 Sum_probs=177.8
Q ss_pred ccCCCCceeccCCCccEEEEEcCCC-cEEEEEEeeccC---CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGE-LHVAIKVLDNAK---GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~-~~vavK~l~~~~---~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
.+++.+..||-|+||.|-++..... ..+|+|.+++.. ....+....|-++|...+.|.||+|+-.+.+..+.|+.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 4566677899999999999986554 348888886542 234566788999999999999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
|-|-||.|...|+++ +.++......++..+.+|++|||+++||.|||||+|+
T Consensus 500 EaClGGElWTiLrdR----------------------------g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENl 551 (732)
T KOG0614|consen 500 EACLGGELWTILRDR----------------------------GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENL 551 (732)
T ss_pred HhhcCchhhhhhhhc----------------------------CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhe
Confidence 999999999999872 3466667788999999999999999999999999999
Q ss_pred EecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHH-HHHHH
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLV 628 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~-~~~~~ 628 (690)
++|.+|.+||.|||+|+....+ +||+......+.++|.||+|+++|||++|++||...... ...++
T Consensus 552 lLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I 631 (732)
T KOG0614|consen 552 LLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI 631 (732)
T ss_pred eeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 9999999999999999876543 556666678889999999999999999999999873322 23344
Q ss_pred HhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCC
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT 672 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt 672 (690)
..+.. .++. +......... ++.+.+..+|.+|-.
T Consensus 632 LkGid--~i~~--Pr~I~k~a~~------Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 632 LKGID--KIEF--PRRITKTATD------LIKKLCRDNPTERLG 665 (732)
T ss_pred Hhhhh--hhhc--ccccchhHHH------HHHHHHhcCcHhhhc
Confidence 33321 1111 1111223333 344456778999864
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.7e-28 Score=251.68 Aligned_cols=239 Identities=20% Similarity=0.256 Sum_probs=185.2
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
..+|+....+|.|.||.|||++ ...+...|+|+++..-..+..-..+|+-+++..+|||||.++|.+...+..++.|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 3567778899999999999999 677889999999877666667778899999999999999999999999999999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
|.+|+|.+.-+. ...+++.++..+++...+|++|||+++-+|||||-.|||+
T Consensus 94 cgggslQdiy~~----------------------------TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill 145 (829)
T KOG0576|consen 94 CGGGSLQDIYHV----------------------------TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL 145 (829)
T ss_pred cCCCcccceeee----------------------------cccchhHHHHHHHhhhhccchhhhcCCcccccccccceee
Confidence 999999987764 4578888999999999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc--------------cCcccC---CCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHH
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSE---NETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKL 627 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~--------------~~e~~~---~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~ 627 (690)
++.|.+|++|||.+...... +||++. ...|..++|||+.|+...|+---.+|.-++.......
T Consensus 146 td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~ 225 (829)
T KOG0576|consen 146 TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALF 225 (829)
T ss_pred cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHH
Confidence 99999999999987543211 444432 2478899999999999999988888854433222222
Q ss_pred HHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
+......+.+.-+-+........+ +++.|+-.+|++|||++.+++
T Consensus 226 LmTkS~~qpp~lkDk~kws~~fh~------fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 226 LMTKSGFQPPTLKDKTKWSEFFHN------FVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred HhhccCCCCCcccCCccchHHHHH------HHHHHhcCCCccCCChhhhee
Confidence 221111111111111112223333 344599999999999987654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=225.37 Aligned_cols=185 Identities=19% Similarity=0.261 Sum_probs=159.5
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccC---CCCHHHHHHHHHHHHhc-CCCCccceeeEEecCCeeEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK---GIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~---~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~l 480 (690)
.++|+..++||+|+|..|..++ ..+.+.+|+|++++.- ..+.+-...|-.+.... +||-+|.++.++.+...++.
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4578889999999999999999 4668899999987542 23334456666666655 69999999999999999999
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|.||+++|+|.-.+++ ++++++..+..+...|+.||.|||++|||.||||..
T Consensus 329 vieyv~ggdlmfhmqr----------------------------qrklpeeharfys~ei~lal~flh~rgiiyrdlkld 380 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQR----------------------------QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLD 380 (593)
T ss_pred EEEEecCcceeeehhh----------------------------hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeecccc
Confidence 9999999999877765 467888899999999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc--------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
|||+|..|.+|+.|||+.+..... +||...+..|+..+|.|++||+++||+.|+.||+
T Consensus 381 nvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfd 452 (593)
T KOG0695|consen 381 NVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 452 (593)
T ss_pred ceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcc
Confidence 999999999999999998753221 6777777899999999999999999999999997
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2e-27 Score=255.07 Aligned_cols=231 Identities=23% Similarity=0.271 Sum_probs=170.7
Q ss_pred CCCCceeccCCCcc-EEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEEEecC
Q 005572 409 FGKESLLAEGRCGP-VYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 409 ~~~~~~lg~G~~g~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
|...+.+|.|+-|+ ||+|.+++ +.||||++-.. ..+-+.+|++.|+.-+ |||||++++.-.++...||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~-R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEG-REVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCC-ceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34456788998886 79999874 58999998542 3456788999998885 9999999988888889999999995
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
.+|.+++..... + .....-.....+..|+++||++||+.+||||||||.||||+.
T Consensus 587 -~sL~dlie~~~~-d-----------------------~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~ 641 (903)
T KOG1027|consen 587 -CSLQDLIESSGL-D-----------------------VEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISV 641 (903)
T ss_pred -hhHHHHHhcccc-c-----------------------hhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEc
Confidence 599999986310 0 000111345678889999999999999999999999999975
Q ss_pred ---C--CCceEcCCCcccccccc-----------------cCcccCCCCCCCCCcchhhHHHHHHHHhC-CCCCCchHHH
Q 005572 567 ---S--LEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLTG-KRGTDDCVKW 623 (690)
Q Consensus 567 ---~--~~~kl~DfGla~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg-~~p~~~~~~~ 623 (690)
+ .+|+|+|||+++....+ |||...+..-+.++||||+||++|..++| +.||.+..+.
T Consensus 642 ~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 642 PSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred cCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 3 57999999998865432 77777777777799999999999999995 8999874332
Q ss_pred HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
-..++....... .+.. ...+ ...+++..++.+||..||++.+|+.
T Consensus 722 ~~NIl~~~~~L~----~L~~----~~d~--eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 722 QANILTGNYTLV----HLEP----LPDC--EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred hhhhhcCcccee----eecc----CchH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 222222111100 0100 1111 4456667799999999999999974
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=224.72 Aligned_cols=181 Identities=24% Similarity=0.301 Sum_probs=150.1
Q ss_pred CCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcCCCCccceeeEEecCC-----eeEE
Q 005572 409 FGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK-----EKLV 480 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~l 480 (690)
.+..+.||-|+||.||.+. -++|+.||.|++...-. ...+.+.+|++.|.-++|.||+..++.-.... +.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 3445789999999999998 56788999998865321 33467888999999999999999998765433 5789
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
|+|.|.. ||+..+- ++..++-..+.-+..||.+||.|||+.+|.||||||.
T Consensus 135 ~TELmQS-DLHKIIV----------------------------SPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPG 185 (449)
T KOG0664|consen 135 LTELMQS-DLHKIIV----------------------------SPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPG 185 (449)
T ss_pred HHHHHHh-hhhheec----------------------------cCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCc
Confidence 9999965 8877764 3566777778889999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccccccc---------------cCcccCC-CCCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN---------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~~~~~---------------~~e~~~~-~~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
|.|++++-..||||||+|+..... +||...+ ..|+.+.||||.||++.|++-.+.-|.
T Consensus 186 NLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQ 259 (449)
T KOG0664|consen 186 NLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQ 259 (449)
T ss_pred cEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhh
Confidence 999999999999999999976543 4555444 378999999999999999999887765
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-26 Score=220.52 Aligned_cols=196 Identities=29% Similarity=0.404 Sum_probs=165.7
Q ss_pred eccCCCccEEEEEcC-CCcEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHhh
Q 005572 415 LAEGRCGPVYRAVLP-GELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHR 492 (690)
Q Consensus 415 lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~ 492 (690)
||+|.+|.||++... ++..+++|++...... ..+.+.+|++.++.++|++|+++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999965 4889999999765322 34678999999999999999999999999899999999999999999
Q ss_pred hhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC-CCCce
Q 005572 493 WLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE-SLEPK 571 (690)
Q Consensus 493 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~-~~~~k 571 (690)
++... ...+++..+..++.+++++++|||+.+++|+||+|.||+++. ++.++
T Consensus 81 ~~~~~---------------------------~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~ 133 (215)
T cd00180 81 LLKEN---------------------------EGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVK 133 (215)
T ss_pred HHHhc---------------------------cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEE
Confidence 98751 135788999999999999999999999999999999999999 89999
Q ss_pred EcCCCcccccccc--------------cCcccCCC-CCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcCCCCc
Q 005572 572 IAGFGLRNIGVKN--------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDA 636 (690)
Q Consensus 572 l~DfGla~~~~~~--------------~~e~~~~~-~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 636 (690)
|+|||.+...... +||..... ..+.+.|+|++|++++||
T Consensus 134 l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------- 187 (215)
T cd00180 134 LADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------- 187 (215)
T ss_pred EecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------
Confidence 9999987644321 33333333 667899999999999999
Q ss_pred cccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 637 LDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 637 ~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
..+.+++..|++.+|++||++.++++.
T Consensus 188 ----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 ----------------PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred ----------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 134455667999999999999999864
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=220.21 Aligned_cols=235 Identities=18% Similarity=0.228 Sum_probs=166.8
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-CCCCccceeeE-EecCCeeEEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGY-CIAGKEKLVLLE 483 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~-~~~~~~~~lv~e 483 (690)
+.|.+.+.+|+|.||.+.+++. ++.+.+|+|.+.... ....+|.+|...--.+ .|.||+.-+++ +.+.+.+..++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 3577788999999999999995 557889999986543 4567888888764444 59999987765 556777889999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
|++.|||.+-+.. ..+.+....+++.|+++|+.|+|++++||||||.+|||
T Consensus 103 ~aP~gdL~snv~~-----------------------------~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiL 153 (378)
T KOG1345|consen 103 FAPRGDLRSNVEA-----------------------------AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENIL 153 (378)
T ss_pred cCccchhhhhcCc-----------------------------ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEE
Confidence 9999999887643 24566778899999999999999999999999999999
Q ss_pred e-c-CCCCceEcCCCcccccccc-----------cCccc---CCC--CCCCCCcchhhHHHHHHHHhCCCCCCc-----h
Q 005572 564 L-A-ESLEPKIAGFGLRNIGVKN-----------VGERS---ENE--TCGPESDVYCFGVILMELLTGKRGTDD-----C 620 (690)
Q Consensus 564 l-~-~~~~~kl~DfGla~~~~~~-----------~~e~~---~~~--~~~~~~DVwSfGvvl~el~tg~~p~~~-----~ 620 (690)
| + +..++|+||||+.+..... +||.. +++ .+.+.+|||.||++++.++||+.||.. -
T Consensus 154 if~~df~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~ 233 (378)
T KOG1345|consen 154 IFDADFYRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK 233 (378)
T ss_pred EecCCccEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc
Confidence 9 3 3457999999997754322 33322 112 567889999999999999999999974 1
Q ss_pred HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 621 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
.-|.......+... .++......-+. ++++-.+-+..+|++|-...++.++
T Consensus 234 ~Y~~~~~w~~rk~~-----~~P~~F~~fs~~---a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 234 PYWEWEQWLKRKNP-----ALPKKFNPFSEK---ALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred hHHHHHHHhcccCc-----cCchhhcccCHH---HHHHHHHhcCCcccccchhHHHHHH
Confidence 11222222222211 111111111122 2233345688899888666665544
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.2e-27 Score=240.14 Aligned_cols=187 Identities=19% Similarity=0.231 Sum_probs=157.8
Q ss_pred HhccCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCC--------CCHHHHHHHHHHHHhcC---CCCccceeeEE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKG--------IDHDDAVAMFDELSRLK---HPNLLPLAGYC 472 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~--------~~~~~~~~e~~~l~~l~---H~niv~l~g~~ 472 (690)
...+|.....+|+|+||.|+.|..+ ....|+||++.+++- .+....-.|+++|+.++ |+||+++++++
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 3457888899999999999999954 467899999865431 11223557999999997 99999999999
Q ss_pred ecCCeeEEEEEec-CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcC
Q 005572 473 IAGKEKLVLLEFM-ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG 551 (690)
Q Consensus 473 ~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~ 551 (690)
++.+.+||+||-- ++-||++|+..+ ..+++....-|+.||+.|+++||+++
T Consensus 639 Eddd~yyl~te~hg~gIDLFd~IE~k----------------------------p~m~E~eAk~IFkQV~agi~hlh~~~ 690 (772)
T KOG1152|consen 639 EDDDYYYLETEVHGEGIDLFDFIEFK----------------------------PRMDEPEAKLIFKQVVAGIKHLHDQG 690 (772)
T ss_pred ecCCeeEEEecCCCCCcchhhhhhcc----------------------------CccchHHHHHHHHHHHhccccccccC
Confidence 9999999999974 567999999763 35888899999999999999999999
Q ss_pred CCCCCCCCCcEEecCCCCceEcCCCcccccccc------------cCcccCCCCC-CCCCcchhhHHHHHHHHhCCCCCC
Q 005572 552 STHGHLVTSSILLAESLEPKIAGFGLRNIGVKN------------VGERSENETC-GPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 552 ~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~------------~~e~~~~~~~-~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
|||||||-+||.++.+|-+||.|||-|.+.... +||...+..| +...|||++||+||.++....||.
T Consensus 691 ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 691 IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred ceecccccccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999999999999999999999999998765443 6666665544 677999999999999999999986
Q ss_pred c
Q 005572 619 D 619 (690)
Q Consensus 619 ~ 619 (690)
+
T Consensus 771 n 771 (772)
T KOG1152|consen 771 N 771 (772)
T ss_pred C
Confidence 4
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-25 Score=219.02 Aligned_cols=184 Identities=29% Similarity=0.396 Sum_probs=157.2
Q ss_pred CCCCceeccCCCccEEEEEcCC-CcEEEEEEeeccCCC-CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecC
Q 005572 409 FGKESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
|...+.||+|++|.||+|...+ +..+|+|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4456789999999999999654 789999999765433 56788899999999999999999999999899999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+++|.+++.... ..+++..+..++.+++.++.|||+.+++|+|++++||+++.
T Consensus 81 ~~~L~~~~~~~~---------------------------~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~ 133 (225)
T smart00221 81 GGDLFDYLRKKG---------------------------GKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGM 133 (225)
T ss_pred CCCHHHHHHhcc---------------------------cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 999999997521 11788899999999999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc---------------cCccc-CCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 567 SLEPKIAGFGLRNIGVKN---------------VGERS-ENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~---------------~~e~~-~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
++.++|+|||.+...... +||.. ....++.++|||+||++++||++|+.||+.
T Consensus 134 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 134 DGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred CCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 999999999987654321 34433 334567799999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.1e-26 Score=217.86 Aligned_cols=239 Identities=20% Similarity=0.180 Sum_probs=170.7
Q ss_pred cCCCCceeccCCCccEEEEE-cCCCcEEEEEEeecc--CCCCHHHHHHHHHHHHhcCCCCccceeeEEecCC------ee
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA--KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK------EK 478 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~~ 478 (690)
+|.....+|.|.- .|..+. .-.+..||+|++... .....+...+|...+..+.|+||++++.++.... +.
T Consensus 18 Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~ 96 (369)
T KOG0665|consen 18 RYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEV 96 (369)
T ss_pred eeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhH
Confidence 3444566777776 555554 233678999987432 1234467788999999999999999999987543 58
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
|+|||||. ++|...++. .++..+...+..|++.|++|||+.+|+|||||
T Consensus 97 y~v~e~m~-~nl~~vi~~------------------------------elDH~tis~i~yq~~~~ik~lhs~~IihRdLk 145 (369)
T KOG0665|consen 97 YLVMELMD-ANLCQVILM------------------------------ELDHETISYILYQMLCGIKHLHSAGIIHRDLK 145 (369)
T ss_pred HHHHHhhh-hHHHHHHHH------------------------------hcchHHHHHHHHHHHHHHHHHHhcceeecccC
Confidence 99999996 489888764 35667788899999999999999999999999
Q ss_pred CCcEEecCCCCceEcCCCcccccccc-------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc---hHH
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD---CVK 622 (690)
Q Consensus 559 ~~NiLl~~~~~~kl~DfGla~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~---~~~ 622 (690)
|+||++..+..+||.|||+|+..... +||..-+..+.+.+||||.||++.||++|+.-|.+ +.+
T Consensus 146 Psnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ 225 (369)
T KOG0665|consen 146 PSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQ 225 (369)
T ss_pred cccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHH
Confidence 99999999999999999999865433 56666666789999999999999999999876643 222
Q ss_pred HHHHHHHhcC---------------------------C-CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHH
Q 005572 623 WVRKLVKEGA---------------------------G-GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQ 674 (690)
Q Consensus 623 ~~~~~~~~~~---------------------------~-~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ 674 (690)
|.+-.-.-+. . .-..|..++.....+..+.-.+-+++.+++..||++|-+++
T Consensus 226 ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~ 305 (369)
T KOG0665|consen 226 WNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVD 305 (369)
T ss_pred HHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHH
Confidence 2211111000 0 00111111111111111122234567789999999999999
Q ss_pred HHHH
Q 005572 675 QVLG 678 (690)
Q Consensus 675 ev~~ 678 (690)
++++
T Consensus 306 daL~ 309 (369)
T KOG0665|consen 306 DALR 309 (369)
T ss_pred HHhc
Confidence 9986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=221.26 Aligned_cols=187 Identities=21% Similarity=0.216 Sum_probs=158.9
Q ss_pred hccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC------CCCccceeeEEecCCee
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK------HPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~------H~niv~l~g~~~~~~~~ 478 (690)
-..|.+....|+|-|++|.+|.. ..+..||||+|.+.. ...+.=..|+++|.+|. --|+++|+-.|...+++
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHL 509 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHL 509 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhccee
Confidence 45788888899999999999984 447799999997653 23344567999999984 34899999999999999
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
|||+|-+.- +|.+.|++.. ....|....+..++.|+.-||..|-..+++|.|||
T Consensus 510 ClVFE~Lsl-NLRevLKKyG-------------------------~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIK 563 (752)
T KOG0670|consen 510 CLVFEPLSL-NLREVLKKYG-------------------------RNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIK 563 (752)
T ss_pred EEEehhhhc-hHHHHHHHhC-------------------------cccceeehHHHHHHHHHHHHHHHHHhcCeeecccC
Confidence 999999854 9999999732 23357788899999999999999999999999999
Q ss_pred CCcEEecCC-CCceEcCCCcccccccc------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 559 TSSILLAES-LEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 559 ~~NiLl~~~-~~~kl~DfGla~~~~~~------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
|.|||+++. ...||||||-|.....+ +||++.+..|+...|+||.||+||||+||+..|.+
T Consensus 564 PDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG 637 (752)
T KOG0670|consen 564 PDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG 637 (752)
T ss_pred ccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence 999999965 56899999998876554 67777778999999999999999999999998875
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=214.52 Aligned_cols=132 Identities=21% Similarity=0.290 Sum_probs=112.4
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC-----C---CCccceeeEEec---
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-----H---PNLLPLAGYCIA--- 474 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-----H---~niv~l~g~~~~--- 474 (690)
.+|...++||-|.|++||++. .++.+.||+|+.+... .-.+....|+++|++++ | .+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 578889999999999999998 6778899999997653 33466788999999884 3 379999999875
Q ss_pred -CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-cCC
Q 005572 475 -GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGS 552 (690)
Q Consensus 475 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~-~~~ 552 (690)
+.+.++|+|+. |-+|..++.. ...+.++...+.+|+.||+.||.|||. .+|
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~--------------------------s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgI 209 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKY--------------------------SNYRGLPLSCVKEICRQVLTGLDYLHRECGI 209 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHH--------------------------hCCCCCcHHHHHHHHHHHHHHHHHHHHhcCc
Confidence 44899999999 5699999987 335678999999999999999999997 578
Q ss_pred CCCCCCCCcEEecC
Q 005572 553 THGHLVTSSILLAE 566 (690)
Q Consensus 553 iHrDlk~~NiLl~~ 566 (690)
||-||||+|||+..
T Consensus 210 IHTDlKPENvLl~~ 223 (590)
T KOG1290|consen 210 IHTDLKPENVLLCS 223 (590)
T ss_pred cccCCCcceeeeec
Confidence 99999999999953
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-24 Score=254.38 Aligned_cols=180 Identities=18% Similarity=0.240 Sum_probs=130.9
Q ss_pred hcCC-CCccceeeEE-------ecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH
Q 005572 459 RLKH-PNLLPLAGYC-------IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530 (690)
Q Consensus 459 ~l~H-~niv~l~g~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 530 (690)
.++| +||+++++++ ...+..+.++||+ .++|.++|.. ....+++
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~---------------------------~~~~~~~ 79 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN---------------------------PDRSVDA 79 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc---------------------------ccccccH
Confidence 4456 6888899887 2334567888988 5599999964 1245889
Q ss_pred HHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec-------------------CCCCceEcCCCcccccc---------
Q 005572 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA-------------------ESLEPKIAGFGLRNIGV--------- 582 (690)
Q Consensus 531 ~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~-------------------~~~~~kl~DfGla~~~~--------- 582 (690)
.+++.++.||++||.|||+++|+||||||+||||+ .++.+|++|||+++...
T Consensus 80 ~~~~~i~~qi~~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~ 159 (793)
T PLN00181 80 FECFHVFRQIVEIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEK 159 (793)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhh
Confidence 99999999999999999999999999999999994 45678888998876321
Q ss_pred ---------------------cccCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHHHHHhcCCCCcccccc
Q 005572 583 ---------------------KNVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRL 641 (690)
Q Consensus 583 ---------------------~~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 641 (690)
..+||......++.++|||||||+||||++|..|+............. ..++..
T Consensus 160 ~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~-----~~~~~~ 234 (793)
T PLN00181 160 LEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHR-----VLPPQI 234 (793)
T ss_pred hhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHh-----hcChhh
Confidence 013444444578999999999999999999998876533222222111 011111
Q ss_pred ccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 642 KLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.........++.+||+.||.+||+|.|+++
T Consensus 235 -------~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 235 -------LLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred -------hhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 111223446677899999999999999975
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.5e-24 Score=200.39 Aligned_cols=235 Identities=24% Similarity=0.422 Sum_probs=173.6
Q ss_pred CceeccCCCccEEEEEcCCCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCC
Q 005572 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGD 489 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gs 489 (690)
..+|.+...|+.|+|+|++. .+++|++.-.. ....++|..|+-.|+.+.||||+.++|.|..+....++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwqgn-divakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQGN-DIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCcccccccccCc-chhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 45688889999999999875 46667775332 2334678889999999999999999999999999999999999999
Q ss_pred HhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCC--CCCCCCCCcEEecCC
Q 005572 490 LHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS--THGHLVTSSILLAES 567 (690)
Q Consensus 490 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~--iHrDlk~~NiLl~~~ 567 (690)
|+..|++. ..-..+-.++.+++.++|+||+|||+... +--.|.++.+++|++
T Consensus 274 lynvlhe~--------------------------t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmided 327 (448)
T KOG0195|consen 274 LYNVLHEQ--------------------------TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDED 327 (448)
T ss_pred HHHHHhcC--------------------------ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecch
Confidence 99999972 23356777899999999999999999643 355788999999999
Q ss_pred CCceEc--C--CCcccccccc-----cCcccCC---CCCCCCCcchhhHHHHHHHHhCCCCCCchHHHHH--HHHHhcCC
Q 005572 568 LEPKIA--G--FGLRNIGVKN-----VGERSEN---ETCGPESDVYCFGVILMELLTGKRGTDDCVKWVR--KLVKEGAG 633 (690)
Q Consensus 568 ~~~kl~--D--fGla~~~~~~-----~~e~~~~---~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~--~~~~~~~~ 633 (690)
.++||+ | |.+-...... +||.... ..--.++|+|||.|++||+.|.+.||.+...... ++..
T Consensus 328 ltarismad~kfsfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkial---- 403 (448)
T KOG0195|consen 328 LTARISMADTKFSFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIAL---- 403 (448)
T ss_pred hhhheecccceeeeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhh----
Confidence 999885 3 3322211111 3333322 2233479999999999999999999987433211 1222
Q ss_pred CCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccC
Q 005572 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 634 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~ 684 (690)
+.+...++.+.+.. +.+++.-|..+||.+||.+..|+-.|+.+.
T Consensus 404 -eglrv~ippgis~h------m~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 404 -EGLRVHIPPGISRH------MNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred -ccccccCCCCccHH------HHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 22344444444333 334444599999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.1e-23 Score=207.94 Aligned_cols=184 Identities=19% Similarity=0.253 Sum_probs=152.7
Q ss_pred HHHHhccCCCCceeccCCCccEEEEEc-C---CCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC-CCCccceeeEEecCC
Q 005572 402 LIAATSHFGKESLLAEGRCGPVYRAVL-P---GELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGK 476 (690)
Q Consensus 402 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~---~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~ 476 (690)
+..-...|..+++||+|.|++||++.. . ....||+|.+.... ....+..|++.|..+. |.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 344456788899999999999999984 3 46789999997654 4566889999999996 999999999999999
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
...+|+||++.-+-.++... ++..++..+...+..||.|+|.+||||||
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~-------------------------------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRD 157 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS-------------------------------LSLAEIRWYLRNLLKALAHLHKNGIVHRD 157 (418)
T ss_pred eeEEEecccCccCHHHHHhc-------------------------------CCHHHHHHHHHHHHHHhhhhhccCccccC
Confidence 99999999999998888864 66788899999999999999999999999
Q ss_pred CCCCcEEecC-CCCceEcCCCcccccc-----------------c-c---------------------------------
Q 005572 557 LVTSSILLAE-SLEPKIAGFGLRNIGV-----------------K-N--------------------------------- 584 (690)
Q Consensus 557 lk~~NiLl~~-~~~~kl~DfGla~~~~-----------------~-~--------------------------------- 584 (690)
|||+|+|.+. .+.-.|.|||+|.... . .
T Consensus 158 iKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anr 237 (418)
T KOG1167|consen 158 IKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANR 237 (418)
T ss_pred CCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceeccc
Confidence 9999999984 5678999999986210 0 0
Q ss_pred ---cCcccCCC-----CCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 585 ---VGERSENE-----TCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 585 ---~~e~~~~~-----~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
.++++||. ..++++||||-||+++-+++++.||-
T Consensus 238 AGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf 279 (418)
T KOG1167|consen 238 AGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFF 279 (418)
T ss_pred CCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccc
Confidence 12233331 34678999999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-22 Score=192.99 Aligned_cols=146 Identities=18% Similarity=0.191 Sum_probs=106.6
Q ss_pred CCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCcccccccc---------cCcccCCCCCCC
Q 005572 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN---------VGERSENETCGP 596 (690)
Q Consensus 526 ~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~---------~~e~~~~~~~~~ 596 (690)
..++|.++..++.||++||+|||+++ ||+|||++.++.+|+ ||+++..... +||......+++
T Consensus 12 ~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~y~aPE~~~~~~~~~ 83 (176)
T smart00750 12 RPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPYFMAPEVIQGQSYTE 83 (176)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccCCCcccccChHHhcCCCCcc
Confidence 46899999999999999999999998 999999999999999 9998754321 566666678899
Q ss_pred CCcchhhHHHHHHHHhCCCCCCchHH---HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCH
Q 005572 597 ESDVYCFGVILMELLTGKRGTDDCVK---WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 597 ~~DVwSfGvvl~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~ 673 (690)
++|||||||++|||+||+.||..... ............ ++... .......+...+.+++.+||+.||++||++
T Consensus 84 ~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~ 159 (176)
T smart00750 84 KADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD---DPRDR-SNLESVSAARSFADFMRVCASRLPQRREAA 159 (176)
T ss_pred hhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC---Ccccc-ccHHHHHhhhhHHHHHHHHHhcccccccCH
Confidence 99999999999999999999875322 122222111100 00000 000011111246778888999999999999
Q ss_pred HHHHHHHhcc
Q 005572 674 QQVLGLLKDI 683 (690)
Q Consensus 674 ~ev~~~L~~i 683 (690)
.|+++.+..+
T Consensus 160 ~~ll~~~~~~ 169 (176)
T smart00750 160 NHYLAHCRAL 169 (176)
T ss_pred HHHHHHHHHH
Confidence 9999988665
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.5e-22 Score=204.64 Aligned_cols=140 Identities=16% Similarity=0.140 Sum_probs=111.2
Q ss_pred HHhccCCCCceeccCCCccEEEEEcC--CCcEEEEEEeeccC-----CCCHHHHHHHHHHHHhcCCCCccceeeEEecCC
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAVLP--GELHVAIKVLDNAK-----GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK 476 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~-----~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~ 476 (690)
....+|...+.||+|+||.||+|+.. ++..+|||++.... ....+.+.+|+++|++++|+||+..+.. .+
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34457888999999999999999853 57778999875321 1124568899999999999999963322 24
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..|+||||+++++|... .. .. ...++.|+++||.|||+++++|||
T Consensus 92 ~~~LVmE~~~G~~L~~~-~~----------------------------~~------~~~~~~~i~~aL~~lH~~gIiHrD 136 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA-RP----------------------------HG------DPAWFRSAHRALRDLHRAGITHND 136 (365)
T ss_pred CcEEEEEccCCCCHHHh-Cc----------------------------cc------hHHHHHHHHHHHHHHHHCCCeeCC
Confidence 57999999999999632 11 00 135788999999999999999999
Q ss_pred C-CCCcEEecCCCCceEcCCCccccc
Q 005572 557 L-VTSSILLAESLEPKIAGFGLRNIG 581 (690)
Q Consensus 557 l-k~~NiLl~~~~~~kl~DfGla~~~ 581 (690)
| ||+|||++.++.+||+|||+|+..
T Consensus 137 L~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 137 LAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred CCCcceEEEcCCCCEEEEECccceec
Confidence 9 999999999999999999998743
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.4e-21 Score=183.11 Aligned_cols=139 Identities=15% Similarity=0.137 Sum_probs=107.4
Q ss_pred CceeccCCCccEEEEEcCCCcEEEEEEeeccCCC--C-------H-----------------HHHHHHHHHHHhcCCCCc
Q 005572 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI--D-------H-----------------DDAVAMFDELSRLKHPNL 465 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--~-------~-----------------~~~~~e~~~l~~l~H~ni 465 (690)
...||+|+||.||+|...+|..||||+++..... . . .....|++.+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3679999999999999778999999999754211 1 0 112348888999988877
Q ss_pred cceeeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHH
Q 005572 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLA 545 (690)
Q Consensus 466 v~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~ 545 (690)
.....+.. ...++||||++++++...... ...+++.+...++.|++.+|.
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----------------------------~~~~~~~~~~~i~~qi~~~L~ 131 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLK----------------------------DAPLSESKARELYLQVIQIMR 131 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhh----------------------------cCCCCHHHHHHHHHHHHHHHH
Confidence 44333222 234899999998776654322 135778889999999999999
Q ss_pred hh-hhcCCCCCCCCCCcEEecCCCCceEcCCCccccc
Q 005572 546 YL-HHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIG 581 (690)
Q Consensus 546 yL-H~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~ 581 (690)
|+ |+.+++||||||+|||++ ++.++|+|||+|...
T Consensus 132 ~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 132 ILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred HHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 99 689999999999999998 578999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-21 Score=187.00 Aligned_cols=169 Identities=10% Similarity=0.115 Sum_probs=131.9
Q ss_pred HhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHH---------HHHHHHHHHhcCCCCccceeeEEecC
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDD---------AVAMFDELSRLKHPNLLPLAGYCIAG 475 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~---------~~~e~~~l~~l~H~niv~l~g~~~~~ 475 (690)
-..+|...+.+|+|+||.||.... ++..+|+|.++......... +.+|++.+.+++||+|.....++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367899999999999999999766 45589999997554333322 57899999999999999999886643
Q ss_pred --------CeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 005572 476 --------KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYL 547 (690)
Q Consensus 476 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yL 547 (690)
...++||||++|.+|.++.. ++. ....+++.++..+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------------------------------~~~----~~~~~i~~~l~~l 151 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------------------------------ISE----DVKAKIKASIESL 151 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh--------------------------------ccH----HHHHHHHHHHHHH
Confidence 35789999999999987632 111 2456999999999
Q ss_pred hhcCCCCCCCCCCcEEecCCCCceEcCCCcccccccc--cCcccCCCCCCCCCcchhhHHHHHHHH
Q 005572 548 HHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN--VGERSENETCGPESDVYCFGVILMELL 611 (690)
Q Consensus 548 H~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~--~~e~~~~~~~~~~~DVwSfGvvl~el~ 611 (690)
|+.+++|||+||+||++++++ ++++|||........ ......+..++.++|+||||+++.-..
T Consensus 152 H~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 152 HQHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAKDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred HHcCCccCCCChHHEEEeCCC-EEEEECCCcccccchhhHHHHHHHhHhcccccccceeEeehHHH
Confidence 999999999999999999988 999999987654322 111223345667999999999876653
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=7e-21 Score=229.20 Aligned_cols=184 Identities=30% Similarity=0.466 Sum_probs=140.6
Q ss_pred CCCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCC
Q 005572 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS 136 (690)
Q Consensus 57 ~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~ 136 (690)
..+|+.|+|++|++++.+| ..+..+++|+.|++++|.+.+.+|..+..+++|+.|+|++|++++.+ +..+..+++
T Consensus 355 ~~~L~~L~Ls~n~l~~~~p-~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~----p~~~~~l~~ 429 (968)
T PLN00113 355 HNNLTVLDLSTNNLTGEIP-EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGEL----PSEFTKLPL 429 (968)
T ss_pred CCCCcEEECCCCeeEeeCC-hhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeEC----ChhHhcCCC
Confidence 3689999999999999998 45678899999999999999999999999999999999999999876 567888999
Q ss_pred CcEEEccCCCCCCccc--cCCCCCC-----------------------cEEEccCCCCc-cCCccCCCCCCCcEEEcccC
Q 005572 137 VQVLNLSSNRFTNLVK--LSQFSKL-----------------------MVLDVSNNDLR-ILPSGFANLSKLRHLDISSC 190 (690)
Q Consensus 137 L~~L~Ls~N~l~~~~~--~~~~~~L-----------------------~~L~ls~N~l~-~~p~~~~~l~~L~~L~ls~N 190 (690)
|+.|++++|++++... +..+++| +.|++++|+++ .+|..+.++++|+.|+|++|
T Consensus 430 L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N 509 (968)
T PLN00113 430 VYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSEN 509 (968)
T ss_pred CCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEEECcCC
Confidence 9999999999987532 3344444 45555555554 34455566666666666666
Q ss_pred cCCcCCCC-cccccccceeecccccCCCCCCCCCCCCCCCCEEEeeCCCCccccCc
Q 005572 191 KISGNIKP-VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGH 245 (690)
Q Consensus 191 ~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g~~~~ 245 (690)
++++.+|. +..+++|+.|+|++|.++|.+|..|..+++|+.|++++|+++|.+|.
T Consensus 510 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 565 (968)
T PLN00113 510 KLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPK 565 (968)
T ss_pred cceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEECCCCcccccCCh
Confidence 66665554 55566777777777777777777777777777777777777776664
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2e-20 Score=197.78 Aligned_cols=197 Identities=26% Similarity=0.373 Sum_probs=152.6
Q ss_pred HHhcCCCCccceeeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q 005572 457 LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRI 536 (690)
Q Consensus 457 l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 536 (690)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+.. ....++|.....+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~---------------------------~~~~~d~~F~~s~ 53 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN---------------------------EDIKLDYFFILSF 53 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc---------------------------cccCccHHHHHHH
Confidence 4568899999999999999999999999999999999975 2457899999999
Q ss_pred HHHHHHHHHhhhhcCC-CCCCCCCCcEEecCCCCceEcCCCccccccc----------------ccCcccCCC-------
Q 005572 537 AIGVARGLAYLHHVGS-THGHLVTSSILLAESLEPKIAGFGLRNIGVK----------------NVGERSENE------- 592 (690)
Q Consensus 537 ~~~ia~gl~yLH~~~~-iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~----------------~~~e~~~~~------- 592 (690)
.++|++||+|+|.-.+ .|+.++++|+++|..|.+|++|||+...... .+||.....
T Consensus 54 ~rdi~~Gl~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~ 133 (484)
T KOG1023|consen 54 IRDISKGLAYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLES 133 (484)
T ss_pred HHHHHHHHHHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccc
Confidence 9999999999999877 6999999999999999999999999876531 155554432
Q ss_pred CCCCCCcchhhHHHHHHHHhCCCCCCch-----HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCC
Q 005572 593 TCGPESDVYCFGVILMELLTGKRGTDDC-----VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSP 667 (690)
Q Consensus 593 ~~~~~~DVwSfGvvl~el~tg~~p~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP 667 (690)
..+.++||||||++++|+++.+.||+.. .......+.. .....+.|.+.... +..-.+..++..||..+|
T Consensus 134 ~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~-~~~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P 208 (484)
T KOG1023|consen 134 ALTQKGDIYSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKK-GGSNPFRPSIELLN----ELPPELLLLVARCWEEIP 208 (484)
T ss_pred cccccCCeehHHHHHHHHHhccCccccccccCChHHHHHHHHh-cCCCCcCcchhhhh----hcchHHHHHHHHhcccCh
Confidence 2567899999999999999999999751 1111111222 12222333332111 111145667788999999
Q ss_pred CCCCCHHHHHHHHhccCC
Q 005572 668 GKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 668 ~~RPt~~ev~~~L~~i~~ 685 (690)
++||++.+|-..++.+..
T Consensus 209 ~~rPs~~~i~~~~~~~~~ 226 (484)
T KOG1023|consen 209 EKRPSIEQIRSKLLTINK 226 (484)
T ss_pred hhCccHHHHHhhhhhhcc
Confidence 999999999999887765
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.7e-20 Score=172.02 Aligned_cols=248 Identities=13% Similarity=0.149 Sum_probs=176.1
Q ss_pred hccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCC-CCccceeeEEecCCeeEEEEE
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKH-PNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e 483 (690)
..+|...+.||.|+||.+|.|. ..+|..||+|+=... ....++..|.++.+.++| ..|..+..|..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 4578889999999999999998 788999999986433 233457778889988875 677777788888888899999
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
.. +-+|.+++.- ....++..+.+-.|-|+..-++|+|.+++|||||||.|+|
T Consensus 92 LL-GPsLEdLfnf---------------------------C~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFL 143 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF---------------------------CSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFL 143 (341)
T ss_pred cc-CccHHHHHHH---------------------------HhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCcccee
Confidence 99 6699888764 2346888899999999999999999999999999999999
Q ss_pred ecC---CCCceEcCCCcccccccc-----cCcccCCC----------------CCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 564 LAE---SLEPKIAGFGLRNIGVKN-----VGERSENE----------------TCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 564 l~~---~~~~kl~DfGla~~~~~~-----~~e~~~~~----------------~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
..- ...+.++|||+|+...+. .||+-... .-+.+-|+=|.|-+|...--|+.||.+
T Consensus 144 MGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 144 MGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred eccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 963 456899999999865332 34332211 124478999999999999999999998
Q ss_pred hHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCCC
Q 005572 620 CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 620 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~~ 686 (690)
+....+....+..........+..-+...+.|+.. .+.-|-..--++-|...-+-+.+.-+...
T Consensus 224 lka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~m---yl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ 287 (341)
T KOG1163|consen 224 LKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAM---YLNYCRGLGFEEKPDYMYLRQLFRILFRT 287 (341)
T ss_pred cchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHH---HHHHHhhcCCCCCCcHHHHHHHHHHHHhh
Confidence 54433322211111111111121122223333322 22347777777788777666665554433
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.2e-20 Score=176.09 Aligned_cols=138 Identities=17% Similarity=0.181 Sum_probs=108.9
Q ss_pred CceeccCCCccEEEEEcCCCcEEEEEEeeccCCC---------------------C-----HHHHHHHHHHHHhcCCCCc
Q 005572 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI---------------------D-----HDDAVAMFDELSRLKHPNL 465 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~e~~~l~~l~H~ni 465 (690)
...||+|+||.||+|+..+|..||||+++..... . ...+..|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 4679999999999999778999999998754211 0 1123568888999999988
Q ss_pred cceeeEEecCCeeEEEEEecCCCCHhhh-hhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 005572 466 LPLAGYCIAGKEKLVLLEFMANGDLHRW-LHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGL 544 (690)
Q Consensus 466 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl 544 (690)
.....+... ..++||||++++++... +.. ..++..+...++.|++.++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~-----------------------------~~~~~~~~~~i~~~l~~~l 130 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKD-----------------------------VPLEEEEAEELYEQVVEQM 130 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhh-----------------------------ccCCHHHHHHHHHHHHHHH
Confidence 655444433 34899999998755433 322 2456778899999999999
Q ss_pred Hhhhh-cCCCCCCCCCCcEEecCCCCceEcCCCccccc
Q 005572 545 AYLHH-VGSTHGHLVTSSILLAESLEPKIAGFGLRNIG 581 (690)
Q Consensus 545 ~yLH~-~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~ 581 (690)
.|+|+ .+++||||||+||+++ ++.++|+|||++...
T Consensus 131 ~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~ 167 (190)
T cd05145 131 RRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVEL 167 (190)
T ss_pred HHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceec
Confidence 99999 9999999999999999 899999999998754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.9e-19 Score=172.57 Aligned_cols=137 Identities=14% Similarity=0.091 Sum_probs=106.6
Q ss_pred CCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhc-----CCCCccceeeEEecCC---eeE-
Q 005572 409 FGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-----KHPNLLPLAGYCIAGK---EKL- 479 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l-----~H~niv~l~g~~~~~~---~~~- 479 (690)
+.....||+|+||.||. ...++. .+||++........+.+.+|+++++.+ +||||++++|++++.. ..+
T Consensus 4 L~~~~~LG~G~~~~Vy~-hp~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA-HPEDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred cCCcceecCCCceEEEE-CCCCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 44567899999999996 333343 479988765444567899999999999 5799999999998863 334
Q ss_pred EEEEe--cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH-HhhhhcCCCCCC
Q 005572 480 VLLEF--MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGL-AYLHHVGSTHGH 556 (690)
Q Consensus 480 lv~e~--~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl-~yLH~~~~iHrD 556 (690)
+|+|| +++|+|.+++.+. .+++. ..++.|++.++ +|||+++|+|||
T Consensus 82 ~I~e~~G~~~~tL~~~l~~~-----------------------------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrD 130 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQC-----------------------------RYEED--VAQLRQLLKKLKRYLLDNRIVTME 130 (210)
T ss_pred EEecCCCCcchhHHHHHHcc-----------------------------cccHh--HHHHHHHHHHHHHHHHHCCEeecC
Confidence 78999 6689999999651 23333 35677888887 999999999999
Q ss_pred CCCCcEEecC----CCCceEcCCCcc
Q 005572 557 LVTSSILLAE----SLEPKIAGFGLR 578 (690)
Q Consensus 557 lk~~NiLl~~----~~~~kl~DfGla 578 (690)
|||+|||++. ++.++|+||+.+
T Consensus 131 lKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 131 LKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9999999974 347999995433
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.2e-18 Score=182.23 Aligned_cols=243 Identities=19% Similarity=0.174 Sum_probs=171.3
Q ss_pred cCCCCceeccCCCccEEEEEcCC--CcEEEEEEeeccCCCCHHHHHHHHHHHHhcCC----CCccceeeEE-ecCCeeEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLPG--ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKH----PNLLPLAGYC-IAGKEKLV 480 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~~--~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H----~niv~l~g~~-~~~~~~~l 480 (690)
+|...+.||+|+||.||.|.... ...+|+|.-..........+..|..++..+.+ +++..+++.. ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 78889999999999999999443 35788888765533333367888888888863 5888888888 46778899
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
||+.+ +-+|.++.... ....++..+..+|+.|+..+|+++|+.|++||||||.
T Consensus 99 VM~l~-G~sL~dl~~~~--------------------------~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~ 151 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRN--------------------------PPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPE 151 (322)
T ss_pred EEecc-CccHHHHHHhC--------------------------CCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHH
Confidence 99998 66999977642 1357888999999999999999999999999999999
Q ss_pred cEEecCC-----CCceEcCCCccc--ccccc-----cCccc-----------------CCCCCCCCCcchhhHHHHHHHH
Q 005572 561 SILLAES-----LEPKIAGFGLRN--IGVKN-----VGERS-----------------ENETCGPESDVYCFGVILMELL 611 (690)
Q Consensus 561 NiLl~~~-----~~~kl~DfGla~--~~~~~-----~~e~~-----------------~~~~~~~~~DVwSfGvvl~el~ 611 (690)
|+++... ..+.+.|||+++ ..... .+++. .....+.+-|+||++-++.|+.
T Consensus 152 N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~ 231 (322)
T KOG1164|consen 152 NFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELL 231 (322)
T ss_pred HeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHh
Confidence 9999865 468999999998 32111 11111 1124467899999999999999
Q ss_pred hCCCCCCchHHH--HHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhccCC
Q 005572 612 TGKRGTDDCVKW--VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 612 tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i~~ 685 (690)
.|..||...... ........ ....... .......++..+... +-..+..++|....+...|++...
T Consensus 232 ~g~LPW~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~---~~~~~~~~~Pdy~~~~~~l~~~~~ 299 (322)
T KOG1164|consen 232 KGSLPWEALEMTDLKSKFEKDP-RKLLTDR----FGDLKPEEFAKILEY---IDSLDYEDKPDYEKLAELLKDVFD 299 (322)
T ss_pred cCCCCCccccccchHHHHHHHh-hhhcccc----ccCCChHHHHHHHHH---hhccCCcCCCCHHHHHHHHHHHHH
Confidence 999998653211 11111110 0000010 111133344333332 334688999999999888766543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.79 E-value=4.9e-18 Score=178.12 Aligned_cols=241 Identities=22% Similarity=0.246 Sum_probs=176.7
Q ss_pred CCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCC---CHHHHHHHHHHHHhcCCC-CccceeeEEecCCeeEEEEEe
Q 005572 409 FGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI---DHDDAVAMFDELSRLKHP-NLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 409 ~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~~e~~~l~~l~H~-niv~l~g~~~~~~~~~lv~e~ 484 (690)
|.....||.|+||.||++... ..+++|.+...... ....+.+|...++.+.|+ +|+++.+++......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455678999999999999976 67899998655432 367789999999999988 799999999777778999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+.++++.+++..... ...+.......+..|++.++.|+|+.+++|||+||+||++
T Consensus 80 ~~~~~l~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~ 134 (384)
T COG0515 80 VDGGSLEDLLKKIGR-------------------------KGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL 134 (384)
T ss_pred CCCCcHHHHHHhccc-------------------------ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee
Confidence 999999977765110 0257788899999999999999999999999999999999
Q ss_pred cCCC-CceEcCCCccccccc-----------c---------cCcccCC---CCCCCCCcchhhHHHHHHHHhCCCCCCch
Q 005572 565 AESL-EPKIAGFGLRNIGVK-----------N---------VGERSEN---ETCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 565 ~~~~-~~kl~DfGla~~~~~-----------~---------~~e~~~~---~~~~~~~DVwSfGvvl~el~tg~~p~~~~ 620 (690)
+... .+|++|||.++.... . +||.... ..+....|+||+|++++++++|..|+...
T Consensus 135 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~ 214 (384)
T COG0515 135 DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGE 214 (384)
T ss_pred cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9988 799999998763221 0 3343333 46778999999999999999999997653
Q ss_pred H-----HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHH
Q 005572 621 V-----KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 621 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~ 679 (690)
. ............. .......... .........++...|+..+|..|.++.+....
T Consensus 215 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 215 KNSSATSQTLKIILELPTP-SLASPLSPSN--PELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred CccccHHHHHHHHHhcCCc-ccccccCccc--cchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 2 2222322222111 0000111000 01111234455667889999999998877653
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=8.1e-20 Score=189.03 Aligned_cols=209 Identities=21% Similarity=0.271 Sum_probs=140.5
Q ss_pred cCCCccccccCCCCCCc--CCCCCCCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEE
Q 005572 36 SSVSTFNISWLKPTNLN--GSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVN 113 (690)
Q Consensus 36 ~~~~~~~~~~~~~~~~~--~~~~~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 113 (690)
..+..++++.+.+..+. +.....++++|+|++|.|+.+-- ..|+++.+|.+|.|+.|+++...+..|..|+.|+.|+
T Consensus 149 ~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~-~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~Ld 227 (873)
T KOG4194|consen 149 PALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLET-GHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLD 227 (873)
T ss_pred hhhhhhhhhhchhhcccCCCCCCCCCceEEeecccccccccc-ccccccchheeeecccCcccccCHHHhhhcchhhhhh
Confidence 34455555555444333 22233589999999999987665 4468889999999999999988888898899999999
Q ss_pred ccCccCCCcc--------------------CCCCCCCCCCCCCCcEEEccCCCCCCcc--ccCCCCCCcEEEccCCCCcc
Q 005572 114 LSKNRFGGTI--------------------GFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLRI 171 (690)
Q Consensus 114 L~~N~l~g~i--------------------~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~L~~L~ls~N~l~~ 171 (690)
|..|++.-.- .......|..+.++++|+|+.|+++.+. -+-+++.|+.|+||+|.|..
T Consensus 228 LnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~r 307 (873)
T KOG4194|consen 228 LNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQR 307 (873)
T ss_pred ccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhhe
Confidence 9999875210 0001112333445556666666665543 24556777777777777764
Q ss_pred C-CccCCCCCCCcEEEcccCcCCcCCCC-cccccccceeecccccCCCCCCCCCCCCCCCCEEEeeCCCCccccCc
Q 005572 172 L-PSGFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGH 245 (690)
Q Consensus 172 ~-p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g~~~~ 245 (690)
| ++++..+++|+.|+||+|+|+...+. +..|+.|+.|+|++|.++..-...|..+++|+.|||++|.+++-|-+
T Consensus 308 ih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IED 383 (873)
T KOG4194|consen 308 IHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIED 383 (873)
T ss_pred eecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEec
Confidence 3 45666777777777777777643322 44467777777777777766666777778888888888888776643
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4e-18 Score=161.13 Aligned_cols=168 Identities=17% Similarity=0.101 Sum_probs=124.2
Q ss_pred CCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCC----CHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEEEe
Q 005572 410 GKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI----DHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 410 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
.+...|++|+||+||.+.- ++..++.+.+.....- ...-+.+|+++|+++. |++|.+++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3457899999999997766 5667777777544321 1124788999999995 5889999886 446899999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC-CCCcEE
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL-VTSSIL 563 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl-k~~NiL 563 (690)
+++.+|.+.+.. ....++.|++++|.|+|++|++|||| ||.|||
T Consensus 80 I~G~~L~~~~~~-----------------------------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NIL 124 (218)
T PRK12274 80 LAGAAMYQRPPR-----------------------------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWL 124 (218)
T ss_pred ecCccHHhhhhh-----------------------------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEE
Confidence 999888654321 01346789999999999999999999 799999
Q ss_pred ecCCCCceEcCCCccccccccc----------------------Cccc-CCC-----CCC-CCCcchhhHHHHHHHHhCC
Q 005572 564 LAESLEPKIAGFGLRNIGVKNV----------------------GERS-ENE-----TCG-PESDVYCFGVILMELLTGK 614 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~~~----------------------~e~~-~~~-----~~~-~~~DVwSfGvvl~el~tg~ 614 (690)
++.++.++|+|||++....... |+.. +.+ ..+ .+.+.++-|.-+|.++|++
T Consensus 125 v~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~ 204 (218)
T PRK12274 125 VQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRR 204 (218)
T ss_pred EcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhcc
Confidence 9999999999999997543321 1111 100 111 2456778999999999998
Q ss_pred CCC
Q 005572 615 RGT 617 (690)
Q Consensus 615 ~p~ 617 (690)
.+.
T Consensus 205 ~~~ 207 (218)
T PRK12274 205 VLH 207 (218)
T ss_pred CCc
Confidence 874
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.3e-19 Score=199.24 Aligned_cols=236 Identities=20% Similarity=0.196 Sum_probs=160.3
Q ss_pred CCceeccCCCccEEEEE-cCCCcEEEEEEeecc--CCCCHHH----HHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 411 KESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA--KGIDHDD----AVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 411 ~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~----~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
..+.+|.|++|.|+... .......+.|..... ....... +..|+-+=..++|||++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45789999999877776 333333444433210 1111111 3445555678899999998888877777666699
Q ss_pred ecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEE
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiL 563 (690)
||++ ||+.++.. ...++..++..+..|+..|+.|+|+.|+.|||+|++|++
T Consensus 402 ~~~~-Dlf~~~~~----------------------------~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll 452 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS----------------------------NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLL 452 (601)
T ss_pred cccH-HHHHHHhc----------------------------ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEE
Confidence 9999 99999865 235777788899999999999999999999999999999
Q ss_pred ecCCCCceEcCCCccccccc--------------ccCcccCCC----CCCC-CCcchhhHHHHHHHHhCCCCCCchHHHH
Q 005572 564 LAESLEPKIAGFGLRNIGVK--------------NVGERSENE----TCGP-ESDVYCFGVILMELLTGKRGTDDCVKWV 624 (690)
Q Consensus 564 l~~~~~~kl~DfGla~~~~~--------------~~~e~~~~~----~~~~-~~DVwSfGvvl~el~tg~~p~~~~~~~~ 624 (690)
++.++.+||+|||.+..... ..||.+||. .|.+ ..||||.||++..|++|+.||.......
T Consensus 453 ~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 453 VTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD 532 (601)
T ss_pred EecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence 99999999999998754321 156666553 4544 5899999999999999999986421110
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHH-HHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEM-VESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
.......... ......+.......+ .+...++.++++.||.+|-|+.+|++
T Consensus 533 ~~~~~~~~~~---~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~ 584 (601)
T KOG0590|consen 533 NSFKTNNYSD---QRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN 584 (601)
T ss_pred cchhhhcccc---ccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence 0000000000 000000000011111 12345778899999999999999986
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.3e-17 Score=160.46 Aligned_cols=241 Identities=15% Similarity=0.154 Sum_probs=170.2
Q ss_pred ccCCCCceeccCCCccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEEEe
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
-+|.+.++||+|+||+++.|+ +-++++||||.=...+ +.-++..|.+..+.+. .++|...+.|-.++-+-.+|+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 368889999999999999998 7778899999865443 3345777888877775 58888887776677777899999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
. |-||.|+..- ..+.++..++..+|.|+..-++|+|++..|.|||||+|+||
T Consensus 106 L-GPSLEDLFD~---------------------------CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLI 157 (449)
T KOG1165|consen 106 L-GPSLEDLFDL---------------------------CGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLI 157 (449)
T ss_pred h-CcCHHHHHHH---------------------------hcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceee
Confidence 8 6688887653 35678999999999999999999999999999999999999
Q ss_pred cCC-----CCceEcCCCcccccccc-----cCcccCC----------------CCCCCCCcchhhHHHHHHHHhCCCCCC
Q 005572 565 AES-----LEPKIAGFGLRNIGVKN-----VGERSEN----------------ETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 565 ~~~-----~~~kl~DfGla~~~~~~-----~~e~~~~----------------~~~~~~~DVwSfGvvl~el~tg~~p~~ 618 (690)
..- ..+.|.|||+|+...+. .||+-.. ..-+.+-|.=|+|=+++..+-|..||.
T Consensus 158 Grp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQ 237 (449)
T KOG1165|consen 158 GRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 237 (449)
T ss_pred cCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccc
Confidence 743 45899999999876432 3433211 123457899999999999999999998
Q ss_pred chHHHHHHHHHh--cCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 619 DCVKWVRKLVKE--GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 619 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
++.....+..-+ +..... ..+..-+....+|+...++.+.+ .+-++-|..+-+...+.+
T Consensus 238 GLKA~tnK~kYeKIGe~Kr~--T~i~~Lc~g~P~efa~Yl~yvR~---L~F~E~PDYdylr~Lf~d 298 (449)
T KOG1165|consen 238 GLKADTNKEKYEKIGETKRS--TPIEVLCEGFPEEFATYLRYVRR---LDFFETPDYDYLRKLFDD 298 (449)
T ss_pred cccCcchHHHHHHhcccccc--CCHHHHHhcCHHHHHHHHHHHHh---cCcccCCCHHHHHHHHHH
Confidence 743221111111 111111 11111223345566555554433 355666766655554443
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=161.72 Aligned_cols=134 Identities=18% Similarity=0.267 Sum_probs=112.4
Q ss_pred ceeccCCCccEEEEEcCCCcEEEEEEeeccCCCC--------HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 413 SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGID--------HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--------~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+.||+|++|.||+|.. .+..+++|+........ ...+.+|++.+..++|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5789999999999987 45578899765332111 23467889999999999998888888777888999999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
+++++|.+++... .+ .+..++.+++.+|.++|+.+++|||++|.|||+
T Consensus 81 ~~G~~L~~~~~~~-------------------------------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~ 128 (211)
T PRK14879 81 IEGEPLKDLINSN-------------------------------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL 128 (211)
T ss_pred eCCcCHHHHHHhc-------------------------------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE
Confidence 9999999998641 12 678899999999999999999999999999999
Q ss_pred cCCCCceEcCCCcccc
Q 005572 565 AESLEPKIAGFGLRNI 580 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~ 580 (690)
+ ++.++|+|||.++.
T Consensus 129 ~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 129 S-GGKIYLIDFGLAEF 143 (211)
T ss_pred E-CCCEEEEECCcccC
Confidence 9 88999999998764
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.4e-18 Score=189.05 Aligned_cols=234 Identities=21% Similarity=0.236 Sum_probs=168.5
Q ss_pred cCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccC-CCCHHHHHHHHHH--HHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 408 HFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAK-GIDHDDAVAMFDE--LSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~~e~~~--l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++...+-+|.++|=.|.||+.+.|. |+||++-+.. ....+.+.++++. ...++|||++.+.-+-......|+|=+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566678999999999999988885 9999985544 3455666665555 4556899999988877777778888888
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
..+ +|+|.|..++ -+...+..=|+.|+..|+.-+|..++.|||||.+||||
T Consensus 103 vkh-nLyDRlSTRP----------------------------FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi 153 (1431)
T KOG1240|consen 103 VKH-NLYDRLSTRP----------------------------FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI 153 (1431)
T ss_pred Hhh-hhhhhhccch----------------------------HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE
Confidence 855 8988886532 25566777799999999999999999999999999999
Q ss_pred cCCCCceEcCCCccccc--c-cc------------------cCcccCCC-----------CCCCCCcchhhHHHHHHHHh
Q 005572 565 AESLEPKIAGFGLRNIG--V-KN------------------VGERSENE-----------TCGPESDVYCFGVILMELLT 612 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~--~-~~------------------~~e~~~~~-----------~~~~~~DVwSfGvvl~el~t 612 (690)
++-.-+.|+||.--+.. . ++ |||++-.. ..+++.||||.||++.||++
T Consensus 154 TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~ 233 (1431)
T KOG1240|consen 154 TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFL 233 (1431)
T ss_pred eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHh
Confidence 99999999999753321 1 11 66665331 26789999999999999988
Q ss_pred -CCCCCCchHHHHHHHHHhcCCCCccccc--cccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhcc
Q 005572 613 -GKRGTDDCVKWVRKLVKEGAGGDALDFR--LKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 613 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~i 683 (690)
|++||.- .+++...... ..++. +..-.... +.++++.+++.||++|-++++.++.=+++
T Consensus 234 Eg~PlF~L-----SQL~aYr~~~-~~~~e~~Le~Ied~~------~Rnlil~Mi~rdPs~RlSAedyL~~yrG~ 295 (1431)
T KOG1240|consen 234 EGRPLFTL-----SQLLAYRSGN-ADDPEQLLEKIEDVS------LRNLILSMIQRDPSKRLSAEDYLQKYRGL 295 (1431)
T ss_pred cCCCcccH-----HHHHhHhccC-ccCHHHHHHhCcCcc------HHHHHHHHHccCchhccCHHHHHHhhhcc
Confidence 6777752 1222211111 11111 11111112 33455669999999999999999875554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=163.89 Aligned_cols=144 Identities=15% Similarity=0.127 Sum_probs=109.6
Q ss_pred HHhccCCCCceeccCCCccEEEEE--cCCCcEEEEEEeeccCCC-------------------C-----HHHHHHHHHHH
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGI-------------------D-----HDDAVAMFDEL 457 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~~vavK~l~~~~~~-------------------~-----~~~~~~e~~~l 457 (690)
.....|...+.||+|+||.||+|. ..+|..||+|+++..... . ...+..|++.+
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 333457788999999999999998 677999999998753210 0 12246788899
Q ss_pred HhcCCCC--ccceeeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q 005572 458 SRLKHPN--LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHR 535 (690)
Q Consensus 458 ~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 535 (690)
.++.|.. +.+++++ ...++||||+++++|..+... ...+...+...
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----------------------------~~~~~~~~~~~ 152 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----------------------------DVEPEEEEEFE 152 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc----------------------------cCCcchHHHHH
Confidence 9887533 3344443 235899999999888765422 11234455678
Q ss_pred HHHHHHHHHHhhhhcC-CCCCCCCCCcEEecCCCCceEcCCCcccc
Q 005572 536 IAIGVARGLAYLHHVG-STHGHLVTSSILLAESLEPKIAGFGLRNI 580 (690)
Q Consensus 536 i~~~ia~gl~yLH~~~-~iHrDlk~~NiLl~~~~~~kl~DfGla~~ 580 (690)
++.|++.+++|||+.+ ++||||||+||+++ +++++|+|||.+..
T Consensus 153 i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 153 LYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred HHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 9999999999999999 99999999999999 88999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.6e-17 Score=158.67 Aligned_cols=143 Identities=17% Similarity=0.126 Sum_probs=110.0
Q ss_pred HHHHHHhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCC----------------------CHHHHHHHHHHH
Q 005572 400 KDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI----------------------DHDDAVAMFDEL 457 (690)
Q Consensus 400 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~----------------------~~~~~~~e~~~l 457 (690)
.++......|...+.||+|+||.||++...++..||||+++..... .......|...+
T Consensus 8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 87 (198)
T cd05144 8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL 87 (198)
T ss_pred HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence 3444444447777899999999999999888999999987643210 011356788888
Q ss_pred HhcCCCC--ccceeeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHH
Q 005572 458 SRLKHPN--LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHR 535 (690)
Q Consensus 458 ~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 535 (690)
..+.|++ +...++ ....++||||+++++|.+.... .....
T Consensus 88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------------------------------~~~~~ 129 (198)
T cd05144 88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------------------------------EDPEE 129 (198)
T ss_pred HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------------------------------ccHHH
Confidence 8888874 444443 2456899999999998765321 12456
Q ss_pred HHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCcccc
Q 005572 536 IAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNI 580 (690)
Q Consensus 536 i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~ 580 (690)
++.++++++.++|+.+++||||||+||+++++++++|+|||++..
T Consensus 130 ~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 130 VLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred HHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence 889999999999999999999999999999999999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.5e-17 Score=182.80 Aligned_cols=136 Identities=20% Similarity=0.247 Sum_probs=110.5
Q ss_pred cCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCC-------CHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI-------DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~-------~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
.|...+.||+|+||.||+|.+.+...++.+.+...... ..+.+.+|++.+..++|++++....++......++
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l 413 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI 413 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence 34557899999999999999765543333323221111 12457889999999999999998888888778899
Q ss_pred EEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCC
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~ 560 (690)
||||+++++|.+++.. +..++.|++++|.|||+.+++|||+||+
T Consensus 414 v~E~~~g~~L~~~l~~------------------------------------~~~~~~~i~~~L~~lH~~giiHrDlkp~ 457 (535)
T PRK09605 414 VMEYIGGKDLKDVLEG------------------------------------NPELVRKVGEIVAKLHKAGIVHGDLTTS 457 (535)
T ss_pred EEEecCCCcHHHHHHH------------------------------------HHHHHHHHHHHHHHHHhCCCccCCCChH
Confidence 9999999999988742 4568999999999999999999999999
Q ss_pred cEEecCCCCceEcCCCcccc
Q 005572 561 SILLAESLEPKIAGFGLRNI 580 (690)
Q Consensus 561 NiLl~~~~~~kl~DfGla~~ 580 (690)
|||+ +++.++|+|||+++.
T Consensus 458 NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 458 NFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred HEEE-ECCcEEEEeCccccc
Confidence 9999 678999999999875
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.2e-18 Score=180.49 Aligned_cols=209 Identities=22% Similarity=0.322 Sum_probs=154.3
Q ss_pred CCCccccccCCCCCCc--CCCCCCCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCC------------------
Q 005572 37 SVSTFNISWLKPTNLN--GSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLK------------------ 96 (690)
Q Consensus 37 ~~~~~~~~~~~~~~~~--~~~~~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~------------------ 96 (690)
++..|+++.+.++.+. +.....+|..|.|+.|+++...+ ..|.+|++|+.|||..|+|.
T Consensus 174 ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~-r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlkl 252 (873)
T KOG4194|consen 174 NIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQ-RSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKL 252 (873)
T ss_pred CceEEeeccccccccccccccccchheeeecccCcccccCH-HHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhh
Confidence 3455666666666554 23333578888888888876544 45566777777777777654
Q ss_pred ------CCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCcc--ccCCCCCCcEEEccCCC
Q 005572 97 ------GSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNND 168 (690)
Q Consensus 97 ------~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~L~~L~ls~N~ 168 (690)
..-.+.|+.+.+++.|+|+.|+++..- ......+++|+.|+||+|.|+.+. ......+|+.|+|++|+
T Consensus 253 qrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn----~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~ 328 (873)
T KOG4194|consen 253 QRNDISKLDDGAFYGLEKMEHLNLETNRLQAVN----EGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNR 328 (873)
T ss_pred hhcCcccccCcceeeecccceeecccchhhhhh----cccccccchhhhhccchhhhheeecchhhhcccceeEeccccc
Confidence 333456777777888888888875331 334556899999999999999873 35556899999999999
Q ss_pred CccCCc-cCCCCCCCcEEEcccCcCCcCCCC-cccccccceeecccccCCCCCCC---CCCCCCCCCEEEeeCCCCcccc
Q 005572 169 LRILPS-GFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNSMNGTFPS---DFPPLSGVKFLNISLNKFTGFV 243 (690)
Q Consensus 169 l~~~p~-~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~---~~~~l~~L~~l~l~~N~~~g~~ 243 (690)
|+.+++ +|..+..|+.|+|+.|+++-.-.. +..+.+|+.|||++|.|++.+.+ .|..+++|+.|++.+|++.. |
T Consensus 329 i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~-I 407 (873)
T KOG4194|consen 329 ITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKS-I 407 (873)
T ss_pred cccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeee-c
Confidence 998875 588899999999999999732222 56689999999999999887653 47889999999999999874 4
Q ss_pred Cchhhhcc
Q 005572 244 GHDKYQKF 251 (690)
Q Consensus 244 ~~~~~~~~ 251 (690)
+...+..+
T Consensus 408 ~krAfsgl 415 (873)
T KOG4194|consen 408 PKRAFSGL 415 (873)
T ss_pred chhhhccC
Confidence 44444433
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.70 E-value=9e-17 Score=156.18 Aligned_cols=130 Identities=22% Similarity=0.277 Sum_probs=105.9
Q ss_pred eeccCCCccEEEEEcCCCcEEEEEEeeccCC-CC-------HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEec
Q 005572 414 LLAEGRCGPVYRAVLPGELHVAIKVLDNAKG-ID-------HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~-------~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
.||+|+||.||+|.+. +..+++|....... .. ...+.+|++.+..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999964 56789998643221 11 244668999999999887766666666667789999999
Q ss_pred CCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEec
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~ 565 (690)
++++|.+++... . ..++.+++++|.++|+.+++|||++|.||+++
T Consensus 80 ~g~~l~~~~~~~----------------------------~-------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~ 124 (199)
T TIGR03724 80 EGKPLKDVIEEG----------------------------N-------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR 124 (199)
T ss_pred CCccHHHHHhhc----------------------------H-------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE
Confidence 999999887541 0 06899999999999999999999999999999
Q ss_pred CCCCceEcCCCcccc
Q 005572 566 ESLEPKIAGFGLRNI 580 (690)
Q Consensus 566 ~~~~~kl~DfGla~~ 580 (690)
++.+++.|||+++.
T Consensus 125 -~~~~~liDfg~a~~ 138 (199)
T TIGR03724 125 -DDKLYLIDFGLGKY 138 (199)
T ss_pred -CCcEEEEECCCCcC
Confidence 89999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.3e-18 Score=153.57 Aligned_cols=167 Identities=25% Similarity=0.397 Sum_probs=137.1
Q ss_pred CcCCCCCCCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCC
Q 005572 51 LNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSR 130 (690)
Q Consensus 51 ~~~~~~~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~ 130 (690)
+.|....++++.|.||+|+|+-+.| .+..+.+|+.|++++|+|. ..|..++.++.|+.|++..|++.- .|..
T Consensus 26 ~~gLf~~s~ITrLtLSHNKl~~vpp--nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~~-----lprg 97 (264)
T KOG0617|consen 26 LPGLFNMSNITRLTLSHNKLTVVPP--NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLNI-----LPRG 97 (264)
T ss_pred cccccchhhhhhhhcccCceeecCC--cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhhc-----Cccc
Confidence 4455555688999999999997766 4688999999999999999 678889999999999999999863 2778
Q ss_pred CCCCCCCcEEEccCCCCCCcc---ccCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCCcCCCCcccccccce
Q 005572 131 NGPFPSVQVLNLSSNRFTNLV---KLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKY 207 (690)
Q Consensus 131 ~~~l~~L~~L~Ls~N~l~~~~---~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~ 207 (690)
||.+|.|+.|||++|++..-. .|-.++.|..|+|++|.++.+|..++++++|+.|.+..|.+-..+..++.++.|++
T Consensus 98 fgs~p~levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll~lpkeig~lt~lre 177 (264)
T KOG0617|consen 98 FGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLLSLPKEIGDLTRLRE 177 (264)
T ss_pred cCCCchhhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchhhCcHHHHHHHHHHH
Confidence 999999999999999987642 35556778888999999999998899999999999998887655555788888889
Q ss_pred eecccccCCCCCCCCCCCC
Q 005572 208 LDVSNNSMNGTFPSDFPPL 226 (690)
Q Consensus 208 L~Ls~N~l~~~~~~~~~~l 226 (690)
|.+.+|+++ .+|..++.+
T Consensus 178 lhiqgnrl~-vlppel~~l 195 (264)
T KOG0617|consen 178 LHIQGNRLT-VLPPELANL 195 (264)
T ss_pred Hhcccceee-ecChhhhhh
Confidence 999998887 455555543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.1e-17 Score=174.69 Aligned_cols=178 Identities=24% Similarity=0.256 Sum_probs=143.7
Q ss_pred eeccCCCccEEEEE-c---CCCcEEEEEEeeccCC--CCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEEEecC
Q 005572 414 LLAEGRCGPVYRAV-L---PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 414 ~lg~G~~g~Vy~~~-~---~~~~~vavK~l~~~~~--~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
.+|+|.||.|+.++ . ..+..+|.|++++... ........|..++..++ ||.+|++...+......+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37999999999875 2 3367788888865432 22234566778888887 9999999999999999999999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecC
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~ 566 (690)
+|+|...+.+ ....+......+...+|-|++++|+.+++|||+|++||+++.
T Consensus 81 gg~lft~l~~----------------------------~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~ 132 (612)
T KOG0603|consen 81 GGDLFTRLSK----------------------------EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLL 132 (612)
T ss_pred cchhhhcccc----------------------------CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecc
Confidence 9999887765 234566666777788999999999999999999999999999
Q ss_pred CCCceEcCCCcccccccc------cCcccCCC--CCCCCCcchhhHHHHHHHHhCCCCCCc
Q 005572 567 SLEPKIAGFGLRNIGVKN------VGERSENE--TCGPESDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 567 ~~~~kl~DfGla~~~~~~------~~e~~~~~--~~~~~~DVwSfGvvl~el~tg~~p~~~ 619 (690)
+|.+|+.|||+++..... .-|++++- .....+|.||||++++||+||-.||..
T Consensus 133 ~Ghi~~tdfglske~v~~~~~cgt~eymApEI~~gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 133 EGHIKLTDFGLSKEAVKEKIACGTYEYRAPEIINGHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cCccccCCchhhhHhHhhhhcccchhhhhhHhhhccCCcccchhhhhhHHHHhhCCCCCch
Confidence 999999999998764322 22333331 577899999999999999999999976
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.7e-18 Score=180.22 Aligned_cols=213 Identities=23% Similarity=0.312 Sum_probs=131.8
Q ss_pred chhhhhHHhh--cCCCccccccCCCCCCc-CCCCCCCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCcc
Q 005572 26 KDQELVSKAF--SSVSTFNISWLKPTNLN-GSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGW 102 (690)
Q Consensus 26 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~-~~~~~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~ 102 (690)
+.....++.| ..++.++++.+....+. +.....++..|+||+|+|..++ ...+-+|+.|-.||||+|++. .+|+.
T Consensus 91 KnsGiP~diF~l~dLt~lDLShNqL~EvP~~LE~AKn~iVLNLS~N~IetIP-n~lfinLtDLLfLDLS~NrLe-~LPPQ 168 (1255)
T KOG0444|consen 91 KNSGIPTDIFRLKDLTILDLSHNQLREVPTNLEYAKNSIVLNLSYNNIETIP-NSLFINLTDLLFLDLSNNRLE-MLPPQ 168 (1255)
T ss_pred ccCCCCchhcccccceeeecchhhhhhcchhhhhhcCcEEEEcccCccccCC-chHHHhhHhHhhhccccchhh-hcCHH
Confidence 3333344444 45666666665543332 2222346667777777776443 344566777777777777776 33444
Q ss_pred ccCCccCcEEEccCccCCCc----------------------cCCC----------------------CCCCCCCCCCCc
Q 005572 103 FWSTQSLTQVNLSKNRFGGT----------------------IGFK----------------------PTSRNGPFPSVQ 138 (690)
Q Consensus 103 ~~~l~~L~~L~L~~N~l~g~----------------------i~~~----------------------~~~~~~~l~~L~ 138 (690)
+..|.+|+.|+|++|.+.-. ..-. -|...-.+++|+
T Consensus 169 ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~Lr 248 (1255)
T KOG0444|consen 169 IRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLR 248 (1255)
T ss_pred HHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhh
Confidence 56666666666666644200 0000 022333455566
Q ss_pred EEEccCCCCCCcc-ccCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCC--cCCCCcccccccceeecccccC
Q 005572 139 VLNLSSNRFTNLV-KLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS--GNIKPVSFLHSLKYLDVSNNSM 215 (690)
Q Consensus 139 ~L~Ls~N~l~~~~-~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~--~~~~~~~~l~~L~~L~Ls~N~l 215 (690)
.|+||+|+|+.+. ......+|++|+||.|+++.+|+.++++++|+.|.+.+|+++ |.+..++.|..|+.+..++|.+
T Consensus 249 rLNLS~N~iteL~~~~~~W~~lEtLNlSrNQLt~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~Levf~aanN~L 328 (1255)
T KOG0444|consen 249 RLNLSGNKITELNMTEGEWENLETLNLSRNQLTVLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQLEVFHAANNKL 328 (1255)
T ss_pred eeccCcCceeeeeccHHHHhhhhhhccccchhccchHHHhhhHHHHHHHhccCcccccCCccchhhhhhhHHHHhhcccc
Confidence 6666666666542 234456777888888888888888888888888888888765 4444477777888888888877
Q ss_pred CCCCCCCCCCCCCCCEEEeeCCCCcc
Q 005572 216 NGTFPSDFPPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 216 ~~~~~~~~~~l~~L~~l~l~~N~~~g 241 (690)
+ .+|..++.+..|+.|.|+.|++..
T Consensus 329 E-lVPEglcRC~kL~kL~L~~NrLiT 353 (1255)
T KOG0444|consen 329 E-LVPEGLCRCVKLQKLKLDHNRLIT 353 (1255)
T ss_pred c-cCchhhhhhHHHHHhcccccceee
Confidence 5 677777777777777777777643
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.66 E-value=4e-18 Score=177.56 Aligned_cols=175 Identities=25% Similarity=0.324 Sum_probs=142.5
Q ss_pred CCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCC
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137 (690)
Q Consensus 58 ~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L 137 (690)
..|+.||||+|+|...+ ..+..-+++.+|+||+|+|.......|-+|.-|-.||||+|++.-. |+..-.+..|
T Consensus 103 ~dLt~lDLShNqL~EvP--~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe~L-----PPQ~RRL~~L 175 (1255)
T KOG0444|consen 103 KDLTILDLSHNQLREVP--TNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLEML-----PPQIRRLSML 175 (1255)
T ss_pred ccceeeecchhhhhhcc--hhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhhhc-----CHHHHHHhhh
Confidence 57999999999998764 4567788999999999999955556688999999999999998532 3344556778
Q ss_pred cEEEccCCCCCCc---------------------------cccCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccC
Q 005572 138 QVLNLSSNRFTNL---------------------------VKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSC 190 (690)
Q Consensus 138 ~~L~Ls~N~l~~~---------------------------~~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N 190 (690)
++|+||+|.+..+ +.+..+.+|..+|+|.|++..+|..+.++.+|+.|+||+|
T Consensus 176 qtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp~vPecly~l~~LrrLNLS~N 255 (1255)
T KOG0444|consen 176 QTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLPIVPECLYKLRNLRRLNLSGN 255 (1255)
T ss_pred hhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCCcchHHHhhhhhhheeccCcC
Confidence 8888888876421 1234567788899999999999999999999999999999
Q ss_pred cCCcCCCCcccccccceeecccccCCCCCCCCCCCCCCCCEEEeeCCCCc
Q 005572 191 KISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240 (690)
Q Consensus 191 ~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~ 240 (690)
+|+..--..+.+.+|+.|+||.|+++ .+|..+..++.|+.|.+.+|+++
T Consensus 256 ~iteL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~ 304 (1255)
T KOG0444|consen 256 KITELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLT 304 (1255)
T ss_pred ceeeeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCccc
Confidence 99854444566888999999999997 77888889999999999999865
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.9e-16 Score=153.49 Aligned_cols=179 Identities=18% Similarity=0.198 Sum_probs=121.2
Q ss_pred CCCCccceeeEEec---------------------------CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCC
Q 005572 461 KHPNLLPLAGYCIA---------------------------GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWD 513 (690)
Q Consensus 461 ~H~niv~l~g~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~ 513 (690)
+|||||++.+++.+ +...|+||.-++. +|+.|+-.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~----------------- 335 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT----------------- 335 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-----------------
Confidence 59999999987754 1247899988755 89999864
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe--cCCCC--ceEcCCCccccccc------
Q 005572 514 HHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL--AESLE--PKIAGFGLRNIGVK------ 583 (690)
Q Consensus 514 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl--~~~~~--~kl~DfGla~~~~~------ 583 (690)
...+...+.-|..|+.+|+.|||.+++.|||+|+.|||+ |+|+. ..|+|||.+---..
T Consensus 336 ------------~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp 403 (598)
T KOG4158|consen 336 ------------RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP 403 (598)
T ss_pred ------------CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc
Confidence 234455667788899999999999999999999999998 45554 57899997532111
Q ss_pred --------------ccCcccCCC------CCCCCCcchhhHHHHHHHHhCCCCCCchHHHHHH--HHHhcCCCCcccccc
Q 005572 584 --------------NVGERSENE------TCGPESDVYCFGVILMELLTGKRGTDDCVKWVRK--LVKEGAGGDALDFRL 641 (690)
Q Consensus 584 --------------~~~e~~~~~------~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~ 641 (690)
.+||++... .--.|+|.|+.|-+.||+++...||..-.+...+ -.++.+ -+.+
T Consensus 404 y~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q-----LPal 478 (598)
T KOG4158|consen 404 YESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ-----LPAL 478 (598)
T ss_pred cccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh-----CCCC
Confidence 045543221 1124899999999999999999999762211110 011111 1223
Q ss_pred ccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHH
Q 005572 642 KLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680 (690)
Q Consensus 642 ~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L 680 (690)
+..++....+++ ...++.||++||+..-....|
T Consensus 479 p~~vpp~~rqlV------~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 479 PSRVPPVARQLV------FDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred cccCChHHHHHH------HHHhcCCccccCCccHHHhHH
Confidence 333333344443 347899999999987666554
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.7e-16 Score=157.92 Aligned_cols=215 Identities=26% Similarity=0.398 Sum_probs=139.4
Q ss_pred cccCcchhhhhHHhhcCCCccccccCCCCCCcC---CCCC------------------------CCccEEEccCCCCCCC
Q 005572 21 STCNSKDQELVSKAFSSVSTFNISWLKPTNLNG---SNPS------------------------TPIRELNLSSRNLSGI 73 (690)
Q Consensus 21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------------------------~~l~~L~Ls~n~l~~~ 73 (690)
..|+....+.++.....++.+...|+..+.+.- .... .++..|||.+|+|...
T Consensus 188 ld~~~N~L~tlP~~lg~l~~L~~LyL~~Nki~~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~ 267 (565)
T KOG0472|consen 188 LDCNSNLLETLPPELGGLESLELLYLRRNKIRFLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEV 267 (565)
T ss_pred cccchhhhhcCChhhcchhhhHHHHhhhcccccCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccC
Confidence 457777777777777777777666655443321 1111 3466667777777654
Q ss_pred CchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCC---------Cc----------c---C-------
Q 005572 74 ISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG---------GT----------I---G------- 124 (690)
Q Consensus 74 ~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~---------g~----------i---~------- 124 (690)
+. .+..+.+|.+||+|+|.|++ .|-.++++ +|+.|-|.+|.+. |+ + +
T Consensus 268 Pd--e~clLrsL~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~ 343 (565)
T KOG0472|consen 268 PD--EICLLRSLERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGG 343 (565)
T ss_pred ch--HHHHhhhhhhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCccc
Confidence 32 34556677777777777774 34456666 6777777777552 00 0 0
Q ss_pred -----CCCCCCC-------------------CCCC----------CCcEEEccCCCCCCcc-------------------
Q 005572 125 -----FKPTSRN-------------------GPFP----------SVQVLNLSSNRFTNLV------------------- 151 (690)
Q Consensus 125 -----~~~~~~~-------------------~~l~----------~L~~L~Ls~N~l~~~~------------------- 151 (690)
..++..+ ...| -.+..+++.|++..++
T Consensus 344 ~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~ 423 (565)
T KOG0472|consen 344 TETAMTLPSESFPDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNK 423 (565)
T ss_pred ccccCCCCCCcccchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCc
Confidence 0000000 0000 1456677777776442
Q ss_pred ------ccCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCCcC----------------------CCC--ccc
Q 005572 152 ------KLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGN----------------------IKP--VSF 201 (690)
Q Consensus 152 ------~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~----------------------~~~--~~~ 201 (690)
.++.+++|+.|+|++|.+..+|..++.+..|+.||+|.|+|... +++ +..
T Consensus 424 isfv~~~l~~l~kLt~L~L~NN~Ln~LP~e~~~lv~Lq~LnlS~NrFr~lP~~~y~lq~lEtllas~nqi~~vd~~~l~n 503 (565)
T KOG0472|consen 424 ISFVPLELSQLQKLTFLDLSNNLLNDLPEEMGSLVRLQTLNLSFNRFRMLPECLYELQTLETLLASNNQIGSVDPSGLKN 503 (565)
T ss_pred cccchHHHHhhhcceeeecccchhhhcchhhhhhhhhheecccccccccchHHHhhHHHHHHHHhccccccccChHHhhh
Confidence 14568999999999999999999999999999999999998521 111 344
Q ss_pred ccccceeecccccCCCCCCCCCCCCCCCCEEEeeCCCCc
Q 005572 202 LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240 (690)
Q Consensus 202 l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~ 240 (690)
+.+|..|||.+|.+. .+|..++++.+|++|++.+|.|.
T Consensus 504 m~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 504 MRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 667788888888886 67777888888888888888876
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.2e-15 Score=152.32 Aligned_cols=188 Identities=16% Similarity=0.198 Sum_probs=117.9
Q ss_pred CCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcC----------CCCccceeeEEe--
Q 005572 410 GKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLK----------HPNLLPLAGYCI-- 473 (690)
Q Consensus 410 ~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~----------H~niv~l~g~~~-- 473 (690)
...+.||.|+|+.||.++. .+++.+|||+...... ...+++.+|.-.+..+. |-.++--++...
T Consensus 15 ~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~ 94 (288)
T PF14531_consen 15 VRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIP 94 (288)
T ss_dssp EEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEET
T ss_pred EEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEc
Confidence 3457899999999999994 5689999999854332 23345555554444322 222222222221
Q ss_pred -------cCC--------eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHH
Q 005572 474 -------AGK--------EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAI 538 (690)
Q Consensus 474 -------~~~--------~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~ 538 (690)
... ..+++|+-+ -+||.+++..-.... .....+....++.+..
T Consensus 95 ~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~---------------------~~~~~l~~~arl~lT~ 152 (288)
T PF14531_consen 95 GKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRA---------------------QTHSPLAFAARLSLTV 152 (288)
T ss_dssp TS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHT---------------------TTSHHHHHHHHHHHHH
T ss_pred CCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcc---------------------cccchhHHHHHHHHHH
Confidence 111 236778877 459988865310000 0012345667788889
Q ss_pred HHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCcccccccc-----------cCccc--------CCCCCCCCCc
Q 005572 539 GVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN-----------VGERS--------ENETCGPESD 599 (690)
Q Consensus 539 ~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~-----------~~e~~--------~~~~~~~~~D 599 (690)
|+.+.+++||+.|++|+||||+|++++.+|.++|+||+-....... +||.. ....++.+.|
T Consensus 153 Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~D 232 (288)
T PF14531_consen 153 QMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATD 232 (288)
T ss_dssp HHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHH
T ss_pred HHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccC
Confidence 9999999999999999999999999999999999999864332211 22222 1124788999
Q ss_pred chhhHHHHHHHHhCCCCCCc
Q 005572 600 VYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 600 VwSfGvvl~el~tg~~p~~~ 619 (690)
.|++|+++|.|.+|+.||+.
T Consensus 233 aW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 233 AWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp HHHHHHHHHHHHHSS-STCC
T ss_pred HHHHHHHHHHHHHccCCCCC
Confidence 99999999999999999974
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=7.3e-15 Score=141.22 Aligned_cols=135 Identities=16% Similarity=0.153 Sum_probs=96.0
Q ss_pred CceeccCCCccEEEEEcCCCcEEEEEEeeccCCCC--HHHH----------------------HHHHHHHHhcCCCC--c
Q 005572 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGID--HDDA----------------------VAMFDELSRLKHPN--L 465 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~--~~~~----------------------~~e~~~l~~l~H~n--i 465 (690)
.+.||+|+||.||+|...++..||||+++...... .... ..|.+.+..+.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999997788899999986532211 1111 23445555554332 3
Q ss_pred cceeeEEecCCeeEEEEEecCCCCHhhh-hhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
Q 005572 466 LPLAGYCIAGKEKLVLLEFMANGDLHRW-LHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGL 544 (690)
Q Consensus 466 v~l~g~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl 544 (690)
.+.+++ ...++||||+++|.+... +.. .... .+...++.+++.++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~-----------------------------~~~~-~~~~~~~~~~~~~l 127 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD-----------------------------VRLL-EDPEELYDQILELM 127 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh-----------------------------hhhc-ccHHHHHHHHHHHH
Confidence 444432 346899999998654321 111 0000 45678999999999
Q ss_pred Hhhhh-cCCCCCCCCCCcEEecCCCCceEcCCCccccc
Q 005572 545 AYLHH-VGSTHGHLVTSSILLAESLEPKIAGFGLRNIG 581 (690)
Q Consensus 545 ~yLH~-~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~ 581 (690)
.++|. .+++||||||+||+++ ++.++++|||.+...
T Consensus 128 ~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 128 RKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred HHHhhccCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 99999 9999999999999999 999999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.59 E-value=5e-15 Score=166.82 Aligned_cols=121 Identities=26% Similarity=0.264 Sum_probs=86.6
Q ss_pred cCcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCccccCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEc
Q 005572 108 SLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDI 187 (690)
Q Consensus 108 ~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~l 187 (690)
+|+.|+|++|+|++. |. ..++|+.|++++|+|+.++.+ ..+|+.|++++|+|+.+|... ++|+.|++
T Consensus 343 ~Lq~LdLS~N~Ls~L-----P~---lp~~L~~L~Ls~N~L~~LP~l--~~~L~~LdLs~N~Lt~LP~l~---s~L~~LdL 409 (788)
T PRK15387 343 GLQELSVSDNQLASL-----PT---LPSELYKLWAYNNRLTSLPAL--PSGLKELIVSGNRLTSLPVLP---SELKELMV 409 (788)
T ss_pred ccceEecCCCccCCC-----CC---CCcccceehhhccccccCccc--ccccceEEecCCcccCCCCcc---cCCCEEEc
Confidence 566666666666532 11 123566666667766665533 357888888888888777543 56888888
Q ss_pred ccCcCCcCCCCcccccccceeecccccCCCCCCCCCCCCCCCCEEEeeCCCCccccCc
Q 005572 188 SSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGH 245 (690)
Q Consensus 188 s~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g~~~~ 245 (690)
++|+|++ +|.. ..+|+.|+|++|+|+ .+|..+..+++|+.|+|++|+|+|.++.
T Consensus 410 S~N~Lss-IP~l--~~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 410 SGNRLTS-LPML--PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred cCCcCCC-CCcc--hhhhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 8888874 4432 356888999999997 6788888899999999999999987664
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=1.7e-14 Score=143.39 Aligned_cols=135 Identities=18% Similarity=0.216 Sum_probs=104.3
Q ss_pred Cceec-cCCCccEEEEEcCCCcEEEEEEeeccC-------------CCCHHHHHHHHHHHHhcCCCCc--cceeeEEecC
Q 005572 412 ESLLA-EGRCGPVYRAVLPGELHVAIKVLDNAK-------------GIDHDDAVAMFDELSRLKHPNL--LPLAGYCIAG 475 (690)
Q Consensus 412 ~~~lg-~G~~g~Vy~~~~~~~~~vavK~l~~~~-------------~~~~~~~~~e~~~l~~l~H~ni--v~l~g~~~~~ 475 (690)
...|| .|+.|+||++... +..++||...... ......+.+|++.+..++|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 35687 8999999999876 4578888774311 1123457889999999998875 6777775442
Q ss_pred C----eeEEEEEecCC-CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc
Q 005572 476 K----EKLVLLEFMAN-GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV 550 (690)
Q Consensus 476 ~----~~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~ 550 (690)
. ..++|+||+++ .+|.+++... .++. ..+.++++++.+||+.
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----------------------------~l~~----~~~~~i~~~l~~lH~~ 161 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-----------------------------PLSE----EQWQAIGQLIARFHDA 161 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-----------------------------CCCH----HHHHHHHHHHHHHHHC
Confidence 2 23599999997 6999888541 1222 2367899999999999
Q ss_pred CCCCCCCCCCcEEecCCCCceEcCCCcccc
Q 005572 551 GSTHGHLVTSSILLAESLEPKIAGFGLRNI 580 (690)
Q Consensus 551 ~~iHrDlk~~NiLl~~~~~~kl~DfGla~~ 580 (690)
|++||||||.|||++.++.++|+|||.+..
T Consensus 162 GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 162 GVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 999999999999999999999999998875
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=3e-17 Score=145.08 Aligned_cols=158 Identities=28% Similarity=0.398 Sum_probs=134.5
Q ss_pred cCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCcc-ccCCCCC
Q 005572 80 RNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV-KLSQFSK 158 (690)
Q Consensus 80 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~~ 158 (690)
-++++.+.|-||+|+++. +|.-+..+.+|+.|++++|++... |..++.++.|+.|+++-|++..++ .|+.++.
T Consensus 30 f~~s~ITrLtLSHNKl~~-vppnia~l~nlevln~~nnqie~l-----p~~issl~klr~lnvgmnrl~~lprgfgs~p~ 103 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLTV-VPPNIAELKNLEVLNLSNNQIEEL-----PTSISSLPKLRILNVGMNRLNILPRGFGSFPA 103 (264)
T ss_pred cchhhhhhhhcccCceee-cCCcHHHhhhhhhhhcccchhhhc-----ChhhhhchhhhheecchhhhhcCccccCCCch
Confidence 356788889999999994 455688999999999999997643 566788999999999999988775 5899999
Q ss_pred CcEEEccCCCCc--cCCccCCCCCCCcEEEcccCcCCcCCCCcccccccceeecccccCCCCCCCCCCCCCCCCEEEeeC
Q 005572 159 LMVLDVSNNDLR--ILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISL 236 (690)
Q Consensus 159 L~~L~ls~N~l~--~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~ 236 (690)
|++|||++|++. .+|..|..+..|+.|+|+.|.|.-.++.++.+++|+.|.+.+|.+- ..|..++.+..|+.|.+.+
T Consensus 104 levldltynnl~e~~lpgnff~m~tlralyl~dndfe~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqg 182 (264)
T KOG0617|consen 104 LEVLDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFEILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQG 182 (264)
T ss_pred hhhhhccccccccccCCcchhHHHHHHHHHhcCCCcccCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhccc
Confidence 999999999996 5888888899999999999998755555888999999999999985 7788899999999999999
Q ss_pred CCCccccC
Q 005572 237 NKFTGFVG 244 (690)
Q Consensus 237 N~~~g~~~ 244 (690)
|+++-..|
T Consensus 183 nrl~vlpp 190 (264)
T KOG0617|consen 183 NRLTVLPP 190 (264)
T ss_pred ceeeecCh
Confidence 99886554
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=6.9e-15 Score=166.61 Aligned_cols=184 Identities=19% Similarity=0.216 Sum_probs=139.0
Q ss_pred HHHHHhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcC---CCCccceeeEEecCCe
Q 005572 401 DLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK---HPNLLPLAGYCIAGKE 477 (690)
Q Consensus 401 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~---H~niv~l~g~~~~~~~ 477 (690)
+.......|.+.+.||+|+||.||+|...++..||+|+=+.... + +|.--.+++.+|+ -+-|+.+...+...+.
T Consensus 692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~-W--EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~ 768 (974)
T KOG1166|consen 692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP-W--EFYICLQVMERLKPQMLPSIMHISSAHVFQNA 768 (974)
T ss_pred eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc-e--eeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence 34445567888899999999999999977799999998654321 1 1222223444444 2345555555566778
Q ss_pred eEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCC
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDl 557 (690)
-++|+||.+.|+|.+++.. .+.++|.-.+.++.|+++-++.||..+|||+||
T Consensus 769 S~lv~ey~~~Gtlld~~N~----------------------------~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDi 820 (974)
T KOG1166|consen 769 SVLVSEYSPYGTLLDLINT----------------------------NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDI 820 (974)
T ss_pred ceeeeeccccccHHHhhcc----------------------------CCCCCchhhhHHHHHHHHHHHHHHhcceecccC
Confidence 8899999999999999963 356889999999999999999999999999999
Q ss_pred CCCcEEec-------CCCCceEcCCCcccccccc----------------cCcccCCCCCCCCCcchhhHHHHHHHHhCC
Q 005572 558 VTSSILLA-------ESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLTGK 614 (690)
Q Consensus 558 k~~NiLl~-------~~~~~kl~DfGla~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~ 614 (690)
||+|+||. ++..++|+|||.+-...-- -.|+..+..++.+.|-|.+.-+++-|+-|+
T Consensus 821 KPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 821 KPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK 900 (974)
T ss_pred CcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence 99999994 3456899999987432210 234555567788888888888888888876
Q ss_pred C
Q 005572 615 R 615 (690)
Q Consensus 615 ~ 615 (690)
.
T Consensus 901 y 901 (974)
T KOG1166|consen 901 Y 901 (974)
T ss_pred H
Confidence 4
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.54 E-value=3.3e-14 Score=131.18 Aligned_cols=131 Identities=19% Similarity=0.149 Sum_probs=110.3
Q ss_pred CceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCC--CCccceeeEEecCCeeEEEEEecCCCC
Q 005572 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKH--PNLLPLAGYCIAGKEKLVLLEFMANGD 489 (690)
Q Consensus 412 ~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~~~~lv~e~~~~gs 489 (690)
.+.||+|.++.||++...+ ..+++|....... ...+.+|+..+..++| .++.+++++....+..++++||++++.
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~ 79 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET 79 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence 4679999999999999765 5799999865432 4678899999999976 599999998888888999999998876
Q ss_pred HhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhc---CCCCCCCCCCcEEecC
Q 005572 490 LHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHV---GSTHGHLVTSSILLAE 566 (690)
Q Consensus 490 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~---~~iHrDlk~~NiLl~~ 566 (690)
+..+ ++.....++.+++++++++|.. +++|+|++|+||++++
T Consensus 80 ~~~~-----------------------------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~ 124 (155)
T cd05120 80 LDEV-----------------------------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDD 124 (155)
T ss_pred cccC-----------------------------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEEC
Confidence 5432 3455677899999999999985 6899999999999999
Q ss_pred CCCceEcCCCcccc
Q 005572 567 SLEPKIAGFGLRNI 580 (690)
Q Consensus 567 ~~~~kl~DfGla~~ 580 (690)
.+.+++.|||.++.
T Consensus 125 ~~~~~l~Df~~~~~ 138 (155)
T cd05120 125 GKILGIIDWEYAGY 138 (155)
T ss_pred CcEEEEEecccccC
Confidence 89999999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.49 E-value=9.1e-14 Score=157.69 Aligned_cols=181 Identities=23% Similarity=0.383 Sum_probs=85.3
Q ss_pred ccccccCCCCCCcCCCCCCCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccC
Q 005572 40 TFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119 (690)
Q Consensus 40 ~~~~~~~~~~~~~~~~~~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 119 (690)
.+.+..+..+.+....+ ..|+.|+|++|+|+.. |... .++|+.|+|++|+|+. +|..+. ++|+.|+|++|++
T Consensus 182 ~L~L~~~~LtsLP~~Ip-~~L~~L~Ls~N~LtsL-P~~l---~~nL~~L~Ls~N~Lts-LP~~l~--~~L~~L~Ls~N~L 253 (754)
T PRK15370 182 ELRLKILGLTTIPACIP-EQITTLILDNNELKSL-PENL---QGNIKTLYANSNQLTS-IPATLP--DTIQEMELSINRI 253 (754)
T ss_pred EEEeCCCCcCcCCcccc-cCCcEEEecCCCCCcC-Chhh---ccCCCEEECCCCcccc-CChhhh--ccccEEECcCCcc
Confidence 34444443333333222 3566667777766643 3222 2356666666666663 343332 3466666666665
Q ss_pred CCccCCCCCCCCCCCCCCcEEEccCCCCCCccccCCCCCCcEEEccCCCCccCCccCCC-------------------CC
Q 005572 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFAN-------------------LS 180 (690)
Q Consensus 120 ~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~p~~~~~-------------------l~ 180 (690)
.. + |..+ ..+|+.|+|++|+|+.++. ...++|+.|++++|+|+.+|..+.. .+
T Consensus 254 ~~-L----P~~l--~s~L~~L~Ls~N~L~~LP~-~l~~sL~~L~Ls~N~Lt~LP~~lp~sL~~L~Ls~N~Lt~LP~~l~~ 325 (754)
T PRK15370 254 TE-L----PERL--PSALQSLDLFHNKISCLPE-NLPEELRYLSVYDNSIRTLPAHLPSGITHLNVQSNSLTALPETLPP 325 (754)
T ss_pred Cc-C----ChhH--hCCCCEEECcCCccCcccc-ccCCCCcEEECCCCccccCcccchhhHHHHHhcCCccccCCccccc
Confidence 42 2 1111 1245556666665554432 1123555555555555555443220 13
Q ss_pred CCcEEEcccCcCCcCCCCcccccccceeecccccCCCCCCCCCCCCCCCCEEEeeCCCCcc
Q 005572 181 KLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 181 ~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g 241 (690)
+|+.|++++|.+++ +|. ...++|+.|+|++|+|+ .+|..+. ++|+.|++++|+++.
T Consensus 326 sL~~L~Ls~N~Lt~-LP~-~l~~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt~ 381 (754)
T PRK15370 326 GLKTLEAGENALTS-LPA-SLPPELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALTN 381 (754)
T ss_pred cceeccccCCcccc-CCh-hhcCcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCCC
Confidence 44555555555443 221 11245555555555554 2333332 345555555555553
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.4e-14 Score=150.57 Aligned_cols=159 Identities=21% Similarity=0.279 Sum_probs=112.5
Q ss_pred eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCC
Q 005572 477 EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 477 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrD 556 (690)
..||.|++|...+|.+||..+++ ....+|...+.++.|++.|+.| ++.+|||
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~-------------------------~e~~s~s~~~~~~~q~~~~~~y---k~~ihrd 381 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRT-------------------------GEERSLSLMLDIFKQIAPAVEY---KGLIHRD 381 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCc-------------------------ccccchhHHHHHHHhhccchhh---ccchhhh
Confidence 57899999999999999986543 3346788889999999999999 9999999
Q ss_pred CCCCcEEecCCCCceEcCCCcccccccc--------------------cCcccCCCCCCCCCcchhhHHHHHHHHh-CCC
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN--------------------VGERSENETCGPESDVYCFGVILMELLT-GKR 615 (690)
Q Consensus 557 lk~~NiLl~~~~~~kl~DfGla~~~~~~--------------------~~e~~~~~~~~~~~DVwSfGvvl~el~t-g~~ 615 (690)
+||.||....+..+||.|||+....... .||......|+.|+||||+|++|+|+++ =..
T Consensus 382 lkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T 461 (516)
T KOG1033|consen 382 LKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFST 461 (516)
T ss_pred ccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhcc
Confidence 9999999999999999999996432211 3455555689999999999999999988 333
Q ss_pred CCCchHHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHH
Q 005572 616 GTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQV 676 (690)
Q Consensus 616 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev 676 (690)
+++.+.. ........+++...... + .-..+..+.+...|.+||++.++
T Consensus 462 ~~er~~t------~~d~r~g~ip~~~~~d~--p-----~e~~ll~~lls~~p~~RP~~~~~ 509 (516)
T KOG1033|consen 462 QFERIAT------LTDIRDGIIPPEFLQDY--P-----EEYTLLQQLLSPSPEERPSAIEV 509 (516)
T ss_pred HHHHHHh------hhhhhcCCCChHHhhcC--c-----HHHHHHHHhcCCCcccCchHHHH
Confidence 3332111 01111122222222222 1 11233345789999999955443
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.4e-16 Score=153.48 Aligned_cols=172 Identities=26% Similarity=0.407 Sum_probs=124.2
Q ss_pred CccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCc
Q 005572 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138 (690)
Q Consensus 59 ~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~ 138 (690)
.+..|+..+|+++..++ . +.++..|..|++.+|+++...|..+. ++.|+.||+..|-++. + |+..+.+.+|.
T Consensus 138 ~l~dl~~~~N~i~slp~-~-~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~t-l----P~~lg~l~~L~ 209 (565)
T KOG0472|consen 138 DLEDLDATNNQISSLPE-D-MVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLET-L----PPELGGLESLE 209 (565)
T ss_pred hhhhhhccccccccCch-H-HHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhhc-C----ChhhcchhhhH
Confidence 46666777777765543 2 34566777777777777766555554 7777777777776642 2 55677777888
Q ss_pred EEEccCCCCCCccccCCCCCCcEEEccCCCCccCCccCC-CCCCCcEEEcccCcCCcCCCCcccccccceeecccccCCC
Q 005572 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFA-NLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNG 217 (690)
Q Consensus 139 ~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~p~~~~-~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 217 (690)
-|+|..|.+..+++|.+++.|..|+++.|+|+.+|.... ++++|..|||..|++...+..+..+.+|+.||+|+|.|+
T Consensus 210 ~LyL~~Nki~~lPef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklke~Pde~clLrsL~rLDlSNN~is- 288 (565)
T KOG0472|consen 210 LLYLRRNKIRFLPEFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLKEVPDEICLLRSLERLDLSNNDIS- 288 (565)
T ss_pred HHHhhhcccccCCCCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccccCchHHHHhhhhhhhcccCCccc-
Confidence 888888888888888888888888888888888876644 778888888888888754444666777888888888887
Q ss_pred CCCCCCCCCCCCCEEEeeCCCCc
Q 005572 218 TFPSDFPPLSGVKFLNISLNKFT 240 (690)
Q Consensus 218 ~~~~~~~~l~~L~~l~l~~N~~~ 240 (690)
..|..++++ .|+.|-+.+|.+.
T Consensus 289 ~Lp~sLgnl-hL~~L~leGNPlr 310 (565)
T KOG0472|consen 289 SLPYSLGNL-HLKFLALEGNPLR 310 (565)
T ss_pred cCCcccccc-eeeehhhcCCchH
Confidence 455677777 7888888887764
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.46 E-value=2.6e-13 Score=153.05 Aligned_cols=176 Identities=26% Similarity=0.288 Sum_probs=87.2
Q ss_pred CCCccccccCCCCCCcCCCCCCCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccC
Q 005572 37 SVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSK 116 (690)
Q Consensus 37 ~~~~~~~~~~~~~~~~~~~~~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 116 (690)
++..|.+..+..+.+.. ..++|++|+|++|+|+.+.+ . .++|+.|+|++|.|+. +|..+ .+|+.|+|++
T Consensus 223 ~L~~L~L~~N~Lt~LP~--lp~~Lk~LdLs~N~LtsLP~--l---p~sL~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls~ 291 (788)
T PRK15387 223 HITTLVIPDNNLTSLPA--LPPELRTLEVSGNQLTSLPV--L---PPGLLELSIFSNPLTH-LPALP---SGLCKLWIFG 291 (788)
T ss_pred CCCEEEccCCcCCCCCC--CCCCCcEEEecCCccCcccC--c---ccccceeeccCCchhh-hhhch---hhcCEEECcC
Confidence 34455554444444332 23589999999999986532 1 3456666666666663 23221 3345555555
Q ss_pred ccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCccccC------------------CCCCCcEEEccCCCCccCCccCCC
Q 005572 117 NRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLS------------------QFSKLMVLDVSNNDLRILPSGFAN 178 (690)
Q Consensus 117 N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~------------------~~~~L~~L~ls~N~l~~~p~~~~~ 178 (690)
|+++.. +. .+++|+.|+|++|+|++++.+. ...+|+.|+|++|+|+.+|...
T Consensus 292 N~Lt~L-----P~---~p~~L~~LdLS~N~L~~Lp~lp~~L~~L~Ls~N~L~~LP~lp~~Lq~LdLS~N~Ls~LP~lp-- 361 (788)
T PRK15387 292 NQLTSL-----PV---LPPGLQELSVSDNQLASLPALPSELCKLWAYNNQLTSLPTLPSGLQELSVSDNQLASLPTLP-- 361 (788)
T ss_pred Cccccc-----cc---cccccceeECCCCccccCCCCcccccccccccCccccccccccccceEecCCCccCCCCCCC--
Confidence 554421 11 1234555555555555433210 1124555555555555554321
Q ss_pred CCCCcEEEcccCcCCcCCCCcccccccceeecccccCCCCCCCCCCCCCCCCEEEeeCCCCcc
Q 005572 179 LSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 179 l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g 241 (690)
.+|+.|++++|+|+. +|.. ..+|+.|+|++|+|++ +|.. .++|+.|++++|++++
T Consensus 362 -~~L~~L~Ls~N~L~~-LP~l--~~~L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss 416 (788)
T PRK15387 362 -SELYKLWAYNNRLTS-LPAL--PSGLKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS 416 (788)
T ss_pred -cccceehhhcccccc-Cccc--ccccceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC
Confidence 334445555555542 3221 2345566666666553 3322 1345556666666554
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.45 E-value=3e-13 Score=153.57 Aligned_cols=162 Identities=26% Similarity=0.378 Sum_probs=119.8
Q ss_pred CCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCC
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137 (690)
Q Consensus 58 ~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L 137 (690)
.+.+.|+|++++|+..+. .+ .+.|+.|+|++|+|+. +|..+. ++|+.|+|++|+|+. + +..+ .++|
T Consensus 178 ~~~~~L~L~~~~LtsLP~--~I--p~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lts-L----P~~l--~~~L 243 (754)
T PRK15370 178 NNKTELRLKILGLTTIPA--CI--PEQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTS-I----PATL--PDTI 243 (754)
T ss_pred cCceEEEeCCCCcCcCCc--cc--ccCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCcccc-C----Chhh--hccc
Confidence 367899999999997532 23 3579999999999995 565443 589999999999874 2 2222 3479
Q ss_pred cEEEccCCCCCCccccCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCCcCCCCcccccccceeecccccCCC
Q 005572 138 QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNG 217 (690)
Q Consensus 138 ~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 217 (690)
+.|+|++|+++.++. ...++|+.|++++|+|+.+|..+. .+|+.|++++|+|++ +|. ...++|+.|++++|+++.
T Consensus 244 ~~L~Ls~N~L~~LP~-~l~s~L~~L~Ls~N~L~~LP~~l~--~sL~~L~Ls~N~Lt~-LP~-~lp~sL~~L~Ls~N~Lt~ 318 (754)
T PRK15370 244 QEMELSINRITELPE-RLPSALQSLDLFHNKISCLPENLP--EELRYLSVYDNSIRT-LPA-HLPSGITHLNVQSNSLTA 318 (754)
T ss_pred cEEECcCCccCcCCh-hHhCCCCEEECcCCccCccccccC--CCCcEEECCCCcccc-Ccc-cchhhHHHHHhcCCcccc
Confidence 999999999997753 123689999999999999998764 589999999999985 332 122467777777777764
Q ss_pred CCCCCCCCCCCCCEEEeeCCCCcc
Q 005572 218 TFPSDFPPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 218 ~~~~~~~~l~~L~~l~l~~N~~~g 241 (690)
+|..+. ++|+.|++++|.+++
T Consensus 319 -LP~~l~--~sL~~L~Ls~N~Lt~ 339 (754)
T PRK15370 319 -LPETLP--PGLKTLEAGENALTS 339 (754)
T ss_pred -CCcccc--ccceeccccCCcccc
Confidence 343332 466677777777665
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=1.3e-13 Score=153.28 Aligned_cols=149 Identities=25% Similarity=0.384 Sum_probs=106.1
Q ss_pred hccCCCCceeccCCCccEEEEEcC-CCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
..+|+.+++|..|+||.||.++.. ..+.+|.|+ .+. ..+.+ ||..+. +..++|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq-----~lilR-----------nilt~a------~npfvv--- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQ-----NLILR-----------NILTFA------GNPFVV--- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-ccc-----chhhh-----------cccccc------CCccee---
Confidence 357888999999999999999854 466788843 221 11111 222222 122222
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
||-...++. ...++ .+.+.+++|||+.+|+|||+||.|.+|
T Consensus 136 ---gDc~tllk~----------------------------~g~lP--------vdmvla~Eylh~ygivhrdlkpdnllI 176 (1205)
T KOG0606|consen 136 ---GDCATLLKN----------------------------IGPLP--------VDMVLAVEYLHSYGIVHRDLKPDNLLI 176 (1205)
T ss_pred ---chhhhhccc----------------------------CCCCc--------chhhHHhHhhccCCeecCCCCCCccee
Confidence 565555543 11121 122788999999999999999999999
Q ss_pred cCCCCceEcCCCcccccccc-----------------------------cCcccCCCCCCCCCcchhhHHHHHHHHhCCC
Q 005572 565 AESLEPKIAGFGLRNIGVKN-----------------------------VGERSENETCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~-----------------------------~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
+.-|.+|+.|||+.+..... +||+...+.|+..+|.|++|+++||.+.|..
T Consensus 177 T~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcv 256 (1205)
T KOG0606|consen 177 TSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCV 256 (1205)
T ss_pred eecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeee
Confidence 99999999999997643211 4445555689999999999999999999999
Q ss_pred CCCc
Q 005572 616 GTDD 619 (690)
Q Consensus 616 p~~~ 619 (690)
||..
T Consensus 257 pffG 260 (1205)
T KOG0606|consen 257 PFFG 260 (1205)
T ss_pred eccC
Confidence 9865
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=6e-15 Score=161.35 Aligned_cols=127 Identities=30% Similarity=0.460 Sum_probs=101.6
Q ss_pred CccCcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCccc--cCCCCCCcEEEccCCCCccCCccCCCCCCCc
Q 005572 106 TQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSGFANLSKLR 183 (690)
Q Consensus 106 l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~ 183 (690)
++.|+.|+|.+|+|+... -+.+-.+..|+.|+|++|++..++. +.++..|+.|+||+|+|+.+|..+.++..|+
T Consensus 358 ~~~Lq~LylanN~Ltd~c----~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~ 433 (1081)
T KOG0618|consen 358 HAALQELYLANNHLTDSC----FPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLTTLPDTVANLGRLH 433 (1081)
T ss_pred hHHHHHHHHhcCcccccc----hhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhH
Confidence 456788888888887665 3345567788999999998888763 7788888899999999998888888888999
Q ss_pred EEEcccCcCCcCCCCcccccccceeecccccCCC-CCCCCCCCCCCCCEEEeeCCC
Q 005572 184 HLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNG-TFPSDFPPLSGVKFLNISLNK 238 (690)
Q Consensus 184 ~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~-~~~~~~~~l~~L~~l~l~~N~ 238 (690)
.|...+|++. ..|.+..++.|+.+|+|.|+++- .+|...+. ++|++|||++|.
T Consensus 434 tL~ahsN~l~-~fPe~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 434 TLRAHSNQLL-SFPELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNT 487 (1081)
T ss_pred HHhhcCCcee-echhhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCc
Confidence 9999888887 55678888999999999999874 34444433 789999999986
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.44 E-value=9.2e-15 Score=159.91 Aligned_cols=182 Identities=25% Similarity=0.403 Sum_probs=135.6
Q ss_pred CCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCC----------------------CCCccccCCccCcEEEcc
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKG----------------------SVPGWFWSTQSLTQVNLS 115 (690)
Q Consensus 58 ~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~----------------------~~p~~~~~l~~L~~L~L~ 115 (690)
.+|+.++++.|++++.. .+++.+.+|+.|+..+|+|+. .+|....++++|+.|+|.
T Consensus 241 ~nl~~~dis~n~l~~lp--~wi~~~~nle~l~~n~N~l~~lp~ri~~~~~L~~l~~~~nel~yip~~le~~~sL~tLdL~ 318 (1081)
T KOG0618|consen 241 LNLQYLDISHNNLSNLP--EWIGACANLEALNANHNRLVALPLRISRITSLVSLSAAYNELEYIPPFLEGLKSLRTLDLQ 318 (1081)
T ss_pred ccceeeecchhhhhcch--HHHHhcccceEecccchhHHhhHHHHhhhhhHHHHHhhhhhhhhCCCcccccceeeeeeeh
Confidence 47888888888888764 567777888888888887742 234444557777777777
Q ss_pred CccCCCcc---------------------CCCCCCCCCCCCCCcEEEccCCCCCCc--cccCCCCCCcEEEccCCCCccC
Q 005572 116 KNRFGGTI---------------------GFKPTSRNGPFPSVQVLNLSSNRFTNL--VKLSQFSKLMVLDVSNNDLRIL 172 (690)
Q Consensus 116 ~N~l~g~i---------------------~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~~~~~~~~L~~L~ls~N~l~~~ 172 (690)
.|++.... +..+...-..++.|+.|+|.+|.|+.- +.+.++.+|+.|+|++|+|..+
T Consensus 319 ~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~f 398 (1081)
T KOG0618|consen 319 SNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSF 398 (1081)
T ss_pred hccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccC
Confidence 77764221 011111111234567777777777653 4577889999999999999999
Q ss_pred Ccc-CCCCCCCcEEEcccCcCCcCCCCcccccccceeecccccCCCCCCCCCCCCCCCCEEEeeCCCCcccc
Q 005572 173 PSG-FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFV 243 (690)
Q Consensus 173 p~~-~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g~~ 243 (690)
|++ +.++..|+.|+||+|+|+.....+..+..|++|...+|+|. .+| .+..+++|+++|++.|+++-..
T Consensus 399 pas~~~kle~LeeL~LSGNkL~~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~ 468 (1081)
T KOG0618|consen 399 PASKLRKLEELEELNLSGNKLTTLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVT 468 (1081)
T ss_pred CHHHHhchHHhHHHhcccchhhhhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhh
Confidence 975 78999999999999999854444777899999999999997 566 7888999999999999998643
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.43 E-value=6.1e-13 Score=143.72 Aligned_cols=145 Identities=21% Similarity=0.144 Sum_probs=101.0
Q ss_pred ccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCC--------------------------CHH------------
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI--------------------------DHD------------ 448 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~--------------------------~~~------------ 448 (690)
..|+. +.||.|++|.||+|++.+|+.||||+.+..-.. +..
T Consensus 118 ~~fd~-~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 118 AEFEE-KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred hhCCC-cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 34553 679999999999999999999999998543100 000
Q ss_pred --HHHHHHHHHHhc----CCCCccceeeEEec-CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCC
Q 005572 449 --DAVAMFDELSRL----KHPNLLPLAGYCIA-GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521 (690)
Q Consensus 449 --~~~~e~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 521 (690)
++.+|.+.+.++ +|.+-+.+-.++++ ....++||||++|++|.++.....
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~----------------------- 253 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE----------------------- 253 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh-----------------------
Confidence 133344444443 23333333333332 345789999999999988765311
Q ss_pred CCCCCCCCHHHHHHHHHHHHH-HHHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCcccccc
Q 005572 522 ISSPEKTNWVTRHRIAIGVAR-GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGV 582 (690)
Q Consensus 522 ~~~~~~l~~~~~~~i~~~ia~-gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 582 (690)
... ++..++.++++ .+..+|..|++|+|++|.||++++++++++.|||++....
T Consensus 254 ----~~~---~~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 254 ----AGL---DRKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ----cCC---CHHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 011 24457777766 4788999999999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=6.1e-14 Score=156.12 Aligned_cols=238 Identities=20% Similarity=0.199 Sum_probs=160.3
Q ss_pred cCCCCceeccCCCccEEEEEcC--CCcEEEEEEeeccC--CCCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeEEEE
Q 005572 408 HFGKESLLAEGRCGPVYRAVLP--GELHVAIKVLDNAK--GIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 408 ~~~~~~~lg~G~~g~Vy~~~~~--~~~~vavK~l~~~~--~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~ 482 (690)
.|...+.||+|+|+.|-..... ....+|+|.+.... ....+....|..+=..+. |+|++++++.....+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 4555667999999999888743 34556677664332 112233344555545555 999999999999999999999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh-hcCCCCCCCCCCc
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH-HVGSTHGHLVTSS 561 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~iHrDlk~~N 561 (690)
||.++|++.+.+... .....+......+..|+..|+.|+| ..++.|||+||+|
T Consensus 101 ~~s~g~~~f~~i~~~--------------------------~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n 154 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHP--------------------------DSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSN 154 (601)
T ss_pred CcccccccccccccC--------------------------CccCCCCcchhhhhhhhccCccccCcccccccCCCCCcc
Confidence 999999998877310 0112334456678999999999999 9999999999999
Q ss_pred EEecCCC-CceEcCCCccccccc--------------ccCcccCCC-----CCCCCCcchhhHHHHHHHHhCCCCCCchH
Q 005572 562 ILLAESL-EPKIAGFGLRNIGVK--------------NVGERSENE-----TCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 562 iLl~~~~-~~kl~DfGla~~~~~--------------~~~e~~~~~-----~~~~~~DVwSfGvvl~el~tg~~p~~~~~ 621 (690)
.+++..+ ..|++|||+|..... ..+|.++|. ...+..|+||.|+++.-+++|..|++...
T Consensus 155 ~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 155 SLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred chhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 9999999 999999999875443 244555543 34678999999999999999999987522
Q ss_pred HHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHH
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~ 677 (690)
.......................... ...++..+++..+|..|.+.+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 235 RKDGRYSSWKSNKGRFTQLPWNSISD------QAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred cccccceeecccccccccCccccCCh------hhhhcccccccCCchhcccccccc
Confidence 11100000000000000111111111 223334457778999999887764
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=1.9e-13 Score=136.37 Aligned_cols=62 Identities=24% Similarity=0.322 Sum_probs=51.7
Q ss_pred CCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccC-ccCC
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSK-NRFG 120 (690)
Q Consensus 58 ~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~ 120 (690)
...++|+|..|+|+.+++ ..|+.+++|+.||||+|.|+.+-|+.|.++++|..|-|.+ |+++
T Consensus 67 ~~tveirLdqN~I~~iP~-~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~ 129 (498)
T KOG4237|consen 67 PETVEIRLDQNQISSIPP-GAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKIT 129 (498)
T ss_pred CcceEEEeccCCcccCCh-hhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchh
Confidence 367889999999987766 4568899999999999999999999999999988876666 7775
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.30 E-value=2.3e-13 Score=142.69 Aligned_cols=183 Identities=23% Similarity=0.257 Sum_probs=89.8
Q ss_pred CCccEEEccCCCCCCCCchhhhcCCCC---ccEEeccCCcCCC----CCCccccCC-ccCcEEEccCccCCCccCCCCCC
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSE---LHSIDLSNNSLKG----SVPGWFWST-QSLTQVNLSKNRFGGTIGFKPTS 129 (690)
Q Consensus 58 ~~l~~L~Ls~n~l~~~~~~~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~g~i~~~~~~ 129 (690)
.+|+.|+|++|.+.+..+ ..+..+.. |+.|++++|++++ .+...+..+ ++|+.|+|++|.+++........
T Consensus 81 ~~L~~L~l~~~~~~~~~~-~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~ 159 (319)
T cd00116 81 CGLQELDLSDNALGPDGC-GVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAK 159 (319)
T ss_pred CceeEEEccCCCCChhHH-HHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHH
Confidence 356666666666654333 22222333 6666666666652 122233344 56666666666655321000011
Q ss_pred CCCCCCCCcEEEccCCCCCCc------cccCCCCCCcEEEccCCCCcc-----CCccCCCCCCCcEEEcccCcCCcC-CC
Q 005572 130 RNGPFPSVQVLNLSSNRFTNL------VKLSQFSKLMVLDVSNNDLRI-----LPSGFANLSKLRHLDISSCKISGN-IK 197 (690)
Q Consensus 130 ~~~~l~~L~~L~Ls~N~l~~~------~~~~~~~~L~~L~ls~N~l~~-----~p~~~~~l~~L~~L~ls~N~l~~~-~~ 197 (690)
.+..++.|++|++++|.+++. ..+..+++|+.|++++|.++. ++..+..+++|+.|++++|.+++. +.
T Consensus 160 ~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l~~~~~~ 239 (319)
T cd00116 160 ALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNLTDAGAA 239 (319)
T ss_pred HHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcCchHHHH
Confidence 223344566666666666531 113344566666666666542 223344556666666666665531 11
Q ss_pred Ccc-----cccccceeecccccCCC----CCCCCCCCCCCCCEEEeeCCCCcc
Q 005572 198 PVS-----FLHSLKYLDVSNNSMNG----TFPSDFPPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 198 ~~~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~l~l~~N~~~g 241 (690)
.+. ..+.|+.|++++|.++. .+...+..+++|+++++++|.++.
T Consensus 240 ~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~ 292 (319)
T cd00116 240 ALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGE 292 (319)
T ss_pred HHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcH
Confidence 111 12456666666666641 122233444566666666666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.6e-12 Score=122.32 Aligned_cols=191 Identities=21% Similarity=0.301 Sum_probs=125.9
Q ss_pred HHHHHHHHHhcCCCCccceeeEEecCC-----eeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 005572 450 AVAMFDELSRLKHPNLLPLAGYCIAGK-----EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524 (690)
Q Consensus 450 ~~~e~~~l~~l~H~niv~l~g~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 524 (690)
...-+.-|-.+.|.|||+++.|+.+.. ...++.|||+.|++..||++.+. .
T Consensus 114 ~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~------------------------~ 169 (458)
T KOG1266|consen 114 RRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK------------------------N 169 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH------------------------h
Confidence 344455567778999999999987643 46789999999999999998432 2
Q ss_pred CCCCCHHHHHHHHHHHHHHHHhhhhcC--CCCCCCCCCcEEecCCCCceEcCCCcccccc------------------cc
Q 005572 525 PEKTNWVTRHRIAIGVARGLAYLHHVG--STHGHLVTSSILLAESLEPKIAGFGLRNIGV------------------KN 584 (690)
Q Consensus 525 ~~~l~~~~~~~i~~~ia~gl~yLH~~~--~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~------------------~~ 584 (690)
+..+....-.+++.||..||.|||+.. ++|+++..+-|++..++-+||.--....... ..
T Consensus 170 ~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~ 249 (458)
T KOG1266|consen 170 QKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFS 249 (458)
T ss_pred hhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccc
Confidence 345666677889999999999999975 5699999999999999999986432211100 00
Q ss_pred cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchH-H-HHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhh
Q 005572 585 VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-K-WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLC 662 (690)
Q Consensus 585 ~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C 662 (690)
++|.-.....+.++|||+||+..+||..+..-..+.. . .+....... .+ +..+.. -...+..|
T Consensus 250 a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~--------i~--~len~l-----qr~~i~kc 314 (458)
T KOG1266|consen 250 APESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANV--------II--GLENGL-----QRGSITKC 314 (458)
T ss_pred cCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhh--------ee--eccCcc-----ccCcCccc
Confidence 2222222345668999999999999988765422100 0 000000000 00 000000 01233459
Q ss_pred cCCCCCCCCCHHHHHHH
Q 005572 663 TADSPGKRPTMQQVLGL 679 (690)
Q Consensus 663 ~~~dP~~RPt~~ev~~~ 679 (690)
++..|..||+|++++..
T Consensus 315 l~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 315 LEGEPNGRPDARLLLFH 331 (458)
T ss_pred ccCCCCCCcchhhhhcC
Confidence 99999999999987643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.25 E-value=1.4e-11 Score=139.42 Aligned_cols=90 Identities=32% Similarity=0.550 Sum_probs=83.1
Q ss_pred CCcEEEccCCCCc-cCCccCCCCCCCcEEEcccCcCCcCCCC-cccccccceeecccccCCCCCCCCCCCCCCCCEEEee
Q 005572 158 KLMVLDVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235 (690)
Q Consensus 158 ~L~~L~ls~N~l~-~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~ 235 (690)
.++.|+|++|.+. .+|..++.+++|+.|+|++|.++|.+|. ++.+++|+.|+|++|+++|.+|..+..+++|+.|+|+
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 3788999999997 5888899999999999999999998885 8889999999999999999999999999999999999
Q ss_pred CCCCccccCchh
Q 005572 236 LNKFTGFVGHDK 247 (690)
Q Consensus 236 ~N~~~g~~~~~~ 247 (690)
+|+++|.+|...
T Consensus 499 ~N~l~g~iP~~l 510 (623)
T PLN03150 499 GNSLSGRVPAAL 510 (623)
T ss_pred CCcccccCChHH
Confidence 999999999754
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.25 E-value=3.2e-11 Score=113.82 Aligned_cols=127 Identities=14% Similarity=0.132 Sum_probs=94.5
Q ss_pred ceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCcc-ceeeEEecCCeeEEEEEecCCCCHh
Q 005572 413 SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL-PLAGYCIAGKEKLVLLEFMANGDLH 491 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv-~l~g~~~~~~~~~lv~e~~~~gsL~ 491 (690)
+.++.|.++.||+++.. +..+++|....... ....+..|++.+..+.+.+++ +++++. ....++||||+++.++.
T Consensus 4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~ 79 (170)
T cd05151 4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELL 79 (170)
T ss_pred eecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccc
Confidence 56889999999999876 55799998754321 223467888888888655544 455443 33457999999998764
Q ss_pred hhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCC-----CCCCCCCCcEEecC
Q 005572 492 RWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS-----THGHLVTSSILLAE 566 (690)
Q Consensus 492 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~-----iHrDlk~~NiLl~~ 566 (690)
+. . . ....++.+++++|+.||+.++ +|+|++|.||+++
T Consensus 80 ~~--~-------------------------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~- 122 (170)
T cd05151 80 TE--D-------------------------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD- 122 (170)
T ss_pred cc--c-------------------------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-
Confidence 32 0 0 012356789999999999885 8999999999999
Q ss_pred CCCceEcCCCcccc
Q 005572 567 SLEPKIAGFGLRNI 580 (690)
Q Consensus 567 ~~~~kl~DfGla~~ 580 (690)
++.+++.|||.+..
T Consensus 123 ~~~~~liDf~~a~~ 136 (170)
T cd05151 123 DGRLWLIDWEYAGM 136 (170)
T ss_pred CCeEEEEecccccC
Confidence 67899999998763
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.22 E-value=3.5e-13 Score=140.27 Aligned_cols=173 Identities=25% Similarity=0.358 Sum_probs=146.2
Q ss_pred CccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCc
Q 005572 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138 (690)
Q Consensus 59 ~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~ 138 (690)
--...||+.|++..+.- . +..+..|+.|.|..|.|. .+|..+.++..|+.|||+.|+++-. +..+..+ -|+
T Consensus 76 dt~~aDlsrNR~~elp~-~-~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~l-----p~~lC~l-pLk 146 (722)
T KOG0532|consen 76 DTVFADLSRNRFSELPE-E-ACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSHL-----PDGLCDL-PLK 146 (722)
T ss_pred chhhhhccccccccCch-H-HHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhcC-----ChhhhcC-cce
Confidence 45678999999986542 3 456678999999999998 7888899999999999999998632 2222222 489
Q ss_pred EEEccCCCCCCcc-ccCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCCcCCCCcccccccceeecccccCCC
Q 005572 139 VLNLSSNRFTNLV-KLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNG 217 (690)
Q Consensus 139 ~L~Ls~N~l~~~~-~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 217 (690)
.|-+++|+++.++ +++...+|..||.+.|.+..+|+.++.+.+|+.|++..|++...++.+..|+ |..||+|.|+++
T Consensus 147 vli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~~lp~El~~Lp-Li~lDfScNkis- 224 (722)
T KOG0532|consen 147 VLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLEDLPEELCSLP-LIRLDFSCNKIS- 224 (722)
T ss_pred eEEEecCccccCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhhhCCHHHhCCc-eeeeecccCcee-
Confidence 9999999999886 5788899999999999999999999999999999999999985555566554 899999999997
Q ss_pred CCCCCCCCCCCCCEEEeeCCCCccc
Q 005572 218 TFPSDFPPLSGVKFLNISLNKFTGF 242 (690)
Q Consensus 218 ~~~~~~~~l~~L~~l~l~~N~~~g~ 242 (690)
.+|-.|..|+.|++|-|.+|.++..
T Consensus 225 ~iPv~fr~m~~Lq~l~LenNPLqSP 249 (722)
T KOG0532|consen 225 YLPVDFRKMRHLQVLQLENNPLQSP 249 (722)
T ss_pred ecchhhhhhhhheeeeeccCCCCCC
Confidence 8899999999999999999999864
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.2e-10 Score=141.27 Aligned_cols=176 Identities=19% Similarity=0.178 Sum_probs=77.2
Q ss_pred CccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCc
Q 005572 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138 (690)
Q Consensus 59 ~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~ 138 (690)
+|+.|+|+++...+.+| .++.+++|+.|+|++|..-..+|..+.++++|+.|+|++|..-..+ |.. ..+++|+
T Consensus 635 ~Lk~L~Ls~~~~l~~ip--~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~L----p~~-i~l~sL~ 707 (1153)
T PLN03210 635 GLRNIDLRGSKNLKEIP--DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEIL----PTG-INLKSLY 707 (1153)
T ss_pred CCCEEECCCCCCcCcCC--ccccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCcc----CCc-CCCCCCC
Confidence 44444444433223333 1344445555555544433444545555555555555543221111 111 1344444
Q ss_pred EEEccCCCCC-CccccCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcC---CcCC---CC--cccccccceee
Q 005572 139 VLNLSSNRFT-NLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKI---SGNI---KP--VSFLHSLKYLD 209 (690)
Q Consensus 139 ~L~Ls~N~l~-~~~~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l---~~~~---~~--~~~l~~L~~L~ 209 (690)
.|++++|... .++. ..++|+.|++++|.++.+|..+ .+++|+.|+++++.. .+.+ ++ ....++|+.|+
T Consensus 708 ~L~Lsgc~~L~~~p~--~~~nL~~L~L~~n~i~~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~ 784 (1153)
T PLN03210 708 RLNLSGCSRLKSFPD--ISTNISWLDLDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLF 784 (1153)
T ss_pred EEeCCCCCCcccccc--ccCCcCeeecCCCccccccccc-cccccccccccccchhhccccccccchhhhhccccchhee
Confidence 4444444211 1111 1234555555555555555433 234444444433211 0000 00 11134566666
Q ss_pred cccccCCCCCCCCCCCCCCCCEEEeeCCCCccccC
Q 005572 210 VSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVG 244 (690)
Q Consensus 210 Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g~~~ 244 (690)
|++|...+.+|..+..+++|+.|++++|..-+.+|
T Consensus 785 Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP 819 (1153)
T PLN03210 785 LSDIPSLVELPSSIQNLHKLEHLEIENCINLETLP 819 (1153)
T ss_pred CCCCCCccccChhhhCCCCCCEEECCCCCCcCeeC
Confidence 66666555666666666666666666654333344
|
syringae 6; Provisional |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.22 E-value=9.3e-13 Score=138.04 Aligned_cols=183 Identities=23% Similarity=0.278 Sum_probs=118.6
Q ss_pred CCccEEEccCCCCCCCCc-----hhhhcCCCCccEEeccCCcCCCCCCccccCCcc---CcEEEccCccCCCccCCCCCC
Q 005572 58 TPIRELNLSSRNLSGIIS-----WKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQS---LTQVNLSKNRFGGTIGFKPTS 129 (690)
Q Consensus 58 ~~l~~L~Ls~n~l~~~~~-----~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~g~i~~~~~~ 129 (690)
+.++.|+++.+.+.+... ...+..+++|+.|++++|.+.+..+..+..+.+ |+.|++++|++++........
T Consensus 51 ~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~ 130 (319)
T cd00116 51 PSLKELCLSLNETGRIPRGLQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAK 130 (319)
T ss_pred CCceEEeccccccCCcchHHHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHH
Confidence 457888888887763111 134566778888888888887666666655555 888888888876311000011
Q ss_pred CCCCC-CCCcEEEccCCCCCCc------cccCCCCCCcEEEccCCCCcc-----CCccCCCCCCCcEEEcccCcCCcCC-
Q 005572 130 RNGPF-PSVQVLNLSSNRFTNL------VKLSQFSKLMVLDVSNNDLRI-----LPSGFANLSKLRHLDISSCKISGNI- 196 (690)
Q Consensus 130 ~~~~l-~~L~~L~Ls~N~l~~~------~~~~~~~~L~~L~ls~N~l~~-----~p~~~~~l~~L~~L~ls~N~l~~~~- 196 (690)
.+..+ ++|+.|++++|.+++. ..+..+++|+.|++++|.++. ++..+..+++|+.|++++|.+++..
T Consensus 131 ~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 210 (319)
T cd00116 131 GLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGA 210 (319)
T ss_pred HHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHH
Confidence 22334 6788888888888742 125566788888888888862 3344555678888888888876421
Q ss_pred ----CCcccccccceeecccccCCCCCCCCC-----CCCCCCCEEEeeCCCCc
Q 005572 197 ----KPVSFLHSLKYLDVSNNSMNGTFPSDF-----PPLSGVKFLNISLNKFT 240 (690)
Q Consensus 197 ----~~~~~l~~L~~L~Ls~N~l~~~~~~~~-----~~l~~L~~l~l~~N~~~ 240 (690)
..+..+++|+.|++++|.+++.....+ .....|+.|++++|.++
T Consensus 211 ~~l~~~~~~~~~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~ 263 (319)
T cd00116 211 SALAETLASLKSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDIT 263 (319)
T ss_pred HHHHHHhcccCCCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCC
Confidence 113446778888888888775221111 12467888888888876
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.21 E-value=1.1e-11 Score=135.28 Aligned_cols=146 Identities=16% Similarity=0.092 Sum_probs=92.9
Q ss_pred hccCCCCceeccCCCccEEEEEcCC-CcEEEEEEeeccCC--------------------------CCHH----------
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKG--------------------------IDHD---------- 448 (690)
Q Consensus 406 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~l~~~~~--------------------------~~~~---------- 448 (690)
..+|+. +.||.|++|.||+|++.+ |+.||||+++..-. .+..
T Consensus 119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l 197 (537)
T PRK04750 119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL 197 (537)
T ss_pred HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence 345776 789999999999999877 99999999864310 0111
Q ss_pred ----HHHHHHHHHHhc----CCCCccceeeEEec-CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCC
Q 005572 449 ----DAVAMFDELSRL----KHPNLLPLAGYCIA-GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519 (690)
Q Consensus 449 ----~~~~e~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (690)
++.+|..-+.++ .+.+.+.+-.++++ ....++||||++|+.+.++-.-..
T Consensus 198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~--------------------- 256 (537)
T PRK04750 198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA--------------------- 256 (537)
T ss_pred HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh---------------------
Confidence 122333333333 24444444444443 346789999999999987522100
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHH-HHHhhhhcCCCCCCCCCCcEEecCCC----CceEcCCCcccccc
Q 005572 520 SHISSPEKTNWVTRHRIAIGVAR-GLAYLHHVGSTHGHLVTSSILLAESL----EPKIAGFGLRNIGV 582 (690)
Q Consensus 520 ~~~~~~~~l~~~~~~~i~~~ia~-gl~yLH~~~~iHrDlk~~NiLl~~~~----~~kl~DfGla~~~~ 582 (690)
...+ +..++...++ -+.-+...|++|+|+||.||+++.++ ++++.|||+.....
T Consensus 257 ------~g~d---~~~la~~~v~~~~~Qif~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 257 ------AGTD---MKLLAERGVEVFFTQVFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------cCCC---HHHHHHHHHHHHHHHHHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 0111 1122222222 12334568999999999999999888 99999999976543
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.6e-10 Score=140.32 Aligned_cols=176 Identities=22% Similarity=0.291 Sum_probs=107.3
Q ss_pred CCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCC
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137 (690)
Q Consensus 58 ~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L 137 (690)
.+|+.|++.+|.+...++ .+ ...+|+.|+|++|.+. .+|..+..+++|+.|+|++|..-..+ + .++.+++|
T Consensus 589 ~~Lr~L~~~~~~l~~lP~-~f--~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~i----p-~ls~l~~L 659 (1153)
T PLN03210 589 PKLRLLRWDKYPLRCMPS-NF--RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEI----P-DLSMATNL 659 (1153)
T ss_pred cccEEEEecCCCCCCCCC-cC--CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcC----C-ccccCCcc
Confidence 457777777777654432 32 3567777777777776 34555667777777777766533332 1 24556777
Q ss_pred cEEEccCCC-CCCcc-ccCCCCCCcEEEccCC-CCccCCccCCCCCCCcEEEcccCcCCcCCCCcccccccceeeccccc
Q 005572 138 QVLNLSSNR-FTNLV-KLSQFSKLMVLDVSNN-DLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNS 214 (690)
Q Consensus 138 ~~L~Ls~N~-l~~~~-~~~~~~~L~~L~ls~N-~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~ 214 (690)
+.|+|++|. +..++ .+..+++|+.|++++| .++.+|..+ ++++|+.|++++|...+.+|.. ..+|+.|+|++|.
T Consensus 660 e~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~--~~nL~~L~L~~n~ 736 (1153)
T PLN03210 660 ETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI--STNISWLDLDETA 736 (1153)
T ss_pred cEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc--cCCcCeeecCCCc
Confidence 777777654 33333 3566677777777764 456666654 5677777777776544444332 3456666666666
Q ss_pred CCCCCCCCC------------------------------CCCCCCCEEEeeCCCCccccCch
Q 005572 215 MNGTFPSDF------------------------------PPLSGVKFLNISLNKFTGFVGHD 246 (690)
Q Consensus 215 l~~~~~~~~------------------------------~~l~~L~~l~l~~N~~~g~~~~~ 246 (690)
++ .+|..+ ...++|+.|++++|...+.+|..
T Consensus 737 i~-~lP~~~~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~s 797 (1153)
T PLN03210 737 IE-EFPSNLRLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSS 797 (1153)
T ss_pred cc-cccccccccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChh
Confidence 54 233221 12357888999988877777754
|
syringae 6; Provisional |
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.19 E-value=2.7e-12 Score=123.66 Aligned_cols=133 Identities=26% Similarity=0.303 Sum_probs=110.1
Q ss_pred CccCcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCccccCCCCCCcEEEccCCCCccCCccCCCCCCCcEE
Q 005572 106 TQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHL 185 (690)
Q Consensus 106 l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L 185 (690)
...|+.||||+|.++.. .....-+|.++.|++|+|.+..+..+..+++|+.||||+|.++.+..+-.++.+++.|
T Consensus 283 Wq~LtelDLS~N~I~~i-----DESvKL~Pkir~L~lS~N~i~~v~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNIKtL 357 (490)
T KOG1259|consen 283 WQELTELDLSGNLITQI-----DESVKLAPKLRRLILSQNRIRTVQNLAELPQLQLLDLSGNLLAECVGWHLKLGNIKTL 357 (490)
T ss_pred Hhhhhhccccccchhhh-----hhhhhhccceeEEeccccceeeehhhhhcccceEeecccchhHhhhhhHhhhcCEeee
Confidence 35689999999987632 2334457889999999999998888999999999999999999887666778889999
Q ss_pred EcccCcCCcCCCCcccccccceeecccccCCCCC-CCCCCCCCCCCEEEeeCCCCccccC
Q 005572 186 DISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTF-PSDFPPLSGVKFLNISLNKFTGFVG 244 (690)
Q Consensus 186 ~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~l~l~~N~~~g~~~ 244 (690)
.|+.|.+. .+..+..+.+|..||+++|+|.... -..+++++-|.++.|.+|.+.+.+.
T Consensus 358 ~La~N~iE-~LSGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~vd 416 (490)
T KOG1259|consen 358 KLAQNKIE-TLSGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSVD 416 (490)
T ss_pred ehhhhhHh-hhhhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccch
Confidence 99999886 4556778899999999999996432 2457888899999999999998765
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.3e-11 Score=133.41 Aligned_cols=178 Identities=26% Similarity=0.380 Sum_probs=124.7
Q ss_pred CCccEEEccCCCCCCCCchhhhcCCC-CccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCC
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMS-ELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS 136 (690)
Q Consensus 58 ~~l~~L~Ls~n~l~~~~~~~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~ 136 (690)
+.++.|++.+|+++.+.+. ...++ +|+.|++++|.+. .+|..+..+++|+.|++++|+++.. +...+.+++
T Consensus 116 ~~l~~L~l~~n~i~~i~~~--~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~~l-----~~~~~~~~~ 187 (394)
T COG4886 116 TNLTSLDLDNNNITDIPPL--IGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLSDL-----PKLLSNLSN 187 (394)
T ss_pred cceeEEecCCcccccCccc--cccchhhcccccccccchh-hhhhhhhccccccccccCCchhhhh-----hhhhhhhhh
Confidence 4577778888877766552 23443 7888888888877 4445577778888888888876543 222235677
Q ss_pred CcEEEccCCCCCCcccc-CCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCCcCCCCcccccccceeecccccC
Q 005572 137 VQVLNLSSNRFTNLVKL-SQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSM 215 (690)
Q Consensus 137 L~~L~Ls~N~l~~~~~~-~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 215 (690)
|+.|++++|+++.++.. .....|++|.+++|.+..++..+.++.++..|.+++|++...+..++.+++|+.|++++|.+
T Consensus 188 L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~~~~~~~~l~~l~~L~~s~n~i 267 (394)
T COG4886 188 LNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLEDLPESIGNLSNLETLDLSNNQI 267 (394)
T ss_pred hhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeeeccchhccccccceeccccccc
Confidence 78888888888777654 34555788888888666666667777777777777777764344466677788888888888
Q ss_pred CCCCCCCCCCCCCCCEEEeeCCCCccccCc
Q 005572 216 NGTFPSDFPPLSGVKFLNISLNKFTGFVGH 245 (690)
Q Consensus 216 ~~~~~~~~~~l~~L~~l~l~~N~~~g~~~~ 245 (690)
+...+ ++.+.+++.|++++|.++...+.
T Consensus 268 ~~i~~--~~~~~~l~~L~~s~n~~~~~~~~ 295 (394)
T COG4886 268 SSISS--LGSLTNLRELDLSGNSLSNALPL 295 (394)
T ss_pred ccccc--ccccCccCEEeccCccccccchh
Confidence 74433 77788888888888888776554
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.3e-10 Score=131.65 Aligned_cols=105 Identities=23% Similarity=0.384 Sum_probs=69.8
Q ss_pred CcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCccccCCCCCCcEEEccCCCCc-cCCccCCCCCCCcEEEc
Q 005572 109 LTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLR-ILPSGFANLSKLRHLDI 187 (690)
Q Consensus 109 L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~-~~p~~~~~l~~L~~L~l 187 (690)
++.|+|++|.++|.+ +..++ .+++|+.|+|++|+|. .+|..++.+++|+.|+|
T Consensus 420 v~~L~L~~n~L~g~i----p~~i~----------------------~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdL 473 (623)
T PLN03150 420 IDGLGLDNQGLRGFI----PNDIS----------------------KLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDL 473 (623)
T ss_pred EEEEECCCCCccccC----CHHHh----------------------CCCCCCEEECCCCcccCcCChHHhCCCCCCEEEC
Confidence 566777777766654 33333 3444455555555554 46666777777888888
Q ss_pred ccCcCCcCCCC-cccccccceeecccccCCCCCCCCCCCC-CCCCEEEeeCCCC
Q 005572 188 SSCKISGNIKP-VSFLHSLKYLDVSNNSMNGTFPSDFPPL-SGVKFLNISLNKF 239 (690)
Q Consensus 188 s~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~~l~l~~N~~ 239 (690)
++|+++|.+|. ++.+++|+.|+|++|+++|.+|..+..+ .++..+++.+|..
T Consensus 474 s~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~~ 527 (623)
T PLN03150 474 SYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAG 527 (623)
T ss_pred CCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCcc
Confidence 88888777665 6677788888888888888888777653 3556777777643
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.15 E-value=6.2e-11 Score=126.19 Aligned_cols=237 Identities=16% Similarity=0.127 Sum_probs=165.6
Q ss_pred HHhccCCCCceeccCCCccEEEEEc--CCCcEEEEEEeeccCCCCHHH--HHHHHHHHHhc-CCCCccceeeEEecCCee
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAVL--PGELHVAIKVLDNAKGIDHDD--AVAMFDELSRL-KHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 404 ~~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~~vavK~l~~~~~~~~~~--~~~e~~~l~~l-~H~niv~l~g~~~~~~~~ 478 (690)
....+|.....||.|.|+.|+.... .++..+++|.+.+.-....++ -..|+.....+ -|.+++++...+..-+..
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 4456788899999999999999873 567889999886554333333 23455555555 488999988888777888
Q ss_pred EEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCC
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk 558 (690)
|+--|||+++++.....- ...++...++++..|++.++.++|+..++|+|+|
T Consensus 342 ~ip~e~~~~~s~~l~~~~----------------------------~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~ 393 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVT----------------------------SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVK 393 (524)
T ss_pred cCchhhhcCcchhhhhHH----------------------------HHhcCcchhhhhHHHHHhccccccchhhhccccc
Confidence 899999999988766532 3456777788999999999999999999999999
Q ss_pred CCcEEecCC-CCceEcCCCccccccc-----------c--cCcccCCCCCCCCCcchhhHHHHHHHHhCCCCCCchHHHH
Q 005572 559 TSSILLAES-LEPKIAGFGLRNIGVK-----------N--VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWV 624 (690)
Q Consensus 559 ~~NiLl~~~-~~~kl~DfGla~~~~~-----------~--~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~p~~~~~~~~ 624 (690)
|+||++..+ +.-+++|||.+....- . ++...+...+..+.|+||||.-+.|.++|..-......|.
T Consensus 394 psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~ 473 (524)
T KOG0601|consen 394 PSNILISNDGFFSKLGDFGCWTRLAFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSL 473 (524)
T ss_pred ccceeeccchhhhhccccccccccceecccccccccccccchhhccccccccccccccccccccccccCcccCcccccce
Confidence 999999886 8899999998752110 0 1222333577889999999999999999876543332221
Q ss_pred HHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHHHHhc
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~~L~~ 682 (690)
... .+ ..+.... ...+...+ +......|+..||.+.++....+-
T Consensus 474 ~i~--~~--------~~p~~~~-~~~~~q~~---~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 TIR--SG--------DTPNLPG-LKLQLQVL---LKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred eee--cc--------cccCCCc-hHHhhhhh---hhhhcCCccccchhhhhhcccchh
Confidence 100 00 0111111 11222222 223677899999999887665443
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=8.7e-10 Score=104.68 Aligned_cols=134 Identities=14% Similarity=0.122 Sum_probs=94.8
Q ss_pred ceeccCCCccEEEEEcCC-------CcEEEEEEeeccCC---------------------CC-HHHH----HHHHHHHHh
Q 005572 413 SLLAEGRCGPVYRAVLPG-------ELHVAIKVLDNAKG---------------------ID-HDDA----VAMFDELSR 459 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~-------~~~vavK~l~~~~~---------------------~~-~~~~----~~e~~~l~~ 459 (690)
..||.|.=+.||.|.-.+ +..+|||+.+.... .. ...+ .+|++.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998543 47899998642110 01 1122 378888888
Q ss_pred cC--CCCccceeeEEecCCeeEEEEEecCCCCHhh-hhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHH
Q 005572 460 LK--HPNLLPLAGYCIAGKEKLVLLEFMANGDLHR-WLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRI 536 (690)
Q Consensus 460 l~--H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 536 (690)
+. .-++.+.+++ ..-++||||+.++.+.. .+++ ..++..+...+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-----------------------------~~~~~~~~~~i 129 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-----------------------------AKLNDEEMKNA 129 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-----------------------------cccCHHHHHHH
Confidence 85 3566666654 45679999997654421 1211 12333455677
Q ss_pred HHHHHHHHHhh-hhcCCCCCCCCCCcEEecCCCCceEcCCCcccc
Q 005572 537 AIGVARGLAYL-HHVGSTHGHLVTSSILLAESLEPKIAGFGLRNI 580 (690)
Q Consensus 537 ~~~ia~gl~yL-H~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~ 580 (690)
..+++.+|.++ |..+++|+||+++|||++ ++.+.|+|||-+-.
T Consensus 130 ~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 130 YYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence 88999999999 899999999999999997 46899999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=100.00 Aligned_cols=144 Identities=21% Similarity=0.268 Sum_probs=103.9
Q ss_pred ceeccCCCccEEEEEcCCCcEEEEEE-eeccCCCC-------HHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEe
Q 005572 413 SLLAEGRCGPVYRAVLPGELHVAIKV-LDNAKGID-------HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~~~~vavK~-l~~~~~~~-------~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
..+++|+=+.+|.+.+.+. ++++|. +++..... .+...+|.+++++++-..|..-.=+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~-~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGL-PAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeeccCc-ceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 3578899999999987554 355554 33332211 23456788899888755544444455667788899999
Q ss_pred cCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEe
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl 564 (690)
.++-.|.+++... +..++..|-.-+.-||..+|+|+||.++||++
T Consensus 81 I~G~~lkd~l~~~-----------------------------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl 125 (204)
T COG3642 81 IEGELLKDALEEA-----------------------------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIIL 125 (204)
T ss_pred eCChhHHHHHHhc-----------------------------------chHHHHHHHHHHHHHHhcCeecCCCccceEEE
Confidence 9998998888651 23467777778888999999999999999999
Q ss_pred cCCCCceEcCCCcccccccccCcccCCCCCCCCCcchh
Q 005572 565 AESLEPKIAGFGLRNIGVKNVGERSENETCGPESDVYC 602 (690)
Q Consensus 565 ~~~~~~kl~DfGla~~~~~~~~e~~~~~~~~~~~DVwS 602 (690)
..+. +.+.|||++.... ..-+.++|+|-
T Consensus 126 ~~~~-i~~IDfGLg~~s~---------~~Ed~aVDl~V 153 (204)
T COG3642 126 SGGR-IYFIDFGLGEFSD---------EVEDKAVDLHV 153 (204)
T ss_pred eCCc-EEEEECCcccccc---------cHHhhhchHHH
Confidence 8665 9999999987421 22244678774
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-11 Score=119.10 Aligned_cols=131 Identities=27% Similarity=0.412 Sum_probs=95.4
Q ss_pred CCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCcccc-CCCCCC
Q 005572 81 NMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKL-SQFSKL 159 (690)
Q Consensus 81 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~-~~~~~L 159 (690)
....|+.||||+|.|+ .+..+..-+|.++.|+||+|++.-. ..+..+++|+.||||+|.++.+... ..+-+.
T Consensus 282 TWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v------~nLa~L~~L~~LDLS~N~Ls~~~Gwh~KLGNI 354 (490)
T KOG1259|consen 282 TWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV------QNLAELPQLQLLDLSGNLLAECVGWHLKLGNI 354 (490)
T ss_pred hHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee------hhhhhcccceEeecccchhHhhhhhHhhhcCE
Confidence 3456888888888888 3445566677888888888886521 2356678888888888887765432 245677
Q ss_pred cEEEccCCCCccCCccCCCCCCCcEEEcccCcCCc--CCCCcccccccceeecccccCCCCC
Q 005572 160 MVLDVSNNDLRILPSGFANLSKLRHLDISSCKISG--NIKPVSFLHSLKYLDVSNNSMNGTF 219 (690)
Q Consensus 160 ~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~--~~~~~~~l~~L~~L~Ls~N~l~~~~ 219 (690)
+.|.|+.|.|..+ +++.++-+|..||+++|++.. ....++.++-|+.|.|-+|.+.+.+
T Consensus 355 KtL~La~N~iE~L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v 415 (490)
T KOG1259|consen 355 KTLKLAQNKIETL-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV 415 (490)
T ss_pred eeeehhhhhHhhh-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence 7888888888766 457778888888888888864 2345778888999999999887543
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.07 E-value=8e-11 Score=109.46 Aligned_cols=14 Identities=43% Similarity=0.703 Sum_probs=3.7
Q ss_pred CCccEEeccCCcCC
Q 005572 83 SELHSIDLSNNSLK 96 (690)
Q Consensus 83 ~~L~~L~Ls~N~l~ 96 (690)
.+|+.||||+|.|+
T Consensus 42 ~~L~~L~Ls~N~I~ 55 (175)
T PF14580_consen 42 DKLEVLDLSNNQIT 55 (175)
T ss_dssp TT--EEE-TTS--S
T ss_pred cCCCEEECCCCCCc
Confidence 33444444444443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-09 Score=117.36 Aligned_cols=156 Identities=19% Similarity=0.173 Sum_probs=116.8
Q ss_pred cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCC
Q 005572 428 LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDW 507 (690)
Q Consensus 428 ~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~ 507 (690)
..++.+|.|...+.......+...+-++.|+.+|||||++++...+..+..|||+|-+. -|..++++
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~----------- 100 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE----------- 100 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH-----------
Confidence 45677899998877654334556777888999999999999999999999999999985 47777765
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhh-hcCCCCCCCCCCcEEecCCCCceEcCCCcccccccccC
Q 005572 508 STDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH-HVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586 (690)
Q Consensus 508 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH-~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~~~ 586 (690)
+.....--.+.||+.||.||| +.+++|++|....|+++..|+-||++|-+........+
T Consensus 101 --------------------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~ 160 (690)
T KOG1243|consen 101 --------------------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA 160 (690)
T ss_pred --------------------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc
Confidence 223334446779999999997 56788999999999999999999999987643222110
Q ss_pred ----cccCCCCCC--------CCCcchhhHHHHHHHHhCCCC
Q 005572 587 ----ERSENETCG--------PESDVYCFGVILMELLTGKRG 616 (690)
Q Consensus 587 ----e~~~~~~~~--------~~~DVwSfGvvl~el~tg~~p 616 (690)
++.-+.... -..|.|-||+++||++.|..+
T Consensus 161 ~~~~~~~~~s~~~P~~~~~s~~s~D~~~Lg~li~el~ng~~~ 202 (690)
T KOG1243|consen 161 PAKSLYLIESFDDPEEIDPSEWSIDSWGLGCLIEELFNGSLL 202 (690)
T ss_pred ccccchhhhcccChhhcCccccchhhhhHHHHHHHHhCcccC
Confidence 000011111 135999999999999999443
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.1e-10 Score=108.60 Aligned_cols=83 Identities=35% Similarity=0.557 Sum_probs=26.3
Q ss_pred CCCCcEEEccCCCCCCccccCCCCCCcEEEccCCCCccCCccC-CCCCCCcEEEcccCcCCc--CCCCcccccccceeec
Q 005572 134 FPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGF-ANLSKLRHLDISSCKISG--NIKPVSFLHSLKYLDV 210 (690)
Q Consensus 134 l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~p~~~-~~l~~L~~L~ls~N~l~~--~~~~~~~l~~L~~L~L 210 (690)
+.+|+.|+||+|.++.+..+..+++|++|++++|+|+.++..+ ..+++|+.|+|++|+|.. .+..+..+++|+.|+|
T Consensus 41 l~~L~~L~Ls~N~I~~l~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L 120 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKLEGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSL 120 (175)
T ss_dssp -TT--EEE-TTS--S--TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-
T ss_pred hcCCCEEECCCCCCccccCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeec
Confidence 3445555555555555555555566666666666666554433 235566666666666542 2223444555555555
Q ss_pred ccccCC
Q 005572 211 SNNSMN 216 (690)
Q Consensus 211 s~N~l~ 216 (690)
.+|.++
T Consensus 121 ~~NPv~ 126 (175)
T PF14580_consen 121 EGNPVC 126 (175)
T ss_dssp TT-GGG
T ss_pred cCCccc
Confidence 555554
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.04 E-value=2.2e-10 Score=122.03 Aligned_cols=231 Identities=16% Similarity=0.171 Sum_probs=154.2
Q ss_pred cCCCCceecc--CCCccEEEEEc---CCCcEEEEEEee--ccCCCCHHHHHHHHHHHHhcC-CCCccceeeEEecCCeeE
Q 005572 408 HFGKESLLAE--GRCGPVYRAVL---PGELHVAIKVLD--NAKGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 408 ~~~~~~~lg~--G~~g~Vy~~~~---~~~~~vavK~l~--~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~ 479 (690)
.|.....+|. |.+|.||.+.. .++..+|+|.-+ .........-.+|+..-.+++ |+|.++.+..++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556678899 99999999985 446778888732 222233333455666666665 999999999999999999
Q ss_pred EEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH----HHHhhhhcCCCCC
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVAR----GLAYLHHVGSTHG 555 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----gl~yLH~~~~iHr 555 (690)
+-+|+|. .+|..+.+... .-++......+..+..+ |+.++|+..++|-
T Consensus 195 iqtE~~~-~sl~~~~~~~~---------------------------~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~ 246 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPC---------------------------NFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHD 246 (524)
T ss_pred eeecccc-chhHHhhhccc---------------------------ccCCchhhhhHHhhhhhcccccccccCCCccccc
Confidence 9999995 68888887521 11333344455566666 9999999999999
Q ss_pred CCCCCcEEecCC-CCceEcCCCcccccccc---------------cCcccCC---CCCCCCCcchhhHHHHHHHHhCCCC
Q 005572 556 HLVTSSILLAES-LEPKIAGFGLRNIGVKN---------------VGERSEN---ETCGPESDVYCFGVILMELLTGKRG 616 (690)
Q Consensus 556 Dlk~~NiLl~~~-~~~kl~DfGla~~~~~~---------------~~e~~~~---~~~~~~~DVwSfGvvl~el~tg~~p 616 (690)
|+||.||++..+ ...++.|||+....... .-|..++ ..++..+|+||+|.+..|..++..+
T Consensus 247 ~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~ 326 (524)
T KOG0601|consen 247 DLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHL 326 (524)
T ss_pred ccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhccc
Confidence 999999999999 77899999986543322 1122222 3577899999999999999998765
Q ss_pred CCch--HHHHHHHHHhcCCCCccccccccCCCCCHHHHHHHHHHHhhhcCCCCCCCCCHHHHHH
Q 005572 617 TDDC--VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 617 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~C~~~dP~~RPt~~ev~~ 678 (690)
...- ..|.. ...+ . +..++...... ++..+...+++.+|..|++.+++..
T Consensus 327 ~~~g~~~~W~~--~r~~---~-ip~e~~~~~s~------~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 327 PSVGKNSSWSQ--LRQG---Y-IPLEFCEGGSS------SLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred ccCCCCCCccc--cccc---c-CchhhhcCcch------hhhhHHHHhcCcchhhhhHHHHHhc
Confidence 4321 22211 0000 0 01111101111 1112445688999999999887653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.4e-09 Score=107.46 Aligned_cols=139 Identities=17% Similarity=0.188 Sum_probs=98.3
Q ss_pred ceeccCCCccEEEEEcCCCcEEEEEEeeccCC-CCHHHHHHHHHHHHhcCC--CCccceeeEEecCC---eeEEEEEecC
Q 005572 413 SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKH--PNLLPLAGYCIAGK---EKLVLLEFMA 486 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~~~---~~~lv~e~~~ 486 (690)
+.++.|.++.||++...+|..+++|....... .....+.+|.+.++.+++ .++.++++++.... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 56899999999999977667899998754332 134578899999998875 45677888776543 5689999999
Q ss_pred CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhh-----------------
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH----------------- 549 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~----------------- 549 (690)
++++.+.+.. ..++..++..++.+++++|.+||+
T Consensus 84 G~~l~~~~~~-----------------------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~ 134 (223)
T cd05154 84 GRVLRDRLLR-----------------------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGY 134 (223)
T ss_pred CEecCCCCCC-----------------------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCch
Confidence 9887665421 112333334444444444444442
Q ss_pred ---------------------------------------cCCCCCCCCCCcEEecC--CCCceEcCCCcccc
Q 005572 550 ---------------------------------------VGSTHGHLVTSSILLAE--SLEPKIAGFGLRNI 580 (690)
Q Consensus 550 ---------------------------------------~~~iHrDlk~~NiLl~~--~~~~kl~DfGla~~ 580 (690)
..++|+|+.+.||+++. ++.+.|.||+.+..
T Consensus 135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 135 LERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34569999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-11 Score=121.86 Aligned_cols=188 Identities=23% Similarity=0.284 Sum_probs=138.9
Q ss_pred CCCCccEEEccCCCCCCCCchhhhcCCCCccEEe-ccCCcCCCCCCccccCCccCcEEEccCccCCCc------------
Q 005572 56 PSTPIRELNLSSRNLSGIISWKFLRNMSELHSID-LSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGT------------ 122 (690)
Q Consensus 56 ~~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~-Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~------------ 122 (690)
...+|+.||||+|+|+.+-|.. |.++.+|..|- +++|+|+....+.|.+|.+|+-|.|.-|++.-.
T Consensus 89 ~l~~LRrLdLS~N~Is~I~p~A-F~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~ 167 (498)
T KOG4237|consen 89 TLHRLRRLDLSKNNISFIAPDA-FKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLS 167 (498)
T ss_pred chhhhceecccccchhhcChHh-hhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcc
Confidence 3468999999999999888854 57788776654 455999877667777777777777776665421
Q ss_pred --------cCCCCCCCCCCCCCCcEEEccCCCCC--------------------C-------------------------
Q 005572 123 --------IGFKPTSRNGPFPSVQVLNLSSNRFT--------------------N------------------------- 149 (690)
Q Consensus 123 --------i~~~~~~~~~~l~~L~~L~Ls~N~l~--------------------~------------------------- 149 (690)
+....-..+..+.+++.+.+..|.+. |
T Consensus 168 lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~ 247 (498)
T KOG4237|consen 168 LLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCS 247 (498)
T ss_pred hhcccchhhhhhccccccchhccchHhhhcCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhh
Confidence 00111123445566666666666521 0
Q ss_pred ---c--------------c--ccCCCCCCcEEEccCCCCccCC-ccCCCCCCCcEEEcccCcCCcCCC-Cccccccccee
Q 005572 150 ---L--------------V--KLSQFSKLMVLDVSNNDLRILP-SGFANLSKLRHLDISSCKISGNIK-PVSFLHSLKYL 208 (690)
Q Consensus 150 ---~--------------~--~~~~~~~L~~L~ls~N~l~~~p-~~~~~l~~L~~L~ls~N~l~~~~~-~~~~l~~L~~L 208 (690)
+ + .|..+++|+.|+|++|+|+.+. .+|..+..++.|.|..|+|.-.-. .+..+..|+.|
T Consensus 248 ~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL 327 (498)
T KOG4237|consen 248 LESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTL 327 (498)
T ss_pred HHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceee
Confidence 0 0 1346789999999999999875 568999999999999999863111 15568899999
Q ss_pred ecccccCCCCCCCCCCCCCCCCEEEeeCCCCccccC
Q 005572 209 DVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVG 244 (690)
Q Consensus 209 ~Ls~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g~~~ 244 (690)
+|.+|+|+..-|..|..+.+|..|+|-.|.|..-.-
T Consensus 328 ~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~ 363 (498)
T KOG4237|consen 328 SLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCR 363 (498)
T ss_pred eecCCeeEEEecccccccceeeeeehccCcccCccc
Confidence 999999999999999999999999999999876443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.00 E-value=3.8e-10 Score=121.97 Aligned_cols=173 Identities=31% Similarity=0.443 Sum_probs=143.2
Q ss_pred EEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCc-cCcEEEccCccCCCccCCCCCCCCCCCCCCcEE
Q 005572 62 ELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQ-SLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVL 140 (690)
Q Consensus 62 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L 140 (690)
.|+++.|.+...+. .+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++... +...+.+++|+.|
T Consensus 97 ~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~~l-----~~~~~~l~~L~~L 168 (394)
T COG4886 97 SLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIESL-----PSPLRNLPNLKNL 168 (394)
T ss_pred eeeccccccccCch--hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchhhh-----hhhhhcccccccc
Confidence 58899998855543 3556788999999999999 5566666674 999999999997632 2356789999999
Q ss_pred EccCCCCCCccccC-CCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCCcCCCCcccccccceeecccccCCCCC
Q 005572 141 NLSSNRFTNLVKLS-QFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTF 219 (690)
Q Consensus 141 ~Ls~N~l~~~~~~~-~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~ 219 (690)
++++|+++.++... ..++|+.|++++|+++.+|.....+..|+.|.+++|++...+..+..+..+..|.+.+|++.. +
T Consensus 169 ~l~~N~l~~l~~~~~~~~~L~~L~ls~N~i~~l~~~~~~~~~L~~l~~~~N~~~~~~~~~~~~~~l~~l~l~~n~~~~-~ 247 (394)
T COG4886 169 DLSFNDLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEELDLSNNSIIELLSSLSNLKNLSGLELSNNKLED-L 247 (394)
T ss_pred ccCCchhhhhhhhhhhhhhhhheeccCCccccCchhhhhhhhhhhhhhcCCcceecchhhhhcccccccccCCceeee-c
Confidence 99999999997765 899999999999999999987777788999999999655455567778889999999999863 3
Q ss_pred CCCCCCCCCCCEEEeeCCCCcccc
Q 005572 220 PSDFPPLSGVKFLNISLNKFTGFV 243 (690)
Q Consensus 220 ~~~~~~l~~L~~l~l~~N~~~g~~ 243 (690)
+..+..+++++.|++++|+++..-
T Consensus 248 ~~~~~~l~~l~~L~~s~n~i~~i~ 271 (394)
T COG4886 248 PESIGNLSNLETLDLSNNQISSIS 271 (394)
T ss_pred cchhccccccceeccccccccccc
Confidence 667888889999999999987643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=4e-09 Score=95.77 Aligned_cols=144 Identities=17% Similarity=0.229 Sum_probs=101.0
Q ss_pred CCceeccCCCccEEEEEcCCCcEEEEEEeeccCC-------CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEEE
Q 005572 411 KESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKG-------IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 411 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
....+-+|+=+.|+++.+.+...+..++..+... .......+|.+.+.+++--.|.--.=++.+...-.|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 4568899999999999988654333334433322 123456789999988864444443344556666678999
Q ss_pred ecCC-CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 484 FMAN-GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 484 ~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
|.++ -++.+|+..... ...........+..|.+.+.-||..+++|+||..+||
T Consensus 91 ~~~g~~~vk~~i~~~~~--------------------------~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNi 144 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTME--------------------------DESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNI 144 (229)
T ss_pred eccchhHHHHHHHHHcc--------------------------CcccchhHHHHHHHHHHHHHHhhhCCeecccccccce
Confidence 9976 488888876211 1111112256888899999999999999999999999
Q ss_pred EecCCC---CceEcCCCcccc
Q 005572 563 LLAESL---EPKIAGFGLRNI 580 (690)
Q Consensus 563 Ll~~~~---~~kl~DfGla~~ 580 (690)
++.+++ .+.+.|||++..
T Consensus 145 ll~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 145 LLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEecCCCcCceEEEeecchhc
Confidence 997654 458999999764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.00 E-value=8.1e-11 Score=119.45 Aligned_cols=158 Identities=25% Similarity=0.285 Sum_probs=67.2
Q ss_pred cCCCCccEEeccCCcCCCCCC--ccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCcc---ccC
Q 005572 80 RNMSELHSIDLSNNSLKGSVP--GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV---KLS 154 (690)
Q Consensus 80 ~~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~---~~~ 154 (690)
..+++++.||||.|-|..-.| .....|++|+.|+|+.|+|...++ ......++.|+.|.|+++.|+.-. -+.
T Consensus 143 k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~---s~~~~~l~~lK~L~l~~CGls~k~V~~~~~ 219 (505)
T KOG3207|consen 143 KILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFIS---SNTTLLLSHLKQLVLNSCGLSWKDVQWILL 219 (505)
T ss_pred hhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCcc---ccchhhhhhhheEEeccCCCCHHHHHHHHH
Confidence 345555555555555542111 123345555555555555543221 111123444555555555554211 133
Q ss_pred CCCCCcEEEccCCC-CccCCccCCCCCCCcEEEcccCcCCcC--CCCcccccccceeecccccCCCC-CCCC-----CCC
Q 005572 155 QFSKLMVLDVSNND-LRILPSGFANLSKLRHLDISSCKISGN--IKPVSFLHSLKYLDVSNNSMNGT-FPSD-----FPP 225 (690)
Q Consensus 155 ~~~~L~~L~ls~N~-l~~~p~~~~~l~~L~~L~ls~N~l~~~--~~~~~~l~~L~~L~Ls~N~l~~~-~~~~-----~~~ 225 (690)
.+++|+.|+|..|. +..-......++.|+.|||++|++-.. .+-.+.++.|+.|+++.+.++.. .|+. ...
T Consensus 220 ~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~ 299 (505)
T KOG3207|consen 220 TFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHT 299 (505)
T ss_pred hCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcc
Confidence 44555555555553 111111223344455555555544321 12234455555555555554322 1111 122
Q ss_pred CCCCCEEEeeCCCCc
Q 005572 226 LSGVKFLNISLNKFT 240 (690)
Q Consensus 226 l~~L~~l~l~~N~~~ 240 (690)
+.+|++|+++.|++.
T Consensus 300 f~kL~~L~i~~N~I~ 314 (505)
T KOG3207|consen 300 FPKLEYLNISENNIR 314 (505)
T ss_pred cccceeeecccCccc
Confidence 345555555555553
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.4e-10 Score=125.67 Aligned_cols=175 Identities=26% Similarity=0.365 Sum_probs=104.0
Q ss_pred CCCCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCC
Q 005572 56 PSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFP 135 (690)
Q Consensus 56 ~~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~ 135 (690)
...+|..|+|.+|+|.++.. .+..+.+|+.||||+|.|+...+ +..++.|+.|++++|.++.. ..+..++
T Consensus 93 ~~~~l~~l~l~~n~i~~i~~--~l~~~~~L~~L~ls~N~I~~i~~--l~~l~~L~~L~l~~N~i~~~------~~~~~l~ 162 (414)
T KOG0531|consen 93 KLKSLEALDLYDNKIEKIEN--LLSSLVNLQVLDLSFNKITKLEG--LSTLTLLKELNLSGNLISDI------SGLESLK 162 (414)
T ss_pred cccceeeeeccccchhhccc--chhhhhcchheeccccccccccc--hhhccchhhheeccCcchhc------cCCccch
Confidence 34566666666666665543 14456666666666666664443 44555566666666665432 2233356
Q ss_pred CCcEEEccCCCCCCccc--cCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCCcCCCCcccccc--cceeecc
Q 005572 136 SVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHS--LKYLDVS 211 (690)
Q Consensus 136 ~L~~L~Ls~N~l~~~~~--~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~--L~~L~Ls 211 (690)
+|+.+++++|.++.... ...+.+|+.+++.+|.+..+. ++..+..+..+++..|.++ .+.++..+.. |+.++++
T Consensus 163 ~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~i~-~~~~~~~l~~~~l~~n~i~-~~~~l~~~~~~~L~~l~l~ 240 (414)
T KOG0531|consen 163 SLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIREIE-GLDLLKKLVLLSLLDNKIS-KLEGLNELVMLHLRELYLS 240 (414)
T ss_pred hhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhccc-chHHHHHHHHhhcccccce-eccCcccchhHHHHHHhcc
Confidence 66666666666666555 366666666666666665442 2333334444466666665 2223333333 7888888
Q ss_pred cccCCCCCCCCCCCCCCCCEEEeeCCCCcccc
Q 005572 212 NNSMNGTFPSDFPPLSGVKFLNISLNKFTGFV 243 (690)
Q Consensus 212 ~N~l~~~~~~~~~~l~~L~~l~l~~N~~~g~~ 243 (690)
+|.+.- ++..+..+..+..|++..|++...-
T Consensus 241 ~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~ 271 (414)
T KOG0531|consen 241 GNRISR-SPEGLENLKNLPVLDLSSNRISNLE 271 (414)
T ss_pred cCcccc-ccccccccccccccchhhccccccc
Confidence 888863 3255667778888888888877643
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=98.92 E-value=4.1e-11 Score=125.17 Aligned_cols=171 Identities=30% Similarity=0.361 Sum_probs=138.4
Q ss_pred EEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCcEEE
Q 005572 62 ELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLN 141 (690)
Q Consensus 62 ~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~ 141 (690)
.|.|++-++....-..+--.++--...||+.|++. .+|..+..+..|..+.|..|.+.- | +..+..+..|+.||
T Consensus 54 ~l~Ls~rrlk~fpr~a~~~~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r~-i----p~~i~~L~~lt~l~ 127 (722)
T KOG0532|consen 54 RLLLSGRRLKEFPRGAASYDLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIRT-I----PEAICNLEALTFLD 127 (722)
T ss_pred ccccccchhhcCCCccccccccchhhhhccccccc-cCchHHHHHHHHHHHHHHhcccee-c----chhhhhhhHHHHhh
Confidence 35566656543321121134556678999999999 778888889999999999999763 2 56788899999999
Q ss_pred ccCCCCCCccc-cCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCCcCCCCcccccccceeecccccCCCCCC
Q 005572 142 LSSNRFTNLVK-LSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFP 220 (690)
Q Consensus 142 Ls~N~l~~~~~-~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~ 220 (690)
|+.|+++.++. ++.+ -|+.|-+++|+++.+|..++.+..|..||.+.|.+....+.++.+.+|+.|++..|++. .+|
T Consensus 128 ls~NqlS~lp~~lC~l-pLkvli~sNNkl~~lp~~ig~~~tl~~ld~s~nei~slpsql~~l~slr~l~vrRn~l~-~lp 205 (722)
T KOG0532|consen 128 LSSNQLSHLPDGLCDL-PLKVLIVSNNKLTSLPEEIGLLPTLAHLDVSKNEIQSLPSQLGYLTSLRDLNVRRNHLE-DLP 205 (722)
T ss_pred hccchhhcCChhhhcC-cceeEEEecCccccCCcccccchhHHHhhhhhhhhhhchHHhhhHHHHHHHHHhhhhhh-hCC
Confidence 99999998864 4433 49999999999999999999899999999999999866666889999999999999997 566
Q ss_pred CCCCCCCCCCEEEeeCCCCcc
Q 005572 221 SDFPPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 221 ~~~~~l~~L~~l~l~~N~~~g 241 (690)
..+..|+ |..||++.|+++-
T Consensus 206 ~El~~Lp-Li~lDfScNkis~ 225 (722)
T KOG0532|consen 206 EELCSLP-LIRLDFSCNKISY 225 (722)
T ss_pred HHHhCCc-eeeeecccCceee
Confidence 6777664 8999999999975
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=98.91 E-value=2.9e-10 Score=115.46 Aligned_cols=181 Identities=25% Similarity=0.297 Sum_probs=128.3
Q ss_pred CCCccEEEccCCCCCCCCch-hhhcCCCCccEEeccCCcCCCCCCcc-ccCCccCcEEEccCccCCCccCCCCCCCCCCC
Q 005572 57 STPIRELNLSSRNLSGIISW-KFLRNMSELHSIDLSNNSLKGSVPGW-FWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPF 134 (690)
Q Consensus 57 ~~~l~~L~Ls~n~l~~~~~~-~~~~~l~~L~~L~Ls~N~l~~~~p~~-~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l 134 (690)
.++++.||||.|-|+.-.+. .+...|++|+.|+||.|++....... -..+++|+.|.|+.+.|+-.- -......+
T Consensus 145 ~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~---V~~~~~~f 221 (505)
T KOG3207|consen 145 LPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKD---VQWILLTF 221 (505)
T ss_pred CCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhhhheEEeccCCCCHHH---HHHHHHhC
Confidence 46899999999999754432 34567999999999999998544332 235788999999999886210 01223457
Q ss_pred CCCcEEEccCCCCCCc--cccCCCCCCcEEEccCCCCccCC--ccCCCCCCCcEEEcccCcCCcC-CCCc------cccc
Q 005572 135 PSVQVLNLSSNRFTNL--VKLSQFSKLMVLDVSNNDLRILP--SGFANLSKLRHLDISSCKISGN-IKPV------SFLH 203 (690)
Q Consensus 135 ~~L~~L~Ls~N~l~~~--~~~~~~~~L~~L~ls~N~l~~~p--~~~~~l~~L~~L~ls~N~l~~~-~~~~------~~l~ 203 (690)
|+|..|+|..|..... .....+..|+.|||++|++-.++ ...+.++.|..|+++.+.++.. .++. ..++
T Consensus 222 Psl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~ 301 (505)
T KOG3207|consen 222 PSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFP 301 (505)
T ss_pred CcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccc
Confidence 8999999999963222 23556788999999999998877 4578899999999999988752 2332 4578
Q ss_pred ccceeecccccCCCCC-CCCCCCCCCCCEEEeeCCCCc
Q 005572 204 SLKYLDVSNNSMNGTF-PSDFPPLSGVKFLNISLNKFT 240 (690)
Q Consensus 204 ~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~l~l~~N~~~ 240 (690)
+|++|+++.|++...- -..+..+.+|+.|.+..|.++
T Consensus 302 kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 302 KLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 9999999999995211 122333445555555555443
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.85 E-value=2.7e-08 Score=103.74 Aligned_cols=180 Identities=16% Similarity=0.218 Sum_probs=132.9
Q ss_pred CccEEEEE-cCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCCccceeeEEec----CCeeEEEEEecCC-CCHhhh
Q 005572 420 CGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA----GKEKLVLLEFMAN-GDLHRW 493 (690)
Q Consensus 420 ~g~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e~~~~-gsL~~~ 493 (690)
-...||+. -.+|..++.|+++..+.........-++.++++.|+|||++..++.. ...+++||+|.++ ++|.++
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 35679998 56788999999955443333344566888999999999999998873 3468899999876 477766
Q ss_pred hhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCCCceEc
Q 005572 494 LHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIA 573 (690)
Q Consensus 494 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~~~kl~ 573 (690)
--..+.... .-.......+.+.++.....++.|+..||.++|+.|..-+-|-+++||++.+.+++|+
T Consensus 369 ~F~~~~~t~-------------~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS 435 (655)
T KOG3741|consen 369 YFANPPFTK-------------RTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRIS 435 (655)
T ss_pred HccCCcccc-------------ccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEe
Confidence 544221110 0001112345567888999999999999999999999999999999999999999999
Q ss_pred CCCcccccccccCcccCCCCCCCCCcchhhHHHHHHHHhCCC
Q 005572 574 GFGLRNIGVKNVGERSENETCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 574 DfGla~~~~~~~~e~~~~~~~~~~~DVwSfGvvl~el~tg~~ 615 (690)
..|+......+..+...+. .+-|.=.||.+++-|.||..
T Consensus 436 ~C~i~Dvl~~d~~~~le~~---Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 436 GCGIMDVLQEDPTEPLESQ---QQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred cccceeeecCCCCcchhHH---hhhhHHHHHHHHHHHhhccc
Confidence 9998776655442322222 25688889999999999843
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.76 E-value=4.3e-09 Score=80.41 Aligned_cols=60 Identities=32% Similarity=0.485 Sum_probs=47.1
Q ss_pred CccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccC
Q 005572 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119 (690)
Q Consensus 59 ~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l 119 (690)
+|+.|+|++|+|+.+.+ ..+.++++|++|++++|.|+...|..|.++++|++|++++|+|
T Consensus 2 ~L~~L~l~~n~l~~i~~-~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPP-DSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TESEEEETSSTESEECT-TTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred cCcEEECCCCCCCccCH-HHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 67888888888876654 5567788888888888888877777888888888888888864
|
... |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.72 E-value=5e-08 Score=92.36 Aligned_cols=124 Identities=23% Similarity=0.324 Sum_probs=80.5
Q ss_pred cEEEEEcCCCcEEEEEEeeccC--------------C--------CC----HHHHHHHHHHHHhcCCC--CccceeeEEe
Q 005572 422 PVYRAVLPGELHVAIKVLDNAK--------------G--------ID----HDDAVAMFDELSRLKHP--NLLPLAGYCI 473 (690)
Q Consensus 422 ~Vy~~~~~~~~~vavK~l~~~~--------------~--------~~----~~~~~~e~~~l~~l~H~--niv~l~g~~~ 473 (690)
.||.|..+++..+|||+.+... . .. .....+|.+.|.++... ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998888899999864311 0 01 12356788999999754 566666542
Q ss_pred cCCeeEEEEEecC--CCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHh-hhhc
Q 005572 474 AGKEKLVLLEFMA--NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAY-LHHV 550 (690)
Q Consensus 474 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~y-LH~~ 550 (690)
.-.|||||++ +..+.. |... .++......++.++...+.. +|..
T Consensus 80 ---~~~ivME~I~~~G~~~~~-l~~~-----------------------------~~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPR-LKDV-----------------------------DLSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp ---TTEEEEE--EETTEEGGC-HHHC-----------------------------GGGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred ---CCEEEEEecCCCccchhh-HHhc-----------------------------cccchhHHHHHHHHHHHHHHHHHhc
Confidence 3469999998 544443 3320 11123455677788886666 5799
Q ss_pred CCCCCCCCCCcEEecCCCCceEcCCCcccc
Q 005572 551 GSTHGHLVTSSILLAESLEPKIAGFGLRNI 580 (690)
Q Consensus 551 ~~iHrDlk~~NiLl~~~~~~kl~DfGla~~ 580 (690)
+++|+|+.+.|||++++ .+.|.|||-+..
T Consensus 127 givHGDLs~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 127 GIVHGDLSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp TEEESS-STTSEEEETT-CEEE--GTTEEE
T ss_pred CceecCCChhhEEeecc-eEEEEecCccee
Confidence 99999999999999988 999999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.3e-09 Score=118.17 Aligned_cols=173 Identities=24% Similarity=0.329 Sum_probs=125.7
Q ss_pred CCCccEEEccCCCCCCCCchhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCC
Q 005572 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS 136 (690)
Q Consensus 57 ~~~l~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~ 136 (690)
...++.++|..|.+..... .+..+++|..|++.+|+|..... .+..+++|++|+|++|+++... .+..++.
T Consensus 71 l~~l~~l~l~~n~i~~~~~--~l~~~~~l~~l~l~~n~i~~i~~-~l~~~~~L~~L~ls~N~I~~i~------~l~~l~~ 141 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAKILN--HLSKLKSLEALDLYDNKIEKIEN-LLSSLVNLQVLDLSFNKITKLE------GLSTLTL 141 (414)
T ss_pred hHhHHhhccchhhhhhhhc--ccccccceeeeeccccchhhccc-chhhhhcchheecccccccccc------chhhccc
Confidence 3467777788888875332 35677889999999999885433 3667888999999999886542 3445666
Q ss_pred CcEEEccCCCCCCccccCCCCCCcEEEccCCCCccCCcc-CCCCCCCcEEEcccCcCCcCCCCcccccccceeecccccC
Q 005572 137 VQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSM 215 (690)
Q Consensus 137 L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~p~~-~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 215 (690)
|+.|++++|.++.+..+..++.|+.+++++|.+..+... ...+.+|+.+++.+|.+. .+..+..+..+..+++..|.+
T Consensus 142 L~~L~l~~N~i~~~~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~-~i~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 142 LKELNLSGNLISDISGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIR-EIEGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred hhhheeccCcchhccCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchh-cccchHHHHHHHHhhcccccc
Confidence 889999999998888888888999999999998877553 467788888889888876 344445556666678888888
Q ss_pred CCCCCCCCCCCCC--CCEEEeeCCCCcc
Q 005572 216 NGTFPSDFPPLSG--VKFLNISLNKFTG 241 (690)
Q Consensus 216 ~~~~~~~~~~l~~--L~~l~l~~N~~~g 241 (690)
+-.-+ +..+.. |+.+++++|.+.-
T Consensus 221 ~~~~~--l~~~~~~~L~~l~l~~n~i~~ 246 (414)
T KOG0531|consen 221 SKLEG--LNELVMLHLRELYLSGNRISR 246 (414)
T ss_pred eeccC--cccchhHHHHHHhcccCcccc
Confidence 63322 222233 7888888888764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.7e-07 Score=92.77 Aligned_cols=139 Identities=14% Similarity=0.105 Sum_probs=96.0
Q ss_pred eccCCCccEEEEEcCCCcEEEEEEeeccCC-----------CCHHHHHHHHHHHHhcCC--CCccceeeEEec-----CC
Q 005572 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKG-----------IDHDDAVAMFDELSRLKH--PNLLPLAGYCIA-----GK 476 (690)
Q Consensus 415 lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~-----------~~~~~~~~e~~~l~~l~H--~niv~l~g~~~~-----~~ 476 (690)
+-+-....|+++.+. |..+.||....... .....+.+|.+.+.++.. -.+...+++.+. ..
T Consensus 30 v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~ 108 (268)
T PRK15123 30 FRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR 108 (268)
T ss_pred EecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence 333333457777764 45788896632210 111247788888887743 233445555543 23
Q ss_pred eeEEEEEecCCC-CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCC
Q 005572 477 EKLVLLEFMANG-DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 477 ~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHr 555 (690)
.-++|+|++++- +|.+++.... ....+...+..++.+++..+.-||..|++|+
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~--------------------------~~~~~~~~~~~ll~~la~~i~~LH~~Gi~Hg 162 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWA--------------------------TNPPDPRLKRMLIKRVATMVRDMHAAGINHR 162 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhc--------------------------ccCCCHHHHHHHHHHHHHHHHHHHHCcCccC
Confidence 467999999876 8999986411 1123345677899999999999999999999
Q ss_pred CCCCCcEEecC-------CCCceEcCCCcccc
Q 005572 556 HLVTSSILLAE-------SLEPKIAGFGLRNI 580 (690)
Q Consensus 556 Dlk~~NiLl~~-------~~~~kl~DfGla~~ 580 (690)
|++++|||++. ++.+.++||+.++.
T Consensus 163 DL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 163 DCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred CCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 99999999985 46789999998753
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.63 E-value=1.8e-08 Score=113.14 Aligned_cols=185 Identities=18% Similarity=0.127 Sum_probs=123.3
Q ss_pred ccCCCCceeccCCCccEEEEEc-CCCcEEEEEEeeccCC---CCHHHHHHHHHHHHhcCCCCccceeeEEecCCeeEEEE
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
..|.+.+-+-+|.++.++.+.- ..+...+.|+...... .+.+...++-.++-..+||-+++...-+......++|+
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 3445556677889998887763 2343444444332211 11222233333333345676666555545567889999
Q ss_pred EecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcE
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~Ni 562 (690)
+|..+|+|...|+.... .+..-.......+.++.+|||...+.|||++|.|.
T Consensus 884 ~~~~~~~~~Skl~~~~~----------------------------~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~ 935 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGC----------------------------LSAEPARSPILERVQSLESLHSSLRKHRDLKPDSL 935 (1205)
T ss_pred HHhccCCchhhhhcCCC----------------------------cccccccchhHHHHhhhhccccchhhcccccccch
Confidence 99999999999987331 22222234556777899999999999999999999
Q ss_pred EecCCCCceEcCCCcccccc-c----------c----------------------------------cCcccCCCCCCCC
Q 005572 563 LLAESLEPKIAGFGLRNIGV-K----------N----------------------------------VGERSENETCGPE 597 (690)
Q Consensus 563 Ll~~~~~~kl~DfGla~~~~-~----------~----------------------------------~~e~~~~~~~~~~ 597 (690)
|+..++..+++|||..+... . . +||.......+..
T Consensus 936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen 936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence 99999999999998432110 0 0 1222223355678
Q ss_pred CcchhhHHHHHHHHhCCCCCCc
Q 005572 598 SDVYCFGVILMELLTGKRGTDD 619 (690)
Q Consensus 598 ~DVwSfGvvl~el~tg~~p~~~ 619 (690)
+|.|++|++++|.++|.+||..
T Consensus 1016 ad~~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 1016 ADWWSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred chhhhhhhhhhhhhcCCCCCCC
Confidence 9999999999999999999875
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.61 E-value=3.5e-08 Score=75.36 Aligned_cols=61 Identities=33% Similarity=0.510 Sum_probs=49.5
Q ss_pred CCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCC
Q 005572 83 SELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRF 147 (690)
Q Consensus 83 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l 147 (690)
++|+.|++++|+|+...+.+|.++++|+.|++++|+++.. ++..+..+++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i----~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSI----PPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEE----ETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCcc----CHHHHcCCCCCCEEeCcCCcC
Confidence 4688999999999987778899999999999999988643 356677788888888887764
|
... |
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.4e-09 Score=114.98 Aligned_cols=126 Identities=29% Similarity=0.317 Sum_probs=67.3
Q ss_pred CcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCccccCCCCCCcEEEccCCCCccCCccCCCCCCCcEEEcc
Q 005572 109 LTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDIS 188 (690)
Q Consensus 109 L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls 188 (690)
|...+.++|++.-. ...+.-++.|+.|||++|+++.+..+..+++|++|||++|.|+.+|.-=..-.+|..|+++
T Consensus 166 L~~a~fsyN~L~~m-----D~SLqll~ale~LnLshNk~~~v~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L~lr 240 (1096)
T KOG1859|consen 166 LATASFSYNRLVLM-----DESLQLLPALESLNLSHNKFTKVDNLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLLNLR 240 (1096)
T ss_pred HhhhhcchhhHHhH-----HHHHHHHHHhhhhccchhhhhhhHHHHhcccccccccccchhccccccchhhhhheeeeec
Confidence 55556666665421 2223334556666666666666655666666666666666666555421111236666666
Q ss_pred cCcCCcCCCCcccccccceeecccccCCCCCC-CCCCCCCCCCEEEeeCCCCc
Q 005572 189 SCKISGNIKPVSFLHSLKYLDVSNNSMNGTFP-SDFPPLSGVKFLNISLNKFT 240 (690)
Q Consensus 189 ~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~l~l~~N~~~ 240 (690)
+|-++ .+-.+.+|.+|+.|||++|-|++--- ..+..|..|+.|+|.+|.+-
T Consensus 241 nN~l~-tL~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALT-TLRGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHH-hhhhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 66655 23344556666666666666543210 11233455666666666553
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.48 E-value=1e-08 Score=101.79 Aligned_cols=161 Identities=19% Similarity=0.250 Sum_probs=84.9
Q ss_pred CCCCccEEeccCCcCCCCCCc----cccCCccCcEEEccCccCCCccC---------CCCCCCCCCCCCCcEEEccCCCC
Q 005572 81 NMSELHSIDLSNNSLKGSVPG----WFWSTQSLTQVNLSKNRFGGTIG---------FKPTSRNGPFPSVQVLNLSSNRF 147 (690)
Q Consensus 81 ~l~~L~~L~Ls~N~l~~~~p~----~~~~l~~L~~L~L~~N~l~g~i~---------~~~~~~~~~l~~L~~L~Ls~N~l 147 (690)
..+.|++||||.|-|.-..+. .+.+..+|++|.|.+|.+.-.-+ .......+.-+.|+++..+.|++
T Consensus 90 ~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrl 169 (382)
T KOG1909|consen 90 GCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRL 169 (382)
T ss_pred cCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeecccc
Confidence 344566666666666533222 23445556666666665431100 00012233445677777777776
Q ss_pred CCcc------ccCCCCCCcEEEccCCCCcc-----CCccCCCCCCCcEEEcccCcCCcCC-----CCcccccccceeecc
Q 005572 148 TNLV------KLSQFSKLMVLDVSNNDLRI-----LPSGFANLSKLRHLDISSCKISGNI-----KPVSFLHSLKYLDVS 211 (690)
Q Consensus 148 ~~~~------~~~~~~~L~~L~ls~N~l~~-----~p~~~~~l~~L~~L~ls~N~l~~~~-----~~~~~l~~L~~L~Ls 211 (690)
.... .+...+.|+.+.++.|.|.. +-..+..++.|+.|||..|-|+-.. ..+..|++|+.|+++
T Consensus 170 en~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~ 249 (382)
T KOG1909|consen 170 ENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLG 249 (382)
T ss_pred ccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccc
Confidence 5442 14444666777777776641 2234566667777777777665211 224556667777777
Q ss_pred cccCCCCCCCC----C-CCCCCCCEEEeeCCCCcc
Q 005572 212 NNSMNGTFPSD----F-PPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 212 ~N~l~~~~~~~----~-~~l~~L~~l~l~~N~~~g 241 (690)
++.++..-... | ...++|++|.+.+|.++-
T Consensus 250 dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~ 284 (382)
T KOG1909|consen 250 DCLLENEGAIAFVDALKESAPSLEVLELAGNEITR 284 (382)
T ss_pred ccccccccHHHHHHHHhccCCCCceeccCcchhHH
Confidence 77665322111 1 224566777777776653
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=2.3e-09 Score=115.07 Aligned_cols=125 Identities=30% Similarity=0.381 Sum_probs=103.8
Q ss_pred CccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCcEEEccCCCCCCccccCCC-CCCcEE
Q 005572 84 ELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQF-SKLMVL 162 (690)
Q Consensus 84 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~-~~L~~L 162 (690)
.|.+.+++.|+|. ....++.-++.|+.|||++|+|+.. ..+..++.|.+|||++|.+..++.++.- .+|+.|
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v------~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~L~~L 237 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV------DNLRRLPKLKHLDLSYNCLRHVPQLSMVGCKLQLL 237 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh------HHHHhcccccccccccchhccccccchhhhhheee
Confidence 4777899999998 5556677889999999999999743 3556789999999999999998765432 259999
Q ss_pred EccCCCCccCCccCCCCCCCcEEEcccCcCCc--CCCCcccccccceeecccccCC
Q 005572 163 DVSNNDLRILPSGFANLSKLRHLDISSCKISG--NIKPVSFLHSLKYLDVSNNSMN 216 (690)
Q Consensus 163 ~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~--~~~~~~~l~~L~~L~Ls~N~l~ 216 (690)
.+++|.++.+ .++.++.+|+.||+++|-|.+ .+.++..|..|+.|.|.+|.+-
T Consensus 238 ~lrnN~l~tL-~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 238 NLRNNALTTL-RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred eecccHHHhh-hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 9999999887 457899999999999999876 3445677888999999999884
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.40 E-value=5.4e-06 Score=78.98 Aligned_cols=138 Identities=13% Similarity=0.077 Sum_probs=99.1
Q ss_pred eccCCCccEEEEEcCCCcEEEEEEeecc-C-----CCCHHHHHHHHHHHHhcC--CCCccceeeEEecC----CeeEEEE
Q 005572 415 LAEGRCGPVYRAVLPGELHVAIKVLDNA-K-----GIDHDDAVAMFDELSRLK--HPNLLPLAGYCIAG----KEKLVLL 482 (690)
Q Consensus 415 lg~G~~g~Vy~~~~~~~~~vavK~l~~~-~-----~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~----~~~~lv~ 482 (690)
-|+|+.+-|++..+.+. .+=+|.-.+. . .-....|.+|+..|.++. .-.+.+.+.+.... -..+||+
T Consensus 26 ~~rgG~SgV~r~~~~g~-~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK-KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeCCc-EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 36788888999887766 4666664311 1 234567999999988885 33355555222221 1367999
Q ss_pred EecCC-CCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCc
Q 005572 483 EFMAN-GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 483 e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~N 561 (690)
|-+++ -||.+++.+.. ....+...+..+..+|++.+.-||+.++.|+|+.++|
T Consensus 105 e~L~g~~~L~~~l~~~~--------------------------~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~kh 158 (216)
T PRK09902 105 EDMAGFISIADWYAQHA--------------------------VSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRH 158 (216)
T ss_pred EeCCCCccHHHHHhcCC--------------------------cCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhh
Confidence 97753 48999986521 2245666788999999999999999999999999999
Q ss_pred EEecCCCC--ceEcCCCccc
Q 005572 562 ILLAESLE--PKIAGFGLRN 579 (690)
Q Consensus 562 iLl~~~~~--~kl~DfGla~ 579 (690)
|+++.++. +++.||--++
T Consensus 159 Ill~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 159 IYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred eeecCCCCeeEEEEEhhccc
Confidence 99986666 9999996554
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.3e-06 Score=83.30 Aligned_cols=106 Identities=23% Similarity=0.260 Sum_probs=82.4
Q ss_pred HHHHHHHHHHHHhcC--CCCccceeeEEecCC----eeEEEEEecCCC-CHhhhhhcCCCCCCCCCCCCCCCCCCCCCCC
Q 005572 447 HDDAVAMFDELSRLK--HPNLLPLAGYCIAGK----EKLVLLEFMANG-DLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519 (690)
Q Consensus 447 ~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (690)
.....+|.+.+..+. .=.+.+.+++.+... ..++|+|++++. +|.+++...
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---------------------- 112 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---------------------- 112 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh----------------------
Confidence 446778888877774 334556667666532 357999999874 899998751
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHhhhhcCCCCCCCCCCcEEecCCC---CceEcCCCcccc
Q 005572 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESL---EPKIAGFGLRNI 580 (690)
Q Consensus 520 ~~~~~~~~l~~~~~~~i~~~ia~gl~yLH~~~~iHrDlk~~NiLl~~~~---~~kl~DfGla~~ 580 (690)
...+...+..++.++++.+.-||+.|++|+|++++|||++.+. .+.+.||+-++.
T Consensus 113 ------~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 113 ------EQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred ------cccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 1144456778999999999999999999999999999999887 899999987664
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.6e-06 Score=81.98 Aligned_cols=129 Identities=19% Similarity=0.236 Sum_probs=91.3
Q ss_pred CCceeccCCCccEEEEEcCCCcEEEEEEeeccC-----------------C-----CCHHHHHHHHHHHHhcCCC--Ccc
Q 005572 411 KESLLAEGRCGPVYRAVLPGELHVAIKVLDNAK-----------------G-----IDHDDAVAMFDELSRLKHP--NLL 466 (690)
Q Consensus 411 ~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----------------~-----~~~~~~~~e~~~l~~l~H~--niv 466 (690)
....||-|.=+.||.|..+.|.++|||.-+... . .......+|++.|.++.-. .|.
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 347899999999999999999999999743210 0 1223467889999988633 666
Q ss_pred ceeeEEecCCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHh
Q 005572 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAY 546 (690)
Q Consensus 467 ~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~y 546 (690)
+-+++ +.-.+||||.++--|...- ++....-.++..|.+-+.-
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r---------------------------------~~~en~~~il~~il~~~~~ 217 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLR---------------------------------LDVENPDEILDKILEEVRK 217 (304)
T ss_pred Ccccc----ccceeeeehcccceeeccc---------------------------------CcccCHHHHHHHHHHHHHH
Confidence 65553 3456999999885554321 1112223344455554444
Q ss_pred hhhcCCCCCCCCCCcEEecCCCCceEcCCC
Q 005572 547 LHHVGSTHGHLVTSSILLAESLEPKIAGFG 576 (690)
Q Consensus 547 LH~~~~iHrDlk~~NiLl~~~~~~kl~DfG 576 (690)
.-..|+||+|+..-||+++++|.+.+.||-
T Consensus 218 ~~~~GiVHGDlSefNIlV~~dg~~~vIDwP 247 (304)
T COG0478 218 AYRRGIVHGDLSEFNILVTEDGDIVVIDWP 247 (304)
T ss_pred HHHcCccccCCchheEEEecCCCEEEEeCc
Confidence 448999999999999999999999999994
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.33 E-value=1.1e-07 Score=94.51 Aligned_cols=184 Identities=19% Similarity=0.219 Sum_probs=114.1
Q ss_pred CCCccEEEccCCCCCCCCc---hhhhcCCCCccEEeccCCcCCC----CCCc-------cccCCccCcEEEccCccCCCc
Q 005572 57 STPIRELNLSSRNLSGIIS---WKFLRNMSELHSIDLSNNSLKG----SVPG-------WFWSTQSLTQVNLSKNRFGGT 122 (690)
Q Consensus 57 ~~~l~~L~Ls~n~l~~~~~---~~~~~~l~~L~~L~Ls~N~l~~----~~p~-------~~~~l~~L~~L~L~~N~l~g~ 122 (690)
...++.|+||+|.+...-. ...+.+.++|+..++|+ -++| .+|. .+...+.|+.||||.|.|.-.
T Consensus 29 ~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd-~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA~G~~ 107 (382)
T KOG1909|consen 29 MDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD-MFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNAFGPK 107 (382)
T ss_pred cCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh-hhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccccCcc
Confidence 3567888888888742211 13456667788887764 3333 3343 234556788888888887522
Q ss_pred cCCCCCCCCCCCCCCcEEEccCCCCCCc---------------cccCCCCCCcEEEccCCCCccCC-----ccCCCCCCC
Q 005572 123 IGFKPTSRNGPFPSVQVLNLSSNRFTNL---------------VKLSQFSKLMVLDVSNNDLRILP-----SGFANLSKL 182 (690)
Q Consensus 123 i~~~~~~~~~~l~~L~~L~Ls~N~l~~~---------------~~~~~~~~L~~L~ls~N~l~~~p-----~~~~~l~~L 182 (690)
-.-.....+.+.++|+.|.|.+|.+... .....-++|+++..++|++..-+ ..|...+.|
T Consensus 108 g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~al~~l~~~kk~~~~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~l 187 (382)
T KOG1909|consen 108 GIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGRALFELAVNKKAASKPKLRVFICGRNRLENGGATALAEAFQSHPTL 187 (382)
T ss_pred chHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHHHHHHHHHHhccCCCcceEEEEeeccccccccHHHHHHHHHhcccc
Confidence 1000001223467788888888876532 01344567888888888886433 335666788
Q ss_pred cEEEcccCcCCcCC-----CCcccccccceeecccccCCCC----CCCCCCCCCCCCEEEeeCCCCcc
Q 005572 183 RHLDISSCKISGNI-----KPVSFLHSLKYLDVSNNSMNGT----FPSDFPPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 183 ~~L~ls~N~l~~~~-----~~~~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~l~l~~N~~~g 241 (690)
+.+.++.|.+.-.- ..+..+++|+.|||.+|-|+.. +...++.+++|+.|+++++.+..
T Consensus 188 eevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcll~~ 255 (382)
T KOG1909|consen 188 EEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCLLEN 255 (382)
T ss_pred ceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeeccccccccc
Confidence 88888888764211 1134577888888888877532 23456667788888888887764
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.18 E-value=6.8e-06 Score=89.68 Aligned_cols=147 Identities=19% Similarity=0.157 Sum_probs=95.8
Q ss_pred HhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccC-----------------------C---CCHHH---------
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAK-----------------------G---IDHDD--------- 449 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~-----------------------~---~~~~~--------- 449 (690)
...+|+. .-|+.++.|.||+|++++|+.||||+.+..- . .+..+
T Consensus 124 ~F~eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l 202 (517)
T COG0661 124 LFSEFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRL 202 (517)
T ss_pred HHHHcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHH
Confidence 3445654 5799999999999999999999999965321 0 11111
Q ss_pred -----HHHHHHHHHhc----CCCCccceeeEEec-CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCC
Q 005572 450 -----AVAMFDELSRL----KHPNLLPLAGYCIA-GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519 (690)
Q Consensus 450 -----~~~e~~~l~~l----~H~niv~l~g~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 519 (690)
+.+|..-+.++ ++.-=+++=.+|++ .....++|||++|-.+.+....+.
T Consensus 203 ~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--------------------- 261 (517)
T COG0661 203 REELDYRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--------------------- 261 (517)
T ss_pred HHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---------------------
Confidence 22233323333 22222333344443 466789999999988888743210
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHH-HHhhhhcCCCCCCCCCCcEEecCCCCceEcCCCcccccc
Q 005572 520 SHISSPEKTNWVTRHRIAIGVARG-LAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGV 582 (690)
Q Consensus 520 ~~~~~~~~l~~~~~~~i~~~ia~g-l~yLH~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~ 582 (690)
..++ +..++..++++ +..+-..|+.|.|..|.||+++.++++-+-|||+.....
T Consensus 262 ------~g~d---~k~ia~~~~~~f~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 262 ------AGID---RKELAELLVRAFLRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ------cCCC---HHHHHHHHHHHHHHHHHhcCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 1122 33455544443 344455899999999999999999999999999976543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-06 Score=85.61 Aligned_cols=42 Identities=17% Similarity=0.203 Sum_probs=24.9
Q ss_pred ccccceeecccccCCCCC-CCCCCCCCCCCEEEeeCCCCcccc
Q 005572 202 LHSLKYLDVSNNSMNGTF-PSDFPPLSGVKFLNISLNKFTGFV 243 (690)
Q Consensus 202 l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~l~l~~N~~~g~~ 243 (690)
++.+-.|+|+.|+|...- -+.+..+++|..|.+++|.+...+
T Consensus 223 ~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~d~l 265 (418)
T KOG2982|consen 223 FPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLSDPL 265 (418)
T ss_pred CCcchhhhhcccccccHHHHHHHcCCchhheeeccCCcccccc
Confidence 455556777777764321 133455667777777777665443
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.04 E-value=2.2e-07 Score=80.06 Aligned_cols=109 Identities=26% Similarity=0.284 Sum_probs=53.4
Q ss_pred ccEEEccCCCCCCCCc-hhhhcCCCCccEEeccCCcCCCCCCccccCCccCcEEEccCccCCCccCCCCCCCCCCCCCCc
Q 005572 60 IRELNLSSRNLSGIIS-WKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138 (690)
Q Consensus 60 l~~L~Ls~n~l~~~~~-~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~g~i~~~~~~~~~~l~~L~ 138 (690)
+..|+|++..|--+.. ...+....+|+..+|++|.|+...+..-...+.++.|+|++|.++.. |..+..++.|+
T Consensus 29 ~h~ldLssc~lm~i~davy~l~~~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neisdv-----PeE~Aam~aLr 103 (177)
T KOG4579|consen 29 LHFLDLSSCQLMYIADAVYMLSKGYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEISDV-----PEELAAMPALR 103 (177)
T ss_pred hhhcccccchhhHHHHHHHHHhCCceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhhhc-----hHHHhhhHHhh
Confidence 4456666665532211 12234455666667777777644333222334556666666655432 22344555555
Q ss_pred EEEccCCCCCCccc-cCCCCCCcEEEccCCCCccCC
Q 005572 139 VLNLSSNRFTNLVK-LSQFSKLMVLDVSNNDLRILP 173 (690)
Q Consensus 139 ~L~Ls~N~l~~~~~-~~~~~~L~~L~ls~N~l~~~p 173 (690)
.||++.|.|...+. +..+.+|..||..+|.+..+|
T Consensus 104 ~lNl~~N~l~~~p~vi~~L~~l~~Lds~~na~~eid 139 (177)
T KOG4579|consen 104 SLNLRFNPLNAEPRVIAPLIKLDMLDSPENARAEID 139 (177)
T ss_pred hcccccCccccchHHHHHHHhHHHhcCCCCccccCc
Confidence 55555555544332 222445555555555555444
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=1.6e-06 Score=94.17 Aligned_cols=80 Identities=29% Similarity=0.438 Sum_probs=63.8
Q ss_pred HHHHHHHHHhhhhc-CCCCCCCCCCcEEecCCCCceEcCCCcccccccc-----------------------cCcccCCC
Q 005572 537 AIGVARGLAYLHHV-GSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN-----------------------VGERSENE 592 (690)
Q Consensus 537 ~~~ia~gl~yLH~~-~~iHrDlk~~NiLl~~~~~~kl~DfGla~~~~~~-----------------------~~e~~~~~ 592 (690)
+.+++.||.|+|.. ++||++|.|++|.++.++..||+.|+.+-..... +||.....
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 45667999999975 6789999999999999999999999875332210 55555556
Q ss_pred CCCCCCcchhhHHHHHHHHhCCCC
Q 005572 593 TCGPESDVYCFGVILMELLTGKRG 616 (690)
Q Consensus 593 ~~~~~~DVwSfGvvl~el~tg~~p 616 (690)
..++++|+||+||++|-+..|..+
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~ 208 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKS 208 (700)
T ss_pred cccccccceeeeeEEEEEecCCcc
Confidence 778899999999999999955444
|
|
| >PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.7e-06 Score=58.34 Aligned_cols=36 Identities=42% Similarity=0.595 Sum_probs=19.1
Q ss_pred CCcEEEccCCCCccCCccCCCCCCCcEEEcccCcCC
Q 005572 158 KLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS 193 (690)
Q Consensus 158 ~L~~L~ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~ 193 (690)
+|++|++++|+|+.+|..++++++|+.|++++|+++
T Consensus 2 ~L~~L~l~~N~i~~l~~~l~~l~~L~~L~l~~N~i~ 37 (44)
T PF12799_consen 2 NLEELDLSNNQITDLPPELSNLPNLETLNLSNNPIS 37 (44)
T ss_dssp T-SEEEETSSS-SSHGGHGTTCTTSSEEEETSSCCS
T ss_pred cceEEEccCCCCcccCchHhCCCCCCEEEecCCCCC
Confidence 455555555555555555555555555555555554
|
... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=97.99 E-value=7.7e-05 Score=73.52 Aligned_cols=72 Identities=14% Similarity=0.143 Sum_probs=53.4
Q ss_pred ceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHHHHHHHHHHhcCCCC--ccceeeEEecCCeeEEEEEecCCCC
Q 005572 413 SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPN--LLPLAGYCIAGKEKLVLLEFMANGD 489 (690)
Q Consensus 413 ~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~~e~~~l~~l~H~n--iv~l~g~~~~~~~~~lv~e~~~~gs 489 (690)
..||+|..+.||+.. +..+++|..... .......+|.+.++.+..-. +.+.++++...+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~~---~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEec---CCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 568999999999842 335778887542 24456788999998886433 4667788877777889999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.94 E-value=9.6e-05 Score=70.81 Aligned_cols=137 Identities=10% Similarity=0.108 Sum_probs=88.3
Q ss_pred HhccCCCCceeccCCCccEEEEEcCCCcEEEEEEeeccCCCCHHHH---------HHHHHHHHhcCC---CCccceeeEE
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDA---------VAMFDELSRLKH---PNLLPLAGYC 472 (690)
Q Consensus 405 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~---------~~e~~~l~~l~H---~niv~l~g~~ 472 (690)
...+|...+++-......|.+-..++ ..+++|..+......++.+ .+++..+.+++- ...+.++.++
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~-~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDG-KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECC-cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 44567777777777766677776665 4788888765432222222 233333444432 2333333333
Q ss_pred ec-----CCeeEEEEEecCCCCHhhhhhcCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHhh
Q 005572 473 IA-----GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYL 547 (690)
Q Consensus 473 ~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gl~yL 547 (690)
+. ....+++|||++|..|.++.. ++. .++..+++++.-+
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------------------------------i~e----~~~~ki~~~ikql 151 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------------------------------IDE----DLAEKIVEAIKQL 151 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh--------------------------------cCH----HHHHHHHHHHHHH
Confidence 22 234568999999987765532 111 2556777889999
Q ss_pred hhcCCCCCCCCCCcEEecCCCCceEcCCCccc
Q 005572 548 HHVGSTHGHLVTSSILLAESLEPKIAGFGLRN 579 (690)
Q Consensus 548 H~~~~iHrDlk~~NiLl~~~~~~kl~DfGla~ 579 (690)
|+.|+.|+|..|.|+++++++ +++.||+..+
T Consensus 152 H~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 152 HKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred HHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 999999999999999998554 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 690 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-24 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 5e-24 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-16 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-16 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-14 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 9e-14 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 9e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-12 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 2e-11 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 3e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 8e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-09 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 5e-09 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 5e-09 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 5e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 1e-08 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 2e-08 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-08 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-08 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-08 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-08 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 5e-08 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 5e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 6e-08 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 6e-08 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-08 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-08 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 9e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-08 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 9e-08 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 9e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-07 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-07 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-07 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-07 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-07 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-07 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-07 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-07 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-07 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-07 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-07 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-07 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-07 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-07 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-07 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-07 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-07 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-07 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-07 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-07 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-07 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-07 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-07 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-07 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-07 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-07 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-07 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 3e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-07 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 4e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-07 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-07 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 5e-07 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-07 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 6e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 7e-07 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 9e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-06 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-06 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-06 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-06 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-06 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-06 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-06 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-06 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-06 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-06 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-06 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-06 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-06 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-06 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 2e-06 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-06 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-06 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-06 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-06 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-06 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-06 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-06 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-06 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-06 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-06 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-06 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-06 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-06 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 4e-06 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 4e-06 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 4e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 4e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 4e-06 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 5e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-06 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-06 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-06 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-06 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-06 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 6e-06 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-06 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-06 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 7e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 1e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-05 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-05 | ||
| 2z66_A | 306 | Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 A | 1e-05 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-05 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-05 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-05 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-05 | ||
| 3fxi_A | 605 | Crystal Structure Of The Human Tlr4-Human Md-2-E.Co | 2e-05 | ||
| 2o6s_A | 208 | Structural Diversity Of The Hagfish Variable Lympho | 2e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-05 | ||
| 4g8a_A | 635 | Crystal Structure Of Human Tlr4 Polymorphic Variant | 3e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-05 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 6e-05 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-05 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 2z63_A | 570 | Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 A | 1e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-04 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-04 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-04 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-04 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-04 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-04 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-04 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 2e-04 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-04 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 2e-04 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-04 | ||
| 4fho_A | 231 | Crystal Structure Of An Internalin C2 (Inlc2) From | 2e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-04 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-04 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-04 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-04 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 3e-04 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-04 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 3e-04 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-04 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 3e-04 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 3e-04 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 3e-04 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 3e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 3e-04 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 3e-04 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-04 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-04 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-04 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 3e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 3e-04 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-04 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 3e-04 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 3e-04 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 3e-04 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 3e-04 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-04 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 3e-04 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-04 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 3e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 3e-04 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-04 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 3e-04 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 3e-04 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-04 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 3e-04 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-04 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-04 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-04 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 3e-04 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 3e-04 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 3e-04 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-04 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-04 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 4e-04 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-04 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-04 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-04 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-04 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-04 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-04 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-04 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-04 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 4e-04 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-04 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-04 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-04 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-04 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-04 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-04 | ||
| 3a79_B | 562 | Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Len | 5e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-04 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-04 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-04 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-04 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-04 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 6e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-04 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-04 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 6e-04 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-04 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-04 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-04 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-04 | ||
| 1h6u_A | 308 | Internalin H: Crystal Structure Of Fused N-Terminal | 7e-04 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 7e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 7e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 8e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-04 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 8e-04 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-04 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-04 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 8e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-04 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-04 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 9e-04 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 9e-04 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 306 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps Ra Complex Length = 605 | Back alignment and structure |
|
| >pdb|2O6S|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors B59 Length = 208 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g And T399i In Complex With Md-2 And Lps Length = 635 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And Hagfish Vlrb.61 Length = 570 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3A79|B Chain B, Crystal Structure Of Tlr2-Tlr6-Pam2csk4 Complex Length = 562 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1H6U|A Chain A, Internalin H: Crystal Structure Of Fused N-Terminal Domains Length = 308 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 690 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 3e-65 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 2e-56 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 5e-55 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-37 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 9e-36 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 2e-33 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-32 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 8e-32 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-31 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 3e-25 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 4e-25 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 7e-22 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 1e-35 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-33 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-33 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-31 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-27 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 2e-26 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 5e-24 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 3e-21 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 7e-21 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-31 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-26 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 8e-23 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 8e-31 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 1e-30 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-30 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-30 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-27 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 3e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 6e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 7e-24 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 2e-15 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 2e-30 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-30 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 3e-29 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-26 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 7e-24 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-23 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 4e-30 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-29 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 7e-26 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 8e-26 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-24 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-29 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-29 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-28 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-28 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-27 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 6e-22 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 3e-19 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-17 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-16 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 7e-29 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-28 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-24 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 1e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-22 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 3e-21 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 6e-21 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 4e-28 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-27 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-25 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-25 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-20 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-19 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-17 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-15 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-11 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-27 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 2e-25 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-22 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-20 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 9e-18 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 8e-17 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-15 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 4e-27 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-27 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 7e-26 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 8e-26 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-24 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-14 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-26 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 4e-26 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 9e-26 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-22 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 1e-22 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 5e-21 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-15 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 4e-06 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-25 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-11 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-07 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 8e-25 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 1e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 4e-24 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-22 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-21 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-10 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 1e-06 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-24 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-23 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-23 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 8e-22 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 3e-23 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-22 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 5e-20 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 1e-12 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-23 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-20 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-20 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-07 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 3e-23 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-22 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-22 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-20 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-19 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-19 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-15 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 6e-14 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 7e-22 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-20 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-20 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-20 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 3e-11 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-20 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-16 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-14 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 5e-10 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-21 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 5e-19 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 1e-13 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 3e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-21 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 4e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-14 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-18 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 4e-18 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-21 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 3e-20 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 4e-18 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-21 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-15 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-14 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-12 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 7e-06 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-20 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-20 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-18 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-20 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 8e-20 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-19 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 1e-19 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 1e-19 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-19 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-19 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-18 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 5e-14 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 1e-08 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-19 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 5e-19 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 6e-19 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 9e-18 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 6e-19 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 8e-19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 9e-19 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 7e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 9e-16 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 3e-14 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 6e-04 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-18 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-18 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-18 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-16 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-14 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-10 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-18 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-12 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-10 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-18 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-17 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-14 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-13 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-10 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-07 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-05 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 3e-18 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 4e-18 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 4e-18 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-18 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 5e-18 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 3e-17 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-10 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 8e-08 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-18 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 8e-18 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 9e-18 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 1e-17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-17 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 5e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-13 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 2e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 2e-17 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-17 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 2e-17 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 3e-17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-17 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 4e-14 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-12 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 5e-11 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-07 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-17 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 3e-17 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-17 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-16 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 1e-16 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-16 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-16 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 1e-15 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 2e-16 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 2e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-16 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-14 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-12 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 3e-16 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 3e-16 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 6e-16 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 7e-14 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 8e-11 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 7e-16 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 7e-16 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-15 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-15 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 2e-15 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-15 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-15 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-14 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-13 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-12 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 3e-15 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 3e-15 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 5e-15 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 9e-15 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-14 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 1e-14 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-14 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-11 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-10 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-10 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 2e-06 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 2e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 9e-08 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-14 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 4e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 6e-14 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-13 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 9e-08 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-06 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 1e-13 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 1e-13 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 2e-13 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 3e-13 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-12 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-11 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-04 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 3e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 3e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-10 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 5e-08 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 4e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 7e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 9e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-10 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-09 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 2e-11 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 1e-09 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-07 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-11 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 5e-11 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 2e-08 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 5e-11 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 6e-11 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 9e-11 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-10 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-09 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-05 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-10 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-10 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-04 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 6e-10 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 6e-10 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 6e-10 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 6e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-06 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 4e-09 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 4e-09 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-08 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 2e-08 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 4e-08 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-08 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-07 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 2e-07 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-07 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 3e-07 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 4e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 6e-07 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 1e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-06 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-06 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 7e-07 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 7e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 8e-07 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 8e-05 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 9e-07 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 9e-07 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-06 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 6e-06 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-06 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-06 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 3e-06 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 4e-06 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 8e-04 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 4e-06 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 4e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 5e-06 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 5e-06 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 6e-06 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 7e-06 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 9e-06 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-05 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 1e-05 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-05 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 1e-05 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-05 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 2e-05 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 2e-05 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-05 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 2e-05 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 2e-05 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-05 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 3e-05 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 4e-05 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-04 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-05 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 6e-05 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-05 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 1e-04 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-04 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-04 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-04 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 3e-04 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-04 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 6e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 217 bits (556), Expect = 3e-65
Identities = 88/325 (27%), Positives = 139/325 (42%), Gaps = 79/325 (24%)
Query: 398 TFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDA----VAM 453
+ ++L A+ +F +++L G G VY+ L VA+K L + + V M
Sbjct: 21 SLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEM 80
Query: 454 FDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWD 513
+S H NLL L G+C+ E+L++ +MANG + L E P +P +
Sbjct: 81 ---ISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPL--------- 128
Query: 514 HHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV-----TSSILLAESL 568
+W R RIA+G ARGLAYLH ++ ++ILL E
Sbjct: 129 ---------------DWPKRQRIALGSARGLAYLHD--HCDPKIIHRDVKAANILLDEEF 171
Query: 569 EPKIAGFGLRNIGVKNVGERSENET------------CGPE----------SDVYCFGVI 606
E + FGL + +T PE +DV+ +GV+
Sbjct: 172 EAVVGDFGLAKLM-------DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVM 224
Query: 607 LMELLTGKRGTDDC----------VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESL 656
L+EL+TG+R D + WV+ L+KE +D L E+ + +
Sbjct: 225 LLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVD--LQGNYKDEEVEQLI 282
Query: 657 RVGYLCTADSPGKRPTMQQVLGLLK 681
+V LCT SP +RP M +V+ +L+
Sbjct: 283 QVALLCTQSSPMERPKMSEVVRMLE 307
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-56
Identities = 74/323 (22%), Positives = 126/323 (39%), Gaps = 65/323 (20%)
Query: 398 TFKDLIAATSHFGKE------SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGID----H 447
+F +L T++F + + + EG G VY+ + VA+K L I
Sbjct: 16 SFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEELK 74
Query: 448 DDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDW 507
+++ +H NL+ L G+ G + ++ +M NG L L L P
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP----- 129
Query: 508 STDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567
+W R +IA G A G+ +LH H + +++ILL E+
Sbjct: 130 --------------------LSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEA 169
Query: 568 LEPKIAGFGLRNIGVKNVGERSENET--------CGPE---------SDVYCFGVILMEL 610
KI+ FGL ++ + PE SD+Y FGV+L+E+
Sbjct: 170 FTAKISDFGLARASE--KFAQTVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEI 227
Query: 611 LTGKRGTDDC------VKWVRKLVKEGAG-GDALDFRLKLGSGDSVAEMVESLRVGYLCT 663
+TG D+ + ++ E D +D ++ SV M V C
Sbjct: 228 ITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYS---VASQCL 284
Query: 664 ADSPGKRPTMQQVLGLLKDIRPS 686
+ KRP +++V LL+++ S
Sbjct: 285 HEKKNKRPDIKKVQQLLQEMTAS 307
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 5e-55
Identities = 80/317 (25%), Positives = 120/317 (37%), Gaps = 64/317 (20%)
Query: 398 TFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDEL 457
DL AT++F + L+ G G VY+ VL VA+K ++ + L
Sbjct: 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETL 89
Query: 458 SRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG 517
S +HP+L+ L G+C E +++ ++M NG+L R L+
Sbjct: 90 SFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD------------------- 130
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL 577
+W R I IG ARGL YLH H + + +ILL E+ PKI FG+
Sbjct: 131 -----LPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGI 185
Query: 578 RNIGVKNVGERSENET------------CGPE----------SDVYCFGVILMELLTGKR 615
G ++T PE SDVY FGV+L E+L +
Sbjct: 186 SKKGT------ELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARS 239
Query: 616 GTDDC--------VKWVRKLVKEGAGGDALDFRLKLG-SGDSVAEMVESLRVGYLCTADS 666
+W + G +D L +S+ + + C A S
Sbjct: 240 AIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD---TAVKCLALS 296
Query: 667 PGKRPTMQQVLGLLKDI 683
RP+M VL L+
Sbjct: 297 SEDRPSMGDVLWKLEYA 313
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-37
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 35 FSSVSTFNISWLKPTNLNGSNP---STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLS 91
+ IS ++G + L++SS N S I + L + S L +D+S
Sbjct: 177 CGELKHLAISG---NKISGDVDVSRCVNLEFLDVSSNNFSTGIPF--LGDCSALQHLDIS 231
Query: 92 NNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV 151
N L G + L +N+S N+F G I P S+Q L+L+ N+FT +
Sbjct: 232 GNKLSGDFSRAISTCTELKLLNISSNQFVGPI---PPLP---LKSLQYLSLAENKFTGEI 285
Query: 152 KLS---QFSKLMVLDVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSL 205
L LD+S N +P F + S L L +SS SG + + + L
Sbjct: 286 PDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGL 345
Query: 206 KYLDVSNNSMNGTFPSDFPPLSG-VKFLNISLNKFTG 241
K LD+S N +G P LS + L++S N F+G
Sbjct: 346 KVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 9e-36
Identities = 53/220 (24%), Positives = 97/220 (44%), Gaps = 23/220 (10%)
Query: 35 FSSVSTFNISWLKPTNLNGSNPSTP-------IRELNLSSRNLSGIISWKFLRNMSELHS 87
+S+++ ++S +L+G + ++ LN+SS L ++ L
Sbjct: 99 SASLTSLDLSR---NSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEV 155
Query: 88 IDLSNNSLKGSVPGWFWSTQSLTQV---NLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSS 144
+DLS NS+ G+ + + ++ +S N+ G + +++ L++SS
Sbjct: 156 LDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDV------SRCVNLEFLDVSS 209
Query: 145 NRFT-NLVKLSQFSKLMVLDVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNIKPVSFL 202
N F+ + L S L LD+S N L + ++L+ L+ISS + G I P L
Sbjct: 210 NNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPI-PPLPL 268
Query: 203 HSLKYLDVSNNSMNGTFPSDFPP-LSGVKFLNISLNKFTG 241
SL+YL ++ N G P + L++S N F G
Sbjct: 269 KSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYG 308
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-33
Identities = 60/205 (29%), Positives = 93/205 (45%), Gaps = 19/205 (9%)
Query: 50 NLNGSNPSTP---IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWST 106
G P P ++ L+L+ +G I L +DLS N G+VP +F S
Sbjct: 258 QFVGPIPPLPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSC 317
Query: 107 QSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFT-----NLVKLSQFSKLMV 161
L + LS N F G + P ++VL+LS N F+ +L LS + L+
Sbjct: 318 SLLESLALSSNNFSGEL---PMDTLLKMRGLKVLDLSFNEFSGELPESLTNLS--ASLLT 372
Query: 162 LDVSNNDL--RILPS-GFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMN 216
LD+S+N+ ILP+ + L+ L + + +G I P + L L +S N ++
Sbjct: 373 LDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKI-PPTLSNCSELVSLHLSFNYLS 431
Query: 217 GTFPSDFPPLSGVKFLNISLNKFTG 241
GT PS LS ++ L + LN G
Sbjct: 432 GTIPSSLGSLSKLRDLKLWLNMLEG 456
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 62/235 (26%), Positives = 98/235 (41%), Gaps = 34/235 (14%)
Query: 22 TCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPS-----TPIRELNLSSRNLSGIISW 76
TC V++ ++S + S T + L LS+ +++G +S
Sbjct: 46 TCRD----------DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVSG 95
Query: 77 KFLRNMSELHSIDLSNNSLKGSVP--GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPF 134
+ + L S+DLS NSL G V S L +N+S N S
Sbjct: 96 --FKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPG---KVSGGLKL 150
Query: 135 PSVQVLNLSSNRFT-----NLVKLSQFSKLMVLDVSNNDLRILPSG---FANLSKLRHLD 186
S++VL+LS+N + V +L L +S N + SG + L LD
Sbjct: 151 NSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKI----SGDVDVSRCVNLEFLD 206
Query: 187 ISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTG 241
+SS S I + +L++LD+S N ++G F + +K LNIS N+F G
Sbjct: 207 VSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVG 261
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 8e-32
Identities = 61/199 (30%), Positives = 85/199 (42%), Gaps = 16/199 (8%)
Query: 48 PTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQ 107
NL NP ++EL L + +G I L N SEL S+ LS N L G++P S
Sbjct: 385 LPNL-CQNPKNTLQELYLQNNGFTGKIP-PTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
Query: 108 SLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLDVS 165
L + L N G I P +++ L L N T + LS + L + +S
Sbjct: 443 KLRDLKLWLNMLEGEI---PQEL-MYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498
Query: 166 NNDLR-ILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSD 222
NN L +P L L L +S+ SGNI P SL +LD++ N NGT P+
Sbjct: 499 NNRLTGEIPKWIGRLENLAILKLSNNSFSGNI-PAELGDCRSLIWLDLNTNLFNGTIPAA 557
Query: 223 FPPLSGVKFLNISLNKFTG 241
+ I+ N G
Sbjct: 558 M----FKQSGKIAANFIAG 572
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-31
Identities = 50/208 (24%), Positives = 90/208 (43%), Gaps = 24/208 (11%)
Query: 50 NLNGSNPSTPI------RELNLSSRNLSGII--SWKFLRNMSELHSIDLSNNSLKGSVPG 101
L+ + L+LS+ ++SG W EL + +S N + G V
Sbjct: 137 TLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD- 195
Query: 102 WFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKL 159
+L +++S N F I P + ++Q L++S N+ + +S ++L
Sbjct: 196 -VSRCVNLEFLDVSSNNFSTGI---PFLGD--CSALQHLDISGNKLSGDFSRAISTCTEL 249
Query: 160 MVLDVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNIKPVSF---LHSLKYLDVSNNSM 215
+L++S+N +P L L++L ++ K +G I P +L LD+S N
Sbjct: 250 KLLNISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEI-PDFLSGACDTLTGLDLSGNHF 306
Query: 216 NGTFPSDFPPLSGVKFLNISLNKFTGFV 243
G P F S ++ L +S N F+G +
Sbjct: 307 YGAVPPFFGSCSLLESLALSSNNFSGEL 334
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 3e-25
Identities = 47/221 (21%), Positives = 79/221 (35%), Gaps = 32/221 (14%)
Query: 50 NLNGSNPS-----TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFW 104
L G P + L LS+ + SG I L + L +DL+ N G++P +
Sbjct: 501 RLTGEIPKWIGRLENLAILKLSNNSFSGNIP-AELGDCRSLIWLDLNTNLFNGTIPAAMF 559
Query: 105 STQSLTQVNLSKNRFGGTIGFKPTSRN------------------GPFPSVQVLNLSSNR 146
N + I + + N++S
Sbjct: 560 KQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRV 619
Query: 147 FT--NLVKLSQFSKLMVLDVSNNDL--RILPSGFANLSKLRHLDISSCKISGNIKPVSF- 201
+ +M LD+S N L I P ++ L L++ ISG+I P
Sbjct: 620 YGGHTSPTFDNNGSMMFLDMSYNMLSGYI-PKEIGSMPYLFILNLGHNDISGSI-PDEVG 677
Query: 202 -LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTG 241
L L LD+S+N ++G P L+ + +++S N +G
Sbjct: 678 DLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSG 718
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 4e-25
Identities = 51/203 (25%), Positives = 86/203 (42%), Gaps = 20/203 (9%)
Query: 50 NLNGSNPS-----TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFW 104
+L G PS T + ++LS+ L+G I K++ + L + LSNNS G++P
Sbjct: 477 DLTGEIPSGLSNCTNLNWISLSNNRLTGEIP-KWIGRLENLAILKLSNNSFSGNIPAELG 535
Query: 105 STQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTN--LVKLSQFSKLMVL 162
+SL ++L+ N F GTI P + Q +++N V +
Sbjct: 536 DCRSLIWLDLNTNLFNGTI---PAAMFK-----QSGKIAANFIAGKRYVYIKNDGMKKEC 587
Query: 163 DVSNNDLR---ILPSGFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNSMNGT 218
+ N L I LS +I+S G+ P S+ +LD+S N ++G
Sbjct: 588 HGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGY 647
Query: 219 FPSDFPPLSGVKFLNISLNKFTG 241
P + + + LN+ N +G
Sbjct: 648 IPKEIGSMPYLFILNLGHNDISG 670
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 7e-22
Identities = 41/202 (20%), Positives = 82/202 (40%), Gaps = 24/202 (11%)
Query: 50 NLNGSNPSTPIREL--NLSSRNLSGIISWKFLRNMSELHSIDLSNN--SLKGSVPGWFWS 105
NG+ P+ + + +++ ++G +++N + N +G
Sbjct: 549 LFNGTIPAA-MFKQSGKIAANFIAGKRY-VYIKNDGMKKECHGAGNLLEFQGIRSEQLNR 606
Query: 106 TQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLD 163
+ N++ +GG + S+ L++S N + + ++ L +L+
Sbjct: 607 LSTRNPCNITSRVYGGHT---SPTF-DNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 662
Query: 164 VSNNDL--RILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTF 219
+ +ND+ I P +L L LD+SS K+ G I P + L L +D+SNN+++G
Sbjct: 663 LGHNDISGSI-PDEVGDLRGLNILDLSSNKLDGRI-PQAMSALTMLTEIDLSNNNLSGPI 720
Query: 220 PSDFPPLSGVKFLNISLNKFTG 241
P +F KF
Sbjct: 721 P------EMGQFETFPPAKFLN 736
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 63/351 (17%), Positives = 102/351 (29%), Gaps = 100/351 (28%)
Query: 397 LTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE 456
L ++L + + A GR G V++A L E +VA+K+ + ++
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-YVAVKIFPIQDKQSWQNEYEVY-S 71
Query: 457 LSRLKHPNLLPLAGYCIAG----KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTW 512
L +KH N+L G G + ++ F G L +L
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA---------------- 115
Query: 513 DHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV----------TSSI 562
+W IA +ARGLAYLH + ++
Sbjct: 116 -------------NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162
Query: 563 LLAESLEPKIAGFGLRNIGVKNVGERSENETCG------PE---------------SDVY 601
LL +L IA FGL + G PE D+Y
Sbjct: 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222
Query: 602 CFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVES------ 655
G++L EL + D V L F ++G S+ +M E
Sbjct: 223 AMGLVLWELASRCTAADGPVD-----------EYMLPFEEEIGQHPSLEDMQEVVVHKKK 271
Query: 656 -----------------LRVGYLCTADSPGKRPTMQQVLGLLKDIRPSADL 689
C R + V + ++ ++
Sbjct: 272 RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLTNI 322
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-33
Identities = 55/264 (20%), Positives = 102/264 (38%), Gaps = 33/264 (12%)
Query: 7 LPLLFSLSLVVLAQSTCNSKDQELVS--KAFSSVSTFNISWLKPTNLNGSNPSTPIRELN 64
L L +L++ + + +++ ++VS+F++ + + + + + L
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLE 310
Query: 65 LSSRNLSGIISWKF------------------LRNMSELHSIDLSNNSL--KGSVPGWFW 104
L + + K ++ L +DLS N L KG +
Sbjct: 311 LVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDF 370
Query: 105 STQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQF---SKLMV 161
T SL ++LS N S ++ L+ + + + S F L+
Sbjct: 371 GTTSLKYLDLSFNGVITMS-----SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 162 LDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGT 218
LD+S+ R+ +G F LS L L ++ N P F L +L +LD+S +
Sbjct: 426 LDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQL 485
Query: 219 FPSDFPPLSGVKFLNISLNKFTGF 242
P+ F LS ++ LN+S N F
Sbjct: 486 SPTAFNSLSSLQVLNMSHNNFFSL 509
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-33
Identities = 47/243 (19%), Positives = 86/243 (35%), Gaps = 14/243 (5%)
Query: 7 LPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLS 66
++ L C + + S+ + K N + L+LS
Sbjct: 298 KDFSYNFGWQHLELVNCKF--GQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLS 355
Query: 67 SRNLSGI-ISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGF 125
LS + + L +DLS N + + F + L ++ +
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMS-- 412
Query: 126 KPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLR--ILPSGFANLSK 181
S ++ L++S + S L VL ++ N + LP F L
Sbjct: 413 -EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRN 471
Query: 182 LRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKF 239
L LD+S C++ P +F L SL+ L++S+N+ + L+ ++ L+ SLN
Sbjct: 472 LTFLDLSQCQLEQLS-PTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHI 530
Query: 240 TGF 242
Sbjct: 531 MTS 533
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-31
Identities = 51/258 (19%), Positives = 86/258 (33%), Gaps = 27/258 (10%)
Query: 3 IFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTP--- 59
L L LV L + ++ A + I + L+
Sbjct: 220 CIQGLAGLEVHRLV-LGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLF 278
Query: 60 -----IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNL 114
+ +L S + + + + ++L N S + L
Sbjct: 279 NCLTNVSSFSLVSVTIERVKDFSYNFG---WQHLELVNCKFGQFPTLKLKSLKRL---TF 332
Query: 115 SKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQF----SKLMVLDVSNNDLR 170
+ N+ G PS++ L+LS N + SQ + L LD+S N +
Sbjct: 333 TSNKGGNAFSE------VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI 386
Query: 171 ILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSG 228
+ S F L +L HLD + + F L +L YLD+S+ F F LS
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 229 VKFLNISLNKFTGFVGHD 246
++ L ++ N F D
Sbjct: 447 LEVLKMAGNSFQENFLPD 464
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 36/167 (21%), Positives = 68/167 (40%), Gaps = 8/167 (4%)
Query: 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSK 116
+ L+ NL + + ++ L +D+S+ + + G F SL + ++
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 117 NRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPS 174
N F ++ L+LS + L + S L VL++S+N+ L +
Sbjct: 455 NSFQENF---LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDT 511
Query: 175 G-FANLSKLRHLDISSCKISGNIKPV--SFLHSLKYLDVSNNSMNGT 218
+ L+ L+ LD S I + K F SL +L+++ N T
Sbjct: 512 FPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACT 558
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 2e-27
Identities = 55/216 (25%), Positives = 88/216 (40%), Gaps = 22/216 (10%)
Query: 40 TFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSV 99
T+ L + + P + + L+LS L + S+ F + EL +DLS ++
Sbjct: 11 TYQCMELNFYKIPDNLPFS-TKNLDLSFNPLRHLGSYSF-FSFPELQVLDLSRCEIQTIE 68
Query: 100 PGWFWSTQSLTQVNLSKNRFGGTI--GFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQ 155
G + S L+ + L+ N F S+Q L +L +
Sbjct: 69 DGAYQSLSHLSTLILTGNPIQSLALGAF------SGLSSLQKLVAVETNLASLENFPIGH 122
Query: 156 FSKLMVLDVSNNDLR--ILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKY---- 207
L L+V++N ++ LP F+NL+ L HLD+SS KI I LH +
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLS 181
Query: 208 LDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFV 243
LD+S N MN P F + + L + N + V
Sbjct: 182 LDLSLNPMNFIQPGAFKEIR-LHKLTLRNNFDSLNV 216
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-26
Identities = 37/251 (14%), Positives = 74/251 (29%), Gaps = 27/251 (10%)
Query: 9 LLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTP--------- 59
+ L L N ++ ++ + L
Sbjct: 196 AFKEIRLHKLTLR-NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254
Query: 60 ----IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLS 115
I E L+ + ++ + S L + +++ + + L
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNF--GWQHLELV 312
Query: 116 KNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLR---IL 172
+FG S++ L +SN+ N L LD+S N L
Sbjct: 313 NCKFGQFP-------TLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCC 365
Query: 173 PSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFP-SDFPPLSGVKF 231
+ L++LD+S + L L++LD ++++ S F L + +
Sbjct: 366 SQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY 425
Query: 232 LNISLNKFTGF 242
L+IS
Sbjct: 426 LDISHTHTRVA 436
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 5e-24
Identities = 32/220 (14%), Positives = 63/220 (28%), Gaps = 37/220 (16%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQV----NLSK 116
+ELN++ + ++ N++ L +DLS+N ++ + + +LS
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSL 186
Query: 117 NRFGGTI--------------------GFKPTSRNGPFPSVQVLNLSSNRFTNLVKL--- 153
N + ++V L F N L
Sbjct: 187 NPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 154 --SQFSKLMVLDVSNNDLR-------ILPSGFANLSKLRHLDISSCKISGNIKPVSFLHS 204
S L L + L + F L+ + + S I +K S+
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFG 305
Query: 205 LKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVG 244
++L++ N L + F + V
Sbjct: 306 WQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVD 345
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 3e-21
Identities = 42/203 (20%), Positives = 83/203 (40%), Gaps = 18/203 (8%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSV-P 100
N+ + ++ S + + L++S + + +S L + ++ NS + + P
Sbjct: 407 NLKQMSEFSVFLSLRN--LIYLDISHTHTRVAFN-GIFNGLSSLEVLKMAGNSFQENFLP 463
Query: 101 GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSK 158
F ++LT ++LS+ + + S+QVLN+S N F +L +
Sbjct: 464 DIFTELRNLTFLDLSQCQLEQLS--PTAFNS--LSSLQVLNMSHNNFFSLDTFPYKCLNS 519
Query: 159 LMVLDVSNNDLRIL-PSGFANL-SKLRHLDISSCKISGNIKPVSF---LHSLKYLDVSNN 213
L VLD S N + + S L L+++ + + SF + + L V
Sbjct: 520 LQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVE 579
Query: 214 SMNGTFPSDFPPLSGVKFLNISL 236
M PSD G+ L++++
Sbjct: 580 RMECATPSD---KQGMPVLSLNI 599
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 7e-21
Identities = 39/192 (20%), Positives = 68/192 (35%), Gaps = 35/192 (18%)
Query: 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNR 118
P N I ++DLS N L+ F+S L ++LS+
Sbjct: 8 PNITYQCMELNFYKIPD----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE 63
Query: 119 FGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FA 177
+ +L S L L ++ N ++ L G F+
Sbjct: 64 IQTIE--------------------DGAYQSL------SHLSTLILTGNPIQSLALGAFS 97
Query: 178 NLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGT-FPSDFPPLSGVKFLNI 234
LS L+ L ++ ++ L +LK L+V++N + P F L+ ++ L++
Sbjct: 98 GLSSLQKLVAVETNLAS-LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDL 156
Query: 235 SLNKFTGFVGHD 246
S NK D
Sbjct: 157 SSNKIQSIYCTD 168
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 1e-31
Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 25/208 (12%)
Query: 50 NLNGSNPS-----TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFW 104
NL G P T + L ++ N+SG I FL + L ++D S N+L G++P
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIP-DFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 105 STQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFT--------NLVKLSQF 156
S +L + NR G I P S + +S NR T NL
Sbjct: 147 SLPNLVGITFDGNRISGAI---PDSYGSFSKLFTSMTISRNRLTGKIPPTFANL------ 197
Query: 157 SKLMVLDVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSM 215
L +D+S N L F + + + ++ ++ ++ V +L LD+ NN +
Sbjct: 198 -NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRI 256
Query: 216 NGTFPSDFPPLSGVKFLNISLNKFTGFV 243
GT P L + LN+S N G +
Sbjct: 257 YGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-26
Identities = 51/240 (21%), Positives = 97/240 (40%), Gaps = 28/240 (11%)
Query: 23 CNSKDQE-LVS--KAFSSVSTFNISWLK-----PTNLNGSNPSTP-----IRELNLSSRN 69
CN +D++ L+ K + +T + SWL G T + L+LS N
Sbjct: 3 CNPQDKQALLQIKKDLGNPTTLS-SWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLN 61
Query: 70 LSG--IISWKFLRNMSELHSIDLSN-NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFK 126
L I L N+ L+ + + N+L G +P L + ++ G I
Sbjct: 62 LPKPYPIP-SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI--- 117
Query: 127 PTSRNGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLR-ILPSGFANLSKL- 182
P ++ L+ S N + + +S L+ + N + +P + + SKL
Sbjct: 118 PDFL-SQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLF 176
Query: 183 RHLDISSCKISGNIKPVSFLH-SLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTG 241
+ IS +++G I P +F + +L ++D+S N + G F + ++++ N
Sbjct: 177 TSMTISRNRLTGKI-PPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAF 235
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 8e-23
Identities = 47/216 (21%), Positives = 81/216 (37%), Gaps = 27/216 (12%)
Query: 36 SSVSTFNISWLKPTNLNGSNPS-----TPIRELNLSSRNLSGII-SWKFLRNMSELHSID 89
+ + I+ TN++G+ P + L+ S LSG + + ++ L I
Sbjct: 101 TQLHYLYITH---TNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPS--ISSLPNLVGIT 155
Query: 90 LSNNSLKGSVPGWFWSTQSLTQV-NLSKNRFGGTIGFKPTS-RNGPFPSVQVLNLSSNRF 147
N + G++P + S L +S+NR G I P + N ++ ++LS N
Sbjct: 156 FDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKI---PPTFANL---NLAFVDLSRNML 209
Query: 148 TNLV--KLSQFSKLMVLDVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNIKPVSF--L 202
+ ++ N L L L LD+ + +I G + P L
Sbjct: 210 EGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTL-PQGLTQL 267
Query: 203 HSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNK 238
L L+VS N++ G P L + NK
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGG-NLQRFDVSAYANNK 302
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 8e-31
Identities = 64/306 (20%), Positives = 113/306 (36%), Gaps = 76/306 (24%)
Query: 412 ESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDE-------LSRLKHP 463
E + +G G V++ L + VAIK L + + F E +S L HP
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ L G +++EF+ GDL+ L
Sbjct: 84 NIVKLYGLMH--NPPRMVMEFVPCGDLYHRLL---------------------------D 114
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH--LVTSSILLAESLE-----PKIAGFG 576
W + R+ + +A G+ Y+ + H L + +I L E K+A FG
Sbjct: 115 KAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174
Query: 577 L----RNIGVKNVG-------E--RSENETCGPESDVYCFGVILMELLTGKRGTDDC--- 620
L + +G E +E E+ ++D Y F +IL +LTG+ D+
Sbjct: 175 LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG 234
Query: 621 -VKWVRKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+K++ + +EG R + + ++E C + P KRP ++
Sbjct: 235 KIKFINMIREEG-------LRPTIPEDCPPRLRNVIEL------CWSGDPKKRPHFSYIV 281
Query: 678 GLLKDI 683
L ++
Sbjct: 282 KELSEL 287
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-30
Identities = 69/300 (23%), Positives = 107/300 (35%), Gaps = 74/300 (24%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLLPLAG 470
+ G G VYRA G+ VA+K + D + + + LKHPN++ L G
Sbjct: 15 IGIGGFGKVYRAFWIGD-EVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
C+ +++EF G L+R L ++
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSG-----------------------------KRIPP 104
Query: 531 VTRHRIAIGVARGLAYLHHVGST---HGHLVTSSILLAESLEP--------KIAGFGL-- 577
A+ +ARG+ YLH H L +S+IL+ + +E KI FGL
Sbjct: 105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 578 ---RNIGVKNVG-------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVR 625
R + G E SDV+ +GV+L ELLTG+ D +
Sbjct: 165 EWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAY 224
Query: 626 KLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+ L + S + A+++E C P RP+ +L L I
Sbjct: 225 GVAMNK-------LALPIPSTCPEPFAKLMED------CWNPDPHSRPSFTNILDQLTTI 271
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-30
Identities = 43/221 (19%), Positives = 85/221 (38%), Gaps = 18/221 (8%)
Query: 37 SVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLK 96
S+S +S T G + + L+LS NL+ + + + +L L N+++
Sbjct: 228 SLSNSQLSTTSNTTFLGLKWTN-LTMLDLSYNNLNVVGN-DSFAWLPQLEYFFLEYNNIQ 285
Query: 97 GSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPF-----PSVQVLNLSSNRFTNLV 151
++ +NL ++ +I + F ++ LN+ N +
Sbjct: 286 HLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIK 345
Query: 152 K--LSQFSKLMVLDVSNNDLRIL---PSGFANL--SKLRHLDISSCKISGNIKPVSF--L 202
+ L L +SN+ + F +L S L L+++ KIS I+ +F L
Sbjct: 346 SNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISK-IESDAFSWL 404
Query: 203 HSLKYLDVSNNSMNGTFPSD-FPPLSGVKFLNISLNKFTGF 242
L+ LD+ N + + L + + +S NK+
Sbjct: 405 GHLEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQL 445
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 49/247 (19%), Positives = 96/247 (38%), Gaps = 25/247 (10%)
Query: 3 IFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRE 62
F LP L L + Q L S + + N+ +L NL S +
Sbjct: 267 SFAWLPQLEYFFL-------EYNNIQHLFSHSLHGLF--NVRYL---NLKRS-----FTK 309
Query: 63 LNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGT 122
++S +L I + F + + L +++ +N + G F +L ++LS +
Sbjct: 310 QSISLASLPKIDDFSF-QWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLR 368
Query: 123 IGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLR--ILPSGFAN 178
T + + +LNL+ N+ + + S L VLD+ N++ + +
Sbjct: 369 TLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRG 428
Query: 179 LSKLRHLDISSCKISGNIKPV-SFLHSLKYLDVSNNSMNG--TFPSDFPPLSGVKFLNIS 235
L + + +S K + + + SL+ L + ++ + PS F PL + L++S
Sbjct: 429 LENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILDLS 488
Query: 236 LNKFTGF 242
N
Sbjct: 489 NNNIANI 495
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 2e-27
Identities = 43/193 (22%), Positives = 79/193 (40%), Gaps = 14/193 (7%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ EL+L S ++ I + F L ++DLS+N L + G ++L ++ LS N+
Sbjct: 99 LTELHLMSNSIQKIKNNPF-VKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKI 157
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDL-RILPSGF 176
S++ L LSSN+ +L L ++N L L
Sbjct: 158 QALK--SEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKL 215
Query: 177 A---NLSKLRHLDISSCKISGNIKPVSFLH----SLKYLDVSNNSMNGTFPSDFPPLSGV 229
+ +R+L +S+ ++S +FL +L LD+S N++N F L +
Sbjct: 216 CLELANTSIRNLSLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQL 274
Query: 230 KFLNISLNKFTGF 242
++ + N
Sbjct: 275 EYFFLEYNNIQHL 287
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 40/197 (20%), Positives = 72/197 (36%), Gaps = 15/197 (7%)
Query: 60 IRELNLSSRNLSGIISW-KFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNR 118
++ L L L + S + + L +DLSNN++ + L ++L N
Sbjct: 456 LQRLMLRRVALKNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNN 515
Query: 119 F----GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRIL 172
P + +LNL SN F + +L ++D+ N+L L
Sbjct: 516 LARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTL 575
Query: 173 PSG-FANLSKLRHLDISSCKISGNIKPVSF---LHSLKYLDVSNNSMNGTFPSDFPPLSG 228
P+ F N L+ L++ I+ ++ F +L LD+ N + T
Sbjct: 576 PASVFNNQVSLKSLNLQKNLITS-VEKKVFGPAFRNLTELDMRFNPFDCT-CESIAWF-- 631
Query: 229 VKFLNISLNKFTGFVGH 245
V ++N + H
Sbjct: 632 VNWINETHTNIPELSSH 648
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-24
Identities = 45/227 (19%), Positives = 84/227 (37%), Gaps = 21/227 (9%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPG 101
+I +K + + L+LS LS + L + LSNN ++
Sbjct: 108 SIQKIKNNPF-VKQKN--LITLDLSHNGLSSTKLGTQ-VQLENLQELLLSNNKIQALKSE 163
Query: 102 WF--WSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFT-----NLVKLS 154
++ SL ++ LS N+ F P + + L L++ + L
Sbjct: 164 ELDIFANSSLKKLELSSNQIKE---FSPGCFHA-IGRLFGLFLNNVQLGPSLTEKLCLEL 219
Query: 155 QFSKLMVLDVSNNDLRILPSG-FANL--SKLRHLDISSCKISGNIKPVSF--LHSLKYLD 209
+ + L +SN+ L + F L + L LD+S ++ + SF L L+Y
Sbjct: 220 ANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNV-VGNDSFAWLPQLEYFF 278
Query: 210 VSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHDKYQKFGKSAF 256
+ N++ F L V++LN+ + + K +F
Sbjct: 279 LEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSF 325
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-24
Identities = 39/195 (20%), Positives = 74/195 (37%), Gaps = 20/195 (10%)
Query: 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSK 116
+ + S L+ + N + ++L++N L+ F LT +++
Sbjct: 3 TVSHEVADCSHLKLTQVPDD-LPTN---ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGF 58
Query: 117 NRFGGTI--GFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRIL 172
N P ++VLNL N + L + + L L + +N ++ +
Sbjct: 59 NTISKLEPELC------QKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKI 112
Query: 173 PSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFP--PLS 227
+ F L LD+S +S K + L +L+ L +SNN + + S
Sbjct: 113 KNNPFVKQKNLITLDLSHNGLSS-TKLGTQVQLENLQELLLSNNKIQALKSEELDIFANS 171
Query: 228 GVKFLNISLNKFTGF 242
+K L +S N+ F
Sbjct: 172 SLKKLELSSNQIKEF 186
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-15
Identities = 38/164 (23%), Positives = 59/164 (35%), Gaps = 17/164 (10%)
Query: 42 NISWLKPTNLNGSNPSTP-----IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLK 96
N++ L G + LNL S I F +++ EL IDL N+L
Sbjct: 515 NLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVF-KDLFELKIIDLGLNNLN 573
Query: 97 GSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFT-------N 149
F + SL +NL KN F ++ L++ N F
Sbjct: 574 TLPASVFNNQVSLKSLNLQKNLITSVE---KKVFGPAFRNLTELDMRFNPFDCTCESIAW 630
Query: 150 LVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS 193
V + + ++S++ L P + +R D SSCK S
Sbjct: 631 FVNWINETHTNIPELSSHYLCNTPPHYHGFP-VRLFDTSSCKDS 673
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 2e-30
Identities = 58/303 (19%), Positives = 109/303 (35%), Gaps = 84/303 (27%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLLPLAG 470
L E G +++ G + +KVL F+E L HPN+LP+ G
Sbjct: 18 LNENHSGELWKGRWQGN-DIVVKVLKVRD--WSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 471 YCIAG-KEKLVLL-EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
C + L+ +M G L+ LHE +
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHE--------------------------GTNFVV 108
Query: 529 NWVTRHRIAIGVARGLAYLHHVGST--HGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
+ + A+ +ARG+A+LH + L + S+++ E + +I+ ++
Sbjct: 109 DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK-------- 160
Query: 587 ERSENET--CG------PE-------------SDVYCFGVILMELLTGKRGTDD--CVKW 623
S PE +D++ F V+L EL+T + D ++
Sbjct: 161 -FSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI 219
Query: 624 VRKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681
K+ EG R + G V+++++ C + P KRP ++ +L+
Sbjct: 220 GMKVALEGL-------RPTIPPGISPHVSKLMKI------CMNEDPAKRPKFDMIVPILE 266
Query: 682 DIR 684
++
Sbjct: 267 KMQ 269
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-30
Identities = 52/219 (23%), Positives = 72/219 (32%), Gaps = 25/219 (11%)
Query: 35 FSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNS 94
SV N L PT G N + +NLS+ +S F S L SI+L N
Sbjct: 414 IGSVDGKNFDPLDPTPFKGIN----VSSINLSNNQISKFPKELF-STGSPLSSINLMGNM 468
Query: 95 LKG-------SVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRF 147
L F +T LT ++L N+ R P + ++LS N F
Sbjct: 469 LTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLS---DDFRATTLPYLVGIDLSYNSF 525
Query: 148 T-------NLVKLSQFSKLMVLDVS-NNDLRILPSGFANLSKLRHLDISSCKISGNIKPV 199
+ N L F D N LR P G L L I S I +
Sbjct: 526 SKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRK-V-NE 583
Query: 200 SFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNK 238
++ LD+ +N S P + +K
Sbjct: 584 KITPNISVLDIKDNPNISIDLSYVCPYIEAGMYMLFYDK 622
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-29
Identities = 36/202 (17%), Positives = 63/202 (31%), Gaps = 24/202 (11%)
Query: 61 RELNLSSRNLSGIISWKF------LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNL 114
++ S + + F + SI+LSNN + F + L+ +NL
Sbjct: 405 SAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINL 464
Query: 115 SKNRFGGTIGFKPTSRNGPF---PSVQVLNLSSNRFTNL---VKLSQFSKLMVLDVSNND 168
N N F + ++L N+ T L + + L+ +D+S N
Sbjct: 465 MGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNS 524
Query: 169 LRILPSGFANLSKLRHLDI------SSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFP 220
P+ N S L+ I + P SL L + +N +
Sbjct: 525 FSKFPTQPLNSSTLKGFGIRNQRDAQGNRTLREW-PEGITLCPSLTQLQIGSNDIR-KVN 582
Query: 221 SDFPPLSGVKFLNISLNKFTGF 242
+ L+I N
Sbjct: 583 EKI--TPNISVLDIKDNPNISI 602
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-26
Identities = 38/219 (17%), Positives = 63/219 (28%), Gaps = 30/219 (13%)
Query: 48 PTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWS-- 105
P N G + L+ + L I + +++S + +ID S N + F
Sbjct: 369 PANFCGFTEQ--VENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426
Query: 106 -----TQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK-------- 152
+++ +NLS N+ + +NL N T + K
Sbjct: 427 PTPFKGINVSSINLSNNQISKFP---KELF-STGSPLSSINLMGNMLTEIPKNSLKDENE 482
Query: 153 -LSQFSKLMVLDVSNNDLRILPS--GFANLSKLRHLDISSCKIS------GNIKPVSFLH 203
L +D+ N L L L L +D+S S N +
Sbjct: 483 NFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSKFPTQPLNSSTLKGFG 542
Query: 204 SLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
D N +P + L I N
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKV 581
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-26
Identities = 40/227 (17%), Positives = 79/227 (34%), Gaps = 29/227 (12%)
Query: 35 FSSVSTFNISWLKPTNL-NGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNN 93
S W + G I+ + + NL L+ M +L ++ N
Sbjct: 285 GISGEQLKDDWQALADAPVGEK----IQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYN 340
Query: 94 SLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK- 152
L+G +P F S L +NL+ N+ P + G V+ L+ + N+ +
Sbjct: 341 QLEGKLPA-FGSEIKLASLNLAYNQITEI----PANFCGFTEQVENLSFAHNKLKYIPNI 395
Query: 153 --LSQFSKLMVLDVSNNDLR--------ILPSGFANLSKLRHLDISSCKISGNIKPV-SF 201
S + +D S N++ L + +++S+ +IS K + S
Sbjct: 396 FDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFST 455
Query: 202 LHSLKYLDVSNNSMNG-------TFPSDFPPLSGVKFLNISLNKFTG 241
L +++ N + +F + +++ NK T
Sbjct: 456 GSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK 502
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 7e-24
Identities = 25/195 (12%), Positives = 60/195 (30%), Gaps = 21/195 (10%)
Query: 50 NLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSL 109
N N K+ N+ +L +++ N +P + + +
Sbjct: 217 PFVAENICEAWENENSEYAQQYKTEDLKW-DNLKDLTDVEVYNCPNLTKLPTFLKALPEM 275
Query: 110 TQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDL 169
+N++ NR + + L K+ ++ + N+L
Sbjct: 276 QLINVACNRGIS------------------GEQLKDDWQALADAPVGEKIQIIYIGYNNL 317
Query: 170 RIL--PSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLS 227
+ + + KL L+ ++ G + L L+++ N + +
Sbjct: 318 KTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTE 377
Query: 228 GVKFLNISLNKFTGF 242
V+ L+ + NK
Sbjct: 378 QVENLSFAHNKLKYI 392
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 1e-23
Identities = 29/207 (14%), Positives = 66/207 (31%), Gaps = 29/207 (14%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWST----QSLTQVNLSK 116
L+L SG + + ++EL + L ++ K + + S Q +
Sbjct: 84 TGLSLEGFGASGRVP-DAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMR 142
Query: 117 NRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQF--SKLMVLDVSNNDLRILPS 174
+ T + F + ++S+ +K S K + +N++ +
Sbjct: 143 MHYQKTFVDYDPRED--FSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITFVSK 200
Query: 175 GFANLSKLRHLDISSCKISGNIK------------------PVSF--LHSLKYLDVSNNS 214
L+KLR + + + + L L ++V N
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCP 260
Query: 215 MNGTFPSDFPPLSGVKFLNISLNKFTG 241
P+ L ++ +N++ N+
Sbjct: 261 NLTKLPTFLKALPEMQLINVACNRGIS 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 72/296 (24%), Positives = 118/296 (39%), Gaps = 71/296 (23%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLLPLAG 470
+ G G V+RA G VA+K+L H + V F + RL+HPN++ G
Sbjct: 45 IGAGSFGTVHRAEWHGS-DVAVKILMEQD--FHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
++ E+++ G L+R LH+ + E+ +
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKS-------------------------GAREQLDE 136
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGH--LVTSSILLAESLEPKIAGFGL-RNIGVKNVGE 587
R +A VA+G+ YLH+ H L + ++L+ + K+ FGL R +K
Sbjct: 137 RRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR---LKASTF 193
Query: 588 RSENETCG------PE----------SDVYCFGVILMELLTGKRGTDD--CVKWVRKLVK 629
S G PE SDVY FGVIL EL T ++ + + V +
Sbjct: 194 LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF 253
Query: 630 EGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+ RL++ VA ++E C + P KRP+ ++ LL+ +
Sbjct: 254 KCK-------RLEIPRNLNPQVAAIIEG------CWTNEPWKRPSFATIMDLLRPL 296
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-29
Identities = 37/205 (18%), Positives = 69/205 (33%), Gaps = 16/205 (7%)
Query: 50 NLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSL 109
N + + N + N+ +L ++L N +P + + L
Sbjct: 459 PFTYDNIAVDWEDANSDYAKQYENEELSW-SNLKDLTDVELYNCPNMTQLPDFLYDLPEL 517
Query: 110 TQVNLSKNRFGGTIGFKPTSRNGP-----FPSVQVLNLSSNRFTNL---VKLSQFSKLMV 161
+N++ NR K P +Q+ + N L + KL +
Sbjct: 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
Query: 162 LDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTF 219
LD +N +R L + F KL L + +I I ++ L S+N +
Sbjct: 578 LDCVHNKVRHLEA-FGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YI 634
Query: 220 PSDF--PPLSGVKFLNISLNKFTGF 242
P+ F + + ++ S NK
Sbjct: 635 PNIFNAKSVYVMGSVDFSYNKIGSE 659
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-26
Identities = 37/194 (19%), Positives = 66/194 (34%), Gaps = 21/194 (10%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLK-------GSVPGWFWSTQSLTQV 112
+ LS + + + S + +I LSNN + G + +T LT +
Sbjct: 675 ASTVTLSYNEIQKFPT-ELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTI 733
Query: 113 NLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNL-VKLSQFSKLMVLDVS------ 165
+L N+ R P + +++S N F++ + S+L +
Sbjct: 734 DLRFNKLTS---LSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAE 790
Query: 166 -NNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFP 224
N LR P+G L L I S I + L LD+++N +
Sbjct: 791 GNRILRQWPTGITTCPSLIQLQIGSNDIR-KV-DEKLTPQLYILDIADNPNISIDVTSVC 848
Query: 225 PLSGVKFLNISLNK 238
P + +K
Sbjct: 849 PYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 8e-26
Identities = 36/205 (17%), Positives = 61/205 (29%), Gaps = 26/205 (12%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQ-----SLTQVNL 114
+ L S L I + +++ + S+D S N + S + + V L
Sbjct: 621 VEGLGFSHNKLKYIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTL 680
Query: 115 SKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNL---------VKLSQFSKLMVLDVS 165
S N PT + + LS+N T++ L +D+
Sbjct: 681 SYNEIQKF----PTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLR 736
Query: 166 NNDLRILPS--GFANLSKLRHLDISSCKIS------GNIKPVSFLHSLKYLDVSNNSMNG 217
N L L L L ++D+S S N + D N +
Sbjct: 737 FNKLTSLSDDFRATTLPYLSNMDVSYNCFSSFPTQPLNSSQLKAFGIRHQRDAEGNRILR 796
Query: 218 TFPSDFPPLSGVKFLNISLNKFTGF 242
+P+ + L I N
Sbjct: 797 QWPTGITTCPSLIQLQIGSNDIRKV 821
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 3e-24
Identities = 25/210 (11%), Positives = 62/210 (29%), Gaps = 31/210 (14%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ L+L+ G + + ++EL + +S S + + K+R
Sbjct: 325 VTGLSLAGFGAKGRVP-DAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRI 383
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKL-------MVLDVSNNDLRIL 172
+ + +L + ++ K + N + +
Sbjct: 384 RMHY---KKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQIGNLTNRITFI 440
Query: 173 PSGFANLSKLRHLDISSCKISGNIK------------------PVSF--LHSLKYLDVSN 212
L+KL+ + ++ + + +S+ L L +++ N
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYN 500
Query: 213 NSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
P L ++ LNI+ N+
Sbjct: 501 CPNMTQLPDFLYDLPELQSLNIACNRGISA 530
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-29
Identities = 61/296 (20%), Positives = 104/296 (35%), Gaps = 68/296 (22%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLLPLAG 470
+ G G VY+ G+ VA+K+L+ + F L + +H N+L G
Sbjct: 32 IGSGSFGTVYKGKWHGD--VAVKMLN--VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 471 YCIAGKEKLVLL-EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTN 529
Y +L ++ ++ L+ LH T K
Sbjct: 88 YST--APQLAIVTQWCEGSSLYHHLHASET---------------------------KFE 118
Query: 530 WVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERS 589
IA ARG+ YLH H L +++I L E KI FGL + G
Sbjct: 119 MKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 590 ENETCG------PE-------------SDVYCFGVILMELLTGK---RGTDDCVKWVRKL 627
+ G PE SDVY FG++L EL+TG+ ++ + + +
Sbjct: 179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238
Query: 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+ D R + ++ C +RP+ ++L ++++
Sbjct: 239 GRGSLSPDLSKVR--SNCPKRMKRLMAE------CLKKKRDERPSFPRILAEIEEL 286
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-29
Identities = 52/251 (20%), Positives = 89/251 (35%), Gaps = 31/251 (12%)
Query: 4 FCRLPLLFSLSLVVLAQSTCNSKDQELVSKAF-SSVSTFNISWLKPTNLNGSNPSTPIRE 62
F L + ++SL + L + +I + + ++
Sbjct: 281 FHCLANVSAMSLA-------GVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPF-LKS 332
Query: 63 LNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFW--STQSLTQVNLSKNRFG 120
L L+ S L ++S L DLS N+L S + T SL ++LS N
Sbjct: 333 LTLTMNKGSISFKKVALPSLSYL---DLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGA- 388
Query: 121 GTIGFKPTSRNGPF---PSVQVLNLSSNRFTNLVKLSQFS---KLMVLDVSNNDLRILPS 174
+ F +Q L+ + + + S F KL+ LD+S + +I
Sbjct: 389 -------IIMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFD 441
Query: 175 G-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKF 231
G F L+ L L ++ N F +L +LD+S + F L ++
Sbjct: 442 GIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQL 501
Query: 232 LNISLNKFTGF 242
LN+S N
Sbjct: 502 LNMSHNNLLFL 512
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 43/254 (16%), Positives = 82/254 (32%), Gaps = 37/254 (14%)
Query: 24 NSKDQELVSKAFSSVSTFNISWLKPTNLNGSN-------------PSTPIRELNLSSRNL 70
N ++ +++ ++ L I E L+ N
Sbjct: 214 NFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTND 273
Query: 71 SGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPT-- 128
KF ++ + ++ L+ S+K +++ + +
Sbjct: 274 FSDDIVKF-HCLANVSAMSLAGVSIKYLEDVPKHF--KWQSLSIIRCQLKQFPTLDLPFL 330
Query: 129 -----SRN--------GPFPSVQVLNLSSNRFTNL----VKLSQFSKLMVLDVSNNDLRI 171
+ N PS+ L+LS N + + L LD+S N I
Sbjct: 331 KSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII 390
Query: 172 LPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGV 229
+ + F L +L+HLD + + +F L L YLD+S + F F L+ +
Sbjct: 391 MSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSL 450
Query: 230 KFLNISLNKFTGFV 243
L ++ N F
Sbjct: 451 NTLKMAGNSFKDNT 464
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-28
Identities = 43/242 (17%), Positives = 85/242 (35%), Gaps = 14/242 (5%)
Query: 8 PLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSS 67
+ L+ C ++ + + + ++ K + + L+LS
Sbjct: 302 DVPKHFKWQSLSIIRCQL--KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSR 359
Query: 68 RNLSGIISWKF-LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFK 126
LS + + L +DLS N + F + L ++ +
Sbjct: 360 NALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVT--- 415
Query: 127 PTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLR--ILPSGFANLSKL 182
S + L++S + L L ++ N + L + FAN + L
Sbjct: 416 EFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNL 475
Query: 183 RHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
LD+S C++ I F LH L+ L++S+N++ S + L + L+ S N+
Sbjct: 476 TFLDLSKCQLEQ-ISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE 534
Query: 241 GF 242
Sbjct: 535 TS 536
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 6e-27
Identities = 38/188 (20%), Positives = 72/188 (38%), Gaps = 14/188 (7%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVP-GWFWSTQSLTQVNLSKNR 118
+R L+LS + + + EL +D +++LK F S + L +++S
Sbjct: 378 LRHLDLSFNGAIIMSAN--FMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTN 435
Query: 119 FGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK---LSQFSKLMVLDVSNNDLRILPSG 175
S+ L ++ N F + + + L LD+S L + G
Sbjct: 436 ----TKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 176 -FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFL 232
F L +L+ L++S + + + L+SL LD S N + + + F
Sbjct: 492 VFDTLHRLQLLNMSHNNLLF-LDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFF 550
Query: 233 NISLNKFT 240
N++ N
Sbjct: 551 NLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 6e-22
Identities = 40/189 (21%), Positives = 66/189 (34%), Gaps = 19/189 (10%)
Query: 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSK 116
P + LS + S +IDLS N LK F + L ++LS+
Sbjct: 10 VVPNITYQCMDQKLSKVPDDIP----SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSR 65
Query: 117 NRFGGTIGFKPTSRNGPF---PSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRI 171
+ + + L L+ N + S + L L L
Sbjct: 66 CEIETIE-------DKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS 118
Query: 172 LPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSG 228
L S L L+ L+++ I P F L +L ++D+S N + +D L
Sbjct: 119 LESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178
Query: 229 VKFLNISLN 237
+N+SL+
Sbjct: 179 NPQVNLSLD 187
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-19
Identities = 36/167 (21%), Positives = 70/167 (41%), Gaps = 16/167 (9%)
Query: 87 SIDLSNNSLKGSVPGW-FWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSN 145
+ + L VP ST+++ +LS N K S + F +Q L+LS
Sbjct: 15 TYQCMDQKLS-KVPDDIPSSTKNI---DLSFNPL---KILKSYSFSN-FSELQWLDLSRC 66
Query: 146 RFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF- 201
+ L L ++ N ++ G F+ L+ L +L K++ ++
Sbjct: 67 EIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLAS-LESFPIG 125
Query: 202 -LHSLKYLDVSNNSMNG-TFPSDFPPLSGVKFLNISLNKFTGFVGHD 246
L +LK L+V++N ++ P+ F L+ + +++S N +D
Sbjct: 126 QLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVND 172
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 31/200 (15%), Positives = 66/200 (33%), Gaps = 26/200 (13%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQV----NLSK 116
++LN++ + + N++ L +DLS N ++ + QV ++S
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 117 NRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDV---------SNN 167
N + + G + L L N ++ + + L L V
Sbjct: 191 NPID---FIQDQAFQG--IKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDER 245
Query: 168 DLRILPSG-FANLSKLR--HLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSD 222
+L I L + ++ V F L ++ + ++ S+ + D
Sbjct: 246 NLEIFEPSIMEGLCDVTIDEFRLTYTNDFS-DDIVKFHCLANVSAMSLAGVSI--KYLED 302
Query: 223 FPPLSGVKFLNISLNKFTGF 242
P + L+I + F
Sbjct: 303 VPKHFKWQSLSIIRCQLKQF 322
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 5e-16
Identities = 27/181 (14%), Positives = 55/181 (30%), Gaps = 31/181 (17%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ L ++ + N + L +DLS L+ G F + L
Sbjct: 450 LNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRL---------- 499
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-F 176
Q+LN+S N L +Q L LD S N +
Sbjct: 500 ------------------QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
Query: 177 ANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISL 236
L ++++ ++ + FL +K ++ + ++ L+ +
Sbjct: 542 HFPKSLAFFNLTNNSVACICEHQKFLQWVKEQKQFLVNVEQMTCATPVEMNTSLVLDFNN 601
Query: 237 N 237
+
Sbjct: 602 S 602
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 57/293 (19%), Positives = 102/293 (34%), Gaps = 71/293 (24%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLLPLAG 470
+ G G V +A + VAIK +++ + F LSR+ HPN++ L G
Sbjct: 16 VGRGAFGVVCKAKWRAK-DVAIKQIES------ESERKAFIVELRQLSRVNHPNIVKLYG 68
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
C+ +++E+ G L+ LH
Sbjct: 69 ACL--NPVCLVMEYAEGGSLYNVLH-------------------------GAEPLPYYTA 101
Query: 531 VTRHRIAIGVARGLAYLHHVGST---HGHLVTSSILLAESLE-PKIAGFGL-RNIG---V 582
+ ++G+AYLH + H L ++LL KI FG +I
Sbjct: 102 AHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT 161
Query: 583 KNVG-------ERSENETCGPESDVYCFGVILMELLTGK---RGTDDCVKWVRKLVKEGA 632
N G E E + DV+ +G+IL E++T + + V G
Sbjct: 162 NNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNG- 220
Query: 633 GGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
R L + ++ C + P +RP+M++++ ++ +
Sbjct: 221 ------TRPPLIKNLPKPIESLMTR------CWSKDPSQRPSMEEIVKIMTHL 261
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-28
Identities = 54/248 (21%), Positives = 91/248 (36%), Gaps = 39/248 (15%)
Query: 4 FCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIREL 63
P L LS+ N+K EL + ++ NL REL
Sbjct: 321 ASNFPSLTHLSI------KGNTKRLELGTGCLENL----------ENL---------REL 355
Query: 64 NLSSRNLSGI-ISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGT 122
+LS ++ LRN+S L S++LS N F L ++L+ R
Sbjct: 356 DLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVK 415
Query: 123 IGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLR----ILPSGF 176
S ++VLNLS + + L L++ N +
Sbjct: 416 D---AQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472
Query: 177 ANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNI 234
L +L L +S C +S I +F L + ++D+S+N + + L G+ +LN+
Sbjct: 473 QTLGRLEILVLSFCDLSS-IDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLKGI-YLNL 530
Query: 235 SLNKFTGF 242
+ N +
Sbjct: 531 ASNHISII 538
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-24
Identities = 38/184 (20%), Positives = 72/184 (39%), Gaps = 26/184 (14%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ L+L+ L + +N+ L ++LS++ L S F +L +NL N F
Sbjct: 402 LELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHF 461
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FAN 178
+N L +L +L +S DL + F +
Sbjct: 462 PKGNI-----------------QKTNSLQTL------GRLEILVLSFCDLSSIDQHAFTS 498
Query: 179 LSKLRHLDISSCKISGNIKPVSFLH-SLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
L + H+D+S +++ + H YL++++N ++ PS P LS + +N+ N
Sbjct: 499 LKMMNHVDLSHNRLTS-SSIEALSHLKGIYLNLASNHISIILPSLLPILSQQRTINLRQN 557
Query: 238 KFTG 241
Sbjct: 558 PLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-24
Identities = 42/207 (20%), Positives = 76/207 (36%), Gaps = 13/207 (6%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPG 101
I +L +++ LNL+ +++GI F + + S++ +
Sbjct: 164 AIHYLSKEDMSSL-QQATNLSLNLNGNDIAGIEPGAF--DSAVFQSLNFGGTQNLLVIFK 220
Query: 102 W--FWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFS 157
+ QSL SV+ +NL + F N+ FS
Sbjct: 221 GLKNSTIQSLWLGTFEDMDDEDIS--PAVFEGLCEMSVESINLQKHYFFNISSNTFHCFS 278
Query: 158 KLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSM 215
L LD++ L LPSG LS L+ L +S+ K + +S SL +L + N+
Sbjct: 279 GLQELDLTATHLSELPSGLVGLSTLKKLVLSANKFEN-LCQISASNFPSLTHLSIKGNTK 337
Query: 216 NGTFPSD-FPPLSGVKFLNISLNKFTG 241
+ L ++ L++S +
Sbjct: 338 RLELGTGCLENLENLRELDLSHDDIET 364
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 35/201 (17%), Positives = 66/201 (32%), Gaps = 19/201 (9%)
Query: 48 PTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQ 107
P L P++ L S L I + F + L +DL+ + F S
Sbjct: 28 PGTL----PNS-TECLEFSFNVLPTIQNTTF-SRLINLTFLDLTRCQIYWIHEDTFQSQH 81
Query: 108 SLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVS 165
L + L+ N I T+ +GP +++ L +++ L L L +
Sbjct: 82 RLDTLVLTANPL---IFMAETALSGP-KALKHLFFIQTGISSIDFIPLHNQKTLESLYLG 137
Query: 166 NNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLK--YLDVSNNSMNGTFP 220
+N + + KL+ LD + I + L L+++ N +
Sbjct: 138 SNHISSIKLPKGFPTEKLKVLDFQNNAIH-YLSKEDMSSLQQATNLSLNLNGNDI-AGIE 195
Query: 221 SDFPPLSGVKFLNISLNKFTG 241
+ + LN +
Sbjct: 196 PGAFDSAVFQSLNFGGTQNLL 216
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 37/190 (19%), Positives = 62/190 (32%), Gaps = 18/190 (9%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ N + L+ I + ++ S N L F +LT ++L++ +
Sbjct: 15 KTYNCENLGLNEIPG-TLPNS---TECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIY 70
Query: 121 GTI--GFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG- 175
F + L L++N + + LS L L + +
Sbjct: 71 WIHEDTF------QSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIP 124
Query: 176 FANLSKLRHLDISSCKISGNIKPV-SFLHSLKYLDVSNNSMNGTFPSDFPPLSG--VKFL 232
N L L + S IS P LK LD NN+++ D L L
Sbjct: 125 LHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSL 184
Query: 233 NISLNKFTGF 242
N++ N G
Sbjct: 185 NLNGNDIAGI 194
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 3e-21
Identities = 34/209 (16%), Positives = 73/209 (34%), Gaps = 14/209 (6%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKF--LRNMSELHSIDLSNNSLKGSV 99
+IS +K + ++ L+ + + + L+ + L S++L+ N + G
Sbjct: 140 HISSIKLPKGFPT---EKLKVLDFQNNAIHYLSKEDMSSLQQATNL-SLNLNGNDIAGIE 195
Query: 100 PGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLS----Q 155
PG F S +N + I +N S+ + ++
Sbjct: 196 PGAFDSA-VFQSLNFGGTQNLLVIF--KGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 156 FSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNS 214
+ +++ + + S F S L+ LD+++ +S + L +LK L +S N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSELPSGLVGLSTLKKLVLSANK 312
Query: 215 MNGTFPSDFPPLSGVKFLNISLNKFTGFV 243
+ L+I N +
Sbjct: 313 FENLCQISASNFPSLTHLSIKGNTKRLEL 341
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 6e-21
Identities = 27/190 (14%), Positives = 60/190 (31%), Gaps = 12/190 (6%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ L +S I L N L S+ L +N + + T+ L ++ N
Sbjct: 108 KHLFFIQTGISSIDF-IPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIH 166
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNL-VKLSQFSKLMVLDVSNNDLRILP---SGF 176
K + + LNL+ N + + L+ ++
Sbjct: 167 YLS--KEDMSSLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKN 224
Query: 177 ANLSKLRHLDISSCKISGNIKPVSFLH----SLKYLDVSNNSMNGTFPSDFPPLSGVKFL 232
+ + L +I P F S++ +++ + + F SG++ L
Sbjct: 225 STIQSLWLGTFEDMDDE-DISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQEL 283
Query: 233 NISLNKFTGF 242
+++ +
Sbjct: 284 DLTATHLSEL 293
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-27
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 33/251 (13%)
Query: 3 IFCRLPLLFSLSLVV--LAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPI 60
+F L + S SLV + + S + + LK +L
Sbjct: 277 LFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSL--------- 327
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSL--KGSVPGWFWSTQSLTQVNLSKNR 118
+ L +S S L + L +DLS N L KG + T SL ++LS N
Sbjct: 328 KRLTFTSNKGGNAFSEVDLPS---LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNG 384
Query: 119 FGGTIGFKPTSRNGPF---PSVQVLNLSSNRFTNLVKLSQF---SKLMVLDVSNNDLRIL 172
+ + F ++ L+ + + + S F L+ LD+S+ R+
Sbjct: 385 V--------ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 173 PSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGV 229
+G F LS L L ++ N P F L +L +LD+S + P+ F LS +
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 230 KFLNISLNKFT 240
+ LN++ N+
Sbjct: 497 QVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 4e-25
Identities = 45/239 (18%), Positives = 88/239 (36%), Gaps = 14/239 (5%)
Query: 8 PLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSS 67
++ L N K + + S+ + K N + L+LS
Sbjct: 299 DFSYNFGWQHLELV--NCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSR 356
Query: 68 RNLSGI-ISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFK 126
LS + + L +DLS N + ++ F + L ++ +
Sbjct: 357 NGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNL---KQMS 412
Query: 127 PTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLR--ILPSGFANLSKL 182
S ++ L++S + S L VL ++ N + LP F L L
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472
Query: 183 RHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKF 239
LD+S C++ + P +F L SL+ L++++N + F L+ ++ + + N +
Sbjct: 473 TFLDLSQCQLEQ-LSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPW 530
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 5e-25
Identities = 48/256 (18%), Positives = 85/256 (33%), Gaps = 27/256 (10%)
Query: 2 KIFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTP-- 59
L L LV+ ++ A + I + L+
Sbjct: 219 TCIQGLAGLEVHRLVLGEFRNEG-NLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDL 277
Query: 60 ------IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVN 113
+ +L S + + + + L ++ +SL ++
Sbjct: 278 FNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFP------TLKLKSLKRLT 331
Query: 114 LSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQF----SKLMVLDVSNNDL 169
+ N+ G PS++ L+LS N + SQ + L LD+S N +
Sbjct: 332 FTSNKGGNAFSEVD------LPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGV 385
Query: 170 RILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLS 227
+ S F L +L HLD + + F L +L YLD+S+ F F LS
Sbjct: 386 ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLS 445
Query: 228 GVKFLNISLNKFTGFV 243
++ L ++ N F
Sbjct: 446 SLEVLKMAGNSFQENF 461
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 1e-20
Identities = 39/211 (18%), Positives = 83/211 (39%), Gaps = 19/211 (9%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPG 101
+ L + ++ L+LS + I + +++S L ++ L+ N ++ G
Sbjct: 39 PLRHLGSYSFFSF---PELQVLDLSRCEIQTIEDGAY-QSLSHLSTLILTGNPIQSLALG 94
Query: 102 WFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFS---K 158
F SL ++ + + G +++ LN++ N + FS
Sbjct: 95 AFSGLSSLQKLVAVETN----LASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150
Query: 159 LMVLDVSNNDLRILPSG-FANLSKLR----HLDISSCKISGNIKPVSFLH-SLKYLDVSN 212
L LD+S+N ++ + L ++ LD+S ++ I+P +F L L + N
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLRN 209
Query: 213 NSMNGTFPSD-FPPLSGVKFLNISLNKFTGF 242
N + L+G++ + L +F
Sbjct: 210 NFDSLNVMKTCIQGLAGLEVHRLVLGEFRNE 240
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 3e-19
Identities = 37/171 (21%), Positives = 74/171 (43%), Gaps = 14/171 (8%)
Query: 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKG-SVPGWFWSTQSLTQVNLSK 116
T ++ L+LS + + S + +L +D +++LK S F S ++L +++S
Sbjct: 373 TSLKYLDLSFNGVITMSS--NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISH 430
Query: 117 NRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK---LSQFSKLMVLDVSNNDLRILP 173
S++VL ++ N F ++ L LD+S L L
Sbjct: 431 TH----TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 174 SG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPS 221
F +LS L+ L+++S ++ ++ F L SL+ + + N + + P
Sbjct: 487 PTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-19
Identities = 41/179 (22%), Positives = 69/179 (38%), Gaps = 13/179 (7%)
Query: 64 NLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTI 123
N I ++DLS N L+ F+S L ++LS+ I
Sbjct: 13 QCMELNFYKIPD----NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCE----I 64
Query: 124 GFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-FANLS 180
+ L L+ N +L S S L L +L L + +L
Sbjct: 65 QTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLK 124
Query: 181 KLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
L+ L+++ I P F L +L++LD+S+N + + +D L + LN+SL+
Sbjct: 125 TLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLD 183
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-17
Identities = 28/146 (19%), Positives = 61/146 (41%), Gaps = 6/146 (4%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ L+ NL + + ++ L +D+S+ + + G F SL + ++ N F
Sbjct: 398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 457
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-F 176
++ L+LS + L + S L VL++++N L+ +P G F
Sbjct: 458 QENF---LPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514
Query: 177 ANLSKLRHLDISSCKISGNIKPVSFL 202
L+ L+ + + + + + +L
Sbjct: 515 DRLTSLQKIWLHTNPWDCSCPRIDYL 540
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 77.1 bits (190), Expect = 6e-15
Identities = 40/200 (20%), Positives = 64/200 (32%), Gaps = 20/200 (10%)
Query: 60 IRELNLSSRNLSGIISWKF--LRNMSELH-SIDLSNNSLKGSVPGWFWSTQSLTQVNLSK 116
+ L+LSS + I L M L+ S+DLS N + PG F L ++ L
Sbjct: 151 LEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAF-KEIRLHKLTLRN 209
Query: 117 NRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKL-----SQFSKLMVLDVSNNDLRI 171
N + + ++V L F N L S L L + L
Sbjct: 210 NFDSLNV---MKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 172 L-------PSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFP 224
L F L+ + + S I +K S+ ++L++ N
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQHLELVNCKFGQFPTLKLK 325
Query: 225 PLSGVKFLNISLNKFTGFVG 244
L + F + V
Sbjct: 326 SLKRLTFTSNKGGNAFSEVD 345
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 27/111 (24%), Positives = 41/111 (36%), Gaps = 13/111 (11%)
Query: 139 VLNLSSNRFT----NLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKIS 193
F NL LD+S N LR L S F + +L+ LD+S C+I
Sbjct: 11 TYQCMELNFYKIPDNL-----PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ 65
Query: 194 GNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
I+ ++ L L L ++ N + F LS ++ L
Sbjct: 66 -TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASL 115
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-27
Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 15/220 (6%)
Query: 29 ELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISW----KFLRNMSE 84
EL F + + P+ + + + + + ++ + + +
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311
Query: 85 LHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSS 144
+ I + N+ + + +SL ++LS+N K ++ G +PS+Q L LS
Sbjct: 312 VKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMV-EEYLKNSACKGAWPSLQTLVLSQ 370
Query: 145 NRFTNLVK----LSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVS 200
N ++ K L L LD+S N +P K+R L++SS I +
Sbjct: 371 NHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSCQWPEKMRFLNLSSTGIR--VVKTC 428
Query: 201 FLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
+L+ LDVSNN+++ +F P L + L IS NK
Sbjct: 429 IPQTLEVLDVSNNNLD-SFSLFLPRL---QELYISRNKLK 464
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-25
Identities = 50/244 (20%), Positives = 89/244 (36%), Gaps = 17/244 (6%)
Query: 3 IFCRLPLLFSLSLVVLAQSTCN-SKDQELVSKAFSSVSTFNISWLKPTNLNGSNPS--TP 59
+ L + ++++ L D V V + K + S
Sbjct: 276 VVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKS 335
Query: 60 IRELNLSSRNLSGII--SWKFLRNMSELHSIDLSNNSLK--GSVPGWFWSTQSLTQVNLS 115
+ L+LS + + L ++ LS N L+ + ++LT +++S
Sbjct: 336 LEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDIS 395
Query: 116 KNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG 175
+N P S P ++ LNLSS + K L VLDVSNN+L
Sbjct: 396 RNT----FHPMPDSCQWP-EKMRFLNLSSTGIRVV-KTCIPQTLEVLDVSNNNLDSFSL- 448
Query: 176 FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235
L +L+ L IS K+ + S L + +S N + F L+ ++ + +
Sbjct: 449 --FLPRLQELYISRNKLK-TLPDASLFPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLH 505
Query: 236 LNKF 239
N +
Sbjct: 506 TNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 5e-22
Identities = 45/202 (22%), Positives = 80/202 (39%), Gaps = 18/202 (8%)
Query: 48 PTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQ 107
P+ L + ++ L+LS ++ I R + L + L ++ + F+S
Sbjct: 21 PSGL----TAA-MKSLDLSFNKITYIGHGDL-RACANLQVLILKSSRINTIEGDAFYSLG 74
Query: 108 SLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSK---LMVLDV 164
SL ++LS N + +S GP S++ LNL N + L S F L L +
Sbjct: 75 SLEHLDLSDNH----LSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRI 130
Query: 165 SNNDL--RILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFP 220
N + I FA L+ L L+I + + N + S + + +L + +
Sbjct: 131 GNVETFSEIRRIDFAGLTSLNELEIKALSLR-NYQSQSLKSIRDIHHLTLHLSESAFLLE 189
Query: 221 SDFPPLSGVKFLNISLNKFTGF 242
LS V++L + F
Sbjct: 190 IFADILSSVRYLELRDTNLARF 211
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 3e-20
Identities = 36/184 (19%), Positives = 72/184 (39%), Gaps = 11/184 (5%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ L L S ++ I F ++ L +DLS+N L WF SL +NL N +
Sbjct: 53 QVLILKSSRINTIEGDAF-YSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPY- 110
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFS---KLMVLDVSNNDLRILPSG-F 176
TS ++Q L + + + ++ F+ L L++ LR S
Sbjct: 111 --QTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSL 168
Query: 177 ANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNI 234
++ + HL + + + + + L S++YL++ + ++ S P +
Sbjct: 169 KSIRDIHHLTLHLSESA-FLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKK 227
Query: 235 SLNK 238
+
Sbjct: 228 LAFR 231
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 9e-18
Identities = 37/166 (22%), Positives = 63/166 (37%), Gaps = 13/166 (7%)
Query: 83 SELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNL 142
D + S S+P T ++ ++LS N+ I + ++QVL L
Sbjct: 5 DASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNK----ITYIGHGDLRACANLQVLIL 57
Query: 143 SSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPV 199
S+R + L LD+S+N L L S F LS L++L++
Sbjct: 58 KSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTS 117
Query: 200 SF--LHSLKYLDVS-NNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
F L +L+ L + + + DF L+ + L I +
Sbjct: 118 LFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNY 163
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 8e-17
Identities = 41/224 (18%), Positives = 81/224 (36%), Gaps = 31/224 (13%)
Query: 2 KIFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTF--------NISWLKPTNLNG 53
++ L + +++ NSK + + + + N
Sbjct: 304 TVYSLLEKVKRITVE-------NSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSAC 356
Query: 54 SNPSTPIRELNLSSRNLSGI-ISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQV 112
++ L LS +L + + + L + L S+D+S N+ +P + + +
Sbjct: 357 KGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFL 415
Query: 113 NLSKNRFGGTIGFKPT-------SRNG------PFPSVQVLNLSSNRFTNLVKLSQFSKL 159
NLS P S N P +Q L +S N+ L S F L
Sbjct: 416 NLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLPRLQELYISRNKLKTLPDASLFPVL 475
Query: 160 MVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSFL 202
+V+ +S N L+ +P G F L+ L+ + + + + + +L
Sbjct: 476 LVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYL 519
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 1e-15
Identities = 28/202 (13%), Positives = 64/202 (31%), Gaps = 26/202 (12%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ L + + I ++ L+ +++ SL+ S + + + L +
Sbjct: 126 QTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSE-- 183
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNL-------------VKLSQFSKLMVLDVSNN 167
F SV+ L L +K F ++ D S N
Sbjct: 184 --SAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFN 241
Query: 168 DLRILPSGFANLSKLRHLDIS-------SCKISGNIKPVSFLH--SLKYLDVSNNSMNGT 218
+L L LS++ D + + S + + + +++ L + +
Sbjct: 242 ELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYD 301
Query: 219 FPSDFPPLSGVKFLNISLNKFT 240
+ + L VK + + +K
Sbjct: 302 LSTVYSLLEKVKRITVENSKVF 323
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-27
Identities = 60/354 (16%), Positives = 104/354 (29%), Gaps = 107/354 (30%)
Query: 397 LTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE 456
+ + L+ GR G VY+ L VA+KV A + + ++
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-PVAVKVFSFANRQNFINEKNIY-R 60
Query: 457 LSRLKHPNLLPLAGYCIAG-----KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDT 511
+ ++H N+ E L+++E+ NG L ++L
Sbjct: 61 VPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL--------------- 105
Query: 512 WDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH---------LVTSSI 562
++WV+ R+A V RGLAYLH H L + ++
Sbjct: 106 --------------HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNV 151
Query: 563 LLAESLEPKIAGFGLR------NIGVKNVGERSENETCG------PE------------- 597
L+ I+ FGL + + + G PE
Sbjct: 152 LVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXES 211
Query: 598 ----SDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMV 653
D+Y G+I E+ E + F+ ++G+ + +M
Sbjct: 212 ALKQVDMYALGLIYWEIFMRCTD---------LFPGESVPEYQMAFQTEVGNHPTFEDMQ 262
Query: 654 E------------------SLRVGYL------CTADSPGKRPTMQQVLGLLKDI 683
SL V L C R T Q + ++
Sbjct: 263 VLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL 316
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 7e-27
Identities = 43/198 (21%), Positives = 85/198 (42%), Gaps = 18/198 (9%)
Query: 50 NLNGSNPS-----TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFW 104
N N S+ S T + L ++ + + + N+++L+S+ L+ N ++ P
Sbjct: 142 NHNLSDLSPLSNMTGLNYLTVTESKVKDVTP---IANLTDLYSLSLNYNQIEDISP--LA 196
Query: 105 STQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDV 164
S SL N+ + L + +N+ T+L L+ S+L L++
Sbjct: 197 SLTSLHYFTAYVNQITDITPV------ANMTRLNSLKIGNNKITDLSPLANLSQLTWLEI 250
Query: 165 SNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFP 224
N + + +L+KL+ L++ S +IS +I ++ L L L ++NN +
Sbjct: 251 GTNQISDIN-AVKDLTKLKMLNVGSNQIS-DISVLNNLSQLNSLFLNNNQLGNEDMEVIG 308
Query: 225 PLSGVKFLNISLNKFTGF 242
L+ + L +S N T
Sbjct: 309 GLTNLTTLFLSQNHITDI 326
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 7e-26
Identities = 30/183 (16%), Positives = 79/183 (43%), Gaps = 14/183 (7%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
I +L ++ ++ I + + ++ L ++L+ N + P + LT + + N+
Sbjct: 46 ITKLVVAGEKVASI---QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI 100
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
+++ L L+ + +++ L+ +K+ L++ N S +N+
Sbjct: 101 TDISAL------QNLTNLRELYLNEDNISDISPLANLTKMYSLNLGANHNLSDLSPLSNM 154
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKF 239
+ L +L ++ K+ ++ P++ L L L ++ N + S L+ + + +N+
Sbjct: 155 TGLNYLTVTESKVK-DVTPIANLTDLYSLSLNYNQI--EDISPLASLTSLHYFTAYVNQI 211
Query: 240 TGF 242
T
Sbjct: 212 TDI 214
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 28/185 (15%), Positives = 77/185 (41%), Gaps = 20/185 (10%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
L +++ +++ + + + ++ + S+ G +L +NL+ N+
Sbjct: 24 GIRAVLQKASVTDVVT---QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQI 78
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
+ L + +N+ T++ L + L L ++ +++ + ANL
Sbjct: 79 TDISPL------SNLVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP-LANL 131
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VKFLNISL 236
+K+ L++ + ++ P+S + L YL V+ + + D P++ + L+++
Sbjct: 132 TKMYSLNLGANHNLSDLSPLSNMTGLNYLTVTESKV-----KDVTPIANLTDLYSLSLNY 186
Query: 237 NKFTG 241
N+
Sbjct: 187 NQIED 191
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 41/211 (19%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 35 FSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNS 94
++ I K T+++ T +REL L+ N+S I L N+++++S++L N
Sbjct: 87 LVKLTNLYIGTNKITDISALQNLTNLRELYLNEDNISDISP---LANLTKMYSLNLGANH 143
Query: 95 LKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLS 154
+ + L + +++++ + L+L+ N+ ++ L+
Sbjct: 144 NLSDLSP-LSNMTGLNYLTVTESKVKDVTPI------ANLTDLYSLSLNYNQIEDISPLA 196
Query: 155 QFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNS 214
+ L N + + AN+++L L I + KI+ ++ P++ L L +L++ N
Sbjct: 197 SLTSLHYFTAYVNQITDITP-VANMTRLNSLKIGNNKIT-DLSPLANLSQLTWLEIGTNQ 254
Query: 215 MNGTFPSDFPPLSG---VKFLNISLNKFTGF 242
+ SD + +K LN+ N+ +
Sbjct: 255 I-----SDINAVKDLTKLKMLNVGSNQISDI 280
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 30/184 (16%), Positives = 73/184 (39%), Gaps = 21/184 (11%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L+L+ + I L +++ LH N + P + L + + N+
Sbjct: 180 YSLSLNYNQIEDISP---LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKIT 234
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
+ L + +N+ +++ + +KL +L+V +N + + NLS
Sbjct: 235 DLSPL------ANLSQLTWLEIGTNQISDINAVKDLTKLKMLNVGSNQISDISV-LNNLS 287
Query: 181 KLRHLDISSCKISG-NIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VKFLNISL 236
+L L +++ ++ +++ + L +L L +S N + +D PL+ + + +
Sbjct: 288 QLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHI-----TDIRPLASLSKMDSADFAN 342
Query: 237 NKFT 240
Sbjct: 343 QVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 37/180 (20%), Positives = 77/180 (42%), Gaps = 14/180 (7%)
Query: 62 ELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGG 121
L ++ I +++E L S+ V +S+T++ ++ +
Sbjct: 4 TLATLPAPINQIFP---DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS 58
Query: 122 TIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSK 181
G +++ LNL+ N+ T++ LS KL L + N + + + NL+
Sbjct: 59 IQGI------EYLTNLEYLNLNGNQITDISPLSNLVKLTNLYIGTNKITDISA-LQNLTN 111
Query: 182 LRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTG 241
LR L ++ IS I P++ L + L++ N N + S ++G+ +L ++ +K
Sbjct: 112 LRELYLNEDNISD-ISPLANLTKMYSLNLGANH-NLSDLSPLSNMTGLNYLTVTESKVKD 169
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 17/103 (16%), Positives = 42/103 (40%), Gaps = 4/103 (3%)
Query: 138 QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIK 197
L + + ++ + + + + + L + L ++ K++ +I+
Sbjct: 3 ATLATLPAPINQIFPDADLAEGIRAVLQKASVTDVVT-QEELESITKLVVAGEKVA-SIQ 60
Query: 198 PVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
+ +L +L+YL+++ N + S L + L I NK T
Sbjct: 61 GIEYLTNLEYLNLNGNQITD--ISPLSNLVKLTNLYIGTNKIT 101
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-26
Identities = 57/305 (18%), Positives = 104/305 (34%), Gaps = 81/305 (26%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLLPLAG 470
+ +GR G VY GE VAI+++D D++D + F + +H N++ G
Sbjct: 41 IGKGRFGQVYHGRWHGE--VAIRLID--IERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
C++ ++ L+ + + +
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVR---------------------------DAKIVLDV 129
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERS 589
+IA + +G+ YLH G H L + ++ ++ + I FGL GV G R
Sbjct: 130 NKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLFSISGVLQAGRRE 188
Query: 590 ENET--CG------PE-------------------SDVYCFGVILMELLTGK---RGTD- 618
+ G PE SDV+ G I EL + +
Sbjct: 189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248
Query: 619 DCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678
+ + W + G + L E+ + L C A +RPT +++
Sbjct: 249 EAIIWQ---MGTG-------MKPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMD 295
Query: 679 LLKDI 683
+L+ +
Sbjct: 296 MLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-26
Identities = 54/311 (17%), Positives = 93/311 (29%), Gaps = 82/311 (26%)
Query: 412 ESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLL 466
+L +G G + + +K L ++ F + + L+HPN+L
Sbjct: 15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIR----FDEETQRTFLKEVKVMRCLEHPNVL 70
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
G K + E++ G L + S
Sbjct: 71 KFIGVLYKDKRLNFITEYIKGGTLRGIIK---------------------------SMDS 103
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL--------- 577
+ W R A +A G+AYLH + H L + + L+ E+ +A FGL
Sbjct: 104 QYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT 163
Query: 578 ---RNIGVKNVGERSENETCG------PE----------SDVYCFGVILMELLTGKRGTD 618
+K + G PE DV+ FG++L E++
Sbjct: 164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADP 223
Query: 619 DCV---KWVRKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTM 673
D + V+ S + C P KRP+
Sbjct: 224 DYLPRTMDFGLNVRGF-------LDRYCPPNCPPSFFPITVR------CCDLDPEKRPSF 270
Query: 674 QQVLGLLKDIR 684
++ L+ +R
Sbjct: 271 VKLEHWLETLR 281
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-26
Identities = 42/182 (23%), Positives = 78/182 (42%), Gaps = 15/182 (8%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L ++ +S I L ++ L + L+ N LK S +LT ++L+ N+
Sbjct: 202 ESLIATNNQISDITP---LGILTNLDELSLNGNQLKDIGT--LASLTNLTDLDLANNQIS 256
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
+ L L +N+ +N+ L+ + L L+++ N L + +NL
Sbjct: 257 NLAPL------SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS-PISNLK 309
Query: 181 KLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
L +L + IS +I PVS L L+ L NN ++ S L+ + +L+ N+ +
Sbjct: 310 NLTYLTLYFNNIS-DISPVSSLTKLQRLFFYNNKVSD--VSSLANLTNINWLSAGHNQIS 366
Query: 241 GF 242
Sbjct: 367 DL 368
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 37/210 (17%), Positives = 84/210 (40%), Gaps = 16/210 (7%)
Query: 33 KAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSN 92
A + + T+ + L + I + ++ L I+ SN
Sbjct: 21 TALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI---DGVEYLNNLTQINFSN 77
Query: 93 NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK 152
N L P + L + ++ N+ ++ L L +N+ T++
Sbjct: 78 NQLTDITP--LKNLTKLVDILMNNNQIADITPL------ANLTNLTGLTLFNNQITDIDP 129
Query: 153 LSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSN 212
L + L L++S+N + + + + L+ L+ L + ++KP++ L +L+ LD+S+
Sbjct: 130 LKNLTNLNRLELSSNTISDISA-LSGLTSLQQLSFGNQVT--DLKPLANLTTLERLDISS 186
Query: 213 NSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
N + + S L+ ++ L + N+ +
Sbjct: 187 NKV--SDISVLAKLTNLESLIATNNQISDI 214
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 39/186 (20%), Positives = 83/186 (44%), Gaps = 22/186 (11%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ L LSS +S I + L ++ L + N + +L ++++S N+
Sbjct: 136 LNRLELSSNTISDISA---LSGLTSLQQLSFGNQVTDLKP---LANLTTLERLDISSNKV 189
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
+++ L ++N+ +++ L + L L ++ N L+ + + A+L
Sbjct: 190 SDISVL------AKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGT-LASL 242
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VKFLNISL 236
+ L LD+++ +IS N+ P+S L L L + N + S+ PL+G + L ++
Sbjct: 243 TNLTDLDLANNQIS-NLAPLSGLTKLTELKLGANQI-----SNISPLAGLTALTNLELNE 296
Query: 237 NKFTGF 242
N+
Sbjct: 297 NQLEDI 302
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-21
Identities = 34/183 (18%), Positives = 78/183 (42%), Gaps = 15/183 (8%)
Query: 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNR 118
P+ ++ I ++E L ++ +V +T + +
Sbjct: 2 PLGSATITQDTP--INQIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLG 57
Query: 119 FGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFAN 178
G ++ +N S+N+ T++ L +KL+ + ++NN + + AN
Sbjct: 58 IKSIDGV------EYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADIT-PLAN 110
Query: 179 LSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNK 238
L+ L L + + +I+ +I P+ L +L L++S+N+++ S L+ ++ L+ N+
Sbjct: 111 LTNLTGLTLFNNQIT-DIDPLKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSFG-NQ 166
Query: 239 FTG 241
T
Sbjct: 167 VTD 169
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 31/199 (15%), Positives = 68/199 (34%), Gaps = 22/199 (11%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
EL L + +S I L ++ L +++L+ N L+ P + ++LT + L N
Sbjct: 268 TELKLGANQISNISP---LAGLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNIS 322
Query: 121 GTIGFKPT--------SRN--------GPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDV 164
N ++ L+ N+ ++L L+ +++ L +
Sbjct: 323 DISPVSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISDLTPLANLTRITQLGL 382
Query: 165 SNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFP 224
++ P + + + + +S S D++ N + T +
Sbjct: 383 NDQAWTNAPVNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDITWNLPSYTNEVSYT 442
Query: 225 PLSGVKFLNISLNKFTGFV 243
V + F+G V
Sbjct: 443 FSQPVTIGKGTTT-FSGTV 460
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 21/151 (13%), Positives = 53/151 (35%), Gaps = 15/151 (9%)
Query: 49 TNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQS 108
++++ + T ++ L + +S + S L N++ ++ + +N + P +
Sbjct: 322 SDISPVSSLTKLQRLFFYNNKVSDVSS---LANLTNINWLSAGHNQISDLTP--LANLTR 376
Query: 109 LTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV---KLSQFSKLMVLDVS 165
+TQ+ L+ + +V + N N L+ +S D++
Sbjct: 377 ITQLGLNDQAWTNAP-------VNYKANVSIPNTVKNVTGALIAPATISDGGSYTEPDIT 429
Query: 166 NNDLRILPSGFANLSKLRHLDISSCKISGNI 196
N S+ + + SG +
Sbjct: 430 WNLPSYTNEVSYTFSQPVTIGKGTTTFSGTV 460
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 45/242 (18%), Positives = 79/242 (32%), Gaps = 42/242 (17%)
Query: 37 SVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRN-MSELHSIDLSNNSL 95
+V I + ++EL L + ++G L +L+ ++L N S
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 96 KG---------------------------SVPGWFWST-QSLTQVNLSKNRFGGTIGFKP 127
+ +L+ ++LS N G G
Sbjct: 134 ATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLIS 193
Query: 128 TSRNGPFPSVQVLNLSSNRFTNLVK-----LSQFSKLMVLDVSNNDLRILP--SGFANLS 180
FP++QVL L + + +L LD+S+N LR S
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253
Query: 181 KLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGT-FPSDFPPLSGVKFLNISLNKF 239
+L L++S + P L LD+S N ++ P + P + L++ N F
Sbjct: 254 QLNSLNLSFTGLKQV--PKGLPAKLSVLDLSYNRLDRNPSPDELPQV---GNLSLKGNPF 308
Query: 240 TG 241
Sbjct: 309 LD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-16
Identities = 35/206 (16%), Positives = 68/206 (33%), Gaps = 27/206 (13%)
Query: 46 LKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLR--NMSELHSIDLSNNSLKGSVP--G 101
S ++ L + + + I + LR +S L + L N + G+ P
Sbjct: 56 ADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPL 115
Query: 102 WFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKL 159
+ L +NL + + + P ++VL+++ N + F L
Sbjct: 116 LEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPAL 175
Query: 160 MVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMN--- 216
LD+S+N R L + C + +L+ L + N M
Sbjct: 176 STLDLSDN----------PELGERGLISALCPLK--------FPTLQVLALRNAGMETPS 217
Query: 217 GTFPSDFPPLSGVKFLNISLNKFTGF 242
G + ++ L++S N
Sbjct: 218 GVCSALAAARVQLQGLDLSHNSLRDA 243
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 4e-11
Identities = 23/142 (16%), Positives = 40/142 (28%), Gaps = 28/142 (19%)
Query: 29 ELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSI 88
L F ++ + +G + +L +
Sbjct: 194 ALCPLKFPTLQVLALRNAGMETPSGVCSAL--------------------AAARVQLQGL 233
Query: 89 DLSNNSLKGSVP-GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRF 147
DLS+NSL+ + L +NLS G + VL+LS NR
Sbjct: 234 DLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-------KQVPKGLPAKLSVLDLSYNRL 286
Query: 148 TNLVKLSQFSKLMVLDVSNNDL 169
+ ++ L + N
Sbjct: 287 DRNPSPDELPQVGNLSLKGNPF 308
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 1e-07
Identities = 24/162 (14%), Positives = 52/162 (32%), Gaps = 16/162 (9%)
Query: 93 NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFT---- 148
N L + + +SL + + F ++ S++ L + + R
Sbjct: 29 NCLGAADVELYGGGRSLEYLLKRVDTEADLGQFTDIIKSL---SLKRLTVRAARIPSRIL 85
Query: 149 -NLVKLSQFSKLMVLDVSNNDL---RILPSGFANLSKLRHLDISSCKISGNIKPVSFLH- 203
+++ S L L + N ++ P A L L++ + + ++ L
Sbjct: 86 FGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQ 145
Query: 204 ----SLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTG 241
LK L ++ + L++S N G
Sbjct: 146 WLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 60/330 (18%), Positives = 107/330 (32%), Gaps = 88/330 (26%)
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
+ +GR G V+ GE VA+KV + ++ + ++H N+L
Sbjct: 42 VKQIGKGRYGEVWMGKWRGE-KVAVKVFFTTEEASWFRETEIY-QTVLMRHENILGFIAA 99
Query: 472 CIAGKEKLVLL----EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
I G L ++ NG L+ +L
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKS-----------------------------TT 130
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGH--------LVTSSILLAESLEPKIAGFGL-- 577
+ + ++A GL +LH + L + +IL+ ++ IA GL
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 578 RNIGVKNVGERSENETCG------PE----------------SDVYCFGVILMELLTGKR 615
+ I N + N G PE +D+Y FG+IL E+
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCV 250
Query: 616 ----------------GTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVG 659
+D + +R++V F + S + + +M + +
Sbjct: 251 SGGIVEEYQLPYHDLVPSDPSYEDMREIV--CIKKLRPSFPNRWSSDECLRQMGKLMTE- 307
Query: 660 YLCTADSPGKRPTMQQVLGLLKDIRPSADL 689
C A +P R T +V L + S D+
Sbjct: 308 --CWAHNPASRLTALRVKKTLAKMSESQDI 335
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 1e-24
Identities = 55/324 (16%), Positives = 103/324 (31%), Gaps = 88/324 (27%)
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
+ +GR G V+R GE +VA+K+ + ++ L+H N+L
Sbjct: 13 LECVGKGRYGEVWRGSWQGE-NVAVKIFSSRDEKSWFRETELY-NTVMLRHENILGFIAS 70
Query: 472 CIAGKEKLVLL----EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
+ + L + G L+ +L
Sbjct: 71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL-----------------------------TT 101
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGH--------LVTSSILLAESLEPKIAGFGL-- 577
+ V+ RI + +A GLA+LH L + +IL+ ++ + IA GL
Sbjct: 102 LDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAV 161
Query: 578 RNIGVKNVGERSENETCG------PE----------------SDVYCFGVILMELLTGKR 615
+ N + N G PE D++ FG++L E+
Sbjct: 162 MHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMV 221
Query: 616 ----------------GTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVG 659
D + +RK+V + + S ++ + + ++
Sbjct: 222 SNGIVEDYKPPFYDVVPNDPSFEDMRKVV--CVDQQRPNIPNRWFSDPTLTSLAKLMK-- 277
Query: 660 YLCTADSPGKRPTMQQVLGLLKDI 683
C +P R T ++ L I
Sbjct: 278 -ECWYQNPSARLTALRIKKTLTKI 300
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-24
Identities = 33/186 (17%), Positives = 73/186 (39%), Gaps = 8/186 (4%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L+ ++ N+S + +I L+NN + + ++L N
Sbjct: 102 ETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
T+ F + + +++ LNL N ++ F+KL LD+S+N L + F + +
Sbjct: 158 -TVNFAELAAS--SDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAA 214
Query: 181 KLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
+ + + + K+ K + F +L++ D+ N + DF + ++
Sbjct: 215 GVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVK 273
Query: 241 GFVGHD 246
G +
Sbjct: 274 KLTGQN 279
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-24
Identities = 33/196 (16%), Positives = 76/196 (38%), Gaps = 20/196 (10%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ ++ +L ++ ++ + +DLS N L L +NLS N
Sbjct: 13 KIEKVTDSSLKQALASLR-QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLY 71
Query: 121 GTIGFKPT--------SRN-----GPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNN 167
T+ + + N PS++ L+ ++N + + S+ + ++NN
Sbjct: 72 ETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV-SCSRGQGKKNIYLANN 130
Query: 168 DLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFP 224
+ +L S++++LD+ +I +L++L++ N +
Sbjct: 131 KITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV- 188
Query: 225 PLSGVKFLNISLNKFT 240
+ +K L++S NK
Sbjct: 189 VFAKLKTLDLSSNKLA 204
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 99.5 bits (248), Expect = 3e-22
Identities = 28/201 (13%), Positives = 65/201 (32%), Gaps = 15/201 (7%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKG-SVP 100
NIS + + G + + L++ ++ + S + +DL N + +
Sbjct: 110 NISRVSCSRGQG------KKNIYLANNKITMLRDLDE-GCRSRVQYLDLKLNEIDTVNFA 162
Query: 101 GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK-LSQFSKL 159
S+ +L +NL N + F ++ L+LSSN+ + + +
Sbjct: 163 ELAASSDTLEHLNLQYNFIY-DV-----KGQVVFAKLKTLDLSSNKLAFMGPEFQSAAGV 216
Query: 160 MVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTF 219
+ + NN L ++ L H D+ F + + V+ ++
Sbjct: 217 TWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLT 276
Query: 220 PSDFPPLSGVKFLNISLNKFT 240
+ + +
Sbjct: 277 GQNEEECTVPTLGHYGAYCCE 297
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 97.6 bits (243), Expect = 1e-21
Identities = 37/160 (23%), Positives = 72/160 (45%), Gaps = 10/160 (6%)
Query: 81 NMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVL 140
N + ++++SLK ++ S ++ +++LS N + + PF +++L
Sbjct: 8 NGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNP----LSQISAADLAPFTKLELL 63
Query: 141 NLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVS 200
NLSSN + L S L LD++NN ++ L + L ++ IS + S
Sbjct: 64 NLSSNVLYETLDLESLSTLRTLDLNNNYVQELL----VGPSIETLHAANNNIS-RV-SCS 117
Query: 201 FLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
K + ++NN + D S V++L++ LN+
Sbjct: 118 RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 2e-10
Identities = 26/180 (14%), Positives = 59/180 (32%), Gaps = 17/180 (9%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLK-GSVP 100
++++ P + + + ++L + L I K LR L DL N G++
Sbjct: 202 KLAFMGPEFQSAAG----VTWISLRNNKLVLIE--KALRFSQNLEHFDLRGNGFHCGTLR 255
Query: 101 GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPF----PSVQVLNLSSNRFTNLVKLSQF 156
+F Q + ++K G P + +L + L+ L +
Sbjct: 256 DFFSKNQRVQ--TVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKR- 312
Query: 157 SKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNS 214
+ +L ++ L N ++ R +D + + + L+ +
Sbjct: 313 KEHALLSGQGSETERLECERENQARQREIDALKEQYR-TVIDQVTLRKQAKITLEQKKKA 371
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 3/68 (4%)
Query: 176 FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLN 233
N ++ + ++ + ++K LD+S N ++ +D P + ++ LN
Sbjct: 6 KQNGNRYKIEKVTDSSLK-QALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLN 64
Query: 234 ISLNKFTG 241
+S N
Sbjct: 65 LSSNVLYE 72
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 33/197 (16%), Positives = 76/197 (38%), Gaps = 20/197 (10%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ ++ +L ++ ++ + +DLS N L L +NLS N
Sbjct: 12 YKIEKVTDSSLKQALASLR-QSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 120 GGTIGFKPT--------SRN-----GPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSN 166
T+ + + N PS++ L+ ++N + + S+ + ++N
Sbjct: 71 YETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRV-SCSRGQGKKNIYLAN 129
Query: 167 NDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDF 223
N + +L S++++LD+ +I +L++L++ N +
Sbjct: 130 NKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV 188
Query: 224 PPLSGVKFLNISLNKFT 240
+ +K L++S NK
Sbjct: 189 -VFAKLKTLDLSSNKLA 204
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 34/210 (16%), Positives = 79/210 (37%), Gaps = 9/210 (4%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L+ ++ N+S + +I L+NN + + ++L N
Sbjct: 102 ETLHAANNNISRVSC----SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
T+ F + + +++ LNL N ++ F+KL LD+S+N L + F + +
Sbjct: 158 -TVNFAELAAS--SDTLEHLNLQYNFIYDVKGQVVFAKLKTLDLSSNKLAFMGPEFQSAA 214
Query: 181 KLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
+ + + + K+ K + F +L++ D+ N + DF + ++
Sbjct: 215 GVTWISLRNNKLVLIEKALRFSQNLEHFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVK 273
Query: 241 GFVGHDKYQKFGKSAFIQGGSFVFDTTKTP 270
+ ++ G++ + P
Sbjct: 274 K-LTGQNEEECTVPTLGHYGAYCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 8e-22
Identities = 37/163 (22%), Positives = 73/163 (44%), Gaps = 10/163 (6%)
Query: 78 FLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137
+N + ++++SLK ++ S ++ +++LS N + + PF +
Sbjct: 5 IKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNP----LSQISAADLAPFTKL 60
Query: 138 QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIK 197
++LNLSSN + L S L LD++NN ++ L + L ++ IS +
Sbjct: 61 ELLNLSSNVLYETLDLESLSTLRTLDLNNNYVQELL----VGPSIETLHAANNNIS-RV- 114
Query: 198 PVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
S K + ++NN + D S V++L++ LN+
Sbjct: 115 SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEID 157
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 19/177 (10%), Positives = 52/177 (29%), Gaps = 31/177 (17%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
++ L+L + + + + L ++L N + ++
Sbjct: 146 VQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY----------------DVKGQVV 189
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNL-VKLSQFSKLMVLDVSNNDLRILPSGFAN 178
F ++ L+LSSN+ + + + + + + NN L ++
Sbjct: 190 --------------FAKLKTLDLSSNKLAFMGPEFQSAAGVTWISLRNNKLVLIEKALRF 235
Query: 179 LSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235
L H D+ F + + V+ ++ + + +
Sbjct: 236 SQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYG 292
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 3e-23
Identities = 42/194 (21%), Positives = 75/194 (38%), Gaps = 20/194 (10%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L++S+ NL I + + L ++ LS+N L S L N+S N
Sbjct: 150 TTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPS---LFHANVSYNLLS 205
Query: 121 GTIGFKPT------SRN-------GPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNN 167
T+ S N + +L L N T+ L + L+ +D+S N
Sbjct: 206 -TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYN 264
Query: 168 DLRILPSG-FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPL 226
+L + F + +L L IS+ ++ + +LK LD+S+N + + P
Sbjct: 265 ELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQPIPTLKVLDLSHNHLL-HVERNQPQF 323
Query: 227 SGVKFLNISLNKFT 240
++ L + N
Sbjct: 324 DRLENLYLDHNSIV 337
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 5e-22
Identities = 34/184 (18%), Positives = 78/184 (42%), Gaps = 15/184 (8%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ + + + + + + ++ ++L++ ++ F ++ ++ + N
Sbjct: 53 QKIVTFKNSTMRKLPAALL-DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA- 110
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-F 176
I + P P + VL L N ++L + KL L +SNN+L + F
Sbjct: 111 ---IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 167
Query: 177 ANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISL 236
+ L++L +SS +++ ++ +S + SL + +VS N + S V+ L+ S
Sbjct: 168 QATTSLQNLQLSSNRLT-HV-DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASH 220
Query: 237 NKFT 240
N
Sbjct: 221 NSIN 224
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 93.5 bits (232), Expect = 5e-20
Identities = 35/190 (18%), Positives = 73/190 (38%), Gaps = 18/190 (9%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
++++ + ++ + ++ + N++++ S + + +NL+ +
Sbjct: 29 FYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ- 86
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-F 176
I T ++Q L + N L L VL + NDL LP G F
Sbjct: 87 ---IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 143
Query: 177 ANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPP--LSGVKFL 232
N KL L +S+ + I+ +F SL+ L +S+N + + + +
Sbjct: 144 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-----THVDLSLIPSLFHA 197
Query: 233 NISLNKFTGF 242
N+S N +
Sbjct: 198 NVSYNLLSTL 207
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 1e-12
Identities = 37/168 (22%), Positives = 64/168 (38%), Gaps = 11/168 (6%)
Query: 28 QELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHS 87
+ ++ + T+ + E++LS L I+ F M L
Sbjct: 224 NVVRGPVNVELTILKLQHNNLTDTAWLLNYPGLVEVDLSYNELEKIMYHPF-VKMQRLER 282
Query: 88 IDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRF 147
+ +SNN L ++ + +L ++LS N + + F ++ L L N
Sbjct: 283 LYISNNRLV-ALNLYGQPIPTLKVLDLSHNH----LLHVERN-QPQFDRLENLYLDHNSI 336
Query: 148 TNLVKLSQFSKLMVLDVSNNDLRI--LPSGFANLSKLRHLDIS-SCKI 192
L KLS L L +S+ND L + F N+++ D CKI
Sbjct: 337 VTL-KLSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKI 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 3e-23
Identities = 34/184 (18%), Positives = 78/184 (42%), Gaps = 15/184 (8%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ + + + + + + ++ ++L++ ++ F ++ ++ + N
Sbjct: 47 QKIVTFKNSTMRKLPAALL-DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNA- 104
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-F 176
I + P P + VL L N ++L + KL L +SNN+L + F
Sbjct: 105 ---IRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF 161
Query: 177 ANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISL 236
+ L++L +SS +++ ++ +S + SL + +VS N + S V+ L+ S
Sbjct: 162 QATTSLQNLQLSSNRLT-HV-DLSLIPSLFHANVSYNLL-----STLAIPIAVEELDASH 214
Query: 237 NKFT 240
N
Sbjct: 215 NSIN 218
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 35/188 (18%), Positives = 72/188 (38%), Gaps = 14/188 (7%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
++++ + ++ + ++ + N++++ S + + +NL+ +
Sbjct: 23 FYDVHIDMQTQDVYFGFEDI-TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQ- 80
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-F 176
I T ++Q L + N L L VL + NDL LP G F
Sbjct: 81 ---IEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIF 137
Query: 177 ANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNI 234
N KL L +S+ + I+ +F SL+ L +S+N + + + N+
Sbjct: 138 HNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IPSLFHANV 193
Query: 235 SLNKFTGF 242
S N +
Sbjct: 194 SYNLLSTL 201
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 38/183 (20%), Positives = 67/183 (36%), Gaps = 22/183 (12%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
N+S LS L + +D S+NS+ LT + L N
Sbjct: 189 FHANVSYNLLS------TLAIPIAVEELDASHNSINVVRGPVN---VELTILKLQHNNLT 239
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSGFAN 178
T +P + ++LS N ++ + +L L +SNN L L
Sbjct: 240 DTAWL------LNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVALNLYGQP 293
Query: 179 LSKLRHLDISSCKISGNIKPVSF-LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
+ L+ LD+S + +++ L+ L + +NS+ T +K L +S N
Sbjct: 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLS--THHTLKNLTLSHN 349
Query: 238 KFT 240
+
Sbjct: 350 DWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 21/109 (19%), Positives = 38/109 (34%), Gaps = 10/109 (9%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L +S+ L + + + + L +DLS+N L V L + L N
Sbjct: 275 ERLYISNNRLVALNL--YGQPIPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV 331
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDL 169
T+ +++ L LS N + + F + V + D
Sbjct: 332 -TLKL------STHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQ 373
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 53/334 (15%), Positives = 104/334 (31%), Gaps = 96/334 (28%)
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFD----ELSRLKHPNLLP 467
+ + +GR G V+R GE VA+K+ ++ + + L+H N+L
Sbjct: 47 QESIGKGRFGEVWRGKWRGE-EVAVKIFS-----SREERSWFREAEIYQTVMLRHENILG 100
Query: 468 LAGYCIAGKEKLVLL----EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
L ++ +G L +L+
Sbjct: 101 FIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR--------------------------- 133
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH--------LVTSSILLAESLEPKIAGF 575
++A+ A GLA+LH L + +IL+ ++ IA
Sbjct: 134 --YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 191
Query: 576 GL--RNIGVKNVGERSENETCG------PE----------------SDVYCFGVILMELL 611
GL R+ + + + N G PE +D+Y G++ E+
Sbjct: 192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251
Query: 612 TGKR----------------GTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVES 655
+D V+ +RK+V + + S +++ M +
Sbjct: 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV--CEQKLRPNIPNRWQSCEALRVMAKI 309
Query: 656 LRVGYLCTADSPGKRPTMQQVLGLLKDIRPSADL 689
+R C + R T ++ L + +
Sbjct: 310 MR---ECWYANGAARLTALRIKKTLSQLSQQEGI 340
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 3e-22
Identities = 39/230 (16%), Positives = 78/230 (33%), Gaps = 34/230 (14%)
Query: 35 FSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMS-----ELHSID 89
V + L+ L +L++ +L +S + + M+ L +D
Sbjct: 160 IFLVCEHELEPLQGKTL---------SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILD 210
Query: 90 LSNNSLKGSVPGWFWST------------QSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137
+S N + G F + + + + T SV
Sbjct: 211 VSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNI--KDPDQNTFAGLARSSV 268
Query: 138 QVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISG 194
+ L+LS +L L VL+++ N + + F L L+ L++S +
Sbjct: 269 RHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG- 327
Query: 195 NIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
+ +F L + Y+D+ N + F L ++ L++ N T
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALTTI 377
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 42/232 (18%), Positives = 81/232 (34%), Gaps = 25/232 (10%)
Query: 35 FSSVSTFNISWLKPTNLNGS--NPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSN 92
+ N+++ K + ++ LNLS L + S F + ++ IDL
Sbjct: 289 LKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNF-YGLPKVAYIDLQK 347
Query: 93 NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGF-----------KPTSRNGPFPSVQVLN 141
N + F + L ++L N K + + +++
Sbjct: 348 NHIAIIQDQTFKFLEKLQTLDLRDNALTTIHFIPSIPDIFLSGNKLVTLPKINLTANLIH 407
Query: 142 LSSNRFTNLVKLSQF---SKLMVLDVSNNDLRILPSG--FANLSKLRHLDISSCKISG-- 194
LS NR NL L L +L ++ N + L L + +
Sbjct: 408 LSENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAW 467
Query: 195 --NIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
+ F L L+ L +++N +N P F L+ ++ L+++ N+ T
Sbjct: 468 ETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVL 519
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 1e-20
Identities = 38/202 (18%), Positives = 80/202 (39%), Gaps = 16/202 (7%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPG 101
NI G S+ +R L+LS + + S + + +L ++L+ N +
Sbjct: 251 NIKDPDQNTFAGLARSS-VRHLDLSHGFVFSLNS-RVFETLKDLKVLNLAYNKINKIADE 308
Query: 102 WFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKL 159
F+ +L +NLS N +G +S P V ++L N + KL
Sbjct: 309 AFYGLDNLQVLNLSYNL----LGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKL 364
Query: 160 MVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTF 219
LD+ +N L + + + + +S K+ + ++ + + +S N +
Sbjct: 365 QTLDLRDNALTTIH----FIPSIPDIFLSGNKLV-TLPKINL--TANLIHLSENRLENLD 417
Query: 220 PSDFPP-LSGVKFLNISLNKFT 240
F + ++ L ++ N+F+
Sbjct: 418 ILYFLLRVPHLQILILNQNRFS 439
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 1e-19
Identities = 42/194 (21%), Positives = 72/194 (37%), Gaps = 23/194 (11%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
R NL+ + + ++ + LS N ++ F + L + L
Sbjct: 7 RIAFYRFCNLTQV-----PQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTP 61
Query: 121 GTIGFKPTSRNGPF---PSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLR---IL 172
TI F P++++L+L S++ L L L + L +
Sbjct: 62 LTI------DKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLK 115
Query: 173 PSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSG-- 228
F NL L LD+S +I SF L+SLK +D S+N + + PL G
Sbjct: 116 DGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKT 175
Query: 229 VKFLNISLNKFTGF 242
+ F +++ N
Sbjct: 176 LSFFSLAANSLYSR 189
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 92.2 bits (229), Expect = 2e-19
Identities = 36/212 (16%), Positives = 73/212 (34%), Gaps = 21/212 (9%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPG 101
I + ++ ++ L L S+ I + RN+ L +DL ++ + P
Sbjct: 35 YIRTVTASSFPFL---EQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD 91
Query: 102 WFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFS---K 158
F L ++ L + ++ L+LS N+ +L F
Sbjct: 92 AFQGLFHLFELRLYFCGL--SDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNS 149
Query: 159 LMVLDVSNNDLRILPSG-FANLS--KLRHLDISSCKISGNIKPVSFLH--------SLKY 207
L +D S+N + ++ L L +++ + + V + L+
Sbjct: 150 LKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLY-SRVSVDWGKCMNPFRNMVLEI 208
Query: 208 LDVSNNSMNGTFPSDFP-PLSGVKFLNISLNK 238
LDVS N +F +S + ++ L
Sbjct: 209 LDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 2e-15
Identities = 45/249 (18%), Positives = 86/249 (34%), Gaps = 23/249 (9%)
Query: 1 MKIFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPI 60
+ +P + + L +K L ++ + ++S + NL+ +
Sbjct: 374 LTTIHFIPSIPDIFL-------SGNKLVTLPKINLTA-NLIHLSENRLENLDILYFLLRV 425
Query: 61 ---RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSV-----PGWFWSTQSLTQV 112
+ L L+ S + L + L N L+ + F L +
Sbjct: 426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVL 485
Query: 113 NLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRIL 172
L+ N + P +++ L+L+SNR T L + L +LD+S N L
Sbjct: 486 YLNHNY----LNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLEILDISRNQLLAP 541
Query: 173 PSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPP-LSGVKF 231
L LDI+ K + +F++ L + +V+ +P SGV
Sbjct: 542 NPDV--FVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSL 599
Query: 232 LNISLNKFT 240
++S
Sbjct: 600 FSLSTEGCD 608
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 6e-14
Identities = 27/112 (24%), Positives = 50/112 (44%), Gaps = 4/112 (3%)
Query: 141 NLSSNRFTNLVKLSQ-FSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKP 198
++ RF NL ++ Q + L +S N +R + + F L +L+ L++ S I
Sbjct: 7 RIAFYRFCNLTQVPQVLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDK 66
Query: 199 VSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHDKY 248
+F L +L+ LD+ ++ + P F L + L + + V D Y
Sbjct: 67 EAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 7e-22
Identities = 45/201 (22%), Positives = 80/201 (39%), Gaps = 22/201 (10%)
Query: 48 PTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQ 107
P + R L+L + + +F + L ++L+ N + PG F +
Sbjct: 27 PEGIPTE-----TRLLDLGKNRIKTLNQDEF-ASFPHLEELELNENIVSAVEPGAFNNLF 80
Query: 108 SLTQVNLSKNRFGGTIGFKPTSRNGPF---PSVQVLNLSSNRFTNLVK--LSQFSKLMVL 162
+L + L NR I G F ++ L++S N+ L+ L L
Sbjct: 81 NLRTLGLRSNRL-KLI------PLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL 133
Query: 163 DVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTF 219
+V +NDL + F+ L+ L L + C ++ +I + LH L L + + ++N
Sbjct: 134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIR 192
Query: 220 PSDFPPLSGVKFLNISLNKFT 240
F L +K L IS +
Sbjct: 193 DYSFKRLYRLKVLEISHWPYL 213
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 34/185 (18%), Positives = 77/185 (41%), Gaps = 13/185 (7%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+L L NL+ I + L ++ L + L + ++ F L + +S +
Sbjct: 155 EQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYL 213
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNL--VKLSQFSKLMVLDVSNNDLRILPSG-FA 177
T+ P G ++ L+++ T + + + L L++S N + +
Sbjct: 214 DTMT--PNCLYG--LNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTIEGSMLH 269
Query: 178 NLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSD-FPPLSGVKFLNI 234
L +L+ + + +++ ++P +F L+ L+ L+VS N + T F + ++ L +
Sbjct: 270 ELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLT-TLEESVFHSVGNLETLIL 327
Query: 235 SLNKF 239
N
Sbjct: 328 DSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 34/185 (18%), Positives = 72/185 (38%), Gaps = 11/185 (5%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+L++S + I+ +++ L S+++ +N L F SL Q+ L K
Sbjct: 107 TKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCN-- 163
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNL--VKLSQFSKLMVLDVS-NNDLRILPSGFA 177
+ PT + VL L + + +L VL++S L +
Sbjct: 164 --LTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCL 221
Query: 178 NLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235
L L I+ C ++ + ++ L L++L++S N ++ S L ++ + +
Sbjct: 222 YGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLV 280
Query: 236 LNKFT 240
+
Sbjct: 281 GGQLA 285
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 3e-20
Identities = 36/189 (19%), Positives = 72/189 (38%), Gaps = 17/189 (8%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
++ L + +L IS + ++ L + L +L L + L
Sbjct: 130 LKSLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI 188
Query: 120 GGTIGFKPTSRNGPF---PSVQVLNLSSNRFTNLVKLSQFS--KLMVLDVSNNDLRILPS 174
R+ F ++VL +S + + + + L L +++ +L +P
Sbjct: 189 N-------AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPY 241
Query: 175 G-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKF 231
+L LR L++S IS I+ L L+ + + + P F L+ ++
Sbjct: 242 LAVRHLVYLRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRV 300
Query: 232 LNISLNKFT 240
LN+S N+ T
Sbjct: 301 LNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 3e-11
Identities = 28/148 (18%), Positives = 52/148 (35%), Gaps = 32/148 (21%)
Query: 43 ISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGW 102
+ + P L G N + L+++ NL+ + + +R++ L ++LS N +
Sbjct: 213 LDTMTPNCLYGLN----LTSLSITHCNLTAV-PYLAVRHLVYLRFLNLSYNPISTIEGSM 267
Query: 103 FWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVL 162
L ++ L + + F L + L VL
Sbjct: 268 LHELLRLQEIQLVGGQLA--------------------VVEPYAFRGL------NYLRVL 301
Query: 163 DVSNNDLRILPSG-FANLSKLRHLDISS 189
+VS N L L F ++ L L + S
Sbjct: 302 NVSGNQLTTLEESVFHSVGNLETLILDS 329
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 8e-22
Identities = 49/209 (23%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 35 FSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNS 94
++T + T + G + L L ++ + L+N++++ ++LS N
Sbjct: 40 LDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDL---APLKNLTKITELELSGNP 96
Query: 95 LKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLS 154
LK +V QS+ ++L+ + ++QVL L N+ TN+ L+
Sbjct: 97 LK-NVSA-IAGLQSIKTLDLTSTQITDVTPLAG------LSNLQVLYLDLNQITNISPLA 148
Query: 155 QFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNS 214
+ L L + N + L + ANLSKL L KIS +I P++ L +L + + NN
Sbjct: 149 GLTNLQYLSIGNAQVSDL-TPLANLSKLTTLKADDNKIS-DISPLASLPNLIEVHLKNNQ 206
Query: 215 MNGTFPSDFPPLSGVK---FLNISLNKFT 240
+ SD PL+ + ++ T
Sbjct: 207 I-----SDVSPLANTSNLFIVTLTNQTIT 230
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 34/182 (18%), Positives = 75/182 (41%), Gaps = 21/182 (11%)
Query: 62 ELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGG 121
++ N++ ++ ++ + ++ + ++ G +L + L N+
Sbjct: 23 KIAAGKSNVTDTVT---QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITD 77
Query: 122 TIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSK 181
K + L LS N N+ ++ + LD+++ + + + A LS
Sbjct: 78 LAPLK------NLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDV-TPLAGLSN 130
Query: 182 LRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VKFLNISLNK 238
L+ L + +I+ NI P++ L +L+YL + N + SD PL+ + L NK
Sbjct: 131 LQVLYLDLNQIT-NISPLAGLTNLQYLSIGNAQV-----SDLTPLANLSKLTTLKADDNK 184
Query: 239 FT 240
+
Sbjct: 185 IS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 31/205 (15%), Positives = 74/205 (36%), Gaps = 13/205 (6%)
Query: 33 KAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSN 92
K + ++ +S N++ I+ L+L+S ++ + L +S L + L
Sbjct: 82 KNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTP---LAGLSNLQVLYLDL 138
Query: 93 NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK 152
N + ++ +L +++ + + L N+ +++
Sbjct: 139 NQIT-NISP-LAGLTNLQYLSIGNAQVSDLTPLA------NLSKLTTLKADDNKISDISP 190
Query: 153 LSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSN 212
L+ L+ + + NN + + S AN S L + +++ I+ N + + V
Sbjct: 191 LASLPNLIEVHLKNNQISDV-SPLANTSNLFIVTLTNQTIT-NQPVFYNNNLVVPNVVKG 248
Query: 213 NSMNGTFPSDFPPLSGVKFLNISLN 237
S P+ N++ N
Sbjct: 249 PSGAPIAPATISDNGTYASPNLTWN 273
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 6e-14
Identities = 17/120 (14%), Positives = 45/120 (37%), Gaps = 10/120 (8%)
Query: 134 FPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS 193
+ + + T+ V + + L + + G L+ L L++ +I+
Sbjct: 18 LANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI-EGVQYLNNLIGLELKDNQIT 76
Query: 194 GNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VKFLNISLNKFTGFVGHDKYQK 250
++ P+ L + L++S N + + ++G +K L+++ + T
Sbjct: 77 -DLAPLKNLTKITELELSGNPL-----KNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSN 130
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 28/186 (15%), Positives = 70/186 (37%), Gaps = 16/186 (8%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
++ L L ++ I L ++ L + + N + + + LT + N+
Sbjct: 131 LQVLYLDLNQITNI---SPLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKI 185
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
P++ ++L +N+ +++ L+ S L ++ ++N + P +
Sbjct: 186 SDISPLAS------LPNLIEVHLKNNQISDVSPLANTSNLFIVTLTNQTITNQPVFY--N 237
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKY--LDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
+ L ++ I P + + Y +++ N + + V F N ++
Sbjct: 238 NNLVVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVP 297
Query: 238 KFTGFV 243
F+G V
Sbjct: 298 -FSGTV 302
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-21
Identities = 40/211 (18%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 33 KAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSN 92
AF+ N+ T+ N I ++ ++ ++ + + ++ + + + L+
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV---QGIQYLPNVTKLFLNG 77
Query: 93 NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK 152
N L + + ++L + L +N+ K ++ L+L N +++
Sbjct: 78 NKLT-DIKP-LANLKNLGWLFLDENKVKDLSSLK------DLKKLKSLSLEHNGISDING 129
Query: 153 LSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSN 212
L +L L + NN + + + + L+KL L + +IS +I P++ L L+ L +S
Sbjct: 130 LVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSK 187
Query: 213 NSMNGTFPSDFPPLSGVK---FLNISLNKFT 240
N + SD L+G+K L + +
Sbjct: 188 NHI-----SDLRALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 36/165 (21%), Positives = 68/165 (41%), Gaps = 18/165 (10%)
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138
+E +L S+ +V S+ Q+ + + G + P+V
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGIQ------YLPNVT 71
Query: 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKP 198
L L+ N+ T++ L+ L L + N ++ L S +L KL+ L + IS +I
Sbjct: 72 KLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDL-SSLKDLKKLKSLSLEHNGIS-DING 129
Query: 199 VSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VKFLNISLNKFT 240
+ L L+ L + NN + +D LS + L++ N+ +
Sbjct: 130 LVHLPQLESLYLGNNKI-----TDITVLSRLTKLDTLSLEDNQIS 169
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 3e-18
Identities = 40/206 (19%), Positives = 84/206 (40%), Gaps = 13/206 (6%)
Query: 35 FSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNS 94
+S+ + ++ G + +L L+ L+ I K L N+ L + L N
Sbjct: 45 LNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDI---KPLANLKNLGWLFLDENK 101
Query: 95 LKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLS 154
+K + + L ++L N G P ++ L L +N+ T++ LS
Sbjct: 102 VK-DLSS-LKDLKKLKSLSLEHNGISDINGLVH------LPQLESLYLGNNKITDITVLS 153
Query: 155 QFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNS 214
+ +KL L + +N + + A L+KL++L +S IS +++ ++ L +L L++ +
Sbjct: 154 RLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQE 211
Query: 215 MNGTFPSDFPPLSGVKFLNISLNKFT 240
+ L + +
Sbjct: 212 CLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 37/184 (20%), Positives = 70/184 (38%), Gaps = 15/184 (8%)
Query: 58 TPIREL-NLSSRNLSG--IISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNL 114
P+ L NL L + L+++ +L S+ L +N + + G L + L
Sbjct: 84 KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYL 141
Query: 115 SKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPS 174
N+ + L+L N+ +++V L+ +KL L +S N + L
Sbjct: 142 GNNKITDITVLSR------LTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-R 194
Query: 175 GFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLD-VSNNSMNGTFPSDFPPLSGVKFLN 233
A L L L++ S + KP++ +L + V N + P + N
Sbjct: 195 ALAGLKNLDVLELFSQECLN--KPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPN 252
Query: 234 ISLN 237
+ +
Sbjct: 253 VKWH 256
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 66/325 (20%), Positives = 113/325 (34%), Gaps = 90/325 (27%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL 460
GK L EG G V +A VA+K+L +NA + D ++ F+ L ++
Sbjct: 26 VLGKT--LGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV 83
Query: 461 KHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWL--HELPTGEPNVEDWSTDTWDHHPGA 518
HP+++ L G C L+++E+ G L +L S ++
Sbjct: 84 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL- 577
++ + A +++G+ YL + H L +IL+AE + KI+ FGL
Sbjct: 144 ERALTMGDLI------SFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
Query: 578 RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLTGKRGTDD 619
R++ ++ + G E SDV+ FGV+L E++T
Sbjct: 198 RDVYEEDSYVKRSQ---GRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------- 247
Query: 620 CVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGY--------------- 660
LG G + L+ G+
Sbjct: 248 -----------------------LGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRL 284
Query: 661 --LCTADSPGKRPTMQQVLGLLKDI 683
C P KRP + L+ +
Sbjct: 285 MLQCWKQEPDKRPVFADISKDLEKM 309
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 97.5 bits (242), Expect = 3e-21
Identities = 41/211 (19%), Positives = 89/211 (42%), Gaps = 21/211 (9%)
Query: 33 KAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSN 92
AF+ N+ T+ N I ++ ++ ++ + + ++ + + + L+
Sbjct: 18 DAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSV---QGIQYLPNVTKLFLNG 74
Query: 93 NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK 152
N L P + ++L + L +N+ K ++ L+L N +++
Sbjct: 75 NKLTDIKP--LTNLKNLGWLFLDENKIKDLSSLK------DLKKLKSLSLEHNGISDING 126
Query: 153 LSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSN 212
L +L L + NN + + + + L+KL L + +IS +I P++ L L+ L +S
Sbjct: 127 LVHLPQLESLYLGNNKITDI-TVLSRLTKLDTLSLEDNQIS-DIVPLAGLTKLQNLYLSK 184
Query: 213 NSMNGTFPSDFPPLSGVK---FLNISLNKFT 240
N + SD L+G+K L + +
Sbjct: 185 NHI-----SDLRALAGLKNLDVLELFSQECL 210
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 93.6 bits (232), Expect = 4e-20
Identities = 38/181 (20%), Positives = 73/181 (40%), Gaps = 15/181 (8%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ E S + I +E +L S+ +V S+ Q+ + +
Sbjct: 1 MGETITVSTPIKQIFP---DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI 55
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
G + P+V L L+ N+ T++ L+ L L + N ++ L S +L
Sbjct: 56 KSVQGIQ------YLPNVTKLFLNGNKLTDIKPLTNLKNLGWLFLDENKIKDL-SSLKDL 108
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKF 239
KL+ L + IS +I + L L+ L + NN + T + L+ + L++ N+
Sbjct: 109 KKLKSLSLEHNGIS-DINGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQI 165
Query: 240 T 240
+
Sbjct: 166 S 166
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 88.6 bits (219), Expect = 2e-18
Identities = 40/205 (19%), Positives = 84/205 (40%), Gaps = 13/205 (6%)
Query: 35 FSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNS 94
+S+ + ++ G + +L L+ L+ I K L N+ L + L N
Sbjct: 42 LNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLTDI---KPLTNLKNLGWLFLDENK 98
Query: 95 LKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLS 154
+K + + L ++L N G P ++ L L +N+ T++ LS
Sbjct: 99 IK-DLSS-LKDLKKLKSLSLEHNGISDINGLV------HLPQLESLYLGNNKITDITVLS 150
Query: 155 QFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNS 214
+ +KL L + +N + + A L+KL++L +S IS +++ ++ L +L L++ +
Sbjct: 151 RLTKLDTLSLEDNQISDI-VPLAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFSQE 208
Query: 215 MNGTFPSDFPPLSGVKFLNISLNKF 239
+ L + +
Sbjct: 209 CLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 75.1 bits (184), Expect = 3e-14
Identities = 31/171 (18%), Positives = 62/171 (36%), Gaps = 18/171 (10%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L L + + L+++ +L S+ L +N + + G L + L N+
Sbjct: 90 GWLFLDENKIKDL---SSLKDLKKLKSLSLEHNGIS-DING-LVHLPQLESLYLGNNKIT 144
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
+ L+L N+ +++V L+ +KL L +S N + L A L
Sbjct: 145 DITVLSR------LTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDL-RALAGLK 197
Query: 181 KLRHLDISSCKISGN----IKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLS 227
L L++ S + + +++K D + + SD
Sbjct: 198 NLDVLELFSQECLNKPINHQSNLVVPNTVKNTD--GSLVTPEIISDDGDYE 246
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 96.0 bits (239), Expect = 4e-21
Identities = 43/183 (23%), Positives = 81/183 (44%), Gaps = 14/183 (7%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L L L+ +I +S+L + L NN ++ F SL +++L + +
Sbjct: 126 NTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKL 184
Query: 121 GTIGFKPTSRNGPF---PSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-F 176
I G F +++ LNL ++ L+ L L++S N + G F
Sbjct: 185 EYI------SEGAFEGLFNLKYLNLGMCNIKDMPNLTPLVGLEELEMSGNHFPEIRPGSF 238
Query: 177 ANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNI 234
LS L+ L + + ++S I+ +F L SL L++++N+++ F PL + L++
Sbjct: 239 HGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHL 297
Query: 235 SLN 237
N
Sbjct: 298 HHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 2e-18
Identities = 41/185 (22%), Positives = 77/185 (41%), Gaps = 12/185 (6%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L L ++ I ++ L++++L +N L G F L ++ L N
Sbjct: 102 EVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNP-- 158
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSS-NRFTNLVK--LSQFSKLMVLDVSNNDLRILPSGFA 177
I P+ PS+ L+L + + + L L++ +++ +P+
Sbjct: 159 --IESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDMPN-LT 215
Query: 178 NLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235
L L L++S I+P SF L SLK L V N+ ++ + F L+ + LN++
Sbjct: 216 PLVGLEELEMSGNHFP-EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLA 274
Query: 236 LNKFT 240
N +
Sbjct: 275 HNNLS 279
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 4e-18
Identities = 50/260 (19%), Positives = 98/260 (37%), Gaps = 50/260 (19%)
Query: 3 IFCRLPLLFSLSLVVLAQS--------TCNSKDQELV--SKAFSSVSTFNISWLKPTNLN 52
+ ++ +L + + +C+++ ++V + S V P +
Sbjct: 24 LTAQVWILCAAIAAAASAGPQNCPSVCSCSNQFSKVVCTRRGLSEV---------PQGI- 73
Query: 53 GSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQV 112
+ R LNL N+ +I R++ L + L NS++ G F SL +
Sbjct: 74 ----PSNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTL 128
Query: 113 NLSKNR--------FGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVL 162
L N F ++ L L +N ++ ++ LM L
Sbjct: 129 ELFDNWLTVIPSGAFEYL------------SKLRELWLRNNPIESIPSYAFNRVPSLMRL 176
Query: 163 DVS-NNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFP 220
D+ L + G F L L++L++ C I ++ ++ L L+ L++S N P
Sbjct: 177 DLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRP 235
Query: 221 SDFPPLSGVKFLNISLNKFT 240
F LS +K L + ++ +
Sbjct: 236 GSFHGLSSLKKLWVMNSQVS 255
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 55/253 (21%), Positives = 97/253 (38%), Gaps = 56/253 (22%)
Query: 22 TCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRN 81
+C+ + SK +SV PT + + L L S L + F
Sbjct: 6 SCSGTEIRCNSKGLTSV---------PTGI-----PSSATRLELESNKLQSLPHGVF-DK 50
Query: 82 MSELHSIDLSNNSL--KGSVPGWFWSTQSLTQVNLSKNRFGG-TIGFKPTSRNGPFPSVQ 138
+++L + LS+N L KG + T SL ++LS N + F ++
Sbjct: 51 LTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLG------LEQLE 104
Query: 139 VLNLSSNRFTNLVKLSQFS---KLMVLDVSNNDLRILPSG-------------------- 175
L+ + + + S F L+ LD+S+ R+ +G
Sbjct: 105 HLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQE 164
Query: 176 ------FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLS 227
F L L LD+S C++ + P +F L SL+ L++S+N+ + L+
Sbjct: 165 NFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLN 223
Query: 228 GVKFLNISLNKFT 240
++ L+ SLN
Sbjct: 224 SLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 51/244 (20%), Positives = 94/244 (38%), Gaps = 39/244 (15%)
Query: 4 FCRLPLLFSLSLVVLAQSTCNSKDQELVSKAF---SSVSTFNISWLKPTNL-NGSNPSTP 59
F +L L LSL S+ + S++ +S+ ++S+ + +
Sbjct: 48 FDKLTQLTKLSL-----SSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQ 102
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ L+ NL + + ++ L +D+S+ + + G F SL + ++ N F
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FAN 178
N + FT L L LD+S L L F +
Sbjct: 163 -------------------QENFLPDIFTEL------RNLTFLDLSQCQLEQLSPTAFNS 197
Query: 179 LSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPL-SGVKFLNIS 235
LS L+ L++S ++ + L+SL+ LD S N + + + S + FLN++
Sbjct: 198 LSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLT 256
Query: 236 LNKF 239
N F
Sbjct: 257 QNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 4e-18
Identities = 43/167 (25%), Positives = 64/167 (38%), Gaps = 15/167 (8%)
Query: 87 SIDLSNNSLKGSVP-GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSN 145
I ++ L SVP G S L L N+ + P + L+LSSN
Sbjct: 11 EIRCNSKGLT-SVPTGIPSSATRL---ELESNK----LQSLPHGVFDKLTQLTKLSLSSN 62
Query: 146 RFTNL-VKLSQF---SKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF 201
+ + L LD+S N + + S F L +L HLD + + F
Sbjct: 63 GLSFKGCCSQSDFGTTSLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVF 122
Query: 202 --LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHD 246
L +L YLD+S+ F F LS ++ L ++ N F D
Sbjct: 123 LSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPD 169
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 4e-21
Identities = 63/326 (19%), Positives = 110/326 (33%), Gaps = 99/326 (30%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVLDNAKGIDHDDAVAMFDELSRLK 461
+E L EG G V+ A ++ VA+K L + D + L+ L+
Sbjct: 18 VLKRE--LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ 75
Query: 462 HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521
H +++ G C G +++ E+M +GDL+++L + D A
Sbjct: 76 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRA------HGPDAMILVDGQPRQAKGE 129
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNI 580
+ + + IA +A G+ YL H L T + L+ +L KI FG+ R++
Sbjct: 130 LGLSQMLH------IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV 183
Query: 581 GVKNVGERSE---NETCG--------PE----------SDVYCFGVILMELLTGKRGTDD 619
++ PE SDV+ FGVIL E+ T
Sbjct: 184 ------YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT------- 230
Query: 620 CVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL-------------- 661
G S E++E + G +
Sbjct: 231 -----------------------YGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDV 267
Query: 662 ---CTADSPGKRPTMQQVLGLLKDIR 684
C P +R ++++ +L +
Sbjct: 268 MLGCWQREPQQRLNIKEIYKILHALG 293
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-21
Identities = 39/188 (20%), Positives = 66/188 (35%), Gaps = 27/188 (14%)
Query: 54 SNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVN 113
EL L++ LS + L S+ S NSL +P S +SL N
Sbjct: 67 DCLDRQAHELELNNLGLSSLPE-----LPPHLESLVASCNSLT-ELPELPQSLKSLLVDN 120
Query: 114 LSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILP 173
+ P ++ L +S+N+ L +L S L ++DV NN L+ LP
Sbjct: 121 NNLKALSDLP-----------PLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLP 169
Query: 174 SGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPP-LSGVKFL 232
L + + ++ + + L L + NNS+ P ++ +
Sbjct: 170 DL---PPSLEFIAAGNNQLE-ELPELQNLPFLTAIYADNNSL-----KKLPDLPLSLESI 220
Query: 233 NISLNKFT 240
N
Sbjct: 221 VAGNNILE 228
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 44/199 (22%), Positives = 65/199 (32%), Gaps = 41/199 (20%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGW------------------ 102
L +S+ L + L+N S L ID+ NNSLK +P
Sbjct: 134 EYLGVSNNQLEKLPE---LQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAAGNNQLEELP 189
Query: 103 -FWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMV 161
+ LT + N S++ + +N L +L L
Sbjct: 190 ELQNLPFLTAIYADNNSL--------KKLPDLPLSLESIVAGNNILEELPELQNLPFLTT 241
Query: 162 LDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPS 221
+ NN L+ LP +L L D + SL +LDVS N +
Sbjct: 242 IYADNNLLKTLPDLPPSLEALNVRDNYLTDLP------ELPQSLTFLDVSENIFS-GLSE 294
Query: 222 DFPPLSGVKFLNISLNKFT 240
P L +LN S N+
Sbjct: 295 LPPNL---YYLNASSNEIR 310
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 7e-14
Identities = 33/174 (18%), Positives = 59/174 (33%), Gaps = 26/174 (14%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ + + L + L ++++ +N L +P S L +
Sbjct: 239 LTTIYADNNLLKTLPDL-----PPSLEALNVRDNYLT-DLPELPQSLTFLDVSENIFSGL 292
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
P++ LN SSN +L L L+VSNN L LP+
Sbjct: 293 SELP-----------PNLYYLNASSNEIRSL--CDLPPSLEELNVSNNKLIELPA---LP 336
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLN 233
+L L S ++ + +LK L V N + FP + ++ +
Sbjct: 337 PRLERLIASFNHLA-EVPE--LPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNS 386
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 27/210 (12%), Positives = 73/210 (34%), Gaps = 28/210 (13%)
Query: 31 VSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDL 90
+ + S++ ++S + L+ P+ + LN SS + + L +++
Sbjct: 272 LPELPQSLTFLDVSENIFSGLSELPPN--LYYLNASSNEIRSLCD-----LPPSLEELNV 324
Query: 91 SNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNL 150
SNN L +P L ++ S N + P +++ L++ N
Sbjct: 325 SNNKLI-ELPALP---PRLERLIASFNHLA-EV---PEL----PQNLKQLHVEYNPLREF 372
Query: 151 VKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDV 210
+ + L ++++ L +P L+ L + + + + S++ L +
Sbjct: 373 PDI--PESVEDLRMNSH-LAEVPE---LPQNLKQLHVETNPLR-EFPDI--PESVEDLRM 423
Query: 211 SNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
++ + + ++ +
Sbjct: 424 NSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 7e-06
Identities = 15/100 (15%), Positives = 31/100 (31%), Gaps = 18/100 (18%)
Query: 155 QFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVS-------------- 200
+ L +++L +P N+ + + N P +
Sbjct: 9 SNTFLQEPLRHSSNLTEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDC 68
Query: 201 FLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
L+++N ++ + P P L + L S N T
Sbjct: 69 LDRQAHELELNNLGLS-SLPELPPHL---ESLVASCNSLT 104
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 1e-20
Identities = 74/336 (22%), Positives = 120/336 (35%), Gaps = 102/336 (30%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL 460
+ ++ + EG G V++A PG VA+K+L + A D ++
Sbjct: 50 EYVRD--IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF 107
Query: 461 KHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWL--HELPTGEPNVEDWSTDTWDHHPGA 518
+PN++ L G C GK +L E+MA GDL+ +L T +
Sbjct: 108 DNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 167
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYL---HHVGSTHGHLVTSSILLAESLEPKIAGF 575
+S E+ IA VA G+AYL V H L T + L+ E++ KIA F
Sbjct: 168 PPPLSCAEQL------CIARQVAAGMAYLSERKFV---HRDLATRNCLVGENMVVKIADF 218
Query: 576 GL-RNIGVKNVGERSE---NETCG--------PE----------SDVYCFGVILMELLTG 613
GL RNI ++ + PE SDV+ +GV+L E+ +
Sbjct: 219 GLSRNI------YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS- 271
Query: 614 KRGTDDCVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL-------- 661
G G + E++ +R G +
Sbjct: 272 -----------------------------YGLQPYYGMAHEEVIYYVRDGNILACPENCP 302
Query: 662 ---------CTADSPGKRPTMQQVLGLLKDIRPSAD 688
C + P RP+ + +L+ + A+
Sbjct: 303 LELYNLMRLCWSKLPADRPSFCSIHRILQRMCERAE 338
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 2e-20
Identities = 43/183 (23%), Positives = 79/183 (43%), Gaps = 14/183 (7%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L L L+ I +S+L + L NN ++ F SL +++L + +
Sbjct: 115 NTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRL 173
Query: 121 GTIGFKPTSRNGPF---PSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-F 176
I G F +++ LNL+ + L+ KL LD+S N L + G F
Sbjct: 174 SYI------SEGAFEGLSNLRYLNLAMCNLREIPNLTPLIKLDELDLSGNHLSAIRPGSF 227
Query: 177 ANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNI 234
L L+ L + +I I+ +F L SL +++++N++ F PL ++ +++
Sbjct: 228 QGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHL 286
Query: 235 SLN 237
N
Sbjct: 287 HHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 1e-19
Identities = 46/197 (23%), Positives = 81/197 (41%), Gaps = 15/197 (7%)
Query: 48 PTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQ 107
P + ST R LNL + II +++ L + LS N ++ G F
Sbjct: 59 PDGI-----STNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLA 112
Query: 108 SLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVS 165
+L + L NR + P ++ L L +N ++ ++ L LD+
Sbjct: 113 NLNTLELFDNR----LTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLG 168
Query: 166 -NNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDF 223
L + G F LS LR+L+++ C + I ++ L L LD+S N ++ P F
Sbjct: 169 ELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSF 227
Query: 224 PPLSGVKFLNISLNKFT 240
L ++ L + ++
Sbjct: 228 QGLMHLQKLWMIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 86.7 bits (215), Expect = 3e-18
Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 12/185 (6%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L LS ++ I F ++ L++++L +N L G F L ++ L N
Sbjct: 91 EILQLSRNHIRTIEIGAF-NGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNP-- 147
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSS-NRFTNLVK--LSQFSKLMVLDVSNNDLRILPSGFA 177
I P+ PS++ L+L R + + + S L L+++ +LR +P+
Sbjct: 148 --IESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREIPN-LT 204
Query: 178 NLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235
L KL LD+S +S I+P SF L L+ L + + + + F L + +N++
Sbjct: 205 PLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263
Query: 236 LNKFT 240
N T
Sbjct: 264 HNNLT 268
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 6e-20
Identities = 63/321 (19%), Positives = 113/321 (35%), Gaps = 71/321 (22%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL 460
FGK L G G V A G + VA+K+L + A + + + EL +
Sbjct: 48 EFGKV--LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREA---LMSELKMM 102
Query: 461 K----HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHEL-PTGEPNVEDWSTDTWDHH 515
H N++ L G C ++ E+ GDL +L + ++
Sbjct: 103 TQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162
Query: 516 PGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGF 575
+ ++ + + A VA+G+ +L H L ++L+ KI F
Sbjct: 163 EEDLNVLTFEDLLCF------AYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF 216
Query: 576 GL-RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLT---- 612
GL R+I + N PE SDV+ +G++L E+ +
Sbjct: 217 GLARDIMSDSNYVVRGN---ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 613 ---GKRGTDDCVKWVRKLVKEGAGGDALDFRLK--LGSGDSVAEMVESLRVGYLCTADSP 667
G + KL++ G F++ + + + +++S C A
Sbjct: 274 PYPGIPVDAN----FYKLIQNG-------FKMDQPFYATEEIYIIMQS------CWAFDS 316
Query: 668 GKRPTMQQVLGLLKDIRPSAD 688
KRP+ + L A+
Sbjct: 317 RKRPSFPNLTSFLGCQLADAE 337
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 8e-20
Identities = 75/320 (23%), Positives = 112/320 (35%), Gaps = 99/320 (30%)
Query: 412 ESLLAEGRCGPVYRAVL---PGELHVAIKVL-DNAKGIDHDDAVAMFDELSRLK----HP 463
+ ++ EG G V +A + + AIK + + A DH D EL L HP
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD---FAGELEVLCKLGHHP 86
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ L G C + +E+ +G+L +L + E + S +S
Sbjct: 87 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF------AIANSTASTLS 140
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGV 582
S + A VARG+ YL H L +IL+ E+ KIA FGL R V
Sbjct: 141 SQQLL------HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 194
Query: 583 KNVGERSENETCG--------PE----------SDVYCFGVILMELLTGKRGTDDCVKWV 624
T G E SDV+ +GV+L E+++
Sbjct: 195 YVKK------TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS------------ 236
Query: 625 RKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL-----------------CT 663
LG G + AE+ E L GY C
Sbjct: 237 ------------------LGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCW 278
Query: 664 ADSPGKRPTMQQVLGLLKDI 683
+ P +RP+ Q+L L +
Sbjct: 279 REKPYERPSFAQILVSLNRM 298
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 1e-19
Identities = 61/299 (20%), Positives = 98/299 (32%), Gaps = 76/299 (25%)
Query: 415 LAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAG 470
+ G G V+ L VA+K + + D E L + HPN++ L G
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSC--RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
C + +++E + GD +L + +
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLR---------------------------TEGARLRV 212
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSE 590
T ++ A G+ YL H L + L+ E KI+ FG+ V S
Sbjct: 213 KTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272
Query: 591 NET------CGPE----------SDVYCFGVILMELLT-------GKRGTDDCVKWVRKL 627
PE SDV+ FG++L E + R+
Sbjct: 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ-----TREF 327
Query: 628 VKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684
V++G RL D+V ++E C A PG+RP+ + L+ IR
Sbjct: 328 VEKG-------GRLPCPELCPDAVFRLMEQ------CWAYEPGQRPSFSTIYQELQSIR 373
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 67/331 (20%), Positives = 114/331 (34%), Gaps = 108/331 (32%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDD----AVAMFDE 456
F +E L E R G VY+ L G VAIK L D A+G ++ A+
Sbjct: 12 RFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR--- 66
Query: 457 LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHP 516
+RL+HPN++ L G + ++ + ++GDLH +L + D
Sbjct: 67 -ARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM------RSPHSDVGSTDDDR 119
Query: 517 GAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
S + P+ + + +A G+ YL H L T ++L+ + L KI+ G
Sbjct: 120 TVKSALEPPDFVH------LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLG 173
Query: 577 L-RNIGVKNVGERSE---NETCG--------PE----------SDVYCFGVILMELLTGK 614
L R + ++ PE SD++ +GV+L E+ +
Sbjct: 174 LFREV------YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS-- 225
Query: 615 RGTDDCVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL--------- 661
G G S ++VE +R +
Sbjct: 226 ----------------------------YGLQPYCGYSNQDVVEMIRNRQVLPCPDDCPA 257
Query: 662 --------CTADSPGKRPTMQQVLGLLKDIR 684
C + P +RP + + L+
Sbjct: 258 WVYALMIECWNEFPSRRPRFKDIHSRLRAWG 288
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 1e-19
Identities = 74/316 (23%), Positives = 113/316 (35%), Gaps = 76/316 (24%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL 460
FGK L G G V A G + VA+K+L +A + + + EL L
Sbjct: 26 SFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA---LMSELKVL 80
Query: 461 K----HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHP 516
H N++ L G C G LV+ E+ GDL +L + D
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDD-- 138
Query: 517 GAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
+ + ++ + VA+G+A+L H L +ILL KI FG
Sbjct: 139 --ELALDLEDLLSF------SYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFG 190
Query: 577 L-RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLT----- 612
L R+I + N PE SDV+ +G+ L EL +
Sbjct: 191 LARDIKNDSNYVVKGN---ARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247
Query: 613 --GKRGTDDCVKWVRKLVKEGAGGDALDFRLK--LGSGDSVAE-MVESLRVGYLCTADSP 667
G K++KEG FR+ + + + M C P
Sbjct: 248 YPGMPVDSK----FYKMIKEG-------FRMLSPEHAPAEMYDIMKT-------CWDADP 289
Query: 668 GKRPTMQQVLGLLKDI 683
KRPT +Q++ L++
Sbjct: 290 LKRPTFKQIVQLIEKQ 305
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 89.9 bits (223), Expect = 1e-19
Identities = 48/221 (21%), Positives = 83/221 (37%), Gaps = 45/221 (20%)
Query: 22 TCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRN 81
C S + +V P +L + L+LS NLS + +
Sbjct: 17 LCASNILSCSKQQLPNV---------PQSL-----PSYTALLDLSHNNLSRLRAEWTPTR 62
Query: 82 MSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLN 141
++ LHS+ LS+N L F +L ++LS N +
Sbjct: 63 LTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSN--------------------HLHT 102
Query: 142 LSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKIS----GNI 196
L F++L L VL + NN + ++ F ++++L+ L +S +IS I
Sbjct: 103 LDEFLFSDL------QALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELI 156
Query: 197 KPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
K + L L LD+S+N + +D L + L+
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLH 197
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 35/211 (16%), Positives = 70/211 (33%), Gaps = 25/211 (11%)
Query: 50 NLNGSNPSTP----IREL-NLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFW 104
GS P + + + + + S N + + +LK +
Sbjct: 18 YFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIETRTGRALK-ATADLLE 76
Query: 105 --STQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNL-VKLSQFSKLMV 161
+ + L P +Q + + + L + QF+ L
Sbjct: 77 DATQPGRVALELRSVPLP-QF---PDQ-AFRLSHLQHMTIDAAGLMELPDTMQQFAGLET 131
Query: 162 LDVSNNDLRILPSGFANLSKLRHLDISSCK--------ISGNIKPVSF--LHSLKYLDVS 211
L ++ N LR LP+ A+L++LR L I +C ++ L +L+ L +
Sbjct: 132 LTLARNPLRALPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLE 191
Query: 212 NNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
+ + P+ L +K L I + +
Sbjct: 192 WTGIR-SLPASIANLQNLKSLKIRNSPLSAL 221
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 35/186 (18%), Positives = 72/186 (38%), Gaps = 12/186 (6%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKN--- 117
+ + + + L + ++ + L ++ L+ N L+ ++P S L ++++
Sbjct: 107 QHMTIDAAGLMEL--PDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPEL 163
Query: 118 -RFGGTIG-FKPTSRNGPFPSVQVLNLSSNRFTNL-VKLSQFSKLMVLDVSNNDLRILPS 174
+ + + ++Q L L +L ++ L L + N+ L L
Sbjct: 164 TELPEPLASTDASGEHQGLVNLQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLSALGP 223
Query: 175 GFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFL 232
+L KL LD+ C N P F LK L + + S T P D L+ ++ L
Sbjct: 224 AIHHLPKLEELDLRGCTALRNY-PPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKL 282
Query: 233 NISLNK 238
++
Sbjct: 283 DLRGCV 288
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 29/172 (16%), Positives = 60/172 (34%), Gaps = 26/172 (15%)
Query: 61 RELNLSSRN--------LSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQV 112
REL++ + L+ + + + L S+ L ++ S+P + Q+L +
Sbjct: 153 RELSIRACPELTELPEPLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSL 211
Query: 113 NLSKNRFGG---TIGFKPTSRNGPFPSVQVLNLSS-NRFTNL-VKLSQFSKLMVLDVSN- 166
+ + I P ++ L+L N + L L + +
Sbjct: 212 KIRNSPLSALGPAIHH--------LPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDC 263
Query: 167 NDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMN 216
++L LP L++L LD+ C + P L + + V +
Sbjct: 264 SNLLTLPLDIHRLTQLEKLDLRGCVNLSRL-PSLIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 1e-08
Identities = 25/146 (17%), Positives = 54/146 (36%), Gaps = 12/146 (8%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ L L + + + + N+ L S+ + N+ L ++ L +++L
Sbjct: 186 QSLRLEWTGIRSLPAS--IANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTAL 242
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSS-NRFTNL-VKLSQFSKLMVLDVSNN-DLRILPSGFA 177
P G ++ L L + L + + + ++L LD+ +L LPS A
Sbjct: 243 RNY---PPIF-GGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIA 298
Query: 178 NLSKLRHLDISSCKISGNIK--PVSF 201
L + + + + PV+
Sbjct: 299 QLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 65/318 (20%), Positives = 109/318 (34%), Gaps = 98/318 (30%)
Query: 415 LAEGRCGPVYRAVLPG------ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPL 468
L EG G V+ A ++ VA+K L A D + L+ L+H +++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
G C G+ L++ E+M +GDL+R+L P+ + + A + +
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSH---GPDAKLLAGGE----DVAPGPLGLGQLL 161
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGE 587
+A VA G+ YL + H L T + L+ + L KI FG+ R+I
Sbjct: 162 A------VASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI------Y 209
Query: 588 RSE---NETCG--------PE----------SDVYCFGVILMELLTGKRGTDDCVKWVRK 626
++ PE SDV+ FGV+L E+ T
Sbjct: 210 STDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT-------------- 255
Query: 627 LVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL-----------------CTAD 665
G S E ++ + G C
Sbjct: 256 ----------------YGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQR 299
Query: 666 SPGKRPTMQQVLGLLKDI 683
P +R +++ V L+ +
Sbjct: 300 EPQQRHSIKDVHARLQAL 317
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 74/329 (22%), Positives = 116/329 (35%), Gaps = 103/329 (31%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG--------ELHVAIKVL-DNAKGIDHDDAVAMFDELS 458
GK L EG G V A G + VA+K+L D+A D D + E+
Sbjct: 38 TLGKP--LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEME 92
Query: 459 RLK----HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDH 514
+K H N++ L G C V++E+ + G+L +L D
Sbjct: 93 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY------DI 146
Query: 515 HPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAG 574
+ ++ + +ARG+ YL H L ++L+ E+ KIA
Sbjct: 147 NRVPEEQMTFKDLV------SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 200
Query: 575 FGL-RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLTGKR 615
FGL R+I + +++ N G PE SDV+ FGV++ E+ T
Sbjct: 201 FGLARDINNIDYYKKTTN---GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--- 254
Query: 616 GTDDCVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGY----------- 660
LG G V E+ + L+ G+
Sbjct: 255 ---------------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNE 287
Query: 661 ------LCTADSPGKRPTMQQVLGLLKDI 683
C P +RPT +Q++ L I
Sbjct: 288 LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 316
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 6e-19
Identities = 42/186 (22%), Positives = 81/186 (43%), Gaps = 15/186 (8%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
L+L + ++ I F +N+ LH++ L NN + PG F L ++ LSKN+
Sbjct: 54 TALLDLQNNKITEIKDGDF-KNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQL 112
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRI--LPSG 175
++Q L + N T + K + ++++V+++ N L+ + +G
Sbjct: 113 -------KELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENG 165
Query: 176 -FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNI 234
F + KL ++ I+ I+ I P SL L + N + + L+ + L +
Sbjct: 166 AFQGMKKLSYIRIADTNIT-TI-PQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGL 223
Query: 235 SLNKFT 240
S N +
Sbjct: 224 SFNSIS 229
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 38/217 (17%), Positives = 75/217 (34%), Gaps = 49/217 (22%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSV--PGWFWSTQSLTQVNLSKNR 118
+EL + ++ + F ++++ ++L N LK S G F + L+ + ++
Sbjct: 124 QELRVHENEITKVRKSVF-NGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTN 182
Query: 119 FGGTIGFKPTS-RNGPFPSVQVLNLSSNR--------FTNLVKL---------------- 153
T+ G PS+ L+L N+ L L
Sbjct: 183 I--------TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNG 234
Query: 154 --SQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF--------LH 203
+ L L ++NN L +P G A+ ++ + + + IS I F
Sbjct: 235 SLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKA 293
Query: 204 SLKYLDVSNNSMNGTF--PSDFPPLSGVKFLNISLNK 238
S + + +N + PS F + + + K
Sbjct: 294 SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 87.3 bits (217), Expect = 6e-19
Identities = 64/326 (19%), Positives = 108/326 (33%), Gaps = 106/326 (32%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL 460
+E L +G G VY V G E VAIK + + A + + + +
Sbjct: 28 TMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 85
Query: 461 KHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
+++ L G G+ LV++E M GDL +L P +
Sbjct: 86 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-----------------LRPAMAN 128
Query: 521 HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RN 579
+ + ++A +A G+AYL+ H L + ++AE KI FG+ R+
Sbjct: 129 NPVLAPPSL-SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 187
Query: 580 IGVKNVGERSENETCG-----------PE----------SDVYCFGVILMELLTGKRGTD 618
I ++ G PE SDV+ FGV+L E+ T
Sbjct: 188 I------YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------ 235
Query: 619 DCVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL------------- 661
L G S +++ + G L
Sbjct: 236 ------------------------LAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFE 271
Query: 662 ----CTADSPGKRPTMQQVLGLLKDI 683
C +P RP+ +++ +K+
Sbjct: 272 LMRMCWQYNPKMRPSFLEIISSIKEE 297
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 8e-19
Identities = 70/312 (22%), Positives = 110/312 (35%), Gaps = 86/312 (27%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG----ELHVAIKVL-DNAKGIDHDD----AVAMFDELS 458
HF + + G G VY L ++H A+K L + + M
Sbjct: 28 HFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM----K 81
Query: 459 RLKHPNLLPLAGYCIAGKEK-LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG 517
HPN+L L G C+ + LV+L +M +GDL ++ T P V+D
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKD----------- 129
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL 577
+ VA+G+ YL H L + +L E K+A FGL
Sbjct: 130 ---------------LIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGL 174
Query: 578 -RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLT-GKR-- 615
R++ K N+T E SDV+ FGV+L EL+T G
Sbjct: 175 ARDMYDKEY-YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY 233
Query: 616 -GTDDCVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRP 671
+ + + +G RL D + E M++ C RP
Sbjct: 234 PDVN--TFDITVYLLQG-------RRLLQPEYCPDPLYEVMLK-------CWHPKAEMRP 277
Query: 672 TMQQVLGLLKDI 683
+ +++ + I
Sbjct: 278 SFSELVSRISAI 289
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 9e-19
Identities = 38/184 (20%), Positives = 85/184 (46%), Gaps = 22/184 (11%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ NL ++++ ++S + +S + + + N++++ S+ G +L +++LS N+
Sbjct: 21 AVKQNLGKQSVTDLVS---QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQI 75
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
K ++ L+++ NR NL + + L L + NN+LR +L
Sbjct: 76 SDLSPLK------DLTKLEELSVNRNRLKNLNGIP-SACLSRLFLDNNELRDT-DSLIHL 127
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VKFLNISL 236
L L I + K+ +I + FL L+ LD+ N + ++ L+ V +++++
Sbjct: 128 KNLEILSIRNNKLK-SIVMLGFLSKLEVLDLHGNEI-----TNTGGLTRLKKVNWIDLTG 181
Query: 237 NKFT 240
K
Sbjct: 182 QKCV 185
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 7e-16
Identities = 30/163 (18%), Positives = 64/163 (39%), Gaps = 19/163 (11%)
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138
++ +L S+ V + N + G + F +++
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQSLAGMQ------FFTNLK 66
Query: 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKP 198
L+LS N+ ++L L +KL L V+ N L+ L +G + L L + + ++ +
Sbjct: 67 ELHLSHNQISDLSPLKDLTKLEELSVNRNRLKNL-NGIPSA-CLSRLFLDNNELR-DTDS 123
Query: 199 VSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VKFLNISLNK 238
+ L +L+ L + NN + L ++ L++ N+
Sbjct: 124 LIHLKNLEILSIRNNKL-----KSIVMLGFLSKLEVLDLHGNE 161
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 9e-16
Identities = 22/109 (20%), Positives = 46/109 (42%), Gaps = 9/109 (8%)
Query: 134 FPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS 193
+ NL T+LV + S + + N++++ L +G + L+ L +S +IS
Sbjct: 18 LANAVKQNLGKQSVTDLVSQKELSGVQNFNGDNSNIQSL-AGMQFFTNLKELHLSHNQIS 76
Query: 194 GNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGV--KFLNISLNKFT 240
++ P+ L L+ L V+ N + + + L + N+
Sbjct: 77 -DLSPLKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELR 119
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 3e-14
Identities = 41/194 (21%), Positives = 82/194 (42%), Gaps = 22/194 (11%)
Query: 35 FSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNS 94
S V FN +L G T ++EL+LS +S + L+++++L + ++ N
Sbjct: 40 LSGVQNFNGDNSNIQSLAGMQFFTNLKELHLSHNQISDL---SPLKDLTKLEELSVNRNR 96
Query: 95 LKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLS 154
LK + L+++ L N T ++++L++ +N+ ++V L
Sbjct: 97 LKNLNGI---PSACLSRLFLDNNELRDTDSLIH------LKNLEILSIRNNKLKSIVMLG 147
Query: 155 QFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS----GNIKPVSFLHSLKYLDV 210
SKL VLD+ N++ G L K+ +D++ K + +++K D
Sbjct: 148 FLSKLEVLDLHGNEITNT-GGLTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDG 206
Query: 211 -----SNNSMNGTF 219
S G++
Sbjct: 207 RWISPYYISNGGSY 220
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 6e-04
Identities = 7/68 (10%), Positives = 25/68 (36%), Gaps = 9/68 (13%)
Query: 174 SGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VK 230
L+ ++ ++ ++ L ++ + N+++ + +K
Sbjct: 13 FPDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNI-----QSLAGMQFFTNLK 66
Query: 231 FLNISLNK 238
L++S N+
Sbjct: 67 ELHLSHNQ 74
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 70/338 (20%), Positives = 118/338 (34%), Gaps = 91/338 (26%)
Query: 389 CSKPLVNYLTFKDLIAATSHFGKE---------SLLAEGRCGPVYRAVLP----GELHVA 435
+ T+++ A F +E ++ G G V L ++ VA
Sbjct: 22 EPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVA 81
Query: 436 IKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHR 492
IK L G E + + HPN++ L G G+ +++ E+M NG L
Sbjct: 82 IKAL--KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 493 WLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS 552
+L H G + + GV G+ YL +G
Sbjct: 140 FLRT------------------HDG---QFTIMQLVGM------LRGVGAGMRYLSDLGY 172
Query: 553 THGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENET------CGPE-------- 597
H L ++L+ +L K++ FGL R + + PE
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 598 --SDVYCFGVILMELLT-GKR------GTDDCVKWVRKLVKEGAGGDALDFRLKLGSG-- 646
SDV+ FGV++ E+L G+R D V V+EG +RL G
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRD-----VISSVEEG-------YRLPAPMGCP 280
Query: 647 DSVAE-MVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
++ + M++ C +RP Q++ +L +
Sbjct: 281 HALHQLMLD-------CWHKDRAQRPRFSQIVSVLDAL 311
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 69/338 (20%), Positives = 116/338 (34%), Gaps = 91/338 (26%)
Query: 389 CSKPLVNYLTFKDLIAATSHFGKE---------SLLAEGRCGPVYRAVLP----GELHVA 435
+ V+ TF+D F KE ++ G G V L E+ VA
Sbjct: 18 GLRTFVDPHTFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVA 77
Query: 436 IKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHR 492
IK L G E + + HPN++ L G K +++ E+M NG L
Sbjct: 78 IKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDS 135
Query: 493 WLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS 552
+L + + + + G+A G+ YL +G
Sbjct: 136 FLRK---------------------HDAQFTVIQLVGM------LRGIASGMKYLSDMGY 168
Query: 553 THGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENET------CGPE-------- 597
H L +IL+ +L K++ FGL R + + PE
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 598 --SDVYCFGVILMELLT-------GKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSG-- 646
SDV+ +G++L E+++ D V K V EG +RL
Sbjct: 229 SASDVWSYGIVLWEVMSYGERPYWEMSNQD-----VIKAVDEG-------YRLPPPMDCP 276
Query: 647 DSVAE-MVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
++ + M++ C RP +Q++ +L +
Sbjct: 277 AALYQLMLD-------CWQKDRNNRPKFEQIVSILDKL 307
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 1e-18
Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 33/230 (14%)
Query: 22 TCNSKDQELV---SKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKF 78
C ++ + + +V P + + + L +S + + F
Sbjct: 7 VCYNEPKVTTSCPQQGLQAV---------PVGI-----PAASQRIFLHGNRISHVPAASF 52
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPF---P 135
R L + L +N L F L Q++LS N ++ F
Sbjct: 53 -RACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV------DPATFHGLG 105
Query: 136 SVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKI 192
+ L+L L + L L + +N L+ LP F +L L HL + +I
Sbjct: 106 RLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRI 165
Query: 193 SGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
S ++ +F LHSL L + N + P F L + L + N +
Sbjct: 166 S-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 29/156 (18%), Positives = 56/156 (35%), Gaps = 31/156 (19%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L+L L + R ++ L + L +N+L+ F +LT + L NR
Sbjct: 108 HTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS 166
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANL 179
++ F L L L + N + + F +L
Sbjct: 167 --------------------SVPERAFRGLHSLD------RLLLHQNRVAHVHPHAFRDL 200
Query: 180 SKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNN 213
+L L + + +S + + L +L+YL +++N
Sbjct: 201 GRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 34/188 (18%), Positives = 64/188 (34%), Gaps = 43/188 (22%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ L L L + R++ L + L N + F SL ++ L +NR
Sbjct: 132 QYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANL 179
++ + F +L +LM L + N+L LP+ A L
Sbjct: 191 --------------------HVHPHAFRDL------GRLMTLYLFANNLSALPTEALAPL 224
Query: 180 SKLRHLDIS------SCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLN 233
L++L ++ C+ L+ S++ + + P L+G
Sbjct: 225 RALQYLRLNDNPWVCDCRA------RPLWAWLQKFRGSSSEVPCSLP---QRLAGRDLKR 275
Query: 234 ISLNKFTG 241
++ N G
Sbjct: 276 LAANDLQG 283
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 2e-18
Identities = 45/220 (20%), Positives = 94/220 (42%), Gaps = 21/220 (9%)
Query: 3 IFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSS--VSTFNISWLKPTNLNGSNPSTPI 60
L L +V Q + + FS+ + F +S + ++ + +P
Sbjct: 271 SGTSLKALSIHQVVSDVFGF----PQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPF 326
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLK--GSVPGWFWSTQSLTQVNLSKNR 118
L+ S+ L+ + +++EL ++ L N LK + +SL Q+++S+N
Sbjct: 327 LHLDFSNNLLTDTVFENC-GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNS 385
Query: 119 FGGTIGFKPTSRNGPF---PSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG 175
+ G S+ LN+SSN T+ + ++ VLD+ +N ++ +P
Sbjct: 386 V------SYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPPRIKVLDLHSNKIKSIPKQ 439
Query: 176 FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNN 213
L L+ L+++S ++ ++ F L SL+ + + N
Sbjct: 440 VVKLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 84.1 bits (208), Expect = 3e-17
Identities = 36/215 (16%), Positives = 76/215 (35%), Gaps = 17/215 (7%)
Query: 37 SVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLR----NMSELHSIDLSN 92
+++ +W + T + ++S+ L G + ++ ++ L + +
Sbjct: 226 TLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVS 285
Query: 93 NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV- 151
+ + ++ N + + L+ S+N T+ V
Sbjct: 286 DVFGFPQSYIYEIFSNMNIKNFTVSG----TRMVHMLCPSKISPFLHLDFSNNLLTDTVF 341
Query: 152 -KLSQFSKLMVLDVSNNDLRILPSG---FANLSKLRHLDISSCKISGNIKPVSF--LHSL 205
++L L + N L+ L + L+ LDIS +S + K SL
Sbjct: 342 ENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSL 401
Query: 206 KYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
L++S+N + T PP +K L++ NK
Sbjct: 402 LSLNMSSNILTDTIFRCLPPR--IKVLDLHSNKIK 434
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 76.1 bits (187), Expect = 1e-14
Identities = 45/258 (17%), Positives = 100/258 (38%), Gaps = 23/258 (8%)
Query: 7 LPLLFSLSLVVLAQSTCNSKD-QELVSKAFSSVSTFNISWLKPTNLNGSNPSTP------ 59
L + SL ++ + ++ K +++ NI + N S
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219
Query: 60 --IRELNLSSRNLSGIISWKFLRNM--SELHSIDLSNNSLKGSVPGWF--WSTQSLTQVN 113
+ L L++ + + L+ + + + +SN L+G + +S SL ++
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279
Query: 114 LSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNR--FTNLVKLSQFSKLMVLDVSNNDLRI 171
+ + GF + F ++ + N + + +++ S+ S + LD SNN L
Sbjct: 280 IHQVVSD-VFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338
Query: 172 LPSG-FANLSKLRHLDISSCKISGNIKPVSF----LHSLKYLDVSNNSMNGTFPSD-FPP 225
+L++L L + ++ + ++ + SL+ LD+S NS++
Sbjct: 339 TVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSW 397
Query: 226 LSGVKFLNISLNKFTGFV 243
+ LN+S N T +
Sbjct: 398 TKSLLSLNMSSNILTDTI 415
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 42/245 (17%), Positives = 82/245 (33%), Gaps = 21/245 (8%)
Query: 48 PTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQ 107
P +L LN+S +S + + ++S+L + +S+N ++ F Q
Sbjct: 16 PKDL----SQK-TTILNISQNYISELWTSDI-LSLSKLRILIISHNRIQYLDISVFKFNQ 69
Query: 108 SLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSK---LMVLDV 164
L ++LS N+ I P +++ L+LS N F L +F L L +
Sbjct: 70 ELEYLDLSHNKL-VKISC------HPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 165 SNNDLRILP-SGFANLSKLRHLDISSCKISGNIKPVSF----LHSLKYLDVSNNSMNGTF 219
S L A+L+ + L + P SL + +N +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFIL 182
Query: 220 PSDFPPLSGVKFLNISLNKFTGFVGHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMP 279
++ ++ NI + + + + +T S I+
Sbjct: 183 DVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQ 242
Query: 280 HVDSS 284
V +
Sbjct: 243 LVWHT 247
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 29/240 (12%), Positives = 76/240 (31%), Gaps = 22/240 (9%)
Query: 10 LFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRN 69
+ L++ + + ++ + +T ++ + PTN + S
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTN-------KEFHFILDVSVK 187
Query: 70 LSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTS 129
+ ++ + E + + L S +L + + N F + +
Sbjct: 188 TVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHT 247
Query: 130 RNGPFPSVQVLNLSSNRFTNLVKLSQFS-------KLMVLDVSNNDLRILPSG-FANLSK 181
+V ++S+ + + F L + V ++ S + S
Sbjct: 248 ------TVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSN 301
Query: 182 LRHLDISSCKISGNIKPV-SFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
+ + + S + +LD SNN + T + L+ ++ L + +N+
Sbjct: 302 MNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK 361
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 32/222 (14%), Positives = 65/222 (29%), Gaps = 41/222 (18%)
Query: 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWF-------------- 103
++ L+LS + K NMS+L + LS L+ S
Sbjct: 90 VNLKHLDLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGE 149
Query: 104 -------------WSTQSLTQVNLSKNRF-------GGTIGFKPTSRNGPFPSVQVLNLS 143
++T+SL V + F T+ S +
Sbjct: 150 TYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYF 209
Query: 144 SNRFTNLVKLSQFSKLMVLDVSNNDLRIL-PSGFANLSKLRHLDISSCKISGNIKPVSF- 201
+ L + S L + ++ + + + + IS+ K+ G + F
Sbjct: 210 LSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFD 269
Query: 202 -----LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNK 238
L +L V ++ + S + N +++
Sbjct: 270 YSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSG 311
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 25/152 (16%), Positives = 58/152 (38%), Gaps = 19/152 (12%)
Query: 2 KIFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPS---- 57
+ L L +L L K+ +++ + + + + +++
Sbjct: 342 ENCGHLTELETLIL-----QMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCS 396
Query: 58 --TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLS 115
+ LN+SS L+ I + +DL +N +K S+P ++L ++N++
Sbjct: 397 WTKSLLSLNMSSNILTDTIFRCLPPR---IKVLDLHSNKIK-SIPKQVVKLEALQELNVA 452
Query: 116 KNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRF 147
N+ + P S+Q + L +N +
Sbjct: 453 SNQ----LKSVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 3e-18
Identities = 75/329 (22%), Positives = 117/329 (35%), Gaps = 103/329 (31%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG--------ELHVAIKVL-DNAKGIDHDDAVAMFDELS 458
GK L EG G V A G + VA+K+L D+A D D + E+
Sbjct: 84 TLGKP--LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSD---LVSEME 138
Query: 459 RLK----HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDH 514
+K H N++ L G C V++E+ + G+L +L ++D
Sbjct: 139 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRA------RRPPGMEYSYDI 192
Query: 515 HPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAG 574
+ ++ + +ARG+ YL H L ++L+ E+ KIA
Sbjct: 193 NRVPEEQMTFKDLV------SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIAD 246
Query: 575 FGL-RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLTGKR 615
FGL R+I N + + T G PE SDV+ FGV++ E+ T
Sbjct: 247 FGLARDI---NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT--- 300
Query: 616 GTDDCVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL---------- 661
LG G V E+ + L+ G+
Sbjct: 301 ---------------------------LGGSPYPGIPVEELFKLLKEGHRMDKPANCTNE 333
Query: 662 -------CTADSPGKRPTMQQVLGLLKDI 683
C P +RPT +Q++ L I
Sbjct: 334 LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 362
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 68/316 (21%), Positives = 112/316 (35%), Gaps = 77/316 (24%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL 460
GK L G G V A G VA+K+L + A +H + EL L
Sbjct: 30 KLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA---LMSELKIL 84
Query: 461 K----HPNLLPLAGYC-IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHH 515
H N++ L G C G +V++EF G+L +L +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV------APE 138
Query: 516 PGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGF 575
++ + VA+G+ +L H L +ILL+E KI F
Sbjct: 139 DLYKDFLTLEHLI------CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 192
Query: 576 GL-RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLT---- 612
GL R+I R + PE SDV+ FGV+L E+ +
Sbjct: 193 GLARDIYKDPDYVRKGD---ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
Query: 613 ---GKRGTDDCVKWVRKLVKEGAGGDALDFRLK--LGSGDSVAEMVESLRVGYLCTADSP 667
G + ++ + +KEG R++ + + + + C P
Sbjct: 250 PYPGVKIDEE----FCRRLKEG-------TRMRAPDYTTPEMYQTMLD------CWHGEP 292
Query: 668 GKRPTMQQVLGLLKDI 683
+RPT +++ L ++
Sbjct: 293 SQRPTFSELVEHLGNL 308
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 77/312 (24%), Positives = 119/312 (38%), Gaps = 72/312 (23%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL 460
FGK L G G V A G L VA+K+L A D+ A+ EL +
Sbjct: 49 QFGKT--LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA---HADEKEALMSELKIM 103
Query: 461 K----HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHP 516
H N++ L G C G LV+ E+ GDL +L +T
Sbjct: 104 SHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSR--------VLETDPAFA 155
Query: 517 GAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
A S S+ + + VA+G+A+L H + ++LL KI FG
Sbjct: 156 IANSTASTRDLL------HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFG 209
Query: 577 L-RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLT-GKR- 615
L R+I + N PE SDV+ +G++L E+ + G
Sbjct: 210 LARDIMNDSNYIVKGN---ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266
Query: 616 --GTDDCVKWVRKLVKEGAGGDALDFRLK--LGSGDSVAEMVESLRVGYLCTADSPGKRP 671
G K KLVK+G +++ + ++ ++++ C A P RP
Sbjct: 267 YPGILVNSK-FYKLVKDG-------YQMAQPAFAPKNIYSIMQA------CWALEPTHRP 312
Query: 672 TMQQVLGLLKDI 683
T QQ+ L++
Sbjct: 313 TFQQICSFLQEQ 324
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 5e-18
Identities = 79/329 (24%), Positives = 117/329 (35%), Gaps = 103/329 (31%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG--------ELHVAIKVL-DNAKGIDHDDAVAMFDELS 458
GK L EG G V A G VA+K+L +A D D + E+
Sbjct: 72 VLGKP--LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD---LISEME 126
Query: 459 RLK----HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDH 514
+K H N++ L G C V++E+ + G+L +L P ++S +
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAR---RPPGLEYSYNP--- 180
Query: 515 HPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAG 574
+SS + A VARG+ YL H L ++L+ E KIA
Sbjct: 181 SHNPEEQLSSKDLV------SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 234
Query: 575 FGL-RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLTGKR 615
FGL R+I + + + T G PE SDV+ FGV+L E+ T
Sbjct: 235 FGLARDI---HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT--- 288
Query: 616 GTDDCVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL---------- 661
LG G V E+ + L+ G+
Sbjct: 289 ---------------------------LGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNE 321
Query: 662 -------CTADSPGKRPTMQQVLGLLKDI 683
C P +RPT +Q++ L I
Sbjct: 322 LYMMMRDCWHAVPSQRPTFKQLVEDLDRI 350
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 5e-18
Identities = 38/231 (16%), Positives = 87/231 (37%), Gaps = 28/231 (12%)
Query: 24 NSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMS 83
+ + +++++ + T++ G T + +L +S N++ + L +
Sbjct: 30 MQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNITTLD----LSQNT 85
Query: 84 ELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPT-------SRN----- 131
L + +N L ++ LT +N N+ + +RN
Sbjct: 86 NLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKLDVSQNPLLTYLNCARNTLTEI 142
Query: 132 --GPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISS 189
+ L+ N+ + ++ ++L LD S N + L + L L+ +
Sbjct: 143 DVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITELD--VSQNKLLNRLNCDT 200
Query: 190 CKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
I+ + ++ L +LD S+N + D PL+ + + + S+N T
Sbjct: 201 NNIT-KL-DLNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFDCSVNPLT 246
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 40/180 (22%), Positives = 70/180 (38%), Gaps = 17/180 (9%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
++ + + ++ L S+D N+S+ + G LT++ + N
Sbjct: 21 ASEVAAAFEMQATDTI-SEEQLATLTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNN-- 75
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
I S+N ++ L SN+ TNL ++ +KL L+ N L L +
Sbjct: 76 --ITTLDLSQN---TNLTYLACDSNKLTNL-DVTPLTKLTYLNCDTNKLTKLD--VSQNP 127
Query: 181 KLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
L +L+ + ++ I VS L LD N D P + + L+ S NK T
Sbjct: 128 LLTYLNCARNTLT-EI-DVSHNTQLTELDCHLN--KKITKLDVTPQTQLTTLDCSFNKIT 183
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 2e-10
Identities = 24/241 (9%), Positives = 66/241 (27%), Gaps = 24/241 (9%)
Query: 4 FCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIREL 63
L L + EL S ++T + ++ ++ +T +
Sbjct: 229 VTPLTQLTYFDC-------SVNPLTELDVSTLSKLTTLHCIQTDLLEIDLTH-NTQLIYF 280
Query: 64 NLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTI 123
+ + + ++L+ +D + + L + L+ +
Sbjct: 281 QAEGCRKIKELD---VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-EL 333
Query: 124 GFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLR 183
++ L+ + + + + L + +P + L
Sbjct: 334 DV------SHNTKLKSLSCVNAHIQDFSSVGKIPALNNNFEAEGQTITMPKETLTNNSL- 386
Query: 184 HLDISSCKISGNIKPVSFL-HSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
+ +S + P++ D + N++ S P F + + G
Sbjct: 387 TIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSEN-GAIVGT 445
Query: 243 V 243
V
Sbjct: 446 V 446
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 8e-08
Identities = 16/103 (15%), Positives = 35/103 (33%), Gaps = 6/103 (5%)
Query: 138 QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIK 197
+ + F + F+ + + L+ L LD + I+ ++
Sbjct: 2 TLKAGQTQSFNDWFPDDNFASEVAAAFEMQATDTIS--EEQLATLTSLDCHNSSIT-DMT 58
Query: 198 PVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
+ L L L ++N++ D + + +L NK T
Sbjct: 59 GIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT 98
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 8e-18
Identities = 65/335 (19%), Positives = 101/335 (30%), Gaps = 124/335 (37%)
Query: 415 LAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDD----AVAMFDELSRLKHP 463
L G G VY + G L VA+K L + D D A+ + S+ H
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII----SKFNHQ 93
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ G + + +L+E MA GDL +L E P S ++
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET---------------RPRPSQPSSLA 138
Query: 524 SPEKTNWVTRHRIAIGVARGLAYL---HHVGSTHGH--------LVTSSILLAESLEPKI 572
+ + +A +A G YL H + H L+T KI
Sbjct: 139 MLDLLH------VARDIACGCQYLEENHFI-----HRDIAARNCLLTCP---GPGRVAKI 184
Query: 573 AGFGL-RNIGVKNVGERSENET------CGPE----------SDVYCFGVILMELLTGKR 615
FG+ R+I + R PE +D + FGV+L E+ +
Sbjct: 185 GDFGMARDIYRASY-YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS--- 240
Query: 616 GTDDCVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL---------- 661
LG S E++E + G
Sbjct: 241 ---------------------------LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGP 273
Query: 662 -------CTADSPGKRPTMQQVLGLLKDIRPSADL 689
C P RP +L ++ D+
Sbjct: 274 VYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDV 308
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 84.7 bits (209), Expect = 8e-18
Identities = 35/301 (11%), Positives = 66/301 (21%), Gaps = 43/301 (14%)
Query: 408 HFGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKH 462
L G V+ V E A+KV + + + +RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLE-DFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNV----EDWSTDTWDHHPGA 518
+ + + N S D
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLR 578
+ H + + R A L G HGH ++ + +
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA- 240
Query: 579 NIGVKNVGERSENETCGP------------------ESDVYCFGVILMELLTGK----RG 616
+ VG R + P + + G+ + +
Sbjct: 241 ---LWKVGTRGP-ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296
Query: 617 TDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQV 676
T ++ G D+L F D V ++ L +R +
Sbjct: 297 TPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRF----LNF--DRRRRLLPLEA 350
Query: 677 L 677
+
Sbjct: 351 M 351
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 9e-18
Identities = 63/326 (19%), Positives = 100/326 (30%), Gaps = 112/326 (34%)
Query: 415 LAEGRCGPVYRAVLPG----ELHVAIKVL--DNAKGIDHDDAVAMFDELSRLKHPNLLPL 468
L EG G V L L VA+K + DN+ + ++ ++ + HPN++ L
Sbjct: 42 LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 469 AGYC-----IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
G C + +V+L FM GDLH +L HI
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS----------------RLETGPKHIP 145
Query: 524 SPEKTNWVTRHRIAIGVARGLAYL---HHVGSTHGHLVTSSILLAESLEPKIAGFGL-RN 579
+ + +A G+ YL + + H L + +L + + +A FGL +
Sbjct: 146 LQTLL------KFMVDIALGMEYLSNRNFL---HRDLAARNCMLRDDMTVCVADFGLSKK 196
Query: 580 IGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLTGKRGTDDCV 621
I + + E SDV+ FGV + E+ T
Sbjct: 197 IYSGDYYRQGRI---AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT--------- 244
Query: 622 KWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL---------------- 661
G G EM + L G+
Sbjct: 245 ---------------------RGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMY 283
Query: 662 -CTADSPGKRPTMQQVLGLLKDIRPS 686
C P RPT + L+ + S
Sbjct: 284 SCWRTDPLDRPTFSVLRLQLEKLLES 309
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 62/323 (19%), Positives = 95/323 (29%), Gaps = 85/323 (26%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPG-----ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL 460
+ K L EG G V VA+K L +A D L L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 461 KHPNLLPLAGYCIAGKEK--LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA 518
H +++ G C +++E++ G L +L
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR---------------------- 128
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL- 577
I + + A + G+AYLH H L ++LL KI FGL
Sbjct: 129 -HSIGLAQLLLF------AQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
Query: 578 RNIGVKNVGERSENET------CGPE----------SDVYCFGVILMELLT-GKRGTDDC 620
+ + + R + PE SDV+ FGV L ELLT
Sbjct: 182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGY-----------------LCT 663
K++ + +V + E L G C
Sbjct: 242 TKFLELIGIA-------------QGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCW 288
Query: 664 ADSPGKRPTMQQVLGLLKDIRPS 686
RPT + ++ +LK +
Sbjct: 289 ETEASFRPTFENLIPILKTVHEK 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 42/200 (21%), Positives = 80/200 (40%), Gaps = 21/200 (10%)
Query: 54 SNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVN 113
S + ++ L+LS+ ++ IS L+ L ++ L++N + F S SL ++
Sbjct: 48 SGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLD 106
Query: 114 LSKNRFGGTIGFKPTS-RNGPF---PSVQVLNLSSNRFTNLVKLSQFSKLMVLDV----S 165
LS N ++ + F S+ LNL N + L + S FS L L + +
Sbjct: 107 LSYNYL--------SNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGN 158
Query: 166 NNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSD 222
+ + FA L+ L L+I + + + +P S + ++ +L +
Sbjct: 159 MDTFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIF 217
Query: 223 FPPLSGVKFLNISLNKFTGF 242
S V+ L + F
Sbjct: 218 VDVTSSVECLELRDTDLDTF 237
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 5e-15
Identities = 34/179 (18%), Positives = 71/179 (39%), Gaps = 11/179 (6%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ L L+S ++ I F ++ L +DLS N L WF SLT +NL N +
Sbjct: 79 QALVLTSNGINTIEEDSF-SSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPY- 136
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSN-RFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-F 176
TS +Q+L + + FT + + + + L L++ +DL+
Sbjct: 137 --KTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSL 194
Query: 177 ANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLN 233
++ + HL + + + + S++ L++ + ++ S+ +
Sbjct: 195 KSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIK 252
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 21/147 (14%), Positives = 49/147 (33%), Gaps = 17/147 (11%)
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138
++ L +++ + L+ P S Q+++ + L + SV+
Sbjct: 170 FAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQ----HILLLEIFVDVTSSVE 225
Query: 139 VLNLSSNRFTNL----------VKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDIS 188
L L L + + +++ L + +S L L+ S
Sbjct: 226 CLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLLNQISGLLELEFS 285
Query: 189 SCKISGNIKPVSF--LHSLKYLDVSNN 213
++ ++ F L SL+ + + N
Sbjct: 286 RNQLK-SVPDGIFDRLTSLQKIWLHTN 311
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 65/314 (20%), Positives = 103/314 (32%), Gaps = 82/314 (26%)
Query: 415 LAEGRCGPVYRAVLPG------ELHVAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLLP 467
L G G VY + G L VA+K L + D D + +S+ H N++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
G + + +LLE MA GDL +L E P S ++ +
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRET---------------RPRPSQPSSLAMLDL 183
Query: 528 TNWVTRHRIAIGVARGLAYL---HHVGSTHGHLVTSSILL---AESLEPKIAGFGL-RNI 580
+ +A +A G YL H + H + + LL KI FG+ R+I
Sbjct: 184 LH------VARDIACGCQYLEENHFI---HRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 581 GVKNVGERSENET------CGPE----------SDVYCFGVILMELLT-------GKRGT 617
+ R PE +D + FGV+L E+ + K
Sbjct: 235 -YRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293
Query: 618 DDCVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQ 675
+ V + V G R+ V ++ C P RP
Sbjct: 294 E-----VLEFVTSG-------GRMDPPKNCPGPVYRIMTQ------CWQHQPEDRPNFAI 335
Query: 676 VLGLLKDIRPSADL 689
+L ++ D+
Sbjct: 336 ILERIEYCTQDPDV 349
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-17
Identities = 30/232 (12%), Positives = 78/232 (33%), Gaps = 46/232 (19%)
Query: 14 SLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGI 73
+ + +Q N D + + + + + +N + + L++ N++ +
Sbjct: 6 TGLKASQDNVNIPDSTFKAYLNGLLGQSSTANITEAQMNS------LTYITLANINVTDL 59
Query: 74 ISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGP 133
+ + + ++N P +L ++ +
Sbjct: 60 ---TGIEYAHNIKDLTINNIHATNYNP--ISGLSNLERLRIMGK---------------- 98
Query: 134 FPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRIL-PSGFANLSKLRHLDISSCKI 192
+++S++ NL L+ L +LD+S++ + L K+ +D+S
Sbjct: 99 -------DVTSDKIPNLSGLT---SLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGA 148
Query: 193 SGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSG---VKFLNISLNKFTG 241
+I P+ L LK L++ + + D+ + + L G
Sbjct: 149 ITDIMPLKTLPELKSLNIQFDGV-----HDYRGIEDFPKLNQLYAFSQTIGG 195
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 56/321 (17%), Positives = 94/321 (29%), Gaps = 79/321 (24%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPG-----ELHVAIKVLDNAKGIDHDDAVAMFDELSRLK 461
H L +G G V VA+K L ++ D + L L+
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 462 HPNLLPLAGYCIAGKEKLVLL--EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
H N++ G C + + + L E++ G L +L
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---------------------QKHK 139
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-R 578
I + + + +G+ YL H L T +IL+ KI FGL +
Sbjct: 140 ERIDHIKLLQY------TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193
Query: 579 NIGVKNVGERSENET------CGPE----------SDVYCFGVILMELLTGKRGTDDCVK 622
+ + + PE SDV+ FGV+L EL T
Sbjct: 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSP 251
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGY------LCTAD----------- 665
+ G V ++E L+ C +
Sbjct: 252 PAEFMRMIGNDKQG---------QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNN 302
Query: 666 SPGKRPTMQQVLGLLKDIRPS 686
+ +RP+ + + + IR
Sbjct: 303 NVNQRPSFRDLALRVDQIRDQ 323
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-17
Identities = 64/325 (19%), Positives = 100/325 (30%), Gaps = 115/325 (35%)
Query: 415 LAEGRCGPVYRAVLPG----ELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLP 467
L +G G V A L + VA+K+L A I D E + HP++
Sbjct: 31 LGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 468 LAGYCI------AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521
L G + +V+L FM +GDLH +L +
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS----------------RIGENPFN 133
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYL---HHVGSTHGHLVTSSILLAESLEPKIAGFGL- 577
+ R + +A G+ YL + + H L + +LAE + +A FGL
Sbjct: 134 LPLQTLV------RFMVDIACGMEYLSSRNFI---HRDLAARNCMLAEDMTVCVADFGLS 184
Query: 578 RNIGVKNVGERSENETCG--------PE----------SDVYCFGVILMELLTGKRGTDD 619
R I + + E SDV+ FGV + E++T
Sbjct: 185 RKIYSGDYYRQGCA---SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT------- 234
Query: 620 CVKWVRKLVKEGAGGDALDFRLKLGS----GDSVAEMVESLRVGYL-------------- 661
G G AE+ L G
Sbjct: 235 -----------------------RGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDL 271
Query: 662 ---CTADSPGKRPTMQQVLGLLKDI 683
C + P +RP+ + L++I
Sbjct: 272 MYQCWSADPKQRPSFTCLRMELENI 296
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 50/316 (15%), Positives = 99/316 (31%), Gaps = 99/316 (31%)
Query: 415 LAEGRCGPVYRAVL--------PGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHP 463
L +G +++ V E V +KVLD A + + + F+ +S+L H
Sbjct: 16 LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMSKLSHK 72
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
+L+ G C+ G E +++ EF+ G L +L + + I+
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK---------------------NKNCIN 111
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP--------KIAGF 575
K A +A + +L HG++ +ILL + K++
Sbjct: 112 ILWKLEV------AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165
Query: 576 GL-RNIGVKNVGERSENET-----CGPE-----------SDVYCFGVILMELLT------ 612
G+ + + PE +D + FG L E+ +
Sbjct: 166 GISITV------LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPL 219
Query: 613 -GKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAE-MVESLRVGYLCTADSPGKR 670
+ ++ +L +A + C P R
Sbjct: 220 SALDSQR-----KLQFYEDR-------HQLPAPKAAELANLINN-------CMDYEPDHR 260
Query: 671 PTMQQVLGLLKDIRPS 686
P+ + ++ L +
Sbjct: 261 PSFRAIIRDLNSLFTP 276
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 3e-17
Identities = 39/193 (20%), Positives = 74/193 (38%), Gaps = 10/193 (5%)
Query: 28 QELVSKAFSSVSTFNISWLKPTNLNG-----SNPSTPIRELNLSSRNLSGIISWKFLRNM 82
+S + NI L ++ + LN + + + +
Sbjct: 318 LFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGC-STL 376
Query: 83 SELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNL 142
L ++ L N LK + T++++ + S+ VLNL
Sbjct: 377 KRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNL 435
Query: 143 SSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF- 201
SSN T V K+ VLD+ NN + +P +L L+ L+++S ++ ++ F
Sbjct: 436 SSNMLTGSVFRCLPPKVKVLDLHNNRIMSIPKDVTHLQALQELNVASNQLK-SVPDGVFD 494
Query: 202 -LHSLKYLDVSNN 213
L SL+Y+ + +N
Sbjct: 495 RLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 36/207 (17%), Positives = 76/207 (36%), Gaps = 13/207 (6%)
Query: 40 TFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSV 99
T + + ++ ++ + +E++ LS +
Sbjct: 287 TITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALY-SVFAEMNIKMLSISDTPFIH 345
Query: 100 PGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLS-QFSK 158
S S T +N ++N F ++ ++ +Q L L N N K++
Sbjct: 346 MVCPPSPSSFTFLNFTQNVFTDSVFQGCST----LKRLQTLILQRNGLKNFFKVALMTKN 401
Query: 159 LMVLDVSNNDLRILPSG-----FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNN 213
+ L+ + L L S A + L++SS ++G++ +K LD+ NN
Sbjct: 402 MSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFR-CLPPKVKVLDLHNN 460
Query: 214 SMNGTFPSDFPPLSGVKFLNISLNKFT 240
+ + P D L ++ LN++ N+
Sbjct: 461 RIM-SIPKDVTHLQALQELNVASNQLK 486
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 5e-12
Identities = 51/279 (18%), Positives = 95/279 (34%), Gaps = 33/279 (11%)
Query: 9 LLFSLSLVVLAQSTCNSKDQ-ELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSS 67
+L + + + + + ++ + V P +L P + L+LS
Sbjct: 16 CALALIVGSMTPFSNELESMVDYSNRNLTHV---------PKDL----PPR-TKALSLSQ 61
Query: 68 RNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKP 127
++S + +SEL + LS+N ++ F Q L +++S NR I
Sbjct: 62 NSISELRMPDI-SFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRL-QNISC-- 117
Query: 128 TSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLM---VLDVSNNDLRILP-SGFANLS-KL 182
P S++ L+LS N F L +F L L +S R L A+L
Sbjct: 118 ----CPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSC 173
Query: 183 RHLDISSCKISGNIKPVSFLHSLKYLDV---SNNSMNGTFPSDFPPLSGVKFLNISLNKF 239
LD+ S I G + + L + N+ + L ++ NI LN
Sbjct: 174 ILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDE 233
Query: 240 TGFVGHDKYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIM 278
+ + + + +T + +
Sbjct: 234 NCQRLMTFLSELTRGPTLL--NVTLQHIETTWKCSVKLF 270
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 5e-11
Identities = 34/242 (14%), Positives = 74/242 (30%), Gaps = 24/242 (9%)
Query: 25 SKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNL--------SGIISW 76
+ + SV+ L LN N + L+ +R +W
Sbjct: 204 HPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTW 263
Query: 77 KFLRNM------SELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGT-IGFKPTS 129
K + + +++ N ++ + ++ +L F +
Sbjct: 264 KCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEA 323
Query: 130 RNGPFPSVQVLNLSSNRFTNLVKL--SQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLD 186
F + + LS + + + S L+ + N + L +L+ L
Sbjct: 324 LYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLI 383
Query: 187 ISSCKISGNIKPVSF-LHSLKYLDVSNNSMN----GTFPSDFPPLSGVKFLNISLNKFTG 241
+ + N V+ ++ L+ + S+N + + LN+S N TG
Sbjct: 384 LQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTG 442
Query: 242 FV 243
V
Sbjct: 443 SV 444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 3e-07
Identities = 32/241 (13%), Positives = 77/241 (31%), Gaps = 27/241 (11%)
Query: 12 SLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLS 71
++ + L+ + + S+ N + L S S + + +L
Sbjct: 165 PVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHL- 223
Query: 72 GIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRN 131
+L +I L++ + + + T+ T +N++ T +K + +
Sbjct: 224 ------------QLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETT--WKCSVKL 269
Query: 132 GPF---PSVQVLNLSSNRFTNLVKLSQFS-------KLMVLDVSNNDLRILPSG-FANLS 180
F V+ LN+ + T + +F+ LM+ V N ++ +
Sbjct: 270 FQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFA 329
Query: 181 KLRHLDISSCKISGNIKPVSF-LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKF 239
++ +S S +L+ + N + L ++ L + N
Sbjct: 330 EMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGL 389
Query: 240 T 240
Sbjct: 390 K 390
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 57/306 (18%), Positives = 102/306 (33%), Gaps = 89/306 (29%)
Query: 415 LAEGRCGPVYRAVL-----PGELHVAIKVL-DNAKGIDHDD----AVAMFDELSRLKHPN 464
L G G VY+ + ++ VAIK L + + + A M + + +P+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM----ASVDNPH 78
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
+ L G C+ +L+ + M G L ++ E +I S
Sbjct: 79 VCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE---------------------HKDNIGS 116
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVK 583
NW + +A+G+ YL H L ++L+ KI FGL + +G
Sbjct: 117 QYLLNW------CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-A 169
Query: 584 NVGERSENET------CGPE----------SDVYCFGVILMELLT-------GKRGTDDC 620
E E SDV+ +GV + EL+T G ++
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 227
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVL 677
+ ++++G RL V M + C RP ++++
Sbjct: 228 ---ISSILEKG-------ERLPQPPICTIDVYMIMRK-------CWMIDADSRPKFRELI 270
Query: 678 GLLKDI 683
+
Sbjct: 271 IEFSKM 276
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 56/319 (17%), Positives = 94/319 (29%), Gaps = 79/319 (24%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPG-----ELHVAIKVLDNAKGIDHDDAVAMFDELSRLK 461
H L +G G V VA+K L ++ D + L L+
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 462 HPNLLPLAGYCIAGKEKLVLL--EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
H N++ G C + + + L E++ G L +L
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL---------------------QKHK 108
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-R 578
I + + + +G+ YL H L T +IL+ KI FGL +
Sbjct: 109 ERIDHIKLLQY------TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162
Query: 579 NIGVKNVGERSENET------CGPE----------SDVYCFGVILMELLTGKRGTDDCVK 622
+ + + PE SDV+ FGV+L EL T
Sbjct: 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSP 220
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGY------LCTAD----------- 665
+ G V ++E L+ C +
Sbjct: 221 PAEFMRMIGNDKQG---------QMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNN 271
Query: 666 SPGKRPTMQQVLGLLKDIR 684
+ +RP+ + + + IR
Sbjct: 272 NVNQRPSFRDLALRVDQIR 290
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 4e-17
Identities = 67/345 (19%), Positives = 115/345 (33%), Gaps = 92/345 (26%)
Query: 383 SAAVIMCSKPLVNYLTFKDLIAATSHFGKE---------SLLAEGRCGPVYRAVL----- 428
+ D A F E ++ G G VY+ +L
Sbjct: 11 DYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSG 70
Query: 429 PGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485
E+ VAIK L G V E + + H N++ L G K +++ E+M
Sbjct: 71 KKEVPVAIKTL--KAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128
Query: 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLA 545
NG L ++L E G S + G+A G+
Sbjct: 129 ENGALDKFLRE------------------KDG---EFSVLQLVGM------LRGIAAGMK 161
Query: 546 YLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENET------CGPE- 597
YL ++ H L +IL+ +L K++ FGL R + + + PE
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 598 ---------SDVYCFGVILMELLT-------GKRGTDDCVKWVRKLVKEGAGGDALDFRL 641
SDV+ FG+++ E++T + V K + +G FRL
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE-----VMKAINDG-------FRL 269
Query: 642 KLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
++ + M++ C +RP ++ +L +
Sbjct: 270 PTPMDCPSAIYQLMMQ-------CWQQERARRPKFADIVSILDKL 307
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 70/307 (22%), Positives = 108/307 (35%), Gaps = 88/307 (28%)
Query: 415 LAEGRCGPVYRAVL----PGELHVAIKVL-DNAKGIDHDD----AVAMFDELSRLKHPNL 465
+ +G G VY + AIK L + + + M L HPN+
Sbjct: 29 IGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM----RGLNHPNV 84
Query: 466 LPLAGYCIAGKE-KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
L L G + + VLL +M +GDL +++ P P V+D
Sbjct: 85 LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDL----------------- 126
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVK 583
+ VARG+ YL H L + +L ES K+A FGL R+I +
Sbjct: 127 ---------ISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR 177
Query: 584 NVGERSENETCG--------PE----------SDVYCFGVILMELLT-------GKRGTD 618
+ E SDV+ FGV+L ELLT D
Sbjct: 178 EY-YSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
Query: 619 DCVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQV 676
+ + +G RL DS+ ++++ C P RPT + +
Sbjct: 237 -----LTHFLAQG-------RRLPQPEYCPDSLYQVMQQ------CWEADPAVRPTFRVL 278
Query: 677 LGLLKDI 683
+G ++ I
Sbjct: 279 VGEVEQI 285
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 1e-16
Identities = 59/320 (18%), Positives = 101/320 (31%), Gaps = 83/320 (25%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPG-----ELHVAIKVL-DNAKGIDHDDAVAMFDELSRL 460
+ L EG G V VA+K L + G D + L L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 461 KHPNLLPLAGYCIAGKEKLVLL--EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA 518
H N++ G C + L EF+ +G L +L P
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL---------------------PKN 119
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL- 577
+ I+ ++ + A+ + +G+ YL H L ++L+ + KI FGL
Sbjct: 120 KNKINLKQQLKY------AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLT 173
Query: 578 RNIGVKNVGERSENET------CGPE----------SDVYCFGVILMELLT-GKRGTDDC 620
+ I +++ PE SDV+ FGV L ELLT +
Sbjct: 174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPM 233
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGY-----------------LCT 663
+++ + +V +V +L+ G C
Sbjct: 234 ALFLKMIGPT-------------HGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCW 280
Query: 664 ADSPGKRPTMQQVLGLLKDI 683
P R + Q ++ + +
Sbjct: 281 EFQPSNRTSFQNLIEGFEAL 300
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-16
Identities = 65/306 (21%), Positives = 107/306 (34%), Gaps = 80/306 (26%)
Query: 412 ESLLAEGRCGPVYRAVLPG----ELHVAIKVL-DNAKGIDHDDAVAMFDELSRLKHPNLL 466
++ G G VY L ++H A+K L + + + HPN+L
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153
Query: 467 PLAGYCIAGKEK-LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
L G C+ + LV+L +M +GDL ++ T P V+D
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKD------------------- 193
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN 584
+ VA+G+ +L H L + +L E K+A FGL R++ K
Sbjct: 194 -------LIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246
Query: 585 VGERSENETCG--------PE----------SDVYCFGVILMELLT-------GKRGTDD 619
+ N+T E SDV+ FGV+L EL+T D
Sbjct: 247 F-DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD- 304
Query: 620 CVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+ + +G RL D + E++ C RP+ +++
Sbjct: 305 ----ITVYLLQG-------RRLLQPEYCPDPLYEVMLK------CWHPKAEMRPSFSELV 347
Query: 678 GLLKDI 683
+ I
Sbjct: 348 SRISAI 353
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 38/187 (20%), Positives = 70/187 (37%), Gaps = 18/187 (9%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
L+L + ++S + + + L+++ L NN + F + L ++ +SKN
Sbjct: 56 TTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHL 114
Query: 120 GGTIGFKPTS-RNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLR---ILP 173
S+ L + NR + K S + +++ N L P
Sbjct: 115 --------VEIPPNLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEP 166
Query: 174 SGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLN 233
F L KL +L IS K++ I P +L L + +N + D S + L
Sbjct: 167 GAFDGL-KLNYLRISEAKLT-GI-PKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLG 223
Query: 234 ISLNKFT 240
+ N+
Sbjct: 224 LGHNQIR 230
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 34/217 (15%), Positives = 69/217 (31%), Gaps = 50/217 (23%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSV--PGWFWSTQSLTQVNLSKNR 118
EL + + + F + ++ I++ N L+ S PG F L + +S+ +
Sbjct: 126 VELRIHDNRIRKVPKGVF-SGLRNMNCIEMGGNPLENSGFEPGAF-DGLKLNYLRISEAK 183
Query: 119 FGGTIGFKPTS-RNGPFPSVQVLNLSSNR--------FTNLVKLSQ-------------- 155
T ++ L+L N+ KL +
Sbjct: 184 L--------TGIPKDLPETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENG 235
Query: 156 -F---SKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF--------LH 203
L L + NN L +P+G +L L+ + + + I+ + F
Sbjct: 236 SLSFLPTLRELHLDNNKLSRVPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRA 294
Query: 204 SLKYLDVSNNSMNGTF--PSDFPPLSGVKFLNISLNK 238
+ + NN + P+ F ++ + K
Sbjct: 295 YYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 63/291 (21%), Positives = 110/291 (37%), Gaps = 64/291 (21%)
Query: 415 LAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCI 473
L G+ G VY V L VA+K L ++ ++ + + +KHPNL+ L G C
Sbjct: 228 LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 474 AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTR 533
++ EFM G+L +L E +S+
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRE--------------------CNRQEVSAVVLLY---- 322
Query: 534 HRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSENET 593
+A ++ + YL H +L + L+ E+ K+A FGL + +
Sbjct: 323 --MATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 380
Query: 594 C-----GPE----------SDVYCFGVILMELLT-GKR---GTDDCVKWVRKLVKEGAGG 634
PE SDV+ FGV+L E+ T G G D V +L+++
Sbjct: 381 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEKD--- 435
Query: 635 DALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+R++ G + V E++ + C +P RP+ ++ + +
Sbjct: 436 ----YRMERPEGCPEKVYELMRA------CWQWNPSDRPSFAEIHQAFETM 476
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 2e-16
Identities = 59/308 (19%), Positives = 102/308 (33%), Gaps = 82/308 (26%)
Query: 412 ESLLAEGRCGPVYRAVL---PGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNL 465
+ L G G V + V ++ VAIKVL +G + D M E + +L +P +
Sbjct: 15 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYI 72
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G C + ++++E G LH++L I
Sbjct: 73 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG---------------------KREEIPVS 110
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN 584
V+ G+ YL H L ++LL KI+ FGL + +G +
Sbjct: 111 NVAEL------LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164
Query: 585 VGERSENET------CGPE----------SDVYCFGVILMELLT-------GKRGTDDCV 621
+ + PE SDV+ +GV + E L+ +G +
Sbjct: 165 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE--- 221
Query: 622 KWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVLG 678
V +++G R++ + M + C RP V
Sbjct: 222 --VMAFIEQG-------KRMECPPECPPELYALMSD-------CWIYKWEDRPDFLTVEQ 265
Query: 679 LLKDIRPS 686
++ S
Sbjct: 266 RMRACYYS 273
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 52/231 (22%), Positives = 91/231 (39%), Gaps = 29/231 (12%)
Query: 29 ELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKF--LRNMSELH 86
L S ++ + + W K N + T I L+LS ++ +F +++
Sbjct: 186 RLSSITLQDMNEYWLGWEKCGNPFKN---TSITTLDLSGNGFKESMAKRFFDAIAGTKIQ 242
Query: 87 SIDLSN----------NSLKGSVPGWFW--STQSLTQVNLSKNRFGGTIGFKPTSRNGPF 134
S+ LSN + K F + +LSK++ I S F
Sbjct: 243 SLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSK----IFALLKSVFSHF 298
Query: 135 PSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCK 191
++ L L+ N + + L+ L++S N L + S F NL KL LD+S
Sbjct: 299 TDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNH 358
Query: 192 ISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSD-FPPLSGVKFLNISLNKF 239
I + SF L +LK L + N + + P F L+ ++ + + N +
Sbjct: 359 IR-ALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 9e-14
Identities = 34/163 (20%), Positives = 60/163 (36%), Gaps = 30/163 (18%)
Query: 83 SELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNL 142
+ ++ +DLS NS+ F Q L + + + G I
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVI------------------- 70
Query: 143 SSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKI-SGNIKPVS 200
+N F L L L + N L +G F L+ L L ++ C + +
Sbjct: 71 RNNTFRGLSSLII------LKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNF 124
Query: 201 F--LHSLKYLDVSNNSMNGTFPSD-FPPLSGVKFLNISLNKFT 240
F L SL+ L + +N++ P+ F + L+++ NK
Sbjct: 125 FKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK 167
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 46/234 (19%), Positives = 79/234 (33%), Gaps = 53/234 (22%)
Query: 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLK--------------------- 96
T + L L N+ I F NM H +DL+ N +K
Sbjct: 129 TSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLS 188
Query: 97 -------------GSVPGWFWSTQSLTQVNLSKNR---------FGGTIGFKPTSRNGPF 134
G + S+T ++LS N F G K S
Sbjct: 189 SITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSN 248
Query: 135 PSVQVLNLSSNRFTNLVKLS----QFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISS 189
+ F + + + S + D+S + + L F++ + L L ++
Sbjct: 249 SYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFALLKSVFSHFTDLEQLTLAQ 308
Query: 190 CKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSD-FPPLSGVKFLNISLNKFT 240
+I+ I +F L L L++S N + G+ S F L ++ L++S N
Sbjct: 309 NEIN-KIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDLSYNHIR 360
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 3e-16
Identities = 60/305 (19%), Positives = 105/305 (34%), Gaps = 92/305 (30%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDD----AVAMFDELSRLKHPNLLPLAG 470
L G+ G V G+ VA+K++ + D+ A M +L HP L+ G
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTM----MKLSHPKLVKFYG 70
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
C ++ E+++NG L +L G + +
Sbjct: 71 VCSKEYPIYIVTEYISNGCLLNYLRS---------------------HGKGLEPSQLLE- 108
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERS 589
+ V G+A+L H L + L+ L K++ FG+ R +
Sbjct: 109 -----MCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYV------LDD 157
Query: 590 ENETCG----------PE----------SDVYCFGVILMELLT-------GKRGTDDCVK 622
+ + PE SDV+ FG+++ E+ + ++
Sbjct: 158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE---- 213
Query: 623 WVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVLGL 679
V V +G RL D++ + M C + P KRPT QQ+L
Sbjct: 214 -VVLKVSQG-------HRLYRPHLASDTIYQIMYS-------CWHELPEKRPTFQQLLSS 258
Query: 680 LKDIR 684
++ +R
Sbjct: 259 IEPLR 263
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 58/318 (18%), Positives = 94/318 (29%), Gaps = 80/318 (25%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPG-----ELHVAIKVLDNAKGIDHDDAVAMFDELSRLK 461
H S L +G G V VA+K L ++ D L L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 462 HPNLLPLAGYCIAGKEKLVLL--EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
++ G + + L E++ +G L +L
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQR---------------------HR 121
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-R 578
+ + + + + + +G+ YL H L +IL+ KIA FGL +
Sbjct: 122 ARLDASRLLLY------SSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAK 175
Query: 579 NIGVKNVGERSENET------CGPE----------SDVYCFGVILMELLTGKRGTDDCVK 622
+ + PE SDV+ FGV+L EL T C
Sbjct: 176 LLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT--YCDKSCSP 233
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGY------LCTAD----------- 665
L G D +++ ++E L G C A+
Sbjct: 234 SAEFLRMMGCERDVP----------ALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAP 283
Query: 666 SPGKRPTMQQVLGLLKDI 683
SP RP+ + L +
Sbjct: 284 SPQDRPSFSALGPQLDML 301
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 6e-16
Identities = 67/294 (22%), Positives = 113/294 (38%), Gaps = 66/294 (22%)
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
E L +G G V+ G VAIK L + + + + +L+H L+ L
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 247
Query: 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWV 531
+ ++ E+M+ G L +L G ++ P+ +
Sbjct: 248 VS-EEPIYIVTEYMSKGSLLDFLKG--------------------ETGKYLRLPQLVDM- 285
Query: 532 TRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSE 590
A +A G+AY+ + H L ++IL+ E+L K+A FGL R I R
Sbjct: 286 -----AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
Query: 591 NET----CGPE----------SDVYCFGVILMELLT-GKR---GTDDCVKWVRKLVKEGA 632
+ PE SDV+ FG++L EL T G+ G + + V V+ G
Sbjct: 341 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG- 397
Query: 633 GGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+R+ +S+ + M + C P +RPT + + L+D
Sbjct: 398 ------YRMPCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDY 438
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 80.6 bits (198), Expect = 6e-16
Identities = 40/199 (20%), Positives = 74/199 (37%), Gaps = 15/199 (7%)
Query: 24 NSKDQELVSKAFSSVSTFNISWLKP-TNLNGS-NPSTPIRELNLSSRNLSGI---ISWKF 78
+S+ + ++ K + + + S ST ++ S + L + W
Sbjct: 326 DSQKECVLLKDRPECWCRDSATDEQLFRCELSVEKSTVLQSELESCKELQELEPENKWCL 385
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVN----LSKNRFGGTIGFKPTSRNGPF 134
L + + ++D + +L V+ + + + +
Sbjct: 386 LTIILLMRALDPLLYEKETL-----QYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEY 440
Query: 135 PSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISG 194
V+VL+L+ T L L Q + LD+S+N LR LP A L L L S +
Sbjct: 441 ADVRVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE- 499
Query: 195 NIKPVSFLHSLKYLDVSNN 213
N+ V+ L L+ L + NN
Sbjct: 500 NVDGVANLPRLQELLLCNN 518
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.0 bits (181), Expect = 7e-14
Identities = 32/173 (18%), Positives = 59/173 (34%), Gaps = 14/173 (8%)
Query: 44 SWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWF 103
W T + P+ + + S + + +R +D +
Sbjct: 382 KWCLLTIILLMRALDPLLYEKETLQYFSTLKAVDPMR----AAYLDDLRSKFLLENSVLK 437
Query: 104 WSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK-LSQFSKLMVL 162
+ ++L+ V L+LS NR L L+ L VL
Sbjct: 438 MEYADVRVLHLAHKDLTVLCHL------EQLLLVTHLDLSHNRLRALPPALAALRCLEVL 491
Query: 163 DVSNNDLRILPSGFANLSKLRHLDISSCKISG--NIKPVSFLHSLKYLDVSNN 213
S+N L + G ANL +L+ L + + ++ I+P+ L L++ N
Sbjct: 492 QASDNALENVD-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGN 543
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 64.0 bits (155), Expect = 8e-11
Identities = 27/161 (16%), Positives = 59/161 (36%), Gaps = 38/161 (23%)
Query: 55 NPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNL 114
+R L+L+ ++L+ + L + + +DLS+N L+ ++P
Sbjct: 438 MEYADVRVLHLAHKDLTVL---CHLEQLLLVTHLDLSHNRLR-ALPPAL----------- 482
Query: 115 SKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPS 174
++VL S N N+ ++ +L L + NN L+ +
Sbjct: 483 -----------------AALRCLEVLQASDNALENVDGVANLPRLQELLLCNNRLQQSAA 525
Query: 175 --GFANLSKLRHLDISS---CKISGNIKPV-SFLHSLKYLD 209
+ +L L++ C+ G + + L S+ +
Sbjct: 526 IQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSIL 566
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 77.6 bits (192), Expect = 7e-16
Identities = 46/218 (21%), Positives = 76/218 (34%), Gaps = 53/218 (24%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDD----AVAMFDELSRLKHPNLLPLAG 470
L G+ G V G+ VAIK++ + D+ A M L H L+ L G
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVM----MNLSHEKLVQLYG 86
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
C + ++ E+MANG L +L E + +
Sbjct: 87 VCTKQRPIFIITEYMANGCLLNYLRE---------------------MRHRFQTQQLLE- 124
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERS 589
+ V + YL H L + L+ + K++ FGL R + + + S
Sbjct: 125 -----MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV-LDDEYTSS 178
Query: 590 ENET-----CGPE----------SDVYCFGVILMELLT 612
PE SD++ FGV++ E+ +
Sbjct: 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYS 216
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 7e-16
Identities = 53/309 (17%), Positives = 103/309 (33%), Gaps = 82/309 (26%)
Query: 411 KESLLAEGRCGPVYRAVLPG---ELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPN 464
++ L G G V + VA+K+L + D + E + +L +P
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
++ + G C + ++++E G L+++L + H+
Sbjct: 80 IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQ----------------------NRHVKD 116
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVK 583
V+ G+ YL H L ++LL KI+ FGL + +
Sbjct: 117 KNIIEL------VHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 170
Query: 584 NVGERSENET------CGPE----------SDVYCFGVILMELLT-------GKRGTDDC 620
+++ PE SDV+ FGV++ E + G +G++
Sbjct: 171 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE-- 228
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVL 677
V ++++G R+ +G + + M C RP V
Sbjct: 229 ---VTAMLEKG-------ERMGCPAGCPREMYDLMNL-------CWTYDVENRPGFAAVE 271
Query: 678 GLLKDIRPS 686
L++
Sbjct: 272 LRLRNYYYD 280
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 61/303 (20%), Positives = 103/303 (33%), Gaps = 82/303 (27%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDD----AVAMFDELSRLKHPNLLPLAG 470
+ G+ G V+ + VAIK + + +D A M +L HP L+ L G
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVM----MKLSHPKLVQLYG 70
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
C+ ++ EFM +G L +L ++
Sbjct: 71 VCLEQAPICLVTEFMEHGCLSDYLRT---------------------QRGLFAAETLLG- 108
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERS 589
+ + V G+AYL H L + L+ E+ K++ FG+ R + + S
Sbjct: 109 -----MCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL-DDQYTSS 162
Query: 590 ENET-----CGPE----------SDVYCFGVILMELLT-------GKRGTDDCVKWVRKL 627
PE SDV+ FGV++ E+ + + ++ V +
Sbjct: 163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE-----VVED 217
Query: 628 VKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684
+ G FRL V + M C + P RP ++L L +I
Sbjct: 218 ISTG-------FRLYKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAEIA 263
Query: 685 PSA 687
S
Sbjct: 264 ESG 266
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 1e-15
Identities = 52/216 (24%), Positives = 84/216 (38%), Gaps = 43/216 (19%)
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
E L G+ G V+ A VA+K + + + +A + + L+H L+ L
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251
Query: 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWV 531
+ ++ EFMA G L +L GS P+ +
Sbjct: 252 VT-KEPIYIITEFMAKGSLLDFLKS--------------------DEGSKQPLPKLID-- 288
Query: 532 TRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSEN 591
+ +A G+A++ H L ++IL++ SL KIA FGL + N E
Sbjct: 289 ----FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
Query: 592 ET-----CGPE----------SDVYCFGVILMELLT 612
PE SDV+ FG++LME++T
Sbjct: 345 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVT 380
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 60/314 (19%), Positives = 109/314 (34%), Gaps = 89/314 (28%)
Query: 407 SHFGKESLLAEGRCGPVYRAVL-----PGELHVAIKVL-DNAKGIDHDD----AVAMFDE 456
+ K +L G G V++ V ++ V IKV+ D + +A+
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAI--- 69
Query: 457 LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHP 516
L H +++ L G C G ++ +++ G L + + H
Sbjct: 70 -GSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQ------------------HR 109
Query: 517 GAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
G + NW + +A+G+ YL G H +L ++LL + ++A FG
Sbjct: 110 G---ALGPQLLLNW------GVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFG 160
Query: 577 L-RNIGVKNVGERSENET------CGPE----------SDVYCFGVILMELLT------- 612
+ + + + +E E SDV+ +GV + EL+T
Sbjct: 161 VADLLPPDDK-QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA 219
Query: 613 GKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGK 669
G R + V L+++G RL V MV+ C
Sbjct: 220 GLRLAE-----VPDLLEKG-------ERLAQPQICTIDVYMVMVK-------CWMIDENI 260
Query: 670 RPTMQQVLGLLKDI 683
RPT +++ +
Sbjct: 261 RPTFKELANEFTRM 274
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 2e-15
Identities = 71/314 (22%), Positives = 101/314 (32%), Gaps = 80/314 (25%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPG----ELHVAIKVLDNAKGIDHDDAVAMFDE---LSR 459
L +G G V R + VA+K L + E +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 460 LKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
L H NL+ L G + K+V E G L L + H G
Sbjct: 78 LDHRNLIRLYGVVLTPPMKMVT-ELAPLGSLLDRLRK------------------HQG-- 116
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-R 578
H + + A+ VA G+ YL H L ++LLA KI FGL R
Sbjct: 117 -HFLLGTLSRY------AVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMR 169
Query: 579 NIGVKNVGERSENET------CGPE----------SDVYCFGVILMELLT-------GKR 615
+ + + C PE SD + FGV L E+ T G
Sbjct: 170 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 229
Query: 616 GTDDCVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPT 672
G+ + + K+ KEG RL + MV+ C A P RPT
Sbjct: 230 GSQ--I--LHKIDKEG-------ERLPRPEDCPQDIYNVMVQ-------CWAHKPEDRPT 271
Query: 673 MQQVLGLLKDIRPS 686
+ L + +P+
Sbjct: 272 FVALRDFLLEAQPT 285
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 78.4 bits (193), Expect = 3e-15
Identities = 41/205 (20%), Positives = 76/205 (37%), Gaps = 30/205 (14%)
Query: 36 SSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSL 95
+ + N+ T L P+ I L + NL+ + + EL ++++S N L
Sbjct: 40 NGNAVLNVGESGLTTLPDCLPAH-ITTLVIPDNNLTSLPA-----LPPELRTLEVSGNQL 93
Query: 96 KGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQ 155
S+P L+ + + L + N+ T+L
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTHLPALP-----------SGLCKLWIFGNQLTSLP--VL 139
Query: 156 FSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSM 215
L L VS+N L LP+ + L L + +++ ++ P+ L+ L VS+N +
Sbjct: 140 PPGLQELSVSDNQLASLPALPSE---LCKLWAYNNQLT-SL-PML-PSGLQELSVSDNQL 193
Query: 216 NGTFPSDFPPLSGVKFLNISLNKFT 240
+ P+ L L N+ T
Sbjct: 194 A-SLPTLPSEL---YKLWAYNNRLT 214
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 41/180 (22%), Positives = 66/180 (36%), Gaps = 32/180 (17%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ +L + S L + + N L S+P L ++++S N+
Sbjct: 107 SIFSNPLTHLPALPS--------GLCKLWIFGNQLT-SLPVLP---PGLQELSVSDNQL- 153
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
S + L +N+ T+L L S L L VS+N L LP+ + L
Sbjct: 154 -------ASLPALPSELCKLWAYNNQLTSLPML--PSGLQELSVSDNQLASLPTLPSELY 204
Query: 181 KLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
KL + + + LK L VS N + + P L K L +S N+ T
Sbjct: 205 KLWAYNNRLTSLP------ALPSGLKELIVSGNRLT-SLPVLPSEL---KELMVSGNRLT 254
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 6e-13
Identities = 25/135 (18%), Positives = 47/135 (34%), Gaps = 19/135 (14%)
Query: 108 SLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNN 167
+N+ ++ + P + + L + N T+L + +L L+VS N
Sbjct: 41 GNAVLNVGESG----LTTLP---DCLPAHITTLVIPDNNLTSL--PALPPELRTLEVSGN 91
Query: 168 DLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLS 227
L LP L +L + + L L + N + + P P L
Sbjct: 92 QLTSLPVLPPGLLELSIFSNPLTHLP------ALPSGLCKLWIFGNQLT-SLPVLPPGL- 143
Query: 228 GVKFLNISLNKFTGF 242
+ L++S N+
Sbjct: 144 --QELSVSDNQLASL 156
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 3e-12
Identities = 36/156 (23%), Positives = 64/156 (41%), Gaps = 21/156 (13%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+EL++S L+ + + SEL+ + NN L S+P L ++ +S NR
Sbjct: 184 QELSVSDNQLASLPT-----LPSELYKLWAYNNRLT-SLPA---LPSGLKELIVSGNR-- 232
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
+ P ++ L +S NR T+L L S L+ L V N L LP +LS
Sbjct: 233 --LTSLPVL----PSELKELMVSGNRLTSLPML--PSGLLSLSVYRNQLTRLPESLIHLS 284
Query: 181 KLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMN 216
+++ +S + + L + + +
Sbjct: 285 SETTVNLEGNPLS--ERTLQALREITSAPGYSGPII 318
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 57/309 (18%), Positives = 99/309 (32%), Gaps = 97/309 (31%)
Query: 415 LAEGRCGPVYRAVL----PGELHVAIKVL-DNAKGIDHDD----AVAMFDELSRLKHPNL 465
+ EG+ G V++ + L VAIK + + A+ M + HP++
Sbjct: 23 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTM----RQFDHPHI 78
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G +++E G+L +L +
Sbjct: 79 VKLIGVIT-ENPVWIIMELCTLGELRSFLQV---------------------RKYSLDLA 116
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN 584
+ A ++ LAYL H + ++L++ + K+ FGL R +
Sbjct: 117 SLILY------AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM---- 166
Query: 585 VGERSENETCG----------PE----------SDVYCFGVILMELLT-------GKRGT 617
E S PE SDV+ FGV + E+L G +
Sbjct: 167 --EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 224
Query: 618 DDCVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQ 674
D V ++ G RL + ++ M + C A P +RP
Sbjct: 225 D-----VIGRIENG-------ERLPMPPNCPPTLYSLMTK-------CWAYDPSRRPRFT 265
Query: 675 QVLGLLKDI 683
++ L I
Sbjct: 266 ELKAQLSTI 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 58/306 (18%), Positives = 103/306 (33%), Gaps = 89/306 (29%)
Query: 415 LAEGRCGPVYRAVL-----PGELHVAIKVL-DNAKGIDHDD----AVAMFDELSRLKHPN 464
L G G VY+ + ++ VAIK L + + + A M + + +P+
Sbjct: 23 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVM----ASVDNPH 78
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
+ L G C+ +L+ + M G L ++ E +I S
Sbjct: 79 VCRLLGICLTSTVQLIT-QLMPFGCLLDYVRE---------------------HKDNIGS 116
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVK 583
NW + +A+G+ YL H L ++L+ KI FGL + +G
Sbjct: 117 QYLLNW------CVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-A 169
Query: 584 NVGERSENET------CGPE----------SDVYCFGVILMELLT-------GKRGTDDC 620
E E SDV+ +GV + EL+T G ++
Sbjct: 170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-- 227
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVL 677
+ ++++G RL V MV+ C RP ++++
Sbjct: 228 ---ISSILEKG-------ERLPQPPICTIDVYMIMVK-------CWMIDADSRPKFRELI 270
Query: 678 GLLKDI 683
+
Sbjct: 271 IEFSKM 276
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 5e-15
Identities = 66/291 (22%), Positives = 112/291 (38%), Gaps = 66/291 (22%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIA 474
L +G G V+ G VAIK L + + + + +L+H L+ L
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS- 332
Query: 475 GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRH 534
+ ++ E+M+ G L +L G ++ P+ +
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKG--------------------ETGKYLRLPQLVDM---- 368
Query: 535 RIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENET 593
A +A G+AY+ + H L ++IL+ E+L K+A FGL R I R +
Sbjct: 369 --AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 426
Query: 594 ----CGPE----------SDVYCFGVILMELLT-GKR---GTDDCVKWVRKLVKEGAGGD 635
PE SDV+ FG++L EL T G+ G + + V V+ G
Sbjct: 427 PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG---- 480
Query: 636 ALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+R+ +S+ + M + C P +RPT + + L+D
Sbjct: 481 ---YRMPCPPECPESLHDLMCQ-------CWRKEPEERPTFEYLQAFLEDY 521
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 9e-15
Identities = 60/301 (19%), Positives = 101/301 (33%), Gaps = 72/301 (23%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDD----AVAMFDELSRLKH 462
+ +G G V G VA+K + A M ++L+H
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYRGN-KVAVKCI--KNDATAQAFLAEASVM----TQLRH 245
Query: 463 PNLLPLAGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521
NL+ L G + K L ++ E+MA G L +L S
Sbjct: 246 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--------------------RGRSV 285
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNI 580
+ ++ V + YL H L ++L++E K++ FGL +
Sbjct: 286 LGGDCLLK------FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339
Query: 581 GVKNVGERSENETCGPE----------SDVYCFGVILMELLT-GKR---GTDDCVKWVRK 626
+ + PE SDV+ FG++L E+ + G+ K V
Sbjct: 340 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVP 397
Query: 627 LVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
V++G +++ G +V + M C RPT Q+ L+ I
Sbjct: 398 RVEKG-------YKMDAPDGCPPAVYDVMKN-------CWHLDAATRPTFLQLREQLEHI 443
Query: 684 R 684
R
Sbjct: 444 R 444
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 76.5 bits (188), Expect = 1e-14
Identities = 49/224 (21%), Positives = 82/224 (36%), Gaps = 53/224 (23%)
Query: 412 ESLLAEGRCGPVYRAVLP---GELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNL 465
+ L G G V + V ++ VAIKVL +G + D M E + +L +P +
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVL--KQGTEKADTEEMMREAQIMHQLDNPYI 398
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G C + ++++E G LH++L I
Sbjct: 399 VRLIGVCQ-AEALMLVMEMAGGGPLHKFLVG---------------------KREEIPVS 436
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN 584
V+ G+ YL H +L ++LL KI+ FGL + +G +
Sbjct: 437 NVAEL------LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD 490
Query: 585 VGERSENET------CGPE----------SDVYCFGVILMELLT 612
+ + PE SDV+ +GV + E L+
Sbjct: 491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 1e-14
Identities = 65/313 (20%), Positives = 110/313 (35%), Gaps = 82/313 (26%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDD----AVAMFDELSRLKH 462
+ L G+ G VY V L VA+K L ++ ++ A M +KH
Sbjct: 16 TMKHK--LGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVM----KEIKH 68
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
PNL+ L G C ++ EFM G+L +L E +
Sbjct: 69 PNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE--------------------CNRQEV 108
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGV 582
S+ +A ++ + YL H L + L+ E+ K+A FGL +
Sbjct: 109 SAVVLLY------MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162
Query: 583 KNVGERSENET-----CGPE----------SDVYCFGVILMELLT-------GKRGTDDC 620
+ PE SDV+ FGV+L E+ T G +
Sbjct: 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-- 220
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQQVL 677
V +L+++ +R++ G + V E M C +P RP+ ++
Sbjct: 221 ---VYELLEKD-------YRMERPEGCPEKVYELMRA-------CWQWNPSDRPSFAEIH 263
Query: 678 GLLKDIRPSADLS 690
+ + + +S
Sbjct: 264 QAFETMFQESSIS 276
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 2e-14
Identities = 37/194 (19%), Positives = 68/194 (35%), Gaps = 37/194 (19%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ ++ + SEL L+ +L S+P +T + +++N
Sbjct: 40 ALPGENRNEAVSLLKECLINQFSEL---QLNRLNLS-SLPDNL--PPQITVLEITQNAL- 92
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL- 179
++ P S++ L+ NR + L + L LDV NN L +LP A L
Sbjct: 93 ISL---PEL----PASLEYLDACDNRLSTL--PELPASLKHLDVDNNQLTMLPELPALLE 143
Query: 180 ----------------SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDF 223
+ L L + + +++ SL+ LDVS N + + P+
Sbjct: 144 YINADNNQLTMLPELPTSLEVLSVRNNQLT---FLPELPESLEALDVSTNLLE-SLPAVP 199
Query: 224 PPLSGVKFLNISLN 237
+ I
Sbjct: 200 VRNHHSEETEIFFR 213
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 36/192 (18%), Positives = 65/192 (33%), Gaps = 27/192 (14%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
L+ LS + + ++ L D+ NN L +P L +N N+
Sbjct: 103 EYLDACDNRLSTL--PELPASLKHL---DVDNNQLT-MLPE---LPALLEYINADNNQL- 152
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
T S++VL++ +N+ T L +L L LDVS N L LP+
Sbjct: 153 -------TMLPELPTSLEVLSVRNNQLTFLPEL--PESLEALDVSTNLLESLPAVPVRNH 203
Query: 181 KLR----HLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNI 234
+I+ +I P + L + + +N ++ + +
Sbjct: 204 HSEETEIFFRCRENRIT-HI-PENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHG 261
Query: 235 SLNKFTGFVGHD 246
F+ G
Sbjct: 262 PRIYFSMSDGQQ 273
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 29/131 (22%), Positives = 50/131 (38%), Gaps = 12/131 (9%)
Query: 113 NLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKL---SQFSKLMVLDVSNNDL 169
+LS+N F TI + + L V L ++ L ++ +L
Sbjct: 12 SLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQFSELQLNRLNL 71
Query: 170 RILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGV 229
LP ++ L+I+ + P SL+YLD +N ++ T P L
Sbjct: 72 SSLPDNL--PPQITVLEITQNALISL--PEL-PASLEYLDACDNRLS-TLPELPASL--- 122
Query: 230 KFLNISLNKFT 240
K L++ N+ T
Sbjct: 123 KHLDVDNNQLT 133
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 61.9 bits (150), Expect = 4e-10
Identities = 26/181 (14%), Positives = 58/181 (32%), Gaps = 32/181 (17%)
Query: 49 TNLNGSN------PSTP--IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVP 100
L+ + P P ++ L++ + L+ + L I+ NN L +P
Sbjct: 103 EYLDACDNRLSTLPELPASLKHLDVDNNQLT-----MLPELPALLEYINADNNQLT-MLP 156
Query: 101 GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNL----VKLSQF 156
SL +++ N+ P S++ L++S+N +L V+
Sbjct: 157 E---LPTSLEVLSVRNNQLTFL----PEL----PESLEALDVSTNLLESLPAVPVRNHHS 205
Query: 157 SKLMV-LDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSM 215
+ + N + +P +L + + +S + L +
Sbjct: 206 EETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSS--RIRESLSQQTAQPDYHGPR 263
Query: 216 N 216
Sbjct: 264 I 264
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 20/167 (11%), Positives = 45/167 (26%), Gaps = 11/167 (6%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+N + L+ + + L + + NN L +P +SL +++S N
Sbjct: 143 EYINADNNQLTML-----PELPTSLEVLSVRNNQLT-FLPELP---ESLEALDVSTNLLE 193
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNL-VKLSQFSKLMVLDVSNNDLRILPSGFANL 179
++ P + + NR T++ + + + +N L +
Sbjct: 194 -SLPAVPVRNHHSEETEIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQ 252
Query: 180 SKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPL 226
+ D SD +
Sbjct: 253 QTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQSDVSQI 299
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 2e-14
Identities = 50/217 (23%), Positives = 84/217 (38%), Gaps = 51/217 (23%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDD----AVAMFDELSRLKHPNLLPLAG 470
L G+ G V+ G VA+K L + D A M +L+H L+ L
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLM----KQLQHQRLVRLYA 75
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
+ ++ E+M NG L +L +G ++ + +
Sbjct: 76 VVT-QEPIYIITEYMENGSLVDFLKT--------------------PSGIKLTINKLLD- 113
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSE 590
+A +A G+A++ H L ++IL++++L KIA FGL + N E
Sbjct: 114 -----MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 591 NET-----CGPE----------SDVYCFGVILMELLT 612
PE SDV+ FG++L E++T
Sbjct: 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVT 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 36/165 (21%), Positives = 67/165 (40%), Gaps = 14/165 (8%)
Query: 80 RNMSELHSIDLSNNSLKGSVP-GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138
++ ++ +L ++P T L +LS+N + + P+ +
Sbjct: 7 SKVASHLEVNCDKRNLT-ALPPDLPKDTTIL---HLSENL----LYTFSLATLMPYTRLT 58
Query: 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKP 198
LNL T L L LD+S+N L+ LP L L LD+S +++ ++
Sbjct: 59 QLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLT-SLPL 117
Query: 199 VSF--LHSLKYLDVSNNSMNGTFPSD-FPPLSGVKFLNISLNKFT 240
+ L L+ L + N + T P P ++ L+++ N T
Sbjct: 118 GALRGLGELQELYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLT 161
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 9e-08
Identities = 40/187 (21%), Positives = 62/187 (33%), Gaps = 51/187 (27%)
Query: 42 NISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPG 101
+ L T + +LNL L+ + L + L DLS+N L+ S+P
Sbjct: 42 LLYTFSLATLMPY---TRLTQLNLDRAELTKLQVDGTLPVLGTL---DLSHNQLQ-SLPL 94
Query: 102 WFWSTQSLTQVNLSKNRFGGTIGFKPTS-RNGPF---PSVQVLNLSSNR--------FTN 149
+ +LT +++S NR TS G +Q L L N T
Sbjct: 95 LGQTLPALTVLDVSFNRL--------TSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 150 LVKLSQ---------------FSK---LMVLDVSNNDLRILPSGFANLSKLRHLDIS--- 188
KL + + L L + N L +P GF L +
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHLLPFAFLHGNP 206
Query: 189 ---SCKI 192
+C+I
Sbjct: 207 WLCNCEI 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 72/350 (20%), Positives = 119/350 (34%), Gaps = 95/350 (27%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG------ELHVAIKVLDNAKGIDHDDAVAMFDELSRLK 461
GK L G G V A G VA+K+L +G H + A+ EL L
Sbjct: 25 KLGKP--LGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILI 80
Query: 462 ----HPNLLPLAGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDW--------- 507
H N++ L G C L V++EF G+L +L +
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140
Query: 508 ---------------------STDTWDHHPGAGSHISSPEKTNWVTRHRI--------AI 538
S + + S + E + + + +
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200
Query: 539 GVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVGERSENETC--- 594
VA+G+ +L H L +ILL+E KI FGL R+I R +
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260
Query: 595 --GPE----------SDVYCFGVILMELLT-------GKRGTDDCVKWVRKLVKEGAGGD 635
PE SDV+ FGV+L E+ + G + ++ + +KEG
Sbjct: 261 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE----FCRRLKEG---- 312
Query: 636 ALDFRLK--LGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
R++ + + + + C P +RPT +++ L ++
Sbjct: 313 ---TRMRAPDYTTPEMYQTMLD------CWHGEPSQRPTFSELVEHLGNL 353
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 4e-14
Identities = 56/312 (17%), Positives = 99/312 (31%), Gaps = 97/312 (31%)
Query: 412 ESLLAEGRCGPVYRAVL----PGELHVAIKVL-DNAKGIDHDD----AVAMFDELSRLKH 462
+ EG+ G V++ + + VAIK + + A+ M + H
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTM----RQFDH 450
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
P+++ L G +++E G+L +L +
Sbjct: 451 PHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQV------------------RKF---SL 488
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIG 581
+ A ++ LAYL H + ++L++ + K+ FGL R +
Sbjct: 489 DLASLILY------AYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM- 541
Query: 582 VKNVGERSENETCG----------PE----------SDVYCFGVILMELLT-------GK 614
E S PE SDV+ FGV + E+L G
Sbjct: 542 -----EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 596
Query: 615 RGTDDCVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRP 671
+ D V ++ G RL + ++ M + C A P +RP
Sbjct: 597 KNND-----VIGRIENG-------ERLPMPPNCPPTLYSLMTK-------CWAYDPSRRP 637
Query: 672 TMQQVLGLLKDI 683
++ L I
Sbjct: 638 RFTELKAQLSTI 649
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 6e-14
Identities = 35/157 (22%), Positives = 67/157 (42%), Gaps = 33/157 (21%)
Query: 89 DLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFT 148
DLS N L+ F+S L ++LS+ ++ + +
Sbjct: 34 DLSFNPLRHLGSYSFFSFPELQVLDLSRC--------------------EIQTIEDGAYQ 73
Query: 149 NLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSL 205
+L LS L ++ N ++ L G F+ LS L+ L ++ +++ L +L
Sbjct: 74 SLSHLST------LILTGNPIQSLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTL 126
Query: 206 KYLDVSNNSMNGTFPSD--FPPLSGVKFLNISLNKFT 240
K L+V++N + +F F L+ ++ L++S NK
Sbjct: 127 KELNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 39/190 (20%), Positives = 79/190 (41%), Gaps = 23/190 (12%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
+ L+LS + I + +++S L ++ L+ N ++ G F SL ++ +
Sbjct: 55 QVLDLSRCEIQTIEDGAY-QSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNL- 112
Query: 121 GTIGFKPTS-RNGPF---PSVQVLNLSSNRFTNLVKLSQFSKLM---VLDVSNNDLRILP 173
S N P +++ LN++ N + FS L LD+S+N ++ +
Sbjct: 113 -------ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIY 165
Query: 174 SG-FANLSKLR----HLDISSCKISGNIKPVSFLH-SLKYLDVSNNSMNGTFPSDFPPLS 227
L ++ LD+S ++ I+P +F LK L + N + F L+
Sbjct: 166 CTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLT 224
Query: 228 GVKFLNISLN 237
++ + + N
Sbjct: 225 SLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-08
Identities = 34/191 (17%), Positives = 63/191 (32%), Gaps = 56/191 (29%)
Query: 3 IFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRE 62
F L L L V + L + L +E
Sbjct: 95 AFSGLSSLQKLVAV-------ETNLASLENFPIG----------HLKTL---------KE 128
Query: 63 LNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVP-GWFWSTQSLTQVNLSKNRFGG 121
LN++ + ++ N++ L +DLS+N ++ S+ + +NLS
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLS------ 181
Query: 122 TIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSK--LMVLDVSNNDLRILPSG-FAN 178
L+LS N + + F + L L + N L+ +P G F
Sbjct: 182 ------------------LDLSLNPMNFI-QPGAFKEIRLKELALDTNQLKSVPDGIFDR 222
Query: 179 LSKLRHLDISS 189
L+ L+ + + +
Sbjct: 223 LTSLQKIWLHT 233
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 5e-06
Identities = 24/84 (28%), Positives = 39/84 (46%), Gaps = 6/84 (7%)
Query: 161 VLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNG 217
LD+S N LR L S F + +L+ LD+S C+I I+ ++ L L L ++ N +
Sbjct: 32 NLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ- 89
Query: 218 TFPSD-FPPLSGVKFLNISLNKFT 240
+ F LS ++ L
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLA 113
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 72.8 bits (178), Expect = 1e-13
Identities = 36/301 (11%), Positives = 77/301 (25%), Gaps = 50/301 (16%)
Query: 409 FGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
+ ++L + A GE + V + + M +E+ RL+ +
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGE-SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 138
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPN--------VEDWSTDTWDHHPGA 518
+ + + + + + ++
Sbjct: 139 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 198
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL- 577
SH S+ + R ++ + V R LA LHH G H +L I+L + + GF
Sbjct: 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 258
Query: 578 RNIGVKNV-------------------GERSENETCGPESDVYCFGVILMELLTGKR--G 616
G V + D + G+ + +
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 617 TDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQV 676
D + + + + + V +L + R Q
Sbjct: 319 DDAALGGSEWIFRSCKN---------------IPQPVRAL-LEGFLRYP-KEDRLLPLQA 361
Query: 677 L 677
+
Sbjct: 362 M 362
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 1e-13
Identities = 54/310 (17%), Positives = 96/310 (30%), Gaps = 94/310 (30%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLP 467
+ + +G G V G VA+K + N +A +++L+H NL+
Sbjct: 24 KLLQT--IGKGEFGDVMLGDYRGN-KVAVKCIKN--DATAQAFLAEASVMTQLRHSNLVQ 78
Query: 468 LAGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L G + K L ++ E+MA G L +L S +
Sbjct: 79 LLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--------------------RGRSVLGGDC 118
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNV 585
++ V + YL H L ++L++E K++ FGL +
Sbjct: 119 LLK------FSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD 172
Query: 586 GERSENETCGPE----------SDVYCFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGD 635
+ + PE SDV+ FG++L E+ +
Sbjct: 173 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS----------------------- 209
Query: 636 ALDFRLKLGS----GDSVAEMVESLRVGY-----------------LCTADSPGKRPTMQ 674
G + ++V + GY C RP+
Sbjct: 210 -------FGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFL 262
Query: 675 QVLGLLKDIR 684
Q+ L+ I+
Sbjct: 263 QLREQLEHIK 272
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 70.3 bits (173), Expect = 2e-13
Identities = 57/314 (18%), Positives = 100/314 (31%), Gaps = 97/314 (30%)
Query: 415 LAEGRCGPVYRAVLPG----ELHVAIKVL-DNAKGIDHDD----AVAMFDELSRLKHPNL 465
L EG G VY V +++VA+K + + + AV M L HP++
Sbjct: 20 LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIM----KNLDHPHI 75
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G + +++E G+L +L + +
Sbjct: 76 VKLIGIIE-EEPTWIIMELYPYGELGHYLER---------------------NKNSLKVL 113
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN 584
+ ++ + + +AYL + H + +IL+A K+ FGL R I
Sbjct: 114 TLVLY------SLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYI---- 163
Query: 585 VGERSENETCG----------PE----------SDVYCFGVILMELLT-------GKRGT 617
E + PE SDV+ F V + E+L+
Sbjct: 164 --EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK 221
Query: 618 DDCVKWVRKLVKEGAGGDALDFRLKLGSG--DSVAE-MVESLRVGYLCTADSPGKRPTMQ 674
D V ++++G RL + M C P RP
Sbjct: 222 D-----VIGVLEKG-------DRLPKPDLCPPVLYTLMTR-------CWDYDPSDRPRFT 262
Query: 675 QVLGLLKDIRPSAD 688
+++ L D+
Sbjct: 263 ELVCSLSDVYQMEK 276
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 41/307 (13%), Positives = 79/307 (25%), Gaps = 53/307 (17%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
+L + A GE + V + + M +E+ RL+ +
Sbjct: 80 VLGQEDPYAYLEATDQETGE-SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138
Query: 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNV--------EDWSTDTWDHHPGAGSHIS 523
+ + + + + + ++ SH S
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGV 582
+ + R ++ + V R LA LHH G H +L I+L + + GF G
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 583 KNV--------------------GERSENETCGPESDVYCFGVILMELLTGKR--GTDDC 620
+ V R D + G+++ + D
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG-- 678
+ FR V ++E L R Q +
Sbjct: 319 LGGSEW-----------IFRSCKNIPQPVRALLEGF----LRY--PKEDRLLPLQAMETP 361
Query: 679 LLKDIRP 685
+ +R
Sbjct: 362 EYEQLRT 368
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-12
Identities = 21/80 (26%), Positives = 39/80 (48%), Gaps = 1/80 (1%)
Query: 134 FPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS 193
+ + L LS+N + LS L +L + N ++ + + A L L IS +I+
Sbjct: 47 LKACKHLALSTNNIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIA 106
Query: 194 GNIKPVSFLHSLKYLDVSNN 213
++ + L +L+ L +SNN
Sbjct: 107 -SLSGIEKLVNLRVLYMSNN 125
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 32/169 (18%), Positives = 61/169 (36%), Gaps = 39/169 (23%)
Query: 50 NLNGSNPSTPIR-ELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQS 108
+ + EL+ + + + L + + LS N++
Sbjct: 16 ERKSVVATEAEKVELHGMIPPIEKMDAT--LSTLKACKHLALSTNNI------------- 60
Query: 109 LTQV-NLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQ-FSKLMVLDVSN 166
++ +LS ++++L+L N + L L L +S
Sbjct: 61 -EKISSLSG-----------------MENLRILSLGRNLIKKIENLDAVADTLEELWISY 102
Query: 167 NDLRILPSGFANLSKLRHLDISSCKIS--GNIKPVSFLHSLKYLDVSNN 213
N + L SG L LR L +S+ KI+ G I ++ L L+ L ++ N
Sbjct: 103 NQIASL-SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGN 150
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 17/87 (19%), Positives = 34/87 (39%), Gaps = 10/87 (11%)
Query: 158 KLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNG 217
+ + L + + + + L +HL +S+ I I +S + +L+ L + N +
Sbjct: 26 EKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGMENLRILSLGRNLI-- 82
Query: 218 TFPSDFPPLSGV----KFLNISLNKFT 240
L V + L IS N+
Sbjct: 83 ---KKIENLDAVADTLEELWISYNQIA 106
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 54/223 (24%), Positives = 79/223 (35%), Gaps = 56/223 (25%)
Query: 414 LLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLA 469
L +G+ G VY A + +A+KVL A+ + E S L+HPN+L L
Sbjct: 16 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75
Query: 470 GYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK- 527
GY ++ L LE+ G ++ + K
Sbjct: 76 GY-FHDATRVYLILEYAPLGTVY----------------------------RELQKLSKF 106
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGE 587
T I +A L+Y H H + ++LL + E KIA FG V
Sbjct: 107 DEQRTATYIT-ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW---SVHAPSS 162
Query: 588 RSENETCG------PE----------SDVYCFGVILMELLTGK 614
R + CG PE D++ GV+ E L GK
Sbjct: 163 R-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 32/187 (17%), Positives = 60/187 (32%), Gaps = 23/187 (12%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNN-SLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ +S + N+S++ I++ N +L P L + +
Sbjct: 58 SRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGL 117
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNR---------FTNLVKLSQFSKLMVLDVSNNDLR 170
F ++ +L ++ N F L + L + NN
Sbjct: 118 KM---FPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNE-----TLTLKLYNNGFT 169
Query: 171 ILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHS-LKYLDVSNNSMNGTFPSD-FPPL 226
+ N +KL + ++ K I +F ++S LDVS S+ PS L
Sbjct: 170 SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKGLEHL 228
Query: 227 SGVKFLN 233
+ N
Sbjct: 229 KELIARN 235
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 30/190 (15%), Positives = 69/190 (36%), Gaps = 38/190 (20%)
Query: 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKN 117
+ ++ +++ I S + L L L+ F + +++++ +S +
Sbjct: 11 HQEEDFRVTCKDIQRIPS--LPPSTQTL---KLIETHLRTIPSHAFSNLPNISRIYVSID 65
Query: 118 RFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNN-DLRILPSG- 175
V + L S+ F NL K++ +++ N +L +
Sbjct: 66 -------------------VTLQQLESHSFYNLSKVTH------IEIRNTRNLTYIDPDA 100
Query: 176 FANLSKLRHLDISSCKISGNIKPVSFLHS---LKYLDVSNNSMNGTFPSD-FPPLSGVKF 231
L L+ L I + + ++ ++S L++++N + P + F L
Sbjct: 101 LKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL 159
Query: 232 -LNISLNKFT 240
L + N FT
Sbjct: 160 TLKLYNNGFT 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 20/86 (23%), Positives = 35/86 (40%), Gaps = 6/86 (6%)
Query: 162 LDVSNNDLRILPSG-FANLSKLRHLDISS-CKISGNIKPVSF--LHSLKYLDVSNNSMNG 217
L + LR +PS F+NL + + +S + ++ SF L + ++++ N
Sbjct: 36 LKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLT 94
Query: 218 TFPSD-FPPLSGVKFLNISLNKFTGF 242
D L +KFL I F
Sbjct: 95 YIDPDALKELPLLKFLGIFNTGLKMF 120
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 66/332 (19%), Positives = 109/332 (32%), Gaps = 69/332 (20%)
Query: 390 SKPLVNYLTFKDLIAATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHD 448
S Y +I H+ L EG V L A+K + + D +
Sbjct: 12 SGRENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE 71
Query: 449 DAVAMFDELSRLKHPNLLPLAGYCI----AGKEKLVLLEFMANGDLHRWLHELPTGEPNV 504
+A D HPN+L L YC+ A E +LL F G L +
Sbjct: 72 EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI---------- 121
Query: 505 EDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564
+ G+ + E + +G+ RGL +H G H L ++ILL
Sbjct: 122 --------ERLKDKGNFL--TEDQIL----WLLLGICRGLEAIHAKGYAHRDLKPTNILL 167
Query: 565 AESLEPKIAGFGLRNIGVKNVGERSENETCG-------------PE-------------S 598
+ +P + G N +V + T PE +
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227
Query: 599 DVYCFGVILMELLTGK---RGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVES 655
DV+ G +L ++ G+ V V+ L + + +
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQ---------LSIPQSPRHSSALWQ 278
Query: 656 LRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687
L + + T D P +RP + +L L+ ++P A
Sbjct: 279 L-LNSMMTVD-PHQRPHIPLLLSQLEALQPPA 308
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 7e-12
Identities = 35/195 (17%), Positives = 72/195 (36%), Gaps = 44/195 (22%)
Query: 22 TCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRN 81
C + ++ + + P ++ P EL L++ + + + +
Sbjct: 10 RCEGTTVDCSNQKLNKI---------PEHI----PQY-TAELRLNNNEFTVLEATGIFKK 55
Query: 82 MSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLN 141
+ +L I+ SNN + G F + ++ L+ N ++ N
Sbjct: 56 LPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSN--------------------RLEN 95
Query: 142 LSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVS 200
+ F L L L + +N + + + F LS +R L + +I+ + P +
Sbjct: 96 VQHKMFKGLESLKT------LMLRSNRITCVGNDSFIGLSSVRLLSLYDNQIT-TVAPGA 148
Query: 201 F--LHSLKYLDVSNN 213
F LHSL L++ N
Sbjct: 149 FDTLHSLSTLNLLAN 163
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 32/186 (17%), Positives = 61/186 (32%), Gaps = 20/186 (10%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
E+ + N I+ + +N+ L + +SN +K + +++ N
Sbjct: 82 HEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINI 141
Query: 121 GTIGFKPTSRNGPF----PSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPS 174
TI F +L L+ N + + + NN+L LP+
Sbjct: 142 HTI------ERNSFVGLSFESVILWLNKNGIQEIHNSAFNGTQLDELNLSDNNNLEELPN 195
Query: 175 G-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKF 231
F S LDIS +I ++ L L+ N P+ L +
Sbjct: 196 DVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK---KLPT-LEKLVALME 250
Query: 232 LNISLN 237
+++
Sbjct: 251 ASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 41/186 (22%), Positives = 67/186 (36%), Gaps = 36/186 (19%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
R ++ I S RN EL L+ G F L ++ +S+N
Sbjct: 12 RVFLCQESKVTEIPS-DLPRNAIEL---RFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 67
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSN-NDLRILPSG-FAN 178
I ++ F+NL KL + + + N+L + F N
Sbjct: 68 EVI-------------------EADVFSNLPKLHE------IRIEKANNLLYINPEAFQN 102
Query: 179 LSKLRHLDISSCKISGNIKPVSFLHS--LKYLDVSNNSMNGTFPSD-FPPLSG-VKFLNI 234
L L++L IS+ I ++ V +HS LD+ +N T + F LS L +
Sbjct: 103 LPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWL 161
Query: 235 SLNKFT 240
+ N
Sbjct: 162 NKNGIQ 167
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 20/111 (18%), Positives = 39/111 (35%), Gaps = 5/111 (4%)
Query: 136 SVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISG 194
S +V ++ T + + L LR++ G F+ L ++IS +
Sbjct: 10 SNRVFLCQESKVTE-IPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 68
Query: 195 NIKPVSF--LHSLKYLDVSNNSMNGTFPSD-FPPLSGVKFLNISLNKFTGF 242
I+ F L L + + + + F L +++L IS
Sbjct: 69 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHL 119
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 40/185 (21%), Positives = 68/185 (36%), Gaps = 28/185 (15%)
Query: 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGW------FWSTQSLT 110
S I+ L++ LS + L + + + L + L + +L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGL--TEARCKDISSALRVNPALA 59
Query: 111 QVNLSKNRFGGTIGFKPTSR--NGPFPSVQVLNLSSNRFTN-----LVK-LSQFSKLMVL 162
++NL N G G + P +Q L+L + T L L L L
Sbjct: 60 ELNLRSNELGDV-GVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 163 DVSNNDL-----RILPSGFA-NLSKLRHLDISSCKISGN-IKPVSFL----HSLKYLDVS 211
+S+N L ++L G +L L + C +S +P++ + K L VS
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 212 NNSMN 216
NN +N
Sbjct: 179 NNDIN 183
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 1e-09
Identities = 50/191 (26%), Positives = 78/191 (40%), Gaps = 34/191 (17%)
Query: 54 SNPSTPIRELNLSSRNL--SGI--ISWKFLRNMSELHSIDLSNNSLKGSVPGWFW----- 104
S S +REL L S L G+ + L S L ++ + + + G
Sbjct: 225 SKAS--LRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGI--TAKGCGDLCRVL 280
Query: 105 -STQSLTQVNLSKNRFG--GTIGFKPTSRNGPFPSVQVLNLSSNRFTN-----LVK-LSQ 155
+ +SL +++L+ N G G T P ++ L + S FT L+Q
Sbjct: 281 RAKESLKELSLAGNELGDEGARLLCETLLE-PGCQLESLWVKSCSFTAACCSHFSSVLAQ 339
Query: 156 FSKLMVLDVSNNDL-----RILPSGFA-NLSKLRHLDISSCKISGN-----IKPVSFLHS 204
L+ L +SNN L R L G S LR L ++ C +S + + HS
Sbjct: 340 NRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHS 399
Query: 205 LKYLDVSNNSM 215
L+ LD+SNN +
Sbjct: 400 LRELDLSNNCL 410
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 3e-07
Identities = 36/192 (18%), Positives = 65/192 (33%), Gaps = 34/192 (17%)
Query: 54 SNPSTPIRELNLSSRNLSGIISWKF----LRNMSELHSIDLSNNSLKGS-----VPGWFW 104
PS I++L+L + L+G LR + L + LS+N L + G
Sbjct: 81 QTPSCKIQKLSLQNCCLTGA-GCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLD 139
Query: 105 STQSLTQVNLSKNRFG--GTIGFKPT-SRNGPFPSVQVLNLSSNRFTNL-VKL------S 154
L ++ L P + L +S+N V++
Sbjct: 140 PQCRLEKLQLEYCSLSAASCEPLASVLRAK---PDFKELTVSNNDINEAGVRVLCQGLKD 196
Query: 155 QFSKLMVLDVSNNDL-----RILPSGFANLSKLRHLDISSCKISGN-IKPVS--FLH--- 203
+L L + + + R L A+ + LR L + S K+ + + LH
Sbjct: 197 SPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSS 256
Query: 204 SLKYLDVSNNSM 215
L+ L + +
Sbjct: 257 RLRTLWIWECGI 268
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 3e-11
Identities = 59/223 (26%), Positives = 87/223 (39%), Gaps = 53/223 (23%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
LL +G VYRA + G VAIK++D + +E +LKHP++L L
Sbjct: 18 LLGKGSFAGVYRAESIHTGL-EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76
Query: 469 AGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
Y + ++LE NG+++R+L S E
Sbjct: 77 YNY-FEDSNYVYLVLEMCHNGEMNRYLKN---------------------RVKPFSENE- 113
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGE 587
RH + + G+ YLH G H L S++LL ++ KIA FGL +K E
Sbjct: 114 ----ARHFMH-QIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQ-LKMPHE 167
Query: 588 RSENETCG----------------PESDVYCFGVILMELLTGK 614
+ CG ESDV+ G + LL G+
Sbjct: 168 KHYT-LCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR 209
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-11
Identities = 23/109 (21%), Positives = 41/109 (37%), Gaps = 8/109 (7%)
Query: 108 SLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNN 167
+++L + T ++ S N L +L L V+NN
Sbjct: 20 RDRELDLRGYKIPVIENLGAT-----LDQFDAIDFSDNEIRKLDGFPLLRRLKTLLVNNN 74
Query: 168 DL-RILPSGFANLSKLRHLDISSCKIS--GNIKPVSFLHSLKYLDVSNN 213
+ RI L L L +++ + G++ P++ L SL YL + N
Sbjct: 75 RICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 18/100 (18%), Positives = 39/100 (39%), Gaps = 1/100 (1%)
Query: 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKP 198
++ L++ + + + LD+ + ++ + A L + +D S +I +
Sbjct: 1 MVKLTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDG 59
Query: 199 VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNK 238
L LK L V+NN + L + L ++ N
Sbjct: 60 FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNS 99
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 50/296 (16%), Positives = 96/296 (32%), Gaps = 72/296 (24%)
Query: 414 LLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
+ G VY+ + VA L + K + + +E L L+HPN++
Sbjct: 33 EIGRGSFKTVYKGLDTETTVE-VAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPNIVRF 90
Query: 469 AGYCIAGKEK----LVLLEFMANGDLHRWLHELPT-GEPNVEDWSTDTWDHHPGAGSHIS 523
+ + +++ E M +G L +L + W
Sbjct: 91 YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ------------- 137
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGST--HGHLVTSSILL-AESLEPKIAGFGLRNI 580
+ +GL +LH H L +I + + KI GL +
Sbjct: 138 ----------------ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181
Query: 581 GVKNVGERSE------------NETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRK 626
+ ++ E DVY FG+ ++E+ T + +C + +
Sbjct: 182 -KRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 240
Query: 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682
V G + D K+ + V E++E C + +R +++ LL
Sbjct: 241 RVTSGVKPASFD---KVAIPE-VKEIIE------GCIRQNKDERYSIKD---LLNH 283
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 63.0 bits (154), Expect = 6e-11
Identities = 49/223 (21%), Positives = 78/223 (34%), Gaps = 56/223 (25%)
Query: 414 LLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLA 469
L +G+ G VY A + +A+KVL ++ + E S L+HPN+L +
Sbjct: 21 PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80
Query: 470 GYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK- 527
Y ++++ L LEF G+L+ + +
Sbjct: 81 NY-FHDRKRIYLMLEFAPRGELY----------------------------KELQKHGRF 111
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGE 587
+ + +A L Y H H + ++L+ E KIA FG V
Sbjct: 112 DEQRSATFME-ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW---SVHAPSL 167
Query: 588 RSENETCG------PE----------SDVYCFGVILMELLTGK 614
R CG PE D++C GV+ E L G
Sbjct: 168 R-RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 9e-11
Identities = 24/83 (28%), Positives = 42/83 (50%), Gaps = 3/83 (3%)
Query: 134 FPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDL-RILPSGFANLSKLRHLDISSCKI 192
F ++ L+ + T++ L + +KL L++S+N + L L HL++S KI
Sbjct: 41 FEELEFLSTINVGLTSIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKI 100
Query: 193 S--GNIKPVSFLHSLKYLDVSNN 213
I+P+ L +LK LD+ N
Sbjct: 101 KDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 2e-05
Identities = 22/101 (21%), Positives = 43/101 (42%), Gaps = 8/101 (7%)
Query: 142 LSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF 201
L + +++ +L VLD S ++ L +L L + ++ +I +
Sbjct: 11 LRNRTPSDVKEL-------VLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIANLPK 62
Query: 202 LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
L+ LK L++S+N ++G + LN+S NK
Sbjct: 63 LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDL 103
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 25/126 (19%), Positives = 53/126 (42%), Gaps = 9/126 (7%)
Query: 28 QELVSKAFSSVSTFNISWLK---PTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSE 84
EL ++ S V + + ++ + L+ + G+ S L +++
Sbjct: 9 LELRNRTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTIN---VGLTSIANLPKLNK 65
Query: 85 LHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSS 144
L ++LS+N + G + +LT +NLS N+ +P + +++ L+L +
Sbjct: 66 LKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKK---LENLKSLDLFN 122
Query: 145 NRFTNL 150
TNL
Sbjct: 123 CEVTNL 128
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 1e-10
Identities = 25/112 (22%), Positives = 49/112 (43%), Gaps = 6/112 (5%)
Query: 105 STQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDV 164
+ ++ ++ L + K F +++ L+L + ++ L + KL L++
Sbjct: 22 TPAAVRELVLDNCKSNDG---KIEGLTAEFVNLEFLSLINVGLISVSNLPKLPKLKKLEL 78
Query: 165 SNNDL-RILPSGFANLSKLRHLDISSCKIS--GNIKPVSFLHSLKYLDVSNN 213
S N + L L L HL++S K+ ++P+ L LK LD+ N
Sbjct: 79 SENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-09
Identities = 36/163 (22%), Positives = 57/163 (34%), Gaps = 31/163 (19%)
Query: 51 LNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLT 110
L P+ +REL L + + L + L N L SV L
Sbjct: 18 LRNRTPAA-VRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLK 74
Query: 111 QVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLR 170
++ LS+NR G + P++ LNLS N+ ++ + L
Sbjct: 75 KLELSENRIFGGLDMLAEK----LPNLTHLNLSGNKLKDI----------------STLE 114
Query: 171 ILPSGFANLSKLRHLDISSCKISGN----IKPVSFLHSLKYLD 209
L L L+ LD+ +C+++ L L YLD
Sbjct: 115 PL----KKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLD 153
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 4e-05
Identities = 19/80 (23%), Positives = 33/80 (41%), Gaps = 1/80 (1%)
Query: 161 VLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFP 220
VLD ++ + A L L + + + ++ + L LK L++S N + G
Sbjct: 30 VLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLD 88
Query: 221 SDFPPLSGVKFLNISLNKFT 240
L + LN+S NK
Sbjct: 89 MLAEKLPNLTHLNLSGNKLK 108
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.2 bits (102), Expect = 6e-05
Identities = 30/144 (20%), Positives = 56/144 (38%), Gaps = 14/144 (9%)
Query: 28 QELVSKAFSSVSTFNISWLK---PTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSE 84
EL ++ ++V + K + + L+L + G+IS L + +
Sbjct: 16 LELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLIN---VGLISVSNLPKLPK 72
Query: 85 LHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSS 144
L ++LS N + G + +LT +NLS N+ +P + ++ L+L +
Sbjct: 73 LKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKK---LECLKSLDLFN 129
Query: 145 NRFTNLVK-----LSQFSKLMVLD 163
TNL +L LD
Sbjct: 130 CEVTNLNDYRESVFKLLPQLTYLD 153
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 43/195 (22%), Positives = 70/195 (35%), Gaps = 45/195 (23%)
Query: 22 TCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRN 81
TC++ + K + + PTNL P T I E+ L + I F
Sbjct: 10 TCSNNIVDCRGKGLTEI---------PTNL----PET-ITEIRLEQNTIKVIPPGAF-SP 54
Query: 82 MSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLN 141
+L IDLSNN + P F +SL + L N ++
Sbjct: 55 YKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGN--------------------KITE 94
Query: 142 LSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVS 200
L + F L L L ++ N + L F +L L L + K+ I +
Sbjct: 95 LPKSLFEGLFSLQL------LLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147
Query: 201 F--LHSLKYLDVSNN 213
F L +++ + ++ N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-10
Identities = 39/172 (22%), Positives = 74/172 (43%), Gaps = 33/172 (19%)
Query: 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVP-GWFWSTQSLTQVNLSK 116
T +R L L+ L + + F + + L ++ +++N L+ ++P G F +L ++ L +
Sbjct: 61 TKLRLLYLNDNKLQTLPAGIF-KELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDR 118
Query: 117 NRFGGTIGFKPTS-RNGPF---PSVQVLNLSSNR--------FTNLVKLSQFSKLMVLDV 164
N+ S F + L+L N F L L + L +
Sbjct: 119 NQL--------KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKE------LRL 164
Query: 165 SNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNN 213
NN L+ +P G F L++L+ L + + ++ + +F L LK L + N
Sbjct: 165 YNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVPEGAFDSLEKLKMLQLQEN 215
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 3e-10
Identities = 21/99 (21%), Positives = 34/99 (34%), Gaps = 5/99 (5%)
Query: 133 PFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVS-NNDLRILPSG-FANLSKLRHLDISSC 190
P S + +L L L L + L+ L L +LR+L I
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 191 KISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLS 227
+ + P +F L L++S N++ LS
Sbjct: 67 GLR-FVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 21/91 (23%), Positives = 38/91 (41%), Gaps = 9/91 (9%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
+ EL + ++ + + LR + EL ++ + + L+ P F T L+++NLS N
Sbjct: 33 LTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNAL 92
Query: 120 GGTIGFKPTSRNGPF--PSVQVLNLSSNRFT 148
+ S+Q L LS N
Sbjct: 93 -------ESLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 45.9 bits (108), Expect = 3e-05
Identities = 13/81 (16%), Positives = 26/81 (32%), Gaps = 2/81 (2%)
Query: 162 LDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTF 219
L + + L L I + + +++ L L+ L + + +
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72
Query: 220 PSDFPPLSGVKFLNISLNKFT 240
P F + LN+S N
Sbjct: 73 PDAFHFTPRLSRLNLSFNALE 93
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 20/140 (14%), Positives = 38/140 (27%), Gaps = 52/140 (37%)
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138
L L + + N Q L
Sbjct: 27 LPGAENLTELYIENQ-------------QHLQ---------------------------- 45
Query: 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIK 197
+L L +L L + + LR + F +L L++S + ++
Sbjct: 46 --HLELRDLRGLGELRN------LTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLS 96
Query: 198 PVSFLH-SLKYLDVSNNSMN 216
+ SL+ L +S N ++
Sbjct: 97 WKTVQGLSLQELVLSGNPLH 116
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 6e-10
Identities = 48/223 (21%), Positives = 71/223 (31%), Gaps = 54/223 (24%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
L +G + E A K++ + + M E L H +++
Sbjct: 22 FLGKGGFAKCFEISDADTKE-VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80
Query: 469 AGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
G+ + + V+LE L + H ++ PE
Sbjct: 81 HGF-FEDNDFVFVVLELCRRRSL---------------------LELHKRRK-ALTEPE- 116
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGE 587
R + G YLH H L ++ L E LE KI FGL V+ GE
Sbjct: 117 ----AR-YYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATK-VEYDGE 170
Query: 588 RSENETCG----------------PESDVYCFGVILMELLTGK 614
R + CG E DV+ G I+ LL GK
Sbjct: 171 R-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 65/296 (21%), Positives = 110/296 (37%), Gaps = 88/296 (29%)
Query: 415 LAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLA 469
+ +G V A +L G VAIK++D + ++ +F E + L HPN++ L
Sbjct: 23 IGKGNFAKVKLARHILTGR-EVAIKIIDKTQ-LNPTSLQKLFREVRIMKILNHPNIVKL- 79
Query: 470 GY-CIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
+ I ++ L L +E+ + G++ +D+
Sbjct: 80 -FEVIETEKTLYLIMEYASGGEV---------------------FDY------------- 104
Query: 528 TNWVTRHRIAIGVAR--------GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRN 579
V R+ AR + Y H H L ++LL + KIA FG N
Sbjct: 105 --LVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN 162
Query: 580 IGVKNVGERSENETCG-----------------PESDVYCFGVILMELLTGKRGTDDC-V 621
+ CG PE DV+ GVIL L++G D +
Sbjct: 163 EFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219
Query: 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
K +R+ V G +R+ ++ E+L +L +P KR T++Q++
Sbjct: 220 KELRERVLRG------KYRIP----FYMSTDCENLLKRFLVL--NPIKRGTLEQIM 263
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 47/231 (20%), Positives = 67/231 (29%), Gaps = 70/231 (30%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
L +G + E A K++ + + M E L H +++
Sbjct: 48 FLGKGGFAKCFEISDADTKE-VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106
Query: 469 AGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
G+ + + V+LE L
Sbjct: 107 HGF-FEDNDFVFVVLELCRRRSLLELH--------------------------------- 132
Query: 528 TNWVTRHRIAIGVAR--------GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRN 579
R + AR G YLH H L ++ L E LE KI FGL
Sbjct: 133 ---KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 189
Query: 580 IGVKNVGERSENETCG----------------PESDVYCFGVILMELLTGK 614
V+ GER + CG E DV+ G I+ LL GK
Sbjct: 190 K-VEYDGER-KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 30/209 (14%), Positives = 51/209 (24%), Gaps = 49/209 (23%)
Query: 412 ESLLAEGRCGPVYRAVLPGELH--VAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLL 466
++A+ L VA+ +D + D LSR+ P +
Sbjct: 36 LIFHGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
+ LV+ E++ G L P SP
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP-------------------------SPV 129
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
R +A H G S + ++ + +A
Sbjct: 130 GA-----IRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM-------- 176
Query: 587 ERSENETCGPESDVYCFGVILMELLTGKR 615
P+ D+ G L LL +
Sbjct: 177 -----PDANPQDDIRGIGASLYALLVNRW 200
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 35/225 (15%), Positives = 72/225 (32%), Gaps = 48/225 (21%)
Query: 60 IRELNLSSRNLS--GI--ISWKFLRNMSELHSIDLSNNSL-------------KGSVPGW 102
+ + LS + FL + L + L NN L + +V
Sbjct: 96 LHTVRLSDNAFGPTAQEPLI-DFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKK 154
Query: 103 FWSTQSLTQVNLSKNRFG--GTIGFKPTSRNGPFPSVQVLNLSSNRFTN------LVK-L 153
+ L + +NR + T ++ + + + N L++ L
Sbjct: 155 AKNAPPLRSIICGRNRLENGSMKEWAKTFQS--HRLLHTVKMVQNGIRPEGIEHLLLEGL 212
Query: 154 SQFSKLMVLDVSNNDL-----RILPSGFANLSKLRHLDISSCKISGN--------IKPVS 200
+ +L VLD+ +N L + LR L ++ C +S +
Sbjct: 213 AYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLE 272
Query: 201 FLHSLKYLDVSNNSMNGTFPSDF-----PPLSGVKFLNISLNKFT 240
+ L+ L + N + + + FL ++ N+F+
Sbjct: 273 NI-GLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 37/232 (15%), Positives = 62/232 (26%), Gaps = 59/232 (25%)
Query: 60 IRELNLSSRNLS-----GIISWKFLRNMSELHSIDLSNNSLKGSVPGW------FWSTQS 108
I +L ++ + L + I LS N++ S +
Sbjct: 6 IEGKSLKLDAITTEDEKSVF--AVLLEDDSVKEIVLSGNTI--GTEAARWLSENIASKKD 61
Query: 109 LTQVNLSKNRFGGTIGFKPT---------SRNGPFPSVQVLNLSSNRFTN-----LVK-L 153
L S G P + P + + LS N F L+ L
Sbjct: 62 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKC---PKLHTVRLSDNAFGPTAQEPLIDFL 118
Query: 154 SQFSKLMVLDVSNNDL--------------RILPSGFANLSKLRHLDISSCKISGNI--- 196
S+ + L L + NN L + N LR + ++ N
Sbjct: 119 SKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL-ENGSMK 177
Query: 197 ---KPVSFLHSLKYLDVSNNSMN-----GTFPSDFPPLSGVKFLNISLNKFT 240
K L + + N + +K L++ N FT
Sbjct: 178 EWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFT 229
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 29/233 (12%), Positives = 70/233 (30%), Gaps = 55/233 (23%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLD-----NAKGIDHDDAVAMFDE------------L 457
L +G+ + + A+K + + + + + +
Sbjct: 39 LNQGKFNKIILCEKDNK-FYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97
Query: 458 SRLKHPNLLPLAGYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHP 516
+ +K+ L G I +++ + E+M N + ++
Sbjct: 98 TDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYF------------------- 137
Query: 517 GAGSHISSPEKTNWVTRHRIAIGVARGLAYLH-HVGSTHGHLVTSSILLAESLEPKIAGF 575
+ V + I V +Y+H H + S+IL+ ++ K++ F
Sbjct: 138 FVLDKNYTCFIPIQVIKCIIK-SVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDF 196
Query: 576 GLRNIGVKNVGE--------------RSENETCGPESDVYCFGVILMELLTGK 614
G V + +E+ G + D++ G+ L +
Sbjct: 197 GESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 57.9 bits (140), Expect = 4e-09
Identities = 58/313 (18%), Positives = 101/313 (32%), Gaps = 55/313 (17%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDE---LSRLK 461
H + +G G V A+ AIK+++ K I+ D + E + +L
Sbjct: 29 HLKGA--IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 462 HPNLLPLAGYCIAGKEKLVLLEFMANGDL--------HRWLHELPTGEPNVEDWSTDTWD 513
HPN+ L + +++E G L + + +
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 514 HHPGAGSHISSPEKTNWVTRHRIAIGVAR----GLAYLHHVGSTHGHLVTSSILLA--ES 567
GS E ++V R ++ + R L YLH+ G H + + L + +S
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 568 LEPKIAGFGL-RNIGVKNVGERSE-NETCG------------------PESDVYCFGVIL 607
E K+ FGL + N GE G P+ D + GV+L
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266
Query: 608 MELLTGKR---GTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTA 664
LL G G +D V + + + ++ + L L
Sbjct: 267 HLLLMGAVPFPGVND--ADTISQVLNK------KLCFENPNYNVLSPLARDLLSNLLNR- 317
Query: 665 DSPGKRPTMQQVL 677
+ +R + L
Sbjct: 318 -NVDERFDAMRAL 329
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-08
Identities = 48/227 (21%), Positives = 81/227 (35%), Gaps = 42/227 (18%)
Query: 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKH 462
++F E + G+ VYRA L + VA+K + +D E L +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
PN++ I E ++LE GDL R + I
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKH------------------FKKQKRLI 133
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIG 581
PE+T W + + + L ++H H + +++ + + K+ GL R
Sbjct: 134 --PERTVW----KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187
Query: 582 VKN------VG-------ERSENETCGPESDVYCFGVILMELLTGKR 615
K VG ER +SD++ G +L E+ +
Sbjct: 188 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQS 234
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 57.2 bits (137), Expect = 2e-08
Identities = 73/520 (14%), Positives = 127/520 (24%), Gaps = 223/520 (42%)
Query: 17 VLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISW 76
+A C S V F I WL N N +P T + L L I
Sbjct: 165 WVALDVCLSYK---VQCKMD----FKIFWLNLKNCN--SPETVLEMLQ----KLLYQIDP 211
Query: 77 KFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS 136
+ +I L +S++
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQ---------------------------------------- 231
Query: 137 VQVLNLSSNRFTNLVKLSQFSK-LMVLD-VSNNDLRILPSGFANLSKLRHLDISSCKI-- 192
L+K + L+VL V N ++ SCKI
Sbjct: 232 --------AELRRLLKSKPYENCLLVLLNVQNAKA------------WNAFNL-SCKILL 270
Query: 193 -SGNIKPVSFLHSLKYLDVSNNSMNGTFPSD-----FPPLSGVKFLNISLNKFTGFVGHD 246
+ + FL + +S + + T D +K+L+
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLL-----LKYLDCRPQD-------- 317
Query: 247 KYQKFGKSAFIQGGSFVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHKHNPAVQKHRSKA 306
+P V NP
Sbjct: 318 -------------------------------LPRE----------VLTTNP--------- 327
Query: 307 KALVIGLSCASAFVFVFGIAIIFCMCRRRKILARRNKW----------AISKPVNQQLPF 356
+ + +I R LA + W I +N P
Sbjct: 328 --RRLSI---------IAESI-------RDGLATWDNWKHVNCDKLTTIIESSLNVLEPA 369
Query: 357 KVEKSGPFS----FETESGTSWMADIKEPTSAAVIMCSKPLVNYLTFKDLIAATSHFGKE 412
+ K F F PT + + + D++ + K
Sbjct: 370 EYRKM--FDRLSVFP--------PSAHIPTILLSL-----IWFDVIKSDVMVVVNKLHKY 414
Query: 413 SLLAEGRCGPVYRAVLPGELHVAIKV-LDNAKGIDHDDAVAMFDELSRLKHPNLLPLA-- 469
SL+ + +P +++ +KV L+N + H V ++ +L+P
Sbjct: 415 SLVEKQPKESTIS--IPS-IYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDDLIPPYLD 470
Query: 470 -------GYCIAGKE--------KLVLLEFMANGDLHRWL 494
G+ + E ++V L+F R+L
Sbjct: 471 QYFYSHIGHHLKNIEHPERMTLFRMVFLDF-------RFL 503
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 54.9 bits (132), Expect = 4e-08
Identities = 42/240 (17%), Positives = 72/240 (30%), Gaps = 60/240 (25%)
Query: 406 TSHFGKESLLAEGRC--GPVYRAV-LPGELHVAIKV--LDNAKGIDHDDAVAMFDELSRL 460
+ +++ +G V A P +V ++ L+
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 461 KHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
HPN++P IA E V+ FMA G
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSA-----------------------------K 114
Query: 521 HISSPEKTNWVTRHRIAI---GVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG- 576
+ + + IA GV + L Y+HH+G H + S IL++ + ++G
Sbjct: 115 DLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRS 174
Query: 577 ----LRNIGVKNVGERSENETCG------PE------------SDVYCFGVILMELLTGK 614
+ + + V + PE SD+Y G+ EL G
Sbjct: 175 NLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 52/237 (21%), Positives = 79/237 (33%), Gaps = 82/237 (34%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
L G G V L G VA+K+L+ K D + E L +HP+++ L
Sbjct: 18 TLGVGTFGKVKIGEHQLTGH-KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 469 AGY-CIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
Y I+ + +E+++ G+L ++
Sbjct: 77 --YQVISTPTDFFMVMEYVSGGELFDYI-------------------------------- 102
Query: 527 KTNWVTRHRIAIGVAR--------GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLR 578
R+ AR + Y H H L ++LL + KIA FGL
Sbjct: 103 ----CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 158
Query: 579 NIGVKNVGERSENE----TCG-----------------PESDVYCFGVILMELLTGK 614
N+ S+ E +CG PE D++ GVIL LL G
Sbjct: 159 NM-------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGT 208
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 43/232 (18%), Positives = 71/232 (30%), Gaps = 65/232 (28%)
Query: 412 ESLLAEGRCGPVYRA---VLPGELHVAIKVLDNAKGIDHD---------DAVAMFDELSR 459
L+ G G VY A V VA+K++ D R
Sbjct: 39 RRLVGRGGMGDVYEAEDTVRERI--VALKLMSETLSSDPVFRTRMQREARTAG------R 90
Query: 460 LKHPNLLPLAGY-CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA 518
L+ P+++P+ + I G+ + + + DL L P
Sbjct: 91 LQEPHVVPIHDFGEIDGQLYVDM-RLINGVDLAAMLRR-----------------QGP-- 130
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL- 577
+P + I + L H G+TH + +IL++ + FG+
Sbjct: 131 ----LAPPRAV-----AIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA 181
Query: 578 RNIGVKN-------VG-------ERSENETCGPESDVYCFGVILMELLTGKR 615
+ VG ER +D+Y +L E LTG
Sbjct: 182 SATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 49/244 (20%), Positives = 82/244 (33%), Gaps = 54/244 (22%)
Query: 415 LAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAM-FDELSRLKHPNLLPL--- 468
L G G V R + GE VAIK + + + + +L HPN++
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQ-VAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80
Query: 469 --AGYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+A + +L +E+ GDL ++L++ +
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF---------------------ENCCGLK 119
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP---KIAGFGLRNIGV 582
E R + ++ L YLH H L +I+L + KI G
Sbjct: 120 EGP---IRT-LLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD 175
Query: 583 KN------VG-------ERSENETCGPESDVYCFGVILMELLTGKR---GTDDCVKWVRK 626
+ VG E E + D + FG + E +TG R V+W K
Sbjct: 176 QGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 627 LVKE 630
+ ++
Sbjct: 236 VREK 239
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 51/237 (21%), Positives = 82/237 (34%), Gaps = 83/237 (35%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
L EG G V A + VA+K + D + + E L L+HP+++ L
Sbjct: 16 TLGEGSFGKVKLATHYKTQQ-KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74
Query: 469 AGY-CIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
Y I +V+ +E+ A G+L ++
Sbjct: 75 --YDVITTPTDIVMVIEY-AGGELFDYI-------------------------------- 99
Query: 527 KTNWVTRHRIAIGVAR--------GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLR 578
V + R+ R + Y H H L ++LL ++L KIA FGL
Sbjct: 100 ----VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLS 155
Query: 579 NIGVKNVGERSENE----TCG-----------------PESDVYCFGVILMELLTGK 614
NI ++ +CG PE DV+ G++L +L G+
Sbjct: 156 NI-------MTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGR 205
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 37/220 (16%), Positives = 71/220 (32%), Gaps = 45/220 (20%)
Query: 414 LLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLA 469
+ EG G IK + N + + E L+ +KHPN++
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEI-NISRMSSKEREESRREVAVLANMKHPNIVQYR 89
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTN 529
+++++ GDL + ++ G E
Sbjct: 90 ESFEENGSLYIVMDYCEGGDLFKRINAQ--------------------KGVLF--QEDQI 127
Query: 530 WVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN---- 584
+ + L ++H H + + +I L + ++ FG+ R +
Sbjct: 128 L----DWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELAR 183
Query: 585 --VG-------ERSENETCGPESDVYCFGVILMELLTGKR 615
+G E EN+ +SD++ G +L EL T K
Sbjct: 184 ACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 52/237 (21%), Positives = 81/237 (34%), Gaps = 82/237 (34%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
L G G V L G VA+K+L+ K D + E L +HP+++ L
Sbjct: 23 TLGVGTFGKVKVGKHELTGH-KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 469 AGY-CIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
Y I+ + + +E+++ G+L ++
Sbjct: 82 --YQVISTPSDIFMVMEYVSGGELFDYI-------------------------------- 107
Query: 527 KTNWVTRHRIAIGVAR--------GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLR 578
R+ +R G+ Y H H L ++LL + KIA FGL
Sbjct: 108 ----CKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS 163
Query: 579 NIGVKNVGERSENE----TCG-----------------PESDVYCFGVILMELLTGK 614
N+ S+ E +CG PE D++ GVIL LL G
Sbjct: 164 NM-------MSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGT 213
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 4e-07
Identities = 30/168 (17%), Positives = 55/168 (32%), Gaps = 41/168 (24%)
Query: 19 AQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKF 78
A C + + + P ++ P EL L+ L I S
Sbjct: 4 AMCHCEGTTVDCTGRGLKEI---------PRDI----PLH-TTELLLNDNELGRISSDGL 49
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138
+ L ++L N L G P F + ++ L +N +
Sbjct: 50 FGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGEN--------------------K 89
Query: 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHL 185
+ +S+ F L +L L++ +N + + G F +L+ L L
Sbjct: 90 IKEISNKMFLGLHQLKT------LNLYDNQISCVMPGSFEHLNSLTSL 131
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 6e-07
Identities = 40/190 (21%), Positives = 72/190 (37%), Gaps = 35/190 (18%)
Query: 57 STPIRELNLSSRNLSGI----ISWKFLRNMSELHSIDLSNNSLKGSVPGWFW-------S 105
+ L+LS NL I + F + + S++LS NSL
Sbjct: 21 PHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSL--GFKNSDELVQILAAI 78
Query: 106 TQSLTQVNLSKNRFG--GTIGFKPTSRNGPFPSVQVLNLSSNRFTN-----LVK--LSQF 156
++T +NLS N + T PF ++ VL+L N F++ + +
Sbjct: 79 PANVTSLNLSGNFLSYKSSDELVKTLAAIPF-TITVLDLGWNDFSSKSSSEFKQAFSNLP 137
Query: 157 SKLMVLDVSNNDL-----RILPSGFANL-SKLRHLDISSCKIS--GNIKPVSFL----HS 204
+ + L++ NDL L A + + + L++ ++ + FL S
Sbjct: 138 ASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASIPAS 197
Query: 205 LKYLDVSNNS 214
+ LD+S N
Sbjct: 198 VTSLDLSANL 207
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 37/222 (16%), Positives = 75/222 (33%), Gaps = 38/222 (17%)
Query: 54 SNPSTPIRELNLSSRNLSGI----ISWKFLRNMSELHSIDLSNNSLKGS-----VPGWFW 104
+ P+ + LNLS LS + + +DL N +
Sbjct: 77 AIPAN-VTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSN 135
Query: 105 STQSLTQVNLSKNRFG--GTIGFKPTSRNGPFPSVQVLNLSSNRFTN--LVKLSQF---- 156
S+T +NL N G + P +V LNL N + +L++F
Sbjct: 136 LPASITSLNLRGNDLGIKSSDELIQILAAIPA-NVNSLNLRGNNLASKNCAELAKFLASI 194
Query: 157 -SKLMVLDVSNNDL-----RILPSGFA-NLSKLRHLDISSCKISGN-IKPVSFL----HS 204
+ + LD+S N L L F+ + + L++ + G ++ + L
Sbjct: 195 PASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKH 254
Query: 205 LKYLDVSNNSMNGTFPSD-------FPPLSGVKFLNISLNKF 239
L+ + + + + FP + + ++ + +
Sbjct: 255 LQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILVDKNGKEI 296
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 41/223 (18%), Positives = 80/223 (35%), Gaps = 39/223 (17%)
Query: 54 SNPSTPIRELNLSSRNLSGI----ISWKFLRNMSELHSIDLSNNSLKGS-----VPGWFW 104
+N + LNLS +L + + + S++LS N L V
Sbjct: 47 ANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDELVKTLAA 106
Query: 105 STQSLTQVNLSKNRFG--GTIGFKPTSRNGPFPSVQVLNLSSNRFTN--LVKLSQF---- 156
++T ++L N F + FK N P S+ LNL N +L Q
Sbjct: 107 IPFTITVLDLGWNDFSSKSSSEFKQAFSNLP-ASITSLNLRGNDLGIKSSDELIQILAAI 165
Query: 157 -SKLMVLDVSNNDL-----RILPSGFANL-SKLRHLDISSCKISGNIKPVSFL------- 202
+ + L++ N+L L A++ + + LD+S+ + K + L
Sbjct: 166 PANVNSLNLRGNNLASKNCAELAKFLASIPASVTSLDLSANLLGL--KSYAELAYIFSSI 223
Query: 203 -HSLKYLDVSNNSMNGT----FPSDFPPLSGVKFLNISLNKFT 240
+ + L++ N ++G L ++ + + +
Sbjct: 224 PNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVK 266
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 37/182 (20%), Positives = 64/182 (35%), Gaps = 36/182 (19%)
Query: 63 LNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFW-------STQSLTQVNLS 115
L+ S + +F + S+DLS N+L + S+T +NLS
Sbjct: 3 YKLTLHPGSNPVE-EFTSIPHGVTSLDLSLNNL--YSISTVELIQAFANTPASVTSLNLS 59
Query: 116 KNRFG--GTIGFKPTSRNGPFPSVQVLNLSSNRFTN--LVKLSQF-----SKLMVLDVSN 166
N G + P +V LNLS N + +L + + VLD+
Sbjct: 60 GNSLGFKNSDELVQILAAIP-ANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGW 118
Query: 167 NDL-----RILPSGFANL-SKLRHLDISSCKISGNIKPVSFL--------HSLKYLDVSN 212
ND F+NL + + L++ + K L ++ L++
Sbjct: 119 NDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGI--KSSDELIQILAAIPANVNSLNLRG 176
Query: 213 NS 214
N+
Sbjct: 177 NN 178
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 50.7 bits (121), Expect = 7e-07
Identities = 28/259 (10%), Positives = 60/259 (23%), Gaps = 58/259 (22%)
Query: 390 SKPLVNYLTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELH------VAIKVLDNAK 443
L + + LL EG VY A +KV A
Sbjct: 48 QCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107
Query: 444 GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPN 503
+ + + L + + +++ E + G L ++
Sbjct: 108 PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY------ 161
Query: 504 VEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563
+ + A+ + + +H HG + + +
Sbjct: 162 ----------------KNTPEKVMPQGLVIS-FAMRMLYMIEQVHDCEIIHGDIKPDNFI 204
Query: 564 LAESLEP-----------KIAGFGLRNIGVKNVGERSENET-CG------PE-------- 597
L + G ++I +K + + C E
Sbjct: 205 LGNGFLEQDDEDDLSAGLALIDLG-QSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN 263
Query: 598 --SDVYCFGVILMELLTGK 614
D + + +L G
Sbjct: 264 YQIDYFGVAATVYCMLFGT 282
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 50.7 bits (120), Expect = 8e-07
Identities = 30/193 (15%), Positives = 65/193 (33%), Gaps = 20/193 (10%)
Query: 18 LAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWK 77
+ ++ E + ISW++ +L S + LN + +S
Sbjct: 131 IVENKEKFAHFEGLFWGDIDFEEQEISWIEQVDL--SPVLDAMPLLNNLKIKGTNNLSIG 188
Query: 78 FLRNMSELHSIDLSNNSLKGSVPGWFWSTQ--SLTQVNLS--KNRFGGTIGFK---PTSR 130
L S+++ + L SV + +L ++ L +G P
Sbjct: 189 KKPR-PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFS 247
Query: 131 NGPFPSVQVLNLSSNRFTN-----LVKLSQFSKLMVLDVSNNDL-----RILPSGFANLS 180
FP+++ L + N ++ +L +D+S L R+L +
Sbjct: 248 KDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIK 307
Query: 181 KLRHLDISSCKIS 193
L+ +++ +S
Sbjct: 308 HLKFINMKYNYLS 320
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 8e-05
Identities = 23/189 (12%), Positives = 56/189 (29%), Gaps = 32/189 (16%)
Query: 80 RNMSELHSIDLSNNSLKGSVPGWFWST------QSLTQVNLSKNRFGGTIGFKPTSRNGP 133
+ + + + W ++ +N K + + R
Sbjct: 136 EKFAHFEGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKIKGTNNLSIGKKPR--- 192
Query: 134 FPSVQVLNLSSNRFTNL----VKLSQFSKLMVLDVS--------NNDLRILPSGFAN--L 179
P+++ L + S + + S L L + + D+ + F+
Sbjct: 193 -PNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRF 251
Query: 180 SKLRHLDISSCKISGNIKPV----SFLHSLKYLDVSNNSMNGT----FPSDFPPLSGVKF 231
L+ L I + + + L L+ +D+S + + +KF
Sbjct: 252 PNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF 311
Query: 232 LNISLNKFT 240
+N+ N +
Sbjct: 312 INMKYNYLS 320
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-07
Identities = 55/302 (18%), Positives = 101/302 (33%), Gaps = 77/302 (25%)
Query: 407 SHFGKESLLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPN 464
F + L+ G G V++A + G+ IK + +++ A L++L H N
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKT-YVIKRVK----YNNEKAEREVKALAKLDHVN 65
Query: 465 ---------------LLPLAGYCIAGKEKL-VLLEFMANGDLHRWLHELPTGEPNVEDWS 508
+ + L + +EF G L +W+ +
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR---------- 115
Query: 509 TDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESL 568
G + + + + +G+ Y+H + L S+I L ++
Sbjct: 116 ----------GEKL--DKVLAL----ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK 159
Query: 569 EPKIAGFG----LRNIGVKN--VG-------ERSENETCGPESDVYCFGVILMELLTGKR 615
+ KI FG L+N G + G E+ ++ G E D+Y G+IL ELL
Sbjct: 160 QVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
Query: 616 GTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQ 675
+ K+ L + +++ L L P RP +
Sbjct: 220 TAFETSKFFTDLRDG---------IISDIFDKKEKTLLQKL----LSK--KPEDRPNTSE 264
Query: 676 VL 677
+L
Sbjct: 265 IL 266
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 9e-07
Identities = 39/173 (22%), Positives = 63/173 (36%), Gaps = 32/173 (18%)
Query: 406 TSHFGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHP 463
+ EG G V A G VA+K++D K + + +H
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQ-VAVKMMDLRKQQRRELLFNEVVIMRDYQHF 102
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ + + G+E VL+EF+ G L + ++ E I+
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE------------------QIA 144
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
+ V V + LAYLH G H + + SILL K++ FG
Sbjct: 145 T------VCEA-----VLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFG 186
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 1e-06
Identities = 33/173 (19%), Positives = 63/173 (36%), Gaps = 32/173 (18%)
Query: 406 TSHFGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHP 463
+ + + +G G VY A V G+ VAI+ ++ + + + + K+P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQE-VAIRQMNLQQQPKKELIINEILVMRENKNP 77
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ + G E V++E++A G L + E E I+
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG------------------QIA 119
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
+ + + L +LH H + + +ILL K+ FG
Sbjct: 120 A-----------VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG 161
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 1e-06
Identities = 50/231 (21%), Positives = 78/231 (33%), Gaps = 71/231 (30%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
L EG G V A + E VA+K++D + +D + + E L H N++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENI--KKEICINKMLNHENVVKF 70
Query: 469 AGYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
G L LE+ + G+L +
Sbjct: 71 YG-HRREGNIQYLFLEYCSGGELFDRI--------------------------------- 96
Query: 528 TNWVTRHRIAIGVAR--------GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRN 579
+ A+ G+ YLH +G TH + ++LL E KI+ FGL
Sbjct: 97 ---EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLAT 153
Query: 580 IGVKNVGERSENETCG-----------------PESDVYCFGVILMELLTG 613
+ N ER N+ CG DV+ G++L +L G
Sbjct: 154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 48/191 (25%), Positives = 80/191 (41%), Gaps = 35/191 (18%)
Query: 19 AQSTCNSKDQELVSKAFSSVSTFN---------ISWLKPTNLNGSNPSTPIRELNLSSRN 69
+ + L K+ + T N + ++ G +R L L
Sbjct: 15 DDAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNK 74
Query: 70 LSGIISWKFLRNMSELHSIDLSNNSLKGSVP-GWFWSTQSLTQVNLSKNRF----GGTIG 124
L I + K L N++ L L+ N L+ S+P G F +L ++ L +N+ G +
Sbjct: 75 LHDISALKELTNLTYL---ILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDG-VF 129
Query: 125 FKPTSRNGPFPSVQVLNLSSNRFTNL---V--KLSQFSKLMVLDVSNNDLRILPSG-FAN 178
K T ++ LNL+ N+ +L V KL + L LD+S N L+ LP G F
Sbjct: 130 DKLT-------NLTYLNLAHNQLQSLPKGVFDKL---TNLTELDLSYNQLQSLPEGVFDK 179
Query: 179 LSKLRHLDISS 189
L++L+ L +
Sbjct: 180 LTQLKDLRLYQ 190
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 6e-06
Identities = 32/157 (20%), Positives = 68/157 (43%), Gaps = 12/157 (7%)
Query: 87 SIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNR 146
+L S+ S+ Q+ + + G + +V+ L L N+
Sbjct: 23 KANLKKKSVT-DAVT-QNELNSIDQIIANNSDIKSVQGIQYLP------NVRYLALGGNK 74
Query: 147 FTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF--LH 203
++ L + + L L ++ N L+ LP+G F L+ L+ L + ++ ++ F L
Sbjct: 75 LHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLT 133
Query: 204 SLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
+L YL++++N + F L+ + L++S N+
Sbjct: 134 NLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ 170
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 55/323 (17%), Positives = 91/323 (28%), Gaps = 84/323 (26%)
Query: 414 LLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAM-FDELSRLKHPNLLPLAG 470
+L +G V+R G+L AIKV +N + D F+ L +L H N++ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDL-FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL-- 72
Query: 471 YCI---AGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
+ I VL +EF G L+ L E + PE
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEP---------------------SNAYGLPE 111
Query: 527 KT-NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP----KIAGFGLRNIG 581
V R V G+ +L G H ++ +I+ + K+ FG
Sbjct: 112 SEFLIVLRD-----VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL 166
Query: 582 VKN---------------------VGERSENETCGPESDVYCFGVILMELLTGK------ 614
+ V + + G D++ GV TG
Sbjct: 167 EDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226
Query: 615 RGTDDCVKWVRKLVKEGAGGDALDFRLKLGSG--------------DSVAEMVESLRVGY 660
G + + K++ G + + ++ +
Sbjct: 227 EGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANI 286
Query: 661 LCTADSPGKRPTMQQVLGLLKDI 683
L K Q DI
Sbjct: 287 LEA--DQEKCWGFDQFFAETSDI 307
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 55/322 (17%), Positives = 94/322 (29%), Gaps = 82/322 (25%)
Query: 414 LLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAM-FDELSRLKHPNLLPLAG 470
+L +G V+R G+L AIKV +N + D F+ L +L H N++ L
Sbjct: 16 ILGQGATANVFRGRHKKTGDL-FAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL-- 72
Query: 471 YCI---AGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
+ I VL +EF G L+ L E + PE
Sbjct: 73 FAIEEETTTRHKVLIMEFCPCGSLYTVLEEP---------------------SNAYGLPE 111
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP----KIAGFGLRNIGV 582
+ V G+ +L G H ++ +I+ + K+ FG
Sbjct: 112 SE---FL-IVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
Query: 583 KN---------------------VGERSENETCGPESDVYCFGVILMELLTGK------R 615
+ V + + G D++ GV TG
Sbjct: 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227
Query: 616 GTDDCVKWVRKLVKEGAGG----------DALDFRLKLGSGDSV----AEMVESLRVGYL 661
G + + K++ G +D+ + S+ ++ + L
Sbjct: 228 GPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANIL 287
Query: 662 CTADSPGKRPTMQQVLGLLKDI 683
K Q DI
Sbjct: 288 EA--DQEKCWGFDQFFAETSDI 307
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 3e-06
Identities = 58/316 (18%), Positives = 99/316 (31%), Gaps = 82/316 (25%)
Query: 406 TSHFGKESLLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHP 463
S F + ++L +G G V +A L AIK + + + ++ L+ L H
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRY-YAIKKIRHTEE-KLSTILSEVMLLASLNHQ 62
Query: 464 N------------LLPLAGYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTD 510
+ K L + +E+ NG L+ +H + E W
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW--- 119
Query: 511 TWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570
R+ + L+Y+H G H L +I + ES
Sbjct: 120 ------------------------RLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNV 155
Query: 571 KIAGFGL----------RNIGVKNVGERSENET--CG------PE-----------SDVY 601
KI FGL + +N+ S+N T G E D+Y
Sbjct: 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY 215
Query: 602 CFGVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYL 661
G+I E++ + V ++KL +++ L +
Sbjct: 216 SLGIIFFEMIYPFSTGMERVNILKKLRS---VSIEFPPDFDDNKMKVEKKIIRLL----I 268
Query: 662 CTADSPGKRPTMQQVL 677
P KRP + +L
Sbjct: 269 DH--DPNKRPGARTLL 282
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 50/232 (21%), Positives = 78/232 (33%), Gaps = 73/232 (31%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
L EG G V A + E VA+K++D + +D + + E L H N++
Sbjct: 14 TLGEGAYGEVQLAVNRVTEE-AVAVKIVDMKRAVDCPENI--KKEICINKMLNHENVVKF 70
Query: 469 AGY-CIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
Y L LE+ + G+L +
Sbjct: 71 --YGHRREGNIQYLFLEYCSGGELFDRI-------------------------------- 96
Query: 527 KTNWVTRHRIAIGVAR--------GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLR 578
+ A+ G+ YLH +G TH + ++LL E KI+ FGL
Sbjct: 97 ----EPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLA 152
Query: 579 NIGVKNVGERSENETCG-----------------PESDVYCFGVILMELLTG 613
+ N ER N+ CG DV+ G++L +L G
Sbjct: 153 TVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 26/162 (16%), Positives = 52/162 (32%), Gaps = 9/162 (5%)
Query: 60 IRELNLS-SRNLSGIISW--KFLRNMSELHSIDLSNNSLKG----SVPGWFWSTQSLTQV 112
I+ L + S W + ++ + L ++ + + +SL V
Sbjct: 166 IKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIARNCRSLVSV 225
Query: 113 NLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRIL 172
+ +GF + N LN + L KL L +S +
Sbjct: 226 KVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNEM 285
Query: 173 PSGFANLSKLRHLDISSCKISGN--IKPVSFLHSLKYLDVSN 212
P F +++R LD+ + + +L+ L+ N
Sbjct: 286 PILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRN 327
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 41.5 bits (97), Expect = 8e-04
Identities = 35/242 (14%), Positives = 70/242 (28%), Gaps = 41/242 (16%)
Query: 30 LVSKAFSSVSTFNISWLKPTNLNGSNPSTPIREL-NLSSRNLSG---------------- 72
LV + + + + + + P R NL S L G
Sbjct: 39 LVCRRWFKIDSETREHVTMALCYTATPDRLSRRFPNLRSLKLKGKPRAAMFNLIPENWGG 98
Query: 73 -IISW--KFLRNMSELHSIDLSN-----NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIG 124
+ W + N+ +L S+ L L + L K T G
Sbjct: 99 YVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARA---DDLETLKLDKCSGFTTDG 155
Query: 125 FKPTSRNGPFPSVQVLNLSSNRFTN-----LVKLSQ-FSKLMVLDVSNNDLR-----ILP 173
+ ++ L + + F+ L +L+Q + L VL+ + L
Sbjct: 156 LLSIVTH--CRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLE 213
Query: 174 SGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLN 233
+ N L + + +I + +L+ + + + P + L + L
Sbjct: 214 TIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLC 273
Query: 234 IS 235
Sbjct: 274 RL 275
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 45/197 (22%), Positives = 73/197 (37%), Gaps = 44/197 (22%)
Query: 19 AQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKF 78
+Q +C+ + SK +SV P + P+ + L L ++ + F
Sbjct: 15 SQCSCSGTTVDCRSKRHASV---------PAGI----PTN-AQILYLHDNQITKLEPGVF 60
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138
++ L + L +N L G F S LT ++L N Q
Sbjct: 61 -DSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN--------------------Q 99
Query: 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKP 198
+ L S F LV L + L + N L LP G L+ L HL + ++ +I
Sbjct: 100 LTVLPSAVFDRLVHLKE------LFMCCNKLTELPRGIERLTHLTHLALDQNQLK-SIPH 152
Query: 199 VSF--LHSLKYLDVSNN 213
+F L SL + + N
Sbjct: 153 GAFDRLSSLTHAYLFGN 169
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 46/237 (19%), Positives = 73/237 (30%), Gaps = 74/237 (31%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVA-MFDE---LSRLKHPNLLP 467
LL EG G V A+K+L K + A + E L RL+H N++
Sbjct: 12 LLGEGSYGKVKEVLDSETLC-RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 468 LAGY---CIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
L K+K+ + +E+ G + E+ D
Sbjct: 71 L--VDVLYNEEKQKMYMVMEYCVCG-----MQEM--------------LDS--------- 100
Query: 524 SPEKTNWVTRHRIAIGVAR--------GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGF 575
V R + A GL YLH G H + ++LL KI+
Sbjct: 101 -------VPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISAL 153
Query: 576 GLRNIGVKNVGERSENETCG------------------PESDVYCFGVILMELLTGK 614
G+ + + + G + D++ GV L + TG
Sbjct: 154 GVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL 210
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 51/209 (24%), Positives = 90/209 (43%), Gaps = 47/209 (22%)
Query: 22 TCNSKDQEL--VSKAFSSVSTFNIS------WLKPTNLNGSNPS-----TPIRELNLSSR 68
TCN +E+ K+ SV + I L+ T L + + T + LNL
Sbjct: 11 TCNEGKKEVDCQGKSLDSVPS-GIPADTEKLDLQSTGLATLSDATFRGLTKLTWLNLDYN 69
Query: 69 NLSGIISWKFLRNMSELHSIDLSNNSLKGSVP-GWFWSTQSLTQVNLSKNRFGGTIGFKP 127
L + + F +++EL ++ L+NN L S+P G F L ++ L N
Sbjct: 70 QLQTLSAGVF-DDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGN---------- 117
Query: 128 TSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLD 186
Q+ +L S F L KL + L ++ N L+ +P+G F L+ L+ L
Sbjct: 118 ----------QLKSLPSGVFDRLTKLKE------LRLNTNQLQSIPAGAFDKLTNLQTLS 161
Query: 187 ISSCKISGNIKPVSF--LHSLKYLDVSNN 213
+S+ ++ ++ +F L L+ + + N
Sbjct: 162 LSTNQLQ-SVPHGAFDRLGKLQTITLFGN 189
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 5e-06
Identities = 31/176 (17%), Positives = 59/176 (33%), Gaps = 36/176 (20%)
Query: 406 TSHFGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHP 463
+ L +G G VY+A G L A KV++ + +D + + L+ HP
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGAL-AAAKVIETKSEEELEDYIVEIEILATCDHP 76
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
++ L G + +++EF G +
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAV------------------DAIMLELDRG----- 113
Query: 524 SPEKTNWVTRHRIAI---GVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
+T +I + + L +LH H L ++L+ + ++A FG
Sbjct: 114 -------LTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFG 162
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 48.0 bits (114), Expect = 6e-06
Identities = 41/241 (17%), Positives = 76/241 (31%), Gaps = 31/241 (12%)
Query: 1 MKIFCRLPL--LFSLSLV-----VLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNG 53
+ IF L L L +S V LA + +L K T +
Sbjct: 18 LGIFSCLCLPELLKVSGVCKRWYRLASDESLWQTLDLTGKNLHPDVTGRLLSQGVIAFRC 77
Query: 54 SNPSTP-----------IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGW 102
++ ++LS+ + L S+L ++ L L +
Sbjct: 78 PRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNT 137
Query: 103 FWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSS-NRFTN----LVKLSQFS 157
+L ++NLS + + + LNLS FT +
Sbjct: 138 LAKNSNLVRLNLSGCSGFSEFALQTLLSS--CSRLDELNLSWCFDFTEKHVQVAVAHVSE 195
Query: 158 KLMVLDVSNNDLRILPSGFA----NLSKLRHLDISSC-KISGN-IKPVSFLHSLKYLDVS 211
+ L++S + S + L HLD+S + + + L+ L++L +S
Sbjct: 196 TITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLS 255
Query: 212 N 212
Sbjct: 256 R 256
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 7e-06
Identities = 35/233 (15%), Positives = 68/233 (29%), Gaps = 50/233 (21%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHP 463
+ + G G + + K L + + + + E L LKHP
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKEL-DYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 464 NLLPLAGYCIAGKEKLV--LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521
N++ I + ++E+ GDL + +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI------------------TKGTKERQY 107
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV-----TSSILLAESLEPKIAGFG 576
+ E+ R+ + L H ++ +++ L K+ FG
Sbjct: 108 L--DEEFVL----RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFG 161
Query: 577 L-RNIGVKN------VG-------ERSENETCGPESDVYCFGVILMELLTGKR 615
L R + VG E+ + +SD++ G +L EL
Sbjct: 162 LARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 214
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 40/178 (22%), Positives = 65/178 (36%), Gaps = 38/178 (21%)
Query: 406 TSHFGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRL 460
F + G G VY A V E+ VAIK + + ++ + E L +L
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQKL 111
Query: 461 KHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
+HPN + G + +++E+ ++D + H
Sbjct: 112 RHPNTIQYRGCYLREHTAWLVMEYCLGS-------------------ASDLLEVHKKPLQ 152
Query: 521 --HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
I++ VT G +GLAYLH H + +ILL+E K+ FG
Sbjct: 153 EVEIAA------VTH-----GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFG 199
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 37/179 (20%), Positives = 66/179 (36%), Gaps = 36/179 (20%)
Query: 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKH 462
+ + ++ G V A P + VAIK ++ K + E +S+ H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEK--CQTSMDELLKEIQAMSQCHH 72
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANG---DLHRWLHELPTGEPNV--EDWSTDTWDHHPG 517
PN++ + E ++++ ++ G D+ + + + V E
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDES----------- 121
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
I++ + R V GL YLH G H + +ILL E +IA FG
Sbjct: 122 ---TIAT------ILRE-----VLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFG 166
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 1e-05
Identities = 40/237 (16%), Positives = 78/237 (32%), Gaps = 71/237 (29%)
Query: 414 LLAEGRCGPVYRAVLP-GELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNL--LP 467
+ G V++ + ++ AIK + N + D+ + +E L++L+ + +
Sbjct: 35 QIGSGGSSKVFQVLNEKKQI-YAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 92
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHE---LPTGEPNVEDWSTDTWDHHPGAGSHISS 524
L Y I + +++E N DL+ WL + + W +
Sbjct: 93 LYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSID------PWERKSYWKN---------- 135
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN 584
+ + +H G H L ++ L+ + K+ FG+ N +
Sbjct: 136 ---------------MLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPD 179
Query: 585 VGERSENETCG------PE---------------------SDVYCFGVILMELLTGK 614
++ G PE SDV+ G IL + GK
Sbjct: 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 34/175 (19%), Positives = 60/175 (34%), Gaps = 36/175 (20%)
Query: 406 TSHFGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHP 463
F L EG G VY+A G++ VAIK + D + + + + P
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQI-VAIKQVPVES--DLQEIIKEISIMQQCDSP 84
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS--H 521
+++ G + +++E+ G + +D +
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSV------------------SDIIRLRNKTLTEDE 126
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
I++ I +GL YLH + H + +ILL K+A FG
Sbjct: 127 IAT-----------ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFG 170
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 1e-05
Identities = 41/233 (17%), Positives = 77/233 (33%), Gaps = 63/233 (27%)
Query: 414 LLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNL--LPL 468
+ G V++ + + AIK + N + D+ + +E L++L+ + + L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 469 AGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
Y I + +++E N DL+ WL + S
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWLKK------------------------KKSIDP-- 107
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGER 588
W + + + +H G H L ++ L+ + K+ FG+ N +
Sbjct: 108 -WERKS-YWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSV 164
Query: 589 SENETCG------PE---------------------SDVYCFGVILMELLTGK 614
++ G PE SDV+ G IL + GK
Sbjct: 165 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 39/181 (21%), Positives = 58/181 (32%), Gaps = 49/181 (27%)
Query: 19 AQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKF 78
+ TC +K + P + P + EL L + + K
Sbjct: 6 TECTCLDTVVRCSNKGLKVL---------PKGI----PRD-VTELYLDGNQFTLVP--KE 49
Query: 79 LRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138
L N L IDLSNN + F + L + LS N +
Sbjct: 50 LSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN--------------------R 89
Query: 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDIS------SCK 191
+ + F L L L + ND+ ++P G F +LS L HL I C
Sbjct: 90 LRCIPPRTFDGLKSLRL------LSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN 143
Query: 192 I 192
+
Sbjct: 144 M 144
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 19/96 (19%), Positives = 41/96 (42%), Gaps = 15/96 (15%)
Query: 535 RIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN-------VG 586
+ G+ + H + H + +IL+ + KI FG+ + + + +G
Sbjct: 115 NFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLG 174
Query: 587 -------ERSENETCGPESDVYCFGVILMELLTGKR 615
E+++ E +D+Y G++L E+L G+
Sbjct: 175 TVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 2e-05
Identities = 37/173 (21%), Positives = 67/173 (38%), Gaps = 31/173 (17%)
Query: 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDH-DDAVAMFDELSRLKHP 463
F K + +G G V++ + + VAIK++D + D +D LS+ P
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
+ G + + +++E++ G L P E I+
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET------------------QIA 122
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
+ + R + +GL YLH H + +++LL+E E K+A FG
Sbjct: 123 T------ILRE-----ILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFG 164
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 46.3 bits (110), Expect = 2e-05
Identities = 41/234 (17%), Positives = 77/234 (32%), Gaps = 65/234 (27%)
Query: 414 LLAEGRCGPVYRAVLP-GELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNL--LP 467
+ G V++ + ++ AIK + N + D+ + +E L++L+ + +
Sbjct: 63 QIGSGGSSKVFQVLNEKKQI-YAIKYV-NLEEADNQTLDSYRNEIAYLNKLQQHSDKIIR 120
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
L Y I + +++E N DL+ WL + S
Sbjct: 121 LYDYEITDQYIYMVMEC-GNIDLNSWLKK------------------------KKSIDPW 155
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNI---GVKN 584
R + + +H G H L ++ L+ + K+ FG+ N +
Sbjct: 156 E----RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTS 210
Query: 585 VGERS------------------------ENETCGPESDVYCFGVILMELLTGK 614
V + S P+SDV+ G IL + GK
Sbjct: 211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 21/98 (21%), Positives = 40/98 (40%), Gaps = 17/98 (17%)
Query: 535 RIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVG------- 586
+ + L + H G H + ++I+++ + K+ FG+ R I
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179
Query: 587 ---------ERSENETCGPESDVYCFGVILMELLTGKR 615
E++ ++ SDVY G +L E+LTG+
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 217
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 46.0 bits (108), Expect = 2e-05
Identities = 33/220 (15%), Positives = 72/220 (32%), Gaps = 26/220 (11%)
Query: 388 MCSKPLVNYLTFKDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVL-----DNA 442
CS+ + F + T + + EG G V++ + VAIK++ D
Sbjct: 4 ECSQK--GPVPFSHCLP-TEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLV 59
Query: 443 KGIDHDDAVAMFDELSRLK------------HPNLLPLAG-YCIAGKEKLVLLE-FMANG 488
G + E+ K + L +C+ G +LL+ +
Sbjct: 60 NGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYN 119
Query: 489 DLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLH 548
++ P + + + ++ G + ++ T I + LA
Sbjct: 120 STKGSANDRPDFFKDDQLFIVLEFEFG-GIDLEQMRTKLSSLATAKSILHQLTASLAVAE 178
Query: 549 H-VGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKNVG 586
+ H L ++LL ++ K+ ++ + + G
Sbjct: 179 ASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCG 218
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 41/262 (15%), Positives = 75/262 (28%), Gaps = 68/262 (25%)
Query: 453 MFDELSRLKHPNLLPLAGYCIAGKEKLVL---LEFMANGDLHRWLHELPTGEPNVEDWST 509
++ R+ + G K+ L ++ +L W++
Sbjct: 108 PSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNR------------- 154
Query: 510 DTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLE 569
S I I +A + +LH G H L S+I
Sbjct: 155 --------RCSLEDREHGVCL----HIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV 202
Query: 570 PKIAGFGL-------------------RNIGVKNVG-------ERSENETCGPESDVYCF 603
K+ FGL VG E+ + D++
Sbjct: 203 VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSL 262
Query: 604 GVILMELLTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCT 663
G+IL ELL + V+ + + L F K MV+ +
Sbjct: 263 GLILFELLYSFSTQMERVRIITDVRN---LKFPLLFTQKY---PQEHMMVQDM------L 310
Query: 664 ADSPGKRPTMQQVL--GLLKDI 683
+ SP +RP ++ + +++
Sbjct: 311 SPSPTERPEATDIIENAIFENL 332
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 3e-05
Identities = 41/186 (22%), Positives = 68/186 (36%), Gaps = 49/186 (26%)
Query: 406 TSHFGKESLLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-- 461
F L+ G G VY+ G+L AIKV+D + D+ + E++ LK
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQL-AAIKVMD----VTGDEEEEIKQEINMLKKY 77
Query: 462 --HPNLLP-----LAGYCIAGKEKL-VLLEFMANG---DLHRWLHELPTGEPNVEDWSTD 510
H N+ + ++L +++EF G DL + E
Sbjct: 78 SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE-------- 129
Query: 511 TWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP 570
I+ + R + RGL++LH H + ++LL E+ E
Sbjct: 130 ----------WIAY------ICRE-----ILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168
Query: 571 KIAGFG 576
K+ FG
Sbjct: 169 KLVDFG 174
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 19/92 (20%), Positives = 30/92 (32%), Gaps = 12/92 (13%)
Query: 535 RIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN--VG----- 586
+ + L+YLH +G + L +I+L E + K+ G I G
Sbjct: 186 AYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQ 244
Query: 587 --ERSENETCGPESDVYCFGVILMELLTGKRG 616
E +D+Y G L L
Sbjct: 245 APEIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 36/220 (16%), Positives = 73/220 (33%), Gaps = 22/220 (10%)
Query: 30 LVSKAFSSVSTFNISWLKPTNLNGSNPSTPIREL-NLSSRNLSGIISWKFLRNMSELHSI 88
LV K++ + + + N +P+T IR + S L G N+
Sbjct: 32 LVCKSWYEIERWCRRKVFIGNCYAVSPATVIRRFPKVRSVELKGK-PHFADFNLVPDGWG 90
Query: 89 DLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSS-NRF 147
++ + L ++ L + + +++ F + +VL LSS F
Sbjct: 91 GYVYPWIEAMSSSY----TWLEEIRLKRMVVTDD-CLELIAKS--FKNFKVLVLSSCEGF 143
Query: 148 TN--LVKLSQ-FSKLMVLDVSNNDL-----RILPSGFANLSKLRHLDISSCKISGNIKPV 199
+ L ++ L LD+ +D+ L + L L+IS + +
Sbjct: 144 STDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSAL 203
Query: 200 SFL----HSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235
L +LK L ++ + ++ L
Sbjct: 204 ERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG 243
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 3e-04
Identities = 27/195 (13%), Positives = 65/195 (33%), Gaps = 29/195 (14%)
Query: 29 ELVSKAFSSVSTFNISWLKPTNLNG------SNPSTPIRELNLS--SRNLSGIISWKFLR 80
++ ++ ++ +++G + T + LN+S + +S + +
Sbjct: 149 AAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVT 208
Query: 81 NMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVL 140
L S+ L+ + L ++ G+ R + L
Sbjct: 209 RCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTG--------GYTAEVRPDVYSG---L 257
Query: 141 NLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGN--IKP 198
+++ + L LS F D L + ++ S+L L++S + +K
Sbjct: 258 SVALSGCKELRCLSGFW-----DAVPAYLPAV---YSVCSRLTTLNLSYATVQSYDLVKL 309
Query: 199 VSFLHSLKYLDVSNN 213
+ L+ L V +
Sbjct: 310 LCQCPKLQRLWVLDY 324
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 4e-05
Identities = 53/320 (16%), Positives = 103/320 (32%), Gaps = 80/320 (25%)
Query: 412 ESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPL 468
+LAEG VY A V G A+K L + + + + + +L HPN++
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGR-EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 469 AGYCIAGKEK-------LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSH 521
GKE+ +LL + G L +L ++ + P
Sbjct: 92 CSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGP------------------- 132
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH--LVTSSILLAESLEPKIAGFGLRN 579
T +I R + ++H H L ++LL+ K+ FG
Sbjct: 133 --LSCDTVL----KIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSAT 186
Query: 580 IGVKNVGERSENETC-----------------------------GPESDVYCFGVILMEL 610
+ G + D++ G IL L
Sbjct: 187 TISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246
Query: 611 LTGKRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKR 670
+ +D K + G + + D+ + SL + + + P +R
Sbjct: 247 CFRQHPFEDGAK---LRIVNG--------KYSIPPHDTQYTVFHSL-IRAMLQVN-PEER 293
Query: 671 PTMQQVLGLLKDIRPSADLS 690
++ +V+ L++I + +++
Sbjct: 294 LSIAEVVHQLQEIAAARNVN 313
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 49/226 (21%), Positives = 83/226 (36%), Gaps = 53/226 (23%)
Query: 409 FGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAV--AMFDELSRLK---H 462
F K S L G G V++ P L +A K++ ++ A+ + EL L
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIH----LEIKPAIRNQIIRELQVLHECNS 90
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHEL-PTGEPNVEDWSTDTWDHHPGAGSH 521
P ++ G + E + +E M G L + L + E
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQ------------------I 132
Query: 522 ISSPEKTNWVTRHRIAIGVARGLAYLHHVGS-THGHLVTSSILLAESLEPKIAGFG---- 576
+ +++I V +GL YL H + S+IL+ E K+ FG
Sbjct: 133 LG-----------KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181
Query: 577 LRNIGVK-NVG-------ERSENETCGPESDVYCFGVILMELLTGK 614
L + VG ER + +SD++ G+ L+E+ G+
Sbjct: 182 LIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 6e-05
Identities = 34/230 (14%), Positives = 65/230 (28%), Gaps = 58/230 (25%)
Query: 409 FGKESLLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
+ + G G V+R G A+K + + + L P ++
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQ-CAVKKVRLEVFRVEELVA-----CAGLSSPRIV 113
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWL-HELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
PL G G + +E + G L + + E
Sbjct: 114 PLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL-------------------- 153
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL-AESLEPKIAGFG----LRNI 580
+ GL YLH HG + ++LL ++ + FG L+
Sbjct: 154 ----YYLGQ-----ALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204
Query: 581 GVKNVGERS---------------ENETCGPESDVYCFGVILMELLTGKR 615
G+ + C + D++ +++ +L G
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 43.7 bits (104), Expect = 1e-04
Identities = 51/233 (21%), Positives = 82/233 (35%), Gaps = 65/233 (27%)
Query: 409 FGKESLLAEGRCGPVYRAVLP--GELHVAIKV--LDNAKGIDHDDAVAMFDE---LSRLK 461
+ K L EG VY+ L VA+K L++ +G A+ E L LK
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGA---PCTAI-REVSLLKDLK 58
Query: 462 HPNLLPLAGYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
H N++ L I ++ L L E++ + DL ++L +
Sbjct: 59 HANIVTLHD-IIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINM----------------H 100
Query: 521 HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RN 579
++ + RGLAY H H L ++L+ E E K+A FGL R
Sbjct: 101 NVKL-----------FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA 149
Query: 580 IGVKN------------------VGERSENETCGPESDVYCFGVILMELLTGK 614
+ +G + D++ G I E+ TG+
Sbjct: 150 KSIPTKTYDNEVVTLWYRPPDILLGST----DYSTQIDMWGVGCIFYEMATGR 198
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 47/234 (20%), Positives = 72/234 (30%), Gaps = 80/234 (34%)
Query: 414 LLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPL 468
+ G G L EL VA+K ++ ID + E L+HPN++
Sbjct: 27 DIGSGNFGVARLMRDKLTKEL-VAVKYIERGAAIDE----NVQREIINHRSLRHPNIVRF 81
Query: 469 AGY-CIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
I L + +E+ + G+L+ +
Sbjct: 82 --KEVILTPTHLAIIMEYASGGELYERI-------------------------------- 107
Query: 527 KTNWVTRHRIAIGVAR--------GLAYLHHVGSTHGHLVTSSILLAESLEP--KIAGFG 576
R + AR G++Y H + H L + LL S P KI FG
Sbjct: 108 ----CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFG 163
Query: 577 LRNIGVKNVGERSENETCG-----------------PESDVYCFGVILMELLTG 613
V + +S T G +DV+ GV L +L G
Sbjct: 164 YSKSSVLHSQPKS---TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVG 214
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 44/230 (19%), Positives = 69/230 (30%), Gaps = 56/230 (24%)
Query: 407 SHFGKESLLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLK 461
F + S L G G V++ G L A+K + D A + + +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRL-YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 462 HPNLLPLAGYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
HP + L L L E L + G+
Sbjct: 116 HPCCVRLEQ-AWEEGGILYLQTEL-CGPSLQQHCEA---------------------WGA 152
Query: 521 HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNI 580
+ PE W LA+LH G H + ++I L K+ FGL
Sbjct: 153 SL--PEAQVW----GYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL--- 203
Query: 581 GVKNVGERSENET-CG------PE---------SDVYCFGVILMELLTGK 614
+ +G E G PE +DV+ G+ ++E+
Sbjct: 204 -LVELGTAGAGEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNM 252
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 54/296 (18%), Positives = 95/296 (32%), Gaps = 70/296 (23%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHP 463
+ L +G G V A+KV+ + D ++ E L +L HP
Sbjct: 29 KGQRV--LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ L + ++ E G+L E+ + + E
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGEL---FDEIISRKRFSE------------------ 125
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA---ESLEPKIAGFGLRNI 580
+ R V G+ Y+H H L ++LL + +I FGL
Sbjct: 126 --VDAARIIRQ-----VLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGL--- 175
Query: 581 GVKNVGERSENETCG---------------PESDVYCFGVILMELLTGKR----GTDDCV 621
+ + G + DV+ GVIL LL+G + +
Sbjct: 176 STHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDI 235
Query: 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
K V++G + +L V+E + L + + T P R + + L
Sbjct: 236 L---KKVEKG------KYTFELPQWKKVSESAKDL-IRKMLTYV-PSMRISARDAL 280
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 30/164 (18%), Positives = 53/164 (32%), Gaps = 41/164 (25%)
Query: 82 MSELHSIDLSNNSLKGSVPGWF-------WSTQSLTQVNLSKNRFG--GTIGFKPTSRNG 132
+S L ++L+ + + +L +VNL+ + G P
Sbjct: 71 LSSLRQLNLAGVRM--TPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLR- 127
Query: 133 PFPSVQVLNLSSNRFTN-----LVKL--SQFSKLMVLDVSNNDL-----RILPSGFANLS 180
+ L L N L L ++ L +SNN L +L G A +
Sbjct: 128 ----ARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNT 183
Query: 181 KLRHLDISSCKIS--GNIKPVSFL-------HSLKYLDVSNNSM 215
+ HL + + G + L L+ L+V+ N
Sbjct: 184 SVTHLSLLHTGLGDEG----LELLAAQLDRNRQLQELNVAYNGA 223
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 5e-04
Identities = 49/235 (20%), Positives = 74/235 (31%), Gaps = 61/235 (25%)
Query: 408 HFGKESLLAEGRCGPVYRAV--LPGELHVAIKVLDNAK-----GIDHDDAVAMFDE---L 457
K L G CG V A + VAI+++ K + D A+ + E L
Sbjct: 138 IMSKT--LGSGACGEVKLAFERKTCKK-VAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 458 SRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG 517
+L HP ++ + + A +V LE M G+L +
Sbjct: 195 KKLNHPCIIKIKNFFDAEDYYIV-LELMEGGELFDKVVG--------------------- 232
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP---KIAG 574
+ E T + + + YLH G H L ++LL+ E KI
Sbjct: 233 ---NKRLKEAT---CKL-YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITD 285
Query: 575 FGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLTG 613
FG I + V D + GVIL L+G
Sbjct: 286 FGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 6e-04
Identities = 58/311 (18%), Positives = 99/311 (31%), Gaps = 72/311 (23%)
Query: 336 KILARRNKWAISKPVNQQLPFKVEKSGPFSFETESGTSWMADIKEPTSAAVIMCSKPLVN 395
+I+A NK SKP P + ++ + + +
Sbjct: 81 RIIAE-NKHGQSKPCEPTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDI 139
Query: 396 YLTFKDLIAATSH--------FGKESLLAEGRCGPVYRAV--LPGELHVAIKVLDNAKGI 445
+ + H +E L G G V+R G A K +
Sbjct: 140 WKQYYPQPVEIKHDHVLDHYDIHEE--LGTGAFGVVHRVTERATGNN-FAAKFVMTPHES 196
Query: 446 DHDDAVAMFDE---LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDL-HRWLHELPTGE 501
D + + E +S L+HP L+ L E +++ EFM+ G+L + E
Sbjct: 197 DKET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE----- 248
Query: 502 PNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVAR----GLAYLHHVGSTHGHL 557
+ +S E A+ R GL ++H H L
Sbjct: 249 -----------------HNKMSEDE----------AVEYMRQVCKGLCHMHENNYVHLDL 281
Query: 558 VTSSILLAESLEP--KIAGFGL-RNIGVKN-----VG-------ERSENETCGPESDVYC 602
+I+ K+ FGL ++ K G E +E + G +D++
Sbjct: 282 KPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWS 341
Query: 603 FGVILMELLTG 613
GV+ LL+G
Sbjct: 342 VGVLSYILLSG 352
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 690 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-34 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-34 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-33 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-32 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-32 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-31 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-30 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-30 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-30 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-30 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-30 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-29 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-28 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-28 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 4e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-28 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 9e-28 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-27 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 6e-27 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 7e-27 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-25 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-24 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-24 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-23 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-23 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-23 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 8e-23 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-16 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-08 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-06 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-05 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-21 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-21 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-20 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-19 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-19 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-19 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-18 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-18 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 8e-18 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-17 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-17 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-16 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-16 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-16 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-15 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-15 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 7e-15 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-09 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-15 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-14 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-14 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-14 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 4e-13 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-12 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-12 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-05 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-11 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-11 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 9e-10 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-09 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-08 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.003 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 6e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-04 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 0.003 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 7e-08 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.003 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 8e-08 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-07 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 0.002 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 5e-05 | |
| d1m9la_ | 198 | c.10.3.1 (A:) Outer arm dynein light chain 1 {Gree | 2e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 3e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 4e-39
Identities = 69/304 (22%), Positives = 107/304 (35%), Gaps = 62/304 (20%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHP 463
+ G G VY+ G+ VA+K+L N A +E L + +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD--VAVKML-NVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N+L GY A + +V ++ L+ LH + T
Sbjct: 65 NILLFMGYSTAPQLAIVT-QWCEGSSLYHHLHIIET------------------------ 99
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK 583
K + IA A+G+ YLH H L +++I L E L KI FGL + +
Sbjct: 100 ---KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSR 156
Query: 584 NVGERSENETCG------PE-------------SDVYCFGVILMELLTGKR--GTDDCVK 622
G + G PE SDVY FG++L EL+TG+ +
Sbjct: 157 WSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 216
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682
+ +V G L L + M + C +RP Q+L ++
Sbjct: 217 QIIFMVGRG----YLSPDLSKVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIEL 269
Query: 683 IRPS 686
+ S
Sbjct: 270 LARS 273
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (336), Expect = 2e-35
Identities = 70/302 (23%), Positives = 114/302 (37%), Gaps = 40/302 (13%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELH------VAIKVLDNAKGID-HDDAVAMFDELSR 459
++ + EG G V++A PG L VA+K+L D D ++
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72
Query: 460 LKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
+PN++ L G C GK +L E+MA GDL+ +L + S +
Sbjct: 73 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV--- 129
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRN 579
P + + IA VA G+AYL H L T + L+ E++ KIA FGL
Sbjct: 130 -SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 188
Query: 580 IGVKNVGERSENETCGP----------------ESDVYCFGVILMELLTGKRG--TDDCV 621
+++ P ESDV+ +GV+L E+ +
Sbjct: 189 NIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248
Query: 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681
+ V V++G L +E + LC + P RP+ + +L+
Sbjct: 249 EEVIYYVRDGN-------ILACPENCP----LELYNLMRLCWSKLPADRPSFCSIHRILQ 297
Query: 682 DI 683
+
Sbjct: 298 RM 299
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-34
Identities = 61/299 (20%), Positives = 106/299 (35%), Gaps = 56/299 (18%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
L G+ G V+ G VA+K L + D +A + + +L+H L+
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L ++ E+M NG L +L S
Sbjct: 72 RLYAVVTQEPIYIIT-EYMENGSLVDFLKT--------------------------PSGI 104
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
K +A +A G+A++ H L ++IL++++L KIA FGL + N
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164
Query: 587 ERS---------------ENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLVK 629
T +SDV+ FG++L E++T R V + ++
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
Query: 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSAD 688
G +R+ E ++ LC + P RPT + +L+D + +
Sbjct: 225 RG-------YRMVRPDNCP----EELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 2e-34
Identities = 56/294 (19%), Positives = 102/294 (34%), Gaps = 58/294 (19%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
+ +G G V G VA+K + N +A +++L+H NL+
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYRGNK-VAVKCIKNDA--TAQAFLAEASVMTQLRHSNLV 63
Query: 467 PLAGYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
L G + K L + E+MA G L +L
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS--------------------------RGR 97
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNV 585
+ ++ V + YL H L ++L++E K++ FGL
Sbjct: 98 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157
Query: 586 G-----------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLVKEGA 632
E + +SDV+ FG++L E+ + R +K V V++G
Sbjct: 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG- 216
Query: 633 GGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684
+++ G +V E++++ C RP+ Q+ L+ I+
Sbjct: 217 ------YKMDAPDGCPPAVYEVMKN------CWHLDAAMRPSFLQLREQLEHIK 258
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 8e-33
Identities = 53/294 (18%), Positives = 98/294 (33%), Gaps = 56/294 (19%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
L G+ G V G+ VAIK++ + D+ + + L H L+
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L G C + ++ E+MANG L +L E
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE---------------------------MRH 95
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
+ + V + YL H L + L+ + K++ FGL + +
Sbjct: 96 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155
Query: 587 ---------------ERSENETCGPESDVYCFGVILMELLTGKRG--TDDCVKWVRKLVK 629
E +SD++ FGV++ E+ + + + +
Sbjct: 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215
Query: 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+G L+L +E V ++ Y C + +RPT + +L + D+
Sbjct: 216 QG---------LRLYRPHLASEKVYTI--MYSCWHEKADERPTFKILLSNILDV 258
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (317), Expect = 8e-33
Identities = 61/332 (18%), Positives = 109/332 (32%), Gaps = 81/332 (24%)
Query: 391 KPLVNYLTFKDLIAATSHFGKE---------SLLAEGRCGPVYRAVLPG----ELHVAIK 437
K ++ TF+D A F KE ++ G G V L E+ VAIK
Sbjct: 1 KIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK 60
Query: 438 VLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWL 494
L G E + + HPN++ L G +++ EFM NG L +L
Sbjct: 61 TLK--SGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFL 118
Query: 495 HELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTH 554
+ + + + + G+A G+ YL + H
Sbjct: 119 RQ---------------------------NDGQFTVIQLVGMLRGIAAGMKYLADMNYVH 151
Query: 555 GHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSENETCG------------------- 595
L +IL+ +L K++ FGL + + + G
Sbjct: 152 RDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 211
Query: 596 PESDVYCFGVILMELLTGKR---GTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEM 652
SDV+ +G+++ E+++ + + + D+RL +
Sbjct: 212 SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ--------DYRL-----PPPMDC 258
Query: 653 VESLR-VGYLCTADSPGKRPTMQQVLGLLKDI 683
+L + C RP Q++ L +
Sbjct: 259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-32
Identities = 56/297 (18%), Positives = 101/297 (34%), Gaps = 56/297 (18%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
S + G+ G V+ + VAIK + + +D + + + +L HP L+
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L G C+ ++ EFM +G L + +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDY---------------------------LRTQRG 96
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
T + + V G+AYL H L + L+ E+ K++ FG+ + +
Sbjct: 97 LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156
Query: 587 ---------------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLVK 629
E +SDV+ FGV++ E+ + + + V + +
Sbjct: 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216
Query: 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686
G FRL S ++ C + P RP ++L L +I S
Sbjct: 217 TG-------FRLYKPRLAS----THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 2e-32
Identities = 70/303 (23%), Positives = 104/303 (34%), Gaps = 50/303 (16%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPGELH------VAIKVLDNAKGIDHDDAVAM-FDELSRL 460
FGK L G G V A G + VA+K+L + + +A+ LS L
Sbjct: 26 SFGKT--LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83
Query: 461 K-HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
H N++ L G C G LV+ E+ GDL +L + D
Sbjct: 84 GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL--- 140
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRN 579
+ + VA+G+A+L H L +ILL KI FGL
Sbjct: 141 -------ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLAR 193
Query: 580 IGVKNVGERSENETCGP----------------ESDVYCFGVILMELLTGKRGTDDC--- 620
+ + P ESDV+ +G+ L EL +
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680
K++KEG FR+ E + C P KRPT +Q++ L+
Sbjct: 254 DSKFYKMIKEG-------FRMLSPEHAP----AEMYDIMKTCWDADPLKRPTFKQIVQLI 302
Query: 681 KDI 683
+
Sbjct: 303 EKQ 305
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 56/297 (18%), Positives = 100/297 (33%), Gaps = 47/297 (15%)
Query: 414 LLAEGRCGPVYRAVLPG------ELHVAIKVLDNAKGIDHDDAVAMFDELSRLK----HP 463
+L G G V A G + VA+K+L + D + A+ EL + H
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALMSELKMMTQLGSHE 101
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ L G C ++ E+ GDL +L E + ++
Sbjct: 102 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK 583
+ + A VA+G+ +L H L ++L+ KI FGL +
Sbjct: 162 T-----FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216
Query: 584 NVGERSENETCGP----------------ESDVYCFGVILMELLTGKR---GTDDCVKWV 624
+ P +SDV+ +G++L E+ +
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276
Query: 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681
KL++ G F++ + E+ ++ C A KRP+ + L
Sbjct: 277 YKLIQNG-------FKMDQPFYAT-EEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG 322
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 120 bits (301), Expect = 1e-30
Identities = 65/296 (21%), Positives = 106/296 (35%), Gaps = 49/296 (16%)
Query: 412 ESLLAEGRCGPVYRAVLPG---ELHVAIKVLDNAKGIDHDDAVAMFDELSRLK----HPN 464
+ ++ EG G V +A + + AIK + + DD EL L HPN
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK--EYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
++ L G C + +E+ +G+L +L + + + P S+
Sbjct: 73 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRK------------SRVLETDPAFAIANST 120
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN 584
+ A VARG+ YL H L +IL+ E+ KIA FGL
Sbjct: 121 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180
Query: 585 VG-------------ERSENETCGPESDVYCFGVILMELLTGKR---GTDDCVKWVRKLV 628
V E SDV+ +GV+L E+++ C + KL
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 240
Query: 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684
+ L D V +++ C + P +RP+ Q+L L +
Sbjct: 241 Q------GYRLEKPLNCDDEVYDLMRQ------CWREKPYERPSFAQILVSLNRML 284
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (299), Expect = 1e-30
Identities = 61/294 (20%), Positives = 101/294 (34%), Gaps = 56/294 (19%)
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
E L +G G V+ G VAIK L + + + + +L+H L+ L
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAV 80
Query: 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWV 531
+V E+M+ G L +L + +
Sbjct: 81 VSEEPIYIVT-EYMSKGSLLDFLKG--------------------------ETGKYLRLP 113
Query: 532 TRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERS-- 589
+A +A G+AY+ + H L ++IL+ E+L K+A FGL + N
Sbjct: 114 QLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
Query: 590 -------------ENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLVKEGAGG 634
+SDV+ FG++L EL T R + V V+ G
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG--- 230
Query: 635 DALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSAD 688
++ E + L C P +RPT + + L+D S +
Sbjct: 231 ------YRMPCPPECPESLHDL--MCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-30
Identities = 61/297 (20%), Positives = 91/297 (30%), Gaps = 66/297 (22%)
Query: 415 LAEGRCGPVYRAVLPGE----LHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLP 467
L +G G V R + VA+K L + E + L H NL+
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
L G + K+V E G L
Sbjct: 76 LYGVVLTPPMKMVT-ELAPLGSLLDR---------------------------LRKHQGH 107
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGE 587
T R A+ VA G+ YL H L ++LLA KI FGL +N
Sbjct: 108 FLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 167
Query: 588 RS-----------------ENETCGPESDVYCFGVILMELLTGKR---GTDDCVKWVRKL 627
+ T SD + FGV L E+ T + + + + K+
Sbjct: 168 YVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227
Query: 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684
KEG +L + + + ++ C A P RPT + L + +
Sbjct: 228 DKEG---------ERLPRPEDCPQDIYNV--MVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 117 bits (295), Expect = 6e-30
Identities = 58/302 (19%), Positives = 110/302 (36%), Gaps = 56/302 (18%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNL 465
+ + L G+ G VY V L VA+K L ++ ++ + + +KHPNL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNL 75
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G C ++ EFM G+L +L E +
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRE--------------------------CNR 109
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNV 585
++ + V +A ++ + YL H L + L+ E+ K+A FGL + +
Sbjct: 110 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169
Query: 586 GERS---------------ENETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKLV 628
+SDV+ FGV+L E+ T + V +L+
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 229
Query: 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSAD 688
++ D+R++ G + + C +P RP+ ++ + + +
Sbjct: 230 EK-------DYRMERPEGCP----EKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278
Query: 689 LS 690
+S
Sbjct: 279 IS 280
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (295), Expect = 6e-30
Identities = 47/326 (14%), Positives = 96/326 (29%), Gaps = 80/326 (24%)
Query: 412 ESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY 471
+ + +GR G V+R GE VA+K+ + + A + L+H N+L
Sbjct: 8 QESIGKGRFGEVWRGKWRGEE-VAVKIFSS-REERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 472 CI----AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
+ ++ ++ +G L +L+
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYLNR-----------------------------YT 96
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGST--------HGHLVTSSILLAESLEPKIAGFGLRN 579
++A+ A GLA+LH H L + +IL+ ++ IA GL
Sbjct: 97 VTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156
Query: 580 I--GVKNVGERSENETCG------PE----------------SDVYCFGVILMELLTGKR 615
+ + + N G PE +D+Y G++ E+
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 616 GTDD------------CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCT 663
+ +++ L + S + ++ C
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP-NRWQSCEALRVMAKIMRECW 275
Query: 664 ADSPGKRPTMQQVLGLLKDIRPSADL 689
+ R T ++ L + +
Sbjct: 276 YANGAARLTALRIKKTLSQLSQQEGI 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 8e-30
Identities = 59/308 (19%), Positives = 101/308 (32%), Gaps = 72/308 (23%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPG----ELHVAIKVLDNAKGIDHDDAVAMFDE---LSRL 460
HF + ++ G G VY L ++H A+K L+ + D + E +
Sbjct: 30 HFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDF 85
Query: 461 KHPNLLPLAGYCIAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
HPN+L L G C+ + ++ L +M +GDL +
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF-------------------------- 119
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRN 579
+ + VA+G+ +L H L + +L E K+A FGL
Sbjct: 120 -IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 178
Query: 580 IGVKNVGERSENET------------------CGPESDVYCFGVILMELLTGKR---GTD 618
+ N+T +SDV+ FGV+L EL+T
Sbjct: 179 DMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238
Query: 619 DCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678
+ L++ RL + E V C RP+ +++
Sbjct: 239 NTFDITVYLLQ--------GRRLLQPEYCP-DPLYE---VMLKCWHPKAEMRPSFSELVS 286
Query: 679 LLKDIRPS 686
+ I +
Sbjct: 287 RISAIFST 294
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 117 bits (294), Expect = 1e-29
Identities = 58/305 (19%), Positives = 94/305 (30%), Gaps = 60/305 (19%)
Query: 392 PLVNYLTFKDLIAATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDA 450
P V L FKD F + G G VY A + VAIK + + ++
Sbjct: 2 PDVAELFFKDDP--EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 451 VAMFDE---LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDW 507
+ E L +L+HPN + G + +++E+
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVH----------- 108
Query: 508 STDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567
+ V + G +GLAYLH H + +ILL+E
Sbjct: 109 -----------------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151
Query: 568 LEPKIAGFGLRNIGVKN---VG----------ERSENETCGPESDVYCFGVILMELLTGK 614
K+ FG +I VG + + DV+ G+ +EL K
Sbjct: 152 GLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
Query: 615 R--GTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT 672
+ + + + + L SG + C P RPT
Sbjct: 212 PPLFNMNAMSALYHIAQNE--------SPALQSGHWSEYFRNFVD---SCLQKIPQDRPT 260
Query: 673 MQQVL 677
+ +L
Sbjct: 261 SEVLL 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 9e-29
Identities = 63/303 (20%), Positives = 110/303 (36%), Gaps = 60/303 (19%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPGELH------VAIKVLDNAKGIDHDDAVAMFDE---LS 458
+E L +G G VY V G + VAIK ++ + + + +E +
Sbjct: 23 TMSRE--LGQGSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMK 78
Query: 459 RLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA 518
+++ L G G+ LV++E M GDL +L A
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR------------------SLRPA 120
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLR 578
++ + ++A +A G+AYL+ H L + ++AE KI FG+
Sbjct: 121 MANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 180
Query: 579 NIGVKNVGERSENETCGP----------------ESDVYCFGVILMELLTGKRG--TDDC 620
+ R + P SDV+ FGV+L E+ T
Sbjct: 181 RDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLL 680
+ V + V EG L D+ +M+ L +C +P RP+ +++ +
Sbjct: 241 NEQVLRFVMEGG---------LLDKPDNCPDMLFEL--MRMCWQYNPKMRPSFLEIISSI 289
Query: 681 KDI 683
K+
Sbjct: 290 KEE 292
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (285), Expect = 1e-28
Identities = 65/307 (21%), Positives = 105/307 (34%), Gaps = 55/307 (17%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPGELH------VAIKVLDNAKGIDHDDAVAMFDELSRL 460
L G G V A G VA+K+L +G H + A+ EL L
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKIL 70
Query: 461 K----HPNLLPLAGYCI-AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHH 515
H N++ L G C G +V++EF G+L +L S
Sbjct: 71 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR------------SKRNEFVP 118
Query: 516 PGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGF 575
+ + VA+G+ +L H L +ILL+E KI F
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDF 178
Query: 576 GLRNIGVKNVGERSENETCGP----------------ESDVYCFGVILMELLTGKR---G 616
GL K+ + + P +SDV+ FGV+L E+ +
Sbjct: 179 GLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 238
Query: 617 TDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQV 676
+ + +KEG R++ + E + C P +RPT ++
Sbjct: 239 GVKIDEEFCRRLKEG-------TRMRAPDYTT----PEMYQTMLDCWHGEPSQRPTFSEL 287
Query: 677 LGLLKDI 683
+ L ++
Sbjct: 288 VEHLGNL 294
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (284), Expect = 1e-28
Identities = 61/310 (19%), Positives = 102/310 (32%), Gaps = 67/310 (21%)
Query: 400 KDLIAATSHFGKESL-LAEGRCGPVYRAVL---PGELHVAIKVLDNAKGIDHDDAVAMFD 455
K L + + L G G V + V ++ VAIKVL +G + D M
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLK--QGTEKADTEEMMR 58
Query: 456 E---LSRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTW 512
E + +L +P ++ L G C A LV+ E G LH++L
Sbjct: 59 EAQIMHQLDNPYIVRLIGVCQAEALMLVM-EMAGGGPLHKFLV----------------- 100
Query: 513 DHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKI 572
E+ + V+ G+ YL H L ++LL KI
Sbjct: 101 ----------GKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKI 150
Query: 573 AGFGL-RNIGVKNVGERSENETCGP----------------ESDVYCFGVILMELLTGKR 615
+ FGL + +G + + + P SDV+ +GV + E L+ +
Sbjct: 151 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
Query: 616 G--TDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673
V +++G R++ E+ + C RP
Sbjct: 211 KPYKKMKGPEVMAFIEQG-------KRMECPPECP-PELYALMS---DCWIYKWEDRPDF 259
Query: 674 QQVLGLLKDI 683
V ++
Sbjct: 260 LTVEQRMRAC 269
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 113 bits (283), Expect = 2e-28
Identities = 50/292 (17%), Positives = 93/292 (31%), Gaps = 59/292 (20%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
+ L +G G VY+A + A KV+D + +D + D L+ HPN++
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIV 72
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L +L+EF A G + + EL
Sbjct: 73 KLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLT------------------------ 108
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNV- 585
+ L YLH H L +IL + K+A FG+ + +
Sbjct: 109 ---ESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ 165
Query: 586 ------------------GERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVR 625
E S++ ++DV+ G+ L+E+ + + ++ +
Sbjct: 166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL 225
Query: 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
K+ K + + + ++ C + R T Q+L
Sbjct: 226 KIAK----SEPPTLAQPSRWSSNFKDFLKK------CLEKNVDARWTTSQLL 267
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 4e-28
Identities = 57/309 (18%), Positives = 107/309 (34%), Gaps = 67/309 (21%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPG-----ELHVAIKVLDNAKGIDHDDAVAMFDE---LS 458
S ++ ++ G G VY+ +L E+ VAIK L G V E +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--AGYTEKQRVDFLGEAGIMG 64
Query: 459 RLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA 518
+ H N++ L G K +++ E+M NG L ++
Sbjct: 65 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF------------------------- 99
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLR 578
+ + + + G+A G+ YL ++ H L +IL+ +L K++ FGL
Sbjct: 100 --LREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 157
Query: 579 NIGVKNVG-----------------ERSENETCGPESDVYCFGVILMELLTGKR--GTDD 619
+ + E SDV+ FG+++ E++T +
Sbjct: 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217
Query: 620 CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679
V K + +G +L + + L C +RP ++ +
Sbjct: 218 SNHEVMKAINDG---------FRLPTPMDCPSAIYQL--MMQCWQQERARRPKFADIVSI 266
Query: 680 LKDIRPSAD 688
L + + D
Sbjct: 267 LDKLIRAPD 275
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 69/307 (22%), Positives = 104/307 (33%), Gaps = 55/307 (17%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLPG--------ELHVAIKVLDNAKGIDHDDAVAMFDELS 458
L EG G V A G VA+K+L D + E+
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLK--SDATEKDLSDLISEME 70
Query: 459 RLK----HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDH 514
+K H N++ L G C V++E+ + G+L +L
Sbjct: 71 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQA------------RRPPGL 118
Query: 515 HPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAG 574
+ E+ + A VARG+ YL H L ++L+ E KIA
Sbjct: 119 EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIAD 178
Query: 575 FGLRNIGVKNVGERSENETCGP----------------ESDVYCFGVILMELLTGKR--G 616
FGL + P +SDV+ FGV+L E+ T
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238
Query: 617 TDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQV 676
V+ + KL+KEG R+ S + E + C P +RPT +Q+
Sbjct: 239 PGVPVEELFKLLKEG-------HRMDKPSNCT----NELYMMMRDCWHAVPSQRPTFKQL 287
Query: 677 LGLLKDI 683
+ L I
Sbjct: 288 VEDLDRI 294
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (279), Expect = 9e-28
Identities = 47/304 (15%), Positives = 106/304 (34%), Gaps = 58/304 (19%)
Query: 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPN 464
+ + + +G G VY A+ + VAI+ ++ + + + + K+PN
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
++ + G E V++E++A G L + E
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE---------------------------- 110
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL------- 577
+ + + L +LH H + + +ILL K+ FG
Sbjct: 111 -TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 578 RNIGVKNVG-------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLV 628
++ VG E + GP+ D++ G++ +E++ G+ ++ ++ + +
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA 229
Query: 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG--LLKDIRPS 686
G + + + + C KR + +++L LK +P
Sbjct: 230 TNG----TPELQNPEKLSAIFRDFLNR------CLDMDVEKRGSAKELLQHQFLKIAKPL 279
Query: 687 ADLS 690
+ L+
Sbjct: 280 SSLT 283
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 9e-28
Identities = 55/298 (18%), Positives = 96/298 (32%), Gaps = 66/298 (22%)
Query: 411 KESLLAEGRCGPVYRAVLPGE---LHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPN 464
++ L G G V + + VA+K+L N + D + E + +L +P
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPY 69
Query: 465 LLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISS 524
++ + G C A LV +E G L+++L +
Sbjct: 70 IVRMIGICEAESWMLV-MEMAELGPLNKYLQQ---------------------------- 100
Query: 525 PEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL------- 577
+ V+ G+ YL H L ++LL KI+ FGL
Sbjct: 101 NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160
Query: 578 ---RNIGVKNVG-------ERSENETCGPESDVYCFGVILMELLTGKRG--TDDCVKWVR 625
E +SDV+ FGV++ E + + V
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220
Query: 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
++++G R+ +G EM + + LC RP V L++
Sbjct: 221 AMLEKG-------ERMGCPAGCP-REMYDLMN---LCWTYDVENRPGFAAVELRLRNY 267
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (277), Expect = 1e-27
Identities = 58/289 (20%), Positives = 100/289 (34%), Gaps = 55/289 (19%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAM-FDELSRLKHPNL 465
+ L EG G V AV E VA+K++D + +D + + L H N+
Sbjct: 6 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 65
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ G+ G + + LE+ + G+L +
Sbjct: 66 VKFYGHRREGNIQYLFLEYCSGGELFDRIE----------------------------PD 97
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNV 585
R + G+ YLH +G TH + ++LL E KI+ FGL + N
Sbjct: 98 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157
Query: 586 GERSENETCG------PE-----------SDVYCFGVILMELLTGKRGTDDCVKWVRKLV 628
ER N+ CG PE DV+ G++L +L G+ D ++
Sbjct: 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 217
Query: 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
L+ K+ + ++ ++P R T+ +
Sbjct: 218 DWKEKKTYLNPWKKI--DSAPLALLHK------ILVENPSARITIPDIK 258
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (271), Expect = 6e-27
Identities = 57/289 (19%), Positives = 101/289 (34%), Gaps = 59/289 (20%)
Query: 407 SHFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKH 462
F L +G+ G VY A + +A+KVL A+ + E S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
PN+L L GY ++LE+ G ++R L +
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQK-------------------------- 99
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL----- 577
K + +A L+Y H H + ++LL + E KIA FG
Sbjct: 100 --LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 157
Query: 578 RNIGVKNVG-------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLV 628
+ G E E + D++ GV+ E L GK + + +++
Sbjct: 158 SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 217
Query: 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+ ++F + +++ +P +RP +++VL
Sbjct: 218 R-------VEFTFPDFVTEGARDLISR------LLKHNPSQRPMLREVL 253
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 7e-27
Identities = 45/226 (19%), Positives = 79/226 (34%), Gaps = 43/226 (19%)
Query: 405 ATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLD-NAKGIDHDDAVAMFDELSRLKH 462
F K S L G G V++ P L +A K++ K + + L
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
P ++ G + E + +E M G L + L +
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-------------------------- 97
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHV-GSTHGHLVTSSILLAESLEPKIAGFGLRNIG 581
+ +++I V +GL YL H + S+IL+ E K+ FG+
Sbjct: 98 --AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL 155
Query: 582 VKN-----VG-------ERSENETCGPESDVYCFGVILMELLTGKR 615
+ + VG ER + +SD++ G+ L+E+ G+
Sbjct: 156 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 104 bits (259), Expect = 9e-25
Identities = 57/288 (19%), Positives = 101/288 (35%), Gaps = 54/288 (18%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
H+ L G G V+R + A K + D + +S L+HP L+
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLV 86
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L E +++ EFM+ G+L + +
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVAD---------------------------EHN 119
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA--ESLEPKIAGFGL-RNIGVK 583
K + V +GL ++H H L +I+ S E K+ FGL ++ K
Sbjct: 120 KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179
Query: 584 NVG------------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLVK 629
E +E + G +D++ GV+ LL+G G ++ + +R +
Sbjct: 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239
Query: 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
D+ + + ++E + + L AD P R T+ Q L
Sbjct: 240 C-------DWNMDDSAFSGISEDGKDF-IRKLLLAD-PNTRMTIHQAL 278
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-24
Identities = 51/301 (16%), Positives = 96/301 (31%), Gaps = 67/301 (22%)
Query: 409 FGKESLLAEGRCGPVYRAVLPGE-----LHVAIKVLDNAKGIDHDDAVAMFDE---LSRL 460
F K +L G G VY+ + E + VAIK L + + DE ++ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASV 68
Query: 461 KHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
+P++ L G C+ +L+ + M G L +
Sbjct: 69 DNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDY--------------------------- 100
Query: 521 HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNI 580
+ + +A+G+ YL H L ++L+ KI FGL +
Sbjct: 101 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL 160
Query: 581 GVKNVGERSENETCGP----------------ESDVYCFGVILMELLTGKR--GTDDCVK 622
E P +SDV+ +GV + EL+T
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682
+ ++++G RL + ++ + C RP ++++
Sbjct: 221 EISSILEKG-------ERLPQPPICT----IDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
Query: 683 I 683
+
Sbjct: 270 M 270
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 101 bits (252), Expect = 8e-24
Identities = 50/288 (17%), Positives = 94/288 (32%), Gaps = 54/288 (18%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
++ L G G V+R V K ++ +D +++L HP L+
Sbjct: 30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLI 89
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
L E +++LEF++ G+L + +
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIA---------------------------AEDY 122
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP--KIAGFGL------R 578
K + GL ++H H + +I+ KI FGL
Sbjct: 123 KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182
Query: 579 NIGVKNVG-------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLVK 629
I E + E G +D++ GV+ LL+G +D ++ ++ + +
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
Query: 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
D+ + SV+ + + L + P KR T+ L
Sbjct: 243 C-------DWEFDEDAFSSVSPEAKDF-IKNLLQKE-PRKRLTVHDAL 281
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.9 bits (246), Expect = 1e-23
Identities = 42/289 (14%), Positives = 86/289 (29%), Gaps = 60/289 (20%)
Query: 414 LLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAM--FDELSRLKHPNLLPLAG 470
+ G G + + K LD + + + + + L LKHPN++
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 471 YCIAGKEKLVLL--EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
I + + E+ GDL + + +
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITK------------------------GTKERQYL 106
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLV-----TSSILLAESLEPKIAGFGLRNIGVK 583
+ R+ + L H ++ +++ L K+ FGL I
Sbjct: 107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 166
Query: 584 NVG--------------ERSENETCGPESDVYCFGVILMELLTGKRG-TDDCVKWVRKLV 628
+ E+ + +SD++ G +L EL T K + +
Sbjct: 167 DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI 226
Query: 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+EG R+ D + E++ RP+++++L
Sbjct: 227 REGK-----FRRIPYRYSDELNEIITR------MLNLKDYHRPSVEEIL 264
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.7 bits (245), Expect = 1e-23
Identities = 50/297 (16%), Positives = 92/297 (30%), Gaps = 71/297 (23%)
Query: 414 LLAEGRCGPVYRAVLPGE----LHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNL 465
+ EG+ G V++ + L VAIK N D F + + + HP++
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT---SDSVREKFLQEALTMRQFDHPHI 70
Query: 466 LPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSP 525
+ L G +++ E G+L +L
Sbjct: 71 VKLIGVITENPVWIIM-ELCTLGELRSFLQVRKYSLD----------------------- 106
Query: 526 EKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNV 585
+ A ++ LAYL H + ++L++ + K+ FGL +
Sbjct: 107 ----LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162
Query: 586 GERS---------------ENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLV 628
++ SDV+ FGV + E+L V +
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222
Query: 629 KEGAGGDALDFRLKLGSG--DSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683
+ G RL + ++ ++ C A P +RP ++ L I
Sbjct: 223 ENG-------ERLPMPPNCPPTLYSLMTK------CWAYDPSRRPRFTELKAQLSTI 266
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.4 bits (242), Expect = 4e-23
Identities = 53/297 (17%), Positives = 92/297 (30%), Gaps = 73/297 (24%)
Query: 409 FGKESLLAEGRCGPVYRAVLPGE-LHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPN 464
F E + G VY+ + + VA L + K + + +E L L+HPN
Sbjct: 13 FDIE--IGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKGLQHPN 69
Query: 465 LLPLAGYC---IAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
++ + GK+ +VL E M +G L +L
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---------------------- 107
Query: 521 HISSPEKTNWVTRHRIAIGVARGLAYLHHVGST--HGHLVTSSILL-AESLEPKIAGFGL 577
+ +GL +LH H L +I + + KI GL
Sbjct: 108 ------VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGL 161
Query: 578 RNIGVKNVGERSENETCG------PE---------SDVYCFGVILMELLTGKR--GTDDC 620
+ G PE DVY FG+ ++E+ T +
Sbjct: 162 ATL----KRASFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQN 217
Query: 621 VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+ + V G + V E++E C + +R +++ +L
Sbjct: 218 AAQIYRRVTSG----VKPASFDKVAIPEVKEIIEG------CIRQNKDERYSIKDLL 264
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 97.8 bits (243), Expect = 8e-23
Identities = 44/284 (15%), Positives = 88/284 (30%), Gaps = 55/284 (19%)
Query: 412 ESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAG 470
L G G V+R V + K + KG D L+ +H N+L L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNILHLHE 68
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
+ +E +++ EF++ D+ ++ S + N
Sbjct: 69 SFESMEELVMIFEFISGLDIFERINT---------------------------SAFELNE 101
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA--ESLEPKIAGFGL-RNIGVKN--- 584
V L +LH H + +I+ S KI FG R + +
Sbjct: 102 REIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161
Query: 585 ---------VGERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVRKLVKEGAG 633
E +++ +D++ G ++ LL+G + + + ++
Sbjct: 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA--- 218
Query: 634 GDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
++ + ++ V L + R T + L
Sbjct: 219 ----EYTFDEEAFKEISIEAMDF-VDRLLVKE-RKSRMTASEAL 256
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 97.9 bits (243), Expect = 1e-22
Identities = 42/289 (14%), Positives = 81/289 (28%), Gaps = 58/289 (20%)
Query: 408 HFGKESLLAEGRCGPVYRAVLP--GELHVAIKVLDNAKGIDHDDAVAMFDE------LSR 459
F ++ G G VY G++ A+K LD + +E +S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKM-YAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 460 LKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
P ++ ++ + +L+ M GDLH L +
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ----------------------- 100
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-- 577
+ A + GL ++H+ + L ++ILL E +I+ GL
Sbjct: 101 -----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC 155
Query: 578 -----------RNIGVKNVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRK 626
G + +D + G +L +LL G +
Sbjct: 156 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215
Query: 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQ 675
+ A++ + ++E +R
Sbjct: 216 EIDRMTLTMAVELPDSF--SPELRSLLEG------LLQRDVNRRLGCLG 256
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 95.8 bits (237), Expect = 8e-22
Identities = 41/229 (17%), Positives = 87/229 (37%), Gaps = 23/229 (10%)
Query: 1 MKIFCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPI 60
L L +L+ + + N V +++ + + + +++ T +
Sbjct: 162 GNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGILTNL 221
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
EL+L+ L I + L +++ L +DL+NN + P LT++ L N+
Sbjct: 222 DELSLNGNQLKDIGT---LASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQIS 276
Query: 121 GTIGFKPTS----------------RNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDV 164
+ ++ L L N +++ +S +KL L
Sbjct: 277 NISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFF 336
Query: 165 SNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNN 213
+NN + + S ANL+ + L +IS P++ L + L +++
Sbjct: 337 ANNKVSDVSS-LANLTNINWLSAGHNQISDLT-PLANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 78.5 bits (192), Expect = 4e-16
Identities = 46/181 (25%), Positives = 79/181 (43%), Gaps = 15/181 (8%)
Query: 62 ELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGG 121
L ++ +S I L N+ EL L+ N LK G S +LT ++L+ N+
Sbjct: 201 SLIATNNQISDITPLGILTNLDEL---SLNGNQLKD--IGTLASLTNLTDLDLANNQISN 255
Query: 122 TIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSK 181
+ L L +N+ +N+ L+ + L L+++ N L S +NL
Sbjct: 256 LAPL------SGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLED-ISPISNLKN 308
Query: 182 LRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTG 241
L +L + IS I PVS L L+ L +NN ++ S L+ + +L+ N+ +
Sbjct: 309 LTYLTLYFNNISD-ISPVSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISD 365
Query: 242 F 242
Sbjct: 366 L 366
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 54.2 bits (129), Expect = 2e-08
Identities = 14/83 (16%), Positives = 33/83 (39%), Gaps = 2/83 (2%)
Query: 134 FPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS 193
L T+ V + ++ L ++ + G L+ L ++ S+ +++
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI-DGVEYLNNLTQINFSNNQLT 79
Query: 194 GNIKPVSFLHSLKYLDVSNNSMN 216
I P+ L L + ++NN +
Sbjct: 80 D-ITPLKNLTKLVDILMNNNQIA 101
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 46.5 bits (109), Expect = 6e-06
Identities = 16/79 (20%), Positives = 34/79 (43%), Gaps = 7/79 (8%)
Query: 154 SQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNN 213
+ ++ M + ++ S +L ++ L I +I V +L++L ++ SNN
Sbjct: 19 TALAEKMKTVLGKTNVTDTVS-QTDLDQVTTLQADRLGIK-SIDGVEYLNNLTQINFSNN 76
Query: 214 SMNGTFPSDFPPLSGVKFL 232
+ +D PL + L
Sbjct: 77 QL-----TDITPLKNLTKL 90
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 14/84 (16%), Positives = 28/84 (33%), Gaps = 7/84 (8%)
Query: 107 QSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSN 166
+ L K T+ V L ++ + + L ++ SN
Sbjct: 22 AEKMKTVLGKTNVTDTVSQTD------LDQVTTLQADRLGIKSIDGVEYLNNLTQINFSN 75
Query: 167 NDLRILPSGFANLSKLRHLDISSC 190
N L + NL+KL + +++
Sbjct: 76 NQLTDITP-LKNLTKLVDILMNNN 98
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 44.2 bits (103), Expect = 4e-05
Identities = 35/240 (14%), Positives = 79/240 (32%), Gaps = 12/240 (5%)
Query: 12 SLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLS 71
+L+ + + + V+T L +++G + ++N S+ L+
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLT 79
Query: 72 GIISWKFLRNMSELHS---------IDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGT 122
I K L + ++ + +L G T NL+
Sbjct: 80 DITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLEL 139
Query: 123 IGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKL 182
+ + + LS +K + +++ S A L+ L
Sbjct: 140 SSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNL 199
Query: 183 RHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242
L ++ +IS I P+ L +L L ++ N + L+ + L+++ N+ +
Sbjct: 200 ESLIATNNQISD-ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 93.3 bits (231), Expect = 1e-21
Identities = 38/310 (12%), Positives = 68/310 (21%), Gaps = 61/310 (19%)
Query: 401 DLIAATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSR 459
+++ H+ + EG G ++ L VAIK + D +
Sbjct: 1 NVVG--VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEP--RRSDAPQLRDEYRTYKL 56
Query: 460 LKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAG 519
L +P Y VL+ + L L
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL----------------------- 93
Query: 520 SHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP-----KIAG 574
K + T A + + +H + + + L+ +
Sbjct: 94 ----CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149
Query: 575 FGLRNIGVKNVG---------------------ERSENETCGPESDVYCFGVILMELLTG 613
FG+ V D+ G + M L G
Sbjct: 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRG 209
Query: 614 KRGTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTM 673
K E G L+ E + + + P
Sbjct: 210 SLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMH---YARNLAFDATPDY 266
Query: 674 QQVLGLLKDI 683
+ GL +
Sbjct: 267 DYLQGLFSKV 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 90.9 bits (225), Expect = 7e-21
Identities = 51/302 (16%), Positives = 93/302 (30%), Gaps = 69/302 (22%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAV------AMFDELSRL 460
++ + +L G V R + P A+K++D G A E+ L
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 461 K----HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHP 516
+ HPN++ L ++ + M G+L +L E
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-------------------- 103
Query: 517 GAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
+ +I + + LH + H L +ILL + + K+ FG
Sbjct: 104 --------KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFG 155
Query: 577 LRNIGVKNV-------------------GERSENETCGPESDVYCFGVILMELLTGKR-- 615
+ G E D++ GVI+ LL G
Sbjct: 156 FSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 215
Query: 616 GTDDCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQ 675
+ +R ++ +++ D ++ V+ L V P KR T ++
Sbjct: 216 WHRKQMLMLRMIMSG-------NYQFGSPEWDDYSDTVKDL-VSRFLVVQ-PQKRYTAEE 266
Query: 676 VL 677
L
Sbjct: 267 AL 268
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 90.1 bits (223), Expect = 2e-20
Identities = 52/292 (17%), Positives = 96/292 (32%), Gaps = 57/292 (19%)
Query: 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAM-FDELSRLKHP 463
+ +L G V A + VAIK + + ++ L ++KHP
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ L +G ++++ ++ G+L + E
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVE--------------------------- 100
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA---ESLEPKIAGFGLRNI 580
R+ V + YLH +G H L ++L E + I+ FGL +
Sbjct: 101 -KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM 159
Query: 581 GVKN------VG-------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVR 625
G E + D + GVI LL G ++ K
Sbjct: 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 219
Query: 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+++K ++ D +++ + + +L D P KR T +Q L
Sbjct: 220 QILKA-------EYEFDSPYWDDISDSAKDF-IRHLMEKD-PEKRFTCEQAL 262
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.8 bits (217), Expect = 1e-19
Identities = 55/288 (19%), Positives = 96/288 (33%), Gaps = 65/288 (22%)
Query: 414 LLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLA 469
+L EG V A L AIK+L+ I + + E +SRL HP + L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 470 GYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTN 529
++ L + NG+L +++ + +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRK----------------------------IGSFD 106
Query: 530 WVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERS 589
+ L YLH G H L +ILL E + +I FG + +
Sbjct: 107 ETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 166
Query: 590 ENETCG------PE----------SDVYCFGVILMELLTGK---RGTDDCVKWVRKLVKE 630
N G PE SD++ G I+ +L+ G R ++ + + +K++K
Sbjct: 167 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF-QKIIK- 224
Query: 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678
L++ ++VE KR +++ G
Sbjct: 225 ------LEYDFPEKFFPKARDLVEK------LLVLDATKRLGCEEMEG 260
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.5 bits (216), Expect = 2e-19
Identities = 47/223 (21%), Positives = 71/223 (31%), Gaps = 47/223 (21%)
Query: 412 ESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE----LSRLKHPNLL 466
+L +G G V+ A AIK L + DD E +HP L
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 66
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
+ + ++E++ GDL HI S
Sbjct: 67 HMFCTFQTKENLFFVMEYLNGGDLM----------------------------YHIQSCH 98
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG 586
K + A + GL +LH G + L +ILL + KIA FG+ +
Sbjct: 99 KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA 158
Query: 587 --------------ERSENETCGPESDVYCFGVILMELLTGKR 615
E + D + FGV+L E+L G+
Sbjct: 159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 86.0 bits (212), Expect = 5e-19
Identities = 35/301 (11%), Positives = 71/301 (23%), Gaps = 57/301 (18%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
+ + G G +Y + VAIK+ H ++ +
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGI 65
Query: 467 PLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPE 526
P +C A + V++ + L
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDL---------------------------FNFCSR 98
Query: 527 KTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES---LEPKIAGFGLRNIGVK 583
K + T +A + + Y+H H + + L+ I FGL
Sbjct: 99 KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158
Query: 584 NVG---------------------ERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK 622
D+ G +LM G
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 218
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKD 682
++ E + +++ +E L C + +P + L ++
Sbjct: 219 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRN 275
Query: 683 I 683
+
Sbjct: 276 L 276
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (208), Expect = 2e-18
Identities = 51/309 (16%), Positives = 89/309 (28%), Gaps = 58/309 (18%)
Query: 405 ATSHFGKESLLAEGRCGPVYRA--VLPGELHVAIKVLDNAKGIDHDDA-----VAMFDEL 457
A + + + EG G V++A + G VA+K + G + VA+ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 458 SRLKHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG 517
+HPN++ L C + + + + L
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTY-------------------- 104
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL 577
T + + RGL +LH H L +IL+ S + K+A FGL
Sbjct: 105 --LDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 162
Query: 578 RNIGVKNVGERS-------------ENETCGPESDVYCFGVILMELLTGKR--GTDDCVK 622
I + S + D++ G I E+ K V
Sbjct: 163 ARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYL--------------CTADSPG 668
+ K++ D+ + + + C +P
Sbjct: 223 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPA 282
Query: 669 KRPTMQQVL 677
KR + L
Sbjct: 283 KRISAYSAL 291
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 82.9 bits (204), Expect = 4e-18
Identities = 50/301 (16%), Positives = 92/301 (30%), Gaps = 65/301 (21%)
Query: 412 ESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLP 467
+L G V+ A L VA+KVL D + E + L HP ++
Sbjct: 12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 71
Query: 468 LAGYCI----AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
+ AG +++E++ L +H
Sbjct: 72 VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT--------------------------- 104
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK 583
+ + L + H G H + ++I+++ + K+ FG+
Sbjct: 105 -EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163
Query: 584 NVG-----------------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWV 624
+ E++ ++ SDVY G +L E+LTG+ D V
Sbjct: 164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223
Query: 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-TMQQVLGLLKDI 683
+ V+E G + +V A +P R T ++ L +
Sbjct: 224 YQHVREDP---IPPSARHEGLSADLDAVVLK------ALAKNPENRYQTAAEMRADLVRV 274
Query: 684 R 684
Sbjct: 275 H 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.1 bits (202), Expect = 8e-18
Identities = 44/296 (14%), Positives = 86/296 (29%), Gaps = 71/296 (23%)
Query: 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHD---DAVAMFDELSRLK- 461
S + LL G G VY + + L VAIK ++ + D + + E+ LK
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 462 ----HPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG 517
++ L + +++LE
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF----------------------- 100
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES-LEPKIAGFG 576
I+ V + + H+ G H + +IL+ + E K+ FG
Sbjct: 101 ----ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 156
Query: 577 LRNIGVKN-----VGER--------SENETCGPESDVYCFGVILMELLTGKR--GTDDCV 621
+ G R + G + V+ G++L +++ G D+ +
Sbjct: 157 SGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216
Query: 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+ ++ + C A P RPT +++
Sbjct: 217 IRGQVFFRQRVSSECQHLIRW-------------------CLALRPSDRPTFEEIQ 253
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.4 bits (200), Expect = 3e-17
Identities = 44/230 (19%), Positives = 77/230 (33%), Gaps = 53/230 (23%)
Query: 409 FGKESLLAEGRCGPVYRAVLP--GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLL 466
+ ++ G G VY+A L GEL VAIK + K + + M +L H N++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGEL-VAIKKVLQDKRFKNRELQIM----RKLDHCNIV 76
Query: 467 PLAGYCIAGKEK------LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
L + + EK ++L+++ H
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH------------------------- 111
Query: 521 HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL-AESLEPKIAGFGLRN 579
+ + + + + R LAY+H G H + ++LL ++ K+ FG
Sbjct: 112 YSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171
Query: 580 IGVKNV--------------GERSENETCGPESDVYCFGVILMELLTGKR 615
V+ DV+ G +L ELL G+
Sbjct: 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 79.8 bits (196), Expect = 8e-17
Identities = 41/224 (18%), Positives = 74/224 (33%), Gaps = 43/224 (19%)
Query: 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKH 462
F L G G V+ + A+KVL + DE LS + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
P ++ + G ++ ++++++ G+L L +
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRK-------------------------- 97
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG----LR 578
++ A V L YLH + L +ILL ++ KI FG +
Sbjct: 98 --SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP 155
Query: 579 NIGVKNVG-------ERSENETCGPESDVYCFGVILMELLTGKR 615
++ G E + D + FG+++ E+L G
Sbjct: 156 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.1 bits (194), Expect = 2e-16
Identities = 41/235 (17%), Positives = 72/235 (30%), Gaps = 57/235 (24%)
Query: 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLK 461
+ S + EG G V A ++ VAIK + + E L R +
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFR 64
Query: 462 HPNLLPLAGYCIAG----KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG 517
H N++ + A + + L+ + DL++ L
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT--------------------- 103
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL 577
+ + + RGL Y+H H L S++LL + + KI FGL
Sbjct: 104 --------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGL 155
Query: 578 RNIGVKNVGERSENET------------------CGPESDVYCFGVILMELLTGK 614
+ + D++ G IL E+L+ +
Sbjct: 156 ARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 77.6 bits (190), Expect = 3e-16
Identities = 50/299 (16%), Positives = 80/299 (26%), Gaps = 65/299 (21%)
Query: 415 LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAGY 471
+ EG G VY+A A+K + K D E L LKH N++ L
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWV 531
K +++ E + V
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKL----------------------------LDVCEGGLESV 100
Query: 532 TRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGVKN------ 584
T + + G+AY H H L ++L+ E KIA FGL R G+
Sbjct: 101 TAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160
Query: 585 --------VGERSENETCGPESDVYCFGVILMELLTGKR------------------GTD 618
++ D++ G I E++ G GT
Sbjct: 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP 220
Query: 619 DCVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
+ W + + + + P +R T +Q L
Sbjct: 221 NSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.5 bits (190), Expect = 4e-16
Identities = 60/295 (20%), Positives = 94/295 (31%), Gaps = 61/295 (20%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAM------FDELSRL 460
++ L G+ V + L A K + + V+ L +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 461 KHPNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGS 520
+HPN++ L + +++LE +A G+L +L E
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAE------------------------ 106
Query: 521 HISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP----KIAGFG 576
E + G+ YLH + H L +I+L + P KI FG
Sbjct: 107 ----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 162
Query: 577 L------RNIGVKNVG-------ERSENETCGPESDVYCFGVILMELLTGKRG-TDDCVK 622
L N G E E G E+D++ GVI LL+G D +
Sbjct: 163 LAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222
Query: 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
V +F + S S A + +R P KR T+Q L
Sbjct: 223 ETLANVSAVNY----EFEDEYFSNTS-ALAKDFIR---RLLVKDPKKRMTIQDSL 269
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 6e-16
Identities = 40/290 (13%), Positives = 88/290 (30%), Gaps = 64/290 (22%)
Query: 414 LLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYC 472
+L G G V + + A+K+L + + + + P+++ +
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVEL----HWRASQCPHIVRIVDVY 74
Query: 473 ---IAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKT 528
AG++ L++ +E + G+L + + +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQD--------------------------RGDQAF 108
Query: 529 NWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEP---KIAGFGLRNIGVKNV 585
I + + YLH + H + ++L K+ FG +
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
Query: 586 GERSENETC-------------GPESDVYCFGVILMELLTGKR-----GTDDCVKWVRKL 627
+ T D++ GVI+ LL G ++
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR 228
Query: 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVL 677
++ G + V+E V+ L + L + P +R T+ + +
Sbjct: 229 IRMG------QYEFPNPEWSEVSEEVKML-IRNLLKTE-PTQRMTITEFM 270
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 2e-15
Identities = 40/234 (17%), Positives = 70/234 (29%), Gaps = 54/234 (23%)
Query: 408 HFGKESLLAEGRCGPVYRAVLPGELH----VAIKVLDNAKGIDHDDAVAMFDE----LSR 459
+F +L G G V+ A+KVL A + L
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 460 LKH-PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGA 518
++ P L+ L + ++L+++ G+L L +
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQ---------------------- 122
Query: 519 GSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLR 578
E+ + L +LH +G + + +ILL + + FGL
Sbjct: 123 ------RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 176
Query: 579 NIGVKNVGE-----------------RSENETCGPESDVYCFGVILMELLTGKR 615
V + E R + D + GV++ ELLTG
Sbjct: 177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 3e-15
Identities = 42/222 (18%), Positives = 61/222 (27%), Gaps = 49/222 (22%)
Query: 414 LLAEGRCGPVYRAVLPG-ELHVAIKVLDNAKGIDHDDAVAMFDE-----LSRLKHPNLLP 467
L EG+ VY+A VAIK + + D + L L HPN++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 468 LAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEK 527
L ++ +FM
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDN----------------------------SLV 96
Query: 528 TNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVG- 586
+ +GL YLH H L +++LL E+ K+A FGL
Sbjct: 97 LTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156
Query: 587 --------------ERSENETCGPESDVYCFGVILMELLTGK 614
G D++ G IL ELL
Sbjct: 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 3e-15
Identities = 39/226 (17%), Positives = 65/226 (28%), Gaps = 46/226 (20%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHP 463
F LL +G G V + A+K+L I D+ E L +HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
L L ++E+ G+L L
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSR--------------------------- 98
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK 583
+ L YLH + + +++L + KI FGL G+
Sbjct: 99 -ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157
Query: 584 NVGERS--------------ENETCGPESDVYCFGVILMELLTGKR 615
+ E+ G D + GV++ E++ G+
Sbjct: 158 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 73.5 bits (179), Expect = 7e-15
Identities = 37/189 (19%), Positives = 68/189 (35%), Gaps = 5/189 (2%)
Query: 54 SNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVN 113
+ L+L + ++ I F +N+ LH++ L NN + PG F L ++
Sbjct: 27 KDLPPDTALLDLQNNKITEIKDGDF-KNLKNLHTLILINNKISKISPGAFAPLVKLERLY 85
Query: 114 LSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILP 173
LSKN+ P + + R + L+Q + + I
Sbjct: 86 LSKNQLKELPEKMPKTLQELRVHENEIT--KVRKSVFNGLNQMIVVELGTNPLKSSGIEN 143
Query: 174 SGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLN 233
F + KL ++ I+ I+ P SL L + N + + L+ + L
Sbjct: 144 GAFQGMKKLSYIRIADTNIT--TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLG 201
Query: 234 ISLNKFTGF 242
+S N +
Sbjct: 202 LSFNSISAV 210
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 56.6 bits (135), Expect = 3e-09
Identities = 46/251 (18%), Positives = 93/251 (37%), Gaps = 26/251 (10%)
Query: 4 FCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIREL 63
F L L +L L N+K ++ AF+ + +L L P
Sbjct: 51 FKNLKNLHTLIL-------INNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQ 103
Query: 64 NL-SSRNLSGIISWKFLRNMSELHSIDLSNNSLK--GSVPGWFWSTQSLTQVNLSKNRFG 120
L N + ++++ ++L N LK G G F + L+ + ++
Sbjct: 104 ELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI- 162
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNL--VKLSQFSKLMVLDVSNNDLRILPSGFAN 178
T G PS+ L+L N+ T + L + L L +S N + + +G
Sbjct: 163 ------TTIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 216
Query: 179 -LSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPP------LSGVKF 231
LR L +++ K+ ++ ++ + + NN+++ +DF P +
Sbjct: 217 NTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSG 276
Query: 232 LNISLNKFTGF 242
+++ N +
Sbjct: 277 VSLFSNPVQYW 287
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.8 bits (180), Expect = 9e-15
Identities = 53/314 (16%), Positives = 93/314 (29%), Gaps = 63/314 (20%)
Query: 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVL--DNAKGIDHDDAVAMFDELSRLKHP 463
S + K + + +G G V++A VA+K + +N K A+ L LKH
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ L C G ++ AG +
Sbjct: 70 NVVNLIEICRTKASP----YNRCKGSIYLVFDFCEHDL----------------AGLLSN 109
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGV 582
K R+ + GL Y+H H + +++L+ K+A FGL R +
Sbjct: 110 VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSL 169
Query: 583 KNVGERSENETC------------------GPESDVYCFGVILMELLTGKRG-TDDCVKW 623
+ + GP D++ G I+ E+ T + +
Sbjct: 170 AKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQH 229
Query: 624 VRKLVKEGAGG---------DALDFRLKLGSGDSVAEMVESLRVGYLCTADS-------- 666
L+ + G D + KL V+ Y+ +
Sbjct: 230 QLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL 289
Query: 667 ---PGKRPTMQQVL 677
P +R L
Sbjct: 290 VLDPAQRIDSDDAL 303
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.3 bits (176), Expect = 2e-14
Identities = 44/301 (14%), Positives = 83/301 (27%), Gaps = 67/301 (22%)
Query: 415 LAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHPNLLPLAG 470
+ EG G V++A VA+K + D + E L LKH N++ L
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 471 YCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNW 530
+ K+ ++ EF + +
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSC----------------------------NGDLDP 100
Query: 531 VTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERS- 589
+ +GL + H H L ++L+ + E K+A FGL V S
Sbjct: 101 EIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
Query: 590 --------------ENETCGPESDVYCFGVILMELLTGKR---GTDDCVKWVRKLVKEGA 632
+ D++ G I EL R +D ++++ +
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 633 GGDALDFRLKLGSGDSVAEMVESLRVGYL----------------CTADSPGKRPTMQQV 676
+ D + + +P +R + ++
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 677 L 677
L
Sbjct: 281 L 281
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.8 bits (175), Expect = 3e-14
Identities = 51/308 (16%), Positives = 87/308 (28%), Gaps = 67/308 (21%)
Query: 408 HFGKESLLAEGRCGPVYRAVLP--GELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKH 462
+F K + EG G VY+A GE+ VA+K + E L L H
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEV-VALKKIRLDT-ETEGVPSTAIREISLLKELNH 60
Query: 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHI 522
PN++ L + ++ EF+ TG P
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIP-------------------- 100
Query: 523 SSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGV 582
+ +GLA+ H H L ++L+ K+A FGL
Sbjct: 101 -------LPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFG 153
Query: 583 KNVG---------------ERSENETCGPESDVYCFGVILMELLTGKR--GTDDCVKWVR 625
V + D++ G I E++T + D + +
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
Query: 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYL----------------CTADSPGK 669
++ + D + + D + R + P K
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273
Query: 670 RPTMQQVL 677
R + + L
Sbjct: 274 RISAKAAL 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.2 bits (176), Expect = 3e-14
Identities = 51/319 (15%), Positives = 88/319 (27%), Gaps = 61/319 (19%)
Query: 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVL--DNAKGIDHDDAVAMFDELSRLKHP 463
+ + + G G V AV VAIK L + A L ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
N++ L + +F +
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDL------------------------GKLM 113
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL-RNIGV 582
EK + + +GL Y+H G H L ++ + E E KI FGL R
Sbjct: 114 KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 173
Query: 583 KNVG-----------ERSENETCGPESDVYCFGVILMELLTGK---RGTDDCVKWVRKLV 628
+ G D++ G I+ E++TGK +G+D + +
Sbjct: 174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233
Query: 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYL-----------------CTADSPGKRP 671
G RL+ + + + L +R
Sbjct: 234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV 293
Query: 672 TMQQVLG--LLKDIRPSAD 688
T + L + + + D
Sbjct: 294 TAGEALAHPYFESLHDTED 312
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 69.1 bits (168), Expect = 4e-13
Identities = 34/223 (15%), Positives = 66/223 (29%), Gaps = 43/223 (19%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHP 463
F + L G G V H A+K+LD K + +E L + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 464 NLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
L+ L +++E++A G++ L +
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRI-------------------------- 135
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK 583
+ + A + YLH + + L ++L+ + ++ FG
Sbjct: 136 --GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193
Query: 584 N-----------VGERSENETCGPESDVYCFGVILMELLTGKR 615
E ++ D + GV++ E+ G
Sbjct: 194 RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYP 236
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 66.0 bits (160), Expect = 3e-12
Identities = 31/227 (13%), Positives = 64/227 (28%), Gaps = 53/227 (23%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNL 465
+ L G+ V+ A+ + V +K+L K L L+ PN+
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNI 92
Query: 466 LPLAGYCIAGKEKLV--LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHIS 523
+ LA + + E + N D + L
Sbjct: 93 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLT------------------------- 127
Query: 524 SPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL-AESLEPKIAGFGLRNIGV 582
+ + L Y H +G H + ++++ E + ++ +GL
Sbjct: 128 ------DYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 181
Query: 583 KN------VG--------ERSENETCGPESDVYCFGVILMELLTGKR 615
V + + D++ G +L ++ K
Sbjct: 182 PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 60.9 bits (147), Expect = 7e-12
Identities = 30/105 (28%), Positives = 45/105 (42%), Gaps = 2/105 (1%)
Query: 138 QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIK 197
+VL+L+ T L L Q + LD+S+N LR LP A L L L S + N+
Sbjct: 1 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVD 59
Query: 198 PVSFLHSLKYLDVSNNSMNGT-FPSDFPPLSGVKFLNISLNKFTG 241
V+ L L+ L + NN + + + LN+ N
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 47.4 bits (112), Expect = 4e-07
Identities = 24/145 (16%), Positives = 46/145 (31%), Gaps = 30/145 (20%)
Query: 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFG 120
R L+L+ ++L+ + L + + +DLS+N L+ P + + L + S N
Sbjct: 1 RVLHLAHKDLTVLCH---LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALE 56
Query: 121 GTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLS 180
G P +Q L L +NR +
Sbjct: 57 NVDGVAN------LPRLQELLLCNNRLQQS--------------------AAIQPLVSCP 90
Query: 181 KLRHLDISSCKISGNIKPVSFLHSL 205
+L L++ + L +
Sbjct: 91 RLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.0 bits (85), Expect = 0.001
Identities = 19/94 (20%), Positives = 33/94 (35%), Gaps = 5/94 (5%)
Query: 4 FCRLPLLFSLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIREL 63
+L L+ L L S + A + S N++G ++EL
Sbjct: 16 LEQLLLVTHLDL-----SHNRLRALPPALAALRCLEVLQASDNALENVDGVANLPRLQEL 70
Query: 64 NLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKG 97
L + L + + L + L ++L NSL
Sbjct: 71 LLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.7 bits (153), Expect = 1e-11
Identities = 33/204 (16%), Positives = 69/204 (33%), Gaps = 14/204 (6%)
Query: 41 FNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVP 100
+ + P + + L+L + R ++ L + L +N+L+
Sbjct: 91 AQLRSVDPATFH---GLGRLHTLHLDRCG-LQELGPGLFRGLAALQYLYLQDNALQALPD 146
Query: 101 GWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLM 160
F +LT + L NR P S+ L L NR ++ +
Sbjct: 147 DTFRDLGNLTHLFLHGNRISSV----PERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 161 VLDVS---NNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNG 217
++ + NN + A L L++L ++ + + L+ S++ +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPC 262
Query: 218 TFPSDFPPLSGVKFLNISLNKFTG 241
+ P L+G ++ N G
Sbjct: 263 SLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.6 bits (101), Expect = 4e-05
Identities = 38/220 (17%), Positives = 63/220 (28%), Gaps = 29/220 (13%)
Query: 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSK 116
+ P + + L + + I L N + F + ++LT + L
Sbjct: 10 NEPKVTTSCPQQGLQAVPVGIP----AASQRIFLHGNRISHVPAASFRACRNLTILWLHS 65
Query: 117 NRFGGTIGFKPTSRN---------------------GPFPSVQVLNLSSNRFTNLVK--L 153
N T + L+L L
Sbjct: 66 NVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLF 125
Query: 154 SQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKPVSF-LHSLKYLDVS 211
+ L L + +N L+ LP F +L L HL + +IS + LHSL L +
Sbjct: 126 RGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLH 185
Query: 212 NNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHDKYQKF 251
N + P F L + L + N +
Sbjct: 186 QNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLR 225
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.2 bits (150), Expect = 5e-11
Identities = 44/230 (19%), Positives = 69/230 (30%), Gaps = 51/230 (22%)
Query: 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLK 461
+ S + G G V A L VA+K L A + E L +K
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMK 75
Query: 462 HPNLLPLAGYCIAGK-----EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHP 516
H N++ L + + L+ + DL+ +
Sbjct: 76 HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-------------------- 115
Query: 517 GAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFG 576
+K + + RGL Y+H H L S++ + E E KI FG
Sbjct: 116 ---------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 166
Query: 577 LRNIGVKNVG------------ERSENETCGPESDVYCFGVILMELLTGK 614
L + D++ G I+ ELLTG+
Sbjct: 167 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 62.4 bits (150), Expect = 6e-11
Identities = 38/221 (17%), Positives = 68/221 (30%), Gaps = 34/221 (15%)
Query: 414 LLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYC 472
L G V+ A + HVA+K++ K + + A L R+ +
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 473 IAGKEKLVL-LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWV 531
KL+ +H + GE + P +
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP-------------LI 125
Query: 532 TRHRIAIGVARGLAYLH-HVGSTHGHLVTSSILLAESLEP------KIAGFGLRNIGVKN 584
+I+ + GL Y+H G H + ++L+ P KIA G ++
Sbjct: 126 YVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH 185
Query: 585 VG-----------ERSENETCGPESDVYCFGVILMELLTGK 614
E G +D++ ++ EL+TG
Sbjct: 186 YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.0 bits (134), Expect = 9e-10
Identities = 18/107 (16%), Positives = 39/107 (36%), Gaps = 3/107 (2%)
Query: 137 VQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGN- 195
L + L + +VL+ ++ L N+ +L L++S+ ++
Sbjct: 22 GSQQALDLKGLRSDPDLVAQNIDVVLNRRSSMAATLRIIEENIPELLSLNLSNNRLYRLD 81
Query: 196 --IKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFT 240
V +LK L++S N + D ++ L + N +
Sbjct: 82 DMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLS 128
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 55.7 bits (133), Expect = 7e-09
Identities = 39/230 (16%), Positives = 66/230 (28%), Gaps = 55/230 (23%)
Query: 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDE---LSRLKHP 463
+ + G G V A + +VAIK L + A + E + + H
Sbjct: 18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHK 76
Query: 464 NLLPLAGYCIAGK------EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPG 517
N++ L K + +++E M EL
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------------------- 117
Query: 518 AGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL 577
+ + G+ +LH G H L S+I++ KI FGL
Sbjct: 118 ------------HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165
Query: 578 RNIGVKN------VG-------ERSENETCGPESDVYCFGVILMELLTGK 614
+ V E D++ G I+ E++ K
Sbjct: 166 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 52.3 bits (124), Expect = 3e-08
Identities = 28/167 (16%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
I ++ ++ ++ + ++L N+++L L+ N L P ++ +K +
Sbjct: 48 IDQIIANNSDIKSVQGIQYLPNVTKLF---LNGNKLTDIKPLANLKNLGWLFLDENKVKD 104
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSS--------------NRFTNLVKLSQFSKLMVLDVS 165
++ ++ + +++ N+ T++ LS+ +KL L +
Sbjct: 105 LSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLE 164
Query: 166 NNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSN 212
+N + + A L+KL++L +S IS +++ ++ L +L L++ +
Sbjct: 165 DNQISDIVP-LAGLTKLQNLYLSKNHIS-DLRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 1e-05
Identities = 13/74 (17%), Positives = 29/74 (39%), Gaps = 6/74 (8%)
Query: 127 PTSRNGPFP-----SVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSK 181
PT F NL T+ V ++ + + + +N+D++ + G L
Sbjct: 11 PTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQ-GIQYLPN 69
Query: 182 LRHLDISSCKISGN 195
+ L ++ K++
Sbjct: 70 VTKLFLNGNKLTDI 83
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.003
Identities = 26/188 (13%), Positives = 52/188 (27%), Gaps = 33/188 (17%)
Query: 12 SLSLVVLAQSTCNSKDQELVSKAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLS 71
+ + + S + +S+ + ++ G + +L L+ L+
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVTKLFLNGNKLT 81
Query: 72 GIISWKFLRNMSELHS-----------------IDLSNNSLKGSVPGWFWSTQSLTQVNL 114
I L+N+ L LS S L + L
Sbjct: 82 DIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYL 141
Query: 115 SKNRFGGTIGFKPTSRN----------------GPFPSVQVLNLSSNRFTNLVKLSQFSK 158
N+ ++ +Q L LS N ++L L+
Sbjct: 142 GNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISDLRALAGLKN 201
Query: 159 LMVLDVSN 166
L VL++ +
Sbjct: 202 LDVLELFS 209
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 6e-08
Identities = 32/208 (15%), Positives = 77/208 (37%), Gaps = 14/208 (6%)
Query: 17 VLAQSTCNSKDQELVSKA-FSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIIS 75
+ + S + V++A ++T + T + G + L L ++ +
Sbjct: 21 AIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLAP 80
Query: 76 WKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQS-----------LTQVNLSKNRFGGTIG 124
K L ++EL ++ T L ++ + +
Sbjct: 81 LKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQ 140
Query: 125 FKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRH 184
S ++Q L++ + + ++L L+ SKL L +N + + A+L L
Sbjct: 141 ITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-LASLPNLIE 199
Query: 185 LDISSCKISGNIKPVSFLHSLKYLDVSN 212
+ + + +IS + P++ +L + ++N
Sbjct: 200 VHLKNNQISD-VSPLANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 3e-05
Identities = 9/62 (14%), Positives = 28/62 (45%), Gaps = 2/62 (3%)
Query: 155 QFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNS 214
+ + + +++ + A+L + L ++ I+ V +L++L L++ +N
Sbjct: 17 ALANAIKIAAGKSNVTDTVT-QADLDGITTLSAFGTGVT-TIEGVQYLNNLIGLELKDNQ 74
Query: 215 MN 216
+
Sbjct: 75 IT 76
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 43.5 bits (101), Expect = 4e-05
Identities = 13/71 (18%), Positives = 26/71 (36%), Gaps = 6/71 (8%)
Query: 127 PTSRNGPFP-----SVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSK 181
PT+ N FP + + + T+ V + + L + + G L+
Sbjct: 6 PTAINVIFPDPALANAIKIAAGKSNVTDTVTQADLDGITTLSAFGTGVTTI-EGVQYLNN 64
Query: 182 LRHLDISSCKI 192
L L++ +I
Sbjct: 65 LIGLELKDNQI 75
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 2e-04
Identities = 36/210 (17%), Positives = 74/210 (35%), Gaps = 45/210 (21%)
Query: 63 LNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGT 122
+ N++ ++ ++ + ++ + ++ G +L + L N+
Sbjct: 24 IAAGKSNVTDTVT---QADLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDL 78
Query: 123 IGFK----------------PTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSN 166
K S S++ L+L+S + T++ L+ S L VL +
Sbjct: 79 APLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDL 138
Query: 167 NDLR---------------------ILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSL 205
N + + ANLSKL L KIS I P++ L +L
Sbjct: 139 NQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISD-ISPLASLPNL 197
Query: 206 KYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235
+ + NN ++ P S + + ++
Sbjct: 198 IEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.003
Identities = 8/67 (11%), Positives = 23/67 (34%), Gaps = 6/67 (8%)
Query: 107 QSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSN 166
+ ++ K+ T+ + L+ T + + + L+ L++ +
Sbjct: 19 ANAIKIAAGKSNVTDTVTQAD------LDGITTLSAFGTGVTTIEGVQYLNNLIGLELKD 72
Query: 167 NDLRILP 173
N + L
Sbjct: 73 NQITDLA 79
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.3 bits (119), Expect = 7e-08
Identities = 19/110 (17%), Positives = 38/110 (34%), Gaps = 1/110 (0%)
Query: 142 LSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF 201
L++ + + + LD+ + ++ + A L + +D S +I +
Sbjct: 3 LTAELIEQAAQYTNAVRDRELDLRGYKIPVIENLGATLDQFDAIDFSDNEIR-KLDGFPL 61
Query: 202 LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHDKYQKF 251
L LK L V+NN + L + L ++ N D
Sbjct: 62 LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASL 111
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.5 bits (83), Expect = 0.003
Identities = 23/140 (16%), Positives = 43/140 (30%), Gaps = 16/140 (11%)
Query: 54 SNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVN 113
+N REL+L + I + + +ID S+N ++ L ++
Sbjct: 15 TNAVR-DRELDLRGYKIPVI--ENLGATLDQFDAIDFSDNEIR-----KLDGFPLLRRLK 66
Query: 114 LSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKL---MVLDVSNNDLR 170
P + L L++N L L + L L + N +
Sbjct: 67 TLLVNNNRICRIGEGLDQ-ALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125
Query: 171 ILP----SGFANLSKLRHLD 186
+ ++R LD
Sbjct: 126 NKKHYRLYVIYKVPQVRVLD 145
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 52.4 bits (124), Expect = 8e-08
Identities = 18/67 (26%), Positives = 24/67 (35%), Gaps = 1/67 (1%)
Query: 155 QFSKLMVLDVSNNDLR-ILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNN 213
L LD+ NN + LP G L L L++S + G I L +NN
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANN 301
Query: 214 SMNGTFP 220
P
Sbjct: 302 KCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 51.3 bits (121), Expect = 2e-07
Identities = 17/72 (23%), Positives = 29/72 (40%), Gaps = 5/72 (6%)
Query: 76 WKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFP 135
+ L+ +DL NN + G++P + L +N+S N G I P N
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI---PQGGN--LQ 291
Query: 136 SVQVLNLSSNRF 147
V ++N+
Sbjct: 292 RFDVSAYANNKC 303
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.3 bits (90), Expect = 0.001
Identities = 41/179 (22%), Positives = 62/179 (34%), Gaps = 5/179 (2%)
Query: 67 SRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFK 126
+ FL + L ++D S N+L G++P S +L + NR G I
Sbjct: 109 THTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAI--- 165
Query: 127 PTSRNGPFPSVQVLNLSSNRFTNLVKLSQF-SKLMVLDVSNNDLRILPSGFANLSKLRHL 185
P S + +S NR T + + L +D+S N L S K
Sbjct: 166 PDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQK 225
Query: 186 DISSCKISGNIKPVSFLHSLKYL-DVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFV 243
+ L D+ NN + GT P L + LN+S N G +
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.4 bits (116), Expect = 8e-07
Identities = 22/117 (18%), Positives = 32/117 (27%), Gaps = 34/117 (29%)
Query: 67 SRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFK 126
N S L +++SNN L +P
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPAL------------------------ 302
Query: 127 PTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLR 183
P ++ L S N + +L L L V N LR P ++ LR
Sbjct: 303 -------PPRLERLIASFNHLAEVPEL--PQNLKQLHVEYNPLREFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 49.1 bits (115), Expect = 1e-06
Identities = 26/158 (16%), Positives = 50/158 (31%), Gaps = 7/158 (4%)
Query: 76 WKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFP 135
FL + +++ + L S+ LT + +
Sbjct: 203 LPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSEL 262
Query: 136 SVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGN 195
+ L+++ L L+VSNN L LP+ +L L S ++
Sbjct: 263 PPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLIELPAL---PPRLERLIASFNHLA-E 318
Query: 196 IKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLN 233
+ +LK L V N + FP + ++ +
Sbjct: 319 VP--ELPQNLKQLHVEYNPLR-EFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 19/89 (21%), Positives = 35/89 (39%), Gaps = 10/89 (11%)
Query: 129 SRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDIS 188
RN P + + ++ +R ++ + L+++N L LP L L S
Sbjct: 14 ERNAPPGNGEQREMAVSR----LRDCLDRQAHELELNNLGLSSLPE---LPPHLESLVAS 66
Query: 189 SCKISGNIKPVSFLHSLKYLDVSNNSMNG 217
++ + SLK L V NN++
Sbjct: 67 CNSLT---ELPELPQSLKSLLVDNNNLKA 92
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 46.3 bits (109), Expect = 2e-06
Identities = 22/165 (13%), Positives = 44/165 (26%), Gaps = 22/165 (13%)
Query: 413 SLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYC 472
L+ EG+ V+ +K ++ H + +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFH-------------------KVGHTSFKKVKEKR 46
Query: 473 IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVT 532
G +L + + R L +L V + +
Sbjct: 47 DYGDLHFSVLAIRSARNEFRALQKL--QGLAVPKVYAWEGNAVLMELIDAKELYRVRVEN 104
Query: 533 RHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGL 577
+ + +A +H G HG L ++L++E I F
Sbjct: 105 PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 2e-06
Identities = 28/182 (15%), Positives = 52/182 (28%), Gaps = 9/182 (4%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRF 119
L+LS L + L ++L +L +
Sbjct: 33 TTILHLSENLLYTFSLATL-MPYTRLTQLNLDRAE-----LTKLQVDGTLPVLGTLDLSH 86
Query: 120 GGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANL 179
+ P +V ++ + L L +L L + N+L+ LP G
Sbjct: 87 NQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTP 146
Query: 180 SKLRHLDISSCKISGNIKPVSF--LHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLN 237
+ + + L +L L + NS+ T P F + F + N
Sbjct: 147 TPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGN 205
Query: 238 KF 239
+
Sbjct: 206 PW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.002
Identities = 9/78 (11%), Positives = 24/78 (30%), Gaps = 5/78 (6%)
Query: 150 LVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSF--LHSLKY 207
+ ++S+ + + ++ +L LP L +S + + L
Sbjct: 3 ICEVSKVASHLEVNCDKRNLTALPPDLPKD--TTILHLSENLLYT-FSLATLMPYTRLTQ 59
Query: 208 LDVSNNSMNGTFPSDFPP 225
L++ + P
Sbjct: 60 LNLDRAELTKLQVDGTLP 77
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.4 bits (111), Expect = 3e-06
Identities = 32/135 (23%), Positives = 51/135 (37%), Gaps = 10/135 (7%)
Query: 86 HSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSN 145
++DL+ +L V G L + R + +P + + VQ ++LS++
Sbjct: 3 QTLDLTGKNLHPDVTG------RLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNS 56
Query: 146 RFTN---LVKLSQFSKLMVLDVSNNDL-RILPSGFANLSKLRHLDISSCKISGNIKPVSF 201
LSQ SKL L + L + + A S L L++S C +
Sbjct: 57 VIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTL 116
Query: 202 LHSLKYLDVSNNSMN 216
L S LD N S
Sbjct: 117 LSSCSRLDELNLSWC 131
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 3e-06
Identities = 16/117 (13%), Positives = 40/117 (34%), Gaps = 3/117 (2%)
Query: 138 QVLNLSSNRFTNLVKLSQFSK-LMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNI 196
Q L+L+ V S+ ++ + + + + +++H+D+S+ I +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 197 KP--VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHDKYQKF 251
+S L+ L + ++ + S + LN+S
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 8e-06
Identities = 11/95 (11%), Positives = 32/95 (33%), Gaps = 14/95 (14%)
Query: 136 SVQVLNLSSNRFTN--LVKL-SQFSKLMVLDVSNNDL-----RILPSGFANLSKLRHLDI 187
+Q L++ ++ +L + V+ + + L + + S L L++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 188 SSCKISGNIKPV------SFLHSLKYLDVSNNSMN 216
S ++ + ++ L + N +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT 97
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 17/96 (17%), Positives = 32/96 (33%), Gaps = 5/96 (5%)
Query: 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKG----SVPGWFWSTQSLTQV 112
S I+ L++ LS + L + + + L + L + +L ++
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAEL 60
Query: 113 NLSKNRFGGTIGFK-PTSRNGPFPSVQVLNLSSNRF 147
NL N G P +Q L+L +
Sbjct: 61 NLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 5e-05
Identities = 19/103 (18%), Positives = 41/103 (39%), Gaps = 11/103 (10%)
Query: 76 WKFLRNMSELHSIDLSNNSLKG----SVPGWFWSTQSLTQVNLSKNRFG--GTIGFKPTS 129
+ S L + L++ + S+ + SL +++LS N G G + +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 130 RNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRIL 172
R P ++ L L ++ ++ +L L+ LR++
Sbjct: 422 RQ-PGCLLEQLVLYDIYWSEEME----DRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 2e-04
Identities = 15/80 (18%), Positives = 30/80 (37%), Gaps = 11/80 (13%)
Query: 153 LSQFSKLMVLDVSNNDL-----RILPSGFANLSKLRHLDISSCKIS--GNIKPVSFLHS- 204
S L VL +++ D+ L + LR LD+S+ + G ++ V +
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 205 ---LKYLDVSNNSMNGTFPS 221
L+ L + + +
Sbjct: 425 GCLLEQLVLYDIYWSEEMED 444
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 3e-04
Identities = 10/87 (11%), Positives = 29/87 (33%), Gaps = 9/87 (10%)
Query: 159 LMVLDVSNNDL--RILPSGFANLSKLRHLDISSCKISGNI-----KPVSFLHSLKYLDVS 211
+ LD+ +L L + + + + C ++ + +L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 212 NNSMNGTFPSDFPPLSGVKFLNISLNK 238
+N + G++ + + K
Sbjct: 64 SNELGDVGVHCVL--QGLQTPSCKIQK 88
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (93), Expect = 5e-04
Identities = 15/99 (15%), Positives = 33/99 (33%), Gaps = 9/99 (9%)
Query: 100 PGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTN--LVKLSQF- 156
G L + L+ + + S++ L+LS+N + +++L +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 157 ----SKLMVLDVSNNDL-RILPSGFANLSKLR-HLDISS 189
L L + + + L K + L + S
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 16/79 (20%), Positives = 29/79 (36%), Gaps = 10/79 (12%)
Query: 173 PSGFANLSKLRHLDISSCKISGN-----IKPVSFLHSLKYLDVSNNSMNGTFPSDFP--- 224
S LR L ++ C +S + + HSL+ LD+SNN +
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 225 --PLSGVKFLNISLNKFTG 241
P ++ L + ++
Sbjct: 422 RQPGCLLEQLVLYDIYWSE 440
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 5e-05
Identities = 33/159 (20%), Positives = 59/159 (37%), Gaps = 11/159 (6%)
Query: 60 IRELNLSSRNLSGIISWKFLRNMSELHS--------IDLSNNSLKGSVPGWFWSTQSLTQ 111
+ L + I ++L N+++++ L N + + +T
Sbjct: 42 VTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITP 101
Query: 112 VNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRI 171
+ N G T+ + P ++ LN + +S S L L N
Sbjct: 102 LANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQ 161
Query: 172 L--PSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYL 208
+ ANL+ L LDISS K+S I ++ L +L+ L
Sbjct: 162 VTDLKPLANLTTLERLDISSNKVSD-ISVLAKLTNLESL 199
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Length = 198 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Score = 41.2 bits (95), Expect = 2e-04
Identities = 11/74 (14%), Positives = 29/74 (39%), Gaps = 8/74 (10%)
Query: 150 LVKLSQFSKLMVLDVSNNDLR-------ILPSGFANLSKLRHLDISSCKISGNIKPVSFL 202
+ + ++ + +L + + + L +HL +S+ I I +S +
Sbjct: 11 IRIFEERKSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KISSLSGM 69
Query: 203 HSLKYLDVSNNSMN 216
+L+ L + N +
Sbjct: 70 ENLRILSLGRNLIK 83
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 13/40 (32%), Positives = 18/40 (45%), Gaps = 1/40 (2%)
Query: 153 LSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCK 191
S ++LD+S + LPS NL KLR + K
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (90), Expect = 8e-04
Identities = 4/47 (8%), Positives = 12/47 (25%)
Query: 72 GIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNR 118
+ S +D+S + + + L + +
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 236
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 3e-04
Identities = 12/155 (7%), Positives = 34/155 (21%), Gaps = 12/155 (7%)
Query: 154 SQFS----KLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNI-----KPVSFLHS 204
++FS L + ++ D + + + ++ + +S I + ++
Sbjct: 1 ARFSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKD 60
Query: 205 LKYLDVSNNSM---NGTFPSDFPPLSGVKFLNISLNKFTGFVGHDKYQKFGKSAFIQGGS 261
L+ + S+ P L L+
Sbjct: 61 LEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKH 120
Query: 262 FVFDTTKTPRPSNNHIMPHVDSSRTPPYKIVHKHN 296
+ + + K
Sbjct: 121 TPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAK 155
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 690 | |||
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.94 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.93 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 99.92 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.92 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 99.91 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.9 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 99.87 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.86 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.85 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.85 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.84 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.83 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.82 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.81 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.76 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.74 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.62 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.6 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.59 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.58 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.58 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.47 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.45 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.44 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.33 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.33 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.27 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.27 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.15 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.81 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 98.77 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.72 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.35 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.32 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.2 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.0 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.82 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.75 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.54 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.42 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.94 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 96.85 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.84 |
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=361.02 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=196.6
Q ss_pred CCHHHHHHHHCCC---------CCCCEECCCCCCCEEEEECCC-C---CEEEEEEEECCCC-CCHHHHHHHHHHHHHCCC
Q ss_conf 4988899995067---------987600457972289998399-9---3799999304689-997899999999872589
Q 005572 397 LTFKDLIAATSHF---------GKESLLAEGRCGPVYRAVLPG-E---LHVAIKVLDNAKG-IDHDDAVAMFDELSRLKH 462 (690)
Q Consensus 397 ~~~~~~~~~~~~~---------~~~~~ig~G~~g~V~~~~~~~-~---~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H 462 (690)
++++++..++.+| ...+.||+|+||.||+|+... + ..||||.+..... ...+++.+|+++|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 88798999996046220800427856980278829999999579978899999997844598999999999999985799
Q ss_pred CCCCCEEEEEECCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 98101212896398148999715899776653008999999777888877899999977789998997899999999998
Q 005572 463 PNLLPLAGYCIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVAR 542 (690)
Q Consensus 463 ~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~ 542 (690)
||||+++|+|.+.+..++|||||++|+|.+++.. ....++|.+++.++.|+|.
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~---------------------------~~~~l~~~~~~~i~~qia~ 139 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ---------------------------NDGQFTVIQLVGMLRGIAA 139 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHT---------------------------TTTCSCHHHHHHHHHHHHH
T ss_pred CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECC---------------------------CCCCCCHHHHHHHHHHHHH
T ss_conf 8886189999628877999972279853002104---------------------------5679999999999999999
Q ss_pred HHHHHHHCCCCCCCCCCCCEEECCCCCCEECCCCCCCCCCC-------------------CCCCCCCCCCCCCCCCCHHH
Q ss_conf 88764306988878777847855999926747776554345-------------------66765688899987753236
Q 005572 543 GLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVK-------------------NVGERSENETCGPESDVYCF 603 (690)
Q Consensus 543 ~l~yLH~~~~~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~-------------------~~~e~~~~~~~~~~~DVwSf 603 (690)
||.|||+++++||||||+|||++.++.+||+|||+++.... .+||......++.++|||||
T Consensus 140 gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~ 219 (299)
T d1jpaa_ 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSY 219 (299)
T ss_dssp HHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHH
T ss_pred HHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEECCCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCC
T ss_conf 88988527983576150448988999199888443157567777653650256668830038788836997861214453
Q ss_pred HHHHHHHHH-CCCCCCCHHH-HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 899999984-8999973489-99999993689975430111699998999999999983301899999999999999972
Q 005572 604 GVILMELLT-GKRGTDDCVK-WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 604 Gvil~el~t-g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~ 681 (690)
||++|||+| |+.||.+... .....+..+.. +..+..++ . .+.+++.+||+.||++||||.+|++.|+
T Consensus 220 Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~-----~~~~~~~~---~---~l~~li~~cl~~~P~~RPs~~ei~~~L~ 288 (299)
T d1jpaa_ 220 GIVMWEVMSYGERPYWDMTNQDVINAIEQDYR-----LPPPMDCP---S---ALHQLMLDCWQKDRNHRPKFGQIVNTLD 288 (299)
T ss_dssp HHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC-----CCCCTTCC---H---HHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC-----CCCCCCCH---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 57899998679999999999999999973788-----99974226---9---9999999975879768929999999999
Q ss_pred CCCCCC
Q ss_conf 128999
Q 005572 682 DIRPSA 687 (690)
Q Consensus 682 ~i~~~~ 687 (690)
.+.+.+
T Consensus 289 ~~l~~p 294 (299)
T d1jpaa_ 289 KMIRNP 294 (299)
T ss_dssp HHHHSG
T ss_pred HHHCCH
T ss_conf 984186
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=359.30 Aligned_cols=251 Identities=22% Similarity=0.341 Sum_probs=202.4
Q ss_pred HHHHHHHCCCCCCCEECCCCCCCEEEEECC-CCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEE
Q ss_conf 889999506798760045797228999839-9937999993046899978999999998725899810121289639814
Q 005572 400 KDLIAATSHFGKESLLAEGRCGPVYRAVLP-GELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 400 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 478 (690)
++|++..++|...+.||+|+||.||+|+.. ++..||||+++... ...+++.+|++++++++|||||+++|+|.+.+..
T Consensus 10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (287)
T d1opja_ 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 88 (287)
T ss_dssp CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred CCCEECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEE
T ss_conf 651745799398659820888089999999999699999977761-0399999999999867999882677527457854
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 89997158997766530089999997778888778999999777899989978999999999988876430698887877
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk 558 (690)
++|||||++|+|.+++.+. ....+++..++.++.|+|.||.|||+++++|||||
T Consensus 89 ~iv~E~~~~g~l~~~l~~~--------------------------~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlK 142 (287)
T d1opja_ 89 YIITEFMTYGNLLDYLREC--------------------------NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLA 142 (287)
T ss_dssp EEEEECCTTCBHHHHHHHS--------------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEECCCCCCHHHHHHHC--------------------------CCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 7876314676067775303--------------------------55415799999999999997888987893057604
Q ss_pred CCCEEECCCCCCEECCCCCCCCCCCC---------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCC--HH
Q ss_conf 78478559999267477765543456---------------67656888999877532368999999848999973--48
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDD--CV 621 (690)
Q Consensus 559 ~~Nill~~~~~~ki~dfGl~~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~--~~ 621 (690)
|+|||++.++.+||+|||+++..... +||...+..++.++|||||||++|||++|..|+.. ..
T Consensus 143 p~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~ 222 (287)
T d1opja_ 143 ARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222 (287)
T ss_dssp GGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCEEEECCCCCEEECCCCCEEECCCCCCEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf 57689989992898324454653788722103556654666927872799981043021789999998679988774259
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 9999999936899754301116999989999999999833018999999999999999721289999
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSAD 688 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~~~~ 688 (690)
......+..+.. +..+..++ . .+.+++..||+.||++||||.+|++.|+.+.+...
T Consensus 223 ~~~~~~i~~~~~-----~~~~~~~~---~---~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~~~ 278 (287)
T d1opja_ 223 SQVYELLEKDYR-----MERPEGCP---E---KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 278 (287)
T ss_dssp HHHHHHHHTTCC-----CCCCTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSSSC
T ss_pred HHHHHHHHCCCC-----CCCCCCCH---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 999999855888-----88874330---9---99999999757797689399999999999987577
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.29 Aligned_cols=240 Identities=23% Similarity=0.336 Sum_probs=195.4
Q ss_pred CCCCCCCEECCCCCCCEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECC
Q ss_conf 06798760045797228999839993799999304689997899999999872589981012128963981489997158
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
++|...+.||+|+||.||+|.+.++..||||+++... ...+++.+|++.+++++||||++++|+|...+..++|||||+
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
Q ss_conf 99776653008999999777888877899999977789998997899999999998887643069888787778478559
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~~ 566 (690)
+|+|.+++.. ....+++..++.++.|+|.||.|||+.+++||||||+|||++.
T Consensus 84 ~g~L~~~l~~---------------------------~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~ 136 (263)
T d1sm2a_ 84 HGCLSDYLRT---------------------------QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGE 136 (263)
T ss_dssp TCBHHHHHHT---------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECG
T ss_pred CCCHHHHHHC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECC
T ss_conf 9918997520---------------------------1347889999999999999877653164310443153266668
Q ss_pred CCCCEECCCCCCCCCCC---------------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHC-CCCCCCHH-HHHHHHHH
Q ss_conf 99926747776554345---------------667656888999877532368999999848-99997348-99999999
Q 005572 567 SLEPKIAGFGLRNIGVK---------------NVGERSENETCGPESDVYCFGVILMELLTG-KRGTDDCV-KWVRKLVK 629 (690)
Q Consensus 567 ~~~~ki~dfGl~~~~~~---------------~~~e~~~~~~~~~~~DVwSfGvil~el~tg-~~p~~~~~-~~~~~~~~ 629 (690)
++.+||+|||+++.... .+||......++.++|||||||++|||+|+ ..|+.... ........
T Consensus 137 ~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~ 216 (263)
T d1sm2a_ 137 NQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216 (263)
T ss_dssp GGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHH
T ss_pred CCCEEECCCCHHEECCCCCCEEECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 87768655321002368873350430017666785786079998403321059999999878988877899999999998
Q ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 36899754301116999989999999999833018999999999999999721289
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~ 685 (690)
.+. ....+ ..+ . . .+.+++..||+.||++||||++|++.|++|.+
T Consensus 217 ~~~--~~~~p---~~~--~-~---~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 217 TGF--RLYKP---RLA--S-T---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp HTC--CCCCC---TTS--C-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HCC--CCCCC---CCC--C-H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 068--88995---436--7-9---99999999765797689199999999999985
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.45 Aligned_cols=247 Identities=24% Similarity=0.332 Sum_probs=193.8
Q ss_pred HHHHCCCCCCCEECCCCCCCEEEEECCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEE
Q ss_conf 99950679876004579722899983999379999930468--9997899999999872589981012128963981489
Q 005572 403 IAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 403 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
++..++|...+.||+|+||.||+|++.+ .||||+++... ....+.+.+|++++++++|||||+++|++.+ +..++
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~l 80 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAI 80 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred CCCCCCEEEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEE
T ss_conf 3154518998898307885899999999--89999997346998999999999999984799878645679715-58999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99715899776653008999999777888877899999977789998997899999999998887643069888787778
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~ 560 (690)
|||||++|+|.++++.. ...+++..++.++.|+|.||+|||+++++||||||+
T Consensus 81 v~Ey~~~g~L~~~l~~~---------------------------~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~ 133 (276)
T d1uwha_ 81 VTQWCEGSSLYHHLHII---------------------------ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSN 133 (276)
T ss_dssp EEECCCEEEHHHHHHTS---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEECCCCCCHHHHHHHC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHH
T ss_conf 99658998889998523---------------------------578999999999999999988875099951614789
Q ss_pred CEEECCCCCCEECCCCCCCCCCCC----------------CCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
Q ss_conf 478559999267477765543456----------------6765688---899987753236899999984899997348
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN----------------VGERSEN---ETCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 561 Nill~~~~~~ki~dfGl~~~~~~~----------------~~e~~~~---~~~~~~~DVwSfGvil~el~tg~~p~~~~~ 621 (690)
|||++.++.+||+|||+++..... +||.... ..++.++|||||||++|||+||+.||.+..
T Consensus 134 NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 134 NIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp GEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred HEEECCCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 97981899788750022133355677631256655743179999950568999953151635999999997889989989
Q ss_pred --HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf --99999999368997543011169999899999999998330189999999999999997212899
Q 005572 622 --KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 622 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~~ 686 (690)
.........+.... ....+...++ . .+.+++.+||+.||++||||.+|++.|+.++..
T Consensus 214 ~~~~~~~~~~~~~~~p-~~~~~~~~~~---~---~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 214 NRDQIIFMVGRGYLSP-DLSKVRSNCP---K---AMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CHHHHHHHHHHTSCCC-CGGGSCTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHCCCCCC-CCHHCCCCCH---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 6999999996588898-6000365554---9---999999997588976892999999999999970
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.20 Aligned_cols=245 Identities=25% Similarity=0.341 Sum_probs=193.3
Q ss_pred HHHHHHCCCCCCCEECCCCCCCEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEE
Q ss_conf 89999506798760045797228999839993799999304689997899999999872589981012128963981489
Q 005572 401 DLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 401 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
++++..++|...+.||+|+||.||+|.++++..||||+++... ...+.+.+|++.+++++|||||+++|+|.+ +..++
T Consensus 7 ~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~i 84 (272)
T d1qpca_ 7 EWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (272)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CEECCHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEE
T ss_conf 7003889938867981079828999999999999999986476-888999999999986799988578731045-97699
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99715899776653008999999777888877899999977789998997899999999998887643069888787778
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~ 560 (690)
|||||++|+|.+++... ....++|..++.++.|||+||.|||+.+++||||||+
T Consensus 85 v~Ey~~~g~L~~~~~~~--------------------------~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~ 138 (272)
T d1qpca_ 85 ITEYMENGSLVDFLKTP--------------------------SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA 138 (272)
T ss_dssp EEECCTTCBHHHHTTSH--------------------------HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEECCCCCHHHHHHHC--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf 99957898288887514--------------------------7898878899999999999999997489546756422
Q ss_pred CEEECCCCCCEECCCCCCCCCCCC---------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC-CCH-HHH
Q ss_conf 478559999267477765543456---------------676568889998775323689999998489999-734-899
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLTGKRGT-DDC-VKW 623 (690)
Q Consensus 561 Nill~~~~~~ki~dfGl~~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~-~~~-~~~ 623 (690)
|||+++++.+||+|||+++..... +||......++.++|||||||++|||+||..|+ ... ...
T Consensus 139 NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~ 218 (272)
T d1qpca_ 139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE 218 (272)
T ss_dssp GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH
T ss_pred HEEEECCCCEEECCCCCEEECCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 51562024404234101477358864420356774444582898379998245645257999999968988888889999
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9999993689975430111699998999999999983301899999999999999972128
Q 005572 624 VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 624 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~ 684 (690)
....+..+. . +..+..++ . .+.+++.+||+.||++||||.+|++.|+++.
T Consensus 219 ~~~~i~~~~--~---~~~p~~~~---~---~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 219 VIQNLERGY--R---MVRPDNCP---E---ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp HHHHHHTTC--C---CCCCTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHCC--C---CCCCCCCH---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 999997068--8---88965571---9---9999999975889768939999999861132
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.97 Aligned_cols=238 Identities=21% Similarity=0.340 Sum_probs=196.2
Q ss_pred CCCCCCCEECCCCCCCEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECC
Q ss_conf 06798760045797228999839993799999304689997899999999872589981012128963981489997158
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMA 486 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~ 486 (690)
++|+..+.||+|+||.||+|+++++..||||+++... ...+++.+|+..+++++||||++++|+|.+.+..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 9979968982078839999998899899999987475-778999999999996689860158899850781699997048
Q ss_pred CCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECC
Q ss_conf 99776653008999999777888877899999977789998997899999999998887643069888787778478559
Q 005572 487 NGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAE 566 (690)
Q Consensus 487 ~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~~ 566 (690)
+|+|..++.. ....+++..+.+++.|+|+||.|||+.+++||||||+||+++.
T Consensus 83 ~g~l~~~~~~---------------------------~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~ 135 (258)
T d1k2pa_ 83 NGCLLNYLRE---------------------------MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVND 135 (258)
T ss_dssp TEEHHHHHHS---------------------------GGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECT
T ss_pred CCCHHHHHHC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECC
T ss_conf 9938886410---------------------------2467768999999999999999875468434665413588769
Q ss_pred CCCCEECCCCCCCCCCCC---------------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHH-HHHHHHH
Q ss_conf 999267477765543456---------------6765688899987753236899999984-8999973489-9999999
Q 005572 567 SLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVK 629 (690)
Q Consensus 567 ~~~~ki~dfGl~~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~~p~~~~~~-~~~~~~~ 629 (690)
++.+||+|||+++..... +||......++.++||||||+++|||+| |+.||..... .+...+.
T Consensus 136 ~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~ 215 (258)
T d1k2pa_ 136 QGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215 (258)
T ss_dssp TCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH
T ss_pred CCCEEECCCHHHEECCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 98479886144202357872252465788775780786379988521033643246739755999988999999999998
Q ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 368997543011169999899999999998330189999999999999997212
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i 683 (690)
.+. ....+ ...+ . .+.+++..||+.||++||||.++++.|.+|
T Consensus 216 ~~~--~~~~p---~~~~---~---~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 216 QGL--RLYRP---HLAS---E---KVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp TTC--CCCCC---TTCC---H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred HCC--CCCCC---CCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf 079--78996---5465---9---999999997668976893999999874188
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.18 Aligned_cols=233 Identities=18% Similarity=0.265 Sum_probs=192.3
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEEC
Q ss_conf 067987600457972289998-3999379999930468999789999999987258998101212896398148999715
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
++|...+.||+|+||.||+|+ ..++..||+|+++.......+.+.+|+++++.++||||+++++++.+.+..++|||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
Q ss_conf 89977665300899999977788887789999997778999899789999999999888764306988878777847855
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~ 565 (690)
++|+|.+++.+ ..+++.++..++.|++.||.|||+++++||||||+|||++
T Consensus 100 ~gg~L~~~~~~-----------------------------~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~ 150 (293)
T d1yhwa1 100 AGGSLTDVVTE-----------------------------TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLG 150 (293)
T ss_dssp TTCBHHHHHHH-----------------------------SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CCCCHHHHHHC-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEC
T ss_conf 79808988641-----------------------------5999999999999999999999987972267768886887
Q ss_pred CCCCCEECCCCCCCCCCC--------------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH--HHHHHHHH
Q ss_conf 999926747776554345--------------66765688899987753236899999984899997348--99999999
Q 005572 566 ESLEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKLVK 629 (690)
Q Consensus 566 ~~~~~ki~dfGl~~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~--~~~~~~~~ 629 (690)
.++.+||+|||+++.... .+||...+..++.++||||+||++|||+||+.||.+.. +.......
T Consensus 151 ~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~ 230 (293)
T d1yhwa1 151 MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (293)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CCCCEEECCCHHHEEECCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
T ss_conf 89968642515641321366644444447773682664479988012031372999998048899899799999999985
Q ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 3689975430111699998999999999983301899999999999999
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
.... . .......+. .+.+++.+||+.||++|||+.|+++
T Consensus 231 ~~~~-~---~~~~~~~s~------~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 231 NGTP-E---LQNPEKLSA------IFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp HCSC-C---CSSGGGSCH------HHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred CCCC-C---CCCCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 7999-8---888553799------9999999986699668909999964
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.28 Aligned_cols=243 Identities=22% Similarity=0.369 Sum_probs=191.5
Q ss_pred CCCCCCCEECCCCCCCEEEEECCCC-----CEEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEE
Q ss_conf 0679876004579722899983999-----3799999304689-997899999999872589981012128963981489
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGE-----LHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~~~~-----~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
+.|...++||+|+||.||+|.+++. ..||||++..... ....++.+|++++++++|||||+++|+|.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99715899776653008999999777888877899999977789998997899999999998887643069888787778
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~ 560 (690)
|+|||.+|++.+++... ...++|.+++.++.|++.||+|||+.+++||||||+
T Consensus 87 v~e~~~~~~l~~~~~~~---------------------------~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~ 139 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK---------------------------DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAAR 139 (283)
T ss_dssp EEECCTTEEHHHHHHHT---------------------------TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEEECCCCCCHHHHHCC---------------------------CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 99721357402221023---------------------------454208999999999998541212123425765644
Q ss_pred CEEECCCCCCEECCCCCCCCCCC-----------------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCC-CCH-H
Q ss_conf 47855999926747776554345-----------------6676568889998775323689999998489999-734-8
Q 005572 561 SILLAESLEPKIAGFGLRNIGVK-----------------NVGERSENETCGPESDVYCFGVILMELLTGKRGT-DDC-V 621 (690)
Q Consensus 561 Nill~~~~~~ki~dfGl~~~~~~-----------------~~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~-~~~-~ 621 (690)
|||++.++.+||+|||+++.... .+||......++.++|||||||++|||+||..|+ ... .
T Consensus 140 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~ 219 (283)
T d1mqba_ 140 NILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN 219 (283)
T ss_dssp GEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred EEEECCCCEEEECCCCHHHCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 27888998499845510300357876526742677773434888870499997355634489899999679886556899
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 999999993689975430111699998999999999983301899999999999999972128999
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~~~ 687 (690)
......+..+.. +..+..+ . ..+.+++.+||+.||++||+|.+|++.|+.+.+.+
T Consensus 220 ~~~~~~i~~~~~-----~~~~~~~--~----~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~p 274 (283)
T d1mqba_ 220 HEVMKAINDGFR-----LPTPMDC--P----SAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP 274 (283)
T ss_dssp HHHHHHHHTTCC-----CCCCTTC--B----HHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred HHHHHHHHCCCC-----CCCCHHH--H----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf 999999863578-----9985045--7----99999999977679768939999999999986695
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.98 Aligned_cols=239 Identities=22% Similarity=0.317 Sum_probs=186.8
Q ss_pred CCCCCCC-EECCCCCCCEEEEECC---CCCEEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEE
Q ss_conf 0679876-0045797228999839---993799999304689-9978999999998725899810121289639814899
Q 005572 407 SHFGKES-LLAEGRCGPVYRAVLP---GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~-~ig~G~~g~V~~~~~~---~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
+++...+ .||+|+||.||+|.++ ++..||||+++.... ...+++.+|+++|++++|||||+++|+|.+ +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 97158997766530089999997778888778999999777899989978999999999988876430698887877784
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~N 561 (690)
||||++|+|.+++.. ....+++..++.++.|+|.||.|||+++++||||||+|
T Consensus 87 mE~~~~g~L~~~l~~---------------------------~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N 139 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG---------------------------KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 139 (285)
T ss_dssp EECCTTEEHHHHHTT---------------------------CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred EEECCCCCHHHHHHC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHH
T ss_conf 980789968997521---------------------------25699999999999999998789986881057676466
Q ss_pred EEECCCCCCEECCCCCCCCCCCC-----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHH-H
Q ss_conf 78559999267477765543456-----------------6765688899987753236899999984-899997348-9
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-K 622 (690)
Q Consensus 562 ill~~~~~~ki~dfGl~~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~~p~~~~~-~ 622 (690)
||++.++.+||+|||+++..... +||......++.++|||||||++|||+| |+.||.+.. .
T Consensus 140 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~ 219 (285)
T d1u59a_ 140 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219 (285)
T ss_dssp EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred EEECCCCCEEECCCHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH
T ss_conf 04546885420331342115543432113562113743358688727999954123220178999993899999997999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 99999993689975430111699998999999999983301899999999999999972128
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~ 684 (690)
.....+..+.. +..+..++ . .+.+++..||+.||++||+|.+|.+.|+.+.
T Consensus 220 ~~~~~i~~~~~-----~~~p~~~~---~---~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 220 EVMAFIEQGKR-----MECPPECP---P---ELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp HHHHHHHTTCC-----CCCCTTCC---H---HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHCCCC-----CCCCCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99999981899-----99997678---9---9999999975779768909999999999999
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.62 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=195.1
Q ss_pred HHHHCCCCCCCEECCCCCCCEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf 99950679876004579722899983999379999930468999789999999987258998101212896398148999
Q 005572 403 IAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 403 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++..++|...+.||+|+||.||+|++++...||||+++... ...+.+.+|+..+++++|||||+++|+|.+ +..++||
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~ 90 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT 90 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred ECCHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEE
T ss_conf 74779979846993079809999999999999999988044-888999999999986666788689999823-9759999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 71589977665300899999977788887789999997778999899789999999999888764306988878777847
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Ni 562 (690)
|||++|+|..++... ....++|.+++.++.|||.||.|||+.+++||||||+||
T Consensus 91 Ey~~~g~l~~~~~~~--------------------------~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NI 144 (285)
T d1fmka3 91 EYMSKGSLLDFLKGE--------------------------TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144 (285)
T ss_dssp CCCTTCBHHHHHSHH--------------------------HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EECCCCCHHHHHHHC--------------------------CCCCCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEE
T ss_conf 944799435420000--------------------------355305999999999999999987541143353123079
Q ss_pred EECCCCCCEECCCCCCCCCCCC---------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC-CH-HHHHH
Q ss_conf 8559999267477765543456---------------6765688899987753236899999984899997-34-89999
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLTGKRGTD-DC-VKWVR 625 (690)
Q Consensus 563 ll~~~~~~ki~dfGl~~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~-~~-~~~~~ 625 (690)
|+++++++||+|||+++..... +||......++.++||||||+++|||+||..|+. .. .....
T Consensus 145 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~ 224 (285)
T d1fmka3 145 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224 (285)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred EECCCCCEEECCCCHHHHCCCCCCEEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 99899929984425554256887335245455665458089837998917741323589999986899999888899999
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 99993689975430111699998999999999983301899999999999999972128999
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~~~ 687 (690)
..+..+.. +.....++ . .+.+++.+||+.||++||+|.+|++.|+......
T Consensus 225 ~~i~~~~~-----~~~~~~~~---~---~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 225 DQVERGYR-----MPCPPECP---E---SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHHTTCC-----CCCCTTSC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHHHCCC-----CCCCCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCCC
T ss_conf 99982689-----99983237---9---9999999975669758919999999876662389
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=342.60 Aligned_cols=271 Identities=25% Similarity=0.318 Sum_probs=202.2
Q ss_pred HHHHHHHCCCCCCCEECCCCCCCEEEEECC------CCCEEEEEEEECCCCC-CHHHHHHHHHHHHHCCCCCCCCEEEEE
Q ss_conf 889999506798760045797228999839------9937999993046899-978999999998725899810121289
Q 005572 400 KDLIAATSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKGI-DHDDAVAMFDELSRLKHPNLLPLAGYC 472 (690)
Q Consensus 400 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~H~niv~l~g~~ 472 (690)
.+++.+.++|+..+.||+|+||.||+|++. ++..||||+++..... ..+++.+|+++++.++||||++++|+|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 31138988938867982078839999998887657788299999988210857999999999999966899765524666
Q ss_pred ECCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 63981489997158997766530089999997778888778999999777899989978999999999988876430698
Q 005572 473 IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS 552 (690)
Q Consensus 473 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~ 552 (690)
...+..++|+||+++|+|.++++...........+.... ............+++..++.++.|+|.||+|||+.++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~i 161 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS----TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKF 161 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC--------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCC----HHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCE
T ss_conf 059803899981589929999985275542100001110----0121034678898999999999999998554135786
Q ss_pred CCCCCCCCCEEECCCCCCEECCCCCCCCCCCC----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-C
Q ss_conf 88787778478559999267477765543456----------------676568889998775323689999998489-9
Q 005572 553 THGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLTGK-R 615 (690)
Q Consensus 553 ~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~-~ 615 (690)
+||||||+|||++.++.+||+|||+++..... +||......+++++|||||||++|||++|. .
T Consensus 162 vHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~ 241 (301)
T d1lufa_ 162 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241 (301)
T ss_dssp CCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EEEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCC
T ss_conf 85488401168989992898331442113677641115777767676798997268898056302523629999806899
Q ss_pred CCCCHH-HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 997348-9999999936899754301116999989999999999833018999999999999999721289
Q 005572 616 GTDDCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 616 p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~ 685 (690)
||.+.. ......+..+.. +..+... . . .+.+++.+||+.||++||||.+|++.|++|.+
T Consensus 242 p~~~~~~~e~~~~v~~~~~-----~~~p~~~--~-~---~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 242 PYYGMAHEEVIYYVRDGNI-----LACPENC--P-L---ELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp TTTTSCHHHHHHHHHTTCC-----CCCCTTC--C-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred CCCCCCHHHHHHHHHCCCC-----CCCCCCC--H-H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 9999899999999973997-----8887325--2-9---99999999748896579399999999998429
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.76 Aligned_cols=263 Identities=20% Similarity=0.300 Sum_probs=196.6
Q ss_pred HHHHHCCCCCCCEECCCCCCCEEEEECCC-C-----CEEEEEEEECC-CCCCHHHHHHHHHHHHHC-CCCCCCCEEEEEE
Q ss_conf 99995067987600457972289998399-9-----37999993046-899978999999998725-8998101212896
Q 005572 402 LIAATSHFGKESLLAEGRCGPVYRAVLPG-E-----LHVAIKVLDNA-KGIDHDDAVAMFDELSRL-KHPNLLPLAGYCI 473 (690)
Q Consensus 402 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~ 473 (690)
|++..++|...+.||+|+||.||+|+... + ..||+|.+... .......+.+|+..+.++ +|||||+++|+|.
T Consensus 32 wei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 65778993970198307881999999857885542049999996633587899999999999997158996868778886
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 39814899971589977665300899999-97778888778999999777899989978999999999988876430698
Q 005572 474 AGKEKLVLLEFMANGDLHRWLHELPTGEP-NVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS 552 (690)
Q Consensus 474 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~ 552 (690)
+.+..++|||||++|+|.++++....... ....+.. . ...........+++..++.++.|++.||.|||++++
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~---~---~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~I 185 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN---Q---KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 185 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------------CCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred ECCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCC---C---CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
T ss_conf 2995899997279995999998625777510221000---0---122200125778999999999999999999973990
Q ss_pred CCCCCCCCCEEECCCCCCEECCCCCCCCCCCC----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCC
Q ss_conf 88787778478559999267477765543456----------------6765688899987753236899999984-899
Q 005572 553 THGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKR 615 (690)
Q Consensus 553 ~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~~ 615 (690)
+||||||+|||++.++.+||+|||+++..... +||...+..++.++|||||||++|||+| |+.
T Consensus 186 iHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 186 VHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp EETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred EECCCCHHCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCC
T ss_conf 50527032144345982898514222204577861562343578765783887279999633030003999999838999
Q ss_pred CCCCH--HHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Q ss_conf 99734--8999999993689975430111699998999999999983301899999999999999972
Q 005572 616 GTDDC--VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLK 681 (690)
Q Consensus 616 p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~ 681 (690)
||.+. .+.....+..+.. +..+..++. .+.+++..||+.||++||||.||++.|.
T Consensus 266 Pf~~~~~~~~~~~~~~~~~~-----~~~p~~~~~------~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 266 PYPGIPVDANFYKLIQNGFK-----MDQPFYATE------EIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SSTTCCCSHHHHHHHHTTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCC-----CCCCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 99998989999999856998-----998876789------9999999975889668939999999974
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=341.64 Aligned_cols=235 Identities=21% Similarity=0.256 Sum_probs=188.2
Q ss_pred CCCCCCCEECCCCCCCEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEEC
Q ss_conf 0679876004579722899983-999379999930468999789999999987258998101212896398148999715
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
+.|+..+.||+|+||.||+|+. .++..||+|+++.......+.+.+|++++++++|||||++++++.+.+..++|||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
Q ss_conf 89977665300899999977788887789999997778999899789999999999888764306988878777847855
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~ 565 (690)
++|+|.+++.+. ...+++.++..++.|++.||.|||+++++||||||+|||++
T Consensus 92 ~~g~L~~~~~~~---------------------------~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~ 144 (288)
T d2jfla1 92 AGGAVDAVMLEL---------------------------ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFT 144 (288)
T ss_dssp TTEEHHHHHHHH---------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEC
T ss_pred CCCCHHHHHHHC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEEC
T ss_conf 998188999862---------------------------89999999999999999999999988988714070031487
Q ss_pred CCCCCEECCCCCCCCCCC--------------CCCCCC-----CCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH--HHH
Q ss_conf 999926747776554345--------------667656-----88899987753236899999984899997348--999
Q 005572 566 ESLEPKIAGFGLRNIGVK--------------NVGERS-----ENETCGPESDVYCFGVILMELLTGKRGTDDCV--KWV 624 (690)
Q Consensus 566 ~~~~~ki~dfGl~~~~~~--------------~~~e~~-----~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~--~~~ 624 (690)
.++.+||+|||+++.... .+||.. ....++.++|||||||++|||+||+.||.+.. +..
T Consensus 145 ~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~ 224 (288)
T d2jfla1 145 LDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224 (288)
T ss_dssp TTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHH
T ss_pred CCCCEEEEECHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf 89998997161230357786410010256264799998320257888880665787899999982088999998999999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 999993689975430111699998999999999983301899999999999999
Q 005572 625 RKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
..... ........ ....+ . .+.+++.+||+.||++|||+.|+++
T Consensus 225 ~~i~~-~~~~~~~~---~~~~s---~---~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 225 LKIAK-SEPPTLAQ---PSRWS---S---NFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp HHHHH-SCCCCCSS---GGGSC---H---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHC-CCCCCCCC---CCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 99970-79987776---56699---9---9999999976699668919999962
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.97 Aligned_cols=231 Identities=23% Similarity=0.340 Sum_probs=183.9
Q ss_pred CEECCCCCCCEEEEECCC---CCEEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEECCC
Q ss_conf 600457972289998399---93799999304689--9978999999998725899810121289639814899971589
Q 005572 413 SLLAEGRCGPVYRAVLPG---ELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFMAN 487 (690)
Q Consensus 413 ~~ig~G~~g~V~~~~~~~---~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~~~ 487 (690)
+.||+|+||.||+|.+++ +..||||+++.... ...+++.+|++++++++|||||+++|+|.+ +..++|||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCC
Q ss_conf 97766530089999997778888778999999777899989978999999999988876430698887877784785599
Q 005572 488 GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAES 567 (690)
Q Consensus 488 gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~~~ 567 (690)
|+|.++++. ...+++..++.++.|+|.||.|||+.+++||||||+|||++.+
T Consensus 92 g~L~~~l~~----------------------------~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~ 143 (277)
T d1xbba_ 92 GPLNKYLQQ----------------------------NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 143 (277)
T ss_dssp EEHHHHHHH----------------------------CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CCHHHHHHH----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCC
T ss_conf 968999752----------------------------2578999999999999999766874795567776113102356
Q ss_pred CCCEECCCCCCCCCCCC-----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHH-HHHHHH
Q ss_conf 99267477765543456-----------------6765688899987753236899999984-8999973489-999999
Q 005572 568 LEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLV 628 (690)
Q Consensus 568 ~~~ki~dfGl~~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~~p~~~~~~-~~~~~~ 628 (690)
+.+|++|||+++..... +||......++.++|||||||++|||+| |+.||.+... .....+
T Consensus 144 ~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i 223 (277)
T d1xbba_ 144 HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML 223 (277)
T ss_dssp TEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH
T ss_pred CCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 75123413453313432344322445677842039166537999843443034031328965899999998999999999
Q ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
Q ss_conf 9368997543011169999899999999998330189999999999999997212
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDI 683 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i 683 (690)
..+.. +..+..++ . .+.+++.+||+.||++||||.+|.+.|+..
T Consensus 224 ~~~~~-----~~~p~~~~---~---~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 224 EKGER-----MGCPAGCP---R---EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp HTTCC-----CCCCTTCC---H---HHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred HCCCC-----CCCCCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf 82899-----99986567---9---999999997588976890989999985288
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.03 Aligned_cols=234 Identities=22% Similarity=0.249 Sum_probs=185.1
Q ss_pred CCCCCCCEECCCCCCCEEEEEC-CCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEE
Q ss_conf 0679876004579722899983-9993799999304689-9978999999998725899810121289639814899971
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++|+..+.||+|+||.||+|+. .++..||+|+++.... ...+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf 46089989721748099999999999799999984566412799999999999857998884696540467436798864
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 58997766530089999997778888778999999777899989978999999999988876430698887877784785
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill 564 (690)
|++|+|.+++.. ...+++.++..++.|++.||.|||+++++||||||+|||+
T Consensus 85 ~~gg~L~~~l~~----------------------------~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl 136 (271)
T d1nvra_ 85 CSGGELFDRIEP----------------------------DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL 136 (271)
T ss_dssp CTTEEGGGGSBT----------------------------TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred CCCCCHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEE
T ss_conf 589808999753----------------------------7999999999999999999999997598357546899788
Q ss_pred CCCCCCEECCCCCCCCCCC----------------CCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCHHHHHH--
Q ss_conf 5999926747776554345----------------66765688899-9877532368999999848999973489999--
Q 005572 565 AESLEPKIAGFGLRNIGVK----------------NVGERSENETC-GPESDVYCFGVILMELLTGKRGTDDCVKWVR-- 625 (690)
Q Consensus 565 ~~~~~~ki~dfGl~~~~~~----------------~~~e~~~~~~~-~~~~DVwSfGvil~el~tg~~p~~~~~~~~~-- 625 (690)
++++.+||+|||+++.... .+||...+..+ +.++||||+||++|||+||+.||........
T Consensus 137 ~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~ 216 (271)
T d1nvra_ 137 DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY 216 (271)
T ss_dssp CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHH
T ss_pred CCCCCEEECCCHHHEEECCCCCCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 78998798323142240468865311132557474287286189999971016173799999982997888898599999
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 99993689975430111699998999999999983301899999999999999
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
....... ....+ ....+ . .+.+++.+||+.||++|||+.|+++
T Consensus 217 ~~~~~~~--~~~~~--~~~~s---~---~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 217 SDWKEKK--TYLNP--WKKID---S---APLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp HHHHTTC--TTSTT--GGGSC---H---HHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred HHHHCCC--CCCCC--CCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9986388--87886--44699---9---9999999976799668909999961
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.55 Aligned_cols=250 Identities=21% Similarity=0.303 Sum_probs=189.6
Q ss_pred HHCCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf 95067987600457972289998-39993799999304689-99789999999987258998101212896398148999
Q 005572 405 ATSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 405 ~~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
..++|+..+.||+|+||.||+|+ ..++..||+|+++.... ...+.+.+|+++++.++|||||+++++|.+.+..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCCCCCCCC
Q ss_conf 7158997766530089999997778888778999999777899989978999999999988876430-698887877784
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGSTHGHLVTSS 561 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~H~dlk~~N 561 (690)
|||++|+|.+++.+ ...+++..+..++.|++.||.|||+ ++++||||||+|
T Consensus 84 Ey~~gg~L~~~l~~----------------------------~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N 135 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKK----------------------------AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN 135 (322)
T ss_dssp ECCTTEEHHHHHHH----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred ECCCCCCHHHHHHH----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHH
T ss_conf 76799868998742----------------------------49999999999999999999999985999714457799
Q ss_pred EEECCCCCCEECCCCCCCCCCC------------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHHHHHHHH-
Q ss_conf 7855999926747776554345------------667656888999877532368999999848999973489999999-
Q 005572 562 ILLAESLEPKIAGFGLRNIGVK------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKWVRKLV- 628 (690)
Q Consensus 562 ill~~~~~~ki~dfGl~~~~~~------------~~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~~~~~~~- 628 (690)
||+++++.+||+|||+|+.... .+||...+..++.++||||+||++|||++|+.||...........
T Consensus 136 ILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~ 215 (322)
T d1s9ja_ 136 ILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215 (322)
T ss_dssp EEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC
T ss_pred EEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 46878998999548776256788621113771411946875899894888998999999999888998998878999999
Q ss_pred ---HHCCCCC-----------CCCCCCCCCCCCCHHH------------------HHHHHHHHHHHCCCCCCCCCCHHHH
Q ss_conf ---9368997-----------5430111699998999------------------9999999833018999999999999
Q 005572 629 ---KEGAGGD-----------ALDFRLKLGSGDSVAE------------------MVESLRVGYLCTADSPGKRPTMQQV 676 (690)
Q Consensus 629 ---~~~~~~~-----------~~~~~~~~~~~~~~~~------------------~~~~~~i~~~C~~~dP~~RPs~~~i 676 (690)
..+.... ...............+ ...+.+++.+||+.||++|||+.|+
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~ 295 (322)
T d1s9ja_ 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295 (322)
T ss_dssp ------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 88751775457742123332211112223541347788766502687667644489999999999868994679089999
Q ss_pred HH--HHHC
Q ss_conf 99--9721
Q 005572 677 LG--LLKD 682 (690)
Q Consensus 677 ~~--~L~~ 682 (690)
++ ++++
T Consensus 296 L~Hpf~~~ 303 (322)
T d1s9ja_ 296 MVHAFIKR 303 (322)
T ss_dssp HTSHHHHH
T ss_pred HHCHHHCC
T ss_conf 60986476
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.95 Aligned_cols=232 Identities=25% Similarity=0.298 Sum_probs=190.9
Q ss_pred CCCCCCCEECCCCCCCEEEEEC-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf 0679876004579722899983-99937999993046---8999789999999987258998101212896398148999
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNA---KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|...+.||+|+||.||+|+. .++..||+|++... +....+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 71589977665300899999977788887789999997778999899789999999999888764306988878777847
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Ni 562 (690)
|||++|+|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||
T Consensus 86 Ey~~~g~L~~~l~~----------------------------~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Ni 137 (263)
T d2j4za1 86 EYAPLGTVYRELQK----------------------------LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL 137 (263)
T ss_dssp ECCTTCBHHHHHHH----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred EECCCCCHHHHHHH----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCC
T ss_conf 50479858988750----------------------------48999999999999999999999988946522023441
Q ss_pred EECCCCCCEECCCCCCCCCCCC------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH-HHHHHHHH
Q ss_conf 8559999267477765543456------------6765688899987753236899999984899997348-99999999
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVK 629 (690)
Q Consensus 563 ll~~~~~~ki~dfGl~~~~~~~------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~-~~~~~~~~ 629 (690)
|++.++.+||+|||+++..... +||...+..++.++|||||||++|||++|+.||.... ........
T Consensus 138 ll~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 217 (263)
T d2j4za1 138 LLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 217 (263)
T ss_dssp EECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred EECCCCCEEECCCCEEEECCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH
T ss_conf 46689987115556335448885235578876349999758998931440467599999832999988899999999997
Q ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 3689975430111699998999999999983301899999999999999
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
... +.++...+ . .+.+++.+||+.||++|||+.|+++
T Consensus 218 ~~~------~~~p~~~s---~---~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 218 RVE------FTFPDFVT---E---GARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp TTC------CCCCTTSC---H---HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred CCC------CCCCCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 189------99986689---9---9999999976479768909999971
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=334.26 Aligned_cols=238 Identities=21% Similarity=0.202 Sum_probs=190.8
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEEC
Q ss_conf 067987600457972289998-3999379999930468999789999999987258998101212896398148999715
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
++|+..+.||+|+||.||+|+ ..++..||+|++..........+.+|++++++++||||+++++++.+.+..++|||||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 03599899931778299999998999799999988726467999999999998679979891999999899999999828
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
Q ss_conf 89977665300899999977788887789999997778999899789999999999888764306988878777847855
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~ 565 (690)
++|+|.+++.. ....+++.++..++.|++.||.|||+++++||||||+|||++
T Consensus 109 ~gg~L~~~~~~---------------------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~ 161 (352)
T d1koba_ 109 SGGELFDRIAA---------------------------EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCE 161 (352)
T ss_dssp CCCBHHHHTTC---------------------------TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CCCHHHHHHHH---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCC
T ss_conf 99808888986---------------------------389989999999999999999999977926513144553113
Q ss_pred --CCCCCEECCCCCCCCCCCC-------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHHH-HHHHHH
Q ss_conf --9999267477765543456-------------676568889998775323689999998489999734899-999999
Q 005572 566 --ESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW-VRKLVK 629 (690)
Q Consensus 566 --~~~~~ki~dfGl~~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~~-~~~~~~ 629 (690)
.++.+||+|||+++..... +||...+..++.++||||+||++|||+||+.||.+.... ......
T Consensus 162 ~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 241 (352)
T d1koba_ 162 TKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241 (352)
T ss_dssp STTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEEEECCCCEECCCCCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 46788489952563034378872010047645348999747998976333898999999996889989979999999998
Q ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 36899754301116999989999999999833018999999999999999
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~ 679 (690)
..... ......... + . .+.+++.+||+.||++|||+.|+++.
T Consensus 242 ~~~~~--~~~~~~~~~--s-~---~~~~li~~~L~~dp~~R~s~~eil~H 283 (352)
T d1koba_ 242 RCDWE--FDEDAFSSV--S-P---EAKDFIKNLLQKEPRKRLTVHDALEH 283 (352)
T ss_dssp HCCCC--CCSSTTTTS--C-H---HHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred HCCCC--CCCCCCCCC--C-H---HHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 47889--893002479--9-9---99999999756996689189999609
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=333.75 Aligned_cols=233 Identities=21% Similarity=0.240 Sum_probs=186.1
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCC---HHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf 067987600457972289998-3999379999930468999---789999999987258998101212896398148999
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGID---HDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
+.|+..+.||+|+||.||+|+ ..++..||||++....... .+.+.+|++++++++|||||+++|++.+.+..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 71589977665300899999977788887789999997778999899789999999999888764306988878777847
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Ni 562 (690)
|||++|+|..++.. ...+++.++..++.|++.||.|||+++++||||||+||
T Consensus 95 E~~~~g~l~~~~~~----------------------------~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI 146 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH----------------------------KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI 146 (309)
T ss_dssp ECCSEEHHHHHHHH----------------------------TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred EECCCCCHHHHHHH----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEE
T ss_conf 80699945789973----------------------------79999999999999999999999868976667884217
Q ss_pred EECCCCCCEECCCCCCCCCCCC----------CCCCCC---CCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHHH--HHHH
Q ss_conf 8559999267477765543456----------676568---889998775323689999998489999734899--9999
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN----------VGERSE---NETCGPESDVYCFGVILMELLTGKRGTDDCVKW--VRKL 627 (690)
Q Consensus 563 ll~~~~~~ki~dfGl~~~~~~~----------~~e~~~---~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~~--~~~~ 627 (690)
|++.++.+||+|||++...... |||... ...++.++|||||||++|||++|+.||.+.... ....
T Consensus 147 Ll~~~~~~Kl~DFG~a~~~~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i 226 (309)
T d1u5ra_ 147 LLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226 (309)
T ss_dssp EEETTTEEEECCCTTCBSSSSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred EECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 98799978984436533467787313476636889983467888672145455899999998788999997999999999
Q ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 993689975430111699998999999999983301899999999999999
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
.. ....... ....+ . .+.+++.+||+.||++|||+.++++
T Consensus 227 ~~-~~~~~~~----~~~~s---~---~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 227 AQ-NESPALQ----SGHWS---E---YFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp HH-SCCCCCS----CTTSC---H---HHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred HH-CCCCCCC----CCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 82-8999888----78889---9---9999999977379657918999971
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=334.21 Aligned_cols=237 Identities=22% Similarity=0.253 Sum_probs=190.1
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEEC
Q ss_conf 067987600457972289998-3999379999930468999789999999987258998101212896398148999715
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
++|...+.||+|+||.||+|+ ..++..||||++........+.+.+|++++++++|||||++++++.+.+..++|||||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEECC
T ss_conf 57589889840768199999988999899999984524316999999999998679979992999999899999999857
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
Q ss_conf 89977665300899999977788887789999997778999899789999999999888764306988878777847855
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~ 565 (690)
++|+|.+++.. ....+++..+..++.|++.||.|||+++++||||||+|||++
T Consensus 106 ~gg~L~~~l~~---------------------------~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~ 158 (350)
T d1koaa2 106 SGGELFEKVAD---------------------------EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT 158 (350)
T ss_dssp CSCBHHHHHTC---------------------------TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CCCCHHHHHHH---------------------------HCCCCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEEC
T ss_conf 99889999976---------------------------237899999999999999999999756976000154673641
Q ss_pred C--CCCCEECCCCCCCCCCCC-------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCH--HHHHHHHH
Q ss_conf 9--999267477765543456-------------676568889998775323689999998489999734--89999999
Q 005572 566 E--SLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--VKWVRKLV 628 (690)
Q Consensus 566 ~--~~~~ki~dfGl~~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~--~~~~~~~~ 628 (690)
. ++.+||+|||+++..... +||...+..++.++||||+||++|||++|+.||... .+....+.
T Consensus 159 ~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 159 TKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp STTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEEEECCHHEECCCCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 68898699954521044256543200068624218899758998726765546599999985989989979999999998
Q ss_pred HHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 936899754301116999989999999999833018999999999999999
Q 005572 629 KEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 629 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~ 679 (690)
. .... .+.......+. .+.+++.+||+.||++|||+.|+++.
T Consensus 239 ~-~~~~--~~~~~~~~~s~------~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 239 S-CDWN--MDDSAFSGISE------DGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp H-TCCC--SCCGGGGGCCH------HHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred H-CCCC--CCCCCCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4-7889--89422358999------99999999756896679089998629
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.04 Aligned_cols=238 Identities=23% Similarity=0.354 Sum_probs=185.3
Q ss_pred CCEECCCCCCCEEEEECCC----CCEEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEECC-CEEEEEEEEC
Q ss_conf 7600457972289998399----93799999304689-9978999999998725899810121289639-8148999715
Q 005572 412 ESLLAEGRCGPVYRAVLPG----ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAG-KEKLVLLEFM 485 (690)
Q Consensus 412 ~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~~ 485 (690)
.++||+|+||.||+|.+.. ...||||+++.... ...+++.+|++.+++++||||++++|+|.+. ...++|||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
Q ss_conf 89977665300899999977788887789999997778999899789999999999888764306988878777847855
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~ 565 (690)
++|+|.++++.. ...+++..++.++.|+|.||.|+|+.+++||||||+|||++
T Consensus 112 ~~g~l~~~~~~~---------------------------~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~ 164 (311)
T d1r0pa_ 112 KHGDLRNFIRNE---------------------------THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLD 164 (311)
T ss_dssp TTCBHHHHHHCT---------------------------TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred ECCCHHHHHCCC---------------------------CCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEEC
T ss_conf 067414421013---------------------------45404899999999988765200336762577668757677
Q ss_pred CCCCCEECCCCCCCCCCCC------------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHHH--HH
Q ss_conf 9999267477765543456------------------676568889998775323689999998489999734899--99
Q 005572 566 ESLEPKIAGFGLRNIGVKN------------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVKW--VR 625 (690)
Q Consensus 566 ~~~~~ki~dfGl~~~~~~~------------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~~--~~ 625 (690)
+++.+||+|||+++..... +||......++.++||||||+++|||+||..|+...... ..
T Consensus 165 ~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~ 244 (311)
T d1r0pa_ 165 EKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT 244 (311)
T ss_dssp TTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CH
T ss_pred CCCCEEEECCCCHHHCCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 99988991065232255665553100256555645567688743799974574661999999997899998889999999
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCCC
Q ss_conf 99993689975430111699998999999999983301899999999999999972128999
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPSA 687 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~~~ 687 (690)
..+..+. .... +..++ . .+.+++.+||+.||++||+|.||++.|+.+....
T Consensus 245 ~~i~~g~--~~~~---p~~~~---~---~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~ 295 (311)
T d1r0pa_ 245 VYLLQGR--RLLQ---PEYCP---D---PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTF 295 (311)
T ss_dssp HHHHTTC--CCCC---CTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred HHHHCCC--CCCC---CCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHH
T ss_conf 9998089--8899---64475---9---9999999976889768939999999999999752
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.11 Aligned_cols=239 Identities=20% Similarity=0.317 Sum_probs=189.2
Q ss_pred CCCCCCCEECCCCCCCEEEEECC-CCC----EEEEEEEECC-CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEE
Q ss_conf 06798760045797228999839-993----7999993046-89997899999999872589981012128963981489
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLP-GEL----HVAIKVLDNA-KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLV 480 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~l 480 (690)
++|+..+.||+|+||.||+|.+. ++. .||+|+++.. .....+++.+|++++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99715899776653008999999777888877899999977789998997899999999998887643069888787778
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~ 560 (690)
++||+.+|+|.+++.. ....+++..++.++.|||.||.|||+++++||||||+
T Consensus 88 v~e~~~~~~l~~~~~~---------------------------~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~ 140 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE---------------------------HKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAAR 140 (317)
T ss_dssp EEECCTTCBHHHHHHH---------------------------TSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred EEEECCCCCCCCCCCC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHH
T ss_conf 9984268740101113---------------------------3457999999999999999999998769504762120
Q ss_pred CEEECCCCCCEECCCCCCCCCCCC----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHH-H
Q ss_conf 478559999267477765543456----------------6765688899987753236899999984-899997348-9
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV-K 622 (690)
Q Consensus 561 Nill~~~~~~ki~dfGl~~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~~p~~~~~-~ 622 (690)
|||++.++.+||+|||+++..... +||......++.++|||||||++|||+| |..||++.. .
T Consensus 141 NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 141 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp GEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred CCEECCCCCEEEECCCCCEECCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 31167998758602552223354445322365105864467088746999835654407999999997799999999989
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 99999993689975430111699998999999999983301899999999999999972128
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~ 684 (690)
.....+..+... ..+..+ . ..+.+++.+||+.||++||||.+|++.|..+.
T Consensus 221 ~~~~~i~~~~~~-----~~p~~~--~----~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 221 EISSILEKGERL-----PQPPIC--T----IDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp GHHHHHHHTCCC-----CCCTTB--C----HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHCCCCC-----CCCCCC--C----HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 999999759989-----998556--8----99999999847899346919999999999987
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=329.43 Aligned_cols=237 Identities=20% Similarity=0.214 Sum_probs=188.8
Q ss_pred CCCCCCCEECCCCCCCEEEEEC-CCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEE
Q ss_conf 0679876004579722899983-9993799999304689-9978999999998725899810121289639814899971
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
+.|...+.||+|+||.||+|+. .++..||||++..... .....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~ 88 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQL 88 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 66699889940658399999999999899999981577312899999999999867998999198999989988898852
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 58997766530089999997778888778999999777899989978999999999988876430698887877784785
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill 564 (690)
|++|+|.+++.+ ...+++.....++.|++.||.|||+++++||||||+|||+
T Consensus 89 ~~gg~L~~~l~~----------------------------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~ 140 (307)
T d1a06a_ 89 VSGGELFDRIVE----------------------------KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLY 140 (307)
T ss_dssp CCSCBHHHHHHT----------------------------CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred CCCCCHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEE
T ss_conf 689848886530----------------------------3678878999999999999875241305568704630011
Q ss_pred C---CCCCCEECCCCCCCCCCCC-------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH-HHHHH
Q ss_conf 5---9999267477765543456-------------67656888999877532368999999848999973489-99999
Q 005572 565 A---ESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKL 627 (690)
Q Consensus 565 ~---~~~~~ki~dfGl~~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~-~~~~~ 627 (690)
. +++.+||+|||+++..... +||...+..+++++||||+||++|||++|+.||.+... .....
T Consensus 141 ~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~ 220 (307)
T d1a06a_ 141 YSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220 (307)
T ss_dssp SSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred CCCCCCCEEEEECCCEEEECCCCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
T ss_conf 04688824998315435872589704400328422591887379998078734515999999859799999899999999
Q ss_pred HHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 9936899754301116999989999999999833018999999999999999
Q 005572 628 VKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 628 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~ 679 (690)
...... ..+.......+ . .+.+++.+||+.||++|||+.|+++.
T Consensus 221 i~~~~~--~~~~~~~~~~s---~---~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 221 ILKAEY--EFDSPYWDDIS---D---SAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp HHTTCC--CCCTTTTTTSC---H---HHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred HHCCCC--CCCCCCCCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 861687--77876666789---9---99999999760897579189998629
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.43 Aligned_cols=237 Identities=19% Similarity=0.215 Sum_probs=187.3
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCCEEEEEEC--CCEEEEE
Q ss_conf 067987600457972289998-399937999993046899--97899999999872589981012128963--9814899
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI--DHDDAVAMFDELSRLKHPNLLPLAGYCIA--GKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~--~~~~~lv 481 (690)
++|+..+.||+|+||.||+|+ ..++..||+|+++..... ..+.+.+|++++++++||||+++++++.+ ....++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC-----CCCCC
Q ss_conf 9715899776653008999999777888877899999977789998997899999999998887643069-----88878
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG-----STHGH 556 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~H~d 556 (690)
||||++|+|.+++.+.. .....+++..+..++.|++.||.|||+.+ ++|||
T Consensus 84 mEy~~~g~L~~~i~~~~------------------------~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrD 139 (269)
T d2java1 84 MEYCEGGDLASVITKGT------------------------KERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139 (269)
T ss_dssp EECCTTEEHHHHHHHHH------------------------HHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------
T ss_pred EECCCCCCHHHHHHHCC------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECC
T ss_conf 95689993899998515------------------------457899999999999999999999997167788788586
Q ss_pred CCCCCEEECCCCCCEECCCCCCCCCCCC--------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH-
Q ss_conf 7778478559999267477765543456--------------6765688899987753236899999984899997348-
Q 005572 557 LVTSSILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV- 621 (690)
Q Consensus 557 lk~~Nill~~~~~~ki~dfGl~~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~- 621 (690)
|||+|||++.++.+||+|||+++..... +||...+..+++++|||||||++|||+||+.||....
T Consensus 140 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 140 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CCHHHCCCCCCCCEEEEECCCEEECCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH
T ss_conf 76542574788857980010003224577755667788232799998399999389887527899998018899899899
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 999999993689975430111699998999999999983301899999999999999
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
......+..+... .++...+. .+.+++.+||+.||++|||+.|+++
T Consensus 220 ~~~~~~i~~~~~~-----~~~~~~s~------~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 220 KELAGKIREGKFR-----RIPYRYSD------ELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp HHHHHHHHHTCCC-----CCCTTSCH------HHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred HHHHHHHHCCCCC-----CCCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf 9999999718998-----89743599------9999999976799557918999972
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.07 Aligned_cols=240 Identities=21% Similarity=0.298 Sum_probs=191.2
Q ss_pred HCCCCCCCEECCCCCCCEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECC-CEEEEEEEE
Q ss_conf 5067987600457972289998399937999993046899978999999998725899810121289639-814899971
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG-KEKLVLLEF 484 (690)
Q Consensus 406 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-~~~~lv~e~ 484 (690)
.++|+..+.||+|+||.||+|.+. +..||||+++.. ...+.+.+|++.+++++||||++++|+|.+. +..++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 899488579820798089999999-909999998857--77999999999998678989854987887238928999963
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 58997766530089999997778888778999999777899989978999999999988876430698887877784785
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill 564 (690)
+++|+|.+++... ....++|..+++++.||+.||.|||+.+++||||||+|||+
T Consensus 83 ~~~g~L~~~l~~~--------------------------~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~ 136 (262)
T d1byga_ 83 MAKGSLVDYLRSR--------------------------GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV 136 (262)
T ss_dssp CTTEEHHHHHHHH--------------------------HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCCCCHHHHHHHC--------------------------CCCCCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEE
T ss_conf 6999899998745--------------------------78888999999999999852321133765536665676014
Q ss_pred CCCCCCEECCCCCCCCCCCC-----------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHHH-HHHHHHHHC
Q ss_conf 59999267477765543456-----------6765688899987753236899999984-8999973489-999999936
Q 005572 565 AESLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCVK-WVRKLVKEG 631 (690)
Q Consensus 565 ~~~~~~ki~dfGl~~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~~p~~~~~~-~~~~~~~~~ 631 (690)
+.++.+|++|||+++..... +||...+..+++++||||||+++|||+| |+.|+..... .....+..+
T Consensus 137 ~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~ 216 (262)
T d1byga_ 137 SEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 216 (262)
T ss_dssp CTTSCEEECCCCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT
T ss_pred CCCCCEEECCCCCCEECCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCC
T ss_conf 68997763245600344787765566646778178727988858877757999999997899999999999999999808
Q ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 899754301116999989999999999833018999999999999999721289
Q 005572 632 AGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 632 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~ 685 (690)
. .+..+...+ . .+.+++.+||+.||++||||.++++.|+.++.
T Consensus 217 ~-----~~~~~~~~~---~---~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 217 Y-----KMDAPDGCP---P---AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp C-----CCCCCTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-----CCCCCCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 9-----999976579---9---99999999756697689399999999999986
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.46 Aligned_cols=229 Identities=20% Similarity=0.278 Sum_probs=179.6
Q ss_pred CCCEECCCCCCCEEEEEC-CCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCCEEEEEEC----CCEEEEEEE
Q ss_conf 876004579722899983-9993799999304689--997899999999872589981012128963----981489997
Q 005572 411 KESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIA----GKEKLVLLE 483 (690)
Q Consensus 411 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~----~~~~~lv~e 483 (690)
..+.||+|+||.||+|.. .++..||+|++..... ...+.+.+|++++++++||||++++|++.+ ....++|||
T Consensus 13 ~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE 92 (270)
T d1t4ha_ 13 FDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92 (270)
T ss_dssp EEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEE
T ss_pred EEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEEE
T ss_conf 51697008284999999999995999999851227989999999999999857999850699998403345888999995
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC--CCCCCCCCCC
Q ss_conf 15899776653008999999777888877899999977789998997899999999998887643069--8887877784
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG--STHGHLVTSS 561 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~H~dlk~~N 561 (690)
||++|+|.+++++ ...+++..+..++.|++.||+|||+++ ++||||||+|
T Consensus 93 ~~~~g~L~~~l~~----------------------------~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~N 144 (270)
T d1t4ha_ 93 LMTSGTLKTYLKR----------------------------FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 144 (270)
T ss_dssp CCCSCBHHHHHHH----------------------------HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGG
T ss_pred CCCCCCHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHH
T ss_conf 7898948999751----------------------------355469999999999999999999789979968767435
Q ss_pred EEEC-CCCCCEECCCCCCCCCCCC------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH--HHHHH
Q ss_conf 7855-9999267477765543456------------6765688899987753236899999984899997348--99999
Q 005572 562 ILLA-ESLEPKIAGFGLRNIGVKN------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRK 626 (690)
Q Consensus 562 ill~-~~~~~ki~dfGl~~~~~~~------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~--~~~~~ 626 (690)
||++ +++.+||+|||+++..... +||... ..++.++|||||||++|||++|+.||.+.. ....+
T Consensus 145 ILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~-~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~ 223 (270)
T d1t4ha_ 145 IFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYR 223 (270)
T ss_dssp EEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH
T ss_pred CEEECCCCCEEEEECCCCEECCCCCCCCCCCCCCCCCHHHHC-CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 116679998898005765423687667755381300898847-8999867110079999999878899987655999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 9993689975430111699998999999999983301899999999999999
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
....+. ..+.+...... .+.+++.+||+.||++|||+.|+++
T Consensus 224 ~i~~~~----~~~~~~~~~~~------~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 224 RVTSGV----KPASFDKVAIP------EVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp HHTTTC----CCGGGGGCCCH------HHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHHCCC----CCCCCCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 997389----98656755789------9999999976379758929999967
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.65 Aligned_cols=236 Identities=22% Similarity=0.245 Sum_probs=188.9
Q ss_pred CCCCCCCEECCCCCCCEEEEEC-CCCCEEEEEEEECCCC------CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEE
Q ss_conf 0679876004579722899983-9993799999304689------99789999999987258998101212896398148
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKG------IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
+.|+..+.||+|+||.||+|+. .++..||||+++.... ...+.+.+|++++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 67798279811789599999999999899999987566321340689999999999998679989993889999799899
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99971589977665300899999977788887789999997778999899789999999999888764306988878777
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~ 559 (690)
+|||||++|+|.+++.+ ...+++..+..++.|++.||.|||+.+++||||||
T Consensus 90 iv~E~~~gg~L~~~i~~----------------------------~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp 141 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE----------------------------KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKP 141 (293)
T ss_dssp EEEECCCSCBHHHHHHH----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred EEEECCCCCCCCCHHCC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCC
T ss_conf 99986778643100103----------------------------56421557899999999998766625422113330
Q ss_pred CCEEECCCC----CCEECCCCCCCCCCCC-------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH
Q ss_conf 847855999----9267477765543456-------------67656888999877532368999999848999973489
Q 005572 560 SSILLAESL----EPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK 622 (690)
Q Consensus 560 ~Nill~~~~----~~ki~dfGl~~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~ 622 (690)
+|||++.++ .+|++|||++...... +||...+..++.++||||+||++|||++|+.||.+...
T Consensus 142 ~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 221 (293)
T d1jksa_ 142 ENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 221 (293)
T ss_dssp GGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CEEEEECCCCCCCCEEECCHHHHHHCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCH
T ss_conf 12798258986664696433442105777631224777743099998189999766522140999999708899889999
Q ss_pred -HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf -99999993689975430111699998999999999983301899999999999999
Q 005572 623 -WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 623 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
........... ..........+. .+.+++.+||+.||++|||+.|+++
T Consensus 222 ~~~~~~i~~~~~--~~~~~~~~~~s~------~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 222 QETLANVSAVNY--EFEDEYFSNTSA------LAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp HHHHHHHHTTCC--CCCHHHHTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHCCC--CCCCHHCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 999999981688--887010478899------9999999986389668919999961
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.07 Aligned_cols=257 Identities=23% Similarity=0.307 Sum_probs=196.3
Q ss_pred HHHHHHCCCCCCCEECCCCCCCEEEEECC------CCCEEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEE
Q ss_conf 89999506798760045797228999839------993799999304689-99789999999987258998101212896
Q 005572 401 DLIAATSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCI 473 (690)
Q Consensus 401 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~ 473 (690)
+|++..++|...+.||+|+||.||+|.+. ++..||||+++.... .....+.+|++++++++||||++++|+|.
T Consensus 14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~ 93 (308)
T d1p4oa_ 14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS 93 (308)
T ss_dssp TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred CEEECHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 00426899188359820788189999987864477896899999870128689999999999999769998841254784
Q ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf 39814899971589977665300899999977788887789999997778999899789999999999888764306988
Q 005572 474 AGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGST 553 (690)
Q Consensus 474 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~ 553 (690)
..+..++|||||++|+|.+++........ .......+++..+.+++.|+|.||.|||+.+++
T Consensus 94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~iv 155 (308)
T d1p4oa_ 94 QGQPTLVIMELMTRGDLKSYLRSLRPAMA------------------NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFV 155 (308)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHH------------------HCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred CCCCEEEEEEECCCCCHHHHHHHCCCCCC------------------CCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 28810677760489988999875033211------------------344468879999999999999999987647965
Q ss_pred CCCCCCCCEEECCCCCCEECCCCCCCCCCCC----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CC
Q ss_conf 8787778478559999267477765543456----------------676568889998775323689999998489-99
Q 005572 554 HGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLTGK-RG 616 (690)
Q Consensus 554 H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~-~p 616 (690)
||||||+|||++.++++||+|||+++..... +||......+++++||||||+++|||+||. .|
T Consensus 156 HrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p 235 (308)
T d1p4oa_ 156 HRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 235 (308)
T ss_dssp CSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCT
T ss_pred ECEECCCCEEECCCCEEEEEECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 43286775403599649994245420235776303134023163237888873699883334443789999999689999
Q ss_pred CCCHH-HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 97348-99999999368997543011169999899999999998330189999999999999997212899
Q 005572 617 TDDCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 617 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~~ 686 (690)
+.+.. ......+..+...+ .+..++ ..+.+++.+||+.+|++||||.+|++.|++..+.
T Consensus 236 ~~~~~~~~~~~~i~~~~~~~-----~p~~~~------~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 236 YQGLSNEQVLRFVMEGGLLD-----KPDNCP------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp TTTSCHHHHHHHHHTTCCCC-----CCTTCC------HHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred CCCCCHHHHHHHHHHCCCCC-----CCCCCH------HHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCC
T ss_conf 99989999999998088888-----863353------9999999997577965893999999997876177
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=329.65 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=191.8
Q ss_pred CCCCCCCEECCCCCCCEEEEECCC-CC--EEEEEEEECC-CCCCHHHHHHHHHHHHHC-CCCCCCCEEEEEECCCEEEEE
Q ss_conf 067987600457972289998399-93--7999993046-899978999999998725-899810121289639814899
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG-EL--HVAIKVLDNA-KGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~~~-~~--~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~~~~~~lv 481 (690)
++|+..+.||+|+||.||+|++.+ +. .||||+++.. .....+.+.+|++.++++ +||||++++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 97158997766530089999997778888778999999777899989978999999999988876430698887877784
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~N 561 (690)
|||+++|+|.++++......... ...........+++.+++.++.|+|.||.|+|+.+++||||||+|
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~------------~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~N 157 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDP------------AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 157 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCH------------HHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred EEECCCCCHHHHHHHCCCCCCCH------------HHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
T ss_conf 98028986999986403555551------------231012345789999999999999999876630895455505204
Q ss_pred EEECCCCCCEECCCCCCCCCCCC-------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCHH-HHHHH
Q ss_conf 78559999267477765543456-------------676568889998775323689999998489-9997348-99999
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGK-RGTDDCV-KWVRK 626 (690)
Q Consensus 562 ill~~~~~~ki~dfGl~~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~-~p~~~~~-~~~~~ 626 (690)
||++.++.+||+|||+++..... +||......++.++|||||||++|||++|. .||.+.. .....
T Consensus 158 IL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 158 ILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp EEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EEECCCCCEEECCCCCCCCCCCCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 89868876387434432244422345530137755553875269999622153138899999836899999999999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC
Q ss_conf 999368997543011169999899999999998330189999999999999997212899
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRPS 686 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~~ 686 (690)
.+..+. .+..+...+ . .+.+++.+||+.||++||||.+|++.|+.+.+.
T Consensus 238 ~i~~~~-----~~~~~~~~~---~---~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~ 286 (309)
T d1fvra_ 238 KLPQGY-----RLEKPLNCD---D---EVYDLMRQCWREKPYERPSFAQILVSLNRMLEE 286 (309)
T ss_dssp HGGGTC-----CCCCCTTBC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred HHHHCC-----CCCCCCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 998268-----888876678---9---999999997678966894999999999999861
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=331.97 Aligned_cols=243 Identities=20% Similarity=0.280 Sum_probs=189.8
Q ss_pred HHHCCCCCCCEECCCCCCCEEEEECCC----CCEEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEE
Q ss_conf 995067987600457972289998399----93799999304689-9978999999998725899810121289639814
Q 005572 404 AATSHFGKESLLAEGRCGPVYRAVLPG----ELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 404 ~~~~~~~~~~~ig~G~~g~V~~~~~~~----~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~ 478 (690)
+..++|...+.||+|+||.||+|.... +..||||.++.... ...+.+.+|++.+++++||||++++|+|.+ +..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~-~~~ 82 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPV 82 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSC
T ss_pred CCHHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEE
T ss_conf 6889969877993078829999999369964499999993656687999999999999986899998569889953-747
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 89997158997766530089999997778888778999999777899989978999999999988876430698887877
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk 558 (690)
++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.+++|||||
T Consensus 83 ~iv~E~~~~g~l~~~~~~~---------------------------~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlK 135 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVR---------------------------KYSLDLASLILYAYQLSTALAYLESKRFVHRDIA 135 (273)
T ss_dssp EEEEECCTTEEHHHHHHHT---------------------------TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEEEEECCCCCHHHHHHCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCC
T ss_conf 9999840698077654224---------------------------7899999999999999877523022674414102
Q ss_pred CCCEEECCCCCCEECCCCCCCCCCCC---------------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHH-
Q ss_conf 78478559999267477765543456---------------6765688899987753236899999984-899997348-
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVKN---------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV- 621 (690)
Q Consensus 559 ~~Nill~~~~~~ki~dfGl~~~~~~~---------------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~~p~~~~~- 621 (690)
|+||+++.++.+||+|||+++..... +||......++.++|||||||++|||+| |..||....
T Consensus 136 p~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~ 215 (273)
T d1mp8a_ 136 ARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 215 (273)
T ss_dssp GGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred HHHEEECCCCCEEECCCHHHEECCCCCCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 65532067896787650342133677623305400583103266751699887452444247899998269999888999
Q ss_pred HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9999999936899754301116999989999999999833018999999999999999721289
Q 005572 622 KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 622 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~ 685 (690)
......+..+.. +..+..++. .+.+++..||+.||++||||.+|++.|+.+.+
T Consensus 216 ~~~~~~i~~~~~-----~~~~~~~~~------~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 216 NDVIGRIENGER-----LPMPPNCPP------TLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp GGHHHHHHTTCC-----CCCCTTCCH------HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHCCCC-----CCCCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999999981899-----989877799------99999999768797689299999999999977
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.57 Aligned_cols=241 Identities=19% Similarity=0.219 Sum_probs=180.5
Q ss_pred CCCCCCCEECCCCCCCEEEEECCCCCEEEEEEEECCCCCCHHHHHHH--HHHHHHCCCCCCCCEEEEEECCC----EEEE
Q ss_conf 06798760045797228999839993799999304689997899999--99987258998101212896398----1489
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAM--FDELSRLKHPNLLPLAGYCIAGK----EKLV 480 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e--~~~l~~l~H~niv~l~g~~~~~~----~~~l 480 (690)
++|...+.||+|+||.||+|++. +..||||+++... .+.+.+| +..+..++||||++++|+|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 68999889820788199999999-9899999987200---4679999999999627998683268899837986048999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH--------CCC
Q ss_conf 997158997766530089999997778888778999999777899989978999999999988876430--------698
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH--------VGS 552 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~--------~~~ 552 (690)
|||||++|+|.+++++ ..++|.++++++.|+|.||+|+|+ +++
T Consensus 79 v~Ey~~~g~L~~~l~~-----------------------------~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~I 129 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR-----------------------------YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAI 129 (303)
T ss_dssp EEECCTTCBHHHHHHH-----------------------------CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEE
T ss_pred EEECCCCCCHHHHHHC-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCE
T ss_conf 9964669898999865-----------------------------89998999999999999999988766520468986
Q ss_pred CCCCCCCCCEEECCCCCCEECCCCCCCCCCCC------------------CCCCCCCC------CCCCCCCCHHHHHHHH
Q ss_conf 88787778478559999267477765543456------------------67656888------9998775323689999
Q 005572 553 THGHLVTSSILLAESLEPKIAGFGLRNIGVKN------------------VGERSENE------TCGPESDVYCFGVILM 608 (690)
Q Consensus 553 ~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~------------------~~e~~~~~------~~~~~~DVwSfGvil~ 608 (690)
+||||||+|||++.++.+||+|||+++..... +||..... .++.++|||||||++|
T Consensus 130 vHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~ 209 (303)
T d1vjya_ 130 AHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 209 (303)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHH
T ss_pred ECCCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHH
T ss_conf 61531731357868877688763866234677762001355250354767822105654546777675012201599999
Q ss_pred HHHHCCCCCCC----------------HHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99848999973----------------48999999993689975430111699998999999999983301899999999
Q 005572 609 ELLTGKRGTDD----------------CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT 672 (690)
Q Consensus 609 el~tg~~p~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs 672 (690)
||+||..|+.. ........... +..++.++.... .......+.+++.+||+.||++|||
T Consensus 210 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps 284 (303)
T d1vjya_ 210 EIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE----QKLRPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLT 284 (303)
T ss_dssp HHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT----SCCCCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCC
T ss_pred HHHHCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHHHC----CCCCCCCCCCCC-CHHHHHHHHHHHHHHCCCCHHHCCC
T ss_conf 99628998876631124101225564309999998750----246888776557-7689999999999976069858959
Q ss_pred HHHHHHHHHCCCC
Q ss_conf 9999999721289
Q 005572 673 MQQVLGLLKDIRP 685 (690)
Q Consensus 673 ~~~i~~~L~~i~~ 685 (690)
|.||++.|+++.+
T Consensus 285 ~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 285 ALRIKKTLSQLSQ 297 (303)
T ss_dssp HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHH
T ss_conf 9999999998888
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.23 Aligned_cols=233 Identities=19% Similarity=0.216 Sum_probs=190.2
Q ss_pred HCCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEE
Q ss_conf 5067987600457972289998-399937999993046---899978999999998725899810121289639814899
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA---KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 406 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv 481 (690)
.++|+..+.||+|+||.||+|+ ..++..||+|+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 97158997766530089999997778888778999999777899989978999999999988876430698887877784
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~N 561 (690)
||||++|+|.+++.. ...+++.....++.|++.||+|||+++++||||||+|
T Consensus 84 ~ey~~gg~L~~~~~~----------------------------~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~N 135 (337)
T d1o6la_ 84 MEYANGGELFFHLSR----------------------------ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLEN 135 (337)
T ss_dssp EECCTTCBHHHHHHH----------------------------HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EECCCCCCHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf 003579860555532----------------------------5677599999999999652113431596224647778
Q ss_pred EEECCCCCCEECCCCCCCCCCCC--------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH-HHHH
Q ss_conf 78559999267477765543456--------------67656888999877532368999999848999973489-9999
Q 005572 562 ILLAESLEPKIAGFGLRNIGVKN--------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRK 626 (690)
Q Consensus 562 ill~~~~~~ki~dfGl~~~~~~~--------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~-~~~~ 626 (690)
||++.++.+||+|||+++..... +||...+..++.++||||+||++|||++|+.||..... ....
T Consensus 136 ILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~ 215 (337)
T d1o6la_ 136 LMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE 215 (337)
T ss_dssp EEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEECCCCCEEEEECCCCCCCCCCCCCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 47658998888205652003567862055100889966665048988833310223067889987899999969999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHH
Q ss_conf 9993689975430111699998999999999983301899999999-----999999
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-----MQQVLG 678 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs-----~~~i~~ 678 (690)
...... +.++...+. .+.+++..||+.||++||+ +.|+++
T Consensus 216 ~i~~~~------~~~p~~~s~------~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 216 LILMEE------IRFPRTLSP------EAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp HHHHCC------CCCCTTSCH------HHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred HHHCCC------CCCCCCCCH------HHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 985289------989866899------999999866638934422565234999972
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.21 Aligned_cols=232 Identities=20% Similarity=0.217 Sum_probs=188.7
Q ss_pred CCCCCCCEECCCCCCCEEEEEC-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf 0679876004579722899983-99937999993046---8999789999999987258998101212896398148999
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNA---KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||+|+||.||+|+. .++..||||++... +....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 71589977665300899999977788887789999997778999899789999999999888764306988878777847
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Ni 562 (690)
|||++|+|.+++.. ...+++..+..++.|++.||+|||+.+++||||||+||
T Consensus 88 Ey~~gg~L~~~~~~----------------------------~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NI 139 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK----------------------------IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI 139 (288)
T ss_dssp CCCTTEEHHHHHHH----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred ECCCCCCHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCC
T ss_conf 70489877776531----------------------------59999999999999999999762165088476774123
Q ss_pred EECCCCCCEECCCCCCCCCCC----------------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH-HHH
Q ss_conf 855999926747776554345----------------667656888999877532368999999848999973489-999
Q 005572 563 LLAESLEPKIAGFGLRNIGVK----------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVR 625 (690)
Q Consensus 563 ll~~~~~~ki~dfGl~~~~~~----------------~~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~-~~~ 625 (690)
|+++++.+||+|||+++.... .+||...+..++.++||||+||++|||+||+.||..... ...
T Consensus 140 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~ 219 (288)
T d1uu3a_ 140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIF 219 (288)
T ss_dssp EECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred CCCCCCEEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf 66888538860321024225677643335556775525844002689896662304569999980388998995999999
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 99993689975430111699998999999999983301899999999999999
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
....... +.++... .. .+.+++.+||+.||++|||+.|++.
T Consensus 220 ~~i~~~~------~~~p~~~--s~----~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 220 QKIIKLE------YDFPEKF--FP----KARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp HHHHTTC------CCCCTTC--CH----HHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred HHHHCCC------CCCCCCC--CH----HHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf 9997189------9998547--99----9999999985579768919789737
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.19 Aligned_cols=263 Identities=25% Similarity=0.310 Sum_probs=197.3
Q ss_pred HHHHHHCCCCCCCEECCCCCCCEEEEEC------CCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHC-CCCCCCCEEEEE
Q ss_conf 8999950679876004579722899983------9993799999304689-9978999999998725-899810121289
Q 005572 401 DLIAATSHFGKESLLAEGRCGPVYRAVL------PGELHVAIKVLDNAKG-IDHDDAVAMFDELSRL-KHPNLLPLAGYC 472 (690)
Q Consensus 401 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~------~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~~ 472 (690)
.+++..++|...+.||+|+||.||+|++ .++..||||+++.... .....+.+|+..++.+ +|||||+++|+|
T Consensus 17 ~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 17 KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp GGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred CCCCCHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEE
T ss_conf 26377899698549820688299999980664477886999999874248779999999999987626999887899898
Q ss_pred ECCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 63981489997158997766530089999997778888778999999777899989978999999999988876430698
Q 005572 473 IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS 552 (690)
Q Consensus 473 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~ 552 (690)
.+.+..++|||||++|+|.++++.......... ............+++..++.++.||+.||.|||++++
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~----------~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~i 166 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK----------TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNC 166 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EECCEEEEEEECCCCCCHHHHHHHCCCCCCCCC----------CCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCE
T ss_conf 319978999973799879999985356654444----------4533222334588999999999999999998875792
Q ss_pred CCCCCCCCCEEECCCCCCEECCCCCCCCCCCC----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCC
Q ss_conf 88787778478559999267477765543456----------------6765688899987753236899999984-899
Q 005572 553 THGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GKR 615 (690)
Q Consensus 553 ~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~~ 615 (690)
+||||||+||+++.++.+|++|||+++..... +||...+..++.++||||||+++|||+| |.+
T Consensus 167 vHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p 246 (311)
T d1t46a_ 167 IHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246 (311)
T ss_dssp CCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCC
T ss_pred EECCCCCCCCCCCCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCC
T ss_conf 66624102100002575210234010233678861586201359687677886179999740010258999999858998
Q ss_pred CCCCH--HHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 99734--8999999993689975430111699998999999999983301899999999999999972128
Q 005572 616 GTDDC--VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 616 p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~ 684 (690)
|+... .+...+.+..+... ..+... . . .+.+++.+||+.||++||||.+|++.|+++.
T Consensus 247 ~~~~~~~~~~~~~~i~~~~~~-----~~~~~~--~-~---~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 247 PYPGMPVDSKFYKMIKEGFRM-----LSPEHA--P-A---EMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp SSTTCCSSHHHHHHHHHTCCC-----CCCTTS--C-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCC-----CCCCCC--C-H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 877899899999998668988-----985436--5-9---9999999975779657929999999998765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.54 Aligned_cols=239 Identities=26% Similarity=0.310 Sum_probs=186.5
Q ss_pred CCCCCCCEECCCCCCCEEEEECCC--C--CEEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEE
Q ss_conf 067987600457972289998399--9--3799999304689---99789999999987258998101212896398148
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPG--E--LHVAIKVLDNAKG---IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~~~--~--~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
++|+..+.||+|+||.||+|++.. + ..||||+++.... ...+++.+|++.+++++||||++++|+|.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99971589977665300899999977788887789999997778999899789999999999888764306988878777
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~ 559 (690)
+|+|||++|++.+++... ...+++..++.++.|+|.||.|||+++++||||||
T Consensus 87 lv~e~~~~~~l~~~~~~~---------------------------~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp 139 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH---------------------------QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAA 139 (273)
T ss_dssp EEEECCTTCBHHHHHHHH---------------------------GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred EEEEEECCCCHHHHHHCC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECH
T ss_conf 146542386125444212---------------------------68999999999999999999875217875205668
Q ss_pred CCEEECCCCCCEECCCCCCCCCCCC-----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCHH
Q ss_conf 8478559999267477765543456-----------------6765688899987753236899999984-899997348
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN-----------------VGERSENETCGPESDVYCFGVILMELLT-GKRGTDDCV 621 (690)
Q Consensus 560 ~Nill~~~~~~ki~dfGl~~~~~~~-----------------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~~p~~~~~ 621 (690)
+||+++.++.+|++|||+++..... +||......++.++|||||||++|||+| |+.||.+..
T Consensus 140 ~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 140 RNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp GGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred HHHCCCCCCCEEECCCHHHHHCCCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 88156556543325611555303588752654763257310799998379999421566148999999968999999969
Q ss_pred H--HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9--99999993689975430111699998999999999983301899999999999999972128
Q 005572 622 K--WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 622 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~ 684 (690)
. ........+. .+......+ . .+.+++..||+.||++||||.+|.+.|++.+
T Consensus 220 ~~~~~~~i~~~~~-----~~~~~~~~~---~---~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 220 GSQILHKIDKEGE-----RLPRPEDCP---Q---DIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp HHHHHHHHHTSCC-----CCCCCTTCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCC-----CCCCCCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf 9999999984799-----999854453---9---9999999976889667929999999999649
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.93 Aligned_cols=264 Identities=22% Similarity=0.249 Sum_probs=194.4
Q ss_pred HHHHHHHHCCCCCCCEECCCCCCCEEEEECC------CCCEEEEEEEECCCC-CCHHHHHHHHHHHHHC-CCCCCCCEEE
Q ss_conf 8889999506798760045797228999839------993799999304689-9978999999998725-8998101212
Q 005572 399 FKDLIAATSHFGKESLLAEGRCGPVYRAVLP------GELHVAIKVLDNAKG-IDHDDAVAMFDELSRL-KHPNLLPLAG 470 (690)
Q Consensus 399 ~~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g 470 (690)
...|++..++|...+.||+|+||.||+|+.. ++..||||+++.... ...+.+.+|...+.++ +|+||+.+++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEE
T ss_conf 82526167997984498416783999999867775557839999998600171789999999999886149984997411
Q ss_pred EEECCC-EEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH
Q ss_conf 896398-1489997158997766530089999997778888778999999777899989978999999999988876430
Q 005572 471 YCIAGK-EKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH 549 (690)
Q Consensus 471 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~ 549 (690)
++.+.+ ..++|||||++|+|.++++......... ...........+++.+++.++.|++.||.|||+
T Consensus 85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~------------~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~ 152 (299)
T d1ywna1 85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY------------KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS 152 (299)
T ss_dssp EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------------------CBCHHHHHHHHHHHHHHHHHHHH
T ss_pred EECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCC------------CCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_conf 54047975799998458992999998536666653------------222023321468999999999999999998873
Q ss_pred CCCCCCCCCCCCEEECCCCCCEECCCCCCCCCCCC----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 69888787778478559999267477765543456----------------67656888999877532368999999848
Q 005572 550 VGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLTG 613 (690)
Q Consensus 550 ~~~~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvil~el~tg 613 (690)
++++||||||+|||+++++.+||+|||+++..... +||...+..++.++|||||||++|||+||
T Consensus 153 ~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~ 232 (299)
T d1ywna1 153 RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 232 (299)
T ss_dssp TTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCCCCCCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHC
T ss_conf 79717867731065779982898457520011356652224751667210203686468899663221367899999868
Q ss_pred C-CCCCCH--HHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 9-999734--89999999936899754301116999989999999999833018999999999999999721289
Q 005572 614 K-RGTDDC--VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 614 ~-~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~ 685 (690)
. .||... .+........+... ..+... . . .+.+++.+||+.||++||||.|+++.|+.+.+
T Consensus 233 ~~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~--~-~---~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 233 GASPYPGVKIDEEFCRRLKEGTRM-----RAPDYT--T-P---EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp SCCSSTTCCCSHHHHHHHHHTCCC-----CCCTTC--C-H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCC-----CCCCCC--C-H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 899998999899999999638988-----888657--8-9---99999999767796679199999999979986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.73 Aligned_cols=260 Identities=26% Similarity=0.317 Sum_probs=196.1
Q ss_pred HHHHHCCCCCCCEECCCCCCCEEEEECCC--------CCEEEEEEEECCCC-CCHHHHHHHHHHHHHC-CCCCCCCEEEE
Q ss_conf 99995067987600457972289998399--------93799999304689-9978999999998725-89981012128
Q 005572 402 LIAATSHFGKESLLAEGRCGPVYRAVLPG--------ELHVAIKVLDNAKG-IDHDDAVAMFDELSRL-KHPNLLPLAGY 471 (690)
Q Consensus 402 ~~~~~~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l-~H~niv~l~g~ 471 (690)
+.+..++|...+.||+|+||.||+|+..+ +..||||+++.... ....++.+|...+.++ +|||||+++|+
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCCCHHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCC
T ss_conf 72258996970098516782899999857875556675499999988112868899999999999981399969734652
Q ss_pred EECCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Q ss_conf 96398148999715899776653008999999777888877899999977789998997899999999998887643069
Q 005572 472 CIAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVG 551 (690)
Q Consensus 472 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~ 551 (690)
|.+.+..++|||||++|+|.++++......... ...........+++.++++++.|+|.||+|||+.+
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~------------~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ 155 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEY------------SYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK 155 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------------------CCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCEEEEEEECCCCCCHHHHHHHHCCCCCCC------------CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 201886899997369990999998606776432------------22334574346799999999999999998766379
Q ss_pred CCCCCCCCCCEEECCCCCCEECCCCCCCCCCCC----------------CCCCCCCCCCCCCCCCHHHHHHHHHHHH-CC
Q ss_conf 888787778478559999267477765543456----------------6765688899987753236899999984-89
Q 005572 552 STHGHLVTSSILLAESLEPKIAGFGLRNIGVKN----------------VGERSENETCGPESDVYCFGVILMELLT-GK 614 (690)
Q Consensus 552 ~~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~----------------~~e~~~~~~~~~~~DVwSfGvil~el~t-g~ 614 (690)
++||||||+|||++.++.+||+|||+++..... +||......+++++||||||+++|||++ |.
T Consensus 156 ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~ 235 (299)
T d1fgka_ 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235 (299)
T ss_dssp CCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred EEEEEECCCCEEECCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCC
T ss_conf 78630221022454789767622111011355555431466788846632667517988825554775888887401798
Q ss_pred CCCCCHH-HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 9997348-999999993689975430111699998999999999983301899999999999999972128
Q 005572 615 RGTDDCV-KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 615 ~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~ 684 (690)
.||.+.. ......+..+.. +..+...+ . .+.+++.+||+.||++||||.||++.|+++.
T Consensus 236 ~p~~~~~~~~~~~~i~~~~~-----~~~p~~~~---~---~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 236 SPYPGVPVEELFKLLKEGHR-----MDKPSNCT---N---ELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp CSSTTCCHHHHHHHHHTTCC-----CCCCSSCC---H---HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHCCCC-----CCCCCCCH---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 98999999999999972888-----89874352---9---9999999976679767939999999998886
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.03 Aligned_cols=236 Identities=17% Similarity=0.138 Sum_probs=186.3
Q ss_pred CCCCCCCEECCCCCCCEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEEC
Q ss_conf 0679876004579722899983-999379999930468999789999999987258998101212896398148999715
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEFM 485 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~~ 485 (690)
++|...+.||+|+||.||+|.. .++..||+|+++... .+...+.+|+++++.++||||+++++++.+.+..|+|||||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 10588789831778399999998999699999975786-65999999999998579979890989998899889999538
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
Q ss_conf 89977665300899999977788887789999997778999899789999999999888764306988878777847855
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~ 565 (690)
++|+|.++++.. ...+++.++..++.|++.||.|||+++++||||||+|||++
T Consensus 84 ~gg~L~~~i~~~---------------------------~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~ 136 (321)
T d1tkia_ 84 SGLDIFERINTS---------------------------AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQ 136 (321)
T ss_dssp CCCBHHHHHTSS---------------------------SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred CCCCHHHHHHHC---------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
T ss_conf 998088998753---------------------------89999999999999999999999876997513554443443
Q ss_pred C--CCCCEECCCCCCCCCCCC-------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH-HHHHHHHH
Q ss_conf 9--999267477765543456-------------6765688899987753236899999984899997348-99999999
Q 005572 566 E--SLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV-KWVRKLVK 629 (690)
Q Consensus 566 ~--~~~~ki~dfGl~~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~-~~~~~~~~ 629 (690)
. ...+|++|||+++..... +||......++.++||||+||++|||++|+.||.... ........
T Consensus 137 ~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~ 216 (321)
T d1tkia_ 137 TRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp SSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCCCEEEEECCCCHHHCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 78851899764411100346775321223322234021048777840113027999999982899999989999999998
Q ss_pred HCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 3689975430111699998999999999983301899999999999999
Q 005572 630 EGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 630 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
..... .+.......+. .+.+++..|++.||++|||+.|+++
T Consensus 217 ~~~~~--~~~~~~~~~s~------~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 217 NAEYT--FDEEAFKEISI------EAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp HTCCC--CCHHHHTTSCH------HHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred HCCCC--CCHHHCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 38999--88022367899------9999999986699668909999963
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=323.51 Aligned_cols=235 Identities=19% Similarity=0.157 Sum_probs=180.9
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCC---CCCHHHHHHH---HHHHHHCCCCCCCCEEEEEECCCEEE
Q ss_conf 067987600457972289998-3999379999930468---9997899999---99987258998101212896398148
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK---GIDHDDAVAM---FDELSRLKHPNLLPLAGYCIAGKEKL 479 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~---~~~~~~~~~e---~~~l~~l~H~niv~l~g~~~~~~~~~ 479 (690)
++|...+.||+|+||.||+|+ ..++..||+|++.... ......+.+| ++.++.++||||+++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99971589977665300899999977788887789999997778999899789999999999888764306988878777
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~ 559 (690)
+|||||++|+|.+++.. ...+++..+..++.|++.||.|||+++++||||||
T Consensus 84 ivmE~~~gg~L~~~l~~----------------------------~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP 135 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ----------------------------HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKP 135 (364)
T ss_dssp EEECCCCSCBHHHHHHH----------------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred EEEEECCCCCHHHHHHH----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECC
T ss_conf 99991489838999873----------------------------25532789999999999999999977962204442
Q ss_pred CCEEECCCCCCEECCCCCCCCCCCC------------CCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH-HHH
Q ss_conf 8478559999267477765543456------------6765688-8999877532368999999848999973489-999
Q 005572 560 SSILLAESLEPKIAGFGLRNIGVKN------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVR 625 (690)
Q Consensus 560 ~Nill~~~~~~ki~dfGl~~~~~~~------------~~e~~~~-~~~~~~~DVwSfGvil~el~tg~~p~~~~~~-~~~ 625 (690)
+|||++.++.+||+|||+++..... +||.... ..+++++||||+||++|||+||+.||..... ...
T Consensus 136 ~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 215 (364)
T d1omwa3 136 ANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215 (364)
T ss_dssp GGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH
T ss_pred CEEEECCCCCEEEEEECEEEECCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHH
T ss_conf 21678588967982201023337886433113455421687603899984410467789999998599988889989999
Q ss_pred HHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCC-----HHHHHH
Q ss_conf 99993689975430111699998999999999983301899999999-----999999
Q 005572 626 KLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPT-----MQQVLG 678 (690)
Q Consensus 626 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs-----~~~i~~ 678 (690)
......... .+..+...+. .+.+++.+||+.||++||| +.|+++
T Consensus 216 ~~~~~~~~~---~~~~~~~~s~------~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 216 EIDRMTLTM---AVELPDSFSP------ELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp HHHHHSSSC---CCCCCSSSCH------HHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred HHHHHCCCC---CCCCCCCCCH------HHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf 999860468---8878877899------999999998566988808874357999974
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=316.62 Aligned_cols=237 Identities=20% Similarity=0.277 Sum_probs=186.7
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCC---------HHHHHHHHHHHHHCC-CCCCCCEEEEEECC
Q ss_conf 067987600457972289998-3999379999930468999---------789999999987258-99810121289639
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGID---------HDDAVAMFDELSRLK-HPNLLPLAGYCIAG 475 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~---------~~~~~~e~~~l~~l~-H~niv~l~g~~~~~ 475 (690)
++|+..+.||+|+||.||+|+ ..++..||||+++...... .+.+.+|+..+++++ ||||+++++++.+.
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 81489997158997766530089999997778888778999999777899989978999999999988876430698887
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~ 555 (690)
+..++|||||++|+|.++++. ...+++.++..++.|++.||+|||+++++||
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~----------------------------~~~l~e~~~~~~~~qi~~al~~lH~~~ivHr 134 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE----------------------------KVTLSEKETRKIMRALLEVICALHKLNIVHR 134 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred CCEEEEEECCCCCHHHHHHHH----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 605999976898668999986----------------------------5999999999999999999999987599432
Q ss_pred CCCCCCEEECCCCCCEECCCCCCCCCCCC-------------CCCCC------CCCCCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 87778478559999267477765543456-------------67656------888999877532368999999848999
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVKN-------------VGERS------ENETCGPESDVYCFGVILMELLTGKRG 616 (690)
Q Consensus 556 dlk~~Nill~~~~~~ki~dfGl~~~~~~~-------------~~e~~------~~~~~~~~~DVwSfGvil~el~tg~~p 616 (690)
||||+|||++.++.+||+|||+++..... +||.. ....++.++||||+||++|||++|+.|
T Consensus 135 Dlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~P 214 (277)
T d1phka_ 135 DLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214 (277)
T ss_dssp CCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCCEEEECCCCCEEECCCHHEEECCCCCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCC
T ss_conf 34625489868998387124031672688721345246788898886053445678899233185656023103228889
Q ss_pred CCCHHH-HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH
Q ss_conf 973489-999999936899754301116999989999999999833018999999999999999
Q 005572 617 TDDCVK-WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL 679 (690)
Q Consensus 617 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~ 679 (690)
|.+... ........+... .........+. .+.+++.+||+.||++|||+.|+++.
T Consensus 215 f~~~~~~~~~~~i~~~~~~--~~~~~~~~~s~------~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 215 FWHRKQMLMLRMIMSGNYQ--FGSPEWDDYSD------TVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp SCCSSHHHHHHHHHHTCCC--CCTTTGGGSCH------HHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred CCCCCHHHHHHHHHHCCCC--CCCCCCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8899999999999818988--89854346899------99999999765896689199999739
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=316.56 Aligned_cols=232 Identities=18% Similarity=0.183 Sum_probs=188.6
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf 067987600457972289998-399937999993046---8999789999999987258998101212896398148999
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA---KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||+|+||.||+|+ ..++..||||+++.. .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 71589977665300899999977788887789999997778999899789999999999888764306988878777847
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Ni 562 (690)
|||++|+|..++.. ...+++.....++.|++.||+|||+++++||||||+||
T Consensus 84 E~~~gg~l~~~~~~----------------------------~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI 135 (316)
T d1fota_ 84 DYIEGGELFSLLRK----------------------------SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI 135 (316)
T ss_dssp CCCCSCBHHHHHHH----------------------------TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred EECCCCCCCCCCCC----------------------------CCCCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHE
T ss_conf 50378632234322----------------------------22111007999999998765541247677055681050
Q ss_pred EECCCCCCEECCCCCCCCCCCC-----------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH-HHHHHHHH
Q ss_conf 8559999267477765543456-----------67656888999877532368999999848999973489-99999993
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKE 630 (690)
Q Consensus 563 ll~~~~~~ki~dfGl~~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~-~~~~~~~~ 630 (690)
|++.++.+||+|||+++..... +||...+..++.++||||+||++|||+||+.||.+... ........
T Consensus 136 Ll~~~g~vkL~DFG~a~~~~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 215 (316)
T d1fota_ 136 LLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215 (316)
T ss_dssp EECTTSCEEECCCSSCEECSSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred EECCCCCEEEECCCCCEEECCCCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHC
T ss_conf 38689988983175216712456434576343599998389998043046533368999759899999699999999970
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHH
Q ss_conf 68997543011169999899999999998330189999999-----9999999
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RP-----s~~~i~~ 678 (690)
+.. .++...+ . .+.+++.+||+.||.+|+ |++++++
T Consensus 216 ~~~------~~p~~~s---~---~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 216 AEL------RFPPFFN---E---DVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp CCC------CCCTTSC---H---HHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC------CCCCCCC---H---HHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf 898------8997789---9---999999999544997666431021999981
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=316.05 Aligned_cols=232 Identities=16% Similarity=0.156 Sum_probs=189.3
Q ss_pred CCCCCCCEECCCCCCCEEEEEC-CCCCEEEEEEEECC---CCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEE
Q ss_conf 0679876004579722899983-99937999993046---8999789999999987258998101212896398148999
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNA---KGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~ 482 (690)
++|+..+.||+|+||.||+|+. .++..||||++... +....+.+.+|+++++.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 71589977665300899999977788887789999997778999899789999999999888764306988878777847
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Ni 562 (690)
||+.+|+|.+++.+ ...+++..+..++.|++.||.|||+++++||||||+||
T Consensus 121 e~~~~g~l~~~l~~----------------------------~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NI 172 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR----------------------------IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL 172 (350)
T ss_dssp ECCTTCBHHHHHHH----------------------------HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred CCCCCCCHHHHHHH----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHC
T ss_conf 23346622666751----------------------------58989999999999999989999859986176799993
Q ss_pred EECCCCCCEECCCCCCCCCCCC-----------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH-HHHHHHHH
Q ss_conf 8559999267477765543456-----------67656888999877532368999999848999973489-99999993
Q 005572 563 LLAESLEPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK-WVRKLVKE 630 (690)
Q Consensus 563 ll~~~~~~ki~dfGl~~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~-~~~~~~~~ 630 (690)
|++.++.+||+|||+++..... +||...+..++.++||||+||++|||+||+.||..... ........
T Consensus 173 Ll~~~g~ikL~DFG~a~~~~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 252 (350)
T d1rdqe_ 173 LIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp EECTTSCEEECCCTTCEECSSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCCCCEEEEECEEEEECCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHC
T ss_conf 60778978861010333225666433676356788997179988533114500789999758899899599999999861
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHH
Q ss_conf 68997543011169999899999999998330189999999-----9999999
Q 005572 631 GAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 631 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RP-----s~~~i~~ 678 (690)
... ..+...+. .+.+++.+||+.||.+|+ |+.++++
T Consensus 253 ~~~------~~p~~~s~------~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 253 GKV------RFPSHFSS------DLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp CCC------CCCTTCCH------HHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred CCC------CCCCCCCH------HHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 798------89766899------999999998340998606553454999971
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=314.86 Aligned_cols=242 Identities=19% Similarity=0.211 Sum_probs=191.6
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCCH---HHHHHHHHHHHHCCCCCCCCEEEEEECCC----EE
Q ss_conf 067987600457972289998-39993799999304689997---89999999987258998101212896398----14
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDH---DDAVAMFDELSRLKHPNLLPLAGYCIAGK----EK 478 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~---~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~ 478 (690)
++|...+.||+|+||.||+|+ ..++..||+|+++.....+. ..+.+|++.++.++||||+++++++...+ ..
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf 20698689960899299999999999899999985566469899999999999998569998873114354326887669
Q ss_pred EEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 89997158997766530089999997778888778999999777899989978999999999988876430698887877
Q 005572 479 LVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLV 558 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk 558 (690)
++|||||++|+|.+++.. ...+++.++..++.|++.||.|||+.+++|||||
T Consensus 87 ~lvmE~~~g~~L~~~~~~----------------------------~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiK 138 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHT----------------------------EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVK 138 (277)
T ss_dssp EEEEECCCEEEHHHHHHH----------------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred EEEEECCCCCEEHHHHCC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 999977889871011203----------------------------5899999999999999999999985795276346
Q ss_pred CCCEEECCCCCCEECCCCCCCCCCC-----------------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
Q ss_conf 7847855999926747776554345-----------------66765688899987753236899999984899997348
Q 005572 559 TSSILLAESLEPKIAGFGLRNIGVK-----------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 559 ~~Nill~~~~~~ki~dfGl~~~~~~-----------------~~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~ 621 (690)
|+|||++.++..+++|||.+..... .+||...+..+++++||||+||++|||+||+.||....
T Consensus 139 P~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 139 PANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp GGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCCCCCCCCCCEEEHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC
T ss_conf 75566575432010034443221235443333464257624369999839999966320265289999976979989969
Q ss_pred --HHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-CHHHHHHHHHCCCC
Q ss_conf --99999999368997543011169999899999999998330189999999-99999999721289
Q 005572 622 --KWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-TMQQVLGLLKDIRP 685 (690)
Q Consensus 622 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RP-s~~~i~~~L~~i~~ 685 (690)
+........... .........+ . .+.+++.+||+.||++|| |++++.+.|..+..
T Consensus 219 ~~~~~~~~~~~~~~---~~~~~~~~~s---~---~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 219 PVSVAYQHVREDPI---PPSARHEGLS---A---DLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp HHHHHHHHHHCCCC---CGGGTSSSCC---H---HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCC---CCCHHCCCCC---H---HHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf 99999999846999---9710034789---9---999999998667976777399999999999758
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.95 Aligned_cols=232 Identities=21% Similarity=0.216 Sum_probs=186.0
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECC---CCCCHHHHHHHHHHHH-HCCCCCCCCEEEEEECCCEEEEE
Q ss_conf 067987600457972289998-399937999993046---8999789999999987-25899810121289639814899
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNA---KGIDHDDAVAMFDELS-RLKHPNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~H~niv~l~g~~~~~~~~~lv 481 (690)
++|...+.||+|+||.||+|+ ..++..||||+++.. .....+.+..|...+. .++||||+++++++.+.+..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 97158997766530089999997778888778999999777899989978999999999988876430698887877784
Q 005572 482 LEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSS 561 (690)
Q Consensus 482 ~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~N 561 (690)
||||++|+|.++++. ...+++.++..++.|++.||.|||+++++||||||+|
T Consensus 82 mEy~~~g~L~~~i~~----------------------------~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~N 133 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS----------------------------CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDN 133 (320)
T ss_dssp EECCTTCBHHHHHHH----------------------------HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGG
T ss_pred EEECCCCCHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCC
T ss_conf 750379808998640----------------------------4789999999999999999999986893403476540
Q ss_pred EEECCCCCCEECCCCCCCCCCC--------------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCH-HHHHHH
Q ss_conf 7855999926747776554345--------------6676568889998775323689999998489999734-899999
Q 005572 562 ILLAESLEPKIAGFGLRNIGVK--------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDC-VKWVRK 626 (690)
Q Consensus 562 ill~~~~~~ki~dfGl~~~~~~--------------~~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~-~~~~~~ 626 (690)
||++.++.+|++|||+++.... .+||...+..++.++||||+||++|||+||+.||.+. ......
T Consensus 134 iL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 213 (320)
T d1xjda_ 134 ILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213 (320)
T ss_dssp EEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEECCCCCEECCCCCHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 44448996301555302323566533454578777689999827998832320112278989873889999989999999
Q ss_pred HHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHH
Q ss_conf 999368997543011169999899999999998330189999999999-9999
Q 005572 627 LVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQ-QVLG 678 (690)
Q Consensus 627 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~-~i~~ 678 (690)
...... +..+...+. .+.+++.+||+.||++||++. ++++
T Consensus 214 ~i~~~~------~~~p~~~s~------~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 214 SIRMDN------PFYPRWLEK------EAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp HHHHCC------CCCCTTSCH------HHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred HHHCCC------CCCCCCCCH------HHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 997189------989756799------99999999654489878388999980
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.87 Aligned_cols=236 Identities=17% Similarity=0.204 Sum_probs=179.6
Q ss_pred CCCCCCC-EECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHC-CCCCCCCEEEEEEC----CCEEE
Q ss_conf 0679876-00457972289998-399937999993046899978999999998725-89981012128963----98148
Q 005572 407 SHFGKES-LLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRL-KHPNLLPLAGYCIA----GKEKL 479 (690)
Q Consensus 407 ~~~~~~~-~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~H~niv~l~g~~~~----~~~~~ 479 (690)
++|.+.. .||+|+||.||+|+ ..++..||||+++. ...+.+|++++.++ +||||+++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEEE
T ss_conf 4879810796545486999999889998999999897-----47799999999986699997829899950346897899
Q ss_pred EEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 99971589977665300899999977788887789999997778999899789999999999888764306988878777
Q 005572 480 VLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVT 559 (690)
Q Consensus 480 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~ 559 (690)
+|||||++|+|.+++... ....+++.++..++.|++.||.|||+.+++||||||
T Consensus 86 ivmEy~~gg~L~~~i~~~--------------------------~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp 139 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR--------------------------GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 139 (335)
T ss_dssp EEEECCCSEEHHHHHHSC--------------------------SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred EEEECCCCCCHHHHHHHC--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 999778998499999862--------------------------787757999999999999999999976986444100
Q ss_pred CCEEECC---CCCCEECCCCCCCCCCCC-------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH-
Q ss_conf 8478559---999267477765543456-------------67656888999877532368999999848999973489-
Q 005572 560 SSILLAE---SLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCVK- 622 (690)
Q Consensus 560 ~Nill~~---~~~~ki~dfGl~~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~~- 622 (690)
+|||+++ ++.+||+|||+++..... +||...+..++.++||||+||++|||+||+.||.+...
T Consensus 140 ~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 140 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred CCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH
T ss_conf 22011355556631135455123336888643226775637927774898888888876451677886588998898877
Q ss_pred -HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf -99999993689975430111699998999999999983301899999999999999
Q 005572 623 -WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 623 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
............. .+ ++.. ........+.+++.+|++.||++|||+.|+++
T Consensus 220 ~~~~~~~~~i~~~~-~~--~~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 271 (335)
T d2ozaa1 220 AISPGMKTRIRMGQ-YE--FPNP--EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271 (335)
T ss_dssp --------CCCSCS-SS--CCTT--HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHCCC-CC--CCCC--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 88999999985388-88--8985--43469999999999975699657909999970
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=310.91 Aligned_cols=252 Identities=18% Similarity=0.220 Sum_probs=187.8
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEE
Q ss_conf 067987600457972289998-39993799999304689--997899999999872589981012128963981489997
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
++|+..+.||+|+||.||+|+ ..++..||+|+++.... ...+++.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 15899776653008999999777888877899999977789998997899999999998887643069888787778478
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nil 563 (690)
|+.+ ++.+++... ....+++..+..++.|++.||.|||+.+++||||||+|||
T Consensus 82 ~~~~-~~~~~~~~~--------------------------~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl 134 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDAS--------------------------ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLL 134 (298)
T ss_dssp CCSE-EHHHHHHHT--------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred ECCC-CHHHHHHHH--------------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEE
T ss_conf 2377-445554420--------------------------2568888999999999999999865288992135711401
Q ss_pred ECCCCCCEECCCCCCCCCCCC--------------CCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCHHH--HHHH
Q ss_conf 559999267477765543456--------------67656888-999877532368999999848999973489--9999
Q 005572 564 LAESLEPKIAGFGLRNIGVKN--------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRK 626 (690)
Q Consensus 564 l~~~~~~ki~dfGl~~~~~~~--------------~~e~~~~~-~~~~~~DVwSfGvil~el~tg~~p~~~~~~--~~~~ 626 (690)
++.++.+|++|||+++..... +||..... .++.++||||+||++|||++|+.||..... ....
T Consensus 135 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~ 214 (298)
T d1gz8a_ 135 INTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 214 (298)
T ss_dssp ECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ECCCCCCEECCCCCCEECCCCCCCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHH
T ss_conf 13467621035786134368864100103652154112213665777422103333134279668799898899999999
Q ss_pred HHHH-CCCCCCCCCC----------CCCCCCCCHHHH-----HHHHHHHHHHCCCCCCCCCCHHHHHHH--HHCCCC
Q ss_conf 9993-6899754301----------116999989999-----999999833018999999999999999--721289
Q 005572 627 LVKE-GAGGDALDFR----------LKLGSGDSVAEM-----VESLRVGYLCTADSPGKRPTMQQVLGL--LKDIRP 685 (690)
Q Consensus 627 ~~~~-~~~~~~~~~~----------~~~~~~~~~~~~-----~~~~~i~~~C~~~dP~~RPs~~~i~~~--L~~i~~ 685 (690)
.... +...+...+. ............ ..+.+++.+|++.||++|||+.|+++. ++++..
T Consensus 215 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~ 291 (298)
T d1gz8a_ 215 IFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291 (298)
T ss_dssp HHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred HHHHCCCCCHHHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 99832898333144422242124345432222044416678999999999976399557918999967870146999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=307.57 Aligned_cols=245 Identities=22% Similarity=0.185 Sum_probs=182.3
Q ss_pred CCCEECCCCCCCEEEEEC-CCCCEEEEEEEECCCCC-----CHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEE
Q ss_conf 876004579722899983-99937999993046899-----978999999998725899810121289639814899971
Q 005572 411 KESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGI-----DHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 411 ~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
..++||+|+||+||+|+. .++..||||+++..... ..+.+.+|+++++.++|||||++++++...+..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 58997766530089999997778888778999999777899989978999999999988876430698887877784785
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill 564 (690)
|.+|++..+... ...+++..+..++.|++.||.|||+++++||||||+|||+
T Consensus 82 ~~~~~~~~~~~~----------------------------~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli 133 (299)
T d1ua2a_ 82 METDLEVIIKDN----------------------------SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 133 (299)
T ss_dssp CSEEHHHHHTTC----------------------------CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred HCCHHHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEE
T ss_conf 345077655412----------------------------6677899999999999999988631635503577625885
Q ss_pred CCCCCCEECCCCCCCCCCCC--------------CCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCHH--HHHHHH
Q ss_conf 59999267477765543456--------------6765688-899987753236899999984899997348--999999
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCV--KWVRKL 627 (690)
Q Consensus 565 ~~~~~~ki~dfGl~~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvil~el~tg~~p~~~~~--~~~~~~ 627 (690)
+.++.+||+|||+++..... +||.... ..++.++||||+||++|||+||..||.... +....+
T Consensus 134 ~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i 213 (299)
T d1ua2a_ 134 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 213 (299)
T ss_dssp CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 37784114657610005787554330204733363999726778880564363042899998596999999999999999
Q ss_pred HHH-CCCCC-CC-------C-CCCCCCCCCCHHHH-----HHHHHHHHHHCCCCCCCCCCHHHHHH--HHHCC
Q ss_conf 993-68997-54-------3-01116999989999-----99999983301899999999999999--97212
Q 005572 628 VKE-GAGGD-AL-------D-FRLKLGSGDSVAEM-----VESLRVGYLCTADSPGKRPTMQQVLG--LLKDI 683 (690)
Q Consensus 628 ~~~-~~~~~-~~-------~-~~~~~~~~~~~~~~-----~~~~~i~~~C~~~dP~~RPs~~~i~~--~L~~i 683 (690)
... +.... .. . .............. ..+.+++.+|++.||++|||+.|+++ ++++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 214 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HHHCCCCCHHHCCCHHCCCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 9851899725452100021344303478988678565689999999999763894569089999679965789
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=300.85 Aligned_cols=244 Identities=18% Similarity=0.174 Sum_probs=184.2
Q ss_pred CCCCCCCEECCCCCCCEEEEECCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEEE
Q ss_conf 0679876004579722899983999379999930468--99978999999998725899810121289639814899971
Q 005572 407 SHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++|...+.||+|+||.||+|+.+++..||||+++... ....+.+.+|+.+|++++||||+++++++...+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 58997766530089999997778888778999999777899989978999999999988876430698887877784785
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill 564 (690)
+.++.+..+.+. ...+++..+..++.|++.||+|||+.+++||||||+|||+
T Consensus 82 ~~~~~~~~~~~~----------------------------~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll 133 (286)
T d1ob3a_ 82 LDQDLKKLLDVC----------------------------EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI 133 (286)
T ss_dssp CSEEHHHHHHTS----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EHHHHHHHHHHH----------------------------CCCCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEE
T ss_conf 004567899860----------------------------4775144568999999999998605748826787750568
Q ss_pred CCCCCCEECCCCCCCCCCCC--------------CCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH--HHHHH
Q ss_conf 59999267477765543456--------------6765688-8999877532368999999848999973489--99999
Q 005572 565 AESLEPKIAGFGLRNIGVKN--------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVK--WVRKL 627 (690)
Q Consensus 565 ~~~~~~ki~dfGl~~~~~~~--------------~~e~~~~-~~~~~~~DVwSfGvil~el~tg~~p~~~~~~--~~~~~ 627 (690)
+.++.+|++|||.+...... +||.... ..++.++||||+||++|||++|+.||.+... ...+.
T Consensus 134 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i 213 (286)
T d1ob3a_ 134 NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRI 213 (286)
T ss_dssp CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CCCCCEEECCCCCCEECCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHH
T ss_conf 68997873236643011467654101024311013788717888884100211175899997797998988989999999
Q ss_pred HHH-CCCC--C--------CCCCCCCCCCCCCHH-----HHHHHHHHHHHHCCCCCCCCCCHHHHHH
Q ss_conf 993-6899--7--------543011169999899-----9999999983301899999999999999
Q 005572 628 VKE-GAGG--D--------ALDFRLKLGSGDSVA-----EMVESLRVGYLCTADSPGKRPTMQQVLG 678 (690)
Q Consensus 628 ~~~-~~~~--~--------~~~~~~~~~~~~~~~-----~~~~~~~i~~~C~~~dP~~RPs~~~i~~ 678 (690)
... +... . ............... ....+.+++.+|++.||++|||++|+++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 214 FRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp HHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HHHHCCCCHHHCCCHHHHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9863899711042123332214333335676466651258999999999986689668909999856
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=301.30 Aligned_cols=249 Identities=20% Similarity=0.234 Sum_probs=181.6
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCC----EEEE
Q ss_conf 067987600457972289998-39993799999304689-99789999999987258998101212896398----1489
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG-IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGK----EKLV 480 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~----~~~l 480 (690)
++|...+.||+|+||.||+|+ ..++..||||+++.... ...+.+.+|+++|+.++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 98599789940648099999999999499999980310958999999999999976898988588899505645541499
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99715899776653008999999777888877899999977789998997899999999998887643069888787778
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~ 560 (690)
+++|+.+|+|.+++.. ..+++..+..++.|++.||+|||+++++||||||+
T Consensus 88 l~~~~~~g~L~~~l~~-----------------------------~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~ 138 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT-----------------------------QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPS 138 (345)
T ss_dssp EEEECCCEEHHHHHHH-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred EEEEECCCCHHHHHHC-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 9996259865664405-----------------------------89999999999999999999999789867778764
Q ss_pred CEEECCCCCCEECCCCCCCCCCCC-----------------CCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCHHH
Q ss_conf 478559999267477765543456-----------------6765688-8999877532368999999848999973489
Q 005572 561 SILLAESLEPKIAGFGLRNIGVKN-----------------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVK 622 (690)
Q Consensus 561 Nill~~~~~~ki~dfGl~~~~~~~-----------------~~e~~~~-~~~~~~~DVwSfGvil~el~tg~~p~~~~~~ 622 (690)
|||++.++.+||+|||++...... +||.... ..+++++||||+||++|||++|+.||.....
T Consensus 139 NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 139 NLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp GEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEEECCCCCEEECCCCCEEECCCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCH
T ss_conf 37887999778754570565047776410101102652000387860478887410100467013377669799788888
Q ss_pred --HHHHHHHHCCCCCCC-------------CCCCCCCCCCCHHHH-----HHHHHHHHHHCCCCCCCCCCHHHHHHH--H
Q ss_conf --999999936899754-------------301116999989999-----999999833018999999999999999--7
Q 005572 623 --WVRKLVKEGAGGDAL-------------DFRLKLGSGDSVAEM-----VESLRVGYLCTADSPGKRPTMQQVLGL--L 680 (690)
Q Consensus 623 --~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~-----~~~~~i~~~C~~~dP~~RPs~~~i~~~--L 680 (690)
............... ............... ..+.+++..|++.||++|||+.|+++. +
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~ 298 (345)
T d1pmea_ 219 LDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298 (345)
T ss_dssp HHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred HHHHHHHHHHCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 99999876520699756642343322220244677557787778378999999999999764895679089998619865
Q ss_pred HCCC
Q ss_conf 2128
Q 005572 681 KDIR 684 (690)
Q Consensus 681 ~~i~ 684 (690)
+...
T Consensus 299 ~~~~ 302 (345)
T d1pmea_ 299 EQYY 302 (345)
T ss_dssp TTTC
T ss_pred CCCC
T ss_conf 5588
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=296.05 Aligned_cols=250 Identities=19% Similarity=0.199 Sum_probs=183.1
Q ss_pred HCCCCCCCEECCCCCCCEEEEEC-CC-CCEEEEEEEECCCC--CCHHHHHHHHHHHHHC---CCCCCCCEEEEEEC----
Q ss_conf 50679876004579722899983-99-93799999304689--9978999999998725---89981012128963----
Q 005572 406 TSHFGKESLLAEGRCGPVYRAVL-PG-ELHVAIKVLDNAKG--IDHDDAVAMFDELSRL---KHPNLLPLAGYCIA---- 474 (690)
Q Consensus 406 ~~~~~~~~~ig~G~~g~V~~~~~-~~-~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l---~H~niv~l~g~~~~---- 474 (690)
.++|++.+.||+|+||.||+|+. .+ +..||||+++.... .....+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Q ss_conf -9814899971589977665300899999977788887789999997778999899789999999999888764306988
Q 005572 475 -GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGST 553 (690)
Q Consensus 475 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~ 553 (690)
....++++||+.+|++...... ....+++.....++.|++.||+|||+++++
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~aL~yLH~~~iv 138 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV---------------------------PEPGVPTETIKDMMFQLLRGLDFLHSHRVV 138 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS---------------------------CTTCSCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred CCCEEEEEEEECCCCCHHHHHHC---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
T ss_conf 67469999974058714444430---------------------------378999899999999999999999758898
Q ss_pred CCCCCCCCEEECCCCCCEECCCCCCCCCCCC-------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCH
Q ss_conf 8787778478559999267477765543456-------------676568889998775323689999998489999734
Q 005572 554 HGHLVTSSILLAESLEPKIAGFGLRNIGVKN-------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 554 H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~-------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~ 620 (690)
||||||+|||++.++.+||+|||+++..... +||...+..++.++||||+||++|||+||+.||...
T Consensus 139 HrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~ 218 (305)
T d1blxa_ 139 HRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGS 218 (305)
T ss_dssp CCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred ECCCCCCEEEECCCCCEEECCHHHHHHHCCCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCC
T ss_conf 35798627898589975421000101100234577765485114831001798881110003289999998787998998
Q ss_pred H--HHHHHHHHHCCCCCC---------CCCC--------CCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--
Q ss_conf 8--999999993689975---------4301--------116999989999999999833018999999999999999--
Q 005572 621 V--KWVRKLVKEGAGGDA---------LDFR--------LKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL-- 679 (690)
Q Consensus 621 ~--~~~~~~~~~~~~~~~---------~~~~--------~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~-- 679 (690)
. +....+......... .... .......... .+.+++.+||+.||++|||+.|+++.
T Consensus 219 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 219 SDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDE---LGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp SHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCH---HHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred CHHHHHHHHHHHHCCCCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 9899999999840799611053211110333022345645440445899---9999999987489667918999966963
Q ss_pred HHCCCC
Q ss_conf 721289
Q 005572 680 LKDIRP 685 (690)
Q Consensus 680 L~~i~~ 685 (690)
++++.+
T Consensus 296 f~~i~~ 301 (305)
T d1blxa_ 296 FQDLER 301 (305)
T ss_dssp GTTCCC
T ss_pred HCCCHH
T ss_conf 407521
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=295.86 Aligned_cols=245 Identities=19% Similarity=0.174 Sum_probs=181.7
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCC--CCCHHHHHHHHHHHHHCCCCCCCCEEEEEECC--------
Q ss_conf 067987600457972289998-3999379999930468--99978999999998725899810121289639--------
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAK--GIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG-------- 475 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-------- 475 (690)
++|++.+.||+|+||.||+|+ ..++..||||++.... .....++.+|+++|++++||||+++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred CEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCC
Q ss_conf 81489997158997766530089999997778888778999999777899989978999999999988876430698887
Q 005572 476 KEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHG 555 (690)
Q Consensus 476 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~ 555 (690)
...++||||+.++.+..+... ...++......++.|++.||.|||+.+++||
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~----------------------------~~~~~~~~~~~i~~qil~~l~~lH~~~ivHr 141 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNV----------------------------LVKFTLSEIKRVMQMLLNGLYYIHRNKILHR 141 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCT----------------------------TCCCCHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred CEEEEEEECCCCCCCCHHHHC----------------------------CCCCCCHHHHHHHHHHHHHHHHHCCCCEEEC
T ss_conf 638999853578741012220----------------------------3443308999999999999988522998856
Q ss_pred CCCCCCEEECCCCCCEECCCCCCCCCCCC------------------CCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCC
Q ss_conf 87778478559999267477765543456------------------67656888-999877532368999999848999
Q 005572 556 HLVTSSILLAESLEPKIAGFGLRNIGVKN------------------VGERSENE-TCGPESDVYCFGVILMELLTGKRG 616 (690)
Q Consensus 556 dlk~~Nill~~~~~~ki~dfGl~~~~~~~------------------~~e~~~~~-~~~~~~DVwSfGvil~el~tg~~p 616 (690)
||||+|||++.++.+|++|||+++..... +||..... .+++++||||+||++|||++|+.|
T Consensus 142 DlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~p 221 (318)
T d3blha1 142 DMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221 (318)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCCCHHEEECCCCCEEEEECCEEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCC
T ss_conf 76722203668996876313500223554443211356602497874289970799989178700678646617448799
Q ss_pred CCCHHHH--HHHHHHH-CCCCCCCCCCC-----------CCCCCCCHHHH-------HHHHHHHHHHCCCCCCCCCCHHH
Q ss_conf 9734899--9999993-68997543011-----------16999989999-------99999983301899999999999
Q 005572 617 TDDCVKW--VRKLVKE-GAGGDALDFRL-----------KLGSGDSVAEM-------VESLRVGYLCTADSPGKRPTMQQ 675 (690)
Q Consensus 617 ~~~~~~~--~~~~~~~-~~~~~~~~~~~-----------~~~~~~~~~~~-------~~~~~i~~~C~~~dP~~RPs~~~ 675 (690)
|.+.... ...+... +.......... .........+. ..+.+++.+||+.||++|||+.|
T Consensus 222 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~e 301 (318)
T d3blha1 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301 (318)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCHHHHHHHHHHHCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 89989999999999841899825534432034443320133445550334044459989999999987389658909999
Q ss_pred HHHH
Q ss_conf 9999
Q 005572 676 VLGL 679 (690)
Q Consensus 676 i~~~ 679 (690)
+++.
T Consensus 302 lL~H 305 (318)
T d3blha1 302 ALNH 305 (318)
T ss_dssp HHHS
T ss_pred HHCC
T ss_conf 9749
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=294.46 Aligned_cols=245 Identities=20% Similarity=0.233 Sum_probs=183.3
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCCEEEEEECCC------E
Q ss_conf 067987600457972289998-399937999993046899--9789999999987258998101212896398------1
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI--DHDDAVAMFDELSRLKHPNLLPLAGYCIAGK------E 477 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~------~ 477 (690)
++|.+.+.||+|+||.||+|. ..++..||||+++..... ..+.+.+|+++|+.++|||||++++++...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCCE
T ss_conf 71899889801778199999999999899999985222596999999999999986689875479998635765555415
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 48999715899776653008999999777888877899999977789998997899999999998887643069888787
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dl 557 (690)
.++||||| +++|..+.+. ..+++..+..++.|++.||.|||+++++||||
T Consensus 98 ~~lv~e~~-~~~l~~~~~~-----------------------------~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDi 147 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH-----------------------------EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDL 147 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred EEEEEECC-CCCHHHHHHH-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 99998405-5218999874-----------------------------02269999999999999999987378764566
Q ss_pred CCCCEEECCCCCCEECCCCCCCCCCCC-----------CCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCHHHH--
Q ss_conf 778478559999267477765543456-----------6765688-89998775323689999998489999734899--
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVKN-----------VGERSEN-ETCGPESDVYCFGVILMELLTGKRGTDDCVKW-- 623 (690)
Q Consensus 558 k~~Nill~~~~~~ki~dfGl~~~~~~~-----------~~e~~~~-~~~~~~~DVwSfGvil~el~tg~~p~~~~~~~-- 623 (690)
||+|||++.++.+|++|||+++..... +||...+ ..++.++||||+||++|||++|+.||......
T Consensus 148 Kp~NIL~~~~~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~ 227 (346)
T d1cm8a_ 148 KPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 227 (346)
T ss_dssp CGGGEEECTTCCEEECCCTTCEECCSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred CCCHHHCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHH
T ss_conf 85111121001221134310220687631024553335889981787899650103003899999978699888976899
Q ss_pred HHHHHHH-CC--------------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH--H
Q ss_conf 9999993-68--------------------99754301116999989999999999833018999999999999999--7
Q 005572 624 VRKLVKE-GA--------------------GGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGL--L 680 (690)
Q Consensus 624 ~~~~~~~-~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~--L 680 (690)
....... +. ..+.....+......... .+.+++.+|++.||++|||+.|+++. +
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dli~~mL~~dP~~R~ta~eiL~Hp~f 304 (346)
T d1cm8a_ 228 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASP---LAVNLLEKMLVLDAEQRVTAGEALAHPYF 304 (346)
T ss_dssp HHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCH---HHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHHHHCCCCCCHHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 999985037884888865300034433115786665566775568999---99999999772995579299999639623
Q ss_pred HCCC
Q ss_conf 2128
Q 005572 681 KDIR 684 (690)
Q Consensus 681 ~~i~ 684 (690)
+++.
T Consensus 305 ~~~~ 308 (346)
T d1cm8a_ 305 ESLH 308 (346)
T ss_dssp TTTC
T ss_pred CCCC
T ss_conf 7587
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=303.01 Aligned_cols=233 Identities=19% Similarity=0.286 Sum_probs=181.9
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCC------CHHHHHHHHHHHHHCC--CCCCCCEEEEEECCCE
Q ss_conf 067987600457972289998-399937999993046899------9789999999987258--9981012128963981
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI------DHDDAVAMFDELSRLK--HPNLLPLAGYCIAGKE 477 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~ 477 (690)
++|.+.+.||+|+||.||+|+ ..++..||||+++..... ....+.+|+.++++++ ||||+++++++.+.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEECCC-CCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
Q ss_conf 4899971589-977665300899999977788887789999997778999899789999999999888764306988878
Q 005572 478 KLVLLEFMAN-GDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGH 556 (690)
Q Consensus 478 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~d 556 (690)
.++||||+.+ +++.+++.. ...+++..+..++.|++.||.|||+.+++|||
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~----------------------------~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrD 135 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE----------------------------RGALQEELARSFFWQVLEAVRHCHNCGVLHRD 135 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH----------------------------HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEEEEEECCCCCHHHHHHHC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 89999833686228999861----------------------------58999999999999999999999877975566
Q ss_pred CCCCCEEECC-CCCCEECCCCCCCCCCCC------------CCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCHHH
Q ss_conf 7778478559-999267477765543456------------676568889-99877532368999999848999973489
Q 005572 557 LVTSSILLAE-SLEPKIAGFGLRNIGVKN------------VGERSENET-CGPESDVYCFGVILMELLTGKRGTDDCVK 622 (690)
Q Consensus 557 lk~~Nill~~-~~~~ki~dfGl~~~~~~~------------~~e~~~~~~-~~~~~DVwSfGvil~el~tg~~p~~~~~~ 622 (690)
|||+|||++. ++.+||+|||+++..... +||...... ++.++||||+||++|||+||+.||....+
T Consensus 136 iKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (273)
T d1xwsa_ 136 IKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE 215 (273)
T ss_dssp CSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH
T ss_pred CCCCCEEEECCCCEEEECCCCCCEECCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH
T ss_conf 76111477447884897754653532444556656587747999984899788653325540345367568899887367
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHCCC
Q ss_conf 99999993689975430111699998999999999983301899999999999999--972128
Q 005572 623 WVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG--LLKDIR 684 (690)
Q Consensus 623 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~--~L~~i~ 684 (690)
... ... .++...+. .+.+++.+||+.||++|||+.|+++ +++++.
T Consensus 216 ----i~~-~~~------~~~~~~s~------~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 216 ----IIR-GQV------FFRQRVSS------ECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp ----HHH-CCC------CCSSCCCH------HHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred ----HHH-CCC------CCCCCCCH------HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf ----761-544------77877999------999999997608975893999985398667887
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=295.23 Aligned_cols=250 Identities=17% Similarity=0.154 Sum_probs=186.7
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCCEEEEEECCCEEEEEEE
Q ss_conf 067987600457972289998-39993799999304689--997899999999872589981012128963981489997
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKG--IDHDDAVAMFDELSRLKHPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~~~~~lv~e 483 (690)
++|+..+.||+|+||.||+|+ ..++..||||+++.... .....+.+|+.+++.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEE
Q ss_conf 15899776653008999999777888877899999977789998997899999999998887643069888787778478
Q 005572 484 FMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSIL 563 (690)
Q Consensus 484 ~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nil 563 (690)
++.+++|..+++. ...+++..+..++.|++.||+|||+++++||||||+|||
T Consensus 82 ~~~~~~l~~~~~~----------------------------~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIl 133 (292)
T d1unla_ 82 FCDQDLKKYFDSC----------------------------NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL 133 (292)
T ss_dssp CCSEEHHHHHHHT----------------------------TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred ECCCCCCCCCCCC----------------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCC
T ss_conf 0233222112123----------------------------565403678999999999987743399860014676121
Q ss_pred ECCCCCCEECCCCCCCCCCCC--------------CCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCC---HHHHHH
Q ss_conf 559999267477765543456--------------67656888-999877532368999999848999973---489999
Q 005572 564 LAESLEPKIAGFGLRNIGVKN--------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDD---CVKWVR 625 (690)
Q Consensus 564 l~~~~~~ki~dfGl~~~~~~~--------------~~e~~~~~-~~~~~~DVwSfGvil~el~tg~~p~~~---~~~~~~ 625 (690)
++.++.+|++|||.++..... +||..... .++.++||||+||++|||++|+.||.. ..+...
T Consensus 134 i~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~ 213 (292)
T d1unla_ 134 INRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213 (292)
T ss_dssp ECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHH
T ss_pred CCCCCCEEEEECCHHHCCCCCCCCCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 13378266520460110468875100103443101466750698888044402654188998518999988999999999
Q ss_pred HHHHH-CCCCC-CC-------CC----CC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHCCC
Q ss_conf 99993-68997-54-------30----11---1699998999999999983301899999999999999--972128
Q 005572 626 KLVKE-GAGGD-AL-------DF----RL---KLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG--LLKDIR 684 (690)
Q Consensus 626 ~~~~~-~~~~~-~~-------~~----~~---~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~--~L~~i~ 684 (690)
..... +.... .. +. .. ..........-..+.+++.+|++.||++|||++|+++ ++.++.
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp HHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred HHHHHCCCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 99861189973551344322211334445443104330656899999999998649966890999996495340798
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=294.65 Aligned_cols=245 Identities=19% Similarity=0.207 Sum_probs=175.1
Q ss_pred CCCCCCEECCCCCCCEEEEEC-CCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEEEECC------CEEEE
Q ss_conf 679876004579722899983-99937999993046899978999999998725899810121289639------81489
Q 005572 408 HFGKESLLAEGRCGPVYRAVL-PGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGYCIAG------KEKLV 480 (690)
Q Consensus 408 ~~~~~~~ig~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~~~~~------~~~~l 480 (690)
+|...++||+|+||+||+|+. .++..||||++..... ...+|++++++++||||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99715899776653008999999777888877899999977789998997899999999998887643069888787778
Q 005572 481 LLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTS 560 (690)
Q Consensus 481 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~ 560 (690)
|||||++|.+..+.+.. .....+++.++..++.|++.||+|||+++++||||||+
T Consensus 97 v~Ey~~~~~~~~l~~~~-------------------------~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~ 151 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYS-------------------------RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQ 151 (350)
T ss_dssp EEECCSEEHHHHHHHHH-------------------------HTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGG
T ss_pred EEECCCCCCHHHHHHHH-------------------------HCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCC
T ss_conf 98416886078888631-------------------------03689999999999999999999998668764578860
Q ss_pred CEEECCC-CCCEECCCCCCCCCCCC-------------CCCCCC-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH--HH
Q ss_conf 4785599-99267477765543456-------------676568-8899987753236899999984899997348--99
Q 005572 561 SILLAES-LEPKIAGFGLRNIGVKN-------------VGERSE-NETCGPESDVYCFGVILMELLTGKRGTDDCV--KW 623 (690)
Q Consensus 561 Nill~~~-~~~ki~dfGl~~~~~~~-------------~~e~~~-~~~~~~~~DVwSfGvil~el~tg~~p~~~~~--~~ 623 (690)
|||++.+ ..+||+|||+++..... +||... ...++.++||||+||++|||++|+.||.... +.
T Consensus 152 NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~ 231 (350)
T d1q5ka_ 152 NLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231 (350)
T ss_dssp GEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH
T ss_pred EEEEECCCCCEEEECCCCHHHCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHH
T ss_conf 37873589711673366054404776532002555556827764046888210002465277855028799898799999
Q ss_pred HHHHHHH-C-----------C-CCCCCCCCC-----C-CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHC
Q ss_conf 9999993-6-----------8-997543011-----1-699998999999999983301899999999999999--9721
Q 005572 624 VRKLVKE-G-----------A-GGDALDFRL-----K-LGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG--LLKD 682 (690)
Q Consensus 624 ~~~~~~~-~-----------~-~~~~~~~~~-----~-~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~--~L~~ 682 (690)
...+... + . .....-+.. . ........ .+.+++.+|++.||++|||+.|+++ ++++
T Consensus 232 l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~---~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~ 308 (350)
T d1q5ka_ 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPP---EAIALCSRLLEYTPTARLTPLEACAHSFFDE 308 (350)
T ss_dssp HHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCH---HHHHHHHHHSCSSGGGSCCHHHHHTSGGGGG
T ss_pred HHHHHHHHCCCHHHHHHHHCCCHHHCCCCCCCCCCHHHHCCCCCCH---HHHHHHHHHCCCCHHHCCCHHHHHCCHHHCC
T ss_conf 9999997489817765430621011035544567444431568999---9999999976589557929999966984524
Q ss_pred CC
Q ss_conf 28
Q 005572 683 IR 684 (690)
Q Consensus 683 i~ 684 (690)
+.
T Consensus 309 ~~ 310 (350)
T d1q5ka_ 309 LR 310 (350)
T ss_dssp GG
T ss_pred CC
T ss_conf 66
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=291.47 Aligned_cols=250 Identities=21% Similarity=0.211 Sum_probs=184.2
Q ss_pred HCCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCCEEEEEECC-----CE
Q ss_conf 5067987600457972289998-399937999993046899--978999999998725899810121289639-----81
Q 005572 406 TSHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI--DHDDAVAMFDELSRLKHPNLLPLAGYCIAG-----KE 477 (690)
Q Consensus 406 ~~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~~-----~~ 477 (690)
.++|...+.||+|+||.||+|+ ..++..||||+++..... ..+.+.+|+++++.++||||+++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 48999715899776653008999999777888877899999977789998997899999999998887643069888787
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dl 557 (690)
.++++||+.+|+|.++++. +.+++..+..++.|++.||.|||+++++||||
T Consensus 97 ~~~i~~~~~gg~L~~~~~~-----------------------------~~l~e~~~~~i~~qil~aL~~LH~~giiHrDi 147 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC-----------------------------QKLTDDHVQFLIYQILRGLKYIHSADIIHRDL 147 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEEEEEEECCCCHHHHCCC-----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 4999996258862320022-----------------------------45309999999999999999997388765166
Q ss_pred CCCCEEECCCCCCEECCCCCCCCCCCC-----------CCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCHHH--H
Q ss_conf 778478559999267477765543456-----------67656888-999877532368999999848999973489--9
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVKN-----------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCVK--W 623 (690)
Q Consensus 558 k~~Nill~~~~~~ki~dfGl~~~~~~~-----------~~e~~~~~-~~~~~~DVwSfGvil~el~tg~~p~~~~~~--~ 623 (690)
||+|||++.++.+|++|||++...... +||..... .++.++||||+||++|||++|+.||..... .
T Consensus 148 Kp~NILi~~~~~~kl~dfg~a~~~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~ 227 (348)
T d2gfsa1 148 KPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 227 (348)
T ss_dssp CGGGEEECTTCCEEECCC----CCTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH
T ss_conf 77633455432200132100012575444434543555835533775678551243205899999768899788988999
Q ss_pred HHHHHHHCCCCCC-CC------------CCCCCCCCCCHHH-----HHHHHHHHHHHCCCCCCCCCCHHHHHH--HHHCC
Q ss_conf 9999993689975-43------------0111699998999-----999999983301899999999999999--97212
Q 005572 624 VRKLVKEGAGGDA-LD------------FRLKLGSGDSVAE-----MVESLRVGYLCTADSPGKRPTMQQVLG--LLKDI 683 (690)
Q Consensus 624 ~~~~~~~~~~~~~-~~------------~~~~~~~~~~~~~-----~~~~~~i~~~C~~~dP~~RPs~~~i~~--~L~~i 683 (690)
...+......... .. ............. -..+.+++.+|++.||++|||+.|+++ ++.+.
T Consensus 228 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 228 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp HHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred HHHHHHHCCCCCHHHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCC
T ss_conf 99999730799757732001024454443035578755566267899999999999775883459389998559954879
Q ss_pred C
Q ss_conf 8
Q 005572 684 R 684 (690)
Q Consensus 684 ~ 684 (690)
.
T Consensus 308 ~ 308 (348)
T d2gfsa1 308 H 308 (348)
T ss_dssp C
T ss_pred C
T ss_conf 9
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=290.27 Aligned_cols=243 Identities=14% Similarity=0.178 Sum_probs=179.5
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEECC--CEEEEEE
Q ss_conf 067987600457972289998-3999379999930468999789999999987258-99810121289639--8148999
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAG--KEKLVLL 482 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~--~~~~lv~ 482 (690)
++|.+.+.||+|+||.||+|+ ..++..||+|+++. ...+++.+|+++|..++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~---~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS---SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECH---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 671897898317481999999889997999999888---99999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
Q ss_conf 71589977665300899999977788887789999997778999899789999999999888764306988878777847
Q 005572 483 EFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSI 562 (690)
Q Consensus 483 e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Ni 562 (690)
|||++|+|..+.+ .+++..+..++.|++.||.|||+++++||||||+||
T Consensus 112 e~~~~~~L~~~~~-------------------------------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NI 160 (328)
T d3bqca1 112 EHVNNTDFKQLYQ-------------------------------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNV 160 (328)
T ss_dssp ECCCSCBGGGTTT-------------------------------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EECCCCCHHHHHC-------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCE
T ss_conf 6317985899746-------------------------------899999999999999999887643344345644123
Q ss_pred EECCCC-CCEECCCCCCCCCCCC-------------CCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCHH---HH-
Q ss_conf 855999-9267477765543456-------------67656888-99987753236899999984899997348---99-
Q 005572 563 LLAESL-EPKIAGFGLRNIGVKN-------------VGERSENE-TCGPESDVYCFGVILMELLTGKRGTDDCV---KW- 623 (690)
Q Consensus 563 ll~~~~-~~ki~dfGl~~~~~~~-------------~~e~~~~~-~~~~~~DVwSfGvil~el~tg~~p~~~~~---~~- 623 (690)
|++.++ .+|++|||+++..... +||..... .++.++||||+|+++|||++|+.||.... ..
T Consensus 161 Li~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~ 240 (328)
T d3bqca1 161 MIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 240 (328)
T ss_dssp EEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHH
T ss_pred EECCCCCEEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHH
T ss_conf 77489983664156542664688744432248642476102688888845232335455587604889998876018999
Q ss_pred -----------HHHHHHHCCCCCC--CCCCCC----------CCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH--
Q ss_conf -----------9999993689975--430111----------699998999999999983301899999999999999--
Q 005572 624 -----------VRKLVKEGAGGDA--LDFRLK----------LGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLG-- 678 (690)
Q Consensus 624 -----------~~~~~~~~~~~~~--~~~~~~----------~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~-- 678 (690)
............. ...... .........-..+.+++.+|++.||++|||++|+++
T Consensus 241 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp 320 (328)
T d3bqca1 241 VRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320 (328)
T ss_dssp HHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHHCCCHHHHHHHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 99999878841555554225444743000003334331121155211244899999999998669956890899996493
Q ss_pred HHHCC
Q ss_conf 97212
Q 005572 679 LLKDI 683 (690)
Q Consensus 679 ~L~~i 683 (690)
++.++
T Consensus 321 ~F~~v 325 (328)
T d3bqca1 321 YFYTV 325 (328)
T ss_dssp GGTTS
T ss_pred CCCCC
T ss_conf 55887
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=293.88 Aligned_cols=239 Identities=14% Similarity=0.136 Sum_probs=177.4
Q ss_pred CCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCCCCCCCEEEE-EECCCEEEEEEEEC
Q ss_conf 67987600457972289998-39993799999304689997899999999872589981012128-96398148999715
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKHPNLLPLAGY-CIAGKEKLVLLEFM 485 (690)
Q Consensus 408 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H~niv~l~g~-~~~~~~~~lv~e~~ 485 (690)
+|...+.||+|+||.||+|+ ..++..||||++.... ...++..|+++++.++|+|++..++. ..+.+..++||||+
T Consensus 8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~ 85 (299)
T d1ckia_ 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL 85 (299)
T ss_dssp TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC
T ss_pred EEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHC--CCHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEEEC
T ss_conf 8999689850788099999998899899999972100--58889999999997038996017999995198778999873
Q ss_pred CCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
Q ss_conf 89977665300899999977788887789999997778999899789999999999888764306988878777847855
Q 005572 486 ANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLA 565 (690)
Q Consensus 486 ~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~ 565 (690)
+|++...+.. ....+++..+..++.|++.||+|||+++++||||||+|||++
T Consensus 86 -~~~l~~~~~~---------------------------~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~ 137 (299)
T d1ckia_ 86 -GPSLEDLFNF---------------------------CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMG 137 (299)
T ss_dssp -CCBHHHHHHH---------------------------TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred -CCCHHHHHHH---------------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCC
T ss_conf -8713332443---------------------------068876899999999999999999979944266787660643
Q ss_pred ---CCCCCEECCCCCCCCCCCC---------------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
Q ss_conf ---9999267477765543456---------------------6765688899987753236899999984899997348
Q 005572 566 ---ESLEPKIAGFGLRNIGVKN---------------------VGERSENETCGPESDVYCFGVILMELLTGKRGTDDCV 621 (690)
Q Consensus 566 ---~~~~~ki~dfGl~~~~~~~---------------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~~ 621 (690)
.+..+|++|||+++..... +||...+..++.++|||||||++|||+||+.||....
T Consensus 138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~ 217 (299)
T d1ckia_ 138 LGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 217 (299)
T ss_dssp CGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred CCCCCCEEEEECCCCCEECCCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCC
T ss_conf 35777615650467513425544554100013577678735329999918998983218861778999984987665530
Q ss_pred HH-----HHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC
Q ss_conf 99-----9999993689975430111699998999999999983301899999999999999972128
Q 005572 622 KW-----VRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIR 684 (690)
Q Consensus 622 ~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~ 684 (690)
.. ......... ....+......+ . .+.+++..||+.+|++||++.++.+.|+.+.
T Consensus 218 ~~~~~~~~~~~~~~~~--~~~~~~~~~~~p---~---~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 218 AATKRQKYERISEKKM--STPIEVLCKGYP---S---EFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp -------HHHHHHHHH--HSCHHHHTTTSC---H---HHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHCCCC--CCCHHHHCCCCC---H---HHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 5779999998523567--898357534788---9---9999999984399557919999999999999
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=291.56 Aligned_cols=232 Identities=18% Similarity=0.190 Sum_probs=179.3
Q ss_pred CCCCCCCEECCCCCCCEEEEEC----CCCCEEEEEEEECCC----CCCHHHHHHHHHHHHHCCC-CCCCCEEEEEECCCE
Q ss_conf 0679876004579722899983----999379999930468----9997899999999872589-981012128963981
Q 005572 407 SHFGKESLLAEGRCGPVYRAVL----PGELHVAIKVLDNAK----GIDHDDAVAMFDELSRLKH-PNLLPLAGYCIAGKE 477 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~~----~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~ 477 (690)
++|+..+.||+|+||.||+|+. .++..||+|+++... ....+.+.+|++++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 48999715899776653008999999777888877899999977789998997899999999998887643069888787
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dl 557 (690)
.++++||+.+|+|.+++... ..++......++.|++.|+.|+|+.+++||||
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~----------------------------~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDi 155 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQR----------------------------ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDI 155 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHH----------------------------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCC
T ss_pred EEEEEECCCCCHHHHHHHHC----------------------------CCCCHHHHHHHHHHHHHHHHHHHCCCEEECCC
T ss_conf 00123123411799998730----------------------------45437888888999999998851499896547
Q ss_pred CCCCEEECCCCCCEECCCCCCCCCCCC---------------CCCCCCC--CCCCCCCCCHHHHHHHHHHHHCCCCCCCH
Q ss_conf 778478559999267477765543456---------------6765688--89998775323689999998489999734
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVKN---------------VGERSEN--ETCGPESDVYCFGVILMELLTGKRGTDDC 620 (690)
Q Consensus 558 k~~Nill~~~~~~ki~dfGl~~~~~~~---------------~~e~~~~--~~~~~~~DVwSfGvil~el~tg~~p~~~~ 620 (690)
||+|||++.++.+||+|||+++..... +||.... ..++.++||||+||++|||++|+.||...
T Consensus 156 Kp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~ 235 (322)
T d1vzoa_ 156 KLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVD 235 (322)
T ss_dssp CGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCT
T ss_pred CCCCEEECCCCCEEEEECCCHHHHCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 73201246999888741320222034444322122233333106876057768871325177779999997689998888
Q ss_pred -----HHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCC-----CHHHHHH
Q ss_conf -----899999999368997543011169999899999999998330189999999-----9999999
Q 005572 621 -----VKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRP-----TMQQVLG 678 (690)
Q Consensus 621 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RP-----s~~~i~~ 678 (690)
............ +..+...+ . .+.+++.+||+.||++|| |++|+++
T Consensus 236 ~~~~~~~~i~~~~~~~~------~~~~~~~s---~---~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 236 GEKNSQAEISRRILKSE------PPYPQEMS---A---LAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp TSCCCHHHHHHHHHHCC------CCCCTTSC---H---HHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred CHHHHHHHHHHHCCCCC------CCCCCCCC---H---HHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 77779999998335689------98865479---9---999999997445898819997450999974
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=285.40 Aligned_cols=242 Identities=18% Similarity=0.170 Sum_probs=180.7
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCCEEEEEEC------CCE
Q ss_conf 067987600457972289998-399937999993046899--97899999999872589981012128963------981
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGI--DHDDAVAMFDELSRLKHPNLLPLAGYCIA------GKE 477 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~--~~~~~~~e~~~l~~l~H~niv~l~g~~~~------~~~ 477 (690)
++|++.+.||+|+||+||+|+ ..++..||||++...... ....+.+|+.+++.++||||+++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 48999715899776653008999999777888877899999977789998997899999999998887643069888787
Q 005572 478 KLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHL 557 (690)
Q Consensus 478 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dl 557 (690)
.++|||||.+| +.+.+.. .+++..+..++.|++.||.|||+.+++||||
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~------------------------------~~~~~~i~~~~~qil~gl~~LH~~giiHrDl 145 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM------------------------------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDL 145 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS------------------------------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEEEECCCHH-HHHHHHC------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCC
T ss_conf 69998414467-7876503------------------------------8999999999999999998865221124567
Q ss_pred CCCCEEECCCCCCEECCCCCCCCCCC-------------CCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCH--HH
Q ss_conf 77847855999926747776554345-------------6676568889998775323689999998489999734--89
Q 005572 558 VTSSILLAESLEPKIAGFGLRNIGVK-------------NVGERSENETCGPESDVYCFGVILMELLTGKRGTDDC--VK 622 (690)
Q Consensus 558 k~~Nill~~~~~~ki~dfGl~~~~~~-------------~~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~~~--~~ 622 (690)
||+|||++.++.+|++|||+++.... .+||...+..+++++||||+||++|||++|+.||... ..
T Consensus 146 KP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~ 225 (355)
T d2b1pa1 146 KPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225 (355)
T ss_dssp CGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred CCCCCCCCCCCCEEEECHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHH
T ss_conf 76321136544313201023211466655332214655558133147777877433356625789865989988897788
Q ss_pred HHHHHH----------------------HHCCC-CCCCCCCCC---CCCCCC---HHHHHHHHHHHHHHCCCCCCCCCCH
Q ss_conf 999999----------------------93689-975430111---699998---9999999999833018999999999
Q 005572 623 WVRKLV----------------------KEGAG-GDALDFRLK---LGSGDS---VAEMVESLRVGYLCTADSPGKRPTM 673 (690)
Q Consensus 623 ~~~~~~----------------------~~~~~-~~~~~~~~~---~~~~~~---~~~~~~~~~i~~~C~~~dP~~RPs~ 673 (690)
...... ..... .....+... ...... ......+.+++.+|++.||++|||+
T Consensus 226 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta 305 (355)
T d2b1pa1 226 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305 (355)
T ss_dssp HHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHHCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCH
T ss_conf 99999972058987999876566777764175435666421264333543210133379999999999876994579089
Q ss_pred HHHHHH
Q ss_conf 999999
Q 005572 674 QQVLGL 679 (690)
Q Consensus 674 ~~i~~~ 679 (690)
.|+++.
T Consensus 306 ~elL~H 311 (355)
T d2b1pa1 306 DDALQH 311 (355)
T ss_dssp HHHHTS
T ss_pred HHHHCC
T ss_conf 999669
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=286.10 Aligned_cols=241 Identities=13% Similarity=0.128 Sum_probs=185.4
Q ss_pred CCCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCC-CCCCCEEEEEECCCEEEEEEEE
Q ss_conf 067987600457972289998-39993799999304689997899999999872589-9810121289639814899971
Q 005572 407 SHFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKH-PNLLPLAGYCIAGKEKLVLLEF 484 (690)
Q Consensus 407 ~~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-~niv~l~g~~~~~~~~~lv~e~ 484 (690)
++|.+.+.||+|+||.||+|+ ..++..||||++.... ....+.+|++++..++| +|++.+++++......++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 80699799841788299999998899799999975025--8299999999999964899987799996018811799996
Q ss_pred CCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEE
Q ss_conf 58997766530089999997778888778999999777899989978999999999988876430698887877784785
Q 005572 485 MANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGSTHGHLVTSSILL 564 (690)
Q Consensus 485 ~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill 564 (690)
+ +|+|.++++.. ...+++.++..++.|++.||+|||+.+++||||||+|||+
T Consensus 83 ~-~~~l~~~~~~~---------------------------~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili 134 (293)
T d1csna_ 83 L-GPSLEDLLDLC---------------------------GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 134 (293)
T ss_dssp C-CCBHHHHHHHT---------------------------TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred C-CCCHHHHHHHH---------------------------CCCHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEE
T ss_conf 4-88879999752---------------------------0311068999999999999999997796626677131523
Q ss_pred CC-----CCCCEECCCCCCCCCCCC---------------------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCC
Q ss_conf 59-----999267477765543456---------------------6765688899987753236899999984899997
Q 005572 565 AE-----SLEPKIAGFGLRNIGVKN---------------------VGERSENETCGPESDVYCFGVILMELLTGKRGTD 618 (690)
Q Consensus 565 ~~-----~~~~ki~dfGl~~~~~~~---------------------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~p~~ 618 (690)
+. ++.+|++|||+++..... +||...+..++.++||||||+++|||+||+.||.
T Consensus 135 ~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~ 214 (293)
T d1csna_ 135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214 (293)
T ss_dssp CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred CCCCCCCCCCEEECCCCEEEECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 47543447956872366057714676654111024676277510267989648888869998983199999986987678
Q ss_pred C-----HHHHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC
Q ss_conf 3-----489999999936899754301116999989999999999833018999999999999999721289
Q 005572 619 D-----CVKWVRKLVKEGAGGDALDFRLKLGSGDSVAEMVESLRVGYLCTADSPGKRPTMQQVLGLLKDIRP 685 (690)
Q Consensus 619 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~C~~~dP~~RPs~~~i~~~L~~i~~ 685 (690)
. ............... ....+.... +. .+.+++..||..+|++||+++.+.+.|+++..
T Consensus 215 ~~~~~~~~~~~~~i~~~~~~~--~~~~l~~~~---p~---~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~ 278 (293)
T d1csna_ 215 GLKAATNKQKYERIGEKKQST--PLRELCAGF---PE---EFYKYMHYARNLAFDATPDYDYLQGLFSKVLE 278 (293)
T ss_dssp SCCSCCHHHHHHHHHHHHHHS--CHHHHTTTS---CH---HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHHCCCCC--CHHHHCCCC---CH---HHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH
T ss_conf 853021999999997056799--958965799---89---99999999843993008599999999999999
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.4e-43 Score=249.43 Aligned_cols=251 Identities=19% Similarity=0.161 Sum_probs=174.6
Q ss_pred CCCCCCEECCCCCCCEEEEE-CCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCC-----------CCCCCCEEEEEEC-
Q ss_conf 67987600457972289998-3999379999930468999789999999987258-----------9981012128963-
Q 005572 408 HFGKESLLAEGRCGPVYRAV-LPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-----------HPNLLPLAGYCIA- 474 (690)
Q Consensus 408 ~~~~~~~ig~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------H~niv~l~g~~~~- 474 (690)
+|.+.+.||+|+||.||+|+ ..++..||||+++... ...+.+.+|+++++.++ |+||+++++++..
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEEC
T ss_conf 5799899750778189999999999799999983431-336899999999998401455555422767647899876312
Q ss_pred -CCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCC
Q ss_conf -981489997158997766530089999997778888778999999777899989978999999999988876430-698
Q 005572 475 -GKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHH-VGS 552 (690)
Q Consensus 475 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~ 552 (690)
....+++++++..+......... .....+++..+..++.|++.||.|||+ .++
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~i~~i~~qil~al~~lh~~~~I 147 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKK-------------------------YEHRGIPLIYVKQISKQLLLGLDYMHRRCGI 147 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHH-------------------------TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCE
T ss_pred CCCCEEEEEEECCCCCCCCCCCCC-------------------------CCCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 565202343200035420000012-------------------------2346786899999999999998887640586
Q ss_pred CCCCCCCCCEEECCCC------CCEECCCCCCCCCCCC-----------CCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC
Q ss_conf 8878777847855999------9267477765543456-----------6765688899987753236899999984899
Q 005572 553 THGHLVTSSILLAESL------EPKIAGFGLRNIGVKN-----------VGERSENETCGPESDVYCFGVILMELLTGKR 615 (690)
Q Consensus 553 ~H~dlk~~Nill~~~~------~~ki~dfGl~~~~~~~-----------~~e~~~~~~~~~~~DVwSfGvil~el~tg~~ 615 (690)
+||||||+|||++.++ .+|++|||.+...... +||......++.++||||+||+++||++|+.
T Consensus 148 vHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 148 IHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp ECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCCHHHEEEECCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCC
T ss_conf 46567705705630576564430567531442123445422366521057132146677764320123789999987889
Q ss_pred CCCCHH--------HHHHHHHHH-CCC---------------------CCCCC-------CCCCCCCCCCHHHHHHHHHH
Q ss_conf 997348--------999999993-689---------------------97543-------01116999989999999999
Q 005572 616 GTDDCV--------KWVRKLVKE-GAG---------------------GDALD-------FRLKLGSGDSVAEMVESLRV 658 (690)
Q Consensus 616 p~~~~~--------~~~~~~~~~-~~~---------------------~~~~~-------~~~~~~~~~~~~~~~~~~~i 658 (690)
||.... ......... +.. ..... ..............-.+.++
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHH
T ss_conf 98987554321026899999998379987886245322000132012202432357764442100015674358999999
Q ss_pred HHHHCCCCCCCCCCHHHHHHH--HHCCC
Q ss_conf 833018999999999999999--72128
Q 005572 659 GYLCTADSPGKRPTMQQVLGL--LKDIR 684 (690)
Q Consensus 659 ~~~C~~~dP~~RPs~~~i~~~--L~~i~ 684 (690)
+.+|+..||.+|||+.|+++. +++..
T Consensus 308 l~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 308 LSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHHCCCCHHHCCCHHHHHCCCCCCCCC
T ss_conf 9998779945790899996693407898
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.94 E-value=6.9e-27 Score=160.89 Aligned_cols=183 Identities=21% Similarity=0.352 Sum_probs=126.6
Q ss_pred CCCCEEECCCCCCCCC--CCHHHHCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9903998139988987--8556542999745876437-868888970003885575897207408873599999989999
Q 005572 58 TPIRELNLSSRNLSGI--ISWKFLRNMSELHSIDLSN-NSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPF 134 (690)
Q Consensus 58 ~~L~~L~L~~N~l~~~--~~~~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l 134 (690)
.++++|+|++|+++|. +| ..++++++|++|+|++ |+++|.+|..+..+++|++|+|++|++.+.. +..+..+
T Consensus 50 ~~v~~L~L~~~~l~g~~~lp-~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~----~~~~~~~ 124 (313)
T d1ogqa_ 50 YRVNNLDLSGLNLPKPYPIP-SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAI----PDFLSQI 124 (313)
T ss_dssp CCEEEEEEECCCCSSCEECC-GGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEEC----CGGGGGC
T ss_pred EEEEEEECCCCCCCCCCCCC-HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCC----CCCCCCH
T ss_conf 79889989899888888798-478467533520202654333002431145420011020356434433----2222201
Q ss_pred CCCCEEECCCCCCCCC--CCCCCCCCCCEEECCCCCCC-CCCCC------------------------------------
Q ss_conf 9975998558989996--34689999759993389985-47956------------------------------------
Q 005572 135 PSVQVLNLSSNRFTNL--VKLSQFSKLMVLDVSNNDLR-ILPSG------------------------------------ 175 (690)
Q Consensus 135 ~~L~~L~Ls~N~l~~~--~~~~~~~~L~~L~Ls~N~l~-~~p~~------------------------------------ 175 (690)
..|+.++++.|.+... ..+..++.++.+++++|.+. .+|..
T Consensus 125 ~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l 204 (313)
T d1ogqa_ 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL 204 (313)
T ss_dssp TTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEEC
T ss_pred HHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 11001111224555568512206740000002355335620312144311232310224643533243322222223333
Q ss_pred ------------CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCC
Q ss_conf ------------88887786887315868767887334222442103135377779999999999789980179775633
Q 005572 176 ------------FANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFV 243 (690)
Q Consensus 176 ------------~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~ 243 (690)
+..+..++.+++++|.+.+.++.+..+++|+.|+|++|+++|.+|..|..+++|+.|++++|+++|.+
T Consensus 205 ~~~~~~~~~~~~~~~~~~l~~l~~~~~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~i 284 (313)
T d1ogqa_ 205 SRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI 284 (313)
T ss_dssp CSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEEC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCC
T ss_conf 33433222222222222211122222222222222224554444447657066608768847999998979588351668
Q ss_pred CC
Q ss_conf 96
Q 005572 244 GH 245 (690)
Q Consensus 244 ~~ 245 (690)
|.
T Consensus 285 P~ 286 (313)
T d1ogqa_ 285 PQ 286 (313)
T ss_dssp CC
T ss_pred CC
T ss_conf 98
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.1e-24 Score=148.83 Aligned_cols=178 Identities=23% Similarity=0.260 Sum_probs=149.9
Q ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99039981399889878556542999745876437868888970003885575897207408873599999989999997
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137 (690)
Q Consensus 58 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L 137 (690)
++++.|+|++|+|+++.+ ..+..+++|+.|+|++|+|+.. | .+..+++|+.|+|++|+++.. +..+..+++|
T Consensus 31 ~~l~~L~Ls~N~i~~l~~-~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~~~-----~~~~~~l~~L 102 (266)
T d1p9ag_ 31 KDTTILHLSENLLYTFSL-ATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQSL-----PLLGQTLPAL 102 (266)
T ss_dssp TTCCEEECTTSCCSEEEG-GGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCSSC-----CCCTTTCTTC
T ss_pred CCCCEEECCCCCCCCCCH-HHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCC
T ss_conf 688989884992898597-7863456552213566544443-1-111122321111122222111-----1121222222
Q ss_pred CEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCC
Q ss_conf 59985589899963--468999975999338998547956-88887786887315868767887-334222442103135
Q 005572 138 QVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLRILPSG-FANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNN 213 (690)
Q Consensus 138 ~~L~Ls~N~l~~~~--~~~~~~~L~~L~Ls~N~l~~~p~~-~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N 213 (690)
+.|++++|.+..+. .+..+.+++.|++++|.+..++.. +..+..|+.+++++|++++..+. +..+++|+.|+|++|
T Consensus 103 ~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N 182 (266)
T d1p9ag_ 103 TVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182 (266)
T ss_dssp CEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSS
T ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCC
T ss_conf 22222223110110011222211112212434210221233322111000000015652237200134212423430139
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf 3777799999999997899801797756339
Q 005572 214 SMNGTFPSDFPPLSGVKFLNISLNKFTGFVG 244 (690)
Q Consensus 214 ~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~~ 244 (690)
.|+ .+|..+..+.+|+.|++++|++.....
T Consensus 183 ~L~-~lp~~~~~~~~L~~L~L~~Np~~CdC~ 212 (266)
T d1p9ag_ 183 SLY-TIPKGFFGSHLLPFAFLHGNPWLCNCE 212 (266)
T ss_dssp CCC-CCCTTTTTTCCCSEEECCSCCBCCSGG
T ss_pred CCC-CCCHHHCCCCCCCEEEECCCCCCCCCC
T ss_conf 785-568667778889999836999878864
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=1.4e-26 Score=159.17 Aligned_cols=155 Identities=19% Similarity=0.147 Sum_probs=112.0
Q ss_pred CCCEECCCCCCCEEEEECCCCCEEEEEEEECCCCC-------------C-----HHHHHHHHHHHHHCCCCCCCCEEEEE
Q ss_conf 87600457972289998399937999993046899-------------9-----78999999998725899810121289
Q 005572 411 KESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGI-------------D-----HDDAVAMFDELSRLKHPNLLPLAGYC 472 (690)
Q Consensus 411 ~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~-------------~-----~~~~~~e~~~l~~l~H~niv~l~g~~ 472 (690)
+.+.||+|+||.||+|...++..||||+++..... . ......|...+.++.|++++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC
T ss_conf 27780248565999999799999999998604434666556563000888999999778999999981699914499862
Q ss_pred ECCCEEEEEEEECCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCC
Q ss_conf 63981489997158997766530089999997778888778999999777899989978999999999988876430698
Q 005572 473 IAGKEKLVLLEFMANGDLHRWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTNWVTRHRIAIGVARGLAYLHHVGS 552 (690)
Q Consensus 473 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~ 552 (690)
. .+++|||++++.+.++ +......++.|++.++.|||+.++
T Consensus 84 ~----~~lvme~~~~~~~~~l-----------------------------------~~~~~~~i~~ql~~~l~~lH~~gi 124 (191)
T d1zara2 84 G----NAVLMELIDAKELYRV-----------------------------------RVENPDEVLDMILEEVAKFYHRGI 124 (191)
T ss_dssp T----TEEEEECCCCEEGGGC-----------------------------------CCSCHHHHHHHHHHHHHHHHHTTE
T ss_pred C----CEEEEEEECCCCCCCH-----------------------------------HHHHHHHHHHHHHHHHHHHHHCCE
T ss_conf 8----8899995045654200-----------------------------------157899999999999999826888
Q ss_pred CCCCCCCCCEEECCCCCCEECCCCCCCCCCCC-CCCCCC----------CCCCCCCCCCHHHHH
Q ss_conf 88787778478559999267477765543456-676568----------889998775323689
Q 005572 553 THGHLVTSSILLAESLEPKIAGFGLRNIGVKN-VGERSE----------NETCGPESDVYCFGV 605 (690)
Q Consensus 553 ~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~-~~e~~~----------~~~~~~~~DVwSfGv 605 (690)
+||||||+|||++++ .++++|||.+.....+ +.+... ...++.++|+||..-
T Consensus 125 iHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~ 187 (191)
T d1zara2 125 VHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYRTEKDINSAID 187 (191)
T ss_dssp ECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred EECCCCHHHEEEECC-CEEEEECCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
T ss_conf 983689036114289-899987788430899870999987799999997578998446899999
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-24 Score=148.88 Aligned_cols=182 Identities=21% Similarity=0.257 Sum_probs=139.8
Q ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCCC
Q ss_conf 99039981399889878556542999745876437868888970003885575897207-40887359999998999999
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSK-NRFGGTIGFKPTSRNGPFPS 136 (690)
Q Consensus 58 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~i~~~~~~~~~~l~~ 136 (690)
+.++.|+|++|+|+.+.+ ..+..++.|+.|++++|.+....+..+..+..+..+.... |.++.. .+..+..+++
T Consensus 32 ~~~~~L~Ls~N~i~~i~~-~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~l----~~~~~~~l~~ 106 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPA-ASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSV----DPATFHGLGR 106 (284)
T ss_dssp TTCSEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCC----CTTTTTTCTT
T ss_pred CCCCEEECCCCCCCCCCH-HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----CCHHHCCCCC
T ss_conf 998889774881798797-78641421300001344543321112122222222222210223544----6201010102
Q ss_pred CCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCC
Q ss_conf 759985589899963--46899997599933899854795-688887786887315868767887-33422244210313
Q 005572 137 VQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLRILPS-GFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSN 212 (690)
Q Consensus 137 L~~L~Ls~N~l~~~~--~~~~~~~L~~L~Ls~N~l~~~p~-~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~ 212 (690)
|++|+++.|.+.... .+....+|+.+++++|.++.+|+ .|..+.+|+.|++++|.++...+. +..+++|+.+++++
T Consensus 107 L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~ 186 (284)
T d1ozna_ 107 LHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQ 186 (284)
T ss_dssp CCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCS
T ss_pred CCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCCCCCHHHHHH
T ss_conf 77875688544320135332000121102001431445805740434050223141765662566654656341314211
Q ss_pred CCCCCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf 53777799999999997899801797756339
Q 005572 213 NSMNGTFPSDFPPLSGVKFLNISLNKFTGFVG 244 (690)
Q Consensus 213 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~~ 244 (690)
|.+.+..|..|..++++++|++++|.+.+..+
T Consensus 187 N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~ 218 (284)
T d1ozna_ 187 NRVAHVHPHAFRDLGRLMTLYLFANNLSALPT 218 (284)
T ss_dssp SCCCEECTTTTTTCTTCCEEECCSSCCSCCCH
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCC
T ss_conf 43466281676653200023333352210000
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=99.92 E-value=9.5e-26 Score=154.68 Aligned_cols=175 Identities=20% Similarity=0.327 Sum_probs=82.0
Q ss_pred CCCCEEECCC-CCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 9903998139-988987855654299974587643786888897000388557589720740887359999998999999
Q 005572 58 TPIRELNLSS-RNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS 136 (690)
Q Consensus 58 ~~L~~L~L~~-N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~ 136 (690)
+.|+.|+|++ |+++|.+|. .++++++|++|+|++|++++..+..+..+..|+.++++.|++.+.+ +..+..++.
T Consensus 76 ~~L~~L~Ls~~N~l~g~iP~-~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~----p~~l~~l~~ 150 (313)
T d1ogqa_ 76 PYLNFLYIGGINNLVGPIPP-AIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL----PPSISSLPN 150 (313)
T ss_dssp TTCSEEEEEEETTEESCCCG-GGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCC----CGGGGGCTT
T ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC----CHHHCCCCC
T ss_conf 53352020265433300243-1145420011020356434433222220111001111224555568----512206740
Q ss_pred CCEEECCCCCCCC-------------------------CC-------------------------CCCCCCCCCEEECCC
Q ss_conf 7599855898999-------------------------63-------------------------468999975999338
Q 005572 137 VQVLNLSSNRFTN-------------------------LV-------------------------KLSQFSKLMVLDVSN 166 (690)
Q Consensus 137 L~~L~Ls~N~l~~-------------------------~~-------------------------~~~~~~~L~~L~Ls~ 166 (690)
++.+++++|.+++ .. .+..+++++.+++++
T Consensus 151 L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~~~~ 230 (313)
T d1ogqa_ 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAK 230 (313)
T ss_dssp CCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEECCS
T ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 00000235533562031214431123231022464353324332222222333333433222222222222211122222
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCC
Q ss_conf 99854795688887786887315868767887-3342224421031353777799999999997899801797
Q 005572 167 NDLRILPSGFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNK 238 (690)
Q Consensus 167 N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~ 238 (690)
|.+...+..+..+++|+.|++++|++++.+|. +..+++|+.|+|++|+++|.+| .+..+++|+.+++++|+
T Consensus 231 ~~l~~~~~~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP-~~~~L~~L~~l~l~~N~ 302 (313)
T d1ogqa_ 231 NSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNK 302 (313)
T ss_dssp SEECCBGGGCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECC-CSTTGGGSCGGGTCSSS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCC-CCCCCCCCCHHHHCCCC
T ss_conf 2222222222245544444476570666087688479999989795883516689-86667998978868895
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=3.9e-23 Score=140.38 Aligned_cols=180 Identities=23% Similarity=0.268 Sum_probs=151.0
Q ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99903998139988987855654299974587643786888897000388557589720740887359999998999999
Q 005572 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS 136 (690)
Q Consensus 57 ~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~ 136 (690)
...+.+++.++++|+.+++ . +. +.++.|+|++|.|++..+..|..+++|+.|+|++|+++.. +.++.+++
T Consensus 9 ~~~~~~v~C~~~~L~~iP~-~-lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l------~~~~~l~~ 78 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLTALPP-D-LP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL------QVDGTLPV 78 (266)
T ss_dssp STTCCEEECTTSCCSSCCS-C-CC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE------ECCSCCTT
T ss_pred CCCCEEEECCCCCCCEECC-C-CC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC------CCCCCCCC
T ss_conf 6898699806999886196-7-57--6889898849928985977863456552213566544443------11111223
Q ss_pred CCEEECCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCC
Q ss_conf 759985589899963-4689999759993389985479-5688887786887315868767887-334222442103135
Q 005572 137 VQVLNLSSNRFTNLV-KLSQFSKLMVLDVSNNDLRILP-SGFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNN 213 (690)
Q Consensus 137 L~~L~Ls~N~l~~~~-~~~~~~~L~~L~Ls~N~l~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N 213 (690)
|++|++++|+++..+ .+..+++|+.|++++|.+..++ ..+..+.++..|++++|.+....+. +..++.|+.+++++|
T Consensus 79 L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N 158 (266)
T d1p9ag_ 79 LGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANN 158 (266)
T ss_dssp CCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCC
T ss_conf 21111122222111112122222222222223110110011222211112212434210221233322111000000015
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCHH
Q ss_conf 3777799999999997899801797756339614
Q 005572 214 SMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHDK 247 (690)
Q Consensus 214 ~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~~~~~ 247 (690)
++++..+..|..+++|+.|++++|+++ .+|...
T Consensus 159 ~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~ 191 (266)
T d1p9ag_ 159 NLTELPAGLLNGLENLDTLLLQENSLY-TIPKGF 191 (266)
T ss_dssp CCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTT
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCC-CCCHHH
T ss_conf 652237200134212423430139785-568667
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=7.6e-23 Score=138.83 Aligned_cols=221 Identities=17% Similarity=0.212 Sum_probs=177.3
Q ss_pred CCCCCCHHHHHHHHH-CCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECC-CCCCC
Q ss_conf 255861054158751-489866203589888767--88999903998139988987855654299974587643-78688
Q 005572 21 STCNSKDQELVSKAF-SSVSTFNISWLKPTNLNG--SNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLS-NNSLK 96 (690)
Q Consensus 21 ~~c~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls-~N~l~ 96 (690)
+.|.......++..+ ..+..++++......+.. ....+.|+.|++++|++..+.+. .+..+..+..++.+ .|.++
T Consensus 16 v~c~~~~L~~iP~~ip~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~-~~~~~~~~~~l~~~~~~~~~ 94 (284)
T d1ozna_ 16 TSCPQQGLQAVPVGIPAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAA-AFTGLALLEQLDLSDNAQLR 94 (284)
T ss_dssp EECCSSCCSSCCTTCCTTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTT-TTTTCTTCCEEECCSCTTCC
T ss_pred EECCCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC
T ss_conf 98479998944978899988897748817987977864142130000134454332111-21222222222222102235
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCC-
Q ss_conf 88970003885575897207408873599999989999997599855898999634--689999759993389985479-
Q 005572 97 GSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILP- 173 (690)
Q Consensus 97 ~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~L~~L~Ls~N~l~~~p- 173 (690)
...+..|.++++|+.|++++|.+.... ...+....+|+.+++++|+++.++. +..+++|+.|++++|.+..++
T Consensus 95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~----~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~ 170 (284)
T d1ozna_ 95 SVDPATFHGLGRLHTLHLDRCGLQELG----PGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPE 170 (284)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCC----TTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECT
T ss_pred CCCCHHHCCCCCCCEEECCCCCCCCCC----CCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCH
T ss_conf 446201010102778756885443201----3533200012110200143144580574043405022314176566256
Q ss_pred CCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCH
Q ss_conf 5688887786887315868767887-334222442103135377779999999999789980179775633961
Q 005572 174 SGFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVGHD 246 (690)
Q Consensus 174 ~~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~~~~ 246 (690)
..|..+++|+.+++++|.+++..+. +..+++|+.|++++|.+.+..+..|..+.+|+.+++++|++.+..+..
T Consensus 171 ~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~~~ 244 (284)
T d1ozna_ 171 RAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRAR 244 (284)
T ss_dssp TTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGGGH
T ss_pred HHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCH
T ss_conf 66546563413142114346628167665320002333335221000002355465688981199887875646
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=2.1e-22 Score=136.42 Aligned_cols=201 Identities=21% Similarity=0.367 Sum_probs=115.9
Q ss_pred HHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 75148986620358988876788999903998139988987855654299974587643786888897000388557589
Q 005572 33 KAFSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQV 112 (690)
Q Consensus 33 ~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 112 (690)
..+..+..++++...+..+.|....++|+.|+|++|+|+++.+ ++.+++|++|++++|.+++..+ +..+++|+.|
T Consensus 41 ~~l~~l~~L~l~~~~I~~l~gl~~L~nL~~L~Ls~N~l~~l~~---l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L 115 (384)
T d2omza2 41 TDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP---LKNLTKLVDILMNNNQIADITP--LANLTNLTGL 115 (384)
T ss_dssp HHHTTCCEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG---GTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEE
T ss_pred HHHCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf 8957878998999898776242458999989681881798863---3477110103013433322221--1123343334
Q ss_pred ECCCCCCCCCCCCCCCC-------------------------------------CCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 72074088735999999-------------------------------------89999997599855898999634689
Q 005572 113 NLSKNRFGGTIGFKPTS-------------------------------------RNGPFPSVQVLNLSSNRFTNLVKLSQ 155 (690)
Q Consensus 113 ~L~~N~l~~~i~~~~~~-------------------------------------~~~~l~~L~~L~Ls~N~l~~~~~~~~ 155 (690)
++++|.+++........ .+.............|..........
T Consensus 116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (384)
T d2omza2 116 TLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAK 195 (384)
T ss_dssp ECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCGGGGG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 43322222222222222221121346631310023222211222221232201111245421101122243332110022
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf 99975999338998547956888877868873158687678873342224421031353777799999999997899801
Q 005572 156 FSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235 (690)
Q Consensus 156 ~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~ 235 (690)
++++..+++++|.++.+++ +....+|+.|++++|.++. ++.+..+++|+.|++++|.+++..+ +..+++|+.++++
T Consensus 196 l~~~~~l~l~~n~i~~~~~-~~~~~~L~~L~l~~n~l~~-~~~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~ 271 (384)
T d2omza2 196 LTNLESLIATNNQISDITP-LGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLG 271 (384)
T ss_dssp CTTCSEEECCSSCCCCCGG-GGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECC
T ss_pred CCCCCEEECCCCCCCCCCC-CCCCCCCCEEECCCCCCCC-CCHHHCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECC
T ss_conf 3532333035774478786-4445778788887777789-6134325653410044674478775--3554668775456
Q ss_pred CCCCCCC
Q ss_conf 7977563
Q 005572 236 LNKFTGF 242 (690)
Q Consensus 236 ~N~l~g~ 242 (690)
.|.+++.
T Consensus 272 ~~~l~~~ 278 (384)
T d2omza2 272 ANQISNI 278 (384)
T ss_dssp SSCCCCC
T ss_pred CCCCCCC
T ss_conf 7445787
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.90 E-value=5.7e-22 Score=134.02 Aligned_cols=181 Identities=18% Similarity=0.232 Sum_probs=105.4
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--------------
Q ss_conf 903998139988987855654299974587643786888897000388557589720740887359--------------
Q 005572 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIG-------------- 124 (690)
Q Consensus 59 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~-------------- 124 (690)
.++.|+|++|+|+.+.+. .+..+++|+.|++++|.+....|..|..+++|+.|++++|+++....
T Consensus 32 ~l~~L~Ls~N~i~~l~~~-~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~n~l~~l~~~~~~~l~~L~~~~n 110 (305)
T d1xkua_ 32 DTALLDLQNNKITEIKDG-DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHEN 110 (305)
T ss_dssp TCCEEECCSSCCCCBCTT-TTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCSBCCSSCCTTCCEEECCSS
T ss_pred CCCEEECCCCCCCCCCHH-HHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCCCCCCCCCCCHHHHHHHHHCCCC
T ss_conf 979897849918986965-7604656523112344344523566527985578315687567676400111323210246
Q ss_pred -----------------------------CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCC
Q ss_conf -----------------------------99999899999975998558989996346899997599933899854-795
Q 005572 125 -----------------------------FKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRI-LPS 174 (690)
Q Consensus 125 -----------------------------~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~-~p~ 174 (690)
......+..+++|+.++++.|+++.++. ..+++|+.|++++|.... .+.
T Consensus 111 ~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l~~-~~~~~L~~L~l~~n~~~~~~~~ 189 (305)
T d1xkua_ 111 EITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQ-GLPPSLTELHLDGNKITKVDAA 189 (305)
T ss_dssp CCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSCCS-SCCTTCSEEECTTSCCCEECTG
T ss_pred CHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCEEECCCCCCCCCCHH
T ss_conf 102344445401331100001233333467776422345656712034677451671-0177667898978867788826
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf 688887786887315868767887-33422244210313537777999999999978998017977563
Q 005572 175 GFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGF 242 (690)
Q Consensus 175 ~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~ 242 (690)
.+..++.++.|++++|.+.+..+. +..+++|+.|+|++|.++ .+|.+|..+++|+.|++++|+++..
T Consensus 190 ~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i 257 (305)
T d1xkua_ 190 SLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI 257 (305)
T ss_dssp GGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred HHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC
T ss_conf 7641341330154455332223454334433224302554002-4631103346789898989865763
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=2.2e-22 Score=136.29 Aligned_cols=174 Identities=20% Similarity=0.301 Sum_probs=123.8
Q ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99903998139988987855654299974587643786888897000388557589720740887359999998999999
Q 005572 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS 136 (690)
Q Consensus 57 ~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~ 136 (690)
..+|++|++++++++.+. .+..+++|++|++++|+|++..| +..+++|+.|++++|++.+.. .++.+++
T Consensus 43 l~~l~~L~l~~~~I~~l~---gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~------~l~~l~~ 111 (384)
T d2omza2 43 LDQVTTLQADRLGIKSID---GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT------PLANLTN 111 (384)
T ss_dssp HTTCCEEECCSSCCCCCT---TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG------GGTTCTT
T ss_pred HCCCCEEECCCCCCCCCC---CCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC------CCCCCCC
T ss_conf 578789989998987762---42458999989681881798863--347711010301343332222------1112334
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCC------------------------------------------CCC
Q ss_conf 75998558989996346899997599933899854------------------------------------------795
Q 005572 137 VQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRI------------------------------------------LPS 174 (690)
Q Consensus 137 L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~------------------------------------------~p~ 174 (690)
|+.|++++|.+++.........+..+....|.+.. ...
T Consensus 112 L~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (384)
T d2omza2 112 LTGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191 (384)
T ss_dssp CCEEECCSSCCCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSSCCCCCG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCC
T ss_conf 33344332222222222222222112134663131002322221122222123220111124542110112224333211
Q ss_pred CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf 6888877868873158687678873342224421031353777799999999997899801797756339
Q 005572 175 GFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVG 244 (690)
Q Consensus 175 ~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~~ 244 (690)
.+..++++..+++++|.+++. ++.....+|+.|++++|.++.. ..+..+++++.+++++|.+++..+
T Consensus 192 ~~~~l~~~~~l~l~~n~i~~~-~~~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~~ 258 (384)
T d2omza2 192 VLAKLTNLESLIATNNQISDI-TPLGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP 258 (384)
T ss_dssp GGGGCTTCSEEECCSSCCCCC-GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGG
T ss_pred CCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCCC
T ss_conf 002235323330357744787-8644457787888877777896--134325653410044674478775
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.87 E-value=2.5e-20 Score=125.05 Aligned_cols=212 Identities=20% Similarity=0.256 Sum_probs=116.0
Q ss_pred CCCCCCHHHHHHHHH-CCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC
Q ss_conf 255861054158751-489866203589888767--88999903998139988987855654299974587643786888
Q 005572 21 STCNSKDQELVSKAF-SSVSTFNISWLKPTNLNG--SNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKG 97 (690)
Q Consensus 21 ~~c~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~ 97 (690)
+.|+......++..+ .++..+++++.....+.. ....++|+.|++++|.+..+.+ ..+..++.|+.|++++|+++.
T Consensus 15 ~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~-~~f~~l~~L~~L~l~~n~l~~ 93 (305)
T d1xkua_ 15 VQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISP-GAFAPLVKLERLYLSKNQLKE 93 (305)
T ss_dssp EECTTSCCCSCCCSCCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCT-TTTTTCTTCCEEECCSSCCSB
T ss_pred EEECCCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCH-HHHHCCCCCCEECCCCCCCCC
T ss_conf 9855999885198889997989784991898696576046565231123443445235-665279855783156875676
Q ss_pred CCC-----------------------------------------------CCCCCCCCCCEEECCCCCCCCCCCCCCCCC
Q ss_conf 897-----------------------------------------------000388557589720740887359999998
Q 005572 98 SVP-----------------------------------------------GWFWSTQSLTQVNLSKNRFGGTIGFKPTSR 130 (690)
Q Consensus 98 ~~p-----------------------------------------------~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~ 130 (690)
... ..+..+++|+.+++++|.+... +
T Consensus 94 l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~~l-----~-- 166 (305)
T d1xkua_ 94 LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTI-----P-- 166 (305)
T ss_dssp CCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCSC-----C--
T ss_pred CCCCHHHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-----C--
T ss_conf 764001113232102461023444454013311000012333334677764223456567120346774516-----7--
Q ss_pred CCCCCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCE
Q ss_conf 999999759985589899963--4689999759993389985479-5688887786887315868767887334222442
Q 005572 131 NGPFPSVQVLNLSSNRFTNLV--KLSQFSKLMVLDVSNNDLRILP-SGFANLSKLRHLDISSCKISGNIKPVSFLHSLKY 207 (690)
Q Consensus 131 ~~~l~~L~~L~Ls~N~l~~~~--~~~~~~~L~~L~Ls~N~l~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~ 207 (690)
...+++++.|++++|..+... .+..++.++.|++++|.+..++ ..+..+++|+.|++++|.++.....+..+++|+.
T Consensus 167 ~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~~lp~~l~~l~~L~~ 246 (305)
T d1xkua_ 167 QGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQV 246 (305)
T ss_dssp SSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCSSCCTTTTTCSSCCE
T ss_pred CCCCCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCE
T ss_conf 10177667898978867788826764134133015445533222345433443322430255400246311033467898
Q ss_pred EECCCCCCCCCCCCCC------CCCCCCCEEEEECCCCC
Q ss_conf 1031353777799999------99999789980179775
Q 005572 208 LDVSNNSMNGTFPSDF------PPLSGVKFLNISLNKFT 240 (690)
Q Consensus 208 L~Ls~N~l~~~~p~~~------~~l~~L~~l~l~~N~l~ 240 (690)
|+|++|+++......| ..+.+|+.+++++|++.
T Consensus 247 L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~ 285 (305)
T d1xkua_ 247 VYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285 (305)
T ss_dssp EECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSC
T ss_pred EECCCCCCCCCCHHHCCCCCHHCCCCCCCEEECCCCCCC
T ss_conf 989898657638100267210021588897889899576
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=1.6e-20 Score=126.17 Aligned_cols=186 Identities=25% Similarity=0.379 Sum_probs=87.3
Q ss_pred HCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 14898662035898887678899990399813998898785565429997458764378688889700038855758972
Q 005572 35 FSSVSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNL 114 (690)
Q Consensus 35 ~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 114 (690)
+.++..+++...+...+.+....++|+.|++++|++++..+ +..++.|+.+++++|.++. ++ .+..+++|+.+++
T Consensus 40 l~~L~~L~l~~~~i~~l~~l~~l~~L~~L~ls~n~i~~~~~---l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l 114 (227)
T d1h6ua2 40 LDGITTLSAFGTGVTTIEGVQYLNNLIGLELKDNQITDLAP---LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDL 114 (227)
T ss_dssp HHTCCEEECTTSCCCCCTTGGGCTTCCEEECCSSCCCCCGG---GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEEC
T ss_pred CCCCCEEECCCCCCCCCHHHHCCCCCCEEECCCCEEECCCC---CCCCCCCCCCCCCCCCCCC-CC-CCCCCCCCCCCCC
T ss_conf 48868997779999766457448888376357853202543---1123343201211122222-22-2222222212212
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 07408873599999989999997599855898999634689999759993389985479568888778688731586876
Q 005572 115 SKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISG 194 (690)
Q Consensus 115 ~~N~l~~~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~ 194 (690)
+.+...+.. .+...+.+..+.++.+.+.....+..+++|+.|++++|.+..++. +..+++|+.|++++|.++.
T Consensus 115 ~~~~~~~~~------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~~-l~~l~~L~~L~Ls~n~l~~ 187 (227)
T d1h6ua2 115 TSTQITDVT------PLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP-LANLSKLTTLKADDNKISD 187 (227)
T ss_dssp TTSCCCCCG------GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCGG-GTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCC------HHCCCCCHHHHHCHHHHHCHHHHHCCCCCCCCCCCCCCCCCCCHH-HCCCCCCEECCCCCCCCCC
T ss_conf 224433110------000023012220000000000000102111002333333331001-0564633564458884177
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEE
Q ss_conf 78873342224421031353777799999999997899801
Q 005572 195 NIKPVSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNIS 235 (690)
Q Consensus 195 ~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~ 235 (690)
++.+..+++|+.|+|++|+++...| +..+++|+.|+++
T Consensus 188 -l~~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~ls 225 (227)
T d1h6ua2 188 -ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225 (227)
T ss_dssp -CGGGGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEE
T ss_pred -CHHHCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEE
T ss_conf -8534479999989795996899802--0369998989712
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.86 E-value=1.2e-20 Score=126.78 Aligned_cols=165 Identities=19% Similarity=0.306 Sum_probs=135.1
Q ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99903998139988987855654299974587643786888897000388557589720740887359999998999999
Q 005572 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS 136 (690)
Q Consensus 57 ~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~ 136 (690)
...|+.|++++|.++.... +..+++|+.|++++|.+++..+ +..+++|+.|++++|++++. +.+..+++
T Consensus 45 L~~L~~L~l~~~~i~~l~~---l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~~l------~~l~~l~~ 113 (210)
T d1h6ta2 45 LNSIDQIIANNSDIKSVQG---IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVKDL------SSLKDLKK 113 (210)
T ss_dssp HHTCCEEECTTSCCCCCTT---GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCG------GGGTTCTT
T ss_pred HCCCCEEECCCCCCCCCHH---HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC------CCCCCCCC
T ss_conf 5484589782798887444---7648998987698960258601--13586212014333332122------21212221
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 75998558989996346899997599933899854795688887786887315868767887334222442103135377
Q 005572 137 VQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMN 216 (690)
Q Consensus 137 L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 216 (690)
|+.|++++|.+..+..+..+++++.+++++|.+...+ .+..+++|+.+++++|.+++ ++++..+++|+.|+|++|.++
T Consensus 114 L~~L~l~~~~~~~~~~l~~l~~l~~l~~~~n~l~~~~-~~~~l~~L~~l~l~~n~l~~-i~~l~~l~~L~~L~Ls~N~i~ 191 (210)
T d1h6ta2 114 LKSLSLEHNGISDINGLVHLPQLESLYLGNNKITDIT-VLSRLTKLDTLSLEDNQISD-IVPLAGLTKLQNLYLSKNHIS 191 (210)
T ss_dssp CCEEECTTSCCCCCGGGGGCTTCCEEECCSSCCCCCG-GGGGCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCEEECCCCCCC
T ss_conf 1122345653221122011111222112223334543-10001332100134643025-645367898999989799899
Q ss_pred CCCCCCCCCCCCCCEEEEEC
Q ss_conf 77999999999978998017
Q 005572 217 GTFPSDFPPLSGVKFLNISL 236 (690)
Q Consensus 217 ~~~p~~~~~l~~L~~l~l~~ 236 (690)
. ++ .+..+++|+.|++++
T Consensus 192 ~-l~-~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 192 D-LR-ALAGLKNLDVLELFS 209 (210)
T ss_dssp B-CG-GGTTCTTCSEEEEEE
T ss_pred C-CH-HHCCCCCCCEEECCC
T ss_conf 8-72-116999989997118
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.85 E-value=6.7e-21 Score=128.20 Aligned_cols=172 Identities=19% Similarity=0.270 Sum_probs=134.2
Q ss_pred CCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 03998139988987855654299974587643786888-89700038855758972074088735999999899999975
Q 005572 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKG-SVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138 (690)
Q Consensus 60 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~ 138 (690)
.+.++.++++|+.++. . + .+.+++|+|++|.|+. ..+..|..+++|+.|+|++|.+.... +..+..+++|+
T Consensus 10 ~~~v~Cs~~~L~~iP~-~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~----~~~~~~~~~L~ 81 (192)
T d1w8aa_ 10 GTTVDCTGRGLKEIPR-D-I--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIE----PNAFEGASHIQ 81 (192)
T ss_dssp TTEEECTTSCCSSCCS-C-C--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBC----TTTTTTCTTCC
T ss_pred CCEEEEECCCCCCCCC-C-C--CCCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCC----CCCCCCCCCCC
T ss_conf 9999970899670298-9-8--9787889848987755302002578762721301363221212----12221122221
Q ss_pred EEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 99855898999634--6899997599933899854795-68888778688731586876788733422244210313537
Q 005572 139 VLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLRILPS-GFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSM 215 (690)
Q Consensus 139 ~L~Ls~N~l~~~~~--~~~~~~L~~L~Ls~N~l~~~p~-~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 215 (690)
+|+|++|+++.++. |..+++|+.|+|++|+|+.++. .|..+++|+.|++++|.+.+..........++.+.+..|.+
T Consensus 82 ~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~~~~~l~~~~l~~~~~ 161 (192)
T d1w8aa_ 82 ELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAA 161 (192)
T ss_dssp EEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHHHHHHHHHHCCSGGGC
T ss_pred EEEECCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCE
T ss_conf 01003553443497998079746552457745353597785687533420003644343530277764235403568982
Q ss_pred CCCCCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf 777999999999978998017977563
Q 005572 216 NGTFPSDFPPLSGVKFLNISLNKFTGF 242 (690)
Q Consensus 216 ~~~~p~~~~~l~~L~~l~l~~N~l~g~ 242 (690)
....|..+ .+++.++++.|.+...
T Consensus 162 ~c~~p~~l---~~~~l~~L~~n~l~C~ 185 (192)
T d1w8aa_ 162 RCGAPSKV---RDVQIKDLPHSEFKCS 185 (192)
T ss_dssp BBCSSTTT---TTSBGGGSCTTTCCCC
T ss_pred EECCCHHH---CCCEEEECCHHHCCCC
T ss_conf 76898433---6988614487557589
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.85 E-value=2.7e-20 Score=124.85 Aligned_cols=160 Identities=22% Similarity=0.378 Sum_probs=105.4
Q ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99039981399889878556542999745876437868888970003885575897207408873599999989999997
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137 (690)
Q Consensus 58 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L 137 (690)
..++.|++++|+++.+. .+..+++|++|++++|++++..| +..+++|+.|++++|.+... ..+..++.|
T Consensus 40 ~~l~~L~l~~~~i~~l~---~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~~------~~l~~l~~L 108 (199)
T d2omxa2 40 DQVTTLQADRLGIKSID---GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADI------TPLANLTNL 108 (199)
T ss_dssp TTCCEEECTTSCCCCCT---TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCC------GGGTTCTTC
T ss_pred CCCCEEECCCCCCCCCC---CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC------CCCCCCCCC
T ss_conf 68789989999997752---02137886757545655667640--16775223111122222222------111112232
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 59985589899963468999975999338998547956888877868873158687678873342224421031353777
Q 005572 138 QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNG 217 (690)
Q Consensus 138 ~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 217 (690)
+.|++++|.+.....+..+++|+.|++++|.+..++ .+..+++|+.|++++|.++. ++++..+++|+.|++++|+++.
T Consensus 109 ~~L~l~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~-~l~~~~~L~~L~l~~n~l~~-l~~l~~l~~L~~L~ls~N~i~~ 186 (199)
T d2omxa2 109 TGLTLFNNQITDIDPLKNLTNLNRLELSSNTISDIS-ALSGLTSLQQLNFSSNQVTD-LKPLANLTTLERLDISSNKVSD 186 (199)
T ss_dssp SEEECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCC-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC
T ss_conf 221112222223210001223677643111100234-33321111112234555567-7011679989999787997998
Q ss_pred CCCCCCCCCCCCCEE
Q ss_conf 799999999997899
Q 005572 218 TFPSDFPPLSGVKFL 232 (690)
Q Consensus 218 ~~p~~~~~l~~L~~l 232 (690)
. + .+..+++|+.|
T Consensus 187 i-~-~l~~L~~L~~L 199 (199)
T d2omxa2 187 I-S-VLAKLTNLESL 199 (199)
T ss_dssp C-G-GGGGCTTCSEE
T ss_pred C-C-CCCCCCCCCCC
T ss_conf 8-1-01278998949
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.84 E-value=2.4e-20 Score=125.14 Aligned_cols=163 Identities=21% Similarity=0.333 Sum_probs=91.0
Q ss_pred ECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 81399889878556542999745876437868888970003885575897207408873599999989999997599855
Q 005572 64 NLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLS 143 (690)
Q Consensus 64 ~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~~L~Ls 143 (690)
++..+.+++.++.. .+..|+.|++++|.++... + +..+++|+.|+|++|++++.. .++.+++|+.|+++
T Consensus 30 ~l~~~~~~~~~~~~---~L~~L~~L~l~~~~i~~l~-~-l~~l~~L~~L~L~~n~i~~l~------~~~~l~~L~~L~l~ 98 (210)
T d1h6ta2 30 NLKKKSVTDAVTQN---ELNSIDQIIANNSDIKSVQ-G-IQYLPNVTKLFLNGNKLTDIK------PLANLKNLGWLFLD 98 (210)
T ss_dssp HTTCSCTTSEECHH---HHHTCCEEECTTSCCCCCT-T-GGGCTTCCEEECCSSCCCCCG------GGTTCTTCCEEECC
T ss_pred HHCCCCCCCCCCHH---HHCCCCEEECCCCCCCCCH-H-HHHCCCCCEEECCCCCCCCCC------CCCCCCCCCCCCCC
T ss_conf 85757657751887---9548458978279888744-4-764899898769896025860------11358621201433
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 89899963468999975999338998547956888877868873158687678873342224421031353777799999
Q 005572 144 SNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFPSDF 223 (690)
Q Consensus 144 ~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 223 (690)
+|++++++.+..+++|+.|++++|.+..++ .+..++.++.++++.|.++. .+....+++|+.+++++|.+++.. .+
T Consensus 99 ~n~i~~l~~l~~l~~L~~L~l~~~~~~~~~-~l~~l~~l~~l~~~~n~l~~-~~~~~~l~~L~~l~l~~n~l~~i~--~l 174 (210)
T d1h6ta2 99 ENKVKDLSSLKDLKKLKSLSLEHNGISDIN-GLVHLPQLESLYLGNNKITD-ITVLSRLTKLDTLSLEDNQISDIV--PL 174 (210)
T ss_dssp SSCCCCGGGGTTCTTCCEEECTTSCCCCCG-GGGGCTTCCEEECCSSCCCC-CGGGGGCTTCSEEECCSSCCCCCG--GG
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCC--CC
T ss_conf 333212221212221112234565322112-20111112221122233345-431000133210013464302564--53
Q ss_pred CCCCCCCEEEEECCCCCC
Q ss_conf 999997899801797756
Q 005572 224 PPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 224 ~~l~~L~~l~l~~N~l~g 241 (690)
..+++|+.|++++|+++.
T Consensus 175 ~~l~~L~~L~Ls~N~i~~ 192 (210)
T d1h6ta2 175 AGLTKLQNLYLSKNHISD 192 (210)
T ss_dssp TTCTTCCEEECCSSCCCB
T ss_pred CCCCCCCEEECCCCCCCC
T ss_conf 678989999897998998
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.83 E-value=2.1e-19 Score=119.97 Aligned_cols=167 Identities=23% Similarity=0.332 Sum_probs=128.9
Q ss_pred CEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 39981399889878556542999745876437868888970003885575897207408873599999989999997599
Q 005572 61 RELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVL 140 (690)
Q Consensus 61 ~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~~L 140 (690)
..+.++.+.+++.++. ..+..++.|++++|.++.. ++ +..+++|+.|++++|++++.. .+..+++|++|
T Consensus 21 i~~~l~~~~~~~~~~~---~~l~~l~~L~l~~~~i~~l-~~-l~~l~nL~~L~Ls~N~l~~~~------~l~~l~~L~~L 89 (199)
T d2omxa2 21 MKTVLGKTNVTDTVSQ---TDLDQVTTLQADRLGIKSI-DG-VEYLNNLTQINFSNNQLTDIT------PLKNLTKLVDI 89 (199)
T ss_dssp HHHHTTCSSTTSEECH---HHHTTCCEEECTTSCCCCC-TT-GGGCTTCCEEECCSSCCCCCG------GGTTCTTCCEE
T ss_pred HHHHHCCCCCCCCCCH---HHHCCCCEEECCCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCCC
T ss_conf 9999677877885598---7946878998999999775-20-213788675754565566764------01677522311
Q ss_pred ECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 85589899963468999975999338998547956888877868873158687678873342224421031353777799
Q 005572 141 NLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNGTFP 220 (690)
Q Consensus 141 ~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~~~p 220 (690)
+++.|.+..++.+..+++|+.|++++|.+..++ .+..+++|+.|++++|.+.. ++.+..+.+|+.|++++|.+++..
T Consensus 90 ~l~~n~~~~~~~l~~l~~L~~L~l~~~~~~~~~-~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~l~- 166 (199)
T d2omxa2 90 LMNNNQIADITPLANLTNLTGLTLFNNQITDID-PLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTDLK- 166 (199)
T ss_dssp ECCSSCCCCCGGGTTCTTCSEEECCSSCCCCCG-GGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCCG-
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHCC-CCCCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 112222222211111223222111222222321-00012236776431111002-343332111111223455556770-
Q ss_pred CCCCCCCCCCEEEEECCCCCCC
Q ss_conf 9999999978998017977563
Q 005572 221 SDFPPLSGVKFLNISLNKFTGF 242 (690)
Q Consensus 221 ~~~~~l~~L~~l~l~~N~l~g~ 242 (690)
.+..+++|+.|++++|++++.
T Consensus 167 -~l~~l~~L~~L~ls~N~i~~i 187 (199)
T d2omxa2 167 -PLANLTTLERLDISSNKVSDI 187 (199)
T ss_dssp -GGTTCTTCCEEECCSSCCCCC
T ss_pred -CCCCCCCCCEEECCCCCCCCC
T ss_conf -116799899997879979988
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.82 E-value=2.5e-19 Score=119.56 Aligned_cols=173 Identities=21% Similarity=0.337 Sum_probs=146.3
Q ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99903998139988987855654299974587643786888897000388557589720740887359999998999999
Q 005572 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPS 136 (690)
Q Consensus 57 ~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~ 136 (690)
..+|+.|++.+|+|+.+ + .+..+++|+.|++++|.+++..| +..+++++.+++++|.++.. ..+..+++
T Consensus 40 l~~L~~L~l~~~~i~~l-~--~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~~i------~~l~~l~~ 108 (227)
T d1h6ua2 40 LDGITTLSAFGTGVTTI-E--GVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLKNV------SAIAGLQS 108 (227)
T ss_dssp HHTCCEEECTTSCCCCC-T--TGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCSCC------GGGTTCTT
T ss_pred CCCCCEEECCCCCCCCC-H--HHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCCCC------CCCCCCCC
T ss_conf 48868997779999766-4--57448888376357853202543--11233432012111222222------22222222
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 75998558989996346899997599933899854795688887786887315868767887334222442103135377
Q 005572 137 VQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMN 216 (690)
Q Consensus 137 L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 216 (690)
|+.++++.+...+...+...+.+..+.++++.+.... .+..+.+|+.|++++|.+.. ...+..+++|+.|+|++|.++
T Consensus 109 L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~-~~~~~~~L~~L~l~~n~~~~-~~~l~~l~~L~~L~Ls~n~l~ 186 (227)
T d1h6ua2 109 IKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNIS-PLAGLTNLQYLSIGNAQVSD-LTPLANLSKLTTLKADDNKIS 186 (227)
T ss_dssp CCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCG-GGGGCTTCCEEECCSSCCCC-CGGGTTCTTCCEEECCSSCCC
T ss_pred CCCCCCCCCCCCCCCHHCCCCCHHHHHCHHHHHCHHH-HHCCCCCCCCCCCCCCCCCC-CHHHCCCCCCEECCCCCCCCC
T ss_conf 2122122244331100000230122200000000000-00102111002333333331-001056463356445888417
Q ss_pred CCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf 7799999999997899801797756339
Q 005572 217 GTFPSDFPPLSGVKFLNISLNKFTGFVG 244 (690)
Q Consensus 217 ~~~p~~~~~l~~L~~l~l~~N~l~g~~~ 244 (690)
+.. .+..+++|+.|++++|++++..+
T Consensus 187 ~l~--~l~~l~~L~~L~Ls~N~lt~i~~ 212 (227)
T d1h6ua2 187 DIS--PLASLPNLIEVHLKNNQISDVSP 212 (227)
T ss_dssp CCG--GGGGCTTCCEEECTTSCCCBCGG
T ss_pred CCH--HHCCCCCCCEEECCCCCCCCCCC
T ss_conf 785--34479999989795996899802
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.81 E-value=4.2e-20 Score=123.80 Aligned_cols=108 Identities=20% Similarity=0.324 Sum_probs=50.3
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 90399813998898785565429997458764378688889700038855758972074088735999999899999975
Q 005572 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138 (690)
Q Consensus 59 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~ 138 (690)
.+++|+|++|+|++.++...+..+++|+.|++++|.+....+..|..+++|+.|+|++|++... ++..|..+++|+
T Consensus 30 ~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l~~l----~~~~F~~l~~L~ 105 (192)
T d1w8aa_ 30 HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKEI----SNKMFLGLHQLK 105 (192)
T ss_dssp TCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCCCEE----CSSSSTTCTTCC
T ss_pred CCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC----CHHHHHCCCCCC
T ss_conf 8788984898775530200257876272130136322121212221122221010035534434----979980797465
Q ss_pred EEECCCCCCCCCCC--CCCCCCCCEEECCCCCCC
Q ss_conf 99855898999634--689999759993389985
Q 005572 139 VLNLSSNRFTNLVK--LSQFSKLMVLDVSNNDLR 170 (690)
Q Consensus 139 ~L~Ls~N~l~~~~~--~~~~~~L~~L~Ls~N~l~ 170 (690)
+|+|++|+|+.++. |..+++|++|+|++|.+.
T Consensus 106 ~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~ 139 (192)
T d1w8aa_ 106 TLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139 (192)
T ss_dssp EEECCSSCCCEECTTSSTTCTTCCEEECTTCCBC
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 5245774535359778568753342000364434
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.76 E-value=3.7e-17 Score=107.71 Aligned_cols=182 Identities=18% Similarity=0.168 Sum_probs=137.2
Q ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCCC
Q ss_conf 99039981399889878556542999745876437868888-970003885575897207-4088735999999899999
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGS-VPGWFWSTQSLTQVNLSK-NRFGGTIGFKPTSRNGPFP 135 (690)
Q Consensus 58 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~-N~l~~~i~~~~~~~~~~l~ 135 (690)
.++++|+|++|+|+.+.+. .+.++++|++|++++|.+... .+..|..++.++.+.+.. |.+... .+..+..++
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~-~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~----~~~~~~~l~ 103 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKG-AFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYI----NPEAFQNLP 103 (242)
T ss_dssp SCCSEEEEESCCCCEECTT-TTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEE----CTTSEECCT
T ss_pred CCCCEEECCCCCCCCCCHH-HHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC----CCCCCCCCC
T ss_conf 9889998769918964966-86146432321102211242010011222222222111112343222----222122222
Q ss_pred CCCEEECCCCCCCCCCCCCC---CCCCCEEECCCCCCCCCC-CCCCCCC-CCCEEECCCCCCCCCCCCCCCCCCC-CEEE
Q ss_conf 97599855898999634689---999759993389985479-5688887-7868873158687678873342224-4210
Q 005572 136 SVQVLNLSSNRFTNLVKLSQ---FSKLMVLDVSNNDLRILP-SGFANLS-KLRHLDISSCKISGNIKPVSFLHSL-KYLD 209 (690)
Q Consensus 136 ~L~~L~Ls~N~l~~~~~~~~---~~~L~~L~Ls~N~l~~~p-~~~~~l~-~L~~L~ls~N~l~~~~~~~~~l~~L-~~L~ 209 (690)
+|+.+++++|.+...+.... +..+..+..+++.+..++ ..+..+. .+..|++++|.++...........+ +.++
T Consensus 104 ~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~~~~~~~~l~~~~~ 183 (242)
T d1xwdc1 104 NLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNL 183 (242)
T ss_dssp TCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECTTTTTTCCEEEEEC
T ss_pred CCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCHHHHCCCC
T ss_conf 22222342111125543332221111222222212111222222222233100122001233332222222011101212
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCC
Q ss_conf 31353777799999999997899801797756339
Q 005572 210 VSNNSMNGTFPSDFPPLSGVKFLNISLNKFTGFVG 244 (690)
Q Consensus 210 Ls~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~~ 244 (690)
+++|.++...+..|..+++|+.|++++|+++...+
T Consensus 184 l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~ 218 (242)
T d1xwdc1 184 SDNNNLEELPNDVFHGASGPVILDISRTRIHSLPS 218 (242)
T ss_dssp TTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCS
T ss_pred CCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCH
T ss_conf 35432464247886689999989897992894597
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.1e-17 Score=110.65 Aligned_cols=212 Identities=11% Similarity=0.092 Sum_probs=148.2
Q ss_pred CCCCCHHHHHH-HHHCCCCCCCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCC-CCCCC
Q ss_conf 55861054158-751489866203589888767--889999039981399889878556542999745876437-86888
Q 005572 22 TCNSKDQELVS-KAFSSVSTFNISWLKPTNLNG--SNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSN-NSLKG 97 (690)
Q Consensus 22 ~c~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~-N~l~~ 97 (690)
.|.......++ ..+.++..++++......+.. .....+|+.|+|++|.+...++...+..+..++.+++.. |.+..
T Consensus 14 ~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~ 93 (242)
T d1xwdc1 14 LCQESKVTEIPSDLPRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLY 93 (242)
T ss_dssp EEESCSCSSCCSCSCSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCE
T ss_pred EEECCCCCCCCCCCCCCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 98189988768888998899987699189649668614643232110221124201001122222222211111234322
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC--CCCCC-CCCCEEECCCCCCCCCCC
Q ss_conf 897000388557589720740887359999998999999759985589899963--46899-997599933899854795
Q 005572 98 SVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLV--KLSQF-SKLMVLDVSNNDLRILPS 174 (690)
Q Consensus 98 ~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~--~~~~~-~~L~~L~Ls~N~l~~~p~ 174 (690)
..+..|.++++|+.+++++|++.... .......+..+..+..+++.+..+. .+..+ ..++.|++++|.++.++.
T Consensus 94 ~~~~~~~~l~~L~~l~l~~~~l~~~~---~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~i~~ 170 (242)
T d1xwdc1 94 INPEAFQNLPNLQYLLISNTGIKHLP---DVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHN 170 (242)
T ss_dssp ECTTSEECCTTCCEEEEESCCCCSCC---CCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCEECT
T ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC
T ss_conf 22221222222222234211112554---333222111122222221211122222222223310012200123333222
Q ss_pred CCCCCCCCCEE-ECCCCCCCCCCCC-CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEEC
Q ss_conf 68888778688-7315868767887-33422244210313537777999999999978998017
Q 005572 175 GFANLSKLRHL-DISSCKISGNIKP-VSFLHSLKYLDVSNNSMNGTFPSDFPPLSGVKFLNISL 236 (690)
Q Consensus 175 ~~~~l~~L~~L-~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~l~~ 236 (690)
......++..+ .+++|.++...+. +..+++|+.|++++|.++...+..|..+..|+.+++..
T Consensus 171 ~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~~~ 234 (242)
T d1xwdc1 171 CAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN 234 (242)
T ss_dssp TTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSEES
T ss_pred CCCCCHHHHCCCCCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCCCCC
T ss_conf 2222011101212354324642478866899999898979928945977973771341476788
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.62 E-value=6.8e-16 Score=100.81 Aligned_cols=106 Identities=18% Similarity=0.165 Sum_probs=45.0
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCC
Q ss_conf 999745876437868888970003885575897207408873599999989999997599855898999634--689999
Q 005572 81 NMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVK--LSQFSK 158 (690)
Q Consensus 81 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~--~~~~~~ 158 (690)
+...++.|+|++|+|+.. +..+..+++|+.|+|++|+++.. ..+..+++|++|++++|+++.++. +..+++
T Consensus 16 n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~~l------~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~ 88 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIRKL------DGFPLLRRLKTLLVNNNRICRIGEGLDQALPD 88 (162)
T ss_dssp CTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCCEE------CCCCCCSSCCEEECCSSCCCEECSCHHHHCTT
T ss_pred CCCCCCEEECCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCC------CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 857484897889978865-76200414599898979978764------77445761306431021345777632233453
Q ss_pred CCEEECCCCCCCCCCC--CCCCCCCCCEEECCCCCCC
Q ss_conf 7599933899854795--6888877868873158687
Q 005572 159 LMVLDVSNNDLRILPS--GFANLSKLRHLDISSCKIS 193 (690)
Q Consensus 159 L~~L~Ls~N~l~~~p~--~~~~l~~L~~L~ls~N~l~ 193 (690)
|+.|++++|.+..++. .+..+++|+.|++++|.++
T Consensus 89 L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~ 125 (162)
T d1a9na_ 89 LTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVT 125 (162)
T ss_dssp CCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGG
T ss_pred CCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCC
T ss_conf 4434203000166542110013653206640799634
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=8.6e-16 Score=100.27 Aligned_cols=100 Identities=21% Similarity=0.331 Sum_probs=46.2
Q ss_pred EEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 99813998898785565429997458764378688889700038855758972074088735999999899999975998
Q 005572 62 ELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLN 141 (690)
Q Consensus 62 ~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~~L~ 141 (690)
.|+|++|+++.... +..+.+|+.|++++|.|+. +|..+..+++|+.|++++|+++
T Consensus 2 ~L~Ls~n~l~~l~~---l~~l~~L~~L~ls~N~l~~-lp~~~~~l~~L~~L~l~~N~i~--------------------- 56 (124)
T d1dcea3 2 VLHLAHKDLTVLCH---LEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE--------------------- 56 (124)
T ss_dssp EEECTTSCCSSCCC---GGGGTTCCEEECCSSCCCC-CCGGGGGCTTCCEEECCSSCCC---------------------
T ss_pred EEECCCCCCCCCCC---CCCCCCCCEEECCCCCCCC-CHHHHHHHHCCCCCCCCCCCCC---------------------
T ss_conf 89868998988710---1058988989797871686-5215655431354532432112---------------------
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCEEECCCCCCC
Q ss_conf 558989996346899997599933899854795--6888877868873158687
Q 005572 142 LSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPS--GFANLSKLRHLDISSCKIS 193 (690)
Q Consensus 142 Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~--~~~~l~~L~~L~ls~N~l~ 193 (690)
.++.+..+++|+.|++++|.+..++. .+..+++|+.|++++|.++
T Consensus 57 -------~l~~~~~l~~L~~L~l~~N~i~~~~~~~~l~~~~~L~~L~l~~N~i~ 103 (124)
T d1dcea3 57 -------NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC 103 (124)
T ss_dssp -------CCGGGTTCSSCCEEECCSSCCCSSSTTGGGGGCTTCCEEECTTSGGG
T ss_pred -------CCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCEEECCCCCCC
T ss_conf -------35741233555768888986588888256537999999989799688
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.60 E-value=3.4e-15 Score=97.00 Aligned_cols=104 Identities=28% Similarity=0.344 Sum_probs=66.5
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 59985589899963468999975999338998547956888877868873158687678873342224421031353777
Q 005572 138 QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMNG 217 (690)
Q Consensus 138 ~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~~ 217 (690)
+.|+|++|+++.++.+..+++|+.|++++|.++.+|..+..+++|+.|++++|.++. ++.+..+++|+.|++++|.+..
T Consensus 1 R~L~Ls~n~l~~l~~l~~l~~L~~L~ls~N~l~~lp~~~~~l~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~l~~N~i~~ 79 (124)
T d1dcea3 1 RVLHLAHKDLTVLCHLEQLLLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALEN-VDGVANLPRLQELLLCNNRLQQ 79 (124)
T ss_dssp SEEECTTSCCSSCCCGGGGTTCCEEECCSSCCCCCCGGGGGCTTCCEEECCSSCCCC-CGGGTTCSSCCEEECCSSCCCS
T ss_pred CEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCHHHHHHHHCCCCCCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC
T ss_conf 989868998988710105898898979787168652156554313545324321123-5741233555768888986588
Q ss_pred CCC-CCCCCCCCCCEEEEECCCCCCC
Q ss_conf 799-9999999978998017977563
Q 005572 218 TFP-SDFPPLSGVKFLNISLNKFTGF 242 (690)
Q Consensus 218 ~~p-~~~~~l~~L~~l~l~~N~l~g~ 242 (690)
... ..+..+++|+.+++++|+++..
T Consensus 80 ~~~~~~l~~~~~L~~L~l~~N~i~~~ 105 (124)
T d1dcea3 80 SAAIQPLVSCPRLVLLNLQGNSLCQE 105 (124)
T ss_dssp SSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred CCCCHHHCCCCCCCEEECCCCCCCCC
T ss_conf 88825653799999998979968868
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.59 E-value=7.2e-13 Score=84.28 Aligned_cols=137 Identities=27% Similarity=0.338 Sum_probs=76.2
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 90399813998898785565429997458764378688889700038855758972074088735999999899999975
Q 005572 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138 (690)
Q Consensus 59 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~ 138 (690)
+++.|+|+++.|+.++. .+++|++|++++|+|+ .+|.. +.+|+.|++++|+++.. + . -.+.|+
T Consensus 39 ~l~~LdLs~~~L~~lp~-----~~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~~l-~----~---lp~~L~ 101 (353)
T d1jl5a_ 39 QAHELELNNLGLSSLPE-----LPPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLKAL-S----D---LPPLLE 101 (353)
T ss_dssp TCSEEECTTSCCSCCCS-----CCTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCSCC-C----S---CCTTCC
T ss_pred CCCEEEECCCCCCCCCC-----CCCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCCHH-H----H---HCCCCC
T ss_conf 99899937999887889-----8789888989999796-33620---33203326655143203-2----1---022111
Q ss_pred EEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 998558989996346899997599933899854795688887786887315868767887334222442103135377
Q 005572 139 VLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSMN 216 (690)
Q Consensus 139 ~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l~ 216 (690)
+|++++|.++.++.+..+++|+.|++++|.+...+... ..+..+.+..+.... ...+..+..++.++++.|.+.
T Consensus 102 ~L~L~~n~l~~lp~~~~l~~L~~L~l~~~~~~~~~~~~---~~l~~l~~~~~~~~~-~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 102 YLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLP---PSLEFIAAGNNQLEE-LPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp EEECCSSCCSSCCCCTTCTTCCEEECCSSCCSCCCCCC---TTCCEEECCSSCCSS-CCCCTTCTTCCEEECCSSCCS
T ss_pred CCCCCCCCCCCCCCHHHHCCCEEECCCCCCCCCCCCCC---CCCCCHHHCCCCCCC-CCCCCCCCCCEECCCCCCCCC
T ss_conf 11334554322210011013123113565100132233---332100001222223-332000122200111233443
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=5.8e-16 Score=101.19 Aligned_cols=122 Identities=20% Similarity=0.260 Sum_probs=74.1
Q ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 99039981399889878556542999745876437868888970003885575897207408873599999989999997
Q 005572 58 TPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137 (690)
Q Consensus 58 ~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L 137 (690)
..+++|+|++|+|+.+.. ....+++|+.|+|++|.|+.. + .+..+++|+.|++++|+++... +..+..+++|
T Consensus 18 ~~lr~L~L~~n~I~~i~~--~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~----~~~~~~l~~L 89 (162)
T d1a9na_ 18 VRDRELDLRGYKIPVIEN--LGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIG----EGLDQALPDL 89 (162)
T ss_dssp TSCEEEECTTSCCCSCCC--GGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEEC----SCHHHHCTTC
T ss_pred CCCCEEECCCCCCCCCCC--CCCCCCCCCEEECCCCCCCCC-C-CCCCCCCHHHHHCCCCCCCCCC----CCCCCCCCCC
T ss_conf 748489788997886576--200414599898979978764-7-7445761306431021345777----6322334534
Q ss_pred CEEECCCCCCCCCC---CCCCCCCCCEEECCCCCCCCCCC----CCCCCCCCCEEEC
Q ss_conf 59985589899963---46899997599933899854795----6888877868873
Q 005572 138 QVLNLSSNRFTNLV---KLSQFSKLMVLDVSNNDLRILPS----GFANLSKLRHLDI 187 (690)
Q Consensus 138 ~~L~Ls~N~l~~~~---~~~~~~~L~~L~Ls~N~l~~~p~----~~~~l~~L~~L~l 187 (690)
+.|++++|+++.+. .+..+++|+.|++++|.+...|. .+..+++|+.||.
T Consensus 90 ~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD~ 146 (162)
T d1a9na_ 90 TELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLDF 146 (162)
T ss_dssp CEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEETT
T ss_pred CCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEECC
T ss_conf 434203000166542110013653206640799634561069999987899583379
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.58 E-value=4.3e-13 Score=85.52 Aligned_cols=136 Identities=18% Similarity=0.221 Sum_probs=56.6
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 98662035898887678899990399813998898785565429997458764378688889700038855758972074
Q 005572 38 VSTFNISWLKPTNLNGSNPSTPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKN 117 (690)
Q Consensus 38 ~~~l~~~~~~~~~~~~~~~~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N 117 (690)
+..++++....+.+... .++|+.|+|+.|+|+.+ | . .+.+|+.|++++|+++.. +.. .+.|+.|++++|
T Consensus 40 l~~LdLs~~~L~~lp~~--~~~L~~L~Ls~N~l~~l-p-~---~~~~L~~L~l~~n~l~~l-~~l---p~~L~~L~L~~n 108 (353)
T d1jl5a_ 40 AHELELNNLGLSSLPEL--PPHLESLVASCNSLTEL-P-E---LPQSLKSLLVDNNNLKAL-SDL---PPLLEYLGVSNN 108 (353)
T ss_dssp CSEEECTTSCCSCCCSC--CTTCSEEECCSSCCSSC-C-C---CCTTCCEEECCSSCCSCC-CSC---CTTCCEEECCSS
T ss_pred CCEEEECCCCCCCCCCC--CCCCCEEECCCCCCCCC-C-C---CHHHHHHHHHHHCCCCHH-HHH---CCCCCCCCCCCC
T ss_conf 98999379998878898--78988898999979633-6-2---033203326655143203-210---221111133455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 0887359999998999999759985589899963468999975999338998547956888877868873158687
Q 005572 118 RFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKIS 193 (690)
Q Consensus 118 ~l~~~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~ 193 (690)
.+... + .++.++.|+.|++++|.+...+. ....+..+.+..+..... ..+..+..++.+.++.|.+.
T Consensus 109 ~l~~l-----p-~~~~l~~L~~L~l~~~~~~~~~~--~~~~l~~l~~~~~~~~~~-~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 109 QLEKL-----P-ELQNSSFLKIIDVDNNSLKKLPD--LPPSLEFIAAGNNQLEEL-PELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCSSC-----C-CCTTCTTCCEEECCSSCCSCCCC--CCTTCCEEECCSSCCSSC-CCCTTCTTCCEEECCSSCCS
T ss_pred CCCCC-----C-CHHHHCCCEEECCCCCCCCCCCC--CCCCCCCHHHCCCCCCCC-CCCCCCCCCEECCCCCCCCC
T ss_conf 43222-----1-00110131231135651001322--333321000012222233-32000122200111233443
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.47 E-value=9.1e-17 Score=105.58 Aligned_cols=126 Identities=18% Similarity=0.247 Sum_probs=83.0
Q ss_pred CCEEECCCC--CCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 039981399--889878556542999745876437868888970003885575897207408873599999989999997
Q 005572 60 IRELNLSSR--NLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSV 137 (690)
Q Consensus 60 L~~L~L~~N--~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L 137 (690)
++.+++..+ .+.. ++ ..+..+++|+.|+|++|+|+.. + .+..+++|+.|+|++|+++.. +.....++.|
T Consensus 25 ~~~~~l~~~~~~i~~-l~-~sl~~L~~L~~L~Ls~n~I~~i-~-~l~~l~~L~~L~Ls~N~i~~i-----~~~~~~~~~L 95 (198)
T d1m9la_ 25 AEKVELHGMIPPIEK-MD-ATLSTLKACKHLALSTNNIEKI-S-SLSGMENLRILSLGRNLIKKI-----ENLDAVADTL 95 (198)
T ss_dssp CSCEECCBCCTTCCC-CH-HHHHHTTTCCEEECSEEEESCC-C-CHHHHTTCCEEECCEEEECSC-----SSHHHHHHHC
T ss_pred CCEEEEECCCCCHHH-HH-HHHHCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCHHHCCCCCCCC-----CCCCCCCCCC
T ss_conf 310025555685200-24-6776260461519944689986-4-424782535734135343210-----0003322123
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCEEECCCCCCCC
Q ss_conf 599855898999634689999759993389985479--568888778688731586876
Q 005572 138 QVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILP--SGFANLSKLRHLDISSCKISG 194 (690)
Q Consensus 138 ~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p--~~~~~l~~L~~L~ls~N~l~~ 194 (690)
+.|++++|+++.+..+..+++|+.|++++|.++.++ ..+..+++|+.|++++|.+..
T Consensus 96 ~~L~l~~N~i~~l~~~~~l~~L~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 96 EELWISYNQIASLSGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp CEEECSEEECCCHHHHHHHHHSSEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCCCCCCCCEEECCCCCCCC
T ss_conf 33333332222222222222341112341021255422123677763023427984346
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.45 E-value=7.5e-13 Score=84.20 Aligned_cols=42 Identities=21% Similarity=0.135 Sum_probs=19.6
Q ss_pred CCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 689999759993389985479568888778688731586876
Q 005572 153 LSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISG 194 (690)
Q Consensus 153 ~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~ 194 (690)
|..+++|+.|+|++|+|+.+|.......+|+.|++++|.+..
T Consensus 76 f~~l~~L~~L~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C 117 (156)
T d2ifga3 76 FHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117 (156)
T ss_dssp GGSCSCCCEEECCSSCCSCCCSTTTCSCCCCEEECCSSCCCC
T ss_pred CCCCCCCCCEECCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
T ss_conf 124554333322678785157456335321243357986338
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.44 E-value=2e-15 Score=98.22 Aligned_cols=178 Identities=19% Similarity=0.198 Sum_probs=127.9
Q ss_pred CCCCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCC
Q ss_conf 9990399813998898785565429997458764378688889700038855758972074-088735999999899999
Q 005572 57 STPIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGSVPGWFWSTQSLTQVNLSKN-RFGGTIGFKPTSRNGPFP 135 (690)
Q Consensus 57 ~~~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-~l~~~i~~~~~~~~~~l~ 135 (690)
...|+.|+|+++.++.......+..+++|++|+++++.+++..+..+..+++|+.|+++++ .+++.. . .......+
T Consensus 45 ~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~-l--~~l~~~~~ 121 (284)
T d2astb2 45 PFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFA-L--QTLLSSCS 121 (284)
T ss_dssp CBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHH-H--HHHHHHCT
T ss_pred CCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCC-C--CHHHHHHH
T ss_conf 78788788989845777999999748776514523467986789998518997571510013412355-4--03657887
Q ss_pred CCCEEECCCC-CCCCC--C-CC-CCCCCCCEEECCCC--CCC--CCCCCCCCCCCCCEEECCCCC-CCCC-CCCCCCCCC
Q ss_conf 9759985589-89996--3-46-89999759993389--985--479568888778688731586-8767-887334222
Q 005572 136 SVQVLNLSSN-RFTNL--V-KL-SQFSKLMVLDVSNN--DLR--ILPSGFANLSKLRHLDISSCK-ISGN-IKPVSFLHS 204 (690)
Q Consensus 136 ~L~~L~Ls~N-~l~~~--~-~~-~~~~~L~~L~Ls~N--~l~--~~p~~~~~l~~L~~L~ls~N~-l~~~-~~~~~~l~~ 204 (690)
+|++|+++++ .++.. . .+ ...++|+.|++++. .++ .+...+..+++|+.|++++|. ++.. +..+..+++
T Consensus 122 ~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~ 201 (284)
T d2astb2 122 RLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNY 201 (284)
T ss_dssp TCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTT
T ss_pred HCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCC
T ss_conf 43565224533233322000100011111012213554244444343423232221235532234778303333213576
Q ss_pred CCEEECCC-CCCCCCCCCCCCCCCCCCEEEEECC
Q ss_conf 44210313-5377779999999999789980179
Q 005572 205 LKYLDVSN-NSMNGTFPSDFPPLSGVKFLNISLN 237 (690)
Q Consensus 205 L~~L~Ls~-N~l~~~~p~~~~~l~~L~~l~l~~N 237 (690)
|++|++++ +.++......+..+++|+.|++.++
T Consensus 202 L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~ 235 (284)
T d2astb2 202 LQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGI 235 (284)
T ss_dssp CCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTS
T ss_pred CCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECC
T ss_conf 8779899999787378999726999898964488
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.33 E-value=2.5e-15 Score=97.72 Aligned_cols=105 Identities=23% Similarity=0.245 Sum_probs=46.5
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 97599855898999634689999759993389985479568888778688731586876788733422244210313537
Q 005572 136 SVQVLNLSSNRFTNLVKLSQFSKLMVLDVSNNDLRILPSGFANLSKLRHLDISSCKISGNIKPVSFLHSLKYLDVSNNSM 215 (690)
Q Consensus 136 ~L~~L~Ls~N~l~~~~~~~~~~~L~~L~Ls~N~l~~~p~~~~~l~~L~~L~ls~N~l~~~~~~~~~l~~L~~L~Ls~N~l 215 (690)
+|++|+|++|+++.+..+..+++|+.|++++|.++.+|..+..+.+|+.|++++|.++. ++.+..+++|+.|++++|.+
T Consensus 49 ~L~~L~Ls~n~I~~i~~l~~l~~L~~L~Ls~N~i~~i~~~~~~~~~L~~L~l~~N~i~~-l~~~~~l~~L~~L~L~~N~i 127 (198)
T d1m9la_ 49 ACKHLALSTNNIEKISSLSGMENLRILSLGRNLIKKIENLDAVADTLEELWISYNQIAS-LSGIEKLVNLRVLYMSNNKI 127 (198)
T ss_dssp TCCEEECSEEEESCCCCHHHHTTCCEEECCEEEECSCSSHHHHHHHCCEEECSEEECCC-HHHHHHHHHSSEEEESEEEC
T ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCHH
T ss_conf 46151994468998644247825357341353432100003322123333333322222-22222222341112341021
Q ss_pred CCCCC-CCCCCCCCCCEEEEECCCCCC
Q ss_conf 77799-999999997899801797756
Q 005572 216 NGTFP-SDFPPLSGVKFLNISLNKFTG 241 (690)
Q Consensus 216 ~~~~p-~~~~~l~~L~~l~l~~N~l~g 241 (690)
+.... ..+..+++|+.|++++|++..
T Consensus 128 ~~~~~~~~l~~l~~L~~L~L~~N~l~~ 154 (198)
T d1m9la_ 128 TNWGEIDKLAALDKLEDLLLAGNPLYN 154 (198)
T ss_dssp CCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCC
T ss_conf 255422123677763023427984346
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.33 E-value=1.3e-14 Score=93.81 Aligned_cols=38 Identities=21% Similarity=0.409 Sum_probs=14.7
Q ss_pred CCCCCEEECCCCCCCCCCC----CCCCCCCCCCEEECCCCCC
Q ss_conf 9974587643786888897----0003885575897207408
Q 005572 82 MSELHSIDLSNNSLKGSVP----GWFWSTQSLTQVNLSKNRF 119 (690)
Q Consensus 82 l~~L~~L~Ls~N~l~~~~p----~~~~~l~~L~~L~L~~N~l 119 (690)
.++|+.|+|++|.++.... ..+...++|+.|++++|.+
T Consensus 92 ~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l 133 (344)
T d2ca6a1 92 CPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL 133 (344)
T ss_dssp CTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCC
T ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCCC
T ss_conf 777563300001345543331011100234321000002466
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.27 E-value=4.5e-13 Score=85.40 Aligned_cols=185 Identities=16% Similarity=0.185 Sum_probs=100.8
Q ss_pred CCCCEEECCCCCCCCCCC---HHHHCCCCCCCEEECCCCCCCCCC---C-------CCCCCCCCCCEEECCCCCCCCCCC
Q ss_conf 990399813998898785---565429997458764378688889---7-------000388557589720740887359
Q 005572 58 TPIRELNLSSRNLSGIIS---WKFLRNMSELHSIDLSNNSLKGSV---P-------GWFWSTQSLTQVNLSKNRFGGTIG 124 (690)
Q Consensus 58 ~~L~~L~L~~N~l~~~~~---~~~~~~l~~L~~L~Ls~N~l~~~~---p-------~~~~~l~~L~~L~L~~N~l~~~i~ 124 (690)
..+++|+|++|.++.... ...+...+.|+.++++++.+.... + ..+...++|+.|+|++|.++..-.
T Consensus 31 ~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~ 110 (344)
T d2ca6a1 31 DSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQ 110 (344)
T ss_dssp SCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHHHTTCTTCCEEECCSCCCCTTTH
T ss_pred CCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 99788978498377899999999998589988888877754334542106787999887547775633000013455433
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCC---------------CCCCCCCCCEEECCCCCCCC-----CCCCCCCCCCCCE
Q ss_conf 999998999999759985589899963---------------46899997599933899854-----7956888877868
Q 005572 125 FKPTSRNGPFPSVQVLNLSSNRFTNLV---------------KLSQFSKLMVLDVSNNDLRI-----LPSGFANLSKLRH 184 (690)
Q Consensus 125 ~~~~~~~~~l~~L~~L~Ls~N~l~~~~---------------~~~~~~~L~~L~Ls~N~l~~-----~p~~~~~l~~L~~ 184 (690)
......+...++|+.|++++|.+.... .....+.|+.|++++|.+.. +...+.....|+.
T Consensus 111 ~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~n~i~~~~~~~l~~~l~~~~~L~~ 190 (344)
T d2ca6a1 111 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHT 190 (344)
T ss_dssp HHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCE
T ss_pred CCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCHHHHHHHHCC
T ss_conf 31011100234321000002466665431111212222110001467642111013650135543322111123332133
Q ss_pred EECCCCCCCCC------CCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEEECCCCCCC
Q ss_conf 87315868767------88733422244210313537777----999999999978998017977563
Q 005572 185 LDISSCKISGN------IKPVSFLHSLKYLDVSNNSMNGT----FPSDFPPLSGVKFLNISLNKFTGF 242 (690)
Q Consensus 185 L~ls~N~l~~~------~~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g~ 242 (690)
|++++|.++.. ...+...++|+.|+|++|.+... +...+...+.|+.|++++|.+++.
T Consensus 191 L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~ 258 (344)
T d2ca6a1 191 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSAR 258 (344)
T ss_dssp EECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHH
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCH
T ss_conf 54333222222232002433211012112223333222222223444332322111103004756715
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.27 E-value=3.7e-11 Score=74.95 Aligned_cols=104 Identities=20% Similarity=0.179 Sum_probs=55.0
Q ss_pred EEECCCCCCCCCC-CCCCCCCCCEEECCCC-CCCCCC-CCCCCCCCCCEEECCCCCCCCCCCC-CCCCCCCCEEECCCCC
Q ss_conf 9985589899963-4689999759993389-985479-5688887786887315868767887-3342224421031353
Q 005572 139 VLNLSSNRFTNLV-KLSQFSKLMVLDVSNN-DLRILP-SGFANLSKLRHLDISSCKISGNIKP-VSFLHSLKYLDVSNNS 214 (690)
Q Consensus 139 ~L~Ls~N~l~~~~-~~~~~~~L~~L~Ls~N-~l~~~p-~~~~~l~~L~~L~ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~ 214 (690)
.++++++++...+ .+..+++|+.|++++| .++.++ ..|.++++|+.|++++|.++...+. +..+++|+.|+|++|.
T Consensus 12 ~l~c~~~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~ 91 (156)
T d2ifga3 12 GLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNA 91 (156)
T ss_dssp CEECCSSCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSC
T ss_pred EEEECCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCC
T ss_conf 69852899765860025765657431689866443692122566666721620212477420111245543333226787
Q ss_pred CCCCCCCCCCCCCCCCEEEEECCCCCCCC
Q ss_conf 77779999999999789980179775633
Q 005572 215 MNGTFPSDFPPLSGVKFLNISLNKFTGFV 243 (690)
Q Consensus 215 l~~~~p~~~~~l~~L~~l~l~~N~l~g~~ 243 (690)
++...+..|..+ +++.|++++|.+....
T Consensus 92 l~~l~~~~~~~~-~l~~L~L~~Np~~C~C 119 (156)
T d2ifga3 92 LESLSWKTVQGL-SLQELVLSGNPLHCSC 119 (156)
T ss_dssp CSCCCSTTTCSC-CCCEEECCSSCCCCCG
T ss_pred CCCCCHHHHCCC-CCCCCCCCCCCCCCCC
T ss_conf 851574563353-2124335798633881
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.15 E-value=1.2e-12 Score=83.11 Aligned_cols=176 Identities=19% Similarity=0.244 Sum_probs=113.1
Q ss_pred CCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 039981399889878556542999745876437868888-9700038855758972074088735999999899999975
Q 005572 60 IRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKGS-VPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQ 138 (690)
Q Consensus 60 L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~ 138 (690)
+..+.++...+..... . ......|++||++++.++.. ....+..+++|+.|+|+++.+++.. ...++..++|+
T Consensus 25 ~~~lrl~~~~~~~~~~-~-~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~----~~~l~~~~~L~ 98 (284)
T d2astb2 25 VIAFRCPRSFMDQPLA-E-HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPI----VNTLAKNSNLV 98 (284)
T ss_dssp CSEEECTTCEECSCCC-S-CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHH----HHHHTTCTTCS
T ss_pred CEEEECCCCCCCCCHH-H-HCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHH----HHHHHCCCCCC
T ss_conf 4274652333455224-4-2567878878898984577799999974877651452346798678----99985189975
Q ss_pred EEECCCC-CCCCC--CC-CCCCCCCCEEECCCC-CCC--CCCCCCCC-CCCCCEEECCCCC--CCCC-CCC-CCCCCCCC
Q ss_conf 9985589-89996--34-689999759993389-985--47956888-8778688731586--8767-887-33422244
Q 005572 139 VLNLSSN-RFTNL--VK-LSQFSKLMVLDVSNN-DLR--ILPSGFAN-LSKLRHLDISSCK--ISGN-IKP-VSFLHSLK 206 (690)
Q Consensus 139 ~L~Ls~N-~l~~~--~~-~~~~~~L~~L~Ls~N-~l~--~~p~~~~~-l~~L~~L~ls~N~--l~~~-~~~-~~~l~~L~ 206 (690)
.|+++++ .++.. .. ...+++|+.|+++++ .++ .+...+.. .+.|+.|+++++. ++.. +.. ...+++|+
T Consensus 99 ~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~ 178 (284)
T d2astb2 99 RLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 178 (284)
T ss_dssp EEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCS
T ss_pred CCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 71510013412355403657887435652245332333220001000111110122135542444443434232322212
Q ss_pred EEECCCC-CCCCCCCCCCCCCCCCCEEEEECC-CCCC
Q ss_conf 2103135-377779999999999789980179-7756
Q 005572 207 YLDVSNN-SMNGTFPSDFPPLSGVKFLNISLN-KFTG 241 (690)
Q Consensus 207 ~L~Ls~N-~l~~~~p~~~~~l~~L~~l~l~~N-~l~g 241 (690)
.|++++| .+++.....+..+++|++|+++++ .+++
T Consensus 179 ~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~ 215 (284)
T d2astb2 179 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIP 215 (284)
T ss_dssp EEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCG
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCH
T ss_conf 3553223477830333321357687798999997873
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=1.1e-10 Score=72.42 Aligned_cols=112 Identities=21% Similarity=0.224 Sum_probs=72.7
Q ss_pred CCCEEECCCCCCCCCCCHHHHCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCC-CC
Q ss_conf 903998139988987855654299974587643786888----8970003885575897207408873599999989-99
Q 005572 59 PIRELNLSSRNLSGIISWKFLRNMSELHSIDLSNNSLKG----SVPGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRN-GP 133 (690)
Q Consensus 59 ~L~~L~L~~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~-~~ 133 (690)
+|+.||++.|++++..-...+..++++++|+|++|.++. .++..+...++|+.|+|++|.+++.-.......+ ..
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCCCC------CCCCCCCCCEEECCCCCCC
Q ss_conf 999759985589899963------4689999759993389985
Q 005572 134 FPSVQVLNLSSNRFTNLV------KLSQFSKLMVLDVSNNDLR 170 (690)
Q Consensus 134 l~~L~~L~Ls~N~l~~~~------~~~~~~~L~~L~Ls~N~l~ 170 (690)
..+|+.|+|++|+++... .+...++|+.|++++|.+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 8877887788877543221012110000343200244433202
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.77 E-value=7.2e-11 Score=73.36 Aligned_cols=110 Identities=22% Similarity=0.213 Sum_probs=58.6
Q ss_pred CCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC--C----CCC-C
Q ss_conf 7458764378688889-700038855758972074088735999999899999975998558989996--3----468-9
Q 005572 84 ELHSIDLSNNSLKGSV-PGWFWSTQSLTQVNLSKNRFGGTIGFKPTSRNGPFPSVQVLNLSSNRFTNL--V----KLS-Q 155 (690)
Q Consensus 84 ~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~i~~~~~~~~~~l~~L~~L~Ls~N~l~~~--~----~~~-~ 155 (690)
.|+.||++.|++++.. ...+..+++++.|+|++|.++..--......+...++|++|+|++|.++.. . .+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEECCCCCCCC-----CCCCCCCCCCCCEEECCCCCCC
Q ss_conf 9997599933899854-----7956888877868873158687
Q 005572 156 FSKLMVLDVSNNDLRI-----LPSGFANLSKLRHLDISSCKIS 193 (690)
Q Consensus 156 ~~~L~~L~Ls~N~l~~-----~p~~~~~l~~L~~L~ls~N~l~ 193 (690)
..+|+.|++++|.++. ++..+..+++|+.|++++|.+.
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 8877887788877543221012110000343200244433202
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.72 E-value=1.5e-07 Score=55.26 Aligned_cols=195 Identities=12% Similarity=0.031 Sum_probs=97.3
Q ss_pred HHHHHHHCCCCCCCEECCCCCCCEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEECCCEE
Q ss_conf 88999950679876004579722899983999379999930468999789999999987258-99810121289639814
Q 005572 400 KDLIAATSHFGKESLLAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEK 478 (690)
Q Consensus 400 ~~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~ 478 (690)
.++....+.+......+-++.+.||+....++ .+.+|+...........+.+|...+..+. +--+.+++.++...+..
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~-~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENE-NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSC-EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEECCC-EEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCE
T ss_conf 99997513527997678998771899990898-69999848876532556999999999876069987289997508964
Q ss_pred EEEEEECCCCCHHHHHHCCCCCC---------------CCCCCCCCCC------------CCCCCCCCCCCCCCCCCCHH
Q ss_conf 89997158997766530089999---------------9977788887------------78999999777899989978
Q 005572 479 LVLLEFMANGDLHRWLHELPTGE---------------PNVEDWSTDT------------WDHHPGAGSHISSPEKTNWV 531 (690)
Q Consensus 479 ~lv~e~~~~gsL~~~l~~~~~~~---------------~~~~~~~~~~------------~~~~~~~~~~~~~~~~l~~~ 531 (690)
++||++.++..+.+......... .....+.... +...................
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCS
T ss_pred EEEEEECCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCH
T ss_conf 99998604334354334402699999989999999855684214357644656555778998776555543033232005
Q ss_pred HHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99999999998887643069888787778478559999267477765543456676568889998775323689999998
Q 005572 532 TRHRIAIGVARGLAYLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSENETCGPESDVYCFGVILMELL 611 (690)
Q Consensus 532 ~~~~i~~~ia~~l~yLH~~~~~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~~~e~~~~~~~~~~~DVwSfGvil~el~ 611 (690)
....+. +...........+++|+|+.+.||+++++...-+.||+.+..... .|-++.+++.+.
T Consensus 166 ~~~~~~-~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~~----------------~~Dla~~~~~~~ 228 (263)
T d1j7la_ 166 DPRELY-DFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRADK----------------WYDIAFCVRSIR 228 (263)
T ss_dssp SHHHHH-HHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEEH----------------HHHHHHHHHHHH
T ss_pred HHHHHH-HHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCCCCH----------------HHHHHHHHHHHH
T ss_conf 799999-999844986781789860047642364996599960231441889----------------999999998721
Q ss_pred H
Q ss_conf 4
Q 005572 612 T 612 (690)
Q Consensus 612 t 612 (690)
.
T Consensus 229 ~ 229 (263)
T d1j7la_ 229 E 229 (263)
T ss_dssp H
T ss_pred H
T ss_conf 2
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.35 E-value=5.7e-09 Score=62.97 Aligned_cols=12 Identities=25% Similarity=0.296 Sum_probs=4.8
Q ss_pred CCEEECCCCCCC
Q ss_conf 868873158687
Q 005572 182 LRHLDISSCKIS 193 (690)
Q Consensus 182 L~~L~ls~N~l~ 193 (690)
|+.|++++|.+.
T Consensus 117 L~~L~L~~Npl~ 128 (162)
T d1koha1 117 LEELWLDGNSLS 128 (162)
T ss_dssp CSSCCCTTSTTS
T ss_pred CCEEECCCCCCC
T ss_conf 042664899767
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.32 E-value=7.5e-06 Score=45.92 Aligned_cols=161 Identities=13% Similarity=0.064 Sum_probs=81.6
Q ss_pred EECCCCC-CCEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCC--CCCCCCEEEEEECCCEEEEEEEECCCCCH
Q ss_conf 0045797-22899983999379999930468999789999999987258--99810121289639814899971589977
Q 005572 414 LLAEGRC-GPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK--HPNLLPLAGYCIAGKEKLVLLEFMANGDL 490 (690)
Q Consensus 414 ~ig~G~~-g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--H~niv~l~g~~~~~~~~~lv~e~~~~gsL 490 (690)
.+..|.. +.||+....++..+.+|...... ...+..|...++.+. .-.+.++++++.+.+..++|||++++-++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 7678654775899993898789999589667---7689999999999986599988613222456615999874413554
Q ss_pred HH--------------HHHCCCCCCCCC--CCCCC--------CCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHHHHH
Q ss_conf 66--------------530089999997--77888--------877899999977-789998997899999999998887
Q 005572 491 HR--------------WLHELPTGEPNV--EDWST--------DTWDHHPGAGSH-ISSPEKTNWVTRHRIAIGVARGLA 545 (690)
Q Consensus 491 ~~--------------~l~~~~~~~~~~--~~~~~--------~~~~~~~~~~~~-~~~~~~l~~~~~~~i~~~ia~~l~ 545 (690)
.+ .+.+-....... ..+.. ..+......... ......... ..........+.
T Consensus 94 ~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~~~~ 170 (255)
T d1nd4a_ 94 LSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAP---AELFARLKARMP 170 (255)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCH---HHHHHHHHHTCC
T ss_pred CCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHH---HHHHHHHHHHCC
T ss_conf 32212689999999999998736885448875541246889999998754110113401121379---999999987187
Q ss_pred HHHHCCCCCCCCCCCCEEECCCCCCEECCCCCCCC
Q ss_conf 64306988878777847855999926747776554
Q 005572 546 YLHHVGSTHGHLVTSSILLAESLEPKIAGFGLRNI 580 (690)
Q Consensus 546 yLH~~~~~H~dlk~~Nill~~~~~~ki~dfGl~~~ 580 (690)
......++|+|+.+.||+++++..+-|.||+.+..
T Consensus 171 ~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 171 DGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 65795678678887635773796589998533265
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.20 E-value=1.5e-07 Score=55.23 Aligned_cols=12 Identities=42% Similarity=0.365 Sum_probs=4.7
Q ss_pred CCCEEECCCCCC
Q ss_conf 975999338998
Q 005572 158 KLMVLDVSNNDL 169 (690)
Q Consensus 158 ~L~~L~Ls~N~l 169 (690)
+|+.|++++|.+
T Consensus 116 ~L~~L~L~~Npl 127 (162)
T d1koha1 116 KLEELWLDGNSL 127 (162)
T ss_dssp CCSSCCCTTSTT
T ss_pred CCCEEECCCCCC
T ss_conf 104266489976
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.00 E-value=8.1e-05 Score=40.28 Aligned_cols=76 Identities=13% Similarity=0.047 Sum_probs=48.0
Q ss_pred CEECCCCCCCEEEEECCC-CCEEEEEEEEC----C---CCCCHHHHHHHHHHHHHCC-C--CCCCCEEEEEECCCEEEEE
Q ss_conf 600457972289998399-93799999304----6---8999789999999987258-9--9810121289639814899
Q 005572 413 SLLAEGRCGPVYRAVLPG-ELHVAIKVLDN----A---KGIDHDDAVAMFDELSRLK-H--PNLLPLAGYCIAGKEKLVL 481 (690)
Q Consensus 413 ~~ig~G~~g~V~~~~~~~-~~~vavK~~~~----~---~~~~~~~~~~e~~~l~~l~-H--~niv~l~g~~~~~~~~~lv 481 (690)
+.||.|....||+....+ +..+.+|.-.. . -....+....|.+.+..+. + ..+.+++++ +++..++|
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lv 109 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV 109 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEEE
T ss_conf 9807985276899995799848999617713034677788877899999999998650579885528998--59887798
Q ss_pred EEECCCCCH
Q ss_conf 971589977
Q 005572 482 LEFMANGDL 490 (690)
Q Consensus 482 ~e~~~~gsL 490 (690)
||++++..+
T Consensus 110 mE~L~~~~~ 118 (392)
T d2pula1 110 MEDLSHLKI 118 (392)
T ss_dssp ECCCTTSEE
T ss_pred EECCCCCCC
T ss_conf 713577653
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.82 E-value=3.1e-06 Score=48.00 Aligned_cols=38 Identities=16% Similarity=0.247 Sum_probs=15.5
Q ss_pred CCCEEECCCC-CCCCCCC---HHHHCCCCCCCEEECCCCCCC
Q ss_conf 9039981399-8898785---565429997458764378688
Q 005572 59 PIRELNLSSR-NLSGIIS---WKFLRNMSELHSIDLSNNSLK 96 (690)
Q Consensus 59 ~L~~L~L~~N-~l~~~~~---~~~~~~l~~L~~L~Ls~N~l~ 96 (690)
.|++|+|+++ .++...- ...+...+.|+.|+|++|.+.
T Consensus 16 ~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~ 57 (167)
T d1pgva_ 16 DLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAIS 57 (167)
T ss_dssp SCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCB
T ss_pred CCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCC
T ss_conf 981978279999898999999999763776454012015621
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.75 E-value=1.1e-06 Score=50.40 Aligned_cols=11 Identities=18% Similarity=0.570 Sum_probs=4.9
Q ss_pred CCCCCEEECCC
Q ss_conf 99745876437
Q 005572 82 MSELHSIDLSN 92 (690)
Q Consensus 82 l~~L~~L~Ls~ 92 (690)
.+.|+.|+|++
T Consensus 14 ~~~L~~L~L~~ 24 (167)
T d1pgva_ 14 DTDLKEVNINN 24 (167)
T ss_dssp CSSCCEEECTT
T ss_pred CCCCCEEEECC
T ss_conf 99981978279
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.54 E-value=0.00047 Score=36.10 Aligned_cols=156 Identities=8% Similarity=0.020 Sum_probs=73.6
Q ss_pred CCEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCCC-----CCCCCEE--EEEECCCEEEEEEEECCCCCHH--
Q ss_conf 228999839993799999304689997899999999872589-----9810121--2896398148999715899776--
Q 005572 421 GPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLKH-----PNLLPLA--GYCIAGKEKLVLLEFMANGDLH-- 491 (690)
Q Consensus 421 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~H-----~niv~l~--g~~~~~~~~~lv~e~~~~gsL~-- 491 (690)
-.||++...+|..+++|+.+... ...+++..|.+.+..+.. +..+..- ......+..+.++++++|..+.
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred CEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCCC
T ss_conf 02699983899979999847877-88999999999999998559987875206898056653479999865277688999
Q ss_pred ------------HHHHCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH---HHHHHHHHHHHHHHH-HHH---C
Q ss_conf ------------65300899--99997778888778999999777899989978---999999999988876-430---6
Q 005572 492 ------------RWLHELPT--GEPNVEDWSTDTWDHHPGAGSHISSPEKTNWV---TRHRIAIGVARGLAY-LHH---V 550 (690)
Q Consensus 492 ------------~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~---~~~~i~~~ia~~l~y-LH~---~ 550 (690)
--++.... ..+....+....+-.. ..........++.. .....+..+...+.- +.. .
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~ 192 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIE--PRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTV 192 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHH--HHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCC
T ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH--HHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 99999998999999886303578655677897887665--6899987476998898999999999999999845456871
Q ss_pred CCCCCCCCCCCEEECCCCCCEECCCCCCCCC
Q ss_conf 9888787778478559999267477765543
Q 005572 551 GSTHGHLVTSSILLAESLEPKIAGFGLRNIG 581 (690)
Q Consensus 551 ~~~H~dlk~~Nill~~~~~~ki~dfGl~~~~ 581 (690)
+++|+|+.+.|||++++ ..+.||+-+...
T Consensus 193 ~liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 193 LRLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp EECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred EEECCCCCCCCEEEECC--CEEEECHHCCCC
T ss_conf 20247888042878389--358865201468
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.42 E-value=0.0013 Score=33.73 Aligned_cols=73 Identities=18% Similarity=0.067 Sum_probs=45.9
Q ss_pred CEECCCCCCCEEEEECCCC--------CEEEEEEEECCCCCCHHHHHHHHHHHHHCC-CCCCCCEEEEEECCCEEEEEEE
Q ss_conf 6004579722899983999--------379999930468999789999999987258-9981012128963981489997
Q 005572 413 SLLAEGRCGPVYRAVLPGE--------LHVAIKVLDNAKGIDHDDAVAMFDELSRLK-HPNLLPLAGYCIAGKEKLVLLE 483 (690)
Q Consensus 413 ~~ig~G~~g~V~~~~~~~~--------~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-H~niv~l~g~~~~~~~~~lv~e 483 (690)
..++.|-.-.+|+....++ ..|.+++.. . .....+..+|..+++.+. +.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEEE
T ss_conf 991785334348999688775445789817999659-9-61165899999999999757999808998189----56999
Q ss_pred ECCCCCHH
Q ss_conf 15899776
Q 005572 484 FMANGDLH 491 (690)
Q Consensus 484 ~~~~gsL~ 491 (690)
|+++-.+.
T Consensus 122 fi~g~~l~ 129 (395)
T d1nw1a_ 122 YIPSRPLS 129 (395)
T ss_dssp CCCEEECC
T ss_pred EECCCCCC
T ss_conf 73455488
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.94 E-value=1.1e-05 Score=45.00 Aligned_cols=38 Identities=13% Similarity=0.164 Sum_probs=15.7
Q ss_pred CCCEEECCC-CCCCCCCC---HHHHCCCCCCCEEECCCCCCC
Q ss_conf 903998139-98898785---565429997458764378688
Q 005572 59 PIRELNLSS-RNLSGIIS---WKFLRNMSELHSIDLSNNSLK 96 (690)
Q Consensus 59 ~L~~L~L~~-N~l~~~~~---~~~~~~l~~L~~L~Ls~N~l~ 96 (690)
.|++|+|++ +.++...- ...+...++|+.|++++|.++
T Consensus 18 ~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~ 59 (166)
T d1io0a_ 18 DLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSN 59 (166)
T ss_dssp TCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCC
T ss_pred CCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 986887689999898999999988841982574301589611
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=96.85 E-value=2.3e-05 Score=43.28 Aligned_cols=40 Identities=13% Similarity=0.192 Sum_probs=15.4
Q ss_pred CCCCCCCEEECCC-CCCCCC----CCCCCCCCCCCCEEECCCCCC
Q ss_conf 2999745876437-868888----970003885575897207408
Q 005572 80 RNMSELHSIDLSN-NSLKGS----VPGWFWSTQSLTQVNLSKNRF 119 (690)
Q Consensus 80 ~~l~~L~~L~Ls~-N~l~~~----~p~~~~~l~~L~~L~L~~N~l 119 (690)
.+.+.|+.|+|++ +.++.. +...+...++|+.|+|++|.+
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l 58 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRS 58 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCC
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCC
T ss_conf 559998688768999989899999998884198257430158961
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.84 E-value=0.06 Score=24.58 Aligned_cols=196 Identities=13% Similarity=0.073 Sum_probs=84.6
Q ss_pred CCHHHHHHHHCCCCCCCE-----ECCCCCCCEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHCC-----CCCCC
Q ss_conf 498889999506798760-----04579722899983999379999930468999789999999987258-----99810
Q 005572 397 LTFKDLIAATSHFGKESL-----LAEGRCGPVYRAVLPGELHVAIKVLDNAKGIDHDDAVAMFDELSRLK-----HPNLL 466 (690)
Q Consensus 397 ~~~~~~~~~~~~~~~~~~-----ig~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----H~niv 466 (690)
++.+++.....+|...+. |..|---..|+.+..++ .+++|+..... ..+++..|++.+..+. -|..+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCC--CHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 8999999999867999856852378885267389997897-28999807899--98899999999875430255545564
Q ss_pred CEE-E--EEECCCEEEEEEEECCCCCHH--------------HHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 121-2--896398148999715899776--------------65300899999977788887789999997778999899
Q 005572 467 PLA-G--YCIAGKEKLVLLEFMANGDLH--------------RWLHELPTGEPNVEDWSTDTWDHHPGAGSHISSPEKTN 529 (690)
Q Consensus 467 ~l~-g--~~~~~~~~~lv~e~~~~gsL~--------------~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 529 (690)
... | +.........++.+..+.... ..++................+.. ..............
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 158 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGW-KVLWDKSEERADEV 158 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHH-HHHHHHHGGGGGGT
T ss_pred EECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHC-CHHHHHHHHHHHHC
T ss_conf 10489762134125502453114655333204678888899876454443202453101110120-02456777765311
Q ss_pred HHHHHHHHHHHHHHHHHHH----HCCCCCCCCCCCCEEECCCCCCEECCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHH
Q ss_conf 7899999999998887643----069888787778478559999267477765543456676568889998775323689
Q 005572 530 WVTRHRIAIGVARGLAYLH----HVGSTHGHLVTSSILLAESLEPKIAGFGLRNIGVKNVGERSENETCGPESDVYCFGV 605 (690)
Q Consensus 530 ~~~~~~i~~~ia~~l~yLH----~~~~~H~dlk~~Nill~~~~~~ki~dfGl~~~~~~~~~e~~~~~~~~~~~DVwSfGv 605 (690)
.......+......+.-.. ..+++|+|+.+.|++++.+...-+.||+.+..... +|-+++
T Consensus 159 ~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~~~~----------------~~DLAi 222 (316)
T d2ppqa1 159 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACNDLL----------------AYDVSI 222 (316)
T ss_dssp STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEEEH----------------HHHHHH
T ss_pred CHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCCCHH----------------HHHHHH
T ss_conf 4127999999987642048554545033378636564020454126742221236402----------------511899
Q ss_pred HHHHHHH
Q ss_conf 9999984
Q 005572 606 ILMELLT 612 (690)
Q Consensus 606 il~el~t 612 (690)
.+..++.
T Consensus 223 ~~~~~~~ 229 (316)
T d2ppqa1 223 CLNAWCF 229 (316)
T ss_dssp HHHHHSB
T ss_pred HHHHHHH
T ss_conf 8887760
|